https://www.medicinesresources.nhs.uk/revised-spcs-tecfidera-dimethyl-fumarate-120-and-240mg-gastro-resistant-hard-capsules-1.html 2021-07-08T08:38:42.2000000Z https://www.medicinesresources.nhs.uk/revised-spcs-locoid-hydrocortisone-butyrate-products.html 2020-01-27T13:30:09.2310000Z https://www.medicinesresources.nhs.uk/revised-spcs-imodium-loperamide-all-products.html 2020-01-27T10:14:48.8240000Z https://www.medicinesresources.nhs.uk/revised-spcs-solu-medrone-methylprednisolone-sodium-succinate-powder-for-injection-all-strengths.html 2020-01-27T13:33:42.1330000Z https://www.medicinesresources.nhs.uk/wuhan-novel-coronavirus-information-for-the-public.html 2020-01-31T09:52:34.2940000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-304-january-2020.html 2020-01-31T10:19:18.4750000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-approves-license-extension-for-ustekinumab-to-include-treatment-of-plaque-psoriasis-in-children-between-6-and-11-years.html 2020-01-27T13:46:49.6890000Z https://www.medicinesresources.nhs.uk/clinical-features-of-patients-infected-with-2019-novel-coronavirus-in-wuhan-china.html 2020-01-27T13:48:26.5580000Z https://www.medicinesresources.nhs.uk/evolving-issues-in-oxygen-therapy-in-acute-care-medicine.html 2020-01-27T13:50:16.2600000Z https://www.medicinesresources.nhs.uk/ethical-and-legal-aspects-of-ambient-intelligence-in-hospitals.html 2020-01-27T13:51:42.2600000Z https://www.medicinesresources.nhs.uk/pericardial-diseases-in-patients-with-cancer-contemporary-prevalence-management-and-outcomes.html 2020-01-27T13:53:09.5450000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-action-within-48-hours-leo-laboritories-picato-150mcg-g-and-500mcg-g-gel-ingenol-mebutate.html 2020-02-03T09:20:19.2510000Z https://www.medicinesresources.nhs.uk/whos-rollout-of-malaria-vaccine-in-africa-can-safety-questions-be-answered-after-only-24-months.html 2020-01-27T14:09:43.9200000Z https://www.medicinesresources.nhs.uk/structural-determinants-of-gender-inequality-why-they-matter-for-adolescent-girls-sexual-and-reproductive-health.html 2020-01-27T14:11:04.1320000Z https://www.medicinesresources.nhs.uk/how-can-we-realise-the-full-potential-of-health-systems-for-nutrition.html 2020-01-27T14:12:54.7210000Z https://www.medicinesresources.nhs.uk/assessing-coverage-of-interventions-for-reproductive-maternal-newborn-child-and-adolescent-health-and-nutrition.html 2020-01-27T14:14:44.1600000Z https://www.medicinesresources.nhs.uk/phase-iii-imvigor010-trial-evaluating-atezolizumab-for-urothelial-carcinoma-fails-to-meet-primary-endpoint-1.html 2020-01-27T14:16:35.9950000Z https://www.medicinesresources.nhs.uk/us-fda-to-review-license-extension-for-atezolizumab-in-combination-with-bevacizumab-for-unresectable-hepatocellular-carcinoma-hcc-in-patients-who-have-not-received-prior-systemic-therapy.html 2020-01-27T14:18:14.6420000Z https://www.medicinesresources.nhs.uk/zinc-acetate-lozenges-for-the-treatment-of-the-common-cold-a-randomised-controlled-trial.html 2020-01-27T14:20:04.5000000Z https://www.medicinesresources.nhs.uk/new-product-cytotect-cp-biotest-human-cytomegalovirus-immunoglobulin-cmvig-100-u-ml-solution-for-infusion.html 2020-01-28T12:33:55.6140000Z https://www.medicinesresources.nhs.uk/new-product-cytotect-cp-biotest-human-cytomegalovirus-immunoglobulin-cmvig-100-u-ml-solution-for-infusion-1.html 2020-01-28T12:40:40.6010000Z https://www.medicinesresources.nhs.uk/tramacet-37-5-mg-325-mg-tramadol-with-paracetamol-film-coated-tablets-and-effervescent-tablets.html 2020-01-28T12:45:12.7370000Z https://www.medicinesresources.nhs.uk/revised-spc-yescarta-axicabtagene-ciloleucel-dispersion-for-infusion.html 2020-01-28T12:53:36.4400000Z https://www.medicinesresources.nhs.uk/revised-spc-zydol-tramadol-all-preparations.html 2020-01-28T12:58:28.0320000Z https://www.medicinesresources.nhs.uk/revised-spc-diafer-iron-iii-isomaltoside-1000-50mg-ml-solution-for-injection.html 2020-01-28T13:03:37.0880000Z https://www.medicinesresources.nhs.uk/us-fda-approved-fidaxomicin-oral-suspension-for-clostridioides-difficile-associated-diarrhoea-cdad-in-children-aged-six-months-and-older.html 2020-01-28T13:10:28.6250000Z https://www.medicinesresources.nhs.uk/dietary-assessment-and-opportunities-to-enhance-nutritional-epidemiology-evidence.html 2020-01-28T13:13:41.9730000Z https://www.medicinesresources.nhs.uk/increased-fluid-intake-to-prevent-urinary-tract-infections-systematic-review-and-meta-analysis.html 2020-01-28T13:18:29.0140000Z https://www.medicinesresources.nhs.uk/current-practice-and-attitudes-towards-vaccination-during-pregnancy-a-survey-of-gps-across-england.html 2020-01-28T13:24:15.6020000Z https://www.medicinesresources.nhs.uk/glucosamine-use-inflammation-and-genetic-susceptibility-and-incidence-of-type-2-diabetes-a-prospective-study-in-uk-biobank.html 2020-01-28T13:28:07.7550000Z https://www.medicinesresources.nhs.uk/increasing-uptake-for-vaccinations-maximising-the-role-of-councils-1.html 2020-01-28T14:39:00.5220000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guidance-on-esketamine-for-treatment-resistant-depression-for-consultation.html 2020-01-28T14:40:39.8690000Z https://www.medicinesresources.nhs.uk/e-cigarette-use-or-vaping-reporting-suspected-adverse-reactions-including-lung-injury.html 2020-02-03T09:28:58.6570000Z https://www.medicinesresources.nhs.uk/ondansetron-small-increased-risk-of-oral-clefts-following-use-in-the-first-12-weeks-of-pregnancy.html 2020-02-03T09:36:56.7200000Z https://www.medicinesresources.nhs.uk/mecasermin-increlex-risk-of-benign-and-malignant-neoplasia.html 2020-02-03T09:45:11.9540000Z https://www.medicinesresources.nhs.uk/v-adrenoreceptors-and-the-risk-of-parkinson-s-disease.html 2020-01-28T14:47:35.8630000Z https://www.medicinesresources.nhs.uk/type-1-diabetes-early-life-origins-and-changing-epidemiology.html 2020-01-28T14:49:02.6230000Z https://www.medicinesresources.nhs.uk/d-index-guided-early-antifungal-therapy-versus-empiric-antifungal-therapy-for-persistent-febrile-neutropenia-a-randomized-controlled-noninferiority-trial.html 2020-07-06T11:54:01.4200000Z https://www.medicinesresources.nhs.uk/tas-102-with-or-without-bevacizumab-in-patients-with-chemorefractory-metastatic-colorectal-cancer-an-investigator-initiated-open-label-randomised-phase-2-trial.html 2020-01-28T14:56:51.3950000Z https://www.medicinesresources.nhs.uk/colorectal-cancer-guidance-ng151-1.html 2020-02-03T09:49:35.6010000Z https://www.medicinesresources.nhs.uk/revised-spc-stelara-ustekinumab-pre-filled-syringes.html 2020-01-29T17:25:35.7740000Z https://www.medicinesresources.nhs.uk/revised-spc-nitrofurantoin-100-mg-tablets.html 2020-01-29T17:26:21.3410000Z https://www.medicinesresources.nhs.uk/class-4-drug-alert-for-information-dr-reddys-laboratories-uk-ltd-finasteride-5mg-tablets.html 2020-01-29T17:24:36.7610000Z https://www.medicinesresources.nhs.uk/first-trimester-pregnancy-exposure-to-modafinil-and-risk-of-congenital-malformations.html 2020-01-29T17:25:48.8250000Z https://www.medicinesresources.nhs.uk/association-of-isolated-diastolic-hypertension-as-defined-by-the-2017-acc-aha-blood-pressure-guideline-with-incident-cardiovascular-outcomes.html 2020-01-29T17:26:04.1260000Z https://www.medicinesresources.nhs.uk/maternity-services-survey-2019.html 2020-01-29T17:26:13.1050000Z https://www.medicinesresources.nhs.uk/adapting-lean-methods-to-facilitate-stakeholder-engagement-and-co-design-in-healthcare.html 2020-01-29T16:15:58.2740000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-ruxolitinib-cream-in-atopic-dermatitis.html 2020-01-29T17:28:35.9160000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-baricitinib-in-atopic-dermatitis.html 2020-01-29T16:27:18.5970000Z https://www.medicinesresources.nhs.uk/linking-risk-factors-and-outcomes-in-autism-spectrum-disorder-is-there-evidence-for-resilience.html 2020-01-29T17:32:19.5310000Z https://www.medicinesresources.nhs.uk/tumour-lysis-syndrome-in-patients-with-chronic-lymphocytic-leukaemia-treated-with-bcl-2-inhibitors-risk-factors-prophylaxis-and-treatment-recommendations.html 2020-01-29T17:32:56.1020000Z https://www.medicinesresources.nhs.uk/prophylaxis-and-management-of-graft-versus-host-disease-after-stem-cell-transplantation-for-haematological-malignancies-updated-consensus-recommendations-of-the-european-society-for-blood-and-marrow-transplantation.html 2020-01-29T17:33:06.4450000Z https://www.medicinesresources.nhs.uk/advances-and-challenges-in-stroke-rehabilitation.html 2020-01-29T17:33:26.0180000Z https://www.medicinesresources.nhs.uk/lorlatinib-for-treating-alk-positive-advanced-non-small-cell-lung-cancer-appraisal-consultation-document.html 2020-01-29T17:33:45.6910000Z https://www.medicinesresources.nhs.uk/wuhan-novel-coronavirus-rps-resource-page.html 2020-01-29T17:34:37.5440000Z https://www.medicinesresources.nhs.uk/taskforce-charter-national-quality-improvement-taskforce-for-children-and-young-peoples-mental-health-inpatient-services-1.html 2020-01-29T17:35:11.2210000Z https://www.medicinesresources.nhs.uk/ticagrelor-hits-primary-endpoint-in-the-thales-phase-iii-trial-for-use-in-stroke.html 2020-01-29T17:35:28.0210000Z https://www.medicinesresources.nhs.uk/rmoc-shared-care-guidance-consultation-running.html 2020-01-29T17:35:44.6210000Z https://www.medicinesresources.nhs.uk/colorectal-cancer-updated-quality-standard-update-qs20.html 2020-02-03T09:59:41.0230000Z https://www.medicinesresources.nhs.uk/revised-spcs-eltroxin-levothyroxine-tablets-all-strengths.html 2020-01-30T15:49:50.2480000Z https://www.medicinesresources.nhs.uk/revised-spc-menveo-meningococcal-group-a-c-w135-and-y-conjugate-vaccine.html 2020-01-30T15:51:16.4140000Z https://www.medicinesresources.nhs.uk/allergens-issues-food-safety-in-the-nhs.html 2020-02-03T10:08:40.7890000Z https://www.medicinesresources.nhs.uk/fda-strengthens-warning-that-untreated-constipation-caused-by-clozapine-can-lead-to-serious-bowel-problems.html 2020-02-03T10:14:11.0750000Z https://www.medicinesresources.nhs.uk/nhsi-hopmop-newsletter-january-2020.html 2020-02-03T10:22:30.2230000Z https://www.medicinesresources.nhs.uk/relief-from-indigestion-a-visual-guide.html 2020-01-30T16:07:43.7850000Z https://www.medicinesresources.nhs.uk/institute-of-cancer-research-report-finds-patients-with-cancer-face-delays-in-accessing-innovative-drugs.html 2020-01-30T16:09:41.4440000Z https://www.medicinesresources.nhs.uk/european-commission-grants-marketing-authorisation-for-expanded-use-of-apalutamide-to-include-treatment-of-metastatic-hormone-sensitive-prostate-cancer-in-combination-with-androgen-deprivation-therapy-adt.html 2020-01-30T16:12:01.1560000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-validates-marketing-authorisation-application-car-t-cell-therapy-kte-x19-for-treatment-of-adults-with-relapsed-or-refractory-mantle-cell-lymphoma.html 2020-01-30T16:13:45.8600000Z https://www.medicinesresources.nhs.uk/qualitywatch-analysis-finds-the-poorest-get-worse-quality-of-nhs-care-in-england.html 2020-01-30T16:15:06.7370000Z https://www.medicinesresources.nhs.uk/what-people-want-from-the-next-ten-years-of-the-nhs.html 2020-01-30T16:16:21.1400000Z https://www.medicinesresources.nhs.uk/provisional-publication-of-never-events-reported-as-occurring-between-1-april-and-31-december-2019.html 2020-01-30T16:18:07.2150000Z https://www.medicinesresources.nhs.uk/update-on-gender-identity-development-service-for-children-and-young-people.html 2020-01-30T16:19:47.8530000Z https://www.medicinesresources.nhs.uk/statistics-on-nhs-stop-smoking-services-in-england-april-2019-to-september-2019.html 2020-01-30T16:21:08.8800000Z https://www.medicinesresources.nhs.uk/hormone-therapy-for-postmenopausal-women.html 2020-01-30T16:23:34.4570000Z https://www.medicinesresources.nhs.uk/nice-publishes-updated-principles.html 2020-02-03T11:07:58.1540000Z https://www.medicinesresources.nhs.uk/faltering-growth-draft-quality-standard-out-for-consultation.html 2020-01-30T16:28:20.4080000Z https://www.medicinesresources.nhs.uk/re-examining-causes-of-surgical-site-infections-following-elective-surgery-in-the-era-of-asepsis.html 2020-01-30T16:29:57.9440000Z https://www.medicinesresources.nhs.uk/inadequate-v-cell-mass-is-essential-for-the-pathogenesis-of-type-2-diabetes.html 2020-01-30T16:31:18.4950000Z https://www.medicinesresources.nhs.uk/recurrent-urinary-tract-infections-in-adult-women.html 2020-01-30T16:33:39.8180000Z https://www.medicinesresources.nhs.uk/veterinarians-encouraged-to-check-and-consider-updated-scientific-advice-on-categorisation-of-antibiotics-when-prescribing-for-animals-in-their-care.html 2020-01-30T16:35:04.6110000Z https://www.medicinesresources.nhs.uk/key-principles-for-the-use-of-electronic-product-information-for-eu-medicines.html 2020-01-30T16:36:08.8270000Z https://www.medicinesresources.nhs.uk/impact-of-regulatory-guidance-on-evaluating-cardiovascular-risk-of-new-glucose-lowering-therapies-to-treat-type-2-diabetes-mellitus-lessons-learned-and-future-directions.html 2020-07-16T12:15:14.3770000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-wockhardt-uk-ltd-levothyroxine-100micrograms-5ml-oral-solution-el-20-a-04.html 2020-01-30T16:39:21.6760000Z https://www.medicinesresources.nhs.uk/writing-outpatient-letters-to-patients.html 2020-01-30T16:40:36.4840000Z https://www.medicinesresources.nhs.uk/thyroid-disease-assessment-and-management-summary-of-nice-guidance.html 2020-01-30T16:42:16.4300000Z https://www.medicinesresources.nhs.uk/abbvie-donating-aluvia-lopinavir-and-ritonavir-to-chinese-government-as-an-ad-hoc-treatment-for-pneumonia-associated-with-coronavirus.html 2020-01-30T16:43:31.5330000Z https://www.medicinesresources.nhs.uk/fda-approves-autoinjector-device-for-ajovy-fremanezumab-vfrm.html 2020-01-30T16:44:49.4340000Z https://www.medicinesresources.nhs.uk/fda-approves-trijardy-xr-empagliflozin-linagliptin-and-metformin-for-lowering-blood-sugar-in-adults-with-type-2-diabetes.html 2020-01-30T16:46:23.6520000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-to-new-drug-application-for-selpercatinib-for-treatment-of-advanced-ret-fusion-positive-non-small-cell-lung-cancer-nsclc-ret-mutant-medullary-thyroid-cancer-and-ret-fusion-positive-thyroid-cancer.html 2020-01-30T16:48:46.5070000Z https://www.medicinesresources.nhs.uk/evidence-of-detrimental-effects-of-prenatal-alcohol-exposure-on-offspring-birthweight-and-neurodevelopment-from-a-systematic-review-of-quasi-experimental-studies.html 2020-01-30T16:52:25.1890000Z https://www.medicinesresources.nhs.uk/association-of-glucose-lowering-medications-with-cardiovascular-outcomes-an-umbrella-review-and-evidence-map.html 2020-02-03T10:30:51.4370000Z https://www.medicinesresources.nhs.uk/family-history-of-gastric-cancer-and-helicobacter-pylori-treatment.html 2020-08-07T13:25:47.4630000Z https://www.medicinesresources.nhs.uk/early-transmission-dynamics-in-wuhan-china-of-novel-coronavirus-infected-pneumonia.html 2020-08-07T14:25:45.5090000Z https://www.medicinesresources.nhs.uk/epidemiological-and-clinical-characteristics-of-99-cases-of-2019-novel-coronavirus-pneumonia-in-wuhan-china-a-descriptive-study.html 2020-01-30T17:02:17.9780000Z https://www.medicinesresources.nhs.uk/maternal-smoking-during-pregnancy-and-fractures-in-offspring-national-register-based-sibling-comparison-study.html 2020-01-30T17:03:54.9620000Z https://www.medicinesresources.nhs.uk/association-of-soy-and-fermented-soy-product-intake-with-total-and-cause-specific-mortality-prospective-cohort-study.html 2020-01-30T17:05:55.8320000Z https://www.medicinesresources.nhs.uk/complementary-and-alternative-medicine-use-in-patients-with-hidradenitis-suppurativa.html 2020-01-30T17:07:22.9040000Z https://www.medicinesresources.nhs.uk/global-and-regional-estimates-of-the-contribution-of-herpes-simplex-virus-type-2-infection-to-hiv-incidence-a-population-attributable-fraction-analysis-using-published-epidemiological-data.html 2020-01-30T17:08:33.5490000Z https://www.medicinesresources.nhs.uk/anabolic-androgenic-steroid-abuse-in-the-united-kingdom-an-update-the-increasing-popularity-of-anabolic-androgenic-steroids.html 2020-01-30T17:10:34.5380000Z https://www.medicinesresources.nhs.uk/new-product-mulpleo-lusutrombopag-3-mg-film-coated-tablets.html 2020-01-31T15:41:50.7630000Z https://www.medicinesresources.nhs.uk/revised-spcs-aldactide-spironolactone-and-hydroflumethiazide-all-strengths.html 2020-01-31T15:43:26.2860000Z https://www.medicinesresources.nhs.uk/revised-spc-erleada-apalutamide-60-mg-film-coated-tablets.html 2020-01-31T15:44:44.8080000Z https://www.medicinesresources.nhs.uk/xeomin-botulinum-toxin-type-a-powder-for-solution-for-injection-all-strengths.html 2020-01-31T15:45:53.8880000Z https://www.medicinesresources.nhs.uk/genticin-gentamicin-0-3-w-v-eye-ear-drops.html 2020-01-31T15:48:10.4090000Z https://www.medicinesresources.nhs.uk/novel-coronavirus.html 2020-02-03T10:34:27.3050000Z https://www.medicinesresources.nhs.uk/positive-results-for-olipudase-alfa-in-two-rcts-treamtent-of-acid-sphingomyelinase-deficiency-asmd-or-nieman-pick-disease-in-adults-and-children.html 2020-01-31T15:54:06.0950000Z https://www.medicinesresources.nhs.uk/the-novel-coronavirus-originating-in-wuhan-china-challenges-for-global-health-governance.html 2020-01-31T17:30:59.6240000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-approval-of-first-treatment-givosiran-for-acute-hepatic-porphyria-ahp.html 2020-01-31T16:04:47.4980000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-approval-of-first-oral-glucagon-like-peptide-glp-1-treatment-semaglutide-rybelsus-c-for-type-2-diabetes.html 2020-01-31T17:24:57.9650000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-license-extension-of-5-aminolevulinic-acid-ameluz-c.html 2020-01-31T17:40:48.4610000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-license-extension-of-rituximab-mabthera-c-for-paediatric-patients.html 2020-01-31T17:40:59.3100000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-license-extension-of-darunavir-cobicistat-rezolsta-c.html 2020-01-31T17:41:14.3750000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-license-extension-of-insulin-glargine-lixisenatide-suliqua-c.html 2020-01-31T17:42:17.8040000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-license-extension-of-cobicistat-tybost-c.html 2020-01-31T17:42:29.4860000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-license-extension-of-venetoclax-venclyxto-c.html 2020-01-31T17:42:34.8150000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-new-medicine-treprostinil-sodium-trepulmix-c-for-treatment-of-chronic-thromboembolic-pulmonary-hypertension.html 2020-01-31T17:40:15.3510000Z https://www.medicinesresources.nhs.uk/gastrointestinal-infections-guidance-for-public-health-management.html 2020-02-03T10:38:46.1460000Z https://www.medicinesresources.nhs.uk/high-dose-chemotherapy-with-hematopoietic-stem-cell-transplant-in-patients-with-high-risk-breast-cancer-and-4-or-more-involved-axillary-lymph-nodes.html 2020-01-31T16:22:39.7810000Z https://www.medicinesresources.nhs.uk/impact-of-hpv-vaccination-and-cervical-screening-on-cervical-cancer-elimination-a-comparative-modelling-analysis-in-78-low-income-and-lower-middle-income-countries.html 2020-01-31T17:36:38.3020000Z https://www.medicinesresources.nhs.uk/electrical-versus-pharmacological-cardioversion-for-emergency-department-patients-with-acute-atrial-fibrillation-raff2-a-partial-factorial-randomised-trial.html 2020-01-31T16:31:10.6860000Z https://www.medicinesresources.nhs.uk/upadacitinib-for-treating-moderate-to-severe-rheumatoid-arthritis-consultation-appraisal-document.html 2020-01-31T16:33:01.2990000Z https://www.medicinesresources.nhs.uk/coronavirus-latest-information-and-advice-situation-in-the-uk.html 2020-02-03T11:01:13.9780000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-generic-medicine-version-of-cinacalcet.html 2020-01-31T17:10:58.0990000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-generic-version-of-azacitidine.html 2020-01-31T17:12:36.0800000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-a-generic-version-of-arsenic-trioxide.html 2020-01-31T17:14:19.2600000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-rituximab-biosimilar-ruxience.html 2020-01-31T17:15:33.4780000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-approval-of-cholera-vaccine-recombinant-live-oral-for-prophylaxis-against-vibrio-cholera-disease-in-adults-and-children.html 2020-01-31T17:17:08.2160000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-approval-of-crisaborole-staquis-for-treatment-of-atopic-dermatitis.html 2020-01-31T17:18:31.1760000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-approval-of-bempedoic-acid-ezetimibe-nustendi-for-treatment-of-primary-hypercholesterolaemia-and-mixed-dyslipidaemia.html 2020-01-31T17:20:07.2720000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-approval-of-darolutamide-nubeqa-for-treatment-of-prostate-cancer.html 2020-01-31T17:21:24.5510000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-approval-of-bempedoic-acid-nilemdo-for-treatment-of-adults-with-primary-hypercholesterolaemia-or-mixed-dyslipidaemia.html 2020-01-31T17:22:50.7890000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-issues-positive-recommendation-for-approval-of-insulin-lispro-liumjev-for-treatment-of-diabetes-mellitus-in-adults.html 2020-01-31T17:24:06.7400000Z https://www.medicinesresources.nhs.uk/revised-spc-sirturo-bedaquiline-fumarate-100mg-tablets.html 2020-02-03T15:29:15.6030000Z https://www.medicinesresources.nhs.uk/revised-spc-cyramza-ramucirumab-10-mg-ml-concentrate-for-solution-for-infusion.html 2020-02-03T15:30:17.0190000Z https://www.medicinesresources.nhs.uk/revised-spc-verzenios-abemaciclib-film-coated-tablets-all-strengths.html 2020-02-03T15:31:26.6540000Z https://www.medicinesresources.nhs.uk/revised-spc-granocyte-lenograstim-all-strengths-and-presentations.html 2020-02-03T15:32:49.3390000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-action-within-48-hours-medreich-plc-ranitidine-150mg-and-300mg-tablets.html 2020-02-10T10:01:08.9250000Z https://www.medicinesresources.nhs.uk/how-we-approach-smoldering-multiple-myeloma.html 2020-07-16T09:22:33.0730000Z https://www.medicinesresources.nhs.uk/continued-misuse-of-orphan-drug-legislation-a-life-threatening-risk-for-mexiletine.html 2020-02-03T15:36:13.7110000Z https://www.medicinesresources.nhs.uk/novel-coronavirus-updated-advice-for-primary-care-and-community-settings-including-pharmacy.html 2020-02-10T10:11:59.9400000Z https://www.medicinesresources.nhs.uk/us-fda-approves-palforzia-arachis-hypogaea-allergen-powder-capsules-for-treatment-of-peanut-allergy.html 2020-02-03T15:45:00.4530000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-accepts-marketing-authorisation-application-for-belantamab-mafodotin-for-the-treatment-of-relapsed-or-refractory-multiple-myeloma.html 2020-02-03T14:17:44.8090000Z https://www.medicinesresources.nhs.uk/bristol-myers-squibb-withdraws-european-license-application-of-nivolumab-with-ipilimumab-for-first-line-treatment-of-advanced-non-small-cell-lung-cancer-nsclc.html 2020-02-03T15:37:52.2210000Z https://www.medicinesresources.nhs.uk/fracture-risks-among-patients-with-atrial-fibrillation-receiving-different-oral-anticoagulants-a-real-world-nationwide-cohort-study.html 2020-02-03T14:23:00.7490000Z https://www.medicinesresources.nhs.uk/nowcasting-and-forecasting-the-potential-domestic-and-international-spread-of-the-2019-ncov-outbreak-originating-in-wuhan-china-a-modelling-study.html 2020-02-03T14:24:30.9420000Z https://www.medicinesresources.nhs.uk/novel-coronavirus-2019-ncov-updated-guidance-on-infection-prevention-and-control.html 2020-02-03T15:44:30.0110000Z https://www.medicinesresources.nhs.uk/the-status-of-tuberculosis-vaccine-development.html 2020-02-03T15:46:56.3540000Z https://www.medicinesresources.nhs.uk/novel-metric-for-evaluating-pre-exposure-prophylaxis-programme-effectiveness-in-real-world-settings.html 2020-02-03T15:49:00.2410000Z https://www.medicinesresources.nhs.uk/ropeginterferon-alfa-2b-versus-standard-therapy-for-polycythaemia-vera-proud-pv-and-continuation-pv-a-randomised-non-inferiority-phase-3-trial-and-its-extension-study.html 2020-02-03T16:05:51.6160000Z https://www.medicinesresources.nhs.uk/systemic-chemotherapy-with-or-without-cetuximab-in-patients-with-resectable-colorectal-liver-metastasis-new-epoc-long-term-results-of-a-multicentre-randomised-controlled-phase-3-tria.html 2020-02-03T15:55:52.7940000Z https://www.medicinesresources.nhs.uk/efficacy-of-faecal-microbiota-transplantation-for-patients-with-irritable-bowel-syndrome-in-a-randomised-double-blind-placebo-controlled-study.html 2020-02-03T15:58:12.5160000Z https://www.medicinesresources.nhs.uk/acute-kidney-injury-and-adverse-renal-events-in-patients-receiving-sglt2-inhibitors-a-systematic-review-and-meta-analysis.html 2020-02-03T16:00:04.7310000Z https://www.medicinesresources.nhs.uk/rescuing-research-participants-after-alzheimer-trials-stop-early.html 2020-02-04T15:31:58.0610000Z https://www.medicinesresources.nhs.uk/tailored-regimens-for-combined-hormonal-contraceptives.html 2020-02-04T15:54:55.9820000Z https://www.medicinesresources.nhs.uk/caring-for-the-transgender-patient-grand-rounds-discussion-from-beth-israel-deaconess-medical-center.html 2020-02-04T15:56:07.0330000Z https://www.medicinesresources.nhs.uk/sitters-as-a-patient-safety-strategy-to-reduce-hospital-falls-a-systematic-review.html 2020-02-04T15:57:03.5090000Z https://www.medicinesresources.nhs.uk/clinical-effectiveness-and-safety-of-aspirin-for-venous-thromboembolism-prophylaxis-after-total-hip-and-knee-replacement-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials.html 2020-02-04T15:43:37.2860000Z https://www.medicinesresources.nhs.uk/associations-of-processed-meat-unprocessed-red-meat-poultry-or-fish-intake-with-incident-cardiovascular-disease-and-all-cause-mortality.html 2020-02-04T15:45:33.2820000Z https://www.medicinesresources.nhs.uk/adolescent-obesity-and-midlife-cancer-risk-a-population-based-cohort-study-of-2-3-million-adolescents-in-israel.html 2020-02-04T15:49:27.1570000Z https://www.medicinesresources.nhs.uk/eams-scientific-opinion-polatuzumab-vedotin-with-bendamustine-and-rituximab-for-relapsed-refractory-diffuse-large-b-cell-lymphoma-dlbcl-in-adults-not-eligible-for-haematopoietic-stem-cell-transplant.html 2020-02-04T15:59:03.7390000Z https://www.medicinesresources.nhs.uk/statistics-on-alcohol-england-2020.html 2020-02-04T16:01:30.8690000Z https://www.medicinesresources.nhs.uk/revised-spc-rizmoic-nalmedene-tablets.html 2020-02-05T15:22:30.2330000Z https://www.medicinesresources.nhs.uk/beta-blockade-for-the-treatment-of-cardiac-arrest-due-to-ventricular-fibrillation-or-pulseless-ventricular-tachycardia-a-systematic-review-and-meta-analysis.html 2020-02-05T16:13:58.3730000Z https://www.medicinesresources.nhs.uk/what-should-be-considered-when-choosing-or-prescribing-saliva-substitutes.html 2020-02-10T10:14:57.0990000Z https://www.medicinesresources.nhs.uk/effect-of-vitamin-c-hydrocortisone-and-thiamine-vs-hydrocortisone-alone-on-time-alive-and-free-of-vasopressor-support-among-patients-with-septic-shock-the-vitamins-randomized-clinical-trial.html 2020-02-05T15:30:30.4970000Z https://www.medicinesresources.nhs.uk/effects-of-iron-isomaltoside-vs-ferric-carboxymaltose-on-hypophosphatemia-in-iron-deficiency-anemia-two-randomized-clinical-trials.html 2020-02-05T15:32:49.9810000Z https://www.medicinesresources.nhs.uk/ace-and-type-2-diabetes-risk-a-mendelian-randomization-study.html 2020-02-05T15:39:30.0810000Z https://www.medicinesresources.nhs.uk/classification-prevalence-and-outcomes-of-anticancer-therapy-induced-cardiotoxicity-the-cardiotox-registry.html 2020-02-10T11:16:15.3820000Z https://www.medicinesresources.nhs.uk/understanding-the-use-of-observational-and-randomized-data-in-cardiovascular-medicine.html 2020-02-05T15:45:15.0990000Z https://www.medicinesresources.nhs.uk/ema-to-support-development-of-vaccines-and-treatments-for-novel-coronavirus.html 2020-02-05T15:47:06.7500000Z https://www.medicinesresources.nhs.uk/clinical-cancer-advances-2020-annual-report-on-progress-against-cancer-from-the-american-society-of-clinical-oncology.html 2020-07-16T10:25:17.8210000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-january-2020.html 2020-02-05T15:49:58.7910000Z https://www.medicinesresources.nhs.uk/nhs-financial-management-and-sustainability.html 2020-02-05T15:52:39.9810000Z https://www.medicinesresources.nhs.uk/revised-spc-bydureon-exenatide-2-mg-powder-and-solvent-for-prolonged-release-suspension-for-injection-in-pre-filled-pen.html 2020-02-06T16:02:15.3140000Z https://www.medicinesresources.nhs.uk/revised-spc-plenvu-powder-for-oral-solution.html 2020-02-06T16:04:13.0880000Z https://www.medicinesresources.nhs.uk/drugs-for-urinary-disorders-are-any-lactose-free.html 2020-02-10T10:18:40.1190000Z https://www.medicinesresources.nhs.uk/refractory-epilepsy-specialist-clinical-advisory-service.html 2020-02-10T10:27:20.7590000Z https://www.medicinesresources.nhs.uk/review-of-capital-expenditure-in-the-nhs.html 2020-02-06T16:13:40.5560000Z https://www.medicinesresources.nhs.uk/bayer-announces-results-from-phase-iv-altair-study-of-two-different-treat-and-extend-t-and-e-dosing-regimens-of-aflibercept-eylea-in-patients-with-wet-age-related-macular-degeneration.html 2020-02-06T16:15:07.2240000Z https://www.medicinesresources.nhs.uk/advancing-pharmacy-education-and-training-a-review.html 2020-02-06T16:16:12.7070000Z https://www.medicinesresources.nhs.uk/rebuilding-our-nhs-why-its-time-to-invest.html 2020-02-06T16:17:55.9840000Z https://www.medicinesresources.nhs.uk/analysis-of-pathways-nhs111-calls-linked-to-hospital-attendances-published.html 2020-02-06T16:19:05.2880000Z https://www.medicinesresources.nhs.uk/placebo-and-nocebo-effects.html 2020-08-10T12:05:11.7700000Z https://www.medicinesresources.nhs.uk/transmission-of-2019-ncov-infection-from-an-asymptomatic-contact-in-germany.html 2020-08-07T11:45:54.5500000Z https://www.medicinesresources.nhs.uk/first-case-of-2019-novel-coronavirus-in-the-united-states-2.html 2020-08-07T14:23:58.6080000Z https://www.medicinesresources.nhs.uk/broader-types-of-data-to-be-used-in-development-of-nice-guidance.html 2020-02-06T16:26:10.6110000Z https://www.medicinesresources.nhs.uk/company-led-drug-alert-iohexol-350mg-ml-and-300-mg-i-ml-solution-for-injection-clda-20-a-01.html 2020-02-06T16:27:17.7240000Z https://www.medicinesresources.nhs.uk/palliative-care-in-oncology-continuing-to-build-the-evidence-base-and-disseminate-effective-care-models.html 2020-07-08T14:55:45.5100000Z https://www.medicinesresources.nhs.uk/2019-novel-coronavirus-important-information-for-clinicians.html 2020-02-06T16:32:59.8480000Z https://www.medicinesresources.nhs.uk/fda-posts-laboratory-testing-results-for-ndma-levels-in-metformin.html 2020-02-06T16:34:18.8010000Z https://www.medicinesresources.nhs.uk/skin-preparation-electrode-gel-recall-of-all-lots-of-lemonprep-pediaprep-wave-prep-and-cardio-prep-due-to-risk-of-contamination-and-transmission-of-infection-mda-2020-004.html 2020-02-06T16:35:34.0470000Z https://www.medicinesresources.nhs.uk/t-slim-x2-insulin-pump-discard-or-destroy-defective-mains-a-c-power-adapters-mda-2020-005.html 2020-02-06T16:37:41.4270000Z https://www.medicinesresources.nhs.uk/coronavirus-shows-how-uk-must-act-quickly-before-being-shut-out-of-europes-health-protection-systems.html 2020-02-06T16:39:19.7840000Z https://www.medicinesresources.nhs.uk/newborn-becomes-youngest-person-diagnosed-with-coronavirus.html 2020-02-06T16:41:57.3740000Z https://www.medicinesresources.nhs.uk/call-for-term-painkiller-to-be-with-replaced-with-pain-reliever.html 2020-02-06T16:43:14.2460000Z https://www.medicinesresources.nhs.uk/dinutuximab-fails-to-meet-its-primary-efficacy-endpoint-in-phase-ii-iii-distinc-trial-in-small-cell-lung-cancer.html 2020-02-06T16:45:10.2280000Z https://www.medicinesresources.nhs.uk/fda-approves-audenz-as-vaccine-for-a-potential-pandemic-associated-with-h5n1-flu-virus.html 2020-02-06T16:46:33.4170000Z https://www.medicinesresources.nhs.uk/upadacitinib-meets-primary-endpoints-in-phase-iii-select-psa-1-study-in-psoriatic-arthritis.html 2020-02-06T16:47:54.6840000Z https://www.medicinesresources.nhs.uk/measles-mumps-rubella-mmr-resources.html 2020-02-06T16:50:03.7700000Z https://www.medicinesresources.nhs.uk/comparison-of-biologics-and-oral-treatments-for-plaque-psoriasis-a-meta-analysis.html 2020-02-10T11:10:46.9860000Z https://www.medicinesresources.nhs.uk/updating-insights-into-rosiglitazone-and-cardiovascular-risk-through-shared-data-individual-patient-and-summary-level-meta-analyses.html 2020-02-06T17:01:30.2010000Z https://www.medicinesresources.nhs.uk/lower-versus-traditional-treatment-threshold-for-neonatal-hypoglycemia.html 2020-08-07T12:30:53.8920000Z https://www.medicinesresources.nhs.uk/fulvestrant-plus-capivasertib-versus-placebo-after-relapse-or-progression-on-an-aromatase-inhibitor-in-metastatic-oestrogen-receptor-positive-breast-cancer-faktion-a-multicentre-randomised-controlled-phase-2-trial.html 2020-02-06T17:05:46.6970000Z https://www.medicinesresources.nhs.uk/a-comparison-of-psoriasis-severity-in-pediatric-patients-treated-with-methotrexate-vs-biologic-agents-2.html 2020-02-06T17:08:57.8390000Z https://www.medicinesresources.nhs.uk/long-term-safety-of-siltuximab-in-patients-with-idiopathic-multicentric-castleman-disease-a-prespecified-open-label-extension-analysis-of-two-trials.html 2020-02-06T17:11:04.4410000Z https://www.medicinesresources.nhs.uk/six-year-follow-up-of-a-trial-of-antenatal-vitamin-d-for-asthma-reduction.html 2020-08-07T12:33:02.8700000Z https://www.medicinesresources.nhs.uk/complications-of-antenatal-corticosteroids-in-infants-born-by-early-term-scheduled-cesarean-section.html 2020-02-06T17:14:56.0660000Z https://www.medicinesresources.nhs.uk/association-of-egg-intake-with-blood-lipids-cardiovascular-disease-and-mortality-in-177-000-people-in-50-countries.html 2020-02-06T17:16:42.1560000Z https://www.medicinesresources.nhs.uk/atrial-fibrillation-patients-experiences-and-perspectives-of-anticoagulation-therapy-changes-1.html 2020-02-06T17:22:09.4380000Z https://www.medicinesresources.nhs.uk/revised-spc-noradrenaline-norepinephrine-0-08-mg-ml-solution-for-infusion.html 2020-02-07T12:44:30.2270000Z https://www.medicinesresources.nhs.uk/revised-spc-maviret-100-mg-glecaprevir-and-40-mg-pibrentasvir-film-coated-tablets.html 2020-02-07T16:45:00.5400000Z https://www.medicinesresources.nhs.uk/revised-spc-melatonin-1mg-ml-oral-solution.html 2020-02-12T15:28:49.7630000Z https://www.medicinesresources.nhs.uk/revised-spcs-xeljanz-tofacitinib-5-and-10-mg-film-coated-tablets.html 2020-02-07T16:45:58.2460000Z https://www.medicinesresources.nhs.uk/behind-the-headlines-could-a-new-study-give-hope-for-earlier-diagnosis-of-cancer.html 2020-02-07T12:51:25.6630000Z https://www.medicinesresources.nhs.uk/attention-deficit-hyperactivity-disorder.html 2020-02-07T16:47:31.7670000Z https://www.medicinesresources.nhs.uk/clinical-evidence-does-not-support-corticosteroid-treatment-for-2019-ncov-lung-injury.html 2020-02-07T12:53:43.0220000Z https://www.medicinesresources.nhs.uk/2019-ncov-transmission-through-the-ocular-surface-must-not-be-ignored.html 2020-02-07T12:55:17.6470000Z https://www.medicinesresources.nhs.uk/thinking-differently-about-commissioning-learning-from-new-approaches-to-local-planning.html 2020-02-07T12:56:45.6910000Z https://www.medicinesresources.nhs.uk/out-of-hours-contact-information.html 2020-02-07T16:48:13.8630000Z https://www.medicinesresources.nhs.uk/university-of-east-london-launching-survey-to-assess-gps-knowledge-of-antidepressant-withdrawal.html 2020-02-07T16:47:57.0980000Z https://www.medicinesresources.nhs.uk/letter-from-british-menopause-society-fsrh-and-rcog-to-health-secretary-calling-for-new-working-group-to-tackle-hrt-and-contraceptive-shortages.html 2020-02-07T13:01:19.6230000Z https://www.medicinesresources.nhs.uk/chinas-wuhan-institute-files-to-patent-use-of-remdesivir-for-coronavirus.html 2020-02-07T13:02:52.4350000Z https://www.medicinesresources.nhs.uk/phase-3-trial-of-fintepla-fenfluramine-oral-solution-for-the-treatment-of-lennox-gastaut-syndrome-meets-primary-endpoint.html 2020-02-07T16:48:34.0750000Z https://www.medicinesresources.nhs.uk/conference-report-positive-1-year-data-from-part-2-of-sunfish-study-evaluating-risdiplam-in-people-aged-2-25-years-with-nonambulatory-type-2-and-type-3-spinal-muscular-atrophy-sma.html 2020-02-07T16:48:46.8280000Z https://www.medicinesresources.nhs.uk/bimekizumab-in-patients-with-active-psoriatic-arthritis-results-from-a-48-week-randomised-double-blind-placebo-controlled-dose-ranging-phase-2b-trial.html 2020-02-07T16:47:17.4500000Z https://www.medicinesresources.nhs.uk/patient-reported-outcomes-following-pembrolizumab-or-placebo-plus-pemetrexed-and-platinum-in-patients-with-previously-untreated-metastatic-non-squamous-non-small-cell-lung-cancer-keynote-189-a-multicentre-double-blind-randomised-placebo-controlled-phase-3-trial.html 2020-02-07T15:56:59.1230000Z https://www.medicinesresources.nhs.uk/gastrointestinal-bleeding-and-the-risk-of-colorectal-cancer-in-anticoagulated-patients-with-atrial-fibrillation.html 2020-02-07T16:00:27.3170000Z https://www.medicinesresources.nhs.uk/involving-community-pharmacists-in-transfer-of-care-from-hospital-indications-of-reduced-30-day-hospital-readmission-rates-for-patients-in-cornwall.html 2020-02-07T16:03:39.1660000Z https://www.medicinesresources.nhs.uk/updated-educational-risk-minimisation-materials-for-opsumit-macitentan-10-mg-film-coated-tablets.html 2020-02-10T10:52:57.5500000Z https://www.medicinesresources.nhs.uk/educational-risk-minimisation-materials-for-ultomiris-ravulizumab-300-mg-concentrate-for-solution-for-infusion.html 2020-02-10T10:59:17.9690000Z https://www.medicinesresources.nhs.uk/revised-spc-tostran-testosterone-2-gel.html 2020-02-10T15:15:15.9930000Z https://www.medicinesresources.nhs.uk/revised-spc-zantac-ranitidine-syrup-and-injection.html 2020-02-10T15:17:40.2320000Z https://www.medicinesresources.nhs.uk/revised-spc-toujeo-300-units-ml-insulin-glargine-solution-for-injection-in-a-pre-filled-pen.html 2020-02-10T15:20:10.5300000Z https://www.medicinesresources.nhs.uk/revised-spc-lantus-100-units-ml-insulin-glargine-all-preparations.html 2020-02-10T15:23:19.3300000Z https://www.medicinesresources.nhs.uk/clinical-evidence-does-not-support-corticosteroid-treatment-for-2019-ncov-lung-injury-1.html 2020-02-10T15:25:35.3880000Z https://www.medicinesresources.nhs.uk/diagnosis-and-management-of-primary-hyperparathyroidism.html 2020-02-10T15:27:11.1470000Z https://www.medicinesresources.nhs.uk/potential-consequences-of-changing-disease-classifications.html 2020-02-10T15:29:19.7300000Z https://www.medicinesresources.nhs.uk/updated-alert-novel-coronvirus-07-february-2020.html 2020-02-16T17:29:22.9150000Z https://www.medicinesresources.nhs.uk/effectiveness-and-safety-of-sofosbuvir-velpatasvir-ribavirin-vs-glecaprevir-pibrentasvir-in-genotype-3-hepatitis-c-virus-infected-patients.html 2020-02-10T15:33:41.1830000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-of-138-hospitalized-patients-with-2019-novel-coronavirus-infected-pneumonia-in-wuhan-china.html 2020-02-10T15:35:29.7070000Z https://www.medicinesresources.nhs.uk/epidemiologic-and-clinical-characteristics-of-novel-coronavirus-infections-involving-13-patients-outside-wuhan-china.html 2020-02-10T15:36:43.5480000Z https://www.medicinesresources.nhs.uk/dietary-modification-and-breast-cancer-mortality-long-term-follow-up-of-the-womens-health-initiative-randomized-trial.html 2020-07-06T11:47:23.0150000Z https://www.medicinesresources.nhs.uk/dexamethasone-treatment-for-the-acute-respiratory-distress-syndrome-a-multicentre-randomised-controlled-trial.html 2020-02-10T15:40:50.6220000Z https://www.medicinesresources.nhs.uk/sodium-zirconium-cyclosilicate-lokelma-r-not-recommended-for-use-within-nhsscotland.html 2020-02-10T15:50:29.7330000Z https://www.medicinesresources.nhs.uk/encorafenib-braftovi-r-accepted-for-use-within-nhsscotland.html 2020-02-10T15:53:03.1600000Z https://www.medicinesresources.nhs.uk/teduglutide-revestive-r-accepted-for-use-within-nhsscotland.html 2020-02-10T15:54:37.2610000Z https://www.medicinesresources.nhs.uk/plerixafor-mozobil-r-accepted-for-use-within-nhsscotland.html 2020-02-10T15:56:55.2720000Z https://www.medicinesresources.nhs.uk/cemiplimab-libtayo-r-accepted-for-use-within-nhsscotland-on-an-interim-basis-subject-to-ongoing-evaluation-and-future-reassessment.html 2020-02-10T15:59:49.8270000Z https://www.medicinesresources.nhs.uk/national-expansion-of-real-time-exemption-checking-service-for-prescriptions.html 2020-02-10T16:01:18.5510000Z https://www.medicinesresources.nhs.uk/p2y12-inhibitors-with-oral-anticoagulation-for-percutaneous-coronary-intervention-with-atrial-fibrillation-a-systematic-review-and-meta-analysis.html 2020-02-10T16:04:06.8790000Z https://www.medicinesresources.nhs.uk/smc-initial-assessment-of-evidence-for-burosumab-for-x-linked-hypophosphataemia-with-radiographic-evidence-of-bone-disease-in-children-1-year-of-age-and-older-and-adolescents.html 2020-02-10T16:08:11.6910000Z https://www.medicinesresources.nhs.uk/smc-initial-assessment-of-evidence-for-voretigene-neparvovec-luxturna-for-treatment-of-vision-loss-due-to-inherited-retinal-dystrophy-caused-by-confirmed-biallelic-rpe65-mutations.html 2020-02-10T16:12:56.3700000Z https://www.medicinesresources.nhs.uk/leg-ulcer-infection-antimicrobial-prescribing-guidance-ng152.html 2020-02-16T17:53:02.9440000Z https://www.medicinesresources.nhs.uk/nice-publishes-updated-clinical-management-and-service-guidance-on-antenatal-and-postnatal-mental-health-cg192.html 2020-02-16T17:57:19.0140000Z https://www.medicinesresources.nhs.uk/nice-publishes-updated-guideline-on-assessment-and-management-of-bipolar-disorder-cg185.html 2020-02-16T17:58:20.4060000Z https://www.medicinesresources.nhs.uk/nice-publishes-updated-guideline-on-diagnosis-and-management-of-epilepsies-cg137.html 2020-02-16T18:00:33.9050000Z https://www.medicinesresources.nhs.uk/revised-spc-bydureon-2mg-powder-and-solvent-for-prolonged-release-suspension-for-injection-in-pre-filled-pen.html 2020-02-11T15:35:01.4880000Z https://www.medicinesresources.nhs.uk/revised-spc-byetta-exenatide-solution-for-injection-prefilled-pen-all-strengths.html 2020-02-11T15:37:19.2800000Z https://www.medicinesresources.nhs.uk/revised-spc-xonvea-doxylamine-succinate-pyridoxine-hydrochloride-10mg-10mg-gastro-resistant-tablets.html 2020-02-11T15:41:01.7490000Z https://www.medicinesresources.nhs.uk/addition-of-maraviroc-versus-placebo-to-standard-antiretroviral-therapy-for-initial-treatment-of-advanced-hiv-infection-a-randomized-trial.html 2020-02-11T15:45:21.3560000Z https://www.medicinesresources.nhs.uk/barriers-and-enablers-to-collaborative-working-between-gps-and-pharmacists-a-qualitative-interview-study.html 2020-02-11T15:48:14.6640000Z https://www.medicinesresources.nhs.uk/optimising-management-of-utis-in-primary-care-a-qualitative-study-of-patient-and-gp-perspectives-to-inform-the-development-of-an-evidence-based-shared-decision-making-resource.html 2020-02-11T15:50:38.1650000Z https://www.medicinesresources.nhs.uk/prevalence-of-drug-interactions-in-hospitalised-elderly-patients-a-systematic-review.html 2020-02-11T15:54:35.2040000Z https://www.medicinesresources.nhs.uk/oral-anticoagulation-for-patients-with-atrial-fibrillation-on-long-term-hemodialysis.html 2020-02-11T15:59:17.9730000Z https://www.medicinesresources.nhs.uk/comparison-of-integrated-outpatient-palliative-care-with-standard-care-in-patients-with-parkinson-disease-and-related-disorders-a-randomized-clinical-trial.html 2020-02-11T16:09:53.2170000Z https://www.medicinesresources.nhs.uk/sotagliflozin-with-insulin-for-treating-type-1-diabetes-guidance-ta622.html 2020-02-16T18:07:02.9340000Z https://www.medicinesresources.nhs.uk/revised-spc-provera-medrocyprogesterone-acetate-preparations.html 2020-02-12T15:44:04.6060000Z https://www.medicinesresources.nhs.uk/revised-spc-syner-kinase-urokinase-preparations.html 2020-02-12T16:56:08.6580000Z https://www.medicinesresources.nhs.uk/revised-spc-invokana-canagliflozin-tablets.html 2020-02-12T15:48:23.5140000Z https://www.medicinesresources.nhs.uk/investigation-into-potential-under-recognised-risk-of-harm-from-the-use-of-propranolol.html 2020-02-12T15:56:15.6610000Z https://www.medicinesresources.nhs.uk/class-4-drug-alert-for-information-accord-healthcare-ltd-atrolak-xl-prolonged-release-tablets-all-strengths-quetiapine-fumarate.html 2020-02-12T16:35:49.6210000Z https://www.medicinesresources.nhs.uk/class-3-fmd-drug-alert-action-within-5-days-glaxo-wellcome-uk-ltd-t-a-gsk-beconase-aqueous-nasal-spray.html 2020-02-12T16:33:56.7930000Z https://www.medicinesresources.nhs.uk/meta-analysis-evaluating-calcium-channel-blockers-and-the-risk-of-peripheral-arterial-disease-in-patients-with-hypertension.html 2020-02-12T16:11:18.5410000Z https://www.medicinesresources.nhs.uk/effect-of-incisional-negative-pressure-wound-therapy-vs-standard-wound-dressing-on-deep-surgical-site-infection-after-surgery-for-lower-limb-fractures-associated-with-major-trauma-the-whist-randomized-clinical-trial.html 2020-02-12T16:13:56.9770000Z https://www.medicinesresources.nhs.uk/physical-activity-cardiorespiratory-fitness-and-cardiovascular-outcomes-in-individuals-with-atrial-fibrillation-the-hunt-study.html 2020-02-12T16:15:27.5590000Z https://www.medicinesresources.nhs.uk/effect-of-vancomycin-or-daptomycin-with-vs-without-an-antistaphylococcal-v-lactam-on-mortality-bacteremia-relapse-or-treatment-failure-in-patients-with-mrsa-bacteremia-a-randomized-clinical-trial.html 2020-02-12T16:17:44.3020000Z https://www.medicinesresources.nhs.uk/comparison-of-the-long-term-impact-and-clinical-outcomes-of-fewer-doses-and-standard-doses-of-human-papillomavirus-vaccine-in-the-united-states-a-database-study.html 2020-02-12T16:20:04.5140000Z https://www.medicinesresources.nhs.uk/rascism-in-medicine-bmj-special-issue.html 2020-02-12T16:21:23.6780000Z https://www.medicinesresources.nhs.uk/infographics-fair-shares-a-guide-to-nhs-allocations.html 2020-02-12T16:22:38.6200000Z https://www.medicinesresources.nhs.uk/monitoring-the-mental-health-act-in-2018-19.html 2020-02-12T16:23:54.7070000Z https://www.medicinesresources.nhs.uk/young-people-s-mental-health-and-wellbeing-research.html 2020-02-12T16:25:40.1510000Z https://www.medicinesresources.nhs.uk/capmatinib-for-metastatic-met-exon-14-skipping-metex14-mutated-non-small-cell-lung-cancer-granted-priority-regulatory-review-in-the-us.html 2020-02-12T16:27:40.1040000Z https://www.medicinesresources.nhs.uk/pembrolizumab-with-axitinib-for-untreated-advanced-renal-cell-carcinoma-appraisal-consultation-document.html 2020-02-12T16:29:37.0070000Z https://www.medicinesresources.nhs.uk/new-product-launches-2019.html 2020-02-16T18:09:52.6260000Z https://www.medicinesresources.nhs.uk/association-between-cigarette-smoking-and-multiple-sclerosis-a-review.html 2020-02-12T16:38:48.3610000Z https://www.medicinesresources.nhs.uk/denosumab-salvage-therapy-in-a-patient-with-a-locally-advanced-and-refractory-sellar-giant-cell-tumour-of-bone.html 2020-02-12T16:42:18.0070000Z https://www.medicinesresources.nhs.uk/advances-in-oral-immunomodulating-therapies-in-relapsing-multiple-sclerosis.html 2020-02-12T16:43:59.1130000Z https://www.medicinesresources.nhs.uk/the-lancet-infectious-diseases-commission-on-antimicrobial-resistance-6-years-later.html 2020-02-12T16:45:08.9450000Z https://www.medicinesresources.nhs.uk/suspected-neurological-conditions-draft-quality-standard.html 2020-02-12T16:46:58.2180000Z https://www.medicinesresources.nhs.uk/asthma-diagnosis-monitoring-and-chronic-asthma-management-updated-guideline-ng80.html 2020-02-16T18:14:17.1280000Z https://www.medicinesresources.nhs.uk/patiromer-for-treating-hyperkalaemia-technology-appraisal-guidance-ta623.html 2020-02-16T18:15:06.7940000Z https://www.medicinesresources.nhs.uk/revised-spc-cipralex-escitalopram-oral-drops-solution-20mg-ml.html 2020-02-13T16:13:42.4610000Z https://www.medicinesresources.nhs.uk/algorithm-based-smartphone-apps-to-assess-risk-of-skin-cancer-in-adults-systematic-review-of-diagnostic-accuracy-studies.html 2020-02-13T16:16:15.4600000Z https://www.medicinesresources.nhs.uk/still-no-place-for-depot-triamcinolone-in-hay-fever.html 2020-02-16T18:20:56.2030000Z https://www.medicinesresources.nhs.uk/dtb-select-are-patient-education-materials-for-deprescribing-fit-for-purpose.html 2020-02-16T18:22:24.2670000Z https://www.medicinesresources.nhs.uk/dtb-select-self-monitoring-blood-glucose-in-non-insulin-type-2-diabetes.html 2020-02-16T18:23:01.8570000Z https://www.medicinesresources.nhs.uk/november-2019-prioritisation-decisions.html 2020-02-16T18:28:57.4340000Z https://www.medicinesresources.nhs.uk/lack-of-skills-and-distrust-preventing-patients-from-using-internet.html 2020-02-13T16:30:50.0070000Z https://www.medicinesresources.nhs.uk/storage-limit-for-frozen-eggs-sperm-and-embryos-to-be-reconsidered.html 2020-02-13T16:32:13.8830000Z https://www.medicinesresources.nhs.uk/2019-20-community-pharmacy-contractual-framework-cpcf-national-clinical-audit-antimicrobial-stewardship.html 2020-02-16T18:35:38.9420000Z https://www.medicinesresources.nhs.uk/plasma-exchange-and-glucocorticoids-in-severe-anca-associated-vasculitis.html 2020-08-20T12:31:12.1400000Z https://www.medicinesresources.nhs.uk/practice-guidance-removal-of-facsimile-fax-machines-from-general-practice.html 2020-02-13T16:35:35.2020000Z https://www.medicinesresources.nhs.uk/effect-of-reduced-exposure-to-vasopressors-on-90-day-mortality-in-older-critically-ill-patients-with-vasodilatory-hypotension-a-randomized-clinical-trial.html 2020-02-13T16:36:57.0380000Z https://www.medicinesresources.nhs.uk/national-diabetes-audit-care-processes-and-treatment-targets-january-to-september-2019.html 2020-02-13T16:36:57.0800000Z https://www.medicinesresources.nhs.uk/comparison-of-tightly-controlled-dose-reduction-of-biologics-with-usual-care-for-patients-with-psoriasis-a-randomized-clinical-trial.html 2020-02-13T16:38:15.0150000Z https://www.medicinesresources.nhs.uk/diabetes-prevention-programme-quarterly-report-january-to-september-2019.html 2020-02-13T16:38:39.8360000Z https://www.medicinesresources.nhs.uk/association-of-monogenic-vs-polygenic-hypercholesterolemia-with-risk-of-atherosclerotic-cardiovascular-disease.html 2020-02-13T16:39:35.2660000Z https://www.medicinesresources.nhs.uk/milk-and-health.html 2020-08-10T12:02:14.0550000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-and-intrauterine-vertical-transmission-potential-of-covid-19-infection-in-nine-pregnant-women-a-retrospective-review-of-medical-records.html 2020-02-13T16:41:33.5210000Z https://www.medicinesresources.nhs.uk/researchers-wanted-to-study-the-publics-views-of-health-related-quality-of-life.html 2020-02-13T16:42:53.5960000Z https://www.medicinesresources.nhs.uk/new-advances-in-the-treatment-of-paediatric-functional-abdominal-pain-disorders.html 2020-02-13T16:45:34.4370000Z https://www.medicinesresources.nhs.uk/covid-19-what-is-next-for-public-health.html 2020-02-13T16:47:01.9600000Z https://www.medicinesresources.nhs.uk/angina-contemporary-diagnosis-and-management.html 2020-02-13T16:48:27.8570000Z https://www.medicinesresources.nhs.uk/low-density-lipoproteins-cause-atherosclerotic-cardiovascular-disease-pathophysiological-genetic-and-therapeutic-insights-a-consensus-statement-from-the-european-atherosclerosis-society-consensus-panel.html 2020-02-13T16:49:37.4010000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-makes-suspected-side-effect-reports-of-veterinary-medicines-authorised-in-eu-publicly-accessible.html 2020-02-13T16:50:43.0410000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-accord-uk-ltd-gliclazide-40-mg-tablets-northstar-livery-pl-20075-0687-el-20-a-08.html 2020-02-13T16:51:53.9790000Z https://www.medicinesresources.nhs.uk/hypnotics-with-novel-modes-of-action.html 2020-02-13T16:53:34.8510000Z https://www.medicinesresources.nhs.uk/what-diagnostic-strategies-can-help-differentiate-cellulitis-from-other-causes-of-red-legs-in-primary-care.html 2020-02-13T16:55:03.3890000Z https://www.medicinesresources.nhs.uk/sanofi-charged-in-france-with-failing-to-adequately-warn-pregnant-women-that-depakine-sodium-valproate-carries-risk-of-birth-defects.html 2020-02-13T16:56:27.2950000Z https://www.medicinesresources.nhs.uk/who-warns-coronavirus-leading-to-depletion-of-global-stocks-of-protective-gear.html 2020-02-13T16:57:44.2040000Z https://www.medicinesresources.nhs.uk/promises-and-perils-of-using-genetic-tests-to-predict-risk-of-disease.html 2020-02-13T16:58:58.6120000Z https://www.medicinesresources.nhs.uk/esperoct-antihemophilic-factor-recombinant-glycopegylated-exei-launched-in-u-s-for-treatment-of-adults-and-children-with-haemophilia-a.html 2020-02-13T17:00:29.4360000Z https://www.medicinesresources.nhs.uk/fda-accepts-new-drug-application-for-libervant-diazepam-buccal-film-for-seizure-clusters.html 2020-02-13T17:02:07.0670000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-new-drug-application-for-combination-oral-cedazuridine-and-decitabine-oral-c-dec-for-previously-untreated-intermediate-and-high-risk-myelodysplastic-syndromes-including-chronic-myelomonocytic-leukaemia-cmml.html 2020-02-13T17:03:16.4020000Z https://www.medicinesresources.nhs.uk/lilly-and-incyte-announce-positive-top-line-results-from-phase-iii-study-breeze-ad5-of-baricitinib-in-patients-with-moderate-to-severe-atopic-dermatitis.html 2020-02-13T17:04:39.0750000Z https://www.medicinesresources.nhs.uk/title-pembrolizumab-in-combination-with-chemotherapy-meets-primary-endpoint-of-progression-free-survival-pfs-as-first-line-treatment-for-metastatic-triple-negative-breast-cancer-mtnbc-in-phase-3-keynote-355-trial.html 2020-02-13T17:16:22.8450000Z https://www.medicinesresources.nhs.uk/fda-accepts-new-drug-application-nda-and-priority-review-for-ripretinib-for-treatment-of-advanced-gastrointestinal-stromal-tumours-gist.html 2020-02-13T17:06:55.3310000Z https://www.medicinesresources.nhs.uk/revised-spcs-cosopt-dorzolamide-hydrochloride-timolol-maleate-20-mg-ml-5-mg-ml-eye-drops-all-products.html 2020-02-14T15:33:10.6820000Z https://www.medicinesresources.nhs.uk/revised-spcs-vokanamet-metformin-hydrochloride-canagliflozin-hemihydrate-film-coated-tablets-all-strengths.html 2020-02-14T15:35:17.7190000Z https://www.medicinesresources.nhs.uk/pharmacovigilance-risk-assessment-committee-prac-recommend-restrictions-in-use-of-cyproterone-due-to-meningioma-non-cancerous-brain-tumour-risk.html 2020-02-14T15:37:35.0330000Z https://www.medicinesresources.nhs.uk/influenza-vaccination-in-patients-with-heart-failure-a-systematic-review-and-meta-analysis-of-observational-studies.html 2020-02-14T15:39:42.1540000Z https://www.medicinesresources.nhs.uk/global-regional-and-national-burden-of-chronic-kidney-disease-1990-2017-a-systematic-analysis-for-the-global-burden-of-disease-study-2017.html 2020-02-14T15:41:58.6220000Z https://www.medicinesresources.nhs.uk/prevalence-and-prevention-of-contact-dermatitis-caused-by-freestyle-libre-a-monocentric-experience.html 2020-02-14T15:46:05.3980000Z https://www.medicinesresources.nhs.uk/long-term-outcomes-and-responses-to-retreatment-in-patients-with-melanoma-treated-with-pd-1-blockade.html 2020-07-10T09:44:54.1290000Z https://www.medicinesresources.nhs.uk/company-announces-first-study-stardust-to-explore-a-treat-to-target-ttt-strategy-for-ustekinumab-in-crohn-s-disease-using-endoscopic-response-to-guide-treatment.html 2020-02-14T16:41:09.9500000Z https://www.medicinesresources.nhs.uk/new-statistics-reveal-highest-number-of-mumps-cases-since-2009.html 2020-02-14T16:43:01.8870000Z https://www.medicinesresources.nhs.uk/acute-coronary-syndromes-acs-draft-guidance.html 2020-02-14T16:45:25.1140000Z https://www.medicinesresources.nhs.uk/management-of-acute-ischemic-stroke.html 2020-02-14T16:47:44.9240000Z https://www.medicinesresources.nhs.uk/non-opioid-treatment-strontium-chloride-sr-89-injection-launched-in-the-us-for-metastatic-bone-pain.html 2020-02-14T16:50:07.3790000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-to-new-drug-application-for-tucatinib-for-treatment-of-locally-advanced-or-metastatic-her2-positive-breast-cancer.html 2020-02-14T16:53:03.9170000Z https://www.medicinesresources.nhs.uk/manufacturers-asked-to-retain-brexit-medicine-stockpiles-amid-supply-concerns-over-coronavirus.html 2020-02-14T16:55:09.1710000Z https://www.medicinesresources.nhs.uk/assessment-of-duration-and-effects-of-3-vs-6-months-of-adjuvant-chemotherapy-in-high-risk-stage-ii-colorectal-cancer.html 2020-02-14T17:32:36.0300000Z https://www.medicinesresources.nhs.uk/drug-safety-update-support-yellow-card-report-suspected-reactions-in-patients-taking-multiple-medicines.html 2020-02-23T18:40:23.7570000Z https://www.medicinesresources.nhs.uk/drug-safety-update-nexplanon-etonogestrel-contraceptive-implants-new-insertion-site-to-reduce-rare-risk-of-neurovascular-injury-and-implant-migration.html 2020-02-23T18:45:47.6890000Z https://www.medicinesresources.nhs.uk/drug-safety-update-valproate-epilim-depakote-pregnancy-prevention-programme-updated-educational-materials.html 2020-02-23T18:46:22.8720000Z https://www.medicinesresources.nhs.uk/drug-safety-update-lemtrada-alemtuzumab-updated-restrictions-and-strengthened-monitoring-requirements-following-review-of-serious-cardiovascular-and-immune-mediated-reactions.html 2020-02-23T18:56:45.9810000Z https://www.medicinesresources.nhs.uk/drug-safety-update-ingenol-mebutate-gel-picato-suspension-of-licence-due-to-risk-of-skin-malignancy.html 2020-02-23T18:47:57.9760000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-methotrexate-for-autoimmune-diseases-recommendations-to-reduce-potentially-fatal-dosing-errors.html 2020-02-23T18:48:32.2280000Z https://www.medicinesresources.nhs.uk/drug-safety-communication-us-fda-requests-withdrawal-of-weight-loss-drug-lorcaserin.html 2020-02-17T13:40:27.6150000Z https://www.medicinesresources.nhs.uk/management-of-male-breast-cancer-asco-guideline.html 2020-07-16T09:53:23.2160000Z https://www.medicinesresources.nhs.uk/understanding-the-role-of-comparative-clinical-studies-in-the-development-of-oncology-biosimilars.html 2020-07-16T09:32:37.1920000Z https://www.medicinesresources.nhs.uk/conference-report-phase-iii-checkmate-214-shows-nivolumab-combination-with-ipilimumab-demonstrates-continued-survival-benefit-in-patients-with-previously-untreated-advanced-or-metastatic-renal-cell-carcinoma.html 2020-02-17T13:44:20.3970000Z https://www.medicinesresources.nhs.uk/conference-report-updated-checkmate-025-phase-iii-trial-shows-improved-5-year-overall-survival-with-nivolumab-vs-everolimus.html 2020-02-17T13:45:53.6490000Z https://www.medicinesresources.nhs.uk/new-product-bydureon-exenatide-2mg-prolonged-release-suspension-for-injection-in-pre-filled-pen-bcise.html 2020-02-17T14:58:59.1490000Z https://www.medicinesresources.nhs.uk/new-product-xeljanz-tofacitinib-11-mg-prolonged-release-tablets.html 2020-02-17T15:00:47.4460000Z https://www.medicinesresources.nhs.uk/colorectal-cancer-in-crohn-s-disease-a-scandinavian-population-based-cohort-study.html 2020-02-17T15:03:48.9150000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-ecalta-100mg-solution-for-infusion-anidulafungin-must-no-longer-be-frozen.html 2020-02-23T18:49:24.2830000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-modafinil-potential-risk-of-congenital-malformations-during-pregnancy.html 2020-02-23T19:01:21.0540000Z https://www.medicinesresources.nhs.uk/improving-patients-time-in-range-on-warfarin.html 2020-02-18T15:24:26.9170000Z https://www.medicinesresources.nhs.uk/revised-spc-zepatier-elbasvir-grazoprevir-50mg-100mg-film-coated-tablets.html 2020-02-18T15:26:30.7250000Z https://www.medicinesresources.nhs.uk/class-4-fmd-drug-alert-for-information-diamorphine-hydrochloride-bp-100mg-lyophilisate-for-solution-for-injection-accord-healthcare-ltd.html 2020-02-23T19:41:02.6610000Z https://www.medicinesresources.nhs.uk/food-standards-agency-fsa-sets-deadline-for-the-cbd-industry-and-provides-safety-advice-to-consumers.html 2020-02-18T15:30:50.5240000Z https://www.medicinesresources.nhs.uk/community-pharmacies-get-four-minor-ailments-referrals-per-day-from-gps-in-pilot.html 2020-02-18T15:32:13.8660000Z https://www.medicinesresources.nhs.uk/conference-report-phase-iii-visible-2-study-investigating-subcutaneous-vedolizumab-for-crohns-disease-meets-primary-outcome-for-clinical-remission.html 2020-02-18T15:35:49.9440000Z https://www.medicinesresources.nhs.uk/updated-nice-technology-appraisal-for-dapagliflozin-with-insulin-for-treating-type-1-diabetes-ta597.html 2020-02-18T15:37:03.2880000Z https://www.medicinesresources.nhs.uk/adverse-effects-of-low-dose-methotrexate-a-randomized-trial.html 2020-02-18T16:10:23.1440000Z https://www.medicinesresources.nhs.uk/aromatase-inhibitors-and-the-risk-of-cardiovascular-outcomes-in-women-with-breast-cancer-a-population-based-cohort-study.html 2020-07-16T12:27:45.4310000Z https://www.medicinesresources.nhs.uk/are-we-offering-patients-the-right-medicines-information-a-retrospective-evaluation-of-readability-and-quality-in-online-patient-drug-information.html 2020-02-18T15:46:39.9730000Z https://www.medicinesresources.nhs.uk/effect-of-no-prehydration-vs-sodium-bicarbonate-prehydration-prior-to-contrast-enhanced-computed-tomography-in-the-prevention-of-postcontrast-acute-kidney-injury-in-adults-with-chronic-kidney-disease-the-kompas-randomized-clinical-trial.html 2020-02-18T15:48:24.5900000Z https://www.medicinesresources.nhs.uk/empirical-anti-mrsa-vs-standard-antibiotic-therapy-and-risk-of-30-day-mortality-in-patients-hospitalized-for-pneumonia.html 2020-02-18T15:52:06.8510000Z https://www.medicinesresources.nhs.uk/effect-of-intravenous-interferon-v-1a-on-death-and-days-free-from-mechanical-ventilation-among-patients-with-moderate-to-severe-acute-respiratory-distress-syndrome-a-randomized-clinical-trial.html 2020-02-18T15:54:20.7960000Z https://www.medicinesresources.nhs.uk/effect-of-fixed-dose-subcutaneous-reslizumab-on-asthma-exacerbations-in-patients-with-severe-uncontrolled-asthma-and-corticosteroid-sparing-in-patients-with-oral-corticosteroid-dependent-asthma-results-from-two-phase-3-randomised-double-blind-placebo-controlled-trials.html 2020-02-18T15:57:44.0530000Z https://www.medicinesresources.nhs.uk/nonsedation-or-light-sedation-in-critically-ill-mechanically-ventilated-patients.html 2020-08-07T12:34:02.5110000Z https://www.medicinesresources.nhs.uk/european-commission-ec-approves-brolucizumab-injection-for-the-treatment-of-wet-age-related-macular-degeneration-amd.html 2020-02-18T16:02:05.6710000Z https://www.medicinesresources.nhs.uk/first-patients-begin-gene-therapy-treatment-for-blindness-as-part-of-nhs-long-term-plan.html 2020-02-18T16:03:39.4950000Z https://www.medicinesresources.nhs.uk/peginterferon-beta-1a-for-treating-relapsing-remitting-multiple-sclerosis-guidance-ta624.html 2020-02-23T19:51:50.8540000Z https://www.medicinesresources.nhs.uk/antiretroviral-therapy-alone-versus-antiretroviral-therapy-with-a-kick-and-kill-approach-on-measures-of-the-hiv-reservoir-in-participants-with-recent-hiv-infection-the-river-trial-a-phase-2-randomised-trial.html 2020-02-19T13:27:20.4490000Z https://www.medicinesresources.nhs.uk/application-of-the-2019-esc-eas-dyslipidaemia-guidelines-to-nationwide-data-of-patients-with-a-recent-myocardial-infarction-a-simulation-study.html 2020-02-19T13:29:30.7620000Z https://www.medicinesresources.nhs.uk/equivalent-inpatient-mortality-among-direct-acting-oral-anticoagulant-and-warfarin-users-presenting-with-major-hemorrhage.html 2020-02-23T19:55:27.7800000Z https://www.medicinesresources.nhs.uk/cabiralizumab-and-nivolumab-combination-treatment-fails-to-meet-primary-endpoint-for-use-in-pancreatic-cancer.html 2020-02-19T13:31:59.6200000Z https://www.medicinesresources.nhs.uk/a-future-for-the-world-s-children-a-who-unicef-lancet-commission.html 2020-02-19T13:34:29.0800000Z https://www.medicinesresources.nhs.uk/nhs-trusts-are-given-new-powers-to-bar-racist-patients.html 2020-02-19T13:35:32.0530000Z https://www.medicinesresources.nhs.uk/european-commission-tafamidis-vyndaqel-for-transthyretin-amyloid-cardiomyopathy-attr-cm.html 2020-02-19T13:36:47.1760000Z https://www.medicinesresources.nhs.uk/researching-zika-in-pregnancy-lessons-for-global-preparedness.html 2020-02-19T13:38:34.3530000Z https://www.medicinesresources.nhs.uk/camsirubicin-received-orphan-designation-in-the-eu-for-soft-tissue-sarcoma.html 2020-02-19T13:40:04.8360000Z https://www.medicinesresources.nhs.uk/what-are-health-inequalities.html 2020-02-19T13:41:30.1670000Z https://www.medicinesresources.nhs.uk/the-king-s-fund-strategy-for-2020-24.html 2020-02-19T13:42:43.3530000Z https://www.medicinesresources.nhs.uk/no-proof-that-the-mediterranean-diet-reduces-frailty-in-older-age.html 2020-02-19T13:44:11.0600000Z https://www.medicinesresources.nhs.uk/mhra-social-media-campaign-to-raise-awareness-of-the-yellow-card-scheme.html 2020-02-19T13:45:23.4690000Z https://www.medicinesresources.nhs.uk/niceimpact-dementia.html 2020-02-19T13:47:48.5670000Z https://www.medicinesresources.nhs.uk/plerixafor-mozobil-r-recommended-for-use-within-nhs-wales-in-combination-with-g-csf.html 2020-02-20T15:43:33.3850000Z https://www.medicinesresources.nhs.uk/dolutegravir-lamivudine-dovato-r-recommended-as-an-option-for-use-within-nhs-wales-for-the-treatment-of-human-immunodeficiency-virus-type-1-hiv-1.html 2020-02-20T15:45:21.9060000Z https://www.medicinesresources.nhs.uk/new-products-ritalin-methylpheniodate-xl-modified-release-hard-capsules-10-20-30-40-and-60mg.html 2020-02-20T17:23:00.7180000Z https://www.medicinesresources.nhs.uk/revised-spc-citrafleet-sodium-picosulfate-light-magnesium-oxide-citric-acid-powder-for-oral-solution-in-sachet.html 2020-02-20T15:49:34.5780000Z https://www.medicinesresources.nhs.uk/revised-spc-vyndaqel-tafamidis-meglumine-20-mg-soft-capsules.html 2020-02-20T15:52:08.0050000Z https://www.medicinesresources.nhs.uk/prevalence-incidence-and-risk-of-cancer-in-patients-with-psoriasis-and-psoriatic-arthritis-a-systematic-review-and-meta-analysis.html 2020-02-20T15:54:33.8510000Z https://www.medicinesresources.nhs.uk/individual-differences-in-response-to-antidepressants-a-meta-analysis-of-placebo-controlled-randomized-clinical-trials.html 2020-02-20T15:57:47.4240000Z https://www.medicinesresources.nhs.uk/shortage-of-ativan-lorazepam-injection-4-mg-in-1-ml.html 2020-02-24T09:32:36.9140000Z https://www.medicinesresources.nhs.uk/shortage-of-penicillamine-125-and-250mg-tablets.html 2020-02-24T10:48:15.1720000Z https://www.medicinesresources.nhs.uk/guidance-to-educational-settings-about-covid-19.html 2020-02-20T16:05:45.9720000Z https://www.medicinesresources.nhs.uk/mhra-to-publish-results-of-four-year-review-into-safety-of-over-the-counter-otc-stimulant-laxatives.html 2020-02-20T17:37:39.9220000Z https://www.medicinesresources.nhs.uk/psnc-briefing-008-20-changes-to-the-gp-contract-in-2020-21.html 2020-02-20T16:08:37.1050000Z https://www.medicinesresources.nhs.uk/medicines-optimisation-clinical-reference-group-terms-of-reference.html 2020-02-20T16:10:08.0240000Z https://www.medicinesresources.nhs.uk/nhs-outcomes-framework-indicators-february-2020-release.html 2020-02-20T16:11:26.9610000Z https://www.medicinesresources.nhs.uk/national-early-warning-score-systems-that-alert-to-deteriorating-adult-patients-in-hospital-medtech-innovation-briefing-mib205.html 2020-02-20T16:12:57.7430000Z https://www.medicinesresources.nhs.uk/treatment-outcomes-for-depression-challenges-and-opportunities.html 2020-02-20T16:14:12.4290000Z https://www.medicinesresources.nhs.uk/class-4-drug-alert-crescent-pharma-ltd-and-flamingo-pharma-uk-ltd-ibuprofen-400mg-tablets-el-20-a-10.html 2020-02-20T16:15:24.0410000Z https://www.medicinesresources.nhs.uk/uk-deal-over-inclisiran.html 2020-02-20T16:16:52.9370000Z https://www.medicinesresources.nhs.uk/using-a-clinical-process-map-to-identify-prescribing-cascades-in-your-patient.html 2020-02-24T10:17:01.1170000Z https://www.medicinesresources.nhs.uk/what-did-we-learn-from-tamiflu.html 2020-02-20T16:19:37.0430000Z https://www.medicinesresources.nhs.uk/gilead-struggles-to-recruit-patients-for-coronavirus-drug-trial-in-china.html 2020-02-20T16:21:01.1420000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-to-atezolizumab-as-first-line-monotherapy-for-advanced-non-squamous-and-squamous-non-small-cell-lung-cancer-nsclc-without-egfr-or-alk-mutations-with-high-pd-l1-expression.html 2020-02-20T16:23:11.9850000Z https://www.medicinesresources.nhs.uk/daily-emollient-during-infancy-for-prevention-of-eczema-the-beep-randomised-controlled-trial.html 2020-02-20T16:44:21.5820000Z https://www.medicinesresources.nhs.uk/skin-emollient-and-early-complementary-feeding-to-prevent-infant-atopic-dermatitis-preventadall-a-factorial-multicentre-cluster-randomised-trial.html 2020-02-20T16:46:47.7170000Z https://www.medicinesresources.nhs.uk/trial-of-nemolizumab-in-moderate-to-severe-prurigo-nodularis.html 2020-08-07T12:34:59.2740000Z https://www.medicinesresources.nhs.uk/contact-isolation-versus-standard-precautions-to-decrease-acquisition-of-extended-spectrum-v-lactamase-producing-enterobacterales-in-non-critical-care-wards-a-cluster-randomised-crossover-trial.html 2020-02-20T16:49:52.8060000Z https://www.medicinesresources.nhs.uk/clinical-effects-of-the-self-administered-subcutaneous-complement-inhibitor-zilucoplan-in-patients-with-moderate-to-severe-generalized-myasthenia-gravis-results-of-a-phase-2-randomized-double-blind-placebo-controlled-multicenter-clinical-trial.html 2020-02-20T16:51:51.4810000Z https://www.medicinesresources.nhs.uk/plasma-lipids-and-risk-of-aortic-valve-stenosis-a-mendelian-randomization-study.html 2020-02-20T16:55:20.0970000Z https://www.medicinesresources.nhs.uk/similar-breast-cancer-risk-in-women-older-than-65-years-initiating-glargine-detemir-and-nph-insulins.html 2020-02-20T17:24:22.3470000Z https://www.medicinesresources.nhs.uk/maternal-and-fetal-outcomes-following-exposure-to-duloxetine-in-pregnancy-cohort-study.html 2020-02-24T10:28:35.7690000Z https://www.medicinesresources.nhs.uk/associations-between-macrolide-antibiotics-prescribing-during-pregnancy-and-adverse-child-outcomes-in-the-uk-population-based-cohort-study.html 2020-02-24T10:35:33.0070000Z https://www.medicinesresources.nhs.uk/trends-and-risk-factors-of-mortality-and-disability-adjusted-life-years-for-chronic-respiratory-diseases-from-1990-to-2017-systematic-analysis-for-the-global-burden-of-disease-study-2017.html 2020-02-20T17:18:42.7350000Z https://www.medicinesresources.nhs.uk/clinical-findings-in-a-group-of-patients-infected-with-the-2019-novel-coronavirus-sars-cov-2-outside-of-wuhan-china-retrospective-case-series.html 2020-02-20T17:20:09.0550000Z https://www.medicinesresources.nhs.uk/revised-spc-ganfort-0-3-mg-ml-bimatoprost-5-mg-ml-timolol-eye-drops-solution.html 2020-02-21T13:04:32.7190000Z https://www.medicinesresources.nhs.uk/revised-spc-dificlir-fidaxomicin-200-mg-film-coated-tablets.html 2020-02-21T13:06:04.1780000Z https://www.medicinesresources.nhs.uk/enfortumab-vedotin-ejfv-padcev-receives-us-breakthrough-therapy-designation-for-treatment-of-patients-with-unresectable-locally-advanced-or-metastatic-urothelial-cancer-unable-to-receive-first-line-cisplatin-based-chemotherapy.html 2020-02-21T13:07:16.1730000Z https://www.medicinesresources.nhs.uk/phase-ii-iii-placebo-controlled-trials-evaluating-deutetrabenazine-for-the-treatment-of-tics-in-paediatric-patients-with-tourette-syndrome-fail-to-meet-primary-endpoints.html 2020-02-21T13:09:55.2720000Z https://www.medicinesresources.nhs.uk/real-world-data-on-freestyle-libre-system-in-patients-with-diabetes-presented-at-conference.html 2020-02-21T13:11:20.3730000Z https://www.medicinesresources.nhs.uk/your-results-may-vary-the-imprecision-of-medical-measurements.html 2020-02-21T13:16:15.9390000Z https://www.medicinesresources.nhs.uk/fda-announces-collaborative-review-of-scientific-evidence-to-support-associations-between-genetic-information-and-specific-medications.html 2020-02-21T13:20:35.8540000Z https://www.medicinesresources.nhs.uk/covid-19-in-singapore-current-experience-critical-global-issues-that-require-attention-and-action.html 2020-02-21T15:28:55.3080000Z https://www.medicinesresources.nhs.uk/the-updated-gp-contract-explained.html 2020-02-21T15:29:53.9040000Z https://www.medicinesresources.nhs.uk/research-suggests-39-of-hospitals-do-not-offer-non-drug-therapies-to-patients-with-dementia-whilst-they-are-in-hospital.html 2020-02-21T17:13:27.9590000Z https://www.medicinesresources.nhs.uk/rabies-post-exposure-treatment-timing-of-vaccine-booster.html 2020-02-21T15:34:47.6760000Z https://www.medicinesresources.nhs.uk/epilepsy-toolkit.html 2020-02-24T10:37:34.4900000Z https://www.medicinesresources.nhs.uk/effects-of-glucagon-like-peptide-1-receptor-agonists-on-major-cardiovascular-events-in-patients-with-type-2-diabetes-mellitus-with-or-without-established-cardiovascular-disease-a-meta-analysis-of-randomized-controlled-trials.html 2020-02-21T17:11:05.5070000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-nerinetide-for-the-treatment-of-acute-ischaemic-stroke-escape-na1-a-multicentre-double-blind-randomised-controlled-trial.html 2020-02-21T17:00:36.5390000Z https://www.medicinesresources.nhs.uk/switching-from-tenofovir-disoproxil-fumarate-to-tenofovir-alafenamide-in-virologically-suppressed-patients-with-chronic-hepatitis-b-a-randomised-double-blind-phase-3-multicentre-non-inferiority-study.html 2020-02-21T17:02:06.1350000Z https://www.medicinesresources.nhs.uk/varenicline-versus-nicotine-replacement-therapy-for-long-term-smoking-cessation-an-observational-study-using-the-clinical-practice-research-datalink.html 2020-02-21T17:05:50.2990000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-for-ambulance-trusts.html 2020-02-28T11:58:44.0150000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-allogeneic-haematopoietic-stem-cell-transplantation-for-adults-with-sickle-cell-disease.html 2020-02-28T12:00:11.7250000Z https://www.medicinesresources.nhs.uk/guidelines-for-the-public-health-management-of-clusters-of-severe-pneumococcal-disease-in-closed-settings.html 2020-02-28T12:01:33.4270000Z https://www.medicinesresources.nhs.uk/revised-spc-hizentra-human-normal-immunoglobulin-200-mg-ml-solution-for-subcutaneous-injection.html 2020-02-24T16:04:13.3490000Z https://www.medicinesresources.nhs.uk/revised-spc-cerazette-desogestrel-75-microgram-film-coated-tablet.html 2020-02-24T15:50:50.5980000Z https://www.medicinesresources.nhs.uk/ampres-chloroprocaine-20-mg-ml-solution-for-injection.html 2020-02-24T16:06:52.9410000Z https://www.medicinesresources.nhs.uk/2020-american-college-of-rheumatology-guideline-for-the-management-of-reproductive-health-in-rheumatic-and-musculoskeletal-diseases.html 2020-02-24T15:56:39.9810000Z https://www.medicinesresources.nhs.uk/genomic-landscape-of-waldenstroem-macroglobulinemia-and-its-impact-on-treatment-strategies.html 2020-07-07T10:36:48.2950000Z https://www.medicinesresources.nhs.uk/new-pharmacy-referral-service-to-help-patients-avoid-hospital-readmission.html 2020-02-28T12:12:59.6840000Z https://www.medicinesresources.nhs.uk/psnc-briefing-010-20-community-pharmacy-funding-in-2020-21.html 2020-02-24T16:03:54.8130000Z https://www.medicinesresources.nhs.uk/standard-anthracycline-based-versus-docetaxel-capecitabine-in-early-high-clinical-and-or-genomic-risk-breast-cancer-in-the-eortc-10041-big-3-04-mindact-phase-iii-trial.html 2020-07-10T09:40:22.5190000Z https://www.medicinesresources.nhs.uk/liberal-versus-restrictive-red-blood-cell-transfusion-thresholds-in-hematopoietic-cell-transplantation-a-randomized-open-label-phase-iii-noninferiority-trial.html 2020-07-06T11:49:50.5230000Z https://www.medicinesresources.nhs.uk/lower-versus-standard-inr-targets-in-atrial-fibrillation-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials.html 2020-02-24T16:23:23.6180000Z https://www.medicinesresources.nhs.uk/updated-class-4-drug-alert-crescent-pharma-ltd-and-flamingo-pharma-ltd-ibuprofen-400mg-tablets-various-batch-numbers.html 2020-02-24T16:19:09.6990000Z https://www.medicinesresources.nhs.uk/guidance-for-social-or-community-care-and-residential-settings-on-covid-19.html 2020-02-28T12:05:52.7950000Z https://www.medicinesresources.nhs.uk/survey-finds-over-half-of-gps-and-nurses-who-treat-type-ii-diabetics-do-not-carry-out-recommended-annual-urine-albumin-to-creatinine-ratio-uacr-test.html 2020-02-25T16:03:12.0660000Z https://www.medicinesresources.nhs.uk/fda-and-european-medicines-agency-accept-filing-of-licensing-application-for-ofatumumab-for-treatment-of-relapsing-forms-of-multiple-sclerosis-in-adults.html 2020-02-25T16:04:41.2240000Z https://www.medicinesresources.nhs.uk/coronavirus-standard-operating-procedure.html 2020-02-28T12:06:43.8010000Z https://www.medicinesresources.nhs.uk/latest-stats-show-nearly-2-million-people-registered-with-a-gp-who-have-non-diabetic-hyperglycaemia.html 2020-02-25T16:11:55.9980000Z https://www.medicinesresources.nhs.uk/practice-level-prescribing-december-2019.html 2020-02-25T16:13:49.4860000Z https://www.medicinesresources.nhs.uk/characteristics-of-and-important-lessons-from-the-coronavirus-disease-2019-covid-19-outbreak-in-china-summary-of-a-report-of-72-314-cases-from-the-chinese-center-for-disease-control-and-prevention.html 2020-02-25T16:15:05.9400000Z https://www.medicinesresources.nhs.uk/explaining-health-state-utility-assessment.html 2020-02-25T16:16:18.6470000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-memantine-10mg-film-coated-tablets-pl-20416-0260-el-20-a-11.html 2020-02-25T16:17:18.5140000Z https://www.medicinesresources.nhs.uk/novel-coronavirus-updated-advice-for-the-nhs-in-england.html 2020-02-28T12:08:51.6770000Z https://www.medicinesresources.nhs.uk/is-streaming-patients-in-emergency-departments-to-primary-care-services-effective-and-safe.html 2020-02-25T16:19:23.6360000Z https://www.medicinesresources.nhs.uk/novartis-launches-external-review-into-safety-of-brolucizumab-injection-for-treatment-of-wet-age-related-macular-degeneration-after-concerns-raised-by-american-society-of-retinal-specialists-asrs.html 2020-02-25T16:20:31.1080000Z https://www.medicinesresources.nhs.uk/health-equity-in-england-the-marmot-review-10-years-on.html 2020-02-25T16:24:07.1610000Z https://www.medicinesresources.nhs.uk/epanutin-phenytoin-30mg-5ml-oral-suspension-supply-disruption-alert.html 2020-02-28T12:14:49.3700000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-biologics-license-application-for-valrox-valoctocogene-roxaparvovec-a-gene-therapy-for-haemophilia-a.html 2020-02-25T16:26:25.4210000Z https://www.medicinesresources.nhs.uk/meloxicam-injection-anjeso-approved-in-us-for-management-of-moderate-to-severe-pain-alone-or-in-combination-with-other-non-nsaid-analgesics.html 2020-02-25T16:27:33.3900000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-for-supplemental-new-drug-application-for-brigatinib-as-first-line-treatment-for-anaplastic-lymphoma-kinase-positive-alk-metastatic-non-small-cell-lung-cancer.html 2020-02-25T16:28:47.6560000Z https://www.medicinesresources.nhs.uk/fda-compiling-list-of-drugs-that-are-at-risk-of-shortage-if-coronavirus-outbreak-continues-to-worsen.html 2020-02-25T16:29:59.0990000Z https://www.medicinesresources.nhs.uk/fda-approves-oral-non-statin-ldl-cholesterol-ldl-c-lowering-treatment-bempedoic-acid-nexletol.html 2020-02-25T16:32:30.8700000Z https://www.medicinesresources.nhs.uk/fda-approves-vyepti-eptinezumab-jjmr-as-preventative-treatment-of-migraines.html 2020-02-25T16:34:07.5950000Z https://www.medicinesresources.nhs.uk/introduction-of-a-new-leg-ulcer-pathway-and-urgostart-dressings-for-venous-leg-ulcers-in-manchester.html 2020-02-25T16:36:55.8190000Z https://www.medicinesresources.nhs.uk/can-bank-and-agency-staff-operate-under-an-organisations-patient-group-directions-pgds.html 2020-02-25T16:38:40.3570000Z https://www.medicinesresources.nhs.uk/effect-of-dose-and-duration-of-reduction-in-dietary-sodium-on-blood-pressure-levels-systematic-review-and-meta-analysis-of-randomised-trials.html 2020-02-25T16:58:02.4720000Z https://www.medicinesresources.nhs.uk/pharmacologic-therapies-in-patients-with-exacerbation-of-chronic-obstructive-pulmonary-disease-a-systematic-review-with-meta-analysis.html 2020-02-25T16:59:18.8030000Z https://www.medicinesresources.nhs.uk/tolerability-of-antiseizure-medications-in-individuals-with-newly-diagnosed-epilepsy.html 2020-02-26T17:17:12.8670000Z https://www.medicinesresources.nhs.uk/evaluation-of-a-common-prescribing-cascade-of-calcium-channel-blockers-and-diuretics-in-older-adults-with-hypertension.html 2020-02-25T17:02:00.6120000Z https://www.medicinesresources.nhs.uk/community-burden-and-transmission-of-acute-gastroenteritis-caused-by-norovirus-and-rotavirus-in-the-netherlands-rotafam-a-prospective-household-based-cohort-study.html 2020-02-25T17:03:48.4710000Z https://www.medicinesresources.nhs.uk/evaluation-of-the-association-between-gastric-acid-suppression-and-risk-of-intestinal-colonization-with-multidrug-resistant-microorganisms-a-systematic-review-and-meta-analysis.html 2020-02-25T17:05:33.2490000Z https://www.medicinesresources.nhs.uk/the-associations-of-major-foods-and-fibre-with-risks-of-ischaemic-and-haemorrhagic-stroke-a-prospective-study-of-418-329-participants-in-the-epic-cohort-across-nine-european-countries.html 2020-02-25T17:08:42.1260000Z https://www.medicinesresources.nhs.uk/revised-spc-zirtek-cetirizine-products.html 2020-02-26T16:36:55.1450000Z https://www.medicinesresources.nhs.uk/revised-spc-noritropin-somatropin-all-presentations.html 2020-02-26T17:22:53.6870000Z https://www.medicinesresources.nhs.uk/revised-spc-lanoxin-digoxin-tablets.html 2020-02-26T16:39:48.5860000Z https://www.medicinesresources.nhs.uk/neonatal-parenteral-nutrition-guidance-ng154.html 2020-02-28T12:24:14.3050000Z https://www.medicinesresources.nhs.uk/impetigo-antimicrobial-prescribing-guidance-ng153.html 2020-02-28T12:22:33.7130000Z https://www.medicinesresources.nhs.uk/medical-device-alert-mda-2020-007-all-t34-and-t34l-t60-ambulatory-syringe-pumps.html 2020-02-26T16:44:04.8930000Z https://www.medicinesresources.nhs.uk/association-of-antiretroviral-therapy-with-anal-high-risk-human-papillomavirus-anal-intraepithelial-neoplasia-and-anal-cancer-in-people-living-with-hiv-a-systematic-review-and-meta-analysis.html 2020-02-26T16:45:32.3880000Z https://www.medicinesresources.nhs.uk/dtb-select-community-pharmacy-interventions-and-health-outcomes.html 2020-02-26T16:50:39.1210000Z https://www.medicinesresources.nhs.uk/dtb-select-ursodeoxycholic-acid-offers-no-benefit-in-obstetric-cholestasis.html 2020-02-26T16:51:51.9600000Z https://www.medicinesresources.nhs.uk/prescribing-for-pregnancy-asthma.html 2020-02-26T16:54:01.9390000Z https://www.medicinesresources.nhs.uk/gefapixant-a-p2x3-receptor-antagonist-for-the-treatment-of-refractory-or-unexplained-chronic-cough-a-randomised-double-blind-controlled-parallel-group-phase-2b-trial.html 2020-02-26T16:55:26.6150000Z https://www.medicinesresources.nhs.uk/coronavirus-vaccine-mrna-1273-ready-for-phase-i-clinical-trial-in-usa.html 2020-02-26T16:56:58.4990000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-supplemental-new-drug-application-for-niraparib-as-first-line-maintenance-treatment-of-ovarian-cancer.html 2020-02-26T16:58:29.8920000Z https://www.medicinesresources.nhs.uk/off-label-use-of-quetiapine-in-nursing-homes-does-medical-specialty-of-prescribing-physicians-play-a-role.html 2020-02-26T17:00:12.1730000Z https://www.medicinesresources.nhs.uk/dapagliflozin-for-type-1-diabetes-ensuring-benefits-outweigh-the-risks.html 2020-02-26T17:17:35.6690000Z https://www.medicinesresources.nhs.uk/goal-attainment-scaling-to-facilitate-person-centred-medicines-related-consultations.html 2020-02-26T17:18:59.0960000Z https://www.medicinesresources.nhs.uk/30-years-of-second-generation-antiseizure-medications-impact-and-future-perspectives.html 2020-02-26T17:20:56.1690000Z https://www.medicinesresources.nhs.uk/health-education-england-launches-self-care-aware-consultation-programme.html 2020-02-26T17:21:48.0500000Z https://www.medicinesresources.nhs.uk/antibiotic-adverse-events-on-an-outpatient-parenteral-antibiotic-service-a-retrospective-cohort-study.html 2020-02-26T17:22:57.7320000Z https://www.medicinesresources.nhs.uk/revised-spc-provera-medroxyprogesterone-acetate-10-mg-tablets.html 2020-02-27T16:10:39.8290000Z https://www.medicinesresources.nhs.uk/pembrolizumab-for-early-triple-negative-breast-cancer.html 2020-08-07T13:27:53.1030000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-lebrikizumab-a-high-affinity-interleukin-13-inhibitor-in-adults-with-moderate-to-severe-atopic-dermatitis-a-phase-2b-randomized-clinical-trial.html 2020-02-27T16:16:27.9440000Z https://www.medicinesresources.nhs.uk/cost-effectiveness-of-an-intervention-to-increase-uptake-of-hepatitis-c-virus-testing-and-treatment-hepcatt-cluster-randomised-controlled-trial-in-primary-care.html 2020-02-27T16:24:18.7390000Z https://www.medicinesresources.nhs.uk/optimal-antithrombotic-regimens-for-patients-with-atrial-fibrillation-undergoing-percutaneous-coronary-intervention-an-updated-network-meta-analysis.html 2020-02-27T16:25:58.2680000Z https://www.medicinesresources.nhs.uk/risk-of-pregnancy-related-venous-thromboembolism-and-obstetrical-complications-in-women-with-inherited-type-i-antithrombin-deficiency-a-retrospective-single-centre-cohort-study.html 2020-02-27T16:27:49.8130000Z https://www.medicinesresources.nhs.uk/assessment-of-long-term-benefit-of-intensive-blood-pressure-control-on-residual-life-span-secondary-analysis-of-the-systolic-blood-pressure-intervention-trial-sprint.html 2020-02-27T16:29:02.8800000Z https://www.medicinesresources.nhs.uk/pharmaceutical-interventions-in-the-emergency-department-cost-effectiveness-and-cost-benefit-analysis.html 2020-02-27T16:31:27.2630000Z https://www.medicinesresources.nhs.uk/new-surveillance-system-for-early-detection-of-covid-19.html 2020-02-28T12:37:02.1210000Z https://www.medicinesresources.nhs.uk/locked-out-prisoners-use-of-hospital-care.html 2020-02-27T16:34:06.8910000Z https://www.medicinesresources.nhs.uk/the-modern-epidemic-of-syphilis.html 2020-08-10T11:56:57.7330000Z https://www.medicinesresources.nhs.uk/lenalidomide-with-rituximab-for-previously-treated-follicular-lymphoma-final-appraisal-document.html 2020-02-27T16:37:03.4520000Z https://www.medicinesresources.nhs.uk/polatuzumab-vedotin-with-rituximab-and-bendamustine-for-treating-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-appraisal-consultation-document.html 2020-02-27T16:38:21.9250000Z https://www.medicinesresources.nhs.uk/european-heart-rhythm-association-ehra-international-consensus-document-on-how-to-prevent-diagnose-and-treat-cardiac-implantable-electronic-device-infections.html 2020-02-27T16:39:43.3320000Z https://www.medicinesresources.nhs.uk/diamorphine-hydrochloride-powder-for-reconstitution-and-injection-5mg-and-10mg-ampoules-supply-disruption-alert.html 2020-02-28T12:40:18.1690000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-oxylan-prolonged-release-tablets-all-strengths-oxycodone-hydrochloride-el-20-a12.html 2020-02-27T16:42:32.7910000Z https://www.medicinesresources.nhs.uk/promoting-sexual-safety-through-empowerment.html 2020-02-27T16:43:52.5060000Z https://www.medicinesresources.nhs.uk/spirit-extension-and-elaboration-for-n-of-1-trials-spent-2019-checklist.html 2020-02-27T16:44:54.3370000Z https://www.medicinesresources.nhs.uk/revitalising-audit-and-feedback-to-improve-patient-care.html 2020-02-27T16:46:04.7020000Z https://www.medicinesresources.nhs.uk/xblifep-cefepime-enmetazobactam-meets-pre-specified-primary-endpoints-in-phase-iii-allium-clinical-trial-in-complicated-urinary-tract-infections.html 2020-02-27T17:11:32.0820000Z https://www.medicinesresources.nhs.uk/gilead-sciences-initiates-two-phase-3-studies-of-investigational-antiviral-remdesivir-for-treatment-of-covid-19.html 2020-02-27T16:49:05.5930000Z https://www.medicinesresources.nhs.uk/dealing-with-acute-constipation-information-for-general-practitioners.html 2020-02-27T16:52:54.2120000Z https://www.medicinesresources.nhs.uk/easy-read-information-sepsis.html 2020-02-27T16:54:57.7570000Z https://www.medicinesresources.nhs.uk/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-and-biological-disease-modifying-antirheumatic-drugs-2019-update.html 2020-02-27T16:57:40.4140000Z https://www.medicinesresources.nhs.uk/safety-of-synthetic-and-biological-dmards-a-systematic-literature-review-informing-the-2019-update-of-the-eular-recommendations-for-the-management-of-rheumatoid-arthritis.html 2020-02-27T16:59:27.2180000Z https://www.medicinesresources.nhs.uk/efficacy-of-pharmacological-treatment-in-rheumatoid-arthritis-a-systematic-literature-research-informing-the-2019-update-of-the-eular-recommendations-for-management-of-rheumatoid-arthritis.html 2020-02-27T17:01:28.8790000Z https://www.medicinesresources.nhs.uk/hypersensitivity-reactions-with-allopurinol-and-febuxostat-a-study-using-the-medicare-claims-data.html 2020-02-27T17:02:43.7760000Z https://www.medicinesresources.nhs.uk/us-fda-approves-amisulpride-injection-for-the-prevention-and-treatment-of-post-operative-nausea-and-vomiting-ponv.html 2020-02-28T13:20:23.4560000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-accepts-submission-of-marketing-authorisation-application-for-niraparib-as-first-line-maintenance-treatment-of-ovarian-cancer.html 2020-02-28T13:22:31.0340000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-application-for-burosumab-for-treatment-of-tumour-induced-osteomalacia-tio-for-priority-review.html 2020-02-28T13:23:59.2950000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-accepts-submission-seeking-approval-of-trelegy-ellipta-fluticasone-furoate-umeclidinium-vilanterol-for-the-treatment-of-asthma-in-adults.html 2020-02-28T13:25:10.0450000Z https://www.medicinesresources.nhs.uk/review-of-drugs-phase-one-report.html 2020-02-28T13:26:52.7500000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-cefiderocol-for-treatment-of-infections-due-to-aerobic-gram-negative-organisms.html 2020-02-28T13:28:01.8250000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-extending-indication-of-brigatinib-to-include-patients-not-previously-treated-with-an-anaplastic-lymphoma-kinase-alk-inhibitor.html 2020-02-28T13:32:08.5300000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-nintedanib-for-treatment-of-systemic-sclerosis-associated-interstitial-lung-disease.html 2020-02-28T13:33:16.2260000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-apremilast-for-treatment-of-behcets-disease-bd.html 2020-02-28T13:34:29.2570000Z https://www.medicinesresources.nhs.uk/european-chmp-does-not-recommend-approval-of-galcanezumab-for-prevention-of-attacks-of-episodic-cluster-headache.html 2020-02-28T13:35:30.5380000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-new-formulation-of-vedolizumab.html 2020-02-28T13:36:40.8110000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-starts-review-of-medicines-for-which-studies-have-been-conducted-by-panexcell-clinical-laboratories-priv-ltd-in-mumbai.html 2020-02-28T13:37:54.4990000Z https://www.medicinesresources.nhs.uk/coronavirus-standard-operating-procedures-for-primary-care-settings.html 2020-03-02T07:52:33.4720000Z https://www.medicinesresources.nhs.uk/revised-spc-stelara-ustekinumab-90-mg-solution-for-injection-vials.html 2020-02-28T16:01:08.2790000Z https://www.medicinesresources.nhs.uk/revised-spc-pentasa-mesalazine-preparations.html 2020-02-28T16:02:54.3390000Z https://www.medicinesresources.nhs.uk/is-there-a-lactose-free-antidepressant.html 2020-02-28T16:07:25.4540000Z https://www.medicinesresources.nhs.uk/positive-rt-pcr-test-results-in-patients-recovered-from-covid-19.html 2020-02-28T16:10:19.6060000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-begins-review-of-trabectedin-yondelis.html 2020-02-28T16:12:52.8460000Z https://www.medicinesresources.nhs.uk/application-seeking-use-of-nivolumab-and-ipilimumab-in-the-first-line-treatment-of-metastatic-non-small-cell-lung-cancer-withdrawn.html 2020-02-28T16:15:44.9310000Z https://www.medicinesresources.nhs.uk/when-can-intermediate-outcomes-be-used-as-surrogate-outcomes.html 2020-02-28T16:19:15.2560000Z https://www.medicinesresources.nhs.uk/epilepsy-in-older-people.html 2020-02-28T16:21:01.2300000Z https://www.medicinesresources.nhs.uk/new-electronic-notifications-service-for-vaccinations-launched-this-winter.html 2020-02-28T16:22:25.4090000Z https://www.medicinesresources.nhs.uk/nhs-comments-on-coronavirus-drive-through-testing-service.html 2020-02-28T16:25:43.6560000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-305-february-2020.html 2020-02-28T16:28:18.8420000Z https://www.medicinesresources.nhs.uk/us-fda-approves-rimegepant-for-migraine.html 2020-02-28T16:30:10.4390000Z https://www.medicinesresources.nhs.uk/nhsi-pmop-newsletter-february-2020.html 2020-02-28T16:32:37.0910000Z https://www.medicinesresources.nhs.uk/educational-risk-minimisation-materials-to-help-reduce-the-risk-associated-with-using-syonell-valproate-semisodium.html 2020-03-02T07:53:21.4080000Z https://www.medicinesresources.nhs.uk/preoperative-chemoradiotherapy-versus-immediate-surgery-for-resectable-and-borderline-resectable-pancreatic-cancer-results-of-the-dutch-randomized-phase-iii-preopanc-trial.html 2020-07-07T10:33:34.8410000Z https://www.medicinesresources.nhs.uk/patient-reminder-card-for-remsima-infliximab.html 2020-02-28T16:38:54.0440000Z https://www.medicinesresources.nhs.uk/intrapartum-care-existing-medical-conditions-and-obstetric-complications-quality-standard-qs192.html 2020-03-03T16:50:41.1510000Z https://www.medicinesresources.nhs.uk/repatha-sureclick-evolocumab.html 2020-03-02T16:00:26.9270000Z https://www.medicinesresources.nhs.uk/revised-spc-zinforo-ceftaroline-fosamil-600mg-powder-for-concentrate-for-solution-for-infusion.html 2020-03-02T15:22:53.5560000Z https://www.medicinesresources.nhs.uk/responding-to-covid-19-a-once-in-a-century-pandemic.html 2020-08-10T10:59:58.4140000Z https://www.medicinesresources.nhs.uk/a-low-carbon-future-could-improve-global-health-and-achieve-economic-benefits.html 2020-03-02T15:28:59.5530000Z https://www.medicinesresources.nhs.uk/over-the-counter-oral-contraceptives-to-reduce-unintended-pregnancies.html 2020-03-02T15:30:52.9000000Z https://www.medicinesresources.nhs.uk/covid-19-new-insights-on-a-rapidly-changing-epidemic.html 2020-03-02T15:32:35.2690000Z https://www.medicinesresources.nhs.uk/lessons-learned-from-the-australian-bushfires-climate-change-air-pollution-and-public-health.html 2020-03-02T15:33:58.0180000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-action-within-48-hours-aop-orphan-pharmaceuticals-tetrabenazine-25mg-tablets.html 2020-03-03T16:59:48.4720000Z https://www.medicinesresources.nhs.uk/preventing-a-covid-19-pandemic.html 2020-03-02T15:37:43.1700000Z https://www.medicinesresources.nhs.uk/healthcare-information-for-all.html 2020-03-02T15:46:11.6560000Z https://www.medicinesresources.nhs.uk/covid-19-preparedness-decentralisation-and-the-hunt-for-patient-zero.html 2020-03-02T15:48:42.0620000Z https://www.medicinesresources.nhs.uk/research-on-peer-review-and-biomedical-publication.html 2020-03-02T15:50:53.2720000Z https://www.medicinesresources.nhs.uk/post-ssri-sexual-dysfunction.html 2020-03-02T15:52:39.6390000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-accepts-license-extension-application-for-sodium-thiosulfate-infusion-for-cisplatin-induced-hearing-loss-in-children.html 2020-03-02T15:54:11.1690000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-of-coronavirus-disease-2019-in-china.html 2020-08-07T14:31:32.6310000Z https://www.medicinesresources.nhs.uk/in-use-product-safety-assessment-report-for-fiasp-r-insulin-aspart.html 2020-03-03T16:52:26.0430000Z https://www.medicinesresources.nhs.uk/covid-19-investigation-and-initial-clinical-management-of-possible-cases-updated-guidance.html 2020-03-03T16:54:04.6640000Z https://www.medicinesresources.nhs.uk/nhs-england-issues-guidance-on-managing-patients-suspected-of-novel-coronavirus-infection-presenting-in-a-community-pharmacy.html 2020-03-03T16:55:17.2980000Z https://www.medicinesresources.nhs.uk/canacinumab-for-periodic-fever-syndromes-in-children-to-be-commissioned-by-nhs-england.html 2020-03-03T16:26:58.3270000Z https://www.medicinesresources.nhs.uk/new-electronic-notifications-service-for-vaccinations-to-be-launched-this-winter.html 2020-03-02T16:09:06.7390000Z https://www.medicinesresources.nhs.uk/what-is-the-evidence-for-the-use-of-potassium-permanganate-for-wound-care.html 2020-03-04T11:07:18.4010000Z https://www.medicinesresources.nhs.uk/still-no-place-for-depot-triamcinolone-in-hay-fever-1.html 2020-03-04T11:08:53.6760000Z https://www.medicinesresources.nhs.uk/delivering-health-and-care-for-people-who-sleep-rough-going-above-and-beyond.html 2020-03-03T15:23:55.7830000Z https://www.medicinesresources.nhs.uk/revised-spc-iqymune-human-normal-immunoglobulin-100mg-ml-solution-for-infusion.html 2020-03-03T15:25:39.4560000Z https://www.medicinesresources.nhs.uk/update-on-nitrosamines-in-eu-medicines.html 2020-03-03T15:27:07.6950000Z https://www.medicinesresources.nhs.uk/colorectal-cancer-summary-of-nice-guidance.html 2020-03-03T15:29:08.5360000Z https://www.medicinesresources.nhs.uk/current-and-future-treatments-for-tuberculosis.html 2020-03-03T15:31:00.4060000Z https://www.medicinesresources.nhs.uk/us-fda-approves-isatuximab-for-relapsed-refractory-multiple-myeloma.html 2020-03-03T15:33:15.9810000Z https://www.medicinesresources.nhs.uk/voicing-the-need-for-amyotrophic-lateral-sclerosis-environmental-research.html 2020-03-03T15:38:34.1320000Z https://www.medicinesresources.nhs.uk/integrated-drug-reviews-at-the-us-food-and-drug-administration-legal-concerns-and-knowledge-lost.html 2020-03-03T15:40:49.2330000Z https://www.medicinesresources.nhs.uk/cerebral-microvascular-complications-of-type-2-diabetes-stroke-cognitive-dysfunction-and-depression.html 2020-03-03T15:43:30.1140000Z https://www.medicinesresources.nhs.uk/the-effect-of-influenza-vaccination-for-the-elderly-on-hospitalization-and-mortality-an-observational-study-with-a-regression-discontinuity-design.html 2020-03-03T15:45:19.0050000Z https://www.medicinesresources.nhs.uk/pharmacotherapy-for-the-treatment-of-cannabis-use-disorder-a-systematic-review.html 2020-03-03T15:46:56.1490000Z https://www.medicinesresources.nhs.uk/association-of-qt-prolonging-medications-with-risk-of-autopsy-defined-causes-of-sudden-death.html 2020-03-03T15:49:01.6060000Z https://www.medicinesresources.nhs.uk/dose-ranging-effect-of-adjunctive-oral-cannabidiol-vs-placebo-on-convulsive-seizure-frequency-in-dravet-syndrome-a-randomized-clinical-trial.html 2020-03-03T15:52:34.9270000Z https://www.medicinesresources.nhs.uk/early-detection-of-diabetic-kidney-disease-by-urinary-proteomics-and-subsequent-intervention-with-spironolactone-to-delay-progression-priority-a-prospective-observational-study-and-embedded-randomised-placebo-controlled-trial.html 2020-03-03T15:56:33.3560000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-meal-time-administration-of-short-acting-exenatide-for-glycaemic-control-in-type-1-diabetes-mag1c-a-randomised-double-blind-placebo-controlled-trial.html 2020-03-03T16:02:56.2660000Z https://www.medicinesresources.nhs.uk/cardiovascular-adverse-events-in-patients-with-non-hodgkin-lymphoma-treated-with-first-line-cyclophosphamide-doxorubicin-vincristine-and-prednisone-chop-or-chop-with-rituximab-r-chop-a-systematic-review-and-meta-analysis.html 2020-03-03T16:05:51.0470000Z https://www.medicinesresources.nhs.uk/efficacy-safety-and-acceptability-of-pharmacologic-treatments-for-pediatric-migraine-prophylaxis-a-systematic-review-and-network-meta-analysis.html 2020-03-03T16:07:54.6320000Z https://www.medicinesresources.nhs.uk/nhs-111-online-to-help-people-with-coronavirus.html 2020-03-03T16:09:22.6850000Z https://www.medicinesresources.nhs.uk/revised-spc-zestoretic-lisinopril-and-hydrochlorthiazide-tablets.html 2020-03-04T15:35:11.9580000Z https://www.medicinesresources.nhs.uk/estimated-research-and-development-investment-needed-to-bring-a-new-medicine-to-market-2009-2018.html 2020-03-04T15:41:10.0490000Z https://www.medicinesresources.nhs.uk/the-association-of-long-term-outcome-and-biological-sex-in-patients-with-acute-heart-failure-from-different-geographic-regions.html 2020-03-04T15:42:49.0430000Z https://www.medicinesresources.nhs.uk/guidelines-for-the-management-of-adult-acute-and-acute-on-chronic-liver-failure-in-the-icu-cardiovascular-endocrine-hematologic-pulmonary-and-renal-considerations.html 2020-03-04T15:45:51.4220000Z https://www.medicinesresources.nhs.uk/fda-grants-rare-paediatric-disease-designation-for-elamipretide-for-barth-syndrome.html 2020-03-04T15:48:29.2240000Z https://www.medicinesresources.nhs.uk/givosiran-approved-for-use-in-the-eu-for-acute-hepatic-porphyria-ahp.html 2020-03-04T15:50:15.6880000Z https://www.medicinesresources.nhs.uk/fda-grants-breakthrough-therapy-designation-for-pirfenidone-in-unclassifiable-interstitial-lung-disease.html 2020-03-04T15:52:13.4360000Z https://www.medicinesresources.nhs.uk/state-of-child-health-in-the-uk.html 2020-03-04T15:53:57.2730000Z https://www.medicinesresources.nhs.uk/ensuring-access-to-safe-effective-and-affordable-cannabis-based-medicines.html 2020-03-04T15:56:02.7260000Z https://www.medicinesresources.nhs.uk/import-restrictions-changed-for-cannabis-based-medicines-to-allow-faster-access.html 2020-03-04T15:57:57.0380000Z https://www.medicinesresources.nhs.uk/how-we-will-continue-to-regulate-in-light-of-novel-coronavirus-covid-19.html 2020-03-04T15:59:57.3410000Z https://www.medicinesresources.nhs.uk/are-placebo-controls-necessary-in-controlled-human-infection-trials-for-vaccines.html 2020-03-04T16:01:30.1410000Z https://www.medicinesresources.nhs.uk/guidelines-for-pregnant-women-with-suspected-sars-cov-2-infection.html 2020-03-04T16:03:58.7680000Z https://www.medicinesresources.nhs.uk/systemic-sclerosis-associated-interstitial-lung-disease.html 2020-03-04T16:06:51.9760000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-data-for-selinexor-for-multiple-myeloma-in-phase-iii-trial.html 2020-03-04T16:11:48.1440000Z https://www.medicinesresources.nhs.uk/fda-approves-isatuximab-irfc-in-combination-with-pomalidomide-and-dexamethasone-for-relapsed-refractory-multiple-myeloma.html 2020-03-04T16:13:46.4790000Z https://www.medicinesresources.nhs.uk/nice-bites-leg-ulcer-infection.html 2020-03-05T11:43:01.3510000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-action-within-48-hours-patient-level-recall-ceska-republika-s-r-o-an-affiliate-of-bausch-and-lomb-uk-limited-emerade-150-micrograms-solution-for-injection-in-pre-filled-syringe.html 2020-03-05T20:31:56.2450000Z https://www.medicinesresources.nhs.uk/covid-19-nhs-preparedness-and-response-letter-from-the-nhs-strategic-incident-director-and-the-incident-director.html 2020-03-09T10:03:47.1050000Z https://www.medicinesresources.nhs.uk/standard-operating-procedure-for-coronavirus-priority-assessment-pods.html 2020-03-09T10:05:11.2120000Z https://www.medicinesresources.nhs.uk/revised-spc-dalacin-c-phosphate-clindamycin-sterile-solution.html 2020-03-05T16:13:08.6340000Z https://www.medicinesresources.nhs.uk/revised-spc-dioralyte-sachets-all-presentations.html 2020-03-05T16:14:57.1380000Z https://www.medicinesresources.nhs.uk/revised-spcs-neoclarityn-desloratadine-5-mg-film-coated-tablets-and-oral-solution.html 2020-03-05T16:16:12.2460000Z https://www.medicinesresources.nhs.uk/fda-requires-stronger-warning-about-risk-of-neuropsychiatric-events-associated-with-asthma-and-allergy-medication-singulair-and-generic-montelukast.html 2020-03-09T10:06:24.0640000Z https://www.medicinesresources.nhs.uk/egg-consumption-and-risk-of-cardiovascular-disease-three-large-prospective-us-cohort-studies-systematic-review-and-updated-meta-analysis.html 2020-03-05T16:20:11.4970000Z https://www.medicinesresources.nhs.uk/vaping-in-england-evidence-update-march-2020.html 2020-03-09T10:07:40.1980000Z https://www.medicinesresources.nhs.uk/the-uk-strategy-for-rare-diseases-2020-update-to-the-implementation-plan-for-england.html 2020-03-05T20:27:27.0170000Z https://www.medicinesresources.nhs.uk/the-nhs-nursing-workforce.html 2020-03-05T16:29:26.9850000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-february-2020.html 2020-03-09T10:10:01.2830000Z https://www.medicinesresources.nhs.uk/new-medicines-newsletter-february-2020.html 2020-03-09T10:11:48.3520000Z https://www.medicinesresources.nhs.uk/lower-carbohydrate-diets-for-adults-with-type-2-diabetes-draft-report.html 2020-03-05T16:34:41.9330000Z https://www.medicinesresources.nhs.uk/subcutaneous-remsima-infliximab-launched-in-uk.html 2020-03-05T20:23:54.9090000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-prime-status-granted-to-adeno-associated-virus-aav-rpgr-gene-therapy-for-treatment-of-inherited-retinal-disease-x-linked-retinitis-pigmentosa-xlrp.html 2020-03-05T16:38:32.9660000Z https://www.medicinesresources.nhs.uk/msd-announces-pembrolizumab-meets-one-of-primary-endpoints-in-phase-iii-keynote-204-trial-in-in-patients-with-relapsed-or-refractory-classical-hodgkin-lymphoma.html 2020-03-05T16:39:59.2090000Z https://www.medicinesresources.nhs.uk/competition-and-markets-authority-cma-rules-that-four-pharma-companies-are-guilty-of-anti-competitive-behaviour.html 2020-03-05T16:41:32.9050000Z https://www.medicinesresources.nhs.uk/achieving-scale-and-spread-learning-for-innovators-and-policy-makers.html 2020-03-05T16:42:34.9680000Z https://www.medicinesresources.nhs.uk/mental-health-crisis-services-rolled-out-across-england.html 2020-03-05T16:43:54.3860000Z https://www.medicinesresources.nhs.uk/pituitary-tumor-endocrinopathies.html 2020-08-10T11:55:47.4420000Z https://www.medicinesresources.nhs.uk/middle-east-respiratory-syndrome.html 2020-03-05T16:46:53.4200000Z https://www.medicinesresources.nhs.uk/feeling-the-strain-what-the-commonwealth-funds-2019-international-survey-of-general-practitioners-means-for-the-uk.html 2020-03-05T16:48:08.5910000Z https://www.medicinesresources.nhs.uk/how-we-re-responding-to-the-outbreak-of-coronavirus-letter-from-care-quality-commission.html 2020-03-05T16:49:30.8220000Z https://www.medicinesresources.nhs.uk/is-it-time-to-nationalise-the-pharmaceutical-industry.html 2020-03-05T16:50:28.3660000Z https://www.medicinesresources.nhs.uk/clinical-negligence-costs-taking-action-to-safeguard-nhs-sustainability.html 2020-03-05T20:19:16.3280000Z https://www.medicinesresources.nhs.uk/fda-accepts-biologics-license-application-and-grants-priority-review-for-tafasitamab-and-lenalidomide-for-treatment-of-relapsed-refractory-diffuse-large-b-cell-lymphoma.html 2020-03-05T16:53:15.7400000Z https://www.medicinesresources.nhs.uk/fda-accepts-filing-of-new-drug-application-investigational-antidepressant-ly03005.html 2020-03-05T16:54:17.5310000Z https://www.medicinesresources.nhs.uk/long-acting-cabotegravir-and-rilpivirine-for-maintenance-of-hiv-1-suppression.html 2020-08-07T12:27:03.1230000Z https://www.medicinesresources.nhs.uk/long-acting-cabotegravir-and-rilpivirine-after-oral-induction-for-hiv-1-infection.html 2020-08-07T13:24:13.0520000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-a-combination-of-olanzapine-and-samidorphan-in-adult-patients-with-an-acute-exacerbation-of-schizophrenia-outcomes-from-the-randomized-phase-3-enlighten-1-study.html 2020-03-05T17:03:22.5730000Z https://www.medicinesresources.nhs.uk/effect-of-a-workplace-based-multicomponent-intervention-on-hypertension-control-a-randomized-clinical-trial.html 2020-03-05T17:08:13.5300000Z https://www.medicinesresources.nhs.uk/associations-between-stopping-prescriptions-for-opioids-length-of-opioid-treatment-and-overdose-or-suicide-deaths-in-us-veterans-observational-evaluation.html 2020-03-05T17:09:39.4500000Z https://www.medicinesresources.nhs.uk/associations-of-habitual-fish-oil-supplementation-with-cardiovascular-outcomes-and-all-cause-mortality-evidence-from-a-large-population-based-cohort-study.html 2020-03-05T17:10:53.3400000Z https://www.medicinesresources.nhs.uk/the-long-term-effects-of-metformin-on-patients-with-type-2-diabetic-kidney-disease.html 2020-03-05T17:12:57.6840000Z https://www.medicinesresources.nhs.uk/early-childhood-antibiotic-treatment-for-otitis-media-and-other-respiratory-tract-infections-is-associated-with-risk-of-type-1-diabetes-a-nationwide-register-based-study-with-sibling-analysis.html 2020-03-05T17:16:56.7460000Z https://www.medicinesresources.nhs.uk/evaluation-of-association-between-oral-and-topical-terbinafine-use-in-pregnancy-and-risk-of-major-malformations-and-spontaneous-abortion.html 2020-03-09T10:14:27.6370000Z https://www.medicinesresources.nhs.uk/analysis-of-pharmacist-identified-medication-related-problems-at-two-united-kingdom-hospitals-a-prospective-observational-study.html 2020-03-05T17:19:12.2330000Z https://www.medicinesresources.nhs.uk/treatment-of-highly-drug-resistant-pulmonary-tuberculosis.html 2020-08-20T12:33:59.2690000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-new-drug-application-for-vibegron-for-the-treatment-of-overactive-bladder.html 2020-03-06T13:02:27.2300000Z https://www.medicinesresources.nhs.uk/european-medicines-agencys-committee-for-orphan-medicinal-products-issues-a-positive-opinion-for-orphan-drug-designation-of-acelarin-for-the-treatment-of-biliary-tract-cancer.html 2020-03-06T13:03:51.9480000Z https://www.medicinesresources.nhs.uk/us-fda-grants-orphan-drug-designation-to-umbralisib-for-the-treatment-of-follicular-lymphoma-fl.html 2020-03-06T13:05:10.6150000Z https://www.medicinesresources.nhs.uk/us-fda-approves-durysta-tm-bimatoprost-implant-intracameral-sustained-release-implant-to-lower-intraocular-pressure-in-patients-with-open-angle-glaucoma-or-ocular-hypertension.html 2020-03-06T13:06:53.9420000Z https://www.medicinesresources.nhs.uk/diet-nutrition-and-cancer-risk-what-do-we-know-and-what-is-the-way-forward.html 2020-03-06T13:08:09.5420000Z https://www.medicinesresources.nhs.uk/coronavirus-disease-2019-covid-19-a-guide-for-uk-gps.html 2020-03-09T10:20:24.5930000Z https://www.medicinesresources.nhs.uk/chief-medical-officer-alert-novel-coronavirus-message-for-all-clinical-staff-encountering-patients-with-respiratory-infections-arrived-from-overseas.html 2020-03-09T10:21:16.8120000Z https://www.medicinesresources.nhs.uk/viewpoint-regulating-medicines-in-a-globalized-world-with-increased-recognition-and-reliance-among-regulators.html 2020-03-06T13:13:30.6070000Z https://www.medicinesresources.nhs.uk/can-we-contain-the-covid-19-outbreak-with-the-same-measures-as-for-sars.html 2020-03-06T13:14:33.3720000Z https://www.medicinesresources.nhs.uk/new-product-vyndaqel-tafamidis-61-mg-soft-capsules.html 2020-03-06T15:55:16.1560000Z https://www.medicinesresources.nhs.uk/new-product-polivy-polatuzumab-vedotin-140-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-03-06T15:27:45.3850000Z https://www.medicinesresources.nhs.uk/revised-spc-feldene-melt-piroxicam-20mg-tablets.html 2020-03-06T15:29:41.9120000Z https://www.medicinesresources.nhs.uk/nice-publishes-draft-quality-standard-on-fetal-alcohol-spectrum-disorder-for-consultation.html 2020-03-06T15:31:25.9950000Z https://www.medicinesresources.nhs.uk/negative-results-from-phase-iii-danube-trial-of-durvalumab-in-metastatic-bladder-cancer.html 2020-03-06T15:32:52.1370000Z https://www.medicinesresources.nhs.uk/avatrombopag-for-treating-thrombocytopenia-in-people-with-chronic-liver-disease-needing-a-planned-invasive-procedure-final-appraisal-document.html 2020-03-06T15:34:26.7990000Z https://www.medicinesresources.nhs.uk/pharmacy-first-minor-ailments-scheme-covering-14-london-boroughs-to-close-at-end-of-march-2020.html 2020-03-06T15:35:30.0340000Z https://www.medicinesresources.nhs.uk/shining-a-spotlight-on-home-groups-governance-for-managing-medicines-safely-and-effectively-by-incorporating-nice-guideline-ng67.html 2020-03-06T15:41:10.6000000Z https://www.medicinesresources.nhs.uk/think-delirium-in-intensive-care.html 2020-03-06T15:47:26.2890000Z https://www.medicinesresources.nhs.uk/bronchiolitis-when-less-is-more.html 2020-03-06T15:53:22.5160000Z https://www.medicinesresources.nhs.uk/adjuvant-chemotherapy-in-upper-tract-urothelial-carcinoma-the-pout-trial-a-phase-3-open-label-randomised-controlled-trial.html 2020-03-06T16:51:50.7220000Z https://www.medicinesresources.nhs.uk/gps-understanding-of-the-benefits-and-harms-of-treatments-for-long-term-conditions-an-online-survey.html 2020-03-06T16:32:11.7750000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-liraglutide-3-0-mg-in-individuals-with-overweight-or-obesity-and-type-2-diabetes-treated-with-basal-insulin-the-scale-insulin-randomized-controlled-tria.html 2020-03-09T10:23:48.8430000Z https://www.medicinesresources.nhs.uk/agreement-and-accuracy-of-medication-persistence-identified-by-patient-self-report-vs-pharmacy-fill-a-secondary-analysis-of-the-cluster-randomized-artemis-trial.html 2020-03-06T16:41:48.4910000Z https://www.medicinesresources.nhs.uk/glycaemic-status-during-pregnancy-and-longitudinal-measures-of-fetal-growth-in-a-multi-racial-us-population-a-prospective-cohort-study.html 2020-03-06T16:43:50.4110000Z https://www.medicinesresources.nhs.uk/meta-analysis-of-intraocular-bleeding-with-dual-antiplatelet-therapy-using-p2y12-inhibitors-prasugrel-or-ticagrelor.html 2020-03-09T15:54:07.5890000Z https://www.medicinesresources.nhs.uk/mexiletine-namuscla-not-recommended-for-use-within-nhsscotland.html 2020-03-09T15:55:39.6210000Z https://www.medicinesresources.nhs.uk/blinatumomab-blincyto-accepted-for-restricted-use-within-nhsscotland.html 2020-03-09T15:58:16.2690000Z https://www.medicinesresources.nhs.uk/lorlatinib-lorviqua-accepted-for-use-within-nhsscotland-on-an-interim-basis-subject-to-ongoing-evaluation-and-reassessment.html 2020-03-09T16:00:41.1330000Z https://www.medicinesresources.nhs.uk/rucaparib-rubraca-accepted-for-restricted-use-within-nhsscotland.html 2020-03-09T16:05:58.6110000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-latest-information-and-advice.html 2020-03-09T16:18:20.9390000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-stereotactic-ablative-radiotherapy-sabr-for-hepatocellular-carcinoma-adults.html 2020-03-10T10:04:29.3650000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-stereotactic-ablative-radiotherapy-sabr-for-patients-with-metachronous-extracranial-oligometastatic-cancer-all-ages.html 2020-03-10T10:09:29.3260000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-dexrazoxane-for-preventing-cardiotoxicity-in-children-and-young-people-under-25-years-receiving-high-dose-anthracyclines-or-related-drugs-for-the-treatment-of-cancer.html 2020-03-10T10:14:32.9030000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-canakinumab-for-treating-periodic-fever-syndromes-traps-hids-mkd-and-fmf-ages-2-years-and-older.html 2020-03-10T10:19:22.7230000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-human-coagulation-factor-x-for-hereditary-factor-x-deficiency-all-ages.html 2020-03-10T10:23:18.1320000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-vonicog-alfa-for-the-treatment-and-prevention-of-bleeding-in-adults-with-von-willebrand-disease.html 2020-03-10T10:25:10.7030000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-temozolomide-as-adjuvant-treatment-for-people-with-newly-diagnosed-anaplastic-astrocytoma-without-1p-19q-codeletion-following-surgery-and-radiotherapy-adults.html 2020-03-10T10:28:53.3600000Z https://www.medicinesresources.nhs.uk/transitions-from-adolescent-secure-to-adult-secure-inpatient-services-practice-guidance-for-all-secure-services.html 2020-03-10T10:31:51.6210000Z https://www.medicinesresources.nhs.uk/new-product-beovu-brolucizumab-120-mg-ml-solution-for-injection-in-pre-filled-syringe.html 2020-03-09T16:21:07.4420000Z https://www.medicinesresources.nhs.uk/revised-spc-nebido-testosterone-undecanoate-1000mg-4ml-solution-for-injection.html 2020-03-09T16:22:53.9180000Z https://www.medicinesresources.nhs.uk/revised-spc-feraccru-iron-maltol-30mg-hard-capsules.html 2020-03-09T16:24:44.3060000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guidance-on-dupilumab-for-treating-severe-asthma-for-consultation.html 2020-03-09T16:26:24.7330000Z https://www.medicinesresources.nhs.uk/how-will-country-based-mitigation-measures-influence-the-course-of-the-covid-19-epidemic.html 2020-03-09T16:28:03.8040000Z https://www.medicinesresources.nhs.uk/lifestyle-and-risk-factor-modification-for-reduction-of-atrial-fibrillation-a-scientific-statement-from-the-american-heart-association.html 2020-07-16T11:32:15.7110000Z https://www.medicinesresources.nhs.uk/cobicistat-a-case-of-mislabelled-drug-drug-interaction-risk.html 2020-03-09T16:31:26.2890000Z https://www.medicinesresources.nhs.uk/coronavirus-disease-2019-covid-19-a-guide-for-uk-gps-1.html 2020-03-10T10:35:21.5180000Z https://www.medicinesresources.nhs.uk/european-commission-grants-approval-of-shorter-duration-of-glecaprevir-pibrentasvir-maviret-for-treatment-naive-genotype-3-hepatitis-c-virus-hcv-patients-with-compensated-cirrhosis.html 2020-03-09T16:35:22.2410000Z https://www.medicinesresources.nhs.uk/drug-currently-in-phase-ii-development-to-be-made-available-for-compassionate-use-in-serious-cases-of-coronivirus-infection.html 2020-03-09T17:21:07.9690000Z https://www.medicinesresources.nhs.uk/us-fda-approves-osilodrostat-for-treatment-of-cushing-s-disease.html 2020-03-09T16:39:27.2680000Z https://www.medicinesresources.nhs.uk/dalcetrapib-reduces-risk-of-new-onset-diabetes-in-patients-with-coronary-heart-disease.html 2020-03-09T17:28:19.4320000Z https://www.medicinesresources.nhs.uk/improving-physician-communication-about-treatment-decisions-reconsideration-of-risks-vs-benefits.html 2020-03-10T13:59:17.4600000Z https://www.medicinesresources.nhs.uk/revised-spc-epclusa-sofosbuvir-velpatasvir-400mg-100mg-film-coated-tablets.html 2020-03-10T14:00:49.4690000Z https://www.medicinesresources.nhs.uk/revised-spc-vosevi-sofosbuvir-velpatasvir-and-voxilaprevir-400mg-100mg-100mg-film-coated-tablets.html 2020-03-10T14:04:37.7750000Z https://www.medicinesresources.nhs.uk/revised-spc-mirapexin-pramipexole-tablets-all-strengths-and-presentations.html 2020-03-11T11:13:35.3690000Z https://www.medicinesresources.nhs.uk/addressing-the-potential-impact-of-novel-coronavirus-disease-covid-19-on-medicines-supply-in-the-eu.html 2020-03-11T11:21:59.3530000Z https://www.medicinesresources.nhs.uk/how-accurate-are-gps-at-integrating-evidence-into-prescribing-decisions.html 2020-03-10T14:08:15.0310000Z https://www.medicinesresources.nhs.uk/are-we-failing-people-with-multiple-health-conditions-an-expert-discussion.html 2020-03-10T14:09:24.5810000Z https://www.medicinesresources.nhs.uk/management-of-dependent-use-of-illicit-opioids.html 2020-03-10T14:10:44.4670000Z https://www.medicinesresources.nhs.uk/phase-iii-atlas-2m-study-evaluating-long-acting-cabotegravir-with-rilpivirine-administered-every-2-months-shows-similar-efficacy-to-once-monthly-administration.html 2020-03-10T14:11:52.2610000Z https://www.medicinesresources.nhs.uk/impact-of-skyrocketing-cost-of-rectal-indomethacin-in-usa.html 2020-03-10T14:13:01.3870000Z https://www.medicinesresources.nhs.uk/us-fda-issues-draft-guidance-for-evaluating-cardiovascular-safety-of-new-medicines-for-type-2-diabetes.html 2020-03-10T14:14:07.9190000Z https://www.medicinesresources.nhs.uk/us-fda-approves-nintedanib-ofev-for-progressive-interstitial-lung-diseases-ild.html 2020-03-10T14:15:10.1320000Z https://www.medicinesresources.nhs.uk/effectiveness-and-safety-of-apixaban-compared-with-rivaroxaban-for-patients-with-atrial-fibrillation-in-routine-practice-a-cohort-study.html 2020-03-10T14:16:25.6870000Z https://www.medicinesresources.nhs.uk/the-incubation-period-of-coronavirus-disease-2019-covid-19-from-publicly-reported-confirmed-cases-estimation-and-application.html 2020-03-10T15:27:38.8750000Z https://www.medicinesresources.nhs.uk/antibiotic-use-and-serious-complications-following-acute-otitis-media-and-acute-sinusitis-a-retrospective-cohort-study.html 2020-03-10T15:39:13.4260000Z https://www.medicinesresources.nhs.uk/medication-review-versus-usual-care-to-improve-drug-therapies-in-hospitalised-older-patients-admitted-to-internal-medicine-wards.html 2020-03-10T15:40:43.5200000Z https://www.medicinesresources.nhs.uk/efficacy-of-gabapentin-for-the-treatment-of-alcohol-use-disorder-in-patients-with-alcohol-withdrawal-symptoms-a-randomized-clinical-trial.html 2020-03-10T15:42:20.9310000Z https://www.medicinesresources.nhs.uk/association-between-renin-angiotensin-system-blockade-discontinuation-and-all-cause-mortality-among-persons-with-low-estimated-glomerular-filtration-rate.html 2020-03-10T15:44:18.4880000Z https://www.medicinesresources.nhs.uk/updated-analysis-from-keynote-189-pembrolizumab-or-placebo-plus-pemetrexed-and-platinum-for-previously-untreated-metastatic-nonsquamous-non-small-cell-lung-cancer.html 2020-07-16T09:56:19.4120000Z https://www.medicinesresources.nhs.uk/adjuvant-131i-metuximab-for-hepatocellular-carcinoma-after-liver-resection-a-randomised-controlled-multicentre-open-label-phase-2-trial.html 2020-03-10T16:08:04.1740000Z https://www.medicinesresources.nhs.uk/prescription-charge-to-rise-to-gbp9-15.html 2020-03-10T15:52:05.0930000Z https://www.medicinesresources.nhs.uk/what-role-do-taxes-and-regulation-play-in-promoting-better-health.html 2020-03-10T15:54:33.3900000Z https://www.medicinesresources.nhs.uk/pharmacists-to-receive-packs-of-gloves-aprons-and-masks-as-protection-against-covid-19.html 2020-03-11T11:26:50.1000000Z https://www.medicinesresources.nhs.uk/tinnitus-assessment-and-management-guidance-ng155-1.html 2020-03-16T09:50:07.6640000Z https://www.medicinesresources.nhs.uk/revised-spc-suliqua-lixisenatide-and-insulin-glargine-in-a-pre-filled-pen.html 2020-03-11T15:10:21.1080000Z https://www.medicinesresources.nhs.uk/revised-spc-alutard-bee-venom-products.html 2020-03-11T15:11:17.1800000Z https://www.medicinesresources.nhs.uk/revised-spc-zyprexa-olanzapine-preparations.html 2020-03-11T15:12:33.8110000Z https://www.medicinesresources.nhs.uk/use-of-fall-risk-increasing-drugs-around-a-fall-related-injury-in-older-adults-a-systematic-review.html 2020-03-11T15:14:07.0940000Z https://www.medicinesresources.nhs.uk/improving-the-quality-of-bowel-preparation-through-an-app-for-inpatients-undergoing-colonoscopy-a-randomized-controlled-trial.html 2020-03-11T15:16:10.4620000Z https://www.medicinesresources.nhs.uk/clinical-course-and-risk-factors-for-mortality-of-adult-inpatients-with-covid-19-in-wuhan-china-a-retrospective-cohort-study.html 2020-03-11T15:18:06.3620000Z https://www.medicinesresources.nhs.uk/evidence-for-hiv-1-cure-after-ccr5d32-d32-allogeneic-haemopoietic-stem-cell-transplantation-30-months-post-analytical-treatment-interruption-a-case-report.html 2020-03-11T15:19:26.5840000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-launch-of-lusutrombopag.html 2020-03-11T15:21:46.1840000Z https://www.medicinesresources.nhs.uk/novel-coronavirus-advice-for-the-nhs-in-england-updated-10th-march.html 2020-03-11T15:23:08.2870000Z https://www.medicinesresources.nhs.uk/nhs-unveils-package-of-measures-to-help-people-find-trusted-health-information-online.html 2020-03-16T09:55:40.1510000Z https://www.medicinesresources.nhs.uk/full-length-nhs-standard-contract-2020-21-particulars-service-conditions-general-conditions.html 2020-03-11T15:25:18.6140000Z https://www.medicinesresources.nhs.uk/science-in-healthcare-delivering-the-nhs-long-term-plan-the-chief-scientific-officers-strategy.html 2020-03-11T15:26:14.6490000Z https://www.medicinesresources.nhs.uk/supported-self-management-summary-guide.html 2020-03-11T15:29:07.1610000Z https://www.medicinesresources.nhs.uk/common-ambition.html 2020-03-11T15:31:16.3690000Z https://www.medicinesresources.nhs.uk/class-4-drug-alert-for-information-mylan-uk-healthcare-limited-aripiprazole-1mg-ml-oral-solution.html 2020-03-16T09:59:01.7750000Z https://www.medicinesresources.nhs.uk/revised-spc-venclyxto-venetoclax-film-coated-tablets-all-strengths.html 2020-03-12T16:03:53.4420000Z https://www.medicinesresources.nhs.uk/revised-spc-maviret-glecaprevir-and-pibrentasvir-100-mg-40-mg-film-coated-tablets.html 2020-03-12T16:05:36.8470000Z https://www.medicinesresources.nhs.uk/revised-spcs-brintellix-vortioxetine-film-coated-tablets-all-strengths.html 2020-03-12T16:06:47.6970000Z https://www.medicinesresources.nhs.uk/administration-of-tobramycin-via-a-nebuliser.html 2020-03-16T10:07:16.4460000Z https://www.medicinesresources.nhs.uk/prevention-of-psychosis-advances-in-detection-prognosis-and-intervention.html 2020-03-12T16:09:36.3300000Z https://www.medicinesresources.nhs.uk/absolute-risk-of-tuberculosis-among-untreated-populations-with-a-positive-tuberculin-skin-test-or-interferon-gamma-release-assay-result-systematic-review-and-meta-analysis.html 2020-03-12T16:11:31.8330000Z https://www.medicinesresources.nhs.uk/dtb-select-can-a-point-of-care-crp-test-reduce-antibiotic-use-in-copd.html 2020-03-12T16:13:31.4340000Z https://www.medicinesresources.nhs.uk/dtb-select-no-benefit-of-faecal-microbiota-transplantation-for-ibs-d.html 2020-03-12T16:15:14.0220000Z https://www.medicinesresources.nhs.uk/dolutegravir-rilpivirine-for-treating-hiv-1-in-adults.html 2020-03-16T10:16:17.7280000Z https://www.medicinesresources.nhs.uk/dolutegravir-lamivudine-for-the-treatment-of-human-immunodeficiency-virus-hiv-1-infected-adults-and-adolescents-over-12-years-of-age.html 2020-03-16T10:19:24.3390000Z https://www.medicinesresources.nhs.uk/ssp-issued-for-fluoxetine-10mg-tablets.html 2020-03-16T10:21:10.2930000Z https://www.medicinesresources.nhs.uk/the-race-to-stop-covid-19.html 2020-03-12T16:20:45.9920000Z https://www.medicinesresources.nhs.uk/pembrolizumab-for-treating-locally-advanced-or-metastatic-urothelial-carcinoma-after-platinum-containing-chemotherapy-final-appraisal-document.html 2020-03-12T16:22:08.0850000Z https://www.medicinesresources.nhs.uk/nhs-to-ramp-up-coronavirus-testing-labs.html 2020-03-12T16:23:19.3050000Z https://www.medicinesresources.nhs.uk/informing-patients-about-expected-outcomes-the-efficacy-effectiveness-gap.html 2020-07-10T09:48:01.3690000Z https://www.medicinesresources.nhs.uk/care-for-critically-ill-patients-with-covid-19.html 2020-03-12T16:29:47.1080000Z https://www.medicinesresources.nhs.uk/getting-safer-faster-key-areas-for-improvement-in-maternity-services.html 2020-03-12T16:30:57.3750000Z https://www.medicinesresources.nhs.uk/continuing-professional-development-requirements-for-uk-health-professionals-a-scoping-review.html 2020-03-12T16:31:57.2570000Z https://www.medicinesresources.nhs.uk/when-to-suspect-a-non-melanoma-skin-cancer.html 2020-03-12T16:33:09.1430000Z https://www.medicinesresources.nhs.uk/covid-19-who-declares-pandemic-because-of-alarming-levels-of-spread-severity-and-inaction.html 2020-03-12T16:34:33.4140000Z https://www.medicinesresources.nhs.uk/inappropriate-use-of-progression-free-survival-in-cancer-drug-approvals.html 2020-03-12T16:35:39.3620000Z https://www.medicinesresources.nhs.uk/improving-researchers-conflict-of-interest-declarations.html 2020-03-12T16:36:49.0640000Z https://www.medicinesresources.nhs.uk/elotuzumab-fails-late-stage-multiple-myeloma-trial-eloquent-1.html 2020-03-12T16:38:32.7760000Z https://www.medicinesresources.nhs.uk/fda-approves-combination-of-nivolumab-and-ipilimumab-as-treatment-for-hepatocellular-carcinoma-in-patients-who-have-been-previously-treated-with-sorafenib.html 2020-03-12T16:40:17.8980000Z https://www.medicinesresources.nhs.uk/update-on-phase-3-gy004-of-cediranib-and-olaparib-in-platinum-sensitive-relapsed-ovarian-cancer.html 2020-03-12T16:41:54.6710000Z https://www.medicinesresources.nhs.uk/fremanezumab-for-preventing-migraine-final-appraisal-document.html 2020-03-12T16:43:16.2600000Z https://www.medicinesresources.nhs.uk/cardiovascular-health-trajectories-from-childhood-through-middle-age-and-their-association-with-subclinical-atherosclerosis.html 2020-03-12T17:05:31.8860000Z https://www.medicinesresources.nhs.uk/association-of-the-duration-of-ideal-cardiovascular-health-through-adulthood-with-cardiometabolic-outcomes-and-mortality-in-the-framingham-offspring-study.html 2020-03-12T17:07:58.4430000Z https://www.medicinesresources.nhs.uk/an-investigation-into-prescribing-errors-made-by-independent-pharmacist-prescribers-and-medical-prescribers-at-a-large-acute-nhs-hospital-trust-a-cross-sectional-study.html 2020-03-12T17:10:15.6780000Z https://www.medicinesresources.nhs.uk/incidence-and-associations-of-chronic-kidney-disease-in-community-participants-with-diabetes-a-5-year-prospective-analysis-of-the-extend45-study.html 2020-03-12T17:12:19.0300000Z https://www.medicinesresources.nhs.uk/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation-and-advanced-chronic-kidney-disease.html 2020-07-16T12:17:30.4650000Z https://www.medicinesresources.nhs.uk/early-dynamics-of-transmission-and-control-of-covid-19-a-mathematical-modelling-study.html 2020-03-12T17:15:35.2220000Z https://www.medicinesresources.nhs.uk/association-of-aspirin-with-hepatocellular-carcinoma-and-liver-related-mortality.html 2020-08-07T13:38:31.1270000Z https://www.medicinesresources.nhs.uk/consequences-of-undervaccination-measles-outbreak-new-york-city-2018-2019.html 2020-08-27T14:21:16.7710000Z https://www.medicinesresources.nhs.uk/new-product-adynovi-rurioctocog-alfa-pegol-1000-iu-powder-and-solvent-for-solution-for-injection-2-ml-solvent.html 2020-03-13T15:22:53.5290000Z https://www.medicinesresources.nhs.uk/revised-spc-dioralyte-products.html 2020-03-13T15:25:29.8670000Z https://www.medicinesresources.nhs.uk/comparison-of-carboplatin-plus-pemetrexed-followed-by-maintenance-pemetrexed-with-docetaxel-monotherapy-in-elderly-patients-with-advanced-nonsquamous-non-small-cell-lung-cancer-a-phase-3-randomized-clinical-trial.html 2020-03-13T15:27:35.2890000Z https://www.medicinesresources.nhs.uk/pertuzumab-trastuzumab-and-docetaxel-for-her2-positive-metastatic-breast-cancer-cleopatra-end-of-study-results-from-a-double-blind-randomised-placebo-controlled-phase-3-study.html 2020-03-13T16:26:51.6260000Z https://www.medicinesresources.nhs.uk/is-e-cigarette-use-in-non-smoking-young-adults-associated-with-later-smoking-a-systematic-review-and-meta-analysis.html 2020-03-13T16:22:31.4810000Z https://www.medicinesresources.nhs.uk/us-fda-grants-fast-track-designation-to-empagliflozin-for-the-treatment-of-chronic-kidney-disease-in-adults.html 2020-03-13T15:32:45.1350000Z https://www.medicinesresources.nhs.uk/novel-coronavirus-advice-for-the-nhs-in-england.html 2020-03-16T10:34:46.7250000Z https://www.medicinesresources.nhs.uk/new-guide-to-help-people-keep-safe-when-getting-medicines-or-treatment-online.html 2020-03-13T15:35:19.7300000Z https://www.medicinesresources.nhs.uk/supporting-the-health-care-workforce-during-the-covid-19-global-epidemic.html 2020-03-13T15:36:47.6880000Z https://www.medicinesresources.nhs.uk/initiation-of-pharmacological-therapy-in-parkinson-s-disease-when-why-and-how.html 2020-03-13T15:38:34.8650000Z https://www.medicinesresources.nhs.uk/covid-19-stay-at-home-guidance.html 2020-03-16T10:39:38.6540000Z https://www.medicinesresources.nhs.uk/critical-care-utilization-for-the-covid-19-outbreak-in-lombardy-italy-early-experience-and-forecast-during-an-emergency-response.html 2020-03-23T13:04:10.8220000Z https://www.medicinesresources.nhs.uk/from-containment-to-mitigation-of-covid-19-in-the-us.html 2020-03-16T15:52:37.8770000Z https://www.medicinesresources.nhs.uk/why-test-for-proportional-hazards.html 2020-03-16T15:28:39.8240000Z https://www.medicinesresources.nhs.uk/when-guidelines-recommend-shared-decision-making.html 2020-03-16T16:02:05.0860000Z https://www.medicinesresources.nhs.uk/new-guide-to-help-people-keep-safe-when-getting-medicines-or-treatment-online-1.html 2020-03-23T09:53:29.1390000Z https://www.medicinesresources.nhs.uk/revised-spc-lamictal-lamotrigine-tablets-and-dispersible-tablets.html 2020-03-16T15:34:22.7140000Z https://www.medicinesresources.nhs.uk/pharmacovigilance-risk-assessment-committee-prac-provides-new-testing-and-treatment-recommendations-for-fluorouracil-capecitabine-tegafur-and-flucytosine.html 2020-03-16T15:36:22.9900000Z https://www.medicinesresources.nhs.uk/pharmacovigilance-risk-assessment-committee-prac-starts-review-of-ifosfamide-containing-medicines.html 2020-03-16T15:37:53.7430000Z https://www.medicinesresources.nhs.uk/pharmacovigilance-risk-assessment-committee-prac-recommends-suspension-of-ulipristal-acetate-for-uterine-fibroids-during-ongoing-ema-review-of-liver-injury-risk.html 2020-03-16T15:40:14.4510000Z https://www.medicinesresources.nhs.uk/covid-19-developers-of-medicines-or-vaccines-to-benefit-from-free-scientific-advice-from-the-european-medicines-agency.html 2020-03-16T15:41:47.0330000Z https://www.medicinesresources.nhs.uk/novel-coronavirus-13-march-community-swabbing-services.html 2020-03-23T13:06:26.0420000Z https://www.medicinesresources.nhs.uk/video-consultations-for-covid-19.html 2020-03-16T15:45:06.9610000Z https://www.medicinesresources.nhs.uk/fda-approves-roches-coronavirus-test-under-emergency-use-authorisation.html 2020-03-16T15:46:43.9090000Z https://www.medicinesresources.nhs.uk/risk-factors-associated-with-acute-respiratory-distress-syndrome-and-death-in-patients-with-coronavirus-disease-2019-pneumonia-in-wuhan-china.html 2020-03-16T15:48:48.0850000Z https://www.medicinesresources.nhs.uk/phase-iii-study-javelin-evaluating-avelumab-for-advanced-head-and-neck-cancer-to-be-terminated-early.html 2020-03-16T16:04:07.5980000Z https://www.medicinesresources.nhs.uk/covid-19-delay-mitigate-and-communicate.html 2020-03-16T16:05:49.5670000Z https://www.medicinesresources.nhs.uk/covid-19-a-pandemic-or-not.html 2020-03-16T16:07:30.7270000Z https://www.medicinesresources.nhs.uk/covid-19-and-italy-what-next.html 2020-03-23T13:07:42.8010000Z https://www.medicinesresources.nhs.uk/guselkumab-in-patients-with-active-psoriatic-arthritis-who-were-biologic-naive-or-had-previously-received-tnfa-inhibitor-treatment-discover-1-a-double-blind-randomised-placebo-controlled-phase-3-trial.html 2020-03-16T16:12:25.0430000Z https://www.medicinesresources.nhs.uk/guselkumab-in-biologic-naive-patients-with-active-psoriatic-arthritis-discover-2-a-double-blind-randomised-placebo-controlled-phase-3-trial.html 2020-03-16T16:16:03.1130000Z https://www.medicinesresources.nhs.uk/revised-spc-ameluz-5-aminolevulinic-acid-hydrochloride-78mg-g-gel.html 2020-03-17T15:20:59.2470000Z https://www.medicinesresources.nhs.uk/revised-spc-efexor-xl-venlafaxine-hard-prolonged-release-capsules-all-strengths.html 2020-03-17T15:22:22.5290000Z https://www.medicinesresources.nhs.uk/mobile-messaging-with-patients.html 2020-03-17T15:23:28.2790000Z https://www.medicinesresources.nhs.uk/on-the-front-lines-of-coronavirus-the-italian-response-to-covid-19.html 2020-03-17T15:24:58.9860000Z https://www.medicinesresources.nhs.uk/redesigning-safety-regulation-in-the-nhs.html 2020-03-17T15:25:57.2570000Z https://www.medicinesresources.nhs.uk/coronavirus-us-volunteers-test-first-vaccine.html 2020-03-23T15:14:21.2120000Z https://www.medicinesresources.nhs.uk/phase-2-proof-of-concept-study-evaluating-aviptadil-for-treatment-of-covid-induced-acute-respiratory-distress-syndrome-ards-to-be-initiated.html 2020-03-23T15:13:26.1400000Z https://www.medicinesresources.nhs.uk/phase-iii-cough-1-and-cough-2-trials-evaluating-gefapixant-for-refractory-or-unexplained-chronic-cough-meet-primary-endpoints.html 2020-03-17T15:29:33.1860000Z https://www.medicinesresources.nhs.uk/studies-using-randomized-trial-data-to-compare-nonrandomized-exposures.html 2020-03-17T15:30:42.5050000Z https://www.medicinesresources.nhs.uk/dual-versus-triple-therapy-for-atrial-fibrillation-after-percutaneous-coronary-intervention-a-systematic-review-and-meta-analysis.html 2020-03-17T15:32:31.1580000Z https://www.medicinesresources.nhs.uk/rivaroxaban-plus-aspirin-versus-aspirin-alone-in-patients-with-prior-percutaneous-coronary-intervention-compass-pci.html 2020-07-22T13:07:24.3260000Z https://www.medicinesresources.nhs.uk/position-statement-of-the-british-cardiovascular-society-on-hypertension-on-ace-inhibitors-and-angiotensin-receptor-blockers.html 2020-03-23T15:12:33.8020000Z https://www.medicinesresources.nhs.uk/phase-iii-study-evaluating-prophylactic-concizumab-for-haemophilia-a-and-b-terminated-early.html 2020-03-17T15:57:26.7640000Z https://www.medicinesresources.nhs.uk/screening-of-faecal-microbiota-transplant-donors-during-the-covid-19-outbreak-suggestions-for-urgent-updates-from-an-international-expert-panel.html 2020-03-17T16:13:00.4960000Z https://www.medicinesresources.nhs.uk/tinnitus.html 2020-03-17T16:04:46.4040000Z https://www.medicinesresources.nhs.uk/editorial-concern-possible-reporting-of-the-same-patients-with-covid-19-in-different-reports.html 2020-03-23T13:11:36.4820000Z https://www.medicinesresources.nhs.uk/advice-on-use-of-ibuprofen-in-patients-with-covid-19.html 2020-03-17T16:16:39.7610000Z https://www.medicinesresources.nhs.uk/managing-covid-19-in-low-and-middle-income-countries.html 2020-03-17T16:17:18.6840000Z https://www.medicinesresources.nhs.uk/not-all-hypertension-is-a-lifelong-disease-a-teachable-moment.html 2020-03-17T16:18:27.2540000Z https://www.medicinesresources.nhs.uk/development-and-validation-of-a-penicillin-allergy-clinical-decision-rule.html 2020-03-17T16:20:29.6690000Z https://www.medicinesresources.nhs.uk/revised-spc-immodium-loperamide-preparations.html 2020-03-18T15:34:20.1250000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-action-within-48-hours-patient-level-recall-esmya-5mg-tablets-ulipristal-acetate.html 2020-03-23T12:23:37.2040000Z https://www.medicinesresources.nhs.uk/novel-coronavirus-anti-inflammatory-medications.html 2020-03-23T15:10:52.8340000Z https://www.medicinesresources.nhs.uk/evidence-of-detrimental-effects-of-prenatal-alcohol-exposure-on-offspring-birthweight-and-neurodevelopment-from-a-systematic-review-of-quasi-experimental-studies-1.html 2020-03-18T15:39:19.6170000Z https://www.medicinesresources.nhs.uk/psychiatric-symptoms-caused-by-cannabis-constituents-a-systematic-review-and-meta-analysis.html 2020-03-18T15:41:10.0280000Z https://www.medicinesresources.nhs.uk/c-reactive-protein-point-of-care-testing-for-safely-reducing-antibiotics-for-acute-exacerbations-of-chronic-obstructive-pulmonary-disease-the-pace-rct.html 2020-03-18T15:42:19.3410000Z https://www.medicinesresources.nhs.uk/non-inferiority-trials-to-evaluate-drug-effects-in-rheumatoid-arthritis.html 2020-03-18T15:43:38.3280000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-outcomes-for-durvalumab-in-first-line-treatment-of-extensive-stage-small-cell-lung-cancer-though-addition-of-tremelimumab-provides-no-benefit.html 2020-03-18T15:45:41.1940000Z https://www.medicinesresources.nhs.uk/covid-19-and-community-mitigation-strategies-in-a-pandemic.html 2020-03-18T15:46:56.3090000Z https://www.medicinesresources.nhs.uk/aerosol-and-surface-stability-of-sars-cov-2-as-compared-with-sars-cov-1.html 2020-08-07T11:47:31.6180000Z https://www.medicinesresources.nhs.uk/what-role-should-the-commercial-food-system-play-in-promoting-health-through-better-diet.html 2020-03-18T15:49:06.6750000Z https://www.medicinesresources.nhs.uk/coronaviruses-and-the-cardiovascular-system-acute-and-long-term-implications.html 2020-03-18T15:50:24.5190000Z https://www.medicinesresources.nhs.uk/measles-eradication-retreating-is-not-an-option.html 2020-03-18T15:51:20.7720000Z https://www.medicinesresources.nhs.uk/empagliflozin-granted-fast-track-designation-by-fda-for-reducing-the-risk-of-kidney-disease-progression.html 2020-03-18T15:52:23.9060000Z https://www.medicinesresources.nhs.uk/revised-spcs-zofran-ondansetron-tablets-all-presentations-1.html 2020-03-19T19:07:36.3690000Z https://www.medicinesresources.nhs.uk/revised-spcs-botox-botulinum-toxin-type-a-100-and-200-units-powder-for-solution-for-injection.html 2020-03-19T19:06:31.7680000Z https://www.medicinesresources.nhs.uk/mepact-4mg-mifamurtide-potential-for-filter-leakage-or-malfunction.html 2020-03-19T19:05:51.9300000Z https://www.medicinesresources.nhs.uk/benzodiazepines-and-opioids-reminder-of-risk-of-potentially-fatal-respiratory-depression.html 2020-03-23T11:57:29.7440000Z https://www.medicinesresources.nhs.uk/sglt2-inhibitors-monitor-ketones-in-blood-during-treatment-interruption-for-surgical-procedures-or-acute-serious-medical-illness.html 2020-03-23T11:55:34.1700000Z https://www.medicinesresources.nhs.uk/baricitinib-olumiant-risk-of-venous-thromboembolism.html 2020-03-23T11:50:52.4170000Z https://www.medicinesresources.nhs.uk/tofacitinib-xeljanz-new-measures-to-minimise-risk-of-venous-thromboembolism-and-of-serious-and-fatal-infections.html 2020-03-23T11:49:21.0350000Z https://www.medicinesresources.nhs.uk/esmya-ulipristal-acetate-suspension-of-the-licence-due-to-risk-of-serious-liver-injury.html 2020-03-23T11:47:15.7640000Z https://www.medicinesresources.nhs.uk/association-between-suicide-reporting-in-the-media-and-suicide-systematic-review-and-meta-analysis.html 2020-03-19T18:56:49.3990000Z https://www.medicinesresources.nhs.uk/dtb-select-more-data-on-the-association-between-ppis-and-fracture-risk.html 2020-03-19T18:55:50.1350000Z https://www.medicinesresources.nhs.uk/dtb-select-updated-evidence-for-oral-mucolytics-in-copd.html 2020-03-19T18:55:10.1520000Z https://www.medicinesresources.nhs.uk/dtb-select-what-evidence-for-bisphosphonate-drug-holidays.html 2020-03-19T18:54:11.8080000Z https://www.medicinesresources.nhs.uk/inclisiran-for-the-treatment-of-heterozygous-familial-hypercholesterolemia.html 2020-08-07T13:50:10.7210000Z https://www.medicinesresources.nhs.uk/two-phase-3-trials-of-inclisiran-in-patients-with-elevated-ldl-cholesterol.html 2020-08-07T13:37:23.4720000Z https://www.medicinesresources.nhs.uk/a-trial-of-lopinavir-ritonavir-in-adults-hospitalized-with-severe-covid-19.html 2020-08-07T14:24:58.1540000Z https://www.medicinesresources.nhs.uk/selumetinib-in-children-with-inoperable-plexiform-neurofibromas.html 2020-08-27T14:27:34.9990000Z https://www.medicinesresources.nhs.uk/outcome-reporting-bias-in-cochrane-systematic-reviews-a-cross-sectional-analysis.html 2020-03-19T18:46:10.6180000Z https://www.medicinesresources.nhs.uk/why-do-patients-take-part-in-research-an-overview-of-systematic-reviews-of-psychosocial-barriers-and-facilitators.html 2020-03-19T18:45:30.3070000Z https://www.medicinesresources.nhs.uk/associations-of-fat-and-carbohydrate-intake-with-cardiovascular-disease-and-mortality-prospective-cohort-study-of-uk-biobank-participants.html 2020-03-19T18:44:38.5380000Z https://www.medicinesresources.nhs.uk/drug-associated-adverse-events-in-the-treatment-of-multidrug-resistant-tuberculosis-an-individual-patient-data-meta-analysis.html 2020-03-19T18:43:45.7360000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-rituximab-in-neuromyelitis-optica-spectrum-disorders-rin-1-study-a-multicentre-randomised-double-blind-placebo-controlled-trial.html 2020-03-19T18:41:30.3610000Z https://www.medicinesresources.nhs.uk/timing-of-high-efficacy-therapy-for-multiple-sclerosis-a-retrospective-observational-cohort-study.html 2020-03-19T18:40:06.2650000Z https://www.medicinesresources.nhs.uk/abdominal-aortic-aneurysm-diagnosis-and-management-nice-guideline-ng156.html 2020-03-23T11:34:21.0980000Z https://www.medicinesresources.nhs.uk/natrox-oxygen-wound-therapy-for-managing-diabetic-foot-ulcers-and-complex-or-chronic-non-healing-wounds-medtech-innovation-briefing-mib208.html 2020-03-23T11:30:57.7590000Z https://www.medicinesresources.nhs.uk/specialty-guides-for-patient-management-during-the-coronavirus-cv-pandemic.html 2020-03-23T15:08:30.2330000Z https://www.medicinesresources.nhs.uk/covid-19-roche-starts-clinical-trial-as-uk-cases-continue-to-rise.html 2020-03-20T02:11:46.2640000Z https://www.medicinesresources.nhs.uk/messaging-tool-for-nhs-to-support-remote-working-during-coronavirus-outbreak.html 2020-03-19T18:29:42.6900000Z https://www.medicinesresources.nhs.uk/data-and-services-to-support-the-management-of-coronavirus.html 2020-03-19T18:24:54.0360000Z https://www.medicinesresources.nhs.uk/ccg-outcomes-indicator-set-march-2020.html 2020-03-19T18:17:35.8630000Z https://www.medicinesresources.nhs.uk/childhood-immunisation-statistics-ccg-gp-practice-level-coverage-dashboard-2018-19.html 2020-03-19T18:16:48.4780000Z https://www.medicinesresources.nhs.uk/managing-potential-supply-issues-with-medicines-during-coronavirus-covid-23.html 2020-03-19T17:46:48.5210000Z https://www.medicinesresources.nhs.uk/clinical-trials-applications-for-coronavirus-covid-19.html 2020-03-19T17:48:23.3010000Z https://www.medicinesresources.nhs.uk/managing-clinical-trials-during-coronavirus-covid-19.html 2020-03-23T15:07:30.9390000Z https://www.medicinesresources.nhs.uk/losartan-and-hydroxychloroquine-being-tested-in-u-s-for-potential-use-in-coronavirus.html 2020-03-19T19:14:51.4510000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-new-drug-application-in-us-for-voclosporin-for-lupus-nephritis.html 2020-03-19T19:16:44.1050000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-data-for-coagulation-factor-xa-recombinant-inactivated-zhzo.html 2020-03-19T19:23:59.2680000Z https://www.medicinesresources.nhs.uk/baricitinib-granted-breakthrough-therapy-designation-btd-in-us-for-treatment-of-alopecia-areata.html 2020-03-19T19:29:37.1610000Z https://www.medicinesresources.nhs.uk/setmelanotide-receives-orphan-designation-in-us-for-the-treatment-of-alstroem-syndrome.html 2020-03-19T19:32:05.1890000Z https://www.medicinesresources.nhs.uk/manufacturers-announces-positive-results-for-abrocitinib-for-moderate-to-severe-atopic-dermatitis-in-phase-iii-trial.html 2020-03-19T19:33:43.3230000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-development-of-anti-gm-csf-monoclonal-antibody-to-prevent-and-treat-acute-respiratory-distress-syndrome-in-patients-with-covid-19.html 2020-03-19T19:35:20.8370000Z https://www.medicinesresources.nhs.uk/johnson-and-johnson-highlight-darunavir-not-been-proven-to-be-effective-treatment-for-covid-19.html 2020-03-19T19:40:55.8900000Z https://www.medicinesresources.nhs.uk/supply-of-standard-export-pack-of-typhim-vi-solution-for-injection-pl-46602-0008-lot-r2a244m-expiry-30-04-2021-single-packs.html 2020-03-19T19:46:15.4690000Z https://www.medicinesresources.nhs.uk/health-security-capacities-in-the-context-of-covid-19-outbreak-an-analysis-of-international-health-regulations-annual-report-data-from-182-countries.html 2020-03-19T19:47:39.5740000Z https://www.medicinesresources.nhs.uk/management-of-kidney-stones-in-2020.html 2020-03-19T19:49:52.5420000Z https://www.medicinesresources.nhs.uk/the-healthcare-and-pharmaceutical-vulnerability-emerging-from-the-new-coronavirus-outbreak.html 2020-03-19T19:57:10.4370000Z https://www.medicinesresources.nhs.uk/first-regulatory-workshop-on-covid-19-facilitates-global-collaboration-on-vaccine-development.html 2020-03-19T19:59:03.5770000Z https://www.medicinesresources.nhs.uk/call-to-pool-research-resources-into-large-multi-centre-multi-arm-clinical-trials-to-generate-sound-evidence-on-covid-19-treatments.html 2020-03-19T20:00:21.9140000Z https://www.medicinesresources.nhs.uk/republished-case-report-sertraline-induced-hypersensitivity-pneumonitis.html 2020-03-19T20:02:43.1300000Z https://www.medicinesresources.nhs.uk/new-psychoactive-substances-themed-issue-bjcp.html 2020-03-19T20:04:30.3370000Z https://www.medicinesresources.nhs.uk/management-of-anca-associated-vasculitis.html 2020-03-19T20:06:22.6160000Z https://www.medicinesresources.nhs.uk/hereditary-angioedema.html 2020-08-10T11:15:33.4260000Z https://www.medicinesresources.nhs.uk/covid-19-the-law-and-limits-of-quarantine.html 2020-08-10T11:01:01.2670000Z https://www.medicinesresources.nhs.uk/facing-covid-19-in-italy-ethics-logistics-and-therapeutics-on-the-epidemics-front-line.html 2020-10-01T12:54:40.4910000Z https://www.medicinesresources.nhs.uk/revised-spc-rezolsta-darunavir-cobicistat-800-mg-150-mg-film-coated-tablets-1.html 2020-03-20T15:33:38.1440000Z https://www.medicinesresources.nhs.uk/february-bnf-bnfc-newsletter.html 2020-03-23T10:51:50.5640000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-urgent-policy-statement-uridine-triacetate-for-the-treatment-of-patients-exhibiting-early-onset-severe-toxicities-following-5-fluorouracil-or-capecitabine-administration-all-ages.html 2020-03-23T10:49:54.4060000Z https://www.medicinesresources.nhs.uk/us-fda-extends-approval-of-epclusa-sofosbuvir-and-velpatasvir-to-include-treatment-of-children-with-hepatitis-c-virus-hcv.html 2020-03-20T15:39:04.4900000Z https://www.medicinesresources.nhs.uk/guidance-for-schools-colleges-and-local-authorities-on-maintaining-educational-provision.html 2020-03-23T13:10:00.6140000Z https://www.medicinesresources.nhs.uk/each-baby-counts-2019-progress-review.html 2020-03-20T15:45:26.2040000Z https://www.medicinesresources.nhs.uk/covid-19-uk-government-calls-on-industry-to-help-boost-testing-capacity-and-to-develop-self-test.html 2020-03-20T15:46:28.5970000Z https://www.medicinesresources.nhs.uk/class-4-falsified-medicines-directive-fmd-drug-alert-hms-wholesale-limited-multiple-products.html 2020-03-23T10:45:07.1460000Z https://www.medicinesresources.nhs.uk/ucial-medicines-protected-for-coronavirus-covid-19-patients.html 2020-03-23T15:05:39.3700000Z https://www.medicinesresources.nhs.uk/generating-comparative-evidence-on-new-drugs-and-devices-before-approval.html 2020-03-20T16:52:19.8680000Z https://www.medicinesresources.nhs.uk/generating-comparative-evidence-on-new-drugs-and-devices-after-approval.html 2020-03-20T16:51:15.8360000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-issues-guidance-for-pharmacists-on-packing-down-paracetamol.html 2020-03-23T15:04:52.5580000Z https://www.medicinesresources.nhs.uk/nhs-england-issues-latest-covid-19-guidance-for-general-practice.html 2020-03-23T15:02:27.9700000Z https://www.medicinesresources.nhs.uk/pharmacies-across-the-uk-close-intermittently-to-cope-with-increasing-pressures-from-covid-19.html 2020-03-23T15:01:37.1300000Z https://www.medicinesresources.nhs.uk/impact-of-direct-oral-anticoagulant-off-label-doses-on-clinical-outcomes-of-atrial-fibrillation-patients-a-systematic-review.html 2020-03-23T10:28:17.8680000Z https://www.medicinesresources.nhs.uk/the-effects-of-intensive-glycemic-control-on-clinical-outcomes-among-patients-with-type-2-diabetes-with-different-levels-of-cardiovascular-risk-and-hemoglobin-a1c-in-the-advance-trial.html 2020-03-20T16:27:46.0820000Z https://www.medicinesresources.nhs.uk/effect-of-bariatric-surgery-on-long-term-cardiovascular-outcomes-a-nationwide-nested-cohort-study.html 2020-03-20T16:30:20.6380000Z https://www.medicinesresources.nhs.uk/the-pre-and-post-authorisation-data-published-by-the-european-medicines-agency-on-the-use-of-biologics-during-pregnancy-and-lactation.html 2020-03-20T16:32:03.0820000Z https://www.medicinesresources.nhs.uk/misuse-of-benzodiazepines-prevalence-and-impact-in-an-inpatient-population-with-psychiatric-disorders.html 2020-03-20T16:33:14.8030000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-306-march-2020.html 2020-03-23T10:22:10.8480000Z https://www.medicinesresources.nhs.uk/sustaining-and-spreading-penicillin-allergy-delabelling-a-narrative-review-of-the-challenges-for-service-delivery-and-patient-safety.html 2020-03-20T16:45:31.8210000Z https://www.medicinesresources.nhs.uk/efficacy-of-levetiracetam-fosphenytoin-and-valproate-for-established-status-epilepticus-by-age-group-2.html 2020-03-23T14:13:19.1220000Z https://www.medicinesresources.nhs.uk/association-of-magnesium-intake-with-type-2-diabetes-and-total-stroke-an-updated-systematic-review-and-meta-analysis.html 2020-03-23T14:14:54.7670000Z https://www.medicinesresources.nhs.uk/antiretroviral-drug-class-and-anaemia-risk-in-the-current-treatment-era-among-people-living-with-hiv-in-the-usa-a-clinical-cohort-study.html 2020-03-23T14:18:14.3840000Z https://www.medicinesresources.nhs.uk/risk-factors-for-small-adult-height-in-childhood-cancer-survivors.html 2020-07-07T10:40:02.5420000Z https://www.medicinesresources.nhs.uk/medicines-that-cannot-be-parallel-exported-from-the-uk.html 2020-03-30T12:13:55.9620000Z https://www.medicinesresources.nhs.uk/the-mhra-has-updated-the-list-of-medicines-that-cannot-be-parallel-exported-from-the-uk-because-they-are-needed-for-uk-patients-82-medicines-have-been-added-to-the-list.html 2020-03-23T16:18:49.6520000Z https://www.medicinesresources.nhs.uk/regulatory-approval-for-coronavirus-covid-19-test-kits.html 2020-03-23T14:27:54.8720000Z https://www.medicinesresources.nhs.uk/novel-coronavirus-covid19-standard-operating-procedure-community-pharmacy.html 2020-03-30T09:42:01.5750000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-updated-guidance-for-schools-and-other-educational-settings-1.html 2020-03-23T16:12:07.5460000Z https://www.medicinesresources.nhs.uk/letter-to-gps-from-the-chief-medical-officer-and-medical-director-of-nhs-england-and-nhs-improvement-on-management-of-adults-classed-vulnerable-to-covid19-infection.html 2020-03-30T09:20:37.9050000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-shares-advice-for-the-public-on-how-they-can-support-pharmacies.html 2020-03-23T14:54:37.3560000Z https://www.medicinesresources.nhs.uk/sars-cov-2-infection-in-children.html 2020-03-23T14:56:00.7030000Z https://www.medicinesresources.nhs.uk/stopping-the-spread-of-covid-19.html 2020-03-23T14:57:30.1710000Z https://www.medicinesresources.nhs.uk/aortic-stenosis-in-women.html 2020-03-23T14:58:45.1610000Z https://www.medicinesresources.nhs.uk/general-pharmaceutical-council-postponement-of-2020-revalidation-submissions.html 2020-03-30T09:14:38.4420000Z https://www.medicinesresources.nhs.uk/sars-cov2-should-inhibitors-of-the-renin-angiotensin-system-be-withdrawn-in-patients-with-covid-19.html 2020-03-23T15:07:43.9180000Z https://www.medicinesresources.nhs.uk/us-fda-to-facilitate-access-to-crucial-medical-products-including-ventilators.html 2020-03-23T15:10:25.7770000Z https://www.medicinesresources.nhs.uk/coronavirus-disease-2019-covid-19-and-cardiovascular-disease.html 2020-03-23T15:11:56.8660000Z https://www.medicinesresources.nhs.uk/covid-19-we-must-keep-faith-in-our-experts.html 2020-03-23T16:29:33.7030000Z https://www.medicinesresources.nhs.uk/bowens-disease.html 2020-03-23T15:15:07.3940000Z https://www.medicinesresources.nhs.uk/gps-can-stop-health-checks-for-over-75s-and-routine-medicine-reviews.html 2020-03-23T15:16:21.5460000Z https://www.medicinesresources.nhs.uk/challenges-for-nhs-hospitals-during-covid-19-epidemic.html 2020-03-23T15:17:53.8540000Z https://www.medicinesresources.nhs.uk/planning-and-provision-of-extracorporeal-membrane-oxygenation-ecmo-services-for-severe-ards-during-the-covid-19-pandemic-and-other-outbreaks-of-emerging-infectious-diseases.html 2020-03-23T15:19:04.2240000Z https://www.medicinesresources.nhs.uk/rational-use-of-face-masks-in-the-covid-19-pandemic.html 2020-03-23T15:24:44.3660000Z https://www.medicinesresources.nhs.uk/mass-gathering-events-and-reducing-further-global-spread-of-covid-19-a-political-and-public-health-dilemma.html 2020-03-23T15:26:18.1700000Z https://www.medicinesresources.nhs.uk/us-fda-grants-emergency-use-authorization-for-eplex-r-sars-cov-2-test.html 2020-03-23T15:27:57.6690000Z https://www.medicinesresources.nhs.uk/fda-provides-guidance-on-production-of-alcohol-based-hand-sanitizer-to-help-boost-supply-and-protect-public-health.html 2020-03-23T15:29:44.9270000Z https://www.medicinesresources.nhs.uk/revised-spc-emerade-adrenaline-solution-for-injection-in-pre-filled-pen-all-strengths-1.html 2020-03-30T08:50:09.3850000Z https://www.medicinesresources.nhs.uk/q-and-a-on-the-impact-of-covid-19-on-research-funded-or-supported-by-national-institute-for-health-research-nihr-1.html 2020-03-23T15:37:19.8140000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-gives-advice-on-the-use-of-non-steroidal-anti-inflammatories-for-covid-19.html 2020-03-30T08:44:02.0060000Z https://www.medicinesresources.nhs.uk/medicines-q-and-a-how-should-adults-with-cancer-be-managed-by-general-dental-practitioners-if-they-need-dental-treatment.html 2020-03-30T08:35:06.8560000Z https://www.medicinesresources.nhs.uk/the-yellow-card-scheme-updated-guidance-for-healthcare-professionals-patients-and-the-public.html 2020-03-23T16:25:16.0490000Z https://www.medicinesresources.nhs.uk/effects-of-interleukin-1v-inhibition-on-incident-anemia-exploratory-analyses-from-a-randomized-trial-1.html 2020-03-24T16:07:56.5860000Z https://www.medicinesresources.nhs.uk/iron-chelation-in-transfusion-dependent-patients-with-low-to-intermediate-1-risk-myelodysplastic-syndromes-a-randomized-trial.html 2020-03-24T14:48:28.7050000Z https://www.medicinesresources.nhs.uk/subcutaneous-versus-intravenous-daratumumab-in-patients-with-relapsed-or-refractory-multiple-myeloma-columba-a-multicentre-open-label-non-inferiority-randomised-phase-3-trial.html 2020-03-24T14:49:46.7370000Z https://www.medicinesresources.nhs.uk/understanding-how-patients-establish-strategies-for-living-with-asthma-a-qualitative-study-in-uk-primary-care-as-part-of-imp2art.html 2020-03-24T14:52:09.2610000Z https://www.medicinesresources.nhs.uk/isoflavone-intake-and-the-risk-of-coronary-heart-disease-in-us-men-and-women-results-from-3-prospective-cohort-studies.html 2020-08-20T11:24:24.3560000Z https://www.medicinesresources.nhs.uk/hospitals-get-ramped-up-for-delivery-of-protective-kit-to-staff-fighting-coronavirus.html 2020-03-24T15:03:58.3310000Z https://www.medicinesresources.nhs.uk/online-isolation-notes-launched-providing-proof-of-coronavirus-absence-from-work.html 2020-03-24T15:05:32.9640000Z https://www.medicinesresources.nhs.uk/chief-executive-of-general-pharmaceutical-council-explains-pharmacy-closures-during-the-covid-19-pandemic-1.html 2020-03-30T11:02:24.3840000Z https://www.medicinesresources.nhs.uk/covid-19-update-medicines-delivery-service-and-111-online-cpcs-referrals.html 2020-03-30T11:00:17.9310000Z https://www.medicinesresources.nhs.uk/qualitywatch-update-on-long-term-conditions.html 2020-03-24T15:10:35.5040000Z https://www.medicinesresources.nhs.uk/covid-19-six-million-doses-of-hydroxychloroquine-donated-to-us-despite-lack-of-evidence.html 2020-03-24T15:12:38.3670000Z https://www.medicinesresources.nhs.uk/case-fatality-rate-and-characteristics-of-patients-dying-in-relation-to-covid-19-in-italy.html 2020-03-24T16:04:48.9500000Z https://www.medicinesresources.nhs.uk/social-media-and-emergency-preparedness-in-response-to-novel-coronavirus.html 2020-03-24T15:23:04.7400000Z https://www.medicinesresources.nhs.uk/phase-iii-node-301-trial-evaluating-etripamil-nasal-spray-for-paroxysmal-supraventricular-tachycardia-psvt-fails-to-meet-primary-outcome.html 2020-03-24T15:24:04.4310000Z https://www.medicinesresources.nhs.uk/world-health-organization-warns-against-untested-drugs-for-covid-19-and-announces-solidarity-trial-evaluating-five-treatment-options.html 2020-03-30T10:55:57.4580000Z https://www.medicinesresources.nhs.uk/us-fda-issues-complete-response-letter-rejecting-license-extension-of-empagliflozin-for-type-1-diabetes.html 2020-03-24T15:27:02.8570000Z https://www.medicinesresources.nhs.uk/gilead-suspends-access-to-remdesivir-due-to-overwhelming-demand-for-the-experimental-covid-19-treatment.html 2020-03-30T12:13:06.3410000Z https://www.medicinesresources.nhs.uk/revised-spc-qtern-saxagliptin-hydrochloride-dapagliflozin-propanediol-monohydrate-5mg-10mg-film-coated-tablets.html 2020-03-30T10:20:25.5220000Z https://www.medicinesresources.nhs.uk/new-product-poteligeo-mogamulizumab-4-mg-ml-concentrate-for-solution-for-infusion.html 2020-03-24T15:38:40.8910000Z https://www.medicinesresources.nhs.uk/revised-spc-remsima-infliximab-120-mg-solution-for-injection-in-pre-filled-pen-and-syringe.html 2020-03-24T15:40:31.0340000Z https://www.medicinesresources.nhs.uk/revised-spc-sacubitril-vigabatrin-film-coated-tablets-and-granules-for-oral-solution.html 2020-03-24T15:41:39.0270000Z https://www.medicinesresources.nhs.uk/who-consolidated-guidelines-on-tuberculosis-module-1-prevention-tuberculosis-preventive-treatment.html 2020-03-30T11:33:03.4390000Z https://www.medicinesresources.nhs.uk/march-bnf-newsletter.html 2020-03-30T11:31:45.6200000Z https://www.medicinesresources.nhs.uk/revised-spc-nasonex-mometasone-furoate-monohydrate-50-micrograms-actuation-nasal-spray-suspension.html 2020-03-25T17:24:15.9550000Z https://www.medicinesresources.nhs.uk/revised-spcs-mabthera-rituximab-concentrate-for-solution-for-infusion-all-strengths.html 2020-03-25T17:24:23.9660000Z https://www.medicinesresources.nhs.uk/revised-spcs-onglyza-saxagliptin-hydrochloride-film-coated-tablets-all-strengths.html 2020-03-25T17:23:47.9140000Z https://www.medicinesresources.nhs.uk/new-product-lenzetto-estradiol-hemihydrate-1-53-mg-spray-transdermal-spray-solution.html 2020-03-25T17:25:16.2670000Z https://www.medicinesresources.nhs.uk/guidance-for-manufacturers-specials-licence-holders-on-packing-down-medicines-during-the-coronavirus-covid-19-outbreak.html 2020-03-30T11:28:39.6800000Z https://www.medicinesresources.nhs.uk/a-randomized-trial-evaluating-the-efficacy-and-safety-of-fast-acting-insulin-aspart-compared-with-insulin-aspart-both-in-combination-with-insulin-degludec-with-or-without-metformin-in-adults-with-type-2-diabetes-onset-9.html 2020-03-25T17:28:39.7450000Z https://www.medicinesresources.nhs.uk/clinical-features-and-obstetric-and-neonatal-outcomes-of-pregnant-patients-with-covid-19-in-wuhan-china-a-retrospective-single-centre-descriptive-study.html 2020-03-25T17:30:39.4360000Z https://www.medicinesresources.nhs.uk/decreasing-antibiotic-use-the-gut-microbiota-and-asthma-incidence-in-children-evidence-from-population-based-and-prospective-cohort-studies.html 2020-03-25T17:31:51.0210000Z https://www.medicinesresources.nhs.uk/pharmacy-bodies-publish-resilience-guidance-to-support-pharmacy-teams-during-the-response-to-the-covid-19-pandemic.html 2020-03-30T11:25:54.7190000Z https://www.medicinesresources.nhs.uk/new-nhs-nightingale-hospital-to-fight-coronavirus.html 2020-03-25T17:37:05.7600000Z https://www.medicinesresources.nhs.uk/nhs-call-for-volunteer-army.html 2020-03-25T17:38:01.0450000Z https://www.medicinesresources.nhs.uk/free-learning-resources-for-healthcare-professionals-from-mims-learning-provide-links-to-nhs-guidance-and-advice-and-research-from-key-journals-on-covid-19.html 2020-03-25T17:38:57.6880000Z https://www.medicinesresources.nhs.uk/covid-19-and-angiotensin-converting-enzyme-inhibitors-and-angiotensin-receptor-blockers-what-is-the-evidence.html 2020-03-25T17:41:12.8070000Z https://www.medicinesresources.nhs.uk/treating-covid-19-off-label-drug-use-compassionate-use-and-randomized-clinical-trials-during-pandemics.html 2020-03-25T17:42:17.6980000Z https://www.medicinesresources.nhs.uk/covid-19-beware-of-falsified-medicines-from-unregistered-websites.html 2020-03-30T11:17:49.8820000Z https://www.medicinesresources.nhs.uk/american-college-of-surgeons-acs-releases-new-clinical-guidance-document-for-elective-surgical-case-triage-during-covid-19.html 2020-03-25T17:47:15.0870000Z https://www.medicinesresources.nhs.uk/us-fda-approves-supplemental-new-drug-application-for-licence-extension-of-eucrisa-crisaborole-ointment-2-in-children-as-young-as-3-months-of-age-with-mild-to-moderate-atopic-dermatitis-ad.html 2020-03-25T20:13:54.2360000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-delivery-of-systemic-anticancer-treatments-guidance-ng161.html 2020-03-30T11:14:34.6720000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-dialysis-service-delivery-guidance-ng160.html 2020-03-30T11:13:27.3580000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-critical-care-in-adults-guidance-ng159.html 2020-03-30T11:08:54.4100000Z https://www.medicinesresources.nhs.uk/national-patient-safety-incident-reports-published-march-2020.html 2020-03-25T18:23:06.1060000Z https://www.medicinesresources.nhs.uk/venous-thromboembolic-diseases-diagnosis-management-and-thrombophilia-testing-guidance-ng158.html 2020-03-30T12:01:21.9030000Z https://www.medicinesresources.nhs.uk/revised-spc-alutard-wasp-venom-maintenance.html 2020-03-26T15:38:02.5690000Z https://www.medicinesresources.nhs.uk/revised-spc-roaccutane-20mg-soft-capsules-1.html 2020-03-26T15:37:06.2010000Z https://www.medicinesresources.nhs.uk/revised-spc-tybost-cobicistat-150mg-film-coated-tablet-1.html 2020-03-26T15:21:52.3940000Z https://www.medicinesresources.nhs.uk/a-phase-3-trial-of-luspatercept-in-patients-with-transfusion-dependent-v-thalassemia.html 2020-08-07T13:26:52.1170000Z https://www.medicinesresources.nhs.uk/fostemsavir-in-adults-with-multidrug-resistant-hiv-1-infection.html 2020-08-07T12:25:58.7280000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-eptinezumab-in-patients-with-chronic-migraine-promise-2.html 2020-03-26T15:27:17.3840000Z https://www.medicinesresources.nhs.uk/manual-acupuncture-versus-sham-acupuncture-and-usual-care-for-prophylaxis-of-episodic-migraine-without-aura-multicentre-randomised-clinical-trial.html 2020-03-26T15:40:09.1130000Z https://www.medicinesresources.nhs.uk/association-of-cardiac-injury-with-mortality-in-hospitalized-patients-with-covid-19-in-wuhan-china.html 2020-03-26T15:29:45.0950000Z https://www.medicinesresources.nhs.uk/sars-cov-2-transmission-in-patients-with-cancer-at-a-tertiary-care-hospital-in-wuhan-china.html 2020-03-26T15:31:35.6700000Z https://www.medicinesresources.nhs.uk/clinical-and-epidemiological-features-of-36-children-with-coronavirus-disease-2019-covid-19-in-zhejiang-china-an-observational-cohort-study.html 2020-03-26T15:32:56.7680000Z https://www.medicinesresources.nhs.uk/gilead-sciences-seeks-to-rescind-orphan-drug-designation-for-remdesivir-for-covid-19.html 2020-03-26T15:42:24.3750000Z https://www.medicinesresources.nhs.uk/us-fda-allows-physicians-to-use-convalescent-plasma-for-treating-critically-ill-covid-19-patients.html 2020-03-26T15:43:26.5700000Z https://www.medicinesresources.nhs.uk/us-fda-grants-ipi-549-in-combination-with-nivolumab-fast-track-designation-for-the-treatment-of-advanced-urothelial-cancer.html 2020-03-26T15:44:50.7140000Z https://www.medicinesresources.nhs.uk/covid-19-a-remote-assessment-in-primary-care.html 2020-03-26T15:45:46.5270000Z https://www.medicinesresources.nhs.uk/covid-19-experts-question-analysis-suggesting-half-uk-population-has-been-infected.html 2020-03-26T15:46:46.5510000Z https://www.medicinesresources.nhs.uk/managing-mental-health-challenges-faced-by-healthcare-workers-during-covid-19-pandemic.html 2020-03-26T15:47:45.4690000Z https://www.medicinesresources.nhs.uk/diamorphine-hydrochloride-powder-for-reconstitution-and-injection-5mg-and-10mg-ampoules-supply-disruption-alert-update.html 2020-03-30T11:58:48.8160000Z https://www.medicinesresources.nhs.uk/class-4-drug-alert-for-information-mylan-uk-healthcare-limited-zamadol-sr-50mg-prolonged-release-capsules.html 2020-03-26T15:50:18.4180000Z https://www.medicinesresources.nhs.uk/preserving-clinical-trial-integrity-during-the-coronavirus-pandemic.html 2020-03-26T15:51:50.5390000Z https://www.medicinesresources.nhs.uk/chloroquine-and-hydroxychloroquine-not-licensed-for-coronavirus-covid-19-treatment.html 2020-03-30T11:55:18.9790000Z https://www.medicinesresources.nhs.uk/endometriosis.html 2020-08-10T11:28:16.1230000Z https://www.medicinesresources.nhs.uk/over-400-000-people-join-nhs-army-of-volunteers-in-one-day.html 2020-03-26T15:57:15.7970000Z https://www.medicinesresources.nhs.uk/coronavirus-learning-for-the-health-and-care-workforce.html 2020-03-30T11:51:56.1340000Z https://www.medicinesresources.nhs.uk/hepatitis-c-cases-down-around-70-in-men-with-hiv-infection-in-london-and-brighton.html 2020-03-26T15:59:13.1290000Z https://www.medicinesresources.nhs.uk/general-pharmaceutical-council-gphc-postpones-pharmacy-pre-registration-assessments.html 2020-03-26T16:00:19.1450000Z https://www.medicinesresources.nhs.uk/national-diet-and-nutrition-survey-assessment-of-salt-intake-from-urinary-sodium-in-adults-aged-19-to-64-years-in-england-2018-to-2019.html 2020-03-26T16:01:32.1860000Z https://www.medicinesresources.nhs.uk/geographic-patterns-of-cancer-survival-in-england-adults-diagnosed-2013-to-2017-and-followed-up-to-2018.html 2020-03-26T16:02:37.9260000Z https://www.medicinesresources.nhs.uk/shortage-of-sodium-bicarbonate-polyfusors-fresenius-kabi-all-strengths.html 2020-03-30T11:50:27.7960000Z https://www.medicinesresources.nhs.uk/shortage-of-diazemuls-diazepam-5mg-ml-emulsion-for-injection-updated.html 2020-03-30T11:48:27.4550000Z https://www.medicinesresources.nhs.uk/reproductive-health-patient-group-direction-pgd-templates.html 2020-03-30T11:47:02.3630000Z https://www.medicinesresources.nhs.uk/new-product-epiduo-0-3-2-5-adapalene-benzoyl-peroxide-gel-1.html 2020-03-27T16:28:21.7840000Z https://www.medicinesresources.nhs.uk/revised-spc-pro-epanutin-fosphenytoin-75-mg-ml-concentrate-for-solution-for-infusion-solution-for-injection.html 2020-03-27T16:29:33.4950000Z https://www.medicinesresources.nhs.uk/new-product-fibryga-human-fibrinogen-1g-powder-and-solvent-for-solution-for-injection-infusion.html 2020-03-27T16:30:42.7130000Z https://www.medicinesresources.nhs.uk/revised-spc-tecentriq-atezolizumab-840-mg-concentrate-for-solution-for-infusion.html 2020-03-27T16:48:58.5930000Z https://www.medicinesresources.nhs.uk/revised-spc-gazyvaro-obinutuzumab-1-000-mg-concentrate-for-solution-for-infusion.html 2020-03-27T16:32:52.7580000Z https://www.medicinesresources.nhs.uk/prevalence-of-chronic-kidney-disease-in-the-community-using-data-from-oxren-a-uk-population-based-cohort-study.html 2020-03-27T16:49:33.9620000Z https://www.medicinesresources.nhs.uk/possible-vertical-transmission-of-sars-cov-2-from-an-infected-mother-to-her-newborn.html 2020-03-27T16:49:57.3400000Z https://www.medicinesresources.nhs.uk/antibodies-in-infants-born-to-mothers-with-covid-19-pneumonia.html 2020-03-27T16:51:14.5730000Z https://www.medicinesresources.nhs.uk/association-of-presalvage-radiotherapy-psa-levels-after-prostatectomy-with-outcomes-of-long-term-antiandrogen-therapy-in-men-with-prostate-cancer.html 2020-03-27T18:30:41.7540000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-of-113-deceased-patients-with-coronavirus-disease-2019-retrospective-study.html 2020-03-27T16:51:59.0630000Z https://www.medicinesresources.nhs.uk/global-regional-and-national-burden-of-neck-pain-in-the-general-population-1990-2017-systematic-analysis-of-the-global-burden-of-disease-study-2017.html 2020-03-27T16:45:43.5610000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-new-drug-application-nda-for-new-formulation-of-baloxavir-for-the-treatment-of-influenza-in-children.html 2020-03-27T16:53:22.4110000Z https://www.medicinesresources.nhs.uk/us-fda-approves-ozanimod-for-the-treatment-of-multiple-sclerosis.html 2020-03-27T16:55:08.0330000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-accepts-marketing-authorisation-application-for-cenobamate-for-the-adjunctive-treatment-of-focal-onset-seizures-in-adults.html 2020-03-27T17:12:24.3420000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-grants-orphan-drug-designation-to-viralym-m-for-treatment-of-viral-diseases-and-infections-in-patients-undergoing-hematopoietic-stem-cell-transplantation.html 2020-03-27T16:57:09.2280000Z https://www.medicinesresources.nhs.uk/regulatory-status-of-equipment-being-used-to-help-prevent-coronavirus-covid-19.html 2020-03-27T18:22:18.8090000Z https://www.medicinesresources.nhs.uk/the-yellow-card-scheme-guidance-for-healthcare-professionals-patients-and-the-public.html 2020-03-27T16:58:56.0110000Z https://www.medicinesresources.nhs.uk/uk-pledges-210-million-pounds-to-global-push-for-coronavirus-vaccine.html 2020-03-27T16:59:52.2170000Z https://www.medicinesresources.nhs.uk/nice-updates-covid-19-rapid-guideline-critical-care-in-adults-ng159.html 2020-03-30T12:10:36.2840000Z https://www.medicinesresources.nhs.uk/coronavirus-effect-on-the-economy-and-public-finances.html 2020-03-27T17:01:40.8080000Z https://www.medicinesresources.nhs.uk/government-launches-coronavirus-information-service-on-whatsapp.html 2020-03-27T17:02:38.3300000Z https://www.medicinesresources.nhs.uk/coronavirus-bill-health-and-social-care-measures.html 2020-03-27T17:13:39.9770000Z https://www.medicinesresources.nhs.uk/over-6000-former-pharmacy-professionals-given-temporary-registration-for-covid-19-emergency.html 2020-03-27T17:05:16.6560000Z https://www.medicinesresources.nhs.uk/quarterly-vaccination-coverage-statistics-for-children-aged-up-to-five-years-in-the-uk-cover-programme-october-to-december-2019.html 2020-03-27T17:06:18.8000000Z https://www.medicinesresources.nhs.uk/covid-19-researchers-launch-app-to-track-spread-of-symptoms-in-the-uk.html 2020-03-27T18:11:49.5120000Z https://www.medicinesresources.nhs.uk/court-of-appeal-rules-that-a-policy-adopted-by-ccgs-in-north-of-england-of-offering-bevacizumab-avastin-for-wet-amd-is-legal.html 2020-03-27T17:07:41.7810000Z https://www.medicinesresources.nhs.uk/medical-students-and-fy1-doctors-to-be-given-early-registration-to-help-combat-covid-19.html 2020-03-27T17:08:57.7780000Z https://www.medicinesresources.nhs.uk/an-approach-to-excessive-daytime-sleepiness-in-adults.html 2020-03-27T17:14:04.6300000Z https://www.medicinesresources.nhs.uk/covid-19-information-for-the-respiratory-community.html 2020-03-30T12:07:40.3650000Z https://www.medicinesresources.nhs.uk/nhs-london-procurement-partnership-medicines-optimisation-and-pharmacy-procurement-create-a-quick-user-guide-for-patients-on-how-to-use-the-rightbreathe-app-and-website-1.html 2020-03-31T13:52:38.3830000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-delivery-of-radiotherapy-guidance-ng162.html 2020-04-06T09:44:41.8470000Z https://www.medicinesresources.nhs.uk/revised-spc-epclusa-400-mg-100-mg-film-coated-tablets.html 2020-03-30T13:24:04.5620000Z https://www.medicinesresources.nhs.uk/class-4-drug-alert-for-information-rosemont-pharmaceuticals-ltd-part-of-the-perrigo-group-paracetamol-250mg-5ml-oral-suspension-500ml.html 2020-03-30T13:25:41.6260000Z https://www.medicinesresources.nhs.uk/rivaroxaban-in-peripheral-artery-disease-after-revascularization.html 2020-08-07T14:22:15.7190000Z https://www.medicinesresources.nhs.uk/vericiguat-in-patients-with-heart-failure-and-reduced-ejection-fraction.html 2020-08-07T14:17:42.5090000Z https://www.medicinesresources.nhs.uk/anticoagulation-with-or-without-clopidogrel-after-transcatheter-aortic-valve-implantation.html 2020-08-07T13:54:59.2110000Z https://www.medicinesresources.nhs.uk/apixaban-for-the-treatment-of-venous-thromboembolism-associated-with-cancer.html 2020-08-07T13:52:39.3720000Z https://www.medicinesresources.nhs.uk/rivaroxaban-or-enoxaparin-in-nonmajor-orthopedic-surgery.html 2020-08-07T13:51:00.2280000Z https://www.medicinesresources.nhs.uk/clinical-and-virological-data-of-the-first-cases-of-covid-19-in-europe-a-case-series.html 2020-03-30T14:25:27.9360000Z https://www.medicinesresources.nhs.uk/effect-of-apabetalone-added-to-standard-therapy-on-major-adverse-cardiovascular-events-in-patients-with-recent-acute-coronary-syndrome-and-type-2-diabetes-a-randomized-clinical-trial.html 2020-03-30T14:26:55.0460000Z https://www.medicinesresources.nhs.uk/chmp-recommends-restrictions-on-use-of-fosfomycin.html 2020-03-30T14:34:12.7470000Z https://www.medicinesresources.nhs.uk/chmp-recommend-no-change-to-market-authorisation-follow-study-assessing-serious-bleeding-risk-of-doacs.html 2020-03-30T14:30:37.3510000Z https://www.medicinesresources.nhs.uk/effect-of-dapagliflozin-on-worsening-heart-failure-and-cardiovascular-death-in-patients-with-heart-failure-with-and-without-diabetes.html 2020-03-30T14:44:17.7780000Z https://www.medicinesresources.nhs.uk/a-putative-placebo-analysis-of-the-effects-of-sacubitril-valsartan-in-heart-failure-across-the-full-range-of-ejection-fraction.html 2020-03-30T14:45:51.5690000Z https://www.medicinesresources.nhs.uk/effects-of-dapagliflozin-in-dapa-hf-according-to-background-heart-failure-therapy.html 2020-03-30T14:47:26.2160000Z https://www.medicinesresources.nhs.uk/the-role-of-combination-antiplatelet-and-anticoagulation-therapy-in-diabetes-and-cardiovascular-disease-insights-from-the-compass-trial.html 2020-07-16T13:35:59.9160000Z https://www.medicinesresources.nhs.uk/peripheral-artery-disease-and-venous-thromboembolic-events-after-acute-coronary-syndrome-role-of-lipoprotein-a-and-modification-by-alirocumab-prespecified-analysis-of-a-randomized-clinical-trial.html 2020-07-22T13:15:05.5240000Z https://www.medicinesresources.nhs.uk/the-effect-of-pcsk9-inhibition-on-the-risk-of-venous-thromboembolism.html 2020-08-20T11:09:39.7930000Z https://www.medicinesresources.nhs.uk/the-risk-benefit-tradeoff-of-antithrombotic-therapy-in-patients-with-atrial-fibrillation-early-and-late-after-an-acute-coronary-syndrome-or-percutaneous-coronary-intervention-insights-from-augustus.html 2020-03-30T14:51:40.0530000Z https://www.medicinesresources.nhs.uk/the-effect-of-control-strategies-to-reduce-social-mixing-on-outcomes-of-the-covid-19-epidemic-in-wuhan-china-a-modelling-study.html 2020-03-30T14:52:32.3690000Z https://www.medicinesresources.nhs.uk/chmp-give-positive-opinion-for-atectura-breezhaler-and-bemrist-breezhaler.html 2020-03-30T14:54:02.4820000Z https://www.medicinesresources.nhs.uk/following-review-chmp-recommend-that-the-benefits-of-medicines-containing-combination-of-methocarbamol-and-paracetamol-continue-to-outweigh-risks.html 2020-03-30T14:55:31.8070000Z https://www.medicinesresources.nhs.uk/chmp-recommends-licence-extension-for-conestat-alfa-ruconest.html 2020-03-30T14:56:40.7480000Z https://www.medicinesresources.nhs.uk/chmp-recommends-licence-extension-for-anakinra-kineret.html 2020-03-30T14:57:35.7480000Z https://www.medicinesresources.nhs.uk/chmp-recommends-licence-extension-for-budesonide-jorveza.html 2020-03-30T14:58:24.0900000Z https://www.medicinesresources.nhs.uk/chmp-recommends-licence-extension-for-etravirine-intelence.html 2020-03-30T14:59:24.5110000Z https://www.medicinesresources.nhs.uk/hmp-gives-positive-opinion-for-licence-extension-for-secukinumab-cosentyx.html 2020-03-30T16:06:17.3410000Z https://www.medicinesresources.nhs.uk/chmp-gives-positive-opinion-for-licence-extension-for-brentuximab-vedotin-adcetris.html 2020-03-30T15:01:22.0100000Z https://www.medicinesresources.nhs.uk/chmp-gives-positive-opinion-for-etanercept-biosimilar-nepexto.html 2020-03-30T15:02:33.6030000Z https://www.medicinesresources.nhs.uk/chmp-gives-positive-opinion-for-onasemnogene-abeparvovec-zolgensma.html 2020-03-30T15:04:06.5430000Z https://www.medicinesresources.nhs.uk/chmp-gives-positive-opinion-for-isatuximab-sarclisa.html 2020-03-30T15:05:08.4180000Z https://www.medicinesresources.nhs.uk/chmp-gives-positive-opinion-on-pretomanid-pretomanid-fgk.html 2020-03-30T15:08:03.6590000Z https://www.medicinesresources.nhs.uk/chmp-gives-positive-opinion-on-influenza-vaccine-surface-antigen-inactivated-adjuvanted-fluad-tetra.html 2020-03-30T15:09:33.3660000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-use-of-evolocumab-in-hiv-with-high-ldl-cholesterol.html 2020-03-30T15:10:41.8520000Z https://www.medicinesresources.nhs.uk/ema-advises-continued-use-of-medicines-for-hypertension-heart-or-kidney-disease-during-covid-19-pandemic.html 2020-03-30T15:12:27.3020000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-difamilast-for-atopic-dermatitis.html 2020-03-30T15:13:23.3480000Z https://www.medicinesresources.nhs.uk/csc-expert-consensus-on-principles-of-clinical-management-of-patients-with-severe-emergent-cardiovascular-diseases-during-the-covid-19-epidemic.html 2020-07-16T13:51:49.2070000Z https://www.medicinesresources.nhs.uk/potential-effects-of-coronaviruses-on-the-cardiovascular-system-a-review.html 2020-03-30T15:17:41.4640000Z https://www.medicinesresources.nhs.uk/covid-19-infection-in-children.html 2020-03-30T15:19:00.3200000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-for-the-public-on-mental-health-and-wellbeing.html 2020-04-06T09:40:13.8380000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-on-supporting-children-and-young-peoples-mental-health-and-wellbeing.html 2020-04-06T09:32:27.4060000Z https://www.medicinesresources.nhs.uk/developing-covid-19-vaccines-at-pandemic-speed.html 2020-03-31T14:32:17.9240000Z https://www.medicinesresources.nhs.uk/gp-practices-helped-to-identify-patients-eligible-for-electronic-repeat-dispensing-erd.html 2020-04-06T09:08:09.2030000Z https://www.medicinesresources.nhs.uk/covid-19-urgent-supplies-of-controlled-drugs.html 2020-04-06T09:05:23.2760000Z https://www.medicinesresources.nhs.uk/march-2020-price-concessions-final-update.html 2020-03-31T14:37:42.6910000Z https://www.medicinesresources.nhs.uk/intravenous-iron-a-framework-for-changing-the-management-of-iron-deficiency.html 2020-03-31T14:41:39.1850000Z https://www.medicinesresources.nhs.uk/paediatric-to-adult-transition-care-for-patients-with-sickle-cell-disease-a-global-perspective.html 2020-03-31T14:47:02.3900000Z https://www.medicinesresources.nhs.uk/quality-improvement-into-practice.html 2020-03-31T14:48:43.4410000Z https://www.medicinesresources.nhs.uk/specification-for-rapidly-manufactured-cpap-system-to-be-used-during-the-coronavirus-covid-19-outbreak.html 2020-04-06T09:02:53.9880000Z https://www.medicinesresources.nhs.uk/nhs-support-via-text-message-for-people-with-symptoms-of-covid-19.html 2020-03-31T14:53:35.0410000Z https://www.medicinesresources.nhs.uk/covid-19-public-health-england-issues-updated-guidance-on-investigation-and-initial-clinical-management-of-possible-cases.html 2020-03-31T14:56:51.5180000Z https://www.medicinesresources.nhs.uk/free-learning-for-retired-healthcare-professionals-returning-because-of-coronavirus.html 2020-04-06T08:58:17.2220000Z https://www.medicinesresources.nhs.uk/general-pharmaceutical-council-and-royal-pharmaceutical-society-issue-letter-on-importance-of-social-distancing.html 2020-03-31T14:59:28.8210000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-to-issue-electronic-certificates-for-medicines.html 2020-03-31T15:01:05.3000000Z https://www.medicinesresources.nhs.uk/improving-access-to-clinical-trials-for-amyotrophic-lateral-sclerosis-treatment.html 2020-03-31T15:02:08.3540000Z https://www.medicinesresources.nhs.uk/evaluation-of-a-paradigm-shift-from-intravenous-antibiotics-to-oral-step-down-therapy-for-infective-endocarditis-ie-a-narrative-review.html 2020-03-31T15:03:40.1190000Z https://www.medicinesresources.nhs.uk/optimizing-the-trade-off-between-learning-and-doing-in-a-pandemic.html 2020-03-31T15:05:09.8900000Z https://www.medicinesresources.nhs.uk/older-clinicians-and-the-surge-in-novel-coronavirus-disease-2019-covid-19.html 2020-03-31T15:06:44.5990000Z https://www.medicinesresources.nhs.uk/covid-19-how-coronavirus-will-change-the-face-of-general-practice-forever.html 2020-03-31T15:08:34.6970000Z https://www.medicinesresources.nhs.uk/covid-19-why-is-the-uk-government-ignoring-whos-advice.html 2020-03-31T15:09:35.6600000Z https://www.medicinesresources.nhs.uk/health-benefits-of-policies-to-reduce-carbon-emissions.html 2020-03-31T15:10:31.3420000Z https://www.medicinesresources.nhs.uk/making-healthcare-and-health-systems-net-zero.html 2020-03-31T15:11:47.0500000Z https://www.medicinesresources.nhs.uk/revised-spc-betaloc-metoprolol-1-mg-ml-solution-for-injection.html 2020-03-31T15:13:13.2930000Z https://www.medicinesresources.nhs.uk/revised-spc-kaletra-200-mg-50-mg-film-coated-tablets.html 2020-03-31T15:14:57.4230000Z https://www.medicinesresources.nhs.uk/phase-iii-study-evaluating-oral-rimegepant-75mg-for-prevention-of-migraine-meets-primary-endpoint.html 2020-03-31T15:16:16.0910000Z https://www.medicinesresources.nhs.uk/new-covid19-hope-clinical-trial-recommendations-introduced-with-the-aim-of-reducing-need-for-mechanical-ventilation-for-covid19-patients.html 2020-03-31T15:17:34.6540000Z https://www.medicinesresources.nhs.uk/us-fda-issues-emergency-use-authorization-eua-allowing-hydroxychloroquine-and-chloroquine-to-be-used-to-treat-covid-19.html 2020-03-31T15:19:20.4610000Z https://www.medicinesresources.nhs.uk/isradipine-versus-placebo-in-early-parkinson-disease-a-randomized-trial.html 2020-03-31T15:21:05.2370000Z https://www.medicinesresources.nhs.uk/estimates-of-the-severity-of-coronavirus-disease-2019-a-model-based-analysis.html 2020-03-31T15:22:24.3520000Z https://www.medicinesresources.nhs.uk/2019-vs-2016-esc-eas-statin-guidelines-for-primary-prevention-of-atherosclerotic-cardiovascular-disease.html 2020-03-31T15:23:42.7560000Z https://www.medicinesresources.nhs.uk/management-of-coronary-disease-in-patients-with-advanced-kidney-disease.html 2020-10-01T09:03:04.6800000Z https://www.medicinesresources.nhs.uk/health-status-after-invasive-or-conservative-care-in-coronary-and-advanced-kidney-disease.html 2020-08-07T14:20:20.0070000Z https://www.medicinesresources.nhs.uk/health-status-outcomes-with-invasive-or-conservative-care-in-coronary-disease.html 2020-08-07T14:19:25.0780000Z https://www.medicinesresources.nhs.uk/revised-spcs-feldene-piroxicam-all-products.html 2020-04-01T15:07:02.7500000Z https://www.medicinesresources.nhs.uk/revised-spcs-atrolak-quetiapine-fumarate-xl-prolonged-release-tablets-all-strengths.html 2020-04-01T15:08:54.6090000Z https://www.medicinesresources.nhs.uk/exceptional-gmp-flexibilities-for-medicines-imported-from-third-countries-during-the-coronavirus-covid-19-outbreak.html 2020-04-05T18:46:18.4580000Z https://www.medicinesresources.nhs.uk/exceptional-good-distribution-practice-gdp-flexibilities-for-medicines-during-the-coronavirus-covid-19-outbreak.html 2020-04-05T18:44:18.5460000Z https://www.medicinesresources.nhs.uk/mhra-regulatory-flexibilities-resulting-from-coronavirus-covid-19.html 2020-04-05T18:41:02.4980000Z https://www.medicinesresources.nhs.uk/national-patient-safety-alert-interruption-of-high-flow-nasal-oxygen-during-transfer.html 2020-04-05T18:38:32.4400000Z https://www.medicinesresources.nhs.uk/mhra-safety-alert-use-of-high-flow-oxygen-therapy-devices-during-the-coronavirus-epidemic.html 2020-04-05T18:36:34.1420000Z https://www.medicinesresources.nhs.uk/dtb-select-ema-advice-on-the-use-of-nsaids-for-covid-19.html 2020-04-01T15:20:06.7930000Z https://www.medicinesresources.nhs.uk/assessment-and-management-of-tinnitus-summary-of-nice-guidance.html 2020-04-01T15:21:38.5160000Z https://www.medicinesresources.nhs.uk/republished-drug-reaction-with-eosinophilia-and-systemic-symptoms-syndrome-in-a-patient-taking-lamotrigine.html 2020-04-01T15:36:44.6800000Z https://www.medicinesresources.nhs.uk/opioid-agonist-treatment-and-risk-of-mortality-during-opioid-overdose-public-health-emergency-population-based-retrospective-cohort-study.html 2020-04-01T15:39:48.8630000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-landiolol-an-ultra-short-acting-v1-selective-antagonist-for-treatment-of-sepsis-related-tachyarrhythmia-j-land-3s-a-multicentre-open-label-randomised-controlled-trial.html 2020-04-01T15:42:20.6300000Z https://www.medicinesresources.nhs.uk/covid-19-in-critically-ill-patients-in-the-seattle-region-case-series.html 2020-08-07T14:35:55.9930000Z https://www.medicinesresources.nhs.uk/a-randomized-controlled-trial-of-liraglutide-for-adolescents-with-obesity.html 2020-08-07T14:18:39.1890000Z https://www.medicinesresources.nhs.uk/covid-19-chloroquine-and-hydroxychloroquine-only-to-be-used-in-clinical-trials-or-emergency-use-programmes.html 2020-04-01T16:04:48.8940000Z https://www.medicinesresources.nhs.uk/data-published-on-potential-covid-19-symptoms-reported-through-nhs-pathways-and-111-online.html 2020-04-05T18:30:40.5930000Z https://www.medicinesresources.nhs.uk/renin-angiotensin-aldosterone-system-raas-inhibitors-in-patients-with-covid-19.html 2020-08-10T12:17:15.8140000Z https://www.medicinesresources.nhs.uk/mhra-approves-new-life-saving-breathing-aid-to-help-keep-coronavirus-covid-19-patients-out-of-intensive-care.html 2020-04-01T16:08:47.2430000Z https://www.medicinesresources.nhs.uk/systemic-therapy-for-melanoma-american-society-of-clinical-oncology-guideline-asco.html 2020-07-16T11:06:05.8380000Z https://www.medicinesresources.nhs.uk/examples-of-notable-practice-in-pharmacy-during-the-covid-19-pandemic.html 2020-04-01T17:25:52.5730000Z https://www.medicinesresources.nhs.uk/update-on-treatments-and-vaccines-against-covid-19-under-development.html 2020-04-01T16:14:41.3530000Z https://www.medicinesresources.nhs.uk/advancing-regulatory-science-in-the-eu-new-strategy-adopted.html 2020-04-01T16:15:46.7150000Z https://www.medicinesresources.nhs.uk/guidance-for-cardiac-electrophysiology-during-the-coronavirus-covid-19-pandemic.html 2020-04-01T16:16:59.9870000Z https://www.medicinesresources.nhs.uk/kidney-stone-disease-an-update-on-its-management-in-primary-care.html 2020-04-01T16:18:46.4610000Z https://www.medicinesresources.nhs.uk/should-we-be-prescribing-testosterone-to-perimenopausal-and-menopausal-women-a-guide-to-prescribing-testosterone-for-women-in-primary-care.html 2020-04-01T16:20:11.8250000Z https://www.medicinesresources.nhs.uk/covid-19-healthcare-staff-in-hotspot-areas-are-prioritised-as-testing-expands.html 2020-04-01T16:23:18.6480000Z https://www.medicinesresources.nhs.uk/prescription-charge-rises-to-gbp9-16.html 2020-04-01T17:31:21.5770000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-haematopoietic-stem-cell-transplantation-guidance-ng164.html 2020-04-05T18:21:22.5390000Z https://www.medicinesresources.nhs.uk/mycopd-for-self-management-of-chronic-obstructive-pulmonary-disease-medtech-innovation-briefing-mib214.html 2020-04-05T18:19:40.2900000Z https://www.medicinesresources.nhs.uk/reducing-the-risk-of-nsaid-related-gastrointestinal-problems-an-update.html 2020-04-05T18:16:04.4230000Z https://www.medicinesresources.nhs.uk/novel-coronavirus-clinical-trials.html 2020-04-05T18:14:19.3980000Z https://www.medicinesresources.nhs.uk/second-study-will-assess-sarilumab-for-covid-19.html 2020-04-02T13:42:51.7650000Z https://www.medicinesresources.nhs.uk/us-fda-approves-sevenfact-coagulation-factor-viia-recombinant-jncw-for-adults-and-adolescents-with-haemophilia-a-or-b-and-inhibitors.html 2020-04-02T17:50:31.4250000Z https://www.medicinesresources.nhs.uk/biologics-license-application-seeking-approval-of-naxitamab-for-relapsed-refractory-high-risk-neuroblastoma-submitted-to-the-us-fda.html 2020-04-02T13:45:07.7350000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-biologics-licence-application-for-remestemcel-l-ryoncil-tm-for-the-treatment-of-children-with-steroid-refractory-acute-graft-versus-host-disease-sr-agvhd.html 2020-04-02T13:46:42.9470000Z https://www.medicinesresources.nhs.uk/medicines-that-cannot-be-parallel-exported-from-the-uk-1.html 2020-04-05T18:10:50.0010000Z https://www.medicinesresources.nhs.uk/coronavirus-nhs-111-has-over-1-7-million-queries-in-15-days.html 2020-04-02T13:50:20.6830000Z https://www.medicinesresources.nhs.uk/coronavirus-expert-panel-to-assess-face-mask-use-by-public.html 2020-04-02T13:51:33.4490000Z https://www.medicinesresources.nhs.uk/coronavirus-potential-drug-treatment-starts-uk-trials.html 2020-04-02T13:52:49.5470000Z https://www.medicinesresources.nhs.uk/acute-recurrent-pericarditis-from-pathophysiology-towards-new-treatment-strategy.html 2020-04-02T13:54:38.3440000Z https://www.medicinesresources.nhs.uk/active-and-effective-measures-for-the-care-of-patients-with-cancer-during-the-covid-19-spread-in-china.html 2020-04-02T13:55:59.9710000Z https://www.medicinesresources.nhs.uk/coronavirus-can-spread-one-to-three-days-before-symptoms-appear-cdc-study.html 2020-04-02T13:57:52.7710000Z https://www.medicinesresources.nhs.uk/data-from-covid-symptom-tracker-app-suggest-loss-of-taste-and-smell-may-be-key-symptoms.html 2020-04-02T14:02:03.9850000Z https://www.medicinesresources.nhs.uk/kte-x19-car-t-cell-therapy-in-relapsed-or-refractory-mantle-cell-lymphoma.html 2020-08-07T13:51:49.2000000Z https://www.medicinesresources.nhs.uk/risk-of-major-adverse-cardiovascular-events-severe-hypoglycemia-and-all-cause-mortality-for-widely-used-antihyperglycemic-dual-and-triple-therapies-for-type-2-diabetes-management-a-cohort-study-of-all-danish-users.html 2020-04-02T15:35:11.1360000Z https://www.medicinesresources.nhs.uk/silver-impregnated-antibiotic-impregnated-or-non-impregnated-ventriculoperitoneal-shunts-to-prevent-shunt-infection-the-basics-three-arm-rct.html 2020-04-02T15:36:31.0470000Z https://www.medicinesresources.nhs.uk/anorexia-nervosa.html 2020-08-20T12:22:54.6720000Z https://www.medicinesresources.nhs.uk/tuberculosis-in-2020-new-approaches-to-a-continuing-global-health-crisis.html 2020-08-10T10:58:53.8770000Z https://www.medicinesresources.nhs.uk/an-uncomplicated-delivery-in-a-patient-with-covid-19-in-the-united-states.html 2020-08-07T11:55:31.1630000Z https://www.medicinesresources.nhs.uk/surge-in-the-number-of-people-using-nhs-tech-during-coronavirus-outbreak.html 2020-04-02T15:41:21.3040000Z https://www.medicinesresources.nhs.uk/updated-leaflets-on-abdominal-aortic-aneurysm.html 2020-04-02T15:44:06.2430000Z https://www.medicinesresources.nhs.uk/emergency-gbp300m-funding-for-covid-19-may-not-be-enough-to-prevent-pharmacy-closures.html 2020-04-02T16:20:35.7810000Z https://www.medicinesresources.nhs.uk/us-fda-approves-durvalumab-imfinzi-as-1st-line-treatment-for-adult-patients-with-extensive-stage-small-cell-lung-cancer.html 2020-04-02T16:21:56.9730000Z https://www.medicinesresources.nhs.uk/the-european-commission-grants-marketing-authorisation-for-darolutamide-nubeqa-for-certain-men-with-non-metastatic-castration-resistant-prostate-cancer.html 2020-04-02T17:30:16.7970000Z https://www.medicinesresources.nhs.uk/ticagrelor-monotherapy-reduces-bleeding-complications-with-no-increased-risk-of-ischaemic-events-in-patients-with-diabetes-undergoing-percutaneous-coronary-intervention-pci.html 2020-04-02T17:29:30.3800000Z https://www.medicinesresources.nhs.uk/what-are-the-therapeutic-options-for-patients-unable-to-take-solid-oral-dosage-forms.html 2020-04-05T18:06:51.6340000Z https://www.medicinesresources.nhs.uk/lifestyle-changes-in-relation-to-initiation-of-antihypertensive-and-lipid-lowering-medication-a-cohort-study.html 2020-07-22T13:00:03.3130000Z https://www.medicinesresources.nhs.uk/proposed-emergency-legislation-could-see-pharmacists-able-to-supply-controlled-drugs-without-a-prescription.html 2020-04-05T18:02:53.4270000Z https://www.medicinesresources.nhs.uk/national-institute-for-health-research-nihr-launches-new-centre-for-engagement-and-dissemination.html 2020-04-02T16:31:32.1610000Z https://www.medicinesresources.nhs.uk/positive-early-data-from-observational-study-of-siltuximab-in-the-treatment-of-sars-cov-2-infection.html 2020-04-02T16:32:40.0460000Z https://www.medicinesresources.nhs.uk/covid-19-update-protection-of-staff-and-managing-supply.html 2020-04-02T16:33:48.8530000Z https://www.medicinesresources.nhs.uk/new-personal-protective-equipment-ppe-guidance-for-nhs-teams.html 2020-04-05T17:59:12.6650000Z https://www.medicinesresources.nhs.uk/comparison-of-dietary-macronutrient-patterns-of-14-popular-named-dietary-programmes-for-weight-and-cardiovascular-risk-factor-reduction-in-adults-systematic-review-and-network-meta-analysis-of-randomised-trials.html 2020-04-05T17:34:18.3020000Z https://www.medicinesresources.nhs.uk/compendium-emergency-readmissions-to-hospital-within-30-days-of-discharge.html 2020-04-03T09:52:21.3010000Z https://www.medicinesresources.nhs.uk/rules-on-sharing-confidential-patient-information-are-relaxed-in-england.html 2020-04-03T09:53:19.6410000Z https://www.medicinesresources.nhs.uk/four-fifths-of-covid-19-cases-are-asymptomatic-china-figures-indicate.html 2020-04-03T09:56:26.1230000Z https://www.medicinesresources.nhs.uk/covid-19-hospitals-can-remove-15-cap-on-testing-of-nhs-staff.html 2020-04-03T09:58:42.4870000Z https://www.medicinesresources.nhs.uk/us-gives-emergency-approval-to-chloroquine-and-hydroxychloroquine-despite-lack-of-evidence.html 2020-04-03T18:48:23.3500000Z https://www.medicinesresources.nhs.uk/new-data-from-the-office-for-national-statistics-suggest-uk-deaths-from-coronavirus-are-higher-than-previously-reported.html 2020-04-03T18:44:23.3990000Z https://www.medicinesresources.nhs.uk/use-of-gravity-infusions-and-bolus-injections-in-adults-during-covid-19.html 2020-04-05T17:27:00.3520000Z https://www.medicinesresources.nhs.uk/covid-19-ppe-guidance-update.html 2020-04-05T17:20:59.7170000Z https://www.medicinesresources.nhs.uk/revised-spc-prevymis-letermovir-240-mg-film-coated-tablets.html 2020-04-03T13:32:01.5620000Z https://www.medicinesresources.nhs.uk/revised-spc-biktarvy-50-mg-200-mg-25-mg-bictegravir-emtricitabine-tenofovir-film-coated-tablets.html 2020-04-03T13:33:23.8660000Z https://www.medicinesresources.nhs.uk/revised-spc-cipralex-escitalopram-oral-drops-solution-20mg-ml-1.html 2020-04-03T13:34:51.5090000Z https://www.medicinesresources.nhs.uk/association-between-breastfeeding-and-ovarian-cancer-risk.html 2020-04-03T13:36:12.5950000Z https://www.medicinesresources.nhs.uk/positive-preliminary-results-for-investigational-vaccine-in-phase-iii-hla-a2-positive-non-small-cell-lung-cancer-study.html 2020-04-03T13:37:39.9800000Z https://www.medicinesresources.nhs.uk/fda-approves-clinical-study-of-tradipitant-in-the-treatment-of-severe-covid-19-pneumonia.html 2020-04-03T13:39:08.5590000Z https://www.medicinesresources.nhs.uk/rituximab-biosimilar-ruxience-approved-in-the-eu.html 2020-04-03T13:40:48.6330000Z https://www.medicinesresources.nhs.uk/information-for-hospital-blood-banks-during-the-coronavirus-covid-19-outbreak.html 2020-04-03T13:42:04.4940000Z https://www.medicinesresources.nhs.uk/mhra-regulatory-flexibilities-resulting-from-coronavirus-covid-20.html 2020-04-03T18:31:09.5900000Z https://www.medicinesresources.nhs.uk/international-regulators-discuss-available-knowledge-supporting-covid-19-medicine-development.html 2020-04-03T13:45:10.9000000Z https://www.medicinesresources.nhs.uk/guidance-on-coronavirus-covid-19-tests-and-testing-kits.html 2020-04-03T13:46:48.8240000Z https://www.medicinesresources.nhs.uk/nightingale-hospital-opens-at-london-s-excel-centre.html 2020-04-03T13:51:54.6670000Z https://www.medicinesresources.nhs.uk/public-satisfaction-with-the-nhs-and-social-care-in-2019-results-from-the-british-social-attitudes-survey.html 2020-04-03T17:41:13.0520000Z https://www.medicinesresources.nhs.uk/three-decades-of-shared-care-guidelines-are-we-any-further-forward-1.html 2020-04-03T15:44:49.5140000Z https://www.medicinesresources.nhs.uk/ventricular-arrhythmia-risk-due-to-hydroxychloroquine-azithromycin-treatment-for-covid-19.html 2020-04-03T17:38:47.2990000Z https://www.medicinesresources.nhs.uk/pharmacies-to-be-required-to-open-on-good-friday-and-easter-monday.html 2020-04-05T17:16:10.6500000Z https://www.medicinesresources.nhs.uk/evidence-from-china-suggests-smokers-at-greater-risk-of-severe-respiratory-disease-from-covid-19.html 2020-04-03T15:51:22.4290000Z https://www.medicinesresources.nhs.uk/drugs-and-the-renin-angiotensin-system-in-covid-19.html 2020-04-03T15:52:35.8080000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-admission-and-care-of-people-in-care-homes.html 2020-04-03T15:55:48.3340000Z https://www.medicinesresources.nhs.uk/are-uk-doctors-getting-sufficient-protective-equipment-against-covid-19.html 2020-04-03T15:57:18.8420000Z https://www.medicinesresources.nhs.uk/how-to-improve-care-across-boundaries.html 2020-04-03T15:58:16.3650000Z https://www.medicinesresources.nhs.uk/acute-lymphoblastic-leukaemia.html 2020-04-03T15:59:29.0690000Z https://www.medicinesresources.nhs.uk/funding-support-for-community-pharmacy-during-coronavirus.html 2020-04-03T16:15:11.9730000Z https://www.medicinesresources.nhs.uk/the-global-regional-and-national-burden-of-oesophageal-cancer-and-its-attributable-risk-factors-in-195-countries-and-territories-1990-2017-a-systematic-analysis-for-the-global-burden-of-disease-study-2017.html 2020-04-03T17:27:59.0960000Z https://www.medicinesresources.nhs.uk/evolving-epidemiology-and-transmission-dynamics-of-coronavirus-disease-2019-outside-hubei-province-china-a-descriptive-and-modelling-study.html 2020-04-03T17:01:27.9340000Z https://www.medicinesresources.nhs.uk/chronic-obstructive-pulmonary-disease-and-lung-cancer-incidence-in-never-smokers-a-cohort-study.html 2020-04-03T17:02:39.7810000Z https://www.medicinesresources.nhs.uk/management-of-hereditary-breast-cancer-american-society-of-clinical-oncology-american-society-for-radiation-oncology-and-society-of-surgical-oncology-guideline.html 2020-07-16T11:16:18.8890000Z https://www.medicinesresources.nhs.uk/addressing-the-covid-19-pandemic-in-populations-with-serious-mental-illness.html 2020-04-06T13:27:27.3480000Z https://www.medicinesresources.nhs.uk/the-dilemma-of-coronavirus-disease-2019-aging-and-cardiovascular-disease-insights-from-cardiovascular-aging-science.html 2020-04-06T13:33:44.3820000Z https://www.medicinesresources.nhs.uk/coronavirus-disease-2019-covid-19-infection-and-renin-angiotensin-system-blockers.html 2020-04-06T13:36:39.1190000Z https://www.medicinesresources.nhs.uk/personal-risk-and-societal-obligation-amidst-covid-19.html 2020-04-06T13:43:01.7560000Z https://www.medicinesresources.nhs.uk/us-food-and-drug-administration-fda-coordinates-national-effort-to-develop-blood-related-therapies-for-covid-19.html 2020-04-06T13:44:28.3600000Z https://www.medicinesresources.nhs.uk/experiences-and-lesson-strategies-for-cardiology-from-the-covid-19-outbreak-in-wuhan-china-by-on-the-scene-cardiologists.html 2020-04-06T13:46:04.5490000Z https://www.medicinesresources.nhs.uk/revised-spc-symkevi-ivacaftor-tezacaftor-100mg-150mg-film-coated-tablets.html 2020-04-06T13:47:45.7430000Z https://www.medicinesresources.nhs.uk/the-variety-of-cardiovascular-presentations-of-covid-19.html 2020-08-06T14:23:04.8240000Z https://www.medicinesresources.nhs.uk/update-on-the-governments-shielding-policy-and-implications-for-general-practice.html 2020-04-06T13:50:35.6780000Z https://www.medicinesresources.nhs.uk/british-thoracic-society-issues-advice-on-prescribing-respiratory-inhaler-products-in-light-of-current-significant-demand.html 2020-04-14T10:54:39.7580000Z https://www.medicinesresources.nhs.uk/patients-encouraged-to-dial-999-in-case-of-suspected-stroke-despite-covid-19.html 2020-04-06T13:54:43.4780000Z https://www.medicinesresources.nhs.uk/further-data-from-two-phase-iii-true-ad-studies-evaluating-roxolitinib-cream-for-atopic-dermatitis-meet-quality-of-life-endpoints.html 2020-04-06T13:56:17.4260000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-provides-recommendations-on-compassionate-use-of-remdesivir-for-covid-19-in-the-european-union.html 2020-04-06T14:12:26.0530000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-rheumatological-autoimmune-inflammatory-and-metabolic-bone-disorders-guidance-ng167.html 2020-04-14T09:31:47.3700000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-severe-asthma-guidance-ng166.html 2020-04-14T09:29:01.3310000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-managing-suspected-or-confirmed-pneumonia-in-adults-in-the-community-guidance-ng165.html 2020-04-14T09:26:42.8580000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-managing-symptoms-including-at-the-end-of-life-in-the-community-guidance-ng163.html 2020-04-14T09:01:53.2560000Z https://www.medicinesresources.nhs.uk/saving-babies-lives-care-bundle-covid-19-information.html 2020-04-06T14:28:25.2610000Z https://www.medicinesresources.nhs.uk/department-of-health-launches-coronavirus-status-checker-for-people-to-share-coronavirus-symptoms-to-help-others.html 2020-04-14T08:57:07.1010000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-scaling-up-testing-programmes.html 2020-04-14T08:46:11.7270000Z https://www.medicinesresources.nhs.uk/trial-of-potential-coronavirus-treatments-rolled-out-across-the-uk.html 2020-04-14T08:43:47.1530000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-for-health-professionals.html 2020-04-14T08:38:29.4550000Z https://www.medicinesresources.nhs.uk/guidance-on-management-of-drugs-requiring-monitoring-during-covid-19.html 2020-04-14T08:34:10.8670000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-march-2020.html 2020-04-14T08:27:55.9210000Z https://www.medicinesresources.nhs.uk/updated-reproductive-health-patient-group-direction-pgd-templates-published.html 2020-04-14T08:25:04.2020000Z https://www.medicinesresources.nhs.uk/potential-coronavirus-covid-19-symptoms-reported-through-nhs-pathways-and-111-online.html 2020-04-07T14:42:10.4620000Z https://www.medicinesresources.nhs.uk/lenalidomide-with-rituximab-for-previously-treated-follicular-lymphoma-technology-appraisal-guidance-ta627.html 2020-04-13T16:36:17.6020000Z https://www.medicinesresources.nhs.uk/deprescribing-in-epilepsy-do-no-harm.html 2020-04-07T14:46:03.3030000Z https://www.medicinesresources.nhs.uk/the-covid-19-pandemic-in-the-usa-clinical-update.html 2020-04-07T15:49:51.7900000Z https://www.medicinesresources.nhs.uk/eu-authorities-agree-new-measures-to-support-availability-of-medicines-used-in-the-covid-19-pandemic.html 2020-04-13T16:34:27.8310000Z https://www.medicinesresources.nhs.uk/revised-spc-soliris-eculizumab-300mg-concentrate-for-solution-for-infusion.html 2020-04-07T14:55:56.9870000Z https://www.medicinesresources.nhs.uk/cipralex-escitalopram-film-coated-tablets-all-strengths.html 2020-04-07T15:48:15.6320000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-emerade-adrenaline-300micrograms-solution-for-injection-in-pre-filled-syringe.html 2020-04-13T16:32:41.6930000Z https://www.medicinesresources.nhs.uk/alert-regarding-appropriate-rate-for-oxygen-usage-issued.html 2020-04-13T16:30:35.8110000Z https://www.medicinesresources.nhs.uk/cardiopulmonary-resuscitation-cpr-after-hospital-admission-with-covid-19.html 2020-04-07T15:04:41.9840000Z https://www.medicinesresources.nhs.uk/health-surveillance-during-covid-19-pandemic.html 2020-04-07T15:06:14.9470000Z https://www.medicinesresources.nhs.uk/autoimmune-complications-of-immunotherapy-pathophysiology-and-management.html 2020-04-07T15:07:43.3140000Z https://www.medicinesresources.nhs.uk/two-phase-iii-trials-evaluating-oral-serlopitant-for-prurigo-nodularis-pn-fail-to-meet-primary-endpoint.html 2020-04-07T15:08:52.2160000Z https://www.medicinesresources.nhs.uk/should-you-treat-this-acutely-ill-medical-inpatient-with-venous-thromboembolism-chemoprophylaxis-grand-rounds-discussion-from-beth-israel-deaconess-medical-center.html 2020-04-07T15:10:19.8320000Z https://www.medicinesresources.nhs.uk/prediction-models-for-diagnosis-and-prognosis-of-covid-19-infection-systematic-review-and-critical-appraisal.html 2020-04-07T15:11:52.6780000Z https://www.medicinesresources.nhs.uk/impact-of-emergency-hospital-admissions-on-patterns-of-primary-care-prescribing-a-retrospective-cohort-analysis-of-electronic-records-in-england.html 2020-04-07T15:13:11.7290000Z https://www.medicinesresources.nhs.uk/baseline-characteristics-and-outcomes-of-1591-patients-infected-with-sars-cov-2-admitted-to-icus-of-the-lombardy-region-italy.html 2020-04-07T15:15:18.7420000Z https://www.medicinesresources.nhs.uk/association-of-healthy-lifestyle-with-years-lived-without-major-chronic-diseases.html 2020-04-07T15:16:51.9190000Z https://www.medicinesresources.nhs.uk/time-kinetics-of-viral-clearance-and-resolution-of-symptoms-in-novel-coronavirus-infection.html 2020-04-07T15:18:21.8780000Z https://www.medicinesresources.nhs.uk/successful-care-transitions-for-older-people-a-systematic-review-and-meta-analysis-of-the-effects-of-interventions-that-support-medication-continuity.html 2020-04-07T15:19:39.0950000Z https://www.medicinesresources.nhs.uk/implementation-of-a-prehospital-stroke-triage-system-using-symptom-severity-and-teleconsultation-in-the-stockholm-stroke-triage-study.html 2020-04-07T15:22:57.9620000Z https://www.medicinesresources.nhs.uk/dtb-select-are-routine-antibiotics-after-operative-vaginal-birth-beneficial.html 2020-04-13T16:27:53.4070000Z https://www.medicinesresources.nhs.uk/bsh-guidance-on-b12-supplements-during-covid-pandemic.html 2020-04-08T15:16:31.7870000Z https://www.medicinesresources.nhs.uk/revised-spc-keytruda-pembrolizumab-powder-for-concentrate-for-solution-for-infusion.html 2020-04-08T16:21:44.9750000Z https://www.medicinesresources.nhs.uk/interferon-gamma-replacement-as-salvage-therapy-in-chronic-pulmonary-aspergillosis-effects-on-frequency-of-acute-exacerbation-and-all-cause-hospital-admission.html 2020-04-08T15:18:49.4940000Z https://www.medicinesresources.nhs.uk/comparison-of-cardiovascular-and-safety-outcomes-of-chlorthalidone-vs-hydrochlorothiazide-to-treat-hypertension.html 2020-04-08T15:20:03.3990000Z https://www.medicinesresources.nhs.uk/effect-of-doxorubicin-plus-olaratumab-vs-doxorubicin-plus-placebo-on-survival-in-patients-with-advanced-soft-tissue-sarcomas-the-announce-randomized-clinical-trial.html 2020-04-08T15:21:59.3960000Z https://www.medicinesresources.nhs.uk/effect-of-intravenous-tenecteplase-dose-on-cerebral-reperfusion-before-thrombectomy-in-patients-with-large-vessel-occlusion-ischemic-stroke-the-extend-ia-tnk-part-2-randomized-clinical-trial.html 2020-04-08T15:23:27.3600000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-the-management-of-anticoagulant-services-during-the-coronavirus-pandemic.html 2020-04-13T16:15:16.3480000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-to-managing-the-patient-with-a-cough-and-a-temperature-during-the-coronavirus-pandemic.html 2020-04-08T15:26:28.4630000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-the-management-of-surge-during-the-coronavirus-pandemic-rapid-learning.html 2020-04-08T15:27:52.7990000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-guidance-for-the-role-and-use-of-non-invasive-respiratory-support-in-adult-patients-with-covid-19-confirmed-or-suspected.html 2020-04-08T15:30:09.4920000Z https://www.medicinesresources.nhs.uk/what-other-countries-can-learn-from-italy-during-the-covid-19-pandemic.html 2020-04-08T15:31:45.1220000Z https://www.medicinesresources.nhs.uk/nhs-launches-mental-health-hotline-for-staff-tackling-covid-19.html 2020-04-08T15:33:29.8820000Z https://www.medicinesresources.nhs.uk/fda-grant-fast-track-designation-for-tozuleristide-for-peadiatric-central-nervous-system-tumours.html 2020-04-08T15:34:56.2460000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-market-authorisation-application-to-the-ema-for-lumasiran-for-primary-hyperoxaluria-type-1.html 2020-04-08T15:36:17.0800000Z https://www.medicinesresources.nhs.uk/pembrolizumab-for-cancer-treatment-based-on-biomarker-regardless-of-tumour-type-given-priority-review-in-the-us.html 2020-04-08T15:37:18.7720000Z https://www.medicinesresources.nhs.uk/fda-grants-fast-track-designation-to-sacituzumab-govitecan-for-neoadjuvant-adjuvant-metastatic-urothelial-cancer.html 2020-04-08T15:38:45.5220000Z https://www.medicinesresources.nhs.uk/covid-19-what-is-the-evidence-for-cloth-masks.html 2020-04-08T15:41:06.9760000Z https://www.medicinesresources.nhs.uk/covid-19-why-germanys-case-fatality-rate-seems-so-low.html 2020-04-08T15:43:12.7840000Z https://www.medicinesresources.nhs.uk/understanding-and-addressing-sources-of-anxiety-among-health-care-professionals-during-the-covid-19-pandemic.html 2020-04-08T15:44:33.1280000Z https://www.medicinesresources.nhs.uk/maintaining-hiv-care-during-the-covid-19-pandemic.html 2020-04-08T15:45:42.4890000Z https://www.medicinesresources.nhs.uk/brigatinib-approved-for-use-in-eu-as-monotherapy-for-first-line-use-in-alk-ve-non-small-cell-lung-cancer.html 2020-04-08T15:46:53.7970000Z https://www.medicinesresources.nhs.uk/manufacturers-report-negative-results-for-serlopitant-in-prurigo-nodularis-studies.html 2020-04-08T15:48:31.6090000Z https://www.medicinesresources.nhs.uk/all-pharmacists-in-gp-surgeries-in-england-can-now-access-medicinescomplete.html 2020-04-13T16:19:50.3830000Z https://www.medicinesresources.nhs.uk/revised-spc-tagrisso-osimertinib-80mg-film-coated-tablets.html 2020-04-09T11:19:37.9150000Z https://www.medicinesresources.nhs.uk/revised-spc-mabthera-rituximab-1400mg-solution-for-subcutaneous-injection.html 2020-04-09T11:20:38.5950000Z https://www.medicinesresources.nhs.uk/revised-spc-mabthera-rituximab-100-mg-concentrate-for-solution-for-infusion.html 2020-04-09T11:21:58.5500000Z https://www.medicinesresources.nhs.uk/revised-spc-gastrografin-gastroenteral-solution.html 2020-04-09T11:23:04.8620000Z https://www.medicinesresources.nhs.uk/revised-spc-cancidas-50-and-70-mg-formerly-caspofungin-msd-caspofungin-70-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-04-09T11:25:46.8500000Z https://www.medicinesresources.nhs.uk/revised-spc-madopar-levodopa-benserazide-200mg-50mg-hard-capsules.html 2020-04-09T11:31:13.7690000Z https://www.medicinesresources.nhs.uk/revised-spc-ozempic-semaglutide-0-25-mg-solution-for-injection-in-pre-filled-pen.html 2020-04-09T11:32:43.7220000Z https://www.medicinesresources.nhs.uk/rps-guidance-on-ethical-professional-decision-making-in-the-covid-19-pandemic.html 2020-04-13T16:12:50.1460000Z https://www.medicinesresources.nhs.uk/medical-device-alert-anaesthetic-machines-off-label-use-during-the-covid-19-pandemic.html 2020-04-13T16:09:54.1210000Z https://www.medicinesresources.nhs.uk/physical-therapy-versus-glucocorticoid-injection-for-osteoarthritis-of-the-knee.html 2020-08-07T12:31:53.0230000Z https://www.medicinesresources.nhs.uk/initial-invasive-or-conservative-strategy-for-stable-coronary-disease.html 2020-08-07T14:15:53.0760000Z https://www.medicinesresources.nhs.uk/nhs-england-specialty-guide-clinical-guide-for-the-management-of-people-with-alcohol-dependence-during-the-coronavirus-pandemic.html 2020-04-13T16:06:51.9620000Z https://www.medicinesresources.nhs.uk/nhs-england-specialty-guide-clinical-guide-for-the-optimal-use-of-oxygen-therapy-during-the-coronavirus-pandemic.html 2020-04-13T16:04:51.7500000Z https://www.medicinesresources.nhs.uk/nhs-england-specialty-guide-clinical-guide-for-the-management-of-essential-cancer-surgery-for-adults-during-the-coronavirus-pandemic.html 2020-04-13T16:03:35.3930000Z https://www.medicinesresources.nhs.uk/nhs-england-specialty-guide-clinical-guide-for-the-management-of-patients-requiring-endoscopy-during-the-coronavirus-pandemic.html 2020-04-13T16:01:38.3250000Z https://www.medicinesresources.nhs.uk/us-fda-grants-sotatercept-breakthrough-therapy-designation-for-pulmonary-arterial-hypertension.html 2020-04-09T15:18:58.6000000Z https://www.medicinesresources.nhs.uk/capacity-covid-a-european-registry-to-determine-the-role-of-cardiovascular-disease-in-the-covid-19-pandemic.html 2020-04-09T15:24:07.1600000Z https://www.medicinesresources.nhs.uk/considerations-for-drug-interactions-on-qtc-in-exploratory-covid-19-coronavirus-disease-2019-treatment.html 2020-08-06T14:16:31.3370000Z https://www.medicinesresources.nhs.uk/global-regulators-stress-need-for-robust-evidence-on-covid-19-treatments.html 2020-04-09T15:32:29.2230000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-establishes-task-force-to-take-quick-and-coordinated-regulatory-action-related-to-covid-19-medicines.html 2020-04-09T15:33:49.5590000Z https://www.medicinesresources.nhs.uk/critical-care-services-in-the-english-nhs.html 2020-04-09T15:35:33.7300000Z https://www.medicinesresources.nhs.uk/neurobiology-clinical-presentation-and-treatment-of-methamphetamine-use-disorder-a-review.html 2020-04-09T15:37:06.8440000Z https://www.medicinesresources.nhs.uk/alpha1-antitrypsin-deficiency.html 2020-10-01T13:29:19.8060000Z https://www.medicinesresources.nhs.uk/coronavirus-parent-information-for-newborn-babies.html 2020-04-09T15:40:48.9240000Z https://www.medicinesresources.nhs.uk/illness-in-newborn-babies.html 2020-04-09T15:42:41.6090000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-for-stepdown-of-infection-control-precautions-within-hospitals-and-discharging-covid-19-patients-from-hospital-to-home-settings.html 2020-04-13T15:52:09.9140000Z https://www.medicinesresources.nhs.uk/advisory-council-on-the-misuse-of-drugs-acmd-advice-on-covid-19-emergency-legislation-to-enable-supply-of-controlled-drugs.html 2020-04-13T15:47:00.2940000Z https://www.medicinesresources.nhs.uk/european-commission-approves-aflibercept-pre-filled-syringe-for-retinal-conditions.html 2020-04-09T16:02:09.0710000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-guidance-on-isolation-for-residential-educational-settings.html 2020-04-09T17:07:42.5340000Z https://www.medicinesresources.nhs.uk/chemotherapy-radiotherapy-and-surgical-tumour-resections-in-england.html 2020-04-09T16:08:54.2200000Z https://www.medicinesresources.nhs.uk/summary-hospital-level-mortality-indicator-shmi-deaths-associated-with-hospitalisation-england-december-2018-november-2019.html 2020-04-09T16:09:58.6170000Z https://www.medicinesresources.nhs.uk/potential-coronavirus-covid-19-symptoms-reported-through-nhs-pathways-and-111-online-1.html 2020-04-09T16:11:19.8750000Z https://www.medicinesresources.nhs.uk/face-masks-for-the-public-during-the-covid-19-crisis.html 2020-04-09T16:12:55.8570000Z https://www.medicinesresources.nhs.uk/use-of-electronic-medical-records-in-development-and-validation-of-risk-prediction-models-of-hospital-readmission-systematic-review.html 2020-04-09T16:47:38.8130000Z https://www.medicinesresources.nhs.uk/quarantine-alone-or-in-combination-with-other-public-health-measures-to-control-covid-19-a-rapid-review.html 2020-04-09T16:48:32.5930000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-continuous-risankizumab-therapy-vs-treatment-withdrawal-in-patients-with-moderate-to-severe-plaque-psoriasis-a-phase-3-randomized-clinical-trial.html 2020-04-09T16:55:02.1620000Z https://www.medicinesresources.nhs.uk/factor-xa-inhibitor-related-intracranial-hemorrhage-fix-ich-results-from-a-multicenter-observational-cohort-receiving-prothrombin-complex-concentrates.html 2020-07-22T13:10:54.2510000Z https://www.medicinesresources.nhs.uk/chloroquine-and-hydroxychloroquine-in-covid-19.html 2020-04-09T16:51:30.7620000Z https://www.medicinesresources.nhs.uk/clinicians-are-leading-service-reconfiguration-to-cope-with-covid-19.html 2020-04-09T16:52:16.5220000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-cystic-fibrosis-guideline-ng170.html 2020-04-20T11:23:24.9190000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-dermatological-conditions-treated-with-drugs-affecting-the-immune-response-guideline-ng169.html 2020-04-20T11:22:06.7360000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-community-based-care-of-patients-with-chronic-obstructive-pulmonary-disease-copd-guideline-ng168.html 2020-04-20T11:20:36.6830000Z https://www.medicinesresources.nhs.uk/naldemedine-rizmoic-r-is-accepted-for-use-within-nhsscotland.html 2020-04-14T14:59:00.8130000Z https://www.medicinesresources.nhs.uk/insulin-glargine-lixisenatide-suliqua-r-is-accepted-for-restricted-use-within-nhsscotland.html 2020-04-14T15:00:15.9680000Z https://www.medicinesresources.nhs.uk/ustekinumab-stelara-r-is-accepted-for-use-within-nhsscotland.html 2020-04-14T15:01:21.5360000Z https://www.medicinesresources.nhs.uk/fampridine-fampyra-r-is-accepted-for-use-within-nhsscotland.html 2020-04-14T15:02:32.8930000Z https://www.medicinesresources.nhs.uk/covid-19-all-haemofiltration-systems-including-machines-and-accessories-serious-risks-if-users-don-t-follow-manufacturer-instructions-for-set-up.html 2020-04-14T15:03:42.5770000Z https://www.medicinesresources.nhs.uk/the-state-of-vaccine-safety-science-systematic-reviews-of-the-evidence.html 2020-04-14T17:15:35.6000000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-the-temporary-reorganisation-of-intrapartum-maternity-care-during-the-coronavirus-pandemic.html 2020-04-20T11:16:07.0340000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-to-surgical-prioritisation-during-the-coronavirus-pandemic.html 2020-04-20T11:12:50.5940000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-reference-guide-for-emergency-medicine.html 2020-04-20T11:05:29.2700000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-the-management-of-critical-care-for-adults-with-covid-19-during-the-coronavirus-pandemic.html 2020-04-20T10:46:46.1220000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-extra-corporeal-membrane-oxygenation-ecmo-for-respiratory-failure-in-adults-during-the-coronavirus-pandemic.html 2020-04-20T10:44:37.3390000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-the-management-of-rheumatology-patients-during-the-coronavirus-pandemic.html 2020-04-20T10:42:28.6240000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-urgent-and-emergency-musculoskeletal-conditions-in-children-under-16-requiring-onward-referral.html 2020-04-20T10:38:53.0810000Z https://www.medicinesresources.nhs.uk/medicines-delivery-services-commissioned-from-both-pharmacies-and-dispensing-doctors-across-england-from-9-april-until-1-july-2020-as-part-of-covid-19-response.html 2020-04-20T10:36:28.6500000Z https://www.medicinesresources.nhs.uk/pharmacologic-treatments-for-coronavirus-disease-2019-covid-19-a-review.html 2020-04-14T15:19:21.6400000Z https://www.medicinesresources.nhs.uk/oncology-practice-during-the-covid-19-pandemic.html 2020-04-14T17:44:38.2160000Z https://www.medicinesresources.nhs.uk/anca-associated-vasculitis.html 2020-04-14T15:22:12.4240000Z https://www.medicinesresources.nhs.uk/rivaroxaban-plasma-levels-and-levetiracetam-a-case-report.html 2020-07-06T11:31:09.8640000Z https://www.medicinesresources.nhs.uk/diagnostic-testing-for-severe-acute-respiratory-syndrome-related-coronavirus-2-a-narrative-review.html 2020-04-14T15:25:06.7690000Z https://www.medicinesresources.nhs.uk/eli-lilly-to-begin-testing-of-baricitinib-in-covid-19-patients.html 2020-04-14T17:16:41.3590000Z https://www.medicinesresources.nhs.uk/recommendations-from-national-regulatory-agencies-for-ongoing-cancer-trials-during-the-covid-19-pandemic.html 2020-04-14T15:27:46.0410000Z https://www.medicinesresources.nhs.uk/fda-approves-saliva-test-for-covid-19.html 2020-04-14T15:28:39.3690000Z https://www.medicinesresources.nhs.uk/integrated-care-systems-explained-making-sense-of-systems-places-and-neighbourhoods.html 2020-04-14T17:37:34.1990000Z https://www.medicinesresources.nhs.uk/shortage-of-acetazolamide-250mg-prolonged-release-capsules-advanz-teva.html 2020-04-20T10:17:41.9000000Z https://www.medicinesresources.nhs.uk/new-medicines-newsletter-march-2020.html 2020-04-20T10:31:11.9000000Z https://www.medicinesresources.nhs.uk/fda-and-european-medicines-agency-accepts-for-review-licence-extension-application-for-nivolumab-and-ipilimumab-as-first-line-treatment-of-metastatic-or-recurrent-non-small-cell-lung-cancer-with-no-egfr-or-alk-genomic-tumour-aberrations.html 2020-04-14T17:35:51.4570000Z https://www.medicinesresources.nhs.uk/nhs-opens-two-more-nightingale-hospitals.html 2020-04-14T15:33:58.1020000Z https://www.medicinesresources.nhs.uk/nhs-digital-streamlines-nhs-smartcard-access-for-new-starters.html 2020-04-14T15:35:01.2430000Z https://www.medicinesresources.nhs.uk/outpatient-management-of-alcohol-related-liver-disease.html 2020-04-14T15:36:45.0760000Z https://www.medicinesresources.nhs.uk/guidance-on-regulatory-requirements-in-the-context-of-the-covid-19-pandemic.html 2020-04-14T15:37:51.7790000Z https://www.medicinesresources.nhs.uk/update-on-eu-actions-to-support-availability-of-medicines-during-covid-19-pandemic.html 2020-04-14T15:39:16.7510000Z https://www.medicinesresources.nhs.uk/clinical-management-of-stable-coronary-artery-disease-in-patients-with-type-2-diabetes-mellitus-a-scientific-statement-from-the-american-heart-association.html 2020-07-16T11:59:57.2100000Z https://www.medicinesresources.nhs.uk/shielding-gp-practices.html 2020-04-14T15:41:42.5520000Z https://www.medicinesresources.nhs.uk/supplemental-biologics-license-application-submitted-to-fda-for-avelumab-for-first-line-maintenance-treatment-of-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma.html 2020-04-14T15:43:00.2820000Z https://www.medicinesresources.nhs.uk/fda-approves-selumetinib-koselugo-for-the-treatment-of-children-aged-from-2-years-with-neurofibromatosis-type-1.html 2020-04-14T17:28:27.4540000Z https://www.medicinesresources.nhs.uk/fda-approves-encorafenib-in-combination-with-cetuximab-for-treatment-of-metastatic-colorectal-cancer-with-a-brafv600e-mutation.html 2020-04-14T15:45:57.1170000Z https://www.medicinesresources.nhs.uk/cansino-biologics-prepares-to-advance-covid-19-vaccine-candidate-into-phase-ii-trial.html 2020-04-14T15:47:01.9910000Z https://www.medicinesresources.nhs.uk/sexual-health-patient-group-direction-pgd-templates.html 2020-04-20T10:25:19.3490000Z https://www.medicinesresources.nhs.uk/adjuvant-capecitabine-with-docetaxel-and-cyclophosphamide-plus-epirubicin-for-triple-negative-breast-cancer-cbcsg010-an-open-label-randomized-multicenter-phase-iii-trial.html 2020-07-07T10:41:26.0880000Z https://www.medicinesresources.nhs.uk/durvalumab-with-or-without-tremelimumab-vs-standard-chemotherapy-in-first-line-treatment-of-metastatic-non-small-cell-lung-cancer-the-mystic-phase-3-randomized-clinical-trial.html 2020-04-14T15:53:34.0250000Z https://www.medicinesresources.nhs.uk/compassionate-use-of-remdesivir-for-patients-with-severe-covid-19.html 2020-08-07T14:48:16.0860000Z https://www.medicinesresources.nhs.uk/impact-of-asparaginase-discontinuation-on-outcome-in-childhood-acute-lymphoblastic-leukemia-a-report-from-the-childrens-oncology-group.html 2020-07-08T14:24:15.9140000Z https://www.medicinesresources.nhs.uk/neurologic-manifestations-of-hospitalized-patients-with-coronavirus-disease-2019-in-wuhan-china.html 2020-04-14T15:58:10.8530000Z https://www.medicinesresources.nhs.uk/association-of-public-health-interventions-with-the-epidemiology-of-the-covid-19-outbreak-in-wuhan-china.html 2020-04-14T16:00:04.9530000Z https://www.medicinesresources.nhs.uk/health-care-costs-of-inflammatory-bowel-disease-in-a-pan-european-community-based-inception-cohort-during-5-years-of-follow-up-a-population-based-study.html 2020-04-14T16:01:25.6610000Z https://www.medicinesresources.nhs.uk/attention-should-be-paid-to-venous-thromboembolism-prophylaxis-in-the-management-of-covid-19.html 2020-04-14T16:07:15.9180000Z https://www.medicinesresources.nhs.uk/association-of-cigarette-smoking-with-antineutrophil-cytoplasmic-antibody-associated-vasculitis-2.html 2020-04-14T16:33:33.4310000Z https://www.medicinesresources.nhs.uk/ibuprofen-and-coronavirus-covid-19.html 2020-04-20T10:11:20.8710000Z https://www.medicinesresources.nhs.uk/revised-spc-kisqali-ribociclib-tablets.html 2020-04-15T14:27:21.2420000Z https://www.medicinesresources.nhs.uk/revised-spc-revatio-sildenafil-preparations.html 2020-04-15T14:29:24.6590000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-evidence-summary-acute-use-of-non-steroidal-anti-inflammatory-drugs-nsaids-for-people-with-or-at-risk-of-covid-19-es23.html 2020-04-20T09:48:11.3020000Z https://www.medicinesresources.nhs.uk/can-breastfeeding-mothers-take-paracetamol-or-paracetamol-combination-products.html 2020-04-20T09:42:57.3950000Z https://www.medicinesresources.nhs.uk/spread-of-sars-cov-2-in-the-icelandic-population.html 2020-08-07T14:42:37.5470000Z https://www.medicinesresources.nhs.uk/effect-of-preemptive-therapy-vs-antiviral-prophylaxis-on-cytomegalovirus-disease-in-seronegative-liver-transplant-recipients-with-seropositive-donors-a-randomized-clinical-trial.html 2020-04-15T14:45:58.7530000Z https://www.medicinesresources.nhs.uk/association-between-physical-activity-and-risk-of-incident-arrhythmias-in-402-406-individuals-evidence-from-the-uk-biobank-cohort.html 2020-04-15T14:48:19.5310000Z https://www.medicinesresources.nhs.uk/continuous-positive-airway-pressure-treatment-glycemia-and-diabetes-risk-in-obstructive-sleep-apnea-and-comorbid-cardiovascular-disease.html 2020-04-15T14:50:08.1320000Z https://www.medicinesresources.nhs.uk/drug-evaluation-during-the-covid-19-pandemic.html 2020-08-10T11:14:27.5360000Z https://www.medicinesresources.nhs.uk/not-dying-alone-modern-compassionate-care-in-the-covid-19-pandemic.html 2020-08-10T11:13:33.4700000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-tislelizumab-in-phase-iii-trial-for-lung-cancer.html 2020-04-15T14:55:03.8170000Z https://www.medicinesresources.nhs.uk/sustainability-of-costs-of-novel-biologicals-are-we-all-heading-for-bankruptcy.html 2020-04-15T14:56:08.8080000Z https://www.medicinesresources.nhs.uk/covid-19-arrhythmic-risk-and-inflammation-mind-the-gap.html 2020-08-06T14:12:08.0330000Z https://www.medicinesresources.nhs.uk/potential-coronavirus-covid-19-symptoms-reported-through-nhs-pathways-and-111-online-data-from-18-mar-to-14-apr-2020.html 2020-04-15T15:00:38.8640000Z https://www.medicinesresources.nhs.uk/lenzetto-estradiol-spray-for-menopause-launched-in-the-uk.html 2020-04-15T15:02:04.5730000Z https://www.medicinesresources.nhs.uk/revised-spc-otezla-apremilast-film-coated-tablets-all-strengths.html 2020-04-16T15:02:41.0740000Z https://www.medicinesresources.nhs.uk/revised-spc-kymriah-tisagenlecleucel-cells-dispersion-for-infusion.html 2020-04-16T15:04:30.4260000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-the-management-of-urgent-and-emergency-spinal-surgical-patients-during-the-coronavirus-pandemic.html 2020-04-20T09:29:05.3740000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-the-management-of-trauma-and-orthopaedic-patients-during-the-coronavirus-pandemic.html 2020-04-20T09:23:54.8710000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-the-management-of-neurotrauma-patients-during-the-coronavirus-pandemic.html 2020-04-20T09:04:55.0690000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-acute-kidney-injury-in-hospitalised-patients-with-covid-19-outside-the-intensive-care-unit-during-the-coronavirus-pandemic.html 2020-04-20T08:58:41.8920000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-renal-replacement-therapy-options-in-critical-care-during-the-coronavirus-pandemic.html 2020-04-20T08:40:17.9510000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-levofloxacin-500mg-tablets-pl-00289-1047-el-20-a-21.html 2020-04-16T15:13:09.2810000Z https://www.medicinesresources.nhs.uk/supply-disruption-alert-neuromuscular-blocking-agents-atracurium-cisatracurium-and-rocuronium.html 2020-04-20T08:37:56.2080000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-calls-for-pre-reg-pharmacists-to-be-provisionally-registered-without-delay.html 2020-04-16T15:22:08.3000000Z https://www.medicinesresources.nhs.uk/preparedness-letter-for-general-practice-14-april.html 2020-04-16T17:20:03.9340000Z https://www.medicinesresources.nhs.uk/advice-on-how-to-establish-a-remote-total-triage-model-in-general-practice-using-online-consultations.html 2020-04-16T15:24:27.4730000Z https://www.medicinesresources.nhs.uk/preparedness-letter-for-primary-dental-care-15-april-2020.html 2020-04-16T15:25:35.3180000Z https://www.medicinesresources.nhs.uk/covid-19-health-literacy-is-an-underestimated-problem.html 2020-04-16T17:18:05.0950000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-in-the-management-of-critically-ill-patients-with-covid-19-the-need-for-an-evidence-base.html 2020-04-20T08:22:00.3660000Z https://www.medicinesresources.nhs.uk/multidisciplinary-research-priorities-for-the-covid-19-pandemic-a-call-for-action-for-mental-health-science.html 2020-04-16T15:29:29.6900000Z https://www.medicinesresources.nhs.uk/utility-of-hyposmia-and-hypogeusia-for-the-diagnosis-of-covid-19.html 2020-04-20T08:33:34.3780000Z https://www.medicinesresources.nhs.uk/covid-19-and-the-stiff-upper-lip-the-pandemic-response-in-the-united-kingdom.html 2020-04-16T15:33:24.0000000Z https://www.medicinesresources.nhs.uk/diagnosis-and-treatment-of-clostridioides-clostridium-difficile-infection-in-adults-in-2020.html 2020-04-16T15:35:14.7570000Z https://www.medicinesresources.nhs.uk/diagnosis-and-management-of-obstructive-sleep-apnea-a-review.html 2020-04-16T15:37:21.2480000Z https://www.medicinesresources.nhs.uk/advice-for-clinicians-on-how-to-treat-comorbid-anxiety-and-depression.html 2020-04-16T15:38:25.4840000Z https://www.medicinesresources.nhs.uk/social-care-for-adults-aged-18-64-in-england.html 2020-04-16T15:39:29.6410000Z https://www.medicinesresources.nhs.uk/joint-statement-from-the-gphc-and-the-rps-on-the-use-of-nhs-volunteers-to-deliver-medicines-in-england.html 2020-04-16T15:40:23.7900000Z https://www.medicinesresources.nhs.uk/the-science-underlying-covid-19-implications-for-the-cardiovascular-system.html 2020-07-17T10:42:12.0980000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-adult-social-care-action-plan.html 2020-04-16T16:45:15.1580000Z https://www.medicinesresources.nhs.uk/covid-19-why-we-need-a-national-health-and-social-care-service.html 2020-04-16T15:44:55.0010000Z https://www.medicinesresources.nhs.uk/south-korean-health-officials-investigating-several-possible-explanations-for-small-but-growing-number-of-recovered-coronavirus-patients-who-later-test-positive-for-virus-again.html 2020-04-16T15:46:05.7980000Z https://www.medicinesresources.nhs.uk/gsk-and-sanofi-to-develop-an-adjuvanted-vaccine-for-covid-19.html 2020-04-16T15:48:01.6390000Z https://www.medicinesresources.nhs.uk/fda-grants-fast-track-designation-to-telitacicept-as-a-treatment-for-systemic-lupus-erythematosus.html 2020-04-16T15:49:16.4260000Z https://www.medicinesresources.nhs.uk/fda-approves-jelmyto-mitomycin-gel-for-treatment-of-low-grade-upper-tract-urothelial-cancer-utuc.html 2020-04-16T15:50:28.3400000Z https://www.medicinesresources.nhs.uk/fda-approves-use-of-ortho-s-high-throughput-automated-covid-19-antibody-test.html 2020-04-16T17:03:29.9160000Z https://www.medicinesresources.nhs.uk/rates-of-co-infection-between-sars-cov-2-and-other-respiratory-pathogens.html 2020-04-16T15:57:29.3860000Z https://www.medicinesresources.nhs.uk/metabolic-factors-lifestyle-habits-and-possible-polyneuropathy-in-early-type-2-diabetes-a-nationwide-study-of-5-249-patients-in-the-danish-centre-for-strategic-research-in-type-2-diabetes-dd2-cohort.html 2020-04-16T15:59:19.5030000Z https://www.medicinesresources.nhs.uk/use-of-glucagon-like-peptide-1-receptor-agonists-and-risk-of-serious-renal-events-scandinavian-cohort-study.html 2020-04-16T17:01:05.3320000Z https://www.medicinesresources.nhs.uk/projecting-the-transmission-dynamics-of-sars-cov-2-through-the-postpandemic-period.html 2020-04-16T16:09:03.7600000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-in-patients-with-covid-19-an-open-label-randomized-controlled-trial.html 2020-04-16T16:40:30.5050000Z https://www.medicinesresources.nhs.uk/revised-spc-lonsurf-20-mg-8-19-mg-trifluridine-and-tipiracil-film-coated-tablets.html 2020-04-17T14:22:20.8470000Z https://www.medicinesresources.nhs.uk/british-thoracic-society-guideline-for-the-use-of-long-term-macrolides-in-adults-with-respiratory-disease.html 2020-04-19T18:59:39.4810000Z https://www.medicinesresources.nhs.uk/glucosamine-what-are-the-adverse-effects.html 2020-04-19T19:02:00.4130000Z https://www.medicinesresources.nhs.uk/bevacizumab-and-platinum-based-combinations-for-recurrent-ovarian-cancer-a-randomised-open-label-phase-3-trial.html 2020-04-17T14:33:27.8260000Z https://www.medicinesresources.nhs.uk/acute-use-of-non-steroidal-anti-inflammatory-drugs-nsaids-in-people-with-or-at-risk-of-covid-19.html 2020-04-19T18:53:51.1650000Z https://www.medicinesresources.nhs.uk/rolling-submission-of-biologic-license-application-for-teplizumab-for-the-delay-or-prevention-of-clinical-type-1-diabetes-in-at-risk-individuals-initiated.html 2020-04-17T14:36:59.9150000Z https://www.medicinesresources.nhs.uk/strengthening-the-links-between-planning-and-health-in-england.html 2020-04-17T14:37:56.4560000Z https://www.medicinesresources.nhs.uk/description-and-proposed-management-of-the-acute-covid-19-cardiovascular-syndrome.html 2020-08-06T14:13:36.1540000Z https://www.medicinesresources.nhs.uk/meeting-highlights-from-icmra-global-regulatory-workshop-on-covid-19-observational-studies-and-real-world-data.html 2020-04-17T14:40:02.3230000Z https://www.medicinesresources.nhs.uk/simulation-helps-nhs-prepare-during-coronavirus-pandemic.html 2020-04-17T14:42:15.7530000Z https://www.medicinesresources.nhs.uk/meeting-the-care-needs-of-older-adults-isolated-at-home-during-the-covid-19-pandemic.html 2020-04-17T14:43:29.0940000Z https://www.medicinesresources.nhs.uk/finding-effective-treatments-for-covid-19-scientific-integrity-and-public-confidence-in-a-time-of-crisis.html 2020-04-17T14:44:51.2920000Z https://www.medicinesresources.nhs.uk/predictive-mathematical-models-of-the-covid-19-pandemic-underlying-principles-and-value-of-projections.html 2020-04-17T14:46:03.9070000Z https://www.medicinesresources.nhs.uk/endoscopy-in-inflammatory-bowel-diseases-during-the-covid-19-pandemic-and-post-pandemic-period.html 2020-04-17T14:47:31.3200000Z https://www.medicinesresources.nhs.uk/police-advice-for-community-pharmacies-on-crime-and-security-during-covid-19.html 2020-04-17T14:51:06.7290000Z https://www.medicinesresources.nhs.uk/us-fda-grants-surufatinib-fast-track-designation-for-treatment-of-advanced-and-progressive-pancreatic-and-non-pancreatic-neuroendocrine-tumours-net.html 2020-04-17T14:52:48.6560000Z https://www.medicinesresources.nhs.uk/boots-and-digital-healthcare-provider-livi-expand-provision-of-remote-access-to-health-advice.html 2020-04-17T14:53:53.1790000Z https://www.medicinesresources.nhs.uk/roche-announces-development-and-upcoming-launch-of-new-covid-19-antibodies-test.html 2020-04-17T14:55:00.2410000Z https://www.medicinesresources.nhs.uk/jcvi-statement-on-immunisation-prioritisation.html 2020-04-19T18:48:44.8770000Z https://www.medicinesresources.nhs.uk/covid-19-mental-health-campaign-launches.html 2020-04-17T14:57:40.3610000Z https://www.medicinesresources.nhs.uk/acalabrutinib-with-or-without-obinutuzumab-versus-chlorambucil-and-obinutuzmab-for-treatment-naive-chronic-lymphocytic-leukaemia-elevate-tn-a-randomised-controlled-phase-3-trial.html 2020-04-17T15:08:57.7250000Z https://www.medicinesresources.nhs.uk/immune-checkpoint-inhibitor-rechallenge-after-immune-related-adverse-events-in-patients-with-cancer.html 2020-04-17T15:11:10.0470000Z https://www.medicinesresources.nhs.uk/the-use-of-not-negative-conclusions-to-describe-results-of-formally-negative-trials-presented-at-oncology-meetings.html 2020-04-17T15:12:27.9460000Z https://www.medicinesresources.nhs.uk/impact-assessment-of-non-pharmaceutical-interventions-against-coronavirus-disease-2019-and-influenza-in-hong-kong-an-observational-study.html 2020-04-20T14:23:20.7650000Z https://www.medicinesresources.nhs.uk/a-randomized-controlled-trial-comparing-glargine-u300-and-glargine-u100-for-the-inpatient-management-of-medicine-and-surgery-patients-with-type-2-diabetes-glargine-u300-hospital-trial.html 2020-04-20T14:24:40.1280000Z https://www.medicinesresources.nhs.uk/a-non-d2-receptor-binding-drug-for-the-treatment-of-schizophrenia.html 2020-08-07T13:30:23.1050000Z https://www.medicinesresources.nhs.uk/systematic-review-of-the-efficacy-and-safety-of-antiretroviral-drugs-against-sars-mers-or-covid-19-initial-assessment.html 2020-04-20T15:28:27.9020000Z https://www.medicinesresources.nhs.uk/maintaining-pharmacy-services-during-the-outbreak.html 2020-04-20T15:27:16.4850000Z https://www.medicinesresources.nhs.uk/fp10-update-changes-to-nhs-prescription-forms-and-tokens.html 2020-04-20T14:32:02.7460000Z https://www.medicinesresources.nhs.uk/nationwide-launch-for-gp-based-trial-of-covid-19-therapies.html 2020-04-20T14:33:37.9210000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-review-of-ingenol-mebutate-upholds-marketing-authorisation-suspension-following-safety-review.html 2020-04-20T14:34:59.3160000Z https://www.medicinesresources.nhs.uk/class-4-drug-alert-glaxosmithkline-consumer-healthcare-uk-ltd-various-otc-cold-and-flu-remedies-and-treatments-for-allergies.html 2020-04-27T11:26:26.2840000Z https://www.medicinesresources.nhs.uk/trials-begin-of-machine-learning-system-to-help-hospitals-plan-and-manage-covid-19-treatment-resources.html 2020-04-20T14:42:40.3920000Z https://www.medicinesresources.nhs.uk/patients-now-able-to-nominate-pharmacy-using-the-nhs-app.html 2020-04-27T11:20:54.1240000Z https://www.medicinesresources.nhs.uk/potential-coronavirus-covid-19-symptoms-reported-through-nhs-pathways-and-111-online-2.html 2020-04-20T14:45:06.0260000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-updated-managing-symptoms-including-at-the-end-of-life-in-the-community-ng163.html 2020-04-27T11:19:35.8440000Z https://www.medicinesresources.nhs.uk/from-mitigation-to-containment-of-the-covid-19-pandemic-putting-the-sars-cov-2-genie-back-in-the-bottle.html 2020-04-20T14:52:07.8780000Z https://www.medicinesresources.nhs.uk/approach-to-narrow-complex-tachycardia-non-invasive-guide-to-interpretation-and-management.html 2020-04-20T14:53:37.5180000Z https://www.medicinesresources.nhs.uk/news2-and-deterioration-in-covid-19.html 2020-04-27T11:15:42.7740000Z https://www.medicinesresources.nhs.uk/us-fda-approves-pemigatinib-for-treatment-of-patients-with-cholangiocarcinoma.html 2020-04-20T14:56:55.3770000Z https://www.medicinesresources.nhs.uk/considerations-for-personal-protective-equipment-ppe-in-the-context-of-acute-supply-shortages-for-coronavirus-disease-2019-covid-19-pandemic.html 2020-04-27T11:11:04.0560000Z https://www.medicinesresources.nhs.uk/dosing-will-be-a-key-success-factor-in-repurposing-antivirals-for-covid-19.html 2020-04-20T15:00:31.6590000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-prophylaxis-for-covid-19-contacts-in-india.html 2020-04-20T15:01:57.1550000Z https://www.medicinesresources.nhs.uk/prevention-of-covid-19-in-patients-with-inflammatory-bowel-disease-in-wuhan-china.html 2020-04-20T15:04:27.8710000Z https://www.medicinesresources.nhs.uk/sars-cov-2-and-viral-sepsis-observations-and-hypotheses.html 2020-04-20T15:06:09.5420000Z https://www.medicinesresources.nhs.uk/whats-happening-in-covid-19-icus-an-intensive-care-doctor-answers-some-common-questions.html 2020-04-20T15:08:17.9530000Z https://www.medicinesresources.nhs.uk/clinical-features-of-covid-19.html 2020-04-20T15:11:47.8970000Z https://www.medicinesresources.nhs.uk/us-fda-approves-tucatinib-in-combination-with-trastuzumab-and-capecitabine-for-adults-with-inoperable-advanced-her2-positive-breast-cancer.html 2020-04-20T15:13:29.6220000Z https://www.medicinesresources.nhs.uk/revised-spc-evotaz-atazanavir-and-cobicistat-300mg-150mg-film-coated-tablets.html 2020-04-20T15:15:29.5400000Z https://www.medicinesresources.nhs.uk/revised-spc-alecensa-alectinib-150-mg-hard-capsules.html 2020-04-20T15:20:26.9360000Z https://www.medicinesresources.nhs.uk/revised-spc-esmeron-rocuronium-bromide-10mg-ml-solution-for-injection.html 2020-04-20T15:23:54.9480000Z https://www.medicinesresources.nhs.uk/revised-spc-avamys-fluticasone-furoate-27-5-micrograms-spray-nasal-spray.html 2020-04-20T15:25:57.1410000Z https://www.medicinesresources.nhs.uk/revised-spc-fragmin-dalteparin-solution-for-injection-all-strengths.html 2020-04-20T15:28:02.2600000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-updated-guidance.html 2020-04-27T11:04:10.8040000Z https://www.medicinesresources.nhs.uk/covid-19-looking-beyond-tomorrow-for-health-care-and-society.html 2020-04-20T15:47:06.4570000Z https://www.medicinesresources.nhs.uk/preoperative-oral-antibiotics-and-surgical-site-infections-in-colon-surgery-oralev-a-multicentre-single-blind-pragmatic-randomised-controlled-trial.html 2020-04-21T14:43:32.3920000Z https://www.medicinesresources.nhs.uk/cannabis-based-medicinal-products-summary-of-nice-guidance.html 2020-04-21T14:45:21.9510000Z https://www.medicinesresources.nhs.uk/tackling-covid-19-are-the-costs-worth-the-benefits.html 2020-04-21T14:46:47.2780000Z https://www.medicinesresources.nhs.uk/new-research-to-assess-extent-of-covid-19-infection-in-young.html 2020-04-27T10:54:36.2530000Z https://www.medicinesresources.nhs.uk/remote-prescribing-guidance-for-health-and-justice-sites.html 2020-04-27T10:50:17.9800000Z https://www.medicinesresources.nhs.uk/supporting-older-people-and-people-living-with-dementia-during-self-isolation.html 2020-04-21T14:52:50.6230000Z https://www.medicinesresources.nhs.uk/nhs-urges-public-to-stay-safe-ahead-of-ramadan.html 2020-04-21T14:54:16.7250000Z https://www.medicinesresources.nhs.uk/trials-begin-of-machine-learning-system-to-help-hospitals-plan-and-manage-covid-19-treatment-resources-1.html 2020-04-21T14:55:32.0960000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guidance-for-consultation-on-andexanet-alfa-for-reversing-anticoagulation.html 2020-04-21T14:57:06.4020000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-update-to-guidance-on-regulatory-expectations-in-the-context-of-covid-19-pandemic.html 2020-04-21T14:58:10.8360000Z https://www.medicinesresources.nhs.uk/primary-and-secondary-prevention-of-cardiovascular-disease-in-the-era-of-the-coronavirus-pandemic.html 2020-08-06T14:24:55.0620000Z https://www.medicinesresources.nhs.uk/plea-for-multitargeted-interventions-for-severe-covid-19.html 2020-04-21T15:12:28.4440000Z https://www.medicinesresources.nhs.uk/managing-covid-19-symptoms-including-at-the-end-of-life-in-the-community-summary-of-nice-guidelines.html 2020-04-21T15:15:45.3300000Z https://www.medicinesresources.nhs.uk/revised-spc-roactemra-tocilizumab-162-mg-solution-for-injection-in-pre-filled-pen.html 2020-04-21T15:17:39.2430000Z https://www.medicinesresources.nhs.uk/revised-spc-crysvita-burosumab-solution-for-subcutaneous-injection.html 2020-04-21T15:19:06.8040000Z https://www.medicinesresources.nhs.uk/universal-weekly-testing-as-the-uk-covid-19-lockdown-exit-strategy.html 2020-04-21T15:20:14.5400000Z https://www.medicinesresources.nhs.uk/clinical-decision-making.html 2020-04-21T15:26:04.1800000Z https://www.medicinesresources.nhs.uk/revised-spc-fyremadel-ganirelix-solution-for-injection-in-pre-filled-syringe.html 2020-04-22T13:17:05.6730000Z https://www.medicinesresources.nhs.uk/revised-spc-gamunex-human-normal-immunoglobulin-solution-for-infusion.html 2020-04-22T13:19:45.6910000Z https://www.medicinesresources.nhs.uk/in-use-product-safety-assessment-report-for-infliximab-biosimilars-update.html 2020-04-27T10:24:10.9960000Z https://www.medicinesresources.nhs.uk/automation-of-in-hospital-pharmacy-dispensing-a-systematic-review.html 2020-04-22T14:43:34.3110000Z https://www.medicinesresources.nhs.uk/connecting-clusters-of-covid-19-an-epidemiological-and-serological-investigation.html 2020-04-22T13:29:32.3680000Z https://www.medicinesresources.nhs.uk/effect-of-intravenous-zoledronic-acid-on-tibiofemoral-cartilage-volume-among-patients-with-knee-osteoarthritis-with-bone-marrow-lesions-a-randomized-clinical-trial.html 2020-04-22T13:32:31.7360000Z https://www.medicinesresources.nhs.uk/biologics-may-prevent-cardiovascular-events-in-rheumatoid-arthritis-by-inhibiting-coronary-plaque-formation-and-stabilizing-high-risk-lesions.html 2020-04-22T13:34:45.3540000Z https://www.medicinesresources.nhs.uk/social-isolation-and-loneliness-as-risk-factors-for-hospital-admissions-for-respiratory-disease-among-older-adults.html 2020-04-22T14:45:22.7970000Z https://www.medicinesresources.nhs.uk/effect-of-changing-case-definitions-for-covid-19-on-the-epidemic-curve-and-transmission-parameters-in-mainland-china-a-modelling-study.html 2020-04-22T13:37:05.0370000Z https://www.medicinesresources.nhs.uk/suicide-risk-and-prevention-during-the-covid-19-pandemic.html 2020-04-22T13:51:12.6720000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-ibrexafungerp-for-vulvovaginal-candidiasis.html 2020-04-22T13:52:50.8960000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-new-drug-application-to-the-fda-for-relugolix-for-advanced-prostate-cancer.html 2020-04-22T13:54:14.1890000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-difelikefalin-for-pruritus-in-haemodialysis-patients.html 2020-04-22T14:48:33.5920000Z https://www.medicinesresources.nhs.uk/larotrectinib-for-treating-advanced-solid-tumours-with-trk-fusions-final-appraisal-determination.html 2020-04-22T14:01:23.6960000Z https://www.medicinesresources.nhs.uk/modelling-the-pandemic.html 2020-04-22T14:02:29.4320000Z https://www.medicinesresources.nhs.uk/ema-launch-enhanced-monitoring-system-for-availability-of-medicines-used-for-treating-covid-19.html 2020-04-22T14:03:47.8640000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-nivolumab-and-cabozantinib-for-kidney-cancer.html 2020-04-22T14:05:10.4940000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-long-term-efficacy-of-siponimod-for-secondary-progressive-multiple-sclerosis.html 2020-04-22T14:06:09.5350000Z https://www.medicinesresources.nhs.uk/managing-high-clinical-suspicion-covid-19-inpatients-with-negative-rt-pcr-a-pragmatic-and-limited-role-for-thoracic-ct.html 2020-04-22T14:07:23.9320000Z https://www.medicinesresources.nhs.uk/supply-distuption-alert-renal-replacement-therapy-in-critical-care-severe-disruption-to-the-supply-of-kits-and-fluids-to-perform-continuous-vein-to-vein-haemofiltration-including-haemodiafiltration.html 2020-04-27T10:31:18.6620000Z https://www.medicinesresources.nhs.uk/bridging-the-quality-gap-in-diagnosis-and-treatment-of-malaria.html 2020-04-22T14:18:45.0980000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-managing-symptoms-including-at-the-end-of-life-in-the-community-updated-guidance-ng163.html 2020-04-27T09:53:37.6410000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-acute-myocardial-injury-guidance-ng171.html 2020-04-27T09:50:12.3100000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-gastrointestinal-and-liver-conditions-treated-with-drugs-affecting-the-immune-response-guidance-ng172.html 2020-04-27T09:51:57.1530000Z https://www.medicinesresources.nhs.uk/fsrh-ceu-clinical-advice-to-support-provision-of-effective-contraception-during-the-covid-19-outbreak.html 2020-04-27T09:45:46.5060000Z https://www.medicinesresources.nhs.uk/covid-19-reminder-of-risk-of-serious-side-effects-with-chloroquine-and-hydroxychloroquine.html 2020-04-23T16:49:24.5530000Z https://www.medicinesresources.nhs.uk/systemic-immunomodulatory-treatments-for-patients-with-atopic-dermatitis-a-systematic-review-and-network-meta-analysis.html 2020-04-23T18:11:00.7960000Z https://www.medicinesresources.nhs.uk/glucose-lowering-drugs-or-strategies-atherosclerotic-cardiovascular-events-and-heart-failure-in-people-with-or-at-risk-of-type-2-diabetes-an-updated-systematic-review-and-meta-analysis-of-randomised-cardiovascular-outcome-trials.html 2020-04-23T18:47:24.3990000Z https://www.medicinesresources.nhs.uk/the-effect-of-corticosteroid-treatment-on-patients-with-coronavirus-infection-a-systematic-review-and-meta-analysis.html 2020-04-23T18:12:26.4240000Z https://www.medicinesresources.nhs.uk/ruxolitinib-for-glucocorticoid-refractory-acute-graft-versus-host-disease.html 2020-08-07T14:21:19.6490000Z https://www.medicinesresources.nhs.uk/denosumab-and-cinacalcet-for-primary-hyperparathyroidism-denocina-a-randomised-double-blind-placebo-controlled-phase-3-trial.html 2020-04-23T18:13:28.4290000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-satralizumab-monotherapy-in-neuromyelitis-optica-spectrum-disorder-a-randomised-double-blind-multicentre-placebo-controlled-phase-3-trial.html 2020-04-23T18:44:09.8650000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-tocilizumab-versus-azathioprine-in-highly-relapsing-neuromyelitis-optica-spectrum-disorder-tango-an-open-label-multicentre-randomised-phase-2-trial.html 2020-04-23T18:44:53.5280000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-topical-clascoterone-cream-1-for-treatment-in-patients-with-facial-acne-two-phase-3-randomized-clinical-trials.html 2020-04-23T18:17:45.2710000Z https://www.medicinesresources.nhs.uk/alterations-in-smell-or-taste-in-mildly-symptomatic-outpatients-with-sars-cov-2-infection.html 2020-04-23T18:18:12.6400000Z https://www.medicinesresources.nhs.uk/presenting-characteristics-comorbidities-and-outcomes-among-5700-patients-hospitalized-with-covid-19-in-the-new-york-city-area.html 2020-04-23T18:18:39.8420000Z https://www.medicinesresources.nhs.uk/off-label-use-of-direct-oral-anticoagulants-compared-with-warfarin-for-left-ventricular-thrombi.html 2020-04-23T18:19:32.8750000Z https://www.medicinesresources.nhs.uk/adolescent-obesity-and-early-onset-type-2-diabetes.html 2020-04-23T18:19:48.7300000Z https://www.medicinesresources.nhs.uk/estimated-population-wide-benefits-and-risks-in-china-of-lowering-sodium-through-potassium-enriched-salt-substitution-modelling-study.html 2020-04-23T18:20:05.4420000Z https://www.medicinesresources.nhs.uk/medicines-reconciliation-in-primary-care-a-study-evaluating-the-quality-of-medication-related-information-provided-on-discharge-from-secondary-care.html 2020-04-23T18:20:23.4050000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-the-management-of-palliative-care-in-hospital-during-the-coronavirus-pandemic.html 2020-04-27T09:38:54.7340000Z https://www.medicinesresources.nhs.uk/evaluation-and-care-of-patients-with-diabetic-retinopathy.html 2020-08-10T12:07:21.7580000Z https://www.medicinesresources.nhs.uk/evidence-based-support-for-autistic-people-across-the-lifespan-maximising-potential-minimising-barriers-and-optimising-the-person-environment-fit.html 2020-04-23T16:50:46.6480000Z https://www.medicinesresources.nhs.uk/the-importance-of-language-in-engagement-between-health-care-professionals-and-people-living-with-obesity-a-joint-consensus-statement.html 2020-04-23T16:51:26.0700000Z https://www.medicinesresources.nhs.uk/risk-factors-and-prevention-strategies-for-diabetic-ketoacidosis-in-people-with-established-type-1-diabetes.html 2020-04-23T16:52:05.3950000Z https://www.medicinesresources.nhs.uk/eahp-launches-covid-19-resource-centre-for-hospital-pharmacists.html 2020-04-23T18:25:47.8540000Z https://www.medicinesresources.nhs.uk/obesity-a-risk-factor-for-severe-covid-19-infection-multiple-potential-mechanisms.html 2020-04-23T16:54:41.1780000Z https://www.medicinesresources.nhs.uk/ibuprofen-can-mask-symptoms-of-infection-and-might-worsen-outcomes-says-european-drugs-agency.html 2020-04-23T18:35:25.6570000Z https://www.medicinesresources.nhs.uk/is-it-wrong-to-prioritise-younger-patients-with-covid-19.html 2020-04-23T18:34:49.0320000Z https://www.medicinesresources.nhs.uk/is-ethnicity-linked-to-incidence-or-outcomes-of-covid-19.html 2020-04-23T16:58:11.5100000Z https://www.medicinesresources.nhs.uk/remdesivir-in-covid-19.html 2020-04-23T16:58:30.9780000Z https://www.medicinesresources.nhs.uk/coronavirus-should-i-start-taking-vitamin-d.html 2020-04-27T09:34:49.9810000Z https://www.medicinesresources.nhs.uk/coronavirus-study-to-track-infection-and-immunity-levels.html 2020-04-23T18:24:25.4510000Z https://www.medicinesresources.nhs.uk/fda-and-ema-accept-applications-for-genentechs-ocrevus-ocrelizumab-shorter-2-hour-infusion-time.html 2020-04-23T18:24:04.6050000Z https://www.medicinesresources.nhs.uk/alexion-announces-plans-to-initiate-phase-3-study-of-ultomiris-r-ravulizumab-cwvz-in-hospitalized-patients-with-severe-covid-19.html 2020-04-23T18:23:45.4410000Z https://www.medicinesresources.nhs.uk/idorsia-moves-forward-with-experimental-insomnia-drug-after-positive-phase-iii-trial.html 2020-04-23T18:32:14.6930000Z https://www.medicinesresources.nhs.uk/novartis-launches-phase-iii-study-of-hydroxychloroquine-in-covid-19-patients.html 2020-04-23T18:07:06.9620000Z https://www.medicinesresources.nhs.uk/mallinckrodt-announces-u-s-food-and-drug-administration-fda-filing-acceptance-of-new-drug-application-for-terlipressin-for-treatment-of-hepatorenal-syndrome-type-1-hrs-1.html 2020-04-23T18:07:47.4020000Z https://www.medicinesresources.nhs.uk/fda-approves-new-therapy-for-triple-negative-breast-cancer-that-has-spread-not-responded-to-other-treatments.html 2020-04-23T18:30:30.2370000Z https://www.medicinesresources.nhs.uk/imbruvica-rituximab-combo-approved-by-fda-for-chronic-lymphocytic-leukemia.html 2020-04-23T18:09:23.7390000Z https://www.medicinesresources.nhs.uk/biogens-expected-filing-for-alzheimers-drug-aducanumab-delayed-until-q3.html 2020-04-23T18:21:55.0530000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-managing-suspected-or-confirmed-pneumonia-in-adults-in-the-community-updated-guidance-ng165.html 2020-04-27T09:29:49.1580000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-rheumatological-autoimmune-inflammatory-and-metabolic-bone-disorders-updated-guidance-ng167.html 2020-04-27T09:27:34.4270000Z https://www.medicinesresources.nhs.uk/how-do-you-convert-an-oral-pyridostigmine-or-neostigmine-dose-to-a-parenteral-neostigmine-dose.html 2020-04-27T09:23:22.0660000Z https://www.medicinesresources.nhs.uk/safety-and-speaking-up-during-the-covid-19-emergency.html 2020-04-24T14:23:21.9170000Z https://www.medicinesresources.nhs.uk/mhra-approves-covid-19-vaccine-trial-in-7-working-days.html 2020-04-27T09:00:46.3400000Z https://www.medicinesresources.nhs.uk/further-medicines-added-to-list-that-cannot-be-parallel-exported-from-the-uk.html 2020-04-27T08:56:57.4490000Z https://www.medicinesresources.nhs.uk/diagnosis-and-management-of-squamous-cell-carcinoma-of-unknown-primary-in-the-head-and-neck-asco-guideline.html 2020-07-16T11:14:00.2480000Z https://www.medicinesresources.nhs.uk/nhs-login-hits-one-million-registered-users.html 2020-04-24T14:30:45.4090000Z https://www.medicinesresources.nhs.uk/community-health-hospital-discharge-and-social-care-weekly-update.html 2020-04-24T14:31:36.4850000Z https://www.medicinesresources.nhs.uk/vulnerable-people-get-direct-line-to-nhs-volunteer-army.html 2020-04-24T14:32:45.7810000Z https://www.medicinesresources.nhs.uk/advance-release-of-resource-to-support-the-nhs-with-covid-19-critical-care-information.html 2020-04-27T08:52:54.8850000Z https://www.medicinesresources.nhs.uk/pharmacy-regulator-asks-pharmacies-to-remove-illegal-covid-19-home-testing-kits-from-sale.html 2020-04-24T15:02:07.8550000Z https://www.medicinesresources.nhs.uk/quadrivalent-meningitis-vaccine-menquadfi-approved-in-the-us.html 2020-04-24T15:03:55.4540000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-of-dapagliflozin-for-hospitalised-covid-19-patients-begins.html 2020-04-24T15:05:05.4270000Z https://www.medicinesresources.nhs.uk/first-weekly-covid-19-surveillance-report-published.html 2020-04-27T08:43:26.8530000Z https://www.medicinesresources.nhs.uk/tuberculosis-in-england-national-quarterly-report-q1-2020-provisional-data.html 2020-04-24T15:07:07.7690000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-calls-for-action-from-government-on-key-policy-asks-during-the-covid-19-pandemic.html 2020-04-24T15:08:07.1330000Z https://www.medicinesresources.nhs.uk/potential-coronavirus-covid-19-symptoms-reported-through-nhs-pathways-and-111-online-3.html 2020-04-24T15:09:14.2980000Z https://www.medicinesresources.nhs.uk/pernicious-anaemia.html 2020-04-24T15:10:52.3240000Z https://www.medicinesresources.nhs.uk/what-is-happening-to-non-covid-deaths.html 2020-04-24T15:11:45.4130000Z https://www.medicinesresources.nhs.uk/administration-of-end-of-life-drugs-by-family-caregivers-during-covid-19-pandemic.html 2020-04-24T15:13:00.0390000Z https://www.medicinesresources.nhs.uk/delayed-versus-early-initiation-of-renal-replacement-therapy-for-severe-acute-kidney-injury-a-systematic-review-and-individual-patient-data-meta-analysis-of-randomised-clinical-trials.html 2020-04-27T08:39:19.6230000Z https://www.medicinesresources.nhs.uk/antiviral-therapy-in-management-of-covid-19-a-systematic-review-on-current-evidence.html 2020-04-27T08:34:11.7770000Z https://www.medicinesresources.nhs.uk/health-sector-spending-and-spending-on-hiv-aids-tuberculosis-and-malaria-and-development-assistance-for-health-progress-towards-sustainable-development-goal-3.html 2020-04-24T16:34:17.2370000Z https://www.medicinesresources.nhs.uk/effect-of-raxibacumab-on-immunogenicity-of-anthrax-vaccine-adsorbed-a-phase-4-open-label-parallel-group-randomised-non-inferiority-study.html 2020-04-24T16:35:27.2350000Z https://www.medicinesresources.nhs.uk/hospitalizations-and-deaths-associated-with-evali.html 2020-08-07T14:00:01.1890000Z https://www.medicinesresources.nhs.uk/hospitalization-for-lactic-acidosis-among-patients-with-reduced-kidney-function-treated-with-metformin-or-sulfonylureas.html 2020-04-24T16:37:03.2360000Z https://www.medicinesresources.nhs.uk/blood-pressure-variability-and-risk-of-heart-failure-in-accord-and-the-vadt.html 2020-04-24T16:37:56.6100000Z https://www.medicinesresources.nhs.uk/association-of-renin-angiotensin-system-inhibitors-with-severity-or-risk-of-death-in-patients-with-hypertension-hospitalized-for-coronavirus-disease-2019-covid-19-infection-in-wuhan-china.html 2020-04-24T16:38:42.7490000Z https://www.medicinesresources.nhs.uk/cardiovascular-implications-of-fatal-outcomes-of-patients-with-coronavirus-disease-2019-covid-19.html 2020-04-24T16:39:38.0180000Z https://www.medicinesresources.nhs.uk/clopidogrel-versus-ticagrelor-or-prasugrel-in-patients-aged-70-years-or-older-with-non-st-elevation-acute-coronary-syndrome-popular-age-the-randomised-open-label-non-inferiority-trial.html 2020-04-24T16:40:51.2840000Z https://www.medicinesresources.nhs.uk/practical-recommendations-for-the-management-of-diabetes-in-patients-with-covid-19.html 2020-04-27T08:08:45.6610000Z https://www.medicinesresources.nhs.uk/psnc-bma-and-dispensing-doctors-association-call-for-temporary-removal-of-the-prescription-charge.html 2020-04-27T14:13:42.6360000Z https://www.medicinesresources.nhs.uk/nhsengland-and-nhsimprovement-intentions-for-friday-8th-may-bank-holiday.html 2020-05-04T10:46:05.3280000Z https://www.medicinesresources.nhs.uk/nhs-business-services-authority-advises-practices-to-consider-putting-all-suitable-patients-on-electronic-repeat-dispensing-as-soon-as-possible.html 2020-05-04T10:48:29.3950000Z https://www.medicinesresources.nhs.uk/nhs-england-urges-public-to-get-care-when-they-need-it.html 2020-05-04T10:50:22.8030000Z https://www.medicinesresources.nhs.uk/nhs-digital-and-nhsx-introduce-gp-connect-to-all-practices.html 2020-05-04T10:52:48.3190000Z https://www.medicinesresources.nhs.uk/mild-or-moderate-covid-19.html 2020-04-27T14:26:07.9780000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-critical-care-in-adults-updated-guideline-ng159.html 2020-05-04T10:58:35.3990000Z https://www.medicinesresources.nhs.uk/child-abuse-awareness-month-during-the-coronavirus-disease-2019-pandemic.html 2020-04-27T14:36:57.0920000Z https://www.medicinesresources.nhs.uk/the-coronavirus-disease-2019-crisis-as-catalyst-for-telemedicine-for-chronic-neurological-disorders.html 2020-04-27T14:38:49.7910000Z https://www.medicinesresources.nhs.uk/diagnosis-and-treatment-of-opioid-use-disorder-in-2020.html 2020-04-27T14:40:34.0060000Z https://www.medicinesresources.nhs.uk/management-of-covid-19-respiratory-distress.html 2020-04-27T14:42:20.4240000Z https://www.medicinesresources.nhs.uk/eu-actions-to-support-availability-of-medicines-during-covid-19-pandemic-update-3.html 2020-05-04T10:56:10.4050000Z https://www.medicinesresources.nhs.uk/fda-reiterates-importance-of-close-patient-supervision-for-off-label-use-of-antimalarial-drugs-to-mitigate-known-risks.html 2020-04-27T14:44:59.2340000Z https://www.medicinesresources.nhs.uk/pulmonary-embolism-in-covid-19-patients-awareness-of-an-increased-prevalence.html 2020-08-20T11:21:32.2240000Z https://www.medicinesresources.nhs.uk/effect-of-the-covid-19-pandemic-on-cancer-treatment-and-research.html 2020-04-27T14:48:08.9770000Z https://www.medicinesresources.nhs.uk/determining-risk-factors-for-mortality-in-liver-transplant-patients-with-covid-19.html 2020-04-27T14:52:25.0920000Z https://www.medicinesresources.nhs.uk/revised-spc-mst-continus-morphine-sulfate-tablets-all-strengths.html 2020-04-27T14:55:35.6410000Z https://www.medicinesresources.nhs.uk/revised-spc-butec-buprenorphine-transdermal-patch-all-strengths.html 2020-04-27T14:57:14.0490000Z https://www.medicinesresources.nhs.uk/revised-spc-feldene-piroxicam-0-5-w-w-gel.html 2020-04-27T14:58:51.2180000Z https://www.medicinesresources.nhs.uk/revised-spc-alunbrig-brigatinib.html 2020-04-27T15:00:40.2670000Z https://www.medicinesresources.nhs.uk/off-label-use-of-inhaled-bronchodilators-in-hospitalised-patients-in-spain-a-multicentre-observational-study.html 2020-04-27T15:02:09.8360000Z https://www.medicinesresources.nhs.uk/mental-health-status-among-children-in-home-confinement-during-the-coronavirus-disease-2019-outbreak-in-hubei-province-china.html 2020-04-27T15:04:40.4230000Z https://www.medicinesresources.nhs.uk/avoiding-peg-filgrastim-prophylaxis-during-the-paclitaxel-portion-of-the-dose-dense-doxorubicin-cyclophosphamide-and-paclitaxel-regimen-a-prospective-study.html 2020-07-10T09:49:09.2480000Z https://www.medicinesresources.nhs.uk/protective-effects-of-dietary-intake-of-antioxidants-and-treatment-related-toxicity-in-childhood-leukemia-a-report-from-the-dallt-cohort.html 2020-07-10T10:00:21.3510000Z https://www.medicinesresources.nhs.uk/minocycline-200-mg-or-400-mg-versus-placebo-for-mild-alzheimer-s-disease-the-made-phase-ii-three-arm-rct.html 2020-04-27T15:14:03.4600000Z https://www.medicinesresources.nhs.uk/shortage-of-ativan-lorazepam-injection-4-mg-in-1-ml-1.html 2020-04-27T15:59:49.2210000Z https://www.medicinesresources.nhs.uk/us-fda-approves-sodium-zirconium-cyclosilicate-for-treatment-of-hyperkalaemia-in-patients-with-end-stage-renal-disease-on-stable-hemodialysis.html 2020-04-27T16:01:14.5540000Z https://www.medicinesresources.nhs.uk/accessing-medicines-for-detainees-released-during-covid-19.html 2020-04-28T14:56:46.4770000Z https://www.medicinesresources.nhs.uk/new-product-alphanate-2000-iu-powder-for-injection-factor-viii-von-willebrand-factor.html 2020-04-28T14:58:08.0070000Z https://www.medicinesresources.nhs.uk/revised-spcs-dhc-continus-dihydrocodeine-tartrate-prolonged-release-tablets-all-strengths.html 2020-04-28T15:00:02.3350000Z https://www.medicinesresources.nhs.uk/revised-spcs-tivicay-dolutegravir-sodium-film-coated-tablets-all-strengths.html 2020-04-28T15:02:01.8080000Z https://www.medicinesresources.nhs.uk/protocol-for-supply-or-administration-of-paracetamol-oral-suspension-120mg-5ml-to-infants-under-12-months-of-age-receiving-primary-doses-of-meningococcal-group-b-menb-vaccine.html 2020-05-04T10:02:46.8800000Z https://www.medicinesresources.nhs.uk/benefits-and-harms-of-prescription-drugs-and-supplements-for-treatment-of-clinical-alzheimer-type-dementia-a-systematic-review-and-meta-analysis.html 2020-07-06T11:26:32.2030000Z https://www.medicinesresources.nhs.uk/epidemiology-and-transmission-of-covid-19-in-391-cases-and-1286-of-their-close-contacts-in-shenzhen-china-a-retrospective-cohort-study.html 2020-04-28T15:16:31.6850000Z https://www.medicinesresources.nhs.uk/covid-19-and-kidney-transplantation.html 2020-08-07T12:03:58.8180000Z https://www.medicinesresources.nhs.uk/the-impact-of-levothyroxine-on-cardiac-function-in-older-adults-with-mild-subclinical-hypothyroidism-a-randomized-clinical-trial.html 2020-04-28T15:24:14.7410000Z https://www.medicinesresources.nhs.uk/ativan-lorazepam-4mg-ml-solution-for-injection-supply-disruption.html 2020-05-04T10:33:30.0540000Z https://www.medicinesresources.nhs.uk/dostarlimab-shows-promise-in-advanced-recurrent-microsatellite-instability-high-mismatch-repair-deficiency-endometrial-cancer-in-pi-garnet-study.html 2020-04-28T16:34:47.6540000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-approves-cefiderocol-for-treatment-of-infections-due-to-aerobic-gram-negative-bacteria-in-adults-with-limited-treatment-options.html 2020-04-28T16:18:53.5270000Z https://www.medicinesresources.nhs.uk/sarilumab-kevzara-demonstrates-mixed-efficacy-results-in-ongoing-covid-19-trial-of-hospitalised-patients-with-severe-or-critical-respiratory-illness-secondary-to-covid-19.html 2020-04-28T16:20:07.3730000Z https://www.medicinesresources.nhs.uk/ustekinumab-for-treating-moderately-to-severely-active-ulcerative-colitis-in-adults-final-appraisal-document.html 2020-04-28T16:21:26.2580000Z https://www.medicinesresources.nhs.uk/legislation-to-allow-pharmacists-to-supply-controlled-drugs-without-prescription-to-be-introduced.html 2020-04-28T16:35:18.9930000Z https://www.medicinesresources.nhs.uk/management-of-patients-with-multiple-myeloma-during-the-covid-19-pandemic.html 2020-04-28T16:35:33.0620000Z https://www.medicinesresources.nhs.uk/international-regulators-pledge-collective-support-to-combat-covid-19-pandemic.html 2020-04-28T16:25:21.6560000Z https://www.medicinesresources.nhs.uk/an-update-on-extravasation-basic-knowledge-for-clinical-pharmacists.html 2020-04-28T16:26:31.7040000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-latest-guidance-for-medicines-safety.html 2020-05-04T10:38:33.1670000Z https://www.medicinesresources.nhs.uk/noradrenaline-norepinephrine-4mg-4ml-concentrate-for-solution-for-infusion-temporary-supply-of-a-different-presentation-in-market-and-changes-to-the-instructions.html 2020-05-04T11:07:34.6470000Z https://www.medicinesresources.nhs.uk/suxamethonium-temporary-foreign-label-product-label-and-patient-information-leaflet-pil-in-portuguese.html 2020-04-28T16:34:57.8150000Z https://www.medicinesresources.nhs.uk/adoport-tacrolimus-2mg-capsules-limited-number-of-packs-with-italian-foil.html 2020-04-28T16:36:03.8270000Z https://www.medicinesresources.nhs.uk/covid-19-what-do-we-know-so-far-about-a-vaccine.html 2020-04-28T16:37:31.9840000Z https://www.medicinesresources.nhs.uk/covid-19-statistician-criticises-uks-reporting-of-swab-tests.html 2020-04-28T16:38:35.0310000Z https://www.medicinesresources.nhs.uk/necrotising-fasciitis.html 2020-04-28T16:39:33.4890000Z https://www.medicinesresources.nhs.uk/pregabalin-and-gabapentin-for-pain.html 2020-04-28T16:40:36.4980000Z https://www.medicinesresources.nhs.uk/april-bnf-bnfc-newsletter.html 2020-05-04T10:26:45.2220000Z https://www.medicinesresources.nhs.uk/revised-spc-colecalciferol-3000iu-ml-oral-solution-thame-laboratories.html 2020-04-29T14:25:52.2510000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-reuse-of-medicines-in-a-care-home-or-hospice-1.html 2020-05-04T09:39:11.0510000Z https://www.medicinesresources.nhs.uk/revised-spc-epanutin-phenytoin-30mg-5ml-oral-suspension.html 2020-04-29T14:30:17.0060000Z https://www.medicinesresources.nhs.uk/how-can-hot-flushes-in-men-being-treated-for-prostate-cancer-be-managed.html 2020-05-04T09:47:36.9720000Z https://www.medicinesresources.nhs.uk/adolescent-obesity-and-early-onset-type-2-diabetes-1.html 2020-04-29T14:34:26.7710000Z https://www.medicinesresources.nhs.uk/use-of-glucagon-like-peptide-1-receptor-agonists-and-risk-of-serious-renal-events-scandinavian-cohort-study-1.html 2020-04-29T14:35:46.7390000Z https://www.medicinesresources.nhs.uk/continuous-positive-airway-pressure-treatment-glycemia-and-diabetes-risk-in-obstructive-sleep-apnea-and-comorbid-cardiovascular-disease-1.html 2020-04-29T14:37:31.5270000Z https://www.medicinesresources.nhs.uk/using-the-bravo-risk-engine-to-predict-cardiovascular-outcomes-in-clinical-trials-with-sodium-glucose-transporter-2-inhibitors.html 2020-04-29T14:38:47.7380000Z https://www.medicinesresources.nhs.uk/olaparib-for-metastatic-castration-resistant-prostate-cancer.html 2020-08-07T13:29:34.8060000Z https://www.medicinesresources.nhs.uk/large-vessel-stroke-as-a-presenting-feature-of-covid-19-in-the-young.html 2020-08-07T11:57:33.5370000Z https://www.medicinesresources.nhs.uk/effect-of-dexrazoxane-on-left-ventricular-systolic-function-and-treatment-outcomes-in-patients-with-acute-myeloid-leukemia-a-report-from-the-childrens-oncology-group.html 2020-07-16T09:30:36.4910000Z https://www.medicinesresources.nhs.uk/considerations-for-ventilator-triage-during-the-covid-19-pandemic.html 2020-04-29T14:45:25.2230000Z https://www.medicinesresources.nhs.uk/reduced-rate-of-hospital-admissions-for-acs-during-covid-19-outbreak-in-northern-italy.html 2020-08-07T11:56:28.9130000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-outcomes-for-risdiplam-in-firefish-part-2-study-1.html 2020-04-29T14:48:04.7720000Z https://www.medicinesresources.nhs.uk/covid19-supporting-unpaid-carers-to-access-medicines-in-wales.html 2020-04-29T14:49:21.3650000Z https://www.medicinesresources.nhs.uk/pooling-of-samples-for-testing-for-sars-cov-2-in-asymptomatic-people.html 2020-04-29T14:51:00.0570000Z https://www.medicinesresources.nhs.uk/nhs-england-speciality-guide-clinical-guide-for-use-of-anaesthetic-machines-to-provide-continuous-invasive-ventilatory-support-for-adult-patients-during-the-coronavirus-pandemic.html 2020-05-04T09:50:16.9240000Z https://www.medicinesresources.nhs.uk/primary-care-interventions-for-prevention-and-cessation-of-tobacco-use-in-children-and-adolescents-us-preventive-services-task-force-recommendation-statement.html 2020-04-29T16:13:46.6330000Z https://www.medicinesresources.nhs.uk/immunotherapies-for-covid-19-lessons-learned-from-sepsis.html 2020-04-29T15:15:06.6750000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-olaparib-with-durvalumab-in-stage-ii-iii-high-risk-her2-negative-breast-cancer-in-i-spy2-trial.html 2020-04-29T15:16:20.0970000Z https://www.medicinesresources.nhs.uk/nhs-warning-to-seek-help-for-cancer-symptoms-as-half-of-public-report-concerns-with-getting-checked.html 2020-05-04T09:56:03.3460000Z https://www.medicinesresources.nhs.uk/mobocertinib-given-breakthrough-designation-therapy-status-for-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations-in-the-us.html 2020-04-29T15:17:30.7170000Z https://www.medicinesresources.nhs.uk/guidance-for-households-with-grandparents-parents-and-children-living-together-where-someone-is-at-increased-risk-or-has-symptoms-of-coronavirus-covid-19-infection.html 2020-05-04T09:41:21.8630000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-to-review-lonafarnib-for-progeria-and-progeroid-laminopathies.html 2020-04-29T15:19:47.5690000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-to-review-lonafarnib-for-progeria-and-progeroid-laminopathies-1.html 2020-04-30T08:57:08.1720000Z https://www.medicinesresources.nhs.uk/covid-19-number-of-outbreaks-in-care-homes-management-information.html 2020-04-29T15:20:31.2110000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-sovateltide-vs-standard-of-care-for-acute-cerebral-ischaemic-stroke.html 2020-04-29T15:21:31.9840000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-results-for-dextenza-corticosteroid-intracanalicular-insert-for-ocular-itching-associated-with-allergic-conjunctivitis-in-phase-iii-trial.html 2020-04-29T15:22:41.8370000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-from-post-hoc-analysis-of-6-years-data-from-phase-iii-open-label-extension-studies-for-ocrelizumab-in-relapsing-multiple-sclerosis.html 2020-04-29T15:23:48.0400000Z https://www.medicinesresources.nhs.uk/manufacturers-report-negative-results-for-avapritinib-vs-regorafenib-in-advanced-gastrointestinal-stromal-tumour.html 2020-04-29T15:24:53.6850000Z https://www.medicinesresources.nhs.uk/eryaspase-given-fast-track-designation-in-us-for-second-line-use-in-pancreatic-cancer.html 2020-04-29T15:26:03.9300000Z https://www.medicinesresources.nhs.uk/bemcentinib-to-be-fast-tracked-for-a-phase-ii-trial-in-the-uk-as-a-potential-covid-19-treatment.html 2020-04-29T15:27:06.5810000Z https://www.medicinesresources.nhs.uk/recovery-trial-the-uk-covid-19-study-resetting-expectations-for-clinical-trials.html 2020-04-29T15:28:06.2750000Z https://www.medicinesresources.nhs.uk/improving-consultations-with-children-and-adolescents.html 2020-04-29T15:29:53.9360000Z https://www.medicinesresources.nhs.uk/ethics-and-resource-scarcity-asco-recommendations-for-the-oncology-community-during-the-covid-19-pandemic.html 2020-07-16T11:30:31.1520000Z https://www.medicinesresources.nhs.uk/spotting-the-signs-of-acute-kidney-injury.html 2020-04-30T15:16:32.6860000Z https://www.medicinesresources.nhs.uk/national-institute-of-allergy-and-infectious-diseases-niaid-sponsored-adaptive-covid-19-treatment-trial-reports-speedier-recovery-from-covid-19.html 2020-04-30T15:18:46.7130000Z https://www.medicinesresources.nhs.uk/abbott-launches-covid-19-lab-based-antibody-test.html 2020-05-04T09:37:02.4530000Z https://www.medicinesresources.nhs.uk/personal-protective-equipment-ppe-resource-for-care-workers-delivering-homecare-domiciliary-care-during-sustained-covid-19-transmission-in-england.html 2020-04-30T15:21:51.0270000Z https://www.medicinesresources.nhs.uk/real-time-assessment-of-community-transmission-react-1-programme-for-coronavirus.html 2020-04-30T15:23:24.3080000Z https://www.medicinesresources.nhs.uk/covid-19-treatments-could-be-fast-tracked-through-new-national-clinical-trial-initiative.html 2020-04-30T15:59:30.8510000Z https://www.medicinesresources.nhs.uk/second-phase-of-nhs-response-to-covid-19-letter-from-sir-simon-stevens-and-amanda-pritchard.html 2020-05-04T09:30:14.8020000Z https://www.medicinesresources.nhs.uk/nice-technology-appraisals-in-the-nhs-in-england-innovation-scorecard-to-september-2019.html 2020-05-04T09:28:27.8460000Z https://www.medicinesresources.nhs.uk/ingestion-of-caustic-substances.html 2020-08-10T11:54:18.8450000Z https://www.medicinesresources.nhs.uk/nice-joins-international-collaboratives-to-respond-to-the-covid-19-pandemic.html 2020-05-04T09:21:40.8760000Z https://www.medicinesresources.nhs.uk/moving-personal-protective-equipment-into-the-community-face-shields-and-containment-of-covid-19.html 2020-04-30T15:35:57.7740000Z https://www.medicinesresources.nhs.uk/update-on-new-legislation-relating-to-controlled-drugs-during-the-covid-19-pandemic-the-misuse-of-drugs-coronavirus-amendments-relating-to-the-supply-of-controlled-drugs-during-a-pandemic-etc-regulations-2020.html 2020-05-04T09:23:47.0450000Z https://www.medicinesresources.nhs.uk/fda-cautions-against-use-of-hydroxychloroquine-or-chloroquine-for-covid-19-outside-of-the-hospital-setting-or-a-clinical-trial-due-to-risk-of-heart-rhythm-problems.html 2020-04-30T17:16:08.7960000Z https://www.medicinesresources.nhs.uk/dtb-select-european-medicines-agency-advice-on-renin-angiotensin-system-medicines-during-covid-19-pandemic.html 2020-04-30T17:14:44.2890000Z https://www.medicinesresources.nhs.uk/inclusion-of-cqc-data-in-ons-deaths-reporting-shows-impact-of-covid-19-on-social-care.html 2020-04-30T15:42:58.9170000Z https://www.medicinesresources.nhs.uk/mitigating-the-wider-health-effects-of-covid-19-pandemic-response.html 2020-04-30T15:44:46.9740000Z https://www.medicinesresources.nhs.uk/astrazeneca-and-oxford-university-announce-landmark-agreement-for-global-development-and-distribution-of-the-universitys-covid-19-vaccine.html 2020-04-30T15:45:52.8610000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-pd-1-checkpoint-inhibitor-cemiplimab-as-monotherapy-for-advanced-or-metastatic-non-small-cell-lung-cancer-halted-due-to-early-signs-of-significant-improvement-in-overall-survival.html 2020-04-30T15:47:38.1030000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-plan-to-initiate-u-s-covid-19-vaccine-trial.html 2020-04-30T15:48:59.0350000Z https://www.medicinesresources.nhs.uk/fda-approves-6-week-dosing-for-pembrolizumab-for-all-approved-adult-indications.html 2020-04-30T15:50:36.7760000Z https://www.medicinesresources.nhs.uk/gilead-reports-positive-results-from-two-trials-of-remdesivir-for-covid-19.html 2020-04-30T17:08:43.9900000Z https://www.medicinesresources.nhs.uk/efficacy-and-tolerability-of-artemisinin-based-and-quinine-based-treatments-for-uncomplicated-falciparum-malaria-in-pregnancy-a-systematic-review-and-individual-patient-data-meta-analysis.html 2020-04-30T16:17:36.9720000Z https://www.medicinesresources.nhs.uk/abemaciclib-plus-trastuzumab-with-or-without-fulvestrant-versus-trastuzumab-plus-standard-of-care-chemotherapy-in-women-with-hormone-receptor-positive-her2-positive-advanced-breast-cancer-monarcher-a-randomised-open-label-phase-2-trial.html 2020-04-30T16:19:40.6800000Z https://www.medicinesresources.nhs.uk/remdesivir-in-adults-with-severe-covid-19-a-randomised-double-blind-placebo-controlled-multicentre-trial.html 2020-05-04T09:18:57.3640000Z https://www.medicinesresources.nhs.uk/effect-of-gonadotropin-releasing-hormone-antagonist-on-risk-of-committing-child-sexual-abuse-in-men-with-pedophilic-disorder-a-randomized-clinical-trial.html 2020-04-30T16:59:38.7630000Z https://www.medicinesresources.nhs.uk/internet-searches-for-unproven-covid-19-therapies-in-the-united-states.html 2020-04-30T16:57:31.1120000Z https://www.medicinesresources.nhs.uk/exploring-the-adverse-effects-of-chemotherapeutic-agents-used-in-the-treatment-of-cervical-and-ovarian-cancer-from-the-patients-perspective-a-content-analysis-of-the-online-discussion-forums.html 2020-04-30T16:36:45.0340000Z https://www.medicinesresources.nhs.uk/use-of-sodium-glucose-co-transporter-2-inhibitors-and-risk-of-serious-renal-events-scandinavian-cohort-study.html 2020-04-30T16:39:00.6560000Z https://www.medicinesresources.nhs.uk/association-between-mental-disorders-and-subsequent-medical-conditions.html 2020-10-01T08:39:12.6340000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-precautionary-suspension-of-ranitidine-medicines-in-the-eu.html 2020-05-01T13:00:01.5280000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-recommendations-on-dihydropyrimidine-dehydrogenase-dpd-testing-prior-to-treatment-with-fluorouracil-capecitabine-tegafur-and-flucytosine.html 2020-05-01T16:05:52.8200000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-luspatercept-for-the-treatment-of-adults-with-adults-with-transfusion-dependent-anaemia-associated-with-myelodysplastic-syndromes-mds-or-beta-thalassaemia.html 2020-05-01T13:03:26.2860000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-glasdegib-for-the-treatment-of-adults-with-acute-myeloid-leukaemia-aml.html 2020-05-01T16:06:32.0200000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-enerzair-breezhaler-indacaterol-glycopyrronium-mometasone-for-maintenance-treatment-of-asthma-in-adults.html 2020-05-01T16:07:32.4540000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-generic-insulin-aspart-insulin-aspart-sanofi-for-the-treatment-of-diabetes-mellitus.html 2020-05-01T13:08:20.5980000Z https://www.medicinesresources.nhs.uk/european-chmp-confirms-recommendation-to-refuse-marketing-authorisation-for-sodium-oxybate-hopveus-for-treatment-of-alcohol-dependence.html 2020-05-01T13:10:06.4270000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-encorafenib-for-the-treatment-of-metastatic-colorectal-cancer-crc.html 2020-05-01T14:32:13.6070000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-use-of-caplacizumab-for-the-treatment-of-acquired-thrombotic-thrombocytopenic-purpura-attp-in-a-wider-age-group.html 2020-05-01T14:33:56.0860000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-carmustine-obvius-for-use-as-a-conditioning-treatment-prior-to-autologous-haematopoietic-progenitor-cell-transplantation.html 2020-05-01T14:36:19.8540000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-use-of-anidulafungin-in-paediatric-patients.html 2020-05-01T14:41:16.2150000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-harvoni-ledipasvir-and-sofosbuvir-for-the-treatment-of-paediatric-patients-with-chronic-hepatitis-c.html 2020-05-01T14:43:45.1090000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-wider-use-of-ivacaftor-in-patients-with-cystic-fibrosis-and-an-r117h-mutation-in-the-cftr-gene.html 2020-05-01T14:45:54.9560000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-ixekizumab-for-the-treatment-of-adults-with-active-axial-spondyloarthritis.html 2020-05-01T14:47:45.2510000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-recommends-approval-of-ravulizumab-for-treatment-of-atypical-haemolytic-uremic-syndrome-ahus.html 2020-05-01T14:49:46.2290000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-antibiotics-for-pneumonia-in-adults-in-hospital-guidance-ng173.html 2020-05-04T08:49:11.8710000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-children-and-young-people-who-are-immunocompromised-guidance-ng174.html 2020-05-04T08:50:05.5870000Z https://www.medicinesresources.nhs.uk/priority-medicines-for-palliative-and-end-of-life-care-during-a-pandemic.html 2020-05-04T08:54:31.8140000Z https://www.medicinesresources.nhs.uk/revised-spc-fasigyn-tinidazole-500mg-film-coated-tablets.html 2020-05-01T14:57:46.5290000Z https://www.medicinesresources.nhs.uk/autologous-haematopoietic-stem-cell-transplantation-versus-bortezomib-melphalan-prednisone-with-or-without-bortezomib-lenalidomide-dexamethasone-consolidation-therapy-and-lenalidomide-maintenance-for-newly-diagnosed-multiple-myeloma-emn02-ho95-a-multicentre-randomised-open-label-phase-3-study.html 2020-05-01T14:59:29.8200000Z https://www.medicinesresources.nhs.uk/message-from-the-uk-cmos-and-medical-directors-of-public-health-england-and-nhs-england.html 2020-05-01T15:01:38.7900000Z https://www.medicinesresources.nhs.uk/family-caregiving-for-individuals-with-heart-failure-a-scientific-statement-from-the-american-heart-association.html 2020-07-16T12:01:30.7960000Z https://www.medicinesresources.nhs.uk/republished-amiodarone-induced-diffuse-alveolar-haemorrhage-a-rare-but-potentially-life-threatening-complication-of-a-commonly-prescribed-medication.html 2020-05-01T15:04:31.2140000Z https://www.medicinesresources.nhs.uk/deprescribing-in-the-time-of-covid-19.html 2020-05-01T15:07:14.1770000Z https://www.medicinesresources.nhs.uk/ema-starts-rolling-review-of-remdesivir-for-covid-19.html 2020-05-01T15:09:34.5700000Z https://www.medicinesresources.nhs.uk/pharmacies-encouraged-to-become-safe-spaces-for-victims-of-domestic-abuse.html 2020-05-01T15:11:18.1990000Z https://www.medicinesresources.nhs.uk/cardiovascular-manifestations-and-treatment-considerations-in-covid-19.html 2020-05-01T15:15:27.6380000Z https://www.medicinesresources.nhs.uk/comparison-of-lifestyle-changes-and-pharmacological-treatment-on-cardiovascular-risk-factors.html 2020-05-01T15:17:40.1260000Z https://www.medicinesresources.nhs.uk/the-increasing-value-of-ehealth-in-the-delivery-of-patient-centred-cancer-care.html 2020-05-01T15:19:09.8820000Z https://www.medicinesresources.nhs.uk/clinical-implications-of-food-drug-interactions-with-small-molecule-kinase-inhibitors.html 2020-05-01T15:21:39.9150000Z https://www.medicinesresources.nhs.uk/potential-coronavirus-covid-19-symptoms-reported-through-nhs-pathways-and-111-online-4.html 2020-05-01T15:24:08.2890000Z https://www.medicinesresources.nhs.uk/effect-of-high-vs-low-doses-of-chloroquine-diphosphate-as-adjunctive-therapy-for-patients-hospitalized-with-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-infection.html 2020-05-01T15:59:55.6220000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-307-april-2020-world-immunization-week.html 2020-05-04T08:57:38.7190000Z https://www.medicinesresources.nhs.uk/mhra-approves-clinical-trial-of-investigational-angiotensin-ii-receptor-type-2-agonist-vp01-for-sars-cov-2-infection.html 2020-05-01T16:02:23.0210000Z https://www.medicinesresources.nhs.uk/weekly-covid-19-surveillance-report-published.html 2020-05-01T16:04:12.5710000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-cabazitaxel-accord-for-the-treatment-of-hormone-refractory-metastatic-prostate-cancer.html 2020-05-01T16:06:37.9930000Z https://www.medicinesresources.nhs.uk/revised-spc-alimemazine-tartrate-7-5mg-5ml-syrup.html 2020-05-04T14:09:25.5590000Z https://www.medicinesresources.nhs.uk/revised-spc-triumeq-abacavir-sulfate-dolutegravir-sodium-lamivudine-tablets.html 2020-05-04T14:11:23.2630000Z https://www.medicinesresources.nhs.uk/the-association-of-energy-and-macronutrient-intake-at-dinner-versus-breakfast-with-disease-specific-and-all-cause-mortality-among-people-with-diabetes-the-u-s-national-health-and-nutrition-examination-survey-2003-2014.html 2020-05-04T14:12:51.0790000Z https://www.medicinesresources.nhs.uk/features-of-16-749-hospitalised-uk-patients-with-covid-19-using-the-isaric-who-clinical-characterisation-protocol.html 2020-05-11T10:47:47.4850000Z https://www.medicinesresources.nhs.uk/contact-tracing-assessment-of-covid-19-transmission-dynamics-in-taiwan-and-risk-at-different-exposure-periods-before-and-after-symptom-onset.html 2020-05-04T14:30:15.3670000Z https://www.medicinesresources.nhs.uk/risk-of-qt-interval-prolongation-associated-with-use-of-hydroxychloroquine-with-or-without-concomitant-azithromycin-among-hospitalized-patients-testing-positive-for-coronavirus-disease-2019-covid-19.html 2020-05-11T11:14:27.9870000Z https://www.medicinesresources.nhs.uk/nhs-urges-public-to-get-essential-vaccines-despite-coronavirus-outbreak.html 2020-05-11T11:15:29.2220000Z https://www.medicinesresources.nhs.uk/risk-assessment-of-bame-nhs-staff-and-covid-19.html 2020-05-11T11:21:23.0380000Z https://www.medicinesresources.nhs.uk/contact-tracing-app-to-be-trialled-on-isle-of-wight.html 2020-05-04T14:38:43.2740000Z https://www.medicinesresources.nhs.uk/fda-issues-emergency-use-green-light-for-remdesivir-for-treatment-of-severe-covid-19-disease.html 2020-05-04T14:40:26.4900000Z https://www.medicinesresources.nhs.uk/eu-leaders-pledge-support-for-global-covid-19-effort.html 2020-05-04T14:41:41.4730000Z https://www.medicinesresources.nhs.uk/vitamin-d-a-rapid-review-of-the-evidence-for-treatment-or-prevention-in-covid-19.html 2020-05-11T11:35:57.4500000Z https://www.medicinesresources.nhs.uk/renin-angiotensin-aldosterone-system-inhibitors-and-risk-of-covid-19.html 2020-08-07T14:47:28.8220000Z https://www.medicinesresources.nhs.uk/cardiovascular-disease-drug-therapy-and-mortality-in-covid-19.html 2020-05-04T15:00:26.0650000Z https://www.medicinesresources.nhs.uk/renin-angiotensin-aldosterone-system-blockers-and-the-risk-of-covid-19.html 2020-05-04T15:02:43.0990000Z https://www.medicinesresources.nhs.uk/rifabutin-based-triple-therapy-rhb-105-for-helicobacter-pylori-eradication-a-double-blind-randomized-controlled-trial.html 2020-05-05T14:54:10.4920000Z https://www.medicinesresources.nhs.uk/comparison-between-rituximab-treatment-for-new-onset-generalized-myasthenia-gravis-and-refractory-generalized-myasthenia-gravis.html 2020-05-05T14:55:29.5420000Z https://www.medicinesresources.nhs.uk/clinical-course-and-outcomes-of-critically-ill-patients-with-sars-cov-2-pneumonia-in-wuhan-china-a-single-centered-retrospective-observational-study.html 2020-05-05T14:56:56.0110000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-azithromycin-maintenance-therapy-in-primary-ciliary-dyskinesia-bestcilia-a-multicentre-double-blind-randomised-placebo-controlled-phase-3-trial.html 2020-05-05T14:58:19.0370000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-shielding-and-protecting-people-defined-on-medical-grounds-as-extremely-vulnerable.html 2020-05-11T09:35:41.0700000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-with-covid-19.html 2020-05-11T10:34:07.7960000Z https://www.medicinesresources.nhs.uk/medicines-and-healthcare-products-regulatory-agency-mhra-coronavirus-yellow-card-reporting-site.html 2020-05-11T09:44:33.9570000Z https://www.medicinesresources.nhs.uk/a-rapid-systematic-review-of-clinical-trials-utilizing-chloroquine-and-hydroxychloroquine-as-a-treatment-for-covid-19.html 2020-05-11T09:57:01.7080000Z https://www.medicinesresources.nhs.uk/intensive-care-icu-management-of-covid-19-challenges-and-recommendations.html 2020-05-05T15:26:16.2100000Z https://www.medicinesresources.nhs.uk/obesity-could-shift-severe-covid-19-disease-to-younger-ages.html 2020-05-05T15:28:03.1670000Z https://www.medicinesresources.nhs.uk/covid-19-immunity-passports-and-vaccination-certificates-scientific-equitable-and-legal-challenges.html 2020-05-05T15:29:25.4660000Z https://www.medicinesresources.nhs.uk/european-society-for-medical-oncology-esmo-cancer-guidelines-during-the-covid-19-pandemic.html 2020-05-05T15:31:26.0320000Z https://www.medicinesresources.nhs.uk/immunomodulation-in-covid-19.html 2020-05-05T15:32:51.3020000Z https://www.medicinesresources.nhs.uk/public-health-measures-and-the-reproduction-number-rt-of-sars-cov-2.html 2020-05-05T15:36:33.2070000Z https://www.medicinesresources.nhs.uk/covid-19-choices-for-a-new-normal.html 2020-05-05T15:41:32.5700000Z https://www.medicinesresources.nhs.uk/randomised-clinical-trials-and-covid-19-managing-expectations.html 2020-05-05T15:43:53.8470000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-review-finds-risks-of-ingenol-mebutate-picato-for-actinic-keratosis-outweigh-benefits.html 2020-05-05T16:11:19.4600000Z https://www.medicinesresources.nhs.uk/evaluation-of-a-paradigm-shift-from-intravenous-antibiotics-to-oral-step-down-therapy-for-the-treatment-of-infective-endocarditis.html 2020-05-05T16:12:51.9090000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-recommend-addition-of-a-new-pharmaceutical-form-of-daratumumab-darzalex.html 2020-05-05T16:14:56.9450000Z https://www.medicinesresources.nhs.uk/committee-for-medicinal-products-for-human-use-chmp-recommend-addition-of-a-new-pharmaceutical-form-of-buprenorphine-naloxone-suboxone.html 2020-05-05T16:16:13.4010000Z https://www.medicinesresources.nhs.uk/covid-19-how-ema-fast-tracks-development-support-and-approval-of-medicines-and-vaccines.html 2020-05-05T16:17:29.3610000Z https://www.medicinesresources.nhs.uk/independent-pharmacist-prescribers-can-improve-patient-pharmacy-care.html 2020-05-05T16:18:30.1100000Z https://www.medicinesresources.nhs.uk/lets-not-fail-pregnant-frontline-workers-during-the-covid-19-pandemic.html 2020-05-05T16:29:53.1260000Z https://www.medicinesresources.nhs.uk/covid-19-and-pregnancy.html 2020-05-11T10:01:37.8560000Z https://www.medicinesresources.nhs.uk/fda-approves-leuprolide-acetate-la-injectable-suspension-for-paediatric-patients-with-central-precocious-puberty.html 2020-05-05T16:22:52.3810000Z https://www.medicinesresources.nhs.uk/us-fda-grant-emergency-approval-for-roches-covid-19-antibody-test.html 2020-05-05T16:24:05.7670000Z https://www.medicinesresources.nhs.uk/company-announces-positive-topline-results-from-phase-3-study-of-single-dose-secnidazole-solosec-for-the-treatment-of-trichomoniasis.html 2020-05-05T16:25:15.5110000Z https://www.medicinesresources.nhs.uk/everything-you-should-know-about-the-coronavirus-outbreak.html 2020-05-05T16:26:22.1850000Z https://www.medicinesresources.nhs.uk/cemiplimab-libtayo-shows-benefit-in-basal-call-carcinoma-bcc.html 2020-05-05T16:32:32.5590000Z https://www.medicinesresources.nhs.uk/dealing-with-returned-medicines-during-the-covid-19-pandemic.html 2020-05-11T10:21:43.2290000Z https://www.medicinesresources.nhs.uk/review-into-factors-impacting-health-outcomes-from-covid-19.html 2020-05-05T16:33:49.9460000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-april-2020.html 2020-05-11T10:27:12.5010000Z https://www.medicinesresources.nhs.uk/reproductive-health-patient-group-direction-pgd-templates-1.html 2020-05-11T10:29:15.9710000Z https://www.medicinesresources.nhs.uk/revised-spc-avelox-moxifloxacin-tablets-1.html 2020-05-06T13:55:46.0780000Z https://www.medicinesresources.nhs.uk/occurrence-prevention-and-management-of-the-psychological-effects-of-emerging-virus-outbreaks-on-healthcare-workers-rapid-review-and-meta-analysis.html 2020-05-06T13:58:18.6890000Z https://www.medicinesresources.nhs.uk/epidemiology-of-and-risk-factors-for-coronavirus-infection-in-health-care-workers-a-living-rapid-review.html 2020-07-06T11:32:21.1060000Z https://www.medicinesresources.nhs.uk/randomized-trial-of-text-messaging-to-reduce-early-discontinuation-of-adjuvant-aromatase-inhibitor-therapy-in-women-with-early-stage-breast-cancer-swog-s1105.html 2020-08-10T14:52:29.3930000Z https://www.medicinesresources.nhs.uk/association-of-use-of-angiotensin-converting-enzyme-inhibitors-and-angiotensin-ii-receptor-blockers-with-testing-positive-for-coronavirus-disease-2019-covid-19.html 2020-05-06T14:03:23.6250000Z https://www.medicinesresources.nhs.uk/l-thyroxine-therapy-for-older-adults-with-subclinical-hypothyroidism-and-hypothyroid-symptoms-secondary-analysis-of-a-randomized-trial.html 2020-07-06T11:29:57.8370000Z https://www.medicinesresources.nhs.uk/lupus-anticoagulant-and-abnormal-coagulation-tests-in-patients-with-covid-19.html 2020-08-07T12:11:25.3110000Z https://www.medicinesresources.nhs.uk/recruiting-patients-for-clinical-trials-for-covid-19-therapeutics.html 2020-05-11T09:18:05.3250000Z https://www.medicinesresources.nhs.uk/manufacturers-report-rapid-time-to-clinical-response-for-lefamulin-in-community-acquired-bacterial-pneumonia.html 2020-05-06T14:11:44.2100000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-umbralisib-and-ublituximab-for-chronic-lymphocytic-leukaemia-in-unity-cll-trial.html 2020-05-06T14:13:15.8690000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-vadadustat-for-anaemia-due-to-chronic-kidney-disease-in-adults-on-dialysis.html 2020-05-06T14:15:12.8790000Z https://www.medicinesresources.nhs.uk/fda-approves-dapagliflozin-for-heart-failure-with-reduced-ejection-fraction.html 2020-05-06T14:16:57.5950000Z https://www.medicinesresources.nhs.uk/manufacturers-report-benefit-with-cemiplimab-in-clinical-trial.html 2020-05-06T14:18:04.8600000Z https://www.medicinesresources.nhs.uk/global-regulators-work-towards-alignment-on-policy-approaches-and-regulatory-flexibility-during-covid-19.html 2020-05-06T14:19:05.5750000Z https://www.medicinesresources.nhs.uk/overlap-weighting-a-propensity-score-method-that-mimics-attributes-of-a-randomized-clinical-trial.html 2020-05-06T14:20:01.8660000Z https://www.medicinesresources.nhs.uk/cavitary-tuberculosis-the-gateway-of-disease-transmission.html 2020-05-06T14:21:11.8170000Z https://www.medicinesresources.nhs.uk/acute-limb-ischaemia-in-two-young-non-atherosclerotic-patients-with-covid-19.html 2020-05-06T14:23:11.1630000Z https://www.medicinesresources.nhs.uk/sars-cov-2-and-influenza-virus-co-infection.html 2020-05-06T14:25:12.8270000Z https://www.medicinesresources.nhs.uk/the-invisible-pandemic.html 2020-05-06T14:26:19.6360000Z https://www.medicinesresources.nhs.uk/statistics-released-on-obesity-related-hospital-admissions-in-england-in-2018-19.html 2020-05-06T14:28:34.7450000Z https://www.medicinesresources.nhs.uk/manufacturers-discontinue-development-of-sarizotan-for-rett-syndrome.html 2020-05-06T14:30:06.1490000Z https://www.medicinesresources.nhs.uk/new-medicines-newsletter-april-2020.html 2020-05-11T09:25:03.9540000Z https://www.medicinesresources.nhs.uk/chiesi-release-batch-specific-variation-for-clenil-100-microgram-inhaler-owing-to-temporary-increased-demand.html 2020-05-06T14:35:07.1930000Z https://www.medicinesresources.nhs.uk/valproate-pregnancy-prevention-programme-temporary-advice-for-management-during-coronavirus-covid-19.html 2020-05-11T09:27:41.6060000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-acute-kidney-injury-in-hospital-guidance-ng175.html 2020-05-11T08:23:36.0980000Z https://www.medicinesresources.nhs.uk/nhs-e-referral-service-support-for-professional-users-in-response-to-the-coronavirus-covid-19-guidance.html 2020-05-07T17:06:27.5670000Z https://www.medicinesresources.nhs.uk/revised-spc-zerbaxa-ceftolozane-1-g-tazobactam-0-5-g-powder-for-concentrate-for-solution-for-infusion.html 2020-05-07T14:14:15.8640000Z https://www.medicinesresources.nhs.uk/revised-spc-opdivo-nivolumab-10-mg-ml-concentrate-for-solution-for-infusion.html 2020-05-07T14:17:33.1640000Z https://www.medicinesresources.nhs.uk/new-product-fiasp-insulin-aspart-100-units-ml-flextouch-solution-for-injection-in-pre-filled-pen.html 2020-05-07T17:04:21.3190000Z https://www.medicinesresources.nhs.uk/all-cause-and-cause-specific-mortality-among-people-using-extramedical-opioids-a-systematic-review-and-meta-analysis.html 2020-05-07T16:22:05.7480000Z https://www.medicinesresources.nhs.uk/space-from-depression-for-treating-adults-with-depression-medtech-innovation-briefing-mib215.html 2020-05-07T14:21:33.8540000Z https://www.medicinesresources.nhs.uk/can-opioids-be-used-for-pain-relief-during-pregnancy.html 2020-05-11T08:26:56.2250000Z https://www.medicinesresources.nhs.uk/dtb-select-dexamethasone-or-prednisolone-for-croup.html 2020-05-14T09:35:19.5170000Z https://www.medicinesresources.nhs.uk/medicines-use-and-safety-updates-may-2020.html 2020-05-11T08:29:06.0350000Z https://www.medicinesresources.nhs.uk/ebola.html 2020-08-10T11:58:40.4760000Z https://www.medicinesresources.nhs.uk/trastuzumab-emtansine-for-adjuvant-treatment-of-her2-positive-early-breast-cancer-final-appraisal-document.html 2020-05-07T14:30:15.1350000Z https://www.medicinesresources.nhs.uk/new-reagent-available-to-support-global-diagnostic-testing-of-coronavirus-covid-19.html 2020-05-07T14:34:43.2350000Z https://www.medicinesresources.nhs.uk/senior-enforcement-advisor-at-uk-medicines-regulator-warns-against-purchasing-fake-or-unlicensed-coronavirus-covid-19-medicines.html 2020-05-07T16:47:57.7500000Z https://www.medicinesresources.nhs.uk/interpreting-diagnostic-tests-for-sars-cov-2.html 2020-05-07T14:37:04.7700000Z https://www.medicinesresources.nhs.uk/the-ethics-of-covid-19-immunity-based-licenses-immunity-passports.html 2020-05-07T14:38:49.8770000Z https://www.medicinesresources.nhs.uk/privileges-and-immunity-certification-during-the-covid-19-pandemic.html 2020-05-07T16:45:43.0770000Z https://www.medicinesresources.nhs.uk/non-infective-endocarditis.html 2020-05-07T14:43:11.1590000Z https://www.medicinesresources.nhs.uk/call-to-action-to-prevent-venous-thromboembolism-in-hospitalized-patients-a-policy-statement-from-the-american-heart-association.html 2020-07-16T12:06:43.2130000Z https://www.medicinesresources.nhs.uk/phosphate-polyfusor-500ml-supply-disruption.html 2020-05-11T08:34:35.5090000Z https://www.medicinesresources.nhs.uk/covid-19-the-challenge-of-patient-rehabilitation-after-intensive-care.html 2020-05-07T14:46:25.1280000Z https://www.medicinesresources.nhs.uk/reducing-risks-from-coronavirus-transmission-in-the-home-the-role-of-viral-load.html 2020-05-07T14:50:45.9570000Z https://www.medicinesresources.nhs.uk/marketing-authorisation-application-submitted-in-eu-for-sublingual-house-dust-mite-hdm-allergen-immunotherapy-tablet-stagr320.html 2020-05-07T16:40:42.0070000Z https://www.medicinesresources.nhs.uk/fda-assigns-fast-track-designation-to-desmoglein-3-chimeric-autoantibody-receptor-t-cells-dsg3-caart-for-treatment-of-mucosal-pemphigus-vulgaris-mpv.html 2020-05-07T15:02:20.2140000Z https://www.medicinesresources.nhs.uk/amgen-announces-positive-top-line-results-from-phase-iii-advance-study-of-apremilast-in-mild-to-moderate-plaque-psoriasis.html 2020-05-07T15:03:22.2620000Z https://www.medicinesresources.nhs.uk/merck-announces-results-of-phase-iii-trial-of-recarbrio-imipenem-cilastatin-and-relebactam-versus-piperacillin-and-tazobactam-pip-taz-in-adult-patients-with-hospital-acquired-or-ventilator-associated-bacterial-pneumonia.html 2020-05-07T15:04:38.0640000Z https://www.medicinesresources.nhs.uk/fda-extends-action-date-of-biologics-license-application-bla-for-car-t-drug-lisocabtagene-maraleucel-liso-cel-to-end-of-2020.html 2020-05-07T16:38:00.1290000Z https://www.medicinesresources.nhs.uk/positive-preliminary-results-announced-from-ongoing-phase-iii-punch-cd3-trial-of-rbx2660-a-microbiome-based-c-difficile-treatment.html 2020-05-07T15:06:46.8670000Z https://www.medicinesresources.nhs.uk/gilead-outlines-efforts-to-expand-global-supply-of-remdesivir-for-covid-19.html 2020-05-07T15:09:42.1450000Z https://www.medicinesresources.nhs.uk/fda-approves-capmatinib-first-targeted-therapy-for-metastatic-non-small-cell-lung-cancer-with-specific-mutation-metex14.html 2020-05-07T16:35:29.0240000Z https://www.medicinesresources.nhs.uk/endovascular-thrombectomy-with-or-without-intravenous-alteplase-in-acute-stroke.html 2020-08-07T14:23:05.8260000Z https://www.medicinesresources.nhs.uk/effect-of-a-face-aging-mobile-app-based-intervention-on-skin-cancer-protection-behavior-in-secondary-schools-in-brazil-a-cluster-randomized-clinical-trial.html 2020-05-07T16:30:36.6110000Z https://www.medicinesresources.nhs.uk/assessment-of-evidence-about-common-infant-symptoms-and-cows-milk-allergy.html 2020-05-07T16:30:59.1540000Z https://www.medicinesresources.nhs.uk/evaluating-the-risk-of-macrovascular-events-and-mortality-among-people-with-multiple-sclerosis-in-england.html 2020-05-07T16:08:02.1300000Z https://www.medicinesresources.nhs.uk/cost-of-hospital-treatment-of-type-1-diabetes-t1dm-and-type-2-diabetes-t2dm-compared-to-the-non-diabetes-population-a-detailed-economic-evaluation.html 2020-05-07T16:09:09.3060000Z https://www.medicinesresources.nhs.uk/use-of-genetic-variation-to-separate-the-effects-of-early-and-later-life-adiposity-on-disease-risk-mendelian-randomisation-study.html 2020-05-07T16:11:07.8110000Z https://www.medicinesresources.nhs.uk/revised-spc-maviret-glecaprevir-and-pibrentasvir-tablets.html 2020-05-11T14:42:05.7060000Z https://www.medicinesresources.nhs.uk/new-product-nubeqa-darolutamide-tablets.html 2020-05-11T14:43:56.5370000Z https://www.medicinesresources.nhs.uk/revised-spc-synthamin-amino-acid-intravenous-infusion.html 2020-05-11T14:45:55.4330000Z https://www.medicinesresources.nhs.uk/monotherapy-with-a-p2y12-inhibitor-or-aspirin-for-secondary-prevention-in-patients-with-established-atherosclerosis-a-systematic-review-and-meta-analysis.html 2020-05-11T14:48:28.6660000Z https://www.medicinesresources.nhs.uk/virological-and-clinical-cure-in-covid-19-patients-treated-with-hydroxychloroquine-a-systematic-review-and-meta-analysis.html 2020-05-11T14:51:17.1380000Z https://www.medicinesresources.nhs.uk/what-are-the-reported-incidences-of-ankle-oedema-with-different-calcium-channel-blockers.html 2020-05-18T11:05:24.6520000Z https://www.medicinesresources.nhs.uk/medicines-q-and-a-how-should-ankle-oedema-caused-by-calcium-channel-blockers-be-treated.html 2020-05-18T11:06:06.0440000Z https://www.medicinesresources.nhs.uk/prescribing-of-anticholinergic-medicines-to-patients-initiating-dementia-medicines.html 2020-05-11T14:56:36.2370000Z https://www.medicinesresources.nhs.uk/triple-combination-of-interferon-beta-1b-lopinavir-ritonavir-and-ribavirin-in-the-treatment-of-patients-admitted-to-hospital-with-covid-19-an-open-label-randomised-phase-2-trial.html 2020-05-11T14:59:09.5860000Z https://www.medicinesresources.nhs.uk/hyperinflammatory-shock-in-children-during-covid-19-pandemic.html 2020-05-18T11:09:34.4460000Z https://www.medicinesresources.nhs.uk/utility-of-a-trigger-tool-trigger-chron-to-detect-adverse-events-associated-with-high-alert-medications-in-patients-with-multimorbidity.html 2020-05-11T15:03:08.3810000Z https://www.medicinesresources.nhs.uk/a-randomized-controlled-trial-comparing-glargine-u300-and-glargine-u100-for-the-inpatient-management-of-medicine-and-surgery-patients-with-type-2-diabetes-glargine-u300-hospital-trial-1.html 2020-05-11T15:04:46.1140000Z https://www.medicinesresources.nhs.uk/effect-of-combined-immune-checkpoint-inhibition-vs-best-supportive-care-alone-in-patients-with-advanced-colorectal-cancer-the-canadian-cancer-trials-group-co-26-study.html 2020-05-11T15:08:09.5100000Z https://www.medicinesresources.nhs.uk/observational-study-of-hydroxychloroquine-in-hospitalized-patients-with-covid-19.html 2020-08-07T14:53:10.4310000Z https://www.medicinesresources.nhs.uk/association-between-angiotensin-blockade-and-incidence-of-influenza-in-the-united-kingdom.html 2020-08-20T11:52:04.5380000Z https://www.medicinesresources.nhs.uk/secukinumab-versus-adalimumab-for-treatment-of-active-psoriatic-arthritis-exceed-a-double-blind-parallel-group-randomised-active-controlled-phase-3b-trial.html 2020-05-11T15:16:33.9410000Z https://www.medicinesresources.nhs.uk/olanzapine-for-the-treatment-of-advanced-cancer-related-chronic-nausea-and-or-vomiting-a-randomized-pilot-trial.html 2020-05-11T15:18:04.3940000Z https://www.medicinesresources.nhs.uk/characteristics-and-outcomes-of-patients-hospitalized-for-covid-19-and-cardiac-disease-in-northern-italy.html 2020-05-11T15:19:38.0490000Z https://www.medicinesresources.nhs.uk/cardiovascular-outcomes-bleeding-risk-and-achieved-blood-pressure-in-patients-on-long-term-anticoagulation-with-the-thrombin-antagonist-dabigatran-or-warfarin-data-from-the-re-ly-trial.html 2020-05-11T15:21:28.2820000Z https://www.medicinesresources.nhs.uk/emapalumab-in-children-with-primary-hemophagocytic-lymphohistiocytosis.html 2020-08-07T13:28:40.6450000Z https://www.medicinesresources.nhs.uk/treatment-of-community-acquired-pneumonia-during-the-coronavirus-disease-2019-covid-19-pandemic.html 2020-07-06T11:36:06.3070000Z https://www.medicinesresources.nhs.uk/sexual-health-in-the-sars-cov-2-era.html 2020-07-06T11:41:30.1190000Z https://www.medicinesresources.nhs.uk/sex-and-gender-differences-in-health-what-the-covid-19-pandemic-can-teach-us.html 2020-07-06T11:39:29.4050000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-on-hba1c-and-body-weight-in-higher-doses-of-dulaglutide-in-people-with-type-2-diabetes.html 2020-05-11T15:32:05.3920000Z https://www.medicinesresources.nhs.uk/fda-approve-olaparib-with-bevacizumab-for-hrd-positive-advanced-ovarian-cancer.html 2020-05-11T15:33:32.6120000Z https://www.medicinesresources.nhs.uk/fda-grants-fast-track-designation-for-omecamtiv-mecarbil-in-heart-failure.html 2020-05-11T15:34:53.6530000Z https://www.medicinesresources.nhs.uk/fda-approves-first-therapy-for-patients-with-lung-and-thyroid-cancers-with-a-certain-genetic-mutation-or-fusion.html 2020-05-11T15:36:39.2070000Z https://www.medicinesresources.nhs.uk/manufacturers-report-sintilimab-plus-gemcitabine-and-platinum-chemotherapy-combination-hits-primary-endpoint-in-locally-advanced-or-metastatic-squamous-non-small-cell-lung-cancer-study.html 2020-05-11T15:38:01.1030000Z https://www.medicinesresources.nhs.uk/palliative-care-for-patients-with-cancer-in-the-covid-19-era.html 2020-05-11T15:40:04.3160000Z https://www.medicinesresources.nhs.uk/the-equitable-distribution-of-covid-19-therapeutics-and-vaccines.html 2020-05-11T15:41:59.3470000Z https://www.medicinesresources.nhs.uk/when-should-clinicians-act-on-non-statistically-significant-results-from-clinical-trials.html 2020-05-11T15:43:31.3730000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-for-young-people-on-staying-at-home-and-away-from-others.html 2020-05-11T15:45:44.4130000Z https://www.medicinesresources.nhs.uk/covid-19-information-on-stopping-drinking-for-people-dependent-on-alcohol.html 2020-05-11T15:52:40.4240000Z https://www.medicinesresources.nhs.uk/2020-american-college-of-rheumatology-guideline-for-the-management-of-gout.html 2020-05-13T08:22:26.6730000Z https://www.medicinesresources.nhs.uk/revised-spcs-ofev-nintedanib-esilate-capsules-all-strengths.html 2020-05-12T15:20:14.4030000Z https://www.medicinesresources.nhs.uk/revised-spc-kanuma-sebelipase-alfa-2mg-ml-concentrate-solution.html 2020-05-12T15:21:40.2880000Z https://www.medicinesresources.nhs.uk/new-product-trisenox-arsenic-trioxide-2mg-ml-concentration-for-solution-for-infusion.html 2020-05-12T16:51:53.4290000Z https://www.medicinesresources.nhs.uk/revised-spcs-diamicron-gliclazide-tablets-all-products.html 2020-05-12T15:24:20.2050000Z https://www.medicinesresources.nhs.uk/revised-spcs-abilify-aripiprazole-all-products.html 2020-05-12T15:25:39.2150000Z https://www.medicinesresources.nhs.uk/how-to-wear-and-make-a-cloth-face-covering.html 2020-05-12T15:27:11.7580000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-tests-for-use-in-community-pharmacies-or-at-home.html 2020-05-12T15:28:33.5900000Z https://www.medicinesresources.nhs.uk/effect-of-acupuncture-for-postprandial-distress-syndrome.html 2020-05-12T16:25:55.4720000Z https://www.medicinesresources.nhs.uk/characteristics-and-clinical-significance-of-myocardial-injury-in-patients-with-severe-coronavirus-disease-2019.html 2020-05-12T16:27:00.6150000Z https://www.medicinesresources.nhs.uk/association-of-treatment-with-hydroxychloroquine-or-azithromycin-with-in-hospital-mortality-in-patients-with-covid-19-in-new-york-state.html 2020-05-18T10:48:22.5870000Z https://www.medicinesresources.nhs.uk/covid-19-and-racial-ethnic-disparities.html 2020-05-12T16:29:45.6120000Z https://www.medicinesresources.nhs.uk/covid-19-and-post-infection-immunity.html 2020-05-12T16:30:41.2060000Z https://www.medicinesresources.nhs.uk/telepsychiatry-and-the-coronavirus-disease-2019-pandemic-current-and-future-outcomes-of-the-rapid-virtualization-of-psychiatric-care.html 2020-05-12T16:31:42.6110000Z https://www.medicinesresources.nhs.uk/opportunities-from-the-coronavirus-disease-2019-pandemic-for-transforming-psychiatric-care-with-telehealth.html 2020-05-12T16:32:26.3730000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-recommends-expanding-remdesivir-compassionate-use-to-patients-not-on-mechanical-ventilation.html 2020-05-18T11:16:44.7580000Z https://www.medicinesresources.nhs.uk/interpreting-a-covid-19-test-result.html 2020-05-12T16:34:59.0200000Z https://www.medicinesresources.nhs.uk/positive-results-in-onset-2-phase-3-trial-of-varenicline-nasal-spray-for-treatment-of-dry-eye-disease.html 2020-05-12T16:36:02.2660000Z https://www.medicinesresources.nhs.uk/positive-results-from-bridge-phase-iii-open-label-switch-over-trial-evaluating-pegunigalsidase-alfa-for-treatment-of-fabry-disease.html 2020-05-12T16:36:46.0750000Z https://www.medicinesresources.nhs.uk/us-fda-clears-initiation-of-phase-3-pulse-cvd19-001-study-for-inopulse-inhaled-nitric-oxide-therapy-to-treat-covid-19.html 2020-05-12T16:37:27.2880000Z https://www.medicinesresources.nhs.uk/nhs-england-confirms-four-new-integrated-care-systems-ics-in-england.html 2020-05-12T16:42:55.6870000Z https://www.medicinesresources.nhs.uk/positive-results-for-isatuximab-sarclisa-in-open-label-phase-3-ikema-relapsed-mutiple-myeloma-trial.html 2020-05-12T16:43:58.5310000Z https://www.medicinesresources.nhs.uk/researchers-assess-use-of-tick-molecule-for-covid-19.html 2020-05-12T16:44:39.1190000Z https://www.medicinesresources.nhs.uk/additional-batches-of-clenil-modulite-beclometasone-100mcg-released-following-authorisation-by-the-mhra.html 2020-05-18T10:57:44.4000000Z https://www.medicinesresources.nhs.uk/lorlatinib-for-previously-treated-alk-positive-advanced-non-small-cell-lung-cancer-guidance-ta628.html 2020-05-18T09:41:39.2130000Z https://www.medicinesresources.nhs.uk/obinutuzumab-with-bendamustine-for-treating-follicular-lymphoma-after-rituximab-guidance-ta629.html 2020-05-18T09:53:50.2330000Z https://www.medicinesresources.nhs.uk/salazopyrin-sulfasalazine-500mg-suppositories-supply-disruption.html 2020-05-18T10:08:05.2740000Z https://www.medicinesresources.nhs.uk/revised-spcs-intelence-etravirine-tablets-all-strengths.html 2020-05-13T13:56:51.4980000Z https://www.medicinesresources.nhs.uk/estimating-excess-1-year-mortality-associated-with-the-covid-19-pandemic-according-to-underlying-conditions-and-age-a-population-based-cohort-study.html 2020-05-13T14:13:00.9090000Z https://www.medicinesresources.nhs.uk/revised-spc-flixabi-infliximab-100-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-05-13T14:02:38.3860000Z https://www.medicinesresources.nhs.uk/revised-spc-simponi-golimumab-solution-for-injection-in-pre-filled-syringe.html 2020-05-13T14:05:07.3650000Z https://www.medicinesresources.nhs.uk/revised-spc-fycompa-perampanel-film-coated-tablets-all-strengths.html 2020-05-13T14:07:08.6810000Z https://www.medicinesresources.nhs.uk/addition-of-androgen-deprivation-therapy-or-brachytherapy-boost-to-external-beam-radiotherapy-for-localized-prostate-cancer-a-network-meta-analysis-of-randomized-trials.html 2020-08-12T09:54:26.7640000Z https://www.medicinesresources.nhs.uk/manifestations-and-prognosis-of-gastrointestinal-and-liver-involvement-in-patients-with-covid-19-a-systematic-review-and-meta-analysis.html 2020-05-13T14:17:43.2520000Z https://www.medicinesresources.nhs.uk/impact-of-corticosteroid-therapy-on-outcomes-of-persons-with-sars-cov-2-sars-cov-or-mers-cov-infection-a-systematic-review-and-meta-analysis.html 2020-05-13T14:24:15.9670000Z https://www.medicinesresources.nhs.uk/dolutegravir-versus-efavirenz-in-women-starting-hiv-therapy-in-late-pregnancy-dolphin-2-an-open-label-randomised-controlled-trial.html 2020-05-13T14:26:55.8190000Z https://www.medicinesresources.nhs.uk/raltegravir-versus-efavirenz-in-antiretroviral-naive-pregnant-women-living-with-hiv-nichd-p1081-an-open-label-randomised-controlled-phase-4-trial.html 2020-05-13T14:30:57.0370000Z https://www.medicinesresources.nhs.uk/elafibranor-fails-interim-analysis-of-resolve-it-phase-iii-trial-of-non-alcoholic-steatohepatitis-nash.html 2020-05-13T14:35:09.4640000Z https://www.medicinesresources.nhs.uk/genetic-study-to-assess-effect-of-coronavirus-on-different-people.html 2020-05-13T14:38:11.5480000Z https://www.medicinesresources.nhs.uk/over-50s-covid-19-prinicple-trial-launches-across-uk.html 2020-05-13T14:40:16.8460000Z https://www.medicinesresources.nhs.uk/covid-19-and-angiotensin-converting-enzyme-inhibitors-and-angiotensin-receptor-blockers-what-is-the-evidence-1.html 2020-05-13T14:45:55.3120000Z https://www.medicinesresources.nhs.uk/new-product-entyvio-vedolizumab-108-mg-solution-for-injection-in-pre-filled-syringe-1.html 2020-05-14T15:14:33.1060000Z https://www.medicinesresources.nhs.uk/revised-spcs-targinact-oxycodone-naloxone-prolonged-release-tablets-all-strengths.html 2020-05-14T17:42:33.8290000Z https://www.medicinesresources.nhs.uk/new-product-buscomint-peppermint-oil-0-2ml-gastro-resistant-capsule-soft.html 2020-05-14T17:41:32.1110000Z https://www.medicinesresources.nhs.uk/public-health-england-approves-covid-antibody-test-developed-by-roche.html 2020-05-18T09:26:50.1780000Z https://www.medicinesresources.nhs.uk/accord-healthcare-to-move-hydroxychloroquine-production-to-uk-to-avoid-shortages.html 2020-05-14T15:24:12.2850000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-rps-calls-for-evidence-on-pharmacy-practice-and-covid-19.html 2020-05-14T15:26:10.4230000Z https://www.medicinesresources.nhs.uk/covid-19-critical-care-training-resource.html 2020-05-18T09:33:39.4360000Z https://www.medicinesresources.nhs.uk/vaccine-ordering-for-2020-21-influenza-season-letter.html 2020-05-18T09:36:25.9850000Z https://www.medicinesresources.nhs.uk/transient-ischemic-attack.html 2020-05-14T15:33:25.8590000Z https://www.medicinesresources.nhs.uk/how-tests-and-testing-kits-for-coronavirus-covid-19-work.html 2020-05-14T15:41:15.1440000Z https://www.medicinesresources.nhs.uk/prevention-of-yellow-fever-in-travellers-an-update.html 2020-05-14T15:44:07.4840000Z https://www.medicinesresources.nhs.uk/targeting-covid-19-the-drugs-being-fast-tracked-through-clinical-trials-and-how-they-work.html 2020-05-14T15:45:32.3990000Z https://www.medicinesresources.nhs.uk/why-we-need-to-pay-attention-to-toxicity-associated-with-herbal-medicines.html 2020-05-14T15:47:54.9410000Z https://www.medicinesresources.nhs.uk/alcohol-smoking-and-other-substance-use-in-the-perinatal-period.html 2020-05-14T15:49:04.8360000Z https://www.medicinesresources.nhs.uk/should-clinicians-use-chloroquine-or-hydroxychloroquine-alone-or-in-combination-with-azithromycin-for-the-prophylaxis-or-treatment-of-covid-19-living-practice-points-from-the-american-college-of-physicians-version-1.html 2020-05-14T15:50:53.5000000Z https://www.medicinesresources.nhs.uk/mavacamten-meets-primary-and-secondary-endpoints-in-phase-iii-explorer-hcm-clinical-trial-of-patients-with-symptomatic-obstructive-hypertrophic-cardiomyopathy.html 2020-05-14T15:52:04.6860000Z https://www.medicinesresources.nhs.uk/cytosorb-approved-in-eu-to-remove-rivaroxaban-during-on-pump-cardiothoracic-surgery.html 2020-05-14T15:53:33.2850000Z https://www.medicinesresources.nhs.uk/three-year-data-from-checkmate-227-confirm-durable-long-term-survival-benefit-for-nivolumab-plus-ipilimumab-vs-chemotherapy-as-first-line-treatment-of-metastatic-non-small-cell-lung-cancer-patients-with-pd-l1-1.html 2020-05-14T15:54:53.5430000Z https://www.medicinesresources.nhs.uk/pre-specified-final-survival-analysis-of-phase-iii-aramis-trial-of-darolutamide-plus-androgen-deprivation-therapy-adt-shows-statistically-significant-improvement-in-overall-survival-in-non-metastatic-castration-resistant-prostate-cancer.html 2020-05-14T17:31:27.6330000Z https://www.medicinesresources.nhs.uk/survival-benefit-reported-in-checkmate-9la-study-of-nivolumab-plus-ipilimumab-with-limited-chemotherapy-vs-chemotherapy-alone-as-first-line-treatment-of-metastatic-non-small-cell-lung-cancer.html 2020-05-14T16:06:55.4380000Z https://www.medicinesresources.nhs.uk/phase-iii-keynote-204-trial-reports-improvement-in-progression-free-survival-pfs-with-pembrolizumab-versus-brentuximab-vedotin-bv-in-patients-with-classical-hodgkin-lymphoma.html 2020-05-14T16:09:53.2100000Z https://www.medicinesresources.nhs.uk/phase-iii-spartan-study-demonstrates-survival-benefit-for-apalutamide-in-combination-with-androgen-deprivation-therapy-adt-compared-to-adt-alone-in-patients-with-non-metastatic-castration-resistant-prostate-cancer.html 2020-05-14T16:11:24.1900000Z https://www.medicinesresources.nhs.uk/pembrolizumab-plus-chemotherapy-demonstrated-improvement-in-progression-free-survival-versus-chemotherapy-in-certain-patients-with-metastatic-triple-negative-breast-cancer-in-phase-iii-keynote-355.html 2020-05-14T16:15:18.9450000Z https://www.medicinesresources.nhs.uk/fda-refuses-review-of-licensing-application-for-idecabtagene-vicleucel-ide-cel-bb2121-for-patients-with-heavily-pretreated-relapsed-and-refractory-multiple-myeloma.html 2020-05-14T16:17:01.0250000Z https://www.medicinesresources.nhs.uk/fda-grants-covid-19-vaccine-candidate-mrna-1273-fast-track-designation.html 2020-05-14T16:18:35.6600000Z https://www.medicinesresources.nhs.uk/continuous-versus-intermittent-infusion-of-vancomycin-and-the-risk-of-acute-kidney-injury-in-critically-ill-adults-a-systematic-review-and-meta-analysis.html 2020-05-14T16:24:47.5290000Z https://www.medicinesresources.nhs.uk/progression-to-type-2-diabetes-in-women-with-a-known-history-of-gestational-diabetes-systematic-review-and-meta-analysis.html 2020-05-14T17:25:09.2710000Z https://www.medicinesresources.nhs.uk/randomized-trial-of-lactin-v-to-prevent-recurrence-of-bacterial-vaginosis.html 2020-08-07T13:59:04.1340000Z https://www.medicinesresources.nhs.uk/atezolizumab-plus-bevacizumab-in-unresectable-hepatocellular-carcinoma.html 2020-08-07T14:13:42.2900000Z https://www.medicinesresources.nhs.uk/ivosidenib-in-idh1-mutant-chemotherapy-refractory-cholangiocarcinoma-claridhy-a-multicentre-randomised-double-blind-placebo-controlled-phase-3-study.html 2020-05-14T17:22:22.8980000Z https://www.medicinesresources.nhs.uk/graduated-compression-stockings-as-adjuvant-to-pharmaco-thromboprophylaxis-in-elective-surgical-patients-gaps-study-randomised-controlled-trial.html 2020-05-14T17:13:53.0000000Z https://www.medicinesresources.nhs.uk/medication-persistence-on-biological-therapies-prescribed-for-the-treatment-of-chronic-inflammatory-arthropathies-a-real-world-data-study.html 2020-05-14T16:37:56.1730000Z https://www.medicinesresources.nhs.uk/maternal-cardiovascular-risk-after-hypertensive-disorder-of-pregnancy.html 2020-05-14T16:47:26.7460000Z https://www.medicinesresources.nhs.uk/variation-in-false-negative-rate-of-reverse-transcriptase-polymerase-chain-reaction-based-sars-cov-2-tests-by-time-since-exposurefree.html 2020-05-14T16:47:14.4400000Z https://www.medicinesresources.nhs.uk/voriconazole-and-the-risk-of-keratinocyte-carcinomas-among-lung-transplant-recipients-in-the-united-states.html 2020-05-14T17:51:46.4900000Z https://www.medicinesresources.nhs.uk/sars-cov-2-rates-in-bcg-vaccinated-and-unvaccinated-young-adults.html 2020-05-14T17:53:17.9170000Z https://www.medicinesresources.nhs.uk/revised-spc-xyrem-sodium-oxybate-500-mg-ml-oral-solution.html 2020-05-15T14:23:59.8460000Z https://www.medicinesresources.nhs.uk/revised-spc-lokelma-zirconium-cyclosilicate-5-g-powder-for-oral-suspension.html 2020-05-15T14:28:30.0320000Z https://www.medicinesresources.nhs.uk/leuprorelin-depot-medicines-prac-recommends-new-measures-to-avoid-handling-errors.html 2020-05-15T14:29:56.3640000Z https://www.medicinesresources.nhs.uk/prac-concludes-review-of-new-information-on-the-known-risk-of-breast-cancer-with-hormone-replacement-therapy.html 2020-05-15T14:31:17.5030000Z https://www.medicinesresources.nhs.uk/the-new-normal-key-considerations-for-effective-serious-illness-communication-over-video-or-telephone-during-the-coronavirus-disease-2019-covid-19-pandemic.html 2020-05-15T14:32:10.1570000Z https://www.medicinesresources.nhs.uk/positive-phase-ii-results-for-investigational-checkpoint-inhibitor-tiragolumab-in-combination-with-atezolizumab-for-non-small-cell-lung-cancer-nsclc.html 2020-05-15T14:33:00.9050000Z https://www.medicinesresources.nhs.uk/positive-results-from-phase-iii-lot-consistency-study-of-20-valent-pneumococcal-conjugate-vaccine-20vpnc-candidate.html 2020-05-15T14:33:59.2060000Z https://www.medicinesresources.nhs.uk/public-told-act-fast-as-nhs-uses-artificial-intelligence-to-speed-up-stroke-care.html 2020-05-15T14:34:57.1910000Z https://www.medicinesresources.nhs.uk/nhs-roadmap-to-safely-bring-back-routine-operations.html 2020-05-15T14:44:21.0850000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-recommends-betalutin-r-177lu-lilotomab-satetraxetan-be-granted-orphan-drug-designation-for-the-treatment-of-marginal-zone-lymphoma.html 2020-05-15T14:45:23.5150000Z https://www.medicinesresources.nhs.uk/european-commission-approves-adcetris-r-brentuximab-vedotin-for-treatment-of-adults-with-previously-untreated-systemic-anaplastic-large-cell-lymphoma.html 2020-05-15T16:08:06.7720000Z https://www.medicinesresources.nhs.uk/initial-findings-from-the-first-wave-of-the-pilot-phase-of-the-coronavirus-covid-19-infection-survey-for-england.html 2020-05-18T07:40:22.8750000Z https://www.medicinesresources.nhs.uk/covid-19-the-support-uk-care-homes-need-to-survive.html 2020-05-15T14:48:16.9840000Z https://www.medicinesresources.nhs.uk/digital-transformation-in-the-nh.html 2020-05-15T16:06:18.1170000Z https://www.medicinesresources.nhs.uk/world-health-organisation-publishes-world-health-statistics-2020-report.html 2020-05-15T14:50:29.2520000Z https://www.medicinesresources.nhs.uk/enalapril-lercanidipine-combination-induced-leukocytoclastic-vasculitis-a-case-report.html 2020-05-15T14:51:32.9140000Z https://www.medicinesresources.nhs.uk/delivering-core-nhs-and-care-services-during-the-covid-19-pandemic-and-beyond-letter-to-the-commons-health-and-social-care-select-committee.html 2020-05-15T16:04:35.8030000Z https://www.medicinesresources.nhs.uk/understanding-the-impact-of-coronavirus-on-autistic-people-and-people-with-a-learning-disability.html 2020-05-15T14:53:23.2280000Z https://www.medicinesresources.nhs.uk/roll-out-of-whole-home-care-testing.html 2020-05-18T11:16:14.3020000Z https://www.medicinesresources.nhs.uk/us-fda-informs-public-about-possible-accuracy-concerns-with-abbott-id-now-point-of-care-test.html 2020-05-15T14:55:40.9250000Z https://www.medicinesresources.nhs.uk/potential-coronavirus-covid-19-symptoms-reported-through-nhs-pathways-and-111-online-5.html 2020-05-15T14:56:34.6830000Z https://www.medicinesresources.nhs.uk/outcomes-following-immune-checkpoint-inhibitor-treatment-of-patients-with-microsatellite-instability-high-cancers.html 2020-05-15T15:43:52.4830000Z https://www.medicinesresources.nhs.uk/use-of-renin-angiotensin-aldosterone-system-inhibitors-and-risk-of-covid-19-requiring-admission-to-hospital-a-case-population-study.html 2020-05-18T09:14:24.0500000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-in-patients-with-mainly-mild-to-moderate-coronavirus-disease-2019-open-label-randomised-controlled-trial.html 2020-05-15T15:47:26.5100000Z https://www.medicinesresources.nhs.uk/clinical-efficacy-of-hydroxychloroquine-in-patients-with-covid-19-pneumonia-who-require-oxygen-observational-comparative-study-using-routine-care-data.html 2020-05-15T15:48:32.4530000Z https://www.medicinesresources.nhs.uk/adjuvant-nivolumab-plus-ipilimumab-or-nivolumab-monotherapy-versus-placebo-in-patients-with-resected-stage-iv-melanoma-with-no-evidence-of-disease-immuned-a-randomised-double-blind-placebo-controlled-phase-2-trial.html 2020-05-15T15:59:39.5050000Z https://www.medicinesresources.nhs.uk/atezolizumab-with-or-without-chemotherapy-in-metastatic-urothelial-cancer-imvigor130-a-multicentre-randomised-placebo-controlled-phase-3-trial.html 2020-05-15T15:53:17.5770000Z https://www.medicinesresources.nhs.uk/safe-working-in-education-childcare-and-childrens-social-care.html 2020-05-15T15:54:36.5700000Z https://www.medicinesresources.nhs.uk/70-million-face-masks-for-nhs-and-care-workers-through-new-industry-deal.html 2020-05-15T15:55:29.2830000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-chronic-kidney-disease-guidance-ng176.html 2020-05-26T08:09:33.7070000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-interstitial-lung-disease-guidance-ng177.html 2020-05-26T08:14:03.3440000Z https://www.medicinesresources.nhs.uk/revised-spc-bexsero-meningococcal-group-b-vaccine-for-injection-in-pre-filled-syringe.html 2020-05-18T14:27:16.7830000Z https://www.medicinesresources.nhs.uk/central-alerting-system-class-2-drug-alert-emerade-500-micrograms-solution-for-injection-in-pre-filled-syringe.html 2020-05-18T14:28:34.6850000Z https://www.medicinesresources.nhs.uk/behavioural-and-pharmaceutical-interventions-for-the-prevention-of-skin-cancers-in-solid-organ-transplant-recipients-a-systematic-review-of-randomised-controlled-trials.html 2020-05-18T14:29:54.6460000Z https://www.medicinesresources.nhs.uk/use-of-corticosteroids-in-coronavirus-disease-2019-pneumonia-a-systematic-review-of-the-literature.html 2020-05-18T14:33:34.2020000Z https://www.medicinesresources.nhs.uk/randomized-phase-iii-study-of-pemetrexed-plus-cisplatin-versus-vinorelbine-plus-cisplatin-for-completely-resected-stage-ii-to-iiia-nonsquamous-non-small-cell-lung-cancer.html 2020-07-10T14:21:44.7420000Z https://www.medicinesresources.nhs.uk/trends-in-oral-anticoagulant-prescribing-in-individuals-with-type-2-diabetes-mellitus-a-population-based-study-in-the-uk.html 2020-05-18T14:36:56.7220000Z https://www.medicinesresources.nhs.uk/risk-factors-for-sars-cov-2-among-patients-in-the-oxford-royal-college-of-general-practitioners-research-and-surveillance-centre-primary-care-network-a-cross-sectional-study.html 2020-05-18T14:38:33.3500000Z https://www.medicinesresources.nhs.uk/covid-19-mental-health-services-must-be-boosted-to-deal-with-tsunami-of-cases-after-lockdown.html 2020-05-18T15:02:28.3310000Z https://www.medicinesresources.nhs.uk/fda-grants-marketing-approval-for-ripretinib-qinlock-for-4th-line-treatment-of-advanced-gastrointestinal-stromal-tumours.html 2020-05-18T14:43:46.0660000Z https://www.medicinesresources.nhs.uk/lancet-letter-use-of-herbal-drugs-to-treat-covid-19-should-be-with-caution.html 2020-05-18T14:46:39.0390000Z https://www.medicinesresources.nhs.uk/central-alerting-system-influenza-season-2019-20-ending-the-prescribing-and-supply-of-antiviral-medicines-in-primary-care.html 2020-05-26T08:15:51.5680000Z https://www.medicinesresources.nhs.uk/severe-covid-19.html 2020-05-18T14:51:15.9570000Z https://www.medicinesresources.nhs.uk/the-independent-sage-report-covid-19-what-are-the-options-for-the-uk.html 2020-05-18T14:54:38.0030000Z https://www.medicinesresources.nhs.uk/the-national-flu-immunisation-programme-2020-21.html 2020-05-26T08:28:48.2340000Z https://www.medicinesresources.nhs.uk/clinical-guide-for-supporting-compassionate-visiting-arrangements-for-those-receiving-care-at-the-end-of-life.html 2020-05-18T14:59:15.6390000Z https://www.medicinesresources.nhs.uk/rps-calls-for-pharmacists-to-have-greater-powers-to-ensure-access-to-medicines.html 2020-05-18T15:03:10.0580000Z https://www.medicinesresources.nhs.uk/gov-t-invests-gbp84m-into-uk-covid-19-vaccines-research-5.html 2020-05-18T16:16:17.6280000Z https://www.medicinesresources.nhs.uk/fda-grants-breakthrough-designation-to-trastuzumab-deruxtecan-enhertu-for-metastatic-non-small-cell-lung-cancer.html 2020-05-18T16:17:37.2930000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-pilot-england-14-may-2020.html 2020-05-18T16:30:29.2330000Z https://www.medicinesresources.nhs.uk/covid-19-general-case-definition-change.html 2020-05-26T08:32:02.6020000Z https://www.medicinesresources.nhs.uk/influenza-season-2019-20-ending-the-prescribing-and-supply-of-antiviral-medicines-in-primary-care.html 2020-05-26T08:34:56.3910000Z https://www.medicinesresources.nhs.uk/revised-spcs-strensiq-asfotase-alfa-40mg-ml-and-100-mg-ml-solution-for-injection.html 2020-05-19T17:46:13.8380000Z https://www.medicinesresources.nhs.uk/revised-spc-imfinzi-durvalumab-50-mg-ml-concentrate-for-solution-for-infusion.html 2020-05-19T15:13:26.4310000Z https://www.medicinesresources.nhs.uk/revised-spcs-cosentyx-secukinumab-150-mg-solution-for-injection-in-pre-filled-pen-and-syringe.html 2020-05-19T17:45:10.7110000Z https://www.medicinesresources.nhs.uk/revised-spc-sovaldi-sofosbuvir-400-mg-film-coated-tablets.html 2020-05-19T15:16:07.6610000Z https://www.medicinesresources.nhs.uk/revised-spc-tetrabenazine-25-mg-tablets.html 2020-05-19T17:43:49.9970000Z https://www.medicinesresources.nhs.uk/position-statement-regarding-covid-19-tests-evaluated-by-public-health-england-phe.html 2020-05-19T15:18:48.2300000Z https://www.medicinesresources.nhs.uk/cppe-corner-new-covid-19-learning-resource-hub.html 2020-05-19T17:42:13.8130000Z https://www.medicinesresources.nhs.uk/department-of-health-and-social-care-to-increase-medicine-reimbursement-prices-by-gbp15-million-in-june-2020.html 2020-05-19T15:21:03.8330000Z https://www.medicinesresources.nhs.uk/hiv-prevention-trial-hptn-083-stopped-early-based-on-positive-efficacy-results.html 2020-05-19T17:40:41.6400000Z https://www.medicinesresources.nhs.uk/coagulation-abnormalities-and-thrombosis-in-patients-with-covid-19.html 2020-05-19T17:39:48.2450000Z https://www.medicinesresources.nhs.uk/steam-inhalation-and-paediatric-burns-during-the-covid-19-pandemic.html 2020-05-19T15:24:58.2940000Z https://www.medicinesresources.nhs.uk/planning-for-a-covid-19-vaccination-program.html 2020-05-19T15:26:14.6210000Z https://www.medicinesresources.nhs.uk/government-announces-that-everyone-in-uk-with-symptoms-now-eligible-for-coronavirus-tests.html 2020-05-26T07:38:42.9540000Z https://www.medicinesresources.nhs.uk/covid-19-and-cardiovascular-disease.html 2020-07-16T13:49:42.2700000Z https://www.medicinesresources.nhs.uk/eu-may-fast-track-approval-of-remdesivir-as-a-covid-19-treatment-ahead-of-us.html 2020-05-19T17:36:40.8180000Z https://www.medicinesresources.nhs.uk/gene-therapy-zolgensma-onasemnogene-abeparvovec-conditionally-approved-in-eu-for-treatment-of-spinal-muscular-atrophy-sma-in-babies-and-young-children-up-to-21-kilograms.html 2020-05-19T17:35:26.4030000Z https://www.medicinesresources.nhs.uk/rucaparib-approved-in-us-as-monotherapy-treatment-for-patients-with-brca1-2-mutant-metastatic-castration-resistant-prostate-cancer-mcrpc-who-have-been-treated-with-androgen-receptor-directed-therapy-and-a-taxane-based-chemotherapy.html 2020-05-19T15:32:45.8050000Z https://www.medicinesresources.nhs.uk/us-fda-approves-pomalidomide-for-aids-related-and-hiv-negative-kaposi-sarcoma.html 2020-05-19T17:33:46.0390000Z https://www.medicinesresources.nhs.uk/us-fda-approves-nivolumab-and-ipilimumab-as-first-line-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-whose-tumours-express-pd-l1-1.html 2020-05-19T15:35:24.0590000Z https://www.medicinesresources.nhs.uk/us-fda-approves-atezolizumab-as-first-line-monotherapy-for-adults-with-metastatic-non-small-cell-lung-cancer-nsclc-whose-tumours-have-high-pd-l1-expression-or-pd-l1-stained-tumor-infiltrating-covering-10-of-tumour-area.html 2020-05-19T17:32:06.3060000Z https://www.medicinesresources.nhs.uk/astrazeneca-aims-for-30-million-doses-of-covid-19-vaccine-for-u-k-by-september-2020.html 2020-05-19T17:31:09.0950000Z https://www.medicinesresources.nhs.uk/moderna-releases-positive-interim-phase-i-data-from-its-clinical-trial-of-its-mrna-1273-vaccine-against-sars-cov-2.html 2020-05-19T15:38:44.0510000Z https://www.medicinesresources.nhs.uk/coronavirus-outbreak-indemnity-faqs.html 2020-05-19T15:41:34.4080000Z https://www.medicinesresources.nhs.uk/updated-national-ambulance-patient-group-directions.html 2020-05-26T07:39:08.5050000Z https://www.medicinesresources.nhs.uk/psychiatric-and-neuropsychiatric-presentations-associated-with-severe-coronavirus-infections-a-systematic-review-and-meta-analysis-with-comparison-to-the-covid-19-pandemic.html 2020-05-19T17:27:57.7450000Z https://www.medicinesresources.nhs.uk/utility-of-broad-spectrum-antibiotics-for-diagnosing-pulmonary-tuberculosis-in-adults-a-systematic-review-and-meta-analysis.html 2020-05-19T17:26:33.4130000Z https://www.medicinesresources.nhs.uk/bacterial-and-fungal-co-infection-in-individuals-with-coronavirus-a-rapid-review-to-support-covid-19-antimicrobial-prescribing.html 2020-05-19T15:52:56.8380000Z https://www.medicinesresources.nhs.uk/neoadjuvant-chemotherapy-in-high-risk-soft-tissue-sarcomas-final-results-of-a-randomized-trial-from-italian-isg-spanish-geis-french-fsg-and-polish-psg-sarcoma-groups.html 2020-07-08T14:35:03.4070000Z https://www.medicinesresources.nhs.uk/associated-with-chemotherapy-induced-vomiting-control-in-pediatric-patients-receiving-moderately-or-highly-emetogenic-chemotherapy-a-pooled-analysis.html 2020-07-08T14:43:37.9260000Z https://www.medicinesresources.nhs.uk/association-between-tumor-necrosis-factor-inhibitor-exposure-and-inflammatory-central-nervous-system-events.html 2020-05-19T17:05:56.7790000Z https://www.medicinesresources.nhs.uk/associations-between-dietary-patterns-and-subclinical-cardiac-injury-an-observational-analysis-from-the-dash-trial.html 2020-05-19T17:06:21.5630000Z https://www.medicinesresources.nhs.uk/association-between-treatment-with-apixaban-dabigatran-rivaroxaban-or-warfarin-and-risk-for-osteoporotic-fractures-among-patients-with-atrial-fibrillation-a-population-based-cohort-study.html 2020-05-19T17:05:12.6070000Z https://www.medicinesresources.nhs.uk/use-of-all-cause-mortality-to-quantify-the-consequences-of-covid-19-in-nembro-lombardy-descriptive-study.html 2020-05-19T17:18:48.8580000Z https://www.medicinesresources.nhs.uk/covid-19-in-people-with-diabetes-urgently-needed-lessons-from-early-reports.html 2020-05-19T17:19:28.4060000Z https://www.medicinesresources.nhs.uk/deep-vein-thrombosis-in-hospitalized-patients-with-coronavirus-disease-2019-covid-19-in-wuhan-china-prevalence-risk-factors-and-outcome.html 2020-07-16T13:41:11.7420000Z https://www.medicinesresources.nhs.uk/acute-heart-failure-in-multisystem-inflammatory-syndrome-in-children-mis-c-in-the-context-of-global-sars-cov-2-pandemic.html 2020-07-22T12:57:59.6580000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-for-commissioners-and-providers-of-services-for-people-who-use-drugs-or-alcohol.html 2020-05-20T14:17:43.3660000Z https://www.medicinesresources.nhs.uk/revised-spc-harvoni-ledipasvir-and-sofosbuvir-tablets.html 2020-05-20T14:20:42.9000000Z https://www.medicinesresources.nhs.uk/revised-spc-bisacodyl-tabs.html 2020-05-20T14:23:54.8090000Z https://www.medicinesresources.nhs.uk/revised-spc-cipramil-citalopram-tablets.html 2020-05-20T14:26:21.1170000Z https://www.medicinesresources.nhs.uk/association-of-blood-pressure-lowering-with-incident-dementia-or-cognitive-impairment-a-systematic-review-and-meta-analysis.html 2020-05-20T14:37:17.5570000Z https://www.medicinesresources.nhs.uk/acei-arb-use-and-risk-of-infection-or-severity-or-mortality-of-covid-19-a-systematic-review-and-meta-analysis.html 2020-05-20T15:58:08.4430000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-in-patients-with-covid-19-a-systematic-review-and-meta-analysis.html 2020-05-20T15:59:25.0530000Z https://www.medicinesresources.nhs.uk/should-azithromycin-be-used-to-treat-covid-19-a-rapid-review.html 2020-05-20T14:57:56.4690000Z https://www.medicinesresources.nhs.uk/type-1-and-type-2-diabetes-and-covid-19-related-mortality-in-england.html 2020-05-20T14:59:29.7320000Z https://www.medicinesresources.nhs.uk/the-covid-19-pandemic-and-the-incidence-of-acute-myocardial-infarction.html 2020-08-07T12:13:10.8010000Z https://www.medicinesresources.nhs.uk/associations-between-maternal-antenatal-corticosteroid-treatment-and-mental-and-behavioral-disorders-in-children.html 2020-05-20T15:04:38.3500000Z https://www.medicinesresources.nhs.uk/collateral-damage-the-impact-on-outcomes-from-cancer-surgery-of-the-covid-19-pandemic.html 2020-05-20T15:08:04.1870000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-insulin-glargine-300-units-ml-gla-300-versus-insulin-glargine-100-units-ml-gla-100-in-children-and-adolescents-6-17-years-with-type-1-diabetes-results-of-the-edition-junior-randomized-controlled-trial.html 2020-05-20T15:09:35.7460000Z https://www.medicinesresources.nhs.uk/outcomes-in-patients-with-hyperglycemia-affected-by-covid-19-can-we-do-more-on-glycemic-control.html 2020-05-20T15:10:54.0270000Z https://www.medicinesresources.nhs.uk/the-influence-of-baseline-diastolic-blood-pressure-on-the-effects-of-intensive-blood-pressure-lowering-on-cardiovascular-outcomes-and-all-cause-mortality-in-type-2-diabetes.html 2020-05-20T15:12:30.2320000Z https://www.medicinesresources.nhs.uk/lack-of-efficacy-of-hydroxychloroquine-in-covid-19.html 2020-05-20T15:58:38.7930000Z https://www.medicinesresources.nhs.uk/manufacturers-report-improved-outcomes-in-patients-with-advanced-hepatocarcinoma-given-cabozantinib-vs-regorafenib-in-match-adjusted-comparison-of-trials.html 2020-05-20T15:15:52.2450000Z https://www.medicinesresources.nhs.uk/fda-to-assess-lonafarib-via-priority-review-process-in-progeria-and-progeroid-laminopathies.html 2020-05-20T15:18:53.1570000Z https://www.medicinesresources.nhs.uk/venous-thromboembolism-in-adults-summary-of-updated-nice-guidance-on-diagnosis-management-and-thrombophilia-testing.html 2020-05-20T15:20:18.5870000Z https://www.medicinesresources.nhs.uk/need-for-transparency-and-reliable-evidence-in-emergency-use-authorizations-for-coronavirus-disease-2019-covid-19-therapies.html 2020-05-20T15:22:14.2410000Z https://www.medicinesresources.nhs.uk/sharing-insight-asking-questions-encouraging-collaboration-cqc-publishes-first-insight-document-on-covid-19-pressures.html 2020-05-20T15:24:07.1860000Z https://www.medicinesresources.nhs.uk/pharmacy-and-medicines-support-to-care-homes-urgent-system-wide-delivery-model.html 2020-05-26T07:34:08.6160000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-children-and-young-people-who-are-immunocompromised-updated-guideline-ng174.html 2020-05-25T13:11:10.5590000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-dialysis-service-delivery-updated-guideline-ng160.html 2020-05-25T13:13:52.4390000Z https://www.medicinesresources.nhs.uk/cytokine-adsorption-devices-for-treating-respiratory-failure-in-people-with-covid-19-medtech-innovation-briefing-mib217.html 2020-05-25T13:22:45.5020000Z https://www.medicinesresources.nhs.uk/overview-of-the-uk-governments-response-to-the-covid-19-pandemic.html 2020-05-21T15:36:10.2040000Z https://www.medicinesresources.nhs.uk/nhs-expands-offer-of-help-to-people-with-diabetes-during-coronavirus-outbreak.html 2020-05-21T15:37:51.1580000Z https://www.medicinesresources.nhs.uk/summary-information-published-on-high-risk-patients-on-the-shielded-patient-list.html 2020-05-21T15:39:48.5070000Z https://www.medicinesresources.nhs.uk/emerging-and-reemerging-sexually-transmitted-infections.html 2020-08-10T12:03:13.4740000Z https://www.medicinesresources.nhs.uk/immunomodulatory-drugs-temporary-pregnancy-prevention-guidance-during-coronavirus-covid-19.html 2020-05-25T13:20:25.7510000Z https://www.medicinesresources.nhs.uk/type-2-diabetes-and-cognitive-dysfunction-towards-effective-management-of-both-comorbidities.html 2020-05-21T15:44:43.3880000Z https://www.medicinesresources.nhs.uk/central-nervous-pathways-of-insulin-action-in-the-control-of-metabolism-and-food-intake.html 2020-05-21T17:40:15.2710000Z https://www.medicinesresources.nhs.uk/vitamin-d-and-covid-19-do-deficient-risk-a-poorer-outcome.html 2020-05-21T15:48:15.6160000Z https://www.medicinesresources.nhs.uk/management-of-cancer-cachexia-asco-guideline.html 2020-07-08T14:54:06.4910000Z https://www.medicinesresources.nhs.uk/olfactory-dysfunction-in-covid-19-diagnosis-and-management.html 2020-05-21T17:37:45.9980000Z https://www.medicinesresources.nhs.uk/general-pharmaceutical-council-gphc-launches-vision-2030-and-five-year-strategic-plan.html 2020-05-21T15:54:56.5440000Z https://www.medicinesresources.nhs.uk/global-regulators-commit-to-cooperate-on-observational-covid-19research.html 2020-05-21T17:34:00.1380000Z https://www.medicinesresources.nhs.uk/esc-guidance-for-the-diagnosis-and-management-of-cv-disease-during-the-covid-19-pandemic.html 2020-05-21T17:33:02.9440000Z https://www.medicinesresources.nhs.uk/medicines-with-one-seller-and-many-buyers-strategies-to-increase-the-power-of-the-payer.html 2020-05-21T15:58:51.9220000Z https://www.medicinesresources.nhs.uk/nhs-englands-medical-director-cautions-against-buying-coronavirus-antibody-tests.html 2020-05-21T16:01:40.1730000Z https://www.medicinesresources.nhs.uk/trial-of-hydroxychloroquine-to-prevent-covid-19-begins-in-uk.html 2020-05-21T16:02:42.8850000Z https://www.medicinesresources.nhs.uk/retrospective-study-of-patient-enrolled-in-medicare-advantage-or-commercially-insured-plans-suggests-older-covid-19-patients-with-hypertension-taking-ace-inhibitors-had-lower-risk-of-covid-19-hospitalisation.html 2020-05-21T16:04:14.6790000Z https://www.medicinesresources.nhs.uk/fda-approves-investigational-new-drug-application-for-use-of-octagam-10-immune-globulin-in-severe-covid-19-patients-with-severe-disease-progression.html 2020-05-21T16:06:17.4290000Z https://www.medicinesresources.nhs.uk/fda-approves-olaparib-for-patients-with-homologous-recombination-repair-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer-mcrpc.html 2020-05-21T16:07:36.1920000Z https://www.medicinesresources.nhs.uk/helicobacter-pylori-eradication-therapy-to-prevent-gastric-cancer-systematic-review-and-meta-analysis.html 2020-05-21T17:28:17.4980000Z https://www.medicinesresources.nhs.uk/melanoma-risk-in-patients-treated-with-biologic-therapy-for-common-inflammatory-diseases-a-systematic-review-and-meta-analysis.html 2020-05-21T16:13:18.8020000Z https://www.medicinesresources.nhs.uk/early-warning-scores-for-detecting-deterioration-in-adult-hospital-patients-systematic-review-and-critical-appraisal-of-methodology.html 2020-05-21T17:26:35.3740000Z https://www.medicinesresources.nhs.uk/association-of-maternal-thyroid-function-with-birthweight-a-systematic-review-and-individual-participant-data-meta-analysis.html 2020-05-21T16:18:20.8380000Z https://www.medicinesresources.nhs.uk/minocycline-and-celecoxib-as-adjunctive-treatments-for-bipolar-depression-a-multicentre-factorial-design-randomised-controlled-trial.html 2020-05-21T17:08:31.1550000Z https://www.medicinesresources.nhs.uk/individual-quarantine-versus-active-monitoring-of-contacts-for-the-mitigation-of-covid-19-a-modelling-study.html 2020-05-21T17:09:45.1210000Z https://www.medicinesresources.nhs.uk/risks-of-mortality-following-nonfatal-intentional-and-unintentional-opioid-overdoses.html 2020-05-21T17:10:35.8180000Z https://www.medicinesresources.nhs.uk/oral-fluconazole-use-in-the-first-trimester-and-risk-of-congenital-malformations-population-based-cohort-study.html 2020-05-26T07:20:59.0240000Z https://www.medicinesresources.nhs.uk/sleep-duration-patterns-in-early-to-middle-adulthood-and-subsequent-risk-of-type-2-diabetes-in-women.html 2020-05-21T17:11:52.4070000Z https://www.medicinesresources.nhs.uk/effects-of-an-electronic-software-prompt-with-health-care-professional-training-on-cardiovascular-and-renal-complications-in-a-multiethnic-population-with-type-2-diabetes-and-microalbuminuria-the-gp-prompt-study-results-of-a-pragmatic-cluster-randomized-trial.html 2020-05-21T17:19:45.2760000Z https://www.medicinesresources.nhs.uk/variations-between-women-and-men-in-risk-factors-treatments-cardiovascular-disease-incidence-and-death-in-27-high-income-middle-income-and-low-income-countries-pure-a-prospective-cohort-study.html 2020-05-21T17:13:12.2570000Z https://www.medicinesresources.nhs.uk/epidemiology-clinical-course-and-outcomes-of-critically-ill-adults-with-covid-19-in-new-york-city-a-prospective-cohort-study.html 2020-05-21T17:13:51.8850000Z https://www.medicinesresources.nhs.uk/nasal-gene-expression-of-angiotensin-converting-enzyme-2-in-children-and-adults.html 2020-05-21T17:15:21.6440000Z https://www.medicinesresources.nhs.uk/valproate-pregnancy-prevention-programme-temporary-advice-for-management-during-coronavirus-covid-21.html 2020-05-25T09:22:01.9770000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-evidence-summary-angiotensin-converting-enzyme-inhibitors-aceis-or-angiotensin-receptor-blockers-arbs-in-people-with-or-at-risk-of-covid-19-evidence-summary-es24.html 2020-05-25T09:28:16.9430000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-evidence-summary-long-term-use-of-non-steroidal-anti-inflammatory-drugs-nsaids-for-people-with-or-at-risk-of-covid-19-evidence-summary-es25.html 2020-05-25T10:33:57.9740000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-evidence-summary-anakinra-for-covid-19-associated-secondary-haemophagocytic-lymphohistiocytosis-evidence-summary-es26.html 2020-05-25T10:37:02.3960000Z https://www.medicinesresources.nhs.uk/effect-of-nivolumab-vs-bevacizumab-in-patients-with-recurrent-glioblastoma-the-checkmate-143-phase-3-randomized-clinical-trial.html 2020-05-22T14:47:12.0690000Z https://www.medicinesresources.nhs.uk/positive-phase-iib-iii-study-data-for-filgotinib-in-the-treatment-of-moderately-to-severely-active-ulcerative-colitis.html 2020-05-22T16:26:19.9840000Z https://www.medicinesresources.nhs.uk/trastuzumab-deruxtecan-granted-orphan-drug-designation-in-the-us-for-the-treatment-of-gastric-cancer.html 2020-05-22T16:25:42.2980000Z https://www.medicinesresources.nhs.uk/pooled-phase-iii-open-label-extension-data-reinforce-safety-of-satralizumab-in-neuromyelitis-optica-spectrum-disorder.html 2020-05-22T16:25:05.0720000Z https://www.medicinesresources.nhs.uk/us-fda-approves-apomorphine-sublingual-film-kynmobi-for-the-treatment-of-parkinsons-disease-off-episodes.html 2020-05-22T14:52:49.3470000Z https://www.medicinesresources.nhs.uk/us-fda-approves-deferiprone-ferriprox-twice-daily-tablets-for-treatment-of-iron-overload-due-to-thalassemia-syndromes.html 2020-05-22T14:54:18.2520000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-issues-positive-opinion-on-application-for-orphan-designation-of-nomacopan-for-bullous-pemphigoid.html 2020-05-22T14:56:35.7670000Z https://www.medicinesresources.nhs.uk/low-dose-aspirin-for-prevention-of-pre-eclampsia-when-over-the-counter-just-isnt.html 2020-05-22T14:57:36.9290000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-new-dedicated-yellow-card-reporting-site-for-medicines-and-medical-devices.html 2020-05-25T10:37:45.8540000Z https://www.medicinesresources.nhs.uk/atezolizumab-with-nab-paclitaxel-for-treating-pd-l1-positive-triple-negative-advanced-breast-cancer-final-appraisal-determination.html 2020-05-22T16:22:11.4960000Z https://www.medicinesresources.nhs.uk/university-of-oxford-covid-19-vaccine-trial-to-include-children-and-older-adults.html 2020-05-22T15:00:47.7960000Z https://www.medicinesresources.nhs.uk/trial-of-rapid-coronavirus-test-launched-in-hampshire.html 2020-05-22T16:19:40.0410000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-pilot-england-21-may-2020.html 2020-05-22T15:02:43.2820000Z https://www.medicinesresources.nhs.uk/government-to-offer-antibody-tests-to-health-and-social-care-staff-and-patients-in-england.html 2020-05-25T10:43:03.4060000Z https://www.medicinesresources.nhs.uk/update-to-supply-disruption-alert-on-neuromuscular-blocking-agents-atracurium-cisatracurium-and-rocuronium.html 2020-05-25T10:52:11.1730000Z https://www.medicinesresources.nhs.uk/criteria-for-pharmacist-provisional-registration-agreed.html 2020-05-22T15:07:47.0370000Z https://www.medicinesresources.nhs.uk/what-products-or-interventions-are-available-to-aid-medication-adherence.html 2020-05-25T10:56:49.1540000Z https://www.medicinesresources.nhs.uk/care-home-resource-hub.html 2020-05-25T10:59:26.4230000Z https://www.medicinesresources.nhs.uk/reappraisal-of-the-treatment-duration-of-antibiotic-regimens-for-acute-uncomplicated-cystitis-in-adult-women-a-systematic-review-and-network-meta-analysis-of-61-randomised-clinical-trials.html 2020-05-22T16:34:00.8700000Z https://www.medicinesresources.nhs.uk/features-of-20-133-uk-patients-in-hospital-with-covid-19-using-the-isaric-who-clinical-characterisation-protocol-prospective-observational-cohort-study.html 2020-05-25T11:06:49.3760000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-or-chloroquine-with-or-without-a-macrolide-for-treatment-of-covid-19-a-multinational-registry-analysis.html 2020-05-25T11:07:43.8280000Z https://www.medicinesresources.nhs.uk/safety-tolerability-and-immunogenicity-of-a-recombinant-adenovirus-type-5-vectored-covid-19-vaccine-a-dose-escalation-open-label-non-randomised-first-in-human-trial.html 2020-05-22T16:37:47.2260000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-308-may-2020.html 2020-05-25T11:12:36.1060000Z https://www.medicinesresources.nhs.uk/urinary-tract-infections-in-children.html 2020-05-22T16:39:39.9040000Z https://www.medicinesresources.nhs.uk/review-finds-children-half-as-likely-to-catch-coronavirus-as-adults.html 2020-05-22T16:40:43.9690000Z https://www.medicinesresources.nhs.uk/covid-19-and-thrombosis-what-do-we-know-about-the-risks-and-treatment.html 2020-05-22T16:41:45.6680000Z https://www.medicinesresources.nhs.uk/phe-evaluations-find-two-covid-19-antibody-tests-are-highly-specific-but-vary-in-sensitivity.html 2020-05-22T16:44:56.8390000Z https://www.medicinesresources.nhs.uk/public-inquiry-into-uks-response-to-covid-19.html 2020-05-22T16:43:25.1960000Z https://www.medicinesresources.nhs.uk/diprivan-propofol-10-mg-ml-1-emulsion-for-injection-or-infusion-interim-supply-of-panamanian-stock-to-mitigate-supply-disruption.html 2020-05-26T11:03:47.4020000Z https://www.medicinesresources.nhs.uk/propofol-10-mg-ml-1-emulsion-for-injection-infusion-interim-supply-of-sweden-stock-to-mitigate-supply-disruption.html 2020-05-26T11:03:18.8630000Z https://www.medicinesresources.nhs.uk/midazolam-1mg-ml-solution-for-injection-or-infusion-supply-disruption-interim-supply-of-french-stock-to-mitigate-supply-disruption.html 2020-05-26T11:05:02.3080000Z https://www.medicinesresources.nhs.uk/esmeron-rocuronium-bromide-10mg-ml-solution-for-injection-supply-of-some-packs-originally-intended-for-australia.html 2020-05-26T11:08:51.0290000Z https://www.medicinesresources.nhs.uk/ioversol-optiray-300-mg-iodine-ml-100ml-syringe-and-bottle-shortage.html 2020-05-26T11:11:44.1750000Z https://www.medicinesresources.nhs.uk/calrecia-calcium-chloride-100mmol-l-solution-for-infusion-interim-supply-of-stock-from-other-european-countries-to-mitigate-supply-disruption.html 2020-05-26T11:13:55.7240000Z https://www.medicinesresources.nhs.uk/sirturo100-mg-bedaquiline-interim-supply-of-irish-stock-to-mitigate-supply-disruption.html 2020-05-26T11:15:08.9710000Z https://www.medicinesresources.nhs.uk/pancuronium-bromide-2mg-ml-temporary-supply-of-alternative-us-product-10mg-10ml-1mg-ml-multiple-dose-vials.html 2020-05-26T11:16:23.6460000Z https://www.medicinesresources.nhs.uk/requip-ropinorole-hydrochloride-tablets-important-changes-to-the-colour-of-carton-and-blister-packs.html 2020-05-26T11:17:55.0070000Z https://www.medicinesresources.nhs.uk/polivy-polatuzumab-vedotin-140mg-powder-for-concentrate-for-solution-for-injection-temporary-plastic-vial-flip-off-cap-colour.html 2020-05-26T11:18:52.7640000Z https://www.medicinesresources.nhs.uk/estimating-lifetime-benefits-of-comprehensive-disease-modifying-pharmacological-therapies-in-patients-with-heart-failure-with-reduced-ejection-fraction-a-comparative-analysis-of-three-randomised-controlled-trials.html 2020-05-26T16:33:33.9070000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-scientific-opinion-remdesivir-in-the-treatment-of-patients-hospitalised-with-suspected-or-laboratory-confirmed-sars-cov-2-infection-who-meet-the-clinical-criteria.html 2020-06-01T10:50:44.4990000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-for-remdesivir-in-the-treatment-of-covid-19-implementation-of-the-scheme-and-management-of-supply.html 2020-06-01T10:56:35.1680000Z https://www.medicinesresources.nhs.uk/nihr-alert-largest-ever-trial-into-a-rare-cancer-of-the-urinary-system-shows-clear-benefits-of-chemotherapy-after-surgery.html 2020-05-26T15:47:59.4290000Z https://www.medicinesresources.nhs.uk/factors-associated-with-hospital-admission-and-critical-illness-among-5279-people-with-coronavirus-disease-2019-in-new-york-city-prospective-cohort-study.html 2020-05-26T15:49:04.0920000Z https://www.medicinesresources.nhs.uk/incidence-clinical-outcomes-and-transmission-dynamics-of-severe-coronavirus-disease-2019-in-california-and-washington-prospective-cohort-study.html 2020-05-26T15:50:30.0410000Z https://www.medicinesresources.nhs.uk/fluoxetine-to-improve-functional-outcomes-in-patients-after-acute-stroke-the-focus-rct.html 2020-05-26T15:53:19.0080000Z https://www.medicinesresources.nhs.uk/cardiovascular-toxicities-associated-with-hydroxychloroquine-and-azithromycin-an-analysis-of-the-world-health-organization-pharmacovigilance-database.html 2020-07-22T12:56:38.5090000Z https://www.medicinesresources.nhs.uk/resistant-hypertension-and-risk-of-adverse-events-in-individuals-with-type-1-diabetes-a-nationwide-prospective-study.html 2020-05-26T15:56:06.6350000Z https://www.medicinesresources.nhs.uk/statin-use-is-prospectively-associated-with-new-onset-diabetes-after-transplantation-in-renal-transplant-recipients.html 2020-05-26T15:57:31.3090000Z https://www.medicinesresources.nhs.uk/do-underlying-cardiovascular-diseases-have-any-impact-on-hospitalised-patients-with-covid-19.html 2020-05-26T15:59:04.5140000Z https://www.medicinesresources.nhs.uk/remdesivir-for-the-treatment-of-covid-19-preliminary-report.html 2020-08-07T14:49:50.2290000Z https://www.medicinesresources.nhs.uk/are-low-molecular-weight-heparins-preferred-to-unfractionated-heparin-in-people-with-renal-impairment-for-treatment-indications.html 2020-05-26T16:53:15.4410000Z https://www.medicinesresources.nhs.uk/early-observation-and-mitigation-of-challenges-in-diabetes-management-of-covid-19-patients-in-intensive-care-units-icus.html 2020-05-26T16:24:16.5600000Z https://www.medicinesresources.nhs.uk/acute-coronary-syndromes-acs-during-covid-19.html 2020-05-26T16:55:24.1250000Z https://www.medicinesresources.nhs.uk/menopause-and-hormone-therapy-in-the-21st-century-why-promote-transdermal-estradiol-and-progesterone.html 2020-05-26T16:56:48.8680000Z https://www.medicinesresources.nhs.uk/translating-science-on-covid-19-to-improve-clinical-care-and-support-the-public-health-response.html 2020-05-26T16:33:21.1210000Z https://www.medicinesresources.nhs.uk/using-insulin-to-treat-poorly-controlled-type-2-diabetes-in-2020.html 2020-05-26T16:36:56.7510000Z https://www.medicinesresources.nhs.uk/following-up-allogeneic-transplantation-recipients-during-the-covid-19-pandemic.html 2020-05-26T16:38:18.1790000Z https://www.medicinesresources.nhs.uk/hiv-postexposure-prophylaxis-during-covid-19.html 2020-05-26T16:39:17.4290000Z https://www.medicinesresources.nhs.uk/health-care-for-chronic-neurological-patients-after-covid-19.html 2020-05-26T16:40:28.2760000Z https://www.medicinesresources.nhs.uk/tobacco-smoking-and-covid-19-infection.html 2020-05-26T16:41:28.9700000Z https://www.medicinesresources.nhs.uk/covid-19-associated-hyperviscosity-a-link-between-inflammation-and-thrombophilia.html 2020-05-26T16:58:49.9640000Z https://www.medicinesresources.nhs.uk/gbp300-million-additional-funding-for-local-authorities-to-support-new-test-and-trace-service.html 2020-05-26T16:59:05.9330000Z https://www.medicinesresources.nhs.uk/world-health-organisation-who-pauses-hydroxycholoroquine-arm-in-covid-19-trial.html 2020-05-26T17:00:36.0650000Z https://www.medicinesresources.nhs.uk/scope-quality-and-inclusivity-of-clinical-guidelines-produced-early-in-the-covid-19-pandemic-rapid-review.html 2020-06-01T11:06:26.2210000Z https://www.medicinesresources.nhs.uk/covid-19-and-acute-kidney-injury-aki-in-hospital-summary-of-nice-guidelines.html 2020-05-26T17:02:32.1130000Z https://www.medicinesresources.nhs.uk/lyme-borreliosis-diagnosis-and-management.html 2020-05-26T16:47:52.8180000Z https://www.medicinesresources.nhs.uk/us-fda-approves-phexxi-lactic-acid-citric-acid-and-potassium-bitartrate-the-first-non-hormonal-prescription-gel-for-the-prevention-of-pregnancy.html 2020-05-26T17:02:55.3270000Z https://www.medicinesresources.nhs.uk/larotrectinib-for-treating-ntrk-fusion-positive-solid-tumours-guidance-ta630.html 2020-06-01T10:32:13.5850000Z https://www.medicinesresources.nhs.uk/revised-spc-singulair-montelukast-preparations.html 2020-05-27T14:50:19.2190000Z https://www.medicinesresources.nhs.uk/revised-spc-clexane-enoxaparin-preparations.html 2020-05-27T14:52:46.6860000Z https://www.medicinesresources.nhs.uk/revised-spc-tildiem-diltiazem-modified-release-tablets.html 2020-05-27T14:54:38.4390000Z https://www.medicinesresources.nhs.uk/revised-spc-equasym-xl-methylphenidate-capsules.html 2020-05-27T14:57:54.1710000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-caprelsa-vandetanib-healthcare-professional-cover-letter.html 2020-05-27T15:57:34.9110000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-mayzent-siponimod-prescriber-checklist.html 2020-05-28T08:50:48.7900000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-evenity-romosozumab-prescriber-guide.html 2020-05-27T15:09:30.2740000Z https://www.medicinesresources.nhs.uk/effect-of-postoperative-continuation-of-antibiotic-prophylaxis-on-the-incidence-of-surgical-site-infection-a-systematic-review-and-meta-analysis.html 2020-05-27T15:13:40.5860000Z https://www.medicinesresources.nhs.uk/low-molecular-weight-heparins-should-treatment-doses-be-used-in-patients-with-renal-impairment.html 2020-06-01T10:37:11.8500000Z https://www.medicinesresources.nhs.uk/are-we-repeating-mistakes-of-the-past-a-review-of-the-evidence-for-esketamine.html 2020-05-28T09:00:37.8830000Z https://www.medicinesresources.nhs.uk/dtb-select-patiromer-plus-spironolactone-in-resistant-hypertension-and-ckd.html 2020-06-01T10:40:49.3970000Z https://www.medicinesresources.nhs.uk/dtb-select-copd-effect-of-metoprolol-in-people-with-no-proven-cardiac-indication.html 2020-06-01T10:41:29.0900000Z https://www.medicinesresources.nhs.uk/what-is-the-dose-of-folic-acid-to-use-with-methotrexate-therapy-for-rheumatoid-arthritis.html 2020-06-01T10:37:53.9070000Z https://www.medicinesresources.nhs.uk/safety-tolerability-and-efficacy-of-viltolarsen-in-boys-with-duchenne-muscular-dystrophy-amenable-to-exon-53-skipping-a-phase-2-randomized-clinical-trial.html 2020-05-27T15:32:39.3650000Z https://www.medicinesresources.nhs.uk/comparison-of-3-treatment-strategies-for-medication-overuse-headache-a-randomized-clinical-trial.html 2020-05-27T15:34:46.2140000Z https://www.medicinesresources.nhs.uk/effect-of-antihypertensive-medication-reduction-vs-usual-care-on-short-term-blood-pressure-control-in-patients-with-hypertension-aged-80-years-and-older-the-optimise-randomized-clinical-trial.html 2020-05-27T15:37:11.1150000Z https://www.medicinesresources.nhs.uk/multicenter-study-of-risk-adapted-therapy-with-dose-adjusted-epoch-r-in-adults-with-untreated-burkitt-lymphoma.html 2020-07-16T11:22:22.8180000Z https://www.medicinesresources.nhs.uk/effect-of-doxycycline-on-aneurysm-growth-among-patients-with-small-infrarenal-abdominal-aortic-aneurysms-a-randomized-clinical-trial.html 2020-05-27T15:40:13.5710000Z https://www.medicinesresources.nhs.uk/evaluation-of-the-efficacy-and-safety-of-deferiprone-compared-with-deferasirox-in-paediatric-patients-with-transfusion-dependent-haemoglobinopathies-deep-2-a-multicentre-randomised-open-label-non-inferiority-phase-3-trial.html 2020-05-27T15:41:34.8970000Z https://www.medicinesresources.nhs.uk/the-effect-of-liraglutide-on-blockade-for-preventing-variceal-bleeding-a-case-series.html 2020-05-27T15:43:12.2760000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-new-drug-application-to-fda-for-voclosporin-for-lupus-nephritis.html 2020-05-27T15:44:17.3960000Z https://www.medicinesresources.nhs.uk/fda-approve-nivolumab-plus-ipilimumab-for-first-line-treatment-of-metastatic-or-recurrent-non-small-cell-lung-cancer.html 2020-05-27T15:45:45.3450000Z https://www.medicinesresources.nhs.uk/choline-chloride-receives-fast-track-designation-from-fda-for-intestinal-failure-associated-liver-disease.html 2020-05-27T15:48:26.6440000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-to-lumasiran-for-primary-hyperoxaluria-type-1.html 2020-05-27T15:49:36.8440000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-efgartigimod-for-myasthenia-gravis-in-late-stage-trial.html 2020-05-27T15:50:50.7670000Z https://www.medicinesresources.nhs.uk/fda-approve-dupilumab-for-atopic-dermatitis-in-children-aged-6-11-years.html 2020-05-27T15:52:28.3350000Z https://www.medicinesresources.nhs.uk/covid-19-coagulopathy-an-evolving-story.html 2020-05-27T15:53:48.9460000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-ribociclib-in-breast-cancer.html 2020-05-27T15:54:47.9440000Z https://www.medicinesresources.nhs.uk/advances-in-the-diagnosis-of-inherited-neuromuscular-diseases-and-implications-for-therapy-development.html 2020-05-27T15:56:21.0550000Z https://www.medicinesresources.nhs.uk/the-covid-19-pandemic-financial-inequality-and-mental-health.html 2020-05-27T15:57:41.7390000Z https://www.medicinesresources.nhs.uk/may-bnf-bnfc-newsletter-1.html 2020-06-01T09:48:46.7090000Z https://www.medicinesresources.nhs.uk/revised-spcs-colomycin-1-and-2-million-international-units-iu-powder-for-solution-for-injection-infusion-or-inhalation.html 2020-06-01T09:52:03.7180000Z https://www.medicinesresources.nhs.uk/revised-spc-bonjela-lidocaine-cetylpyridinium-junior-gel.html 2020-06-01T09:54:44.7540000Z https://www.medicinesresources.nhs.uk/revised-spc-ruconest-conestat-alfa-2100-u-powder-for-solution-for-injection.html 2020-05-28T17:20:40.7440000Z https://www.medicinesresources.nhs.uk/prep-to-be-phased-into-routine-commissioning-across-england-during-2020-2021.html 2020-05-28T17:22:30.8590000Z https://www.medicinesresources.nhs.uk/acute-on-chronic-liver-failure.html 2020-08-10T12:11:04.2070000Z https://www.medicinesresources.nhs.uk/atezolizumab-with-carboplatin-and-etoposide-for-untreated-extensive-stage-small-cell-lung-cancer-final-appraisal-document.html 2020-05-28T17:25:01.7630000Z https://www.medicinesresources.nhs.uk/small-droplet-aerosols-in-poorly-ventilated-spaces-and-sars-cov-2-transmission.html 2020-05-28T17:26:38.7790000Z https://www.medicinesresources.nhs.uk/clinical-practice-guideline-for-systemic-antifungal-prophylaxis-in-pediatric-patients-with-cancer-and-hematopoietic-stem-cell-transplantation-recipients.html 2020-07-08T14:45:26.5810000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-commissions-independent-research-to-prepare-for-real-world-monitoring-of-covid-19-vaccines.html 2020-05-28T17:33:36.0920000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-publishes-two-scientific-articles-outlining-importance-of-early-interactions-as-an-opportunity-to-improve-generation-of-evidence-required-for-bringing-innovation-to-patients.html 2020-05-28T17:34:36.9670000Z https://www.medicinesresources.nhs.uk/european-medicines-regulatory-network-fully-mobilised-in-fight-against-covid-19.html 2020-05-28T17:36:08.8740000Z https://www.medicinesresources.nhs.uk/covid-19-has-ebm-been-replaced-by-hype-based-medicine.html 2020-05-28T18:59:31.4490000Z https://www.medicinesresources.nhs.uk/government-launches-nhs-test-and-trace-service.html 2020-05-28T17:42:02.3340000Z https://www.medicinesresources.nhs.uk/company-led-drug-alert-duavive-conjugated-oestrogen-bazedoxifene-acetate-0-45mg-20mg-modified-release-tablets-eu-1-14-960-001.html 2020-05-28T17:44:09.5620000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-sodium-benzoate-amzoate-2g-in-10-ml-sterile-solution-for-injection-el-20-a-24.html 2020-05-28T17:45:36.1660000Z https://www.medicinesresources.nhs.uk/can-the-uk-emulate-the-south-korean-approach-to-covid-19.html 2020-05-28T17:47:00.8570000Z https://www.medicinesresources.nhs.uk/research-on-covid-19-is-suffering-imperfect-incentives-at-every-stage.html 2020-05-28T17:49:26.8000000Z https://www.medicinesresources.nhs.uk/underscoring-the-importance-of-allopurinol-in-treating-gout-results-of-a-food-and-drug-administration-mandated-safety-trial.html 2020-05-28T17:51:45.8190000Z https://www.medicinesresources.nhs.uk/cloth-masks-may-prevent-transmission-of-covid-19-an-evidence-based-risk-based-approach.html 2020-05-28T17:52:50.2810000Z https://www.medicinesresources.nhs.uk/european-governments-halt-use-of-hydroxychloroquine-to-treat-covid-19-patients-as-safety-concerns-grow.html 2020-06-01T09:59:55.2300000Z https://www.medicinesresources.nhs.uk/fda-finds-high-levels-of-carcinogen-ndma-in-some-metformin-products-in-us.html 2020-05-28T17:55:29.6480000Z https://www.medicinesresources.nhs.uk/positive-data-from-dreamm-2-and-dreamm-6-trials-of-belantamab-mafodotin-in-patients-with-relapsed-refractory-multiple-myeloma-presented-at-conference.html 2020-05-28T17:58:39.4080000Z https://www.medicinesresources.nhs.uk/post-hoc-analysis-of-phase-iii-asclepios-i-and-ii-trials-of-ofatumumab-in-treatment-of-relapsing-multiple-sclerosis-reported-at-conference.html 2020-05-28T18:00:08.1310000Z https://www.medicinesresources.nhs.uk/genentech-announces-positive-data-from-phase-iii-archway-study-of-port-delivery-system-pds-for-ranibizumab-in-treatment-of-neovascular-age-related-macular-degeneration.html 2020-05-28T18:01:29.2900000Z https://www.medicinesresources.nhs.uk/mycobacterium-tuberculosis-bloodstream-infection-prevalence-diagnosis-and-mortality-risk-in-seriously-ill-adults-with-hiv-a-systematic-review-and-meta-analysis-of-individual-patient-data.html 2020-05-28T18:09:06.6710000Z https://www.medicinesresources.nhs.uk/impact-of-cardiovascular-disease-and-cardiac-injury-on-in-hospital-mortality-in-patients-with-covid-19-a-systematic-review-and-meta-analysis.html 2020-05-28T18:12:00.7490000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-or-chloroquine-for-treatment-or-prophylaxis-of-covid-19-a-living-systematic-review.html 2020-05-28T18:13:19.8360000Z https://www.medicinesresources.nhs.uk/national-regional-and-worldwide-epidemiology-of-psoriasis-systematic-analysis-and-modelling-study.html 2020-05-28T18:50:19.0020000Z https://www.medicinesresources.nhs.uk/remdesivir-for-5-or-10-days-in-patients-with-severe-covid-19.html 2020-08-07T14:54:05.2290000Z https://www.medicinesresources.nhs.uk/ascend-phase-iii-randomized-trial-of-acalabrutinib-versus-idelalisib-plus-rituximab-or-bendamustine-plus-rituximab-in-relapsed-or-refractory-chronic-lymphocytic-leukemia.html 2020-07-08T14:37:05.8410000Z https://www.medicinesresources.nhs.uk/presymptomatic-sars-cov-2-infections-and-transmission-in-a-skilled-nursing-facility.html 2020-08-07T14:50:52.4050000Z https://www.medicinesresources.nhs.uk/hospitalization-and-mortality-among-black-patients-and-white-patients-with-covid-19.html 2020-08-10T12:13:09.5380000Z https://www.medicinesresources.nhs.uk/loss-of-smell-and-taste-in-2013-european-patients-with-mild-to-moderate-covid-19.html 2020-05-28T18:28:49.3710000Z https://www.medicinesresources.nhs.uk/risk-for-covid-19-resurgence-related-to-duration-and-effectiveness-of-physical-distancing-in-ontario-canada.html 2020-05-28T18:30:11.3630000Z https://www.medicinesresources.nhs.uk/financial-ties-between-leaders-of-influential-us-professional-medical-associations-and-industry-cross-sectional-study.html 2020-05-28T18:32:29.0860000Z https://www.medicinesresources.nhs.uk/invasive-breast-cancer-and-breast-cancer-mortality-after-ductal-carcinoma-in-situ-in-women-attending-for-breast-screening-in-england-1988-2014-population-based-observational-cohort-study.html 2020-05-28T18:33:57.1880000Z https://www.medicinesresources.nhs.uk/revised-spc-micardisplus-80-mg-12-5-mg-telmisartan-hydrochlorothiazide-tablets.html 2020-05-29T14:23:47.8090000Z https://www.medicinesresources.nhs.uk/revised-spc-kineret-anakinra-100-mg-solution-for-injection-in-a-pre-filled-syringe.html 2020-05-29T14:25:00.7860000Z https://www.medicinesresources.nhs.uk/revised-spc-mirena-levonorgestrel-20-micrograms-24-hours-intrauterine-delivery-system.html 2020-05-29T14:26:09.8350000Z https://www.medicinesresources.nhs.uk/new-product-amoxicillin-1000mg-dispersible-tablets-sigma-pharmaceuticals-plc.html 2020-05-29T14:27:19.0880000Z https://www.medicinesresources.nhs.uk/revised-spc-klean-prep-69g-sachet-powder-for-oral-solution.html 2020-05-29T14:28:38.1710000Z https://www.medicinesresources.nhs.uk/supply-disruption-alert-zyban-r-bupropion-hydrochloride-150mg-prolonged-release-tablets.html 2020-06-01T08:43:14.8690000Z https://www.medicinesresources.nhs.uk/supply-disruption-alert-danazol-100mg-and-200mg-capsules.html 2020-06-01T08:46:50.3080000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-to-investigate-combination-of-tocilizumab-and-remdesivir-in-severe-covid-19-pneumonia.html 2020-05-29T14:33:11.7520000Z https://www.medicinesresources.nhs.uk/positive-results-from-phase-iii-trial-of-pembrolizumab-in-microsatellite-instability-high-msi-h-or-mismatch-repair-deficient-dmmr-unresectable-or-metastatic-colorectal-cancer.html 2020-05-29T14:35:19.7690000Z https://www.medicinesresources.nhs.uk/us-fda-grants-fast-track-designation-to-onvansertib-for-treatment-of-kras-mutated-metastatic-colorectal-cancer.html 2020-05-29T14:36:26.0180000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-pilot-28-may-2020.html 2020-05-29T14:37:35.5940000Z https://www.medicinesresources.nhs.uk/independent-sage-publishes-final-report-when-should-a-school-reopen.html 2020-05-29T16:13:29.4940000Z https://www.medicinesresources.nhs.uk/covid-19-test-and-trace-programmes-are-important-but-no-silver-bullet.html 2020-05-29T14:42:23.2330000Z https://www.medicinesresources.nhs.uk/nhs-test-and-trace-how-it-works.html 2020-05-29T14:43:43.2370000Z https://www.medicinesresources.nhs.uk/conducting-clinical-research-during-the-covid-19-pandemic-protecting-scientific-integrity.html 2020-05-29T14:45:21.1710000Z https://www.medicinesresources.nhs.uk/statistics-on-nhs-stop-smoking-services-in-england-april-2019-to-december-2019.html 2020-05-29T14:46:35.8140000Z https://www.medicinesresources.nhs.uk/first-seacole-centre-opens-doors-as-nhs-expands-covid-rehab-services.html 2020-05-29T14:47:49.1730000Z https://www.medicinesresources.nhs.uk/millions-of-patients-benefiting-from-remote-consultations-as-family-doctors-respond-to-covid-19.html 2020-05-29T14:49:11.2710000Z https://www.medicinesresources.nhs.uk/mental-health-apps-to-support-children-and-young-people.html 2020-05-29T16:16:25.4560000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-publishes-covid-19-care-homes-training-resource.html 2020-06-01T08:49:08.3300000Z https://www.medicinesresources.nhs.uk/positive-results-for-osimertinib-in-patients-with-egfr-mutated-lung-cancer.html 2020-05-29T14:55:20.9320000Z https://www.medicinesresources.nhs.uk/covid-19-advice-for-smokers-and-vapers.html 2020-05-29T14:56:38.3000000Z https://www.medicinesresources.nhs.uk/heatwave-plan-for-england.html 2020-06-01T08:52:49.0590000Z https://www.medicinesresources.nhs.uk/hepatitis-c-in-england-2020.html 2020-06-01T09:00:31.6170000Z https://www.medicinesresources.nhs.uk/cancer-registration-statistics-england-2018-final-release.html 2020-05-29T15:00:59.4920000Z https://www.medicinesresources.nhs.uk/can-breastfeeding-mothers-take-ibuprofen.html 2020-06-01T09:01:13.5560000Z https://www.medicinesresources.nhs.uk/enzalutamide-and-survival-in-nonmetastatic-castration-resistant-prostate-cancer.html 2020-08-07T14:32:57.1480000Z https://www.medicinesresources.nhs.uk/oral-relugolix-for-androgen-deprivation-therapy-in-advanced-prostate-cancer.html 2020-08-07T14:33:37.3680000Z https://www.medicinesresources.nhs.uk/trastuzumab-deruxtecan-in-previously-treated-her2-positive-gastric-cancer.html 2020-08-07T14:34:21.6180000Z https://www.medicinesresources.nhs.uk/clinical-impact-of-covid-19-on-patients-with-cancer-ccc19-a-cohort-study.html 2020-06-01T09:16:26.3430000Z https://www.medicinesresources.nhs.uk/covid-19-mortality-in-patients-with-cancer-on-chemotherapy-or-other-anticancer-treatments-a-prospective-cohort-study.html 2020-06-01T09:19:31.6230000Z https://www.medicinesresources.nhs.uk/description-of-covid-19-in-hiv-infected-individuals-a-single-centre-prospective-cohort.html 2020-05-29T16:15:18.2750000Z https://www.medicinesresources.nhs.uk/pembrolizumab-or-placebo-plus-etoposide-and-platinum-as-first-line-therapy-for-extensive-stage-small-cell-lung-cancer-randomized-double-blind-phase-iii-keynote-604-study.html 2020-07-16T11:28:13.1560000Z https://www.medicinesresources.nhs.uk/one-year-persistence-of-potentially-inappropriate-medication-use-in-older-adults-a-population-based-study.html 2020-05-29T16:18:09.7580000Z https://www.medicinesresources.nhs.uk/a-3-year-prospective-study-of-a-multidisciplinary-early-proactive-therapeutic-drug-monitoring-programme-of-infliximab-treatments-in-inflammatory-bowel-disease.html 2020-05-29T16:19:18.8400000Z https://www.medicinesresources.nhs.uk/efficacy-of-savolitinib-vs-sunitinib-in-patients-with-met-driven-papillary-renal-cell-carcinoma-the-savoir-phase-3-randomized-clinical-trial.html 2020-05-29T16:20:45.7770000Z https://www.medicinesresources.nhs.uk/risk-of-major-bleeding-among-users-of-direct-oral-anticoagulants-combined-with-interacting-drugs-a-population-based-nested-case-control-study.html 2020-06-01T09:27:29.0170000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-on-shielding-and-protecting-people-defined-on-medical-grounds-as-extremely-vulnerable.html 2020-06-08T10:20:40.3010000Z https://www.medicinesresources.nhs.uk/one-year-efficacy-and-safety-of-prasugrel-and-ticagrelor-in-patients-with-acute-coronary-syndromes-results-from-a-prospective-and-multicentre-achilles-registry.html 2020-06-01T14:26:44.4640000Z https://www.medicinesresources.nhs.uk/comparative-efficacy-and-safety-of-oral-p2y12-inhibitors-in-acute-coronary-syndrome-network-meta-analysis-of-52-816-patients-from-12-randomized-trials.html 2020-07-16T13:46:38.4840000Z https://www.medicinesresources.nhs.uk/neuroleptic-strategies-for-terminal-agitation-in-patients-with-cancer-and-delirium-at-an-acute-palliative-care-unit-a-single-centre-double-blind-parallel-group-randomised-trial.html 2020-06-01T14:32:49.2590000Z https://www.medicinesresources.nhs.uk/characterization-and-clinical-course-of-1000-patients-with-coronavirus-disease-2019-in-new-york-retrospective-case-series.html 2020-06-01T14:36:50.2530000Z https://www.medicinesresources.nhs.uk/use-of-antipsychotics-and-the-risk-of-acute-respiratory-failure-among-adults-a-disease-risk-score-matched-nested-case-control-study.html 2020-06-01T14:39:28.7430000Z https://www.medicinesresources.nhs.uk/real-world-evaluation-of-the-impact-of-statin-intensity-on-adherence-and-persistence-to-therapy-a-scottish-population-based-study.html 2020-06-01T14:42:12.2640000Z https://www.medicinesresources.nhs.uk/use-of-sodium-glucose-cotransporter-2-inhibitors-and-risk-of-acute-kidney-injury-in-older-adults-with-diabetes-a-population-based-cohort-study.html 2020-06-01T14:44:07.7290000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-2-part-vaccine-containing-zabdeno-and-mvabea-for-prophylaxis-against-zaire-ebolavirus-disease.html 2020-06-01T15:24:26.5860000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-bulevirtide-for-treatment-of-chronic-hepatitis-delta-virus-hdv-infection-in-compensated-liver-disease.html 2020-06-01T14:53:05.1670000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-alpelisib-piqray-for-treatment-of-locally-advanced-or-metastatic-breast-cancer-with-pik3ca-mutation.html 2020-06-01T16:19:04.3830000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-entrectinib-rozlytrek-for-treatment-of-advanced-solid-tumours-and-non-small-cell-lung-cancer-nsclc.html 2020-06-01T15:00:51.8360000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-lefamulin-xenleta-for-treatment-of-community-acquired-pneumonia-in-adults.html 2020-06-01T15:02:20.4530000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-biosimilar-of-trastuzumab-zercepac.html 2020-06-01T15:03:49.4170000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-olaparib-lynparza-for-pancreatic-cancer.html 2020-06-01T15:08:26.6360000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-nintedanib-ofev.html 2020-06-01T15:11:27.3070000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-ixekizumab-taltz.html 2020-06-01T15:13:50.7230000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-tedizolid-sivextro.html 2020-06-01T15:15:43.0240000Z https://www.medicinesresources.nhs.uk/covid-19-reminder-of-the-risks-of-chloroquine-and-hydroxychloroquine.html 2020-06-08T10:24:31.4960000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-oriahnn-elagolix-estradiol-and-norethindrone-acetate-capsules-for-management-of-heavy-menstrual-bleeding-associated-with-uterine-leiomyomas-in-premenopausal-women.html 2020-06-01T15:23:29.6810000Z https://www.medicinesresources.nhs.uk/action-taken-to-halt-sales-of-fingerprick-coronavirus-covid-19-antibody-testing-kits.html 2020-06-01T15:26:17.4920000Z https://www.medicinesresources.nhs.uk/top-nhs-doctor-issues-advice-for-children-going-back-to-school.html 2020-06-01T16:17:42.3120000Z https://www.medicinesresources.nhs.uk/resumption-of-dental-services-in-england.html 2020-06-01T15:33:54.3140000Z https://www.medicinesresources.nhs.uk/accord-withdraws-marketing-authorisation-application-of-erlotinib.html 2020-06-01T15:35:37.5190000Z https://www.medicinesresources.nhs.uk/mylan-ireland-withdraws-marketing-authorisation-application-of-fingolimod-mylan.html 2020-06-08T10:32:14.0740000Z https://www.medicinesresources.nhs.uk/mortality-and-pulmonary-complications-in-patients-undergoing-surgery-with-perioperative-sars-cov-2-infection-an-international-cohort-study.html 2020-06-01T15:42:19.6380000Z https://www.medicinesresources.nhs.uk/physical-distancing-face-masks-and-eye-protection-to-prevent-person-to-person-transmission-of-sars-cov-2-and-covid-19-a-systematic-review-and-meta-analysis-3.html 2020-06-08T09:05:32.6800000Z https://www.medicinesresources.nhs.uk/long-term-rituximab-use-to-maintain-remission-of-antineutrophil-cytoplasmic-antibody-associated-vasculitis.html 2020-06-02T16:14:42.2740000Z https://www.medicinesresources.nhs.uk/evaluation-of-the-safety-and-efficacy-of-immunotherapy-rechallenge-in-patients-with-renal-cell-carcinoma.html 2020-06-02T14:54:04.6260000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-and-risk-factors-associated-with-covid-19-disease-severity-in-patients-with-cancer-in-wuhan-china-a-multicentre-retrospective-cohort-study.html 2020-06-02T14:55:10.3150000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-outcomes-and-risk-factors-for-mortality-in-patients-with-cancer-and-covid-19-in-hubei-china-a-multicentre-retrospective-cohort-study.html 2020-06-02T14:56:26.3240000Z https://www.medicinesresources.nhs.uk/revised-spc-rigevidon-ethinylestradiol-levonorgestrel-tablets.html 2020-06-02T16:16:22.2930000Z https://www.medicinesresources.nhs.uk/new-products-myloxifin-naloxone-hydrochloride-oxycodone-hydrochloride-prolonged-release-tablets-all-strengths.html 2020-06-02T16:18:20.1980000Z https://www.medicinesresources.nhs.uk/revised-spc-erythroped-erythromycin-ethylsuccinate-sf-250mg-5ml.html 2020-06-02T16:29:54.3720000Z https://www.medicinesresources.nhs.uk/revised-spcs-imbruvica-ibrutinib-tablets-all-strengths.html 2020-06-02T16:30:21.2880000Z https://www.medicinesresources.nhs.uk/revised-spc-tygacil-tigecycline-50mg-powder-for-solution-for-infusion.html 2020-06-02T16:21:26.1880000Z https://www.medicinesresources.nhs.uk/nihr-alert-apps-to-help-patients-take-medication-on-time-need-to-be-evaluated-in-a-consistent-way.html 2020-06-02T16:30:46.9990000Z https://www.medicinesresources.nhs.uk/ixekizumab-receives-us-fda-approval-for-the-treatment-of-active-non-radiographic-axial-spondyloarthritis-nr-axspa.html 2020-06-02T16:32:05.0470000Z https://www.medicinesresources.nhs.uk/us-fda-approves-brilinta-ticagrelor-to-reduce-the-risk-of-a-first-heart-attack-or-stroke-in-high-risk-patients-with-coronary-artery-disease.html 2020-06-02T16:32:58.0340000Z https://www.medicinesresources.nhs.uk/us-fda-authorises-company-to-undertake-phase-2-trial-with-rayaldee-calcifediol-extended-release-capsules-as-a-treatment-for-patients-with-mild-to-moderate-covid-19.html 2020-06-02T16:38:12.4730000Z https://www.medicinesresources.nhs.uk/us-fda-approves-tecentriq-atezolizumab-in-combination-with-avastin-bevacizumab-for-unresectable-or-metastatic-hepatocellular-carcinoma-hcc-in-patients-who-have-not-received-previous-systemic-therapy.html 2020-06-02T16:37:50.8740000Z https://www.medicinesresources.nhs.uk/salbutamol-inhaler-prescribing-jumped-60-at-start-of-covid-19-pandemic.html 2020-06-02T16:37:37.5750000Z https://www.medicinesresources.nhs.uk/company-seeks-to-expand-licence-of-rinvoq-upadacitinib-in-the-us-and-eu-to-include-treatment-of-adults-with-active-psoriatic-arthritis.html 2020-06-02T16:37:04.3090000Z https://www.medicinesresources.nhs.uk/palbociclib-unlikely-to-meet-primary-endpoint-in-early-breast-cancer-trial.html 2020-06-02T16:40:08.1130000Z https://www.medicinesresources.nhs.uk/serious-shortage-protocol-05-ssp05-fluoxetine-10mg-tablets-extended-from-12th-june-2020-to-11th-september-2020.html 2020-06-02T16:40:43.5270000Z https://www.medicinesresources.nhs.uk/fremanezumab-for-preventing-migraine-guidance-ta631.html 2020-06-08T08:47:12.4790000Z https://www.medicinesresources.nhs.uk/revised-spc-kiovig-human-normal-immunoglobulin-solution-for-infusion.html 2020-06-03T14:38:55.8400000Z https://www.medicinesresources.nhs.uk/revised-spc-perjeta-pertuzumab-concentrate-for-solution-for-infusion.html 2020-06-03T14:52:57.9940000Z https://www.medicinesresources.nhs.uk/update-early-access-to-medicines-scheme-for-remdesivir-in-the-treatment-of-covid-19-implementation-of-the-scheme-and-management-of-supply.html 2020-06-08T08:52:38.3240000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-beovu-brolucizumab-patient-guide-to-therapy.html 2020-06-03T14:57:50.6710000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-truxima-rituximab-patient-alert-card.html 2020-06-03T14:59:53.7500000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-myalepta-metreleptin-healthcare-professional-guide.html 2020-06-03T15:51:39.7880000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-sprayvato-esketamine-nasal-spray-healthcare-professional-guide.html 2020-06-03T15:52:41.6030000Z https://www.medicinesresources.nhs.uk/electroconvulsive-therapy-for-depression-a-review-of-the-quality-of-ect-versus-sham-ect-trials-and-meta-analyses.html 2020-06-03T15:09:36.8620000Z https://www.medicinesresources.nhs.uk/effect-of-low-dose-aspirin-on-health-outcomes-an-umbrella-review-of-systematic-reviews-and-meta-analyses.html 2020-06-03T15:47:45.5930000Z https://www.medicinesresources.nhs.uk/regulatory-approval-characteristics-of-antimicrobial-versus-non-antimicrobial-products-1984-2018-an-evaluation-of-food-and-drug-administration-flexibilities.html 2020-06-03T15:14:45.6500000Z https://www.medicinesresources.nhs.uk/association-between-thrombolytic-door-to-needle-time-and-1-year-mortality-and-readmission-in-patients-with-acute-ischemic-stroke.html 2020-06-03T15:16:27.6450000Z https://www.medicinesresources.nhs.uk/effects-of-non-pharmaceutical-interventions-on-covid-19-cases-deaths-and-demand-for-hospital-services-in-the-uk-a-modelling-study.html 2020-06-03T15:54:47.6240000Z https://www.medicinesresources.nhs.uk/effect-of-c-reactive-protein-guided-antibiotic-treatment-duration-7-day-treatment-or-14-day-treatment-on-30-day-clinical-failure-rate-in-patients-with-uncomplicated-gram-negative-bacteremia-a-randomized-clinical-trial.html 2020-06-03T15:19:27.4550000Z https://www.medicinesresources.nhs.uk/ibuprofen-to-be-tested-in-clinical-trial-in-uk-for-treating-patients-with-respiratory-distress-due-tocovid-19.html 2020-06-03T15:56:19.3960000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-ozanimod-in-trial-investigating-use-in-moderate-to-severe-ulcerative-colitis.html 2020-06-03T15:23:08.0500000Z https://www.medicinesresources.nhs.uk/fda-to-review-naxitamab-for-use-in-neuroblastoma-under-priority-review-process.html 2020-06-03T15:24:04.2240000Z https://www.medicinesresources.nhs.uk/congenital-syphilis-the-great-imitator-case-report-and-review.html 2020-06-03T15:25:15.6990000Z https://www.medicinesresources.nhs.uk/getting-the-best-from-your-pharmacy-team-during-covid-19-a-guide-for-unpaid-carers.html 2020-06-03T15:26:27.7800000Z https://www.medicinesresources.nhs.uk/principles-of-safe-video-consulting-in-general-practice-during-covid-19.html 2020-06-03T15:29:10.5360000Z https://www.medicinesresources.nhs.uk/isatuximab-approved-for-use-in-eu-for-multiple-myeloma.html 2020-06-03T15:30:24.1350000Z https://www.medicinesresources.nhs.uk/sulopenem-fails-to-meet-primary-endpoint-in-phase-iii-trial.html 2020-06-03T15:31:34.8090000Z https://www.medicinesresources.nhs.uk/metronidazole-is-it-safe-to-use-with-breastfeeding.html 2020-06-08T08:59:37.9500000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-how-to-self-isolate-when-you-travel-to-the-uk.html 2020-06-08T08:35:49.2650000Z https://www.medicinesresources.nhs.uk/revised-spcs-cabometyx-cabozantinib-film-coated-tablets-all-strengths.html 2020-06-04T17:20:53.5990000Z https://www.medicinesresources.nhs.uk/revised-spcs-jakavi-ruxolitinib-tablets-all-strengths.html 2020-06-04T15:38:22.1640000Z https://www.medicinesresources.nhs.uk/revised-spc-adcetris-brentuximab-vedotin-50-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-06-04T15:39:25.1500000Z https://www.medicinesresources.nhs.uk/revised-spc-cometriq-cabozantinib-20-mg-hard-capsules.html 2020-06-04T15:41:09.0480000Z https://www.medicinesresources.nhs.uk/switching-from-doxazosin-xl-tablets-to-doxazosin-standard-release-tablets.html 2020-06-08T08:23:08.5160000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-may-2020.html 2020-06-08T08:30:09.4140000Z https://www.medicinesresources.nhs.uk/incorrect-penicillin-allergies-labels-fuel-antibiotic-resistance.html 2020-06-04T15:44:08.8110000Z https://www.medicinesresources.nhs.uk/nhs-urges-trusts-to-raise-awareness-around-covid-19.html 2020-06-04T15:45:04.0510000Z https://www.medicinesresources.nhs.uk/cardiovascular-consequences-of-acute-kidney-injury.html 2020-08-10T12:12:10.9620000Z https://www.medicinesresources.nhs.uk/bedbugs.html 2020-08-20T12:24:30.6030000Z https://www.medicinesresources.nhs.uk/isatuximab-plus-pomalidomide-and-dexamethasone-for-treating-relapsed-and-refractory-multiple-myeloma-appraisal-consultation-document.html 2020-06-04T17:27:32.8420000Z https://www.medicinesresources.nhs.uk/innovation-and-inspiration-how-providers-are-responding-to-coronavirus-covid-19.html 2020-06-04T15:48:37.7150000Z https://www.medicinesresources.nhs.uk/managing-access-to-advanced-therapy-medicinal-products-challenges-for-nhs-wales.html 2020-06-04T15:49:39.8490000Z https://www.medicinesresources.nhs.uk/covid-19-how-does-the-nhs-test-and-trace-service-work.html 2020-06-04T15:50:36.6030000Z https://www.medicinesresources.nhs.uk/head-to-head-should-governments-continue-lockdown-to-slow-the-spread-of-covid-19.html 2020-06-04T15:51:28.9280000Z https://www.medicinesresources.nhs.uk/bmj-feature-even-covid-19-cant-kill-the-anti-vaccination-movement.html 2020-06-04T15:52:28.9940000Z https://www.medicinesresources.nhs.uk/prevalence-of-asymptomatic-sars-cov-2-infection-a-narrative-review.html 2020-06-04T15:53:32.1200000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-filing-new-drug-application-for-tivozanib-as-a-treatment-of-relapsed-or-refractory-renal-cell-carcinoma.html 2020-06-04T15:54:35.4730000Z https://www.medicinesresources.nhs.uk/positive-data-reported-from-phase-2b-study-of-gusacitinib-in-patients-with-chronic-hand-eczema.html 2020-06-04T15:55:21.3300000Z https://www.medicinesresources.nhs.uk/new-data-from-two-phase-iii-trials-discover-1-and-discover-2-of-guselkumab-demonstrated-improvements-in-multiple-clinical-outcomes-in-patients-with-active-psoriatic-arthritis.html 2020-06-04T15:56:36.6640000Z https://www.medicinesresources.nhs.uk/fda-extends-review-of-supplemental-biologics-license-application-for-ofatumumab-for-relapsing-multiple-sclerosis-by-three-months.html 2020-06-04T15:57:41.2500000Z https://www.medicinesresources.nhs.uk/durable-efficacy-and-consistent-safety-profile-at-52-weeks-in-finch-1-and-3-studies-of-filgotinib-in-rheumatoid-arthritis.html 2020-06-04T17:34:38.5980000Z https://www.medicinesresources.nhs.uk/global-antimicrobial-resistance-and-use-surveillance-system-glass-report-early-implementation-2020.html 2020-06-04T15:59:23.7880000Z https://www.medicinesresources.nhs.uk/rituximab-for-high-risk-mature-b-cell-non-hodgkins-lymphoma-in-children.html 2020-08-07T14:01:18.8750000Z https://www.medicinesresources.nhs.uk/a-randomized-trial-of-hydroxychloroquine-as-postexposure-prophylaxis-for-covid-19.html 2020-08-07T14:55:02.1470000Z https://www.medicinesresources.nhs.uk/fixed-dose-combination-bictegravir-emtricitabine-and-tenofovir-alafenamide-versus-dolutegravir-containing-regimens-for-initial-treatment-of-hiv-1-infection-week-144-results-from-two-randomised-double-blind-multicentre-phase-3-non-inferiority-trials.html 2020-06-04T16:03:25.7080000Z https://www.medicinesresources.nhs.uk/effect-of-convalescent-plasma-therapy-on-time-to-clinical-improvement-in-patients-with-severe-and-life-threatening-covid-19-a-randomized-clinical-trial.html 2020-06-04T17:38:54.3510000Z https://www.medicinesresources.nhs.uk/effect-of-aspirin-vs-placebo-on-the-prevention-of-depression-in-older-people-a-randomized-clinical-trial.html 2020-06-04T17:39:57.5460000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-abrocitinib-in-patients-with-moderate-to-severe-atopic-dermatitis-a-randomized-clinical-trial.html 2020-06-04T17:18:24.1270000Z https://www.medicinesresources.nhs.uk/accuracy-of-blood-pressure-monitors-owned-by-patients-with-hypertension-accu-rate-study-a-cross-sectional-observational-study-in-central-england.html 2020-06-04T17:18:03.5040000Z https://www.medicinesresources.nhs.uk/kawasaki-like-multisystem-inflammatory-syndrome-in-children-during-the-covid-19-pandemic-in-paris-france-prospective-observational-study.html 2020-06-04T17:17:46.7250000Z https://www.medicinesresources.nhs.uk/evaluating-the-credibility-of-anchor-based-estimates-of-minimal-important-differences-for-patient-reported-outcomes-instrument-development-and-reliability-study.html 2020-06-04T17:16:41.4380000Z https://www.medicinesresources.nhs.uk/joint-replacement-primary-hip-knee-and-shoulder-guidance-ng157.html 2020-06-08T07:19:14.2930000Z https://www.medicinesresources.nhs.uk/new-product-tavlesse-fostamatinib.html 2020-06-05T15:46:28.8200000Z https://www.medicinesresources.nhs.uk/revised-spc-solu-medrone-methylprednisolone-40-mg-powder-for-injection.html 2020-06-05T15:49:33.7850000Z https://www.medicinesresources.nhs.uk/revised-spcs-nivestim-filgrastim-solution-for-injection-infusion.html 2020-06-05T15:50:49.2020000Z https://www.medicinesresources.nhs.uk/nihr-alert-patients-are-often-unsatisfied-with-the-explanation-they-receive-when-something-goes-wrong.html 2020-06-05T15:51:52.2160000Z https://www.medicinesresources.nhs.uk/european-commission-grants-marketing-authorisation-for-nepexto-r-biosimilar-etanercept.html 2020-06-05T15:53:20.7810000Z https://www.medicinesresources.nhs.uk/long-term-data-from-phase-iii-studies-of-upadacitinib-in-rheumatoid-arthritis-presented-at-conference.html 2020-06-05T15:54:25.3140000Z https://www.medicinesresources.nhs.uk/european-commission-grants-marketing-authorisation-for-subcutaneous-formulation-of-daratumumab-for-the-treatment-of-multiple-myeloma.html 2020-06-05T15:55:28.0710000Z https://www.medicinesresources.nhs.uk/conducting-clinical-trials-in-heart-failure-during-and-after-the-covid-19-pandemic-an-expert-consensus-position-paper-from-the-heart-failure-association-hfa-of-the-european-society-of-cardiology-esc.html 2020-06-05T15:56:53.3800000Z https://www.medicinesresources.nhs.uk/face-coverings-to-become-compulsory-for-people-using-public-transport.html 2020-06-05T15:58:27.2230000Z https://www.medicinesresources.nhs.uk/diabetes-and-coronary-artery-disease-not-just-a-risk-factor.html 2020-06-05T15:59:55.0310000Z https://www.medicinesresources.nhs.uk/serodiagnostics-for-severe-acute-respiratory-syndrome-related-coronavirus-2.html 2020-06-05T16:01:11.9270000Z https://www.medicinesresources.nhs.uk/analysis-of-death-registrations-not-involving-coronavirus-covid-19-england-and-wales-28-december-2019-to-1-may-2020.html 2020-06-05T17:02:29.8280000Z https://www.medicinesresources.nhs.uk/latest-data-from-the-coronavirus-infection-survey-pilot-suggest-decrease-in-number-of-people-testing-positive.html 2020-06-05T16:05:25.0520000Z https://www.medicinesresources.nhs.uk/authors-retract-lancet-study-indicating-hydroxychloroquine-was-linked-with-higher-death-rates-in-patients-with-covid-19.html 2020-06-05T17:00:51.0240000Z https://www.medicinesresources.nhs.uk/active-case-finding-with-case-management-the-key-to-tackling-the-covid-19-pandemic.html 2020-06-05T16:09:21.0220000Z https://www.medicinesresources.nhs.uk/survey-results-suggest-around-half-of-people-with-cardiovascular-disease-find-it-harder-to-access-treatment-during-the-pandemic.html 2020-06-05T16:11:04.6360000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-approves-ixekizumab-for-the-treatment-of-adults-with-active-axial-spondyloarthritis.html 2020-06-05T16:11:57.4070000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-approves-encorafenib-in-combination-with-cetuximab-for-treatment-of-adults-with-brafv600e-mutant-metastatic-colorectal-cancer.html 2020-06-05T16:12:59.3590000Z https://www.medicinesresources.nhs.uk/national-child-measurement-programme-ncmp-trends-in-child-bmi-between-2006-to-2007-and-2018-to-2019.html 2020-06-05T16:14:14.3840000Z https://www.medicinesresources.nhs.uk/sexual-and-reproductive-health-return-on-investment-tool.html 2020-06-05T16:15:21.0160000Z https://www.medicinesresources.nhs.uk/the-role-of-alcohol-use-and-drinking-patterns-in-socioeconomic-inequalities-in-mortality-a-systematic-review.html 2020-06-05T16:56:53.5700000Z https://www.medicinesresources.nhs.uk/association-of-noninvasive-oxygenation-strategies-with-all-cause-mortality-in-adults-with-acute-hypoxemic-respiratory-failure-a-systematic-review-and-meta-analysis.html 2020-06-05T16:18:45.9520000Z https://www.medicinesresources.nhs.uk/association-of-hypertension-and-antihypertensive-treatment-with-covid-19-mortality-a-retrospective-observational-study.html 2020-06-08T08:08:52.8040000Z https://www.medicinesresources.nhs.uk/association-of-reduced-intensity-conditioning-regimens-with-overall-survival-among-patients-with-non-hodgkin-lymphoma-undergoing-allogeneic-transplant.html 2020-06-05T16:22:03.0360000Z https://www.medicinesresources.nhs.uk/the-virtual-wards-supporting-patients-with-covid-19-in-the-community.html 2020-06-05T16:23:10.4220000Z https://www.medicinesresources.nhs.uk/bma-urges-plan-to-tackle-backlog-of-patients-awaiting-non-covid-treatment.html 2020-06-05T16:24:13.4030000Z https://www.medicinesresources.nhs.uk/revised-spc-glucagen-hypokit-1-mg.html 2020-06-08T15:51:46.8800000Z https://www.medicinesresources.nhs.uk/revised-spc-ovranette-ethinylestradiol-levonorgestrel-tablets.html 2020-06-08T15:54:56.3470000Z https://www.medicinesresources.nhs.uk/new-product-darzalex-1-800-mg-solution-for-injection.html 2020-06-08T15:56:16.1340000Z https://www.medicinesresources.nhs.uk/visiting-healthcare-inpatient-settings-during-the-covid-19-pandemic.html 2020-06-15T12:08:32.6650000Z https://www.medicinesresources.nhs.uk/results-from-laboratory-based-tests-for-covid-19-antibodies-using-capillary-blood-sample-collection-kits-may-not-be-reliable.html 2020-06-15T12:37:01.1110000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-epistatus-midazolam-10mg-ml-oromucosal-solution-multi-dose-bottles-torbay-pharmaceuticals.html 2020-06-08T15:58:03.4280000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-evidence-summary-remdesivir-for-treating-hospitalised-patients-with-suspected-or-confirmed-covid-19-es27.html 2020-06-15T12:37:49.0090000Z https://www.medicinesresources.nhs.uk/determining-the-optimal-strategy-for-reopening-schools-work-and-society-in-the-uk-balancing-earlier-opening-and-the-impact-of-test-and-trace-strategies-with-the-risk-of-occurrence-of-a-secondary-covid-19-pandemic-wave.html 2020-06-08T15:31:36.1220000Z https://www.medicinesresources.nhs.uk/risk-of-early-neurodevelopmental-outcomes-associated-with-prenatal-exposure-to-the-antiepileptic-drugs-most-commonly-used-during-pregnancy-a-french-nationwide-population-based-cohort-study.html 2020-06-08T16:14:42.9570000Z https://www.medicinesresources.nhs.uk/jhacute-toxicity-related-to-misuse-non-medical-use-of-tramadol-experience-of-the-european-drug-emergencies-network-plus-euro-den-plus-project.html 2020-06-08T16:34:32.7840000Z https://www.medicinesresources.nhs.uk/are-high-cost-drug-funding-mechanisms-fit-for-purpose-a-retrospective-study-of-individual-funding-requests-in-an-nhs-tertiary-hospital.html 2020-06-08T16:16:54.3080000Z https://www.medicinesresources.nhs.uk/ripretinib-in-patients-with-advanced-gastrointestinal-stromal-tumours-invictus-a-double-blind-randomised-placebo-controlled-phase-3-trial.html 2020-06-08T15:38:15.5650000Z https://www.medicinesresources.nhs.uk/tafasitamab-plus-lenalidomide-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-l-mind-a-multicentre-prospective-single-arm-phase-2-study.html 2020-06-08T15:39:50.1830000Z https://www.medicinesresources.nhs.uk/remdesivir-in-treatment-of-covid-19-a-systematic-benefit-risk-assessment.html 2020-06-08T15:41:08.9180000Z https://www.medicinesresources.nhs.uk/pharmacogenomics-of-anti-cancer-drugs-personalizing-the-choices-and-dose-to-manage-drug-response.html 2020-06-08T16:20:23.3400000Z https://www.medicinesresources.nhs.uk/innovation-and-inspiration-examples-of-how-providers-are-responding-to-coronavirus-covid-19.html 2020-06-08T15:43:16.6820000Z https://www.medicinesresources.nhs.uk/dtb-prescribing-for-pregnancy-epilepsy.html 2020-06-08T16:23:38.1100000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-recarbrio-imipenem-cilastatin-and-relebactam-for-treatment-of-hospital-acquired-or-ventilator-associated-bacterial-pneumonia.html 2020-06-08T15:46:33.1630000Z https://www.medicinesresources.nhs.uk/caring-for-women-who-are-planning-a-pregnancy-pregnant-or-postpartum-during-the-covid-19-pandemic.html 2020-06-08T15:50:16.9980000Z https://www.medicinesresources.nhs.uk/waiting-for-certainty-on-covid-19-antibody-tests-at-what-cost.html 2020-10-01T13:02:43.0190000Z https://www.medicinesresources.nhs.uk/false-negative-tests-for-sars-cov-2-infection-challenges-and-implications.html 2020-06-08T15:52:36.3900000Z https://www.medicinesresources.nhs.uk/potential-coronavirus-covid-19-symptoms-reported-through-nhs-pathways-and-111-online-6.html 2020-06-08T15:53:30.7820000Z https://www.medicinesresources.nhs.uk/thousands-of-patients-to-benefit-from-nhs-at-home-roll-out.html 2020-06-08T15:54:33.6890000Z https://www.medicinesresources.nhs.uk/extra-mental-health-support-for-pupils-and-teachers.html 2020-06-08T15:56:42.7730000Z https://www.medicinesresources.nhs.uk/covid-19-restoration-of-community-health-services-for-children-and-young-people-second-phase-of-nhs-response.html 2020-06-08T15:57:52.6430000Z https://www.medicinesresources.nhs.uk/estimated-number-of-adults-who-are-morbidly-obese-in-england.html 2020-06-08T15:58:54.4780000Z https://www.medicinesresources.nhs.uk/21-products-reclassified-as-special-containers.html 2020-06-08T16:33:14.5340000Z https://www.medicinesresources.nhs.uk/new-medicines-newsletter-may-2020.html 2020-06-08T16:28:49.7250000Z https://www.medicinesresources.nhs.uk/revised-spcs-dupixent-dupilumab-solution-for-injection-all-products.html 2020-06-09T17:07:39.2500000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-scientific-opinion-nivolumab-for-treatment-of-adult-patients-with-unresectable-advanced-recurrent-or-metastatic-oesophageal-cancer-after-prior-chemotherapy.html 2020-06-15T10:33:33.2710000Z https://www.medicinesresources.nhs.uk/clinical-effectiveness-of-pharmacist-led-versus-conventionally-delivered-antiviral-treatment-for-hepatitis-c-virus-in-patients-receiving-opioid-substitution-therapy-a-pragmatic-cluster-randomised-trial.html 2020-06-09T17:10:00.1460000Z https://www.medicinesresources.nhs.uk/ethnicity-and-outcomes-of-covid-19-patients-in-england.html 2020-06-15T10:04:40.5950000Z https://www.medicinesresources.nhs.uk/inhibition-of-bruton-tyrosine-kinase-in-patients-with-severe-covid-19.html 2020-06-09T15:49:03.7230000Z https://www.medicinesresources.nhs.uk/early-treatment-with-baloxavir-marboxil-in-high-risk-adolescent-and-adult-outpatients-with-uncomplicated-influenza-capstone-2-a-randomised-placebo-controlled-phase-3-trial.html 2020-06-09T17:10:52.0230000Z https://www.medicinesresources.nhs.uk/association-between-mode-of-delivery-among-pregnant-women-with-covid-19-and-maternal-and-neonatal-outcomes-in-spain.html 2020-06-09T15:53:51.5380000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-of-58-children-with-a-pediatric-inflammatory-multisystem-syndrome-temporally-associated-with-sars-cov-2.html 2020-06-09T17:24:54.7640000Z https://www.medicinesresources.nhs.uk/multisystem-inflammatory-syndrome-related-to-covid-19-in-previously-healthy-children-and-adolescents-in-new-york-city.html 2020-06-09T17:13:50.0040000Z https://www.medicinesresources.nhs.uk/risk-of-hospitalization-with-hemorrhage-among-older-adults-taking-clarithromycin-vs-azithromycin-and-direct-oral-anticoagulants.html 2020-06-09T16:14:09.8260000Z https://www.medicinesresources.nhs.uk/characteristics-and-outcomes-of-pregnant-women-admitted-to-hospital-with-confirmed-sars-cov-2-infection-in-uk-national-population-based-cohort-study.html 2020-06-09T17:14:09.4640000Z https://www.medicinesresources.nhs.uk/immunomodulation-by-macrolides-therapeutic-potential-for-critical-care.html 2020-06-09T17:26:09.9290000Z https://www.medicinesresources.nhs.uk/eu-actions-to-support-availability-of-medicines-during-covid-19-pandemic-update-7.html 2020-06-09T16:30:09.7230000Z https://www.medicinesresources.nhs.uk/ema-receives-application-for-conditional-authorisation-of-first-covid-19-treatment-in-the-eu.html 2020-06-15T10:25:28.6160000Z https://www.medicinesresources.nhs.uk/nhs-launches-new-online-support-for-people-with-diabetes-during-the-coronavirus-pandemic.html 2020-06-15T08:47:12.2530000Z https://www.medicinesresources.nhs.uk/covid-19-infection-control-could-cut-community-pharmacy-capacity-for-flu-vaccinations-by-two-thirds.html 2020-06-09T17:27:19.3640000Z https://www.medicinesresources.nhs.uk/cardiovascular-considerations-in-caring-for-pregnant-patients-a-scientific-statement-from-the-american-heart-association.html 2020-08-20T10:36:22.9950000Z https://www.medicinesresources.nhs.uk/department-of-health-and-social-care-rolls-out-testing-in-all-adult-social-care-settings-including-to-people-with-a-learning-disability.html 2020-06-09T16:44:22.3270000Z https://www.medicinesresources.nhs.uk/recurrent-vulvovaginal-candidiasis.html 2020-06-09T16:53:50.7150000Z https://www.medicinesresources.nhs.uk/assessment-and-management-of-adults-with-asthma-during-the-covid-19-pandemic.html 2020-06-09T16:55:14.4740000Z https://www.medicinesresources.nhs.uk/uk-post-brexit-drug-stockpiles-at-risk-amid-virus.html 2020-06-09T17:28:17.2400000Z https://www.medicinesresources.nhs.uk/after-care-needs-of-inpatients-recovering-from-covid-19.html 2020-06-15T10:30:52.9970000Z https://www.medicinesresources.nhs.uk/results-from-phase-iii-trial-of-once-daily-diazoxide-choline-controlled-release-dccr-tablets-for-patients-with-prader-willi-syndrome-pws.html 2020-06-09T17:30:24.4270000Z https://www.medicinesresources.nhs.uk/company-announce-28-day-clinical-outcomes-data-from-mavrilimumab-open-label-treatment-protocol-in-severe-covid-19-pneumonia-and-active-u-s-investigational-new-drug-application-for-phase-2-3-clinical-trial.html 2020-06-09T17:31:21.6760000Z https://www.medicinesresources.nhs.uk/new-molecular-entity-lumasiran-shows-positive-results-in-clinical-trial-for-treatment-of-rare-kidney-stone-disease-primary-hyperoxaluria-type-1-ph1.html 2020-06-09T17:32:13.3210000Z https://www.medicinesresources.nhs.uk/new-molecular-entity-roxadustat-shows-non-inferiority-to-darbepoetin-alfa-for-anaemia-in-non-dialysis-dependent-adults-with-stage-3-5-chronic-kidney-disease.html 2020-06-09T17:33:01.0820000Z https://www.medicinesresources.nhs.uk/early-intervention-of-palliative-care-in-the-emergency-department-during-the-covid-19-pandemic.html 2020-06-10T11:33:20.1650000Z https://www.medicinesresources.nhs.uk/association-of-hydroxychloroquine-with-qtc-interval-in-patients-with-covid-19.html 2020-08-20T11:30:07.6870000Z https://www.medicinesresources.nhs.uk/clinical-practice-and-teaching-of-pharmaceutical-care-procedures-for-obstetric-diseases.html 2020-06-10T11:41:52.4480000Z https://www.medicinesresources.nhs.uk/trastuzumab-emtansine-for-adjuvant-treatment-of-her2-positive-early-breast-cancer-guidance-ta632.html 2020-06-15T09:30:44.5660000Z https://www.medicinesresources.nhs.uk/revised-spc-zebinix-eslicarbazepine-200mg-tablets.html 2020-06-10T12:54:47.8560000Z https://www.medicinesresources.nhs.uk/revised-spc-seroquel-quetiapine-tablets.html 2020-06-10T12:56:05.3510000Z https://www.medicinesresources.nhs.uk/second-update-early-access-to-medicines-scheme-for-remdesivir-in-the-treatment-of-covid-19-implementation-of-the-scheme-and-management-of-supply.html 2020-06-15T09:40:23.0140000Z https://www.medicinesresources.nhs.uk/mucoactive-agents-for-acute-respiratory-failure-in-the-critically-ill-a-systematic-review-and-meta-analysis.html 2020-06-10T12:58:34.5510000Z https://www.medicinesresources.nhs.uk/screening-for-unhealthy-drug-use-updated-evidence-report-and-systematic-review-for-the-us-preventive-services-task-force.html 2020-06-10T15:29:47.2120000Z https://www.medicinesresources.nhs.uk/sofosbuvir-plus-ribavirin-and-sofosbuvir-plus-ledipasvir-in-patients-with-genotype-1-or-3-hepatitis-c-virus-and-severe-renal-impairment-a-multicentre-phase-2b-non-randomised-open-label-study.html 2020-06-10T13:04:47.0180000Z https://www.medicinesresources.nhs.uk/opioid-prescribing-after-childbirth-and-risk-for-serious-opioid-related-events-a-cohort-study.html 2020-06-10T13:07:04.9260000Z https://www.medicinesresources.nhs.uk/association-of-migraine-with-aura-and-other-risk-factors-with-incident-cardiovascular-disease-in-women.html 2020-06-10T15:29:28.9900000Z https://www.medicinesresources.nhs.uk/characteristics-of-registered-clinical-trials-assessing-treatments-for-covid-19-a-cross-sectional-analysis.html 2020-06-10T13:09:41.3480000Z https://www.medicinesresources.nhs.uk/maintenance-of-clinical-remission-in-early-axial-spondyloarthritis-following-certolizumab-pegol-dose-reduction.html 2020-06-10T15:30:29.6500000Z https://www.medicinesresources.nhs.uk/ivacaftor-gains-licence-extension-in-eu.html 2020-06-10T14:22:14.1660000Z https://www.medicinesresources.nhs.uk/covid-19-and-cushing-s-syndrome-recommendations-for-a-special-population-with-endogenous-glucocorticoid-excess.html 2020-06-10T14:23:46.0470000Z https://www.medicinesresources.nhs.uk/pembrolizumab-monotherapy-and-combination-therapy-fails-to-meet-primary-endpoint-in-study-for-advanced-metastatic-urothelial-cancer.html 2020-06-10T14:24:59.5560000Z https://www.medicinesresources.nhs.uk/when-the-dust-settles-preventing-a-mental-health-crisis-in-covid-19-clinicians.html 2020-06-10T14:26:20.7040000Z https://www.medicinesresources.nhs.uk/addressing-the-public-mental-health-challenge-of-covid-19.html 2020-06-10T14:27:37.9110000Z https://www.medicinesresources.nhs.uk/study-launched-to-monitor-prevalence-of-covid-19-in-schools.html 2020-06-10T14:28:44.3370000Z https://www.medicinesresources.nhs.uk/namilumab-and-infliximab-being-tested-as-possible-covid-19-therapy.html 2020-06-10T14:29:33.3930000Z https://www.medicinesresources.nhs.uk/interventions-supporting-long-term-adherence-and-decreasing-cardiovascular-events-after-myocardial-infarction-island-pragmatic-randomised-controlled-trial.html 2020-06-10T15:02:34.3310000Z https://www.medicinesresources.nhs.uk/revised-spc-kenalog-triamcinolone-acetonide-intra-articular-intramuscular-injection.html 2020-06-11T14:31:56.0080000Z https://www.medicinesresources.nhs.uk/revised-spc-libtayo-cemiplimab-350-mg-concentrate-for-solution-for-infusion.html 2020-06-11T16:45:04.5510000Z https://www.medicinesresources.nhs.uk/revised-spcs-tecentriq-atezolizumab-840-and-1200-mg-concentrate-for-solution-for-infusion.html 2020-06-11T14:34:52.4470000Z https://www.medicinesresources.nhs.uk/revised-spc-tybost-cobicistat-150mg-film-coated-tablet.html 2020-06-11T14:36:11.3240000Z https://www.medicinesresources.nhs.uk/update-on-the-flu-vaccination-service-2020-21.html 2020-06-11T16:42:56.5620000Z https://www.medicinesresources.nhs.uk/covid-19-nhse-and-i-issues-guidance-on-minimising-spread-of-infection.html 2020-06-11T16:42:09.4720000Z https://www.medicinesresources.nhs.uk/nhs-waiting-lists-could-hit-10-million-by-end-of-2020.html 2020-06-11T16:41:13.0730000Z https://www.medicinesresources.nhs.uk/provisional-publication-of-never-events-reported-as-occurring-between-1-april-and-30-april-2020.html 2020-06-11T14:41:09.1480000Z https://www.medicinesresources.nhs.uk/nhs-england-announces-more-convenient-cancer-treatment-for-patients-during-covid-19-pandemic.html 2020-06-11T14:42:49.5560000Z https://www.medicinesresources.nhs.uk/down-syndrome.html 2020-10-01T13:07:22.3380000Z https://www.medicinesresources.nhs.uk/intravenous-fluid-therapy-in-children-and-young-people-in-hospital-updated-guidance-ng29.html 2020-06-11T14:46:45.3380000Z https://www.medicinesresources.nhs.uk/tafamidis-for-treating-transthyretin-amyloidosis-with-cardiomyopathy-appraisal-consultation-document.html 2020-06-11T14:48:22.5280000Z https://www.medicinesresources.nhs.uk/new-mims-table-on-glp-1-agonists-for-the-treatment-of-type-ii-diabetes.html 2020-06-11T14:49:36.2600000Z https://www.medicinesresources.nhs.uk/management-of-primary-hepatic-malignancies-during-the-covid-19-pandemic-recommendations-for-risk-mitigation-from-a-multidisciplinary-perspective.html 2020-06-11T14:50:54.3980000Z https://www.medicinesresources.nhs.uk/adult-congenital-heart-disease-and-the-covid-19-pandemic.html 2020-06-11T16:36:00.9120000Z https://www.medicinesresources.nhs.uk/recent-advances-in-percutaneous-coronary-intervention.html 2020-06-11T14:53:26.3310000Z https://www.medicinesresources.nhs.uk/meeting-people-from-outside-your-household-during-covid-19.html 2020-06-11T14:54:37.8030000Z https://www.medicinesresources.nhs.uk/using-socioeconomics-to-counter-health-disparities-arising-from-the-covid-19-pandemic.html 2020-06-11T14:56:16.3800000Z https://www.medicinesresources.nhs.uk/two-year-results-from-arc004-a-follow-on-study-to-phase-3-palisade-trial-of-palforzia-peanut-allergen-powder-in-patients-with-peanut-allergy.html 2020-06-11T14:58:33.9860000Z https://www.medicinesresources.nhs.uk/fda-orphan-drug-designation-granted-to-mitapivat-for-treatment-of-thalassemia.html 2020-06-11T15:00:18.0460000Z https://www.medicinesresources.nhs.uk/pfizer-announces-positive-top-line-results-from-jade-teen-trial-of-abrocitinib-in-adolescents-with-moderate-to-severe-atopic-dermatitis.html 2020-06-11T15:03:15.4800000Z https://www.medicinesresources.nhs.uk/fda-approves-nivolumab-for-treatment-of-patients-with-advanced-oesophageal-squamous-cell-carcinoma-after-prior-fluoropyrimidines-and-platinum-based-chemotherapy.html 2020-06-11T15:31:02.4740000Z https://www.medicinesresources.nhs.uk/health-at-home-how-to-access-nhs-services-online.html 2020-06-11T16:29:57.8600000Z https://www.medicinesresources.nhs.uk/thoracoscopy-and-talc-poudrage-compared-with-intercostal-drainage-and-talc-slurry-infusion-to-manage-malignant-pleural-effusion-the-tapps-rct.html 2020-06-11T15:46:08.2300000Z https://www.medicinesresources.nhs.uk/phase-3-trial-of-rnai-therapeutic-givosiran-for-acute-intermittent-porphyria.html 2020-08-27T14:29:04.2930000Z https://www.medicinesresources.nhs.uk/use-of-personal-protective-equipment-against-coronavirus-disease-2019-by-healthcare-professionals-in-wuhan-china-cross-sectional-study.html 2020-06-11T16:17:40.6900000Z https://www.medicinesresources.nhs.uk/association-of-normal-systolic-blood-pressure-level-with-cardiovascular-disease-in-the-absence-of-risk-factors.html 2020-06-11T15:52:28.9900000Z https://www.medicinesresources.nhs.uk/association-between-adult-acne-and-dietary-behaviors-findings-from-the-nutrinet-sante-prospective-cohort-study.html 2020-06-11T15:54:44.2530000Z https://www.medicinesresources.nhs.uk/assessment-of-incidence-and-risk-factors-of-intracerebral-hemorrhage-among-participants-in-the-framingham-heart-study-between-1948-and-2016.html 2020-06-11T16:14:24.7390000Z https://www.medicinesresources.nhs.uk/revised-spc-xalacom-eye-drops-solution-timolol.html 2020-06-12T13:02:42.2150000Z https://www.medicinesresources.nhs.uk/revised-spcs-braftovi-encorafenib-50-mg-and-75mg-hard-capsules.html 2020-06-12T13:03:58.4360000Z https://www.medicinesresources.nhs.uk/revised-spc-ecalta-anidulafungin-100-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-06-12T13:04:59.4620000Z https://www.medicinesresources.nhs.uk/revised-spcs-lorviqua-lorlatinib-25-mg-and-100mg-film-coated-tablets.html 2020-06-12T13:06:06.4160000Z https://www.medicinesresources.nhs.uk/republished-infant-with-status-epilepticus-secondary-to-systemic-lidocaine-toxicity-from-topical-application.html 2020-06-12T13:07:07.5590000Z https://www.medicinesresources.nhs.uk/caplacizumab-for-treating-adults-experiencing-an-episode-of-acquired-thrombotic-thrombocytopenic-purpura-appraisal-consultation.html 2020-06-12T13:08:12.2410000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-pilot-england-12-june-2020.html 2020-06-12T13:09:01.8020000Z https://www.medicinesresources.nhs.uk/multigroup-adaptively-randomized-trials-are-advantageous-for-comparing-coronavirus-disease-2019-covid-19-interventions.html 2020-06-12T13:10:46.3760000Z https://www.medicinesresources.nhs.uk/readying-the-nhs-and-adult-social-care-in-england-for-covid-19.html 2020-06-12T13:11:48.1770000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-to-review-tralokinumab-for-atopic-dermatitis.html 2020-06-12T13:12:36.8830000Z https://www.medicinesresources.nhs.uk/us-fda-approves-inebilizumab-for-the-treatment-of-neuromyelitis-optica-spectrum-disorder.html 2020-06-12T15:23:41.4600000Z https://www.medicinesresources.nhs.uk/alcohol-attributable-fractions-for-england-an-update.html 2020-06-12T13:14:40.9690000Z https://www.medicinesresources.nhs.uk/new-nhs-england-operational-guidance-from-15-june-2020.html 2020-06-15T08:26:20.3160000Z https://www.medicinesresources.nhs.uk/real-world-budget-impact-of-the-adoption-of-insulin-glargine-biosimilars-in-primary-care-in-england-2015-2018.html 2020-06-15T08:57:23.5690000Z https://www.medicinesresources.nhs.uk/atezolizumab-vemurafenib-and-cobimetinib-as-first-line-treatment-for-unresectable-advanced-brafv600-mutation-positive-melanoma-imspire150-primary-analysis-of-the-randomised-double-blind-placebo-controlled-phase-3-trial.html 2020-06-12T14:53:49.4070000Z https://www.medicinesresources.nhs.uk/cancer-prevention-with-aspirin-in-hereditary-colorectal-cancer-lynch-syndrome-10-year-follow-up-and-registry-based-20-year-data-in-the-capp2-study-a-double-blind-randomised-placebo-controlled-trial.html 2020-06-15T09:01:27.3570000Z https://www.medicinesresources.nhs.uk/covid-19-shielding-guidance-for-children-and-young-people-updated.html 2020-06-12T14:57:40.6390000Z https://www.medicinesresources.nhs.uk/meningococcal-disease-and-sexual-transmission-urogenital-and-anorectal-infections-and-invasive-disease-due-to-neisseria-meningitidis.html 2020-06-12T14:58:52.3550000Z https://www.medicinesresources.nhs.uk/recommendations-for-head-and-neck-surgical-oncology-practice-in-a-setting-of-acute-severe-resource-constraint-during-the-covid-19-pandemic-an-international-consensus.html 2020-06-12T15:00:08.9220000Z https://www.medicinesresources.nhs.uk/local-authorities-across-england-receive-funding-to-support-new-test-and-trace-service.html 2020-06-12T15:32:14.1600000Z https://www.medicinesresources.nhs.uk/deaths-involving-covid-19-by-local-area-and-socioeconomic-deprivation-deaths-occurring-between-1-march-and-31-may-2020.html 2020-06-12T15:33:16.4640000Z https://www.medicinesresources.nhs.uk/revised-spc-bridion-sugammadex-sodium-100-mg-ml-solution-for-injection.html 2020-06-15T14:18:28.7390000Z https://www.medicinesresources.nhs.uk/revised-spc-keytruda-pembrolizumab-25-mg-ml-concentrate-for-solution-for-infusion.html 2020-06-15T14:22:29.9400000Z https://www.medicinesresources.nhs.uk/revised-spc-revlimid-lenalidomide-capsules-all-strengths.html 2020-06-15T14:23:49.7970000Z https://www.medicinesresources.nhs.uk/international-rare-cancers-initiative-multicenter-randomized-phase-ii-trial-of-cisplatin-and-fluorouracil-versus-carboplatin-and-paclitaxel-in-advanced-anal-cancer-interaact.html 2020-08-12T09:55:49.3470000Z https://www.medicinesresources.nhs.uk/covid-19-in-patients-with-thoracic-malignancies-teravolt-first-results-of-an-international-registry-based-cohort-study.html 2020-06-15T14:30:36.1450000Z https://www.medicinesresources.nhs.uk/association-between-copd-exacerbations-and-lung-function-decline-during-maintenance-therapy.html 2020-06-15T14:52:01.1620000Z https://www.medicinesresources.nhs.uk/conference-data-viale-a-phase-iii-rct-of-venetoclax-plus-azacitidine-demonstrates-survival-benefits-in-untreated-aml.html 2020-06-15T14:33:33.2750000Z https://www.medicinesresources.nhs.uk/conference-data-andromeda-phase-iii-rct-of-subcutaneous-daratumumab-combination-in-untreated-light-chain-al-amyloidosis.html 2020-06-15T14:34:47.9480000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-dispersible-tablet-formulation-of-dolutegravir-and-extension-of-paediatric-indication-for-hiv.html 2020-06-15T14:36:27.6730000Z https://www.medicinesresources.nhs.uk/nhs-england-announces-overwhelming-take-up-of-new-primary-care-network-contract.html 2020-06-15T14:37:52.6290000Z https://www.medicinesresources.nhs.uk/https-www-england-nhs-uk-coronavirus-wp-content-uploads-sites-52-2020-06-c0586-minimising-nosocomial-infections-in-the-nhs-pdf.html 2020-06-16T09:32:02.5520000Z https://www.medicinesresources.nhs.uk/long-term-condition-support.html 2020-06-16T10:04:32.3530000Z https://www.medicinesresources.nhs.uk/getting-the-nhs-back-on-track-planning-for-the-next-phase-of-covid-19.html 2020-06-15T14:47:30.1580000Z https://www.medicinesresources.nhs.uk/entrectinib-for-treating-ros1-positive-advanced-non-small-cell-lung-cancer-final-appraisal-document.html 2020-06-15T14:49:25.6780000Z https://www.medicinesresources.nhs.uk/researchers-to-test-trv027-a-potential-covid-19-treatment-in-uk.html 2020-06-15T14:50:38.6610000Z https://www.medicinesresources.nhs.uk/fda-grants-accelerated-approval-of-gardasil-hpv-vaccine-for-prevention-of-oropharyngeal-and-other-head-and-neck-cancers.html 2020-06-15T14:52:15.6490000Z https://www.medicinesresources.nhs.uk/astra-zeneca-signs-deal-with-europe-s-inclusive-vaccines-alliance-for-coronavirus-vaccine-supply.html 2020-06-15T14:54:09.0440000Z https://www.medicinesresources.nhs.uk/revised-spc-keytruda-pembrolizumab-50-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-06-16T14:18:52.6560000Z https://www.medicinesresources.nhs.uk/revised-spcs-sevodyne-buprenorphine-transdermal-patch-all-strengths.html 2020-06-16T14:20:21.0200000Z https://www.medicinesresources.nhs.uk/revestive-teduglutide-solution-for-injection-all-strengths.html 2020-06-16T16:52:59.7710000Z https://www.medicinesresources.nhs.uk/revised-spcs-taltz-ixekizumab-80-mg-solution-for-injection-all-products.html 2020-06-16T14:23:19.6070000Z https://www.medicinesresources.nhs.uk/revised-spc-xaluprine-mercaptopurine-monohydrate-20-mg-ml-oral-suspension.html 2020-06-16T14:24:27.5570000Z https://www.medicinesresources.nhs.uk/long-term-v-blocker-therapy-and-clinical-outcomes-after-acute-myocardial-infarction-in-patients-without-heart-failure-nationwide-cohort-study.html 2020-06-16T16:17:32.7370000Z https://www.medicinesresources.nhs.uk/hookworm-treatment-for-relapsing-multiple-sclerosis.html 2020-06-16T16:18:48.2090000Z https://www.medicinesresources.nhs.uk/hospital-wide-sars-cov-2-antibody-screening-in-3056-staff-in-a-tertiary-center-in-belgium.html 2020-06-17T10:18:26.7740000Z https://www.medicinesresources.nhs.uk/aqueous-olanexidine-versus-aqueous-povidone-iodine-for-surgical-skin-antisepsis-on-the-incidence-of-surgical-site-infections-after-clean-contaminated-surgery-a-multicentre-prospective-blinded-endpoint-randomised-controlled-trial.html 2020-06-16T16:20:51.1320000Z https://www.medicinesresources.nhs.uk/short-course-direct-acting-antivirals-and-ezetimibe-to-prevent-hcv-infection-in-recipients-of-organs-from-hcv-infected-donors-a-phase-3-single-centre-open-label-study.html 2020-06-16T16:27:11.8160000Z https://www.medicinesresources.nhs.uk/heat-inactivated-bifidobacterium-bifidum-mimbb75-syn-hi-001-in-the-treatment-of-irritable-bowel-syndrome-a-multicentre-randomised-double-blind-placebo-controlled-clinical-trial.html 2020-06-16T16:27:26.6310000Z https://www.medicinesresources.nhs.uk/interim-results-from-protective-2-rct-in-us-demonstrates-superiority-of-plinabulin-in-combination-with-pegfilgrastim-for-chemotherapy-induced-neutropenia-prevention.html 2020-06-17T09:29:46.5060000Z https://www.medicinesresources.nhs.uk/us-fda-revokes-emergency-use-authorization-for-chloroquine-and-hydroxychloroquine-stating-not-enough-supporting-evidence-for-treating-covid-19.html 2020-06-17T10:28:26.6440000Z https://www.medicinesresources.nhs.uk/diabetes-epidemiology-in-the-covid-19-pandemic.html 2020-06-16T16:02:35.6630000Z https://www.medicinesresources.nhs.uk/us-fda-warns-co-administration-of-remdesivir-and-chloroquine-phosphate-or-hydroxychloroquine-sulfate-may-result-in-reduced-antiviral-activity-of-remdesivir.html 2020-06-17T13:15:56.6070000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-annual-report-2019-published.html 2020-06-16T16:04:38.6610000Z https://www.medicinesresources.nhs.uk/monoclonal-antibodies-mabs-for-prevention-and-treatment-of-covid-19.html 2020-06-16T16:06:00.7750000Z https://www.medicinesresources.nhs.uk/british-society-of-gastroenterology-endorsed-guidance-for-the-management-of-immune-checkpoint-inhibitor-induced-enterocolitis.html 2020-06-16T16:34:22.8040000Z https://www.medicinesresources.nhs.uk/evorel-hormonal-replacement-therapy-hrt-range-now-back-in-stock.html 2020-06-16T16:34:33.9300000Z https://www.medicinesresources.nhs.uk/landmark-it-deal-between-nhsx-nhs-digital-and-microsoft-will-provide-access-to-digital-tools-and-save-hundreds-of-millions-of-pounds-for-the-nhs.html 2020-06-16T16:09:16.3950000Z https://www.medicinesresources.nhs.uk/government-scientific-advisory-group-for-emergencies-sage-committee-suggests-flu-vaccinations-for-entire-uk-population.html 2020-06-16T16:10:22.5690000Z https://www.medicinesresources.nhs.uk/zepzelca-lurbinectedin-given-us-accelerated-approval-for-treatment-of-adults-with-metastatic-small-cell-lung-cancer-sclc-with-disease-progression-on-or-after-platinum-based-chemotherapy.html 2020-06-16T16:35:59.2710000Z https://www.medicinesresources.nhs.uk/uk-led-clinical-trial-recovery-shows-steroid-dexamethasone-reduces-deaths-among-patients-with-severe-covid-19.html 2020-06-17T11:25:09.4040000Z https://www.medicinesresources.nhs.uk/public-perceptions-of-health-and-social-care-in-light-of-covid-19-may-2020.html 2020-06-16T16:14:06.8120000Z https://www.medicinesresources.nhs.uk/covid-19-nhs-test-and-trace-releases-first-figures-with-experts-calling-for-improvements.html 2020-06-16T16:31:42.7000000Z https://www.medicinesresources.nhs.uk/ustekinumab-for-treating-moderately-to-severely-active-ulcerative-colitis-guidance-ta633.html 2020-06-22T09:10:04.8640000Z https://www.medicinesresources.nhs.uk/revised-spc-onpattro-patisiran-solution-for-infusion.html 2020-06-17T14:54:02.9190000Z https://www.medicinesresources.nhs.uk/revised-spc-imnovid-pomalidomide-capsules.html 2020-06-17T14:55:20.8860000Z https://www.medicinesresources.nhs.uk/ferric-citrate-in-the-management-of-hyperphosphataemia-and-iron-deficiency-anaemia-a-meta-analysis-in-patients-with-chronic-kidney-disease.html 2020-06-17T14:56:43.7830000Z https://www.medicinesresources.nhs.uk/dtb-select-doac-dose-adjustment-in-renal-impairment.html 2020-06-22T09:12:31.2480000Z https://www.medicinesresources.nhs.uk/how-should-severe-vitamin-b12-deficiency-in-pregnancy-be-managed.html 2020-06-22T09:19:29.6220000Z https://www.medicinesresources.nhs.uk/effect-of-continuous-glucose-monitoring-on-hypoglycemia-in-older-adults-with-type-1-diabetes-a-randomized-clinical-trial.html 2020-06-17T15:02:26.3620000Z https://www.medicinesresources.nhs.uk/effect-of-continuous-glucose-monitoring-on-glycemic-control-in-adolescents-and-young-adults-with-type-1-diabetes-a-randomized-clinical-trial.html 2020-06-17T15:05:19.9150000Z https://www.medicinesresources.nhs.uk/amoxicillin-induced-crystal-nephropathy-a-nationwide-french-pharmacovigilance-databases-study.html 2020-06-17T15:07:25.0140000Z https://www.medicinesresources.nhs.uk/therapeutic-index-of-inhaled-corticosteroids-in-asthma-a-dose-response-comparison-on-airway-hyperresponsiveness-and-adrenal-axis-suppression.html 2020-06-17T15:08:52.2460000Z https://www.medicinesresources.nhs.uk/health-system-costs-of-treating-latent-tuberculosis-infection-with-four-months-of-rifampin-versus-nine-months-of-isoniazid-in-different-settings.html 2020-06-17T15:10:10.7530000Z https://www.medicinesresources.nhs.uk/can-tramadol-really-induce-hyponatraemia-a-pharmacovigilance-study.html 2020-06-17T16:05:37.2740000Z https://www.medicinesresources.nhs.uk/effect-of-ticagrelor-monotherapy-vs-ticagrelor-with-aspirin-on-major-bleeding-and-cardiovascular-events-in-patients-with-acute-coronary-syndrome-the-tico-randomized-clinical-trial.html 2020-06-17T15:13:48.9810000Z https://www.medicinesresources.nhs.uk/effectiveness-of-isolation-testing-contact-tracing-and-physical-distancing-on-reducing-transmission-of-sars-cov-2-in-different-settings-a-mathematical-modelling-study.html 2020-06-17T15:16:22.7890000Z https://www.medicinesresources.nhs.uk/diabetes-and-covid-19-risks-management-and-learnings-from-other-national-disasters.html 2020-06-17T15:21:38.8550000Z https://www.medicinesresources.nhs.uk/manufacturers-report-ertugliflozin-meets-primary-endpoint-in-vertis-cv-trial-for-patients-with-type-2-diabetes-and-atherosclerotic-cardiovascular-disease.html 2020-06-17T15:24:41.5480000Z https://www.medicinesresources.nhs.uk/the-economy-of-wellbeing-what-is-it-and-what-are-the-implications-for-health.html 2020-06-17T15:25:45.2510000Z https://www.medicinesresources.nhs.uk/advances-in-the-diagnosis-and-management-of-igg4-related-disease.html 2020-06-17T15:27:23.0100000Z https://www.medicinesresources.nhs.uk/routine-vaccination-during-covid-19-pandemic-response.html 2020-06-17T15:28:59.0180000Z https://www.medicinesresources.nhs.uk/challenges-and-opportunities-to-include-patient-centric-product-design-in-industrial-medicines-development-to-improve-therapeutic-goals.html 2020-06-17T15:30:15.3650000Z https://www.medicinesresources.nhs.uk/adrenal-crises-in-older-patients.html 2020-06-17T15:32:00.1610000Z https://www.medicinesresources.nhs.uk/causes-consequences-and-treatment-of-metabolically-unhealthy-fat-distribution.html 2020-06-17T15:34:04.2580000Z https://www.medicinesresources.nhs.uk/therapeutic-blockade-of-granulocyte-macrophage-colony-stimulating-factor-gm-csf-in-covid-19-associated-hyperinflammation-challenges-and-opportunities.html 2020-06-17T15:35:44.3070000Z https://www.medicinesresources.nhs.uk/delivering-evidence-based-critical-care-for-mechanically-ventilated-patients-with-covid-19.html 2020-06-17T15:38:24.5590000Z https://www.medicinesresources.nhs.uk/acute-coronary-syndromes-draft-guidance-consultation.html 2020-06-17T15:39:51.1200000Z https://www.medicinesresources.nhs.uk/mhra-suspends-recruitment-to-covid-19-hydroxychloroquine-trials.html 2020-06-22T09:33:31.0880000Z https://www.medicinesresources.nhs.uk/covid-19-understanding-the-impact-on-bame-communities.html 2020-06-17T15:42:47.5650000Z https://www.medicinesresources.nhs.uk/awake-prone-positioning-in-covid-19.html 2020-06-17T15:44:24.2580000Z https://www.medicinesresources.nhs.uk/conferece-report-data-from-the-relief-study-show-improved-outcomes-with-freestyle-r-libre-system.html 2020-06-17T15:45:31.9540000Z https://www.medicinesresources.nhs.uk/covid-19-clinical-trials-a-teachable-moment-for-improving-our-research-infrastructure-and-relevance.html 2020-06-17T15:46:40.2280000Z https://www.medicinesresources.nhs.uk/dexamethasone-in-the-treatment-of-covid-19-implementation-and-management-of-supply-for-treatment-in-hospitals.html 2020-06-22T09:40:38.2280000Z https://www.medicinesresources.nhs.uk/clinical-guide-for-triaging-patients-with-lower-gastrointestinal-symptoms.html 2020-06-22T09:55:24.9950000Z https://www.medicinesresources.nhs.uk/management-of-patients-with-musculoskeletal-and-rheumatic-conditions-who-are-on-corticosteroids-require-initiation-of-oral-iv-corticosteroids-require-a-corticosteroid-injection.html 2020-06-22T09:58:34.5200000Z https://www.medicinesresources.nhs.uk/ketotifen-ketofall-0-1-mg-in-0-4-ml-solution-eye-drops-recommended-as-an-option-for-restricted-use-within-nhs-wales.html 2020-06-18T15:09:08.7190000Z https://www.medicinesresources.nhs.uk/new-product-lyumjev-insulin-lispro-100-units-ml-solution-for-injection-vial-cartridge-and-pre-filled-pens-kwikpen.html 2020-06-18T15:10:22.4370000Z https://www.medicinesresources.nhs.uk/revised-spc-constella-linaclotide-290-micrograms-hard-capsules.html 2020-06-18T15:11:48.5940000Z https://www.medicinesresources.nhs.uk/revised-spc-multaq-dronedarone-400mg-film-coated-tablets.html 2020-06-18T15:13:07.7030000Z https://www.medicinesresources.nhs.uk/phase-iii-impassion031-study-suggests-atezolizumab-in-combination-with-chemotherapy-shows-promise-in-early-triple-negative-breast-cancer.html 2020-06-18T15:15:52.6460000Z https://www.medicinesresources.nhs.uk/prehospital-stroke-management-in-the-thrombectomy-era.html 2020-06-18T15:17:12.2960000Z https://www.medicinesresources.nhs.uk/use-of-glucagon-like-peptide-1-receptor-agonists-in-patients-with-type-2-diabetes-and-cardiovascular-disease-a-review.html 2020-06-18T15:18:48.1800000Z https://www.medicinesresources.nhs.uk/public-perceptions-of-health-and-social-care-in-light-of-covid-19-results-from-an-ipsos-mori-survey-commissioned-by-the-health-foundation.html 2020-06-18T15:20:05.3840000Z https://www.medicinesresources.nhs.uk/regulating-drugs-medical-devices-and-diagnostic-tests-in-the-european-union-early-lessons-from-the-covid-19-pandemic.html 2020-06-18T15:21:26.9190000Z https://www.medicinesresources.nhs.uk/piperacillin-tazobactam-induced-coagulopathy-in-a-patient-through-a-vitamin-k-dependent-mechanism.html 2020-06-18T18:06:31.4280000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-endorses-two-statements-about-the-importance-safety-and-effectiveness-of-vaccines.html 2020-06-18T15:25:52.0610000Z https://www.medicinesresources.nhs.uk/pioneering-scheme-underway-to-pay-pharmaceutical-companies-upfront-for-access-to-their-antibiotic-product-based-on-its-value-to-the-nhs.html 2020-06-22T11:20:41.4240000Z https://www.medicinesresources.nhs.uk/cqc-publishes-data-on-deaths-in-care-settings-broken-down-by-ethnicity.html 2020-06-18T17:51:36.3130000Z https://www.medicinesresources.nhs.uk/the-adaptive-designs-consort-extension-ace-statement-a-checklist-with-explanation-and-elaboration-guideline-for-reporting-randomised-trials-that-use-an-adaptive-design.html 2020-06-18T18:04:21.6580000Z https://www.medicinesresources.nhs.uk/investigating-coeliac-disease-in-adults.html 2020-06-18T15:32:42.9780000Z https://www.medicinesresources.nhs.uk/risks-to-health-and-the-nhs-in-the-post-brexit-era.html 2020-06-18T18:02:02.2430000Z https://www.medicinesresources.nhs.uk/has-swedens-controversial-covid-19-strategy-been-successful.html 2020-06-18T15:40:19.3390000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-for-covid-19-the-end-of-the-line.html 2020-06-18T15:41:51.4630000Z https://www.medicinesresources.nhs.uk/harnessing-the-power-of-health-taxes.html 2020-06-18T15:42:51.2480000Z https://www.medicinesresources.nhs.uk/world-health-organization-halts-trial-of-hydroxychloroquine-in-covid-19-patients.html 2020-06-18T15:43:56.0730000Z https://www.medicinesresources.nhs.uk/interim-analysis-of-phase-iii-monarche-study-of-abemaciclib-combined-with-standard-adjuvant-endocrine-therapy-in-patients-with-high-risk-node-positive-hr-her2-early-breast-cancer-meets-primary-endpoint.html 2020-06-18T15:47:09.0110000Z https://www.medicinesresources.nhs.uk/new-drug-application-submitted-to-fda-for-umbralisib-as-a-treatment-for-patients-with-previously-treated-marginal-zone-lymphoma-mzl-or-follicular-lymphoma-fl.html 2020-06-18T15:48:59.2230000Z https://www.medicinesresources.nhs.uk/fda-approves-pembrolizumab-for-treatment-of-adult-and-paediatric-patients-with-unresectable-or-metastatic-tumour-mutational-burden-high-tmb-h-solid-tumours-determined-through-biomarker-based-testing.html 2020-06-18T15:50:37.0660000Z https://www.medicinesresources.nhs.uk/association-between-medication-use-and-bullous-pemphigoid-a-systematic-review-and-meta-analysis.html 2020-06-18T15:57:20.1980000Z https://www.medicinesresources.nhs.uk/enrollment-of-older-patients-women-and-racial-ethnic-minority-groups-in-contemporary-acute-coronary-syndrome-clinical-trials-a-systematic-review.html 2020-06-18T15:59:18.2100000Z https://www.medicinesresources.nhs.uk/medical-management-with-interventional-therapy-versus-medical-management-alone-for-unruptured-brain-arteriovenous-malformations-aruba-final-follow-up-of-a-multicentre-non-blinded-randomised-controlled-trial.html 2020-06-18T16:00:46.5760000Z https://www.medicinesresources.nhs.uk/use-of-an-electronic-decision-support-tool-to-reduce-polypharmacy-in-elderly-people-with-chronic-diseases-cluster-randomised-controlled-trial.html 2020-06-22T10:04:49.7820000Z https://www.medicinesresources.nhs.uk/berzosertib-plus-gemcitabine-versus-gemcitabine-alone-in-platinum-resistant-high-grade-serous-ovarian-cancer-a-multicentre-open-label-randomised-phase-2-trial.html 2020-06-18T16:13:27.2580000Z https://www.medicinesresources.nhs.uk/development-of-persistent-opioid-use-after-cardiac-surgery.html 2020-06-18T16:16:28.4040000Z https://www.medicinesresources.nhs.uk/renin-angiotensin-system-blockers-and-susceptibility-to-covid-19-a-multinational-open-science-cohort-study.html 2020-06-18T17:40:22.9890000Z https://www.medicinesresources.nhs.uk/age-dependent-effects-in-the-transmission-and-control-of-covid-19-epidemics.html 2020-06-18T17:40:53.1640000Z https://www.medicinesresources.nhs.uk/carotid-intima-media-thickness-progression-as-surrogate-marker-for-cardiovascular-risk-meta-analysis-of-119-clinical-trials-involving-100-667-patients.html 2020-08-20T10:47:32.4200000Z https://www.medicinesresources.nhs.uk/systemic-inflammatory-response-syndrome-is-a-major-contributor-to-covid-19-associated-coagulopathy-insights-from-a-prospective-single-center-cohort-study.html 2020-08-20T10:55:39.6140000Z https://www.medicinesresources.nhs.uk/household-secondary-attack-rate-of-covid-19-and-associated-determinants-in-guangzhou-china-a-retrospective-cohort-study.html 2020-06-18T17:45:21.0050000Z https://www.medicinesresources.nhs.uk/conference-report-bimekizumab-achieved-superior-skin-clearance-in-be-vivid-and-be-ready-phase-iii-studies-in-adults-with-moderate-to-severe-plaque-psoriasis.html 2020-06-18T17:52:41.0300000Z https://www.medicinesresources.nhs.uk/abbvie-presents-new-late-breaking-data-showing-skyrizi-r-risankizumab-rzaa-achieves-superior-rates-of-complete-skin-clearance-versus-cosentyx-r-secukinumab-at-52-weeks.html 2020-06-18T17:38:32.5650000Z https://www.medicinesresources.nhs.uk/revised-spcs-xeloda-capecitabine-film-coated-tablets.html 2020-06-19T14:23:56.1010000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-renal-transplantation-guidance-ng178.html 2020-06-22T10:37:37.5720000Z https://www.medicinesresources.nhs.uk/joint-committee-on-vaccination-and-immunisation-interim-advice-on-priority-groups-for-covid-19-vaccination.html 2020-06-22T10:53:40.8500000Z https://www.medicinesresources.nhs.uk/republished-hyperkinetic-reaction-to-dihydrocodeine.html 2020-06-19T14:28:59.1310000Z https://www.medicinesresources.nhs.uk/new-directions-in-the-treatment-of-opioid-withdrawal.html 2020-06-19T14:30:18.2640000Z https://www.medicinesresources.nhs.uk/update-from-the-uk-chief-medical-officers-on-the-uk-alert-level.html 2020-06-22T10:59:42.3130000Z https://www.medicinesresources.nhs.uk/application-for-approval-of-cpp-1x-sul-for-the-treatment-of-familial-adenomatous-polyposis-fap-submitted-to-the-european-medicines-agency.html 2020-06-19T14:33:44.9810000Z https://www.medicinesresources.nhs.uk/us-fda-approves-burosumab-for-the-treatment-of-tumour-induced-osteomalacia-tio.html 2020-06-19T14:35:22.3960000Z https://www.medicinesresources.nhs.uk/us-fda-accelerated-approval-of-tazemetostat-for-relapsed-refractory-follicular-lymphoma-r-rfl.html 2020-06-19T14:37:55.8570000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-of-osilodrostat-in-cushings-disease-meets-primary-endpoint.html 2020-06-19T15:44:54.4680000Z https://www.medicinesresources.nhs.uk/gilead-announces-plans-to-study-remdesivir-in-paediatric-patients-with-covid-19.html 2020-06-19T14:40:56.9620000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-to-review-marketing-authorisation-application-for-zanubrutinib-for-the-treatment-of-waldenstroems-macroglobulinemia-wm.html 2020-06-19T14:42:30.4910000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-upadacitinib-monotherapy-in-the-treatment-of-adults-and-adolescents-with-moderate-to-severe-atopic-dermatitis.html 2020-06-19T14:43:50.2580000Z https://www.medicinesresources.nhs.uk/cqc-says-inspections-suspended-for-covid-19-crisis-will-restart-in-autumn.html 2020-06-19T14:45:02.2340000Z https://www.medicinesresources.nhs.uk/covid-19-understanding-inequalities-in-mental-health-during-the-pandemic.html 2020-06-19T14:46:18.6340000Z https://www.medicinesresources.nhs.uk/emerging-treatment-paradigms-for-egfr-mutant-lung-cancers-progressing-on-osimertinib-a-review.html 2020-06-19T14:48:00.4150000Z https://www.medicinesresources.nhs.uk/special-considerations-in-the-management-of-adult-patients-with-acute-leukaemias-and-myeloid-neoplasms-in-the-covid-19-era-recommendations-from-a-panel-of-international-experts.html 2020-06-19T14:51:13.2060000Z https://www.medicinesresources.nhs.uk/sleep-disturbance-and-psychiatric-disorders.html 2020-06-19T14:52:31.1760000Z https://www.medicinesresources.nhs.uk/nhs-community-pharmacist-check-ups-top-300-000.html 2020-06-19T14:53:50.0640000Z https://www.medicinesresources.nhs.uk/the-safety-and-efficacy-of-aspirin-discontinuation-on-a-background-of-a-p2y12-inhibitor-in-patients-after-percutaneous-coronary-intervention-a-systematic-review-and-meta-analysis.html 2020-06-19T15:44:40.9520000Z https://www.medicinesresources.nhs.uk/a-systematic-review-and-meta-analysis-to-evaluate-the-clinical-outcomes-in-covid-19-patients-on-angiotensin-converting-enzyme-inhibitors-or-angiotensin-receptor-blockers.html 2020-06-22T11:06:44.1800000Z https://www.medicinesresources.nhs.uk/comparative-efficacy-and-acceptability-of-antidepressants-psychotherapies-and-their-combination-for-acute-treatment-of-children-and-adolescents-with-depressive-disorder-a-systematic-review-and-network-meta-analysis.html 2020-06-19T15:52:08.0570000Z https://www.medicinesresources.nhs.uk/effects-of-a-high-dose-24-h-infusion-of-tranexamic-acid-on-death-and-thromboembolic-events-in-patients-with-acute-gastrointestinal-bleeding-halt-it-an-international-randomised-double-blind-placebo-controlled-trial.html 2020-06-22T11:12:44.1380000Z https://www.medicinesresources.nhs.uk/effect-of-delaying-treatment-of-first-episode-psychosis-on-symptoms-and-social-outcomes-a-longitudinal-analysis-and-modelling-study.html 2020-06-19T15:52:51.9830000Z https://www.medicinesresources.nhs.uk/ethnicity-and-outcomes-from-covid-19-the-isaric-ccp-uk-prospective-observational-cohort-study-of-hospitalised-patients.html 2020-06-22T11:14:35.8860000Z https://www.medicinesresources.nhs.uk/cost-effectiveness-of-diabetes-prevention-interventions-targeting-high-risk-individuals-and-whole-populations-a-systematic-review.html 2020-06-22T14:50:55.4240000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-and-outcomes-of-patients-with-diabetes-and-covid-19-in-association-with-glucose-lowering-medication.html 2020-06-22T14:52:39.7570000Z https://www.medicinesresources.nhs.uk/association-of-angiotensin-converting-enzyme-inhibitor-or-angiotensin-receptor-blocker-use-with-covid-19-diagnosis-and-mortality.html 2020-06-23T09:03:34.5100000Z https://www.medicinesresources.nhs.uk/association-of-sedentary-behavior-with-cancer-mortality-in-middle-aged-and-older-us-adults.html 2020-06-22T14:59:01.2340000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-metoclopramide-nasal-spray-gimoti-for-diabetic-gastroparesis.html 2020-06-22T15:00:34.9540000Z https://www.medicinesresources.nhs.uk/pilot-of-optigene-home-coronavirus-saliva-test.html 2020-06-22T15:02:27.1880000Z https://www.medicinesresources.nhs.uk/coronavirus-scam-warning-over-nhs-test-and-trace.html 2020-06-22T15:04:03.8480000Z https://www.medicinesresources.nhs.uk/precision-medicine-in-diabetes-a-consensus-report-from-the-american-diabetes-association-ada-and-the-european-association-for-the-study-of-diabetes-easd.html 2020-06-22T15:05:21.4460000Z https://www.medicinesresources.nhs.uk/diabetes-self-management-education-and-support-in-adults-with-type-2-diabetes-a-consensus-report.html 2020-06-22T15:06:32.8420000Z https://www.medicinesresources.nhs.uk/rifampicin-induced-shock-during-re-exposure-for-treatment-of-latent-tuberculosis.html 2020-06-22T15:10:00.2560000Z https://www.medicinesresources.nhs.uk/dtb-editorial-virtual-revolution.html 2020-06-22T15:11:45.5500000Z https://www.medicinesresources.nhs.uk/heat-health-watch-alert-level-2-alert-and-readiness.html 2020-06-22T15:13:54.4950000Z https://www.medicinesresources.nhs.uk/nhs-practitioner-health.html 2020-06-22T15:41:30.2080000Z https://www.medicinesresources.nhs.uk/patient-record-flag-can-positively-affect-care-of-people-with-learning-disabilities.html 2020-06-22T15:25:55.1140000Z https://www.medicinesresources.nhs.uk/gps-predict-huge-surge-in-patients-with-post-traumatic-stress-disorder-due-to-covid-19.html 2020-06-22T15:28:36.6940000Z https://www.medicinesresources.nhs.uk/gsk-clover-s-covid-19-vaccine-moves-into-human-trials.html 2020-06-22T15:44:51.2450000Z https://www.medicinesresources.nhs.uk/american-society-of-haematology-2020-guidelines-for-sickle-cell-disease-management-of-acute-and-chronic-pain.html 2020-06-22T15:36:44.4020000Z https://www.medicinesresources.nhs.uk/childhood-trust-report-warns-of-serious-mental-health-conditions-in-children-due-to-covid-19.html 2020-06-22T15:42:13.6450000Z https://www.medicinesresources.nhs.uk/covid-19-local-health-teams-trace-eight-times-more-contacts-than-national-service.html 2020-06-22T15:43:41.1550000Z https://www.medicinesresources.nhs.uk/new-product-esperoct-turoctocog-alfa-pegol-500-iu-1000-iu-1500-iu-2000-iu-3000-iu-injection.html 2020-06-23T16:10:49.8460000Z https://www.medicinesresources.nhs.uk/new-product-sarclisa-isatuximab-20mg-ml-concentrate-for-solution-for-infusion.html 2020-06-23T14:57:13.8860000Z https://www.medicinesresources.nhs.uk/revised-spc-cablivi-caplacizumab-10-mg-powder-and-solvent-for-solution-for-injection.html 2020-06-23T16:11:25.4710000Z https://www.medicinesresources.nhs.uk/revised-spcs-viepax-venlafaxine-hydrochloride-xl-prolonged-release-tablets-all-strengths.html 2020-06-23T15:02:51.2540000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-scientific-opinion-raxone-to-treat-the-decline-of-respiratory-function-in-patients-with-duchenne-muscular-dystrophy-dmd.html 2020-06-25T13:18:42.7320000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-scientific-opinion-atezolizumab-in-combination-with-bevacizumab-for-the-treatment-of-adult-patients-with-unresectable-hepatocellular-carcinoma-who-have-received-no-prior-systemic-therapy.html 2020-06-23T16:06:50.3590000Z https://www.medicinesresources.nhs.uk/treatment-of-locally-advanced-esophageal-carcinoma.html 2020-08-17T08:35:32.1840000Z https://www.medicinesresources.nhs.uk/trends-and-variation-in-unsafe-prescribing-of-methotrexate-a-cohort-study-in-english-nhs-primary-care.html 2020-06-24T12:49:56.9480000Z https://www.medicinesresources.nhs.uk/safety-efficacy-and-feasibility-of-intranasal-insulin-for-the-treatment-of-mild-cognitive-impairment-and-alzheimer-disease-dementia.html 2020-06-23T16:07:31.8200000Z https://www.medicinesresources.nhs.uk/serum-detection-of-nonadherence-to-adjuvant-tamoxifen-and-breast-cancer-recurrence-risk.html 2020-08-10T14:39:44.8970000Z https://www.medicinesresources.nhs.uk/nihr-alert-interactive-dashboard-identifies-patients-at-risk-of-unsafe-prescribing-in-a-flexible-and-sustainable-way.html 2020-06-23T16:31:51.0330000Z https://www.medicinesresources.nhs.uk/nihr-alert-public-health-messages-on-alcohol-need-to-consider-how-and-why-people-drink-not-just-how-much.html 2020-06-23T16:09:11.9420000Z https://www.medicinesresources.nhs.uk/psychological-interventions-to-improve-self-management-of-type-1-and-type-2-diabetes-a-systematic-review.html 2020-06-23T16:35:12.1080000Z https://www.medicinesresources.nhs.uk/sodium-bicarbonate-to-improve-physical-function-in-patients-over-60-years-with-advanced-chronic-kidney-disease-the-bicarb-rct.html 2020-06-23T16:36:08.0760000Z https://www.medicinesresources.nhs.uk/nhs-digital-supports-development-of-risk-prediction-model-for-more-tailored-covid-19-shielding-advice.html 2020-06-23T16:36:28.3210000Z https://www.medicinesresources.nhs.uk/plans-to-ease-guidance-for-over-2-million-shielding.html 2020-06-23T16:36:53.8170000Z https://www.medicinesresources.nhs.uk/new-saliva-test-for-coronavirus-piloted-in-southampton.html 2020-06-23T16:14:14.3350000Z https://www.medicinesresources.nhs.uk/plans-to-start-testing-on-an-inhaled-form-of-remdesivir-revealed.html 2020-06-23T16:37:13.9560000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-to-consider-expanding-use-of-bavencio-avelumab-for-first-line-maintenance-treatment-of-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma.html 2020-06-23T16:37:49.9430000Z https://www.medicinesresources.nhs.uk/management-of-patients-with-liver-derangement-during-the-covid-19-pandemic-position-statement-from-the-asia-pacific-working-group-for-liver-derangement.html 2020-06-23T16:38:06.9450000Z https://www.medicinesresources.nhs.uk/managing-heart-failure-related-peripheral-oedema-in-primary-care.html 2020-06-23T16:38:31.7520000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-supplemental-biologics-license-application-sbla-for-botox-onabotulinumtoxina-for-the-treatment-of-paediatric-patients-with-neurogenic-detrusor-overactivity.html 2020-06-23T16:39:03.5030000Z https://www.medicinesresources.nhs.uk/avatrombopag-for-treating-thrombocytopenia-in-people-with-chronic-liver-disease-needing-a-planned-invasive-procedure-guidance-ta626.html 2020-06-25T13:36:38.4230000Z https://www.medicinesresources.nhs.uk/personal-protective-equipment-and-heat-risk-of-heat-stress.html 2020-06-24T13:30:25.8260000Z https://www.medicinesresources.nhs.uk/risk-for-nephrogenic-systemic-fibrosis-after-exposure-to-newer-gadolinium-agents-a-systematic-review.html 2020-06-24T13:32:28.2210000Z https://www.medicinesresources.nhs.uk/effect-of-intraoperative-dexamethasone-on-major-complications-and-mortality-among-infants-undergoing-cardiac-surgery-the-decision-randomized-clinical-trial.html 2020-06-24T13:33:56.9540000Z https://www.medicinesresources.nhs.uk/evaluation-of-quality-indicators-for-nutrition-and-metabolism-in-critically-ill-patients-role-of-the-pharmacist.html 2020-06-24T13:35:32.9420000Z https://www.medicinesresources.nhs.uk/randomized-trial-comparing-double-versus-triple-bortezomib-based-regimen-in-patients-with-multiple-myeloma-and-acute-kidney-injury-due-to-cast-nephropathy.html 2020-08-12T14:04:59.1390000Z https://www.medicinesresources.nhs.uk/severe-and-fatal-medication-errors-in-hospitals-findings-from-the-norwegian-incident-reporting-system.html 2020-06-24T13:40:06.0400000Z https://www.medicinesresources.nhs.uk/oseltamivir-for-coronavirus-illness-post-hoc-exploratory-analysis-of-an-open-label-pragmatic-randomised-controlled-trial-in-european-primary-care-from-2016-to-2018.html 2020-06-24T13:41:40.8810000Z https://www.medicinesresources.nhs.uk/community-pharmacy-based-study-of-adherence-to-non-vitamin-k-antagonist-oral-anticoagulants.html 2020-06-24T13:43:44.0000000Z https://www.medicinesresources.nhs.uk/participation-of-african-american-persons-in-clinical-trials-supporting-u-s-food-and-drug-administration-approval-of-cancer-drugs.html 2020-06-24T13:45:28.8700000Z https://www.medicinesresources.nhs.uk/effect-of-dexamethasone-in-hospitalized-patients-with-covid-19-preliminary-report.html 2020-06-25T13:39:46.5120000Z https://www.medicinesresources.nhs.uk/risk-for-subdeltoid-bursitis-after-influenza-vaccination-a-population-based-cohort-study.html 2020-06-24T13:52:59.0480000Z https://www.medicinesresources.nhs.uk/noninferiority-trials-to-evaluate-drug-effects-in-rheumatoid-arthritis.html 2020-06-24T14:15:27.1200000Z https://www.medicinesresources.nhs.uk/epidyolex-reclassified-to-schedule-v-of-the-misuse-of-drugs-regulations-2001.html 2020-06-25T13:37:14.2250000Z https://www.medicinesresources.nhs.uk/fda-grant-fast-track-designation-for-aviptadil-for-respiratory-distress-in-covid-19.html 2020-06-24T14:18:45.3410000Z https://www.medicinesresources.nhs.uk/over-a-decade-of-experience-with-carboplatin-therapeutic-drug-monitoring-in-a-childhood-cancer-setting-in-the-united-kingdom.html 2020-06-24T14:20:22.6340000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-results-from-phase-3-study-evaluating-once-daily-relugolix-combination-therapy-in-women-with-endometriosis-and-priority-review-from-fda-for-use-in-prostate-cancer-pc.html 2020-06-24T14:23:58.4590000Z https://www.medicinesresources.nhs.uk/cancer-x-coronavirus-the-impact-on-young-people.html 2020-06-24T14:29:43.3440000Z https://www.medicinesresources.nhs.uk/prescribing-guidelines-for-patients-with-a-first-episode-psychosis.html 2020-06-24T14:35:58.9110000Z https://www.medicinesresources.nhs.uk/supply-of-emtricitabine-200mg-tenofovir-disoproxil-245mg-as-pre-exposure-prophylaxis-prep-for-the-prevention-of-hiv-infection-national-pgd-template.html 2020-06-24T14:39:14.0460000Z https://www.medicinesresources.nhs.uk/revised-spc-ferinject-ferric-carboxymaltose.html 2020-06-25T15:04:47.4010000Z https://www.medicinesresources.nhs.uk/revised-spcs-tenoretic-100-mg-25-mg-and-tenoret-50-mg-12-5-mg-atenolol-chlortalidone-film-coated-tablets.html 2020-06-25T15:06:05.3620000Z https://www.medicinesresources.nhs.uk/withdrawal-of-antihypertensive-drugs-in-older-people.html 2020-06-29T08:36:18.4210000Z https://www.medicinesresources.nhs.uk/masks-for-prevention-of-respiratory-virus-infections-including-sars-cov-2-in-health-care-and-community-settings-a-living-rapid-review.html 2020-06-25T17:04:35.2820000Z https://www.medicinesresources.nhs.uk/dtb-select-does-deprescribing-in-older-people-improve-outcomes.html 2020-06-25T15:12:14.8670000Z https://www.medicinesresources.nhs.uk/guide-for-audit-and-risk-committees-on-financial-reporting-and-management-during-covid-19.html 2020-06-25T15:13:11.0850000Z https://www.medicinesresources.nhs.uk/commentary-asymptomatic-sars-cov-2-infection-the-tip-or-the-iceberg.html 2020-06-25T15:14:20.3960000Z https://www.medicinesresources.nhs.uk/blue-brown-and-now-green.html 2020-06-25T15:15:32.6210000Z https://www.medicinesresources.nhs.uk/new-consortium-for-monitoring-the-safety-and-effectiveness-of-covid-19-vaccines.html 2020-06-25T15:16:53.1010000Z https://www.medicinesresources.nhs.uk/principle-trial-calls-on-uk-primary-care-to-support-patient-recruitment.html 2020-06-25T15:21:34.4900000Z https://www.medicinesresources.nhs.uk/phenelzine-sulphate-15mg-tablets-nardil-supply-disruption.html 2020-06-29T08:44:50.6440000Z https://www.medicinesresources.nhs.uk/salicylate-toxicity.html 2020-06-25T15:24:05.1330000Z https://www.medicinesresources.nhs.uk/entrectinib-for-treating-ntrk-fusion-positive-solid-tumours-final-appraisal-document.html 2020-06-25T15:24:57.3720000Z https://www.medicinesresources.nhs.uk/siponimod-for-treating-secondary-progressive-multiple-sclerosis-appraisal-consultation-document.html 2020-06-25T17:00:19.3720000Z https://www.medicinesresources.nhs.uk/management-of-patients-with-severe-mental-illness-during-the-coronavirus-disease-2019-pandemic.html 2020-06-25T15:26:44.6180000Z https://www.medicinesresources.nhs.uk/european-regulators-make-recommendations-drawing-on-lessons-learnt-from-presence-of-nitrosamines-in-sartan-medicines.html 2020-06-25T15:27:44.2930000Z https://www.medicinesresources.nhs.uk/dilemmas-in-commissioning-biological-therapies.html 2020-06-25T16:58:19.7700000Z https://www.medicinesresources.nhs.uk/covid-19-antibody-tests-a-briefing.html 2020-06-29T08:39:05.2270000Z https://www.medicinesresources.nhs.uk/commercial-influence-and-covid-19.html 2020-06-25T16:19:46.2970000Z https://www.medicinesresources.nhs.uk/call-for-a-rapid-forward-looking-review-of-the-uks-preparedness-for-a-second-wave-of-covid-19-an-open-letter-to-the-leaders-of-all-uk-political-parties.html 2020-06-25T15:33:09.4810000Z https://www.medicinesresources.nhs.uk/why-covid-19-antibody-tests-are-not-the-game-changer-the-uk-government-claims.html 2020-06-25T16:55:51.9800000Z https://www.medicinesresources.nhs.uk/merck-announces-its-investigational-15-valent-pneumococcal-conjugate-vaccine-v114-met-safety-and-immunogenicity-objectives-in-initial-phase-iii-studies-in-adults.html 2020-06-25T15:36:03.8370000Z https://www.medicinesresources.nhs.uk/fda-approves-selinexor-for-treatment-of-adults-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-dlbcl.html 2020-06-25T15:37:21.8960000Z https://www.medicinesresources.nhs.uk/positive-results-from-phase-2-willow-study-of-brensocatib-in-patients-with-non-cystic-fibrosis-bronchiectasis-presented-at-conference.html 2020-06-25T15:38:32.5700000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-weekly-subcutaneous-sc-ravulizumab-for-paroxysmal-nocturnal-haemoglobinuria-pnh-meets-primary-endpoint.html 2020-06-25T15:39:41.8610000Z https://www.medicinesresources.nhs.uk/fda-approves-pembrolizumab-for-treatment-of-patients-with-recurrent-or-metastatic-cutaneous-squamous-cell-carcinoma-that-is-not-curable-by-surgery-or-radiation.html 2020-06-25T15:41:02.2450000Z https://www.medicinesresources.nhs.uk/febrile-neutropenia-patient-group-direction-improving-treatment-and-sepsis-management-in-paediatric-oncology-patients-in-wales.html 2020-06-25T16:51:51.5230000Z https://www.medicinesresources.nhs.uk/pharmacist-led-hypertension-review-project-in-black-african-or-african-caribbean-origin-patients.html 2020-06-25T15:47:41.4620000Z https://www.medicinesresources.nhs.uk/surveillance-of-influenza-and-other-respiratory-viruses-in-the-uk-winter-2019-to-2020.html 2020-06-25T15:49:22.4550000Z https://www.medicinesresources.nhs.uk/effects-of-allopurinol-on-the-progression-of-chronic-kidney-disease.html 2020-10-01T08:52:32.1870000Z https://www.medicinesresources.nhs.uk/serum-urate-lowering-with-allopurinol-and-kidney-function-in-type-1-diabetes.html 2020-10-01T09:24:56.5650000Z https://www.medicinesresources.nhs.uk/triple-inhaled-therapy-at-two-glucocorticoid-doses-in-moderate-to-very-severe-copd.html 2020-10-01T09:20:32.1270000Z https://www.medicinesresources.nhs.uk/new-onset-atrial-fibrillation-incidence-characteristics-and-related-events-following-a-national-covid-19-lockdown-of-5-6-million-people.html 2020-06-25T16:43:35.4830000Z https://www.medicinesresources.nhs.uk/association-between-atopic-eczema-and-cancer-in-england-and-denmark.html 2020-06-25T16:02:34.1840000Z https://www.medicinesresources.nhs.uk/home-monitoring-with-technology-supported-management-in-chronic-heart-failure-a-randomised-trial.html 2020-06-25T16:19:18.7700000Z https://www.medicinesresources.nhs.uk/de-implementation-strategy-to-reduce-inappropriate-use-of-intravenous-and-urinary-catheters-ricat-a-multicentre-prospective-interrupted-time-series-and-before-and-after-study.html 2020-06-25T16:20:46.2380000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-for-ceftazidime-avibactam-zavicefta-1.html 2020-06-26T13:26:30.8700000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-foromalizumab-xolair.html 2020-06-26T16:10:24.3330000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-forinfliximab-remsima.html 2020-07-29T10:14:12.2940000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-for-sofosbuvir-velpatasvir-epclusa.html 2020-06-26T13:32:28.1800000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-forsecukinumab-cosentyx.html 2020-06-26T13:35:42.9180000Z https://www.medicinesresources.nhs.uk/european-chmp-issues-negative-opinion-for-pexidartinib-turalio-in-treatment-of-tenosynovial-giant-cell-tumour.html 2020-06-26T13:37:22.6980000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-biosimilar-of-teriparatide-qutavina-20-micrograms-80-microlitres-solution-for-injection.html 2020-06-26T13:38:24.7030000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-biosimilar-of-teriparatide-livogiva-20-micrograms-80-microlitres-solution-for-injection.html 2020-06-26T13:44:16.6130000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-biosimilar-of-bevacizumab-aybintio-25-mg-ml-concentrate-for-solution-for-infusion.html 2020-06-26T13:45:39.4720000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-remdesivir-veklury.html 2020-06-26T13:47:29.7630000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-caffeine-citrate-gencebok-for-treatment-of-primary-apnoea-of-premature-newborns.html 2020-06-26T13:48:41.6150000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-elexacaftor-tezacaftor-ivacaftor-kaftrio.html 2020-06-26T13:51:51.2710000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-imlifidase-idefirix.html 2020-06-26T16:13:45.0980000Z https://www.medicinesresources.nhs.uk/global-regulators-discuss-data-requirements-for-phase-3-trials-of-covid-19-vaccines.html 2020-06-26T13:54:58.9960000Z https://www.medicinesresources.nhs.uk/republished-case-report-medication-related-osteonecrosis-mronj-of-the-mandible-and-maxilla.html 2020-06-26T13:58:36.2910000Z https://www.medicinesresources.nhs.uk/first-clinical-trial-of-tlr7-and-8-inhibitor-as-a-potential-treatment-for-severe-symptoms-of-covid-19-infection.html 2020-06-26T14:00:11.2410000Z https://www.medicinesresources.nhs.uk/us-fda-approves-fenfluramine-fintepla-for-treatment-of-seizures-associated-with-dravet-syndrome-in-patients-age-2-and-older.html 2020-06-26T14:01:12.6010000Z https://www.medicinesresources.nhs.uk/topical-terbinafine-meets-primary-endpoint-in-phase-3-study-of-onychomycosis-patients.html 2020-06-26T14:02:14.9520000Z https://www.medicinesresources.nhs.uk/denosumab-raloxifene-romosozumab-and-teriparatide-to-prevent-osteoporotic-fragility-fractures-a-systematic-review-and-economic-evaluation.html 2020-06-29T08:44:03.0210000Z https://www.medicinesresources.nhs.uk/osteoporosis-evidence-for-vitamin-d-and-calcium-in-older-people.html 2020-06-26T15:00:30.8610000Z https://www.medicinesresources.nhs.uk/shortage-of-isoniazid-50mg-tablets.html 2020-06-26T15:01:36.4210000Z https://www.medicinesresources.nhs.uk/abiraterone-for-newly-diagnosed-high-risk-hormone-sensitive-metastatic-prostate-cancer-final-appraisal-document.html 2020-06-26T15:57:53.1580000Z https://www.medicinesresources.nhs.uk/the-state-of-health-care-quality-measurement-in-the-era-of-covid-19.html 2020-06-26T15:04:01.5930000Z https://www.medicinesresources.nhs.uk/evaluation-of-chilblains-as-a-manifestation-of-the-covid-19-pandemic.html 2020-06-26T15:52:54.9030000Z https://www.medicinesresources.nhs.uk/assessment-of-acute-acral-lesions-in-a-case-series-of-children-and-adolescents-during-the-covid-19-pandemic.html 2020-06-26T16:05:44.8730000Z https://www.medicinesresources.nhs.uk/neurological-and-neuropsychiatric-complications-of-covid-19-in-153-patients-a-uk-wide-surveillance-study.html 2020-09-17T13:27:35.7000000Z https://www.medicinesresources.nhs.uk/oral-nitrate-supplementation-to-enhance-pulmonary-rehabilitation-in-copd-on-epic-a-multicentre-double-blind-placebo-controlled-randomised-parallel-group-study.html 2020-06-26T15:56:26.2870000Z https://www.medicinesresources.nhs.uk/revised-spc-topogyne-misoprostol-400-microgram-tablets.html 2020-06-29T14:23:38.6460000Z https://www.medicinesresources.nhs.uk/kalydeco-ivacaftor-all-formulations.html 2020-06-29T16:18:53.4980000Z https://www.medicinesresources.nhs.uk/revised-spc-dynastat-parecoxib-sodium-all-formulations.html 2020-06-29T14:27:21.2560000Z https://www.medicinesresources.nhs.uk/revised-spc-evra-ethinylestradiol-norelgestromin-transdermal-patch.html 2020-06-29T14:28:36.2880000Z https://www.medicinesresources.nhs.uk/routine-revascularization-versus-initial-medical-therapy-for-stable-ischemic-heart-disease-a-systematic-review-and-meta-analysis-of-randomized-trials.html 2020-08-20T10:54:11.3110000Z https://www.medicinesresources.nhs.uk/comparison-of-intravitreal-dexamethasone-implant-and-anti-vegf-drugs-in-the-treatment-of-retinal-vein-occlusion-induced-oedema-a-meta-analysis-and-systematic-review.html 2020-06-29T14:32:11.5380000Z https://www.medicinesresources.nhs.uk/evaluation-of-the-general-practice-pharmacist-gpp-intervention-to-optimise-prescribing-in-irish-primary-care-a-non-randomised-pilot-study.html 2020-06-29T14:33:28.5530000Z https://www.medicinesresources.nhs.uk/association-between-hydrochlorothiazide-exposure-and-different-incident-skin-lip-and-oral-cavity-cancers-a-series-of-population-based-nested-case-control-studies.html 2020-07-06T10:55:48.2270000Z https://www.medicinesresources.nhs.uk/safety-and-effectiveness-of-a-four-factor-prothrombin-complex-concentrate-for-vitamin-k-antagonist-reversal-following-a-fixed-dose-strategy.html 2020-06-29T14:38:58.8930000Z https://www.medicinesresources.nhs.uk/patterns-of-oral-anticoagulation-use-with-cardioversion-in-clinical-practice.html 2020-06-29T14:40:20.2120000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-and-outcomes-in-patients-with-coronavirus-disease-2019-and-multiple-sclerosis.html 2020-06-29T14:41:55.7260000Z https://www.medicinesresources.nhs.uk/sodium-and-health-concordance-and-controversy.html 2020-06-29T14:43:32.7300000Z https://www.medicinesresources.nhs.uk/can-nutrition-support-healthy-cognitive-ageing-and-reduce-dementia-risk.html 2020-06-29T14:45:02.4440000Z https://www.medicinesresources.nhs.uk/pegylated-liposomal-doxorubicin-related-palmar-plantar-erythrodysesthesia-a-literature-review-of-pharmaceutical-and-clinical-aspects.html 2020-06-29T16:12:40.8330000Z https://www.medicinesresources.nhs.uk/lancet-seminar-pancreatic-cancer.html 2020-06-29T14:48:57.2700000Z https://www.medicinesresources.nhs.uk/ensuring-uptake-of-vaccines-against-sars-cov-2.html 2020-10-01T13:04:13.1180000Z https://www.medicinesresources.nhs.uk/nhs-boosts-support-for-pregnant-black-and-ethnic-minority-women.html 2020-06-29T16:10:53.2480000Z https://www.medicinesresources.nhs.uk/health-secretary-calls-on-country-to-get-tested-as-access-is-expanded-even-further.html 2020-06-29T14:53:59.7750000Z https://www.medicinesresources.nhs.uk/evaluating-social-prescribing.html 2020-06-29T16:09:16.9210000Z https://www.medicinesresources.nhs.uk/shielding-update-letter-to-patients-22-june-2020.html 2020-06-29T15:10:21.5870000Z https://www.medicinesresources.nhs.uk/us-fda-issues-complete-response-letter-rejecting-allergans-biologics-license-application-for-abicipar-pegol-for-neovascular-age-related-macular-degeneration.html 2020-06-29T15:11:49.4030000Z https://www.medicinesresources.nhs.uk/us-fda-grants-marketing-approval-of-octreotide-mycapssa-capsules-for-maintenance-therapy-of-adults-with-acromegaly.html 2020-06-29T15:13:36.6200000Z https://www.medicinesresources.nhs.uk/bayes-based-dosing-of-infliximab-in-inflammatory-bowel-diseases-short-term-efficacy.html 2020-06-29T15:16:27.0690000Z https://www.medicinesresources.nhs.uk/product-discontinuation-tremfya-guselkumab-100-mg-solution-for-injection-in-pre-filled-syringe.html 2020-06-30T14:46:44.5220000Z https://www.medicinesresources.nhs.uk/revised-spc-tygacil-tigecycline-50mg-powder-for-solution-for-infusion-1.html 2020-06-30T14:48:33.4860000Z https://www.medicinesresources.nhs.uk/new-product-magnesium-4mmol-chewable-tablets.html 2020-06-30T14:49:30.6970000Z https://www.medicinesresources.nhs.uk/revised-spc-soliris-eculizumab-300-mg-concentrate-for-solution-for-infusion.html 2020-06-30T14:50:48.9480000Z https://www.medicinesresources.nhs.uk/direct-acting-oral-anticoagulants-doacs-reminder-of-bleeding-risk-including-availability-of-reversal-agents.html 2020-07-06T09:40:00.1950000Z https://www.medicinesresources.nhs.uk/cyproterone-acetate-new-advice-to-minimise-risk-of-meningioma.html 2020-07-06T09:46:25.3230000Z https://www.medicinesresources.nhs.uk/comparative-effectiveness-of-glucose-lowering-drugs-for-type-2-diabetes.html 2020-07-06T11:00:59.9940000Z https://www.medicinesresources.nhs.uk/use-of-anakinra-to-prevent-mechanical-ventilation-in-severe-covid-19-a-case-series.html 2020-06-30T15:01:20.9190000Z https://www.medicinesresources.nhs.uk/prescription-of-suboptimal-statin-treatment-regimens-a-retrospective-cohort-study-of-trends-and-variation-in-english-primary-care.html 2020-07-06T10:03:17.7640000Z https://www.medicinesresources.nhs.uk/cangrelor-tirofiban-and-chewed-or-standard-prasugrel-regimens-in-patients-with-st-segment-elevation-myocardial-infarction-primary-results-of-the-fabolus-faster-trial.html 2020-08-20T10:50:24.1510000Z https://www.medicinesresources.nhs.uk/prediction-of-adverse-cardiac-events-in-pregnant-women-with-valvular-rheumatic-heart-disease.html 2020-06-30T15:06:03.1310000Z https://www.medicinesresources.nhs.uk/finomel-emulsion-for-infusion-42-glucose-10-amino-acid-20-lipid-interim-supply-of-belgian-stock-to-mitigate-supply-disruption.html 2020-06-30T15:46:10.5270000Z https://www.medicinesresources.nhs.uk/semglee-100-units-ml-x-3ml-prefilled-pens-insulin-glargine-interim-supply-of-polish-stock-to-mitigate-supply-disruption.html 2020-06-30T15:47:52.9460000Z https://www.medicinesresources.nhs.uk/short-term-availability-of-belimumab-pre-filled-pen-formulation-for-subcutaneous-sc-administration-during-the-current-covid-19-situation.html 2020-06-30T15:49:21.3720000Z https://www.medicinesresources.nhs.uk/important-information-for-healthcare-professionals-regarding-administration-of-verorab-rabies-vaccine-inactivated.html 2020-06-30T15:50:34.6760000Z https://www.medicinesresources.nhs.uk/clozaril-25-mg-tablets-clozapine-interim-supply-of-danish-and-swedish-stock-to-mitigate-supply-disruption.html 2020-06-30T15:51:34.8820000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-depo-provera-150mg-ml-injection-1ml-vial.html 2020-06-30T15:52:38.6750000Z https://www.medicinesresources.nhs.uk/covid-19-oxford-team-begins-vaccine-trials-in-brazil-and-south-africa-to-determine-efficacy.html 2020-06-30T15:53:53.3020000Z https://www.medicinesresources.nhs.uk/food-and-mood-how-do-diet-and-nutrition-affect-mental-wellbeing.html 2020-06-30T15:55:01.1430000Z https://www.medicinesresources.nhs.uk/health-effects-of-vitamin-and-mineral-supplements.html 2020-06-30T15:56:29.6520000Z https://www.medicinesresources.nhs.uk/us-fda-approves-pembrolizumab-for-first-line-treatment-of-patients-with-unresectable-or-metastatic-microsatellite-instability-high-or-mismatch-repair-deficient-colorectal-cancer.html 2020-06-30T15:57:43.0080000Z https://www.medicinesresources.nhs.uk/us-fda-approves-phesgo-pertuzumab-trastuzumab-and-hyaluronidase-for-treatment-of-breast-cancer.html 2020-06-30T15:58:57.0370000Z https://www.medicinesresources.nhs.uk/company-announces-positive-data-from-phase-3-trial-rhapsody-of-rilonacept-in-recurrent-pericarditis.html 2020-06-30T16:00:11.6040000Z https://www.medicinesresources.nhs.uk/no-clinical-benefit-from-use-of-lopinavir-ritonavir-in-hospitalised-covid-19-patients-studied-in-recovery-trial.html 2020-06-30T16:56:21.6870000Z https://www.medicinesresources.nhs.uk/european-commission-approves-reblozyl-luspatercept-for-treatment-of-transfusion-dependent-anaemia-associated-with-myelodysplastic-syndromes-or-beta-thalassaemia.html 2020-06-30T16:56:50.0780000Z https://www.medicinesresources.nhs.uk/availability-of-epipen-0-15mg-and-0-3mg-adrenaline-auto-injectors-us-labelled-epipen-0-3mg.html 2020-07-06T10:33:48.3090000Z https://www.medicinesresources.nhs.uk/oral-vitamin-b12-what-are-the-prescribing-considerations-and-what-formulations-are-available.html 2020-07-06T10:38:31.1370000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-evidence-summary-vitamin-d-for-covid-19.html 2020-07-06T10:42:08.4850000Z https://www.medicinesresources.nhs.uk/multisystem-inflammatory-syndrome-in-u-s-children-and-adolescents.html 2020-10-01T12:32:52.8610000Z https://www.medicinesresources.nhs.uk/multisystem-inflammatory-syndrome-in-children-in-new-york-state.html 2020-06-30T16:55:02.6350000Z https://www.medicinesresources.nhs.uk/atezolizumab-with-nab-paclitaxel-for-untreated-pd-l1-positive-locally-advanced-or-metastatic-triple-negative-breast-cancer-guidance-ta639.html 2020-07-06T06:51:20.5740000Z https://www.medicinesresources.nhs.uk/atezolizumab-with-carboplatin-and-etoposide-for-untreated-extensive-stage-small-cell-lung-cancer-guidance-ta638.html 2020-07-06T06:46:41.7230000Z https://www.medicinesresources.nhs.uk/clinical-guidance-for-healthcare-professionals-on-maintaining-immunisation-programmes-during-covid-19.html 2020-07-06T06:52:28.0710000Z https://www.medicinesresources.nhs.uk/provision-of-pre-exposure-prophylaxis-prep-for-hiv-prevention-in-wales-april-2020.html 2020-07-01T15:26:17.9030000Z https://www.medicinesresources.nhs.uk/revised-spc-xermelo-telotristat-ethyl-250-mg-film-coated-tablets.html 2020-07-01T15:28:10.0450000Z https://www.medicinesresources.nhs.uk/new-product-inhixa-enoxaparin-sodium-30-000-iu-300-mg-3-ml-solution-for-injection-in-multidose-vial.html 2020-07-01T16:57:21.7280000Z https://www.medicinesresources.nhs.uk/new-product-zolgensma-onasemnogene-abeparvovec-2-x-1013-vector-genomes-ml-solution-for-infusion.html 2020-07-01T17:04:43.3890000Z https://www.medicinesresources.nhs.uk/rapid-antigen-detection-and-molecular-tests-for-group-a-streptococcal-infections-for-acute-sore-throat-systematic-review-and-economic-evaluation.html 2020-07-01T16:11:23.6830000Z https://www.medicinesresources.nhs.uk/scientific-advisory-committee-on-nutrition-sacn-and-nice-find-insufficient-evidence-for-vitamin-d-in-prevention-or-treatment-of-acute-respiratory-tract-infections-artis.html 2020-07-06T07:10:11.2090000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-309-june-2020.html 2020-07-06T07:10:57.9710000Z https://www.medicinesresources.nhs.uk/increased-access-to-elocta-efmoroctocog-alfa-on-nhs-through-lifting-of-previous-volume-restrictions.html 2020-07-01T15:41:18.5470000Z https://www.medicinesresources.nhs.uk/general-pharmaceutical-council-issues-joint-letter-with-the-competition-and-markets-authority-to-pharmacies-on-pricing-during-the-covid-19-pandemic.html 2020-07-01T15:42:23.1890000Z https://www.medicinesresources.nhs.uk/revalidation-requirements-from-september-2020-for-pharmacists-during-covid-19-pandemic.html 2020-07-01T15:44:01.3910000Z https://www.medicinesresources.nhs.uk/effects-of-tobacco-cigarettes-e-cigarettes-and-waterpipe-smoking-on-endothelial-function-and-clinical-outcomes.html 2020-07-01T16:12:16.8830000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-and-korean-ministry-of-food-and-drug-safety-to-share-confidential-information-on-treatment-diagnosis-or-prevention-of-covid-19.html 2020-07-01T15:47:14.1800000Z https://www.medicinesresources.nhs.uk/non-adherence-in-non-inferiority-trials-pitfalls-and-recommendations.html 2020-07-01T15:50:18.5460000Z https://www.medicinesresources.nhs.uk/the-moral-imperative-to-include-pregnant-women-in-clinical-trials-of-interventions-for-covid-19.html 2020-07-01T15:51:52.1760000Z https://www.medicinesresources.nhs.uk/why-n95-should-be-the-standard-for-all-covid-19-inpatient-care.html 2020-07-01T15:53:16.0860000Z https://www.medicinesresources.nhs.uk/gilead-prices-covid-19-drug-remdesivir-at-usd2340-per-patient-in-developed-nations.html 2020-07-01T16:44:23.8700000Z https://www.medicinesresources.nhs.uk/cannabis-based-gel-zygel-for-fragile-x-syndrome-fails-to-meet-studys-primary-endpoint.html 2020-07-01T15:56:25.3220000Z https://www.medicinesresources.nhs.uk/european-chmp-supports-licence-change-for-ataluren-translarna-for-non-ambulatory-patients-with-duchenne-muscular-dystrophy.html 2020-07-01T16:42:52.3720000Z https://www.medicinesresources.nhs.uk/new-drug-application-submitted-to-fda-for-accelerated-approval-of-melflufen-injection-in-combination-with-dexamethasone-for-treatment-of-triple-class-refractory-multiple-myeloma.html 2020-07-01T15:59:48.4860000Z https://www.medicinesresources.nhs.uk/new-drug-application-submitted-to-fda-for-tenapanor-for-the-control-of-serum-phosphorus-in-adult-patients-with-ckd-on-dialysis.html 2020-07-01T16:01:20.2030000Z https://www.medicinesresources.nhs.uk/fda-approves-triheptanoin-dojolvi-as-a-source-of-calories-and-fatty-acids-for-the-treatment-of-long-chain-fatty-acid-oxidation-disorders-lc-faod.html 2020-07-01T16:03:22.5880000Z https://www.medicinesresources.nhs.uk/patients-with-cystic-fibrosis-to-have-access-to-kaftrio-ivacaftor-tezacaftor-elexacaftor-under-deal-between-nhs-and-vertex.html 2020-07-06T07:22:21.4310000Z https://www.medicinesresources.nhs.uk/fda-approves-supplemental-biologics-license-application-for-avelumab-bavencio-as-first-line-maintenance-treatment-for-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma.html 2020-07-01T16:07:02.6010000Z https://www.medicinesresources.nhs.uk/scripps-research-institute-reports-mutated-covid-19-viral-strain-g614-in-u-s-and-europe-that-is-10-times-more-contagious-than-original-strain-d614.html 2020-07-01T16:08:11.6010000Z https://www.medicinesresources.nhs.uk/progesterone-to-prevent-miscarriage-in-women-with-early-pregnancy-bleeding-the-prism-rct.html 2020-07-01T16:11:50.5670000Z https://www.medicinesresources.nhs.uk/the-effect-of-frailty-on-survival-in-patients-with-covid-19-cope-a-multicentre-european-observational-cohort-study.html 2020-07-01T16:37:59.6090000Z https://www.medicinesresources.nhs.uk/endotheliopathy-in-covid-19-associated-coagulopathy-evidence-from-a-single-centre-cross-sectional-study.html 2020-07-01T16:36:25.3790000Z https://www.medicinesresources.nhs.uk/association-between-penicillin-allergy-documentation-and-antibiotic-use.html 2020-07-01T16:18:59.3820000Z https://www.medicinesresources.nhs.uk/the-relationship-between-alcohol-related-hospital-admission-and-specialist-alcohol-treatment-provision-across-local-authorities-in-england-since-passage-of-the-health-and-social-care-act-2012.html 2020-07-01T16:21:01.3170000Z https://www.medicinesresources.nhs.uk/greater-risk-of-severe-covid-19-in-black-asian-and-minority-ethnic-populations-is-not-explained-by-cardiometabolic-socioeconomic-or-behavioural-factors-or-by-25-oh-vitamin-d-status-study-of-1326-cases-from-the-uk-biobank.html 2020-07-01T16:31:26.6990000Z https://www.medicinesresources.nhs.uk/a-retrospective-study-of-intramuscular-clozapine-prescription-for-treatment-initiation-and-maintenance-in-treatment-resistant-psychosis.html 2020-07-01T16:26:22.2080000Z https://www.medicinesresources.nhs.uk/revised-spcs-glivec-imatinib-100-and-400-mg-film-coated-tablets-1.html 2020-07-02T14:48:13.3600000Z https://www.medicinesresources.nhs.uk/new-product-aethoxysklerol-lauromacrogol-2-5-5-0-10-20-and-30mg-ml-solution-for-injection.html 2020-07-02T14:49:07.5000000Z https://www.medicinesresources.nhs.uk/new-product-mucolight-acetylcysteine-600mg-tablets.html 2020-07-02T14:50:35.7840000Z https://www.medicinesresources.nhs.uk/revised-spc-zejula-niraparib-100-mg-hard-capsules.html 2020-07-02T14:51:55.8920000Z https://www.medicinesresources.nhs.uk/european-commission-approves-ebola-vaccine-regimen-for-the-prevention-of-ebola-virus-disease-caused-by-zaire-ebolavirus-species-in-individuals-aged-one-year-and-above.html 2020-07-02T14:53:05.2480000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-june-2020.html 2020-07-05T15:34:07.6790000Z https://www.medicinesresources.nhs.uk/medicines-use-and-safety-update-july-2020.html 2020-07-05T15:38:41.5950000Z https://www.medicinesresources.nhs.uk/fda-approves-phase-iii-clinical-trial-evaluating-siltuximab-plus-standard-of-care-for-patients-with-covid-19-associated-acute-respiratory-distress-syndrome-ards.html 2020-07-02T14:55:21.1000000Z https://www.medicinesresources.nhs.uk/children-in-lockdown-the-consequences-of-the-coronavirus-crisis-for-children-living-in-poverty.html 2020-07-02T16:14:20.3320000Z https://www.medicinesresources.nhs.uk/recovery-position-what-next-for-the-nhs.html 2020-07-02T16:09:31.2940000Z https://www.medicinesresources.nhs.uk/bipolar-disorder.html 2020-10-01T13:21:22.4380000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-rheumatological-autoimmune-inflammatory-and-metabolic-bone-disorders-updated-guideline-ng167.html 2020-07-05T15:41:03.2480000Z https://www.medicinesresources.nhs.uk/colchicine-for-acute-and-chronic-coronary-syndromes.html 2020-07-02T16:08:00.4760000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-has-endorsed-a-joint-statement-on-prioritisation-of-covid-19-clinical-trials-published-by-the-international-coalition-of-medicines-regulatory-authorities-icmra.html 2020-07-02T16:07:12.9960000Z https://www.medicinesresources.nhs.uk/government-launches-second-phase-of-independent-review-into-drug-misuse.html 2020-07-02T16:06:15.9060000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-mepacrine-hydrochloride-100-mg-tablets-batch-85641-el-20-a-27.html 2020-07-02T15:03:01.4080000Z https://www.medicinesresources.nhs.uk/mhra-approves-resumption-of-global-covid-19-prevention-trial-of-hydroxychloroquine-copcov.html 2020-07-02T15:04:00.8180000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-committee-for-orphan-medicinal-products-issues-positive-opinion-on-application-for-orphan-drug-designation-of-imetelstat-as-potential-treatment-for-myelodysplastic-syndromes-mds.html 2020-07-02T15:05:09.6770000Z https://www.medicinesresources.nhs.uk/new-drug-application-resubmitted-to-fda-for-furoscix-subcutaneous-furosemide-for-treatment-of-congestion-in-patients-with-heart-failure.html 2020-07-02T15:06:06.3380000Z https://www.medicinesresources.nhs.uk/marketing-authorization-application-submitted-to-european-medicines-agency-for-setmelanotide-as-treatment-of-pro-opiomelanocortin-pomc-and-leptin-receptor-lepr-deficiency-obesities.html 2020-07-02T16:03:40.9200000Z https://www.medicinesresources.nhs.uk/new-drug-application-submitted-to-fda-for-pralsetinib-for-treatment-of-advanced-ret-mutant-and-ret-fusion-positive-thyroid-cancers.html 2020-07-02T15:09:28.0280000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-announce-early-positive-data-from-ongoing-phase-1-2-study-of-mrna-based-vaccine-candidate-bnt162b1-against-sars-cov-2.html 2020-07-02T15:10:38.4780000Z https://www.medicinesresources.nhs.uk/new-h1n1-strain-reported-in-china.html 2020-07-02T15:11:29.4870000Z https://www.medicinesresources.nhs.uk/developing-a-medications-policy-and-procedures-for-use-in-social-care.html 2020-07-02T15:14:41.2510000Z https://www.medicinesresources.nhs.uk/efficacy-of-vitamin-d3-supplementation-for-the-prevention-of-pulmonary-tuberculosis-and-mortality-in-hiv-a-randomised-double-blind-placebo-controlled-trial.html 2020-07-02T15:16:34.4460000Z https://www.medicinesresources.nhs.uk/population-based-estimates-of-healthy-working-life-expectancy-in-england-at-age-50-years-analysis-of-data-from-the-english-longitudinal-study-of-ageing.html 2020-07-02T15:19:23.7540000Z https://www.medicinesresources.nhs.uk/severe-hypoglycemia-and-risk-of-falls-in-type-2-diabetes-the-atherosclerosis-risk-in-communities-aric-study.html 2020-07-02T15:22:37.6310000Z https://www.medicinesresources.nhs.uk/association-between-glycemic-status-and-the-risk-of-parkinson-disease-a-nationwide-population-based-study.html 2020-07-02T15:24:03.8810000Z https://www.medicinesresources.nhs.uk/association-of-bempedoic-acid-administration-with-atherogenic-lipid-levels-in-phase-3-randomized-clinical-trials-of-patients-with-hypercholesterolemia.html 2020-07-02T15:27:06.2510000Z https://www.medicinesresources.nhs.uk/evaluation-of-a-comprehensive-skin-toxicity-program-for-patients-treated-with-epidermal-growth-factor-receptor-inhibitors-at-a-cancer-treatment-center.html 2020-07-02T15:57:17.6700000Z https://www.medicinesresources.nhs.uk/association-of-end-point-definition-and-randomized-clinical-trial-duration-in-clinical-trials-of-schizophrenia-medications.html 2020-07-02T15:32:40.1740000Z https://www.medicinesresources.nhs.uk/treatment-with-ace-inhibitors-or-arbs-and-risk-of-severe-lethal-covid-19-a-meta-analysis.html 2020-07-05T15:51:59.0650000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-of-pracinostat-in-acute-myeloid-leukaemia-discontinued.html 2020-07-03T14:20:32.5670000Z https://www.medicinesresources.nhs.uk/us-fda-approves-fostemsavir-for-the-treatment-of-hiv-in-heavily-pre-treated-adults-with-limited-treatment-options.html 2020-07-03T14:21:55.6080000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-of-sarilumab-in-covid-19-patients-requiring-mechanical-ventilation-fails-to-meet-primary-and-key-secondary-endpoints.html 2020-07-03T14:22:55.8080000Z https://www.medicinesresources.nhs.uk/results-from-the-2019-adult-inpatient-survey-published.html 2020-07-05T14:49:46.8290000Z https://www.medicinesresources.nhs.uk/anti-pd-1-therapy-associated-type-1-diabetes-in-a-pediatricpaediatric-patient-with-relapsed-classical-hodgkin-lymphoma.html 2020-07-03T14:54:19.8700000Z https://www.medicinesresources.nhs.uk/limited-evidence-for-the-health-effects-and-safety-of-intermittent-fasting-among-patients-with-type-2-diabetes.html 2020-07-07T10:19:49.8120000Z https://www.medicinesresources.nhs.uk/covid-19-pandemic-an-opportunity-to-reduce-and-eliminate-low-value-practices-in-oncology.html 2020-07-03T14:53:00.1810000Z https://www.medicinesresources.nhs.uk/regular-coronavirus-retesting-rolled-out-for-care-home-staff-and-residents.html 2020-07-03T14:33:45.7170000Z https://www.medicinesresources.nhs.uk/returning-the-nhs-to-an-even-keel.html 2020-07-03T14:35:15.6800000Z https://www.medicinesresources.nhs.uk/new-nhs-test-and-trace-guidance-for-pharmacy-contractors.html 2020-07-03T14:36:39.1760000Z https://www.medicinesresources.nhs.uk/nearly-a-quarter-of-pcns-did-not-claim-nhs-funding-to-hire-extra-pharmacists.html 2020-07-03T14:37:43.5110000Z https://www.medicinesresources.nhs.uk/electronic-prescription-service-eps-prescriptions-now-over-85-of-total-items.html 2020-07-03T14:39:18.9770000Z https://www.medicinesresources.nhs.uk/strategic-health-authorities-and-regions-lessons-from-history.html 2020-07-03T14:40:12.6820000Z https://www.medicinesresources.nhs.uk/neurological-associations-of-covid-19.html 2020-07-03T14:41:22.0450000Z https://www.medicinesresources.nhs.uk/covid-19-patient-rehabilitation-booklet.html 2020-07-03T14:44:14.8310000Z https://www.medicinesresources.nhs.uk/dual-antiplatelet-therapy-post-mi-an-audit-of-post-acute-coronary-syndrome-ticagrelor-prescription-at-leigh-family-practice.html 2020-07-03T14:46:31.9890000Z https://www.medicinesresources.nhs.uk/prevalence-of-mutations-associated-with-resistance-to-macrolides-and-fluoroquinolones-in-mycoplasma-genitalium-a-systematic-review-and-meta-analysis.html 2020-07-03T14:49:19.0640000Z https://www.medicinesresources.nhs.uk/in-hospital-use-of-statins-is-associated-with-a-reduced-risk-of-mortality-among-individuals-with-covid-19.html 2020-07-03T14:56:15.4730000Z https://www.medicinesresources.nhs.uk/influence-of-renin-angiotensin-system-inhibitors-on-lower-respiratory-tract-infections-in-type-2-diabetes-the-fremantle-diabetes-study-phase-ii.html 2020-07-03T14:57:48.0770000Z https://www.medicinesresources.nhs.uk/temporal-trend-in-young-onset-type-2-diabetes-the-macrovascular-and-mortality-risk-study-of-u-k-primary-care-electronic-medical-records.html 2020-07-03T14:58:53.3280000Z https://www.medicinesresources.nhs.uk/randomized-double-blind-clinical-trial-comparing-ultra-rapid-lispro-with-lispro-in-a-basal-bolus-regimen-in-patients-with-type-2-diabetes-pronto-t2d.html 2020-07-03T15:00:05.7710000Z https://www.medicinesresources.nhs.uk/risk-of-ischemic-stroke-in-patients-with-coronavirus-disease-2019-covid-19-vs-patients-with-influenza.html 2020-07-03T15:01:15.7060000Z https://www.medicinesresources.nhs.uk/teriparatide-promotes-bone-healing-in-medication-related-osteonecrosis-of-the-jaw-a-placebo-controlled-randomized-trial.html 2020-08-10T14:48:06.6970000Z https://www.medicinesresources.nhs.uk/differential-benefit-of-adjuvant-docetaxel-based-chemotherapy-in-patients-with-early-breast-cancer-according-to-baseline-body-mass-index.html 2020-08-10T14:43:21.9140000Z https://www.medicinesresources.nhs.uk/revised-spc-yescarta-axicabtagene-ciloleucel-dispersion-for-infusion-1.html 2020-07-03T15:56:28.9150000Z https://www.medicinesresources.nhs.uk/revised-spc-cyramza-10-mg-ml-concentrate-for-solution-for-infusion.html 2020-07-03T15:57:22.2600000Z https://www.medicinesresources.nhs.uk/revised-spcs-topamax-topiramate-all-formulations.html 2020-07-03T15:58:21.7930000Z https://www.medicinesresources.nhs.uk/revised-spcs-pradaxa-dabigatran-hard-capsules.html 2020-07-03T15:59:27.8190000Z https://www.medicinesresources.nhs.uk/revised-spc-ultomiris-ravulizumab-300-mg-concentrate-for-solution-for-infusion.html 2020-07-03T16:00:42.3790000Z https://www.medicinesresources.nhs.uk/revised-spcs-oxycontin-oxycodone-prolonged-release-tablets.html 2020-07-03T16:01:50.7980000Z https://www.medicinesresources.nhs.uk/publication-of-an-interim-clinical-commissioning-policy-remdesivir-for-patients-hospitalised-with-covid-19-adults-and-children-of-12-years-and-older.html 2020-07-05T14:36:26.6380000Z https://www.medicinesresources.nhs.uk/meeting-people-from-outside-your-household.html 2020-07-09T10:06:34.6620000Z https://www.medicinesresources.nhs.uk/the-effect-of-food-taxes-and-subsidies-on-population-health-and-health-costs-a-modelling-study.html 2020-07-07T10:22:46.8230000Z https://www.medicinesresources.nhs.uk/the-effect-of-initiation-of-renin-angiotensin-system-inhibitors-on-haemoglobin-a-national-cohort-study.html 2020-07-06T14:19:40.7710000Z https://www.medicinesresources.nhs.uk/bmj-editorial-dexamethasone-in-the-management-of-covid-19.html 2020-07-06T14:58:37.2670000Z https://www.medicinesresources.nhs.uk/do-psychotropic-drugs-used-during-covid-19-therapy-have-an-effect-on-the-treatment-process.html 2020-07-10T14:38:16.5650000Z https://www.medicinesresources.nhs.uk/european-commission-grants-conditional-marketing-authorisation-to-remdesivir-veklury-for-treatment-of-covid-19.html 2020-07-09T10:07:54.7700000Z https://www.medicinesresources.nhs.uk/dont-rely-on-temperature-screening-products-for-detection-of-coronavirus-covid-19-says-mhra.html 2020-07-09T10:24:30.3510000Z https://www.medicinesresources.nhs.uk/nhs-to-launch-online-covid-19-rehab-service.html 2020-07-13T07:29:02.1590000Z https://www.medicinesresources.nhs.uk/coronavirus-health-and-social-care-key-issues-and-sources.html 2020-07-06T14:36:17.0290000Z https://www.medicinesresources.nhs.uk/regional-coronavirus-cases-and-triage-figures-published-in-new-interactive-dashboard.html 2020-07-06T14:37:15.7710000Z https://www.medicinesresources.nhs.uk/gsk-complete-the-cycle-inhaler-recycling-scheme-to-close-september-2020.html 2020-07-10T14:41:53.9620000Z https://www.medicinesresources.nhs.uk/uk-study-to-research-long-term-health-impact-of-covid-19.html 2020-07-06T14:39:28.8730000Z https://www.medicinesresources.nhs.uk/early-guidance-on-the-2020-21-seasonal-influenza-vaccination-advanced-service.html 2020-07-07T12:57:54.8190000Z https://www.medicinesresources.nhs.uk/evorel-supply-update-july-2020.html 2020-07-06T14:44:40.0260000Z https://www.medicinesresources.nhs.uk/evidence-for-the-impact-of-interventions-and-medicines-reconciliation-on-problematic-polypharmacy-in-the-uk-a-rapid-review-of-systematic-reviews.html 2020-07-06T14:50:59.3040000Z https://www.medicinesresources.nhs.uk/warfarin-and-food-herbal-or-dietary-supplement-interactions-a-systematic-review.html 2020-07-06T14:52:15.4740000Z https://www.medicinesresources.nhs.uk/nihr-alert-new-research-supports-the-move-to-raise-the-blood-pressure-target-for-frail-older-people.html 2020-07-06T14:56:07.4010000Z https://www.medicinesresources.nhs.uk/nihr-alert-combined-drug-and-psychological-therapies-may-be-most-effective-for-depression.html 2020-07-06T14:58:57.9640000Z https://www.medicinesresources.nhs.uk/trodelvy-sacituzumab-govitecan-successful-in-phase-iii-ascent-breast-cancer-study-1.html 2020-07-07T16:09:49.2480000Z https://www.medicinesresources.nhs.uk/yselty-linzagolix-demonstrates-positive-results-in-two-phase-iii-trials-for-uterine-fibroids.html 2020-07-07T16:14:27.7790000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infections-in-the-community-in-england-july-2020.html 2020-07-07T14:46:52.8140000Z https://www.medicinesresources.nhs.uk/analysis-of-response-data-for-assessing-treatment-effects-in-comparative-clinical-studies.html 2020-07-07T14:47:51.1060000Z https://www.medicinesresources.nhs.uk/majority-of-children-currently-considered-extremely-clinical-vulnerable-to-covid-19-will-no-longer-need-to-shield.html 2020-07-07T16:15:49.6710000Z https://www.medicinesresources.nhs.uk/early-guidance-on-the-2020-21-seasonal-influenza-vaccination-advanced-service-1.html 2020-07-09T10:33:16.3770000Z https://www.medicinesresources.nhs.uk/budget-for-already-delayed-pre-exposure-prophylaxis-prep-rollout-in-england-cut-by-almost-a-third.html 2020-07-07T14:51:06.8340000Z https://www.medicinesresources.nhs.uk/the-european-commission-has-approved-enerzair-breezhaler-indacaterol-acetate-glycopyrronium-bromide-and-mometasone-furoate-for-uncontrolled-asthma.html 2020-07-07T16:17:07.3260000Z https://www.medicinesresources.nhs.uk/nhs-launches-your-covid-recovery-service.html 2020-07-07T14:52:55.0390000Z https://www.medicinesresources.nhs.uk/the-development-of-covid-19-vaccines-safeguards-needed.html 2020-07-07T14:54:54.7130000Z https://www.medicinesresources.nhs.uk/developing-a-sars-cov-2-vaccine-at-warp-speed.html 2020-07-07T16:07:40.7100000Z https://www.medicinesresources.nhs.uk/regeneron-launches-phase-iii-covid-19-prevention-trial-with-antibody-cocktail-regn-cov2.html 2020-07-07T14:58:00.0330000Z https://www.medicinesresources.nhs.uk/new-product-veklury-remdesivir-100-mg-solution-for-infusion-all-products.html 2020-07-09T10:09:00.9260000Z https://www.medicinesresources.nhs.uk/new-product-isturisa-osilodrostat-phosphate-film-coated-tablets-all-strengths.html 2020-07-07T16:32:25.7150000Z https://www.medicinesresources.nhs.uk/comparative-effectiveness-of-biological-medicines-in-rheumatoid-arthritis-systematic-review-and-network-meta-analysis-including-aggregate-results-from-re-analysed-individual-patient-data.html 2020-07-09T10:12:14.2560000Z https://www.medicinesresources.nhs.uk/association-between-oral-corticosteroid-bursts-and-severe-adverse-events.html 2020-07-07T16:52:27.7130000Z https://www.medicinesresources.nhs.uk/clinical-validity-of-serum-antibodies-to-sars-cov-2.html 2020-07-07T16:42:01.2420000Z https://www.medicinesresources.nhs.uk/obesity-and-covid-19-in-new-york-city-a-retrospective-cohort-study.html 2020-07-07T16:42:42.2120000Z https://www.medicinesresources.nhs.uk/association-between-treatment-with-apixaban-dabigatran-rivaroxaban-or-warfarin-and-risk-for-osteoporotic-fractures-among-patients-with-atrial-fibrillation.html 2020-07-07T16:44:01.1320000Z https://www.medicinesresources.nhs.uk/association-between-palliative-care-and-healthcare-outcomes-among-adults-with-terminal-non-cancer-illness-population-based-matched-cohort-study.html 2020-07-07T16:44:55.1560000Z https://www.medicinesresources.nhs.uk/prevalence-of-sars-cov-2-in-spain-ene-covid-a-nationwide-population-based-seroepidemiological-study.html 2020-07-07T16:45:53.8960000Z https://www.medicinesresources.nhs.uk/cabozantinib-in-patients-with-platinum-refractory-metastatic-urothelial-carcinoma-an-open-label-single-centre-phase-2-trial.html 2020-07-07T16:46:51.7260000Z https://www.medicinesresources.nhs.uk/user-testing-guidelines-to-improve-the-safety-of-intravenous-medicines-administration-a-randomised-in-situ-simulation-study.html 2020-07-07T16:47:25.9310000Z https://www.medicinesresources.nhs.uk/service-users-experiences-of-contacting-nhs-patient-medicines-helpline-services-a-qualitative-study.html 2020-07-07T16:47:58.9400000Z https://www.medicinesresources.nhs.uk/revised-spc-tetralysal-lymecycline-capsules.html 2020-07-08T14:25:59.2970000Z https://www.medicinesresources.nhs.uk/revised-spc-vokanamet-canagliflozin-metformin-tablets.html 2020-07-08T14:27:21.2190000Z https://www.medicinesresources.nhs.uk/revised-spc-stribild-elvitegravir-cobicistat-emtricitabine-tenofovir-disoproxil-film-coated-tablets.html 2020-07-08T14:28:11.6960000Z https://www.medicinesresources.nhs.uk/revised-spc-tybost-cobicistat-tablets.html 2020-07-08T14:29:20.2110000Z https://www.medicinesresources.nhs.uk/antipsychotic-medication-versus-psychological-intervention-versus-a-combination-of-both-in-adolescents-with-first-episode-psychosis-maps-a-multicentre-three-arm-randomised-controlled-pilot-and-feasibility-study.html 2020-07-08T16:00:35.7030000Z https://www.medicinesresources.nhs.uk/association-of-statin-use-with-all-cause-and-cardiovascular-mortality-in-us-veterans-75-years-and-older.html 2020-07-08T14:33:27.0360000Z https://www.medicinesresources.nhs.uk/effect-of-probiotic-use-on-antibiotic-administration-among-care-home-residents-a-randomized-clinical-trial.html 2020-07-08T14:35:02.0310000Z https://www.medicinesresources.nhs.uk/varicose-veins-in-primary-care.html 2020-07-08T14:36:27.5190000Z https://www.medicinesresources.nhs.uk/fda-approves-decitabine-and-cedazuridine-oral-tablets-for-myelodysplastic-syndromes.html 2020-07-08T14:37:30.5430000Z https://www.medicinesresources.nhs.uk/manufacturers-report-efbemalenograstim-alpha-hits-primary-and-secondary-endpoints-in-phase-iii-trial.html 2020-07-08T14:38:41.7470000Z https://www.medicinesresources.nhs.uk/increase-in-use-of-electronic-prescriptions-during-coronavirus.html 2020-07-08T14:39:43.8600000Z https://www.medicinesresources.nhs.uk/viiv-reports-new-phase-iib-iii-data-for-cabotegravir-in-hiv-pre-exposure-prophyalxis.html 2020-07-08T16:02:42.9700000Z https://www.medicinesresources.nhs.uk/olaparib-approved-for-use-in-eu-for-pancreatic-cancer.html 2020-07-08T14:42:04.5920000Z https://www.medicinesresources.nhs.uk/covid-19-the-inside-story-of-the-recovery-trial.html 2020-07-09T09:57:53.7850000Z https://www.medicinesresources.nhs.uk/workforce-race-inequalities-and-inclusion-in-nhs-providers.html 2020-07-08T15:53:50.4540000Z https://www.medicinesresources.nhs.uk/revised-spc-nerlynx-neratinib-40-mg-film-coated-tablets-1.html 2020-07-09T14:46:28.7470000Z https://www.medicinesresources.nhs.uk/revised-spc-chloraprep-chlorhexidine-gluconate.html 2020-07-09T16:06:32.9910000Z https://www.medicinesresources.nhs.uk/new-product-sovaldi-sofosbuvir-200-and-400-mg-coated-granules-in-sachet.html 2020-07-09T14:49:44.8680000Z https://www.medicinesresources.nhs.uk/revised-spc-solvaldi-sofosbuvir-400-mg-and-200-mg-film-coated-tablets.html 2020-07-09T14:51:44.1420000Z https://www.medicinesresources.nhs.uk/revised-spc-delstrigo-doravirine-100-mg-lamivudine-300-mg-tenofovir-245-mg-film-coated-tablets.html 2020-07-09T14:53:10.3930000Z https://www.medicinesresources.nhs.uk/evaluation-of-the-use-of-capecitabine-for-the-treatment-and-prevention-of-actinic-keratoses-squamous-cell-carcinoma-and-basal-cell-carcinoma-a-systematic-review.html 2020-07-09T14:54:37.3260000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-statement-serum-eye-drops-for-the-treatment-of-severe-ocular-surface-disease-all-ages.html 2020-07-10T14:24:12.4840000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-infliximab-for-refractory-or-progressive-neurosarcoidosis-adults-and-post-pubescent-children.html 2020-07-10T14:24:41.1330000Z https://www.medicinesresources.nhs.uk/use-of-corticosteroids-in-asthma-and-copd-patients-with-or-without-covid-19.html 2020-07-13T07:23:24.8450000Z https://www.medicinesresources.nhs.uk/competition-and-markets-authority-cma-levies-fines-of-gbp2-3-million-to-three-companies-who-conspired-to-inflate-price-of-fludrocortisone.html 2020-07-09T15:00:11.6140000Z https://www.medicinesresources.nhs.uk/cppe-launches-its-first-national-online-workshop.html 2020-07-09T15:01:10.5280000Z https://www.medicinesresources.nhs.uk/general-practice-in-the-post-covid-world-challenges-and-opportunities-for-general-practice.html 2020-07-09T15:02:06.9110000Z https://www.medicinesresources.nhs.uk/provisional-publication-of-never-events-reported-as-occurring-between-1-april-and-31-may-2020.html 2020-07-10T14:25:32.1380000Z https://www.medicinesresources.nhs.uk/degenerative-cervical-spondylosis.html 2020-10-01T13:41:21.7320000Z https://www.medicinesresources.nhs.uk/first-do-no-harm-the-report-of-the-independent-medicines-and-medical-devices-safety-review.html 2020-07-10T14:32:07.3040000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-to-host-workshop-on-safe-use-of-medicines-during-pregnancy-and-breastfeeding.html 2020-07-09T16:07:49.8190000Z https://www.medicinesresources.nhs.uk/european-union-to-coordinate-purchase-of-critical-treatments-vaccines-and-equipment-for-its-members-to-tackle-covid-shortages.html 2020-07-09T15:16:37.6130000Z https://www.medicinesresources.nhs.uk/u-s-fda-approves-qwo-collagenase-clostridium-histolyticum-aaes-for-the-treatment-of-cellulite.html 2020-07-09T15:17:40.0200000Z https://www.medicinesresources.nhs.uk/u-s-fda-grants-orphan-drug-designation-to-gene-therapy-for-treatment-of-cln5-batten-disease.html 2020-07-09T15:18:45.5760000Z https://www.medicinesresources.nhs.uk/u-s-fda-grants-rare-paediatric-disease-designation-to-silmitasertib-for-treatment-of-recurrent-sonic-hedgehog-medulloblastoma.html 2020-07-09T16:27:00.0160000Z https://www.medicinesresources.nhs.uk/gsk-and-medicago-announce-partnership-to-develop-novel-adjuvanted-covid-19-vaccine.html 2020-07-09T15:20:44.6940000Z https://www.medicinesresources.nhs.uk/u-s-fda-declines-approval-of-pembrolizumab-plus-lenvatinib-combination-as-first-line-treatment-for-unresectable-hepatocellular-carcinoma.html 2020-07-09T15:21:38.9930000Z https://www.medicinesresources.nhs.uk/u-s-fda-grants-orphan-drug-designation-to-imsidolimab-for-treatment-of-generalised-pustular-psoriasis-gpp.html 2020-07-09T16:28:19.3410000Z https://www.medicinesresources.nhs.uk/biogen-submits-biologics-license-application-to-u-s-fda-for-aducanumab-as-treatment-of-alzheimers-disease.html 2020-07-09T16:07:32.2770000Z https://www.medicinesresources.nhs.uk/guidance-on-the-use-of-h2-antagonists-for-the-prevention-and-management-of-hypersensitivity.html 2020-07-10T14:34:09.7370000Z https://www.medicinesresources.nhs.uk/capturing-beneficial-change-from-the-covid-19-pandemic-response-from-the-british-geriatrics-society.html 2020-07-09T15:25:41.1540000Z https://www.medicinesresources.nhs.uk/trial-of-nemolizumab-and-topical-agents-for-atopic-dermatitis-with-pruritus.html 2020-10-01T09:40:48.3240000Z https://www.medicinesresources.nhs.uk/a-randomized-trial-of-a-multifactorial-strategy-to-prevent-serious-fall-injuries.html 2020-10-01T10:49:41.7700000Z https://www.medicinesresources.nhs.uk/baloxavir-marboxil-for-prophylaxis-against-influenza-in-household-contacts.html 2020-08-27T14:57:15.7840000Z https://www.medicinesresources.nhs.uk/effectiveness-of-sequential-psychological-and-medication-therapies-for-insomnia-disorder-a-randomized-clinical-trial.html 2020-07-09T16:12:52.6260000Z https://www.medicinesresources.nhs.uk/the-association-between-hba1c-and-time-in-hypoglycemia-during-cgm-and-self-monitoring-of-blood-glucose-in-people-with-type-1-diabetes-and-multiple-daily-insulin-injections-a-randomized-clinical-trial-gold-4.html 2020-07-09T16:39:56.8160000Z https://www.medicinesresources.nhs.uk/body-weight-variability-and-the-risk-of-cardiovascular-outcomes-and-mortality-in-patients-with-type-2-diabetes-a-nationwide-cohort-study.html 2020-07-09T16:16:16.0730000Z https://www.medicinesresources.nhs.uk/comparison-of-the-freestyle-libre-pro-flash-continuous-glucose-monitoring-cgm-system-and-point-of-care-capillary-glucose-testing-poc-in-hospitalized-patients-with-type-2-diabetes-t2d-treated-with-basal-bolus-insulin-regimen.html 2020-07-09T16:42:32.6340000Z https://www.medicinesresources.nhs.uk/association-of-plasma-biomarkers-of-fruit-and-vegetable-intake-with-incident-type-2-diabetes-epic-interact-case-cohort-study-in-eight-european-countries.html 2020-07-09T16:43:28.7250000Z https://www.medicinesresources.nhs.uk/intake-of-whole-grain-foods-and-risk-of-type-2-diabetes-results-from-three-prospective-cohort-studies.html 2020-07-09T16:19:59.2010000Z https://www.medicinesresources.nhs.uk/quality-of-life-assessed-using-skindex-16-scores-among-patients-with-acne-receiving-isotretinoin-treatment.html 2020-07-09T16:20:55.0100000Z https://www.medicinesresources.nhs.uk/maintenance-inhaler-therapy-preferences-of-patients-with-asthma-or-chronic-obstructive-pulmonary-disease-a-discrete-choice-experiment.html 2020-07-09T16:21:50.1050000Z https://www.medicinesresources.nhs.uk/anticipatory-prescribing-in-community-end-of-life-care-in-the-uk-and-ireland-during-the-covid-19-pandemic-online-survey.html 2020-07-09T16:22:58.2960000Z https://www.medicinesresources.nhs.uk/revised-spcs-benlysta-belimumab-powder-for-concentrate-for-solution-for-infusion.html 2020-07-10T14:35:31.3150000Z https://www.medicinesresources.nhs.uk/revised-spc-sustanon-testosterone-250-250mg-ml-solution-for-injection.html 2020-07-10T14:36:49.9380000Z https://www.medicinesresources.nhs.uk/revised-spcs-diflucan-fluconazole-preparations.html 2020-07-10T14:38:09.0090000Z https://www.medicinesresources.nhs.uk/revised-spc-octaplex-1000-iu-powder-and-solvent-for-solution-for-injection.html 2020-07-10T14:46:05.0420000Z https://www.medicinesresources.nhs.uk/cfhealthhub-for-managing-cystic-fibrosis-during-the-covid-19-pandemic-medtech-innovation-briefing-mib219.html 2020-07-13T07:15:39.3490000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-proposition-bendamustine-for-relapsed-multiple-myeloma-all-ages.html 2020-07-13T07:17:20.6360000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-ustekinumab-for-refractory-crohns-disease-in-pre-pubescent-children.html 2020-07-10T14:50:08.8040000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-telotristat-for-treating-carcinoid-syndrome-diarrhoea-adults.html 2020-07-13T07:18:07.9880000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-idebenone-for-treating-people-over-12-years-of-age-with-lebers-hereditary-optic-neuropathy.html 2020-07-13T07:18:27.8470000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-rituximab-for-refractory-systemic-lupus-erythematosus-sle-in-adults-and-post-pubescent-children.html 2020-07-13T07:18:46.2880000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-vedolizumab-for-refractory-ulcerative-colitis-in-pre-pubescent-children.html 2020-07-13T07:19:04.4100000Z https://www.medicinesresources.nhs.uk/ticagrelor-granted-fda-priority-review-for-secondary-prevention-of-acute-ischaemic-stroke-or-transient-ischaemic-attack.html 2020-07-10T14:56:33.7580000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-finerenone-added-to-standard-of-care-for-chronic-kidney-disease-in-patients-with-type-2-diabetes-meets-primary-endpoint.html 2020-07-10T14:58:04.1850000Z https://www.medicinesresources.nhs.uk/us-fda-approves-oxymetazoline-ophthalmic-solution-upneeq-tm-for-the-treatment-of-acquired-blepharoptosis.html 2020-07-10T14:59:19.6290000Z https://www.medicinesresources.nhs.uk/pembrolizumab-granted-fda-priority-review-for-the-second-line-treatment-of-relapsed-refractory-classical-hodgkin-lymphoma.html 2020-07-10T15:00:35.0060000Z https://www.medicinesresources.nhs.uk/zero-covid-uk-why-is-england-not-pursuing-an-elimination-strategy.html 2020-07-10T15:01:53.8720000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-finalises-opinion-on-presence-of-nitrosamines-in-medicines.html 2020-07-10T15:03:15.7420000Z https://www.medicinesresources.nhs.uk/international-regulators-align-positions-on-phase-3-covid-19-vaccine-trials.html 2020-07-10T15:04:51.0390000Z https://www.medicinesresources.nhs.uk/pandemic-peak-sars-cov-2-infection-and-seroconversion-rates-in-london-frontline-health-care-workers.html 2020-07-10T15:06:44.4160000Z https://www.medicinesresources.nhs.uk/stroke.html 2020-07-10T15:09:44.4630000Z https://www.medicinesresources.nhs.uk/the-value-of-antimicrobial-peptides-in-the-age-of-resistance.html 2020-07-10T15:11:01.0550000Z https://www.medicinesresources.nhs.uk/obesity-and-covid-19-a-call-for-action-from-people-living-with-obesity.html 2020-07-10T15:12:16.5890000Z https://www.medicinesresources.nhs.uk/brentuximab-vedotin-in-combination-for-untreated-systemic-anaplastic-large-cell-lymphoma-final-appraisal-determination.html 2020-07-10T15:14:56.1920000Z https://www.medicinesresources.nhs.uk/uk-survey-finds-many-women-still-unaware-of-risks-around-use-of-valproate-in-pregnancy.html 2020-07-13T07:20:52.4240000Z https://www.medicinesresources.nhs.uk/once-daily-mometasone-plus-indacaterol-versus-mometasone-or-twice-daily-fluticasone-plus-salmeterol-in-patients-with-inadequately-controlled-asthma-palladium-a-randomised-double-blind-triple-dummy-controlled-phase-3-study.html 2020-07-10T15:28:06.3980000Z https://www.medicinesresources.nhs.uk/once-daily-single-inhaler-mometasone-indacaterol-glycopyrronium-versus-mometasone-indacaterol-or-twice-daily-fluticasone-salmeterol-in-patients-with-inadequately-controlled-asthma-iridium-a-randomised-double-blind-controlled-phase-3-study.html 2020-07-10T15:30:36.4620000Z https://www.medicinesresources.nhs.uk/influenza-vaccination-is-associated-with-reduced-cardiovascular-mortality-in-adults-with-diabetes-a-nationwide-cohort-study.html 2020-07-10T15:32:20.3880000Z https://www.medicinesresources.nhs.uk/ruxolitinib-cream-for-treatment-of-vitiligo-a-randomised-controlled-phase-2-trial.html 2020-07-10T15:36:20.8310000Z https://www.medicinesresources.nhs.uk/the-routine-immunisation-schedule-from-june-2020.html 2020-07-13T07:21:11.7150000Z https://www.medicinesresources.nhs.uk/revised-spc-levonelle-one-step-levonorgestrel-tablets-otc-product.html 2020-07-15T08:56:08.8820000Z https://www.medicinesresources.nhs.uk/revised-spcs-aldactide-spironolactone-and-hydroflumethiazide-all-strengths-1.html 2020-07-15T08:53:41.1410000Z https://www.medicinesresources.nhs.uk/revised-spc-libtayo-cemiplimab-350-mg-concentrate-for-solution-for-infusion-1.html 2020-07-13T14:21:23.5180000Z https://www.medicinesresources.nhs.uk/revised-spc-kyleena-jayedess-levonorgestrel-19-5-mg-intrauterine-delivery-system.html 2020-07-15T08:50:51.7580000Z https://www.medicinesresources.nhs.uk/for-patients-the-public-and-professional-users-a-guide-to-covid-19-tests-and-testing-kits.html 2020-07-13T14:25:05.7240000Z https://www.medicinesresources.nhs.uk/abuse-self-harm-and-suicidal-ideation-in-the-uk-during-the-covid-19-pandemic.html 2020-07-13T14:28:19.4490000Z https://www.medicinesresources.nhs.uk/temporal-trend-in-young-onset-type-2-diabetes-the-macrovascular-and-mortality-risk-study-of-u-k-primary-care-electronic-medical-records-1.html 2020-07-13T14:29:57.1910000Z https://www.medicinesresources.nhs.uk/change-in-the-incidence-of-stillbirth-and-preterm-delivery-during-the-covid-19-pandemic.html 2020-07-13T14:55:52.9060000Z https://www.medicinesresources.nhs.uk/persistent-symptoms-in-patients-after-acute-covid-19.html 2020-07-13T14:36:21.5270000Z https://www.medicinesresources.nhs.uk/antithymocyte-globulin-for-matched-sibling-donor-transplantation-in-patients-with-hematologic-malignancies-a-multicenter-open-label-randomized-controlled-study.html 2020-08-12T09:59:48.5260000Z https://www.medicinesresources.nhs.uk/haematological-characteristics-and-risk-factors-in-the-classification-and-prognosis-evaluation-of-covid-19-a-retrospective-cohort-study.html 2020-07-13T14:41:16.0880000Z https://www.medicinesresources.nhs.uk/pathophysiology-transmission-diagnosis-and-treatment-of-coronavirus-disease-2019-covid-19-a-review.html 2020-07-13T14:43:07.9180000Z https://www.medicinesresources.nhs.uk/rebuilding-the-nhs-resetting-outpatient-services-for-the-21st-century-in-the-context-of-covid-19.html 2020-07-13T14:44:41.2520000Z https://www.medicinesresources.nhs.uk/transition-between-covid-19-care-home-support-and-the-enhanced-health-in-care-homes-service-in-the-network-contract-des-and-training-requirements-for-personalised-care-roles.html 2020-07-13T14:46:28.9560000Z https://www.medicinesresources.nhs.uk/fda-orphan-drug-designation-granted-to-aldesleukin-for-treatment-of-amyotrophic-lateral-sclerosis-als.html 2020-07-13T14:56:28.6090000Z https://www.medicinesresources.nhs.uk/nice-links-with-colombias-institute-of-health-technology-assessment.html 2020-07-13T14:51:13.5250000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-duodopa-levodopa-carbidopa-intestinal-gel-best-practice-patient-aftercare.html 2020-07-15T08:33:38.6780000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-spravato-esketamine-28-mg-nasal-spray-healthcare-professional-guide.html 2020-07-13T15:05:09.5750000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-myalepta-metreletin-powder-for-solution-healthcare-professional-guide.html 2020-07-13T15:06:54.4070000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-increlex-mecasermin-solution-for-injection-dosing-guide.html 2020-07-13T15:08:46.5520000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-toctino-alitretinoin-prescriber-pharmacist-checklist.html 2020-07-15T08:22:45.6890000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-gilenya-fingolimod-prescribers-checklist.html 2020-07-13T15:11:56.4120000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-granted-fda-fast-track-designation-for-two-investigational-mrna-based-vaccine-candidates-against-sars-cov-2-covid-23.html 2020-07-13T16:15:09.0090000Z https://www.medicinesresources.nhs.uk/new-products-pergoveris-lutropin-alfa-follitropin-alfa-injection-all-products.html 2020-07-14T16:42:05.0200000Z https://www.medicinesresources.nhs.uk/new-product-ajovy-fremanezumab-225-mg-injection-all-products.html 2020-07-14T16:53:00.4710000Z https://www.medicinesresources.nhs.uk/new-products-quofenix-delafloxacin-meglumine-all-products.html 2020-07-14T16:53:25.7320000Z https://www.medicinesresources.nhs.uk/revised-spcs-dupixent-dupilumab-injection-all-products.html 2020-07-14T15:31:58.8130000Z https://www.medicinesresources.nhs.uk/revised-spc-lemtrada-alemtuzumab-12-mg-concentrate-for-solution-for-infusion.html 2020-07-14T15:34:06.9910000Z https://www.medicinesresources.nhs.uk/revised-spcs-kevzara-sarilumab-injection-all-products.html 2020-07-14T15:35:44.4200000Z https://www.medicinesresources.nhs.uk/airborne-transmission-of-sars-cov-2-theoretical-considerations-and-available-evidence.html 2020-07-14T15:37:58.3850000Z https://www.medicinesresources.nhs.uk/caring-for-older-adults-with-diabetes-during-the-covid-19-pandemic.html 2020-07-14T16:59:36.6180000Z https://www.medicinesresources.nhs.uk/the-efficacy-of-ppe-for-covid-19-type-respiratory-illnesses-in-primary-and-community-care-staff.html 2020-07-14T15:41:00.3700000Z https://www.medicinesresources.nhs.uk/palliative-care-for-patients-with-severe-covid-19.html 2020-07-14T15:43:00.4630000Z https://www.medicinesresources.nhs.uk/tecentriq-atezolizumab-and-avastin-bevacizumab-combination-fails-to-meet-primary-endpoint-in-ovarian-cancer-trial.html 2020-07-14T17:00:40.8000000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-positive-scientific-opinion-issued-for-lumasiran-in-the-treatment-of-primary-hyperoxaluria-type-1-in-all-age-groups.html 2020-07-14T17:02:35.0370000Z https://www.medicinesresources.nhs.uk/informing-critical-care-drug-requirements-in-response-to-the-covid-19-pandemic.html 2020-07-14T16:20:41.9410000Z https://www.medicinesresources.nhs.uk/methylphenidate-and-mortality-in-children-with-attention-deficit-hyperactivity-disorder-population-based-cohort-study.html 2020-07-14T16:55:57.9510000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-glimepiride-with-or-without-linagliptin-treatment-in-patients-with-hnf1a-diabetes-maturity-onset-diabetes-of-the-young-type-3-a-randomized-double-blinded-placebo-controlled-crossover-trial-glimlina.html 2020-07-16T10:51:20.4840000Z https://www.medicinesresources.nhs.uk/in-terms-of-secondary-outcome-measures-compared-with-glimepiride-plus-placebo-glimepiride-plus-linagliptin-displayed-statistically-significant-reductions-in-coefficient-of-variation-on-continuous-glucose-monitoring-3-6-p-0-0401-hba1c-0-5-p-0-0048-and-glimepiride-dose-0-7-mg-day-p-0-0099.html 2020-07-14T16:58:08.5360000Z https://www.medicinesresources.nhs.uk/pulmonary-embolism-in-covid-19-patients-a-french-multicentre-cohort-study.html 2020-07-14T16:58:56.8490000Z https://www.medicinesresources.nhs.uk/patient-group-direction-pgd-use-in-a-service-provided-by-multiple-organisations.html 2020-07-15T07:36:10.2480000Z https://www.medicinesresources.nhs.uk/revised-spc-brintellix-vortioxetine-tablets.html 2020-07-15T15:10:56.5260000Z https://www.medicinesresources.nhs.uk/convalescent-plasma-or-hyperimmune-immunoglobulin-for-people-with-covid-19-a-living-systematic-review.html 2020-07-15T15:13:41.5450000Z https://www.medicinesresources.nhs.uk/some-antidepressants-can-help-people-quit-smoking-but-other-medications-may-offer-greater-benefits.html 2020-07-16T13:09:01.7700000Z https://www.medicinesresources.nhs.uk/covid-19-pandemic-and-admission-rates-for-and-management-of-acute-coronary-syndromes-in-england.html 2020-07-15T15:16:49.8820000Z https://www.medicinesresources.nhs.uk/association-between-universal-masking-in-a-health-care-system-and-sars-cov-2-positivity-among-health-care-workers.html 2020-07-15T16:05:51.6900000Z https://www.medicinesresources.nhs.uk/effect-of-maternal-docosahexaenoic-acid-supplementation-on-bronchopulmonary-dysplasia-free-survival-in-breastfed-preterm-infants-a-randomized-clinical-trial.html 2020-07-15T15:21:00.7930000Z https://www.medicinesresources.nhs.uk/outcomes-of-universal-covid-19-testing-following-detection-of-incident-cases-in-11-long-term-care-facilities.html 2020-07-15T15:22:19.3290000Z https://www.medicinesresources.nhs.uk/an-mrna-vaccine-against-sars-cov-2-preliminary-report.html 2020-10-01T12:40:47.3970000Z https://www.medicinesresources.nhs.uk/fertility-mortality-migration-and-population-scenarios-for-195-countries-and-territories-from-2017-to-2100-a-forecasting-analysis-for-the-global-burden-of-disease-study.html 2020-07-15T15:26:26.5230000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-upadacitinib-monotherapy-in-methotrexate-naive-patients-with-moderately-to-severely-active-rheumatoid-arthritis-select-early-a-randomized-double-blind-active-comparator-multi-center-multi-country-trial.html 2020-07-15T15:28:11.3900000Z https://www.medicinesresources.nhs.uk/eltrombopag-as-bridging-therapy-to-haematopoietic-stem-cell-transplant-in-severe-or-very-severe-aplastic-anaemia-during-the-covid19-pandemic-in-adults-rapid-policy-statement.html 2020-07-15T15:29:53.5570000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-action-within-48-hours-ferring-pharmaceuticals-limited-desmopressin-nasal-spray-all-strengths.html 2020-07-17T08:54:33.5040000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-action-within-48-hours-dr-reddy-s-laboratories-uk-limited-nitrofurantoin-50mg-tablets.html 2020-07-17T08:53:06.0120000Z https://www.medicinesresources.nhs.uk/covid-19-an-opportunity-to-reduce-unnecessary-healthcare.html 2020-07-15T15:34:33.7280000Z https://www.medicinesresources.nhs.uk/fda-approve-guselkumab-for-use-in-active-psoriatic-arthritis.html 2020-07-15T15:35:57.9560000Z https://www.medicinesresources.nhs.uk/fda-advisory-committee-votes-in-favour-of-positive-benefit-risk-profile-for-belantamab-mafodotin-for-relapsed-refractory-multiple-myeloma.html 2020-07-15T15:37:18.2210000Z https://www.medicinesresources.nhs.uk/fda-grants-orphan-drug-designation-for-inzomelid-for-the-cryopyrin-associated-periodic-syndromes-caps.html 2020-07-15T15:38:51.5330000Z https://www.medicinesresources.nhs.uk/covid-19-what-do-we-know-about-long-covid.html 2020-07-15T15:40:12.1170000Z https://www.medicinesresources.nhs.uk/use-of-run-in-periods-in-randomised-trials.html 2020-07-15T15:41:53.1520000Z https://www.medicinesresources.nhs.uk/prevention-and-management-of-chemotherapy-induced-peripheral-neuropathy-in-survivors-of-adult-cancers-asco-guideline-update.html 2020-08-17T08:38:31.9480000Z https://www.medicinesresources.nhs.uk/study-indicates-lockdown-significantly-reduced-coronavirus.html 2020-07-15T15:44:19.5260000Z https://www.medicinesresources.nhs.uk/specialist-neonatal-respiratory-care-for-babies-born-preterm-quality-standard-qs193.html 2020-07-15T15:45:35.5600000Z https://www.medicinesresources.nhs.uk/revised-spc-aldactide-spironolactone-and-hydroflumethiazide-50mg-tablets.html 2020-07-16T14:54:30.7570000Z https://www.medicinesresources.nhs.uk/national-report-highlights-life-threatening-risk-posed-by-delay-in-group-b-strep-treatment.html 2020-07-17T08:48:15.9670000Z https://www.medicinesresources.nhs.uk/cardiovascular-disease-in-homeless-versus-housed-individuals-a-systematic-review-of-observational-and-interventional-studies.html 2020-07-16T14:57:46.7780000Z https://www.medicinesresources.nhs.uk/association-between-prediabetes-and-risk-of-all-cause-mortality-and-cardiovascular-disease-updated-meta-analysis.html 2020-07-16T14:59:19.4690000Z https://www.medicinesresources.nhs.uk/antiplatelet-agents-for-preventing-pre-eclampsia-and-its-complications.html 2020-07-16T15:19:00.8310000Z https://www.medicinesresources.nhs.uk/early-enteral-nutrition-within-48-hours-versus-delayed-enteral-nutrition-after-48-hours-with-or-without-supplemental-parenteral-nutrition-in-critically-ill-adults.html 2020-07-16T15:18:04.3000000Z https://www.medicinesresources.nhs.uk/community-pharmacy-personnel-interventions-for-smoking-cessation.html 2020-07-16T15:16:58.3830000Z https://www.medicinesresources.nhs.uk/chemotherapy-versus-surgery-for-initial-treatment-in-advanced-ovarian-epithelial-cancer.html 2020-07-16T15:15:32.5880000Z https://www.medicinesresources.nhs.uk/which-medicines-can-be-used-to-treat-allergic-rhinitis-during-pregnancy.html 2020-07-17T08:28:55.7480000Z https://www.medicinesresources.nhs.uk/nihr-alert-asthma-patients-with-a-history-of-opioid-use-have-worse-outcomes.html 2020-07-17T08:27:21.2300000Z https://www.medicinesresources.nhs.uk/nihr-alert-most-patients-undergoing-planned-surgery-do-not-need-compression-stockings.html 2020-07-17T08:23:25.4760000Z https://www.medicinesresources.nhs.uk/us-fda-advisory-committee-voted-in-favour-of-approving-terlipressin-for-hepatorenal-syndrome-type-1-hrs-1.html 2020-07-16T17:06:52.9160000Z https://www.medicinesresources.nhs.uk/new-nhs-exemplars-to-help-close-inequality-gap-for-people-with-a-learning-disability.html 2020-07-16T15:26:55.5180000Z https://www.medicinesresources.nhs.uk/acute-ischemic-stroke.html 2020-07-16T15:28:12.7790000Z https://www.medicinesresources.nhs.uk/low-back-pain-and-sciatica-in-over-16s-4-assessment-and-management-draft-guideline-for-consultation.html 2020-07-16T17:04:59.1730000Z https://www.medicinesresources.nhs.uk/first-sglt2-inhibitor-canagliflozin-approved-to-treat-diabetic-kidney-disease-in-uk.html 2020-07-16T15:32:07.3460000Z https://www.medicinesresources.nhs.uk/enanthem-in-patients-with-covid-19-and-skin-rash.html 2020-07-16T17:03:33.9400000Z https://www.medicinesresources.nhs.uk/meeting-maternal-mental-health-needs-during-the-covid-19-pandemic.html 2020-07-16T15:34:06.5990000Z https://www.medicinesresources.nhs.uk/several-companies-voluntarily-recall-extended-release-metformin-in-us-due-to-exceeding-nitrosodimethylamine-ndma-threshold.html 2020-07-16T15:35:22.1160000Z https://www.medicinesresources.nhs.uk/types-and-uses-of-coronavirus-covid-19-tests.html 2020-07-16T15:36:32.0340000Z https://www.medicinesresources.nhs.uk/gbp62-million-to-help-discharge-people-with-learning-disabilities-or-autism-into-the-community.html 2020-07-16T15:37:37.8210000Z https://www.medicinesresources.nhs.uk/react-1-study-of-coronavirus-transmission-may-2020-results.html 2020-07-16T17:00:52.0550000Z https://www.medicinesresources.nhs.uk/gsk-wins-legal-case-over-withdrawal-effects-of-paroxetine-after-13-years-and-gbp9-33m-in-costs.html 2020-07-16T15:40:46.6220000Z https://www.medicinesresources.nhs.uk/covid-19-doctors-in-france-report-case-of-baby-infected-in-utero.html 2020-07-16T15:42:03.9440000Z https://www.medicinesresources.nhs.uk/trial-of-roflumilast-cream-for-chronic-plaque-psoriasis.html 2020-10-01T10:04:46.9980000Z https://www.medicinesresources.nhs.uk/ticagrelor-and-aspirin-or-aspirin-alone-in-acute-ischemic-stroke-or-tia.html 2020-10-01T09:34:15.7980000Z https://www.medicinesresources.nhs.uk/effect-of-long-acting-injectable-antipsychotics-vs-usual-care-on-time-to-first-hospitalization-in-early-phase-schizophrenia-a-randomized-clinical-trial.html 2020-07-16T16:01:46.5380000Z https://www.medicinesresources.nhs.uk/physical-distancing-interventions-and-incidence-of-coronavirus-disease-2019-natural-experiment-in-149-countries.html 2020-07-16T16:55:30.0790000Z https://www.medicinesresources.nhs.uk/the-healthiness-and-sustainability-of-national-and-global-food-based-dietary-guidelines-modelling-study.html 2020-07-16T16:05:03.8190000Z https://www.medicinesresources.nhs.uk/evaluation-of-financial-conflicts-of-interest-among-physician-authors-of-american-college-of-rheumatology-clinical-practice-guidelines.html 2020-07-16T16:06:18.8540000Z https://www.medicinesresources.nhs.uk/association-of-factor-v-leiden-with-subsequent-atherothrombotic-events-a-genius-chd-study-of-individual-participant-data.html 2020-08-20T10:43:22.8320000Z https://www.medicinesresources.nhs.uk/reorganisation-of-primary-care-for-older-adults-during-covid-19-a-cross-sectional-database-study-in-the-uk.html 2020-07-16T16:10:02.4610000Z https://www.medicinesresources.nhs.uk/effect-of-flash-glucose-monitoring-on-glycemic-control-hypoglycemia-diabetes-related-distress-and-resource-utilization-in-the-association-of-british-clinical-diabetologists-abcd-nationwide-audit.html 2020-07-17T07:50:32.3870000Z https://www.medicinesresources.nhs.uk/assessment-of-limitations-to-optimization-of-guideline-directed-medical-therapy-in-heart-failure-from-the-guide-it-trial-a-secondary-analysis-of-a-randomized-clinical-trial.html 2020-07-16T16:13:21.8480000Z https://www.medicinesresources.nhs.uk/association-of-anti-programmed-cell-death-1-antibody-treatment-with-risk-of-recurrence-of-toxic-effects-after-immune-related-adverse-events-of-ipilimumab-in-patients-with-metastatic-melanoma.html 2020-07-16T16:14:37.4150000Z https://www.medicinesresources.nhs.uk/factors-associated-with-death-in-critically-ill-patients-with-coronavirus-disease-2019-in-the-us.html 2020-07-16T16:17:20.0150000Z https://www.medicinesresources.nhs.uk/risk-factors-associated-with-mortality-among-patients-with-covid-19-in-intensive-care-units-in-lombardy-italy.html 2020-07-16T16:18:37.9980000Z https://www.medicinesresources.nhs.uk/the-impact-of-cardiovascular-disease-and-chronic-kidney-disease-on-life-expectancy-and-direct-medical-cost-in-a-10-year-diabetes-cohort-study.html 2020-07-16T16:20:25.2460000Z https://www.medicinesresources.nhs.uk/new-products-harvoni-ledipasvir-and-sofosbuvir-coated-granules-in-sachet-33-75-mg-150-mg-and-45-mg-200-mg-strengths.html 2020-07-17T12:43:07.8320000Z https://www.medicinesresources.nhs.uk/revised-spc-harvoni-ledipasvir-and-sofosbuvir-film-coated-tablets.html 2020-07-17T12:45:20.9850000Z https://www.medicinesresources.nhs.uk/revised-spc-taltz-ixekizumab-80-mg-solution-for-injection-in-pre-filled-syringe.html 2020-07-17T12:47:58.3490000Z https://www.medicinesresources.nhs.uk/interventions-for-pityriasis-rosea.html 2020-07-17T12:50:13.2930000Z https://www.medicinesresources.nhs.uk/oxandrolone-for-growth-hormone-treated-girls-aged-up-to-18-years-with-turner-syndrome.html 2020-07-17T12:52:13.2730000Z https://www.medicinesresources.nhs.uk/nonsteroidal-anti-inflammatory-drugs-for-assisted-reproductive-technology.html 2020-07-17T12:54:07.8260000Z https://www.medicinesresources.nhs.uk/interventions-to-reduce-staphylococcus-aureus-in-the-management-of-eczema.html 2020-07-17T12:56:02.5260000Z https://www.medicinesresources.nhs.uk/switching-between-liquid-and-tablet-capsule-formulations-which-medicines-require-extra-care.html 2020-07-20T07:22:12.8780000Z https://www.medicinesresources.nhs.uk/delivery-of-the-hpv-vaccine-and-impact-of-school-closures-statement-from-the-jcvi.html 2020-07-20T07:19:03.4930000Z https://www.medicinesresources.nhs.uk/fda-panel-votes-in-favour-of-approving-terlipressin-for-the-treatment-of-adults-hepatorenal-syndrome.html 2020-07-17T12:59:48.9400000Z https://www.medicinesresources.nhs.uk/rilonacept-granted-orphan-drug-designation-in-the-us-for-the-treatment-of-pericarditis.html 2020-07-17T13:00:53.6910000Z https://www.medicinesresources.nhs.uk/application-for-approval-of-wynzora-r-cream-calcipotriol-and-betamethasone-dipropionate-for-the-treatment-of-plaque-psoriasis-submitted-to-the-eu.html 2020-07-17T13:01:58.6840000Z https://www.medicinesresources.nhs.uk/dapagliflozin-granted-fast-track-designation-in-the-us-for-reduction-of-risk-of-hospitalisation-for-heart-failure-or-cardiovascular-death-following-acute-myocardial-infarction.html 2020-07-17T13:03:07.1810000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-new-drug-application-for-vericiguat-for-review.html 2020-07-17T13:04:11.4180000Z https://www.medicinesresources.nhs.uk/working-years-of-life-lost-due-to-alcohol-mortality.html 2020-07-17T13:05:16.0470000Z https://www.medicinesresources.nhs.uk/wider-impacts-of-covid-19-on-health-monitoring-tool.html 2020-07-17T13:07:20.5880000Z https://www.medicinesresources.nhs.uk/the-impact-of-disease-drug-interactions-on-drug-development-and-clinical-practice.html 2020-07-17T13:08:45.8640000Z https://www.medicinesresources.nhs.uk/management-of-non-culprit-coronary-plaques-in-patients-with-acute-coronary-syndrome.html 2020-07-17T14:13:50.3120000Z https://www.medicinesresources.nhs.uk/general-pharmaceutical-council-publishes-annual-report-for-2019-20.html 2020-07-17T14:17:01.3130000Z https://www.medicinesresources.nhs.uk/atrial-fibrillation-and-the-prothrombotic-state-revisiting-virchows-triad-in-2020.html 2020-07-17T14:18:10.5570000Z https://www.medicinesresources.nhs.uk/next-generation-bruton-tyrosine-kinase-inhibitors.html 2020-08-17T11:11:49.3040000Z https://www.medicinesresources.nhs.uk/how-mental-health-care-should-change-as-a-consequence-of-the-covid-19-pandemic.html 2020-07-17T14:21:39.5940000Z https://www.medicinesresources.nhs.uk/the-road-to-renewal-five-priorities-for-health-and-care-following-covid-19.html 2020-07-17T16:06:48.7780000Z https://www.medicinesresources.nhs.uk/gilteritinib-for-treating-relapsed-or-refractory-acute-myeloid-leukaemia-final-appraisal-document.html 2020-07-17T14:27:26.8310000Z https://www.medicinesresources.nhs.uk/written-instruction-for-the-administration-of-seasonal-flu-vaccination-2020-21-version.html 2020-07-20T06:56:55.8650000Z https://www.medicinesresources.nhs.uk/the-hidden-impact-of-covid-19.html 2020-07-17T14:31:35.1140000Z https://www.medicinesresources.nhs.uk/dexmedetomidine-for-reduction-of-atrial-fibrillation-and-delirium-after-cardiac-surgery-decade-a-randomised-placebo-controlled-trial.html 2020-07-17T15:50:46.9560000Z https://www.medicinesresources.nhs.uk/carfilzomib-dexamethasone-and-daratumumab-versus-carfilzomib-and-dexamethasone-for-patients-with-relapsed-or-refractory-multiple-myeloma-candor-results-from-a-randomised-multicentre-open-label-phase-3-study.html 2020-07-17T15:54:04.1360000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-in-nonhospitalized-adults-with-early-covid-19.html 2020-07-17T15:56:13.2720000Z https://www.medicinesresources.nhs.uk/s-1-plus-leucovorin-and-oxaliplatin-versus-s-1-plus-cisplatin-as-first-line-therapy-in-patients-with-advanced-gastric-cancer-solar-a-randomised-open-label-phase-3-trial.html 2020-07-17T15:58:18.9350000Z https://www.medicinesresources.nhs.uk/glecaprevir-pibrentasvir-to-treat-chronic-hepatitis-c-virus-infection-in-asia-two-multicentre-phase-3-studies-a-randomised-double-blind-study-voyage-1-and-an-open-label-single-arm-study-voyage-2.html 2020-07-17T16:00:32.7400000Z https://www.medicinesresources.nhs.uk/revised-spc-signifor-pasireotide-60mg-powder-for-injection-all-strengths.html 2020-07-20T14:27:38.3740000Z https://www.medicinesresources.nhs.uk/revised-spc-co-cyprindiol-cyproterone-acetate-ethinylestradiol-tablets.html 2020-07-20T14:28:54.6770000Z https://www.medicinesresources.nhs.uk/new-powers-and-framework-to-help-contain-coronavirus-covid-19-locally.html 2020-07-27T09:56:28.0890000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-aspar-pharmaceuticals-limited-ibuprofen-200mg-and-400mg-tablets-packaged-in-various-liveries-el-20-a-30.html 2020-07-20T14:39:07.0330000Z https://www.medicinesresources.nhs.uk/sorafenib-maintenance-after-allogeneic-hematopoietic-stem-cell-transplantation-for-acute-myeloid-leukemia-with-flt3-internal-tandem-duplication-mutation-sormain.html 2020-08-12T09:57:20.6130000Z https://www.medicinesresources.nhs.uk/effectiveness-of-a-multimedia-educational-intervention-to-improve-understanding-of-the-risks-and-benefits-of-palliative-chemotherapy-in-patients-with-advanced-cancer-a-randomized-clinical-trial.html 2020-07-20T14:36:00.4890000Z https://www.medicinesresources.nhs.uk/chronic-comorbidities-among-survivors-of-adolescent-and-young-adult-cancer.html 2020-08-17T08:30:53.8010000Z https://www.medicinesresources.nhs.uk/neratinib-plus-capecitabine-versus-lapatinib-plus-capecitabine-in-her2-positive-metastatic-breast-cancer-previously-treated-with-2-her2-directed-regimens-phase-iii-nala-trial.html 2020-08-12T09:58:33.7330000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-the-live-attenuated-intranasal-pertussis-vaccine-bpze1-a-phase-1b-double-blind-randomised-placebo-controlled-dose-escalation-study.html 2020-07-20T14:41:34.5410000Z https://www.medicinesresources.nhs.uk/impact-of-delays-on-effectiveness-of-contact-tracing-strategies-for-covid-19-a-modelling-study.html 2020-07-20T14:43:05.7140000Z https://www.medicinesresources.nhs.uk/dexamethasone-in-hospitalized-patients-with-covid-19-preliminary-report.html 2020-10-01T12:31:35.3330000Z https://www.medicinesresources.nhs.uk/the-nhs-deserves-better-use-of-hospital-medicines-data.html 2020-07-20T14:47:43.8450000Z https://www.medicinesresources.nhs.uk/millions-could-be-vaccinated-against-covid-19-as-uk-secures-strong-portfolio-of-promising-vaccines.html 2020-07-27T10:02:33.0930000Z https://www.medicinesresources.nhs.uk/gphc-publishes-annual-report-for-2019-20.html 2020-07-20T14:51:57.6690000Z https://www.medicinesresources.nhs.uk/temporary-circulatory-support-for-cardiogenic-shock.html 2020-07-20T14:54:09.6770000Z https://www.medicinesresources.nhs.uk/positive-clinical-trial-data-for-sng001-an-inhaled-formulation-of-interferon-beta-in-hospitalised-covid-19-patients.html 2020-07-20T15:00:58.3310000Z https://www.medicinesresources.nhs.uk/phase-iii-oasis-2-study-of-mirikizumab-meets-all-primary-endpoints-vs-secukinumab-in-plaque-psoriasis.html 2020-07-20T14:59:23.7700000Z https://www.medicinesresources.nhs.uk/adjuvant-systemic-chemotherapy-vs-active-surveillance-following-up-front-resection-of-isolated-synchronous-colorectal-peritoneal-metastases.html 2020-07-20T15:01:53.5250000Z https://www.medicinesresources.nhs.uk/association-of-chemotherapy-with-survival-in-elderly-patients-with-multiple-comorbidities-and-estrogen-receptor-positive-node-positive-breast-cancer.html 2020-07-20T15:03:11.8060000Z https://www.medicinesresources.nhs.uk/relapse-prevention-interventions-for-smoking-cessation.html 2020-07-20T15:04:31.9700000Z https://www.medicinesresources.nhs.uk/interventions-for-preventing-falls-in-people-after-stroke.html 2020-07-20T15:05:50.4220000Z https://www.medicinesresources.nhs.uk/patient-group-direction-pgd-supply-of-oral-metronidazole-for-the-treatment-of-bacterial-vaginosis-or-trichomonas-vaginalis.html 2020-07-27T10:17:18.8060000Z https://www.medicinesresources.nhs.uk/patient-group-direction-pgd-administration-of-ceftriaxone-injection-reconstituted-with-lidocaine-1-w-v-injection-by-intramuscular-injection-for-the-treatment-of-uncomplicated-neisseria-gonorrhoeae-infection.html 2020-07-27T10:21:22.1970000Z https://www.medicinesresources.nhs.uk/revised-spc-maxtrex-methotrexate-2-5-and-10-mg-tablets.html 2020-07-21T14:41:23.6770000Z https://www.medicinesresources.nhs.uk/intra-pleural-fibrinolytic-therapy-versus-placebo-or-a-different-fibrinolytic-agent-in-the-treatment-of-adult-parapneumonic-effusions-and-empyema.html 2020-07-21T14:45:57.2360000Z https://www.medicinesresources.nhs.uk/interventions-for-involving-older-patients-with-multi-morbidity-in-decision-making-during-primary-care-consultations.html 2020-07-21T14:49:34.7350000Z https://www.medicinesresources.nhs.uk/clobazam-add-on-therapy-for-drug-resistant-epilepsy.html 2020-07-21T14:50:48.5510000Z https://www.medicinesresources.nhs.uk/topiramate-add-on-therapy-for-drug-resistant-focal-epilepsy.html 2020-07-21T14:52:03.8500000Z https://www.medicinesresources.nhs.uk/remsima-infliximab-biosimilar-for-subcutaneous-injection-for-managing-rheumatoid-arthritis-evidence-summary-es29.html 2020-07-27T10:23:17.8690000Z https://www.medicinesresources.nhs.uk/dtb-select-mhra-doac-safety-reminder.html 2020-07-27T10:24:10.0590000Z https://www.medicinesresources.nhs.uk/dtb-select-dexamethasone-for-covid-19-preliminary-findings.html 2020-07-21T14:57:02.3890000Z https://www.medicinesresources.nhs.uk/nihr-alert-drug-users-who-lack-access-to-clean-water-use-dangerous-alternatives-to-prepare-injections.html 2020-07-21T15:13:11.4720000Z https://www.medicinesresources.nhs.uk/covid-19-in-people-with-diabetes-understanding-the-reasons-for-worse-outcomes.html 2020-07-21T15:14:18.2690000Z https://www.medicinesresources.nhs.uk/eisenmenger-syndrome-diagnosis-prognosis-and-clinical-management.html 2020-07-21T15:15:43.2490000Z https://www.medicinesresources.nhs.uk/cannabis-oil-disguised-as-confectionary.html 2020-07-21T15:16:46.5930000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-ennogen-pharma-limited-trimogal-100mg-and-200mg-tablets-el-20-a-31.html 2020-07-21T15:18:00.6260000Z https://www.medicinesresources.nhs.uk/placebos-in-chronic-pain-evidence-theory-ethics-and-use-in-clinical-practice.html 2020-07-21T15:19:28.1570000Z https://www.medicinesresources.nhs.uk/u-s-fda-accepts-licensing-application-for-pimavanserin-to-treat-dementia-patients-with-hallucinations-and-delusions.html 2020-07-21T15:20:42.0600000Z https://www.medicinesresources.nhs.uk/dexmedetomidine-sublingual-film-meets-primary-and-secondary-endpoints-in-two-phase-3-trials-evaluating-acute-treatment-of-agitation-in-patients-with-schizophrenia-serenity-i-and-bipolar-disorder-serenity-ii.html 2020-07-21T15:24:18.5650000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-from-post-marketing-study-of-trikafta-elexacaftor-tezacaftor-ivacaftor-and-ivacaftor-in-people-ages-12-and-older-with-cystic-fibrosis-who-have-one-copy-of-f508del-mutation-and-one-gating-or-residual-function-mutation.html 2020-07-21T15:25:51.6560000Z https://www.medicinesresources.nhs.uk/dtb-select-intranasal-versus-intramuscular-naloxone-for-opioid-overdose.html 2020-07-21T15:51:30.4480000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-fluoxetine-on-functional-recovery-after-acute-stroke-effects-a-randomised-double-blind-placebo-controlled-trial.html 2020-07-21T15:48:37.3630000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-fluoxetine-on-functional-outcome-after-acute-stroke-affinity-a-randomised-double-blind-placebo-controlled-trial.html 2020-07-21T15:50:39.7840000Z https://www.medicinesresources.nhs.uk/nonsteroidal-anti-inflammatory-drugs-vs-cognitive-behavioral-therapy-for-arthritis-pain-a-randomized-withdrawal-trial.html 2020-07-21T15:51:50.1910000Z https://www.medicinesresources.nhs.uk/assessment-of-shared-decision-making-for-stroke-prevention-in-patients-with-atrial-fibrillation-a-randomized-clinical-trial.html 2020-07-21T15:52:50.3510000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-the-chadox1-ncov-19-vaccine-against-sars-cov-2-a-preliminary-report-of-a-phase-1-2-single-blind-randomised-controlled-trial.html 2020-07-27T10:26:57.6960000Z https://www.medicinesresources.nhs.uk/immunogenicity-and-safety-of-a-recombinant-adenovirus-type-5-vectored-covid-19-vaccine-in-healthy-adults-aged-18-years-or-older-a-randomised-double-blind-placebo-controlled-phase-2-trial.html 2020-07-27T10:28:45.4730000Z https://www.medicinesresources.nhs.uk/age-and-weight-adapted-dose-of-prasugrel-versus-standard-dose-of-ticagrelor-in-patients-with-acute-coronary-syndromes.html 2020-07-21T15:59:28.6360000Z https://www.medicinesresources.nhs.uk/thrombosis-in-hospitalized-patients-with-covid-19-in-a-new-york-city-health-system.html 2020-07-21T16:00:42.9150000Z https://www.medicinesresources.nhs.uk/comparison-of-reported-deaths-from-covid-19-and-increase-in-total-mortality-in-italy.html 2020-07-21T16:01:38.1430000Z https://www.medicinesresources.nhs.uk/ketoacidosis-in-children-and-adolescents-with-newly-diagnosed-type-1-diabetes-during-the-covid-19-pandemic-in-germany.html 2020-07-21T16:03:05.4190000Z https://www.medicinesresources.nhs.uk/acute-liver-injury-following-turmeric-use-in-tuscany-an-analysis-of-the-italian-phytovigilance-database-and-systematic-review-of-case-reports.html 2020-07-21T16:04:08.1890000Z https://www.medicinesresources.nhs.uk/effect-of-delays-in-the-2-week-wait-cancer-referral-pathway-during-the-covid-19-pandemic-on-cancer-survival-in-the-uk-a-modelling-study.html 2020-07-21T16:06:21.1610000Z https://www.medicinesresources.nhs.uk/the-impact-of-the-covid-19-pandemic-on-cancer-deaths-due-to-delays-in-diagnosis-in-england-uk-a-national-population-based-modelling-study.html 2020-07-21T16:08:13.9650000Z https://www.medicinesresources.nhs.uk/revised-spc-maxitrol-products.html 2020-07-22T16:03:00.3040000Z https://www.medicinesresources.nhs.uk/new-product-hydrocortisone-10mg-soluble-tablets-creo-pharma.html 2020-07-22T16:04:38.2860000Z https://www.medicinesresources.nhs.uk/peroxisome-proliferator-activated-receptor-gamma-agonists-for-preventing-recurrent-stroke-and-other-vascular-events-in-people-with-stroke-or-transient-ischaemic-attack.html 2020-07-22T16:05:47.8030000Z https://www.medicinesresources.nhs.uk/botulinum-toxin-type-a-in-the-treatment-of-lower-limb-spasticity-in-children-with-cerebral-palsy.html 2020-07-22T16:07:07.3890000Z https://www.medicinesresources.nhs.uk/pi3k-akt-mtor-inhibitors-for-advanced-or-recurrent-endometrial-cancer.html 2020-07-22T16:08:23.6010000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-clopidogrel-versus-prasugrel-and-ticagrelor-for-coronary-artery-disease-treatment-in-patients-with-cyp2c19-lof-alleles-a-systemic-review-and-meta-analysis.html 2020-07-22T16:09:58.9930000Z https://www.medicinesresources.nhs.uk/regimens-of-vitamin-d-supplementation-for-women-during-pregnancy.html 2020-07-22T16:11:25.7100000Z https://www.medicinesresources.nhs.uk/antioxidant-supplementation-for-lung-disease-in-cystic-fibrosis.html 2020-07-22T16:12:38.9790000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-treating-chronic-prostatitis-chronic-pelvic-pain-syndrome.html 2020-07-22T16:13:50.9550000Z https://www.medicinesresources.nhs.uk/valproate-for-acute-mania.html 2020-07-22T16:14:47.4490000Z https://www.medicinesresources.nhs.uk/dynamic-changes-in-paediatric-invasive-pneumococcal-disease-after-sequential-switches-of-conjugate-vaccine-in-belgium-a-national-retrospective-observational-study.html 2020-07-22T16:16:37.5990000Z https://www.medicinesresources.nhs.uk/invasive-pneumococcal-disease-incidence-in-children-and-adults-in-france-during-the-pneumococcal-conjugate-vaccine-era-an-interrupted-time-series-analysis-of-data-from-a-17-year-national-prospective-surveillance-study.html 2020-07-22T16:38:50.7340000Z https://www.medicinesresources.nhs.uk/impact-of-a-weekly-glucagon-like-peptide-1-receptor-agonist-albiglutide-on-glycemic-control-and-on-reducing-prandial-insulin-use-in-type-2-diabetes-inadequately-controlled-on-multiple-insulin-therapy-a-randomized-trial.html 2020-07-22T16:19:03.6610000Z https://www.medicinesresources.nhs.uk/effect-of-levothyroxine-on-left-ventricular-ejection-fraction-in-patients-with-subclinical-hypothyroidism-and-acute-myocardial-infarction-a-randomized-clinical-trial.html 2020-07-22T16:20:11.5700000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-oral-immunotherapy-with-ar101-in-european-children-with-a-peanut-allergy-artemis-a-multicentre-double-blind-randomised-placebo-controlled-phase-3-trial.html 2020-07-22T16:21:22.5900000Z https://www.medicinesresources.nhs.uk/the-safety-of-delayed-versus-immediate-antibiotic-prescribing-for-upper-respiratory-tract-infections.html 2020-07-22T16:22:22.3150000Z https://www.medicinesresources.nhs.uk/mental-health-before-and-during-the-covid-19-pandemic-a-longitudinal-probability-sample-survey-of-the-uk-population.html 2020-07-22T16:23:29.3520000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-upadacitinib-monotherapy-in-phase-3-study-for-atopic-dermatitis.html 2020-07-22T16:24:14.8200000Z https://www.medicinesresources.nhs.uk/trehalose-given-orphan-drug-designation-by-the-ema-for-the-treatment-of-sanfilippo-syndrome.html 2020-07-22T16:25:11.1050000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-new-drug-application-for-voclosporin-for-lupus-nephritis.html 2020-07-22T16:26:03.1680000Z https://www.medicinesresources.nhs.uk/anosmia-and-loss-of-smell-in-the-era-of-covid-19.html 2020-07-22T16:26:55.8250000Z https://www.medicinesresources.nhs.uk/the-safer-management-of-controlled-drugs.html 2020-07-27T10:30:30.9030000Z https://www.medicinesresources.nhs.uk/perioperative-cardiovascular-risk-assessment-and-management-for-noncardiac-surgery-a-review.html 2020-07-22T16:28:52.8710000Z https://www.medicinesresources.nhs.uk/gphc-position-on-covid-19-rapid-antibody-tests.html 2020-07-22T16:29:46.4160000Z https://www.medicinesresources.nhs.uk/tracking-healthcare-activity-and-outcomes-for-shielded-patients-england.html 2020-07-22T16:30:43.8560000Z https://www.medicinesresources.nhs.uk/manufacturers-discontinue-development-of-pimavanserin-for-adjunctive-major-depressive-disorder.html 2020-07-22T16:31:32.7620000Z https://www.medicinesresources.nhs.uk/revised-spcs-kaletra-lopinavir-ritonavir-preparations.html 2020-07-23T15:36:56.1930000Z https://www.medicinesresources.nhs.uk/revised-spc-ajovy-fremanezumab-225-mg-pre-filled-pen-for-injection.html 2020-07-23T15:38:12.6930000Z https://www.medicinesresources.nhs.uk/july-bnf-bnfc-newsletter.html 2020-07-27T10:32:22.1520000Z https://www.medicinesresources.nhs.uk/interventions-for-preventing-bone-disease-in-kidney-transplant-recipients.html 2020-07-23T15:41:06.6080000Z https://www.medicinesresources.nhs.uk/mobile-phone-text-messaging-and-app-based-interventions-for-smoking-cessation.html 2020-07-23T15:43:25.8790000Z https://www.medicinesresources.nhs.uk/palliative-care-interventions-for-people-with-multiple-sclerosis.html 2020-07-23T16:26:11.3190000Z https://www.medicinesresources.nhs.uk/fluoxetine-for-adults-who-are-overweight-or-obese.html 2020-07-23T15:45:45.5600000Z https://www.medicinesresources.nhs.uk/natriuretic-peptide-guided-treatment-for-the-prevention-of-cardiovascular-events-in-patients-without-heart-failure.html 2020-07-23T15:47:30.1240000Z https://www.medicinesresources.nhs.uk/dietary-intake-of-total-animal-and-plant-proteins-and-risk-of-all-cause-cardiovascular-and-cancer-mortality-systematic-review-and-dose-response-meta-analysis-of-prospective-cohort-studies.html 2020-07-23T16:24:30.0190000Z https://www.medicinesresources.nhs.uk/update-on-development-of-biosimilar-versions-of-adalimumab-with-particular-focus-on-excipients-and-injection-site-reactions.html 2020-07-27T10:34:26.9010000Z https://www.medicinesresources.nhs.uk/association-between-topical-beta-blockers-and-risks-of-cardiovascular-and-respiratory-disease-in-patients-with-glaucoma-a-retrospective-cohort-study.html 2020-07-23T15:51:39.0750000Z https://www.medicinesresources.nhs.uk/evaluation-of-risk-of-bullous-pemphigoid-with-initiation-of-dipeptidyl-peptidase-4-inhibitor-vs-second-generation-sulfonylurea.html 2020-07-23T15:53:11.5470000Z https://www.medicinesresources.nhs.uk/historically-controlled-comparison-of-glucocorticoids-with-or-without-tocilizumab-versus-supportive-care-only-in-patients-with-covid-19-associated-cytokine-storm-syndrome-results-of-the-chic-study.html 2020-07-23T16:21:51.7240000Z https://www.medicinesresources.nhs.uk/us-fda-approves-xywav-calcium-magnesium-potassium-and-sodium-oxybates-for-the-treatment-of-cataplexy-or-excessive-daytime-sleepiness-in-patients-aged-7-years-with-narcolepsy.html 2020-07-23T15:56:33.0870000Z https://www.medicinesresources.nhs.uk/positive-data-for-port-delivery-system-with-ranibizumab-pds-from-the-phase-iii-archway-study-in-patients-with-neovascular-age-related-macular-degeneration.html 2020-07-23T15:58:12.5930000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-pfizer-limited-ecalta-anidulafungin-100mg-powder-for-concentrate-for-solution-for-infusion-el-20-a-32.html 2020-07-23T16:00:18.5240000Z https://www.medicinesresources.nhs.uk/lipids-and-lipoproteins-in-2020.html 2020-07-23T16:01:35.1710000Z https://www.medicinesresources.nhs.uk/coffee-caffeine-and-health.html 2020-10-01T13:15:18.0490000Z https://www.medicinesresources.nhs.uk/update-on-policies-for-visiting-arrangements-in-care-homes-during-coronavirus.html 2020-07-23T16:04:45.1760000Z https://www.medicinesresources.nhs.uk/survey-suggests-coronavirus-pandemic-has-improved-attitudes-to-self-care.html 2020-07-23T16:08:12.8220000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-termination-of-phase-iii-study-of-elafibranor-for-non-alcoholic-steatohepatitis-nash-with-fibrosis.html 2020-07-23T16:09:04.8620000Z https://www.medicinesresources.nhs.uk/pneumococcal-vaccination-guidance-for-health-professionals.html 2020-07-23T16:10:13.7450000Z https://www.medicinesresources.nhs.uk/revised-spcs-lynparza-olaparib-film-coated-tablets.html 2020-07-24T14:19:04.1760000Z https://www.medicinesresources.nhs.uk/revised-spcs-strepsils-amylmetacresol-2-4-dichlorobenzyl-alcohol-1.html 2020-07-24T14:21:29.0140000Z https://www.medicinesresources.nhs.uk/revised-spc-qutenza-capsaicin-179mg-cutaneous-patch.html 2020-07-24T16:13:57.6010000Z https://www.medicinesresources.nhs.uk/evidence-of-harm-from-illicit-or-fake-benzodiazepines.html 2020-07-27T10:35:47.7210000Z https://www.medicinesresources.nhs.uk/the-alert-recommends-that-adult-and-young-peoples-drug-and-alcohol-treatment-and-recovery-services-should-supply-naloxone-so-that-it-is-available-for-all-those-at-risk-of-an-opioid-overdose.html 2020-07-24T15:56:34.6120000Z https://www.medicinesresources.nhs.uk/tiagabine-add-on-therapy-for-drug-resistant-focal-epilepsy.html 2020-07-24T14:30:28.6570000Z https://www.medicinesresources.nhs.uk/treatments-for-seizures-in-catamenial-menstrual-related-epilepsy.html 2020-07-24T14:32:45.1760000Z https://www.medicinesresources.nhs.uk/inhaled-nitric-oxide-for-treating-pain-crises-in-people-with-sickle-cell-disease.html 2020-07-24T14:34:35.2830000Z https://www.medicinesresources.nhs.uk/combined-spinal-epidural-versus-spinal-anaesthesia-for-caesarean-section.html 2020-07-24T14:36:26.7050000Z https://www.medicinesresources.nhs.uk/medical-and-surgical-interventions-for-the-treatment-of-urinary-stones-in-children.html 2020-07-24T14:39:23.2200000Z https://www.medicinesresources.nhs.uk/risks-and-impact-of-angiotensin-converting-enzyme-inhibitors-or-angiotensin-receptor-blockers-on-sars-cov-2-infection-in-adults.html 2020-07-24T16:20:30.6360000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-of-ruxolitinib-in-graft-versus-host-disease-meets-primary-endpoint.html 2020-07-24T14:43:19.3700000Z https://www.medicinesresources.nhs.uk/positive-results-for-favipiravir-in-a-small-phase-iii-study-in-covid-19-patients-in-india.html 2020-07-24T14:45:23.9140000Z https://www.medicinesresources.nhs.uk/mavacamten-receives-breakthrough-therapy-designation-in-the-us-for-the-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy.html 2020-07-24T14:47:12.8380000Z https://www.medicinesresources.nhs.uk/application-for-approval-of-vosoritide-for-treatment-of-children-with-achondroplasia-dwarfism-submitted-to-the-european-medicines-agency.html 2020-07-24T14:48:56.4510000Z https://www.medicinesresources.nhs.uk/most-comprehensive-flu-programme-in-uk-history-will-be-rolled-out-this-winter.html 2020-07-27T10:37:32.6400000Z https://www.medicinesresources.nhs.uk/class-3-medicines-recall-accord-healthcare-limited-irinotecan-hydrochloride-concentrate-for-solution-for-infusion-20mg-ml-5ml-vial-el-20-a-33.html 2020-07-24T14:53:15.2340000Z https://www.medicinesresources.nhs.uk/face-coverings-now-mandatory-in-shops-supermarkets-shopping-centres-and-enclosed-transport-hubs.html 2020-07-24T14:56:40.3830000Z https://www.medicinesresources.nhs.uk/fda-recommends-health-care-professionals-discuss-naloxone-with-all-patients-when-prescribing-opioid-pain-relievers-or-medicines-to-treat-opioid-use-disorder-oud.html 2020-07-24T14:58:21.0490000Z https://www.medicinesresources.nhs.uk/mental-health-and-primary-care-networks-understanding-the-opportunities.html 2020-07-24T15:58:36.0340000Z https://www.medicinesresources.nhs.uk/the-link-between-kidney-disease-and-cancer-complications-and-treatment.html 2020-07-24T15:59:10.0410000Z https://www.medicinesresources.nhs.uk/rapid-decay-of-anti-sars-cov-2-antibodies-in-persons-with-mild-covid-19.html 2020-08-20T12:17:15.9650000Z https://www.medicinesresources.nhs.uk/resuming-health-services-during-the-covid-19-pandemic-what-can-the-nhs-learn-from-other-countries.html 2020-07-24T15:12:27.5820000Z https://www.medicinesresources.nhs.uk/breztri-aerosphere-budesonide-glycopyrrolate-formoterol-fumarate-approved-in-the-us-for-the-treatment-of-copd.html 2020-07-24T15:13:46.6170000Z https://www.medicinesresources.nhs.uk/uk-government-unveils-gbp100-million-extra-funding-to-boost-vaccine-manufacturing-capabilities-1.html 2020-07-24T15:15:59.9710000Z https://www.medicinesresources.nhs.uk/house-of-lords-science-and-technology-committee-urges-government-to-take-immediate-action-to-avert-winter-covid-19-spike.html 2020-07-24T15:17:26.9490000Z https://www.medicinesresources.nhs.uk/preparing-for-a-challenging-winter-2020-21.html 2020-07-24T15:19:20.4350000Z https://www.medicinesresources.nhs.uk/flu-vaccination-2020-to-2021-programme-briefing-for-schools.html 2020-07-27T10:40:19.4900000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-310-july-2020.html 2020-07-27T10:41:09.1180000Z https://www.medicinesresources.nhs.uk/emtricitabine-and-tenofovir-alafenamide-vs-emtricitabine-and-tenofovir-disoproxil-fumarate-for-hiv-pre-exposure-prophylaxis-discover-primary-results-from-a-randomised-double-blind-multicentre-active-controlled-phase-3-non-inferiority-trial.html 2020-07-24T16:19:47.5450000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-abrocitinib-in-adults-and-adolescents-with-moderate-to-severe-atopic-dermatitis-jade-mono-1-a-multicentre-double-blind-randomised-placebo-controlled-phase-3-trial.html 2020-07-24T16:03:32.0600000Z https://www.medicinesresources.nhs.uk/continuing-versus-tapering-glucocorticoids-after-achievement-of-low-disease-activity-or-remission-in-rheumatoid-arthritis-semira-a-double-blind-multicentre-randomised-controlled-trial.html 2020-07-24T16:18:30.0820000Z https://www.medicinesresources.nhs.uk/neonatal-management-and-outcomes-during-the-covid-19-pandemic-an-observation-cohort-study.html 2020-07-24T16:09:26.3680000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-with-or-without-azithromycin-in-mild-to-moderate-covid-19.html 2020-10-01T12:30:00.4290000Z https://www.medicinesresources.nhs.uk/health-and-cost-impact-of-stepping-down-asthma-medication-for-uk-patients-2001-2017-a-population-based-observational-study.html 2020-07-24T16:12:34.3060000Z https://www.medicinesresources.nhs.uk/independent-risk-factors-for-simvastatin-related-myopathy-and-relevance-to-different-types-of-muscle-symptom.html 2020-07-24T16:16:14.5880000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-arranging-planned-care-in-hospitals-and-diagnostic-services-guidance-ng179.html 2020-07-28T14:32:18.1650000Z https://www.medicinesresources.nhs.uk/pharmaceutical-policies-effects-of-educational-or-regulatory-policies-targeting-prescribers.html 2020-07-27T14:30:16.0840000Z https://www.medicinesresources.nhs.uk/statins-for-children-with-familial-hypercholesterolemia.html 2020-07-27T14:32:19.8550000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-umifenovir-for-coronavirus-disease-2019-covid-19-a-systematic-review-and-meta-analysis.html 2020-07-27T14:34:07.7430000Z https://www.medicinesresources.nhs.uk/vaccines-for-preventing-herpes-zoster-in-older-adults.html 2020-07-27T14:35:58.8880000Z https://www.medicinesresources.nhs.uk/baclofen-for-alcohol-withdrawal.html 2020-07-27T14:37:29.0490000Z https://www.medicinesresources.nhs.uk/intranasal-corticosteroids-for-non-allergic-rhinitis.html 2020-07-27T14:39:02.8490000Z https://www.medicinesresources.nhs.uk/interventions-for-prodromal-stage-of-psychosis.html 2020-07-27T14:40:44.1430000Z https://www.medicinesresources.nhs.uk/assessment-of-who-antibiotic-consumption-and-access-targets-in-76-countries-2000-15-an-analysis-of-pharmaceutical-sales-data.html 2020-07-27T14:43:16.6530000Z https://www.medicinesresources.nhs.uk/second-look-surgery-plus-hyperthermic-intraperitoneal-chemotherapy-versus-surveillance-in-patients-at-high-risk-of-developing-colorectal-peritoneal-metastases-prophylochip-prodige-15-a-randomised-phase-3-study.html 2020-07-27T14:45:07.0960000Z https://www.medicinesresources.nhs.uk/does-screening-for-adverse-effects-improve-health-outcomes-in-epilepsy-a-randomized-trial.html 2020-07-27T14:47:43.2160000Z https://www.medicinesresources.nhs.uk/comprehensive-genomic-analysis-in-nrg-oncology-rtog-9802-a-phase-iii-trial-of-radiation-versus-radiation-plus-procarbazine-lomustine-ccnu-and-vincristine-in-high-risk-low-grade-glioma.html 2020-07-27T14:50:45.5320000Z https://www.medicinesresources.nhs.uk/cancer-and-leukemia-group-b-90203-alliance-radical-prostatectomy-with-or-without-neoadjuvant-chemohormonal-therapy-in-localized-high-risk-prostate-cancer.html 2020-08-12T14:06:20.3120000Z https://www.medicinesresources.nhs.uk/reduced-morbidity-and-mortality-in-survivors-of-childhood-acute-lymphoblastic-leukemia-a-report-from-the-childhood-cancer-survivor-study.html 2020-08-12T14:10:13.3690000Z https://www.medicinesresources.nhs.uk/randomized-phase-iii-trial-of-pegvorhyaluronidase-alfa-with-nab-paclitaxel-plus-gemcitabine-for-patients-with-hyaluronan-high-metastatic-pancreatic-adenocarcinoma.html 2020-07-27T14:55:53.4160000Z https://www.medicinesresources.nhs.uk/real-world-effectiveness-its-predictors-and-onset-of-action-of-cholinesterase-inhibitors-and-memantine-in-dementia-retrospective-health-record-study.html 2020-07-28T15:28:59.9860000Z https://www.medicinesresources.nhs.uk/fda-approves-brexucabtagene-autoleucel-for-adult-patients-with-relapsed-or-refractory-mantle-cell-lymphoma.html 2020-07-27T15:03:08.8810000Z https://www.medicinesresources.nhs.uk/conference-report-influenza-and-pneumonia-vaccinations-linked-to-lower-risk-of-alzheimer-s-dementia.html 2020-07-27T15:05:17.1750000Z https://www.medicinesresources.nhs.uk/abilify-mycite-aripiprazole-withdrawal-of-the-marketing-authorisation-application-for-use-in-schizophrenia-and-manic-episodes-of-bipolar-disorder.html 2020-07-27T15:06:34.5440000Z https://www.medicinesresources.nhs.uk/rayoqta-abicipar-pegol-withdrawal-of-the-marketing-authorisation-application-for-use-in-wet-age-related-macular-degeneration.html 2020-07-27T15:08:05.6370000Z https://www.medicinesresources.nhs.uk/chmp-recommend-update-of-market-authorisation-for-everolimus-votubia.html 2020-07-27T15:11:38.4990000Z https://www.medicinesresources.nhs.uk/chmp-recommend-market-authorisation-change-for-fortacin-lidocaine-prilocaine-cutaneous-spray.html 2020-07-27T15:14:36.4260000Z https://www.medicinesresources.nhs.uk/chmp-recommend-market-authorisation-for-dapivirine-vaginal-ring-25-mg.html 2020-07-27T15:16:57.6580000Z https://www.medicinesresources.nhs.uk/chmp-recommend-market-authorisation-for-generic-fampridine-fampridine-accord.html 2020-07-27T15:19:06.2350000Z https://www.medicinesresources.nhs.uk/chmp-recommend-market-authorisation-for-biosimilar-bevacizumab-equidacent-brand.html 2020-07-27T15:22:15.5250000Z https://www.medicinesresources.nhs.uk/chmp-recommend-market-authorisation-for-bupivacaine-meloxicam-zynrelef.html 2020-07-27T15:24:13.5020000Z https://www.medicinesresources.nhs.uk/chmp-recommend-market-authorisation-for-filgotionib-jyseleca.html 2020-07-27T15:26:24.1250000Z https://www.medicinesresources.nhs.uk/chmp-recommend-market-authorisation-for-acalabrutinib-calquence.html 2020-07-27T15:28:26.4580000Z https://www.medicinesresources.nhs.uk/chmp-recommend-market-authorisation-for-belantamab-mafodotin-blenrep.html 2020-07-27T15:29:55.4530000Z https://www.medicinesresources.nhs.uk/chmp-recommend-market-authorisation-for-avapritinib-ayvakyt.html 2020-07-27T15:31:28.1240000Z https://www.medicinesresources.nhs.uk/chmp-recommends-market-authorisation-for-liposomal-amikacin-arikayce-liposomal.html 2020-07-27T15:32:40.3240000Z https://www.medicinesresources.nhs.uk/chmp-recommend-market-authorisation-of-crizanlizumab-adakveo.html 2020-07-27T15:34:38.2210000Z https://www.medicinesresources.nhs.uk/chmp-recommend-licence-extension-for-herpes-zoster-vaccine-recombinant-adjuvanted-shingrix.html 2020-07-27T15:35:51.7970000Z https://www.medicinesresources.nhs.uk/chmp-recommend-licence-extension-for-darunavir-prezista.html 2020-07-27T15:37:34.1650000Z https://www.medicinesresources.nhs.uk/chmp-recommend-licence-extension-for-catridecacog-novothirteen.html 2020-07-27T15:39:39.6760000Z https://www.medicinesresources.nhs.uk/chmp-recommend-licence-extension-for-lurasidone-latuda.html 2020-07-27T15:41:33.8730000Z https://www.medicinesresources.nhs.uk/chmp-recommends-licence-extension-for-ivacaftor-kalydeco.html 2020-07-27T15:42:55.6030000Z https://www.medicinesresources.nhs.uk/chmp-recommends-licence-extension-for-durvalumab-imfinzi.html 2020-07-27T15:44:00.7140000Z https://www.medicinesresources.nhs.uk/chmp-recommend-licence-extension-for-ibrutinib-imbruvica.html 2020-07-27T15:45:18.5520000Z https://www.medicinesresources.nhs.uk/chmp-recommends-licence-extension-for-hyqvia-brand-human-normal-immunoglobulin.html 2020-07-27T15:48:54.2570000Z https://www.medicinesresources.nhs.uk/chmp-recommends-licence-extension-for-burosumab-crysvita.html 2020-07-27T15:50:53.2780000Z https://www.medicinesresources.nhs.uk/chmp-recommends-refusal-of-market-authorisation-for-emapalumab-gamifant-for-primary-haemophagocytic-lymphohistiocytosis-hlh-in-children-under-18-years-of-age.html 2020-07-27T15:52:18.8700000Z https://www.medicinesresources.nhs.uk/chmp-recommends-refusal-of-market-authorisation-for-tagraxofusp-elzonris-for-blastic-plasmacytoid-dendritic-cell-neoplasm.html 2020-07-27T15:53:50.9390000Z https://www.medicinesresources.nhs.uk/how-to-move-beyond-quality-improvement-projects.html 2020-07-27T15:56:16.9810000Z https://www.medicinesresources.nhs.uk/primary-care-assessment-and-management-of-common-physical-symptoms-in-pregnancy.html 2020-07-27T15:58:10.5660000Z https://www.medicinesresources.nhs.uk/consultation-outcome-calorie-labelling-for-food-and-drink-served-outside-of-the-home.html 2020-07-27T15:59:35.9100000Z https://www.medicinesresources.nhs.uk/new-obesity-strategy-unveiled-as-country-urged-to-lose-weight-to-beat-coronavirus-covid-19-and-protect-the-nhs.html 2020-07-27T16:01:31.4560000Z https://www.medicinesresources.nhs.uk/ema-starts-review-of-dexamethasone-for-treating-adults-with-covid-19-requiring-respiratory-support.html 2020-07-27T16:02:48.0310000Z https://www.medicinesresources.nhs.uk/particle-sizes-of-infectious-aerosols-implications-for-infection-control.html 2020-07-27T16:04:03.6570000Z https://www.medicinesresources.nhs.uk/resuming-health-services-during-the-covid-19-pandemic-what-can-the-nhs-learn-from-other-countries-1.html 2020-07-27T16:05:08.7790000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-eu-marketing-application-for-vosoritide.html 2020-07-27T16:06:31.6890000Z https://www.medicinesresources.nhs.uk/revised-spc-zytiga-abiraterone-acetate-500-mg-film-coated-tablets.html 2020-07-28T14:52:05.6020000Z https://www.medicinesresources.nhs.uk/interventions-for-preventing-falls-in-people-with-multiple-sclerosis.html 2020-07-28T16:36:20.7460000Z https://www.medicinesresources.nhs.uk/selective-serotonin-reuptake-inhibitors-ssris-for-stroke-recovery.html 2020-07-28T16:36:38.3260000Z https://www.medicinesresources.nhs.uk/antibiotics-for-asymptomatic-bacteriuria-in-pregnancy.html 2020-07-28T15:07:43.9940000Z https://www.medicinesresources.nhs.uk/sodium-glucose-cotransporter-2-inhibitors-and-the-risk-for-diabetic-ketoacidosis.html 2020-07-28T16:39:16.0250000Z https://www.medicinesresources.nhs.uk/delayed-denosumab-injections-and-fracture-risk-among-patients-with-osteoporosis.html 2020-07-28T16:39:51.2960000Z https://www.medicinesresources.nhs.uk/cancer-incidence-following-a-high-normal-platelet-count-cohort-study-using-electronic-healthcare-records-from-english-primary-care.html 2020-07-28T16:41:37.4670000Z https://www.medicinesresources.nhs.uk/diabetes-glycated-hemoglobin-and-the-risk-of-myocardial-infarction-in-women-and-men-a-prospective-cohort-study-of-the-uk-biobank.html 2020-07-28T15:12:33.4790000Z https://www.medicinesresources.nhs.uk/treatment-and-prevention-of-pouchitis-after-ileal-pouch-anal-anastomosis-for-chronic-ulcerative-colitis.html 2020-07-28T16:35:28.2470000Z https://www.medicinesresources.nhs.uk/characteristics-and-strength-of-evidence-of-covid-19-studies-registered-on-clinicaltrials-gov.html 2020-07-28T16:44:11.3250000Z https://www.medicinesresources.nhs.uk/trends-in-antihypertensive-medication-use-among-individuals-with-a-history-of-stroke-and-hypertension-2005-to-2016.html 2020-07-28T16:45:06.1840000Z https://www.medicinesresources.nhs.uk/outcomes-of-cardiovascular-magnetic-resonance-imaging-in-patients-recently-recovered-from-coronavirus-disease-2019-covid-19.html 2020-07-28T16:45:48.8960000Z https://www.medicinesresources.nhs.uk/association-of-nonoperative-management-using-antibiotic-therapy-vs-laparoscopic-appendectomy-with-treatment-success-and-disability-days-in-children-with-uncomplicated-appendicitis.html 2020-07-28T16:46:49.3900000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-osilodrostat-in-patients-with-cushing-s-disease-linc-3-a-multicentre-phase-iii-study-with-a-doubleblind-randomised-withdrawal-phase.html 2020-07-28T16:48:06.7790000Z https://www.medicinesresources.nhs.uk/the-future-of-pharmacy-transformation-and-growth.html 2020-07-28T16:50:41.3580000Z https://www.medicinesresources.nhs.uk/excess-weight-and-covid-19-insights-from-new-evidence.html 2020-08-02T17:47:31.3370000Z https://www.medicinesresources.nhs.uk/people-at-high-risk-of-diabetes-fast-tracked-into-prevention-programme.html 2020-07-28T16:52:12.2680000Z https://www.medicinesresources.nhs.uk/revised-spc-kyntheum-brodalumab-210-mg-solution-for-injection.html 2020-08-02T18:05:22.5070000Z https://www.medicinesresources.nhs.uk/revised-spc-norvir-ritonavir-products.html 2020-07-29T16:04:51.5710000Z https://www.medicinesresources.nhs.uk/revised-spc-kaletra-ritonavir-lopinavir-products.html 2020-07-29T16:05:09.2440000Z https://www.medicinesresources.nhs.uk/safety-information-for-patient-parent-to-minimise-the-risk-of-serious-side-effects-soliris-eculizumab.html 2020-07-29T15:23:12.9870000Z https://www.medicinesresources.nhs.uk/mortality-risk-associated-with-venous-thromboembolism-a-systematic-review-and-bayesian-meta-analysis.html 2020-07-29T15:24:14.3610000Z https://www.medicinesresources.nhs.uk/interventions-for-idiopathic-steroid-resistant-nephrotic-syndrome-in-children.html 2020-07-29T15:26:11.3390000Z https://www.medicinesresources.nhs.uk/dietary-interventions-for-adult-cancer-survivors.html 2020-07-29T15:28:20.6860000Z https://www.medicinesresources.nhs.uk/comparison-of-different-human-papillomavirus-hpv-vaccine-types-and-dose-schedules-for-prevention-of-hpv-related-disease-in-females-and-males.html 2020-07-29T15:29:53.0360000Z https://www.medicinesresources.nhs.uk/multiple-drug-combinations-of-bortezomib-lenalidomide-and-thalidomide-for-first-line-treatment-in-adults-with-transplant-ineligible-multiple-myeloma-a-network-meta-analysis.html 2020-07-29T15:31:06.5640000Z https://www.medicinesresources.nhs.uk/prontosan-for-acute-and-chronic-wounds-medtech-innovation-briefing-mib220.html 2020-08-02T18:06:39.2550000Z https://www.medicinesresources.nhs.uk/assessment-of-covid-19-in-primary-care-the-identification-of-symptoms-signs-characteristics-comorbidities-and-clinical-signs-in-adults-which-may-indicate-a-higher-risk-of-progression-to-severe-disease.html 2020-07-29T15:34:01.4310000Z https://www.medicinesresources.nhs.uk/six-new-projects-hoping-to-further-improve-understanding-of-links-between-ethnicity-and-susceptibility-to-covid-19-being-funded-by-nihr-and-uk-research-and-innovation.html 2020-07-29T15:34:58.9260000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-awards-prime-status-to-adp-a2m4-for-treatment-of-synovial-sarcoma.html 2020-07-29T15:36:00.8370000Z https://www.medicinesresources.nhs.uk/mhra-and-national-fire-chiefs-council-launch-new-campaign-to-raise-awareness-of-fire-risk-and-precautions-that-need-to-be-taken-by-users-of-skin-creams.html 2020-08-02T18:17:44.4060000Z https://www.medicinesresources.nhs.uk/brain-insulin-resistance-in-alzheimer-s-disease-and-related-disorders-mechanisms-and-therapeutic-approaches.html 2020-07-29T15:38:26.1990000Z https://www.medicinesresources.nhs.uk/management-of-anticoagulant-refractory-thrombotic-antiphospholipid-syndrome.html 2020-07-29T15:39:24.2730000Z https://www.medicinesresources.nhs.uk/hiv-associated-burkitt-lymphoma.html 2020-07-29T15:40:37.3320000Z https://www.medicinesresources.nhs.uk/hepatitis-b-virus-screening-and-management-for-patients-with-cancer-prior-to-therapy-asco-provisional-clinical-opinion-update.html 2020-08-10T14:34:21.9830000Z https://www.medicinesresources.nhs.uk/new-horizons-in-pharmacologic-therapy-for-secondary-stroke-prevention.html 2020-07-29T15:44:40.0230000Z https://www.medicinesresources.nhs.uk/update-from-uk-chief-pharmaceutical-officers-general-pharmaceutical-council-and-pharmaceutical-society-ni-on-reforms-to-initial-education-and-training-of-pharmacists.html 2020-07-29T15:45:49.8080000Z https://www.medicinesresources.nhs.uk/dtb-commentary-is-tramadol-associated-with-an-increase-in-all-cause-mortality-among-patients-with-osteoarthritis.html 2020-07-29T15:46:57.2940000Z https://www.medicinesresources.nhs.uk/dtb-select-warning-on-use-of-ondansetron-in-first-trimester-of-pregnancy.html 2020-07-29T15:48:45.1080000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-kyowa-kirin-limited-abstral-200-microgram-sublingual-tablets-el-20-a-34.html 2020-07-29T15:49:42.7420000Z https://www.medicinesresources.nhs.uk/readying-the-nhs-and-social-care-for-the-covid-19-peak.html 2020-07-29T15:50:57.8690000Z https://www.medicinesresources.nhs.uk/from-blockbuster-to-nichebuster-how-a-flawed-legislation-helped-create-a-new-profit-model-for-the-drug-industry.html 2020-07-29T15:52:02.1970000Z https://www.medicinesresources.nhs.uk/american-college-of-rheumatology-guidance-for-the-management-of-rheumatic-disease-in-adult-patients-during-the-covid-19-pandemic.html 2020-07-29T15:53:11.3620000Z https://www.medicinesresources.nhs.uk/is-risk-compensation-threatening-public-health-in-the-covid-19-pandemic.html 2020-07-29T15:54:45.3870000Z https://www.medicinesresources.nhs.uk/covacta-trial-of-tocilizumab-in-patients-hospitalised-with-severe-covid-19-related-pneumonia-fails-to-meet-primary-end.html 2020-07-29T15:56:21.0270000Z https://www.medicinesresources.nhs.uk/eu-executive-signs-deal-with-gilead-for-covid-19-treatment-remdesivir-veklury.html 2020-07-29T15:57:20.9750000Z https://www.medicinesresources.nhs.uk/positive-results-from-phase-iiib-be-radiant-study-of-bimekizumab-vs-secukinumab-in-patients-with-moderate-to-severe-plaque-psoriasis.html 2020-07-29T15:58:19.6670000Z https://www.medicinesresources.nhs.uk/fda-grants-orphan-drug-designation-to-zenocutuzumab-zeno-for-treatment-of-pancreatic-cancer.html 2020-07-29T16:22:45.2170000Z https://www.medicinesresources.nhs.uk/european-commission-grants-marketing-authorisation-for-subcutaneous-formulation-of-infliximab-remsima-sc-for-additional-five-indications.html 2020-07-29T16:06:20.5870000Z https://www.medicinesresources.nhs.uk/moderna-launches-phase-iii-cove-coronavirus-efficacy-trial-of-mrna-1273-vaccine.html 2020-07-29T16:02:48.0150000Z https://www.medicinesresources.nhs.uk/webmd-poll-finds-only-one-in-four-in-us-will-opt-to-receive-covid-19-vaccine-when-first-available.html 2020-07-29T16:04:08.4160000Z https://www.medicinesresources.nhs.uk/third-phase-iii-study-ad-up-of-upadacitinib-plus-topical-corticosteroids-tcs-reports-improved-skin-and-itch-symptoms-in-atopic-dermatitis-patients.html 2020-07-29T16:05:05.1180000Z https://www.medicinesresources.nhs.uk/adrenaline-epinephrine-injection-1-10-000-in-a-prefilled-syringe-pl-12064-0006-mah-letter-on-fmd-serialisation-information-on-the-packs.html 2020-07-29T16:25:09.8630000Z https://www.medicinesresources.nhs.uk/renal-and-ureteric-stones-quality-standard-qs195.html 2020-08-03T11:55:58.0130000Z https://www.medicinesresources.nhs.uk/use-of-factory-calibrated-real-time-continuous-glucose-monitoring-improves-time-in-target-and-hba1c-in-a-multiethnic-cohort-of-adolescents-and-young-adults-with-type-1-diabetes-the-millennial-study.html 2020-07-29T16:10:43.9670000Z https://www.medicinesresources.nhs.uk/cannabidiol-for-the-treatment-of-cannabis-use-disorder-a-phase-2a-double-blind-placebo-controlled-randomised-adaptive-bayesian-trial.html 2020-07-29T16:11:34.4020000Z https://www.medicinesresources.nhs.uk/association-of-menopausal-hormone-therapy-with-breast-cancer-incidence-and-mortality-during-long-term-follow-up-of-the-womens-health-initiative-randomized-clinical-trials.html 2020-08-02T18:28:39.6460000Z https://www.medicinesresources.nhs.uk/case-characteristics-resource-use-and-outcomes-of-10-021-patients-with-covid-19-admitted-to-920-german-hospitals-an-observational-study.html 2020-07-29T16:16:11.6620000Z https://www.medicinesresources.nhs.uk/association-of-sustained-immunotherapy-with-disability-outcomes-in-patients-with-active-secondary-progressive-multiple-sclerosis.html 2020-07-29T16:17:13.3180000Z https://www.medicinesresources.nhs.uk/discontinuation-of-cholinesterase-inhibitor-treatment-in-institutionalised-patients-with-advanced-dementia.html 2020-07-29T16:28:44.2150000Z https://www.medicinesresources.nhs.uk/management-of-osteoporosis-and-the-prevention-of-fragility-fractures-update-of-sign-guideline-142.html 2020-08-02T18:48:50.5100000Z https://www.medicinesresources.nhs.uk/revised-spc-magnaspartate-magnesium-aspartate-dehydrate-243mg-powder-for-oral-solution.html 2020-07-30T14:27:08.0640000Z https://www.medicinesresources.nhs.uk/new-product-treprostinil-tillomed-5-mg-ml-and-10-mg-ml-solution-for-infusion.html 2020-07-30T14:28:00.6290000Z https://www.medicinesresources.nhs.uk/national-intelligence-report-early-warning-scores-to-detect-deterioration-in-covid-19-inpatients.html 2020-08-02T18:56:24.2680000Z https://www.medicinesresources.nhs.uk/influence-of-clinical-trials-of-acute-coronary-syndrome-beyond-the-primary-hypothesis-a-systematic-review.html 2020-07-30T14:30:58.9090000Z https://www.medicinesresources.nhs.uk/chinese-herbal-medicine-for-coronavirus-disease-2019-a-systematic-review-and-meta-analysis.html 2020-07-30T14:32:22.6290000Z https://www.medicinesresources.nhs.uk/progestogen-for-preventing-miscarriage-in-women-with-recurrent-miscarriage-of-unclear-etiology.html 2020-07-30T14:33:31.3660000Z https://www.medicinesresources.nhs.uk/prenatal-administration-of-progestogens-for-preventing-spontaneous-preterm-birth-in-women-with-a-multiple-pregnancy.html 2020-07-30T16:43:57.2420000Z https://www.medicinesresources.nhs.uk/long-term-gnrh-agonist-therapy-before-in-vitro-fertilisation-ivf-for-improving-fertility-outcomes-in-women-with-endometriosis.html 2020-07-30T14:36:58.8000000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-the-prevention-of-acute-postoperative-pain-in-adults-following-brain-surgery.html 2020-07-30T14:38:18.9780000Z https://www.medicinesresources.nhs.uk/treatment-of-chronic-lymphocytic-leukemia.html 2020-07-30T14:39:34.4490000Z https://www.medicinesresources.nhs.uk/mogamulizumab-for-previously-treated-mycosis-fungoides-and-sezary-syndrome-appraisal-consultation-document.html 2020-07-30T14:40:38.5140000Z https://www.medicinesresources.nhs.uk/updated-covid-19-rapid-guideline-haematopoietic-stem-cell-transplantation.html 2020-08-02T18:32:39.1740000Z https://www.medicinesresources.nhs.uk/optimising-treatments-for-sexually-transmitted-infections-surveillance-pharmacokinetics-and-pharmacodynamics-therapeutic-strategies-and-molecular-resistance-prediction.html 2020-07-30T14:44:16.4280000Z https://www.medicinesresources.nhs.uk/adult-social-care-and-covid-19-assessing-the-policy-response-in-england-so-far.html 2020-07-30T16:31:49.9690000Z https://www.medicinesresources.nhs.uk/nhs-test-and-trace-launches-campaign-to-encourage-everyone-with-symptoms-to-get-a-free-test.html 2020-07-30T16:25:44.6970000Z https://www.medicinesresources.nhs.uk/takeda-led-trial-of-covid-19-plasma-treatment-delayed.html 2020-07-30T14:53:24.8320000Z https://www.medicinesresources.nhs.uk/export-and-hoarding-of-restricted-medicines-updated-guidance.html 2020-07-30T14:54:16.9700000Z https://www.medicinesresources.nhs.uk/launch-of-the-new-nhs-people-plan.html 2020-07-30T16:23:57.5120000Z https://www.medicinesresources.nhs.uk/statement-from-the-uk-chief-medical-officers-on-extension-of-self-isolation-period-30-july-2020.html 2020-08-02T18:59:50.2970000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-biologics-license-application-for-ansuvimab-as-a-treatment-for-ebola.html 2020-07-30T14:58:55.4780000Z https://www.medicinesresources.nhs.uk/abbvie-announces-positive-data-from-phase-iii-advance-trial-for-cgrp-receptor-antagonist-atogepant-in-migraine-prevention.html 2020-07-30T14:59:57.7080000Z https://www.medicinesresources.nhs.uk/fda-grants-breakthrough-therapy-designation-to-hif-2a-inhibitor-mk-6482-for-treatment-of-certain-patients-with-von-hippel-lindau-vhl-disease-associated-renal-cell-carcinoma-rcc.html 2020-07-30T16:22:12.0910000Z https://www.medicinesresources.nhs.uk/biologics-license-application-submitted-to-fda-for-idecabtagene-vicleucel-ide-cel-bb2121-for-treatment-of-adults-with-relapsed-and-refractory-multiple-myeloma.html 2020-07-30T15:02:36.7700000Z https://www.medicinesresources.nhs.uk/funding-withdrawn-from-university-hospital-southampton-nhs-trust-conducting-covid-19-accord-clinical-study-of-axl-kinase-inhibitor-bemcentinib.html 2020-07-30T15:03:38.5890000Z https://www.medicinesresources.nhs.uk/positive-data-reported-from-phase-iii-dapa-ckd-clinical-trial-of-dapagliflozin-in-end-stage-kidney-disease.html 2020-07-30T15:04:47.7440000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-begin-global-phase-ii-iii-covid-19-vaccine-trial.html 2020-07-30T15:05:58.7310000Z https://www.medicinesresources.nhs.uk/respiratory-syncytial-virus-vaccination-during-pregnancy-and-effects-in-infants.html 2020-08-27T13:42:39.4310000Z https://www.medicinesresources.nhs.uk/single-dose-nirsevimab-for-prevention-of-rsv-in-preterm-infants.html 2020-08-27T14:40:13.7340000Z https://www.medicinesresources.nhs.uk/efficacy-of-a-psychosocial-pain-management-intervention-for-men-and-women-with-substance-use-disorders-and-chronic-pain-a-randomized-clinical-trial.html 2020-07-30T15:13:45.4370000Z https://www.medicinesresources.nhs.uk/effect-of-intravenous-acetaminophen-on-postoperative-hypoxemia-after-abdominal-surgery-the-factor-randomized-clinical-trial.html 2020-07-30T15:16:34.7990000Z https://www.medicinesresources.nhs.uk/investigation-of-a-covid-19-outbreak-in-germany-resulting-from-a-single-travel-associated-primary-case-a-case-series.html 2020-07-30T15:18:54.0220000Z https://www.medicinesresources.nhs.uk/observations-of-the-global-epidemiology-of-covid-19-from-the-prepandemic-period-using-web-based-surveillance-a-cross-sectional-analysis.html 2020-07-30T16:10:49.3500000Z https://www.medicinesresources.nhs.uk/body-mass-index-and-risk-for-intubation-or-death-in-sars-cov-2-infection-a-retrospective-cohort-study.html 2020-07-30T15:28:13.5180000Z https://www.medicinesresources.nhs.uk/alteplase-for-acute-ischemic-stroke-in-patients-aged-greater-than-80-years.html 2020-08-20T10:58:55.1830000Z https://www.medicinesresources.nhs.uk/what-is-the-clinical-significance-of-potential-drug-interactions-with-local-anaesthetic-preparations-used-in-primary-care-dentistry.html 2020-08-02T19:00:18.3910000Z https://www.medicinesresources.nhs.uk/what-matters-most-to-patients-when-choosing-treatment-for-mild-moderate-asthma-results-from-a-discrete-choice-experiment.html 2020-07-30T15:30:20.8000000Z https://www.medicinesresources.nhs.uk/adult-social-care-and-covid-19-assessing-the-impact-on-social-care-users-and-staff-in-england-so-far.html 2020-07-30T16:29:56.8510000Z https://www.medicinesresources.nhs.uk/revised-spc-xgeva-denosumab-120-mg-solution-for-injection.html 2020-07-31T14:13:11.9580000Z https://www.medicinesresources.nhs.uk/new-product-suboxone-buprenorphine-naloxone-sublingual-film-various-strengths.html 2020-07-31T14:15:25.5990000Z https://www.medicinesresources.nhs.uk/revised-spc-revaxis-diphtheria-tetanus-and-poliomyelitis-inactivated-vaccine-suspension-for-injection-in-pre-filled-syringe.html 2020-07-31T14:16:34.8150000Z https://www.medicinesresources.nhs.uk/revised-spc-ofev-nintedanib-100-mg-soft-capsules.html 2020-07-31T14:17:45.4150000Z https://www.medicinesresources.nhs.uk/liposomal-and-lipid-complex-formulations-name-change-to-reduce-medication-errors.html 2020-08-02T19:04:13.8340000Z https://www.medicinesresources.nhs.uk/systemically-administered-vegf-pathway-inhibitors-risk-of-aneurysm-and-artery-dissection.html 2020-08-02T19:07:22.1050000Z https://www.medicinesresources.nhs.uk/clonazepam-monotherapy-for-treating-people-with-newly-diagnosed-epilepsy.html 2020-07-31T14:22:08.1230000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-painful-sickle-cell-vaso-occlusive-crises-in-adults.html 2020-07-31T14:23:36.4300000Z https://www.medicinesresources.nhs.uk/adalimumab-for-induction-of-remission-in-crohn-s-disease.html 2020-07-31T14:24:54.9320000Z https://www.medicinesresources.nhs.uk/hypertonic-saline-versus-other-intracranial-pressure-lowering-agents-for-people-with-acute-traumatic-brain-injury.html 2020-07-31T14:26:10.6300000Z https://www.medicinesresources.nhs.uk/pharmacy-based-management-for-depression-in-adults.html 2020-07-31T16:20:02.1270000Z https://www.medicinesresources.nhs.uk/drug-treatments-for-covid-19-living-systematic-review-and-network-meta-analysis.html 2020-08-02T19:13:01.1840000Z https://www.medicinesresources.nhs.uk/remdesivir-for-severe-covid-19-a-clinical-practice-guideline.html 2020-08-02T19:15:54.5880000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-of-empagliflozin-in-adults-with-heart-failure-and-reduced-ejection-fraction-meets-primary-endpoint.html 2020-07-31T14:34:05.2010000Z https://www.medicinesresources.nhs.uk/osimertinib-granted-breakthrough-therapy-designation-in-the-us-for-the-adjuvant-treatment-of-stage-ib-iiia-egfr-mutated-non-small-cell-lung-cancer.html 2020-07-31T14:35:29.4730000Z https://www.medicinesresources.nhs.uk/application-for-approval-of-tecovirimat-for-multiple-indications-submitted-to-the-european-medicines-agency.html 2020-07-31T16:16:17.8530000Z https://www.medicinesresources.nhs.uk/pevonedistat-granted-breakthrough-therapy-designation-for-the-treatment-of-higher-risk-myelodysplastic-syndromes-hr-mds.html 2020-07-31T14:37:42.0330000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-two-applications-seeking-approval-of-pembrolizumab-for-the-treatment-of-patients-with-triple-negative-breast-cancer-tnbc.html 2020-07-31T14:38:51.8450000Z https://www.medicinesresources.nhs.uk/new-rules-on-gatherings-in-some-parts-of-northern-england.html 2020-07-31T14:39:57.3750000Z https://www.medicinesresources.nhs.uk/uk-biobank-covid-19-seroprevalence-study-round-1-results.html 2020-07-31T14:41:07.7720000Z https://www.medicinesresources.nhs.uk/dementia-prevention-intervention-and-care-2020-report-of-the-lancet-commission.html 2020-07-31T14:42:17.9180000Z https://www.medicinesresources.nhs.uk/atopic-dermatitis.html 2020-07-31T14:43:51.2730000Z https://www.medicinesresources.nhs.uk/avelumab-with-axitinib-for-untreated-advanced-or-metastatic-renal-cell-carcinoma-final-appraisal-document.html 2020-07-31T14:45:16.1200000Z https://www.medicinesresources.nhs.uk/rcgp-survey-provides-snapshot-of-how-gp-care-is-accessed-in-latest-stages-of-pandemic.html 2020-07-31T14:46:56.4240000Z https://www.medicinesresources.nhs.uk/we-are-the-nhs-people-plan-for-2020-2021-action-for-us-all.html 2020-07-31T14:48:04.2710000Z https://www.medicinesresources.nhs.uk/alpelisib-in-combination-with-fulvestrant-approved-in-the-eu-for-the-treatment-of-breast-cancer.html 2020-07-31T14:49:45.4410000Z https://www.medicinesresources.nhs.uk/rare-tick-borne-infections-diagnosed-in-england.html 2020-07-31T14:50:48.6260000Z https://www.medicinesresources.nhs.uk/guidance-for-stepdown-of-infection-control-precautions-and-discharging-covid-19-patients-update.html 2020-07-31T14:52:06.2850000Z https://www.medicinesresources.nhs.uk/united-kingdom-drug-situation-focal-point-annual-report.html 2020-07-31T14:53:11.0610000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-pilot-england-31-july-2020.html 2020-07-31T14:54:16.6920000Z https://www.medicinesresources.nhs.uk/health-and-care-workers-to-self-isolate-on-return-to-england-from-high-risk-countries.html 2020-07-31T14:55:38.0380000Z https://www.medicinesresources.nhs.uk/protecting-your-child-against-flu-information-for-parents-and-carers.html 2020-07-31T14:57:42.1810000Z https://www.medicinesresources.nhs.uk/revised-spc-kisqali-ribociclib-tablets-1.html 2020-08-03T14:50:33.4070000Z https://www.medicinesresources.nhs.uk/safe-use-of-emollient-skin-creams-to-treat-dry-skin-conditions.html 2020-08-10T09:07:21.4620000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-ondexxya-andexanet-alfa.html 2020-08-03T14:54:00.5830000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-myalepta-metreleptin-5-8-mg-vial.html 2020-08-03T14:57:06.5860000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-viaflex-specials-products-containing-sodium-chloride-heparin-sodium-potassium-chloride-and-magnesium-sulfate.html 2020-08-03T14:58:09.5550000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-belvo-valproate-semisodium-250-mg-gastro-resistant-tablets.html 2020-08-03T14:59:08.5630000Z https://www.medicinesresources.nhs.uk/impact-of-eu-regulatory-label-changes-for-diclofenac-in-people-with-cardiovascular-disease-in-four-countries-interrupted-time-series-regression-analysis.html 2020-08-03T15:00:37.0920000Z https://www.medicinesresources.nhs.uk/clinical-outcomes-and-adverse-events-in-patients-hospitalised-with-covid-19-treated-with-off-label-hydroxychloroquine-and-azithromycin.html 2020-08-03T15:02:04.0680000Z https://www.medicinesresources.nhs.uk/intakes-of-folate-vitamin-b6-and-vitamin-b12-in-relation-to-diabetes-incidence-among-american-young-adults-a-30-year-follow-up-study.html 2020-08-03T15:04:29.8310000Z https://www.medicinesresources.nhs.uk/informing-critical-care-drug-requirements-in-response-to-the-covid-19-pandemic-1.html 2020-08-03T15:05:42.0640000Z https://www.medicinesresources.nhs.uk/risk-of-severe-covid-19-disease-with-ace-inhibitors-and-angiotensin-receptor-blockers-cohort-study-including-8-3-million-people.html 2020-08-10T09:05:09.5950000Z https://www.medicinesresources.nhs.uk/effect-of-intravenous-acetaminophen-on-postoperative-hypoxemia-after-abdominal-surgery-the-factor-randomized-clinical-trial-1.html 2020-08-03T15:09:50.7290000Z https://www.medicinesresources.nhs.uk/risk-of-covid-19-among-front-line-health-care-workers-and-the-general-community-a-prospective-cohort-study.html 2020-08-03T15:10:49.2290000Z https://www.medicinesresources.nhs.uk/advances-and-roadblocks-in-the-treatment-of-malaria.html 2020-08-03T15:12:11.1650000Z https://www.medicinesresources.nhs.uk/two-monthly-report-on-the-status-on-the-non-devolved-provisions-of-the-coronavirus-act-2020-july-2020.html 2020-08-03T15:13:29.6280000Z https://www.medicinesresources.nhs.uk/roll-out-of-2-new-rapid-coronavirus-tests-ahead-of-winter.html 2020-08-10T09:03:03.3830000Z https://www.medicinesresources.nhs.uk/risk-of-seizures-with-antidepressants-what-is-the-evidence.html 2020-08-03T15:16:52.6870000Z https://www.medicinesresources.nhs.uk/fda-authorises-first-tests-that-estimate-antibodies-from-past-covid-19-infection.html 2020-08-03T15:18:22.2080000Z https://www.medicinesresources.nhs.uk/class-3-drug-alert-action-within-5-days-accord-uk-limited-digoxin-tablets-bp-250-microgram-pl-0142-0083.html 2020-08-03T15:19:38.1140000Z https://www.medicinesresources.nhs.uk/targetable-biological-mechanisms-implicated-in-emergent-psychiatric-conditions-associated-with-sars-cov-2-infection.html 2020-08-03T15:20:45.8010000Z https://www.medicinesresources.nhs.uk/nhs-rolls-out-covid-friendly-cancer-treatments.html 2020-08-03T15:49:00.6270000Z https://www.medicinesresources.nhs.uk/launch-of-your-covid-recovery-website.html 2020-08-03T15:31:35.7880000Z https://www.medicinesresources.nhs.uk/third-phase-of-nhs-response-to-covid-19.html 2020-08-10T08:59:50.6470000Z https://www.medicinesresources.nhs.uk/european-approval-of-paediatric-license-extension-of-secukinumab-cosentyx-for-moderate-to-severe-plaque-psoriasis.html 2020-08-03T15:33:27.0400000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-crescent-pharma-ltd-syreniring-0-120-mg-0-015-mg-per-24-hours-vaginal-delivery-system-el-20-a-36.html 2020-08-03T15:38:08.8310000Z https://www.medicinesresources.nhs.uk/updates-to-the-shielding-programme-on-national-and-regional-levels.html 2020-08-03T15:55:01.5800000Z https://www.medicinesresources.nhs.uk/new-product-recarbrio-imipenem-monohydrate-cilastatin-sodium-relebactam-monohydrate-500-mg-500-mg-250-mg-powder-for-solution-for-infusion.html 2020-08-04T14:49:11.6710000Z https://www.medicinesresources.nhs.uk/revised-spcs-jardiance-empagliflozin-film-coated-tablets-all-strengths.html 2020-08-04T14:50:43.6160000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-clexane-enoxaparin-sodium-4-000-iu-40mg-0-4ml-syringes-labelling-error-on-specific-batch.html 2020-08-10T08:58:38.4930000Z https://www.medicinesresources.nhs.uk/intravenous-iron-therapy-for-non-anaemic-iron-deficient-adults.html 2020-08-04T14:57:35.5540000Z https://www.medicinesresources.nhs.uk/non-vitamin-k-antagonist-oral-anticoagulants-noacs-post-percutaneous-coronary-intervention-a-network-meta-analysis.html 2020-08-04T14:59:28.4690000Z https://www.medicinesresources.nhs.uk/omega-3-and-omega-6-polyunsaturated-fatty-acids-for-dry-eye-disease.html 2020-08-04T15:02:14.3800000Z https://www.medicinesresources.nhs.uk/beta-blockers-for-suspected-or-diagnosed-acute-myocardial-infarction.html 2020-08-04T15:03:54.5930000Z https://www.medicinesresources.nhs.uk/metformin-for-ovulation-induction-excluding-gonadotrophins-in-women-with-polycystic-ovary-syndrome.html 2020-08-04T15:05:29.5110000Z https://www.medicinesresources.nhs.uk/risks-and-impact-of-angiotensin-converting-enzyme-inhibitors-or-angiotensin-receptor-blockers-on-sars-cov-2-infection-in-adults-1.html 2020-08-10T08:57:42.0470000Z https://www.medicinesresources.nhs.uk/dual-antiplatelet-therapy-after-percutaneous-coronary-intervention-and-drug-eluting-stents-a-systematic-review-and-network-meta-analysis.html 2020-08-20T11:03:48.6640000Z https://www.medicinesresources.nhs.uk/long-term-rituximab-use-to-maintain-remission-of-antineutrophil-cytoplasmic-antibody-associated-vasculitis-1.html 2020-08-04T16:38:27.3290000Z https://www.medicinesresources.nhs.uk/determining-the-optimal-strategy-for-reopening-schools-the-impact-of-test-and-trace-interventions-and-the-risk-of-occurrence-of-a-second-covid-19-epidemic-wave-in-the-uk-a-modelling-study.html 2020-08-04T16:38:47.4260000Z https://www.medicinesresources.nhs.uk/european-commission-grants-conditional-marketing-authorisation-for-rozlytrek-entrectinib-for-treatment-of-advanced-solid-tumours-expressing-a-neurotrophic-tyrosine-receptor-kinase-ntrk-gene-fusion.html 2020-08-04T15:38:21.5770000Z https://www.medicinesresources.nhs.uk/us-fda-approves-spravato-esketamine-nasal-spray-to-treat-depressive-symptoms-in-adults-with-major-depressive-disorder-with-acute-suicidal-ideation-or-behaviour.html 2020-08-04T15:39:49.6240000Z https://www.medicinesresources.nhs.uk/not-all-cancer-patients-should-be-regarded-as-vulnerable-to-covid-19-says-expert-oncology-group.html 2020-08-04T16:39:19.7570000Z https://www.medicinesresources.nhs.uk/chronic-pain-assessment-and-management-draft-guidance.html 2020-08-04T16:39:42.7170000Z https://www.medicinesresources.nhs.uk/us-fda-approves-new-indication-for-epidiolex-cannabidiol-cbd-oral-solution-to-treat-seizures-associated-with-tuberous-sclerosis-complex.html 2020-08-04T16:40:53.9250000Z https://www.medicinesresources.nhs.uk/covid-19-uk-hospitals-to-get-rapid-tests-from-september.html 2020-08-04T15:45:09.9220000Z https://www.medicinesresources.nhs.uk/primary-biliary-cholangitis-pbc-treatment-seladelpar-meets-primary-endpoint-in-phase-iii-study.html 2020-08-04T17:11:49.6970000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-solaris-eculizumab-solution-for-infusion-physician-s-guide.html 2020-08-04T16:42:57.6050000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-colobreathe-colistimethate-sodium-inhalation-powder-patient-card.html 2020-08-04T16:43:09.1740000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-aripiprazole-1-mg-ml-oral-solution.html 2020-08-04T16:43:26.0670000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-idacio-adalimumab-injection-all-products.html 2020-08-04T17:13:57.3440000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-viagra-connect-sildenafil-citrate.html 2020-08-04T16:47:45.0970000Z https://www.medicinesresources.nhs.uk/treosulfan-with-fludarabine-for-malignant-disease-before-allogeneic-stem-cell-transplant-ta64-guidance.html 2020-08-10T08:55:08.6950000Z https://www.medicinesresources.nhs.uk/revised-spc-vpriv-velaglucerase-alfa-solution-for-infusion.html 2020-08-05T14:19:30.9870000Z https://www.medicinesresources.nhs.uk/revised-spc-plaquenil-hydroxychloroquine-sulfate-tablets.html 2020-08-05T14:20:59.2580000Z https://www.medicinesresources.nhs.uk/revised-spc-zejula-niraparib-tosylate-monohydrate-capsules.html 2020-08-05T14:22:46.2590000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-vyndaqel-tafamidis-healthcare-professional-guide.html 2020-08-05T14:23:49.6510000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-patient-booklet-for-the-use-of-lucentis-ranibizumab-for-proliferative-diabetic-retinopathy-pdr-and-or-visual-impairment-due-to-diabetic-macular-oedema-dmo.html 2020-08-05T14:26:32.8480000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-xalkori-crizotinib-patient-information-booklet.html 2020-08-05T14:28:18.0610000Z https://www.medicinesresources.nhs.uk/corticosteroids-for-treating-sepsis-in-children-and-adults.html 2020-08-05T14:29:59.2150000Z https://www.medicinesresources.nhs.uk/transient-neurological-symptoms-tns-following-spinal-anaesthesia-with-lidocaine-versus-other-local-anaesthetics-in-adult-surgical-patients-a-network-meta-analysis.html 2020-08-05T14:31:34.4560000Z https://www.medicinesresources.nhs.uk/intravenous-immunoglobulins-for-epilepsy.html 2020-08-05T14:32:52.0190000Z https://www.medicinesresources.nhs.uk/metformin-for-prevention-or-delay-of-type-2-diabetes-mellitus-and-its-associated-complications-in-persons-at-increased-risk-for-the-development-of-type-2-diabetes-mellitus.html 2020-08-05T14:34:13.6900000Z https://www.medicinesresources.nhs.uk/trajectories-of-antidepressant-drugs-during-pregnancy-a-cohort-study-from-a-community-based-sample.html 2020-08-05T14:35:38.5530000Z https://www.medicinesresources.nhs.uk/effects-of-interleukin-1v-inhibition-on-incident-hip-and-knee-replacement-exploratory-analyses-from-a-randomized-double-blind-placebo-controlled-trial.html 2020-08-05T15:39:18.8270000Z https://www.medicinesresources.nhs.uk/efficacy-of-maintenance-olaparib-for-patients-with-newly-diagnosed-advanced-ovarian-cancer-with-a-brca-mutation-subgroup-analysis-findings-from-the-solo1-trial.html 2020-08-17T08:32:18.2840000Z https://www.medicinesresources.nhs.uk/bevacizumab-plus-mfolfox6-versus-mfolfox6-alone-as-first-line-treatment-for-ras-mutant-unresectable-colorectal-liver-limited-metastases-the-become-randomized-controlled-trial.html 2020-08-12T14:02:30.6970000Z https://www.medicinesresources.nhs.uk/effect-of-long-term-vitamin-d3-supplementation-vs-placebo-on-risk-of-depression-or-clinically-relevant-depressive-symptoms-and-on-change-in-mood-scores-a-randomized-clinical-trial.html 2020-08-05T14:47:28.2370000Z https://www.medicinesresources.nhs.uk/bulevirtide-receives-conditional-marketing-authorization-in-the-eu.html 2020-08-05T14:49:10.6390000Z https://www.medicinesresources.nhs.uk/sisunatovir-receives-fast-track-designation-in-us-for-serious-respiratory-syncytial-virus-rsv-infection.html 2020-08-05T14:50:59.9830000Z https://www.medicinesresources.nhs.uk/medical-marijuana-recreational-cannabis-and-cardiovascular-health-a-scientific-statement-from-the-american-heart-association.html 2020-08-20T11:00:21.7730000Z https://www.medicinesresources.nhs.uk/diabetes-and-covid-19-moving-from-news-to-knowledge-and-a-glucose-hypothesis.html 2020-08-05T14:55:07.9980000Z https://www.medicinesresources.nhs.uk/heart-failure-with-reduced-ejection-fraction-a-review.html 2020-08-05T15:41:40.1110000Z https://www.medicinesresources.nhs.uk/heart-failure.html 2020-08-05T14:58:37.4750000Z https://www.medicinesresources.nhs.uk/chlormethine-gel-for-treating-mycosis-fungoides-type-cutaneous-t-cell-lymphoma-appraisal-consultation-document.html 2020-08-05T15:00:27.6190000Z https://www.medicinesresources.nhs.uk/technology-and-innovation-for-long-term-health-conditions.html 2020-08-05T15:03:31.3780000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-tisagenlecleucel-for-follicular-lymphoma-trial.html 2020-08-05T15:06:44.5890000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-july-2020.html 2020-08-10T08:53:53.8820000Z https://www.medicinesresources.nhs.uk/direct-healthcare-professional-communication-flucytosine-updated-recommendations-for-the-use-in-patients-with-dihydropyrimidine-dehydrogenase-dpd-deficiency.html 2020-08-10T08:53:00.7940000Z https://www.medicinesresources.nhs.uk/direct-healthcare-professional-communication-5-fluorouracil-i-v-capecitabine-and-tegafur-containing-products-pre-treatment-testing-to-identify-dpd-deficient-patients-at-increased-risk-of-severe-and-fatal-toxicity.html 2020-08-10T08:51:52.2810000Z https://www.medicinesresources.nhs.uk/revised-spcs-cosentyx-secukinumab-150-mg-solution-for-injection-in-pre-filled-pen-and-syringe-1.html 2020-08-06T17:02:47.5780000Z https://www.medicinesresources.nhs.uk/revised-spcs-abasaglar-insulin-glargine-100-units-ml-solution-for-injection-in-a-pre-filled-pen-and-cartridge.html 2020-08-06T15:28:02.9920000Z https://www.medicinesresources.nhs.uk/revised-spcs-adcetris-brentuximab-vedotin-50-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-08-06T15:30:25.2050000Z https://www.medicinesresources.nhs.uk/revised-spcs-cimzia-certolizumab-pegol-200-mg-solution-for-injection-in-pre-filled-pen-and-dose-dispenser-cartridge.html 2020-08-06T15:32:08.1690000Z https://www.medicinesresources.nhs.uk/revised-spcs-zocor-simvastatin-film-coated-tablets-all-strenghts.html 2020-08-06T15:34:25.1990000Z https://www.medicinesresources.nhs.uk/revised-spcs-keppra-levetiracetam-products.html 2020-08-06T15:35:56.4390000Z https://www.medicinesresources.nhs.uk/revised-spcs-dolutegravir-products.html 2020-08-06T15:38:28.0030000Z https://www.medicinesresources.nhs.uk/revised-spcs-genotropin-somatropin-products.html 2020-08-06T15:39:48.6600000Z https://www.medicinesresources.nhs.uk/risk-of-death-from-unintended-administration-of-sodium-nitrite.html 2020-08-10T08:50:47.2180000Z https://www.medicinesresources.nhs.uk/educational-risk-minimisation-materials-to-help-reduce-the-risk-associated-with-using-jinarc-tolvaptan-tablets.html 2020-08-10T08:48:45.9420000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-treatment-resistant-depression-in-adults.html 2020-08-06T15:49:29.5850000Z https://www.medicinesresources.nhs.uk/treatments-for-preventing-recurrence-of-infection-with-pseudomonas-aeruginosa-in-people-with-cystic-fibrosis.html 2020-08-06T15:51:22.2370000Z https://www.medicinesresources.nhs.uk/target-of-rapamycin-inhibitors-tor-i-sirolimus-and-everolimus-for-primary-immunosuppression-in-kidney-transplant-recipients.html 2020-08-06T15:53:35.7600000Z https://www.medicinesresources.nhs.uk/anti-il-12-23p40-antibodies-for-maintenance-of-remission-in-crohn-s-disease.html 2020-08-06T15:55:22.5590000Z https://www.medicinesresources.nhs.uk/nihr-alert-damage-to-kidneys-and-eyes-may-start-before-people-are-diagnosed-with-diabetes.html 2020-08-06T15:57:09.7730000Z https://www.medicinesresources.nhs.uk/new-medicines-newsletter-july-2020.html 2020-08-10T08:47:09.1120000Z https://www.medicinesresources.nhs.uk/the-national-flu-immunisation-programme-2020-to-2021-update.html 2020-08-10T08:46:11.6570000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-approves-licence-extension-to-include-reduced-maintenance-dose-of-certolizumab-pegol-in-adult-patients-with-axial-spondyloarthritis.html 2020-08-06T16:02:47.4760000Z https://www.medicinesresources.nhs.uk/astrazeneca-reports-positive-results-from-phase-iiib-trial-of-benralizumab-in-severe-eosinophilic-asthma-patients.html 2020-08-06T17:20:25.7040000Z https://www.medicinesresources.nhs.uk/letter-in-the-times-from-rps-president-calling-for-all-community-pharmacists-to-be-allowed-to-make-changes-to-prescriptions.html 2020-08-06T16:06:11.9680000Z https://www.medicinesresources.nhs.uk/antimicrobial-stewardship-programmes-in-primary-care-2020-progress-report.html 2020-08-06T16:08:17.2760000Z https://www.medicinesresources.nhs.uk/the-experience-of-people-approaching-later-life-in-lockdown-the-impact-of-covid-19-on-50-70-year-olds-in-england.html 2020-08-06T17:22:23.4530000Z https://www.medicinesresources.nhs.uk/cancer-research-uk-survey-finds-one-third-of-patients-say-coronavirus-has-impacted-their-treatment.html 2020-08-06T17:23:20.7380000Z https://www.medicinesresources.nhs.uk/native-valve-infective-endocarditis.html 2020-08-06T16:17:17.5240000Z https://www.medicinesresources.nhs.uk/metastatic-pancreatic-cancer-asco-guideline-update.html 2020-08-06T16:18:55.3270000Z https://www.medicinesresources.nhs.uk/recovery-from-severe-covid-19-leveraging-the-lessons-of-survival-from-sepsis.html 2020-08-06T17:26:01.5750000Z https://www.medicinesresources.nhs.uk/will-legalization-and-commercialization-of-cannabis-use-increase-the-incidence-and-prevalence-of-psychosis.html 2020-08-06T16:24:58.2260000Z https://www.medicinesresources.nhs.uk/tapering-antipsychotic-treatment.html 2020-08-06T16:26:25.0520000Z https://www.medicinesresources.nhs.uk/react-1-study-of-coronavirus-transmission-june-2020-results.html 2020-08-06T16:27:59.0260000Z https://www.medicinesresources.nhs.uk/the-changing-face-of-paracetamol-toxicity-and-new-regimens-for-an-old-antidote-acetylcysteine.html 2020-08-06T17:29:09.2310000Z https://www.medicinesresources.nhs.uk/covid-19-where-are-we-on-immunity-and-vaccines.html 2020-08-06T16:30:35.5140000Z https://www.medicinesresources.nhs.uk/coroner-warns-about-poor-drug-reviews-after-patient-dies-from-tramadol-overdose.html 2020-08-10T08:43:16.6780000Z https://www.medicinesresources.nhs.uk/letter-to-pharma-requesting-they-replenish-stockpiles-for-brexit-and-further-pandemic-this-winter.html 2020-08-06T17:32:09.4230000Z https://www.medicinesresources.nhs.uk/pulmonary-embolism-update-on-management-and-controversies.html 2020-08-06T16:33:43.1310000Z https://www.medicinesresources.nhs.uk/rosuvastatin-myotoxicity-after-starting-canagliflozin-treatment-a-case-report.html 2020-08-06T16:36:18.9360000Z https://www.medicinesresources.nhs.uk/reducing-inpatient-hypoglycemia-in-the-general-wards-using-real-time-continuous-glucose-monitoring-the-glucose-telemetry-system-a-randomized-clinical-trial.html 2020-08-06T16:37:37.1440000Z https://www.medicinesresources.nhs.uk/u-s-fda-grants-neurorx-inc-investigational-new-drug-permission-to-test-rlf-100-aviptadil-for-inhaled-use-in-patients-with-moderate-and-severe-covid-19-to-prevent-progression-to-respiratory-failure.html 2020-08-06T17:34:31.9650000Z https://www.medicinesresources.nhs.uk/assessment-and-treatment-outcomes-of-persistent-radiation-induced-alopecia-in-patients-with-cancer.html 2020-08-06T16:40:12.9630000Z https://www.medicinesresources.nhs.uk/over-exposed-andunder-protected-the-devastating-impact-of-covid-19-on-black-and-minority-ethnic-communities-in-great-britain.html 2020-08-06T16:39:32.8820000Z https://www.medicinesresources.nhs.uk/coronavirus-safety-concerns-halt-use-of-50-million-nhs-masks.html 2020-08-06T16:40:37.3790000Z https://www.medicinesresources.nhs.uk/association-between-abcb1-genetic-variants-and-persistent-chemotherapy-induced-alopecia-in-women-with-breast-cancer.html 2020-08-06T16:42:37.2320000Z https://www.medicinesresources.nhs.uk/fda-approves-monjuvi-tafasitamab-cxix-in-combination-with-lenalidomide-for-treatment-of-adult-patients-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-dlbcl.html 2020-08-06T17:37:45.0120000Z https://www.medicinesresources.nhs.uk/horizon-therapeutics-announces-positive-data-from-optic-phase-3-confirmatory-clinical-trial-and-optic-x-open-label-extension-clinical-trial-of-tepezza-teprotumumab-trbw-for-thyroid-eye-disease.html 2020-08-06T16:43:36.1180000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-of-new-drug-applications-ndas-for-tasimelteon-in-treatment-of-smith-magenis-syndrome-sms.html 2020-08-06T16:45:05.1580000Z https://www.medicinesresources.nhs.uk/phase-iii-crown-trial-of-lorlatinib-as-first-line-treatment-of-alk-positive-lung-cancer-meets-primary-endpoint-at-an-interim-analysis.html 2020-08-06T16:49:44.1590000Z https://www.medicinesresources.nhs.uk/novavax-announces-data-from-phase-i-of-phase-i-ii-placebo-controlled-trial-of-covid-19-vaccine-nvx-cov2373-with-and-without-matrix-m-adjuvant.html 2020-08-06T16:51:02.3070000Z https://www.medicinesresources.nhs.uk/us-fda-approves-blenrep-belantamab-mafodotin-blmf-for-the-treatment-relapsed-or-refractory-multiple-myeloma.html 2020-08-06T17:41:16.5350000Z https://www.medicinesresources.nhs.uk/ofatumumab-versus-teriflunomide-in-multiple-sclerosis.html 2020-08-06T17:42:21.5310000Z https://www.medicinesresources.nhs.uk/maternal-use-of-specific-antidepressant-medications-during-early-pregnancy-and-the-risk-of-selected-birth-defects.html 2020-08-10T08:41:54.9630000Z https://www.medicinesresources.nhs.uk/sodium-glucose-cotransporter-2-inhibitors-and-the-risk-of-below-knee-amputation-a-multicenter-observational-study.html 2020-08-06T16:58:15.2270000Z https://www.medicinesresources.nhs.uk/assessment-and-treatment-outcomes-of-persistent-radiation-induced-alopecia-in-patients-with-cancer-1.html 2020-08-06T17:00:57.9140000Z https://www.medicinesresources.nhs.uk/association-between-abcb1-genetic-variants-and-persistent-chemotherapy-induced-alopecia-in-women-with-breast-cancer-1.html 2020-08-06T17:03:12.8410000Z https://www.medicinesresources.nhs.uk/revised-spc-cymbalta-duloxetine-hard-gastro-resistant-capsules.html 2020-08-07T15:53:25.4970000Z https://www.medicinesresources.nhs.uk/revised-spcs-plavix-clopidogrel-film-coated-tablets.html 2020-08-07T15:12:27.4890000Z https://www.medicinesresources.nhs.uk/revised-spc-colestid-colestipol-granules-for-oral-suspension.html 2020-08-07T15:18:48.2750000Z https://www.medicinesresources.nhs.uk/mortality-in-adults-with-multidrug-resistant-tuberculosis-and-hiv-by-antiretroviral-therapy-and-tuberculosis-drug-use-an-individual-patient-data-meta-analysis.html 2020-08-07T15:20:20.9570000Z https://www.medicinesresources.nhs.uk/modafinil-for-people-with-schizophrenia-or-related-disorders.html 2020-08-07T15:21:35.4910000Z https://www.medicinesresources.nhs.uk/prophylactic-antibiotics-for-penetrating-abdominal-trauma.html 2020-08-07T15:23:25.1190000Z https://www.medicinesresources.nhs.uk/prophylactic-antibiotics-for-penetrating-abdominal-trauma-duration-of-use-and-antibiotic-choice.html 2020-08-07T15:24:36.5040000Z https://www.medicinesresources.nhs.uk/shortened-treatment-regimens-versus-the-standard-regimen-for-drug-sensitive-pulmonary-tuberculosis.html 2020-08-07T15:26:31.1690000Z https://www.medicinesresources.nhs.uk/drug-treatment-for-spinal-muscular-atrophy-type-i.html 2020-08-07T15:27:43.5600000Z https://www.medicinesresources.nhs.uk/nihr-alert-new-tool-for-assessing-the-severity-of-type-2-diabetes-could-help-personalise-treatment-and-improve-outcomes.html 2020-08-07T15:29:06.8410000Z https://www.medicinesresources.nhs.uk/oseltamivir-or-zanamivir-can-they-be-used-in-breastfeeding-mothers-for-the-treatment-or-prophylaxis-of-influenza.html 2020-08-10T08:36:06.7760000Z https://www.medicinesresources.nhs.uk/clinical-portrait-of-the-sars-cov-2-epidemic-in-european-cancer-patients.html 2020-08-07T15:34:31.0980000Z https://www.medicinesresources.nhs.uk/clinical-course-and-molecular-viral-shedding-among-asymptomatic-and-symptomatic-patients-with-sars-cov-2-infection-in-a-community-treatment-center-in-the-republic-of-korea.html 2020-08-07T16:00:51.8840000Z https://www.medicinesresources.nhs.uk/evaluation-of-overall-survival-in-patients-with-anaplastic-thyroid-carcinoma-2000-2019.html 2020-08-07T15:39:21.5270000Z https://www.medicinesresources.nhs.uk/octapharma-ag-conducting-phase-iii-trial-to-evaluate-intravenous-immunoglobulin-ivig-in-the-treatment-of-covid-19.html 2020-08-07T15:40:32.3540000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-atezolizumab-added-to-paclitaxel-in-the-first-line-treatment-of-metastatic-triple-negative-breast-cancer-impassion131-fails-to-meet-primary-endpoint.html 2020-08-07T15:43:48.2180000Z https://www.medicinesresources.nhs.uk/us-fda-approves-expanded-use-for-dovato-dolutegravir-lamivudine-as-a-complete-regimen-for-adults-with-hiv-who-are-virologically-suppressed-on-another-regimen.html 2020-08-07T15:45:25.1560000Z https://www.medicinesresources.nhs.uk/results-from-care-pws-phase-iii-study-of-intranasal-carbetocin-in-the-treatment-of-prader-willi-syndrome-released.html 2020-08-07T15:47:08.7760000Z https://www.medicinesresources.nhs.uk/biologics-license-application-for-omburtamab-for-the-treatment-of-paediatric-patients-with-cns-leptomeningeal-metastasis-from-neuroblastoma-submitted-to-the-us-fda.html 2020-08-07T15:48:30.9840000Z https://www.medicinesresources.nhs.uk/cumberlege-review-exposes-stubborn-and-dangerous-flaws-in-healthcare.html 2020-08-07T15:49:51.3580000Z https://www.medicinesresources.nhs.uk/insect-bites.html 2020-08-07T15:51:33.7930000Z https://www.medicinesresources.nhs.uk/how-might-covid-19-affect-the-number-of-gps-available-to-see-patients-in-england.html 2020-08-07T15:53:32.8700000Z https://www.medicinesresources.nhs.uk/current-perspective-on-age-related-macular-degeneration.html 2020-08-07T15:54:59.5940000Z https://www.medicinesresources.nhs.uk/antimicrobial-prescribing-secondary-bacterial-infection-of-eczema-and-other-common-skin-conditions-guideline-consultation.html 2020-08-07T15:56:52.3330000Z https://www.medicinesresources.nhs.uk/european-commission-approves-omalizumab-as-an-add-on-therapy-for-the-treatment-of-adults-with-severe-chronic-rhinosinusitis-with-nasal-polyps.html 2020-08-07T15:58:19.4200000Z https://www.medicinesresources.nhs.uk/flu-immunisation-training-recommendations-for-2020-to-2021.html 2020-08-07T15:59:57.5680000Z https://www.medicinesresources.nhs.uk/covid-19-mouth-care-for-patients-with-a-confirmed-or-suspected-case.html 2020-08-07T16:02:23.4200000Z https://www.medicinesresources.nhs.uk/pfizer-signs-deal-to-manufacture-gilead-s-remdesivir-for-covid-19.html 2020-08-07T16:04:15.9890000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-pilot-england-and-wales-7-august-2020.html 2020-08-07T16:08:17.6260000Z https://www.medicinesresources.nhs.uk/can-topical-steroids-be-applied-at-the-same-time-as-emollients.html 2020-08-10T08:28:55.1240000Z https://www.medicinesresources.nhs.uk/vitamin-d-intake-is-associated-with-decreased-risk-of-immune-checkpoint-inhibitor-induced-colitis.html 2020-08-10T14:13:32.9420000Z https://www.medicinesresources.nhs.uk/preadmission-diabetes-specific-risk-factors-for-mortality-in-hospitalized-patients-with-diabetes-and-coronavirus-disease-2019.html 2020-08-10T12:59:01.4380000Z https://www.medicinesresources.nhs.uk/case-rates-treatment-approaches-and-outcomes-in-acute-myocardial-infarction-during-the-coronavirus-disease-2019-pandemic.html 2020-08-10T13:00:13.3520000Z https://www.medicinesresources.nhs.uk/fda-approves-risdiplam-for-spinal-muscular-atrophy-in-adults-and-children.html 2020-08-11T08:53:43.7780000Z https://www.medicinesresources.nhs.uk/fda-approves-oliceridine-olinvyk-an-opioid-agonist-for-management-of-moderate-to-severe-acute-pain-in-adults.html 2020-08-10T13:31:13.2670000Z https://www.medicinesresources.nhs.uk/fda-accepts-biologics-license-application-and-grant-priority-review-of-aducanumab-as-treatment-of-alzheimers-disease.html 2020-08-10T13:04:51.1860000Z https://www.medicinesresources.nhs.uk/research-study-into-long-term-health-impacts-of-covid-19-launched-in-the-uk.html 2020-08-10T13:06:04.7220000Z https://www.medicinesresources.nhs.uk/precision-nutrition-the-answer-to-what-to-eat-to-stay-healthy.html 2020-08-10T13:07:29.7080000Z https://www.medicinesresources.nhs.uk/unwavering-regulatory-safeguards-for-covid-19-vaccines.html 2020-08-10T13:08:40.8060000Z https://www.medicinesresources.nhs.uk/successful-elimination-of-covid-19-transmission-in-new-zealand.html 2020-08-10T13:09:35.4040000Z https://www.medicinesresources.nhs.uk/implementing-phase-3-of-the-nhs-response-to-the-covid-19-pandemic.html 2020-08-15T12:57:54.0040000Z https://www.medicinesresources.nhs.uk/mixed-phase-iii-data-for-etrolizumab-in-moderately-to-severely-active-ulcerative-colitis.html 2020-08-10T13:11:18.4630000Z https://www.medicinesresources.nhs.uk/improved-survival-with-nivolumab-plus-ipilimumab-in-untreated-malignant-pleural-mesothelioma.html 2020-08-10T13:12:12.2610000Z https://www.medicinesresources.nhs.uk/oxford-researchers-investigating-hydroxychloroquine-and-chloroquine-for-prevention-of-covid-19.html 2020-08-10T13:12:53.7500000Z https://www.medicinesresources.nhs.uk/evorel-supply-update-august-2020.html 2020-08-10T13:13:44.1520000Z https://www.medicinesresources.nhs.uk/interventions-for-managing-halitosis.html 2020-08-10T14:26:46.7210000Z https://www.medicinesresources.nhs.uk/community-pharmacy-interventions-for-health-promotion-effects-on-professional-practice-and-health-outcomes.html 2020-08-10T14:28:06.9780000Z https://www.medicinesresources.nhs.uk/iron-therapy-for-preoperative-anaemia.html 2020-08-10T14:29:59.0630000Z https://www.medicinesresources.nhs.uk/treatments-for-primary-delusional-infestation.html 2020-08-10T14:31:40.1510000Z https://www.medicinesresources.nhs.uk/probiotics-for-people-with-cystic-fibrosis.html 2020-08-10T14:35:15.1070000Z https://www.medicinesresources.nhs.uk/topical-antibiotics-for-chronic-suppurative-otitis-media.html 2020-08-10T14:37:09.8200000Z https://www.medicinesresources.nhs.uk/revised-spc-imfinzi-durvalumab-50-mg-ml-concentrate-for-solution-for-infusion-1.html 2020-08-10T14:49:44.7160000Z https://www.medicinesresources.nhs.uk/revised-spc-fluarix-tetra-influenza-suspension-for-injection-in-pre-filled-syringe.html 2020-08-10T14:50:03.3430000Z https://www.medicinesresources.nhs.uk/revised-spc-monuril-fosfomycin-3g-granules-for-oral-solution.html 2020-08-10T14:57:52.1940000Z https://www.medicinesresources.nhs.uk/revised-spc-atripla-tenofovir-disoproxil-fumarate-efavirenz-emtricitabine-tablets.html 2020-08-10T14:57:31.8800000Z https://www.medicinesresources.nhs.uk/revised-spc-duodopa-levodopa-carbidopa-intestinal-gel.html 2020-08-10T14:56:04.5990000Z https://www.medicinesresources.nhs.uk/central-alerting-system-class-2-drug-alert-action-within-48-hours-huddersfield-pharmacy-specials-phosphates-solution-for-infusion-500ml-unlicensed.html 2020-08-10T14:51:22.7900000Z https://www.medicinesresources.nhs.uk/new-products-rybelsus-semaglutide-tablets-all-strengths.html 2020-08-11T16:47:21.4760000Z https://www.medicinesresources.nhs.uk/revised-spc-qutenza-capsaicin-179mg-cutaneous-patch-1.html 2020-08-11T16:46:34.2260000Z https://www.medicinesresources.nhs.uk/new-products-piqray-alpelisib-film-coated-tablets-all-strengths.html 2020-08-11T16:46:58.7840000Z https://www.medicinesresources.nhs.uk/trends-in-excess-mortality-associated-with-atrial-fibrillation-over-45-years-framingham-heart-study-community-based-cohort-study.html 2020-08-11T16:47:53.9910000Z https://www.medicinesresources.nhs.uk/intravenous-immunoglobulin-for-preventing-infection-in-preterm-and-or-low-birth-weight-infants.html 2020-08-11T17:40:47.9520000Z https://www.medicinesresources.nhs.uk/intravenous-immunoglobulin-for-suspected-or-proven-infection-in-neonates.html 2020-08-11T15:35:50.0580000Z https://www.medicinesresources.nhs.uk/hormone-replacement-therapy-after-surgery-for-epithelial-ovarian-cancer.html 2020-08-11T17:42:02.1470000Z https://www.medicinesresources.nhs.uk/late-erythropoiesis-stimulating-agents-to-prevent-red-blood-cell-transfusion-in-preterm-or-low-birth-weight-infants.html 2020-08-11T15:39:04.2050000Z https://www.medicinesresources.nhs.uk/pharmacological-psychological-and-non-invasive-brain-stimulation-interventions-for-treating-depression-after-stroke.html 2020-08-11T16:48:45.0760000Z https://www.medicinesresources.nhs.uk/management-of-post-acute-covid-19-in-primary-care.html 2020-08-11T16:49:14.2760000Z https://www.medicinesresources.nhs.uk/nivolumab-meets-primary-endpoint-in-phase-3-trial-as-adjuvant-therapy-for-patients-with-resected-oesophageal-or-gastroesophageal-junction-cancer.html 2020-08-11T16:49:49.8760000Z https://www.medicinesresources.nhs.uk/decision-making-and-mental-capacity-guidance-qs194.html 2020-08-15T12:49:09.0600000Z https://www.medicinesresources.nhs.uk/sorafenib-maintenance-in-patients-with-flt3-itd-acute-myeloid-leukaemia-undergoing-allogeneic-haematopoietic-stem-cell-transplantation-an-open-label-multicentre-randomised-phase-3-trial.html 2020-08-11T16:21:30.1950000Z https://www.medicinesresources.nhs.uk/maintaining-a-cancer-service-in-the-midst-of-the-covid-19-pandemic-a-single-centre-experience.html 2020-08-11T16:26:50.2070000Z https://www.medicinesresources.nhs.uk/venous-thromboembolism-risk-assessment-in-psychiatric-inpatients-audit.html 2020-08-11T16:51:10.1860000Z https://www.medicinesresources.nhs.uk/how-can-referrals-of-obese-patients-to-the-local-exercise-referral-scheme-be-increased-a-uk-based-primary-care-quality-improvement-study.html 2020-08-11T17:21:12.1200000Z https://www.medicinesresources.nhs.uk/care-quality-commission-covid-19-inpatient-survey.html 2020-08-11T16:31:17.0680000Z https://www.medicinesresources.nhs.uk/active-monitoring-radical-prostatectomy-and-radical-radiotherapy-in-psa-detected-clinically-localised-prostate-cancer-the-protect-three-arm-rct.html 2020-08-11T17:23:15.1900000Z https://www.medicinesresources.nhs.uk/psnc-discusses-closing-pharmacy-for-part-of-day-to-provide-flu-vaccines.html 2020-08-11T17:24:20.3520000Z https://www.medicinesresources.nhs.uk/randox-recalls-coronavirus-test-kits-after-safety-concerns.html 2020-08-11T17:25:10.3270000Z https://www.medicinesresources.nhs.uk/destiny-pharma-announces-positive-interim-safety-review-of-its-ongoing-phase-iib-study-of-antibiotic-xf-73-nasal-gel-for-prevention-of-post-surgical-staphylococcal-infections.html 2020-08-11T17:26:01.3860000Z https://www.medicinesresources.nhs.uk/patient-group-direction-use-by-temporary-provisional-professional-registrants.html 2020-08-15T12:34:48.1190000Z https://www.medicinesresources.nhs.uk/patient-group-direction-use-in-end-of-life-care.html 2020-08-15T12:32:00.2470000Z https://www.medicinesresources.nhs.uk/brentuximab-vedotin-in-combination-for-untreated-systemic-anaplastic-large-cell-lymphoma-guidance-ta641-1.html 2020-08-15T12:27:21.9470000Z https://www.medicinesresources.nhs.uk/gilteritinib-for-treating-relapsed-or-refractory-acute-myeloid-leukaemia-guidance-ta642.html 2020-08-15T12:15:09.6060000Z https://www.medicinesresources.nhs.uk/entrectinib-for-treating-ros1-positive-advanced-non-small-cell-lung-cancer-guidance-ta643.html 2020-08-15T12:11:46.9430000Z https://www.medicinesresources.nhs.uk/entrectinib-for-treating-ntrk-fusion-positive-solid-tumours-guidance-ta644.html 2020-08-16T17:21:49.8350000Z https://www.medicinesresources.nhs.uk/revised-spc-buccolam-midazolam-oromucosal-solution.html 2020-08-14T15:19:36.9550000Z https://www.medicinesresources.nhs.uk/revised-spc-nordimet-methotrexate-solution-for-injection-in-pre-filled.html 2020-08-12T14:34:25.6830000Z https://www.medicinesresources.nhs.uk/hydroxycarbamide-oral-solution-xromi-r-is-accepted-for-restricted-use-within-nhsscotland.html 2020-08-12T14:36:27.3840000Z https://www.medicinesresources.nhs.uk/vedolizumab-108mg-solution-for-subcutaneous-injection-in-pre-filled-syringe-or-pre-filled-pen-entyvio-r-is-accepted-for-restricted-use-within-nhsscotland-for-treatment-of-crohns-disease.html 2020-08-12T14:39:13.7810000Z https://www.medicinesresources.nhs.uk/neratinib-nerlynx-r-is-accepted-for-use-within-nhsscotland.html 2020-08-12T14:40:04.8970000Z https://www.medicinesresources.nhs.uk/vedolizumab-108mg-solution-for-subcutaneous-injection-in-pre-filled-syringe-or-pre-filled-pen-entyvio-r-is-accepted-for-use-within-nhsscotland-for-treatment-of-ulcerative-colitis.html 2020-08-12T14:41:10.3890000Z https://www.medicinesresources.nhs.uk/interventions-for-renal-vasculitis-in-adults.html 2020-08-12T14:44:39.6740000Z https://www.medicinesresources.nhs.uk/systemic-pharmacological-treatments-for-chronic-plaque-psoriasis-a-network-meta-analysis.html 2020-08-14T15:10:02.5660000Z https://www.medicinesresources.nhs.uk/intravesical-bacillus-calmette-guerin-versus-mitomycin-c-for-ta-and-t1-bladder-cancer.html 2020-08-12T14:48:45.2180000Z https://www.medicinesresources.nhs.uk/antibiotics-versus-topical-antiseptics-for-chronic-suppurative-otitis-media.html 2020-08-12T14:50:44.0590000Z https://www.medicinesresources.nhs.uk/drug-treatment-for-spinal-muscular-atrophy-types-ii-and-iii.html 2020-08-12T14:52:09.1230000Z https://www.medicinesresources.nhs.uk/topical-antiseptics-for-chronic-suppurative-otitis-media.html 2020-08-12T14:57:16.3100000Z https://www.medicinesresources.nhs.uk/tapering-canakinumab-monotherapy-in-patients-with-systemic-juvenile-idiopathic-arthritis-in-clinical-remission-results-from-an-open-label-randomized-phase-iiib-iv-study.html 2020-08-12T14:58:54.5520000Z https://www.medicinesresources.nhs.uk/open-label-phase-ii-study-with-anakinra-in-intravenous-immunoglobulin-resistant-kawasaki-disease.html 2020-08-12T14:59:59.7910000Z https://www.medicinesresources.nhs.uk/bone-mass-and-density-in-youth-with-type-2-diabetes-obesity-and-healthy-weight.html 2020-08-12T15:02:04.5810000Z https://www.medicinesresources.nhs.uk/effect-of-6-months-of-flash-glucose-monitoring-in-youth-with-type-1-diabetes-and-high-risk-control-a-randomized-controlled-trial.html 2020-08-12T15:03:02.5550000Z https://www.medicinesresources.nhs.uk/hyperglycemia-at-hospital-admission-is-associated-with-severity-of-the-prognosis-in-patients-hospitalized-for-covid-19-the-pisa-covid-19-study.html 2020-08-12T15:04:05.1950000Z https://www.medicinesresources.nhs.uk/has-covid-19-delayed-the-diagnosis-and-worsened-the-presentation-of-type-1-diabetes-in-children.html 2020-08-12T15:05:41.6100000Z https://www.medicinesresources.nhs.uk/prevalence-of-sars-cov-2-infection-among-health-care-workers-in-a-tertiary-community-hospital.html 2020-08-12T15:07:03.7880000Z https://www.medicinesresources.nhs.uk/brigatinib-versus-crizotinib-in-advanced-alk-inhibitor-naive-alk-positive-non-small-cell-lung-cancer-second-interim-analysis-of-the-phase-iii-alta-1l.html 2020-08-12T15:08:07.0560000Z https://www.medicinesresources.nhs.uk/successful-treatment-of-interstitial-pneumonitis-with-anakinra-in-a-patient-with-adult-onset-stills-disease-case-report.html 2020-08-12T15:09:28.9260000Z https://www.medicinesresources.nhs.uk/pegunigalsidase-alfa-receives-priority-review-designation-in-the-us-for-treatment-of-fabry-disease.html 2020-08-12T15:10:35.4630000Z https://www.medicinesresources.nhs.uk/manufacturers-report-topline-results-from-study-211-supporting-24-mg-as-appropriate-starting-dose-for-lenvatinib-in-patients-with-differentiated-thyroid-cancer-1.html 2020-08-12T15:12:03.9930000Z https://www.medicinesresources.nhs.uk/new-bnf-app-to-be-launched-later-this-month.html 2020-08-12T15:13:17.0030000Z https://www.medicinesresources.nhs.uk/distinguishing-between-type-1-and-type-2-diabetes.html 2020-08-12T15:14:14.9950000Z https://www.medicinesresources.nhs.uk/covid-lockdown-england-sees-fewer-cases-of-colds-flu-and-bronchitis.html 2020-08-12T15:15:21.6250000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-results-from-the-checkmate-649-phase-iii-trial-investigating-nivolumab-and-chemotherapy-vs-chemotherapy-alone-in-first-line-treatment-of-gastric-and-oesophageal-cancers.html 2020-08-12T15:16:15.7080000Z https://www.medicinesresources.nhs.uk/racial-disproportionality-in-covid-clinical-trials.html 2020-08-12T15:17:10.7800000Z https://www.medicinesresources.nhs.uk/russia-approves-covid-19-vaccine-ahead-of-phase-iii-studies.html 2020-08-12T15:18:04.5180000Z https://www.medicinesresources.nhs.uk/communicating-risks-and-benefits-to-cardiology-patients.html 2020-08-12T15:19:08.4090000Z https://www.medicinesresources.nhs.uk/management-of-acute-pulmonary-embolism.html 2020-08-12T15:20:45.7080000Z https://www.medicinesresources.nhs.uk/inclusion-of-pregnant-women-in-covid-19-vaccine-development.html 2020-08-12T15:22:05.5430000Z https://www.medicinesresources.nhs.uk/risdiplam-liquid-approved-for-use-in-spinal-muscular-atrophy-in-the-us.html 2020-08-12T15:23:29.8730000Z https://www.medicinesresources.nhs.uk/expanding-the-primary-care-workforce.html 2020-08-12T15:24:41.2580000Z https://www.medicinesresources.nhs.uk/our-place-local-authorities-and-the-publics-mental-health.html 2020-08-12T15:26:28.4260000Z https://www.medicinesresources.nhs.uk/nhs-reset-mental-health-services-and-covid-19-preparing-for-the-rising-tide.html 2020-08-12T15:46:50.2050000Z https://www.medicinesresources.nhs.uk/advice-on-the-preparation-and-or-administration-of-contrast-agents-supplied-under-a-patient-group-direction.html 2020-08-14T15:05:53.8600000Z https://www.medicinesresources.nhs.uk/belimumab-benlysta-r-recommended-as-an-option-for-restricted-use-within-nhs-wales-for-active-autoantibody-positive-systemic-lupus-erythematosus-1.html 2020-08-13T16:57:11.3930000Z https://www.medicinesresources.nhs.uk/hydroxycarbamide-xromi-100-mg-ml-oral-solution-recommended-as-an-option-for-restricted-use-within-nhs-wales-for-prevention-of-vaso-occlusive-complications-of-sickle-cell-disease.html 2020-08-13T16:57:30.1540000Z https://www.medicinesresources.nhs.uk/cariprazine-reagila-not-recommended-for-use-within-nhs-wales-for-treatment-of-schizophrenia-in-adults.html 2020-08-13T14:36:27.0990000Z https://www.medicinesresources.nhs.uk/revised-spc-eliquis-apixaban-2-5-and-5-0-mg-film-coated-tablets.html 2020-08-13T14:37:29.1270000Z https://www.medicinesresources.nhs.uk/revised-spc-solu-cortef-hydrocortisone-sodium-succinate.html 2020-08-13T14:40:49.3000000Z https://www.medicinesresources.nhs.uk/revised-spcs-votrient-pazopanib-200-and-400-mg-film-coated-tablets.html 2020-08-13T14:42:31.2050000Z https://www.medicinesresources.nhs.uk/revised-spc-restandol-testocaps-testosterone-undecanoate-40-mg-capsule-soft.html 2020-08-13T14:43:41.4750000Z https://www.medicinesresources.nhs.uk/ibuprofen-for-the-prevention-of-patent-ductus-arteriosus-in-preterm-and-or-low-birth-weight-infants.html 2020-08-13T14:44:52.2570000Z https://www.medicinesresources.nhs.uk/oral-janus-kinase-inhibitors-for-maintenance-of-remission-in-ulcerative-colitis-cochrane-systematic-review-intervention-version-published.html 2020-08-13T16:57:56.1210000Z https://www.medicinesresources.nhs.uk/paracetamol-acetaminophen-for-prevention-or-treatment-of-pain-in-newborns.html 2020-08-13T14:49:44.8720000Z https://www.medicinesresources.nhs.uk/nihr-alert-fluoxetine-does-not-improve-outcomes-after-stroke.html 2020-08-13T16:58:47.8170000Z https://www.medicinesresources.nhs.uk/nihr-alert-high-rates-of-delirium-persistent-fatigue-and-post-traumatic-stress-disorder-were-common-after-severe-infection-in-previous-coronavirus-outbreaks.html 2020-08-13T16:58:28.4820000Z https://www.medicinesresources.nhs.uk/quarterly-monitoring-report-qmr-29-how-is-the-nhs-performing-1.html 2020-08-13T15:09:49.9910000Z https://www.medicinesresources.nhs.uk/provisional-publication-of-never-events-reported-as-occurring-between-1-april-and-30-june-2020.html 2020-08-14T14:25:01.4820000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-smofkabiven-extra-nitrogen-electrolyte-free-el-20-a-39-pl-08828-0269.html 2020-08-13T15:11:39.2190000Z https://www.medicinesresources.nhs.uk/mims-summary-of-semaglutide-rybelsus-first-oral-glp-1-agonist-launched-for-type-ii-diabetes.html 2020-08-13T16:59:05.3960000Z https://www.medicinesresources.nhs.uk/car-t-cell-therapy-for-cancer-and-hiv-through-novel-approaches-to-hiv-associated-haematological-malignancies.html 2020-08-13T15:13:38.3790000Z https://www.medicinesresources.nhs.uk/challenges-in-the-management-of-older-patients-with-acute-coronary-syndromes-in-the-covid-19-pandemic.html 2020-08-13T15:19:18.0580000Z https://www.medicinesresources.nhs.uk/react-2-real-time-assessment-of-community-transmission-prevalence-of-coronavirus-covid-19-antibodies-in-june-2020.html 2020-08-14T14:23:15.3740000Z https://www.medicinesresources.nhs.uk/new-uk-wide-methodology-agreed-to-record-covid-19-deaths.html 2020-08-13T15:22:07.0410000Z https://www.medicinesresources.nhs.uk/what-is-known-about-possible-covid-19-transmission-from-freight-and-packages.html 2020-08-13T15:22:57.6200000Z https://www.medicinesresources.nhs.uk/delivering-value-through-disinvestment-an-exploration-and-analysis-of-appropriate-disinvestment-in-medicine-considered-low-value-for-funding-by-nhs-wales-consultation.html 2020-08-13T15:31:15.1250000Z https://www.medicinesresources.nhs.uk/conference-report-interim-analysis-of-phase-iii-orient-11-trial-of-sintilimab-in-combination-with-pemetrexed-pm-and-platinum-chemotherapy-pc-as-first-line-treatment-in-people-with-nonsquamous-non-small-cell-lung-cancer-without-sensitive-egfr-mutation-or-alk-rearrangement.html 2020-08-13T15:28:46.1140000Z https://www.medicinesresources.nhs.uk/chi-med-plans-to-submit-marketing-authorization-application-maa-for-surufatinib-for-treatment-of-pancreatic-and-non-pancreatic-neuroendocrine-tumours-net-following-scientific-advice-from-european-medicines-agency-s-committee-for-medicinal-products-for-human-use-chmp.html 2020-08-13T15:29:49.5000000Z https://www.medicinesresources.nhs.uk/fda-assigns-fast-track-designation-to-aqst-108-sublingual-film-formulation-delivering-systemic-epinephrine-for-treatment-of-allergic-reactions-including-anaphylaxis.html 2020-08-13T15:32:42.6010000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-biologics-license-application-for-evinacumab-as-a-treatment-for-patients-with-homozygous-familial-hypercholesterolaemia.html 2020-08-13T15:33:39.7720000Z https://www.medicinesresources.nhs.uk/fda-approves-viltepso-viltolarsen-injection-for-treatment-of-duchenne-muscular-dystrophy-dmd-in-patients-who-have-confirmed-mutation-of-dmd-gene-that-is-amenable-to-exon-53-skipping.html 2020-08-13T15:34:36.8320000Z https://www.medicinesresources.nhs.uk/epigenetic-therapies-for-cancer.html 2020-08-13T15:35:31.4750000Z https://www.medicinesresources.nhs.uk/compression-therapy-to-prevent-recurrent-cellulitis-of-the-leg.html 2020-08-13T15:41:34.6010000Z https://www.medicinesresources.nhs.uk/azacitidine-and-venetoclax-in-previously-untreated-acute-myeloid-leukemia.html 2020-08-13T16:56:15.1410000Z https://www.medicinesresources.nhs.uk/prioritising-primary-care-patients-with-unexpected-weight-loss-for-cancer-investigation-diagnostic-accuracy-study.html 2020-08-13T16:55:33.1140000Z https://www.medicinesresources.nhs.uk/obesity-and-mortality-among-patients-diagnosed-with-covid-19-results-from-an-integrated-health-care-organization.html 2020-08-13T16:55:07.5710000Z https://www.medicinesresources.nhs.uk/suboptimal-prescribing-behaviour-associated-with-clinical-software-design-features-a-retrospective-cohort-study-in-english-nhs-primary-care.html 2020-08-13T16:54:27.7920000Z https://www.medicinesresources.nhs.uk/antidopaminergic-antiemetics-and-trauma-related-hospitalization-a-population-based-self-controlled-case-series-study.html 2020-08-13T16:54:10.3820000Z https://www.medicinesresources.nhs.uk/benchmarking-the-cost-effectiveness-of-interventions-delaying-diabetes-a-simulation-study-based-on-navigator-data.html 2020-08-13T16:53:52.5130000Z https://www.medicinesresources.nhs.uk/integrated-management-of-atrial-fibrillation-in-primary-care-results-of-the-all-in-cluster-randomized-trial.html 2020-08-13T16:59:33.0120000Z https://www.medicinesresources.nhs.uk/rhythm-control-for-patients-with-atrial-fibrillation-complicated-with-heart-failure-in-the-contemporary-era-of-catheter-ablation-a-stratified-pooled-analysis-of-randomized-data.html 2020-08-13T16:50:59.2330000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-pcsk9-inhibition-with-evolocumab-in-reducing-cardiovascular-events-in-patients-with-metabolic-syndrome-receiving-statin-therapy-secondary-analysis-from-the-fourier-randomized-clinical-trial.html 2020-08-13T16:52:59.4310000Z https://www.medicinesresources.nhs.uk/association-between-topical-calcineurin-inhibitor-use-and-keratinocyte-carcinoma-risk-among-adults-with-atopic-dermatitis.html 2020-08-13T16:52:32.3030000Z https://www.medicinesresources.nhs.uk/association-of-social-relationships-with-incident-cardiovascular-events-and-all-cause-mortality.html 2020-08-13T16:51:56.0960000Z https://www.medicinesresources.nhs.uk/steroid-emergency-card-to-support-early-recognition-and-treatment-of-adrenal-crisis-in-adults.html 2020-08-15T13:22:25.4580000Z https://www.medicinesresources.nhs.uk/paracetamol-acetaminophen-for-patent-ductus-arteriosus-in-preterm-or-low-birth-weight-infants.html 2020-08-14T09:20:39.0950000Z https://www.medicinesresources.nhs.uk/a-case-of-topical-metronidazole-induced-encephalopathy.html 2020-08-14T09:22:05.1370000Z https://www.medicinesresources.nhs.uk/new-products-rozlytrek-entrectinib-100-mg-and-200mg-hard-capsules.html 2020-08-14T11:27:42.4320000Z https://www.medicinesresources.nhs.uk/revised-spc-dalacin-t-clindamycin-topical-solution.html 2020-08-14T11:29:09.9110000Z https://www.medicinesresources.nhs.uk/new-product-metaraminol-0-5-mg-ml-solution-for-injection-in-pre-filled-syringe-aguettant-ltd.html 2020-08-14T11:30:41.1800000Z https://www.medicinesresources.nhs.uk/revised-spcs-rapifen-and-rapifen-ic-alfentanil.html 2020-08-14T11:32:06.1780000Z https://www.medicinesresources.nhs.uk/renal-and-bone-effects-risk-minimisation-material-tenofovir-disoproxil-glenmark-for-children-and-adolescents-with-hiv-1.html 2020-08-14T11:34:14.8510000Z https://www.medicinesresources.nhs.uk/isatuximab-risk-minimisation-materials-managing-risk-of-interference-with-blood-compatibility-tests.html 2020-08-15T13:16:58.3540000Z https://www.medicinesresources.nhs.uk/interventions-for-chronic-pruritus-of-unknown-origin.html 2020-08-14T11:38:42.2640000Z https://www.medicinesresources.nhs.uk/pharmacological-treatment-other-than-corticosteroids-intravenous-immunoglobulin-and-plasma-exchange-for-guillain-barre-syndrome.html 2020-08-14T11:40:11.5300000Z https://www.medicinesresources.nhs.uk/hygiene-and-emollient-interventions-for-maintaining-skin-integrity-in-older-people-in-hospital-and-residential-care-settings.html 2020-08-14T11:41:54.5300000Z https://www.medicinesresources.nhs.uk/rapid-versus-slow-withdrawal-of-antiepileptic-drugs.html 2020-08-14T11:43:15.6110000Z https://www.medicinesresources.nhs.uk/contact-settings-and-risk-for-transmission-in-3410-close-contacts-of-patients-with-covid-19-in-guangzhou-china.html 2020-08-14T11:44:30.3320000Z https://www.medicinesresources.nhs.uk/patient-group-direction-template-administration-of-intramuscular-im-medroxyprogesterone-acetate-dmpa-injection.html 2020-08-16T17:18:56.8610000Z https://www.medicinesresources.nhs.uk/patient-group-direction-template-insertion-of-the-progestogen-only-intra-uterine-system-ius.html 2020-08-15T13:15:38.0700000Z https://www.medicinesresources.nhs.uk/minimising-wastage-of-critical-medicines-during-covid-19-updated-august-2020.html 2020-08-15T13:10:55.4620000Z https://www.medicinesresources.nhs.uk/the-association-between-cigarette-smoking-cancer-screening-and-cancer-stage-a-prospective-study-of-the-womens-health-initiative-observational-cohort-1.html 2020-08-14T13:29:17.8520000Z https://www.medicinesresources.nhs.uk/long-term-effectiveness-and-safety-of-infliximab-golimumab-and-ustekinumab-in-patients-with-psoriatic-arthritis-from-a-canadian-prospective-observational-registry.html 2020-08-14T13:30:28.8230000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-trastuzumab-emtansine-plus-capecitabine-vs-trastuzumab-emtansine-alone-in-patients-with-previously-treated-erbb2-her2-positive-metastatic-breast-cancer-a-phase-1-and-randomized-phase-2-trial.html 2020-08-14T13:31:44.2640000Z https://www.medicinesresources.nhs.uk/effect-of-adjuvant-paclitaxel-and-carboplatin-on-survival-in-women-with-triple-negative-breast-cancer-a-phase-3-randomized-clinical-trial.html 2020-08-14T13:32:50.7470000Z https://www.medicinesresources.nhs.uk/uk-signs-deals-for-a-further-90-million-coronavirus-vaccine-doses.html 2020-08-14T16:14:11.5820000Z https://www.medicinesresources.nhs.uk/bma-online-survey-of-doctors-raises-concerns-about-long-term-impact-of-covid-19.html 2020-08-14T13:36:42.3470000Z https://www.medicinesresources.nhs.uk/tick-bite.html 2020-08-14T13:39:08.8260000Z https://www.medicinesresources.nhs.uk/us-fda-advisory-committee-votes-in-favour-that-data-support-the-efficacy-and-safety-of-remestemcel-l-ryoncil-tm-in-the-treatment-of-children-with-steroid-refractory-acute-graft-versus-host-disease.html 2020-08-14T13:40:03.6740000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-new-drug-application-for-umbralisib-for-previously-treated-marginal-zone-lymphoma-and-follicular-lymphoma.html 2020-08-14T16:11:34.1130000Z https://www.medicinesresources.nhs.uk/4d-310-gene-therapy-granted-fda-fast-track-designation-for-treatment-of-fabry-disease.html 2020-08-14T13:44:10.5030000Z https://www.medicinesresources.nhs.uk/selective-inhibitor-of-the-activation-of-myostatin-srk-015-receives-rare-pediatric-disease-designation-from-us-fda-for-the-treatment-of-spinal-muscular-atrophy.html 2020-08-14T13:45:19.3370000Z https://www.medicinesresources.nhs.uk/investigational-antibody-targeting-two-immune-checkpoint-molecules-granted-fast-track-designation-by-the-fda-for-the-treatment-of-recurrent-and-metastatic-cervical-cancer.html 2020-08-14T13:46:39.5290000Z https://www.medicinesresources.nhs.uk/meeting-people-from-outside-your-household-updated-guidance.html 2020-08-14T13:52:32.7220000Z https://www.medicinesresources.nhs.uk/test-and-trace-service-reaches-more-than-250-000-people-since-launch.html 2020-08-14T13:54:29.8860000Z https://www.medicinesresources.nhs.uk/neonatal-collapse-alongside-skin-to-skin-contact.html 2020-08-14T13:57:55.7170000Z https://www.medicinesresources.nhs.uk/nihr-alert-early-warning-scores-used-in-hospitals-must-be-based-on-sound-science-2.html 2020-08-14T14:44:04.7080000Z https://www.medicinesresources.nhs.uk/effect-of-an-inactivated-vaccine-against-sars-cov-2-on-safety-and-immunogenicity-outcomes-interim-analysis-of-2-randomized-clinical-trials.html 2020-08-14T14:47:40.6960000Z https://www.medicinesresources.nhs.uk/parp-inhibitors-in-the-management-of-ovarian-cancer-asco-guideline.html 2020-08-14T14:50:12.9350000Z https://www.medicinesresources.nhs.uk/chronic-pancreatitis.html 2020-08-14T14:51:28.6730000Z https://www.medicinesresources.nhs.uk/opportunistic-screening-for-atrial-fibrillation-by-clinical-pharmacists-in-uk-general-practice-during-the-influenza-vaccination-season-a-cross-sectional-feasibility-study.html 2020-08-14T15:42:09.9460000Z https://www.medicinesresources.nhs.uk/associations-of-type-1-and-type-2-diabetes-with-covid-19-related-mortality-in-england-a-whole-population-study.html 2020-08-14T15:43:27.9520000Z https://www.medicinesresources.nhs.uk/risk-factors-for-covid-19-related-mortality-in-people-with-type-1-and-type-2-diabetes-in-england-a-population-based-cohort-study.html 2020-08-14T15:44:25.4320000Z https://www.medicinesresources.nhs.uk/covid-19-reducing-transmission-what-you-can-do-to-help.html 2020-08-14T15:45:08.0140000Z https://www.medicinesresources.nhs.uk/heterogeneous-trends-in-burden-of-heart-disease-mortality-by-subtypes-in-the-united-states-1999-2018-observational-analysis-of-vital-statistics.html 2020-08-14T15:53:34.2360000Z https://www.medicinesresources.nhs.uk/tocilizumab-for-severe-covid-19-a-systematic-review-and-meta-analysis.html 2020-08-17T14:40:01.0540000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-antiviral-prophylaxis-during-pregnancy-to-prevent-mother-to-child-transmission-of-hepatitis-b-virus-a-systematic-review-and-meta-analysis.html 2020-08-17T14:20:34.3330000Z https://www.medicinesresources.nhs.uk/accuracy-of-hbeag-to-identify-pregnant-women-at-risk-of-transmitting-hepatitis-b-virus-to-their-neonates-a-systematic-review-and-meta-analysis.html 2020-08-17T14:21:59.0170000Z https://www.medicinesresources.nhs.uk/risk-of-anemia-with-metformin-use-in-type-2-diabetes-a-mastermind-study.html 2020-08-17T14:23:25.9420000Z https://www.medicinesresources.nhs.uk/chemotherapy-and-covid-19-outcomes-in-patients-with-cancer.html 2020-08-17T14:26:01.8660000Z https://www.medicinesresources.nhs.uk/lubiprostone-in-patients-with-non-alcoholic-fatty-liver-disease-a-randomised-double-blind-placebo-controlled-phase-2a-trial.html 2020-08-17T14:27:43.6960000Z https://www.medicinesresources.nhs.uk/uk-secures-60-million-doses-of-novavaxs-covid-19-vaccine-candidate-nvx-cov2373.html 2020-08-17T14:28:51.9240000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-secnidazole-solosec-in-females-with-trichomoniasis.html 2020-08-17T14:43:53.4950000Z https://www.medicinesresources.nhs.uk/fda-approves-satralizumab-enspryng-for-neuromyelitis-optica-spectrum-disorder.html 2020-08-17T14:31:47.8990000Z https://www.medicinesresources.nhs.uk/covid-19-breaking-the-chain-of-household-transmission.html 2020-08-17T14:32:56.4360000Z https://www.medicinesresources.nhs.uk/clinical-update-influenza-in-the-covid-19-era.html 2020-08-17T14:35:39.3030000Z https://www.medicinesresources.nhs.uk/clinical-update-vaccine-refusal-and-measles-outbreaks-in-the-us.html 2020-08-17T14:37:22.4400000Z https://www.medicinesresources.nhs.uk/chemo-doorstep-drops-help-to-keep-cancer-patients-safe.html 2020-08-18T09:06:28.5350000Z https://www.medicinesresources.nhs.uk/hospital-discharge-and-preventing-unnecessary-hospital-admissions-covid-19.html 2020-08-17T14:40:07.6170000Z https://www.medicinesresources.nhs.uk/public-health-england-to-be-replaced.html 2020-08-17T14:41:57.1390000Z https://www.medicinesresources.nhs.uk/antibiotic-prescribing-indicators.html 2020-08-24T09:15:34.5040000Z https://www.medicinesresources.nhs.uk/revised-spc-co-cyprindiol-cyproterone-acetate-ethinylestradiol-tablets-1.html 2020-08-17T14:46:36.8310000Z https://www.medicinesresources.nhs.uk/improving-vaccination-uptake-among-adolescents.html 2020-08-17T14:49:05.6140000Z https://www.medicinesresources.nhs.uk/topical-and-device-based-treatments-for-fungal-infections-of-the-toenails.html 2020-08-17T14:50:49.1840000Z https://www.medicinesresources.nhs.uk/cisplatin-versus-carboplatin-in-combination-with-third-generation-drugs-for-advanced-non-small-cell-lung-cancer.html 2020-08-17T14:52:22.0150000Z https://www.medicinesresources.nhs.uk/anti-inflammatory-medications-for-obstructive-sleep-apnoea-in-children.html 2020-08-17T14:54:05.3150000Z https://www.medicinesresources.nhs.uk/npsa-rapid-response-report-preventing-fatalities-from-medication-loading-doses-a-ukmi-risk-assessment-tool-to-support-local-implementation.html 2020-08-24T08:58:57.6540000Z https://www.medicinesresources.nhs.uk/hypertonic-saline-versus-other-intracranial-pressure-lowering-agents-for-people-with-acute-traumatic-brain-injury-1.html 2020-08-18T14:53:59.7970000Z https://www.medicinesresources.nhs.uk/interventions-for-chronic-palmoplantar-pustulosis.html 2020-08-18T14:55:17.5330000Z https://www.medicinesresources.nhs.uk/drug-therapy-for-delirium-in-terminally-ill-adults.html 2020-08-18T14:56:32.8980000Z https://www.medicinesresources.nhs.uk/different-infusion-durations-for-preventing-platinum-induced-hearing-loss-in-children-with-cancer.html 2020-08-18T15:09:29.4150000Z https://www.medicinesresources.nhs.uk/self-management-interventions-to-reduce-healthcare-use-and-improve-quality-of-life-among-patients-with-asthma-systematic-review-and-network-meta-analysis.html 2020-08-18T15:11:07.1300000Z https://www.medicinesresources.nhs.uk/autopsy-findings-and-venous-thromboembolism-in-patients-with-covid-19.html 2020-08-18T15:12:56.5310000Z https://www.medicinesresources.nhs.uk/new-onset-type-1-diabetes-in-children-during-covid-19-multicenter-regional-findings-in-the-u-k.html 2020-08-18T15:15:08.6730000Z https://www.medicinesresources.nhs.uk/stimulant-laxatives-bisacodyl-senna-and-sennosides-sodium-picosulfate-available-over-the-counter-new-measures-to-support-safe-use.html 2020-08-24T09:25:55.1460000Z https://www.medicinesresources.nhs.uk/covid-19-research-and-treatment-trials.html 2020-08-24T09:44:46.3480000Z https://www.medicinesresources.nhs.uk/effect-of-sustained-release-morphine-for-refractory-breathlessness-in-chronic-obstructive-pulmonary-disease-on-health-status.html 2020-08-18T16:37:48.3260000Z https://www.medicinesresources.nhs.uk/antibiotic-use-and-the-development-of-inflammatory-bowel-disease-a-national-case-control-study-in-sweden.html 2020-08-18T16:38:21.8740000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-positive-scientific-opinion-dupilumab-in-the-treatment-of-children-aged-6-to-11-years-of-age-with-severe-atopic-dermatitis-allergic-eczema.html 2020-08-24T09:46:05.4210000Z https://www.medicinesresources.nhs.uk/number-of-volunteers-offering-to-participate-in-uk-covid-19-vaccine-studies-shown-in-new-nhs-digital-dashboard.html 2020-08-18T16:18:23.4660000Z https://www.medicinesresources.nhs.uk/covid-19-and-multisystem-inflammatory-syndrome-in-children-and-adolescents.html 2020-08-18T16:20:37.8850000Z https://www.medicinesresources.nhs.uk/policy-implications-of-the-orphan-drug-designation-for-remdesivir-to-treat-covid-19.html 2020-08-18T16:41:26.5920000Z https://www.medicinesresources.nhs.uk/asthma-related-health-outcomes-associated-with-short-acting-v2-agonist-inhaler-use-an-observational-uk-study-as-part-of-the-sabina-global-program.html 2020-08-18T16:40:59.5540000Z https://www.medicinesresources.nhs.uk/rehabilitation-for-adults-with-complex-psychosis-guidance-ng181-1.html 2020-08-24T09:51:10.1130000Z https://www.medicinesresources.nhs.uk/perioperative-care-in-adults-guidance-ng180.html 2020-08-24T09:51:34.7140000Z https://www.medicinesresources.nhs.uk/revised-spc-xolair-omalizumab-solution-for-injection.html 2020-08-19T14:22:51.0380000Z https://www.medicinesresources.nhs.uk/revised-spc-botox-botulinum-toxin-type-a-powder-for-solution-for-injection.html 2020-08-19T14:24:55.1070000Z https://www.medicinesresources.nhs.uk/management-of-acute-pain-from-non-low-back-musculoskeletal-injuries-a-systematic-review-and-network-meta-analysis-of-randomized-trials.html 2020-08-24T09:57:07.2260000Z https://www.medicinesresources.nhs.uk/predictors-of-prolonged-opioid-use-after-initial-prescription-for-acute-musculoskeletal-injuries-in-adults-a-systematic-review-and-meta-analysis-of-observational-studies.html 2020-08-19T14:31:40.8590000Z https://www.medicinesresources.nhs.uk/treatment-for-ascites-in-adults-with-decompensated-liver-cirrhosis-a-network-meta-analysis.html 2020-08-19T14:33:02.2660000Z https://www.medicinesresources.nhs.uk/induction-immunosuppression-in-adults-undergoing-liver-transplantation-a-network-meta-analysis.html 2020-08-19T14:34:05.0680000Z https://www.medicinesresources.nhs.uk/antibiotic-prophylaxis-to-prevent-spontaneous-bacterial-peritonitis-in-people-with-liver-cirrhosis-a-network-meta-analysis.html 2020-08-19T14:35:03.7470000Z https://www.medicinesresources.nhs.uk/granulocyte-colony-stimulating-factor-administration-for-subfertile-women-undergoing-assisted-reproduction.html 2020-08-19T14:38:03.1950000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-sildenafil-added-to-pirfenidone-in-patients-with-advanced-idiopathic-pulmonary-fibrosis-and-risk-of-pulmonary-hypertension-a-double-blind-randomised-placebo-controlled-phase-2b-trial.html 2020-08-19T14:43:39.8480000Z https://www.medicinesresources.nhs.uk/seizure-outcome-and-use-of-antiepileptic-drugs-after-epilepsy-surgery-according-to-histopathological-diagnosis-a-retrospective-multicentre-cohort-study.html 2020-08-19T14:44:57.2710000Z https://www.medicinesresources.nhs.uk/safety-tolerability-and-efficacy-of-orally-administered-atogepant-for-the-prevention-of-episodic-migraine-in-adults-a-double-blind-randomised-phase-2b-3-trial.html 2020-08-19T14:46:49.8510000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-once-daily-nitisinone-for-patients-with-alkaptonuria-sonia-2-an-international-multicentre-open-label-randomised-controlled-trial.html 2020-08-19T15:20:22.7890000Z https://www.medicinesresources.nhs.uk/effects-of-a-major-deletion-in-the-sars-cov-2-genome-on-the-severity-of-infection-and-the-inflammatory-response-an-observational-cohort-study.html 2020-08-19T14:52:32.4680000Z https://www.medicinesresources.nhs.uk/evaluating-the-association-of-clinical-characteristics-with-neutralizing-antibody-levels-in-patients-who-have-recovered-from-mild-covid-19-in-shanghai-china.html 2020-08-19T14:54:11.1860000Z https://www.medicinesresources.nhs.uk/effect-of-ascorbic-acid-corticosteroids-and-thiamine-on-organ-injury-in-septic-shock-the-acts-randomized-clinical-trial.html 2020-08-19T14:55:17.5870000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-over-2-years-of-exenatide-plus-dapagliflozin-in-the-duration-8-study-a-multicenter-double-blind-phase-3-randomized-controlled-trial.html 2020-08-19T14:56:15.4060000Z https://www.medicinesresources.nhs.uk/manufacturers-report-data-from-interim-analysis-of-odyssey-study-for-tradipitant-in-covid-19-pneumonia.html 2020-08-19T14:58:08.2620000Z https://www.medicinesresources.nhs.uk/babies-in-lockdown-listening-to-parents-to-build-back-better.html 2020-08-19T15:01:00.6630000Z https://www.medicinesresources.nhs.uk/fda-approve-satralizumab-for-neuromyelitis-optica-spectrum-disorder-nmsod.html 2020-08-19T15:02:36.2920000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-to-review-risdiplam-for-use-in-spinal-muscular-atrophy.html 2020-08-19T15:04:13.8710000Z https://www.medicinesresources.nhs.uk/updated-covid-19-guidance-for-young-people-on-shielding-and-protecting-people-most-likely-to-become-unwell-if-they-catch-coronavirus.html 2020-08-19T15:05:35.5900000Z https://www.medicinesresources.nhs.uk/advances-in-diagnosis-classification-pathophysiology-and-management-of-trigeminal-neuralgia.html 2020-08-19T15:06:52.6130000Z https://www.medicinesresources.nhs.uk/gestational-diabetes-opportunities-for-improving-maternal-and-child-health.html 2020-08-19T15:08:54.1490000Z https://www.medicinesresources.nhs.uk/revised-spcs-cosentyx-secukinumab-150-mg-solution-for-injection-in-pre-filled-pen-and-syringe-2.html 2020-08-20T16:54:00.7090000Z https://www.medicinesresources.nhs.uk/revised-spcs-ventolin-salbutamol-syrup.html 2020-08-20T16:54:46.6030000Z https://www.medicinesresources.nhs.uk/revised-spcs-duoresp-spiromax-budesonide-formoterol-inhalation-powder-all-strengths.html 2020-08-20T14:31:47.3060000Z https://www.medicinesresources.nhs.uk/effectiveness-of-honey-for-symptomatic-relief-in-upper-respiratory-tract-infections-a-systematic-review-and-meta-analysis.html 2020-08-24T10:07:04.3520000Z https://www.medicinesresources.nhs.uk/effectiveness-and-safety-of-systemic-therapy-for-psoriasis-in-older-adults-a-systematic-review.html 2020-08-20T14:35:49.2050000Z https://www.medicinesresources.nhs.uk/inclusion-of-older-adults-in-randomized-clinical-trials-for-systemic-medications-for-atopic-dermatitis-a-systematic-review.html 2020-08-20T14:39:03.1050000Z https://www.medicinesresources.nhs.uk/benzodiazepines-for-treatment-of-patients-with-delirium-excluding-those-who-are-cared-for-in-an-intensive-care-unit.html 2020-08-20T14:41:15.4150000Z https://www.medicinesresources.nhs.uk/interventions-for-treating-oral-lichen-planus-corticosteroid-therapies-cochrane-systematic-review-intervention-version-published-see-what-s-new.html 2020-08-20T17:14:52.2470000Z https://www.medicinesresources.nhs.uk/timing-of-hypertonic-saline-inhalation-for-cystic-fibrosis.html 2020-08-20T14:45:01.4720000Z https://www.medicinesresources.nhs.uk/biologics-for-chronic-rhinosinusitis.html 2020-08-20T14:47:44.2290000Z https://www.medicinesresources.nhs.uk/figures-released-by-cancer-research-uk-show-deaths-due-to-melanoma-rocket-70-since-1970s.html 2020-08-20T15:38:59.9660000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-for-a-new-four-weekly-fixed-dose-regimen-of-durvalumab-for-treatment-of-non-small-cell-lung-cancer-nsclc-and-bladder-cancer.html 2020-08-20T15:39:59.0020000Z https://www.medicinesresources.nhs.uk/new-framework-launched-to-help-nhs-and-public-sector-organisations-manage-cyber-threats.html 2020-08-20T15:40:54.2060000Z https://www.medicinesresources.nhs.uk/quality-and-outcomes-framework-qof-prevalence-achievements-and-personalised-care-adjustments-report-england-2019-20.html 2020-08-20T15:41:49.6110000Z https://www.medicinesresources.nhs.uk/polatuzumab-vedotin-with-rituximab-and-bendamustine-for-treating-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-final-appraisal-document.html 2020-08-20T15:43:05.4190000Z https://www.medicinesresources.nhs.uk/no-one-wants-to-look-after-the-fibro-patient-understanding-models-and-patient-perspectives-of-care-for-fibromyalgia-reviews-of-current-evidence.html 2020-08-20T15:44:04.0290000Z https://www.medicinesresources.nhs.uk/covid-19-and-dexamethasone-a-potential-strategy-to-avoid-steroid-related-strongyloides-hyperinfection.html 2020-08-20T15:47:00.5690000Z https://www.medicinesresources.nhs.uk/polymyalgia-rheumatica-and-giant-cell-arteritis.html 2020-08-20T15:48:53.7380000Z https://www.medicinesresources.nhs.uk/fatal-toxic-epidermal-necrolysis-probably-related-to-glimepiride-in-a-patient-with-a-medical-history-of-hypersensitivity-to-sulfamethoxazole-trimethoprim.html 2020-08-20T15:50:14.9150000Z https://www.medicinesresources.nhs.uk/the-perils-of-preprints.html 2020-08-20T15:51:16.0430000Z https://www.medicinesresources.nhs.uk/airborne-transmission-of-covid-19.html 2020-08-20T15:53:48.1250000Z https://www.medicinesresources.nhs.uk/how-covid-19-has-highlighted-the-importance-of-design-as-well-as-price-in-the-nhs-supply-chain.html 2020-08-20T15:55:09.3920000Z https://www.medicinesresources.nhs.uk/face-coverings-for-covid-19-from-medical-intervention-to-social-practice.html 2020-08-20T15:56:31.2920000Z https://www.medicinesresources.nhs.uk/prescribing-dilemmas-a-guide-for-prescribers-consultation.html 2020-08-20T15:57:37.4390000Z https://www.medicinesresources.nhs.uk/anosmia-as-a-presenting-symptom-of-sars-cov-2-infection-in-healthcare-workers-a-systematic-review-of-the-literature-case-series-and-recommendations-for-clinical-assessment-and-management.html 2020-08-20T17:26:08.5270000Z https://www.medicinesresources.nhs.uk/fda-accepts-new-drug-application-for-once-daily-oral-relugolix-combination-tablet-relugolix-40-mg-estradiol-1-0-mg-and-norethindrone-acetate-0-5-mg-for-treatment-of-women-with-heavy-menstrual-bleeding-associated-with-uterine-fibroids.html 2020-08-20T16:47:55.6990000Z https://www.medicinesresources.nhs.uk/pembrolizumab-in-combination-with-chemotherapy-meet-primary-endpoints-in-phase-iii-keynote-590-trial-for-first-line-treatment-of-locally-advanced-or-metastatic-oesophageal-cancer.html 2020-08-20T17:29:09.2150000Z https://www.medicinesresources.nhs.uk/challenges-of-return-to-work-in-an-ongoing-pandemic.html 2020-08-20T16:02:52.4740000Z https://www.medicinesresources.nhs.uk/trigeminal-neuralgia.html 2020-08-20T16:03:58.1540000Z https://www.medicinesresources.nhs.uk/fda-rejects-biologics-license-application-for-valoctocogene-roxaparvovec-valrox-for-severe-haemophilia-a.html 2020-08-20T17:30:39.8650000Z https://www.medicinesresources.nhs.uk/fda-rejects-new-drug-application-for-filgotinib-for-treatment-of-moderately-to-severely-active-rheumatoid-arthritis.html 2020-08-20T16:06:29.4140000Z https://www.medicinesresources.nhs.uk/the-demise-of-public-health-england.html 2020-08-20T16:09:56.9270000Z https://www.medicinesresources.nhs.uk/evinacumab-for-homozygous-familial-hypercholesterolemia.html 2020-08-20T16:24:53.6290000Z https://www.medicinesresources.nhs.uk/childrens-oncology-group-aall0434-a-phase-iii-randomized-clinical-trial-testing-nelarabine-in-newly-diagnosed-t-cell-acute-lymphoblastic-leukemia.html 2020-08-20T16:26:43.2420000Z https://www.medicinesresources.nhs.uk/evaluation-for-sars-cov-2-in-breast-milk-from-18-infected-women.html 2020-08-20T16:47:03.4240000Z https://www.medicinesresources.nhs.uk/atypical-femur-fracture-risk-versus-fragility-fracture-prevention-with-bisphosphonates.html 2020-08-24T10:10:51.9790000Z https://www.medicinesresources.nhs.uk/air-pollution-and-family-related-determinants-of-asthma-onset-and-persistent-wheezing-in-children-nationwide-case-control-study.html 2020-08-20T16:44:00.6600000Z https://www.medicinesresources.nhs.uk/comparison-of-molecular-testing-strategies-for-covid-19-control-a-mathematical-modelling-study.html 2020-08-20T16:45:08.5510000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-and-risk-factors-associated-with-covid-19-severity-in-patients-with-haematological-malignancies-in-italy-a-retrospective-multicentre-cohort-study.html 2020-08-20T17:35:38.2530000Z https://www.medicinesresources.nhs.uk/the-trade-off-dilemma-in-pharmacotherapy-of-covid-19-systematic-review-meta-analysis-and-implications.html 2020-08-20T17:37:06.3270000Z https://www.medicinesresources.nhs.uk/revised-spcs-exjade-deferasirox-film-coated-tablets.html 2020-08-21T14:35:20.0520000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-heart-failure-in-people-with-chronic-kidney-disease.html 2020-08-21T14:37:29.3820000Z https://www.medicinesresources.nhs.uk/dihydrocodeine-for-detoxification-and-maintenance-treatment-in-individuals-with-opiate-use-disorders.html 2020-08-21T14:38:50.6130000Z https://www.medicinesresources.nhs.uk/different-unfractionated-heparin-doses-for-preventing-arterial-thrombosis-in-children-undergoing-cardiac-catheterization.html 2020-08-21T14:40:10.3500000Z https://www.medicinesresources.nhs.uk/early-erythropoiesis-stimulating-agents-in-preterm-or-low-birth-weight-infants.html 2020-08-21T14:41:31.2630000Z https://www.medicinesresources.nhs.uk/association-of-type-2-diabetes-with-cancer-a-meta-analysis-with-bias-analysis-for-unmeasured-confounding-in-151-cohorts-comprising-32-million-people.html 2020-08-21T14:44:30.3130000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-short-and-long-acting-glucagon-like-peptide-1-receptor-agonists-on-a-background-of-basal-insulin-in-type-2-diabetes-a-meta-analysis.html 2020-08-21T14:46:27.2220000Z https://www.medicinesresources.nhs.uk/negative-pressure-wound-therapy-compared-with-standard-dressings-following-surgical-treatment-of-major-trauma-to-the-lower-limb-the-whist-rct.html 2020-08-21T14:48:07.1410000Z https://www.medicinesresources.nhs.uk/individual-patient-data-meta-analysis-of-folfoxiri-plus-bevacizumab-versus-doublets-plus-bevacizumab-as-initial-therapy-of-unresectable-metastatic-colorectal-cancer.html 2020-08-21T14:49:49.6690000Z https://www.medicinesresources.nhs.uk/effect-of-alirocumab-on-major-adverse-cardiovascular-events-according-to-renal-function-in-patients-with-a-recent-acute-coronary-syndrome-prespecified-analysis-from-the-odyssey-outcomes-randomized-clinical-trial.html 2020-08-21T14:51:12.9880000Z https://www.medicinesresources.nhs.uk/lithium-carbonate-priadel-200mg-and-400mg-modified-release-tablets-supply-disruption.html 2020-08-24T10:18:26.3430000Z https://www.medicinesresources.nhs.uk/all-wales-adult-asthma-management-and-prescribing-guidelines.html 2020-08-24T10:38:48.7450000Z https://www.medicinesresources.nhs.uk/us-fda-approves-use-of-carfilzomib-in-combination-with-daratumumab-plus-dexamethasone-for-the-treatment-of-relapsed-or-refractory-multiple-myeloma.html 2020-08-21T14:55:22.5050000Z https://www.medicinesresources.nhs.uk/kdoqi-clinical-practice-guideline-for-nutrition-in-ckd-2020-update.html 2020-08-21T14:58:09.1050000Z https://www.medicinesresources.nhs.uk/us-fda-awards-fast-track-designation-to-paxalisib-for-glioblastoma.html 2020-08-21T14:59:35.8290000Z https://www.medicinesresources.nhs.uk/fda-approves-ofatumumab-for-the-treatment-of-relapsing-forms-of-multiple-sclerosis.html 2020-08-21T15:01:38.0010000Z https://www.medicinesresources.nhs.uk/royal-college-of-pathologists-raises-concerns-about-the-direct-sale-of-covid-19-antibody-testing-devices-to-consumers.html 2020-08-21T15:34:17.4200000Z https://www.medicinesresources.nhs.uk/fears-grow-of-nutritional-crisis-in-lockdown-uk.html 2020-08-21T15:07:02.5530000Z https://www.medicinesresources.nhs.uk/metformin-should-not-be-used-to-treat-prediabetes.html 2020-08-21T15:08:26.9460000Z https://www.medicinesresources.nhs.uk/new-gbp3-3-million-fund-to-give-babies-from-deprived-areas-or-bame-backgrounds-the-best-start-in-life.html 2020-08-21T15:09:49.0670000Z https://www.medicinesresources.nhs.uk/sex-and-gender-modifiers-of-health-disease-and-medicine.html 2020-08-21T15:11:06.4500000Z https://www.medicinesresources.nhs.uk/review-of-dysthymia-and-persistent-depressive-disorder-history-correlates-and-clinical-implications.html 2020-08-21T15:12:55.8940000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-scientific-opinion-nivolumab-for-treatment-of-adult-patients-with-unresectable-advanced-recurrent-or-metastatic-oesophageal-cancer-after-prior-chemotherapy-1.html 2020-08-24T10:35:38.3810000Z https://www.medicinesresources.nhs.uk/nice-consults-on-draft-quality-standard-on-abortion-care.html 2020-08-21T15:15:53.8300000Z https://www.medicinesresources.nhs.uk/nice-consults-on-draft-quality-standard-on-fetal-alcohol-spectrum-disorder.html 2020-08-21T15:17:56.8830000Z https://www.medicinesresources.nhs.uk/celebs-with-cancer-back-nhs-call-for-people-to-get-symptoms-checked.html 2020-08-21T15:19:29.1940000Z https://www.medicinesresources.nhs.uk/omega-3-supplementation-and-cardiovascular-disease-formulation-based-systematic-review-and-meta-analysis-with-trial-sequential-analysis.html 2020-08-21T15:54:04.2820000Z https://www.medicinesresources.nhs.uk/psychosis-relapse-during-treatment-with-long-acting-injectable-antipsychotics-in-individuals-with-schizophrenia-spectrum-disorders-an-individual-participant-data-meta-analysis.html 2020-08-21T15:55:37.0930000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-smoking-cessation-among-people-with-schizophrenia-spectrum-disorders-a-systematic-review-meta-analysis-and-network-meta-analysis.html 2020-08-21T15:57:22.1590000Z https://www.medicinesresources.nhs.uk/beta-blocker-use-and-acute-exacerbations-of-copd-following-myocardial-infarction-a-danish-nationwide-cohort-study.html 2020-08-21T15:58:39.3850000Z https://www.medicinesresources.nhs.uk/general-versus-local-anesthesia-with-conscious-sedation-in-transcatheter-aortic-valve-implantation-the-randomized-solve-tavi-trial.html 2020-08-21T15:59:44.2370000Z https://www.medicinesresources.nhs.uk/prescribing-in-covid-19-patients-should-we-take-into-account-inflammation.html 2020-08-21T16:00:54.1810000Z https://www.medicinesresources.nhs.uk/hospital-discharge-service-policy-and-operating-model.html 2020-08-24T14:21:20.6940000Z https://www.medicinesresources.nhs.uk/reintroduction-of-nhs-continuing-healthcare.html 2020-08-24T14:23:54.7950000Z https://www.medicinesresources.nhs.uk/nihr-alert-the-weekly-break-from-dialysis-is-harmful-to-patients-with-kidney-failure.html 2020-08-24T14:26:22.7920000Z https://www.medicinesresources.nhs.uk/effect-of-remdesivir-vs-standard-care-on-clinical-status-at-11-days-in-patients-with-moderate-covid-19a-randomized-clinical-trial.html 2020-09-01T09:19:47.4550000Z https://www.medicinesresources.nhs.uk/addressing-postpandemic-clinician-mental-health.html 2020-08-24T14:33:20.4320000Z https://www.medicinesresources.nhs.uk/fda-issues-emergency-use-authorisation-for-convalescent-plasma-as-potential-promising-covid-19-treatment.html 2020-08-24T14:37:40.5360000Z https://www.medicinesresources.nhs.uk/phase-iii-combi-i-trial-of-spartalizumab-in-advanced-melanoma-fails-to-meet-primary-endpoint.html 2020-08-24T14:39:15.7010000Z https://www.medicinesresources.nhs.uk/eu-grants-marketing-authorisation-of-ivacaftor-tezacaftor-elexacaftor-kaftrio-for-cystic-fibrosis.html 2020-08-24T14:45:20.0560000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-release-preliminary-phase-i-data-for-bnt162b-covid-19-vaccine.html 2020-08-24T14:47:06.9660000Z https://www.medicinesresources.nhs.uk/new-nhs-medicines-guides-available.html 2020-09-01T09:21:08.6690000Z https://www.medicinesresources.nhs.uk/statement-from-the-uk-chief-medical-officers-on-schools-and-childcare-reopening.html 2020-09-01T09:21:32.6410000Z https://www.medicinesresources.nhs.uk/pharmacys-role-in-primary-care-network-multidisciplinary-teams-supporting-care-homes.html 2020-08-24T15:03:07.8740000Z https://www.medicinesresources.nhs.uk/stroking-out-while-black-the-complex-role-of-racism.html 2020-08-24T15:04:18.2730000Z https://www.medicinesresources.nhs.uk/central-alerting-system-class-2-drug-alert-action-within-48-hours-sanofi-fasturtec-7-5mg-5ml-powder-and-solvent-for-concentrate-for-solution-for-infusion.html 2020-08-24T15:06:27.2980000Z https://www.medicinesresources.nhs.uk/medicine-supply-notification-diazepam-diazemuls-10mg-2ml-emulsion-for-injection.html 2020-08-24T15:09:17.9500000Z https://www.medicinesresources.nhs.uk/revised-spc-clomid-clomifene-citrate-50mg-tablets.html 2020-08-24T15:11:23.7570000Z https://www.medicinesresources.nhs.uk/boostrix-ipv-diphtheria-tetanus-pertussis-poliomyelitis-suspension-for-injection-in-pre-filled-syringe.html 2020-08-24T15:24:29.9080000Z https://www.medicinesresources.nhs.uk/early-versus-late-erythropoietin-for-preventing-red-blood-cell-transfusion-in-preterm-and-or-low-birth-weight-infants.html 2020-08-24T15:14:34.9650000Z https://www.medicinesresources.nhs.uk/ibuprofen-for-the-treatment-of-patent-ductus-arteriosus-in-preterm-or-low-birth-weight-or-both-infants.html 2020-08-24T15:16:37.7230000Z https://www.medicinesresources.nhs.uk/anti-vascular-endothelial-growth-factor-for-neovascular-glaucoma.html 2020-08-24T15:17:50.8300000Z https://www.medicinesresources.nhs.uk/first-line-combination-therapy-versus-first-line-monotherapy-for-primary-hypertension.html 2020-08-24T15:19:14.8890000Z https://www.medicinesresources.nhs.uk/covid-19-should-doctors-recommend-treatments-and-vaccines-when-full-data-are-not-publicly-available.html 2020-08-24T15:26:49.8560000Z https://www.medicinesresources.nhs.uk/what-factors-to-consider-when-advising-on-medicines-suitable-for-a-halal-diet.html 2020-09-01T09:43:00.7890000Z https://www.medicinesresources.nhs.uk/revised-spcs-herceptin-trastuzumab-150mg-powder-for-concentrate-for-solution-for-infusion.html 2020-08-25T16:51:59.2730000Z https://www.medicinesresources.nhs.uk/darzalex-daratumumab-1-800-mg-solution-for-injection.html 2020-08-25T16:52:54.7480000Z https://www.medicinesresources.nhs.uk/imbruvica-ibrutinib-mg-film-coated-tablets-all-strengths.html 2020-08-25T16:53:30.2290000Z https://www.medicinesresources.nhs.uk/surfactant-for-pulmonary-haemorrhage-in-neonates.html 2020-08-25T15:21:05.8480000Z https://www.medicinesresources.nhs.uk/acute-cardiovascular-events-associated-with-influenza-in-hospitalized-adults.html 2020-08-25T17:07:23.7320000Z https://www.medicinesresources.nhs.uk/risk-of-amputation-with-canagliflozin-across-categories-of-age-and-cardiovascular-risk-in-three-us-nationwide-databases-cohort-study.html 2020-08-25T17:08:16.0290000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-2-fingolimod-doses-vs-glatiramer-acetate-for-the-treatment-of-patients-with-relapsing-remitting-multiple-sclerosis.html 2020-08-25T17:09:17.9000000Z https://www.medicinesresources.nhs.uk/carfilzomib-kyprolis-approved-by-us-fda-as-combination-regimen-with-daratumumab-darzalex-and-dexamethasone-for-patients-with-relapsed-refractory-multiple-myeloma.html 2020-08-25T17:10:00.8530000Z https://www.medicinesresources.nhs.uk/perioperative-oral-eltrombopag-versus-intravenous-immunoglobulin-in-patients-with-immune-thrombocytopenia-a-non-inferiority-multicentre-randomised-trial.html 2020-08-25T17:17:34.8490000Z https://www.medicinesresources.nhs.uk/covid-19-prevalence-and-mortality-in-patients-with-cancer-and-the-effect-of-primary-tumour-subtype-and-patient-demographics-a-prospective-cohort-study.html 2020-08-25T17:18:12.8970000Z https://www.medicinesresources.nhs.uk/mifepristone-and-misoprostol-versus-misoprostol-alone-for-the-management-of-missed-miscarriage-mifemiso-a-randomised-double-blind-placebo-controlled-trial.html 2020-08-25T17:19:47.2790000Z https://www.medicinesresources.nhs.uk/astrazeneca-kicks-off-phase-1-trial-of-potential-covid-19-therapy.html 2020-08-25T17:21:17.4000000Z https://www.medicinesresources.nhs.uk/company-announces-positive-top-line-results-from-contessa-phase-3-study-of-tesetaxel-in-patients-with-metastatic-breast-cancer.html 2020-08-25T17:23:57.1490000Z https://www.medicinesresources.nhs.uk/company-announces-iv-rigosertib-did-not-meet-primary-endpoint-of-significantly-improved-survival-versus-best-supportive-care-in-higher-risk-myelodysplastic-syndromes.html 2020-08-25T17:24:39.9720000Z https://www.medicinesresources.nhs.uk/restrictions-on-otc-prescribing-have-saved-less-than-a-third-of-the-money-that-nhs-england-forecast-1.html 2020-08-26T11:17:51.5470000Z https://www.medicinesresources.nhs.uk/covid-19-infection-prevention-and-control-ipc.html 2020-09-01T09:26:25.3540000Z https://www.medicinesresources.nhs.uk/enteral-lactoferrin-supplementation-for-prevention-of-sepsis-and-necrotizing-enterocolitis-in-preterm-infants.html 2020-08-26T11:22:52.2300000Z https://www.medicinesresources.nhs.uk/antibiotic-prophylaxis-for-operative-vaginal-delivery.html 2020-08-26T11:24:16.5570000Z https://www.medicinesresources.nhs.uk/new-product-kaftrio-ivacaftor-tezacaftor-elexacaftor-tablets.html 2020-08-26T14:37:38.8790000Z https://www.medicinesresources.nhs.uk/revised-spc-lantus-preparations.html 2020-08-26T14:39:36.6680000Z https://www.medicinesresources.nhs.uk/revised-spc-bosulif-bosutinib-tablets.html 2020-08-26T14:40:45.5700000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-promoting-smoking-cessation-during-pregnancy.html 2020-08-26T14:42:09.8440000Z https://www.medicinesresources.nhs.uk/probiotics-for-induction-of-remission-in-ulcerative-colitis.html 2020-08-26T14:45:13.2640000Z https://www.medicinesresources.nhs.uk/probiotics-for-maintenance-of-remission-in-ulcerative-colitis.html 2020-08-26T14:46:36.7640000Z https://www.medicinesresources.nhs.uk/omega-3-fatty-acids-for-the-primary-and-secondary-prevention-of-cardiovascular-disease.html 2020-08-26T14:48:03.0110000Z https://www.medicinesresources.nhs.uk/early-intervention-for-people-at-high-risk-of-developing-bipolar-disorder-a-systematic-review-of-clinical-trials.html 2020-08-26T14:49:26.3340000Z https://www.medicinesresources.nhs.uk/effect-of-genotype-guided-oral-p2y12-inhibitor-selection-vs-conventional-clopidogrel-therapy-on-ischemic-outcomes-after-percutaneous-coronary-intervention-the-tailor-pci-randomized-clinical-trial.html 2020-08-26T15:52:33.3590000Z https://www.medicinesresources.nhs.uk/effect-of-vitamin-d3-supplementation-on-severe-asthma-exacerbations-in-children-with-asthma-and-low-vitamin-d-levels-the-vdka-randomized-clinical-trial.html 2020-08-26T14:53:43.5210000Z https://www.medicinesresources.nhs.uk/improvement-of-ejection-fraction-and-mortality-in-ischaemic-heart-failure.html 2020-08-26T14:54:58.6970000Z https://www.medicinesresources.nhs.uk/improving-pain-management-in-childhood-acute-otitis-media-in-general-practice-a-cluster-randomised-controlled-trial-of-a-gp-targeted-educational-intervention.html 2020-08-26T14:56:38.2840000Z https://www.medicinesresources.nhs.uk/high-prevalence-of-the-new-onset-or-worsening-of-hepatitis-c-related-musculoskeletal-symptoms-after-commencing-direct-acting-antiviral-therapies-a-challenging-novel-observation.html 2020-08-26T14:58:47.0940000Z https://www.medicinesresources.nhs.uk/fda-to-review-tepotinib-for-use-in-metastatic-nsclc-with-metex14-skipping-alterations.html 2020-08-26T15:00:04.7790000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-market-authorisation-application-to-fda-for-upadacitinib-for-ankylosing-spondylitis.html 2020-08-26T15:02:54.6590000Z https://www.medicinesresources.nhs.uk/enasidenib-fails-to-meet-primary-endpoint-in-acute-myeloid-leukaemia-trial.html 2020-08-26T15:04:05.4040000Z https://www.medicinesresources.nhs.uk/two-metres-or-one-what-is-the-evidence-for-physical-distancing-in-covid-19.html 2020-08-26T15:05:03.5330000Z https://www.medicinesresources.nhs.uk/british-journal-of-clinical-pharmacology-themed-edition-immuno-oncology.html 2020-08-26T15:10:09.5000000Z https://www.medicinesresources.nhs.uk/the-computer-says-no-are-there-tools-and-algorithms-that-will-help-us-stop-potentially-inappropriate-medications.html 2020-08-26T15:11:07.6420000Z https://www.medicinesresources.nhs.uk/considerations-for-reduction-of-risk-of-perioperative-stroke-in-adult-patients-undergoing-cardiac-and-thoracic-aortic-operations-a-scientific-statement-from-the-american-heart-association.html 2020-08-26T15:12:21.0530000Z https://www.medicinesresources.nhs.uk/pharmacotherapy-for-pulmonary-arterial-hypertension.html 2020-08-26T15:20:09.2170000Z https://www.medicinesresources.nhs.uk/new-electronic-discharge-summaries-save-the-nhs-time-and-admin-costs.html 2020-08-26T15:21:24.3010000Z https://www.medicinesresources.nhs.uk/who-pays-determining-responsibility-for-nhs-payments-to-providers.html 2020-08-26T15:22:51.5920000Z https://www.medicinesresources.nhs.uk/how-covid-19-has-magnified-some-of-social-cares-key-problems.html 2020-08-27T10:52:51.0110000Z https://www.medicinesresources.nhs.uk/gphc-response-to-concerns-from-the-pda-about-reporting-of-exposure-to-covid-19-in-the-workplace.html 2020-08-26T15:25:27.7540000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-asciminib-in-chronic-myeloid-leukaemia-in-phase-iii-trial.html 2020-08-26T15:26:28.4930000Z https://www.medicinesresources.nhs.uk/maternity-services-in-smaller-hospitals-a-call-to-action.html 2020-08-26T15:27:45.9070000Z https://www.medicinesresources.nhs.uk/respiratory-follow-up-of-patients-with-covid-19-pneumonia.html 2020-08-26T15:28:54.7070000Z https://www.medicinesresources.nhs.uk/towards-a-personalised-treatment-approach-for-asthma-attacks.html 2020-08-26T15:29:52.5330000Z https://www.medicinesresources.nhs.uk/anaphylaxis-assessment-and-referral-after-emergency-treatment-updated-guideline-cg134-1.html 2020-09-01T09:27:31.4080000Z https://www.medicinesresources.nhs.uk/revised-spcs-insuman-basal-human-insulin-products.html 2020-08-27T15:21:19.8010000Z https://www.medicinesresources.nhs.uk/revised-spc-jylamvo-methotrexate-2-mg-ml-oral-solution.html 2020-08-27T15:24:07.0370000Z https://www.medicinesresources.nhs.uk/revised-spc-pharmorubicin-epirubicin-2-mg-ml-solution-for-injection-or-infusion.html 2020-08-27T15:25:10.8300000Z https://www.medicinesresources.nhs.uk/revised-spcs-zavedos-idarubicin-products.html 2020-08-27T15:26:15.6690000Z https://www.medicinesresources.nhs.uk/revised-spc-doxorubicin-solution-for-injection.html 2020-08-27T15:27:14.3050000Z https://www.medicinesresources.nhs.uk/emollients-and-risk-of-severe-and-fatal-burns-new-resources-available.html 2020-09-01T09:28:18.4690000Z https://www.medicinesresources.nhs.uk/isotretinoin-roaccutane-reminder-of-important-risks-and-precautions.html 2020-09-01T09:28:31.6200000Z https://www.medicinesresources.nhs.uk/baricitinib-olumiant-increased-risk-of-diverticulitis-particularly-in-patients-with-risk-factors.html 2020-09-01T09:28:44.6640000Z https://www.medicinesresources.nhs.uk/denosumab-60mg-prolia-increased-risk-of-multiple-vertebral-fractures-after-stopping-or-delaying-ongoing-treatment.html 2020-09-01T09:28:59.7420000Z https://www.medicinesresources.nhs.uk/clozapine-and-other-antipsychotics-monitoring-blood-concentrations-for-toxicity.html 2020-09-01T09:29:12.0140000Z https://www.medicinesresources.nhs.uk/potential-impact-of-missing-outcome-data-on-treatment-effects-in-systematic-reviews-imputation-study.html 2020-08-27T15:35:54.6740000Z https://www.medicinesresources.nhs.uk/individuals-with-obesity-and-covid-19-a-global-perspective-on-the-epidemiology-and-biological-relationships.html 2020-08-27T15:36:59.6850000Z https://www.medicinesresources.nhs.uk/treatment-of-newly-diagnosed-glioblastoma-in-the-elderly-a-network-meta-analysis.html 2020-08-27T16:13:35.0200000Z https://www.medicinesresources.nhs.uk/lamotrigine-add-on-therapy-for-drug-resistant-focal-epilepsy.html 2020-08-27T16:12:07.1130000Z https://www.medicinesresources.nhs.uk/glucocorticoid-replacement-regimens-for-treating-congenital-adrenal-hyperplasia.html 2020-08-27T16:12:47.7900000Z https://www.medicinesresources.nhs.uk/antibiotic-treatment-for-stenotrophomonas-maltophilia-in-people-with-cystic-fibrosis.html 2020-08-27T15:42:14.3530000Z https://www.medicinesresources.nhs.uk/what-are-the-clinically-significant-drug-interactions-with-tobacco-smoking.html 2020-09-01T09:37:03.1480000Z https://www.medicinesresources.nhs.uk/preserving-macrolides-infographic.html 2020-08-27T15:44:38.9940000Z https://www.medicinesresources.nhs.uk/blenrep-belantamab-mafodotin-blmf-receives-conditional-approval-in-eu-as-a-treatment-for-patients-with-relapsed-for-refractory-multiple-myeloma.html 2020-08-27T15:45:42.2320000Z https://www.medicinesresources.nhs.uk/idefirix-imlifidase-receives-conditional-approval-in-eu-to-desensitise-kidney-transplant-patients-with-a-highly-sensitised-immune-system.html 2020-08-27T15:46:50.4100000Z https://www.medicinesresources.nhs.uk/the-impact-of-covid-19-on-the-use-of-digital-technology-in-the-nhs.html 2020-08-27T15:47:44.5500000Z https://www.medicinesresources.nhs.uk/more-gp-practices-and-community-pharmacies-go-live-with-electronic-notifications-for-urgent-supply-of-medicines.html 2020-08-27T15:48:34.3940000Z https://www.medicinesresources.nhs.uk/atherosclerotic-plaque-healing.html 2020-08-27T15:49:34.0670000Z https://www.medicinesresources.nhs.uk/wockhardt-uks-amoxicillin-sodium-250mg-500mg-and-1g-powder-for-solution-for-injection-caution-and-monitoring-requirements.html 2020-08-27T15:52:22.6400000Z https://www.medicinesresources.nhs.uk/comparing-sars-cov-2-with-sars-cov-and-influenza-pandemics.html 2020-08-27T15:53:23.0940000Z https://www.medicinesresources.nhs.uk/evidence-for-action-a-one-health-learning-platform-on-interventions-to-tackle-antimicrobial-resistance.html 2020-08-27T15:54:26.6830000Z https://www.medicinesresources.nhs.uk/pathogen-influence-on-epidemiology-diagnostic-evaluation-and-management-of-infective-endocarditis.html 2020-08-27T15:55:44.2230000Z https://www.medicinesresources.nhs.uk/ppe-care-workers-delivering-homecare-during-the-covid-19-response.html 2020-09-01T09:36:40.8620000Z https://www.medicinesresources.nhs.uk/fda-removes-boxed-warning-about-risk-of-leg-and-foot-amputations-for-canagliflozin.html 2020-08-27T15:58:04.0330000Z https://www.medicinesresources.nhs.uk/dtb-commentary-moderate-calorie-restriction-improves-cardiometabolic-risk-factors-in-healthy-individuals.html 2020-08-27T16:00:14.2660000Z https://www.medicinesresources.nhs.uk/dtb-forum-pharmaceutical-marketing-greater-than-the-sum-of-its-parts.html 2020-08-27T16:02:03.3700000Z https://www.medicinesresources.nhs.uk/new-payment-for-people-self-isolating-in-highest-risk-areas.html 2020-08-27T16:02:59.1750000Z https://www.medicinesresources.nhs.uk/fda-approves-for-winlevi-clascoterone-cream-1-for-treatment-of-acne-vulgaris-in-people-aged-12-and-older.html 2020-08-27T16:03:59.3420000Z https://www.medicinesresources.nhs.uk/supplemental-new-drug-application-submitted-to-fda-for-cabozantinib-in-combination-with-nivolumab-for-treatment-of-advanced-renal-cell-carcinoma.html 2020-08-27T16:05:15.3180000Z https://www.medicinesresources.nhs.uk/fda-accepts-new-drug-application-for-casimersen-for-treatment-of-patients-with-duchenne-muscular-dystrophy-amenable-to-skipping-exon-45-of-dystrophin-gene.html 2020-08-27T16:22:49.5240000Z https://www.medicinesresources.nhs.uk/case-report-33-year-old-man-in-hong-kong-caught-covid-19-twice.html 2020-08-27T16:25:22.1990000Z https://www.medicinesresources.nhs.uk/fda-seeks-further-information-on-new-drug-application-for-veverimer-to-treat-metabolic-acidosis-in-patients-with-chronic-kidney-disease.html 2020-08-27T16:10:35.1440000Z https://www.medicinesresources.nhs.uk/positive-phase-3-data-from-psoaring-1-and-psoaring-2-trials-reported-for-tapinarof-cream-in-treatment-of-plaque-psoriasis.html 2020-08-27T16:26:25.6250000Z https://www.medicinesresources.nhs.uk/positive-data-reported-in-phase-ii-elektra-study-of-soticlestat-in-children-with-dravet-syndrome-ds-or-lennox-gastaut-syndrome-lgs.html 2020-08-27T16:12:49.5460000Z https://www.medicinesresources.nhs.uk/randomized-trial-of-closed-loop-control-in-children-with-type-1-diabetes.html 2020-08-27T16:14:25.6380000Z https://www.medicinesresources.nhs.uk/randomized-comparison-of-pazopanib-and-doxorubicin-as-first-line-treatment-in-patients-with-metastatic-soft-tissue-sarcoma-age-60-years-or-older-results-of-a-german-intergroup-study.html 2020-08-27T16:16:48.0720000Z https://www.medicinesresources.nhs.uk/diabetes-as-a-risk-factor-for-poor-early-outcomes-in-patients-hospitalized-with-covid-19.html 2020-08-27T16:17:45.7330000Z https://www.medicinesresources.nhs.uk/analysis-of-reports-of-unintended-pregnancies-associated-with-the-combined-use-of-non-enzyme-inducing-antibiotics-and-hormonal-contraceptives.html 2020-09-01T09:43:43.1580000Z https://www.medicinesresources.nhs.uk/introduction-of-a-prescribing-ward-round-to-reduce-prescribing-errors-on-a-paediatric-intensive-care-unit.html 2020-08-27T16:29:32.5670000Z https://www.medicinesresources.nhs.uk/revised-spc-efudix-fluorouracil-5-cream.html 2020-08-28T14:31:50.4050000Z https://www.medicinesresources.nhs.uk/revised-spc-insulin-lispro-insuman-infusat-comb-rapid-human-insulin-and-toujeo-insulin-glargine.html 2020-08-28T14:33:55.7940000Z https://www.medicinesresources.nhs.uk/july-bnf-bnfc-newsletter-1.html 2020-09-01T09:39:38.8110000Z https://www.medicinesresources.nhs.uk/postnatal-corticosteroids-for-transient-tachypnoea-of-the-newborn.html 2020-08-28T14:43:17.0640000Z https://www.medicinesresources.nhs.uk/topical-benzoyl-peroxide-for-acne.html 2020-08-28T14:44:31.2660000Z https://www.medicinesresources.nhs.uk/immunosuppressive-agents-for-treating-iga-nephropathy.html 2020-08-28T14:45:32.0510000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-preventing-clotting-of-extracorporeal-circuits-during-continuous-renal-replacement-therapy.html 2020-08-28T14:46:43.6430000Z https://www.medicinesresources.nhs.uk/what-is-the-optimum-systemic-treatment-for-advanced-metastatic-renal-cell-carcinoma-of-favourable-intermediate-and-poor-risk-respectively-a-systematic-review-and-network-meta-analysis.html 2020-08-28T14:47:42.1910000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-of-children-and-young-people-admitted-to-hospital-with-covid-19-in-united-kingdom-prospective-multicentre-observational-cohort-study.html 2020-08-28T14:48:46.1650000Z https://www.medicinesresources.nhs.uk/glucose-as-the-fifth-vital-sign-a-randomized-controlled-trial-of-continuous-glucose-monitoring-in-a-non-icu-hospital-setting.html 2020-08-28T14:49:54.3170000Z https://www.medicinesresources.nhs.uk/invasive-versus-non-invasive-management-of-older-patients-with-non-st-elevation-myocardial-infarction-senior-nstemi-a-cohort-study-based-on-routine-clinical-data.html 2020-08-28T14:50:58.6730000Z https://www.medicinesresources.nhs.uk/veliparib-with-carboplatin-and-paclitaxel-in-brca-mutated-advanced-breast-cancer-brocade3-a-randomised-double-blind-placebo-controlled-phase-3-trial.html 2020-08-28T14:53:15.1130000Z https://www.medicinesresources.nhs.uk/pathophysiology-of-covid-19-associated-acute-respiratory-distress-syndrome-a-multicentre-prospective-observational-study.html 2020-08-28T14:55:15.6230000Z https://www.medicinesresources.nhs.uk/drive-through-testing-for-sars-cov-2-in-symptomatic-health-and-social-care-workers-and-household-members-an-observational-cohort-study.html 2020-08-28T14:56:31.7530000Z https://www.medicinesresources.nhs.uk/dtb-editorial-making-medicines-safer.html 2020-08-28T15:03:27.6020000Z https://www.medicinesresources.nhs.uk/personal-protective-equipment-ppe-care-workers-delivering-homecare-during-the-covid-19-response.html 2020-08-28T15:05:03.2780000Z https://www.medicinesresources.nhs.uk/gastric-cancer.html 2020-08-28T15:06:14.5110000Z https://www.medicinesresources.nhs.uk/pembrolizumab-with-axitinib-for-untreated-advanced-renal-cell-carcinoma-final-appraisal-document.html 2020-08-28T15:07:39.4800000Z https://www.medicinesresources.nhs.uk/new-volume-related-pqs-payment-structure-introduced.html 2020-08-28T15:08:48.2180000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-311-august-2020.html 2020-09-01T09:39:50.8100000Z https://www.medicinesresources.nhs.uk/faltering-growth-quality-standard-qs-197.html 2020-09-01T09:42:00.2590000Z https://www.medicinesresources.nhs.uk/community-pharmacies-promoting-health-and-wellbeing-quality-standard-qs-196.html 2020-09-01T09:39:24.7320000Z https://www.medicinesresources.nhs.uk/new-measures-to-support-development-of-safe-covid-19-vaccines-for-uk.html 2020-08-28T15:16:08.3320000Z https://www.medicinesresources.nhs.uk/transarterial-chemo-embolisation-versus-no-intervention-or-placebo-for-liver-metastases.html 2020-08-28T15:18:00.1360000Z https://www.medicinesresources.nhs.uk/self-administered-versus-provider-administered-medical-abortion.html 2020-08-28T15:19:35.9240000Z https://www.medicinesresources.nhs.uk/new-product-dotagraf-gadoteric-acid-0-5-mmol-ml-solution-for-injection-1.html 2020-09-01T15:01:21.4940000Z https://www.medicinesresources.nhs.uk/revised-spcs-tivicay-dolutegravir-film-coated-tablets-all-strengths.html 2020-09-01T15:02:29.9820000Z https://www.medicinesresources.nhs.uk/revised-spc-epidyolex-cannabidiol-100-mg-ml-oral-solution.html 2020-09-01T15:03:48.5840000Z https://www.medicinesresources.nhs.uk/national-patient-safety-alert-foreign-body-aspiration-during-intubation-advanced-airway-management-or-ventilation.html 2020-09-07T08:47:52.9430000Z https://www.medicinesresources.nhs.uk/sglt2-inhibitors-in-patients-with-heart-failure-with-reduced-ejection-fraction-a-meta-analysis-of-the-emperor-reduced-and-dapa-hf-trials.html 2020-09-01T15:05:36.6670000Z https://www.medicinesresources.nhs.uk/ovarian-suppression-for-adjuvant-treatment-of-hormone-receptor-positive-early-breast-cancer.html 2020-09-01T17:20:31.2870000Z https://www.medicinesresources.nhs.uk/sclerotherapy-versus-sham-or-no-intervention-for-primary-prophylaxis-of-oesophageal-variceal-bleeding-in-children-with-chronic-liver-disease-or-portal-vein-thrombosis.html 2020-09-01T15:08:41.5320000Z https://www.medicinesresources.nhs.uk/drugs-for-preventing-lung-cancer-in-healthy-people.html 2020-09-01T15:09:50.9790000Z https://www.medicinesresources.nhs.uk/oxcarbazepine-add-on-for-drug-resistant-focal-epilepsy.html 2020-09-01T15:11:21.2840000Z https://www.medicinesresources.nhs.uk/service-specification-community-pharmacy-hepatitis-c-antibody-testing-service-advanced-service.html 2020-09-07T08:52:44.0610000Z https://www.medicinesresources.nhs.uk/durvalumab-imfinzi-approved-in-eu-for-the-first-line-treatment-of-adults-with-extensive-stage-small-cell-lung-cancer-es-sclc.html 2020-09-01T15:19:51.1470000Z https://www.medicinesresources.nhs.uk/nihr-alert-anti-inflammatory-drugs-do-not-lift-depression-in-bipolar-disorder.html 2020-09-01T17:14:32.6940000Z https://www.medicinesresources.nhs.uk/soups-and-shakes-diet-to-be-provided-on-nhs-to-5000-more-patients.html 2020-09-01T17:25:09.8500000Z https://www.medicinesresources.nhs.uk/initiation-discontinuation-and-restarting-hiv-pre-exposure-prophylaxis-ongoing-implementation-strategies.html 2020-09-01T17:25:56.4680000Z https://www.medicinesresources.nhs.uk/outpatient-management-of-heart-valve-disease-following-the-covid-19-pandemic-implications-for-present-and-future-care.html 2020-09-01T15:24:15.3170000Z https://www.medicinesresources.nhs.uk/generation-covid-19-building-the-case-to-protect-young-peoples-future-health.html 2020-09-01T17:14:48.6400000Z https://www.medicinesresources.nhs.uk/fda-approves-automated-insulin-delivery-and-monitoring-system-for-use-in-children-aged-2-to-6-with-type-1-diabetes.html 2020-09-01T15:27:04.5100000Z https://www.medicinesresources.nhs.uk/2020-esc-guidelines-for-the-management-of-acute-coronary-syndromes-in-patients-presenting-without-persistent-st-segment-elevation.html 2020-09-01T17:28:05.2570000Z https://www.medicinesresources.nhs.uk/2020-esc-guidelines-on-sports-cardiology-and-exercise-in-patients-with-cardiovascular-disease-the-task-force-on-sports-cardiology-and-exercise-in-patients-with-cardiovascular-disease-of-the-european-society-of-cardiology-esc.html 2020-09-01T17:15:04.1990000Z https://www.medicinesresources.nhs.uk/2020-esc-guidelines-for-the-diagnosis-and-management-of-atrial-fibrillation-developed-in-collaboration-with-the-european-association-of-cardio-thoracic-surgery-eacts.html 2020-09-01T15:32:07.7300000Z https://www.medicinesresources.nhs.uk/2020-esc-guidelines-for-the-management-of-adult-congenital-heart-disease-the-task-force-for-the-management-of-adult-congenital-heart-disease-of-the-european-society-of-cardiology-esc.html 2020-09-01T17:30:29.0290000Z https://www.medicinesresources.nhs.uk/dtb-select-lithium-in-pregnancy.html 2020-09-07T08:57:16.4050000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-gl-pharma-gmbh-oxylan-40mg-prolonged-release-tablets-el-20-a-41.html 2020-09-07T09:01:35.0800000Z https://www.medicinesresources.nhs.uk/hepatitis-c-virus.html 2020-09-01T15:38:12.4380000Z https://www.medicinesresources.nhs.uk/sanofi-report-sarilumab-fails-as-possible-covid-19-treatment.html 2020-09-01T17:32:56.9580000Z https://www.medicinesresources.nhs.uk/positive-phase-ii-clinical-data-for-vupanorsen-in-patients-with-hypertriglyceridemia-type-2-diabetes-and-non-alcoholic-fatty-liver-disease-presented-at-conference.html 2020-09-01T15:40:56.3780000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-of-new-drug-application-for-melflufen-melphalan-flufenamide-as-treatment-of-patients-with-triple-class-refractory-multiple-myeloma.html 2020-09-01T17:34:58.8000000Z https://www.medicinesresources.nhs.uk/global-allergy-and-airways-patient-platform-gaapp-and-astrazeneca-launch-break-over-reliance-campaign-to-help-asthma-patients-break-over-reliance-on-their-saba-blue-reliever-inhaler-to-prevent-asthma-attacks.html 2020-09-01T15:43:14.9150000Z https://www.medicinesresources.nhs.uk/prasugrel-based-de-escalation-of-dual-antiplatelet-therapy-after-percutaneous-coronary-intervention-in-patients-with-acute-coronary-syndrome-host-reduce-polytech-acs-an-open-label-multicentre-non-inferiority-randomised-trial.html 2020-09-01T16:07:40.0910000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-trimetazidine-after-percutaneous-coronary-intervention-atpci-a-randomised-double-blind-placebo-controlled-trial.html 2020-09-01T16:08:31.0400000Z https://www.medicinesresources.nhs.uk/mavacamten-for-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy-explorer-hcm-a-randomised-double-blind-placebo-controlled-phase-3-trial.html 2020-09-01T17:38:04.8250000Z https://www.medicinesresources.nhs.uk/tocilizumab-in-systemic-sclerosis-a-randomised-double-blind-placebo-controlled-phase-3-trial.html 2020-09-02T08:53:03.6120000Z https://www.medicinesresources.nhs.uk/carfilzomib-or-bortezomib-in-combination-with-lenalidomide-and-dexamethasone-for-patients-with-newly-diagnosed-multiple-myeloma-without-intention-for-immediate-autologous-stem-cell-transplantation-endurance-a-multicentre-open-label-phase-3-randomised-controlled-trial.html 2020-09-01T16:13:00.4920000Z https://www.medicinesresources.nhs.uk/colchicine-in-patients-with-chronic-coronary-disease.html 2020-09-01T16:14:00.1770000Z https://www.medicinesresources.nhs.uk/low-dose-edoxaban-in-very-elderly-patients-with-atrial-fibrillation.html 2020-09-01T16:15:09.2990000Z https://www.medicinesresources.nhs.uk/early-rhythm-control-therapy-in-patients-with-atrial-fibrillation.html 2020-09-01T17:12:34.6650000Z https://www.medicinesresources.nhs.uk/evolocumab-in-pediatric-heterozygous-familial-hypercholesterolemia.html 2020-09-01T17:42:25.3620000Z https://www.medicinesresources.nhs.uk/aspirin-with-or-without-clopidogrel-after-transcatheter-aortic-valve-implantation.html 2020-09-01T16:19:03.8530000Z https://www.medicinesresources.nhs.uk/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure.html 2020-09-01T17:47:58.7340000Z https://www.medicinesresources.nhs.uk/the-effect-of-adding-ticagrelor-to-standard-aspirin-on-saphenous-vein-graft-patency-in-patients-undergoing-coronary-artery-bypass-grafting-popular-cabg-a-randomized-double-blind-placebo-controlled-trial-1.html 2020-09-01T17:07:20.2700000Z https://www.medicinesresources.nhs.uk/pulmonary-arterial-thrombosis-in-covid-19-with-fatal-outcome-results-from-a-prospective-single-center-clinicopathologic-case-series.html 2020-09-01T17:07:02.1450000Z https://www.medicinesresources.nhs.uk/replacement-of-red-and-processed-meat-with-other-food-sources-of-protein-and-the-risk-of-type-2-diabetes-in-european-populations-the-epic-interact-study.html 2020-09-01T17:08:22.0110000Z https://www.medicinesresources.nhs.uk/the-expected-30-year-benefits-of-early-versus-delayed-primary-prevention-of-cardiovascular-disease-by-lipid-lowering.html 2020-09-01T17:11:52.5110000Z https://www.medicinesresources.nhs.uk/avelumab-with-axitinib-for-untreated-advanced-renal-cell-carcinoma-guidance-ta645-1.html 2020-09-07T09:06:29.4020000Z https://www.medicinesresources.nhs.uk/immunogenicity-and-persistence-of-trivalent-measles-mumps-and-rubella-vaccines-a-systematic-review-and-meta-analysis.html 2020-09-07T09:34:23.2050000Z https://www.medicinesresources.nhs.uk/clinical-manifestations-risk-factors-and-maternal-and-perinatal-outcomes-of-coronavirus-disease-2019-in-pregnancy-living-systematic-review-and-meta-analysis.html 2020-09-02T14:25:47.3060000Z https://www.medicinesresources.nhs.uk/treatments-for-priapism-in-boys-and-men-with-sickle-cell-disease.html 2020-09-02T14:27:34.9680000Z https://www.medicinesresources.nhs.uk/antibiotic-treatment-for-burkholderia-cepacia-complex-in-people-with-cystic-fibrosis-experiencing-a-pulmonary-exacerbation.html 2020-09-02T16:38:09.6260000Z https://www.medicinesresources.nhs.uk/treatments-for-the-prevention-of-sudden-unexpected-death-in-epilepsy-sudep.html 2020-09-02T16:37:37.7300000Z https://www.medicinesresources.nhs.uk/interventions-for-preventing-silent-cerebral-infarcts-in-people-with-sickle-cell-disease.html 2020-09-02T14:31:38.0450000Z https://www.medicinesresources.nhs.uk/six-versus-12-months-adjuvant-trastuzumab-in-patients-with-her2-positive-early-breast-cancer-the-persephone-non-inferiority-rct.html 2020-09-02T14:32:58.6120000Z https://www.medicinesresources.nhs.uk/carboplatin-plus-etoposide-versus-topotecan-as-second-line-treatment-for-patients-with-sensitive-relapsed-small-cell-lung-cancer-an-open-label-multicentre-randomised-phase-3-trial.html 2020-09-02T15:49:30.0880000Z https://www.medicinesresources.nhs.uk/lisocabtagene-maraleucel-for-patients-with-relapsed-or-refractory-large-b-cell-lymphomas-transcend-nhl-001-a-multicentre-seamless-design-study.html 2020-09-02T14:36:02.4410000Z https://www.medicinesresources.nhs.uk/venetoclax-plus-obinutuzumab-versus-chlorambucil-plus-obinutuzumab-for-previously-untreated-chronic-lymphocytic-leukaemia-cll14-follow-up-results-from-a-multicentre-open-label-randomised-phase-3-trial.html 2020-09-02T14:37:35.4950000Z https://www.medicinesresources.nhs.uk/association-between-quadrivalent-human-papillomavirus-vaccination-and-selected-syndromes-with-autonomic-dysfunction-in-danish-females-population-based-self-controlled-case-series-analysis.html 2020-09-02T14:38:45.4130000Z https://www.medicinesresources.nhs.uk/maternal-influenza-a-h1n1-immunization-during-pregnancy-and-risk-for-autism-spectrum-disorder-in-offspring-a-cohort-study.html 2020-09-02T16:35:52.0370000Z https://www.medicinesresources.nhs.uk/humoral-immune-response-to-sars-cov-2-in-iceland.html 2020-09-02T15:51:04.6640000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-adjunctive-lacosamide-in-the-treatment-of-primary-generalised-tonic-clonic-seizures-a-double-blind-randomised-placebo-controlled-trial.html 2020-09-02T14:43:54.2610000Z https://www.medicinesresources.nhs.uk/comparison-between-ticagrelor-and-clopidogrel-in-elderly-patients-with-an-acute-coronary-syndrome-insights-from-the-swedeheart-registry.html 2020-09-02T15:52:25.9450000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-lenzilumab-in-covid-19-case-control-study.html 2020-09-02T14:51:42.0030000Z https://www.medicinesresources.nhs.uk/omega-3-phospholipid-fails-to-improve-triglyceride-levels-in-phase-iii-trial.html 2020-09-02T14:52:50.7650000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-new-drug-application-for-maralixibat-to-fda-for-cholestatic-pruritus-in-patients-with-alagille-syndrome.html 2020-09-02T14:54:43.3760000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-interim-results-from-long-term-study-of-efficacy-and-safety-of-ozanimod-in-relapsing-forms-of-multiple-sclerosis.html 2020-09-02T14:56:19.6520000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-data-from-gather1-phase-3-study-for-avacincaptad-pegol-in-geographic-atrophy-secondary-to-age-related-macular-degeneration.html 2020-09-02T14:57:31.9110000Z https://www.medicinesresources.nhs.uk/indications-based-prescribing-a-challenge-for-hospital-prescribers.html 2020-09-02T14:58:42.9010000Z https://www.medicinesresources.nhs.uk/class-4-fmd-drug-alert-for-information-kingsley-specials-ltd-wda-h-49276-multiple-products.html 2020-09-02T14:59:39.4270000Z https://www.medicinesresources.nhs.uk/benefits-and-risks-of-bariatric-surgery-in-adults-a-review.html 2020-09-02T15:01:01.9700000Z https://www.medicinesresources.nhs.uk/brca1-versus-brca2-and-parp-inhibitor-sensitivity-in-prostate-cancer-more-different-than-alike.html 2020-09-02T15:02:41.8580000Z https://www.medicinesresources.nhs.uk/meeting-the-needs-of-people-with-a-learning-disability-and-autistic-people.html 2020-09-02T15:04:27.2200000Z https://www.medicinesresources.nhs.uk/sofosbuvir-velpatasvir-sofosbuvir-epclusa-approved-for-use-in-paediatrics-in-the-eu-for-treatment-of-chronic-hepatitis-c-infection.html 2020-09-02T15:06:10.0750000Z https://www.medicinesresources.nhs.uk/developing-and-implementing-guidance-for-staff-delegating-clinical-tasks-to-informal-carers-and-relatives-during-the-covid-19-pandemic.html 2020-09-07T09:52:50.8830000Z https://www.medicinesresources.nhs.uk/time-to-treatment-initiation-of-colchicine-and-cardiovascular-outcomes-after-myocardial-infarction-in-the-colchicine-cardiovascular-outcomes-trial-colcot-1.html 2020-09-02T15:30:09.0790000Z https://www.medicinesresources.nhs.uk/association-of-selective-serotonin-reuptake-inhibitor-use-after-intracerebral-hemorrhage-with-hemorrhage-recurrence-and-depression-severity.html 2020-09-02T15:31:47.3850000Z https://www.medicinesresources.nhs.uk/use-of-hiv-pre-exposure-prophylaxis-among-men-who-have-sex-with-men-in-england-data-from-the-aurah2-prospective-study.html 2020-09-02T15:33:59.5160000Z https://www.medicinesresources.nhs.uk/white-rice-intake-and-incident-diabetes-a-study-of-132-373-participants-in-21-countries.html 2020-09-02T15:35:25.1450000Z https://www.medicinesresources.nhs.uk/childhood-bmi-and-fasting-glucose-and-insulin-predict-adult-type-2-diabetes-the-international-childhood-cardiovascular-cohort-i3c-consortium.html 2020-09-02T15:36:45.5140000Z https://www.medicinesresources.nhs.uk/impact-of-covid-19-on-percutaneous-coronary-intervention-for-st-elevation-myocardial-infarction.html 2020-09-02T15:38:03.6350000Z https://www.medicinesresources.nhs.uk/association-of-new-onset-atrial-fibrillation-after-noncardiac-surgery-with-subsequent-stroke-and-transient-ischemic-attack.html 2020-09-02T15:39:34.1850000Z https://www.medicinesresources.nhs.uk/medicines-use-and-safety-updates-september-2020.html 2020-09-07T09:48:04.2970000Z https://www.medicinesresources.nhs.uk/hepatitis-b-virus-persistence-and-reactivation.html 2020-09-02T15:45:06.6040000Z https://www.medicinesresources.nhs.uk/fda-to-review-licence-extension-for-elexacaftor-tezacaftor-ivacaftor-and-ivacaftor-for-additional-cftr-mutations.html 2020-09-02T15:46:38.4670000Z https://www.medicinesresources.nhs.uk/pharmacologic-approaches-to-glycemic-treatment-of-type-2-diabetes-synopsis-of-the-2020-american-diabetes-association-s-standards-of-medical-care-in-diabetes-clinical-guideline.html 2020-09-02T15:49:53.4800000Z https://www.medicinesresources.nhs.uk/colchicine-in-patients-with-acute-coronary-syndrome-the-australian-cops-randomized-clinical-trial.html 2020-09-02T15:51:00.7010000Z https://www.medicinesresources.nhs.uk/edoxaban-in-atrial-fibrillation-patients-with-percutaneous-coronary-intervention-by-acute-or-chronic-coronary-syndrome-presentation-a-pre-specified-analysis-of-the-entrust-af-pci-trial.html 2020-09-02T15:52:52.9390000Z https://www.medicinesresources.nhs.uk/effect-of-intensive-blood-pressure-lowering-on-cardiovascular-outcomes-a-systematic-review-prepared-for-the-2020-u-s-department-of-veterans-affairs-u-s-department-of-defense-guidelines.html 2020-09-02T16:14:21.5390000Z https://www.medicinesresources.nhs.uk/psychiatric-drugs-given-to-children-and-adolescents-have-been-ranked-in-order-of-safety.html 2020-09-03T13:09:21.5110000Z https://www.medicinesresources.nhs.uk/revised-spc-fampyra-fampridine-10-mg-prolonged-release-tablets.html 2020-09-03T15:06:32.1470000Z https://www.medicinesresources.nhs.uk/revised-spc-kalydeco-ivacaftor-150-mg-film-coated-tablets.html 2020-09-03T17:21:27.3170000Z https://www.medicinesresources.nhs.uk/revised-spc-tamiflu-oseltamivir-6-mg-ml-powder-for-oral-suspension.html 2020-09-03T17:23:34.7680000Z https://www.medicinesresources.nhs.uk/revised-spcs-kalydeco-ivacaftor-granules-in-sachet-all-strengths.html 2020-09-03T17:24:28.4600000Z https://www.medicinesresources.nhs.uk/revised-spc-tecentriq-atezolizumab-840-mg-concentrate-for-solution-for-infusion-1.html 2020-09-03T15:19:17.6280000Z https://www.medicinesresources.nhs.uk/revised-spcs-progynova-estradiol-valerate-1-and-2-mg-tablets.html 2020-09-03T15:20:57.7490000Z https://www.medicinesresources.nhs.uk/aspirin-and-other-non-steroidal-anti-inflammatory-drugs-for-the-prevention-of-dementia.html 2020-09-03T15:22:13.3420000Z https://www.medicinesresources.nhs.uk/normal-saline-0-9-sodium-chloride-versus-heparin-intermittent-flushing-for-the-prevention-of-occlusion-in-long-term-central-venous-catheters-in-infants-and-children.html 2020-09-03T15:23:18.7560000Z https://www.medicinesresources.nhs.uk/antiepileptic-drugs-as-prophylaxis-for-postcraniotomy-seizures.html 2020-09-03T17:29:22.9740000Z https://www.medicinesresources.nhs.uk/treating-progressive-disseminated-histoplasmosis-in-people-living-with-hiv.html 2020-09-03T15:25:35.2410000Z https://www.medicinesresources.nhs.uk/update-publication-of-an-interim-clinical-commissioning-policy-remdesivir-for-patients-hospitalised-with-covid-19-adults-and-children-aged-12-years-and-older.html 2020-09-07T10:04:55.1180000Z https://www.medicinesresources.nhs.uk/caring-for-patients-with-copd-and-covid-19-a-viewpoint-to-spark-discussion.html 2020-09-03T15:28:49.2240000Z https://www.medicinesresources.nhs.uk/new-medicines-newsletter-august-2020.html 2020-09-07T10:09:08.6390000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-august-2020.html 2020-09-07T10:09:36.3460000Z https://www.medicinesresources.nhs.uk/letter-from-phe-and-nhs-test-and-trace-to-school-and-college-leaders.html 2020-09-03T15:31:18.1000000Z https://www.medicinesresources.nhs.uk/fda-approves-onureg-oral-azacitidine-for-the-continued-treatment-of-adults-with-acute-myeloid-leukaemia-aml.html 2020-09-03T15:32:16.4600000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-health-education-england-and-royal-college-of-gps-to-provide-free-online-workshops-for-all-community-pharmacists-across-england.html 2020-09-03T15:33:22.4500000Z https://www.medicinesresources.nhs.uk/delayed-transfer-of-care-dtoc-improvement-tool.html 2020-09-03T15:34:20.8320000Z https://www.medicinesresources.nhs.uk/the-good-childhood-report-2020.html 2020-09-03T15:36:03.0050000Z https://www.medicinesresources.nhs.uk/esketamine-for-treating-treatment-resistant-depression-appraisal-consultation-document.html 2020-09-03T15:36:55.6210000Z https://www.medicinesresources.nhs.uk/safeguarding-adults-in-care-homes-draft-guideline-out-for-consultation.html 2020-09-03T17:35:30.2890000Z https://www.medicinesresources.nhs.uk/updated-covid-19-rapid-guideline-critical-care-in-adults-ng159.html 2020-09-07T10:11:05.2260000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-scientific-opinion-avelumab-in-the-treatment-of-bladder-cancer.html 2020-09-07T10:44:15.1190000Z https://www.medicinesresources.nhs.uk/optimal-management-of-acute-coronary-syndromes-in-the-era-of-covid-19.html 2020-09-03T15:40:54.1840000Z https://www.medicinesresources.nhs.uk/control-of-nitrosamine-impurities-in-human-drugs-fda-guidance-for-industry.html 2020-09-03T15:42:10.6010000Z https://www.medicinesresources.nhs.uk/distributing-vaccines-and-treatments-for-covid-19-and-flu-open-consultation.html 2020-09-07T10:39:30.8750000Z https://www.medicinesresources.nhs.uk/gbp500-million-funding-for-quick-result-covid-19-test-trials.html 2020-09-03T15:44:06.5530000Z https://www.medicinesresources.nhs.uk/corticosteroids-in-the-treatment-of-suspected-or-confirmed-covid-19.html 2020-09-07T10:14:41.7010000Z https://www.medicinesresources.nhs.uk/are-we-underestimating-seroprevalence-of-sars-cov-2.html 2020-09-03T15:46:03.0990000Z https://www.medicinesresources.nhs.uk/primary-care-networks-the-impact-of-covid-19-and-the-challenges-ahead.html 2020-09-03T15:46:56.4540000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-receives-application-for-marketing-authorisation-of-dexamethasone-taw-for-covid-19.html 2020-09-07T10:21:58.8030000Z https://www.medicinesresources.nhs.uk/sanofi-and-gsk-launch-phase-1-2-study-of-their-protein-based-covid-19-vaccine-candidate.html 2020-09-03T15:49:15.3890000Z https://www.medicinesresources.nhs.uk/failure-to-act-how-tech-giants-continue-to-defy-calls-to-rein-in-vaccine-misinformation.html 2020-09-03T15:53:20.3470000Z https://www.medicinesresources.nhs.uk/medicinova-announces-development-progress-on-intranasal-formulation-of-sars-cov-2-vaccine-for-covid-19.html 2020-09-03T15:54:17.5940000Z https://www.medicinesresources.nhs.uk/astrazeneca-az-expands-phase-iii-covid-19-vaccine-trial-of-azd1222-into-u-s.html 2020-09-03T15:55:58.9470000Z https://www.medicinesresources.nhs.uk/final-analysis-of-the-observational-giotag-study-sequential-afatinib-and-osimertinib-in-patients-with-egfr-mutation-positive-non-small-cell-lung-cancer.html 2020-09-03T15:57:02.3660000Z https://www.medicinesresources.nhs.uk/spectrum-of-fibrotic-lung-diseases.html 2020-09-03T15:57:56.3570000Z https://www.medicinesresources.nhs.uk/a-menace-to-the-public-health-contact-tracing-and-the-limits-of-persuasion.html 2020-09-03T15:58:52.2370000Z https://www.medicinesresources.nhs.uk/j-and-j-abandons-influenza-a-treatment-programme-for-pimodivir-after-interim-analysis.html 2020-09-03T15:59:48.5010000Z https://www.medicinesresources.nhs.uk/sexually-transmitted-infections-and-screening-for-chlamydia-in-england-2019.html 2020-09-03T17:49:31.2450000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-new-drug-application-for-oral-paclitaxel-and-encequidar-in-metastatic-breast-cancer.html 2020-09-03T16:04:34.2970000Z https://www.medicinesresources.nhs.uk/association-between-administration-of-systemic-corticosteroids-and-mortality-among-critically-ill-patients-with-covid-19-a-meta-analysis.html 2020-09-07T10:27:30.4450000Z https://www.medicinesresources.nhs.uk/effect-of-hydrocortisone-on-mortality-and-organ-support-in-patients-with-severe-covid-19-the-remap-cap-covid-19-corticosteroid-domain-randomized-clinical-trial.html 2020-09-07T10:30:36.4280000Z https://www.medicinesresources.nhs.uk/effect-of-dexamethasone-on-days-alive-and-ventilator-free-in-patients-with-moderate-or-severe-acute-respiratory-distress-syndrome-and-covid-19-the-codex-randomized-clinical-trial.html 2020-09-07T10:34:12.6600000Z https://www.medicinesresources.nhs.uk/effect-of-hydrocortisone-on-21-day-mortality-or-respiratory-support-among-critically-ill-patients-with-covid-19-a-randomized-clinical-trial.html 2020-09-07T10:36:18.1720000Z https://www.medicinesresources.nhs.uk/trial-of-sodium-phenylbutyrate-taurursodiol-for-amyotrophic-lateral-sclerosis.html 2020-09-03T16:33:43.4000000Z https://www.medicinesresources.nhs.uk/five-year-analysis-of-adjuvant-dabrafenib-plus-trametinib-in-stage-iii-melanoma.html 2020-09-03T16:34:38.6350000Z https://www.medicinesresources.nhs.uk/phase-1-2-trial-of-a-sars-cov-2-recombinant-spike-protein-nanoparticle-vaccine.html 2020-09-03T16:35:41.1560000Z https://www.medicinesresources.nhs.uk/debio-1143-and-high-dose-cisplatin-chemoradiotherapy-in-high-risk-locoregionally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-a-double-blind-multicentre-randomised-phase-2-study.html 2020-09-03T18:00:10.1410000Z https://www.medicinesresources.nhs.uk/seroprevalence-of-sars-cov-2-antibodies-in-children-a-prospective-multicentre-cohort-study.html 2020-09-03T18:01:32.6470000Z https://www.medicinesresources.nhs.uk/personal-use-of-permanent-hair-dyes-and-cancer-risk-and-mortality-in-us-women-prospective-cohort-study.html 2020-09-03T16:38:39.6470000Z https://www.medicinesresources.nhs.uk/effect-of-dapagliflozin-in-dapa-hf-according-to-background-glucose-lowering-therapy.html 2020-09-03T17:17:14.3100000Z https://www.medicinesresources.nhs.uk/point-of-care-serological-assays-for-delayed-sars-cov-2-case-identification-among-health-care-workers-in-the-uk-a-prospective-multicentre-cohort-study.html 2020-09-03T17:18:42.9230000Z https://www.medicinesresources.nhs.uk/association-between-drug-use-and-subsequent-diagnosis-of-lupus-erythematosus.html 2020-09-03T17:19:49.7400000Z https://www.medicinesresources.nhs.uk/association-of-selective-serotonin-reuptake-inhibitors-with-the-risk-of-type-2-diabetes-in-children-and-adolescents.html 2020-09-03T17:20:51.7750000Z https://www.medicinesresources.nhs.uk/revised-spcs-lyumjev-insulin-lispro-formulations.html 2020-09-04T15:03:11.4930000Z https://www.medicinesresources.nhs.uk/the-incidence-and-risk-of-cutaneous-toxicities-associated-with-dabrafenib-in-melanoma-patients-a-systematic-review-and-meta-analysis.html 2020-09-04T15:04:23.5020000Z https://www.medicinesresources.nhs.uk/vitamin-c-supplementation-for-prevention-and-treatment-of-pneumonia.html 2020-09-04T15:06:14.0390000Z https://www.medicinesresources.nhs.uk/organised-inpatient-stroke-unit-care-for-stroke-network-meta-analysis.html 2020-09-04T15:07:26.6390000Z https://www.medicinesresources.nhs.uk/antidepressants-for-smoking-cessation.html 2020-09-04T15:09:35.9110000Z https://www.medicinesresources.nhs.uk/antibiotic-prophylaxis-for-prevention-of-postoperative-wound-infection-in-adults-undergoing-open-elective-inguinal-or-femoral-hernia-repair.html 2020-09-04T15:11:45.2550000Z https://www.medicinesresources.nhs.uk/nihr-alert-male-prisoners-develop-unhealthy-hearts-at-younger-ages-than-people-on-the-outside.html 2020-09-04T15:13:25.5810000Z https://www.medicinesresources.nhs.uk/once-daily-subcutaneous-vosoritide-therapy-in-children-with-achondroplasia-a-randomised-double-blind-phase-3-placebo-controlled-multicentre-trial.html 2020-09-04T16:06:11.0510000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-pembrolizumab-or-pembrolizumab-plus-chemotherapy-vs-chemotherapy-alone-for-patients-with-first-line-advanced-gastric-cancer-the-keynote-062-phase-3-randomized-clinical-trial.html 2020-09-04T15:17:54.8330000Z https://www.medicinesresources.nhs.uk/effect-of-eribulin-with-or-without-pembrolizumab-on-progression-free-survival-for-patients-with-hormone-receptor-positive-erbb2-negative-metastatic-breast-cancer-a-randomized-clinical-trial.html 2020-09-04T15:19:09.4250000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-an-rad26-and-rad5-vector-based-heterologous-prime-boost-covid-19-vaccine-in-two-formulations-two-open-non-randomised-phase-1-2-studies-from-russia.html 2020-09-04T15:21:13.2270000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-a-novel-hexavalent-group-b-streptococcus-conjugate-vaccine-in-healthy-non-pregnant-adults-a-phase-1-2-randomised-placebo-controlled-observer-blinded-dose-escalation-trial.html 2020-09-04T15:22:50.0730000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-vadadustat-in-anaemia-due-to-chronic-kidney-disease-meets-primary-efficacy-endpoint-but-fails-safety-endpoint.html 2020-09-04T15:25:19.6490000Z https://www.medicinesresources.nhs.uk/the-trouble-with-antidepressants-why-the-evidence-overplays-benefits-and-underplays-risks-an-essay-by-john-b-warren.html 2020-09-04T15:26:23.6210000Z https://www.medicinesresources.nhs.uk/covid-19-the-problems-with-case-counting.html 2020-09-04T15:27:24.8350000Z https://www.medicinesresources.nhs.uk/suicide-rates-continue-to-rise-in-england-and-wales.html 2020-09-04T15:28:22.8050000Z https://www.medicinesresources.nhs.uk/new-lighthouse-lab-to-boost-nhs-test-and-trace-capacity.html 2020-09-04T15:29:34.1160000Z https://www.medicinesresources.nhs.uk/acute-pancreatitis.html 2020-09-04T15:39:11.8930000Z https://www.medicinesresources.nhs.uk/encorafenib-in-dual-or-triple-therapy-for-previously-treated-braf-v600e-mutation-positive-metastatic-colorectal-cancer.html 2020-09-04T15:40:29.5010000Z https://www.medicinesresources.nhs.uk/only-verbal-consent-now-required-for-various-community-pharmacy-services.html 2020-09-04T15:41:17.6270000Z https://www.medicinesresources.nhs.uk/impacts-of-current-funding-policy-and-economic-environment-on-independent-pharmacy-in-england.html 2020-09-04T15:42:23.1960000Z https://www.medicinesresources.nhs.uk/prospective-active-national-surveillance-of-preschools-and-primary-schools-for-sars-cov-2-infection-and-transmission-in-england-june-2020.html 2020-09-04T16:11:58.3820000Z https://www.medicinesresources.nhs.uk/important-information-about-supplies-of-diphtheria-anti-toxin.html 2020-09-07T11:13:59.7770000Z https://www.medicinesresources.nhs.uk/medication-related-experiences-of-patients-with-polypharmacy-a-systematic-review-of-qualitative-studies.html 2020-09-07T14:16:37.2280000Z https://www.medicinesresources.nhs.uk/role-of-beta-blockers-following-percutaneous-coronary-intervention-for-acute-coronary-syndrome.html 2020-09-07T14:17:52.1140000Z https://www.medicinesresources.nhs.uk/sex-differences-in-prevalence-treatment-and-control-of-cardiovascular-risk-factors-in-england.html 2020-09-07T15:10:30.3460000Z https://www.medicinesresources.nhs.uk/effect-of-multilevel-upper-airway-surgery-vs-medical-management-on-the-apnea-hypopnea-index-and-patient-reported-daytime-sleepiness-among-patients-with-moderate-or-severe-obstructive-sleep-apnea.html 2020-09-07T15:12:31.6560000Z https://www.medicinesresources.nhs.uk/azithromycin-in-addition-to-standard-of-care-versus-standard-of-care-alone-in-the-treatment-of-patients-admitted-to-the-hospital-with-severe-covid-19-in-brazil-coalition-ii-a-randomised-clinical-trial.html 2020-09-07T14:29:02.1210000Z https://www.medicinesresources.nhs.uk/preoperative-intravenous-iron-to-treat-anaemia-before-major-abdominal-surgery-preventt-a-randomised-double-blind-controlled-trial.html 2020-09-14T09:41:03.1380000Z https://www.medicinesresources.nhs.uk/inhaled-molgramostim-therapy-in-autoimmune-pulmonary-alveolar-proteinosis.html 2020-09-07T14:33:30.5300000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-pralsetinib-gavreto-for-the-teatment-of-adults-with-metastatic-ret-fusion-positive-non-small-cell-lung-cancer.html 2020-09-07T15:14:53.7470000Z https://www.medicinesresources.nhs.uk/fda-grants-orphan-drug-designation-for-prosetin-for-treatment-of-amyotrophic-lateral-sclerosis.html 2020-09-07T14:36:40.7460000Z https://www.medicinesresources.nhs.uk/a-living-who-guideline-on-drugs-for-covid-19.html 2020-09-14T09:47:30.1900000Z https://www.medicinesresources.nhs.uk/attitudes-toward-a-potential-sars-cov-2-vaccine-a-survey-of-u-s-adults.html 2020-09-07T14:40:01.2270000Z https://www.medicinesresources.nhs.uk/bmj-editorial-uks-record-on-pandemic-deaths.html 2020-09-07T14:41:29.1250000Z https://www.medicinesresources.nhs.uk/government-delivers-250-000-clear-face-masks-to-support-people-with-hearing-loss.html 2020-09-07T14:43:53.8640000Z https://www.medicinesresources.nhs.uk/prac-recommends-revoking-marketing-authorisation-of-ulipristal-acetate-for-uterine-fibroids.html 2020-09-14T09:53:04.0020000Z https://www.medicinesresources.nhs.uk/class-3-medicines-recall-accord-healthcare-limited-amlodipine-10mg-tablets.html 2020-09-07T14:49:27.7930000Z https://www.medicinesresources.nhs.uk/directed-enhanced-service-specification-seasonal-influenza-and-pneumococcal-polysaccharide-vaccination-programme-2020-21.html 2020-09-07T14:51:22.5960000Z https://www.medicinesresources.nhs.uk/the-whole-society-approach-making-a-giant-leap-on-childhood-health.html 2020-09-07T14:53:25.5590000Z https://www.medicinesresources.nhs.uk/weight-management-services-during-covid-19-phase-1-insights.html 2020-09-07T14:55:33.2170000Z https://www.medicinesresources.nhs.uk/a-risk-stratified-approach-to-planned-cancer-care-during-the-covid-19-pandemic.html 2020-09-07T15:01:18.5800000Z https://www.medicinesresources.nhs.uk/new-product-nustendi-bempedoic-acid-ezetimibe-180mg-10mg-film-coated-tablets.html 2020-09-07T15:03:05.0930000Z https://www.medicinesresources.nhs.uk/nilemdo-bempedoic-acid-80mg-film-coated-tablets.html 2020-09-07T15:19:51.7560000Z https://www.medicinesresources.nhs.uk/clonazepam-add-on-therapy-for-drug-resistant-epilepsy.html 2020-09-07T15:06:46.9120000Z https://www.medicinesresources.nhs.uk/vaccines-for-measles-mumps-rubella-and-varicella-in-children.html 2020-09-07T15:08:13.0070000Z https://www.medicinesresources.nhs.uk/vitamin-d-calcium-or-a-combination-of-vitamin-d-and-calcium-for-the-treatment-of-nutritional-rickets-in-children.html 2020-09-07T15:10:01.4090000Z https://www.medicinesresources.nhs.uk/interventions-for-fatigue-in-inflammatory-bowel-disease.html 2020-09-07T15:12:18.1280000Z https://www.medicinesresources.nhs.uk/how-do-amlodipine-and-felodipine-compare-for-the-treatment-of-hypertension-or-prophylaxis-of-stable-angina.html 2020-09-14T09:56:29.4360000Z https://www.medicinesresources.nhs.uk/revised-spcs-latuda-lurasidone-hydrochloride-film-coated-tablets-all-strengths.html 2020-09-08T16:08:03.9370000Z https://www.medicinesresources.nhs.uk/interventions-for-the-management-of-malignant-pleural-effusions-a-network-meta-analysis.html 2020-09-08T16:13:24.4730000Z https://www.medicinesresources.nhs.uk/pharmacological-treatment-for-familial-amyloid-polyneuropathy.html 2020-09-08T16:14:25.6620000Z https://www.medicinesresources.nhs.uk/low-molecular-weight-heparin-for-prevention-of-microvascular-occlusion-in-digital-replantation.html 2020-09-08T16:15:16.8230000Z https://www.medicinesresources.nhs.uk/non-corticosteroid-immunosuppressive-medications-for-steroid-sensitive-nephrotic-syndrome-in-children.html 2020-09-08T16:15:48.0170000Z https://www.medicinesresources.nhs.uk/delivering-a-paediatric-elective-surgery-service-during-the-covid-19-pandemic.html 2020-09-08T14:57:11.2270000Z https://www.medicinesresources.nhs.uk/high-dose-enerzair-breezhaler-indacaterol-acetate-glycopyrronium-bromide-and-mometasone-furoate-further-cuts-asthma-exacerbations.html 2020-09-08T16:17:36.3940000Z https://www.medicinesresources.nhs.uk/european-union-expands-imbruvica-ibrutinib-indications-to-include-untreated-chronic-lymphocytic-leukaemia-patients.html 2020-09-08T15:00:49.3090000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-warns-of-huge-extra-cost-to-nhs-after-withdrawal-of-bipolar-drug-priadel-lithium-carbonate-used-as-a-first-line-treatment-for-bipolar-disorder.html 2020-09-14T08:35:05.4410000Z https://www.medicinesresources.nhs.uk/lenalidomide-maintenance-treatment-after-an-autologous-stem-cell-transplant-for-newly-diagnosed-multiple-myeloma-appraisal-consultation-document.html 2020-09-08T16:25:37.5310000Z https://www.medicinesresources.nhs.uk/pharmaceutical-services-negotiating-committee-psnc-pharmacy-advice-audit-shows-pharmacies-in-england-carry-out-one-million-consultations-a-week.html 2020-09-08T16:26:05.3140000Z https://www.medicinesresources.nhs.uk/new-voluntary-calorie-guidelines-aim-to-help-industry-tackle-obesity.html 2020-09-08T16:26:31.6780000Z https://www.medicinesresources.nhs.uk/phase-iv-replace-study-met-its-primary-endpoint-in-pulmonary-arterial-hypertension-patients-who-transitioned-to-riociguat-after-insufficient-response-to-pde5-inhibitors.html 2020-09-08T16:27:34.5580000Z https://www.medicinesresources.nhs.uk/caplacizumab-cablivi-r-accepted-for-use-within-nhs-scotland-1.html 2020-09-08T15:49:39.2730000Z https://www.medicinesresources.nhs.uk/andexanet-alfa-ondexxya-r-accepted-for-use-within-nhs-scotland-on-interim-basis-subject-to-ongoing-evaluation-and-future-reassessment.html 2020-09-08T15:50:50.9720000Z https://www.medicinesresources.nhs.uk/fluocinolone-acetonide-iluvien-r-accepted-for-use-within-nhs-scotland.html 2020-09-08T15:51:40.8370000Z https://www.medicinesresources.nhs.uk/esketamine-spravato-r-in-combination-with-selective-serotonin-reuptake-inhibitor-or-serotonin-norepinephrine-reuptake-inhibitor-accepted-for-use-within-nhs-scotland.html 2020-09-08T15:52:34.1170000Z https://www.medicinesresources.nhs.uk/pembrolizumab-keytruda-r-accepted-for-restricted-use-within-nhs-scotland.html 2020-09-08T16:31:54.5510000Z https://www.medicinesresources.nhs.uk/gilteritinib-xospata-r-accepted-for-use-within-nhs-scotland.html 2020-09-08T15:54:25.1350000Z https://www.medicinesresources.nhs.uk/semaglutide-rybelsus-r-accepted-for-restricted-use-within-nhs-scotland.html 2020-09-08T15:56:10.0340000Z https://www.medicinesresources.nhs.uk/polatuzumab-vedotin-polivy-r-accepted-for-use-within-nhs-scotland-on-interim-basis-subject-to-ongoing-evaluation-and-future-reassessment.html 2020-09-08T15:57:09.0960000Z https://www.medicinesresources.nhs.uk/ex-vivo-expanded-autologous-human-corneal-epithelial-cells-containing-stem-cells-holoclar-r-accepted-for-use-within-nhs-scotland-on-interim-basis-subject-to-ongoing-evaluation-and-future-reassessment.html 2020-09-08T15:57:58.4960000Z https://www.medicinesresources.nhs.uk/brolucizumab-beovu-r-accepted-for-use-within-nhs-scotland.html 2020-09-08T15:59:06.8250000Z https://www.medicinesresources.nhs.uk/pertuzumab-perjeta-r-accepted-for-restricted-use-within-nhs-scotland.html 2020-09-08T15:59:53.3630000Z https://www.medicinesresources.nhs.uk/sodium-zirconium-cyclosilicate-lokelma-r-accepted-for-restricted-use-within-nhs-scotland.html 2020-09-08T16:30:17.9720000Z https://www.medicinesresources.nhs.uk/cannabidiol-epidyolex-r-accepted-for-use-within-nhs-scotland-for-dravet-syndrome.html 2020-09-08T16:34:58.4830000Z https://www.medicinesresources.nhs.uk/cannabidiol-epidyolex-r-accepted-for-use-within-nhs-scotland-for-lennox-gastaut-syndrome.html 2020-09-08T16:35:20.6840000Z https://www.medicinesresources.nhs.uk/pembrolizumab-keytruda-r-accepted-for-restricted-use-within-nhs-scotland-for-metastatic-or-unresectable-recurrent-head-and-neck-squamous-cell-carcinoma.html 2020-09-08T16:35:42.4690000Z https://www.medicinesresources.nhs.uk/new-product-epclusa-sofosbuvir-200-mg-and-velpatasvir-50-mg-film-coated-tablets.html 2020-09-09T16:16:43.1480000Z https://www.medicinesresources.nhs.uk/revised-spc-dexamfetamine-sulfate-tablets.html 2020-09-09T14:57:50.8400000Z https://www.medicinesresources.nhs.uk/revised-spc-seroxat-paroxetine-tablets.html 2020-09-09T14:59:50.0210000Z https://www.medicinesresources.nhs.uk/revised-spc-prezista-darunavir-tablets.html 2020-09-09T15:01:20.2240000Z https://www.medicinesresources.nhs.uk/revised-spc-imfinzi-durvalumab-solution-for-infusion.html 2020-09-09T15:02:49.5410000Z https://www.medicinesresources.nhs.uk/new-product-vagirux-estradiol-10-micrograms-vaginal-tablets.html 2020-09-09T15:04:19.3340000Z https://www.medicinesresources.nhs.uk/revised-spc-laxido-macrogol-paediatric-plain-powder-for-oral-solution.html 2020-09-09T15:05:47.7270000Z https://www.medicinesresources.nhs.uk/revised-spc-vemlidy-tenofovir-alafenamide-film-coated-tablets.html 2020-09-09T15:07:13.0040000Z https://www.medicinesresources.nhs.uk/treatment-of-distal-deep-vein-thrombosis.html 2020-09-09T16:19:51.4400000Z https://www.medicinesresources.nhs.uk/patient-initiated-appointment-systems-for-adults-with-chronic-conditions-in-secondary-care.html 2020-09-09T16:20:13.9730000Z https://www.medicinesresources.nhs.uk/early-versus-late-parenteral-nutrition-for-critically-ill-term-and-late-preterm-infants.html 2020-09-09T16:21:16.8210000Z https://www.medicinesresources.nhs.uk/antimetabolites-as-an-adjunct-to-dacryocystorhinostomy-for-nasolacrimal-duct-obstruction.html 2020-09-09T16:21:56.0680000Z https://www.medicinesresources.nhs.uk/phase-2-trial-of-the-dpp-1-inhibitor-brensocatib-in-bronchiectasis.html 2020-09-09T15:12:40.1680000Z https://www.medicinesresources.nhs.uk/multicenter-international-society-for-immunotherapy-of-cancer-study-of-the-consensus-immunoscore-for-the-prediction-of-survival-and-response-to-chemotherapy-in-stage-iii-colon-cancer.html 2020-09-09T15:14:15.7320000Z https://www.medicinesresources.nhs.uk/outcomes-of-intensive-systolic-blood-pressure-reduction-in-patients-with-intracerebral-hemorrhage-and-excessively-high-initial-systolic-blood-pressure-post-hoc-analysis-of-a-randomized-clinical-trial.html 2020-09-09T15:16:09.2580000Z https://www.medicinesresources.nhs.uk/association-between-plant-and-animal-protein-intake-and-overall-and-cause-specific-mortality.html 2020-09-09T15:17:54.5280000Z https://www.medicinesresources.nhs.uk/the-content-and-conduct-of-gp-consultations-for-dermatology-problems-a-cross-sectional-study.html 2020-09-10T11:52:59.3410000Z https://www.medicinesresources.nhs.uk/composite-type-2-biomarker-strategy-versus-a-symptom-risk-based-algorithm-to-adjust-corticosteroid-dose-in-patients-with-severe-asthma-a-multicentre-single-blind-parallel-group-randomised-controlled-trial.html 2020-09-09T15:20:35.0990000Z https://www.medicinesresources.nhs.uk/prevalence-of-suspected-covid-19-infection-in-patients-from-ethnic-minority-populations-a-cross-sectional-study-in-primary-care.html 2020-09-10T11:51:49.7210000Z https://www.medicinesresources.nhs.uk/trends-in-generalised-anxiety-disorders-and-symptoms-in-primary-care-uk-population-based-cohort-study.html 2020-09-09T15:23:05.6030000Z https://www.medicinesresources.nhs.uk/role-of-the-hospital-pharmacist-in-an-italian-antimicrobial-stewardship-programme.html 2020-09-09T15:25:05.8250000Z https://www.medicinesresources.nhs.uk/inappropriate-empirical-antibiotic-therapy-for-bloodstream-infections-based-on-discordant-in-vitro-susceptibilities-a-retrospective-cohort-analysis-of-prevalence-predictors-and-mortality-risk-in-us-hospitals.html 2020-09-09T15:26:06.2950000Z https://www.medicinesresources.nhs.uk/gps-decisions-about-prescribing-end-of-life-anticipatory-medications-a-qualitative-study.html 2020-09-09T15:27:08.5620000Z https://www.medicinesresources.nhs.uk/covid-19-mental-health-and-wellbeing-surveillance-report.html 2020-09-09T16:26:09.0140000Z https://www.medicinesresources.nhs.uk/public-perceptions-of-health-and-social-care-in-light-of-covid-19-july-2020.html 2020-09-09T15:30:05.0790000Z https://www.medicinesresources.nhs.uk/help-to-care-mobile-app-supporting-care-workers-and-carers-to-identify-and-prevent-deterioration.html 2020-09-14T08:30:00.3980000Z https://www.medicinesresources.nhs.uk/fda-grants-orphan-drug-designation-for-belumosudil-for-systemic-sclerosis.html 2020-09-09T15:34:52.6060000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-resubmission-of-biologics-license-application-to-fda-for-plasminogen-ryplazim-for-congenital-plasminogen-deficiency.html 2020-09-09T15:36:29.7940000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-from-pivotal-phase-3-logics-study-for-use-of-levoketoconazole-for-endogenous-cushings-syndrome.html 2020-09-09T15:37:54.6400000Z https://www.medicinesresources.nhs.uk/manufacturers-report-that-odevixibat-meets-primary-endpoint-in-phase-3-trial-investigating-use-in-progressive-familial-intrahepatic-cholestasis.html 2020-09-09T15:39:06.6440000Z https://www.medicinesresources.nhs.uk/fda-grant-breakthrough-designation-therapy-status-for-plinabulin-for-chemotherapy-induced-neutropenia.html 2020-09-09T15:40:46.3960000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-marketing-authorisation-application-for-lonapegsomatropin-for-paediatric-growth-hormone-deficiency-to-the-european-medicines-agency.html 2020-09-09T15:42:03.5750000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-from-phase-3-adapt-po-trial-for-oral-tebipenem-for-complicated-urinary-tract-infection-and-acute-pyelonephritis.html 2020-09-09T15:43:27.4020000Z https://www.medicinesresources.nhs.uk/lenabasum-fails-to-meet-primary-endpoint-in-phase-iii-trial-for-systemic-sclerosis.html 2020-09-09T15:46:50.7940000Z https://www.medicinesresources.nhs.uk/positive-data-to-be-presented-at-conference-for-dupilumab-in-open-label-extension-study-in-asthma.html 2020-09-09T15:49:10.6060000Z https://www.medicinesresources.nhs.uk/second-international-guidelines-for-the-diagnosis-and-management-of-hereditary-hemorrhagic-telangiectasia.html 2020-09-09T15:50:43.8500000Z https://www.medicinesresources.nhs.uk/oxford-university-vaccine-trial-paused-after-participant-falls-ill.html 2020-09-09T16:29:44.5450000Z https://www.medicinesresources.nhs.uk/testing-for-sars-cov-2-antibodies.html 2020-09-09T15:53:06.7330000Z https://www.medicinesresources.nhs.uk/mek-inhibitors-for-the-treatment-of-low-grade-serous-ovarian-cancer-expanding-therapeutic-options-for-a-rare-ovarian-cancer-subtype.html 2020-09-09T15:54:17.9840000Z https://www.medicinesresources.nhs.uk/two-steps-forward-and-one-step-back-for-precision-in-prostate-cancer-treatment.html 2020-09-09T15:55:32.7540000Z https://www.medicinesresources.nhs.uk/childhood-obesity.html 2020-09-09T15:56:56.7080000Z https://www.medicinesresources.nhs.uk/social-prescribing.html 2020-09-09T15:58:17.5960000Z https://www.medicinesresources.nhs.uk/four-week-direct-acting-antiviral-prophylaxis-for-kidney-transplantation-from-hepatitis-c-viremic-donors-to-hepatitis-c-negative-recipients-an-open-label-nonrandomized-study.html 2020-09-09T16:02:00.7290000Z https://www.medicinesresources.nhs.uk/association-of-fluoroquinolones-with-the-risk-of-aortic-aneurysm-or-aortic-dissection.html 2020-09-09T16:33:03.9950000Z https://www.medicinesresources.nhs.uk/association-of-infections-and-use-of-fluoroquinolones-with-the-risk-of-aortic-aneurysm-or-aortic-dissection.html 2020-09-09T16:33:50.9350000Z https://www.medicinesresources.nhs.uk/effects-of-dpp-4-inhibitor-linagliptin-versus-sulfonylurea-glimepiride-as-add-on-to-metformin-on-renal-physiology-in-overweight-patients-with-type-2-diabetes-renalis-a-randomized-double-blind-trial.html 2020-09-09T16:09:58.0330000Z https://www.medicinesresources.nhs.uk/sofosbuvir-and-daclatasvir-compared-with-standard-of-care-in-the-treatment-of-patients-admitted-to-hospital-with-moderate-or-severe-coronavirus-infection-covid-19-a-randomized-controlled-trial.html 2020-09-09T16:12:09.2620000Z https://www.medicinesresources.nhs.uk/effect-of-out-of-hospital-tranexamic-acid-vs-placebo-on-6-month-functional-neurologic-outcomes-in-patients-with-moderate-or-severe-traumatic-brain-injury.html 2020-09-09T16:15:58.1110000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-upadacitinib-monotherapy-in-methotrexate-naive-patients-with-moderately-to-severely-active-rheumatoid-arthritis-select-early-a-multicenter-multi-country-randomized-double-blind-active-comparator-controlled-trial.html 2020-09-09T16:35:54.2510000Z https://www.medicinesresources.nhs.uk/revised-spc-oxynorm-oxycodone-10-and-50-mg-ml-solution-for-injection-or-infusion.html 2020-09-10T15:55:04.4230000Z https://www.medicinesresources.nhs.uk/revised-spc-inegy-tablets-ezetimibe-simvastatin-all-strengths.html 2020-09-10T17:00:14.9260000Z https://www.medicinesresources.nhs.uk/revised-spc-esperoct-turoctocog-alfa-pegol-powder-and-solvent-for-solution-for-injection-all-strengths.html 2020-09-10T15:57:06.8190000Z https://www.medicinesresources.nhs.uk/revised-spc-maxidex-dexamethasone.html 2020-09-10T15:58:04.9580000Z https://www.medicinesresources.nhs.uk/revised-spc-lucentis-ranibizumab-10-mg-ml-solution-for-injection.html 2020-09-10T15:59:09.0480000Z https://www.medicinesresources.nhs.uk/prevalence-incidence-and-years-lived-with-disability-due-to-gout-and-its-attributable-risk-factors-for-195-countries-and-territories-1990-2017-a-systematic-analysis-of-the-global-burden-of-disease-study-2017.html 2020-09-10T16:00:11.8080000Z https://www.medicinesresources.nhs.uk/association-between-high-blood-pressure-and-long-term-cardiovascular-events-in-young-adults-systematic-review-and-meta-analysis.html 2020-09-10T16:01:05.7190000Z https://www.medicinesresources.nhs.uk/non-steroidal-anti-inflammatory-drugs-for-acute-low-back-pain-cochrane-systematic-review-intervention-version-published-see-what-s-new.html 2020-09-11T11:40:21.2090000Z https://www.medicinesresources.nhs.uk/personal-protective-equipment-for-preventing-highly-infectious-diseases-due-to-exposure-to-contaminated-body-fluids-in-healthcare-staff.html 2020-09-10T16:03:25.7240000Z https://www.medicinesresources.nhs.uk/omega-3-fatty-acid-supplementation-for-cystic-fibrosis.html 2020-09-10T17:23:21.1440000Z https://www.medicinesresources.nhs.uk/epidural-corticosteroid-injections-for-lumbosacral-radicular-pain.html 2020-09-10T17:24:42.0440000Z https://www.medicinesresources.nhs.uk/nihr-alert-most-patients-welcome-advice-from-gps-on-changing-their-behaviour-to-improve-health.html 2020-09-10T16:06:15.4030000Z https://www.medicinesresources.nhs.uk/public-health-england-launches-new-every-mind-matters-campaign.html 2020-09-10T16:07:34.0210000Z https://www.medicinesresources.nhs.uk/hospital-accident-and-emergency-activity-2019-20.html 2020-09-10T16:08:32.3350000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-zopiclone-tablets-ratiopharm-uk-limited-and-generics-uk-limited-t-a-mylan-el-20-a-44.html 2020-09-10T16:09:27.8070000Z https://www.medicinesresources.nhs.uk/omeprazole-induced-subacute-cutaneous-lupus-erythematosus.html 2020-09-10T17:29:08.7910000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-testing-guidance-for-employers.html 2020-09-10T17:28:31.7090000Z https://www.medicinesresources.nhs.uk/new-public-information-campaign-hands-face-space-launched-to-prevent-spread-of-coronavirus-indoors-this-winter.html 2020-09-10T16:12:27.8570000Z https://www.medicinesresources.nhs.uk/withdrawal-of-guidance-considerations-for-personal-protective-equipment-in-the-context-of-acute-supply-shortages-for-coronavirus-disease-2019-covid-19-pandemic.html 2020-09-14T06:16:36.3040000Z https://www.medicinesresources.nhs.uk/underrepresentation-of-the-elderly-in-clinical-trials-time-for-action.html 2020-09-10T16:14:10.0170000Z https://www.medicinesresources.nhs.uk/do-proms-improve-outcomes-in-patients-with-depression-in-primary-care.html 2020-09-10T16:15:05.4640000Z https://www.medicinesresources.nhs.uk/coroner-finds-hospital-errors-including-use-of-glucose-instead-of-saline-infusion-led-to-patients-death.html 2020-09-10T16:15:51.8490000Z https://www.medicinesresources.nhs.uk/pharma-companies-promise-not-to-bow-to-political-pressure-to-rush-production-of-covid-19-vaccine.html 2020-09-10T16:16:47.6200000Z https://www.medicinesresources.nhs.uk/gilead-first-how-a-monopoly-on-remdesivir-led-to-rationing.html 2020-09-10T16:19:03.6430000Z https://www.medicinesresources.nhs.uk/should-countries-aim-for-elimination-in-the-covid-19-pandemic-head-to-head.html 2020-09-10T16:19:50.4760000Z https://www.medicinesresources.nhs.uk/use-of-normal-risk-to-improve-understanding-of-dangers-of-covid-19.html 2020-09-10T16:20:53.4000000Z https://www.medicinesresources.nhs.uk/eu-review-extended-for-marketing-authorisation-application-for-haemophilia-a-gene-therapy-valrox-valoctocogene-roxaparvove.html 2020-09-10T16:21:45.8770000Z https://www.medicinesresources.nhs.uk/benralizumab-meets-both-co-primary-endpoints-of-reduced-nasal-polyp-size-and-blockage-in-ostro-phase-iii-trial-in-patients-with-chronic-rhinosinusitis-with-nasal-polyps.html 2020-09-10T16:22:46.6710000Z https://www.medicinesresources.nhs.uk/fda-approves-trelegy-ellipta-fluticasone-furoate-umeclidinium-vilanterol-ff-umec-vi-for-treatment-of-asthma-in-adults.html 2020-09-10T17:37:07.0580000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-to-potentially-supply-eu-with-200-million-doses-of-mrna-based-vaccine-candidate-against-sars-cov-2.html 2020-09-10T16:24:42.7900000Z https://www.medicinesresources.nhs.uk/company-releases-positive-topline-results-from-phase-iii-trial-assessing-filsuvez-gel-as-a-treatment-for-dystrophic-and-junctional-epidermolysis-bullosa-eb.html 2020-09-10T17:38:15.6130000Z https://www.medicinesresources.nhs.uk/new-data-presented-at-conference-show-satralizumab-enspryng-reduces-risk-and-severity-of-relapse-in-neuromyelitis-optica-spectrum-disorder-nmosd.html 2020-09-10T16:26:49.2230000Z https://www.medicinesresources.nhs.uk/pharmacologic-treatment-of-attention-deficit-hyperactivity-disorder.html 2020-09-10T16:27:47.2240000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-once-daily-single-inhaler-triple-therapy-ff-umec-vi-versus-ff-vi-in-patients-with-inadequately-controlled-asthma-captain-a-double-blind-randomised-phase-3a-trial.html 2020-09-10T17:40:58.7950000Z https://www.medicinesresources.nhs.uk/nonmetastatic-castration-resistant-prostate-cancer-and-survival-with-darolutamide.html 2020-09-10T17:42:56.2460000Z https://www.medicinesresources.nhs.uk/eflornithine-plus-sulindac-for-prevention-of-progression-in-familial-adenomatous-polyposis.html 2020-09-10T17:42:15.9860000Z https://www.medicinesresources.nhs.uk/effectiveness-of-a-high-volume-injection-as-treatment-for-chronic-achilles-tendinopathy-randomised-controlled-trial.html 2020-09-10T17:45:54.4950000Z https://www.medicinesresources.nhs.uk/risk-stratification-of-patients-admitted-to-hospital-with-covid-19-using-the-isaric-who-clinical-characterisation-protocol-development-and-validation-of-the-4c-mortality-score.html 2020-09-10T17:46:31.1890000Z https://www.medicinesresources.nhs.uk/association-between-early-severe-cardiovascular-events-and-the-initiation-of-treatment-with-the-anti-interleukin-12-23p40-antibody-ustekinumab.html 2020-09-10T17:47:20.9710000Z https://www.medicinesresources.nhs.uk/clinical-outcomes-in-young-us-adults-hospitalized-with-covid-19.html 2020-09-10T17:48:21.2870000Z https://www.medicinesresources.nhs.uk/revised-spcs-zydol-tramadol-products.html 2020-09-11T15:56:15.4430000Z https://www.medicinesresources.nhs.uk/revised-spcs-co-diovan-80-12-5-mg-valsartan-hydrochlorothiazide-tablets.html 2020-09-11T15:08:26.1110000Z https://www.medicinesresources.nhs.uk/revised-spc-dianette-cyproterone-acetate-ethinylestradiol.html 2020-09-11T15:09:56.7190000Z https://www.medicinesresources.nhs.uk/growth-hormone-therapy-for-people-with-thalassaemia.html 2020-09-11T15:11:09.5220000Z https://www.medicinesresources.nhs.uk/vitamin-d-supplementation-for-sickle-cell-disease.html 2020-09-11T15:12:15.2180000Z https://www.medicinesresources.nhs.uk/stiripentol-add-on-therapy-for-drug-resistant-focal-epilepsy.html 2020-09-11T15:13:21.7960000Z https://www.medicinesresources.nhs.uk/strategies-for-optimising-antenatal-corticosteroid-administration-for-women-with-anticipated-preterm-birth.html 2020-09-11T15:14:41.0390000Z https://www.medicinesresources.nhs.uk/synergo-for-non-muscle-invasive-bladder-cancer-medtech-innovation-briefing-mib226.html 2020-09-13T14:23:55.1940000Z https://www.medicinesresources.nhs.uk/statement-on-the-potential-toxicological-risks-from-electronic-nicotine-and-non-nicotine-delivery-systems-e-n-nds-e-cigarettes.html 2020-09-11T16:04:04.8420000Z https://www.medicinesresources.nhs.uk/dtb-select-how-best-to-manage-late-preterm-pre-eclampsia.html 2020-09-11T15:22:26.2000000Z https://www.medicinesresources.nhs.uk/mapping-global-trends-in-vaccine-confidence-and-investigating-barriers-to-vaccine-uptake-a-large-scale-retrospective-temporal-modelling-study.html 2020-09-11T15:24:02.7330000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-ixazomib-in-multiple-myeloma-fails-to-meet-primary-endpoint.html 2020-09-11T15:25:01.2910000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-nasal-dihydroergotamine-dhe-in-acute-migraine-fails-to-meet-primary-endpoint.html 2020-09-11T15:25:44.4090000Z https://www.medicinesresources.nhs.uk/merck-announces-further-positive-data-for-its-investigational-15-valent-pneumococcal-conjugate-vaccine-v114.html 2020-09-11T15:26:26.7660000Z https://www.medicinesresources.nhs.uk/new-drug-application-for-epsolay-5-encapsulated-benzoyl-peroxide-cream-for-the-treatment-of-inflammatory-lesions-of-rosacea-submitted-to-fda.html 2020-09-11T15:27:21.7340000Z https://www.medicinesresources.nhs.uk/application-seeking-approval-of-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-for-the-treatment-of-light-chain-amyloidosis-submitted-to-the-us-fda.html 2020-09-11T15:28:19.5540000Z https://www.medicinesresources.nhs.uk/paediatric-data-for-elexacaftor-tezacaftor-ivacaftor-in-the-treatment-of-cystic-fibrosis-cf.html 2020-09-11T16:10:00.3680000Z https://www.medicinesresources.nhs.uk/phase-iii-data-for-fenfluramine-oral-solution-in-the-treatment-of-seizures-associated-with-dravet-syndrome.html 2020-09-11T15:30:14.1330000Z https://www.medicinesresources.nhs.uk/womens-lives-womens-rights-strengthening-access-to-contraception-beyond-the-pandemic.html 2020-09-11T15:31:46.4660000Z https://www.medicinesresources.nhs.uk/operation-moonshot-gp-clinics-could-be-used-to-improve-access-to-covid-19-tests.html 2020-09-11T15:32:37.3680000Z https://www.medicinesresources.nhs.uk/fairly-prioritizing-groups-for-access-to-covid-19-vaccines.html 2020-09-11T15:33:44.9860000Z https://www.medicinesresources.nhs.uk/complicated-pneumonia-in-children.html 2020-09-11T15:34:49.0300000Z https://www.medicinesresources.nhs.uk/mims-table-on-the-monitoring-of-ace-inhibitors-and-angiotensin-ii-antagonists-in-primary-care.html 2020-09-11T16:15:04.3400000Z https://www.medicinesresources.nhs.uk/crisaborole-for-treating-mild-to-moderate-atopic-dermatitis-in-people-aged-2-years-and-older-appraisal-consultation.html 2020-09-11T15:36:34.0950000Z https://www.medicinesresources.nhs.uk/andexanet-alfa-for-reversing-anticoagulation-from-apixaban-or-rivaroxaban-second-appraisal-consultation.html 2020-09-11T16:16:53.7420000Z https://www.medicinesresources.nhs.uk/osimertinib-for-untreated-egfr-mutation-positive-non-small-cell-lung-cancer-final-appraisal-document.html 2020-09-11T15:38:42.0750000Z https://www.medicinesresources.nhs.uk/flu-vaccines-for-the-2020-to-2021-season-poster.html 2020-09-11T15:39:42.6660000Z https://www.medicinesresources.nhs.uk/effects-of-intensive-blood-pressure-treatment-on-orthostatic-hypotension-a-systematic-review-and-individual-participant-based-meta-analysis.html 2020-09-11T15:47:12.9090000Z https://www.medicinesresources.nhs.uk/sars-cov-2-seroprevalence-and-asymptomatic-viral-carriage-in-healthcare-workers-a-cross-sectional-study.html 2020-09-11T15:48:41.8810000Z https://www.medicinesresources.nhs.uk/valaciclovir-to-prevent-vertical-transmission-of-cytomegalovirus-after-maternal-primary-infection-during-pregnancy-a-randomised-double-blind-placebo-controlled-trial.html 2020-09-11T15:50:17.8550000Z https://www.medicinesresources.nhs.uk/effect-of-recombinant-human-granulocyte-colony-stimulating-factor-for-patients-with-coronavirus-disease-2019-covid-19-and-lymphopenia-a-randomized-clinical-trial.html 2020-09-11T15:52:11.5710000Z https://www.medicinesresources.nhs.uk/observational-study-on-off-label-use-of-tocilizumab-in-patients-with-severe-covid-19.html 2020-09-11T15:53:13.0620000Z https://www.medicinesresources.nhs.uk/comparative-effectiveness-of-the-sodium-glucose-cotransporter-2-inhibitor-empagliflozin-versus-other-antihyperglycemics-on-risk-of-major-adverse-kidney-events.html 2020-09-11T15:55:19.7320000Z https://www.medicinesresources.nhs.uk/what-are-the-cost-savings-and-health-benefits-of-improving-detection-and-management-for-six-high-cardiovascular-risk-conditions-in-england-an-economic-evaluation.html 2020-09-11T15:56:26.0940000Z https://www.medicinesresources.nhs.uk/changes-over-a-decade-in-psychotropic-prescribing-for-people-with-intellectual-disabilities-prospective-cohort-study.html 2020-09-11T15:57:30.5480000Z https://www.medicinesresources.nhs.uk/revised-spc-ninlaro-ixazomib-citrate-hard-capsules-2.html 2020-09-14T12:19:58.8810000Z https://www.medicinesresources.nhs.uk/revised-spc-truvada-tenofovir-disoproxil-fumarate-emtricitabine-tablets.html 2020-09-14T12:22:21.4460000Z https://www.medicinesresources.nhs.uk/revised-spc-lisoretic-hydrochlorothiazide-lisinopril-dihydrate-tablets.html 2020-09-14T12:24:33.8770000Z https://www.medicinesresources.nhs.uk/recent-updates-from-the-bnf-bnf-80.html 2020-09-16T09:38:15.3820000Z https://www.medicinesresources.nhs.uk/non-nutritive-sweeteners-for-diabetes-mellitus.html 2020-09-14T12:28:16.9540000Z https://www.medicinesresources.nhs.uk/oral-galactagogues-natural-therapies-or-drugs-for-increasing-breast-milk-production-in-mothers-of-non-hospitalised-term-infants.html 2020-09-14T12:30:02.8060000Z https://www.medicinesresources.nhs.uk/adalimumab-for-maintenance-of-remission-in-crohn-s-disease.html 2020-09-14T12:31:06.3970000Z https://www.medicinesresources.nhs.uk/combination-antimicrobial-susceptibility-testing-for-acute-exacerbations-in-chronic-infection-of-pseudomonas-aeruginosa-in-cystic-fibrosis.html 2020-09-14T12:32:10.3260000Z https://www.medicinesresources.nhs.uk/changes-in-blood-pressure-thresholds-for-initiating-antihypertensive-medication-in-patients-with-diabetes-a-repeated-cross-sectional-study-focusing-on-the-impact-of-age-and-frailty.html 2020-09-14T12:34:14.1920000Z https://www.medicinesresources.nhs.uk/haemorrhagic-complications-in-patients-with-renal-insufficiency-during-treatment-or-prophylaxis-with-dalteparin.html 2020-09-14T12:35:55.3220000Z https://www.medicinesresources.nhs.uk/case-report-dramatic-improvement-of-bullous-pemphigoid-with-omalizumab-in-an-elderly-patient.html 2020-09-14T12:37:11.8420000Z https://www.medicinesresources.nhs.uk/evaluation-of-adjuvant-chemotherapy-in-patients-with-resected-pancreatic-cancer-after-neoadjuvant-folfirinox-treatment-1.html 2020-09-14T13:20:07.3920000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-propose-expansion-of-pivotal-covid-19-vaccine-trial.html 2020-09-14T13:21:14.9610000Z https://www.medicinesresources.nhs.uk/gphc-takes-action-against-six-pharmacies-regarding-the-sale-of-codeine-linctus.html 2020-09-14T13:24:39.6130000Z https://www.medicinesresources.nhs.uk/covid-19-and-the-path-to-immunity.html 2020-09-14T13:28:17.0180000Z https://www.medicinesresources.nhs.uk/how-to-communicate-better-with-people-with-hearing-loss.html 2020-09-14T14:41:08.5720000Z https://www.medicinesresources.nhs.uk/largest-testing-programme-for-coronavirus-reinforces-need-for-vigilance.html 2020-09-16T09:56:49.3200000Z https://www.medicinesresources.nhs.uk/astra-zeneca-resumes-trial-of-covid-19-vaccine.html 2020-09-14T13:43:18.3140000Z https://www.medicinesresources.nhs.uk/inactivated-influenza-vaccine-information-for-healthcare-practitioners.html 2020-09-16T09:57:25.0200000Z https://www.medicinesresources.nhs.uk/joint-appeal-to-amend-medicines-legislation-and-enable-all-pharmacists-to-alter-prescriptions.html 2020-09-14T13:50:02.0760000Z https://www.medicinesresources.nhs.uk/thickening-agents-what-to-consider-when-choosing-a-product.html 2020-09-14T13:51:39.1610000Z https://www.medicinesresources.nhs.uk/flu-vaccination-funding-for-2020-21.html 2020-09-14T13:53:25.4420000Z https://www.medicinesresources.nhs.uk/rational-selection-of-inhalation-devices-in-the-treatment-of-chronic-obstructive-pulmonary-disease-by-means-of-the-system-of-objectified-judgement-analysis-soja.html 2020-09-14T13:57:17.8210000Z https://www.medicinesresources.nhs.uk/effectiveness-of-curcuma-longa-extract-for-the-treatment-of-symptoms-and-effusion-synovitis-of-knee-osteoarthritis-2.html 2020-09-15T13:55:08.0750000Z https://www.medicinesresources.nhs.uk/ganaxolone-achieves-primary-endpoint-in-phase-3-trial-for-cdkl5-deficiency-disorder-rare-form-of-genetic-epilepsy.html 2020-09-15T13:56:00.8120000Z https://www.medicinesresources.nhs.uk/dextromethorphan-bupropion-modulated-delivery-tablet-shows-significant-improvement-in-patient-reported-outcomes-in-major-depressive-disorder.html 2020-09-15T15:43:02.1280000Z https://www.medicinesresources.nhs.uk/hepatorenal-syndrome-pathophysiology-diagnosis-and-management.html 2020-09-15T15:44:02.6810000Z https://www.medicinesresources.nhs.uk/covid-19-recovery-trial-will-evaluate-antiviral-antibody-cocktail.html 2020-09-15T13:59:22.9840000Z https://www.medicinesresources.nhs.uk/personal-protective-equipment-for-preventing-highly-infectious-diseases-due-to-exposure-to-contaminated-body-fluids-in-healthcare-staff-1.html 2020-09-15T14:03:26.4840000Z https://www.medicinesresources.nhs.uk/a-comparison-of-different-antibiotic-regimens-for-the-treatment-of-infective-endocarditis.html 2020-09-15T15:45:08.0070000Z https://www.medicinesresources.nhs.uk/convalescent-plasma-or-hyperimmune-immunoglobulin-for-people-with-covid-19-a-rapid-review.html 2020-09-15T15:45:33.3990000Z https://www.medicinesresources.nhs.uk/revised-spcs-enbrel-etanercept-solution-for-injection-all-products.html 2020-09-15T15:46:36.8370000Z https://www.medicinesresources.nhs.uk/pharmacies-to-be-paid-50p-more-per-flu-vaccination-in-2020-2022.html 2020-09-15T15:50:32.9230000Z https://www.medicinesresources.nhs.uk/shionogi-launches-novel-antibiotic-fetcroja-cefiderocol-in-the-uk-for-treatment-of-infections-caused-by-aerobic-gram-negative-bacteria-in-adults.html 2020-09-15T15:51:04.1890000Z https://www.medicinesresources.nhs.uk/what-factors-should-be-considered-when-using-lmwh-to-treat-venous-thromboembolism-in-patients-with-high-body-weight.html 2020-09-21T07:41:06.1480000Z https://www.medicinesresources.nhs.uk/adverse-outcomes-and-mortality-in-users-of-non-steroidal-anti-inflammatory-drugs-who-tested-positive-for-sars-cov-2-a-danish-nationwide-cohort-study.html 2020-09-15T15:52:18.1780000Z https://www.medicinesresources.nhs.uk/covid-19-prevention-and-treatment-a-critical-analysis-of-chloroquine-and-hydroxychloroquine-clinical-pharmacology.html 2020-09-15T15:52:58.7300000Z https://www.medicinesresources.nhs.uk/revised-spc-oramorph-morphine-oral-solution-2.html 2020-09-16T13:32:01.0620000Z https://www.medicinesresources.nhs.uk/interventions-for-sexual-dysfunction-following-stroke.html 2020-09-16T15:33:41.5950000Z https://www.medicinesresources.nhs.uk/phosphodiesterase-4-inhibitors-for-chronic-obstructive-pulmonary-disease.html 2020-09-16T13:34:06.7340000Z https://www.medicinesresources.nhs.uk/negative-pressure-wound-therapy-for-surgical-wounds-healing-by-primary-closure.html 2020-09-16T13:35:44.1740000Z https://www.medicinesresources.nhs.uk/topical-azelaic-acid-salicylic-acid-nicotinamide-sulphur-zinc-and-fruit-acid-alpha-hydroxy-acid-for-acne.html 2020-09-16T13:36:48.2210000Z https://www.medicinesresources.nhs.uk/post-traumatic-stress-disorder-as-a-risk-factor-for-dementia-systematic-review-and-meta-analysis-main-link.html 2020-09-16T13:40:56.1920000Z https://www.medicinesresources.nhs.uk/association-of-routine-infant-vaccinations-with-antibody-levels-among-preterm-infants.html 2020-09-16T13:43:22.6670000Z https://www.medicinesresources.nhs.uk/title-association-of-intra-arrest-transport-vs-continued-on-scene-resuscitation-with-survival-to-hospital-discharge-among-patients-with-out-of-hospital-cardiac-arrest.html 2020-09-16T15:38:42.7360000Z https://www.medicinesresources.nhs.uk/olanzapine-for-prevention-of-vomiting-in-children-and-adolescents-receiving-highly-emetogenic-chemotherapy-investigator-initiated-randomized-open-label-trial.html 2020-09-16T13:48:08.0290000Z https://www.medicinesresources.nhs.uk/long-term-follow-up-of-ibrutinib-monotherapy-in-symptomatic-previously-treated-patients-with-waldenstroem-macroglobulinemia.html 2020-09-16T13:50:32.0530000Z https://www.medicinesresources.nhs.uk/therapy-escalation-following-an-elevated-hba1c-in-adults-aged-45-years-and-older-living-with-diabetes-in-australia-a-real-world-observational-analysis.html 2020-09-16T13:51:43.0870000Z https://www.medicinesresources.nhs.uk/final-overall-survival-results-from-a-phase-3-study-to-compare-tivozanib-to-sorafenib-as-third-or-fourth-line-therapy-in-subjects-with-metastatic-renal-cell-carcinoma.html 2020-09-16T13:54:54.7680000Z https://www.medicinesresources.nhs.uk/long-term-safety-tolerability-and-efficacy-of-fremanezumab-in-migraine-a-randomized-study.html 2020-09-16T13:55:49.4620000Z https://www.medicinesresources.nhs.uk/safety-immunogenicity-and-efficacy-of-a-clostridioides-difficile-toxoid-vaccine-candidate-a-phase-3-multicentre-observer-blind-randomised-controlled-trial.html 2020-09-16T13:57:18.8840000Z https://www.medicinesresources.nhs.uk/effect-of-dapagliflozin-as-an-adjunct-to-insulin-over-52-weeks-in-individuals-with-type-1-diabetes-post-hoc-renal-analysis-of-the-depict-randomised-controlled-trials.html 2020-09-16T13:58:43.0120000Z https://www.medicinesresources.nhs.uk/metformin-in-women-with-type-2-diabetes-in-pregnancy-mity-a-multicentre-international-randomised-placebo-controlled-trial.html 2020-09-16T15:42:47.3830000Z https://www.medicinesresources.nhs.uk/fmd-alert-class-2-medicines-recall-neupro-4-mg-24-hour-and-vimpat-100-mg-tablets-from-several-wholesalers.html 2020-09-16T15:32:22.4360000Z https://www.medicinesresources.nhs.uk/the-longitudinal-immune-response-to-coronavirus-disease-2019-chasing-the-cytokine-storm.html 2020-09-16T14:16:43.4400000Z https://www.medicinesresources.nhs.uk/developing-guidelines-before-during-and-after-the-covid-19-pandemic.html 2020-09-16T14:18:33.7530000Z https://www.medicinesresources.nhs.uk/painful-perianal-ulcers-with-nicorandil.html 2020-09-16T14:19:45.9620000Z https://www.medicinesresources.nhs.uk/drug-induced-arrhythmias-a-scientific-statement-from-the-american-heart-association.html 2020-09-16T14:20:51.9780000Z https://www.medicinesresources.nhs.uk/totality-of-evidence-in-trials-of-sodium-glucose-co-transporter-2-inhibitors-in-the-patients-with-heart-failure-with-reduced-ejection-fraction-implications-for-clinical-practice.html 2020-09-16T14:21:48.3720000Z https://www.medicinesresources.nhs.uk/ask-about-asthma.html 2020-09-16T14:27:45.6160000Z https://www.medicinesresources.nhs.uk/making-history-health-visiting-during-covid-19.html 2020-09-16T14:30:06.8570000Z https://www.medicinesresources.nhs.uk/next-steps-for-funding-mental-healthcare-in-england-delivering-the-long-term-plan.html 2020-09-16T14:31:45.7950000Z https://www.medicinesresources.nhs.uk/the-future-of-public-health-the-nihp-and-other-public-health-functions.html 2020-09-16T14:33:21.2950000Z https://www.medicinesresources.nhs.uk/mavrilimumab-receives-orphan-designation-in-the-us-for-the-treatment-of-giant-cell-arteritis.html 2020-09-16T14:36:03.9980000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-marketing-authorisation-application-in-eu-for-lenadogene-nolparvovec-for-vision-loss-due-to-leber-hereditary-optic-neuropathy.html 2020-09-16T14:37:02.3760000Z https://www.medicinesresources.nhs.uk/licence-extension-application-for-use-of-nivolumab-plus-ipilimumab-for-first-line-treatment-of-malignant-pleural-mesothelioma-to-be-reviewed-in-the-eu.html 2020-09-16T15:46:36.3610000Z https://www.medicinesresources.nhs.uk/familial-hypercholesterolaemia-history-diagnosis-screening-management-and-challenges.html 2020-09-16T14:39:15.0130000Z https://www.medicinesresources.nhs.uk/magrolimab-receives-fda-breakthrough-therapy-designation-for-treatment-of-myelodysplastic-syndrome.html 2020-09-16T14:40:11.1510000Z https://www.medicinesresources.nhs.uk/empagliflozin-receives-fast-track-designation-in-us-for-use-to-improve-outcomes-following-a-heart-attack.html 2020-09-16T14:42:24.2390000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-ganaxolone-in-children-and-young-adults-with-cdkl5-deficiency-disorder.html 2020-09-16T14:44:02.6430000Z https://www.medicinesresources.nhs.uk/convalescent-plasma-for-covid-19.html 2020-09-16T15:48:27.6750000Z https://www.medicinesresources.nhs.uk/diabetes-in-ageing-pathways-for-developing-the-evidence-base-for-clinical-guidance.html 2020-09-16T14:47:03.4430000Z https://www.medicinesresources.nhs.uk/revised-spc-epanutin-phenytoin-infatabs-50-mg-chewable-tablets-and-30mg-5ml-oral-suspension.html 2020-09-17T18:55:27.7990000Z https://www.medicinesresources.nhs.uk/revised-spc-lemtrada-alemtuzumab-12-mg-concentrate-for-solution-for-infusion-1.html 2020-09-17T18:54:38.6530000Z https://www.medicinesresources.nhs.uk/revised-spc-aimovig-erenumab-solution-for-injection-in-pre-filled-syringe-all-strengths.html 2020-09-17T18:51:27.7580000Z https://www.medicinesresources.nhs.uk/revised-spc-suboxone-buprenorphine-naloxone-sublingual-film-all-strengths.html 2020-09-17T18:50:54.7970000Z https://www.medicinesresources.nhs.uk/economic-analyses-of-mental-health-and-substance-use-interventions-in-the-workplace-a-systematic-literature-review-and-narrative-synthesis.html 2020-09-17T18:50:11.5650000Z https://www.medicinesresources.nhs.uk/computerised-clinical-decision-support-systems-and-absolute-improvements-in-care-meta-analysis-of-controlled-clinical-trials.html 2020-09-17T18:49:30.9950000Z https://www.medicinesresources.nhs.uk/anti-epidermal-growth-factor-receptor-therapy-for-glioblastoma-in-adults.html 2020-09-17T18:48:41.3650000Z https://www.medicinesresources.nhs.uk/pharmacological-psychological-and-non-invasive-brain-stimulation-interventions-for-preventing-depression-after-stroke.html 2020-09-17T18:48:02.9750000Z https://www.medicinesresources.nhs.uk/interventions-for-improving-medication-taking-ability-and-adherence-in-older-adults-prescribed-multiple-medications.html 2020-09-17T18:46:40.8420000Z https://www.medicinesresources.nhs.uk/interventions-for-preventing-venous-thromboembolism-in-adults-undergoing-knee-arthroscopy.html 2020-09-17T18:45:55.7750000Z https://www.medicinesresources.nhs.uk/nihr-alert-terminally-ill-patients-and-their-families-often-need-more-help-to-manage-their-medicines.html 2020-09-17T18:45:26.8650000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-galcanezumab-in-patients-for-whom-previous-migraine-preventive-medication-from-two-to-four-categories-had-failed-conquer-a-multicentre-randomised-double-blind-placebo-controlled-phase-3b-trial.html 2020-09-17T18:44:29.1060000Z https://www.medicinesresources.nhs.uk/intravesical-bacteriophages-for-treating-urinary-tract-infections-in-patients-undergoing-transurethral-resection-of-the-prostate-a-randomised-placebo-controlled-double-blind-clinical-trial.html 2020-09-17T18:43:37.6370000Z https://www.medicinesresources.nhs.uk/quality-of-life-in-patients-with-metastatic-prostate-cancer-following-treatment-with-cabazitaxel-versus-abiraterone-or-enzalutamide-card-an-analysis-of-a-randomised-multicentre-open-label-phase-4-study.html 2020-09-17T18:42:55.4680000Z https://www.medicinesresources.nhs.uk/two-year-randomized-controlled-trial-of-belimumab-in-lupus-nephritis.html 2020-09-17T18:42:09.0160000Z https://www.medicinesresources.nhs.uk/opportunistic-screening-versus-usual-care-for-detection-of-atrial-fibrillation-in-primary-care-cluster-randomised-controlled-trial.html 2020-09-17T18:41:12.1110000Z https://www.medicinesresources.nhs.uk/randomized-controlled-trial-of-trastuzumab-with-or-without-chemotherapy-for-her2-positive-early-breast-cancer-in-older-patients.html 2020-09-17T18:40:24.4590000Z https://www.medicinesresources.nhs.uk/remote-optimization-of-guideline-directed-medical-therapy-in-patients-with-heart-failure-with-reduced-ejection-fraction.html 2020-09-17T18:39:51.9450000Z https://www.medicinesresources.nhs.uk/incidence-of-new-primary-cutaneous-melanoma-in-patients-with-metastatic-melanoma-treated-with-immune-checkpoint-inhibitors-a-single-center-cohort-study.html 2020-09-17T18:39:17.8070000Z https://www.medicinesresources.nhs.uk/premature-permanent-discontinuation-of-apixaban-or-warfarin-in-patients-with-atrial-fibrillation.html 2020-09-17T18:38:36.2900000Z https://www.medicinesresources.nhs.uk/diabetic-ketoacidosis-and-related-events-with-sotagliflozin-added-to-insulin-in-adults-with-type-1-diabetes-a-pooled-analysis-of-the-intandem-1-and-2-studies.html 2020-09-17T18:37:47.9210000Z https://www.medicinesresources.nhs.uk/comparative-effectiveness-of-sglt2-inhibitors-glp-1-receptor-agonists-dpp-4-inhibitors-and-sulfonylureas-on-risk-of-kidney-outcomes-emulation-of-a-target-trial-using-health-care-databases.html 2020-09-17T18:34:30.4680000Z https://www.medicinesresources.nhs.uk/association-between-nutritional-profiles-of-foods-underlying-nutri-score-front-of-pack-labels-and-mortality-epic-cohort-study-in-10-european-countries.html 2020-09-17T18:33:48.0510000Z https://www.medicinesresources.nhs.uk/impact-of-a-pay-for-performance-scheme-for-long-acting-reversible-contraceptive-larc-advice-on-contraceptive-uptake-and-abortion-in-british-primary-care-an-interrupted-time-series-study.html 2020-09-17T18:33:09.6390000Z https://www.medicinesresources.nhs.uk/nice-indicator-menu-2020.html 2020-09-18T12:24:49.9580000Z https://www.medicinesresources.nhs.uk/advice-and-guidance-high-impact-intervention-guides.html 2020-09-17T18:31:57.3500000Z https://www.medicinesresources.nhs.uk/eu-exit-end-of-transition-period-letter-from-professor-keith-willett.html 2020-09-17T18:31:22.8220000Z https://www.medicinesresources.nhs.uk/annual-progress-report-for-the-nhs-patient-safety-strategy-year-one.html 2020-09-17T18:29:49.6320000Z https://www.medicinesresources.nhs.uk/2020-21-influenza-season-letters.html 2020-09-17T18:29:14.7300000Z https://www.medicinesresources.nhs.uk/tolerance-in-the-age-of-immunotherapy.html 2020-09-17T18:28:28.6950000Z https://www.medicinesresources.nhs.uk/targeting-cd38-with-daratumumab-in-refractory-systemic-lupus-erythematosus.html 2020-09-17T18:27:37.9700000Z https://www.medicinesresources.nhs.uk/one-pharmacists-report-helps-safer-use-of-inhalers-in-the-uk.html 2020-09-17T18:26:49.9460000Z https://www.medicinesresources.nhs.uk/stop-withdrawal-of-bipolar-disorder-treatment-health-secretary-urged.html 2020-09-17T18:25:54.0240000Z https://www.medicinesresources.nhs.uk/dreams-and-nightmares-in-healthy-adults-and-in-patients-with-sleep-and-neurological-disorders.html 2020-09-17T18:24:25.2520000Z https://www.medicinesresources.nhs.uk/cognitive-impairment-in-multiple-sclerosis-clinical-management-mri-and-therapeutic-avenues.html 2020-09-17T18:23:31.0380000Z https://www.medicinesresources.nhs.uk/intake-and-metabolism-of-omega-3-and-omega-6-polyunsaturated-fatty-acids-nutritional-implications-for-cardiometabolic-diseases.html 2020-09-17T18:22:23.2700000Z https://www.medicinesresources.nhs.uk/national-learning-report-giving-families-a-voice-hsibs-approach-to-patient-and-family-engagement-during-investigations.html 2020-09-17T18:21:23.6850000Z https://www.medicinesresources.nhs.uk/prescribing-medicines-to-older-people-how-to-consider-the-impact-of-ageing-on-human-organ-and-body-functions.html 2020-09-17T18:20:14.9430000Z https://www.medicinesresources.nhs.uk/keeping-people-safe-and-supported-through-the-pandemic.html 2020-09-17T18:19:06.5450000Z https://www.medicinesresources.nhs.uk/covid-19-do-many-people-have-pre-existing-immunity.html 2020-09-17T18:18:12.6910000Z https://www.medicinesresources.nhs.uk/neurocrine-biosciences-presents-new-data-analyses-demonstrating-efficacy-of-fda-approved-once-daily-ongentys-r-opicapone-in-patients-with-parkinson-s-disease-at-the-mds-virtual-congress-2020.html 2020-09-17T18:17:34.2930000Z https://www.medicinesresources.nhs.uk/novartis-presents-data-at-actrims-ectrims-for-kesimpta-r-ofatumumab-in-newly-diagnosed-treatment-naive-adults-with-relapsing-multiple-sclerosis.html 2020-09-17T18:16:42.4850000Z https://www.medicinesresources.nhs.uk/eli-lilly-reports-positive-results-in-phase-iii-migraine-attack-study.html 2020-09-17T18:15:50.9940000Z https://www.medicinesresources.nhs.uk/fda-grants-dupixent-r-dupilumab-breakthrough-therapy-designation-for-eosinophilic-esophagitis.html 2020-09-17T18:14:38.3430000Z https://www.medicinesresources.nhs.uk/vertex-announces-european-medicines-agency-type-ii-variation-marketing-authorization-application-validation-for-kaftrio-r-ivacaftor-tezacaftor-elexacaftor-in-combination-with-ivacaftor-in-people-with-one-copy-of-the-f508del-mutation.html 2020-09-17T18:13:29.0880000Z https://www.medicinesresources.nhs.uk/baricitinib-in-combination-with-remdesivir-reduces-time-to-recovery-in-hospitalized-patients-with-covid-19-in-niaid-sponsored-actt-2-trial.html 2020-09-17T18:12:49.4760000Z https://www.medicinesresources.nhs.uk/mallinckrodt-receives-a-complete-response-letter-from-the-u-s-food-and-drug-administration-fda-for-terlipressin-for-the-treatment-of-hepatorenal-syndrome-type-1-hrs-1.html 2020-09-17T18:11:55.8150000Z https://www.medicinesresources.nhs.uk/eli-lillys-antibody-therapy-against-covid-19-reduced-hospitalization.html 2020-09-17T18:10:02.1160000Z https://www.medicinesresources.nhs.uk/revised-spc-rixathon-rituximab-concentrate-for-solution-for-infusion-all-strengths.html 2020-09-17T18:08:12.7390000Z https://www.medicinesresources.nhs.uk/orphazyme-s-rare-lipid-disorder-drug-gets-priority-review-from-the-fda.html 2020-09-17T18:06:16.2030000Z https://www.medicinesresources.nhs.uk/revised-spc-hyqvia-human-normal-immunoglobulin-100-mg-ml-solution-for-infusion-for-subcutaneous-use-1.html 2020-09-18T13:07:55.3650000Z https://www.medicinesresources.nhs.uk/revised-spc-orkambi-lumacaftor-and-ivacaftor-100-mg-125-mg-granules-in-sachet.html 2020-09-18T13:09:13.3260000Z https://www.medicinesresources.nhs.uk/chelation-therapy-for-atherosclerotic-cardiovascular-disease-1.html 2020-09-18T13:12:35.1730000Z https://www.medicinesresources.nhs.uk/treatment-regimens-for-administration-of-anti-vascular-endothelial-growth-factor-agents-for-neovascular-age-related-macular-degeneration.html 2020-09-18T15:48:10.4010000Z https://www.medicinesresources.nhs.uk/pharmacological-treatment-for-buerger-s-disease.html 2020-09-18T13:18:31.5570000Z https://www.medicinesresources.nhs.uk/aspirin-or-heparin-or-both-for-improving-pregnancy-outcomes-in-women-with-persistent-antiphospholipid-antibodies-and-recurrent-pregnancy-loss.html 2020-09-18T15:46:31.8170000Z https://www.medicinesresources.nhs.uk/impact-of-perioperative-care-on-healthcare-resource-use-rapid-research-review.html 2020-09-18T13:22:28.4700000Z https://www.medicinesresources.nhs.uk/changes-in-management-of-type-2-diabetes-before-and-after-severe-hypoglycemia.html 2020-09-18T13:23:23.5850000Z https://www.medicinesresources.nhs.uk/periprocedural-euglycemic-diabetic-ketoacidosis-associated-with-sodium-glucose-cotransporter-2-inhibitor-therapy-during-colonoscopy.html 2020-09-18T15:44:45.3000000Z https://www.medicinesresources.nhs.uk/transmission-of-sars-cov-2-a-review-of-viral-host-and-environmental-factors.html 2020-09-18T13:28:27.1170000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-tislelizumab-in-the-first-line-treatment-of-non-squamous-non-small-cell-lung-cancer-presented-at-conference.html 2020-09-18T13:29:23.6390000Z https://www.medicinesresources.nhs.uk/us-fda-grants-orphan-drug-designation-for-cannabidiol-zygel-for-the-treatment-of-22q11-2-deletion-syndrome.html 2020-09-18T13:30:17.3910000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-new-drug-application-for-avacopan-for-the-treatment-of-anca-associated-vasculitis.html 2020-09-18T15:42:12.5180000Z https://www.medicinesresources.nhs.uk/long-term-survival-data-for-nivolumab-plus-ipilimumab-in-first-line-treatment-of-advanced-or-metastatic-renal-cell-carcinoma-presented-at-conference.html 2020-09-18T13:31:57.5280000Z https://www.medicinesresources.nhs.uk/surgery-during-covid-19-co-producing-patient-resources.html 2020-09-18T15:41:04.0470000Z https://www.medicinesresources.nhs.uk/update-from-the-cas-helpdesk-changes-to-mhra-alerts-and-amendments-to-the-website.html 2020-09-21T07:41:37.6380000Z https://www.medicinesresources.nhs.uk/early-years-healthy-development-review-call-for-evidence.html 2020-09-18T13:35:54.0110000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-exparel-bupivacaine-dispersion-for-injection-for-treatment-of-post-operative-pain.html 2020-09-18T15:37:57.0830000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-menquadfi-meningococcal-vaccine-for-prophylaxis-against-invasive-meningococcal-disease-caused-by-neisseria-meningitidis-serogroups-a-c-w-and-y.html 2020-09-18T13:47:36.3460000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-obiltoxaximab-sfl-for-treatment-or-post-exposure-prophylaxis-of-inhalational-anthrax.html 2020-09-18T13:48:32.3320000Z https://www.medicinesresources.nhs.uk/structured-medication-reviews-and-medicines-optimisation-guidance.html 2020-09-21T07:41:54.0500000Z https://www.medicinesresources.nhs.uk/primary-prevention-of-asthma-from-risk-and-protective-factors-to-targeted-strategies-for-prevention.html 2020-09-18T13:51:24.9720000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-scientific-opinion-risdiplam-in-the-treatment-of-type-1-and-type-2-spinal-muscular-atrophy-sma-in-patients-2-months-of-age-and-older.html 2020-09-18T13:52:29.7430000Z https://www.medicinesresources.nhs.uk/hospital-admitted-patient-care-activity-2019-20.html 2020-09-18T13:53:15.4980000Z https://www.medicinesresources.nhs.uk/gp-referral-to-nhs-community-pharmacist-consultation-service-bristol-north-somerset-and-south-gloucestershire-pilot.html 2020-09-18T15:33:06.2260000Z https://www.medicinesresources.nhs.uk/effect-of-omega-3-dosage-on-cardiovascular-outcomes-an-updated-meta-analysis-and-meta-regression-of-interventional-trials.html 2020-09-18T15:56:23.4410000Z https://www.medicinesresources.nhs.uk/avelumab-maintenance-therapy-for-advanced-or-metastatic-urothelial-carcinoma.html 2020-09-18T15:57:35.6220000Z https://www.medicinesresources.nhs.uk/effect-of-aspirin-on-deaths-associated-with-sepsis-in-healthy-older-people-antisepsis-a-randomised-double-blind-placebo-controlled-primary-prevention-trial.html 2020-09-18T15:58:47.5220000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-nab-paclitaxel-vs-paclitaxel-on-survival-in-patients-with-platinum-refractory-metastatic-urothelial-cancer-the-canadian-cancer-trials-group-bl-12-randomized-clinical-trial.html 2020-09-18T16:00:03.6560000Z https://www.medicinesresources.nhs.uk/paternal-exposure-to-antiepileptic-drugs-and-offspring-outcomes-a-nationwide-population-based-cohort-study-in-sweden.html 2020-09-21T07:42:16.7410000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-extension-of-delamanid-deltyba-indication-to-include-treatment-of-adolescents-and-children-with-weight-30-kg.html 2020-09-18T16:03:07.9890000Z https://www.medicinesresources.nhs.uk/nivolumab-for-advanced-squamous-non-small-cell-lung-cancer-after-chemotherapy-final-evaluation-document.html 2020-09-18T16:04:30.1250000Z https://www.medicinesresources.nhs.uk/volanesorsen-for-treating-familial-chylomicronaemia-syndrome-final-evaluation-document.html 2020-09-18T16:06:04.8690000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-use-of-perampanel-in-younger-patients.html 2020-09-18T16:07:08.6520000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-use-of-flucelvax-tetra-in-a-wider-age-range.html 2020-09-18T16:08:16.1090000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-extension-to-existing-indication-for-kalydeco-ivacaftor-and-new-tablet-strength.html 2020-09-18T16:09:58.6670000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-new-indications-for-olaparib.html 2020-09-18T16:11:42.8970000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-baricitinib-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-in-adults.html 2020-09-18T16:12:51.7120000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-an-extension-to-the-existing-indication-for-nivolumab-for-non-small-cell-lung-cancer.html 2020-09-18T16:13:49.8160000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-nitisinone-for-the-treatment-of-alkaptonuria-in-adults.html 2020-09-18T16:14:45.8400000Z https://www.medicinesresources.nhs.uk/change-in-antibodies-to-sars-cov-2-over-60-days-among-health-care-personnel-in-nashville-tennessee.html 2020-09-21T14:28:39.9310000Z https://www.medicinesresources.nhs.uk/nonfatal-opioid-overdoses-at-an-urban-emergency-department-during-the-covid-19-pandemic.html 2020-09-21T14:32:52.4090000Z https://www.medicinesresources.nhs.uk/analysis-of-drug-test-results-before-and-after-the-us-declaration-of-a-national-emergency-concerning-the-covid-19-outbreak-pandemic.html 2020-09-21T14:35:33.2360000Z https://www.medicinesresources.nhs.uk/neoadjuvant-atezolizumab-in-combination-with-sequential-nab-paclitaxel-and-anthracycline-based-chemotherapy-versus-placebo-and-chemotherapy-in-patients-with-early-stage-triple-negative-breast-cancer-impassion031.html 2020-09-21T14:36:49.6060000Z https://www.medicinesresources.nhs.uk/osimertinib-in-resected-egfr-mutated-non-small-cell-lung-cancer.html 2020-09-21T14:38:07.6380000Z https://www.medicinesresources.nhs.uk/survival-with-olaparib-in-metastatic-castration-resistant-prostate-cancer.html 2020-09-21T14:39:23.5030000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-licence-extension-of-tezacaftor-ivacaftor-symkevi.html 2020-09-21T14:40:32.2280000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-licence-extension-of-atezolizumab-tecentriq.html 2020-09-21T14:41:44.0640000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-velphoro-polynuclear-iron-iii-oxyhydroxide-sucrose-and-starches.html 2020-09-21T14:42:53.3300000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-ipilimumab-yervoy.html 2020-09-21T14:44:00.1860000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-new-formulation-of-ravulizumab-ultomiris.html 2020-09-21T14:45:04.9070000Z https://www.medicinesresources.nhs.uk/positive-results-from-phase-iii-empacta-rct-of-tocilizumab-treatment-of-hospitalised-adults-with-covid-19-meets-primary-endpoint.html 2020-09-21T14:46:09.2040000Z https://www.medicinesresources.nhs.uk/severe-covid-19-infections-knowledge-gained-and-remaining-questions.html 2020-09-21T14:48:26.8160000Z https://www.medicinesresources.nhs.uk/surge-in-smokers-trying-to-quit-see-increased-success-rates-in-2020.html 2020-09-21T14:50:38.8390000Z https://www.medicinesresources.nhs.uk/new-product-fetcroja-cefiderocol-sulfate-tosylate-1-g-powder.html 2020-09-21T14:55:01.1930000Z https://www.medicinesresources.nhs.uk/levetiracetam-add-on-for-drug-resistant-focal-epilepsy.html 2020-09-21T14:56:11.6170000Z https://www.medicinesresources.nhs.uk/ketogenic-diets-for-drug-resistant-epilepsy.html 2020-09-21T14:57:32.1850000Z https://www.medicinesresources.nhs.uk/skin-preparation-for-preventing-infection-following-caesarean-section.html 2020-09-21T14:58:59.8120000Z https://www.medicinesresources.nhs.uk/potassium-binders-for-chronic-hyperkalaemia-in-people-with-chronic-kidney-disease.html 2020-09-21T15:00:10.3390000Z https://www.medicinesresources.nhs.uk/adjuvant-nivolumab-versus-ipilimumab-in-resected-stage-iiib-c-and-stage-iv-melanoma-checkmate-238-4-year-results-from-a-multicentre-double-blind-randomised-controlled-phase-3-trial.html 2020-09-21T15:01:17.9970000Z https://www.medicinesresources.nhs.uk/surufatinib-in-advanced-pancreatic-neuroendocrine-tumours-sanet-p-a-randomised-double-blind-placebo-controlled-phase-3-study.html 2020-09-21T15:26:16.4670000Z https://www.medicinesresources.nhs.uk/surufatinib-in-advanced-extrapancreatic-neuroendocrine-tumours-sanet-ep-a-randomised-double-blind-placebo-controlled-phase-3-study.html 2020-09-21T15:27:59.8960000Z https://www.medicinesresources.nhs.uk/influenza-vaccination-principles-for-collaboration-across-great-britain.html 2020-09-25T12:16:40.9880000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-endorses-use-of-dexamethasone-in-covid-19-patients-on-oxygen-or-mechanical-ventilation.html 2020-09-25T11:51:40.8180000Z https://www.medicinesresources.nhs.uk/risk-for-serious-infection-with-low-dose-glucocorticoids-in-patients-with-rheumatoid-arthritis-a-cohort-study.html 2020-09-22T16:19:19.7000000Z https://www.medicinesresources.nhs.uk/interventions-to-improve-statin-tolerance-and-adherence-in-patients-at-risk-for-cardiovascular-disease-a-systematic-review-for-the-2020-u-s-department-of-veterans-affairs-and-u-s-department-of-defense-guidelines-for-management-of-dyslipidemia.html 2020-09-22T16:21:23.2910000Z https://www.medicinesresources.nhs.uk/nivolumab-plus-chemotherapy-demonstrates-significant-overall-survival-os-benefit-vs-chemotherapy-in-first-line-treatment-of-gastric-and-oesophageal-cancers.html 2020-09-22T16:22:29.8490000Z https://www.medicinesresources.nhs.uk/pembrolizumab-plus-chemotherapy-demonstrates-significant-overall-survival-os-benefit-vs-chemotherapy-as-first-line-treatment-for-locally-advanced-or-metastatic-eosophageal-cancer.html 2020-09-22T16:23:13.2510000Z https://www.medicinesresources.nhs.uk/first-line-treatment-with-pembrolizumab-doubled-five-year-survival-rate-vs-chemotherapy-in-certain-patients-with-metastatic-non-small-cell-lung-cancer-whose-tumours-express-pd-l1.html 2020-09-22T14:53:54.3350000Z https://www.medicinesresources.nhs.uk/company-announces-positive-data-from-phase-3-claridhy-study-of-ivosidenib-tablets-first-in-class-inhibitor-of-mutated-idh1-protein-in-previously-treated-idh1-mutant-cholangiocarcinoma-patients.html 2020-09-22T16:34:37.6960000Z https://www.medicinesresources.nhs.uk/emerging-immunotherapies-in-multiple-myeloma.html 2020-09-22T16:24:10.0220000Z https://www.medicinesresources.nhs.uk/so-near-yet-so-far-why-wont-the-uk-prescribe-medical-cannabis.html 2020-09-22T14:58:25.0310000Z https://www.medicinesresources.nhs.uk/natural-history-of-uncomplicated-urinary-tract-infection-without-antibiotics-a-systematic-review.html 2020-09-22T15:00:04.6370000Z https://www.medicinesresources.nhs.uk/corticosteroids-as-standalone-or-add-on-treatment-for-sore-throat.html 2020-09-22T15:01:49.2780000Z https://www.medicinesresources.nhs.uk/inhaled-mannitol-for-cystic-fibrosis.html 2020-09-22T15:03:04.1140000Z https://www.medicinesresources.nhs.uk/levetiracetam-add-on-for-drug-resistant-focal-epilepsy-1.html 2020-09-22T15:04:06.2680000Z https://www.medicinesresources.nhs.uk/revised-spcs-bupeaze-buprenorphine-transdermal-patches-all-strengths-1.html 2020-09-22T15:22:42.9700000Z https://www.medicinesresources.nhs.uk/ensuring-adequate-palliative-and-hospice-care-during-covid-19-surges.html 2020-09-22T16:24:33.2170000Z https://www.medicinesresources.nhs.uk/hormonal-contraception-in-women-with-hypertension.html 2020-09-22T16:36:47.4820000Z https://www.medicinesresources.nhs.uk/new-plan-to-help-protect-care-homes-from-coronavirus-over-winter.html 2020-09-22T16:37:22.2480000Z https://www.medicinesresources.nhs.uk/insect-bites-and-stings-antimicrobial-prescribing-ng182.html 2020-09-25T11:54:42.0310000Z https://www.medicinesresources.nhs.uk/carfilzomib-with-dexamethasone-and-lenalidomide-for-treating-multiple-myeloma-after-at-least-1-previous-therapy-appraisal-consultation-document.html 2020-09-22T16:30:08.7330000Z https://www.medicinesresources.nhs.uk/nihr-alert-more-precise-classification-of-risk-in-prostate-cancer-reveals-a-huge-variation-in-treatment.html 2020-09-22T16:14:01.2070000Z https://www.medicinesresources.nhs.uk/first-line-maintenance-treatment-with-olaparib-provides-long-term-progression-free-survival-pfs-benefit-in-brca-mutated-advanced-ovarian-cancer-at-five-year-follow-up-of-solo-1-phase-iii-trial.html 2020-09-22T16:15:19.3060000Z https://www.medicinesresources.nhs.uk/abemaciclib-combined-with-endocrine-therapy-for-the-adjuvant-treatment-of-hr-her2-node-positive-high-risk-early-breast-cancer-monarche.html 2020-09-22T16:30:33.4010000Z https://www.medicinesresources.nhs.uk/low-back-pain-and-sciatica-in-over-16s-assessment-and-management-updated-guidance-ng59.html 2020-09-25T11:55:25.2280000Z https://www.medicinesresources.nhs.uk/revised-spc-indipam-xl-indapamide-1-5-mg-prolonged-release-tablets.html 2020-09-23T12:07:55.2070000Z https://www.medicinesresources.nhs.uk/revised-spcs-zofran-ondansetron-preparations.html 2020-09-23T12:10:18.3510000Z https://www.medicinesresources.nhs.uk/t-slim-x2-insulin-pump-for-managing-blood-glucose-levels-in-type-1-diabetes-medtech-innovation-briefing-mib227.html 2020-09-25T11:57:41.5690000Z https://www.medicinesresources.nhs.uk/pitavastatin-for-lowering-lipids.html 2020-09-23T12:13:42.2160000Z https://www.medicinesresources.nhs.uk/tea-tree-oil-for-demodex-blepharitis.html 2020-09-23T12:15:11.8740000Z https://www.medicinesresources.nhs.uk/probiotic-treatment-for-women-with-gestational-diabetes-to-improve-maternal-and-infant-health-and-well-being.html 2020-09-23T12:16:53.2550000Z https://www.medicinesresources.nhs.uk/should-patients-drink-alcohol-whilst-taking-long-term-low-dose-methotrexate.html 2020-09-25T11:58:09.6320000Z https://www.medicinesresources.nhs.uk/once-weekly-insulin-for-type-2-diabetes-without-previous-insulin-treatment.html 2020-09-23T12:19:26.6410000Z https://www.medicinesresources.nhs.uk/phase-ii-trial-of-pepinemab-in-huntingtons-disease-does-not-meet-primary-endpoints.html 2020-09-23T12:20:26.0350000Z https://www.medicinesresources.nhs.uk/150-nations-join-world-health-organisation-who-effort-to-fairly-distribute-covid-19-vaccine-across-the-globe.html 2020-09-23T12:21:36.1210000Z https://www.medicinesresources.nhs.uk/ctx001-tm-granted-priority-medicines-prime-designation-by-the-european-medicines-agency-for-the-treatment-of-sickle-cell-disease-scd.html 2020-09-23T12:22:34.4080000Z https://www.medicinesresources.nhs.uk/journal-of-internal-medicine-themed-issue-looks-at-first-six-months-of-covid-19.html 2020-09-24T13:11:06.7510000Z https://www.medicinesresources.nhs.uk/mask-management-dry-eyes-and-misty-glasses.html 2020-09-25T12:21:23.4330000Z https://www.medicinesresources.nhs.uk/nhs-announces-independent-review-into-gender-identity-services-for-children-and-young-people.html 2020-09-23T12:33:19.1360000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-from-checkmate-577-for-adjuvant-nivolumab-in-oesophageal-or-gastroesophageal-junction-cancer.html 2020-09-23T12:35:59.3660000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-extension-to-existing-indication-for-niraparib.html 2020-09-23T12:37:36.0670000Z https://www.medicinesresources.nhs.uk/record-numbers-offered-flu-vaccine-as-those-with-flu-and-covid-19-more-likely-to-die.html 2020-09-23T16:06:29.1040000Z https://www.medicinesresources.nhs.uk/polatuzumab-vedotin-with-rituximab-and-bendamustine-for-treating-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-guidance-ta649-1.html 2020-09-25T11:58:41.0130000Z https://www.medicinesresources.nhs.uk/evaluating-prophylactic-heparin-in-ambulatory-patients-with-solid-tumours-a-systematic-review-and-individual-participant-data-meta-analysis.html 2020-09-23T15:05:05.8510000Z https://www.medicinesresources.nhs.uk/cardiovascular-adverse-events-associated-with-hydroxychloroquine-and-chloroquine-a-comprehensive-pharmacovigilance-analysis-of-pre-covid-19-reports.html 2020-09-25T12:09:15.7660000Z https://www.medicinesresources.nhs.uk/under-reported-relationship-a-comparative-study-of-pharmaceutical-industry-and-patient-organisation-payment-disclosures-in-the-uk-2012-2016.html 2020-09-23T15:16:33.3340000Z https://www.medicinesresources.nhs.uk/durvalumab-alone-and-durvalumab-plus-tremelimumab-versus-chemotherapy-in-previously-untreated-patients-with-unresectable-locally-advanced-or-metastatic-urothelial-carcinoma-danube-a-randomised-open-label-multicentre-phase-3-trial.html 2020-09-23T15:20:51.4120000Z https://www.medicinesresources.nhs.uk/neurorx-submits-request-for-emergency-use-authorization-with-the-us-fda-for-aviptadil-in-the-treatment-of-patients-with-critical-covid-19-and-respiratory-failure-who-have-exhausted-approved-therapy.html 2020-09-23T15:22:15.9890000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-updated-guideline-on-the-management-of-atrial-fibrillation.html 2020-09-23T15:27:16.2880000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-updated-guideline-on-the-management-of-diabetes-in-pregnancy.html 2020-09-23T15:29:42.6940000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-updated-guideline-on-the-diagnosis-and-management-of-diabetes-type-1-and-2-in-children-and-young-people.html 2020-09-23T15:30:56.1630000Z https://www.medicinesresources.nhs.uk/the-courage-of-compassion-supporting-nurses-and-midwives-to-deliver-high-quality-care.html 2020-09-23T15:32:49.4960000Z https://www.medicinesresources.nhs.uk/sanofi-and-glaxosmithkline-agree-a-deal-with-eu-for-300-million-covid-19-vaccine-doses.html 2020-09-23T15:37:05.1960000Z https://www.medicinesresources.nhs.uk/pandemic-delivery-service-further-extension-for-patients-in-local-outbreak-areas.html 2020-09-23T15:38:48.8830000Z https://www.medicinesresources.nhs.uk/evaluating-detection-of-sars-cov-2-antibodies-at-home-study.html 2020-09-23T15:41:24.4130000Z https://www.medicinesresources.nhs.uk/using-economic-development-to-improve-health-and-reduce-health-inequalities.html 2020-09-23T15:42:34.0400000Z https://www.medicinesresources.nhs.uk/mandatory-disclosure-of-financial-interests-of-journals-and-editors.html 2020-09-23T15:43:34.6360000Z https://www.medicinesresources.nhs.uk/covid-19-government-urged-to-publish-results-of-pilots-of-contract-tracing-app.html 2020-09-23T15:44:36.5560000Z https://www.medicinesresources.nhs.uk/covid-19-whats-going-wrong-with-testing-in-the-uk.html 2020-09-23T15:47:10.4170000Z https://www.medicinesresources.nhs.uk/effects-of-the-covid-19-pandemic-on-supply-and-use-of-blood-for-transfusion.html 2020-09-23T15:48:33.8570000Z https://www.medicinesresources.nhs.uk/covid-19-new-restrictions-to-curb-rising-infection-rate-are-set-throughout-uk.html 2020-09-23T16:16:19.5740000Z https://www.medicinesresources.nhs.uk/upper-respiratory-viral-load-in-asymptomatic-individuals-and-mildly-symptomatic-patients-with-sars-cov-2-infection.html 2020-09-23T16:18:37.9230000Z https://www.medicinesresources.nhs.uk/asthma-and-all-cause-mortality-in-children-and-young-adults-a-population-based-study.html 2020-09-23T16:19:51.1850000Z https://www.medicinesresources.nhs.uk/national-burden-estimates-of-hospitalisations-for-acute-lower-respiratory-infections-due-to-respiratory-syncytial-virus-in-young-children-in-2019-among-58-countries-a-modelling-study.html 2020-09-23T16:21:49.1990000Z https://www.medicinesresources.nhs.uk/new-product-syncrodin-melatonin-3-mg-film-coated-tablets.html 2020-09-24T15:27:08.1480000Z https://www.medicinesresources.nhs.uk/investigation-into-the-role-of-clinical-pharmacy-services-in-helping-to-identify-and-reduce-high-risk-prescribing-errors-in-hospital.html 2020-09-24T17:15:32.2130000Z https://www.medicinesresources.nhs.uk/opioids-risk-of-dependence-and-addiction.html 2020-09-25T12:04:20.4030000Z https://www.medicinesresources.nhs.uk/insulins-all-types-risk-of-cutaneous-amyloidosis-at-injection-site.html 2020-09-25T12:05:29.5820000Z https://www.medicinesresources.nhs.uk/methotrexate-once-weekly-for-autoimmune-diseases-new-measures-to-reduce-risk-of-fatal-overdose-due-to-inadvertent-daily-instead-of-weekly-dosing.html 2020-09-25T12:06:00.5920000Z https://www.medicinesresources.nhs.uk/transdermal-fentanyl-patches-for-non-cancer-pain-do-not-use-in-opioid-naive-patients.html 2020-09-25T12:06:48.7580000Z https://www.medicinesresources.nhs.uk/central-fatness-and-risk-of-all-cause-mortality-systematic-review-and-dose-response-meta-analysis-of-72-prospective-cohort-studies.html 2020-09-24T15:34:15.6560000Z https://www.medicinesresources.nhs.uk/low-molecular-weight-heparin-for-prevention-of-central-venous-catheter-related-thrombosis-in-children.html 2020-09-24T17:19:08.7080000Z https://www.medicinesresources.nhs.uk/vitamin-a-and-fish-oils-for-preventing-the-progression-of-retinitis-pigmentosa.html 2020-09-24T17:19:50.0210000Z https://www.medicinesresources.nhs.uk/negative-pressure-wound-therapy-for-surgical-wounds-healing-by-primary-closure-1.html 2020-09-24T15:37:45.1300000Z https://www.medicinesresources.nhs.uk/progestogen-releasing-intrauterine-systems-for-heavy-menstrual-bleeding.html 2020-09-24T17:21:15.1260000Z https://www.medicinesresources.nhs.uk/medicine-use-in-diving-what-information-is-available.html 2020-09-24T17:22:46.9050000Z https://www.medicinesresources.nhs.uk/can-oral-bisphosphonates-be-given-to-people-with-renal-impairment-to-treat-osteoporosis.html 2020-09-25T12:07:44.5010000Z https://www.medicinesresources.nhs.uk/plerixafor-for-stem-cell-mobilisation-in-adults-and-children.html 2020-09-25T12:07:30.5400000Z https://www.medicinesresources.nhs.uk/rituximab-and-eculizumab-for-the-prevention-and-management-of-delayed-haemolytic-transfusion-reactions-and-hyperhaemolysis-in-patients-with-haemoglobinopathies.html 2020-09-25T12:08:47.9070000Z https://www.medicinesresources.nhs.uk/vonicog-alfa-for-the-treatment-and-prevention-of-bleeding-in-adults-with-von-willebrand-disease.html 2020-09-25T12:01:34.8460000Z https://www.medicinesresources.nhs.uk/monitoring-approaches-for-health-care-workers-during-the-covid-19-pandemic.html 2020-09-24T17:25:05.9390000Z https://www.medicinesresources.nhs.uk/whistleblowing-disclosures-report-2020.html 2020-09-24T15:48:25.7630000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-launches-public-consultation-on-draft-guideline-on-registry-based-studies.html 2020-09-24T15:49:40.1240000Z https://www.medicinesresources.nhs.uk/nhs-covid-19-app-launches-across-england-and-wales.html 2020-09-24T15:57:38.6470000Z https://www.medicinesresources.nhs.uk/safely-returning-clinically-vulnerable-people-to-work.html 2020-09-24T15:59:05.4710000Z https://www.medicinesresources.nhs.uk/growth-concerns-in-the-early-weeks-of-life.html 2020-09-24T16:00:35.1190000Z https://www.medicinesresources.nhs.uk/operation-moonshot-proposals-are-scientifically-unsound.html 2020-09-24T17:30:00.3350000Z https://www.medicinesresources.nhs.uk/rolling-biologics-license-application-submitted-to-fda-for-balstilimab-for-treatment-of-recurrent-or-metastatic-cervical-cancer.html 2020-09-24T17:32:58.8530000Z https://www.medicinesresources.nhs.uk/biologics-license-application-submitted-to-fda-for-loncastuximab-tesirine-for-treatment-of-relapsed-or-refractory-diffuse-large-b-cell-lymphoma.html 2020-09-24T16:04:13.8470000Z https://www.medicinesresources.nhs.uk/fda-and-european-medicines-agency-accept-marketing-application-submissions-for-bimekizumab-for-treatment-of-adults-with-moderate-to-severe-plaque-psoriasis.html 2020-09-24T16:05:59.2590000Z https://www.medicinesresources.nhs.uk/fda-accepts-biologics-license-application-bla-for-investigational-b-cell-maturation-antigen-bcma-directed-chimeric-antigen-receptor-car-t-cell-immunotherapy-ide-cel-for-treatment-of-multiple-myeloma.html 2020-09-24T16:07:15.5170000Z https://www.medicinesresources.nhs.uk/fda-accepts-supplemental-new-drug-application-for-crizotinib-for-treatment-of-paediatric-alk-positive-anaplastic-large-cell-lymphoma.html 2020-09-24T16:08:36.1040000Z https://www.medicinesresources.nhs.uk/fda-requiring-labeling-changes-for-benzodiazepines.html 2020-09-24T16:10:25.0560000Z https://www.medicinesresources.nhs.uk/j-and-j-s-one-dose-covid-19-vaccine-candidate-jnj-78436735-begins-phase-iii-trial.html 2020-09-24T17:36:33.2920000Z https://www.medicinesresources.nhs.uk/fda-authorises-first-point-of-care-poc-antibody-test-for-covid-19.html 2020-09-24T16:13:44.6480000Z https://www.medicinesresources.nhs.uk/safety-leaflet-on-opioid-medicines-and-the-risk-of-addiction.html 2020-09-24T16:19:12.8390000Z https://www.medicinesresources.nhs.uk/effect-of-prophylactic-negative-pressure-wound-therapy-vs-standard-wound-dressing-on-surgical-site-infection-in-obese-women-after-cesarean-delivery-a-randomized-clinical-trial.html 2020-09-24T16:24:00.5120000Z https://www.medicinesresources.nhs.uk/effect-of-clopidogrel-and-aspirin-vs-aspirin-alone-on-migraine-headaches-after-transcatheter-atrial-septal-defect-closure-one-year-results-of-the-canoa-randomized-clinical-trial.html 2020-09-24T16:25:06.7210000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-vp-102-a-proprietary-drug-device-combination-product-containing-cantharidin-0-7-w-v-in-children-and-adults-with-molluscum-contagiosum-two-phase-3-randomized-clinical-trials.html 2020-09-24T17:39:35.6800000Z https://www.medicinesresources.nhs.uk/cardiovascular-outcomes-with-ertugliflozin-in-type-2-diabetes.html 2020-09-24T16:27:16.8030000Z https://www.medicinesresources.nhs.uk/effect-of-escalating-and-deescalating-financial-incentives-vs-usual-care-to-improve-antidepressant-adherence-a-pilot-randomized-clinical-trial.html 2020-09-24T17:41:11.0760000Z https://www.medicinesresources.nhs.uk/congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency.html 2020-09-24T16:29:29.5250000Z https://www.medicinesresources.nhs.uk/sodium-glucose-cotransporter-2-inhibitors-and-risk-of-major-adverse-cardiovascular-events-multi-database-retrospective-cohort-study-1.html 2020-09-24T17:02:14.3120000Z https://www.medicinesresources.nhs.uk/navigating-stormy-waters-10-years-of-operation-of-the-european-union-regulatory-network-incident-management-plan-for-medicines-for-human-use.html 2020-09-24T17:01:16.9900000Z https://www.medicinesresources.nhs.uk/metformin-use-is-associated-with-slowed-cognitive-decline-and-reduced-incident-dementia-in-older-adults-with-type-2-diabetes-the-sydney-memory-and-ageing-study.html 2020-09-24T17:03:29.7850000Z https://www.medicinesresources.nhs.uk/association-of-sars-cov-2-test-status-and-pregnancy-outcomes.html 2020-09-24T17:04:45.2820000Z https://www.medicinesresources.nhs.uk/covid-19-among-people-experiencing-homelessness-in-england-a-modelling-study.html 2020-09-24T17:06:35.3310000Z https://www.medicinesresources.nhs.uk/pulmonary-post-mortem-findings-in-a-series-of-covid-19-cases-from-northern-italy-a-two-centre-descriptive-study.html 2020-09-24T17:09:26.8340000Z https://www.medicinesresources.nhs.uk/performance-characteristics-of-five-immunoassays-for-sars-cov-2-a-head-to-head-benchmark-comparison.html 2020-09-24T17:53:15.7040000Z https://www.medicinesresources.nhs.uk/effects-of-once-weekly-subcutaneous-semaglutide-on-kidney-function-and-safety-in-patients-with-type-2-diabetes-a-post-hoc-analysis-of-the-sustain-1-7-randomised-controlled-trials.html 2020-09-24T17:11:10.2140000Z https://www.medicinesresources.nhs.uk/associations-between-prenatal-cannabis-exposure-and-childhood-outcomes-results-from-the-abcd-study.html 2020-09-24T17:48:41.7050000Z https://www.medicinesresources.nhs.uk/september-bnf-bnfc-newsletter.html 2020-09-25T16:58:10.0720000Z https://www.medicinesresources.nhs.uk/september-bnf-bnfc-newsletter-1.html 2020-09-25T16:56:26.0390000Z https://www.medicinesresources.nhs.uk/doravirine-pifeltro-r.html 2020-09-25T17:01:53.5100000Z https://www.medicinesresources.nhs.uk/doravirine-lamivudine-tenofovir-disoproxil-fumarate-delstrigo-r.html 2020-09-25T17:03:04.1620000Z https://www.medicinesresources.nhs.uk/revised-spcs-ventolin-salbutamol-nebules-2-5-and-5-0-mg.html 2020-09-25T17:03:50.1490000Z https://www.medicinesresources.nhs.uk/revised-spc-kevzara-sarilumab-solution-for-injection-in-pre-filled-pen-all-strengths.html 2020-09-25T17:04:37.5020000Z https://www.medicinesresources.nhs.uk/new-product-daurismo-glasdegib-25-and-100-mg-film-coated-tablets.html 2020-09-25T17:05:37.5610000Z https://www.medicinesresources.nhs.uk/revised-spcs-efexor-xl-75-and-225-mg-prolonged-release-capsules-hard-products.html 2020-09-25T17:07:41.5750000Z https://www.medicinesresources.nhs.uk/revised-spcs-humalog-insulin-lispro-products.html 2020-09-25T17:08:22.9690000Z https://www.medicinesresources.nhs.uk/revised-spc-trelegy-ellipta-92-micrograms-55-micrograms-22-micrograms-fluticasone-furoate-umeclidinium-bromide-vilanterol-trifenatate-inhalation-powder-pre-dispensed.html 2020-09-25T17:09:24.2530000Z https://www.medicinesresources.nhs.uk/benadryl-diphenhydramine-drug-safety-communication-serious-problems-with-high-doses-of-the-allergy-medicine.html 2020-09-25T17:13:24.8140000Z https://www.medicinesresources.nhs.uk/evaluation-of-daratumumab-for-the-treatment-of-multiple-myeloma-in-patients-with-high-risk-cytogenetic-factors-a-systematic-review-and-meta-analysis.html 2020-09-25T17:14:07.9860000Z https://www.medicinesresources.nhs.uk/withdrawal-of-antihypertensive-drugs-in-older-people-cochrane-systematic-review-intervention-version-published.html 2020-09-25T17:15:13.4340000Z https://www.medicinesresources.nhs.uk/metformin-monotherapy-for-adults-with-type-2-diabetes-mellitus.html 2020-09-25T17:16:18.6220000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-rapid-tests-to-guide-antibiotic-prescriptions-for-sore-throat.html 2020-09-25T17:17:27.6320000Z https://www.medicinesresources.nhs.uk/dapagliflozin-in-patients-with-chronic-kidney-disease.html 2020-09-25T17:18:25.3910000Z https://www.medicinesresources.nhs.uk/imiquimod-versus-podophyllotoxin-with-and-without-human-papillomavirus-vaccine-for-anogenital-warts-the-hipvac-factorial-rct.html 2020-09-25T17:19:20.8170000Z https://www.medicinesresources.nhs.uk/effectiveness-of-fevipiprant-in-reducing-exacerbations-in-patients-with-severe-asthma-luster-1-and-luster-2-two-phase-3-randomised-controlled-trials.html 2020-09-25T17:20:12.7920000Z https://www.medicinesresources.nhs.uk/gabapentin-for-chronic-pelvic-pain-in-women-gapp2-a-multicentre-randomised-double-blind-placebo-controlled-trial.html 2020-09-25T17:22:06.1750000Z https://www.medicinesresources.nhs.uk/risk-of-covid-19-related-death-among-patients-with-chronic-obstructive-pulmonary-disease-or-asthma-prescribed-inhaled-corticosteroids-an-observational-cohort-study-using-the-opensafely-platform.html 2020-09-25T17:24:10.9800000Z https://www.medicinesresources.nhs.uk/interactions-between-sars-cov-2-and-influenza-and-the-impact-of-coinfection-on-disease-severity-a-test-negative-design.html 2020-09-25T17:25:29.3700000Z https://www.medicinesresources.nhs.uk/lessons-learnt-from-easing-covid-19-restrictions-an-analysis-of-countries-and-regions-in-asia-pacific-and-europe.html 2020-09-25T17:26:20.6530000Z https://www.medicinesresources.nhs.uk/diagnosis-of-physical-and-mental-health-conditions-in-primary-care-during-the-covid-19-pandemic-a-retrospective-cohort-study.html 2020-09-25T17:28:06.6780000Z https://www.medicinesresources.nhs.uk/gastrointestinal-complications-in-critically-ill-patients-with-and-without-covid-19.html 2020-09-25T17:29:00.9790000Z https://www.medicinesresources.nhs.uk/efficacy-of-plinabulin-vs-pegfilgrastim-for-prevention-of-chemotherapy-induced-neutropenia-in-adults-with-non-small-cell-lung-cancer-a-phase-2-randomized-clinical-trial.html 2020-09-25T17:30:06.5160000Z https://www.medicinesresources.nhs.uk/accord-healthcare-launches-herceptin-biosimilar-in-the-uk.html 2020-09-25T18:02:13.7040000Z https://www.medicinesresources.nhs.uk/uk-consumers-seeking-advice-from-pharmacists-during-pandemic-research-finds.html 2020-09-25T17:32:03.0890000Z https://www.medicinesresources.nhs.uk/protecting-the-most-vulnerable-mental-health-patients-during-a-pandemic.html 2020-09-25T17:32:51.6410000Z https://www.medicinesresources.nhs.uk/dementia-wellbeing-in-the-covid-19-pandemic.html 2020-09-25T17:35:09.2730000Z https://www.medicinesresources.nhs.uk/rationale-for-immune-checkpoint-inhibitors-plus-targeted-therapy-in-metastatic-melanoma-a-review.html 2020-09-25T17:35:57.8040000Z https://www.medicinesresources.nhs.uk/the-long-term-impacts-of-new-care-models-on-hospital-use-an-evaluation-of-the-integrated-care-transformation-programme-in-mid-nottinghamshire.html 2020-09-25T17:36:53.1420000Z https://www.medicinesresources.nhs.uk/what-the-gbp13bn-debt-write-off-means-for-the-nhs.html 2020-09-25T17:37:59.2370000Z https://www.medicinesresources.nhs.uk/general-pharmaceutical-council-gphc-consultation-on-english-language-guidance.html 2020-09-25T17:38:46.1420000Z https://www.medicinesresources.nhs.uk/latest-nhs-test-and-trace-figures-for-coronavirus-in-england.html 2020-09-25T17:39:23.3910000Z https://www.medicinesresources.nhs.uk/strengthening-the-uk-primary-care-response-to-covid-19.html 2020-09-25T17:40:16.6860000Z https://www.medicinesresources.nhs.uk/case-30-2020-a-54-year-old-man-with-sudden-cardiac-arrest.html 2020-09-25T17:41:21.4080000Z https://www.medicinesresources.nhs.uk/novavax-initiates-phase-iii-trial-of-covid-19-vaccine-candidate-nvx-cov2373-in-uk-in-partnership-with-governments-vaccines-taskforce.html 2020-09-25T17:48:28.1260000Z https://www.medicinesresources.nhs.uk/interim-analysis-checkmate-274-trial-of-nivolumab-in-patients-with-high-risk-muscle-invasive-urothelial-carcinoma-meets-primary-endpoints.html 2020-09-25T17:49:36.9340000Z https://www.medicinesresources.nhs.uk/fda-assigns-orphan-drug-and-rare-pediatric-disease-designations-to-spiro-2101-for-treatment-of-cystic-fibrosis.html 2020-09-25T17:51:28.5210000Z https://www.medicinesresources.nhs.uk/fda-grants-setrusumab-rare-pediatric-disease-designation-for-treatment-of-osteogenesis-imperfecta-oi.html 2020-09-25T17:53:09.1770000Z https://www.medicinesresources.nhs.uk/fda-assigns-orphan-drug-designation-to-gene-therapy-nr082-for-treatment-of-leber-s-hereditary-optic-neuropathy-associated-with-nd4-mutation.html 2020-09-25T17:54:22.2990000Z https://www.medicinesresources.nhs.uk/the-new-national-genomic-healthcare-strategy-genome-uk-the-future-of-healthcare-1.html 2020-10-04T15:56:33.6440000Z https://www.medicinesresources.nhs.uk/susceptibility-to-sars-cov-2-infection-among-children-and-adolescents-compared-with-adults-a-systematic-review-and-meta-analysis.html 2020-10-04T16:01:41.3650000Z https://www.medicinesresources.nhs.uk/serum-25-hydroxyvitamin-d-level-in-relation-to-weight-change-and-the-risk-of-weight-gain-in-adults-of-normal-weight-at-baseline-the-norwegian-hunt-cohort-study.html 2020-09-28T13:44:19.5440000Z https://www.medicinesresources.nhs.uk/clinical-risk-score-to-predict-in-hospital-mortality-in-covid-19-patients-a-retrospective-cohort-study.html 2020-09-28T13:47:38.9130000Z https://www.medicinesresources.nhs.uk/antidiabetes-agents-and-incident-depression-a-nationwide-population-based-study.html 2020-09-28T13:49:16.3020000Z https://www.medicinesresources.nhs.uk/dabigatran-trough-concentrations-in-very-elderly-patients.html 2020-09-28T14:23:55.2370000Z https://www.medicinesresources.nhs.uk/prevalence-of-sars-cov-2-antibodies-in-a-large-nationwide-sample-of-patients-on-dialysis-in-the-usa-a-cross-sectional-study.html 2020-09-28T14:25:14.2660000Z https://www.medicinesresources.nhs.uk/extracorporeal-membrane-oxygenation-support-in-covid-19-an-international-cohort-study-of-the-extracorporeal-life-support-organization-registry.html 2020-09-28T13:58:23.7680000Z https://www.medicinesresources.nhs.uk/personal-protective-equipment-ppe-strategy-stabilise-and-build-resilience.html 2020-10-04T16:03:23.7860000Z https://www.medicinesresources.nhs.uk/childhood-vaccination-coverage-statistics-england-2019-20.html 2020-09-28T14:01:38.7880000Z https://www.medicinesresources.nhs.uk/european-commission-grants-marketing-authorisation-for-filgotinib-jyselca-for-treatment-of-moderate-to-severe-active-rheumatoid-arthritis.html 2020-09-28T14:04:35.5820000Z https://www.medicinesresources.nhs.uk/fda-approves-mepolizumab-nucala-for-adults-and-children-aged-12-years-and-older-with-hypereosinophilic-syndrome-hes.html 2020-09-28T14:07:34.0910000Z https://www.medicinesresources.nhs.uk/da-issues-complete-response-letter-for-libervant-diazepam-buccal-film-for-seizure-clusters.html 2020-09-28T14:29:56.8340000Z https://www.medicinesresources.nhs.uk/european-approval-of-avapritinib-ayvakyt-for-the-treatment-of-gastrointestinal-stromal-tumours-gist.html 2020-09-28T14:10:30.4550000Z https://www.medicinesresources.nhs.uk/convalescent-plasma-for-the-treatment-of-covid-19-perspectives-of-the-national-institutes-of-health-covid-19-treatment-guidelines-panel.html 2020-09-28T14:12:14.9380000Z https://www.medicinesresources.nhs.uk/new-legal-duty-to-self-isolate-comes-into-force-today.html 2020-09-28T14:13:49.5140000Z https://www.medicinesresources.nhs.uk/huge-increase-in-uk-personal-protective-equipment-production.html 2020-09-28T14:15:27.3360000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-how-to-self-isolate-when-you-travel-to-the-uk-1.html 2020-09-28T14:37:15.4370000Z https://www.medicinesresources.nhs.uk/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-25-september-2020.html 2020-10-04T16:04:30.0770000Z https://www.medicinesresources.nhs.uk/guidance-to-parents-and-guardians-when-you-should-book-a-coronavirus-test-for-your-child.html 2020-09-28T14:19:07.1960000Z https://www.medicinesresources.nhs.uk/surge-in-people-checking-their-risk-of-type-2-diabetes.html 2020-09-28T14:39:59.5720000Z https://www.medicinesresources.nhs.uk/revised-spc-efexor-venlafaxine-xl150-mg-hard-prolonged-release-capsules.html 2020-09-28T14:26:01.7680000Z https://www.medicinesresources.nhs.uk/vitamin-k-supplementation-for-cystic-fibrosis.html 2020-09-28T14:27:15.2720000Z https://www.medicinesresources.nhs.uk/telephone-interventions-for-symptom-management-in-adults-with-cancer.html 2020-09-28T14:28:29.1600000Z https://www.medicinesresources.nhs.uk/interventions-to-prevent-women-from-developing-gestational-diabetes-mellitus-an-overview-of-cochrane-reviews.html 2020-09-28T14:29:42.7790000Z https://www.medicinesresources.nhs.uk/a-systematic-review-of-the-effect-of-delayed-appropriate-antibiotic-treatment-on-the-outcomes-of-patients-with-severe-bacterial-infections.html 2020-09-28T14:31:03.3630000Z https://www.medicinesresources.nhs.uk/level-or-not-comparing-general-practice-in-areas-of-high-and-low-socioeconomic-deprivation-in-england.html 2020-09-28T14:32:21.3660000Z https://www.medicinesresources.nhs.uk/the-use-of-generic-anti-epileptics-drugs-in-patients-with-epilepsy.html 2020-10-04T15:35:23.3630000Z https://www.medicinesresources.nhs.uk/renin-angiotensin-aldosterone-system-inhibitors-and-risk-of-death-in-patients-hospitalised-with-covid-19-a-retrospective-italian-cohort-study-of-43-000-patients.html 2020-09-29T15:57:37.4480000Z https://www.medicinesresources.nhs.uk/interventions-for-preventing-mastitis-after-childbirth.html 2020-09-29T13:54:35.6160000Z https://www.medicinesresources.nhs.uk/alcohol-intake-reduction-for-controlling-hypertension.html 2020-09-29T15:58:42.8760000Z https://www.medicinesresources.nhs.uk/magnesium-for-skeletal-muscle-cramps.html 2020-09-29T13:57:54.1280000Z https://www.medicinesresources.nhs.uk/sublingual-immunotherapy-for-asthma.html 2020-09-29T15:59:26.7540000Z https://www.medicinesresources.nhs.uk/us-fda-approves-xeljanz-tofacitinib-tablets-and-oral-solution-for-the-treatment-of-active-polyarticular-course-juvenile-idiopathic-arthritis-1.html 2020-09-29T16:01:24.7420000Z https://www.medicinesresources.nhs.uk/us-fda-grants-orphan-drug-and-fast-track-designation-to-elezanumab-a-monoclonal-antibody-repulsive-guidance-molecule-a-rgma-inhibitor-for-treatment-of-spinal-cord-injury.html 2020-09-29T14:30:20.6350000Z https://www.medicinesresources.nhs.uk/us-fda-approves-haegarda-a-subcutaneous-c1-esterase-inhibitor-for-prevention-of-hereditary-angioedema-hae-attacks-in-paediatric-patients.html 2020-09-29T14:31:29.3900000Z https://www.medicinesresources.nhs.uk/covid-19-glitch-leaves-more-than-60-000-tests-carried-out-in-england-unable-to-link-test-results-to-new-contact-tracing-app.html 2020-09-29T14:32:31.5330000Z https://www.medicinesresources.nhs.uk/covid-19-government-poised-to-amend-regulations-to-allow-use-of-unlicensed-vaccine.html 2020-09-29T14:33:53.6000000Z https://www.medicinesresources.nhs.uk/impact-of-covid-19-on-loneliness-mental-health-and-health-service-utilisation-a-prospective-cohort-study-of-older-adults-with-multimorbidity-in-primary-care.html 2020-09-29T14:35:25.3840000Z https://www.medicinesresources.nhs.uk/socioeconomic-status-and-hrt-prescribing-a-study-of-practice-level-data-in-england.html 2020-09-29T16:04:46.5710000Z https://www.medicinesresources.nhs.uk/dtb-review-three-new-drugs-for-the-prevention-of-migraine.html 2020-10-04T15:36:49.4070000Z https://www.medicinesresources.nhs.uk/incidence-and-associated-risk-factors-of-antituberculosis-drug-induced-hepatotoxicity-among-hospitalised-patients-in-wuhan-china.html 2020-09-29T16:05:35.1870000Z https://www.medicinesresources.nhs.uk/the-exclusion-of-older-persons-from-vaccine-and-treatment-trials-for-coronavirus-disease-2019-missing-the-target.html 2020-09-29T16:06:35.8540000Z https://www.medicinesresources.nhs.uk/covid-19-severity-and-outcomes-in-patients-with-cancer-a-matched-cohort-study.html 2020-09-29T16:26:02.6730000Z https://www.medicinesresources.nhs.uk/nice-impact-report-end-of-life-care-for-adults.html 2020-10-04T15:37:34.8000000Z https://www.medicinesresources.nhs.uk/nihr-alert-tranexamic-acid-should-not-be-used-for-patients-with-severe-gastrointestinal-bleeding.html 2020-10-04T15:38:59.8610000Z https://www.medicinesresources.nhs.uk/first-uk-patient-given-gsks-experimental-arthritis-drug-in-covid-19-trial.html 2020-09-29T16:28:10.8650000Z https://www.medicinesresources.nhs.uk/health-matters-flu-immunisation-programme-and-covid-19.html 2020-09-29T16:29:15.1290000Z https://www.medicinesresources.nhs.uk/remdesivir-for-patients-hospitalised-with-covid-19-adults-and-children-aged-12-years-and-older-supply-disruption.html 2020-10-04T15:41:10.4270000Z https://www.medicinesresources.nhs.uk/pembrolizumab-with-axitinib-for-untreated-advanced-renal-cell-carcinoma-guidance-ta650.html 2020-10-04T15:11:39.4120000Z https://www.medicinesresources.nhs.uk/naldemedine-for-treating-opioid-induced-constipation-guidance-ta651.html 2020-10-04T15:22:52.8970000Z https://www.medicinesresources.nhs.uk/revised-spc-buvidal-buprenorphine-prolonged-release-solution-for-injection.html 2020-09-30T14:23:06.0380000Z https://www.medicinesresources.nhs.uk/revised-spc-livial-tibolone-tablets.html 2020-09-30T14:25:17.2600000Z https://www.medicinesresources.nhs.uk/new-product-prevymis-letermovir-concentrate-for-solution-for-infusion.html 2020-09-30T14:27:02.3350000Z https://www.medicinesresources.nhs.uk/revised-spc-crestor-rosuvastatin-tablets.html 2020-09-30T14:28:21.8250000Z https://www.medicinesresources.nhs.uk/new-product-ruxience-rituximab-concentrate-for-solution-for-infusion.html 2020-09-30T14:29:38.1290000Z https://www.medicinesresources.nhs.uk/revised-spc-loperamide-tablets.html 2020-09-30T14:31:17.2710000Z https://www.medicinesresources.nhs.uk/revised-spc-copaxone-glatiramer-solution-for-injection-in-pre-filled-syringe.html 2020-09-30T16:23:18.2660000Z https://www.medicinesresources.nhs.uk/revised-spc-atrovent-ipratropium-respirator-solutions.html 2020-09-30T14:33:47.4890000Z https://www.medicinesresources.nhs.uk/hepatocellular-carcinoma-incidence-with-tenofovir-versus-entecavir-in-chronic-hepatitis-b-a-systematic-review-and-meta-analysis.html 2020-09-30T14:35:39.6280000Z https://www.medicinesresources.nhs.uk/vigabatrin-add-on-therapy-for-drug-resistant-focal-epilepsy.html 2020-09-30T14:36:44.9970000Z https://www.medicinesresources.nhs.uk/interventions-for-treating-people-with-symptoms-of-bladder-pain-syndrome-a-network-meta-analysis.html 2020-09-30T14:38:21.0040000Z https://www.medicinesresources.nhs.uk/topical-anaesthesia-plus-intracameral-lidocaine-versus-topical-anaesthesia-alone-for-phacoemulsification-cataract-surgery-in-adults.html 2020-09-30T14:41:04.3990000Z https://www.medicinesresources.nhs.uk/signs-and-symptoms-to-determine-if-a-patient-presenting-in-primary-care-or-hospital-outpatient-settings-has-covid-19-disease.html 2020-10-04T15:29:55.8210000Z https://www.medicinesresources.nhs.uk/intravenous-versus-oral-antibiotics-for-eradication-of-pseudomonas-aeruginosa-in-cystic-fibrosis-torpedo-cf-a-randomised-controlled-trial.html 2020-09-30T14:45:35.3130000Z https://www.medicinesresources.nhs.uk/infant-respiratory-syncytial-virus-prophylaxis-and-nasopharyngeal-microbiota-until-6-years-of-life-a-subanalysis-of-the-maki-randomised-controlled-trial.html 2020-09-30T14:47:36.4390000Z https://www.medicinesresources.nhs.uk/natalizumab-in-acute-ischemic-stroke-action-ii-a-randomized-placebo-controlled-trial.html 2020-09-30T14:49:07.4710000Z https://www.medicinesresources.nhs.uk/hospital-admissions-for-acute-myocardial-infarction-before-and-after-lockdown-according-to-regional-prevalence-of-covid-19-and-patient-profile-in-france-a-registry-study.html 2020-09-30T14:55:17.0560000Z https://www.medicinesresources.nhs.uk/the-burden-of-neurological-diseases-in-europe-an-analysis-for-the-global-burden-of-disease-study-2017.html 2020-09-30T14:56:19.1140000Z https://www.medicinesresources.nhs.uk/effect-of-calcifediol-treatment-and-best-available-therapy-versus-best-available-therapy-on-intensive-care-unit-admission-and-mortality-among-patients-hospitalized-for-covid-19-a-pilot-randomized-clinical-study.html 2020-09-30T15:00:21.9500000Z https://www.medicinesresources.nhs.uk/sitagliptin-treatment-at-the-time-of-hospitalization-was-associated-with-reduced-mortality-in-patients-with-type-2-diabetes-and-covid-19-a-multicenter-case-control-retrospective-observational-study.html 2020-09-30T15:01:44.8470000Z https://www.medicinesresources.nhs.uk/regular-use-of-proton-pump-inhibitors-and-risk-of-type-2-diabetes-results-from-three-prospective-cohort-studies.html 2020-09-30T15:02:51.9350000Z https://www.medicinesresources.nhs.uk/morbidity-and-mortality-associated-with-prescription-cannabinoid-drug-use-in-copd.html 2020-09-30T15:04:54.9350000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-sars-cov-2-mrna-1273-vaccine-in-older-adults.html 2020-09-30T15:06:15.3370000Z https://www.medicinesresources.nhs.uk/key-evidence-supporting-prescription-opioids-approved-by-the-u-s-food-and-drug-administration-1997-to-2018.html 2020-09-30T15:07:16.6970000Z https://www.medicinesresources.nhs.uk/american-college-of-rheumatology-guidance-for-the-management-of-pediatric-rheumatic-disease-during-the-covid-19-pandemic-version-1.html 2020-09-30T15:08:59.7680000Z https://www.medicinesresources.nhs.uk/expert-perspective-an-evidence-based-approach-to-refractory-cutaneous-lupus-erythematosus.html 2020-09-30T15:11:01.7690000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-from-the-jupiter-02-phase-iii-study-for-toripalimab-in-recurrent-or-metastatic-nasopharyngeal-carcinoma.html 2020-09-30T15:12:00.5470000Z https://www.medicinesresources.nhs.uk/fda-to-review-fosdenopterin-for-molybdenum-cofactor-deficiency-mocd-type-a.html 2020-09-30T15:13:15.1960000Z https://www.medicinesresources.nhs.uk/manufacturers-to-submit-new-drug-application-for-accelerated-approval-of-pacritinib-for-myelofibrosis-with-severe-thrombocytopenia.html 2020-09-30T15:14:26.9390000Z https://www.medicinesresources.nhs.uk/class-3-drug-alert-action-within-5-days-theramex-ireland-ltd-t-a-theramex-hq-uk-ltd-alfa-d-0-25-microgram-capsules-pl-49876-0001-and-alfa-d-1-microgram-capsules-pl-49876-0003.html 2020-09-30T15:16:13.5700000Z https://www.medicinesresources.nhs.uk/advances-in-understanding-and-reducing-the-burden-of-severe-asthma-in-children.html 2020-09-30T15:17:35.1030000Z https://www.medicinesresources.nhs.uk/the-genetics-of-asthma-and-the-promise-of-genomics-guided-drug-target-discovery.html 2020-09-30T15:22:16.9530000Z https://www.medicinesresources.nhs.uk/investigation-into-how-government-increased-the-number-of-ventilators-available-to-the-nhs-in-response-to-covid-19.html 2020-09-30T15:23:49.8580000Z https://www.medicinesresources.nhs.uk/worst-hit-dementia-during-coronavirus.html 2020-09-30T15:25:10.6170000Z https://www.medicinesresources.nhs.uk/avalglucosidase-alfa-granted-promising-innovative-medicine-pim-status-for-pompe-disease.html 2020-09-30T15:26:28.4120000Z https://www.medicinesresources.nhs.uk/management-of-suspected-bacterial-lower-urinary-tract-infection-in-adult-women.html 2020-10-04T14:55:33.3580000Z https://www.medicinesresources.nhs.uk/new-product-aybintio-bevacizumab-25-mg-ml-concentrate-for-solution-for-infusion.html 2020-10-01T16:46:37.5180000Z https://www.medicinesresources.nhs.uk/revised-spc-bavencio-avelumab-20-mg-ml-concentrate-for-solution-for-infusion.html 2020-10-01T15:28:39.8630000Z https://www.medicinesresources.nhs.uk/topical-treatment-for-facial-burns.html 2020-10-01T16:48:02.5220000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-treating-intrahepatic-cholestasis-of-pregnancy.html 2020-10-01T16:49:14.5480000Z https://www.medicinesresources.nhs.uk/zonisamide-add-on-therapy-for-focal-epilepsy.html 2020-10-01T16:50:21.2340000Z https://www.medicinesresources.nhs.uk/beta-blockers-for-congestive-heart-failure-in-children.html 2020-10-01T16:51:14.2990000Z https://www.medicinesresources.nhs.uk/the-covid-19-vaccines-being-backed-by-the-uk-and-when-we-might-get-them.html 2020-10-01T15:34:45.3510000Z https://www.medicinesresources.nhs.uk/accord-uk-launches-pelgraz-pegfilgrastim-pre-filled-injector-pfi-and-app.html 2020-10-01T15:35:37.2590000Z https://www.medicinesresources.nhs.uk/novartis-gene-therapies-unveils-new-interim-data-from-ongoing-phase-iii-str1ve-eu-trial-of-zolgensma-onasemnogene-abeparvovec-in-patients-with-spinal-muscular-atrophy-sma-type-1.html 2020-10-01T16:55:01.4080000Z https://www.medicinesresources.nhs.uk/self-care-week-16-22-november-2020.html 2020-10-01T15:37:50.7870000Z https://www.medicinesresources.nhs.uk/readiness-for-increase-in-hospital-admissions-for-covid-19-letter-from-keith-willett-and-pauline-philip.html 2020-10-01T17:01:00.9890000Z https://www.medicinesresources.nhs.uk/nhs-to-introduce-one-stop-shops-in-the-community-for-life-saving-checks.html 2020-10-01T15:39:51.6160000Z https://www.medicinesresources.nhs.uk/myelodysplastic-syndromes.html 2020-10-01T15:40:55.0710000Z https://www.medicinesresources.nhs.uk/covid-19-and-heart-failure-with-preserved-ejection-fraction.html 2020-10-01T15:42:18.8840000Z https://www.medicinesresources.nhs.uk/worst-rank-score-methods-a-nonparametric-approach-to-informatively-missing-data.html 2020-10-01T15:43:32.2790000Z https://www.medicinesresources.nhs.uk/react-1-real-time-assessment-of-community-transmission-of-coronavirus-covid-19-in-september-2020.html 2020-10-01T15:44:51.5650000Z https://www.medicinesresources.nhs.uk/cardiorenal-protection-with-the-newer-antidiabetic-agents-in-patients-with-diabetes-and-chronic-kidney-disease-a-scientific-statement-from-the-american-heart-association.html 2020-10-01T15:45:51.2260000Z https://www.medicinesresources.nhs.uk/covid-19-a-v-shaped-recovery-for-the-nhs.html 2020-10-01T15:46:51.7450000Z https://www.medicinesresources.nhs.uk/neonatal-sepsis.html 2020-10-01T15:49:05.6980000Z https://www.medicinesresources.nhs.uk/shared-care-prescribing-and-monitoring-guidance-in-wales-out-for-consultation.html 2020-10-01T15:50:00.3840000Z https://www.medicinesresources.nhs.uk/phase-iii-orient-32-trial-of-tyvyt-sintilimab-injection-in-combination-with-byvasda-bevacizumab-biosimilar-as-first-line-treatment-of-patients-with-advanced-hepatocellular-carcinoma-meets-primary-endpoints.html 2020-10-01T15:52:19.6900000Z https://www.medicinesresources.nhs.uk/abbott-secures-ce-mark-for-its-next-generation-freestyle-r-libre-3-system.html 2020-10-01T17:07:37.5120000Z https://www.medicinesresources.nhs.uk/scientists-advise-pfizer-to-wait-until-november-to-seek-fda-authorisation-for-its-covid-19-vaccine.html 2020-10-01T17:09:50.6790000Z https://www.medicinesresources.nhs.uk/arcutis-announces-positive-topline-data-from-phase-ii-trial-of-topical-roflumilast-foam-0-3-as-a-potential-treatment-for-seborrheic-dermatitis.html 2020-10-01T15:55:20.2220000Z https://www.medicinesresources.nhs.uk/fda-grants-fast-track-designation-for-eganelisib-in-combination-with-checkpoint-inhibitor-and-chemotherapy-for-first-line-treatment-of-patients-with-inoperable-locally-advanced-or-metastatic-triple-negative-breast-cancer.html 2020-10-01T15:56:14.2220000Z https://www.medicinesresources.nhs.uk/new-drug-application-submitted-to-fda-for-belumosudil-in-patients-with-chronic-graft-versus-host-disease.html 2020-10-01T15:57:15.6490000Z https://www.medicinesresources.nhs.uk/iterum-therapeutics-announces-positive-pre-new-drug-application-meeting-with-fda-for-sulopenem-for-treatment-of-uncomplicated-urinary-tract-infections.html 2020-10-01T15:58:19.0570000Z https://www.medicinesresources.nhs.uk/janssen-submits-new-drug-application-to-fda-for-selexipag-intravenous-injection-to-treat-pulmonary-arterial-hypertension.html 2020-10-01T15:59:17.9930000Z https://www.medicinesresources.nhs.uk/outlook-therapeutics-provides-update-on-progress-towards-first-approved-ophthalmic-formulation-of-bevacizumab-vikg-lytenava-for-advanced-macular-degeneration.html 2020-10-01T16:00:06.0230000Z https://www.medicinesresources.nhs.uk/fda-approves-licence-extension-of-golimumab-to-include-paediatric-use-for-active-psoriatic-arthritis.html 2020-10-01T16:01:11.2760000Z https://www.medicinesresources.nhs.uk/topline-data-announced-for-phase-ii-compare-study-evaluating-sel-212-pegadricase-co-administered-with-immtor-immune-tolerance-platform-for-treatment-of-chronic-refractory-gout-and-a-therapeutic-uricase-enzyme-pegadricase-to-pegloticase-krystexxa-r-the-currently-approved-uricase-in-the-us.html 2020-10-01T17:14:51.8220000Z https://www.medicinesresources.nhs.uk/company-announces-phase-iii-ascent-study-shows-trodelvy-sacituzumab-govitecan-hziy-extends-overall-survival-os-in-brain-metastases-negative-patients-with-metastatic-triple-negative-breast-cancer.html 2020-10-01T16:03:43.1330000Z https://www.medicinesresources.nhs.uk/conference-report-roxadustat-demonstrates-non-inferiority-to-darbepoetin-in-phase-iii-dolomites-study-of-anaemia-in-non-dialysis-dependent-adult-patients-with-chronic-kidney-disease.html 2020-10-01T16:04:40.4810000Z https://www.medicinesresources.nhs.uk/padcev-enfortumab-vedotin-ejfv-improved-overall-survival-at-planned-interim-analysis-of-phase-3-ev-301-trial-in-previously-treated-patients-with-locally-advanced-or-metastatic-urothelial-cancer.html 2020-10-01T16:05:37.4980000Z https://www.medicinesresources.nhs.uk/reproductive-health-patient-group-direction-pgd-templates-insertion-of-etonogestrel-and-administration-of-lidocaine-hydrochloride-1-injection.html 2020-10-04T15:03:20.0210000Z https://www.medicinesresources.nhs.uk/prescribing-outlook-2020.html 2020-10-04T15:03:46.5860000Z https://www.medicinesresources.nhs.uk/cancer-in-the-uk-2020-socio-economic-deprivation.html 2020-10-01T16:10:34.5270000Z https://www.medicinesresources.nhs.uk/atezolizumab-for-first-line-treatment-of-pd-l1-selected-patients-with-nsclc.html 2020-10-01T16:12:01.5440000Z https://www.medicinesresources.nhs.uk/nebulised-alx-0171-for-respiratory-syncytial-virus-lower-respiratory-tract-infection-in-hospitalised-children-a-double-blind-randomised-placebo-controlled-phase-2b-trial.html 2020-10-01T16:13:35.7830000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-two-heterologous-hiv-vaccine-regimens-in-healthy-hiv-uninfected-adults-traverse-a-randomised-parallel-group-placebo-controlled-double-blind-phase-1-2a-study.html 2020-10-01T16:14:40.9050000Z https://www.medicinesresources.nhs.uk/dolutegravir-with-emtricitabine-and-tenofovir-alafenamide-or-tenofovir-disoproxil-fumarate-versus-efavirenz-emtricitabine-and-tenofovir-disoproxil-fumarate-for-initial-treatment-of-hiv-1-infection-advance-week-96-results-from-a-randomised-phase-3-non-inferiority-trial.html 2020-10-01T17:22:42.0610000Z https://www.medicinesresources.nhs.uk/five-year-outcomes-with-nivolumab-in-patients-with-wild-type-braf-advanced-melanoma.html 2020-10-01T16:18:15.3960000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-baricitinib-combined-with-topical-corticosteroids-for-treatment-of-moderate-to-severe-atopic-dermatitis-a-randomized-clinical-trial.html 2020-10-01T16:19:26.0870000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-hydroxychloroquine-vs-placebo-for-pre-exposure-sars-cov-2-prophylaxis-among-health-care-workers-a-randomized-clinical-trial.html 2020-10-01T16:20:38.4770000Z https://www.medicinesresources.nhs.uk/place-and-causes-of-acute-cardiovascular-mortality-during-the-covid-19-pandemic.html 2020-10-01T17:25:37.4180000Z https://www.medicinesresources.nhs.uk/in-hospital-cardiac-arrest-in-critically-ill-patients-with-covid-19-multicenter-cohort-study.html 2020-10-01T16:23:46.3030000Z https://www.medicinesresources.nhs.uk/menstrual-cycle-regularity-and-length-across-the-reproductive-lifespan-and-risk-of-premature-mortality-prospective-cohort-study.html 2020-10-01T16:24:44.1130000Z https://www.medicinesresources.nhs.uk/statin-therapy-and-risk-of-polyneuropathy-in-type-2-diabetes-a-danish-cohort-study.html 2020-10-01T16:42:25.7900000Z https://www.medicinesresources.nhs.uk/diabetes-as-a-risk-factor-for-poor-early-outcomes-in-patients-hospitalized-with-covid-20.html 2020-10-01T16:43:04.8840000Z https://www.medicinesresources.nhs.uk/hpv-vaccination-and-the-risk-of-invasive-cervical-cancer.html 2020-10-01T16:33:45.1540000Z https://www.medicinesresources.nhs.uk/rivaroxaban-and-aspirin-in-patients-with-symptomatic-lower-extremity-peripheral-artery-disease-a-subanalysis-of-the-compass-randomized-clinical-trial.html 2020-10-01T16:44:44.6870000Z https://www.medicinesresources.nhs.uk/guidance-on-the-use-of-diphtheria-anti-toxin.html 2020-10-02T15:36:33.7920000Z https://www.medicinesresources.nhs.uk/new-product-jyseleca-filgotinib-100-mg-and-200mg-film-coated-tablets.html 2020-10-02T15:37:28.2810000Z https://www.medicinesresources.nhs.uk/revised-spcs-tagrisso-osimertinib-40mg-and-80mg-film-coated-tablets.html 2020-10-02T15:39:16.0240000Z https://www.medicinesresources.nhs.uk/new-product-dyzantil-sodium-valproate-valproic-acid-200mg-prolonged-release-tablets.html 2020-10-02T15:40:08.6710000Z https://www.medicinesresources.nhs.uk/glp-1-receptor-agonists-for-parkinson-s-disease.html 2020-10-02T15:41:11.2230000Z https://www.medicinesresources.nhs.uk/primary-prophylaxis-for-venous-thromboembolism-in-people-undergoing-major-amputation-of-the-lower-extremity.html 2020-10-02T15:42:13.1600000Z https://www.medicinesresources.nhs.uk/fluid-and-pharmacological-agents-for-adhesion-prevention-after-gynaecological-surgery.html 2020-10-02T15:43:19.5790000Z https://www.medicinesresources.nhs.uk/probiotics-for-induction-of-remission-in-crohn-s-disease.html 2020-10-02T15:44:28.8980000Z https://www.medicinesresources.nhs.uk/us-fda-grants-fast-track-designation-to-gene-therapy-for-duchenne-muscular-dystrophy-dmd.html 2020-10-02T15:45:36.1870000Z https://www.medicinesresources.nhs.uk/fda-seeks-further-information-before-allowing-phase-iii-trial-of-astrazenecas-investigational-covid-19-vaccine-to-resume-in-the-us.html 2020-10-02T16:29:11.4060000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-results-for-lumasiran-in-the-treatment-of-primary-hyperoxaluria-type-1-ph1.html 2020-10-02T15:48:46.7740000Z https://www.medicinesresources.nhs.uk/us-fda-requests-further-data-on-remestemcel-l-before-approving-it-for-the-treatment-of-paediatric-steroid-refractory-graft-versus-host-disease-gvhd.html 2020-10-02T15:49:45.9340000Z https://www.medicinesresources.nhs.uk/phase-2a-study-of-first-in-class-direct-ampk-activator-in-the-treatment-of-non-alcoholic-steatohepatitis-nash-meets-primary-endpoint.html 2020-10-02T15:50:55.9720000Z https://www.medicinesresources.nhs.uk/care-quality-commission-publishes-workforce-race-equality-standard-wres-report-for-2020.html 2020-10-02T15:51:49.5290000Z https://www.medicinesresources.nhs.uk/adult-social-care-infection-control-fund-round-2-guidance.html 2020-10-02T15:52:52.0390000Z https://www.medicinesresources.nhs.uk/safe-opioid-disposal-remove-the-risk-outreach-toolkit.html 2020-10-02T15:53:51.3990000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-starts-first-rolling-review-of-a-covid-19-vaccine-in-the-eu.html 2020-10-02T15:54:43.9450000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-reminds-physicians-to-use-tecentriq-atezolizumab-with-nab-paclitaxel-not-conventional-paclitaxel-when-treating-breast-cancer.html 2020-10-02T15:55:49.4070000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-pilot-england-wales-and-northern-ireland-2-october-2020.html 2020-10-02T15:56:53.0730000Z https://www.medicinesresources.nhs.uk/sars-cov-2-vaccine-development-and-implementation-scenarios-options-key-decisions.html 2020-10-02T15:59:16.9320000Z https://www.medicinesresources.nhs.uk/childhood-in-the-time-of-covid.html 2020-10-02T16:01:45.7520000Z https://www.medicinesresources.nhs.uk/nhs-becomes-the-worlds-first-national-health-system-to-commit-to-become-carbon-net-zero.html 2020-10-02T16:34:06.8450000Z https://www.medicinesresources.nhs.uk/framework-of-actions-to-contain-carbapenemase-producing-enterobacterales.html 2020-10-02T16:04:36.8340000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-313-september-2020.html 2020-10-04T14:49:35.8490000Z https://www.medicinesresources.nhs.uk/briefings-on-adult-neurosurgery-and-specialised-neurology-services-for-adults.html 2020-10-02T16:17:23.7200000Z https://www.medicinesresources.nhs.uk/covid-19-anti-tnf-drug-adalimumab-to-be-trialled-for-patients-in-the-community.html 2020-10-02T16:18:23.4710000Z https://www.medicinesresources.nhs.uk/health-and-social-care-committee-report-delivering-core-nhs-and-care-services-during-the-pandemic-and-beyond.html 2020-10-04T14:52:02.4240000Z https://www.medicinesresources.nhs.uk/management-of-adults-with-primary-frozen-shoulder-in-secondary-care-uk-frost-a-multicentre-pragmatic-three-arm-superiority-randomised-clinical-trial.html 2020-10-02T16:22:27.1100000Z https://www.medicinesresources.nhs.uk/use-of-biologics-to-treat-relapsing-and-or-refractory-eosinophilic-granulomatosis-with-polyangiitis-data-from-a-european-collaborative-study.html 2020-10-02T16:23:24.2060000Z https://www.medicinesresources.nhs.uk/developing-a-behavioural-intervention-package-to-identify-and-amend-incorrect-penicillin-allergy-records-in-uk-general-practice-and-subsequently-change-antibiotic-use.html 2020-10-02T16:24:22.0770000Z https://www.medicinesresources.nhs.uk/association-between-immune-checkpoint-inhibitors-with-cardiovascular-events-and-atherosclerotic-plaque.html 2020-10-02T16:25:27.4480000Z https://www.medicinesresources.nhs.uk/seroprevalence-of-sars-cov-2-antibodies-in-people-with-an-acute-loss-in-their-sense-of-smell-and-or-taste-in-a-community-based-population-in-london-uk-an-observational-cohort-study.html 2020-10-02T16:26:46.0570000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-nivolumab-plus-ipilimumab-in-patients-with-advanced-hepatocellular-carcinoma-previously-treated-with-sorafenib-the-checkmate-040-randomized-clinical-trial.html 2020-10-02T16:28:00.0140000Z https://www.medicinesresources.nhs.uk/pre-and-postoperative-capecitabine-without-or-with-oxaliplatin-in-locally-advanced-rectal-cancer-petacc-6-trial-by-eortc-gitcg-and-rog-aio-agitg-bgdo-and-ffcd.html 2020-10-02T16:40:29.8990000Z https://www.medicinesresources.nhs.uk/effect-of-a-single-day-of-increased-as-needed-budesonide-formoterol-use-on-short-term-risk-of-severe-exacerbations-in-patients-with-mild-asthma-a-post-hoc-analysis-of-the-sygma-1-study.html 2020-10-02T16:30:05.0940000Z https://www.medicinesresources.nhs.uk/revised-spcs-lynparza-olaparib-all-formulations.html 2020-10-05T13:22:54.8110000Z https://www.medicinesresources.nhs.uk/revised-spc-eylea-aflibercept-40mg-ml-solution-for-injection-in-a-vial.html 2020-10-05T13:36:03.0120000Z https://www.medicinesresources.nhs.uk/revised-spc-exocin-ofloxacin-3-mg-ml-eye-drops.html 2020-10-05T13:37:16.9150000Z https://www.medicinesresources.nhs.uk/antibiotic-adjuvant-therapy-for-pulmonary-infection-in-cystic-fibrosis.html 2020-10-05T13:38:36.7920000Z https://www.medicinesresources.nhs.uk/gm-csf-granulocyte-macrophage-colony-stimulating-factor-supplementation-in-culture-media-for-women-undergoing-assisted-reproduction.html 2020-10-05T13:39:36.3930000Z https://www.medicinesresources.nhs.uk/statins-for-asthma-1.html 2020-10-05T13:40:49.7550000Z https://www.medicinesresources.nhs.uk/anti-vascular-endothelial-growth-factor-for-macular-oedema-secondary-to-branch-retinal-vein-occlusion.html 2020-10-05T13:41:59.6150000Z https://www.medicinesresources.nhs.uk/interventions-for-mycosis-fungoides.html 2020-10-05T13:43:19.4810000Z https://www.medicinesresources.nhs.uk/helicobacter-pylori-eradication-for-the-prevention-of-gastric-neoplasia.html 2020-10-05T13:44:48.5560000Z https://www.medicinesresources.nhs.uk/effect-of-alcohol-on-blood-pressure.html 2020-10-05T13:45:52.6600000Z https://www.medicinesresources.nhs.uk/interventions-for-non-tubal-ectopic-pregnancy.html 2020-10-05T13:47:22.2350000Z https://www.medicinesresources.nhs.uk/reduction-in-osteoarthritis-risk-after-treatment-with-ticagrelor-compared-to-clopidogrel-a-propensity-score-matching-analysis.html 2020-10-05T13:49:26.0710000Z https://www.medicinesresources.nhs.uk/the-effects-of-vitamin-d-and-marine-omega-3-fatty-acid-supplementation-on-chronic-knee-pain-in-older-us-adults-results-from-a-randomized-trial.html 2020-10-05T13:51:36.7700000Z https://www.medicinesresources.nhs.uk/plasma-ace2-and-risk-of-death-or-cardiometabolic-diseases-a-case-cohort-analysis.html 2020-10-05T13:52:54.1560000Z https://www.medicinesresources.nhs.uk/american-college-of-rheumatology-clinical-guidance-for-multisystem-inflammatory-syndrome-in-children-associated-with-sars-cov-2-and-hyperinflammation-in-pediatric-covid-19-version-1.html 2020-10-05T15:06:04.0370000Z https://www.medicinesresources.nhs.uk/prac-to-assess-reports-of-acute-kidney-injury-in-with-remdesivir-veklury-in-patients-with-covid-19.html 2020-10-05T13:58:49.2720000Z https://www.medicinesresources.nhs.uk/resilient-health-and-care-learning-the-lessons-of-covid-19.html 2020-10-05T15:07:53.2880000Z https://www.medicinesresources.nhs.uk/european-commission-approve-burosumab-crysvita-for-use-in-older-adolescents-and-adults-with-x-linked-hypophosphataemia.html 2020-10-05T14:01:27.4580000Z https://www.medicinesresources.nhs.uk/https-www-england-nhs-uk-wp-content-uploads-2020-10-bm2025pu-item-5-diagnostics-recovery-and-renewal-pdf-1.html 2020-10-05T14:05:07.4310000Z https://www.medicinesresources.nhs.uk/primary-care-immunisation-webinar-series-2020.html 2020-10-05T14:06:24.3630000Z https://www.medicinesresources.nhs.uk/phe-statement-on-delayed-reporting-of-covid-19-cases.html 2020-10-05T15:10:24.4090000Z https://www.medicinesresources.nhs.uk/type-2-diabetes-prevention-programme-and-type-1-diabetes-glucose-monitoring.html 2020-10-05T14:08:54.0390000Z https://www.medicinesresources.nhs.uk/giving-oral-medicines-and-supplements-to-children.html 2020-10-09T11:31:04.0300000Z https://www.medicinesresources.nhs.uk/salt-and-cardiovascular-disease-insufficient-evidence-to-recommend-low-sodium-intake-4.html 2020-10-05T14:56:32.0740000Z https://www.medicinesresources.nhs.uk/remdesivir-for-adults-with-covid-19-a-living-systematic-review-for-an-american-college-of-physicians-practice-points-2.html 2020-10-09T11:35:58.3630000Z https://www.medicinesresources.nhs.uk/incidence-and-severity-of-covid-19-in-hiv-positive-persons-receiving-antiretroviral-therapy.html 2020-10-06T16:27:49.7910000Z https://www.medicinesresources.nhs.uk/covid-19-how-to-prioritize-worse-off-populations-in-allocating-safe-and-effective-vaccines.html 2020-10-06T16:28:13.5040000Z https://www.medicinesresources.nhs.uk/pregnancy-protection-and-pregnancies-in-women-prescribed-ace-inhibitors-or-arbs-a-cross-sectional-study-in-primary-care.html 2020-10-06T16:28:39.9140000Z https://www.medicinesresources.nhs.uk/impact-of-lowering-the-risk-threshold-for-statin-treatment-on-statin-prescribing-a-descriptive-study-in-english-primary-care.html 2020-10-06T16:53:06.1730000Z https://www.medicinesresources.nhs.uk/interventions-commonly-available-during-pandemics-for-heavy-menstrual-bleeding-an-overview-of-cochrane-reviews.html 2020-10-06T16:30:58.1320000Z https://www.medicinesresources.nhs.uk/corticosteroid-therapy-for-nephrotic-syndrome-in-children.html 2020-10-06T14:25:11.6450000Z https://www.medicinesresources.nhs.uk/oral-5-aminosalicylic-acid-for-maintenance-of-remission-in-ulcerative-colitis.html 2020-10-06T14:27:32.3100000Z https://www.medicinesresources.nhs.uk/effectiveness-and-safety-of-pirfenidone-for-idiopathic-pulmonary-fibrosis-6.html 2020-10-06T16:32:24.1860000Z https://www.medicinesresources.nhs.uk/effects-of-antifungal-drugs-on-the-plasma-concentrations-and-dosage-of-tacrolimus-in-kidney-transplant-patients.html 2020-10-06T14:43:48.6980000Z https://www.medicinesresources.nhs.uk/long-term-health-consequences-of-covid-19.html 2020-10-06T14:46:23.5720000Z https://www.medicinesresources.nhs.uk/prevalence-management-and-outcomes-of-sars-cov-2-infections-in-older-people-and-those-with-dementia-in-mental-health-wards-in-london-uk-a-retrospective-observational-study.html 2020-10-06T16:33:59.3840000Z https://www.medicinesresources.nhs.uk/lopinavir-ritonavir-in-patients-admitted-to-hospital-with-covid-19-recovery-a-randomised-controlled-open-label-platform-trial.html 2020-10-09T11:36:33.3210000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-boots-dermacare-1-w-w-hydrocortisone-ointment.html 2020-10-06T16:39:13.1450000Z https://www.medicinesresources.nhs.uk/shortage-of-ativan-lorazepam-injection-4-mg-in-1-ml-2.html 2020-10-06T16:39:50.1130000Z https://www.medicinesresources.nhs.uk/competition-and-markets-authority-cma-opens-investigation-into-suspected-anti-competitive-practices-in-the-supply-of-lithium-based-drugs-used-to-treat-bipolar-disorder.html 2020-10-09T11:38:06.3480000Z https://www.medicinesresources.nhs.uk/revised-spcs-eylea-aflibercept-40-mg-ml-solution-for-injection-pre-filled-syringe-and-vial.html 2020-10-06T16:41:08.5740000Z https://www.medicinesresources.nhs.uk/revised-spcs-fobumix-budesonide-formoterol-fumarate-dehydrate-easyhaler-all-products.html 2020-10-06T16:41:46.5530000Z https://www.medicinesresources.nhs.uk/revised-spcs-cosentyx-secukinumab-150-mg-solution-for-injection-in-pre-filled-and-syringe.html 2020-10-06T16:42:28.6380000Z https://www.medicinesresources.nhs.uk/ms-teams-use-in-the-nhs-soars-as-pandemic-continues.html 2020-10-06T16:43:04.0840000Z https://www.medicinesresources.nhs.uk/healthcare-workers-should-pause-the-nhs-covid-19-app-when-at-work.html 2020-10-06T16:43:57.0460000Z https://www.medicinesresources.nhs.uk/fluoxetine-40mg-capsules-serious-shortage-protocol-ssp-expired.html 2020-10-06T16:44:50.6950000Z https://www.medicinesresources.nhs.uk/behaviour-change-digital-and-mobile-health-interventions-guidance-ng183.html 2020-10-09T11:40:53.0020000Z https://www.medicinesresources.nhs.uk/new-product-ilaxten-bilastine-10-mg-orodispersible-tablets.html 2020-10-07T14:11:07.0050000Z https://www.medicinesresources.nhs.uk/revised-spc-sevodyne-buprenorphine-transdermal-patch.html 2020-10-07T14:12:06.8830000Z https://www.medicinesresources.nhs.uk/revised-spc-imigran-sumatriptan-preparations.html 2020-10-07T14:13:18.3740000Z https://www.medicinesresources.nhs.uk/digital-contact-tracing-technologies-in-epidemics-a-rapid-review.html 2020-10-07T14:14:06.9380000Z https://www.medicinesresources.nhs.uk/interventions-for-escalation-of-therapy-for-acute-exacerbations-of-asthma-in-children-an-overview-of-cochrane-reviews.html 2020-10-07T14:15:56.0840000Z https://www.medicinesresources.nhs.uk/glucose-lowering-agents-for-treating-pre-existing-and-new-onset-diabetes-in-kidney-transplant-recipients.html 2020-10-07T14:16:59.2220000Z https://www.medicinesresources.nhs.uk/printed-educational-materials-effects-on-professional-practice-and-healthcare-outcomes.html 2020-10-07T14:18:33.7340000Z https://www.medicinesresources.nhs.uk/anaconda-s-for-sedation-with-volatile-anaesthetics-in-intensive-care-mib229.html 2020-10-07T14:19:49.0450000Z https://www.medicinesresources.nhs.uk/fifteen-year-quality-of-life-outcomes-in-men-with-localised-prostate-cancer-population-based-australian-prospective-study.html 2020-10-07T14:20:59.0880000Z https://www.medicinesresources.nhs.uk/physical-therapy-referral-from-primary-care-for-acute-back-pain-with-sciatica-a-randomized-controlled-trial.html 2020-10-07T14:21:59.6020000Z https://www.medicinesresources.nhs.uk/effectiveness-safety-and-cost-analysis-of-dalbavancin-in-clinical-practice.html 2020-10-07T15:20:15.0820000Z https://www.medicinesresources.nhs.uk/ixazomib-as-postinduction-maintenance-for-patients-with-newly-diagnosed-multiple-myeloma-not-undergoing-autologous-stem-cell-transplantation-the-phase-iii-tourmaline-mm4-trial.html 2020-10-07T14:26:03.1040000Z https://www.medicinesresources.nhs.uk/elective-cancer-surgery-in-covid-19-free-surgical-pathways-during-the-sars-cov-2-pandemic-an-international-multicenter-comparative-cohort-study.html 2020-10-07T14:27:06.1640000Z https://www.medicinesresources.nhs.uk/long-term-follow-up-of-anti-cd19-chimeric-antigen-receptor-t-cell-therapy.html 2020-10-07T14:29:58.9520000Z https://www.medicinesresources.nhs.uk/randomized-trial-of-afatinib-plus-cetuximab-versus-afatinib-alone-for-first-line-treatment-of-egfr-mutant-non-small-cell-lung-cancer-final-results-from-swog-s1403.html 2020-10-07T14:30:47.9870000Z https://www.medicinesresources.nhs.uk/a-randomized-trial-comparing-antibiotics-with-appendectomy-for-appendicitis.html 2020-10-07T14:32:34.5360000Z https://www.medicinesresources.nhs.uk/glycemic-control-and-the-risk-of-acute-kidney-injury-in-patients-with-type-2-diabetes-and-chronic-kidney-disease-parallel-population-based-cohort-studies-in-u-s-and-swedish-routine-care.html 2020-10-07T14:37:21.7590000Z https://www.medicinesresources.nhs.uk/potential-benefits-and-harms-of-gastric-bypass-surgery-in-obese-individuals-with-type-1-diabetes-a-nationwide-matched-observational-cohort-study.html 2020-10-07T15:23:11.3150000Z https://www.medicinesresources.nhs.uk/cobitolimod-for-moderate-to-severe-left-sided-ulcerative-colitis-conduct-a-phase-2b-randomised-double-blind-placebo-controlled-dose-ranging-induction-trial.html 2020-10-07T15:22:55.3660000Z https://www.medicinesresources.nhs.uk/relative-risk-of-cardiovascular-disease-is-higher-in-women-with-type-2-diabetes-but-not-in-those-with-prediabetes-as-compared-with-men.html 2020-10-07T14:40:25.4140000Z https://www.medicinesresources.nhs.uk/the-impact-of-covid-19-on-the-continuity-of-cardiovascular-care-the-authors-discuss-the-challenges-and-offer-potential-solutions-to-facilitate-safe-and-effective-clinical-care-during-and-after-this-unique-pandemic.html 2020-10-07T14:41:15.0140000Z https://www.medicinesresources.nhs.uk/the-impact-of-covid-19-on-the-continuity-of-cardiovascular-care-the-authors-discuss-the-challenges-and-offer-potential-solutions-to-facilitate-safe-and-effective-clinical-care-during-and-after-this-unique-pandemic-1.html 2020-10-07T15:24:18.5430000Z https://www.medicinesresources.nhs.uk/the-changing-demographics-of-covid-19.html 2020-10-07T14:43:33.8690000Z https://www.medicinesresources.nhs.uk/diagnosis-of-evali-in-the-covid-19-era.html 2020-10-07T14:44:25.8810000Z https://www.medicinesresources.nhs.uk/nice-is-consulting-on-the-way-it-assesses-the-resource-impact-of-its-guidance.html 2020-10-07T14:45:13.9180000Z https://www.medicinesresources.nhs.uk/shared-decision-making-is-key-to-good-patient-care-gmc-guidance.html 2020-10-07T14:46:01.3790000Z https://www.medicinesresources.nhs.uk/supply-issues-regarding-roche-reagent.html 2020-10-07T15:37:23.0700000Z https://www.medicinesresources.nhs.uk/impact-of-comorbidities-and-glycemia-at-admission-and-dipeptidyl-peptidase-4-inhibitors-in-patients-with-type-2-diabetes-with-covid-19-a-case-series-from-an-academic-hospital-in-lombardy-italy.html 2020-10-07T15:39:27.9510000Z https://www.medicinesresources.nhs.uk/incidence-and-outcome-of-myocardial-infarction-treated-with-percutaneous-coronary-intervention-during-covid-19-pandemic.html 2020-10-07T15:40:46.4660000Z https://www.medicinesresources.nhs.uk/world-health-organization-guidelines-on-treatment-of-hepatitis-c-virus-infection-best-practice-advice-from-the-american-college-of-physicians.html 2020-10-07T15:42:16.4590000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-lasmiditan-for-migraine-in-phase-3-study.html 2020-10-07T15:47:06.0330000Z https://www.medicinesresources.nhs.uk/public-perceptions-of-health-and-social-care-in-light-of-covid-19-july-2021.html 2020-10-07T15:47:24.7430000Z https://www.medicinesresources.nhs.uk/ema-to-review-samsung-bioepis-and-biogen-biosimilar-ranibizumab.html 2020-10-07T15:46:00.9650000Z https://www.medicinesresources.nhs.uk/revise-spc-dupixent-dupilumab-solution-for-injection-in-pre-filled-syringe-all-strengths.html 2020-10-08T16:09:36.4790000Z https://www.medicinesresources.nhs.uk/revise-spc-inflectra-infliximab-100-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-10-08T16:09:52.1080000Z https://www.medicinesresources.nhs.uk/revise-spc-motilium-domperidone-10mg-film-coated-tablets.html 2020-10-08T16:11:49.5460000Z https://www.medicinesresources.nhs.uk/association-between-the-reproductive-health-of-young-women-and-cardiovascular-disease-in-later-life-umbrella-review.html 2020-10-08T15:15:14.2490000Z https://www.medicinesresources.nhs.uk/association-of-sglt2-inhibitors-with-cardiovascular-and-kidney-outcomes-in-patients-with-type-2-diabetes-a-meta-analysis.html 2020-10-08T15:16:14.7950000Z https://www.medicinesresources.nhs.uk/topical-antibiotics-with-steroids-for-chronic-suppurative-otitis-media.html 2020-10-08T16:13:27.5540000Z https://www.medicinesresources.nhs.uk/proton-pump-inhibitors-for-chronic-obstructive-pulmonary-disease.html 2020-10-08T15:18:39.4210000Z https://www.medicinesresources.nhs.uk/oral-versus-intra-vaginal-imidazole-and-triazole-anti-fungal-treatment-of-uncomplicated-vulvovaginal-candidiasis-thrush.html 2020-10-08T15:19:59.3090000Z https://www.medicinesresources.nhs.uk/reduction-in-saturated-fat-intake-for-cardiovascular-disease.html 2020-10-08T15:21:13.9640000Z https://www.medicinesresources.nhs.uk/nihr-alert-a-decision-aid-may-help-people-with-newly-diagnosed-multiple-sclerosis-consider-their-options-for-treatment.html 2020-10-08T15:22:15.6720000Z https://www.medicinesresources.nhs.uk/sugar-reduction-report-on-progress-between-2015-and-2019.html 2020-10-08T15:23:10.5670000Z https://www.medicinesresources.nhs.uk/socially-distanced-education-and-training-to-support-safe-working-practices-during-the-pandemic.html 2020-10-08T15:24:12.6800000Z https://www.medicinesresources.nhs.uk/annual-hospital-outpatient-report-published-for-2019-20.html 2020-10-08T15:25:12.6000000Z https://www.medicinesresources.nhs.uk/nice-technology-appraisals-in-the-nhs-in-england-innovation-scorecard-to-march-2020.html 2020-10-08T15:26:03.9220000Z https://www.medicinesresources.nhs.uk/secondary-mitral-regurgitation.html 2020-10-08T15:27:04.5620000Z https://www.medicinesresources.nhs.uk/nice-and-sign-announce-latest-rapid-covid-19-guideline-will-address-long-covid.html 2020-10-08T15:28:26.9970000Z https://www.medicinesresources.nhs.uk/updated-covid-19-rapid-guideline-cystic-fibrosis.html 2020-10-09T11:44:48.7410000Z https://www.medicinesresources.nhs.uk/medicines-marketing-authorisation-holders-submission-of-nitrosamine-risk-evaluation-risk-assessment-and-confirmatory-testing.html 2020-10-08T15:30:52.4040000Z https://www.medicinesresources.nhs.uk/mhra-draft-guidance-on-the-licensing-of-biosimilar-products-out-for-consultation.html 2020-10-08T15:31:47.9270000Z https://www.medicinesresources.nhs.uk/government-invests-in-uk-developed-antibody-tests-from-uk-rapid-test-consortium.html 2020-10-08T15:32:42.2780000Z https://www.medicinesresources.nhs.uk/assessing-and-addressing-cardiovascular-health-in-lgbtq-adults-a-scientific-statement-from-the-american-heart-association.html 2020-10-08T15:34:06.0960000Z https://www.medicinesresources.nhs.uk/nurse-prescribers-formulary-content-within-the-british-national-formulary.html 2020-10-08T15:35:36.0810000Z https://www.medicinesresources.nhs.uk/autonomic-dysreflexia-in-spinal-cord-injury.html 2020-10-08T15:36:47.9290000Z https://www.medicinesresources.nhs.uk/covid-19-which-rapid-tests-is-the-uk-pinning-its-hopes-on.html 2020-10-08T16:26:02.8740000Z https://www.medicinesresources.nhs.uk/specialist-long-covid-clinics-to-be-set-up-in-england.html 2020-10-08T15:40:25.6350000Z https://www.medicinesresources.nhs.uk/covid-deaths-three-times-higher-than-flu-and-pneumonia.html 2020-10-08T15:42:13.8040000Z https://www.medicinesresources.nhs.uk/kiniksa-announces-positive-data-from-phase-ii-trial-of-mavrilimumab-in-giant-cell-arteritis.html 2020-10-08T15:43:18.3250000Z https://www.medicinesresources.nhs.uk/biontech-and-pfizer-initiate-rolling-submission-to-european-medicines-agency-ema-for-sars-cov-2-vaccine-candidate-bnt162b2.html 2020-10-08T15:44:18.4500000Z https://www.medicinesresources.nhs.uk/tlc-receives-australian-and-taiwan-approval-to-initiate-phase-i-clinical-trial-of-tlc19-inhalable-liposomal-hydroxychloroquine-for-covid-19.html 2020-10-08T16:07:20.3470000Z https://www.medicinesresources.nhs.uk/fda-grants-nivatrotamab-orphan-drug-designation-and-rare-pediatric-disease-designation-for-the-treatment-of-patients-with-neuroblastoma.html 2020-10-08T15:47:22.9300000Z https://www.medicinesresources.nhs.uk/bristol-myers-squibb-announces-phase-iii-checkmate-816-trial-of-nivolumab-met-its-primary-endpoint-in-patients-with-resectable-non-small-cell-lung-cancer.html 2020-10-08T15:48:21.8160000Z https://www.medicinesresources.nhs.uk/gilead-sciences-signs-joint-procurement-agreement-with-european-commission-for-remdesivir-veklury-for-the-treatment-of-covid-19-in-adult-and-adolescent-patients-with-pneumonia-requiring-supplemental-oxygen.html 2020-10-08T15:49:33.4070000Z https://www.medicinesresources.nhs.uk/combination-study-with-js016-and-ly-cov555-for-patients-with-mild-to-moderate-covid-19-symptoms-met-primary-and-secondary-endpoints.html 2020-10-08T15:50:21.4080000Z https://www.medicinesresources.nhs.uk/ukmi-information-resources.html 2020-10-09T11:50:54.1690000Z https://www.medicinesresources.nhs.uk/improving-medication-adherence-resources-to-support-local-delivery.html 2020-10-08T15:52:26.2360000Z https://www.medicinesresources.nhs.uk/consultant-pharmacist-toolkit.html 2020-10-08T15:53:32.7870000Z https://www.medicinesresources.nhs.uk/interferon-beta-1b-and-lopinavir-ritonavir-for-middle-east-respiratory-syndrome.html 2020-10-08T16:05:13.1560000Z https://www.medicinesresources.nhs.uk/randomized-phase-iii-keynote-181-study-of-pembrolizumab-versus-chemotherapy-in-advanced-esophageal-cancer.html 2020-10-08T16:06:54.2100000Z https://www.medicinesresources.nhs.uk/effect-of-passive-choice-and-active-choice-interventions-in-the-electronic-health-record-to-cardiologists-on-statin-prescribing-a-cluster-randomized-clinical-trial.html 2020-10-08T16:08:07.3730000Z https://www.medicinesresources.nhs.uk/therapeutic-versus-prophylactic-anticoagulation-for-severe-covid-19-a-randomized-phase-ii-clinical-trial-hesacovid.html 2020-10-08T16:09:32.1800000Z https://www.medicinesresources.nhs.uk/pulmonary-adverse-events-in-patients-receiving-low-dose-methotrexate-in-the-randomized-double-blind-placebo-controlled-cardiovascular-inflammation-reduction-trial.html 2020-10-08T16:10:40.6770000Z https://www.medicinesresources.nhs.uk/effect-of-exercise-training-for-five-years-on-all-cause-mortality-in-older-adults-the-generation-100-study-randomised-controlled-trial.html 2020-10-08T16:11:44.1900000Z https://www.medicinesresources.nhs.uk/association-between-fda-and-ema-expedited-approval-programs-and-therapeutic-value-of-new-medicines-retrospective-cohort-study.html 2020-10-08T16:12:44.8320000Z https://www.medicinesresources.nhs.uk/effect-of-school-closures-on-mortality-from-coronavirus-disease-2019-old-and-new-predictions.html 2020-10-08T16:13:55.3120000Z https://www.medicinesresources.nhs.uk/antiphospholipid-antibodies-in-critically-ill-patients-with-covid-19.html 2020-10-08T16:15:20.7440000Z https://www.medicinesresources.nhs.uk/impact-of-cardiovascular-risk-factors-and-genetics-on-10-year-absolute-risk-of-dementia-risk-charts-for-targeted-prevention.html 2020-10-08T16:16:36.3860000Z https://www.medicinesresources.nhs.uk/association-of-high-potency-cannabis-use-with-mental-health-and-substance-use-in-adolescence.html 2020-10-08T16:37:22.6760000Z https://www.medicinesresources.nhs.uk/eu-wide-cross-sectional-observational-study-of-lipid-modifying-therapy-use-in-secondary-and-primary-care-the-da-vinci-study.html 2020-10-08T16:38:07.4210000Z https://www.medicinesresources.nhs.uk/lithium-carbonate-priadel-200mg-and-400mg-modified-release-tablets-supply-disruption-update.html 2020-10-09T11:50:32.5230000Z https://www.medicinesresources.nhs.uk/revised-spcs-fragmin-dalteparin-solution-for-injection.html 2020-10-09T14:25:57.7130000Z https://www.medicinesresources.nhs.uk/revised-spcs-oxycontin-oxycodone-prolonged-release-tablets-1.html 2020-10-09T14:27:31.9620000Z https://www.medicinesresources.nhs.uk/revised-spcs-plenachol-d3-capsules-colecalciferol-cholecalciferol.html 2020-10-09T16:18:17.3730000Z https://www.medicinesresources.nhs.uk/revised-spcs-palladone-hydromorphone-hydrochloride-capsules.html 2020-10-09T14:29:54.9450000Z https://www.medicinesresources.nhs.uk/revised-spc-crysvita-burosumab-20-mg-solution-for-injection.html 2020-10-09T14:30:53.8730000Z https://www.medicinesresources.nhs.uk/revised-spcs-revlimid-lenalidomide-hard-capsules.html 2020-10-09T14:32:15.2590000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-filgotinib-jyseleca.html 2020-10-12T07:04:17.9900000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-kymriah-tisagenlecleucel.html 2020-10-12T07:04:31.8910000Z https://www.medicinesresources.nhs.uk/antibiotic-therapy-for-pelvic-inflammatory-disease.html 2020-10-09T14:38:43.5520000Z https://www.medicinesresources.nhs.uk/intravenous-immunoglobulin-for-presumed-viral-myocarditis-in-children-and-adults.html 2020-10-09T14:40:06.6150000Z https://www.medicinesresources.nhs.uk/multiple-versus-fewer-antiplatelet-agents-for-preventing-early-recurrence-after-ischaemic-stroke-or-transient-ischaemic-attack.html 2020-10-09T14:41:23.7850000Z https://www.medicinesresources.nhs.uk/primaquine-alternative-dosing-schedules-for-preventing-malaria-relapse-in-people-with-plasmodium-vivax.html 2020-10-09T14:42:41.3860000Z https://www.medicinesresources.nhs.uk/regeneron-pharmaceuticals-applies-to-us-fda-for-emergency-use-authorization-for-its-antibody-cocktail-against-covid-19.html 2020-10-09T14:43:40.9470000Z https://www.medicinesresources.nhs.uk/fda-grants-givinostat-rare-paediatric-disease-designation-for-duchenne-muscular-dystrophy.html 2020-10-09T14:45:40.7380000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-somatrogon-in-children-3-to-less-than-18-years-with-growth-hormone-deficiency.html 2020-10-09T14:47:07.1750000Z https://www.medicinesresources.nhs.uk/european-commission-approves-agreement-with-janssen-for-supply-of-200-million-doses-of-its-covid-19-vaccine-candidate.html 2020-10-09T14:48:50.6310000Z https://www.medicinesresources.nhs.uk/positive-interim-data-from-phase-ii-study-of-sars-cov-2-neutralising-antibodies-ly-cov016-and-ly-cov555-in-the-outpatient-setting.html 2020-10-09T14:50:56.7350000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-omecamtiv-mecarbil-in-patients-with-heart-failure-with-reduced-ejection-fraction-hfref.html 2020-10-09T16:10:39.7930000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-marketing-authorization-under-exceptional-circumstances-for-obiltoxaximab-sfl-for-the-treatment-of-inhalation-anthrax.html 2020-10-09T16:09:56.2090000Z https://www.medicinesresources.nhs.uk/enrolment-begins-into-phase-iii-trial-evaluating-anti-coronavirus-hyperimmune-ivig-in-adults-hospitalised-with-covid-19.html 2020-10-09T16:09:24.6500000Z https://www.medicinesresources.nhs.uk/american-society-of-hematology-publishes-draft-guidelines-on-the-use-of-anticoagulation-in-patients-with-covid-19-for-review.html 2020-10-09T14:56:05.9950000Z https://www.medicinesresources.nhs.uk/new-era-of-personalised-epilepsy-management.html 2020-10-09T16:08:13.9450000Z https://www.medicinesresources.nhs.uk/bmj-publishes-collection-of-analysis-articles-on-brain-health.html 2020-10-15T11:24:15.3580000Z https://www.medicinesresources.nhs.uk/us-fda-issues-guidance-for-industry-on-emergency-use-authorization-for-vaccines-to-prevent-covid-19.html 2020-10-09T15:00:48.7340000Z https://www.medicinesresources.nhs.uk/500-covid-19-test-sites-now-open-as-new-lab-partnerships-boost-capacity.html 2020-10-09T15:02:32.4330000Z https://www.medicinesresources.nhs.uk/nice-launches-public-consultation-on-proposals-to-simplify-how-medicines-and-medical-devices-are-selected-for-evaluation.html 2020-10-09T15:03:40.1500000Z https://www.medicinesresources.nhs.uk/celebs-and-lockdown-heroes-urge-public-to-get-cancer-symptoms-checked-and-attend-routine-appointments.html 2020-10-09T16:04:53.4620000Z https://www.medicinesresources.nhs.uk/twenty-charities-representing-rare-and-less-common-cancers-launch-20-for-20-campaign-to-highlight-pandemics-disruption-to-services.html 2020-10-09T15:07:46.3360000Z https://www.medicinesresources.nhs.uk/clinical-trials-how-the-uk-can-transform-the-clinical-research-environment.html 2020-10-09T15:09:57.6980000Z https://www.medicinesresources.nhs.uk/effect-of-hydroxychloroquine-in-hospitalized-patients-with-covid-19.html 2020-10-09T15:54:42.8640000Z https://www.medicinesresources.nhs.uk/clinical-impact-of-molecular-point-of-care-testing-for-suspected-covid-19-in-hospital-cov-19poc-a-prospective-interventional-non-randomised-controlled-study.html 2020-10-09T15:56:30.5520000Z https://www.medicinesresources.nhs.uk/association-of-measurable-residual-disease-with-survival-outcomes-in-patients-with-acute-myeloid-leukemia-a-systematic-review-and-meta-analysis.html 2020-10-09T15:58:10.9400000Z https://www.medicinesresources.nhs.uk/accuracy-of-sie-sies-gitmo-consensus-criteria-for-unfitness-to-predict-early-mortality-after-intensive-chemotherapy-in-adults-with-aml-or-other-high-grade-myeloid-neoplasm.html 2020-10-09T15:59:51.0460000Z https://www.medicinesresources.nhs.uk/risk-minimisation-material-risk-of-hyperglycaemia-with-piqray-r-alpelisib-information-for-prescribers.html 2020-10-12T07:04:02.6730000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-bayer-intrauterine-system-ius-educational-pack-kyleena-jaydess-mirena.html 2020-10-12T07:03:48.2970000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-ruxience-rituximab.html 2020-10-12T07:02:39.4930000Z https://www.medicinesresources.nhs.uk/mobile-technologies-to-support-healthcare-provider-to-healthcare-provider-communication-and-management-of-care.html 2020-10-12T10:47:21.6080000Z https://www.medicinesresources.nhs.uk/erythropoietin-plus-iron-versus-control-treatment-including-placebo-or-iron-for-preoperative-anaemic-adults-undergoing-non-cardiac-surgery.html 2020-10-12T10:48:43.3920000Z https://www.medicinesresources.nhs.uk/metformin-versus-the-combined-oral-contraceptive-pill-for-hirsutism-acne-and-menstrual-pattern-in-polycystic-ovary-syndrome.html 2020-10-12T10:50:28.4810000Z https://www.medicinesresources.nhs.uk/oral-5-aminosalicylic-acid-for-induction-of-remission-in-ulcerative-colitis.html 2020-10-12T10:51:29.9700000Z https://www.medicinesresources.nhs.uk/adherence-to-lipid-lowering-guidelines-for-secondary-prevention-and-potential-reduction-in-cvd-events-in-swedish-primary-care-a-cross-sectional-study.html 2020-10-12T10:52:41.1950000Z https://www.medicinesresources.nhs.uk/severity-of-respiratory-failure-at-admission-and-in-hospital-mortality-in-patients-with-covid-19-a-prospective-observational-multicentre-study.html 2020-10-12T10:53:58.0690000Z https://www.medicinesresources.nhs.uk/can-children-swallow-tablets-outcome-data-from-a-feasibility-study-to-assess-the-acceptability-of-different-sized-placebo-tablets-in-children-creating-acceptable-tablets-cat.html 2020-10-12T10:55:39.5800000Z https://www.medicinesresources.nhs.uk/efficacy-of-dapagliflozin-on-renal-function-and-outcomes-in-patients-with-heart-failure-with-reduced-ejection-fraction-results-of-dapa-hf.html 2020-10-12T11:00:46.8850000Z https://www.medicinesresources.nhs.uk/topline-phase-iii-data-of-avatrombopag-for-treatment-of-chemotherapy-induced-thrombocytopenia.html 2020-10-12T11:01:54.6900000Z https://www.medicinesresources.nhs.uk/positive-data-from-phase-iii-true-north-trial-of-ozanimod-in-adults-with-moderate-to-severe-ulcerative-colitis.html 2020-10-12T11:03:26.2970000Z https://www.medicinesresources.nhs.uk/the-nhs-check-study-to-assess-effect-of-covid-19-on-wellbeing-of-nhs-staff-in-england.html 2020-10-12T11:04:31.6750000Z https://www.medicinesresources.nhs.uk/state-of-the-nation-2020-children-and-young-peoples-wellbeing.html 2020-10-12T11:05:43.8760000Z https://www.medicinesresources.nhs.uk/lancet-series-functional-gastrointestinal-disorders.html 2020-10-12T14:11:21.6990000Z https://www.medicinesresources.nhs.uk/flu-vaccines-and-supply-for-the-national-flu-programme-2020-to-2021.html 2020-10-19T08:48:41.9490000Z https://www.medicinesresources.nhs.uk/flu-vaccination-for-pregnant-women-essential-this-winter.html 2020-10-12T14:33:12.2360000Z https://www.medicinesresources.nhs.uk/clinical-review-management-of-hypertriglyceridemia.html 2020-10-12T14:34:20.8930000Z https://www.medicinesresources.nhs.uk/astra-zenecas-long-acting-covid-19-antibody-azd7442-advances-into-phase-iii-development.html 2020-10-12T14:35:34.9730000Z https://www.medicinesresources.nhs.uk/oral-non-steroidal-anti-inflammatory-drugs-versus-other-oral-analgesic-agents-for-acute-soft-tissue-injury.html 2020-10-12T14:36:50.3020000Z https://www.medicinesresources.nhs.uk/maintenance-treatment-with-antipsychotic-drugs-for-schizophrenia.html 2020-10-12T14:38:15.8700000Z https://www.medicinesresources.nhs.uk/pancreatic-enzyme-replacement-therapy-for-people-with-cystic-fibrosis.html 2020-10-12T14:48:54.7450000Z https://www.medicinesresources.nhs.uk/perioperative-antibiotics-for-preventing-post-surgical-site-infections-in-solid-organ-transplant-recipients.html 2020-10-12T14:41:01.2380000Z https://www.medicinesresources.nhs.uk/rituximab-for-treating-inhibitors-in-people-with-inherited-severe-haemophilia.html 2020-10-12T14:42:01.6880000Z https://www.medicinesresources.nhs.uk/budesonide-jorveza-r-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-eosinophilic-esophagitis.html 2020-10-12T14:43:33.2660000Z https://www.medicinesresources.nhs.uk/ibrutinib-imbruvica-r-is-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-waldenstroem-s-macroglobulinaemia.html 2020-10-12T14:44:43.4820000Z https://www.medicinesresources.nhs.uk/lenalidomide-capsules-revlimid-r-accepted-for-use-within-nhsscotland-as-maintenance-treatment-of-newly-diagnosed-multiple-myeloma.html 2020-10-12T14:45:59.5470000Z https://www.medicinesresources.nhs.uk/meropenem-vaborbactam-vaborem-r-accepted-for-restricted-use-within-nhsscotland.html 2020-10-12T14:51:42.0590000Z https://www.medicinesresources.nhs.uk/carfilzomib-kyprolis-r-is-accepted-for-restricted-use-within-nhsscotland-for-treatment-of-adults-with-multiple-myeloma.html 2020-10-12T14:48:14.0130000Z https://www.medicinesresources.nhs.uk/daratumumab-subcutaneous-injection-darzalex-r-is-accepted-for-restricted-use-within-nhsscotland-for-treatment-of-relapsed-and-refractory-multiple-myeloma.html 2020-10-12T14:49:22.8390000Z https://www.medicinesresources.nhs.uk/lenalidomide-revlimid-r-is-accepted-for-use-within-nhsscotland-for-treatment-of-adults-with-previously-treated-follicular-lymphoma.html 2020-10-12T14:50:48.0230000Z https://www.medicinesresources.nhs.uk/phase-2b-3-trial-shows-efficacy-of-filgotinib-for-induction-and-maintenance-of-remission-in-moderately-and-severely-active-ulcerative-colitis-uc.html 2020-10-13T15:18:17.2950000Z https://www.medicinesresources.nhs.uk/revised-spcs-lustral-sertraline-hydrochloride-coated-tablets-all-strengths.html 2020-10-13T15:19:47.8710000Z https://www.medicinesresources.nhs.uk/effect-of-dapagliflozin-according-to-baseline-systolic-blood-pressure-in-the-dapagliflozin-and-prevention-of-adverse-outcomes-in-heart-failure-trial-dapa-hf.html 2020-10-13T17:09:25.1160000Z https://www.medicinesresources.nhs.uk/a-randomized-controlled-trial-of-dapagliflozin-on-left-ventricular-hypertrophy-in-people-with-type-two-diabetes-the-dapa-lvh-trial.html 2020-10-13T15:24:30.8270000Z https://www.medicinesresources.nhs.uk/stroke-thrombolysis-with-tenecteplase-to-reduce-emergency-department-spread-of-coronavirus-disease-2019-and-shortages-of-alteplase.html 2020-10-13T17:11:19.1380000Z https://www.medicinesresources.nhs.uk/mental-health-disorders-related-to-covid-19-related-deaths.html 2020-10-13T15:28:41.1340000Z https://www.medicinesresources.nhs.uk/genomic-evidence-for-reinfection-with-sars-cov-2-a-case-study.html 2020-10-13T17:12:23.9040000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-cefiderocol-or-best-available-therapy-for-the-treatment-of-serious-infections-caused-by-carbapenem-resistant-gram-negative-bacteria-credible-cr-a-randomised-open-label-multicentre-pathogen-focused-descriptive-phase-3-trial.html 2020-10-13T17:18:30.2470000Z https://www.medicinesresources.nhs.uk/cefiderocol-versus-high-dose-extended-infusion-meropenem-for-the-treatment-of-gram-negative-nosocomial-pneumonia-apeks-np-a-randomised-double-blind-phase-3-non-inferiority-trial.html 2020-10-13T17:26:23.8990000Z https://www.medicinesresources.nhs.uk/warfarin-and-other-anticoagulants-monitoring-of-patients-during-the-covid-19-pandemic.html 2020-10-19T09:26:21.3180000Z https://www.medicinesresources.nhs.uk/improving-quality-and-patient-safety-utilising-nice-guidance-and-the-one-together-framework.html 2020-10-13T16:10:42.2100000Z https://www.medicinesresources.nhs.uk/nihr-alert-prozac-fluoxetine-may-be-the-best-treatment-for-young-people-with-depression-but-more-research-is-needed.html 2020-10-13T17:31:02.0100000Z https://www.medicinesresources.nhs.uk/company-announces-positive-long-term-data-for-two-drug-hiv-regimen-dolutegravir-sodium-and-lamivudine-dovato-r.html 2020-10-13T16:12:30.5740000Z https://www.medicinesresources.nhs.uk/avelumab-bavencio-r-accepted-for-use-within-nhs-scotland-in-combination-with-axitinib-for-the-first-line-treatment-of-adult-patients-with-advanced-renal-cell-carcinoma.html 2020-10-13T17:32:11.3380000Z https://www.medicinesresources.nhs.uk/scottish-medicines-consortium-completes-initial-assessment-of-evidence-for-cerliponase-alfa-brineura-for-treatment-of-neuronal-ceroid-lipofuscinosis-type-2-cln2-disease-using-the-ultra-orphan-framework.html 2020-10-13T17:32:46.6620000Z https://www.medicinesresources.nhs.uk/siponimod-mayzent-r-accepted-for-use-within-nhs-scotland-for-treatment-of-adult-patients-with-secondary-progressive-multiple-sclerosis-spms-with-active-disease.html 2020-10-13T17:33:09.9830000Z https://www.medicinesresources.nhs.uk/osimertinib-for-untreated-egfr-mutation-positive-non-small-cell-lung-cancer-guidance-ta654.html 2020-10-19T09:39:26.8730000Z https://www.medicinesresources.nhs.uk/osimertinib-for-treating-egfr-t790m-mutation-positive-advanced-non-small-cell-lung-cancer-guidance-ta653.html 2020-10-19T09:45:00.7360000Z https://www.medicinesresources.nhs.uk/blood-pressure-targets-for-the-treatment-of-people-with-hypertension-and-cardiovascular-disease.html 2020-10-14T14:53:43.3990000Z https://www.medicinesresources.nhs.uk/systemic-treatments-for-eczema-a-network-meta-analysis.html 2020-10-14T15:54:34.9330000Z https://www.medicinesresources.nhs.uk/anti-cytokine-targeted-therapies-for-anca-associated-vasculitis.html 2020-10-14T14:56:12.9400000Z https://www.medicinesresources.nhs.uk/prophylactic-anti-staphylococcal-antibiotics-for-cystic-fibrosis.html 2020-10-14T14:57:24.7400000Z https://www.medicinesresources.nhs.uk/association-of-receipt-of-palliative-care-interventions-with-health-care-use-quality-of-life-and-symptom-burden-among-adults-with-chronic-noncancer-illness-a-systematic-review-and-meta-analysis.html 2020-10-14T14:58:49.2580000Z https://www.medicinesresources.nhs.uk/brain-and-nerve-complications-are-more-common-than-expected-in-younger-patients-with-severe-covid-19.html 2020-10-15T14:06:09.1510000Z https://www.medicinesresources.nhs.uk/is-it-safe-to-use-visible-blue-light-emitting-diode-phototherapy-for-neonatal-jaundice-in-infants-who-are-also-treated-with-amiodarone.html 2020-10-14T15:57:06.2350000Z https://www.medicinesresources.nhs.uk/prescribing-trends-over-time-by-non-medical-independent-prescribers-in-primary-care-settings-across-wales-2011-2018-a-secondary-database-analysis.html 2020-10-14T15:04:03.9320000Z https://www.medicinesresources.nhs.uk/assessment-of-the-effectiveness-of-a-pharmacist-approach-for-improving-disease-specific-knowledge-and-treatment-in-patients-with-chronic-obstructive-pulmonary-disease.html 2020-10-14T15:05:06.6800000Z https://www.medicinesresources.nhs.uk/immune-checkpoint-inhibitor-associated-diabetes-a-single-institution-experience-1.html 2020-10-14T15:07:08.7390000Z https://www.medicinesresources.nhs.uk/lipoprotein-a-lowering-by-alirocumab-reduces-the-total-burden-of-cardiovascular-events-independent-of-low-density-lipoprotein-cholesterol-lowering-odyssey-outcomes-trial.html 2020-10-14T15:08:04.7490000Z https://www.medicinesresources.nhs.uk/effect-of-sustained-smoking-cessation-counseling-and-provision-of-medication-vs-shorter-term-counseling-and-medication-advice-on-smoking-abstinence-in-patients-recently-diagnosed-with-cancer-a-randomized-clinical-trial.html 2020-10-14T15:09:39.8250000Z https://www.medicinesresources.nhs.uk/covid-19-in-new-zealand-and-the-impact-of-the-national-response-a-descriptive-epidemiological-study.html 2020-10-14T15:10:54.4990000Z https://www.medicinesresources.nhs.uk/longitudinal-antibody-and-t-cell-responses-in-ebola-virus-disease-survivors-and-contacts-an-observational-cohort-study.html 2020-10-14T15:12:39.6400000Z https://www.medicinesresources.nhs.uk/sudden-irreversible-hearing-loss-post-covid-19.html 2020-10-14T15:14:55.8090000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-data-on-aviptadil-for-respiratory-failure-related-to-critical-covid-19.html 2020-10-14T15:15:58.4800000Z https://www.medicinesresources.nhs.uk/manufacturers-make-rolling-new-drug-submission-to-fda-for-pacritinib-in-myelofibrosis-patients-with-severe-thrombocytopenia.html 2020-10-14T15:17:06.9070000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-dupilumab-in-phase-iii-paediatric-asthma-study.html 2020-10-14T15:18:07.5120000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-action-within-48-hours-sanofi-epilim-500mg-gastro-resistant-tablets-pl-04425-0303.html 2020-10-14T16:00:29.7590000Z https://www.medicinesresources.nhs.uk/right-ventricle-in-heart-failure-with-preserved-ejection-fraction.html 2020-10-14T15:20:30.9660000Z https://www.medicinesresources.nhs.uk/sars-cov-2-immunity-review-and-applications-to-phase-3-vaccine-candidates.html 2020-10-14T15:21:33.8070000Z https://www.medicinesresources.nhs.uk/nutritional-approaches-for-gastroparesis.html 2020-10-14T15:23:05.7490000Z https://www.medicinesresources.nhs.uk/reducing-health-inequalities-for-people-living-with-frailty-a-resource-for-commissioners-service-providers-and-health-care-and-support-staff.html 2020-10-14T15:25:53.1770000Z https://www.medicinesresources.nhs.uk/cutting-edge-treatments-to-be-fast-tracked-to-patients-through-international-collaborations.html 2020-10-14T15:27:24.1970000Z https://www.medicinesresources.nhs.uk/clinically-extremely-vulnerable-receive-updated-advice-tailored-to-local-covid-alert-levels.html 2020-10-14T15:28:21.6330000Z https://www.medicinesresources.nhs.uk/discontinuation-due-to-neuropsychiatric-adverse-events-with-efavirenz-and-dolutegravir-based-antiretroviral-therapy-a-comparative-real-life-study.html 2020-10-14T15:34:18.8370000Z https://www.medicinesresources.nhs.uk/effects-of-canagliflozin-on-anaemia-in-patients-with-type-2-diabetes-and-chronic-kidney-disease-a-post-hoc-analysis-from-the-credence-trial.html 2020-10-14T15:35:25.3780000Z https://www.medicinesresources.nhs.uk/lanifibranor-receive-breakthrough-designation-in-the-us-for-non-alcoholic-steatohepatitis-nash.html 2020-10-14T15:36:24.1170000Z https://www.medicinesresources.nhs.uk/johnson-and-johnson-pause-covid-19-vaccine-trial-after-unexplained-illness-in-study-participant.html 2020-10-14T15:37:38.9470000Z https://www.medicinesresources.nhs.uk/estimating-the-cost-of-growing-the-nhs-cancer-workforce-in-england-by-2029.html 2020-10-14T15:38:48.2080000Z https://www.medicinesresources.nhs.uk/neuropsychiatric-complications-of-covid-19.html 2020-10-14T15:40:03.4320000Z https://www.medicinesresources.nhs.uk/investigation-into-management-of-venous-thromboembolism-risk-in-patients-following-thrombolysis-for-an-acute-stroke.html 2020-10-19T09:51:18.6110000Z https://www.medicinesresources.nhs.uk/class-3-drug-alert-action-within-5-days-accord-healthcare-limited-metoprolol-50mg-tablets-pl-20075-0304.html 2020-10-14T15:42:05.5310000Z https://www.medicinesresources.nhs.uk/rps-calls-for-action-to-fight-counterfeit-medicines.html 2020-10-14T15:43:38.5930000Z https://www.medicinesresources.nhs.uk/efficacy-immunogenicity-and-safety-of-a-plant-derived-quadrivalent-virus-like-particle-influenza-vaccine-in-adults-18-64-years-and-older-adults-65-years-two-multicentre-randomised-phase-3-trials.html 2020-10-14T15:50:51.9650000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-312-october-2020-flu-special-edition.html 2020-10-19T10:20:33.3180000Z https://www.medicinesresources.nhs.uk/revised-spc-concerta-methylphenidate-xl-prolonged-release-tablets-all-strengths.html 2020-10-15T14:42:47.8380000Z https://www.medicinesresources.nhs.uk/a-5-decade-analysis-of-incidence-trends-of-ischemic-stroke-after-transient-ischemic-attack-a-systematic-review-and-meta-analysis.html 2020-10-15T14:43:47.9510000Z https://www.medicinesresources.nhs.uk/travel-related-control-measures-to-contain-the-covid-19-pandemic-a-rapid-review.html 2020-10-19T11:15:39.2820000Z https://www.medicinesresources.nhs.uk/universal-screening-for-sars-cov-2-infection-a-rapid-review-1.html 2020-10-19T11:17:23.8860000Z https://www.medicinesresources.nhs.uk/quarantine-alone-or-in-combination-with-other-public-health-measures-to-control-covid-19-a-rapid-review-1.html 2020-10-19T11:18:38.7780000Z https://www.medicinesresources.nhs.uk/thickening-agents-and-thickened-fluids-do-they-interact-with-medicines.html 2020-10-19T11:19:32.8810000Z https://www.medicinesresources.nhs.uk/how-can-people-who-need-thickened-fluids-take-medicines.html 2020-10-19T11:20:43.2780000Z https://www.medicinesresources.nhs.uk/weekly-national-flu-and-covid-19-surveillance-reports-published.html 2020-10-15T15:24:25.1630000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-confirms-eligibility-for-submission-of-modernas-covid-19-vaccine-candidate-mrna-1273.html 2020-10-15T15:25:35.2850000Z https://www.medicinesresources.nhs.uk/siponimod-for-treating-secondary-progressive-multiple-sclerosis-final-appraisal-document.html 2020-10-15T15:26:29.8310000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-writes-to-british-retail-consortium-about-risks-of-supermarket-medicine-substitutions-as-part-of-home-delivery-practice.html 2020-10-19T11:28:55.1570000Z https://www.medicinesresources.nhs.uk/how-will-brexit-affect-the-uks-response-to-coronavirus.html 2020-10-15T15:28:17.0860000Z https://www.medicinesresources.nhs.uk/proposals-for-more-efficient-and-responsive-access-to-medicines-for-patients.html 2020-10-19T11:30:26.5300000Z https://www.medicinesresources.nhs.uk/is-it-lawful-and-ethical-to-prioritize-racial-minorities-for-covid-19-vaccines.html 2020-10-15T15:31:14.6010000Z https://www.medicinesresources.nhs.uk/antiretroviral-drugs-for-treatment-and-prevention-of-hiv-infection-in-adults-2020-recommendations-of-the-international-antiviral-society-usa-panel.html 2020-10-15T15:32:19.3460000Z https://www.medicinesresources.nhs.uk/the-bigger-picture-learning-from-two-decades-of-changing-nhs-care-in-england.html 2020-10-15T15:33:14.2890000Z https://www.medicinesresources.nhs.uk/benzodiazepines-it-s-time-to-return-to-the-evidence.html 2020-10-15T15:34:49.0110000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-the-importance-of-transparency-and-fact-based-education.html 2020-10-15T17:49:28.3030000Z https://www.medicinesresources.nhs.uk/warfarin-in-patients-with-mechanical-heart-valves.html 2020-10-15T15:37:11.1310000Z https://www.medicinesresources.nhs.uk/high-court-in-london-to-rule-on-whether-children-with-gender-dysphoria-can-continue-to-be-given-hormone-blockers-to-delay-puberty.html 2020-10-15T17:47:04.6410000Z https://www.medicinesresources.nhs.uk/eli-lilly-pauses-phase-iii-activ-3-covid-19-antibody-bamlanivimab-trial-for-safety-reasons.html 2020-10-15T15:39:14.5720000Z https://www.medicinesresources.nhs.uk/covid-19-exposes-nhs-fault-lines-in-england.html 2020-10-15T17:45:18.8830000Z https://www.medicinesresources.nhs.uk/living-with-covid19.html 2020-10-19T11:35:12.6430000Z https://www.medicinesresources.nhs.uk/nitrofurantoin-in-treatment-of-urinary-tract-infection-common-prescribing-errors-consultation.html 2020-10-19T11:36:01.5340000Z https://www.medicinesresources.nhs.uk/new-long-term-follow-up-data-from-phase-ii-clinical-trial-of-tepezza-teprotumumab-trbw-in-thyroid-eye-disease.html 2020-10-15T16:04:36.4470000Z https://www.medicinesresources.nhs.uk/positive-results-from-aspen-1-phase-iii-trial-of-daxibotulinumtoxina-in-cervical-dystonia-meets-primary-efficacy-endpoint-at-both-125-and-250-unit-doses.html 2020-10-15T16:05:53.8550000Z https://www.medicinesresources.nhs.uk/fda-accepts-supplemental-new-drug-application-for-nurtec-rimegepant-orally-disintegrating-tablet-odt-for-preventive-treatment-of-migraine.html 2020-10-15T16:06:49.5690000Z https://www.medicinesresources.nhs.uk/phase-3-astral-2-and-astral-3-studies-of-guadecitabine-in-patients-with-previously-treated-acute-myeloid-leukaemia-and-myelodysplastic-syndromes-fail-to-meet-primary-endpoint.html 2020-10-15T16:07:45.2420000Z https://www.medicinesresources.nhs.uk/fda-approves-inmazeb-atoltivimab-maftivimab-and-odesivimab-ebgn-the-first-treatment-for-ebola-virus.html 2020-10-15T16:08:40.6640000Z https://www.medicinesresources.nhs.uk/pfizer-receives-fda-approval-to-test-adolescents-in-covid-19-vaccine-trial.html 2020-10-15T16:09:51.6020000Z https://www.medicinesresources.nhs.uk/trial-of-upadacitinib-or-abatacept-in-rheumatoid-arthritis.html 2020-10-15T17:22:48.1830000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-two-rna-based-covid-19-vaccine-candidates.html 2020-10-15T17:24:23.4760000Z https://www.medicinesresources.nhs.uk/six-months-of-hybrid-closed-loop-versus-manual-insulin-delivery-with-fingerprick-blood-glucose-monitoring-in-adults-with-type-1-diabetes-a-randomized-controlled-trial.html 2020-10-15T17:24:50.8620000Z https://www.medicinesresources.nhs.uk/effect-of-pre-hospital-crushed-prasugrel-tablets-in-patients-with-stemi-planned-for-primary-percutaneous-coronary-intervention-the-randomized-compare-crush-trial.html 2020-10-15T17:26:05.7130000Z https://www.medicinesresources.nhs.uk/artscan-iii-a-randomized-phase-iii-study-comparing-chemoradiotherapy-with-cisplatin-versus-cetuximab-in-patients-with-locoregionally-advanced-head-and-neck-squamous-cell-cancer.html 2020-10-15T17:26:35.5660000Z https://www.medicinesresources.nhs.uk/adjuvant-sorafenib-for-renal-cell-carcinoma-at-intermediate-or-high-risk-of-relapse-results-from-the-sorce-randomized-phase-iii-intergroup-trial.html 2020-10-15T17:27:12.9500000Z https://www.medicinesresources.nhs.uk/effect-of-risankizumab-on-patient-reported-outcomes-in-moderate-to-severe-psoriasis-the-ultimma-1-and-ultimma-2-randomized-clinical-trials.html 2020-10-15T17:29:15.8290000Z https://www.medicinesresources.nhs.uk/genomewide-association-study-of-severe-covid-19-with-respiratory-failure.html 2020-10-15T17:29:54.2860000Z https://www.medicinesresources.nhs.uk/a-perfect-storm-root-cause-analysis-of-supra-therapeutic-anticoagulation-with-vitamin-k-antagonists-during-the-covid-19-pandemic.html 2020-10-19T11:37:55.0300000Z https://www.medicinesresources.nhs.uk/revised-spc-zinforo-ceftaroline-600-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-10-16T15:05:08.5890000Z https://www.medicinesresources.nhs.uk/revised-spc-cordarone-amiodarone-x-200-mg-tablets.html 2020-10-16T15:06:07.9170000Z https://www.medicinesresources.nhs.uk/levonorgestrel-releasing-intrauterine-system-for-endometrial-hyperplasia.html 2020-10-16T15:07:10.8390000Z https://www.medicinesresources.nhs.uk/vitamin-e-supplementation-in-people-with-cystic-fibrosis.html 2020-10-16T15:08:19.8620000Z https://www.medicinesresources.nhs.uk/time-course-for-blood-pressure-lowering-of-beta-blockers-with-partial-agonist-activity.html 2020-10-16T15:09:21.1490000Z https://www.medicinesresources.nhs.uk/pharmacotherapy-for-hyperuricaemia-in-hypertensive-patients.html 2020-10-16T15:10:24.5600000Z https://www.medicinesresources.nhs.uk/acute-covid-19-and-the-incidence-of-ischemic-stroke-and-acute-myocardial-infarction.html 2020-10-16T15:11:32.4630000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-an-inactivated-sars-cov-2-vaccine-bbibp-corv-a-randomised-double-blind-placebo-controlled-phase-1-2-trial.html 2020-10-16T16:00:24.0450000Z https://www.medicinesresources.nhs.uk/global-age-sex-specific-fertility-mortality-healthy-life-expectancy-hale-and-population-estimates-in-204-countries-and-territories-1950-2019-a-comprehensive-demographic-analysis-for-the-global-burden-of-disease-study-2019.html 2020-10-16T15:14:11.4220000Z https://www.medicinesresources.nhs.uk/global-burden-of-369-diseases-and-injuries-in-204-countries-and-territories-1990-2019-a-systematic-analysis-for-the-global-burden-of-disease-study-2019.html 2020-10-16T15:14:55.5930000Z https://www.medicinesresources.nhs.uk/amisulpride-aripiprazole-and-olanzapine-in-patients-with-schizophrenia-spectrum-disorders-best-intro-a-pragmatic-rater-blind-semi-randomised-trial.html 2020-10-16T16:03:02.0330000Z https://www.medicinesresources.nhs.uk/associations-between-statin-use-and-suicidality-depression-anxiety-and-seizures-a-swedish-total-population-cohort-study.html 2020-10-16T15:17:18.8380000Z https://www.medicinesresources.nhs.uk/positive-results-from-study-of-peginterferon-lambda-in-the-treatment-of-outpatients-with-mild-to-moderate-covid-19.html 2020-10-16T15:23:59.6400000Z https://www.medicinesresources.nhs.uk/data-from-open-label-extension-of-voyage-1-study-of-guselkumab-in-adults-with-moderate-to-severe-psoriasis-released.html 2020-10-16T15:25:01.4800000Z https://www.medicinesresources.nhs.uk/fda-recommends-avoiding-use-of-nsaids-in-pregnancy-at-20-weeks-or-later-because-they-can-result-in-low-amniotic-fluid.html 2020-10-16T16:06:20.8040000Z https://www.medicinesresources.nhs.uk/care-quality-commission-publishes-annual-state-of-care-report-2019-20.html 2020-10-19T11:38:50.9400000Z https://www.medicinesresources.nhs.uk/deaths-related-to-drug-poisoning-in-england-and-wales-2019-registrations.html 2020-10-16T15:28:37.9010000Z https://www.medicinesresources.nhs.uk/assessment-of-mental-health-services-in-acute-trusts.html 2020-10-16T15:29:36.1000000Z https://www.medicinesresources.nhs.uk/mental-health-rehabilitation-inpatient-services-2019-update.html 2020-10-16T15:30:29.4350000Z https://www.medicinesresources.nhs.uk/government-response-consultation-on-changes-to-the-human-medicines-regulations-to-support-the-rollout-of-covid-19-and-flu-vaccines.html 2020-10-16T16:08:36.7250000Z https://www.medicinesresources.nhs.uk/local-covid-19-alert-level-update-15-october-2020.html 2020-10-16T15:32:30.7810000Z https://www.medicinesresources.nhs.uk/sensible-medicine-balancing-intervention-and-inaction-during-the-covid-19-pandemic.html 2020-10-16T15:33:27.7590000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-updated-guidance-on-postnatal-care-for-consultation.html 2020-10-16T15:34:20.7570000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-updated-guidance-on-caesarean-section-for-consultation.html 2020-10-16T15:35:18.7900000Z https://www.medicinesresources.nhs.uk/nice-gears-up-to-support-world-evidence-based-healthcare-ebhc-day.html 2020-10-16T15:36:32.0480000Z https://www.medicinesresources.nhs.uk/isatuximab-with-pomalidomide-and-dexamethasone-for-treating-relapsed-and-refractory-multiple-myeloma-final-appraisal-document.html 2020-10-16T15:37:38.7520000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-inclisiran-leqvio-for-the-treatment-of-adults-with-primary-hypercholesterolaemia-or-mixed-dyslipidaemia.html 2020-10-16T16:06:01.5790000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-fenfluramine-fintepla-for-the-treatment-of-seizures-associated-with-dravet-syndrome.html 2020-10-16T16:09:51.5930000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-gene-therapy-libmeldy-for-the-treatment-of-children-with-the-late-infantile-or-early-juvenile-forms-of-metachromatic-leukodystrophy.html 2020-10-16T16:13:35.7940000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-lumasiran-oxlumo-for-the-treatment-of-primary-hyperoxaluria-type-1-ph1.html 2020-10-16T16:14:28.8850000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-palforzia-for-desensitising-children-and-adolescents-to-peanut-allergy.html 2020-10-16T16:13:19.7450000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-first-car-t-cell-medicine-tecartus-for-the-treatment-of-relapsed-or-refractory-mantle-cell-lymphoma.html 2020-10-16T16:14:13.3230000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-trixeo-aerosphere-formoterol-glycopyrronium-bromide-budesonide-for-maintenance-treatment-of-copd.html 2020-10-16T16:15:12.6900000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-two-new-long-acting-antiretroviral-injections-for-the-treatment-of-hiv-1-infection.html 2020-10-16T16:16:24.5580000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-new-route-of-administration-for-existing-formulation-of-peginterferon-beta-1a-plegridy.html 2020-10-16T16:17:22.2820000Z https://www.medicinesresources.nhs.uk/effect-of-n-acetylcysteine-on-prevention-of-contrast-associated-acute-kidney-injury-in-patients-with-stemi-undergoing-primary-percutaneous-coronary-intervention-a-systematic-review-and-meta-analysis-of-randomised-controlled-trials.html 2020-10-19T13:09:29.4940000Z https://www.medicinesresources.nhs.uk/tralokinumab-for-moderate-to-severe-atopic-dermatitis-results-from-two-52-week-randomized-double-blind-multicentre-placebo-controlled-phase-iii-trials-ecztra-1-and-ecztra-2.html 2020-10-19T13:11:37.3410000Z https://www.medicinesresources.nhs.uk/deaths-in-people-from-black-asian-and-minority-ethnic-communities-from-both-covid-19-and-non-covid-causes-in-the-first-weeks-of-the-pandemic-in-london-a-hospital-case-note-review.html 2020-10-26T10:59:08.0270000Z https://www.medicinesresources.nhs.uk/updating-ethnic-contrasts-in-deaths-involving-the-coronavirus-covid-19-england-and-wales-deaths-occurring-2-march-to-28-july-2020.html 2020-10-20T13:55:51.4110000Z https://www.medicinesresources.nhs.uk/who-reports-interim-results-of-solidarity-trial-of-covid-19-drugs.html 2020-10-19T13:15:05.0300000Z https://www.medicinesresources.nhs.uk/fda-approval-of-venetoclax-venclexta-for-newly-diagnosed-acute-myeloid-leukaemia.html 2020-10-19T13:16:10.4780000Z https://www.medicinesresources.nhs.uk/withdrawal-of-european-marketing-authorization-application-for-ivosidenib-for-relapsed-or-refractory-idh1-mutant-acute-myeloid-leukaemia.html 2020-10-19T13:17:08.9350000Z https://www.medicinesresources.nhs.uk/producing-and-using-timely-comparative-evidence-on-drugs-lessons-from-clinical-trials-for-covid-19.html 2020-10-19T13:18:13.3870000Z https://www.medicinesresources.nhs.uk/new-measures-to-support-roll-out-of-vaccines-in-the-uk.html 2020-10-20T13:57:56.7490000Z https://www.medicinesresources.nhs.uk/postlicensure-evaluation-of-covid-19-vaccines.html 2020-10-19T13:21:00.6980000Z https://www.medicinesresources.nhs.uk/answering-key-questions-about-covid-19-vaccines.html 2020-10-19T13:22:19.2700000Z https://www.medicinesresources.nhs.uk/suicide-prevention-in-the-covid-19-era.html 2020-10-19T13:23:09.1530000Z https://www.medicinesresources.nhs.uk/emergency-use-authorization-of-covid-vaccines-safety-and-efficacy-follow-up-considerations.html 2020-10-19T14:18:17.6920000Z https://www.medicinesresources.nhs.uk/trustworthiness-before-trust-covid-19-vaccine-trials-and-the-black-community.html 2020-10-19T13:25:04.6020000Z https://www.medicinesresources.nhs.uk/advancing-mental-health-equalities-strategy.html 2020-10-19T13:26:00.3250000Z https://www.medicinesresources.nhs.uk/heart-failure-a-blueprint-for-change.html 2020-10-19T14:21:00.7180000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-onivyde-pegylated-liposomal-irinotecan-4-3-mg-ml.html 2020-10-19T13:28:37.0750000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-envarsus-tacrolimus-1mg-interim-supply-disruption.html 2020-10-19T13:30:00.4310000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-micafungin-safety-checklist-for-prescribing-physicians.html 2020-10-19T13:31:00.0010000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-bavencio-avelumab-patient-alert-card-and-information-brochure.html 2020-10-19T13:32:49.0500000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-blinatumomab-blincyto-for-acute-lymphoblastic-leukaemia-1.html 2020-10-19T14:33:57.1920000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-of-dupilumab-dupixent-for-severe-atopic-dermatitis.html 2020-10-19T14:35:08.1040000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-dapagliflozin-edistride-and-forxiga-for-heart-failure.html 2020-10-19T14:36:08.9700000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-of-adalimumab-humira-for-moderately-to-severely-active-ulcerative-colitis.html 2020-10-19T14:37:19.0250000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-nivolumab-opdivo-for-squamous-cell-carcinoma.html 2020-10-19T14:38:44.0150000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-recarbrio-imipenem-cilastatin-relebactam.html 2020-10-19T14:40:06.0270000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-guselkumab-tremfya-for-active-psoriatic-arthritis.html 2020-10-19T14:41:17.1710000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-lacosamide-vimpat-for-idiopathic-generalised-epilepsy.html 2020-10-19T14:42:46.3400000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-intramuscular-route-of-administration-for-peginterferon-beta-1a-plegridy.html 2020-10-19T14:43:54.6830000Z https://www.medicinesresources.nhs.uk/homecare-prescription-management-during-covid-19-exemplar-risk-assessment-national-homecare-medicines-committee.html 2020-10-20T14:02:44.6740000Z https://www.medicinesresources.nhs.uk/medicines-q-and-a-what-is-the-evidence-for-verapamil-for-prevention-of-cluster-headache.html 2020-10-20T13:24:43.4400000Z https://www.medicinesresources.nhs.uk/revised-spc-enstilar-calcipotriol-betamethasone-cutaneous-foam.html 2020-10-20T14:14:16.7880000Z https://www.medicinesresources.nhs.uk/revised-spc-vfend-voriconazole-products.html 2020-10-20T14:15:58.8800000Z https://www.medicinesresources.nhs.uk/anti-cd19-chimeric-antigen-receptor-t-cell-therapy-in-acute-lymphocytic-leukaemia-a-systematic-review-and-meta-analysis.html 2020-10-20T14:17:05.8060000Z https://www.medicinesresources.nhs.uk/severity-and-mortality-of-covid-19-in-patients-with-diabetes-hypertension-and-cardiovascular-disease-a-meta-analysis.html 2020-10-20T14:19:30.0080000Z https://www.medicinesresources.nhs.uk/angiotensin-converting-enzyme-inhibitors-and-angiotensin-ii-receptor-blockers-and-outcomes-in-patients-with-covid-19-a-systematic-review-and-meta-analysis.html 2020-10-21T08:31:13.8380000Z https://www.medicinesresources.nhs.uk/cytokine-elevation-in-severe-and-critical-covid-19-a-rapid-systematic-review-meta-analysis-and-comparison-with-other-inflammatory-syndromes.html 2020-10-20T14:23:03.5230000Z https://www.medicinesresources.nhs.uk/palivizumab-passive-immunisation-against-respiratory-syncytial-virus-rsv-in-at-risk-pre-term-infants.html 2020-10-21T08:40:44.0220000Z https://www.medicinesresources.nhs.uk/rmoc-buprenorphine-long-acting-injection-guidance-consultation-running-until-13-11-2020.html 2020-10-21T13:02:29.3560000Z https://www.medicinesresources.nhs.uk/rmoc-hydroxychloroquine-retinopathy-monitoring-consultation-running-until-13-11-2020.html 2020-10-21T13:03:29.9180000Z https://www.medicinesresources.nhs.uk/what-are-the-differences-between-different-brands-of-mesalazine-tablets.html 2020-10-21T13:06:26.9460000Z https://www.medicinesresources.nhs.uk/conference-report-respiratory-impairment-persists-for-weeks-post-discharge-in-hospitalised-covid-19-patients.html 2020-10-20T14:29:29.4790000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-to-supplemental-new-drug-application-for-osimertinib-as-adjuvant-treatment-of-early-stage-ib-ii-iiia-egfr-mutated-non-small-cell-lung-cancer-after-complete-tumour-resection-with-curative-intent.html 2020-10-20T14:30:37.4140000Z https://www.medicinesresources.nhs.uk/national-institute-for-biological-standards-and-control-nibsc-selected-to-test-coronavirus-vaccines-globally.html 2020-10-20T14:32:07.6660000Z https://www.medicinesresources.nhs.uk/medicines-shortages-increase-as-prescribing-costs-rise-gbp158-million.html 2020-10-20T14:33:17.0890000Z https://www.medicinesresources.nhs.uk/consensus-treatment-recommendations-from-the-tenth-international-workshop-for-waldenstroem-macroglobulinaemia.html 2020-10-20T14:34:11.5540000Z https://www.medicinesresources.nhs.uk/high-risk-mantle-cell-lymphoma-definition-current-challenges-and-management.html 2020-10-20T14:36:13.3880000Z https://www.medicinesresources.nhs.uk/herd-immunity-and-implications-for-sars-cov-2-control.html 2020-10-20T14:37:32.3880000Z https://www.medicinesresources.nhs.uk/cardiovascular-risk-prediction-tools-made-relevant-for-gps-and-patients.html 2020-10-20T14:38:32.3310000Z https://www.medicinesresources.nhs.uk/uk-pandemic-preparedness.html 2020-10-20T14:39:46.3510000Z https://www.medicinesresources.nhs.uk/contemporary-diagnosis-and-management-of-rheumatic-heart-disease-implications-for-closing-the-gap-a-scientific-statement-from-the-american-heart-association.html 2020-10-20T14:41:29.7140000Z https://www.medicinesresources.nhs.uk/lifelong-aspirin-for-all-in-the-secondary-prevention-of-chronic-coronary-syndrome-still-sacrosanct-or-is-reappraisal-warranted.html 2020-10-20T14:42:48.9500000Z https://www.medicinesresources.nhs.uk/medical-devices-safety-bulletin-mdsb-2020-01.html 2020-10-20T14:43:52.3450000Z https://www.medicinesresources.nhs.uk/video-consultations-in-primary-and-specialist-care-during-the-covid-19-pandemic-and-beyond.html 2020-10-20T14:44:45.4250000Z https://www.medicinesresources.nhs.uk/galcanezumab-for-preventing-migraine-final-appraisal-document.html 2020-10-20T14:45:56.7770000Z https://www.medicinesresources.nhs.uk/use-of-n95-surgical-and-cloth-masks-to-prevent-covid-19-in-health-care-and-community-settings-living-practice-points-from-the-american-college-of-physicians-version-1.html 2020-10-20T14:47:12.0650000Z https://www.medicinesresources.nhs.uk/how-to-quantify-and-interpret-treatment-effects-in-comparative-clinical-studies-of-covid-19.html 2020-10-20T16:11:11.3380000Z https://www.medicinesresources.nhs.uk/ethical-framework-for-assessing-manual-and-digital-contact-tracing-for-covid-19.html 2020-10-20T14:49:33.6700000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-what-physicians-need-to-know.html 2020-10-20T14:50:40.1890000Z https://www.medicinesresources.nhs.uk/pfizer-will-not-seek-emergency-use-authorization-eua-for-its-covid-19-vaccine-bnt162b2-until-end-of-november.html 2020-10-20T14:52:06.2800000Z https://www.medicinesresources.nhs.uk/abbvie-submits-regulatory-applications-to-fda-and-ema-for-upadacitinib-in-atopic-dermatitis.html 2020-10-20T14:54:29.4290000Z https://www.medicinesresources.nhs.uk/what-is-herd-immunity.html 2020-10-20T14:56:49.1880000Z https://www.medicinesresources.nhs.uk/hpv-vaccination-coverage-in-adolescent-females-and-males-in-england-2019-to-2020.html 2020-10-20T14:58:39.0730000Z https://www.medicinesresources.nhs.uk/cessation-of-non-vitamin-k-antagonist-oral-anticoagulants-in-patients-with-atrial-fibrillation.html 2020-10-20T15:03:48.3310000Z https://www.medicinesresources.nhs.uk/sustained-impact-of-real-time-continuous-glucose-monitoring-in-adults-with-type-1-diabetes-on-insulin-pump-therapy-results-after-the-24-month-rescue-study.html 2020-10-20T15:42:59.7170000Z https://www.medicinesresources.nhs.uk/triaging-of-respiratory-protective-equipment-on-the-assumed-risk-of-sars-cov-2-aerosol-exposure-in-patient-facing-healthcare-workers-delivering-secondary-care-a-rapid-review.html 2020-10-20T15:06:41.6960000Z https://www.medicinesresources.nhs.uk/excess-mortality-in-the-first-covid-pandemic-peak-cross-sectional-analyses-of-the-impact-of-age-sex-ethnicity-household-size-and-long-term-conditions-in-people-of-known-sars-cov-2-status-in-england.html 2020-10-20T15:09:13.3110000Z https://www.medicinesresources.nhs.uk/uncoded-chronic-kidney-disease-in-primary-care-a-cross-sectional-study-of-inequalities-and-cardiovascular-disease-risk-management.html 2020-10-20T15:11:11.1330000Z https://www.medicinesresources.nhs.uk/microbleeds-and-the-effect-of-anticoagulation-in-patients-with-embolic-stroke-of-undetermined-source-an-exploratory-analysis-of-the-navigate-esus-randomized-clinical-trial.html 2020-10-20T15:13:37.5410000Z https://www.medicinesresources.nhs.uk/pregnancy-and-fetal-outcomes-following-exposure-to-modafinil-and-armodafinil-during-pregnancy.html 2020-10-20T15:15:17.9550000Z https://www.medicinesresources.nhs.uk/evaluation-of-a-pharmacist-led-actionable-audit-and-feedback-intervention-for-improving-medication-safety-in-uk-primary-care-an-interrupted-time-series-analysis.html 2020-10-21T13:11:00.6360000Z https://www.medicinesresources.nhs.uk/volanesorsen-for-treating-familial-chylomicronaemia-syndrome-guidance-hst13.html 2020-10-23T09:21:00.1910000Z https://www.medicinesresources.nhs.uk/nivolumab-for-advanced-squamous-non-small-cell-lung-cancer-after-chemotherapy-guidance-ta655.html 2020-10-23T09:40:55.7730000Z https://www.medicinesresources.nhs.uk/revised-spc-cipralex-escitalopram-film-coated-tablets.html 2020-10-21T14:49:58.6000000Z https://www.medicinesresources.nhs.uk/revised-spc-oxynorm-oxycodone-solution-for-injection-or-infusion.html 2020-10-21T14:52:08.6430000Z https://www.medicinesresources.nhs.uk/does-adherence-to-lipid-lowering-medications-improve-cancer-survival-a-nationwide-study-of-breast-and-colorectal-cancer-and-melanoma.html 2020-10-21T14:53:37.9400000Z https://www.medicinesresources.nhs.uk/risk-of-osteoporosis-and-fragility-fractures-in-asthma-due-to-oral-and-inhaled-corticosteroids-two-population-based-nested-case-control-studies.html 2020-10-21T14:55:14.5640000Z https://www.medicinesresources.nhs.uk/newly-diagnosed-diabetes-and-outcomes-after-acute-myocardial-infarction-in-young-adults.html 2020-10-21T14:56:30.9520000Z https://www.medicinesresources.nhs.uk/baseline-vitamin-d-status-sleep-patterns-and-the-risk-of-incident-type-2-diabetes-in-data-from-the-uk-biobank-study.html 2020-10-21T14:58:39.8950000Z https://www.medicinesresources.nhs.uk/association-between-early-treatment-with-tocilizumab-and-mortality-among-critically-ill-patients-with-covid-19.html 2020-10-23T10:14:19.7550000Z https://www.medicinesresources.nhs.uk/effect-of-tocilizumab-vs-usual-care-in-adults-hospitalized-with-covid-19-and-moderate-or-severe-pneumonia-a-randomized-clinical-trial.html 2020-10-23T10:31:15.5260000Z https://www.medicinesresources.nhs.uk/effect-of-tocilizumab-vs-standard-care-on-clinical-worsening-in-patients-hospitalized-with-covid-19-pneumonia-a-randomized-clinical-trial.html 2020-10-23T10:32:17.4810000Z https://www.medicinesresources.nhs.uk/real-time-cgm-is-superior-to-flash-glucose-monitoring-for-glucose-control-in-type-1-diabetes-the-corrida-randomized-controlled-trial.html 2020-10-21T15:10:56.5170000Z https://www.medicinesresources.nhs.uk/natalizumab-versus-fingolimod-for-patients-with-active-relapsing-remitting-multiple-sclerosis-results-from-reveal-a-prospective-randomised-head-to-head-study.html 2020-10-21T15:12:36.5660000Z https://www.medicinesresources.nhs.uk/effect-of-praliciguat-on-peak-rate-of-oxygen-consumption-in-patients-with-heart-failure-with-preserved-ejection-fraction-the-capacity-hfpef-randomized-clinical-trial.html 2020-10-21T16:06:43.1680000Z https://www.medicinesresources.nhs.uk/effect-of-vericiguat-vs-placebo-on-quality-of-life-in-patients-with-heart-failure-and-preserved-ejection-fraction-the-vitality-hfpef-randomized-clinical-trial.html 2020-10-21T16:07:16.3130000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-from-two-phase-3-adult-studies-evaluating-investigational-15-valent-pneumococcal-conjugate-vaccine.html 2020-10-21T15:22:58.9490000Z https://www.medicinesresources.nhs.uk/asthma-fund-launched-to-support-development-and-adoption-of-new-technologies.html 2020-10-21T15:25:47.8300000Z https://www.medicinesresources.nhs.uk/psnc-briefing-037-20-serious-shortage-protocol-ssp-ssp08-salazopyrin-r-en-tabs-500mg.html 2020-10-23T10:37:17.7510000Z https://www.medicinesresources.nhs.uk/psnc-briefing-036-20-serious-shortage-protocol-ssp-ssp07-fluoxetine-30mg-capsules.html 2020-10-23T10:37:37.0530000Z https://www.medicinesresources.nhs.uk/nice-bites-pneumonia-antimicrobial-prescribing.html 2020-10-23T10:43:42.3960000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-results-for-xywav-tm-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-in-phase-iii-study-in-cataplexy-or-excessive-daytime-sleepiness-with-narcolepsy.html 2020-10-21T15:31:29.6480000Z https://www.medicinesresources.nhs.uk/selection-of-optimal-adjuvant-chemotherapy-and-targeted-therapy-for-early-breast-cancer-asco-guideline-update.html 2020-10-21T15:33:32.7160000Z https://www.medicinesresources.nhs.uk/dtb-select-steroid-emergency-cards-action-needed.html 2020-10-26T10:56:40.5400000Z https://www.medicinesresources.nhs.uk/national-dose-banding-table-isatuximab-20mg-ml.html 2020-10-23T12:38:12.4880000Z https://www.medicinesresources.nhs.uk/national-dose-banding-table-isatuximab-20mg-ml-1.html 2020-10-22T17:42:29.6530000Z https://www.medicinesresources.nhs.uk/revised-spc-erivedge-vismodegib-150-mg-hard-capsules.html 2020-10-22T14:29:54.4260000Z https://www.medicinesresources.nhs.uk/revised-spc-wakix-pitolisant-4-5-mg-18mg-film-coated-tablets.html 2020-10-22T14:30:55.8090000Z https://www.medicinesresources.nhs.uk/what-is-the-optimal-prokinetic-dose-of-erythromycin-in-adults.html 2020-10-23T12:42:20.3260000Z https://www.medicinesresources.nhs.uk/nihr-alert-sharing-electronic-records-with-patients-led-to-improved-control-of-type-two-diabetes.html 2020-10-22T14:34:07.4300000Z https://www.medicinesresources.nhs.uk/46th-ukmi-conference-virtual-2020-iposters.html 2020-10-22T17:39:33.3370000Z https://www.medicinesresources.nhs.uk/tuberculosis-in-england-national-quarterly-report-q3-2020-1-july-to-30-september-2020.html 2020-10-22T14:36:07.9520000Z https://www.medicinesresources.nhs.uk/world-antimicrobial-awareness-week-waaw-and-european-antibiotic-awareness-day-eaad-resources-toolkit-for-healthcare-professionals-in-england-in-the-context-of-the-covid-19-pandemic.html 2020-10-23T12:57:32.0900000Z https://www.medicinesresources.nhs.uk/preliminary-positive-results-announced-from-second-phase-ii-study-of-lyme-disease-vaccine-candidate-vla15.html 2020-10-22T14:39:36.1740000Z https://www.medicinesresources.nhs.uk/leniolisib-granted-orphan-drug-designation-by-european-commission-for-treatment-activated-phosphoinositide-3-kinase-delta-syndrome-apds.html 2020-10-22T14:41:00.8090000Z https://www.medicinesresources.nhs.uk/nhs-strengthens-mental-health-support-for-staff.html 2020-10-22T14:42:01.9360000Z https://www.medicinesresources.nhs.uk/ccg-outcomes-indicator-set-october-2020.html 2020-10-22T14:44:38.8340000Z https://www.medicinesresources.nhs.uk/mental-health-of-children-and-young-people-in-england-2020-wave-1-follow-up-to-the-2017-survey.html 2020-10-22T17:36:28.3050000Z https://www.medicinesresources.nhs.uk/sensory-ganglionopathy.html 2020-10-22T14:48:09.3160000Z https://www.medicinesresources.nhs.uk/medical-care-of-adults-with-down-syndrome-a-clinical-guideline.html 2020-10-22T14:50:14.0080000Z https://www.medicinesresources.nhs.uk/reporting-requirements-for-medicine-shortages-and-discontinuations.html 2020-10-23T13:12:39.0570000Z https://www.medicinesresources.nhs.uk/health-secretary-warns-of-long-term-effects-of-covid-19-as-new-film-released.html 2020-10-22T14:52:40.2390000Z https://www.medicinesresources.nhs.uk/me-too-pharmaceutical-products-history-definitions-examples-and-relevance-to-drug-shortages-and-essential-medicines-lists.html 2020-10-22T14:54:25.4420000Z https://www.medicinesresources.nhs.uk/recognising-and-explaining-functional-neurological-disorder.html 2020-10-22T17:33:10.8790000Z https://www.medicinesresources.nhs.uk/will-covid-19-vaccines-save-lives-current-trials-arent-designed-to-tell-us.html 2020-10-22T14:57:21.2530000Z https://www.medicinesresources.nhs.uk/novartis-seeks-to-repurpose-its-investigational-oral-spinal-muscular-atrophy-sma-drug-branaplam-to-treat-huntingtons-disease-hd.html 2020-10-22T17:31:09.0180000Z https://www.medicinesresources.nhs.uk/update-alert-3-hydroxychloroquine-or-chloroquine-for-the-treatment-or-prophylaxis-of-covid-19free.html 2020-10-22T17:31:51.4670000Z https://www.medicinesresources.nhs.uk/death-of-volunteer-in-clinical-trial-in-brazil-of-covid-19-vaccine-developed-by-astrazeneca-and-oxford-university.html 2020-10-22T15:01:24.1330000Z https://www.medicinesresources.nhs.uk/roche-and-prothena-will-advance-prasinezumab-into-late-stage-clinical-development-study-in-parkinsons-disease.html 2020-10-22T15:03:09.4900000Z https://www.medicinesresources.nhs.uk/fda-grants-fast-track-designation-to-ublituximab-in-combination-with-umbralisib-for-treatment-of-chronic-lymphocytic-leukaemia.html 2020-10-22T15:04:20.6000000Z https://www.medicinesresources.nhs.uk/written-instruction-for-the-administration-of-seasonal-flu-vaccination-2020-21-version-1.html 2020-10-23T13:15:38.6460000Z https://www.medicinesresources.nhs.uk/preparation-of-ready-to-administer-medicines-covid-19-wave-2-update.html 2020-10-23T13:17:04.7190000Z https://www.medicinesresources.nhs.uk/anti-siglec-8-antibody-for-eosinophilic-gastritis-and-duodenitis.html 2020-10-22T15:27:31.3510000Z https://www.medicinesresources.nhs.uk/efficacy-of-tocilizumab-in-patients-hospitalized-with-covid-19.html 2020-10-23T13:20:32.4140000Z https://www.medicinesresources.nhs.uk/effects-of-intensive-versus-standard-blood-pressure-control-on-domain-specific-cognitive-function-a-substudy-of-the-sprint-randomised-controlled-trial.html 2020-10-22T17:17:45.1440000Z https://www.medicinesresources.nhs.uk/effect-of-empagliflozin-on-the-clinical-stability-of-patients-with-heart-failure-and-a-reduced-ejection-fraction-the-emperor-reduced-trial.html 2020-10-22T15:32:31.7860000Z https://www.medicinesresources.nhs.uk/association-of-maternal-prepregnancy-diabetes-and-gestational-diabetes-mellitus-with-congenital-anomalies-of-the-newborn.html 2020-10-22T15:33:49.2330000Z https://www.medicinesresources.nhs.uk/living-risk-prediction-algorithm-qcovid-for-risk-of-hospital-admission-and-mortality-from-coronavirus-19-in-adults-national-derivation-and-validation-cohort-study.html 2020-10-22T15:35:15.4040000Z https://www.medicinesresources.nhs.uk/covid-19-mortality-risk-in-down-syndrome-results-from-a-cohort-study-of-8-million-adults.html 2020-10-22T15:38:06.4540000Z https://www.medicinesresources.nhs.uk/the-impact-of-covid-19-on-cancer-care-how-the-pandemic-is-delaying-cancer-diagnosis-and-treatment-for-american-seniors.html 2020-10-22T15:42:47.0250000Z https://www.medicinesresources.nhs.uk/mental-health-and-wellbeing-during-the-covid-19-pandemic-longitudinal-analyses-of-adults-in-the-uk-covid-19-mental-health-and-wellbeing-study.html 2020-10-22T15:44:12.2560000Z https://www.medicinesresources.nhs.uk/prediagnostic-use-of-low-dose-aspirin-and-risk-of-incident-metastasis-and-all-cause-mortality-among-patients-with-colorectal-cancer.html 2020-10-22T15:45:58.5700000Z https://www.medicinesresources.nhs.uk/improving-junior-doctor-medicine-prescribing-and-patient-safety-an-intervention-using-personalised-structured-video-enhanced-feedback-and-deliberate-practice.html 2020-10-22T15:47:16.3300000Z https://www.medicinesresources.nhs.uk/long-term-risk-of-hip-or-forearm-fractures-in-older-occasional-users-of-benzodiazepines.html 2020-10-22T16:35:37.9000000Z https://www.medicinesresources.nhs.uk/the-phenotype-of-adverse-drug-effects-do-emergency-visits-due-to-adverse-drug-reactions-look-different-in-older-people-results-from-the-adred-study.html 2020-10-22T15:50:33.8240000Z https://www.medicinesresources.nhs.uk/cytokine-levels-in-critically-ill-patients-with-covid-19-and-other-conditions.html 2020-10-22T15:52:32.7930000Z https://www.medicinesresources.nhs.uk/meropenem-vaborbactam-vaborem-r-recommended-as-an-option-for-restricted-use-within-nhs-wales.html 2020-10-23T14:41:52.2600000Z https://www.medicinesresources.nhs.uk/revised-spcs-abilify-aripiprazole-preparations.html 2020-10-23T14:42:57.1600000Z https://www.medicinesresources.nhs.uk/revised-spc-foscavir-foscarnet-24-mg-ml-solution-for-infusion.html 2020-10-23T14:43:54.4470000Z https://www.medicinesresources.nhs.uk/revised-spc-jardiance-empagliflozin-film-coated-tablets.html 2020-10-23T14:44:59.3220000Z https://www.medicinesresources.nhs.uk/revised-spc-ecalta-anidulafungin-100-mg-powder-for-concentrate-for-solution-for-infusion-1.html 2020-10-23T14:46:52.5850000Z https://www.medicinesresources.nhs.uk/revised-spc-imraldi-adalimumab-40-mg-solution-for-injection-in-pre-filled-pen.html 2020-10-23T14:48:18.5950000Z https://www.medicinesresources.nhs.uk/revised-spcs-keppra-levetiracetam-products-1.html 2020-10-23T15:46:55.6710000Z https://www.medicinesresources.nhs.uk/revised-spc-praxbind-idarucizumab-2-5-g-50-ml-solution-for-injection-infusion.html 2020-10-23T14:50:26.3170000Z https://www.medicinesresources.nhs.uk/5-fluorouracil-intravenous-capecitabine-tegafur-dpd-testing-recommended-before-initiation-to-identify-patients-at-increased-risk-of-severe-and-fatal-toxicity.html 2020-10-26T09:22:25.3900000Z https://www.medicinesresources.nhs.uk/flucytosine-ancotil-new-contraindication-in-patients-with-dpd-deficiency.html 2020-10-26T09:23:53.9500000Z https://www.medicinesresources.nhs.uk/niraparib-zejula-reports-of-severe-hypertension-and-posterior-reversible-encephalopathy-syndrome-pres-particularly-in-early-treatment.html 2020-10-26T09:30:48.9260000Z https://www.medicinesresources.nhs.uk/dolutegravir-tivicay-triumeq-juluca-updated-advice-on-increased-risk-of-neural-tube-defects.html 2020-10-26T09:38:27.6040000Z https://www.medicinesresources.nhs.uk/warfarin-and-other-anticoagulants-monitoring-of-patients-during-the-covid-19-pandemic-1.html 2020-10-26T09:43:34.5560000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-reimbursement-for-the-use-of-generic-drugs-for-pre-exposure-prophylaxis-prep-for-the-prevention-of-hiv.html 2020-10-26T09:49:44.8930000Z https://www.medicinesresources.nhs.uk/clinical-endpoints-for-evaluating-efficacy-in-covid-19-vaccine-trials.html 2020-10-23T14:58:19.7380000Z https://www.medicinesresources.nhs.uk/us-fda-grants-full-approval-to-remdesivir-for-the-treatment-of-covid-19.html 2020-10-23T14:59:20.7570000Z https://www.medicinesresources.nhs.uk/results-from-phase-iii-study-of-lumasiran-in-paediatric-patients-with-primary-hyperoxaluria-type-1-presented-at-conference.html 2020-10-23T15:00:24.3490000Z https://www.medicinesresources.nhs.uk/clinical-trial-data-for-tenapanor-for-management-of-hyperphosphataemia-in-dialysis-patients-presented-at-the-annual-meeting-of-the-american-society-of-nephrology.html 2020-10-23T15:03:18.4190000Z https://www.medicinesresources.nhs.uk/phase-iii-data-for-narsoplimab-in-the-treatment-of-hematopoietic-stem-cell-transplant-associated-thrombotic-microangiopathy-hsct-tma.html 2020-10-23T15:53:20.4120000Z https://www.medicinesresources.nhs.uk/covid-19-experts-say-vaccine-trials-need-more-transparency-to-enable-scrutiny-and-earn-public-trust.html 2020-10-23T15:06:33.1110000Z https://www.medicinesresources.nhs.uk/covid-19-government-shelves-plans-to-invest-gbp100bn-in-mass-testing.html 2020-10-23T15:07:49.7610000Z https://www.medicinesresources.nhs.uk/coroner-calls-for-mhra-to-review-side-effects-of-doxycycline-after-student-jumped-from-plane.html 2020-10-23T15:09:10.4750000Z https://www.medicinesresources.nhs.uk/covid-19-human-challenge-studies-will-see-people-purposefully-infected-with-virus.html 2020-10-23T15:39:10.3970000Z https://www.medicinesresources.nhs.uk/out-of-sight-who-cares-restraint-segregation-and-seclusion-review.html 2020-10-23T15:11:31.8570000Z https://www.medicinesresources.nhs.uk/sewage-signals-early-warning-of-coronavirus-outbreaks.html 2020-10-23T15:12:30.7720000Z https://www.medicinesresources.nhs.uk/flublok-vaccine-given-authorisation-for-temporary-supply-in-the-uk-to-meet-public-health-need.html 2020-10-26T10:00:43.4810000Z https://www.medicinesresources.nhs.uk/icmra-meeting-covid-19-real-world-evidence-and-observational-studies.html 2020-10-23T15:16:08.9900000Z https://www.medicinesresources.nhs.uk/the-current-landscape-of-immune-checkpoint-blockade-in-hepatocellular-carcinoma.html 2020-10-23T15:17:20.6870000Z https://www.medicinesresources.nhs.uk/the-global-incidence-and-diagnosis-of-fungal-keratitis.html 2020-10-23T15:18:25.4220000Z https://www.medicinesresources.nhs.uk/every-report-counts-report-suspected-adverse-drug-reactions-and-take-part-in-medsafetyweek-2-8-november-2020.html 2020-10-26T10:15:13.4850000Z https://www.medicinesresources.nhs.uk/company-led-drug-alert-optiray-r-300mg-i-ml-solution-for-injection-or-infusion-and-optiray-r-350mg-i-ml-solution-for-injection-or-infusion.html 2020-10-23T15:21:59.3060000Z https://www.medicinesresources.nhs.uk/national-seasonal-influenza-immunisation-programme-2020-21-primary-care-frequently-asked-questions.html 2020-10-26T10:35:21.6530000Z https://www.medicinesresources.nhs.uk/claiming-reimbursement-for-reasonable-additional-costs-for-flu-delivery.html 2020-10-23T15:24:59.4750000Z https://www.medicinesresources.nhs.uk/pembrolizumab-for-untreated-metastatic-or-unresectable-recurrent-head-and-neck-squamous-cell-carcinoma-hnscc-final-appraisal-document.html 2020-10-23T16:00:25.2800000Z https://www.medicinesresources.nhs.uk/ten-things-pharmacists-should-know-about-covid-19-vaccines.html 2020-10-23T15:27:48.8610000Z https://www.medicinesresources.nhs.uk/weekly-national-flu-and-covid-19-surveillance-report-published-week-43.html 2020-10-23T15:28:50.5540000Z https://www.medicinesresources.nhs.uk/an-overview-of-nhs-procurement-of-medicines-and-pharmaceutical-products-and-services-for-acute-care-in-the-united-kingdom-updated-october-2020.html 2020-10-26T10:39:29.4410000Z https://www.medicinesresources.nhs.uk/systemic-therapy-and-sequencing-options-in-advanced-hepatocellular-carcinoma-a-systematic-review-and-network-meta-analysis.html 2020-10-23T16:07:23.2170000Z https://www.medicinesresources.nhs.uk/oral-once-daily-berotralstat-for-the-prevention-of-hereditary-angioedema-attacks-a-randomized-double-blind-placebo-controlled-phase-3-trial.html 2020-10-23T16:09:53.2390000Z https://www.medicinesresources.nhs.uk/convalescent-plasma-in-the-management-of-moderate-covid-19-in-adults-in-india-open-label-phase-ii-multicentre-randomised-controlled-trial-placid-trial.html 2020-10-26T10:53:06.1420000Z https://www.medicinesresources.nhs.uk/risk-for-in-hospital-complications-associated-with-covid-19-and-influenza-veterans-health-administration-united-states-october-1-2018-may-31-2020.html 2020-10-23T16:13:59.5680000Z https://www.medicinesresources.nhs.uk/benefits-of-medication-charts-provided-at-transitions-of-care-a-narrative-systematic-review.html 2020-10-23T16:15:50.5780000Z https://www.medicinesresources.nhs.uk/the-temporal-association-of-introducing-and-lifting-non-pharmaceutical-interventions-with-the-time-varying-reproduction-number-r-of-sars-cov-2-a-modelling-study-across-131-countries.html 2020-10-23T16:17:00.6370000Z https://www.medicinesresources.nhs.uk/revised-spc-testim-testosterone-50-mg-transdermal-gel.html 2020-10-26T15:49:14.0120000Z https://www.medicinesresources.nhs.uk/revised-spc-alprolix-eftrenonacog-alfa-powder-and-solvent-for-solution-for-injection.html 2020-10-26T15:11:14.6010000Z https://www.medicinesresources.nhs.uk/revised-spc-symtuza-cobicistat-darunavir-emtricitabine-tenofovir-and-rezolsta-cobicistat-darunavir-tablets.html 2020-10-26T15:12:16.1960000Z https://www.medicinesresources.nhs.uk/direct-healthcare-professional-communication-sandostatin-r-lar-r-octreotide-30mg-powder-and-solvent-for-suspension-for-injection.html 2020-10-26T15:13:22.4510000Z https://www.medicinesresources.nhs.uk/direct-healthcare-professional-communication-nulojix-belatacept.html 2020-11-02T11:42:34.6690000Z https://www.medicinesresources.nhs.uk/direct-healthcare-professional-communication-semglee-insulin-glargine-100-units-ml-x-3ml-prefilled-pens.html 2020-10-26T15:40:53.2810000Z https://www.medicinesresources.nhs.uk/dtb-republished-case-report-unintentional-overdose-of-hyoscine-hydrobromide-in-a-young-child.html 2020-10-26T15:19:44.9840000Z https://www.medicinesresources.nhs.uk/republished-case-report-an-unusually-impressive-atorvastatin-induced-elevation-of-serum-alkaline-phosphatase.html 2020-10-26T15:26:43.7400000Z https://www.medicinesresources.nhs.uk/direct-healthcare-professional-communication-nytol-diphenhydramine-liquid-caramel-flavour-10mg-5ml-oral-solution-1.html 2020-10-26T15:22:35.4090000Z https://www.medicinesresources.nhs.uk/a-systematic-review-examining-the-characteristics-of-users-of-nhs-patient-medicines-helpline-services-and-the-types-of-enquiries-they-make.html 2020-10-26T15:27:36.0150000Z https://www.medicinesresources.nhs.uk/covid-19-in-patients-with-inflammatory-arthritis-a-prospective-study-on-the-effects-of-comorbidities-and-disease-modifying-antirheumatic-drugs-on-clinical-outcomes.html 2020-10-26T15:29:05.3180000Z https://www.medicinesresources.nhs.uk/effect-of-finerenone-on-chronic-kidney-disease-outcomes-in-type-2-diabetes.html 2020-10-26T15:30:19.2940000Z https://www.medicinesresources.nhs.uk/hospitalization-for-covid-19-in-patients-treated-with-selected-immunosuppressant-and-immunomodulating-agents-compared-to-the-general-population-a-danish-cohort-study.html 2020-10-26T15:31:32.3600000Z https://www.medicinesresources.nhs.uk/type-2-diabetes-and-covid-19-related-mortality-in-the-critical-care-setting-a-national-cohort-study-in-england-march-july-2020.html 2020-10-26T15:32:44.6580000Z https://www.medicinesresources.nhs.uk/effect-of-regional-citrate-anticoagulation-vs-systemic-heparin-anticoagulation-during-continuous-kidney-replacement-therapy-on-dialysis-filter-life-span-and-mortality-among-critically-ill-patients-with-acute-kidney-injury-a-randomized-clinical-trial.html 2020-10-26T15:34:03.2420000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-md1003-high-dose-biotin-in-patients-with-progressive-multiple-sclerosis-spi2-a-randomised-double-blind-placebo-controlled-phase-3-trial.html 2020-10-26T15:57:28.9710000Z https://www.medicinesresources.nhs.uk/pembrolizumab-plus-axitinib-versus-sunitinib-monotherapy-as-first-line-treatment-of-advanced-renal-cell-carcinoma-keynote-426-extended-follow-up-from-a-randomised-open-label-phase-3-trial.html 2020-10-26T15:36:19.9220000Z https://www.medicinesresources.nhs.uk/ventilation-management-and-clinical-outcomes-in-invasively-ventilated-patients-with-covid-19-provent-covid-a-national-multicentre-observational-cohort-study.html 2020-10-26T15:37:31.0650000Z https://www.medicinesresources.nhs.uk/boots-to-offer-12-minute-covid-nasal-swab-test.html 2020-10-26T15:38:27.7740000Z https://www.medicinesresources.nhs.uk/virology-transmission-and-pathogenesis-of-sars-cov-2.html 2020-10-26T15:39:19.0700000Z https://www.medicinesresources.nhs.uk/steroidal-and-non-steroidal-mineralocorticoid-receptor-antagonists-in-cardiorenal-medicine.html 2020-10-26T15:40:22.5350000Z https://www.medicinesresources.nhs.uk/fibrosis-atrial-fibrillation-and-stroke-clinical-updates-and-emerging-mechanistic-models.html 2020-10-26T15:41:35.9260000Z https://www.medicinesresources.nhs.uk/bone-and-joint-resources.html 2020-10-26T15:42:37.3520000Z https://www.medicinesresources.nhs.uk/time-trends-and-prescribing-patterns-of-opioid-drugs-in-uk-primary-care-patients-with-non-cancer-pain-a-retrospective-cohort-study-1.html 2020-10-27T15:21:26.5070000Z https://www.medicinesresources.nhs.uk/are-the-steroids-a-blanket-solution-for-covid-19-a-systematic-review-and-meta-analysis.html 2020-11-02T10:17:46.7090000Z https://www.medicinesresources.nhs.uk/new-advances-in-the-diagnosis-and-management-of-hepatocellular-carcinoma.html 2020-10-27T16:48:19.8850000Z https://www.medicinesresources.nhs.uk/covid-19-why-are-age-and-obesity-risk-factors-for-serious-disease.html 2020-10-27T15:26:48.2040000Z https://www.medicinesresources.nhs.uk/revised-spcs-skilarence-dimethyl-fumarate-gastro-resistant-tablets-all-strengths.html 2020-10-27T16:49:27.1310000Z https://www.medicinesresources.nhs.uk/drug-rash-with-eosinophilia-and-systemic-symptoms-dress-syndrome-in-a-paediatric-patient-taking-zonisamide.html 2020-10-27T15:31:21.3580000Z https://www.medicinesresources.nhs.uk/association-of-therapies-with-reduced-pain-and-improved-quality-of-life-in-patients-with-fibromyalgia-a-systematic-review-and-meta-analysis.html 2020-11-02T10:14:17.5520000Z https://www.medicinesresources.nhs.uk/preventing-the-spread-of-sars-cov-2-with-masks-and-other-low-tech-interventions.html 2020-10-27T15:33:31.8140000Z https://www.medicinesresources.nhs.uk/national-multiple-sclerosis-society-recommendations-for-autologous-hematopoietic-stem-cell-transplant-ahsct-in-multiple-sclerosis-ms.html 2020-10-27T15:34:28.7290000Z https://www.medicinesresources.nhs.uk/flu-vaccination-for-people-with-learning-disability-and-autism.html 2020-10-27T15:54:23.4050000Z https://www.medicinesresources.nhs.uk/the-impact-of-covid-19-to-date-on-older-peoples-mental-and-physical-health.html 2020-10-27T15:55:55.4700000Z https://www.medicinesresources.nhs.uk/effect-of-timing-of-and-adherence-to-social-distancing-measures-on-covid-19-burden-in-the-united-states-a-simulation-modelling-approach.html 2020-10-27T16:46:25.1180000Z https://www.medicinesresources.nhs.uk/fda-approves-eysuvis-loteprednol-etabonate-ophthalmic-suspension-0-25-for-short-term-treatment-of-dry-eye-disease.html 2020-10-27T16:47:46.9110000Z https://www.medicinesresources.nhs.uk/dtb-commentary-effect-of-dapagliflozin-on-cardiovascular-events-in-patients-with-type-2-diabetes.html 2020-10-27T16:52:35.0950000Z https://www.medicinesresources.nhs.uk/avatrombopag-and-lusutrombopag-for-thrombocytopenia-in-people-with-chronic-liver-disease-needing-an-elective-procedure-a-systematic-review-and-cost-effectiveness-analysis.html 2020-10-27T16:56:47.3990000Z https://www.medicinesresources.nhs.uk/flu-vaccination-why-you-are-being-asked-to-wait.html 2020-10-27T16:57:36.5910000Z https://www.medicinesresources.nhs.uk/glaziers-and-window-breakers.html 2020-10-27T16:58:30.6140000Z https://www.medicinesresources.nhs.uk/avapritinib-for-treating-unresectable-or-metastatic-gastrointestinal-stromal-tumours-appraisal-consultation-document.html 2020-10-27T16:59:25.9940000Z https://www.medicinesresources.nhs.uk/october-bnf-bnfc-newsletter.html 2020-11-02T10:08:16.9710000Z https://www.medicinesresources.nhs.uk/low-vitamin-d-and-risk-of-bacterial-pneumonias-mendelian-randomisation-studies-in-two-population-based-cohorts.html 2020-10-27T17:02:09.6660000Z https://www.medicinesresources.nhs.uk/learning-from-a-pandemic-how-the-post-covid-nhs-can-reach-its-full-potential.html 2020-10-28T15:34:59.8150000Z https://www.medicinesresources.nhs.uk/react-2-real-time-assessment-of-community-transmission-antibody-waning.html 2020-11-01T23:12:55.7890000Z https://www.medicinesresources.nhs.uk/covid-19-high-risk-patients-who-dont-need-immediate-hospital-attention-to-use-pulse-oximetry-at-home-to-spot-serious-deterioration.html 2020-10-28T15:37:52.8320000Z https://www.medicinesresources.nhs.uk/revised-spcs-zydelig-idelalisib-film-coated-tablets-all-strengths.html 2020-10-28T16:32:56.0250000Z https://www.medicinesresources.nhs.uk/revised-spc-constella-linaclotide-290-micrograms-hard-capsules-1.html 2020-10-28T16:33:17.4330000Z https://www.medicinesresources.nhs.uk/association-of-ticagrelor-vs-clopidogrel-with-net-adverse-clinical-events-in-patients-with-acute-coronary-syndrome-undergoing-percutaneous-coronary-intervention.html 2020-10-28T15:43:03.3550000Z https://www.medicinesresources.nhs.uk/what-defines-an-efficacious-covid-19-vaccine-a-review-of-the-challenges-assessing-the-clinical-efficacy-of-vaccines-against-sars-cov-2.html 2020-10-28T15:44:17.9500000Z https://www.medicinesresources.nhs.uk/the-uk-government-s-vaccine-taskforce-strategy-for-protecting-the-uk-and-the-world.html 2020-10-28T15:45:39.2240000Z https://www.medicinesresources.nhs.uk/nhs-england-announces-release-of-government-flu-vaccine-stockpile-as-us-vaccine-given-temporary-licence.html 2020-10-28T15:47:06.6350000Z https://www.medicinesresources.nhs.uk/gps-say-elderly-are-not-seeking-help-for-potential-cancer-symptoms.html 2020-10-28T15:48:39.1180000Z https://www.medicinesresources.nhs.uk/hospital-discharge-must-be-improved-to-manage-covid-19-second-peak.html 2020-10-28T15:50:17.1710000Z https://www.medicinesresources.nhs.uk/antimicrobial-prescribing-imipenem-with-cilastatin-and-relebactam-evidence-summary.html 2020-11-01T23:00:09.7830000Z https://www.medicinesresources.nhs.uk/testing-for-hepatitis-in-a-and-e-departments-is-likely-to-be-cost-effective-in-many-areas-of-the-uk.html 2020-10-28T16:41:36.9660000Z https://www.medicinesresources.nhs.uk/fda-accepts-enhertu-trastuzumab-deruxtecan-supplemental-biologics-licence-application-sbla-and-priority-review-for-her2-positive-metastatic-gastric-cancer.html 2020-10-28T16:43:05.3690000Z https://www.medicinesresources.nhs.uk/uks-mhra-starts-rolling-review-of-modernas-covid-19-vaccine.html 2020-10-28T16:43:30.4450000Z https://www.medicinesresources.nhs.uk/which-emergency-contraceptives-can-be-used-while-breastfeeding.html 2020-11-02T15:40:57.5060000Z https://www.medicinesresources.nhs.uk/risk-of-overcorrection-in-rapid-intermittent-bolus-vs-slow-continuous-infusion-therapies-of-hypertonic-saline-for-patients-with-symptomatic-hyponatremia-the-salsa-randomized-clinical-trial.html 2020-10-28T16:44:24.9180000Z https://www.medicinesresources.nhs.uk/darolutamide-with-androgen-deprivation-therapy-for-treating-non-metastatic-hormone-relapsed-prostate-cancer-final-appraisal-document.html 2020-10-28T16:45:01.0180000Z https://www.medicinesresources.nhs.uk/revised-spc-crysvita-burosumab-solution-for-injection-all-strengths.html 2020-10-29T16:03:08.9670000Z https://www.medicinesresources.nhs.uk/risk-of-post-thrombotic-syndrome-after-deep-vein-thrombosis-treated-with-rivaroxaban-versus-vitamin-k-antagonists-a-systematic-review-and-meta-analysis.html 2020-10-29T16:04:22.5730000Z https://www.medicinesresources.nhs.uk/chloroquine-and-hydroxychloroquine-for-the-treatment-of-covid-19-a-systematic-review-and-meta-analysis.html 2020-11-01T18:45:19.3710000Z https://www.medicinesresources.nhs.uk/bendamustine-for-relapsed-refractory-classical-hodgkin-lymphoma-all-ages.html 2020-11-01T18:46:30.6810000Z https://www.medicinesresources.nhs.uk/newly-launched-freestyle-libre-2-sensors-enter-the-drug-tariff-and-dnd-list-from-november-2020.html 2020-10-29T17:16:45.5460000Z https://www.medicinesresources.nhs.uk/untangling-ibs-from-ibd.html 2020-10-29T16:09:20.7020000Z https://www.medicinesresources.nhs.uk/new-consultant-pharmacist-credentialing.html 2020-10-29T16:10:32.2070000Z https://www.medicinesresources.nhs.uk/improving-care-of-people-with-mental-health-conditions-in-scotland-how-pharmacists-can-help.html 2020-10-29T16:11:26.4920000Z https://www.medicinesresources.nhs.uk/590-peoples-stories-of-leaving-hospital-during-covid-19.html 2020-10-29T17:51:38.1270000Z https://www.medicinesresources.nhs.uk/ask-your-pharmacist-ayp-campaign-2020.html 2020-10-29T16:13:31.0890000Z https://www.medicinesresources.nhs.uk/social-care-funding-and-workforce.html 2020-10-29T16:14:36.1650000Z https://www.medicinesresources.nhs.uk/nhs-and-other-professional-bodies-response-to-the-sunday-times-25-october-2020.html 2020-10-29T16:15:40.8670000Z https://www.medicinesresources.nhs.uk/nice-announces-start-of-review-of-nusinersen-managed-access-agreement-maa.html 2020-10-29T16:16:54.8370000Z https://www.medicinesresources.nhs.uk/mims-summary-of-new-treatment-olumiant-baricitinib-for-treatment-of-adults-with-moderate-to-severe-atopic-dermatitis.html 2020-10-29T16:18:11.5080000Z https://www.medicinesresources.nhs.uk/access-to-new-medicines-in-the-english-nhs.html 2020-11-01T18:49:24.5640000Z https://www.medicinesresources.nhs.uk/anticoagulation-in-atrial-fibrillation.html 2020-10-29T16:20:59.3910000Z https://www.medicinesresources.nhs.uk/national-report-charts-challenges-of-managing-covid-19-transmission-in-hospitals.html 2020-10-29T16:22:49.2580000Z https://www.medicinesresources.nhs.uk/gphc-launches-consultation-on-fitness-to-practise-strategy.html 2020-10-29T16:23:46.9990000Z https://www.medicinesresources.nhs.uk/react-1-study-of-coronavirus-transmission-october-2020-interim-results.html 2020-11-01T18:51:36.0440000Z https://www.medicinesresources.nhs.uk/prevention-of-complications-in-the-cardiac-intensive-care-unit-a-scientific-statement-from-the-american-heart-association.html 2020-10-29T18:04:29.9950000Z https://www.medicinesresources.nhs.uk/class-3-medicines-recall-theramex-ireland-ltd-t-a-theramex-hq-uk-ltd-alfad-0-25-microgram-capsules-pl-49876-0001-el-20-a-50.html 2020-10-29T18:05:28.9110000Z https://www.medicinesresources.nhs.uk/covid-19-is-a-second-wave-hitting-europe.html 2020-10-29T16:28:35.7720000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-and-european-medicines-agency-accepts-regulatory-submission-for-abrocitinib-as-treatment-of-moderate-to-severe-atopic-dermatitis.html 2020-10-29T16:29:48.2440000Z https://www.medicinesresources.nhs.uk/arikayce-amikacin-liposomal-590-mg-nebuliser-dispersion-approved-in-eu-for-treatment-of-nontuberculous-mycobacterial-lung-infections-caused-by-mycobacterium-avium-complex-in-adult-non-cystic-fibrosis-patients-with-limited-treatment-options.html 2020-10-29T16:31:11.5660000Z https://www.medicinesresources.nhs.uk/pfizer-enters-final-stretch-of-late-stage-covid-19-vaccine-trial.html 2020-10-29T17:17:24.9910000Z https://www.medicinesresources.nhs.uk/abbvie-to-present-new-analyses-from-pivotal-phase-3-studies-for-upadacitinib-in-atopic-dermatitis.html 2020-10-29T16:35:24.6490000Z https://www.medicinesresources.nhs.uk/lilly-statement-regarding-nihs-activ-3-clinical-trial.html 2020-11-01T18:56:47.2260000Z https://www.medicinesresources.nhs.uk/sars-cov-2-neutralizing-antibody-ly-cov555-in-outpatients-with-covid-19.html 2020-10-29T18:13:21.4750000Z https://www.medicinesresources.nhs.uk/tranexamic-acid-in-patients-with-intracerebral-haemorrhage-stop-aust-a-multicentre-randomised-placebo-controlled-phase-2-trial.html 2020-10-29T18:13:58.3280000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-the-hiv-1-attachment-inhibitor-prodrug-fostemsavir-in-heavily-treatment-experienced-individuals-week-96-results-of-the-phase-3-brighte-study.html 2020-10-29T17:00:13.1450000Z https://www.medicinesresources.nhs.uk/influence-and-management-of-conflicts-of-interest-in-randomised-clinical-trials-qualitative-interview-study.html 2020-10-29T17:02:06.7790000Z https://www.medicinesresources.nhs.uk/use-of-hormone-replacement-therapy-and-risk-of-breast-cancer-nested-case-control-studies-using-the-qresearch-and-cprd-databases.html 2020-11-01T22:51:41.4570000Z https://www.medicinesresources.nhs.uk/risk-of-hospital-admission-with-coronavirus-disease-2019-in-healthcare-workers-and-their-households-nationwide-linkage-cohort-study.html 2020-10-29T18:16:49.4360000Z https://www.medicinesresources.nhs.uk/clinical-and-budget-impacts-of-changes-in-oral-anticoagulation-prescribing-for-atrial-fibrillation.html 2020-10-29T17:07:00.1180000Z https://www.medicinesresources.nhs.uk/observational-study-of-drug-related-problems-and-clinical-pharmacists-interventions-in-a-french-paediatric-hospital.html 2020-10-29T18:18:36.9270000Z https://www.medicinesresources.nhs.uk/hospital-volumes-of-5-medical-emergencies-in-the-covid-19-pandemic-in-2-us-medical-centers.html 2020-10-29T18:24:40.8450000Z https://www.medicinesresources.nhs.uk/hospitalizations-for-chronic-disease-and-acute-conditions-in-the-time-of-covid-19.html 2020-10-29T18:24:18.5410000Z https://www.medicinesresources.nhs.uk/testing-strategies-for-lynch-syndrome-in-people-with-endometrial-cancer-diagnostics-guidance-dg42.html 2020-11-01T18:08:48.1020000Z https://www.medicinesresources.nhs.uk/community-pharmacy-in-the-context-of-coronavirus-covid-19-updated-guidance-and-standard-operating-procedures.html 2020-11-01T18:15:26.8870000Z https://www.medicinesresources.nhs.uk/influenza-the-green-book-chapter-19-updated.html 2020-11-01T18:17:00.2980000Z https://www.medicinesresources.nhs.uk/cold-weather-plan-for-england-2020-to-2021.html 2020-11-01T18:21:11.6590000Z https://www.medicinesresources.nhs.uk/revised-spc-ranexa-ranolazine-prolonged-release-tablets-all-strengths.html 2020-10-30T16:46:34.1040000Z https://www.medicinesresources.nhs.uk/revised-spc-humulin-human-insulin-products.html 2020-11-01T18:22:16.0230000Z https://www.medicinesresources.nhs.uk/revised-spc-transtec-buprenorphine-transdermal-patch-all-strengths.html 2020-10-30T16:48:51.4970000Z https://www.medicinesresources.nhs.uk/patient-information-booklet-about-treatment-with-jetrea-ocriplasmin-0-375-mg-0-3-ml-solution-for-injection.html 2020-10-30T16:51:02.9710000Z https://www.medicinesresources.nhs.uk/important-risk-minimization-information-for-healthcare-professionals-prescribing-olumiant-baricitinib-for-treatment-of-atopic-dermatitis.html 2020-11-01T18:28:34.9310000Z https://www.medicinesresources.nhs.uk/esbriet-pirfenidone-safety-checklist-for-prescribing-physicians.html 2020-10-30T16:54:35.8300000Z https://www.medicinesresources.nhs.uk/use-of-dornase-alfa-in-the-paediatric-intensive-care-unit-current-literature-and-a-national-cross-sectional-survey.html 2020-10-30T16:56:04.5730000Z https://www.medicinesresources.nhs.uk/can-low-dose-aspirin-be-used-in-breastfeeding-mothers-as-an-antiplatelet-agent.html 2020-11-01T18:29:27.2330000Z https://www.medicinesresources.nhs.uk/weekly-national-influenza-and-covid-19-surveillance-report-week-44-report-up-to-week-43-data-29-october-2020.html 2020-10-30T16:58:00.7120000Z https://www.medicinesresources.nhs.uk/regulator-following-up-boots-provision-of-rapid-point-of-care-covid-19-antigen-test.html 2020-10-30T16:59:30.6160000Z https://www.medicinesresources.nhs.uk/nice-sign-and-rcgp-set-out-further-details-about-the-uk-guideline-on-management-of-the-long-term-effects-of-covid-19.html 2020-10-30T17:26:03.4110000Z https://www.medicinesresources.nhs.uk/liraglutide-for-managing-overweight-and-obesity-final-appraisal-document.html 2020-10-30T17:04:48.3750000Z https://www.medicinesresources.nhs.uk/thermometer-recall-safe-and-sound-infrared-ear-thermometer.html 2020-10-30T17:05:44.2220000Z https://www.medicinesresources.nhs.uk/mhra-consults-on-draft-guidance-on-randomised-controlled-trials-generating-real-world-evidence-to-support-regulatory-decisions.html 2020-10-30T17:06:36.3560000Z https://www.medicinesresources.nhs.uk/covid-19-transmission-up-in-the-air.html 2020-10-30T17:07:36.5560000Z https://www.medicinesresources.nhs.uk/dexamethasone-in-hospitalised-patients-with-covid-19-addressing-uncertainties.html 2020-10-30T17:08:40.9820000Z https://www.medicinesresources.nhs.uk/summary-of-evidence-to-reduce-the-two-dose-infant-priming-schedule-to-a-single-dose-of-the-13-valent-pneumococcal-conjugate-vaccine-in-the-national-immunisation-programme-in-the-uk.html 2020-10-30T17:09:42.6150000Z https://www.medicinesresources.nhs.uk/catecholamine-physiology-and-its-implications-in-patients-with-covid-19.html 2020-10-30T17:10:39.3600000Z https://www.medicinesresources.nhs.uk/insulin-s-centenary-the-birth-of-an-idea.html 2020-10-30T17:11:38.7510000Z https://www.medicinesresources.nhs.uk/scientific-consensus-on-the-covid-19-pandemic-we-need-to-act-now.html 2020-10-30T17:12:40.3840000Z https://www.medicinesresources.nhs.uk/stroke-systems-of-care-in-high-income-countries-what-is-optimal.html 2020-10-30T17:13:31.7770000Z https://www.medicinesresources.nhs.uk/professional-standards-authority-publishes-gphc-performance-review-for-2019-20.html 2020-10-30T17:14:29.2340000Z https://www.medicinesresources.nhs.uk/prac-reviews-european-medicines-agency-ema-guidance-on-risk-management-plan-requirements-for-covid-19-vaccines.html 2020-10-30T17:48:07.4740000Z https://www.medicinesresources.nhs.uk/pagets-disease-of-bone-when-and-why-to-refer-to-specialist-care.html 2020-10-30T17:16:22.5410000Z https://www.medicinesresources.nhs.uk/impact-of-opioid-use-disorders-on-outcomes-and-readmission-following-cardiac-operations.html 2020-10-30T17:17:39.6300000Z https://www.medicinesresources.nhs.uk/conference-report-seqirus-presents-first-of-its-kind-study-on-cell-based-quadrivalent-influenza-vaccine-qivc-efficacy-in-children-2-to-less-than-18-years-old.html 2020-10-30T17:17:34.2910000Z https://www.medicinesresources.nhs.uk/astrazena-reports-benralizumab-eliminates-oral-corticosteroid-ocs-use-in-majority-of-oral-corticosteroid-dependent-patients-with-asthma-in-ponente-phase-iiib-trial.html 2020-10-30T17:27:31.6080000Z https://www.medicinesresources.nhs.uk/multisystem-immune-related-adverse-events-associated-with-immune-checkpoint-inhibitors-for-treatment-of-non-small-cell-lung-cancer.html 2020-10-30T17:18:57.2050000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-supplemental-biologics-license-application-sbla-for-libtayo-cemiplimab-rwlc-for-advanced-non-small-cell-lung-cancer-with-pd-l1-expression-of-50.html 2020-10-30T17:19:36.2440000Z https://www.medicinesresources.nhs.uk/integrated-survival-estimates-for-cancer-treatment-delay-among-adults-with-cancer-during-the-covid-19-pandemic.html 2020-10-30T17:41:35.5510000Z https://www.medicinesresources.nhs.uk/transforming-nhs-pharmacy-aseptic-services-in-england.html 2020-11-01T18:34:22.2440000Z https://www.medicinesresources.nhs.uk/venetoclax-or-placebo-in-combination-with-bortezomib-and-dexamethasone-in-patients-with-relapsed-or-refractory-multiple-myeloma-bellini-a-randomised-double-blind-multicentre-phase-3-trial.html 2020-10-30T17:22:38.5280000Z https://www.medicinesresources.nhs.uk/long-term-follow-up-from-the-oratorio-trial-of-ocrelizumab-for-primary-progressive-multiple-sclerosis-a-post-hoc-analysis-from-the-ongoing-open-label-extension-of-the-randomised-placebo-controlled-phase-3-trial.html 2020-10-30T17:37:12.4060000Z https://www.medicinesresources.nhs.uk/revised-spc-cimzia-certolizumab-pegol-all-presentations.html 2020-11-23T10:37:51.9450000Z https://www.medicinesresources.nhs.uk/revised-spc-tasigna-nilotinib-hydrochloride-monohydrate-capsules-all-strengths.html 2020-11-02T12:24:15.1370000Z https://www.medicinesresources.nhs.uk/metoprolol-for-prophylaxis-of-postoperative-atrial-fibrillation-in-cardiac-surgery-patients-systematic-review-and-meta-analysis.html 2020-11-02T12:25:29.4890000Z https://www.medicinesresources.nhs.uk/preoperative-iron-treatment-in-anaemic-patients-undergoing-elective-total-hip-or-knee-arthroplasty-a-systematic-review-and-meta-analysis.html 2020-11-02T12:26:48.6750000Z https://www.medicinesresources.nhs.uk/value-of-coronary-artery-calcium-scanning-in-association-with-the-net-benefit-of-aspirin-in-primary-prevention-of-atherosclerotic-cardiovascular-disease.html 2020-11-02T12:28:10.9720000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-antibody-cocktail-regn-cov2.html 2020-11-02T12:30:01.1030000Z https://www.medicinesresources.nhs.uk/suspension-of-patient-signatures-on-prescription-dental-and-general-ophthalmic-services-forms.html 2020-11-03T12:16:52.8860000Z https://www.medicinesresources.nhs.uk/uk-flu-vaccination-supply-protected-with-new-restrictions-on-exports.html 2020-11-02T12:33:20.0070000Z https://www.medicinesresources.nhs.uk/dtb-forum-how-do-your-patients-use-their-medicines-at-home-and-why-is-it-important-to-know.html 2020-11-02T15:15:24.9250000Z https://www.medicinesresources.nhs.uk/the-esc-clinical-practice-guidelines-for-the-management-of-adult-congenital-heart-disease-2020.html 2020-11-02T15:16:21.0390000Z https://www.medicinesresources.nhs.uk/antithrombotic-therapy-for-patients-with-chronic-coronary-syndromes.html 2020-11-02T12:41:26.7340000Z https://www.medicinesresources.nhs.uk/milestone-1-million-yellow-card-report-for-suspected-side-effects-in-medsafetyweek.html 2020-11-02T12:42:36.2500000Z https://www.medicinesresources.nhs.uk/nhs-response-to-the-prime-ministers-announcement-31-october-2020.html 2020-11-02T12:45:54.2140000Z https://www.medicinesresources.nhs.uk/cannabinoids-cannabis-and-cannabis-based-medicines-for-pain-management-an-overview-of-systematic-reviews.html 2020-11-02T15:15:48.1380000Z https://www.medicinesresources.nhs.uk/can-mothers-breastfeed-after-a-medical-termination-of-pregnancy.html 2020-11-03T12:22:25.4610000Z https://www.medicinesresources.nhs.uk/risk-factors-for-visual-field-deterioration-in-the-united-kingdom-glaucoma-treatment-study.html 2020-11-02T15:19:10.3060000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-canakinumab-in-patients-with-systemic-juvenile-idiopathic-arthritis-with-and-without-fever-at-baseline-results-from-an-open-label-active-treatment-extension-study.html 2020-11-02T15:21:54.0910000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-setmelanotide-an-mc4r-agonist-in-individuals-with-severe-obesity-due-to-lepr-or-pomc-deficiency-single-arm-open-label-multicentre-phase-3-trials.html 2020-11-02T15:24:20.3170000Z https://www.medicinesresources.nhs.uk/cvdprevent-a-national-primary-care-audit.html 2020-11-03T13:37:51.5980000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-october-2020.html 2020-11-03T13:40:02.4550000Z https://www.medicinesresources.nhs.uk/european-approval-of-niraparib-for-first-line-monotherapy-in-adults-with-advanced-ovarian-cancer.html 2020-11-02T15:31:16.3930000Z https://www.medicinesresources.nhs.uk/commencement-of-gp-referrals-to-cpcs.html 2020-11-02T15:33:54.6490000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-scientific-opinion-berotralstat-in-the-treatment-of-hereditary-angioedema-2.html 2020-11-03T13:48:43.5680000Z https://www.medicinesresources.nhs.uk/milestone-1-million-yellow-card-report-for-suspected-side-effects-in-medsafetyweek-1.html 2020-11-02T16:48:45.4740000Z https://www.medicinesresources.nhs.uk/phase-3-study-meets-primary-endpoint-with-significant-increase-in-progression-free-survival-in-patients-with-unresectable-dedifferentiated-liposarcoma.html 2020-11-03T17:34:16.5850000Z https://www.medicinesresources.nhs.uk/us-fda-approves-bronchitol-mannitol-inhalation-powder-as-add-on-maintenance-therapy-to-improve-pulmonary-function-in-adult-patients-with-cystic-fibrosis-cf.html 2020-11-03T17:38:20.6520000Z https://www.medicinesresources.nhs.uk/aldosterone-antagonists-in-addition-to-renin-angiotensin-system-antagonists-for-preventing-the-progression-of-chronic-kidney-disease.html 2020-11-03T15:24:35.0930000Z https://www.medicinesresources.nhs.uk/renin-inhibitors-versus-angiotensin-converting-enzyme-ace-inhibitors-for-primary-hypertension.html 2020-11-03T15:26:04.5480000Z https://www.medicinesresources.nhs.uk/strategies-for-improving-adherence-to-antiepileptic-drug-treatment-in-people-with-epilepsy.html 2020-11-03T15:27:21.9710000Z https://www.medicinesresources.nhs.uk/platinum-containing-regimens-for-triple-negative-metastatic-breast-cancer.html 2020-11-03T15:28:37.5480000Z https://www.medicinesresources.nhs.uk/dtb-forum-how-do-your-patients-use-their-medicines-at-home-and-why-is-it-important-to-know-1.html 2020-11-03T17:40:09.3420000Z https://www.medicinesresources.nhs.uk/chronic-pain-analgesia-armageddon.html 2020-11-03T15:31:04.1680000Z https://www.medicinesresources.nhs.uk/orthostatic-hypotension-oh-a-pragmatic-guide-to-diagnosis-and-treatment.html 2020-11-09T10:10:10.9070000Z https://www.medicinesresources.nhs.uk/revised-spc-zessly-infliximab-100-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-11-03T15:33:50.5840000Z https://www.medicinesresources.nhs.uk/revised-spc-mezavant-xl-1200mg-gastro-resistant-prolonged-release-tablets.html 2020-11-03T17:42:45.1150000Z https://www.medicinesresources.nhs.uk/revised-spcs-hyrimoz-adalimumab-20-mg-solution-for-injection-in-pre-filled-syringe-or-pen-all-strengths-and-products.html 2020-11-03T15:36:45.3840000Z https://www.medicinesresources.nhs.uk/revised-spc-dalacin-clindamycin-t-topical-solution.html 2020-11-03T17:43:22.5880000Z https://www.medicinesresources.nhs.uk/revised-spc-flucelvax-tetra-influenza-vaccine-surface-antigen-inactivated-suspension-for-injection-in-pre-filled-syringe.html 2020-11-03T17:43:42.4060000Z https://www.medicinesresources.nhs.uk/diagnosis-and-treatment-of-lower-extremity-venous-thromboembolism.html 2020-11-03T17:11:52.0460000Z https://www.medicinesresources.nhs.uk/randomized-phase-iii-study-of-irinotecan-plus-cisplatin-versus-etoposide-plus-cisplatin-for-completely-resected-high-grade-neuroendocrine-carcinoma-of-the-lung-jcog1205-1206.html 2020-11-03T17:12:49.5490000Z https://www.medicinesresources.nhs.uk/comprehensive-guidance-on-the-diagnosis-and-management-of-primary-mesenchymal-tumours-of-the-thyroid-gland.html 2020-11-03T17:13:50.4490000Z https://www.medicinesresources.nhs.uk/sars-cov-2-seroprevalence-and-transmission-risk-factors-among-high-risk-close-contacts-a-retrospective-cohort-study.html 2020-11-09T10:17:11.4370000Z https://www.medicinesresources.nhs.uk/first-3-in-1-inhaler-combining-indacaterol-glycopyrronium-and-mometasone-furoate-launched-in-the-uk-for-treatment-of-asthma.html 2020-11-03T17:16:00.0150000Z https://www.medicinesresources.nhs.uk/once-daily-niraparib-approved-by-european-commission-for-first-line-monotherapy-maintenance-treatment-for-adults-with-advanced-ovarian-cancer.html 2020-11-03T17:46:25.2190000Z https://www.medicinesresources.nhs.uk/liverpool-to-be-regularly-tested-for-coronavirus-in-first-whole-city-testing-pilot.html 2020-11-03T17:18:16.7920000Z https://www.medicinesresources.nhs.uk/stroke-prevention-in-atrial-fibrillation-af-protect-and-perfect-optimising-anticoagulation-treatment.html 2020-11-09T10:35:23.3890000Z https://www.medicinesresources.nhs.uk/robust-sars-cov-2-specific-t-cell-immunity-is-maintained-at-6-months-following-primary-infection.html 2020-11-03T17:48:56.6010000Z https://www.medicinesresources.nhs.uk/human-and-animal-bites-antimicrobial-prescribing-guidance-ng184.html 2020-11-09T10:49:38.6440000Z https://www.medicinesresources.nhs.uk/revised-spc-ciproxin-ciprofloxacin-solution-for-infusion.html 2020-11-04T16:53:18.7700000Z https://www.medicinesresources.nhs.uk/new-product-nutrizym-22-pancreatin-capsules.html 2020-11-04T15:00:14.0180000Z https://www.medicinesresources.nhs.uk/revised-spc-plenvu-macrogol-powder-for-oral-solution.html 2020-11-04T15:01:27.5450000Z https://www.medicinesresources.nhs.uk/revised-spc-moviprep-macrogol-powder-for-oral-solution.html 2020-11-04T15:02:46.3530000Z https://www.medicinesresources.nhs.uk/prophylactic-corticosteroids-for-paediatric-heart-surgery-with-cardiopulmonary-bypass.html 2020-11-04T16:55:42.2990000Z https://www.medicinesresources.nhs.uk/prophylaxis-of-thromboembolism-during-therapy-with-asparaginase-in-adults-with-acute-lymphoblastic-leukaemia-all.html 2020-11-04T15:05:43.8130000Z https://www.medicinesresources.nhs.uk/calcium-channel-blockers-for-people-with-chronic-kidney-disease-requiring-dialysis.html 2020-11-04T15:07:03.9570000Z https://www.medicinesresources.nhs.uk/prophylactic-anticoagulants-for-people-hospitalised-with-covid-19.html 2020-11-09T11:14:47.9390000Z https://www.medicinesresources.nhs.uk/therapeutic-efficacy-of-tacrolimus-in-vernal-keratoconjunctivitis-a-meta-analysis-of-randomised-controlled-trials.html 2020-11-04T16:57:39.8530000Z https://www.medicinesresources.nhs.uk/dexcom-g6-for-real-time-continuous-glucose-monitoring-mib233.html 2020-11-09T10:55:43.3120000Z https://www.medicinesresources.nhs.uk/clearguard-hd-antimicrobial-barrier-cap-for-preventing-haemodialysis-catheter-related-bloodstream-infections-mib234.html 2020-11-09T11:01:50.3120000Z https://www.medicinesresources.nhs.uk/how-unconscious-bias-can-discriminate-against-patients-and-affect-their-care.html 2020-11-04T15:14:11.3780000Z https://www.medicinesresources.nhs.uk/nomenclature-for-kidney-function-and-disease-executive-summary-and-glossary-from-a-kidney-disease-improving-global-outcomes-kdigo-consensus-conference.html 2020-11-04T15:15:12.6100000Z https://www.medicinesresources.nhs.uk/nivolumab-for-adjuvant-treatment-of-completely-resected-melanoma-with-lymph-node-involvement-or-metastatic-disease-cdf-review-of-ta558-id1681.html 2020-11-04T15:20:34.3680000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-the-long-term-efficacy-of-baricitinib-in-eczema.html 2020-11-04T15:21:34.0300000Z https://www.medicinesresources.nhs.uk/trends-in-hiv-testing-new-diagnoses-and-people-receiving-hiv-related-care-in-the-united-kingdom-data-to-the-end-of-december-2019.html 2020-11-04T15:22:55.1770000Z https://www.medicinesresources.nhs.uk/accessing-government-secured-flu-vaccines-guidance-for-community-pharmacies.html 2020-11-09T11:13:22.9250000Z https://www.medicinesresources.nhs.uk/effect-of-an-online-weight-management-program-integrated-with-population-health-management-on-weight-change-a-randomized-clinical-trial.html 2020-11-04T15:55:45.0230000Z https://www.medicinesresources.nhs.uk/intensive-risk-factor-management-and-cardiovascular-autonomic-neuropathy-in-type-2-diabetes-the-accord-trial.html 2020-11-04T17:00:16.7360000Z https://www.medicinesresources.nhs.uk/association-of-reperfusion-after-thrombolysis-with-clinical-outcome-across-the-4-5-to-9-hours-and-wake-up-stroke-time-window-a-meta-analysis-of-the-extend-and-epithet-randomized-clinical-trials.html 2020-11-04T15:59:37.4910000Z https://www.medicinesresources.nhs.uk/rivaroxaban-and-aspirin-in-peripheral-artery-disease-lower-extremity-revascularization-impact-of-concomitant-clopidogrel-on-efficacy-and-safety.html 2020-11-04T17:06:44.7270000Z https://www.medicinesresources.nhs.uk/human-papilloma-virus-vaccination-in-males-a-pharmacovigilance-study-on-the-vaccine-adverse-event-reporting-system.html 2020-11-04T16:03:58.8970000Z https://www.medicinesresources.nhs.uk/variability-in-size-and-characteristics-of-primary-care-networks-in-england-observational-study.html 2020-11-04T16:06:20.6620000Z https://www.medicinesresources.nhs.uk/evaluation-of-the-incidence-of-bleeding-in-patients-prescribed-rivaroxaban-for-the-treatment-and-prevention-of-deep-vein-thrombosis-and-pulmonary-embolism-in-uk-secondary-care-an-observational-cohort-study.html 2020-11-04T16:08:16.3840000Z https://www.medicinesresources.nhs.uk/effect-of-nintedanib-on-lung-function-in-patients-with-systemic-sclerosis-associated-interstitial-lung-disease-further-analyses-of-the-senscis-trial.html 2020-11-04T16:10:19.4990000Z https://www.medicinesresources.nhs.uk/race-ethnicity-association-with-covid-19-outcomes-in-rheumatic-disease-data-from-the-covid-19-global-rheumatology-alliance-physician-registry.html 2020-11-04T16:15:43.8530000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-deucravacitinib-in-phase-iii-eczema-trial.html 2020-11-04T16:16:59.0210000Z https://www.medicinesresources.nhs.uk/positive-results-for-selinexor-in-advanced-unresectable-dedifferentiated-liposarcoma.html 2020-11-04T17:17:46.6800000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-to-perform-regulatory-review-of-avacopan-for-anca-associated-vasculitis.html 2020-11-04T16:20:34.0220000Z https://www.medicinesresources.nhs.uk/fda-to-perform-regulatory-review-of-vosoritide-for-use-in-children-with-achondroplasia.html 2020-11-04T16:22:03.9240000Z https://www.medicinesresources.nhs.uk/revised-spc-obizur-susoctocog-alfa-500-u-powder-and-solvent-for-solution-for-injection.html 2020-11-05T16:09:41.8350000Z https://www.medicinesresources.nhs.uk/revised-spc-kigabeq-vigabatrin-100-and-500-mg-soluble-tablets.html 2020-11-05T16:11:14.9720000Z https://www.medicinesresources.nhs.uk/revised-spc-phenergan-promethazine-tablets-all-strenghts.html 2020-11-05T16:13:21.9390000Z https://www.medicinesresources.nhs.uk/revised-spc-ferinject-ferric-carboxymaltose-1.html 2020-11-05T16:15:17.8000000Z https://www.medicinesresources.nhs.uk/new-product-symbicort-100-micrograms-budesonide-3-micrograms-formoterol-actuation-pressurised-inhalation-suspension.html 2020-11-05T16:17:12.7830000Z https://www.medicinesresources.nhs.uk/mortality-due-to-cancer-treatment-delay-systematic-review-and-meta-analysis.html 2020-11-09T11:24:26.1720000Z https://www.medicinesresources.nhs.uk/pcsk9-monoclonal-antibodies-for-the-primary-and-secondary-prevention-of-cardiovascular-disease.html 2020-11-05T16:21:34.6870000Z https://www.medicinesresources.nhs.uk/relief-of-pain-due-to-uterine-cramping-involution-after-birth.html 2020-11-05T16:23:27.4040000Z https://www.medicinesresources.nhs.uk/drugs-for-preventing-postoperative-nausea-and-vomiting-in-adults-after-general-anaesthesia-a-network-meta-analysis.html 2020-11-05T18:09:59.8200000Z https://www.medicinesresources.nhs.uk/drug-treatments-for-managing-cystic-fibrosis-related-diabetes.html 2020-11-05T16:27:56.2460000Z https://www.medicinesresources.nhs.uk/july-2020-prioritisation-decisions.html 2020-11-09T11:34:48.6660000Z https://www.medicinesresources.nhs.uk/sapropterin-for-phenylketonuria-all-ages.html 2020-11-09T11:38:09.6150000Z https://www.medicinesresources.nhs.uk/defibrotide-for-severe-veno-occlusive-disease-following-stem-cell-transplant.html 2020-11-09T11:44:30.1100000Z https://www.medicinesresources.nhs.uk/mercaptamine-hydrochloride-viscous-eyedrops-for-corneal-cystine-deposits-in-people-aged-older-than-2-years.html 2020-11-09T12:21:38.3970000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-begins-evaluation-of-marketing-authorisation-application-for-filgotinib-as-treatment-of-adults-with-moderately-to-severely-active-ulcerative-colitis-who-have-failed-on-or-were-intolerant-to-conventional-or-biologic-therapy.html 2020-11-05T16:33:28.9440000Z https://www.medicinesresources.nhs.uk/dapagliflozin-approved-in-eu-for-treatment-of-symptomatic-heart-failure-with-reduced-ejection-fraction-hfref.html 2020-11-05T16:34:25.4730000Z https://www.medicinesresources.nhs.uk/gp-referrals-to-community-pharmacy-begin-this-month.html 2020-11-05T16:35:12.6410000Z https://www.medicinesresources.nhs.uk/performance-tracker-2020-how-public-services-have-coped-with-coronavirus.html 2020-11-05T16:38:23.0500000Z https://www.medicinesresources.nhs.uk/migraine.html 2020-11-05T16:39:24.5400000Z https://www.medicinesresources.nhs.uk/drug-pricing-tracker-launched-by-mims.html 2020-11-05T16:40:16.6620000Z https://www.medicinesresources.nhs.uk/guideline-recommendations-and-the-positioning-of-newer-drugs-in-type-2-diabetes-care.html 2020-11-05T16:41:18.2770000Z https://www.medicinesresources.nhs.uk/challenges-in-creating-herd-immunity-to-sars-cov-2-infection-by-mass-vaccination.html 2020-11-05T16:42:17.5890000Z https://www.medicinesresources.nhs.uk/trends-of-global-burden-of-atrial-fibrillation-flutter-from-global-burden-of-disease-study-2017.html 2020-11-05T16:43:12.2690000Z https://www.medicinesresources.nhs.uk/pharmacology-before-during-and-after-percutaneous-coronary-intervention.html 2020-11-05T16:44:16.4380000Z https://www.medicinesresources.nhs.uk/management-of-asymptomatic-severe-aortic-stenosis-check-or-all-in.html 2020-11-05T16:45:09.3350000Z https://www.medicinesresources.nhs.uk/new-guidance-to-support-safe-care-home-visits-during-lockdown.html 2020-11-05T17:27:01.9220000Z https://www.medicinesresources.nhs.uk/clinically-extremely-vulnerable-receive-updated-guidance-in-line-with-new-national-restrictions.html 2020-11-05T16:47:00.7740000Z https://www.medicinesresources.nhs.uk/use-of-multiple-period-cluster-randomised-crossover-trial-designs-for-comparative-effectiveness-research.html 2020-11-05T16:47:46.5360000Z https://www.medicinesresources.nhs.uk/a-lump-in-the-throat-laryngopharyngeal-reflux.html 2020-11-05T16:48:43.1050000Z https://www.medicinesresources.nhs.uk/the-bmj-interview-chris-whitty-englands-chief-medical-officer-on-covid-19.html 2020-11-05T17:27:23.3040000Z https://www.medicinesresources.nhs.uk/harms-of-public-health-interventions-against-covid-19-must-not-be-ignored.html 2020-11-05T16:50:23.7300000Z https://www.medicinesresources.nhs.uk/sun-pharma-announces-5-year-sustained-efficacy-and-safety-results-from-pooled-resurface-1-and-resurface-2-extension-studies-for-tildrakizumab-ilumetri-in-patients-with-moderate-to-severe-plaque-psoriasis.html 2020-11-05T16:51:16.3640000Z https://www.medicinesresources.nhs.uk/sobi-launch-doptelet-r-avatrombopag-in-europe.html 2020-11-05T16:52:43.3720000Z https://www.medicinesresources.nhs.uk/oxford-astrazeneca-s-phase-iii-covid-19-vaccine-data-could-be-available-by-december.html 2020-11-05T17:56:10.0600000Z https://www.medicinesresources.nhs.uk/gilead-s-faces-criticism-over-effectiveness-pricing-and-us-government-support-of-remdesivir.html 2020-11-05T17:55:05.9700000Z https://www.medicinesresources.nhs.uk/vertex-announces-european-commission-approval-for-ivacaftor-kalydeco-to-treat-eligible-infants-with-cystic-fibrosis-as-early-as-four-months-of-age.html 2020-11-05T17:46:22.6760000Z https://www.medicinesresources.nhs.uk/alternative-parenteral-acid-suppressants-covering-main-indications-of-intravenous-ranitidine-in-children.html 2020-11-09T12:22:25.4400000Z https://www.medicinesresources.nhs.uk/getting-it-right-first-time-developing-a-standard-approach-to-care-for-people-living-with-motor-neurone-disease-in-greater-manchester.html 2020-11-09T12:26:26.5400000Z https://www.medicinesresources.nhs.uk/screening-and-intervention-to-prevent-falls-and-fractures-in-older-people.html 2020-11-05T17:02:47.8500000Z https://www.medicinesresources.nhs.uk/consistency-of-variety-of-machine-learning-and-statistical-models-in-predicting-clinical-risks-of-individual-patients-longitudinal-cohort-study-using-cardiovascular-disease-as-exemplar.html 2020-11-05T17:03:50.8350000Z https://www.medicinesresources.nhs.uk/incident-type-2-diabetes-and-risk-of-fracture-a-comparative-cohort-analysis-using-u-k-primary-care-records.html 2020-11-05T17:05:01.6270000Z https://www.medicinesresources.nhs.uk/self-reported-health-without-clinically-measurable-benefits-among-adult-users-of-multivitamin-and-multimineral-supplements-a-cross-sectional-study.html 2020-11-05T17:05:59.6520000Z https://www.medicinesresources.nhs.uk/conference-report-first-phase-iiib-imaging-study-ultimate-primarily-looking-at-time-course-of-response-to-secukinumab-in-biologic-naive-patients-with-active-psoriatic-arthritis-shows-early-synovitis-reduction.html 2020-11-05T17:28:10.2910000Z https://www.medicinesresources.nhs.uk/failure-to-demonstrate-efficacy-of-aducanumab-an-analysis-of-the-emerge-and-engage-trials-as-reported-by-biogen-december-2019.html 2020-11-05T17:30:30.0720000Z https://www.medicinesresources.nhs.uk/new-product-ilaxten-bilastine-2-5-mg-ml-oral-solution-1.html 2020-11-06T15:20:27.3350000Z https://www.medicinesresources.nhs.uk/revised-spc-imraldi-40-mg-solution-for-injection-in-pre-filled-syringe.html 2020-11-06T15:21:25.4070000Z https://www.medicinesresources.nhs.uk/nihr-alert-national-infection-control-campaigns-led-to-a-rapid-decline-in-superbug-infections-in-uk-intensive-care-units.html 2020-11-06T15:22:22.5830000Z https://www.medicinesresources.nhs.uk/publication-of-a-revised-clinical-commissioning-policy-remdesivir-for-patients-hospitalised-with-covid-19-adults-and-children-aged-12-years-and-older.html 2020-11-09T12:41:46.9100000Z https://www.medicinesresources.nhs.uk/olaparib-approved-in-the-eu-as-monotherapy-for-treatment-of-adults-with-brca1-2-mutated-metastatic-castration-resistant-prostate-cancer.html 2020-11-06T15:25:40.1800000Z https://www.medicinesresources.nhs.uk/olaparib-approved-in-the-eu-for-use-in-combination-with-bevacizumab-as-first-line-maintenance-treatment-for-homologous-recombination-deficiency-hrd-positive-advanced-ovarian-cancer.html 2020-11-06T15:26:29.5390000Z https://www.medicinesresources.nhs.uk/mirum-pharmaceuticals-broadens-expanded-access-program-for-maralixibat-in-alagille-syndrome-to-europe-and-australia.html 2020-11-06T15:27:31.8510000Z https://www.medicinesresources.nhs.uk/phase-iii-data-for-semaglutide-as-an-adjunct-to-intensive-behavioural-therapy-for-weight-loss-in-adults-with-obesity-or-overweight.html 2020-11-06T16:53:09.6240000Z https://www.medicinesresources.nhs.uk/interim-analysis-supports-long-term-safety-of-nintedanib-in-the-treatment-of-systemic-sclerosis-associated-interstitial-lung-disease.html 2020-11-06T15:30:12.8950000Z https://www.medicinesresources.nhs.uk/office-for-statistics-regulation-calls-for-uk-governments-to-provide-more-transparency-around-covid-data.html 2020-11-06T15:33:52.7520000Z https://www.medicinesresources.nhs.uk/digital-transformation-in-the-nhs.html 2020-11-06T15:34:42.4720000Z https://www.medicinesresources.nhs.uk/covid-19-nhs-hospitals-are-urged-to-recruit-more-patients-to-recovery-trial-to-find-what-treatments-work.html 2020-11-06T15:35:33.9860000Z https://www.medicinesresources.nhs.uk/medical-devices-safety-bulletin-mdsb-2020-02.html 2020-11-06T15:36:30.2270000Z https://www.medicinesresources.nhs.uk/midostaurin-for-treating-advanced-systemic-mastocytosis-appraisal-consultation.html 2020-11-06T16:53:56.3030000Z https://www.medicinesresources.nhs.uk/nice-to-become-single-point-of-access-for-covid-19-guidance-and-advice.html 2020-11-09T12:43:25.5450000Z https://www.medicinesresources.nhs.uk/nivolumab-for-previously-treated-unresectable-advanced-oesophageal-cancer-appraisal-consultation.html 2020-11-06T15:46:04.5150000Z https://www.medicinesresources.nhs.uk/upadacitinib-for-treating-severe-rheumatoid-arthritis-final-appraisal-document.html 2020-11-06T15:47:09.9220000Z https://www.medicinesresources.nhs.uk/aspirin-to-be-investigated-as-a-possible-treatment-for-covid-19-in-the-recovery-trial.html 2020-11-06T15:48:06.7340000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-of-canakinumab-in-covid-19-fails-to-meet-primary-endpoint.html 2020-11-06T16:54:11.6390000Z https://www.medicinesresources.nhs.uk/what-injections-can-be-given-orally-or-via-enteral-feeding-tubes.html 2020-11-09T12:47:44.8040000Z https://www.medicinesresources.nhs.uk/arthritogenic-alphaviruses-epidemiological-and-clinical-perspective-on-emerging-arboviruses.html 2020-11-06T15:55:18.5880000Z https://www.medicinesresources.nhs.uk/muse-urethral-sticks-alprostadil-supply-of-packs-with-known-anti-tamper-seal-issue.html 2020-11-06T15:56:24.3440000Z https://www.medicinesresources.nhs.uk/clenil-r-modulite-r-100mcg-beclometasone-release-of-batches-actions-needed-from-dispensers.html 2020-11-06T15:57:31.8040000Z https://www.medicinesresources.nhs.uk/height-and-body-mass-index-trajectories-of-school-aged-children-and-adolescents-from-1985-to-2019-in-200-countries-and-territories-a-pooled-analysis-of-2181-population-based-studies-with-65-million-participants.html 2020-11-06T16:25:33.9260000Z https://www.medicinesresources.nhs.uk/efficacy-of-circulating-tumor-cell-count-driven-vs-clinician-driven-first-line-therapy-choice-in-hormone-receptor-positive-erbb2-negative-metastatic-breast-cancer-the-stic-ctc-randomized-clinical-trial.html 2020-11-06T16:52:10.0970000Z https://www.medicinesresources.nhs.uk/effect-of-taxane-chemotherapy-with-or-without-indoximod-in-metastatic-breast-cancer-a-randomized-clinical-trial.html 2020-11-06T16:52:20.7210000Z https://www.medicinesresources.nhs.uk/effect-of-vitamin-d-supplementation-on-asthma-control-in-patients-with-vitamin-d-deficiency-the-acvid-randomised-clinical-trial.html 2020-11-06T16:28:29.5030000Z https://www.medicinesresources.nhs.uk/effects-of-a-tailored-text-messaging-intervention-among-diverse-adults-with-type-2-diabetes-evidence-from-the-15-month-reach-randomized-controlled-trial.html 2020-11-06T16:31:27.8980000Z https://www.medicinesresources.nhs.uk/pentoxifylline-for-intermittent-claudication.html 2020-11-06T16:48:23.2290000Z https://www.medicinesresources.nhs.uk/probiotics-to-prevent-necrotising-enterocolitis-in-very-preterm-or-very-low-birth-weight-infants.html 2020-11-06T16:49:28.7890000Z https://www.medicinesresources.nhs.uk/electronic-cigarettes-for-smoking-cessation.html 2020-11-06T16:50:34.1420000Z https://www.medicinesresources.nhs.uk/new-product-zeposia-ozanimod-hard-capsules-1.html 2020-11-09T15:25:44.1760000Z https://www.medicinesresources.nhs.uk/new-product-zejula-niraparib-capsules.html 2020-11-09T14:51:12.3430000Z https://www.medicinesresources.nhs.uk/revised-spc-orfadin-nitisinone-all-formulations.html 2020-11-09T15:26:52.8160000Z https://www.medicinesresources.nhs.uk/ordering-medication-using-proxy-access-guidance-for-care-homes-gp-practices-and-community-pharmacies.html 2020-11-11T11:26:29.1890000Z https://www.medicinesresources.nhs.uk/intravenous-alteplase-for-stroke-with-unknown-time-of-onset-guided-by-advanced-imaging-systematic-review-and-meta-analysis-of-individual-patient-data.html 2020-11-09T14:56:14.6110000Z https://www.medicinesresources.nhs.uk/targeted-therapy-for-metastatic-renal-cell-carcinoma.html 2020-11-09T14:57:39.1550000Z https://www.medicinesresources.nhs.uk/antiplatelet-and-anticoagulant-agents-for-secondary-prevention-of-stroke-and-other-thromboembolic-events-in-people-with-antiphospholipid-syndrome.html 2020-11-09T14:59:03.7070000Z https://www.medicinesresources.nhs.uk/convalescent-plasma-or-hyperimmune-immunoglobulin-for-people-with-covid-19-a-living-systematic-review-1.html 2020-11-09T15:01:29.5740000Z https://www.medicinesresources.nhs.uk/what-is-the-risk-of-interaction-between-opioids-and-monoamine-oxidase-inhibitors-maois.html 2020-11-09T15:03:05.3450000Z https://www.medicinesresources.nhs.uk/what-is-st-marks-electrolyte-mix-solution.html 2020-11-09T15:04:55.2380000Z https://www.medicinesresources.nhs.uk/ticagrelor-added-to-aspirin-in-acute-ischemic-stroke-or-transient-ischemic-attack-in-prevention-of-disabling-stroke-a-randomized-clinical-trial.html 2020-11-09T15:07:00.8440000Z https://www.medicinesresources.nhs.uk/association-of-serum-25-hydroxyvitamin-d-concentrations-with-all-cause-and-cause-specific-mortality-among-individuals-with-diabetes.html 2020-11-09T15:09:51.0050000Z https://www.medicinesresources.nhs.uk/reductions-in-methicillin-resistant-staphylococcus-aureus-clostridium-difficile-infection-and-intensive-care-unit-acquired-bloodstream-infection-across-the-united-kingdom-following-implementation-of-a-national-infection-control-campaign.html 2020-11-09T15:11:10.9900000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-tofacitinib-in-ankylosing-spondylitis.html 2020-11-09T15:12:29.8080000Z https://www.medicinesresources.nhs.uk/immediate-actions-in-response-to-mink-variant-sars-cov-2-virus-in-denmark.html 2020-11-11T11:33:34.1200000Z https://www.medicinesresources.nhs.uk/social-media-giants-agree-package-of-measures-with-uk-government-to-tackle-vaccine-disinformation.html 2020-11-09T15:17:23.0600000Z https://www.medicinesresources.nhs.uk/dtb-forum-what-price-priadel.html 2020-11-09T15:18:27.4500000Z https://www.medicinesresources.nhs.uk/the-assessment-of-venous-thromboembolism-risks-associated-with-pregnancy.html 2020-11-09T15:19:43.2700000Z https://www.medicinesresources.nhs.uk/obstructive-sleep-apnoea-intermittent-hypoxia-and-heart-failure-with-a-preserved-ejection-fraction.html 2020-11-09T15:24:33.1370000Z https://www.medicinesresources.nhs.uk/class-4-drug-alert-for-information-kolanticon-gel-200ml-pl-17509-0084-intrapharm-laboratories-limited.html 2020-11-09T15:25:40.5790000Z https://www.medicinesresources.nhs.uk/first-episode-rapid-early-intervention-for-eating-disorders-freed.html 2020-11-09T15:26:41.2120000Z https://www.medicinesresources.nhs.uk/directed-enhanced-service-specification-seasonal-influenza-and-pneumococcal-polysaccharide-vaccination-programme-2020-22.html 2020-11-09T15:27:36.6910000Z https://www.medicinesresources.nhs.uk/new-workload-prioritisation-guidance-to-support-gps-through-next-wave-of-covid-19.html 2020-11-09T15:28:58.1800000Z https://www.medicinesresources.nhs.uk/early-phase-iii-data-indicate-pfizer-biontechs-covid-19-vaccine-90-effective.html 2020-11-09T15:42:58.6490000Z https://www.medicinesresources.nhs.uk/european-approval-of-nivolumab-plus-ipilimumab-for-first-line-treatment-of-metastatic-non-small-cell-lung-cancer.html 2020-11-09T15:43:54.8150000Z https://www.medicinesresources.nhs.uk/new-pricing-models-could-improve-access-to-innovative-cancer-drugs.html 2020-11-09T15:44:49.0200000Z https://www.medicinesresources.nhs.uk/psnc-discussing-pharmacy-involvement-in-covid-vaccinations.html 2020-11-09T15:46:24.9950000Z https://www.medicinesresources.nhs.uk/development-and-validation-of-a-modified-full-age-spectrum-creatinine-based-equation-to-estimate-glomerular-filtration-rate-gfr-2.html 2020-11-10T15:12:19.6810000Z https://www.medicinesresources.nhs.uk/diabetes-management-in-chronic-kidney-disease-synopsis-of-the-2020-kdigo-clinical-practice-guideline.html 2020-11-10T15:13:39.5240000Z https://www.medicinesresources.nhs.uk/tezepelumab-phase-3-trial-meets-primary-endpoint-of-a-statistically-significant-and-clinically-meaningful-reduction-in-exacerbations-in-broad-range-of-patients-with-severe-asthma.html 2020-11-10T17:25:07.2690000Z https://www.medicinesresources.nhs.uk/company-announces-positive-topline-results-for-nefecon-targeted-release-oral-budesonide-formulation-for-treatment-of-iga-nephropathy.html 2020-11-10T17:26:35.9600000Z https://www.medicinesresources.nhs.uk/treatment-of-epithelial-ovarian-cancer.html 2020-11-10T15:20:15.7230000Z https://www.medicinesresources.nhs.uk/covid-19-hospitals-forced-to-suspend-routine-care-amid-second-surge.html 2020-11-10T17:27:06.1310000Z https://www.medicinesresources.nhs.uk/treatment-of-masked-hypertension-with-a-chinese-herbal-formula-a-randomized-placebo-controlled-trial.html 2020-11-10T17:28:16.6560000Z https://www.medicinesresources.nhs.uk/heparin-induced-thrombocytopenia-in-severe-covid-19.html 2020-11-10T15:27:27.4340000Z https://www.medicinesresources.nhs.uk/acute-cardiovascular-manifestations-in-286-children-with-multisystem-inflammatory-syndrome-associated-with-covid-19-infection-in-europe.html 2020-11-10T17:29:07.0580000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-update-fda-authorises-monoclonal-antibody-for-treatment-of-covid-19.html 2020-11-10T17:30:14.6310000Z https://www.medicinesresources.nhs.uk/bidirectional-associations-between-covid-19-and-psychiatric-disorder-retrospective-cohort-studies-of-62-354-covid-19-cases-in-the-usa-2.html 2020-11-10T17:43:28.5070000Z https://www.medicinesresources.nhs.uk/long-term-cardiovascular-safety-of-febuxostat-compared-with-allopurinol-in-patients-with-gout-fast-a-multicentre-prospective-randomised-open-label-non-inferiority-trial.html 2020-11-11T11:22:59.6160000Z https://www.medicinesresources.nhs.uk/risk-of-severe-covid-19-among-workers-and-their-household-members.html 2020-11-10T17:32:22.2320000Z https://www.medicinesresources.nhs.uk/effect-of-hydroxychloroquine-on-clinical-status-at-14-days-in-hospitalized-patients-with-covid-19-a-randomized-clinical-trial.html 2020-11-11T11:16:46.2680000Z https://www.medicinesresources.nhs.uk/new-product-zeposia-ozanimod-hydrochloride-0-92-mg-hard-capsules.html 2020-11-10T17:45:04.0840000Z https://www.medicinesresources.nhs.uk/new-product-otigo-lidocaine-hydrochloride-phenazone-40-mg-10-mg-g-ear-drops-solution.html 2020-11-10T17:45:44.1600000Z https://www.medicinesresources.nhs.uk/isotretinoin-an-expert-review-of-suspected-psychiatric-and-sexual-side-effects-call-for-information-from-patients-patient-representatives-healthcare-professionals-researchers-and-organisations.html 2020-11-11T11:15:46.4990000Z https://www.medicinesresources.nhs.uk/home-delivery-of-medicines-service-commissioned-from-5-november-2020-until-3-december-2020.html 2020-11-10T17:47:06.0980000Z https://www.medicinesresources.nhs.uk/myalgic-encephalomyelitis-or-encephalopathy-chronic-fatigue-syndrome-diagnosis-and-management-draft-guideline.html 2020-11-10T17:48:33.2670000Z https://www.medicinesresources.nhs.uk/new-medicines-newsletter-october-2020.html 2020-11-10T17:49:02.5150000Z https://www.medicinesresources.nhs.uk/can-the-early-use-of-botulinum-toxin-in-post-stroke-spasticity-reduce-contracture-development-a-randomised-controlled-trial.html 2020-11-10T17:51:37.2440000Z https://www.medicinesresources.nhs.uk/revised-spc-duotrav-travoprost-and-timolol-eye-drops.html 2020-11-11T15:57:39.6540000Z https://www.medicinesresources.nhs.uk/revised-spc-remsima-infliximab-infusion.html 2020-11-11T17:05:26.2660000Z https://www.medicinesresources.nhs.uk/risk-factors-and-prognosis-for-covid-19-induced-acute-kidney-injury-a-meta-analysis.html 2020-11-11T16:00:14.4930000Z https://www.medicinesresources.nhs.uk/venous-thromboembolism-risk-with-jak-inhibitors-a-meta-analysis.html 2021-04-01T10:29:25.7780000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-lowering-ldl-cholesterol-in-older-patients-a-systematic-review-and-meta-analysis-of-randomised-controlled-trials.html 2020-11-12T09:32:15.3710000Z https://www.medicinesresources.nhs.uk/elevated-ldl-cholesterol-and-increased-risk-of-myocardial-infarction-and-atherosclerotic-cardiovascular-disease-in-individuals-aged-70-100-years-a-contemporary-primary-prevention-cohort.html 2020-11-11T17:08:13.1110000Z https://www.medicinesresources.nhs.uk/efficacy-of-tocilizumab-in-patients-with-hand-osteoarthritis-double-blind-randomised-placebo-controlled-multicentre-trial.html 2020-11-11T16:11:10.8060000Z https://www.medicinesresources.nhs.uk/effect-of-vitamin-d-supplementation-omega-3-fatty-acid-supplementation-or-a-strength-training-exercise-program-on-clinical-outcomes-in-older-adults-the-do-health-randomized-clinical-trial.html 2020-11-11T16:14:42.8240000Z https://www.medicinesresources.nhs.uk/effect-of-e-cigarettes-plus-counselling-vs-counselling-alone-on-smoking-cessation-a-randomized-clinical-trial.html 2020-11-11T16:17:39.7580000Z https://www.medicinesresources.nhs.uk/speed-evidence-and-safety-characteristics-of-vaccine-approvals-by-the-us-food-and-drug-administration.html 2020-11-11T16:19:32.4050000Z https://www.medicinesresources.nhs.uk/characteristics-complications-and-outcomes-among-1549-patients-hospitalised-with-covid-19-in-a-secondary-hospital-in-madrid-spain-a-retrospective-case-series-study.html 2020-11-11T16:21:07.6220000Z https://www.medicinesresources.nhs.uk/efficacy-of-intensive-acupuncture-versus-sham-acupuncture-in-knee-osteoarthritis-a-randomized-controlled-trial.html 2020-11-11T16:23:12.8690000Z https://www.medicinesresources.nhs.uk/the-impact-of-bariatric-surgery-on-incident-microvascular-complications-in-patients-with-type-2-diabetes-a-matched-controlled-population-based-retrospective-cohort-study.html 2020-11-11T16:25:16.4090000Z https://www.medicinesresources.nhs.uk/the-impact-of-physical-activity-on-the-prevention-of-type-2-diabetes-evidence-and-lessons-learned-from-the-diabetes-prevention-program-a-long-standing-clinical-trial-incorporating-subjective-and-objective-activity-measures.html 2020-11-11T16:26:23.7680000Z https://www.medicinesresources.nhs.uk/long-covid-a-cross-sectional-study-of-persisting-symptoms-biomarker-and-imaging-abnormalities-following-hospitalisation-for-covid-19.html 2020-11-11T16:27:42.3630000Z https://www.medicinesresources.nhs.uk/venetoclax-with-obinutuzumab-for-untreated-chronic-lymphocytic-leukaemia-final-appraisal-document.html 2020-11-11T16:29:25.7290000Z https://www.medicinesresources.nhs.uk/fda-grants-emergency-authorisation-for-bamlanivimab-for-high-risk-covid-19-patients.html 2020-11-11T16:30:50.3620000Z https://www.medicinesresources.nhs.uk/antibiotic-use-and-resistance-what-the-public-know.html 2020-11-11T16:32:37.0750000Z https://www.medicinesresources.nhs.uk/parents-urged-to-keep-childhood-vaccination-appointments-during-national-covid-19-restrictions.html 2020-11-11T16:33:53.9710000Z https://www.medicinesresources.nhs.uk/elective-care-in-england-assessing-the-impact-of-covid-19-and-where-next.html 2020-11-11T16:35:07.2220000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-medac-gmbh-t-a-medac-pharma-llp-sodiofolin-50mg-ml-solution-for-injection-100mg-2ml-pl-11587-0005-el-20-a-52.html 2020-11-11T16:36:36.8860000Z https://www.medicinesresources.nhs.uk/supporting-doctors-throughout-the-second-covid-19-wave-cas-alert-from-the-chief-medical-officer.html 2020-11-12T09:32:43.1100000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-lenvatinib-in-combination-with-pembrolizumab-and-or-everolimus-in-phase-3-keynote-581-clear-trial.html 2020-11-11T16:45:18.4350000Z https://www.medicinesresources.nhs.uk/new-therapies-for-neuromyelitis-optica-spectrum-disorder.html 2020-11-11T16:46:43.3130000Z https://www.medicinesresources.nhs.uk/devimistat-receives-fda-fast-track-designation-for-pancreatic-cancer.html 2020-11-11T17:14:31.1350000Z https://www.medicinesresources.nhs.uk/manufacturers-report-bemarituzumab-effective-for-first-line-advanced-gastric-and-gastroesophageal-junction-cancer.html 2020-11-11T16:49:54.9890000Z https://www.medicinesresources.nhs.uk/fostamatinib-for-treating-persistent-or-chronic-immune-thrombocytopenia-appraisal-consultation-document.html 2020-11-11T16:50:51.9260000Z https://www.medicinesresources.nhs.uk/national-prescribing-indicators-2020-2021-nhs-wales-analysis-of-prescribing-data-to-june-2020.html 2020-11-11T16:52:07.0790000Z https://www.medicinesresources.nhs.uk/grade-approach-to-drawing-conclusions-from-a-network-meta-analysis-using-a-partially-contextualised-framework.html 2020-11-11T16:53:04.6970000Z https://www.medicinesresources.nhs.uk/end-of-life-care-updated-quality-standard-out-for-consultation.html 2020-11-11T16:54:13.8830000Z https://www.medicinesresources.nhs.uk/acalabrutinib-approved-for-use-in-the-eu-for-chronic-lymphocytic-leukaemia.html 2020-11-11T16:55:35.5000000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-study-results-suggesting-long-acting-cabotegravir-superior-to-standard-of-care-for-pre-exposure-prophylaxis-prep-in-women.html 2020-11-11T16:57:13.7070000Z https://www.medicinesresources.nhs.uk/antimicrobial-impregnated-central-venous-catheters-for-preventing-neonatal-bloodstream-infection-the-prevail-rct.html 2020-11-11T16:59:15.6700000Z https://www.medicinesresources.nhs.uk/validating-clinical-practice-guidelines-for-the-management-of-children-with-non-blanching-rashes-in-the-uk-pic-a-prospective-multicentre-cohort-study.html 2020-11-11T17:01:36.6590000Z https://www.medicinesresources.nhs.uk/preprints-involving-medical-research-do-the-benefits-outweigh-the-challenges.html 2020-11-11T17:17:10.0920000Z https://www.medicinesresources.nhs.uk/patiromer-veltassa-r-not-recommended-for-use-within-nhs-scotland-for-treatment-of-hyperkalaemia-in-adults.html 2020-11-11T17:37:50.3940000Z https://www.medicinesresources.nhs.uk/trastuzumab-emtansine-kadcyla-r-accepted-for-use-within-nhs-scotland-for-adjuvant-treatment-of-adult-patients-with-her2-positive-early-breast-cancer-and-residual-invasive-disease-in-breast-and-or-lymph-nodes.html 2020-11-11T17:26:34.5190000Z https://www.medicinesresources.nhs.uk/atezolizumab-tecentriq-r-accepted-for-use-within-nhs-scotland-in-combination-with-nab-paclitaxel-for-treatment-of-adults-with-unresectable-locally-advanced-or-metastatic-triple-negative-breast-cancer.html 2020-11-11T17:28:14.9780000Z https://www.medicinesresources.nhs.uk/romosozumab-evenity-r-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-severe-osteoporosis-in-postmenopausal-women-at-high-risk-of-fracture.html 2020-11-11T17:29:44.4560000Z https://www.medicinesresources.nhs.uk/darolutamide-nubeqa-is-accepted-for-use-within-nhs-scotland.html 2020-11-11T17:31:12.0820000Z https://www.medicinesresources.nhs.uk/atezolizumab-tecentriq-r-accepted-for-use-within-nhs-scotland.html 2020-11-11T17:32:09.1140000Z https://www.medicinesresources.nhs.uk/scottish-medicines-consortium-completes-its-initial-assessment-of-evidence-for-the-volanesorsen-waylivra-using-ultra-orphan-framework-uof.html 2020-11-11T17:33:17.4500000Z https://www.medicinesresources.nhs.uk/trabectedin-yondelis-accepted-for-use-within-nhs-scotland.html 2020-11-11T17:34:07.2090000Z https://www.medicinesresources.nhs.uk/revised-spc-sevredol-morphine-tablets-all-strengths.html 2020-11-12T16:17:23.0330000Z https://www.medicinesresources.nhs.uk/revised-spc-zavicefta-2-g-0-5g-ceftazidime-avibactam-powder-for-concentrate-for-solution-for-infusion.html 2020-11-12T16:18:31.7930000Z https://www.medicinesresources.nhs.uk/revised-spc-abilify-maintena-aripiprazole-400-mg-powder-and-solvent-for-prolonged-release-suspension-for-injection-all-presentations.html 2020-11-12T16:19:36.3300000Z https://www.medicinesresources.nhs.uk/new-product-enerzair-breezhaler-indacaterol-glycopyrronium-mometasone.html 2020-11-12T16:20:33.3550000Z https://www.medicinesresources.nhs.uk/new-product-calquence-acalabrutinib-100-mg-hard-capsules.html 2020-11-12T16:23:04.0600000Z https://www.medicinesresources.nhs.uk/national-report-highlights-impact-and-suggests-improvements-to-reduce-the-risk-of-delays-to-critical-interventions-during-birth.html 2020-11-13T13:22:10.2200000Z https://www.medicinesresources.nhs.uk/ethnicity-and-clinical-outcomes-in-covid-19-a-systematic-review-and-meta-analysis.html 2020-11-13T13:21:50.4810000Z https://www.medicinesresources.nhs.uk/help-us-help-you-campaign-urges-public-not-to-ignore-persistent-tummy-troubles.html 2020-11-12T16:29:00.3480000Z https://www.medicinesresources.nhs.uk/include-roadmap-can-help-researchers-make-trials-more-inclusive.html 2020-11-12T18:22:52.3730000Z https://www.medicinesresources.nhs.uk/health-matters-cold-weather-and-covid-19.html 2020-11-12T16:30:55.7160000Z https://www.medicinesresources.nhs.uk/urgent-preparing-for-general-practice-to-contribute-to-a-potential-covid-19-vaccination-programme.html 2020-11-13T13:21:34.3260000Z https://www.medicinesresources.nhs.uk/pcn-development-funding-guidance-2020-21.html 2020-11-12T16:34:32.1820000Z https://www.medicinesresources.nhs.uk/esophageal-motility-disorders-and-gastroesophageal-reflux-disease.html 2020-11-12T16:35:33.0350000Z https://www.medicinesresources.nhs.uk/trying-to-protect-the-nhs-in-the-united-kingdom.html 2020-11-12T16:36:32.1100000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-delivery-of-systemic-anticancer-treatments-updated-guideline-ng161.html 2020-11-13T13:17:45.2000000Z https://www.medicinesresources.nhs.uk/guidance-on-minimising-disruptions-to-the-conduct-and-integrity-of-clinical-trials-of-medicines-during-covid-19.html 2020-11-12T16:38:51.9830000Z https://www.medicinesresources.nhs.uk/mims-summary-of-approval-of-dapagliflozin-forxiga-to-treat-heart-failure.html 2020-11-12T16:40:13.4150000Z https://www.medicinesresources.nhs.uk/therapy-for-early-covid-19-a-critical-need.html 2020-11-12T16:41:42.5070000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-mylan-uk-healthcare-ltd-ancotil-2-5-g-250-ml-solution-for-infusion-pl-46302-0116-el-20-a-53.html 2020-11-12T16:42:48.1460000Z https://www.medicinesresources.nhs.uk/grade-approach-to-drawing-conclusions-from-a-network-meta-analysis-using-a-minimally-contextualised-framework.html 2020-11-12T16:44:35.9420000Z https://www.medicinesresources.nhs.uk/diabetic-ketoacidosis-with-sglt2-inhibitors.html 2020-11-12T16:45:29.7480000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-should-we-allow-human-challenge-studies-to-infect-healthy-volunteers-with-sars-cov-2.html 2020-11-12T16:46:39.8370000Z https://www.medicinesresources.nhs.uk/how-will-brexit-affect-the-supply-of-medicines.html 2020-11-12T18:13:21.9500000Z https://www.medicinesresources.nhs.uk/have-large-increases-in-fast-track-referrals-improved-bowel-cancer-outcomes-in-uk.html 2020-11-12T16:49:00.1900000Z https://www.medicinesresources.nhs.uk/sanofi-genzyme-pauses-haemophilia-clinical-development-program-for-fitusiran.html 2020-11-12T16:49:55.3750000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-nvxcov2373-granted-fast-track-designation-by-u-s-fda.html 2020-11-12T16:51:03.4870000Z https://www.medicinesresources.nhs.uk/bayer-submits-regulatory-applications-for-finerenone-in-u-s-and-eu-for-patients-with-chronic-kidney-disease-ckd-and-type-2-diabetes-t2d.html 2020-11-12T16:52:43.6170000Z https://www.medicinesresources.nhs.uk/conference-report-deucravacitinib-improves-signs-symptoms-of-psoriatic-arthritis.html 2020-11-12T16:53:42.8550000Z https://www.medicinesresources.nhs.uk/us-fda-advisory-committee-does-not-support-approval-of-aducanumab-for-treatment-of-alzheimers-disease.html 2020-11-12T16:54:42.6320000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-reach-agreement-to-supply-eu-with-200-million-doses-of-bnt162b2-mrna-based-vaccine-candidate-against-sars-cov-2.html 2020-11-12T16:55:55.3650000Z https://www.medicinesresources.nhs.uk/second-interim-analysis-of-clinical-outcomes-results-in-recommendation-to-continue-remestemcel-l-phase-3-trial-in-patients-with-moderate-to-severe-acute-respiratory-distress-syndrome-due-to-covid-19.html 2020-11-12T18:08:23.1950000Z https://www.medicinesresources.nhs.uk/pfizer-announces-positive-results-from-phase-3-jade-regimen-study-in-patients-with-moderate-to-severe-atopic-dermatitis.html 2020-11-12T16:58:42.5470000Z https://www.medicinesresources.nhs.uk/prescribing-costs-in-hospitals-and-the-community-2019-2020.html 2020-11-12T16:59:53.5730000Z https://www.medicinesresources.nhs.uk/national-diabetes-audit-care-processes-and-treatment-targets-1st-quarter-january-to-june-2020.html 2020-11-12T17:01:19.8210000Z https://www.medicinesresources.nhs.uk/national-diabetes-audit-non-diabetic-hyperglycaemia-2018-2019-diabetes-prevention-programme.html 2020-11-12T17:02:19.7180000Z https://www.medicinesresources.nhs.uk/statistics-on-nhs-stop-smoking-services-in-england-april-2019-to-march-2020.html 2020-11-12T17:03:26.7900000Z https://www.medicinesresources.nhs.uk/an-interactive-website-to-aid-young-women-s-choice-of-contraception-feasibility-and-efficacy-rct.html 2020-11-12T17:05:12.8110000Z https://www.medicinesresources.nhs.uk/macrolide-and-nonmacrolide-resistance-with-mass-azithromycin-distribution.html 2020-11-12T18:04:43.8640000Z https://www.medicinesresources.nhs.uk/the-association-between-loneliness-and-depressive-symptoms-among-adults-aged-50-years-and-older-a-12-year-population-based-cohort-study.html 2020-11-12T17:07:41.1210000Z https://www.medicinesresources.nhs.uk/investigation-of-suicidality-and-psychological-adverse-events-in-patients-treated-with-finasteride.html 2020-11-12T17:09:56.4350000Z https://www.medicinesresources.nhs.uk/endocrine-therapy-use-and-cardiovascular-risk-in-postmenopausal-breast-cancer-survivors.html 2020-11-12T17:11:23.3060000Z https://www.medicinesresources.nhs.uk/accuracy-of-uk-rapid-test-consortium-uk-rtc-abc-19-rapid-test-for-detection-of-previous-sars-cov-2-infection-in-key-workers-test-accuracy-study.html 2020-11-12T17:13:03.4530000Z https://www.medicinesresources.nhs.uk/pregravid-contraceptive-use-and-fecundability-prospective-cohort-study.html 2020-11-12T17:33:38.1370000Z https://www.medicinesresources.nhs.uk/towards-safer-risperidone-prescribing-in-alzheimer-s-disease.html 2020-11-12T17:16:16.1140000Z https://www.medicinesresources.nhs.uk/revised-spcs-elvanse-lisdexamfetamine-hard-capsules-all-strengths.html 2020-11-13T13:27:43.3210000Z https://www.medicinesresources.nhs.uk/revised-spc-biktarvy-50-mg-200-mg-25-mg-bictegravir-emtricitabine-tenofovir-alafenamide-fumarate-film-coated-tablets.html 2020-11-13T13:28:51.3840000Z https://www.medicinesresources.nhs.uk/revised-spc-carbocisteine-375-mg-capsules-hard.html 2020-11-13T13:29:51.0090000Z https://www.medicinesresources.nhs.uk/phase-ii-trials-of-acalabrutinib-in-patients-hospitalised-with-covid-19-failed-to-meet-primary-endpoint.html 2020-11-13T13:30:47.6810000Z https://www.medicinesresources.nhs.uk/positive-phase-ii-data-for-bemarituzumab-in-the-treatment-of-her2-negative-gastric-or-gastroesophageal-junction-cancer.html 2020-11-13T18:46:53.9870000Z https://www.medicinesresources.nhs.uk/phase-iii-data-suggests-long-acting-cabotegravir-injection-more-effective-than-daily-oral-truvada-emtricitabine-tenofovir-for-hiv-pre-exposure-prophylaxis-in-women.html 2020-11-13T13:33:42.8460000Z https://www.medicinesresources.nhs.uk/medecins-sans-frontieres-msf-calls-on-governments-to-demand-transparency-on-vaccine-deals.html 2020-11-13T13:34:50.9670000Z https://www.medicinesresources.nhs.uk/government-faces-legal-action-over-gbp75m-contract-for-covid-19-antibody-tests.html 2020-11-13T13:38:18.8940000Z https://www.medicinesresources.nhs.uk/the-lancet-commission-on-diabetes-using-data-to-transform-diabetes-care-and-patient-lives.html 2020-11-13T13:39:55.4590000Z https://www.medicinesresources.nhs.uk/caplacizumab-with-plasma-exchange-and-immunosuppression-for-treating-acute-acquired-thrombotic-thrombocytopenic-purpura-final-appraisal-document.html 2020-11-13T13:40:58.9850000Z https://www.medicinesresources.nhs.uk/covid-19-deaths-of-people-with-learning-disabilities.html 2020-11-13T13:42:09.6470000Z https://www.medicinesresources.nhs.uk/application-seeking-approval-of-subcutaneous-formulation-of-daratumumab-for-the-treatment-of-relapsed-refractory-multiple-myeloma-submitted-to-the-european-medicines-agency-1.html 2020-11-13T15:19:22.8390000Z https://www.medicinesresources.nhs.uk/spatio-temporal-model-to-estimate-life-expectancy-and-to-detect-unusual-trends-at-the-local-authority-level-in-england.html 2020-11-13T15:21:35.7350000Z https://www.medicinesresources.nhs.uk/a-randomized-controlled-trial-to-evaluate-the-effects-of-a-smartphone-application-based-lifestyle-coaching-program-on-gestational-weight-gain-glycemic-control-maternal-and-neonatal-outcomes-in-women-with-gestational-diabetes-mellitus-the-smart-gdm-study.html 2020-11-13T15:23:23.7260000Z https://www.medicinesresources.nhs.uk/levetiracetam-as-an-alternative-to-phenytoin-for-second-line-emergency-treatment-of-children-with-convulsive-status-epilepticus-the-eclipse-rct.html 2020-11-13T15:24:33.8830000Z https://www.medicinesresources.nhs.uk/effect-of-ibd-medications-on-covid-19-outcomes-results-from-an-international-registry.html 2020-11-13T15:26:04.5540000Z https://www.medicinesresources.nhs.uk/fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19-a-randomized-clinical-trial.html 2020-11-13T18:35:24.2300000Z https://www.medicinesresources.nhs.uk/assessment-of-sars-cov-2-rna-test-results-among-patients-who-recovered-from-covid-19-with-prior-negative-results.html 2020-11-13T15:28:59.7680000Z https://www.medicinesresources.nhs.uk/nihr-alert-ongoing-pain-after-knee-replacement-people-need-support-and-encouragement-to-seek-help.html 2020-11-13T16:40:22.5560000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-inhaled-nebulised-interferon-beta-1a-sng001-for-treatment-of-sars-cov-2-infection-a-randomised-double-blind-placebo-controlled-phase-2-trial.html 2020-11-13T16:41:35.0510000Z https://www.medicinesresources.nhs.uk/a-placebo-controlled-trial-of-subcutaneous-semaglutide-in-nonalcoholic-steatohepatitis.html 2020-11-13T16:42:32.3710000Z https://www.medicinesresources.nhs.uk/use-of-effective-contraception-following-provision-of-the-progestogen-only-pill-for-women-presenting-to-community-pharmacies-for-emergency-contraception-bridge-it-a-pragmatic-cluster-randomised-crossover-trial.html 2020-11-13T16:43:36.6440000Z https://www.medicinesresources.nhs.uk/once-per-week-selinexor-bortezomib-and-dexamethasone-versus-twice-per-week-bortezomib-and-dexamethasone-in-patients-with-multiple-myeloma-boston-a-randomised-open-label-phase-3-trial.html 2020-11-13T16:44:35.3640000Z https://www.medicinesresources.nhs.uk/react-1-study-of-coronavirus-transmission-october-2020-final-results.html 2020-11-16T07:53:40.3660000Z https://www.medicinesresources.nhs.uk/measuring-the-impact-of-exposure-to-covid-19-vaccine-misinformation-on-vaccine-intent-in-the-uk-and-us.html 2020-11-13T18:39:23.2090000Z https://www.medicinesresources.nhs.uk/covid-19-letters-to-clinically-extremely-vulnerable-people.html 2020-11-13T16:48:21.3840000Z https://www.medicinesresources.nhs.uk/one-in-ten-hospital-trusts-have-been-asked-to-approve-unlicensed-cannabis-based-medicinal-prescriptions.html 2020-11-13T18:44:16.5580000Z https://www.medicinesresources.nhs.uk/preparations-for-a-potential-covid-19-vaccination-programme.html 2020-11-13T16:50:44.1200000Z https://www.medicinesresources.nhs.uk/the-overlap-between-irritable-bowel-syndrome-and-organic-gastrointestinal-diseases.html 2020-11-13T16:52:08.8430000Z https://www.medicinesresources.nhs.uk/tuberculosis-in-england-2020-report.html 2020-11-13T16:53:23.9870000Z https://www.medicinesresources.nhs.uk/revised-spc-zyban-buproprion-150-mg-prolonged-release-tablets-1.html 2020-11-16T12:25:00.5730000Z https://www.medicinesresources.nhs.uk/revised-spc-granpidam-sildenafil-20-mg-film-coated-tablets.html 2020-11-16T12:26:44.2850000Z https://www.medicinesresources.nhs.uk/revised-spc-forxiga-dapagliflozin-all-presentations.html 2020-11-16T12:28:07.6050000Z https://www.medicinesresources.nhs.uk/revised-spcs-lynparza-olaparib-all-strengths.html 2020-11-16T12:29:38.4800000Z https://www.medicinesresources.nhs.uk/revised-spc-tecentriq-atezolizumab-840-mg-concentrate-for-solution-for-infusion-2.html 2020-11-16T12:31:00.7190000Z https://www.medicinesresources.nhs.uk/revised-spc-imvaggis-estriol-0-03-mg-pessary.html 2020-11-16T12:33:12.2080000Z https://www.medicinesresources.nhs.uk/effects-of-n-3-fatty-acid-supplements-in-elderly-patients-after-myocardial-infarction-a-randomized-controlled-trial.html 2020-11-16T12:35:20.4770000Z https://www.medicinesresources.nhs.uk/sustained-intensive-treatment-and-long-term-effects-on-hba1c-reduction-silver-study-by-cgm-in-people-with-type-1-diabetes-treated-with-mdi.html 2020-11-16T12:45:27.0200000Z https://www.medicinesresources.nhs.uk/current-use-and-safety-of-novel-oral-anticoagulants-in-adults-with-congenital-heart-disease-results-of-a-nationwide-analysis-including-more-than-44-000-patients.html 2020-11-16T15:45:20.5190000Z https://www.medicinesresources.nhs.uk/effect-of-high-dose-omega-3-fatty-acids-vs-corn-oil-on-major-adverse-cardiovascular-events-in-patients-at-high-cardiovascular-risk-the-strength-randomized-clinical-trial.html 2020-11-16T12:49:41.3980000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-zeposia-ozanimod-capsules.html 2020-11-18T09:40:58.0260000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-arava-leflunomide-all-strengths.html 2020-11-18T09:40:14.4980000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-oruvail-ketoprofen-2-5-gel.html 2020-11-18T09:39:26.8270000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-gilenya-fingolimod.html 2020-11-18T09:38:29.2710000Z https://www.medicinesresources.nhs.uk/darunavir-cobicistat-rezolsta-r.html 2020-11-16T12:59:35.0330000Z https://www.medicinesresources.nhs.uk/fda-accepts-supplemental-new-drug-application-for-secnidazole-for-treatment-of-trichomoniasis.html 2020-11-16T13:00:39.4970000Z https://www.medicinesresources.nhs.uk/fda-approval-of-pembrolizumab-with-chemotherapy-for-locally-recurrent-unresectable-or-metastatic-triple-negative-breast-cancer.html 2020-11-16T13:01:47.0210000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-netarsudil-and-latanoprost-ophthalmic-solution-roclanda-for-primary-open-angle-glaucoma-or-ocular-hypertension.html 2020-11-16T13:03:42.6330000Z https://www.medicinesresources.nhs.uk/using-antibiotics-wisely-for-respiratory-tract-infection-in-the-era-of-covid-19.html 2020-11-16T13:04:54.5140000Z https://www.medicinesresources.nhs.uk/two-new-megalabs-to-open-in-2021-to-transform-the-uks-diagnostic-facilities.html 2020-11-16T13:05:42.5300000Z https://www.medicinesresources.nhs.uk/the-need-for-more-and-better-testing-for-covid-19.html 2020-11-16T13:07:07.5880000Z https://www.medicinesresources.nhs.uk/ticagrelor-versus-clopidogrel-in-elective-percutaneous-coronary-intervention-alpheus-a-randomised-open-label-phase-3b-trial-1.html 2020-11-16T15:28:07.4850000Z https://www.medicinesresources.nhs.uk/ferric-carboxymaltose-for-iron-deficiency-at-discharge-after-acute-heart-failure-a-multicentre-double-blind-randomised-controlled-trial.html 2020-11-16T16:08:13.0920000Z https://www.medicinesresources.nhs.uk/sexual-health-patient-group-direction-pgd-templates-2.html 2020-11-23T11:09:00.0730000Z https://www.medicinesresources.nhs.uk/nhs-launches-40-long-covid-clinics-to-tackle-persistent-symptoms.html 2020-11-16T15:35:13.3630000Z https://www.medicinesresources.nhs.uk/covid-19-therapy-corticosteroids-including-dexamethasone-and-hydrocortisone.html 2020-11-23T11:14:14.6710000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-carfilzomib-kyprolis.html 2020-11-16T15:37:57.4330000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-and-paediatric-formulations-of-dabigatran-etexilate-pradaxa.html 2020-11-16T15:39:15.1400000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-and-new-formulation-of-dolutegravir-tivicay.html 2020-11-16T15:40:18.2300000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-sodium-oxybate-xyrem.html 2020-11-16T15:41:27.2540000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-and-new-strength-of-trimbow-beclometasone-formoterol-glycopyrronium-bromide.html 2020-11-16T16:09:38.1560000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-and-new-strength-of-rivaroxaban-xarelto.html 2020-11-16T15:46:46.0040000Z https://www.medicinesresources.nhs.uk/european-chmp-negative-opinion-of-emapalumab-gamifant-for-treatment-of-primary-haemophagocytic-lymphohistiocytosis-in-children-under-18-years-of-age.html 2020-11-16T15:48:07.4690000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-tagraxofusp-elzonris-for-treatment-of-blastic-plasmacytoid-dendritic-cell-neoplasm.html 2020-11-16T15:49:33.8800000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-bevacizumab-biosimilar-onbevzi-1.html 2020-11-16T15:52:09.3900000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-baloxavir-marboxil-xofluza-for-treatment-and-post-exposure-prophylaxis-of-uncomplicated-influenza.html 2020-11-16T15:53:05.0200000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-phesgo-pertuzumab-trastuzumab-for-treatment-of-early-and-metastatic-breast-cancer.html 2020-11-16T15:53:56.2270000Z https://www.medicinesresources.nhs.uk/nitrosamines-ema-aligns-recommendations-for-sartans-with-those-for-other-medicines.html 2020-11-18T09:36:08.5190000Z https://www.medicinesresources.nhs.uk/ulipristal-acetate-for-uterine-fibroids-ema-recommends-restricting-use.html 2020-11-18T09:37:21.6320000Z https://www.medicinesresources.nhs.uk/withdrawal-of-the-marketing-authorisation-application-idebenone-puldysa.html 2020-11-16T15:58:09.0300000Z https://www.medicinesresources.nhs.uk/withdrawal-of-the-marketing-authorisation-application-valoctocogene-roxaparvovec-roctavian.html 2020-11-16T15:59:18.4200000Z https://www.medicinesresources.nhs.uk/withdrawal-of-the-marketing-authorisation-application-ivosidenib-tibsovo.html 2020-11-16T16:00:16.1820000Z https://www.medicinesresources.nhs.uk/odevixibat-demonstrates-continued-and-durable-reductions-in-serum-bile-acids-in-patients-with-progressive-familial-intrahepatic-cholestasis-pfic-in-open-label-phase-iii-extension-study.html 2020-11-17T17:59:27.0020000Z https://www.medicinesresources.nhs.uk/company-announces-positive-topline-results-from-protective-2-phase-3-trial-of-investigational-drug-plinabulin-in-combination-with-pegfilgrastim-for-prevention-of-chemotherapy-induced-neutropenia.html 2020-11-17T18:00:10.4750000Z https://www.medicinesresources.nhs.uk/company-announces-positive-results-from-the-enhance-global-phase-3-study-evaluating-new-oral-drug-seladelpar-for-primary-biliary-cholangitis.html 2020-11-17T18:13:38.1220000Z https://www.medicinesresources.nhs.uk/covid-19-moderna-vaccine-is-nearly-95-effective-trial-involving-high-risk-and-elderly-people-shows.html 2020-11-17T18:04:21.8980000Z https://www.medicinesresources.nhs.uk/covid-19-third-candidate-vaccine-developed-by-janssen-pharmaceutical-companies-will-be-tested-in-clinical-trials-involving-patients-in-the-uk.html 2020-11-17T18:12:09.2210000Z https://www.medicinesresources.nhs.uk/association-of-non-malignant-diseases-with-thrombocytosis-a-prospective-cohort-study-in-general-practice.html 2020-11-17T18:16:41.7530000Z https://www.medicinesresources.nhs.uk/modafinil-provigil-increased-risk-of-congenital-malformations-if-used-during-pregnancy.html 2020-11-23T10:46:43.2560000Z https://www.medicinesresources.nhs.uk/pirfenidone-esbriet-risk-of-serious-liver-injury-updated-advice-on-liver-function-testing.html 2020-11-23T10:47:19.1770000Z https://www.medicinesresources.nhs.uk/ferric-carboxymaltose-ferinject-risk-of-symptomatic-hypophosphataemia-leading-to-osteomalacia-and-fractures.html 2020-11-23T10:55:44.4780000Z https://www.medicinesresources.nhs.uk/bupropion-zyban-risk-of-serotonin-syndrome-with-use-with-other-serotonergic-drugs.html 2020-11-23T10:43:15.1320000Z https://www.medicinesresources.nhs.uk/dtb-select-prescribing-cascade-calcium-channel-blockers-and-diuretics.html 2020-11-17T18:19:03.2080000Z https://www.medicinesresources.nhs.uk/revised-spcs-simponi-golimumab-solution-for-injection-in-pre-filled-pen-or-syringe-all-strengths.html 2020-11-17T16:12:54.6400000Z https://www.medicinesresources.nhs.uk/revised-spcs-ropilynz-ropinirole-hydrochloride-xl-prolonged-release-tablets-all-strengths.html 2020-11-17T16:13:58.7160000Z https://www.medicinesresources.nhs.uk/prospective-observational-study-of-medication-reviews-in-internal-medicine-wards-evaluation-of-drug-related-problems.html 2020-11-17T18:20:06.0830000Z https://www.medicinesresources.nhs.uk/implementation-of-a-pharmacy-e-interconsultation-integrated-in-patient-medical-records.html 2020-11-17T16:16:33.4370000Z https://www.medicinesresources.nhs.uk/effect-of-blood-pressure-lowering-drugs-and-antibiotics-on-abdominal-aortic-aneurysm-growth-a-systematic-review-and-meta-analysis.html 2020-11-17T18:20:54.4380000Z https://www.medicinesresources.nhs.uk/evaluation-of-time-to-benefit-of-statins-for-the-primary-prevention-of-cardiovascular-events-in-adults-aged-50-to-75-years-a-meta-analysis.html 2020-11-17T18:21:28.5080000Z https://www.medicinesresources.nhs.uk/european-medicine-agency-ema-starts-rolling-review-of-mrna-1273-covid-19-vaccine-by-moderna-biotech-spain.html 2020-11-17T18:11:38.3110000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-of-avelumab-maintenance-after-first-line-induction-chemotherapy-versus-continuation-of-chemotherapy-in-patients-with-gastric-cancers-results-from-javelin-gastric-100.html 2020-11-17T18:26:31.9150000Z https://www.medicinesresources.nhs.uk/systemic-therapy-for-advanced-hepatocellular-carcinoma-asco-guideline.html 2020-11-17T18:27:20.2530000Z https://www.medicinesresources.nhs.uk/long-term-safety-and-efficacy-of-patisiran-for-hereditary-transthyretin-mediated-amyloidosis-with-polyneuropathy-12-month-results-of-an-open-label-extension-study.html 2020-11-17T18:28:04.5850000Z https://www.medicinesresources.nhs.uk/phase-3-trial-of-interleukin-1-trap-rilonacept-in-recurrent-pericarditis.html 2020-11-17T18:28:41.2240000Z https://www.medicinesresources.nhs.uk/cryoablation-or-drug-therapy-for-initial-treatment-of-atrial-fibrillation.html 2020-11-17T18:29:28.0080000Z https://www.medicinesresources.nhs.uk/sotagliflozin-in-patients-with-diabetes-and-recent-worsening-heart-failure.html 2020-11-17T18:30:07.9980000Z https://www.medicinesresources.nhs.uk/sotagliflozin-in-patients-with-diabetes-and-chronic-kidney-disease.html 2020-11-17T18:30:47.5860000Z https://www.medicinesresources.nhs.uk/rivaroxaban-in-patients-with-atrial-fibrillation-and-a-bioprosthetic-mitral-valve.html 2020-11-17T18:31:26.0520000Z https://www.medicinesresources.nhs.uk/siponimod-for-treating-secondary-progressive-multiple-sclerosis-guidance-ta656.html 2020-11-23T07:51:38.1080000Z https://www.medicinesresources.nhs.uk/carfilzomib-for-previously-treated-multiple-myeloma-guidance-ta657.html 2020-11-23T10:20:03.2580000Z https://www.medicinesresources.nhs.uk/isatuximab-with-pomalidomide-and-dexamethasone-for-treating-relapsed-and-refractory-multiple-myeloma-guidance-ta658.html 2020-11-23T10:25:29.4560000Z https://www.medicinesresources.nhs.uk/galcanezumab-for-preventing-migraine-guidance-ta659.html 2020-11-23T10:30:13.7480000Z https://www.medicinesresources.nhs.uk/acute-coronary-syndromes-guidance-ng185.html 2020-11-23T07:47:58.0170000Z https://www.medicinesresources.nhs.uk/revised-spc-cardicor-bisoprolol-tablets.html 2020-11-18T15:53:44.9390000Z https://www.medicinesresources.nhs.uk/treatment-of-hypertension-reduces-cognitive-decline-in-older-adults-a-systematic-review-and-meta-analysis.html 2020-11-18T15:56:28.0300000Z https://www.medicinesresources.nhs.uk/nihr-alert-first-line-chemotherapy-for-ovarian-cancer-given-once-every-three-weeks-may-preserve-quality-of-life.html 2020-11-18T15:58:26.8010000Z https://www.medicinesresources.nhs.uk/association-of-body-mass-index-and-age-with-morbidity-and-mortality-in-patients-hospitalized-with-covid-19-results-from-the-american-heart-association-covid-19-cardiovascular-disease-registry.html 2020-11-18T15:59:29.8660000Z https://www.medicinesresources.nhs.uk/effect-of-an-emergency-department-care-bundle-on-30-day-hospital-discharge-and-survival-among-elderly-patients-with-acute-heart-failure-the-elisabeth-randomized-clinical-trial.html 2020-11-18T16:00:28.1450000Z https://www.medicinesresources.nhs.uk/effects-of-empagliflozin-on-first-and-recurrent-clinical-events-in-patients-with-type-2-diabetes-and-atherosclerotic-cardiovascular-disease-a-secondary-analysis-of-the-empa-reg-outcome-trial.html 2020-11-18T16:01:25.0990000Z https://www.medicinesresources.nhs.uk/n-of-1-trial-of-a-statin-placebo-or-no-treatment-to-assess-side-effects.html 2020-11-18T16:02:29.4990000Z https://www.medicinesresources.nhs.uk/phase-ii-open-label-study-of-anakinra-in-intravenous-immunoglobulin-resistant-kawasaki-disease.html 2020-11-18T16:03:26.7450000Z https://www.medicinesresources.nhs.uk/estimated-impact-of-the-covid-19-pandemic-on-cancer-services-and-excess-1-year-mortality-in-people-with-cancer-and-multimorbidity-near-real-time-data-on-cancer-care-cancer-deaths-and-a-population-based-cohort-study.html 2020-11-18T16:05:22.9200000Z https://www.medicinesresources.nhs.uk/supply-disruption-with-harvoni-45-mg-200-mg-film-coated-tablets-ledipasvir-sofosbuvir-in-the-uk.html 2020-11-18T16:06:46.9020000Z https://www.medicinesresources.nhs.uk/monofer-100mg-ml-solution-for-injection-infusion-and-diafer-50mg-ml-solution-for-injection-name-change-from-iron-isomaltoside-to-ferric-derisomaltose.html 2020-11-18T16:13:15.6510000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-finerenone-in-phase-iii-study.html 2020-11-18T16:15:07.8760000Z https://www.medicinesresources.nhs.uk/cabotegravir-receives-fda-breakthrough-for-hiv-prevention.html 2020-11-18T16:15:57.8950000Z https://www.medicinesresources.nhs.uk/can-healthcare-adapt-to-a-world-of-tightening-ecological-constraints-challenges-on-the-road-to-a-post-growth-future.html 2020-11-18T16:16:47.2680000Z https://www.medicinesresources.nhs.uk/covid-19-government-ramps-up-moonshot-mass-testing.html 2020-11-18T16:17:45.7580000Z https://www.medicinesresources.nhs.uk/the-use-of-human-donor-milk.html 2020-11-18T16:19:13.7360000Z https://www.medicinesresources.nhs.uk/long-covid-damage-to-multiple-organs-presents-in-young-low-risk-patients.html 2020-11-18T16:20:11.1530000Z https://www.medicinesresources.nhs.uk/european-antibiotic-awareness-day.html 2020-11-18T16:24:52.8080000Z https://www.medicinesresources.nhs.uk/beyond-the-clot-perfusion-imaging-of-the-pulmonary-vasculature-after-covid-20.html 2020-11-18T16:26:38.5750000Z https://www.medicinesresources.nhs.uk/gbp16-million-to-introduce-digital-prescribing-in-hospitals.html 2020-11-18T16:27:25.9040000Z https://www.medicinesresources.nhs.uk/new-film-shows-importance-of-ventilation-to-reduce-spread-of-covid-19.html 2020-11-18T16:28:11.0300000Z https://www.medicinesresources.nhs.uk/investigation-into-government-procurement-during-the-covid-19-pandemic.html 2020-11-18T16:28:57.3600000Z https://www.medicinesresources.nhs.uk/new-inquiry-launched-to-assess-impact-of-pandemic-on-pharmacy-services.html 2020-11-18T16:29:36.3450000Z https://www.medicinesresources.nhs.uk/english-surveillance-programme-for-antimicrobial-utilisation-and-resistance-espaur-report-2019-to-2020.html 2020-11-18T16:30:51.4400000Z https://www.medicinesresources.nhs.uk/sleep-disorders-in-autoimmune-encephalitis.html 2020-11-18T16:31:42.2720000Z https://www.medicinesresources.nhs.uk/neuroinflammation-in-intracerebral-haemorrhage-immunotherapies-with-potential-for-translation.html 2020-11-18T17:12:29.5730000Z https://www.medicinesresources.nhs.uk/letter-to-medicines-and-medical-products-suppliers-17-november-2020.html 2020-11-18T16:33:26.8700000Z https://www.medicinesresources.nhs.uk/prevalence-and-incidence-of-hepatitis-c-virus-infection-in-men-who-have-sex-with-men-a-systematic-review-and-meta-analysis.html 2020-11-18T16:35:48.3510000Z https://www.medicinesresources.nhs.uk/digital-care-transformation-interim-report-from-the-first-5000-patients-enrolled-in-a-remote-algorithm-based-cardiovascular-risk-management-program-to-improve-lipid-and-hypertension-control.html 2020-11-18T16:36:28.5060000Z https://www.medicinesresources.nhs.uk/an-electronically-delivered-patient-activation-tool-for-intensification-of-medications-for-chronic-heart-failure-with-reduced-ejection-fraction-the-epic-hf-trial.html 2020-11-18T16:37:37.8990000Z https://www.medicinesresources.nhs.uk/racial-and-ethnic-differences-in-presentation-and-outcomes-for-patients-hospitalized-with-covid-19-findings-from-the-american-heart-association-s-covid-19-cardiovascular-disease-registry.html 2020-11-18T16:38:37.1020000Z https://www.medicinesresources.nhs.uk/public-health-england-to-review-guidance-against-the-use-of-rapid-covid-19-tests-in-community-pharmacies.html 2020-11-18T16:40:01.1530000Z https://www.medicinesresources.nhs.uk/letter-to-medicines-and-medical-products-suppliers-17-november-2021.html 2020-11-18T16:40:58.7530000Z https://www.medicinesresources.nhs.uk/antirheumatic-disease-therapies-for-the-treatment-of-covid-19-a-systematic-review-and-meta-analysis-1.html 2020-11-22T13:06:23.4600000Z https://www.medicinesresources.nhs.uk/psychological-interventions-as-an-alternative-and-add-on-to-antidepressant-medication-to-prevent-depressive-relapse-systematic-review-and-meta-analysis.html 2020-11-19T15:53:29.2130000Z https://www.medicinesresources.nhs.uk/strategies-to-reduce-the-use-of-low-value-medical-tests-in-primary-care-a-systematic-review.html 2020-11-19T15:54:58.1260000Z https://www.medicinesresources.nhs.uk/population-vitamin-d-supplementation-in-uk-adults-too-much-of-nothing.html 2020-11-19T22:05:39.3870000Z https://www.medicinesresources.nhs.uk/nihr-alert-people-with-thyroid-cancer-who-are-asked-to-follow-a-low-iodine-diet-need-clear-information-1.html 2020-11-19T16:00:12.3130000Z https://www.medicinesresources.nhs.uk/nihr-alert-teenagers-use-of-antidepressants-is-rising-with-variations-across-regions-and-ethnic-groups.html 2020-11-19T16:01:32.9790000Z https://www.medicinesresources.nhs.uk/nihr-alert-women-with-cancer-of-the-stomach-or-oesophagus-are-more-likely-to-survive-than-men-but-they-have-worse-side-effects-from-chemotherapy.html 2020-11-19T16:03:32.3910000Z https://www.medicinesresources.nhs.uk/falsified-medicines-directive-will-close-in-great-britain-at-end-of-2020.html 2020-11-19T16:48:08.9950000Z https://www.medicinesresources.nhs.uk/european-commission-signs-contract-with-curevac-for-access-to-405-million-doses-of-its-investigational-covid-19-vaccine.html 2020-11-19T16:49:42.4240000Z https://www.medicinesresources.nhs.uk/recarbrio-imipenem-cilastatin-relebactam-launched-in-uk.html 2020-11-19T16:51:00.2880000Z https://www.medicinesresources.nhs.uk/national-tariff-payment-system.html 2020-11-22T13:19:11.8900000Z https://www.medicinesresources.nhs.uk/nhs-digital-publishes-information-on-ethnicity-recording-in-the-nhs-to-aid-planning-and-research-for-covid-19.html 2020-11-19T21:45:08.6530000Z https://www.medicinesresources.nhs.uk/endometrial-cancer.html 2020-11-19T16:55:55.1300000Z https://www.medicinesresources.nhs.uk/melphalan-chemosaturation-with-percutaneous-hepatic-artery-perfusion-and-hepatic-vein-isolation-for-primary-or-metastatic-cancer-in-the-liver-interventional-procedures-consultation-document.html 2020-11-19T17:01:50.7910000Z https://www.medicinesresources.nhs.uk/public-assessment-report-of-the-reclassification-of-benacort-hayfever-relief-for-adults-64-micrograms-nasal-spray-from-pom-to-gsl.html 2020-11-19T17:03:06.6770000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-covid-19-vaccine-mhra-statement.html 2020-11-23T07:06:43.9300000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-aannounce-covid-19-vaccine-has-met-all-primary-efficacy-endpoints-in-phase-iii-trial-and-plan-to-submit-emergency-use-authorisation-to-fda.html 2020-11-23T07:12:49.2280000Z https://www.medicinesresources.nhs.uk/the-digital-revolution-eight-technologies-that-will-change-health-and-care.html 2020-11-19T17:10:28.0130000Z https://www.medicinesresources.nhs.uk/bladder-cancer-a-review.html 2020-11-19T21:34:03.7270000Z https://www.medicinesresources.nhs.uk/a-proposed-framework-and-timeline-of-the-spectrum-of-disease-due-to-sars-cov-2-infection-illness-beyond-acute-infection-and-public-health-implications.html 2020-11-19T17:13:41.7810000Z https://www.medicinesresources.nhs.uk/supply-of-tests-for-covid-19-from-pharmacies.html 2020-11-19T17:14:45.9600000Z https://www.medicinesresources.nhs.uk/elevation-of-transaminases-associated-with-teriparatide-treatment-a-case-report.html 2020-11-19T17:17:56.7670000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-organises-public-meeting-on-covid-19-vaccines.html 2020-11-19T17:19:10.2310000Z https://www.medicinesresources.nhs.uk/dhsc-announces-expansion-of-vivaldi-study-to-test-thousands-more-care-home-staff-and-residents-for-their-immune-response-to-coronavirus-covid-19.html 2020-11-19T21:26:50.6750000Z https://www.medicinesresources.nhs.uk/inpatient-experience-during-the-covid-19-pandemic-national-report.html 2020-11-19T17:21:34.5290000Z https://www.medicinesresources.nhs.uk/how-care-homes-managed-infection-prevention-and-control-during-the-coronavirus-pandemic-2020.html 2020-11-19T17:22:41.7190000Z https://www.medicinesresources.nhs.uk/false-positive-urine-screen-test-for-mdma-in-a-patient-exposed-to-mebeverine.html 2020-11-19T17:24:13.7260000Z https://www.medicinesresources.nhs.uk/olfactory-and-gustatory-impairments-in-covid-19-patients-role-in-early-diagnosis-and-interferences-by-concomitant-drugs.html 2020-11-19T17:26:31.6390000Z https://www.medicinesresources.nhs.uk/acute-otitis-media-in-children.html 2020-11-19T17:27:59.4370000Z https://www.medicinesresources.nhs.uk/nhs-reorganisation-after-the-pandemic.html 2020-11-19T17:29:02.2520000Z https://www.medicinesresources.nhs.uk/national-diabetes-inpatient-audit-nadia-2019.html 2020-11-23T07:18:48.7880000Z https://www.medicinesresources.nhs.uk/national-diabetes-inpatient-audit-harms-2019.html 2020-11-23T07:21:59.2190000Z https://www.medicinesresources.nhs.uk/first-line-lorlatinib-or-crizotinib-in-advanced-alk-positive-lung-cancer.html 2020-11-19T17:35:38.7780000Z https://www.medicinesresources.nhs.uk/polypill-with-or-without-aspirin-in-persons-without-cardiovascular-disease.html 2020-11-19T17:36:48.3270000Z https://www.medicinesresources.nhs.uk/cardiac-myosin-activation-with-omecamtiv-mecarbil-in-systolic-heart-failure.html 2020-11-19T17:39:11.7580000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-chadox1-ncov-19-vaccine-administered-in-a-prime-boost-regimen-in-young-and-old-adults-cov002-a-single-blind-randomised-controlled-phase-2-3-trial.html 2020-11-19T17:41:24.5290000Z https://www.medicinesresources.nhs.uk/effectiveness-of-adding-a-mask-recommendation-to-other-public-health-measures-to-prevent-sars-cov-2-infection-in-danish-mask-wearers-a-randomized-controlled-trial.html 2020-11-19T21:58:53.1450000Z https://www.medicinesresources.nhs.uk/association-of-low-dose-triple-combination-therapy-with-therapeutic-inertia-and-prescribing-patterns-in-patients-with-hypertension-a-secondary-analysis-of-the-triumph-trial.html 2020-11-19T18:18:10.4520000Z https://www.medicinesresources.nhs.uk/psoriasis-flares-following-systemic-glucocorticoid-exposure-in-patients-with-a-history-of-psoriasis.html 2020-11-19T21:54:08.3660000Z https://www.medicinesresources.nhs.uk/first-line-drug-treatment-for-hypertension-and-reductions-in-blood-pressure-according-to-age-and-ethnicity-cohort-study-in-uk-primary-care.html 2020-11-19T18:16:41.4010000Z https://www.medicinesresources.nhs.uk/association-between-mental-illness-and-covid-19-susceptibility-and-clinical-outcomes-in-south-korea-a-nationwide-cohort-study.html 2020-11-19T18:15:08.7040000Z https://www.medicinesresources.nhs.uk/omeros-completes-rolling-submission-of-biologics-license-application-bla-to-fda-for-narsoplimab-for-treatment-of-hematopoietic-stem-cell-transplant-associated-thrombotic-microangiopathy-hsct-tma.html 2020-11-19T18:27:40.6320000Z https://www.medicinesresources.nhs.uk/revised-spcs-imnovid-pomalidomde-hard-capsules-1.html 2020-11-20T11:24:57.2250000Z https://www.medicinesresources.nhs.uk/revised-spc-ropilynz-xl-ropinirole-8-mg-prolonged-release-tablets.html 2020-11-20T11:26:05.2950000Z https://www.medicinesresources.nhs.uk/revised-spc-prolia-denosumab-60-mg-solution-for-injection-in-pre-filled-syringe.html 2020-11-20T11:27:11.5310000Z https://www.medicinesresources.nhs.uk/revised-spcs-shortec-oxycodone-hard-capsules.html 2020-11-20T11:30:15.6270000Z https://www.medicinesresources.nhs.uk/revised-spcs-setofilm-ondansetron-orodispersible-films.html 2020-11-20T11:32:50.4430000Z https://www.medicinesresources.nhs.uk/sars-cov-2-clinical-syndromes-and-predictors-of-disease-severity-in-hospitalized-children-and-youth.html 2020-11-20T11:34:03.3810000Z https://www.medicinesresources.nhs.uk/final-results-from-the-open-label-extension-of-the-phase-iii-help-study-of-lanadelumab-flyo-as-long-term-prophylaxis-in-patients-with-hereditary-angioedema.html 2020-11-20T11:35:12.1310000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-grants-lacutamab-priority-medicines-prime-designation-for-the-treatment-of-relapsed-or-refractory-sezary-syndrome.html 2020-11-20T11:36:05.4460000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-grants-brensocatib-priority-medicines-prime-designation-for-the-treatment-of-non-cystic-fibrosis-bronchiectasis-ncfbe.html 2020-11-20T11:37:01.5650000Z https://www.medicinesresources.nhs.uk/vixarelimab-granted-breakthrough-therapy-designation-in-the-us-for-the-treatment-of-pruritus-associated-with-prurigo-nodularis.html 2020-11-20T11:38:13.8360000Z https://www.medicinesresources.nhs.uk/us-fda-review-of-lisocabtagene-maraleucel-liso-cel-for-the-treatment-of-relapsed-or-refractory-large-b-cell-lymphoma-delayed.html 2020-11-20T11:39:16.9280000Z https://www.medicinesresources.nhs.uk/us-fda-rejects-sutimlimab-for-cold-agglutinin-disease-cad.html 2020-11-20T11:40:08.1850000Z https://www.medicinesresources.nhs.uk/positive-data-from-phase-iii-study-of-octreotide-capsules-mycapssa-r-for-the-maintenance-treatment-of-adults-with-acromegaly.html 2020-11-20T19:50:36.4120000Z https://www.medicinesresources.nhs.uk/positive-phase-ii-iii-trial-data-for-lenacapavir-in-the-treatment-of-adults-with-multidrug-resistant-hiv.html 2020-11-20T11:42:16.1860000Z https://www.medicinesresources.nhs.uk/fda-grants-emergency-use-authorisation-eua-to-combination-of-baricitinib-and-remdesivir-in-hospitalized-covid-19-patients.html 2020-11-20T11:44:08.1940000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-etranacogene-dezaparvove-for-patients-with-moderate-to-moderately-severe-haemophilia-b.html 2020-11-20T11:45:03.9160000Z https://www.medicinesresources.nhs.uk/european-commission-grants-zanidatamab-orphan-drug-designation-for-gastric-cancer.html 2020-11-20T11:46:17.3320000Z https://www.medicinesresources.nhs.uk/lumasiran-approved-in-the-eu-for-the-treatment-of-primary-hyperoxaluria-type-1-ph1-in-all-ages.html 2020-11-20T11:47:35.9160000Z https://www.medicinesresources.nhs.uk/positive-data-from-vibegron-long-term-extension-study-announced.html 2020-11-20T11:48:36.0320000Z https://www.medicinesresources.nhs.uk/us-fda-and-european-medicines-agency-accept-applications-for-high-strength-adalimumab-biosimilar-avt02.html 2020-11-20T11:49:52.4800000Z https://www.medicinesresources.nhs.uk/trehalose-granted-orphan-drug-designation-in-the-us-for-the-treatment-of-amyotrophic-lateral-sclerosis.html 2020-11-20T11:51:04.5980000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-reducing-the-risk-of-venous-thromboembolism-in-over-16s-with-covid-19-guidance-ng186-1.html 2020-11-22T10:44:26.1380000Z https://www.medicinesresources.nhs.uk/november-bnf-bnfc-newsletter.html 2020-11-22T10:49:39.1750000Z https://www.medicinesresources.nhs.uk/covid-19-response-oxygen-supply-and-fire-safety.html 2020-11-22T10:52:59.4170000Z https://www.medicinesresources.nhs.uk/mhra-creates-new-website-section-for-information-on-covid-19-vaccines.html 2020-11-20T15:26:56.7780000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-organises-public-meeting-on-covid-19-vaccines.html 2020-11-20T15:33:34.9760000Z https://www.medicinesresources.nhs.uk/draft-updated-venous-thromboembolic-diseases-quality-standard-out-for-consultation.html 2020-11-20T15:34:46.3680000Z https://www.medicinesresources.nhs.uk/nice-is-getting-ready-for-the-end-of-the-transition-period-after-brexit.html 2020-11-20T15:36:00.2150000Z https://www.medicinesresources.nhs.uk/researchers-report-that-critically-ill-patients-treated-with-tocilizumab-show-improved-outcomes.html 2020-11-20T15:37:23.7730000Z https://www.medicinesresources.nhs.uk/improving-care-for-heart-failure-with-reduced-ejection-fraction-hfref-a-potential-polypill-based-strategy.html 2020-11-20T15:38:27.5450000Z https://www.medicinesresources.nhs.uk/pfizer-to-submit-us-emergency-use-application-for-its-covid-19-vaccine.html 2020-11-20T15:40:23.7500000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-uk-20-november-2020.html 2020-11-20T15:41:53.7000000Z https://www.medicinesresources.nhs.uk/therapeutics-and-covid-19-living-guideline.html 2020-11-20T18:52:03.2620000Z https://www.medicinesresources.nhs.uk/association-of-v-blocker-use-with-survival-and-pulmonary-function-in-patients-with-chronic-obstructive-pulmonary-and-cardiovascular-disease-a-systematic-review-and-meta-analysis.html 2020-11-20T16:54:14.6670000Z https://www.medicinesresources.nhs.uk/adverse-effects-of-non-steroidal-anti-inflammatory-drugs-in-patients-with-viral-respiratory-infections-rapid-systematic-review.html 2020-11-20T16:55:30.7910000Z https://www.medicinesresources.nhs.uk/early-neuromuscular-blocking-agents-for-adults-with-acute-respiratory-distress-syndrome-a-systematic-review-meta-analysis-and-meta-regression.html 2020-11-20T16:56:27.4910000Z https://www.medicinesresources.nhs.uk/etanercept-or-methotrexate-withdrawal-in-rheumatoid-arthritis-patients-in-sustained-remission-on-combination-therapy-a-randomized-double-blind-trial.html 2020-11-20T16:57:35.8670000Z https://www.medicinesresources.nhs.uk/modifiable-and-non-modifiable-risk-factors-for-covid-19-and-comparison-to-risk-factors-for-influenza-and-pneumonia-results-from-a-uk-biobank-prospective-cohort-study.html 2020-11-20T16:58:50.5830000Z https://www.medicinesresources.nhs.uk/antibodies-to-sars-cov-2-are-associated-with-protection-against-reinfection.html 2020-11-20T18:48:22.7320000Z https://www.medicinesresources.nhs.uk/free-flu-vaccinations-rolled-out-to-over-50s-from-december.html 2020-11-20T17:00:46.7190000Z https://www.medicinesresources.nhs.uk/homecare-workers-to-be-tested-weekly-for-covid-19.html 2020-11-20T17:01:47.8560000Z https://www.medicinesresources.nhs.uk/expanded-study-tests-immune-response-of-care-home-staff-and-residents.html 2020-11-20T17:02:48.6960000Z https://www.medicinesresources.nhs.uk/statement-on-the-childhood-flu-programme-the-alternative-offer-to-live-attenuated-influenza-vaccine-laiv.html 2020-11-20T17:04:30.8150000Z https://www.medicinesresources.nhs.uk/national-diabetes-audit-non-diabetic-hyperglycaemia-2019-2020-diabetes-prevention-programme-data-release.html 2020-11-20T17:06:03.7200000Z https://www.medicinesresources.nhs.uk/revised-spc-deltyba-delamanid-50-mg-film-coated-tablets.html 2020-11-23T12:18:00.6800000Z https://www.medicinesresources.nhs.uk/revised-spc-cerazette-desogestrel-75-microgram-film-coated-tablet-1.html 2020-11-23T12:19:04.7960000Z https://www.medicinesresources.nhs.uk/revised-spc-fycompa-perampanel-all-presentations.html 2020-11-23T12:20:06.9850000Z https://www.medicinesresources.nhs.uk/indirect-comparison-between-immunotherapy-alone-and-immunotherapy-plus-chemotherapy-as-first-line-treatment-for-advanced-non-small-cell-lung-cancer-a-systematic-review.html 2020-11-23T12:21:18.4890000Z https://www.medicinesresources.nhs.uk/analysis-of-measles-mumps-rubella-mmr-titers-of-recovered-covid-19-patients.html 2020-11-23T12:24:00.9550000Z https://www.medicinesresources.nhs.uk/concurrent-use-of-opioids-and-benzodiazepines-z-drugs-in-alberta-canada-and-the-risk-of-hospitalisation-and-death-a-case-cross-over-study.html 2020-11-23T12:25:01.5970000Z https://www.medicinesresources.nhs.uk/influence-of-allopurinol-on-thiopurine-associated-toxicity-a-retrospective-population-based-cohort-study.html 2020-11-23T12:26:37.5800000Z https://www.medicinesresources.nhs.uk/impact-of-spironolactone-exposure-on-prostate-cancer-incidence-amongst-men-with-heart-failure-a-pharmacoepidemiological-study.html 2020-11-23T12:28:06.4860000Z https://www.medicinesresources.nhs.uk/conference-data-phase-iii-orient-rct-of-sintilimab-plus-bevacizumab-as-first-line-treatment-in-advanced-hepatocellular-carcinoma.html 2020-11-23T12:29:09.0550000Z https://www.medicinesresources.nhs.uk/fda-issues-emergency-use-authorization-eua-for-casirivimab-and-imdevimab-combination-for-treatment-of-mild-to-moderate-covid-19-in-adults-and-children.html 2020-11-23T12:30:29.0960000Z https://www.medicinesresources.nhs.uk/world-health-organization-who-recommends-against-using-remdesivir-as-a-treatment-for-covid-19.html 2020-11-23T12:31:45.4240000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-lonafarib-for-hutchinson-gilford-progeria-syndrome-and-processing-deficient-progeroid-laminopathies.html 2020-11-23T12:33:13.5450000Z https://www.medicinesresources.nhs.uk/ethical-and-scientific-considerations-regarding-the-early-approval-and-deployment-of-a-covid-19-vaccine.html 2020-11-23T12:34:22.6490000Z https://www.medicinesresources.nhs.uk/oxford-university-breakthrough-on-global-covid-19-vaccine.html 2020-11-23T12:39:15.7570000Z https://www.medicinesresources.nhs.uk/covid-19-what-now-for-remdesivir.html 2020-11-23T14:59:25.5800000Z https://www.medicinesresources.nhs.uk/update-to-living-who-guideline-on-drugs-for-covid-19.html 2020-11-27T10:54:46.4100000Z https://www.medicinesresources.nhs.uk/2020-aha-acc-guideline-for-the-diagnosis-and-treatment-of-patients-with-hypertrophic-cardiomyopathy.html 2020-11-23T12:43:04.0140000Z https://www.medicinesresources.nhs.uk/weight-loss-through-lifestyle-changes-impact-in-the-primary-prevention-of-cardiovascular-diseases.html 2020-11-23T15:17:51.2190000Z https://www.medicinesresources.nhs.uk/older-adults-and-the-mental-health-effects-of-covid-19.html 2020-11-23T15:19:35.3890000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-deployment-strategy-and-operational-readiness.html 2020-11-27T09:04:41.3580000Z https://www.medicinesresources.nhs.uk/state-of-ageing-in-2020.html 2020-11-23T15:22:04.4370000Z https://www.medicinesresources.nhs.uk/advances-in-the-diagnosis-and-management-of-gastroesophageal-reflux-disease.html 2020-11-23T15:23:08.2560000Z https://www.medicinesresources.nhs.uk/how-to-optimise-duration-of-antibiotic-treatment-in-patients-with-sepsis.html 2020-11-23T15:24:18.4850000Z https://www.medicinesresources.nhs.uk/the-use-of-therapeutic-dose-anticoagulation-and-its-effect-on-mortality-in-patients-with-covid-19-a-systematic-review-1.html 2020-11-24T16:38:37.5680000Z https://www.medicinesresources.nhs.uk/covid-19-what-do-we-know-about-the-late-stage-vaccine-candidates.html 2020-11-27T09:16:03.2430000Z https://www.medicinesresources.nhs.uk/the-rural-dispensing-practice-better-medication-adherence-and-clinical-outcomes-compared-to-non-dispensing-practices-a-cross-sectional-analysis-of-routine-data.html 2020-11-24T15:56:36.4280000Z https://www.medicinesresources.nhs.uk/randomized-double-blind-clinical-trial-comparing-ultra-rapid-lispro-with-lispro-in-a-basal-bolus-regimen-in-patients-with-type-2-diabetes-pronto-t2d-1.html 2020-11-24T16:41:58.5630000Z https://www.medicinesresources.nhs.uk/fda-expands-approval-of-uncomplicated-influenza-treatment-xofluza-baloxavir-marboxil-to-include-post-exposure-prevention.html 2020-11-24T16:43:16.7310000Z https://www.medicinesresources.nhs.uk/revised-spcs-kalydeco-ivacaftor-granules-in-sachet-all-strengths-1.html 2020-11-24T16:43:56.8000000Z https://www.medicinesresources.nhs.uk/revised-spcs-ovitrelle-choriogonadotropin-alfa-250-micrograms-0-5-ml-prefilled-syringe-or-pen.html 2020-11-24T16:44:13.6580000Z https://www.medicinesresources.nhs.uk/revised-spc-galzemic-galantamine-hydrobromide-4-mg-ml-oral-solution.html 2020-11-24T16:05:10.2340000Z https://www.medicinesresources.nhs.uk/revised-spc-opdivo-nivolumab-10-mg-ml-concentrate-for-solution-for-infusion-1.html 2020-11-24T16:44:42.5970000Z https://www.medicinesresources.nhs.uk/revised-spc-yervoy-ipilimumab-5-mg-ml-concentrate-for-solution-for-infusion.html 2020-11-24T16:44:58.8490000Z https://www.medicinesresources.nhs.uk/the-effect-of-green-mediterranean-diet-on-cardiometabolic-risk-a-randomised-controlled-trial.html 2020-11-24T17:22:23.2070000Z https://www.medicinesresources.nhs.uk/diagnosis-management-and-pathophysiology-of-arterial-and-venous-thrombosis-in-covid-19.html 2020-11-24T17:23:15.4110000Z https://www.medicinesresources.nhs.uk/safety-of-direct-oral-anticoagulant-exposure-during-pregnancy-a-retrospective-cohort-study.html 2020-11-24T17:23:42.0890000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-amantadine-modafinil-and-methylphenidate-for-fatigue-in-multiple-sclerosis-a-randomised-placebo-controlled-crossover-double-blind-trial.html 2020-11-24T17:24:35.6140000Z https://www.medicinesresources.nhs.uk/national-guidance-for-post-covid-syndrome-assessment-clinics.html 2020-11-27T09:17:37.0080000Z https://www.medicinesresources.nhs.uk/pharmacist-led-atrial-fibrillation-case-finding-programme-prevents-an-estimated-90-strokes.html 2020-11-24T17:25:20.3880000Z https://www.medicinesresources.nhs.uk/encorafenib-plus-cetuximab-for-previously-treated-braf-v600e-mutation-positive-metastatic-colorectal-cancer-final-appraisal-determination.html 2020-11-24T17:25:33.5960000Z https://www.medicinesresources.nhs.uk/hormonal-contraception-and-the-risk-of-severe-asthma-exacerbation-17-year-population-based-cohort-study.html 2020-11-24T17:25:53.5450000Z https://www.medicinesresources.nhs.uk/managing-uncertainty.html 2020-11-24T17:26:31.0450000Z https://www.medicinesresources.nhs.uk/spending-review-2020-priorities-for-the-nhs-social-care-and-the-nations-health.html 2020-11-24T16:52:15.0670000Z https://www.medicinesresources.nhs.uk/association-between-abo-and-rh-blood-groups-and-sars-cov-2-infection-or-severe-covid-19-illness.html 2020-11-24T17:27:44.7100000Z https://www.medicinesresources.nhs.uk/tebentafusp-demonstrates-superior-overall-survival-compared-to-investigators-choice-in-phase-3-clinical-trial-of-patients-with-previously-untreated-metastatic-uveal-melanoma.html 2020-11-24T17:28:15.3480000Z https://www.medicinesresources.nhs.uk/pembrolizumab-for-untreated-metastatic-or-unresectable-recurrent-head-and-neck-squamous-cell-carcinoma-guidance-ta661.html 2020-11-27T09:18:32.6330000Z https://www.medicinesresources.nhs.uk/darolutamide-with-androgen-deprivation-therapy-for-treating-hormone-relapsed-non-metastatic-prostate-cancer-guidance-ta660.html 2020-11-27T09:18:48.0340000Z https://www.medicinesresources.nhs.uk/revised-spc-ovestin-estriol-cream.html 2020-11-25T16:37:24.2430000Z https://www.medicinesresources.nhs.uk/nihr-alert-the-vanguard-programme-to-integrate-health-and-social-care-achieved-some-of-its-aims-but-took-time-to-show-an-effect.html 2020-11-25T16:40:58.2530000Z https://www.medicinesresources.nhs.uk/nihr-alert-managing-medication-older-people-and-their-families-need-support-to-deal-with-the-hidden-burden-of-medication.html 2020-11-25T16:42:21.2420000Z https://www.medicinesresources.nhs.uk/dtb-select-does-melatonin-prevent-postoperative-delirium.html 2020-11-27T09:19:23.2760000Z https://www.medicinesresources.nhs.uk/estimated-sars-cov-2-seroprevalence-in-the-us-as-of-september-2020.html 2020-11-25T16:46:24.4440000Z https://www.medicinesresources.nhs.uk/strategies-for-enhancing-the-initiation-of-cholesterol-lowering-medication-among-patients-at-high-cardiovascular-disease-risk-a-qualitative-descriptive-exploration-of-patient-and-general-practitioners-perspectives-on-a-facilitated-relay-intervention-in-alberta-canada.html 2020-11-25T16:48:12.0780000Z https://www.medicinesresources.nhs.uk/effect-of-nebulized-magnesium-vs-placebo-added-to-albuterol-on-hospitalization-among-children-with-refractory-acute-asthma-treated-in-the-emergency-department-a-randomized-clinical-trial.html 2020-11-25T16:50:15.2310000Z https://www.medicinesresources.nhs.uk/gp-perspectives-on-acne-management-in-primary-care-qualitative-interview-study.html 2020-11-25T17:04:17.8720000Z https://www.medicinesresources.nhs.uk/ketamine-for-the-treatment-of-prehospital-acute-pain-a-systematic-review-of-benefit-and-harm.html 2020-11-25T16:53:39.3620000Z https://www.medicinesresources.nhs.uk/improvement-of-signs-and-symptoms-of-nonradiographic-axial-spondyloarthritis-in-patients-treated-with-secukinumab-primary-results-of-a-randomized-placebo-controlled-phase-iii-study.html 2020-11-25T16:55:39.2910000Z https://www.medicinesresources.nhs.uk/a-randomized-trial-of-convalescent-plasma-in-covid-19-severe-pneumonia.html 2020-11-25T16:57:30.0100000Z https://www.medicinesresources.nhs.uk/a-cluster-randomized-trial-of-hydroxychloroquine-for-prevention-of-covid-19.html 2020-11-25T16:59:17.3170000Z https://www.medicinesresources.nhs.uk/interim-position-statement-tocilizumab-for-patients-admitted-to-icu-with-covid-19-pneumonia-adults.html 2020-11-27T09:19:48.2360000Z https://www.medicinesresources.nhs.uk/flash-glucose-monitoring-national-arrangements-for-funding-of-relevant-diabetes-patients-updated.html 2020-11-27T12:23:39.5880000Z https://www.medicinesresources.nhs.uk/fda-approves-new-fixed-dosing-regimen-for-durvalumab-in-non-small-cell-lung-cancer-and-bladder-cancer.html 2020-11-25T17:05:07.6640000Z https://www.medicinesresources.nhs.uk/reducing-healthcare-inequalities-and-enhancing-the-nhs.html 2020-11-25T17:10:54.1930000Z https://www.medicinesresources.nhs.uk/workforce-wellbeing-survey-2020.html 2020-11-25T17:12:30.7570000Z https://www.medicinesresources.nhs.uk/critical-care-services-in-the-english-nhs-1.html 2020-11-27T12:45:22.7890000Z https://www.medicinesresources.nhs.uk/flublok-quadrivalent-vaccine-patient-group-direction-template.html 2020-11-27T09:20:50.3300000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-results-for-us-expanded-access-use-of-aviptadil-in-patients-with-critical-covid-19-and-severe-comorbidity.html 2020-11-25T17:20:04.4090000Z https://www.medicinesresources.nhs.uk/nivolumab-approved-for-use-in-eu-as-second-line-treatment-for-unresectable-advanced-recurrent-or-metastatic-oesophageal-squamous-cell-carcinoma.html 2020-11-25T17:21:29.7040000Z https://www.medicinesresources.nhs.uk/manufacturer-reports-positive-secondary-endpoint-results-from-phase-3-sonics-study-of-levoketoconazole-for-cushings-syndrome.html 2020-11-25T17:22:58.7520000Z https://www.medicinesresources.nhs.uk/if-social-determinants-of-health-are-so-important-shouldnt-we-ask-patients-about-them.html 2020-11-25T17:24:16.7070000Z https://www.medicinesresources.nhs.uk/covid-19-misinformation-and-antimicrobial-resistance.html 2020-11-25T17:25:47.4940000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-programme-2020-21-outcome-of-general-practice-site-designation-process-and-next-steps.html 2020-11-27T09:21:16.5230000Z https://www.medicinesresources.nhs.uk/community-mental-health-survey-2020.html 2020-11-25T17:28:30.0340000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-abstral-200-microgram-sublingual-tablets.html 2020-11-25T17:30:58.6560000Z https://www.medicinesresources.nhs.uk/behavioral-counseling-interventions-to-promote-a-healthy-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-with-cardiovascular-risk-factors-us-preventive-services-task-force-recommendation-statement.html 2020-11-25T17:33:28.7510000Z https://www.medicinesresources.nhs.uk/herd-immunity-for-covid-19.html 2020-11-25T17:34:35.3440000Z https://www.medicinesresources.nhs.uk/the-supply-of-personal-protective-equipment-ppe-during-the-covid-19-pandemic.html 2020-11-25T17:35:57.2010000Z https://www.medicinesresources.nhs.uk/ccg-annual-assessment-2019-20.html 2020-11-25T17:38:59.1640000Z https://www.medicinesresources.nhs.uk/cvd-prevention-during-the-covid-19-pandemic-a-guide-for-primary-care.html 2020-11-27T09:58:40.9990000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-314-november-2020.html 2020-11-27T09:21:38.5000000Z https://www.medicinesresources.nhs.uk/revised-spcs-imnovid-pomalidomide-hard-capsules.html 2020-11-26T15:49:46.0300000Z https://www.medicinesresources.nhs.uk/revised-spcs-trulicity-dulaglutide-solution-for-injection-in-pre-filled-pen.html 2020-11-26T15:51:15.7160000Z https://www.medicinesresources.nhs.uk/revised-spcs-esbriet-pirfenidone-film-coated-tablets-and-hard-capsules.html 2020-11-26T15:53:56.2510000Z https://www.medicinesresources.nhs.uk/revised-spc-yellox-bromfenac-0-9-mg-ml-eye-drops-solution.html 2020-11-26T15:55:01.1530000Z https://www.medicinesresources.nhs.uk/revised-spc-duodopa-intestinal-gel.html 2020-11-26T15:56:20.7220000Z https://www.medicinesresources.nhs.uk/revised-spcs-lenvima-and-kisplyx-lenvatinib-hard-capsules.html 2020-11-26T15:57:30.2260000Z https://www.medicinesresources.nhs.uk/revised-spc-palladone-sr-hydromorphone-capsules.html 2020-11-26T15:58:35.9050000Z https://www.medicinesresources.nhs.uk/revised-spc-janumet-sitagliptin-metformin-50-mg-1000-mg-film-coated-tablets.html 2020-11-26T15:59:29.1780000Z https://www.medicinesresources.nhs.uk/nihr-alert-care-home-residents-on-multiple-medications-have-an-increased-risk-of-falling.html 2020-11-26T16:00:25.8190000Z https://www.medicinesresources.nhs.uk/nihr-alert-the-wheld-programme-for-people-with-dementia-helps-care-home-staff-deliver-person-centred-care.html 2020-11-26T16:01:24.9230000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-urgent-policy-statement-pharmacogenomic-testing-for-dpyd-polymorphisms-with-fluoropyrimidine-therapies.html 2020-11-27T09:22:01.1250000Z https://www.medicinesresources.nhs.uk/european-commission-approves-agreement-to-secure-80-million-doses-of-modernas-covid-19-vaccine-mrna-1273.html 2020-11-26T16:03:46.0730000Z https://www.medicinesresources.nhs.uk/us-fda-approves-danyelza-r-naxitamab-gqgk-for-use-in-combination-with-gm-csf-for-the-treatment-of-relapsed-or-refractory-high-risk-neuroblastoma.html 2020-11-26T16:04:54.6860000Z https://www.medicinesresources.nhs.uk/phase-ii-study-of-vibegron-in-women-with-abdominal-pain-due-to-irritable-bowel-syndrome-fails-to-meet-primary-endpoint.html 2020-11-26T16:05:55.9040000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-betahistine-8mg-and-16mg-tablets-kent-pharmaceuticals-limited.html 2020-11-26T16:07:03.0090000Z https://www.medicinesresources.nhs.uk/priadel-lithium-carbonate-will-remain-on-the-market-after-new-price-is-agreed-by-the-government.html 2020-11-27T09:23:20.3200000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-covid-19-vaccine-mhra-statement-confirming-data-received.html 2020-11-26T16:09:25.7930000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guidance-on-crizanlizumab-for-preventing-sickle-cell-crises-in-sickle-cell-disease-for-consultation.html 2020-11-26T16:10:55.2810000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-uk-26-november-2020.html 2020-11-26T16:11:59.5730000Z https://www.medicinesresources.nhs.uk/ibrutinibs-cardiotoxicity-an-opportunity-for-postmarketing-regulation.html 2020-11-26T16:13:01.6150000Z https://www.medicinesresources.nhs.uk/statistics-on-women-s-smoking-status-at-time-of-delivery-england-quarter-2-2020-21.html 2020-11-26T16:14:14.9090000Z https://www.medicinesresources.nhs.uk/statistics-on-nhs-stop-smoking-services-in-england-april-2020-to-june-2020.html 2020-11-26T16:15:15.8440000Z https://www.medicinesresources.nhs.uk/cardiovascular-disease-prevention-during-the-covid-19-pandemic.html 2020-11-26T16:16:34.7400000Z https://www.medicinesresources.nhs.uk/general-practice-asked-to-help-identify-potential-participants-for-study-evaluating-early-community-treatment-for-covid-19.html 2020-11-26T16:18:29.7990000Z https://www.medicinesresources.nhs.uk/eahp-position-paper-on-pharmacy-preparations-and-compounding.html 2020-11-26T16:20:08.2550000Z https://www.medicinesresources.nhs.uk/guselkumab-approved-in-the-eu-for-the-treatment-of-active-psoriatic-arthritis.html 2020-11-26T16:21:46.8730000Z https://www.medicinesresources.nhs.uk/gsk-launches-phase-iii-study-of-respiratory-syncytial-virus-rsv-vaccine-in-pregnant-mothers.html 2020-11-26T16:23:05.9500000Z https://www.medicinesresources.nhs.uk/substance-misuse-treatment-for-adults-statistics-2019-to-2020.html 2020-11-26T16:24:14.7940000Z https://www.medicinesresources.nhs.uk/improving-flow-along-care-pathways.html 2020-11-26T16:25:33.1710000Z https://www.medicinesresources.nhs.uk/the-impact-of-extensive-care-service-and-enhanced-primary-care-in-fylde-coast.html 2020-11-26T16:26:30.0770000Z https://www.medicinesresources.nhs.uk/treatment-interventions-to-maintain-abstinence-from-alcohol-in-primary-care-systematic-review-and-network-meta-analysis.html 2020-11-26T18:34:36.9490000Z https://www.medicinesresources.nhs.uk/sequential-combination-of-pharmacotherapy-and-psychotherapy-in-major-depressive-disorder-a-systematic-review-and-meta-analysis.html 2020-11-26T16:52:13.1230000Z https://www.medicinesresources.nhs.uk/association-between-neuraxial-anaesthesia-or-general-anaesthesia-for-lower-limb-revascularisation-surgery-in-adults-and-clinical-outcomes-population-based-comparative-effectiveness-study.html 2020-11-26T16:54:21.1610000Z https://www.medicinesresources.nhs.uk/gestational-age-and-hospital-admissions-during-childhood-population-based-record-linkage-study-in-england-tigar-study.html 2020-11-26T16:55:22.3640000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-prednisone-versus-placebo-in-short-term-prevention-of-episodic-cluster-headache-a-multicentre-double-blind-randomised-controlled-trial.html 2020-11-26T16:56:57.3670000Z https://www.medicinesresources.nhs.uk/remdesivir-a-pendulum-in-a-pandemic.html 2020-11-26T16:58:32.4240000Z https://www.medicinesresources.nhs.uk/will-covid-19-vaccines-be-cost-effective-and-does-it-matter.html 2020-11-26T17:00:13.6720000Z https://www.medicinesresources.nhs.uk/nhs-will-get-gbp3bn-of-recovery-funding-to-tackle-pandemic-fallout.html 2020-11-26T17:01:45.5930000Z https://www.medicinesresources.nhs.uk/open-consultation-home-use-of-both-pills-for-early-medical-abortion.html 2020-11-27T09:23:50.5820000Z https://www.medicinesresources.nhs.uk/revised-spc-fabrazyme-agalsidase-beta-5-mg-and-35-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-11-27T16:04:36.4170000Z https://www.medicinesresources.nhs.uk/revised-spc-dupixent-dupilumab-solution-for-injection-all-products.html 2020-11-27T16:06:26.5060000Z https://www.medicinesresources.nhs.uk/revised-spc-feldene-piroxicam-products.html 2020-11-27T18:03:33.4750000Z https://www.medicinesresources.nhs.uk/update-to-information-on-psychiatric-disorders-for-chloroquine-and-hydroxychloroquine.html 2020-11-27T16:09:42.5880000Z https://www.medicinesresources.nhs.uk/association-of-cyp2c19-and-cyp2d6-poor-and-intermediate-metabolizer-status-with-antidepressant-and-antipsychotic-exposure-a-systematic-review-and-meta-analysis.html 2020-11-27T16:11:00.6930000Z https://www.medicinesresources.nhs.uk/are-financial-payments-from-the-pharmaceutical-industry-associated-with-physician-prescribing-a-systematic-review.html 2020-11-27T16:12:31.7110000Z https://www.medicinesresources.nhs.uk/what-are-the-considerations-when-crushing-tablets-or-opening-capsules-in-a-care-home-setting.html 2020-11-27T16:13:43.5900000Z https://www.medicinesresources.nhs.uk/dtb-select-safety-of-topical-and-oral-terbinafine-in-pregnancy.html 2020-11-27T16:15:15.3940000Z https://www.medicinesresources.nhs.uk/esketamine-for-treatment-resistant-depression.html 2020-11-27T16:16:48.8650000Z https://www.medicinesresources.nhs.uk/dtb-select-non-pharmacological-interventions-to-reduce-agitation-in-dementia.html 2020-11-27T16:18:34.6720000Z https://www.medicinesresources.nhs.uk/public-health-england-publishes-covid-19-vaccine-guidance-for-health-and-social-care-workers.html 2020-11-30T09:13:44.1460000Z https://www.medicinesresources.nhs.uk/rmoc-best-value-biologic-insulin-glargine-toolkit-consultation-running-until-24-12-2020.html 2020-11-27T16:48:24.3390000Z https://www.medicinesresources.nhs.uk/revealed-the-generic-price-hikes-increasing-the-nhs-drugs-bill.html 2020-11-27T17:52:50.2880000Z https://www.medicinesresources.nhs.uk/european-regulators-to-review-tepotinib-for-treatment-of-advanced-non-small-cell-lung-cancer-nsclc-in-adults-harbouring-mesenchymal-epithelial-transition-factor-gene-met-exon-14-metex14-skipping-alterations.html 2020-11-27T16:50:13.5340000Z https://www.medicinesresources.nhs.uk/impact-of-covid-19-on-pharmacists-mental-health-and-wellbeing.html 2020-11-27T16:51:15.2460000Z https://www.medicinesresources.nhs.uk/the-place-for-remdesivir-in-covid-19-treatment.html 2020-11-27T16:52:07.6450000Z https://www.medicinesresources.nhs.uk/direct-oral-anticoagulants-evidence-and-unresolved-issues.html 2020-11-27T16:53:08.1740000Z https://www.medicinesresources.nhs.uk/joint-letter-supporting-pharmacy-professionals-and-teams-through-the-second-covid-19-wave.html 2020-11-30T09:15:38.0690000Z https://www.medicinesresources.nhs.uk/brexit-information-for-pharmacy-professionals-and-pharmacy-owners.html 2020-11-30T09:16:18.4810000Z https://www.medicinesresources.nhs.uk/hype-and-hope-of-bedtime-dosing-of-antihypertensives-better-to-sleep-on-it.html 2020-11-27T18:18:43.1560000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-aventis-pharma-limited-t-a-sanofi-largactil-50mg-2ml-solution-for-injection-el-20-a-56.html 2020-11-27T16:57:18.5280000Z https://www.medicinesresources.nhs.uk/designated-settings-for-covid-19-patients-leaving-hospital.html 2020-11-27T16:58:32.1610000Z https://www.medicinesresources.nhs.uk/drugs-for-chronic-pain.html 2020-11-27T16:59:38.3950000Z https://www.medicinesresources.nhs.uk/covid-19-what-sweden-taught-scandinavia-for-the-second-wave.html 2020-11-27T17:00:45.8910000Z https://www.medicinesresources.nhs.uk/material-to-support-appropriate-prescribing-of-hypnotics-and-anxiolytics-consultation.html 2020-11-27T17:02:02.5500000Z https://www.medicinesresources.nhs.uk/gout-drug-colchicine-to-be-tested-as-covid-19-treatment-in-uk-trial.html 2020-11-27T17:02:57.2920000Z https://www.medicinesresources.nhs.uk/blood-test-for-50-types-of-cancer-to-be-trialled-by-nhs.html 2020-11-27T17:03:51.7650000Z https://www.medicinesresources.nhs.uk/government-asks-mhra-to-evaluate-oxford-astrazeneca-covid-19-vaccine.html 2020-11-27T18:26:18.4070000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-to-biologics-license-application-for-loncastuximab-tesirine-for-treatment-of-relapsed-refractory-diffuse-large-b-cell-lymphoma.html 2020-11-27T17:06:30.5900000Z https://www.medicinesresources.nhs.uk/marketing-authorization-application-for-3-antigen-prophylactic-hepatitis-b-vaccine-submitted-to-european-medicines-agency.html 2020-11-27T17:07:45.6000000Z https://www.medicinesresources.nhs.uk/fda-accepts-supplemental-biologics-license-application-for-rilonacept-for-treatment-of-recurrent-pericarditis.html 2020-11-27T17:08:40.4880000Z https://www.medicinesresources.nhs.uk/oramed-initiates-phase-3-trial-of-oral-insulin.html 2020-11-27T17:09:36.8720000Z https://www.medicinesresources.nhs.uk/comparing-covid-19-vaccines-timelines-types-and-prices.html 2020-11-27T17:10:39.6420000Z https://www.medicinesresources.nhs.uk/european-commission-approves-licence-extension-for-symkevi-tezacaftor-ivacaftor-with-kalydeco-ivacaftor-for-treatment-of-cystic-fibrosis-in-patients-ages-6-years-and-older-with-specific-gene-mutations.html 2020-11-27T17:11:45.8560000Z https://www.medicinesresources.nhs.uk/home-based-narrowband-uvb-topical-corticosteroid-or-combination-for-children-and-adults-with-vitiligo-hi-light-vitiligo-three-arm-rct.html 2020-11-27T17:21:25.9970000Z https://www.medicinesresources.nhs.uk/major-bleeding-risk-associated-with-oral-anticoagulant-in-real-clinical-practice-a-multicentre-3-year-period-population-based-prospective-cohort-study.html 2020-11-27T17:22:45.7280000Z https://www.medicinesresources.nhs.uk/probability-of-success-and-timelines-for-the-development-of-vaccines-for-emerging-and-reemerged-viral-infectious-diseases.html 2020-11-27T18:10:20.9760000Z https://www.medicinesresources.nhs.uk/surviving-covid-19-after-hospital-discharge-symptom-functional-and-adverse-outcomes-of-home-health-recipients.html 2020-11-27T17:53:48.0980000Z https://www.medicinesresources.nhs.uk/infection-fatality-risk-for-sars-cov-2-in-community-dwelling-population-of-spain-nationwide-seroepidemiological-study.html 2020-11-27T17:54:15.1820000Z https://www.medicinesresources.nhs.uk/helping-parents-of-children-with-respiratory-infections-decide-when-to-seek-medical-help-an-appropriateness-study.html 2020-11-27T17:55:10.9880000Z https://www.medicinesresources.nhs.uk/the-impact-of-multimorbidity-on-health-care-costs-and-utilisation-a-systematic-review-of-the-uk-literature.html 2020-11-27T18:04:42.3250000Z https://www.medicinesresources.nhs.uk/effectiveness-of-a-multicomponent-pharmacist-intervention-at-hospital-discharge-for-drug-related-problems-a-cluster-randomised-cross-over-trial.html 2020-11-27T17:57:22.8050000Z https://www.medicinesresources.nhs.uk/potentially-inappropriate-medication-use-and-related-hospital-admissions-in-aged-care-residents-the-impact-of-dementia.html 2020-11-27T17:57:47.7900000Z https://www.medicinesresources.nhs.uk/susceptibility-to-covid-19-in-patients-treated-with-antimalarials-a-population-based-study-in-emilia-romagna-northern-italy.html 2020-11-27T17:58:57.9440000Z https://www.medicinesresources.nhs.uk/revised-spc-xagrid-anagrelide-0-5mg-hard-capsule.html 2020-11-30T15:30:41.3450000Z https://www.medicinesresources.nhs.uk/revised-spc-recarbrio-imipenem-cilastatin-relebactam-powder-for-solution-for-infusion.html 2020-11-30T15:31:59.7350000Z https://www.medicinesresources.nhs.uk/intravesical-nadofaragene-firadenovec-gene-therapy-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer-a-single-arm-open-label-repeat-dose-clinical-trial.html 2020-11-30T15:33:29.7300000Z https://www.medicinesresources.nhs.uk/the-effect-of-clinical-decision-making-for-initiation-of-systemic-anticancer-treatments-in-response-to-the-covid-19-pandemic-in-england-a-retrospective-analysis.html 2020-11-30T16:03:36.2930000Z https://www.medicinesresources.nhs.uk/react-1-study-of-coronavirus-transmission-november-2020-interim-results.html 2020-11-30T15:36:01.5540000Z https://www.medicinesresources.nhs.uk/fda-approval-of-setmelanotide-imcivree-for-chronic-weight-management-in-patients-with-obesity-due-to-pomc-pcsk1-or-lepr-deficiency.html 2020-11-30T16:05:01.0100000Z https://www.medicinesresources.nhs.uk/risk-assessment-of-therapeutic-agents-under-consideration-to-treat-covid-19-in-paediatric-patients-and-pregnant-women.html 2020-11-30T15:39:32.1820000Z https://www.medicinesresources.nhs.uk/uk-government-secures-additional-2-million-doses-of-moderna-covid-19-vaccine.html 2020-11-30T15:40:51.1370000Z https://www.medicinesresources.nhs.uk/at-risk-groups-to-receive-free-winter-supply-of-vitamin-d.html 2020-12-07T10:30:59.8450000Z https://www.medicinesresources.nhs.uk/improving-the-nations-health-the-future-of-the-public-health-system-in-england.html 2020-12-07T10:37:56.0700000Z https://www.medicinesresources.nhs.uk/european-approval-of-paediatric-license-extension-of-dupilumab-dupixent-for-severe-atopic-dermatitis.html 2020-11-30T15:45:02.0750000Z https://www.medicinesresources.nhs.uk/flu-vaccination-information-about-the-extended-programme.html 2020-11-30T16:13:20.0340000Z https://www.medicinesresources.nhs.uk/moderna-to-seek-u-s-and-eu-authorisation-for-its-covid-19-vaccine-following-final-results.html 2020-11-30T15:53:04.3260000Z https://www.medicinesresources.nhs.uk/urgent-preparing-for-community-pharmacy-to-contribute-to-a-potential-covid-19-vaccination-programme.html 2020-11-30T15:55:59.4320000Z https://www.medicinesresources.nhs.uk/vaccinating-the-uk-against-covid-19.html 2020-11-30T15:57:04.8630000Z https://www.medicinesresources.nhs.uk/efficacy-safety-and-tolerability-of-a-levonorgestrel-ethinyl-estradiol-transdermal-delivery-system-phase-3-clinical-trial-results.html 2020-12-01T17:33:32.5470000Z https://www.medicinesresources.nhs.uk/test-for-hiv-wherever-blood-is-taken-commission-recommends.html 2020-12-01T17:35:59.3910000Z https://www.medicinesresources.nhs.uk/influence-of-polypharmacy-on-patients-with-heart-failure-with-preserved-ejection-fraction-a-retrospective-analysis-on-adverse-outcomes-in-the-topcat-trial.html 2020-12-01T17:36:43.8250000Z https://www.medicinesresources.nhs.uk/inappropriate-prescriptions-of-direct-oral-anticoagulants-among-patients-with-atrial-fibrillation-in-general-practice-a-cross-sectional-analysis-of-the-french-cacao-cohort-study.html 2020-12-01T15:51:15.0390000Z https://www.medicinesresources.nhs.uk/orthopaedic-corticosteroid-injections-and-risk-of-acute-coronary-syndrome-a-cohort-study.html 2020-12-01T15:52:47.9710000Z https://www.medicinesresources.nhs.uk/national-patient-safety-alert-deterioration-due-to-rapid-offload-of-pleural-effusion-fluid-from-chest-drains.html 2020-12-01T17:37:22.5970000Z https://www.medicinesresources.nhs.uk/revised-spc-opdivo-nivolumab-10-mg-ml-concentrate-for-solution-for-infusion-2.html 2020-12-01T17:37:36.8530000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-starts-rolling-review-of-janssens-covid-19-vaccine-ad26-cov2-s.html 2020-12-07T10:20:54.5640000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-receives-application-for-conditional-marketing-authorisation-of-covid-19-mrna-vaccine-bnt162b2.html 2020-12-01T16:02:15.6220000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-receives-application-for-conditional-marketing-authorisation-of-moderna-covid-19-vaccine.html 2020-12-01T16:03:38.1840000Z https://www.medicinesresources.nhs.uk/possible-consequences-of-the-approval-of-a-disease-modifying-therapy-for-alzheimer-disease-ad.html 2020-12-01T17:12:37.7870000Z https://www.medicinesresources.nhs.uk/hospital-acquired-sars-cov-2-infection-lessons-for-public-health.html 2020-12-01T17:47:54.4630000Z https://www.medicinesresources.nhs.uk/effect-of-cannabidiol-and-d9-tetrahydrocannabinol-on-driving-performance-a-randomized-clinical-trial.html 2020-12-01T17:16:32.1180000Z https://www.medicinesresources.nhs.uk/the-case-for-an-hiv-cure-and-how-to-get-there.html 2020-12-01T17:19:13.9100000Z https://www.medicinesresources.nhs.uk/how-homeshare-schemes-can-help-nhs-deliver-improved-outcomes-for-older-people-1.html 2020-12-01T17:50:16.3480000Z https://www.medicinesresources.nhs.uk/guidance-on-additional-2020-21-winter-funding-for-post-discharge-support-for-mental-health-patients.html 2020-12-01T17:29:15.2650000Z https://www.medicinesresources.nhs.uk/community-testing-to-help-lift-restrictions-in-highest-tiers.html 2020-12-02T11:22:56.1780000Z https://www.medicinesresources.nhs.uk/revised-spc-tremfya-guselkumab-solution-for-injection-in-pre-filled-pen.html 2020-12-02T14:52:46.7550000Z https://www.medicinesresources.nhs.uk/update-alert-6-risks-and-impact-of-angiotensin-converting-enzyme-inhibitors-or-angiotensin-receptor-blockers-on-sars-cov-2-infection-in-adults.html 2020-12-02T14:53:42.1930000Z https://www.medicinesresources.nhs.uk/band-ligation-versus-sclerotherapy-for-primary-prophylaxis-of-oesophageal-variceal-bleeding-in-children-with-chronic-liver-disease-or-portal-vein-thrombosis.html 2020-12-02T14:55:13.9550000Z https://www.medicinesresources.nhs.uk/inotropic-agents-and-vasodilator-strategies-for-the-treatment-of-cardiogenic-shock-or-low-cardiac-output-syndrome.html 2020-12-02T14:56:18.7210000Z https://www.medicinesresources.nhs.uk/interventions-to-support-the-resilience-and-mental-health-of-frontline-health-and-social-care-professionals-during-and-after-a-disease-outbreak-epidemic-or-pandemic-a-mixed-methods-systematic-review.html 2020-12-02T14:57:23.3520000Z https://www.medicinesresources.nhs.uk/ivabradine-as-adjuvant-treatment-for-chronic-heart-failure.html 2020-12-02T14:58:38.2120000Z https://www.medicinesresources.nhs.uk/racial-and-ethnic-disparities-in-covid-19-related-infections-hospitalizations-and-deaths-a-systematic-review.html 2020-12-02T14:59:45.9650000Z https://www.medicinesresources.nhs.uk/antimicrobial-prescribing-cefiderocol-es1.html 2020-12-06T17:16:13.1890000Z https://www.medicinesresources.nhs.uk/bleeding-risk-with-rivaroxaban-compared-with-vitamin-k-antagonists-in-patients-aged-80-years-or-older-with-atrial-fibrillation.html 2020-12-02T15:02:04.5850000Z https://www.medicinesresources.nhs.uk/clinical-spectrum-of-coronavirus-disease-2019-in-iceland-population-based-cohort-study.html 2020-12-02T15:03:45.5290000Z https://www.medicinesresources.nhs.uk/post-lockdown-sars-cov-2-nucleic-acid-screening-in-nearly-ten-million-residents-of-wuhan-china.html 2020-12-02T15:07:17.8350000Z https://www.medicinesresources.nhs.uk/study-of-tofacitinib-in-refractory-dermatomyositis-stir-an-open-label-pilot-study-of-10-patients.html 2020-12-02T15:08:25.4350000Z https://www.medicinesresources.nhs.uk/inflammatory-myositis-in-cancer-patients-receiving-immune-checkpoint-inhibitors.html 2020-12-02T15:09:27.1710000Z https://www.medicinesresources.nhs.uk/glycemic-control-and-risk-of-cellulitis.html 2020-12-02T16:12:27.7620000Z https://www.medicinesresources.nhs.uk/phase-ii-randomized-trial-of-rituximab-plus-cyclophosphamide-followed-by-belimumab-for-the-treatment-of-lupus-nephritis.html 2020-12-02T16:13:29.2180000Z https://www.medicinesresources.nhs.uk/vaccine-effectiveness-of-live-attenuated-and-trivalent-inactivated-influenza-vaccination-in-2010-11-to-2015-16-the-sive-ii-record-linkage-study.html 2020-12-02T16:14:28.8160000Z https://www.medicinesresources.nhs.uk/active-conventional-treatment-and-three-different-biological-treatments-in-early-rheumatoid-arthritis-phase-iv-investigator-initiated-randomised-observer-blinded-clinical-trial.html 2020-12-02T16:15:17.0940000Z https://www.medicinesresources.nhs.uk/patient-prioritisation-for-hospital-pharmacy-services-current-approaches-in-the-uk.html 2020-12-02T16:16:17.2650000Z https://www.medicinesresources.nhs.uk/clinical-practice-guidelines-by-the-infectious-diseases-society-of-america-idsa-american-academy-of-neurology-aan-and-american-college-of-rheumatology-acr-2020-guidelines-for-the-prevention-diagnosis-and-treatment-of-lyme-disease.html 2020-12-02T16:17:20.9560000Z https://www.medicinesresources.nhs.uk/uk-authorises-pfizer-biontech-covid-19-vaccine.html 2020-12-06T17:19:57.6360000Z https://www.medicinesresources.nhs.uk/workplace-health-long-term-sickness-absence-and-capability-to-work-draft-quality-standard.html 2020-12-02T16:19:37.9080000Z https://www.medicinesresources.nhs.uk/clinical-guide-during-the-covid-19-pandemic-for-the-management-of-patients-with-musculoskeletal-and-rheumatic-conditions-who-are-using-corticosteroids.html 2020-12-06T17:21:20.2240000Z https://www.medicinesresources.nhs.uk/inactivated-influenza-vaccine-information-for-healthcare-practitioners-update.html 2020-12-06T17:24:13.3160000Z https://www.medicinesresources.nhs.uk/childhood-flu-programme-2020-2021-information-for-healthcare-practitioners-update.html 2020-12-06T17:26:10.7730000Z https://www.medicinesresources.nhs.uk/rps-calls-for-ban-on-promotional-deals-for-paracetamol.html 2020-12-02T16:24:10.9800000Z https://www.medicinesresources.nhs.uk/supporting-and-developing-community-end-of-life-care-during-the-covid-19-pandemic-an-example-of-collaborative-working.html 2020-12-02T16:26:31.3120000Z https://www.medicinesresources.nhs.uk/high-court-rules-children-are-highly-unlikely-to-be-able-to-consent-to-taking-puberty-blockers.html 2020-12-02T16:28:42.5450000Z https://www.medicinesresources.nhs.uk/treatment-variation-in-early-breast-cancer-in-the-uk.html 2020-12-02T16:29:34.1940000Z https://www.medicinesresources.nhs.uk/racing-to-immunity-journey-to-a-covid-19-vaccine-and-lessons-for-the-future.html 2020-12-02T16:31:14.3060000Z https://www.medicinesresources.nhs.uk/is-there-a-safe-and-effective-way-to-wean-patients-off-long-term-glucocorticoids.html 2020-12-02T16:32:23.0920000Z https://www.medicinesresources.nhs.uk/declarations-of-pharma-funding-are-still-not-transparent-enough.html 2020-12-02T16:33:08.3070000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-we-need-more-than-the-mum-test.html 2020-12-02T16:34:11.1010000Z https://www.medicinesresources.nhs.uk/hearing-loss-in-children-a-review.html 2020-12-02T16:35:09.3110000Z https://www.medicinesresources.nhs.uk/fragmented-health-systems-in-covid-19-rectifying-the-misalignment-between-global-health-security-and-universal-health-coverage.html 2020-12-02T16:36:29.5280000Z https://www.medicinesresources.nhs.uk/shedding-of-viable-sars-cov-2-after-immunosuppressive-therapy-for-cancer.html 2020-12-02T16:37:27.1610000Z https://www.medicinesresources.nhs.uk/association-of-use-of-a-meningococcus-group-b-vaccine-with-group-b-invasive-meningococcal-disease-among-children-in-portugal.html 2020-12-02T16:51:47.2180000Z https://www.medicinesresources.nhs.uk/fda-approve-pralsetinib-for-advanced-or-metastatic-ret-mutant-and-ret-fusion-positive-thyroid-cancer.html 2020-12-02T16:52:45.2270000Z https://www.medicinesresources.nhs.uk/rolling-submission-to-be-reviewed-by-fda-for-ublituximab-in-combination-with-umbralisib-for-chronic-lymphocytic-leukaemia-cll.html 2020-12-02T16:53:40.3860000Z https://www.medicinesresources.nhs.uk/policy-makers-must-act-on-incomplete-evidence-in-responding-to-covid-19.html 2020-12-02T16:55:05.4110000Z https://www.medicinesresources.nhs.uk/supply-disruption-alert-atracurium-besilate-solution-for-injection-vials-and-ampoules-all-strengths.html 2020-12-06T17:28:43.5580000Z https://www.medicinesresources.nhs.uk/revised-spc-tasigna-nilotinib-hard-capsules-all-strengths-1.html 2020-12-03T18:25:12.7630000Z https://www.medicinesresources.nhs.uk/revised-spc-lyrica-pregabalin-all-products.html 2020-12-06T16:51:56.6820000Z https://www.medicinesresources.nhs.uk/revised-spc-kanuma-sebelipase-alfa-2mg-ml-concentrate-solution-1.html 2020-12-03T18:23:57.2700000Z https://www.medicinesresources.nhs.uk/revised-spc-praluent-alirocumab-75-and-150-mg-solution-for-injection-in-pre-filled-pen.html 2020-12-03T18:22:27.3070000Z https://www.medicinesresources.nhs.uk/procurement-usability-and-adoption-of-smart-infusion-pumps.html 2020-12-06T16:57:38.0470000Z https://www.medicinesresources.nhs.uk/antiandrogen-or-estradiol-treatment-or-both-during-hormone-therapy-in-transitioning-transgender-women-1.html 2020-12-04T09:52:59.8000000Z https://www.medicinesresources.nhs.uk/iron-chelators-for-acute-stroke.html 2020-12-03T18:19:35.0070000Z https://www.medicinesresources.nhs.uk/peripheral-nerve-blocks-for-hip-fractures-in-adults.html 2020-12-03T18:19:10.2180000Z https://www.medicinesresources.nhs.uk/pneumococcal-conjugate-vaccines-for-preventing-acute-otitis-media-in-children.html 2020-12-03T18:18:45.3520000Z https://www.medicinesresources.nhs.uk/pembrolizumab-in-microsatellite-instability-high-advanced-colorectal-cancer.html 2020-12-03T18:18:11.8630000Z https://www.medicinesresources.nhs.uk/repurposed-antiviral-drugs-for-covid-19-interim-who-solidarity-trial-results.html 2020-12-06T17:01:05.0860000Z https://www.medicinesresources.nhs.uk/randomized-trial-replication-using-observational-data-for-comparative-effectiveness-of-secukinumab-and-ustekinumab-in-psoriasis-a-study-from-the-british-association-of-dermatologists-biologics-and-immunomodulators-register.html 2020-12-03T18:16:27.8930000Z https://www.medicinesresources.nhs.uk/red-meat-intake-and-risk-of-coronary-heart-disease-among-us-men-prospective-cohort-study.html 2020-12-03T18:16:03.5830000Z https://www.medicinesresources.nhs.uk/cancer-risk-in-individuals-with-major-birth-defects-large-nordic-population-based-case-control-study-among-children-adolescents-and-adults.html 2020-12-03T18:15:37.6940000Z https://www.medicinesresources.nhs.uk/long-term-clinical-outcomes-of-losartan-in-patients-with-marfan-syndrome-follow-up-of-the-multicentre-randomized-controlled-compare-trial.html 2020-12-03T18:15:11.0770000Z https://www.medicinesresources.nhs.uk/covid-19-severity-is-tripled-in-the-diabetes-community-a-prospective-analysis-of-the-pandemics-impact-in-type-1-and-type-2-diabetes.html 2020-12-03T18:14:36.8040000Z https://www.medicinesresources.nhs.uk/enhanced-service-specification-covid-19-vaccination-programme-2020-21.html 2020-12-06T17:03:57.7970000Z https://www.medicinesresources.nhs.uk/gender-identity-development-service-for-children-and-adolescent-service-specification-amendments.html 2020-12-03T18:13:26.7100000Z https://www.medicinesresources.nhs.uk/bts-clinical-statement-on-pulmonary-sarcoidosis.html 2020-12-03T18:12:55.3380000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-november-2020.html 2020-12-06T17:09:24.4930000Z https://www.medicinesresources.nhs.uk/chronic-pain-in-adults-2017.html 2020-12-03T18:12:03.2820000Z https://www.medicinesresources.nhs.uk/prescribed-medicines-review-report.html 2020-12-03T18:11:40.3160000Z https://www.medicinesresources.nhs.uk/a-astrazeneca-sells-rights-to-rosuvastatin-to-gruenenthal.html 2020-12-03T18:11:00.1160000Z https://www.medicinesresources.nhs.uk/drug-safety-research-unit-dsru-plans-post-authorisation-study-of-covid-19-vaccines-in-the-uk.html 2020-12-03T18:10:08.7510000Z https://www.medicinesresources.nhs.uk/rps-statement-on-the-role-of-pharmacists-in-the-covid-19-vaccination-programme.html 2020-12-03T18:09:46.3360000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-calls-on-government-to-discuss-proposals-to-allowing-pharmacists-to-make-minor-changes-to-prescription-when-medicine-is-out-of-stock.html 2020-12-03T18:09:06.1630000Z https://www.medicinesresources.nhs.uk/cytokine-storm.html 2020-12-03T18:08:41.7520000Z https://www.medicinesresources.nhs.uk/fda-approval-of-remdesivir-a-step-in-the-right-direction.html 2020-12-03T18:08:19.1270000Z https://www.medicinesresources.nhs.uk/placebo-controlled-trials-of-covid-19-vaccines-why-we-still-need-them.html 2020-12-03T18:07:57.1110000Z https://www.medicinesresources.nhs.uk/mims-table-on-sglt2-inhibitors-for-treatment-of-type-ii-diabetes.html 2020-12-03T18:07:31.9710000Z https://www.medicinesresources.nhs.uk/corticosteroids-for-covid-19-the-search-for-an-optimum-duration-of-therapy.html 2020-12-03T18:06:58.0710000Z https://www.medicinesresources.nhs.uk/antibiotic-prescribing-in-general-practice-during-covid-19.html 2020-12-03T18:06:31.4010000Z https://www.medicinesresources.nhs.uk/the-2020-report-of-the-lancet-countdown-on-health-and-climate-change-responding-to-converging-crises.html 2020-12-03T18:05:32.8610000Z https://www.medicinesresources.nhs.uk/better-care-fund-policy-statement-2020-to-2021.html 2020-12-03T18:05:05.2000000Z https://www.medicinesresources.nhs.uk/class-3-medicines-recall-lupin-healthcare-uk-limited-simvador-10mg-20mg-and-40mg-tablets-el-20-a-57.html 2020-12-03T18:04:36.1010000Z https://www.medicinesresources.nhs.uk/review-of-do-not-attempt-cardiopulmonary-resuscitation-decisions-during-the-covid-19-pandemic-interim-report.html 2020-12-03T17:53:53.5910000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-accepts-submission-of-marketing-authorization-for-neffytm-ars-1-epinephrine-nasal-spray-for-emergency-treatment-of-severe-allergic-reactions-including-anaphylaxis.html 2020-12-03T17:53:03.6970000Z https://www.medicinesresources.nhs.uk/positive-results-for-phase-ii-long-term-safety-study-evaluating-topical-roflumilast-cream-arq-151-as-potential-once-daily-topical-treatment-for-plaque-psoriasis.html 2020-12-03T17:52:13.9650000Z https://www.medicinesresources.nhs.uk/fda-grants-fast-track-designation-for-remestemcel-l-in-the-treatment-of-acute-respiratory-distress-syndrome-due-to-covid-19.html 2020-12-03T17:50:57.9800000Z https://www.medicinesresources.nhs.uk/obiltoxaximab-receives-marketing-authorization-from-european-commission-for-the-treatment-of-inhalation-anthrax.html 2020-12-03T17:49:49.2420000Z https://www.medicinesresources.nhs.uk/fda-approves-roche-covid-19-test-that-aims-to-test-vaccines-antibody-response.html 2020-12-03T17:48:54.9320000Z https://www.medicinesresources.nhs.uk/atlantis-phase-iii-study-evaluating-lurbinectedin-zepzelca-in-combination-with-doxorubicin-for-patients-with-small-cell-lung-cancer-fails-to-meet-primary-outcome.html 2020-12-03T17:48:19.3390000Z https://www.medicinesresources.nhs.uk/choosing-an-oral-liquid-medicine-for-children-position-statement-2020-2.html 2020-12-06T17:10:01.7410000Z https://www.medicinesresources.nhs.uk/implementing-point-of-care-d-dimer-tests-for-deep-vein-thrombosis-dvt.html 2020-12-03T17:46:57.9690000Z https://www.medicinesresources.nhs.uk/new-product-veraseal-human-fibrinogen-and-human-thrombin.html 2020-12-04T13:38:24.4940000Z https://www.medicinesresources.nhs.uk/revised-spcs-estradot-transdermal-patches.html 2020-12-04T13:39:24.1840000Z https://www.medicinesresources.nhs.uk/uterotonic-agents-for-first-line-treatment-of-postpartum-haemorrhage-a-network-meta-analysis.html 2020-12-04T13:40:11.6050000Z https://www.medicinesresources.nhs.uk/progestogens-or-progestogen-releasing-intrauterine-systems-for-uterine-fibroids-other-than-preoperative-medical-therapy.html 2020-12-04T13:41:02.2300000Z https://www.medicinesresources.nhs.uk/physical-interventions-to-interrupt-or-reduce-the-spread-of-respiratory-viruses.html 2020-12-04T13:42:18.9460000Z https://www.medicinesresources.nhs.uk/botulinum-toxin-type-a-therapy-for-blepharospasm.html 2020-12-04T13:43:54.3760000Z https://www.medicinesresources.nhs.uk/mediterranean-diet-and-risk-of-rheumatoid-arthritis-findings-from-the-french-e3n-epic-cohort-study.html 2020-12-04T17:48:26.7750000Z https://www.medicinesresources.nhs.uk/differences-in-risk-factors-for-anticoagulant-related-nephropathy-between-warfarin-and-direct-oral-anticoagulants-analysis-of-the-japanese-adverse-drug-event-report-database.html 2020-12-04T13:45:57.5870000Z https://www.medicinesresources.nhs.uk/nicotine-replacement-treatment-e-cigarettes-and-an-online-behavioural-intervention-to-reduce-relapse-in-recent-ex-smokers-a-multinational-four-arm-rct.html 2020-12-04T13:48:08.8440000Z https://www.medicinesresources.nhs.uk/irinotecan-liposomal-injection-onivyde-granted-fast-track-designation-in-the-us-for-the-treatment-of-small-cell-lung-cancer.html 2020-12-04T17:51:21.2810000Z https://www.medicinesresources.nhs.uk/application-seeking-approval-of-amivantamab-for-metastatic-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations-submitted-to-the-us-fda.html 2020-12-04T13:53:11.9210000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-grants-orphan-drug-designation-for-aspartylglucosaminuria-agu-gene-therapy.html 2020-12-04T13:54:06.4010000Z https://www.medicinesresources.nhs.uk/role-of-tdm-based-dose-adjustments-for-taxane-anticancer-drugs.html 2020-12-04T13:55:14.8490000Z https://www.medicinesresources.nhs.uk/vertical-integration-of-gp-practices-with-acute-hospitals-in-england-and-wales-rapid-evaluation-1.html 2020-12-04T17:53:05.2510000Z https://www.medicinesresources.nhs.uk/integrating-care-next-steps-to-building-strong-and-effective-integrated-care-systems-across-england.html 2020-12-04T17:55:03.4930000Z https://www.medicinesresources.nhs.uk/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19.html 2020-12-06T16:17:41.0580000Z https://www.medicinesresources.nhs.uk/fda-alerts-healthcare-professionals-about-the-risk-of-medication-errors-with-tranexamic-acid-injection-resulting-in-inadvertent-intrathecal-spinal-injection.html 2020-12-04T14:05:25.1950000Z https://www.medicinesresources.nhs.uk/accessing-government-secured-flu-vaccines-guidance-for-gps.html 2020-12-04T14:07:05.4300000Z https://www.medicinesresources.nhs.uk/managing-asthma-in-adolescents-and-adults-2020-asthma-guideline-update-from-the-national-asthma-education-and-prevention-program.html 2020-12-04T14:09:56.9570000Z https://www.medicinesresources.nhs.uk/government-to-add-covid-19-to-vaccine-damage-payments-scheme.html 2020-12-04T14:10:53.3830000Z https://www.medicinesresources.nhs.uk/durability-of-responses-after-sars-cov-2-mrna-1273-vaccination.html 2020-12-04T14:12:41.2410000Z https://www.medicinesresources.nhs.uk/how-england-will-end-new-cases-of-hiv-final-report-and-recommendations-1.html 2020-12-04T14:14:22.3540000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-programme-information-for-healthcare-practitioners.html 2020-12-06T16:24:01.6350000Z https://www.medicinesresources.nhs.uk/rapid-policy-statement-ruxolitinib-for-chronic-graft-versus-host-disease.html 2020-12-06T16:26:44.0540000Z https://www.medicinesresources.nhs.uk/rapid-policy-statement-ruxolitinib-for-acute-graft-versus-host-disease.html 2020-12-06T16:34:13.7630000Z https://www.medicinesresources.nhs.uk/nhs-chief-confirms-11-new-integrated-care-systems-serving-14-million-people.html 2020-12-04T14:19:45.9000000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-uk-4-december-2020.html 2020-12-04T14:20:39.3420000Z https://www.medicinesresources.nhs.uk/nihr-alert-rituximab-helps-cure-almost-all-children-with-non-hodgkins-lymphoma-1.html 2020-12-04T17:00:35.3260000Z https://www.medicinesresources.nhs.uk/nihr-alert-paramedics-value-a-structured-handover-of-care-for-patients-with-suspected-stroke.html 2020-12-04T17:42:31.1640000Z https://www.medicinesresources.nhs.uk/pembrolizumab-plus-chemotherapy-versus-placebo-plus-chemotherapy-for-previously-untreated-locally-recurrent-inoperable-or-metastatic-triple-negative-breast-cancer-keynote-355-a-randomised-placebo-controlled-double-blind-phase-3-clinical-trial.html 2020-12-04T17:05:53.6080000Z https://www.medicinesresources.nhs.uk/detecting-covid-19-infection-hotspots-in-england-using-large-scale-self-reported-data-from-a-mobile-application-a-prospective-observational-study.html 2020-12-04T17:19:27.6160000Z https://www.medicinesresources.nhs.uk/covid-19-public-health-measures-a-reduction-in-hospital-admissions-for-copd-exacerbations.html 2020-12-04T17:22:11.2300000Z https://www.medicinesresources.nhs.uk/patient-outcomes-after-hospitalisation-with-covid-19-and-implications-for-follow-up-results-from-a-prospective-uk-cohort.html 2020-12-04T17:23:11.7940000Z https://www.medicinesresources.nhs.uk/cognitive-decline-associated-with-anticholinergics-benzodiazepines-and-z-drugs-findings-from-the-irish-longitudinal-study-on-ageing-tilda.html 2020-12-04T17:25:00.6220000Z https://www.medicinesresources.nhs.uk/trends-in-polypharmacy-and-potentially-inappropriate-medication-pim-in-older-and-middle-aged-people-treated-for-diabetes.html 2020-12-04T17:26:59.1770000Z https://www.medicinesresources.nhs.uk/durability-of-triple-combination-therapy-versus-stepwise-addition-therapy-in-patients-with-new-onset-t2dm-3-year-follow-up-of-edict.html 2020-12-04T17:28:30.0210000Z https://www.medicinesresources.nhs.uk/efficacy-of-capecitabine-plus-irinotecan-vs-irinotecan-monotherapy-as-second-line-treatment-in-patients-with-advanced-gallbladder-cancer-a-multicenter-phase-2-randomized-clinical-trial-gb-select.html 2020-12-04T17:33:01.2940000Z https://www.medicinesresources.nhs.uk/new-medicines-newsletter-november-2020.html 2020-12-04T17:33:50.0860000Z https://www.medicinesresources.nhs.uk/epclusa-200-mg-50-mg-film-coated-tablets-sofosbuvir-velpatasvir-supply-of-irish-product.html 2020-12-04T17:39:04.6930000Z https://www.medicinesresources.nhs.uk/bipolar-disorders.html 2020-12-04T17:39:54.6060000Z https://www.medicinesresources.nhs.uk/revised-spc-humira-adalimumab-all-presentations.html 2020-12-07T12:59:46.8530000Z https://www.medicinesresources.nhs.uk/botulinum-toxin-type-a-therapy-for-hemifacial-spasm.html 2020-12-07T13:01:33.5960000Z https://www.medicinesresources.nhs.uk/pioglitazone-for-prevention-or-delay-of-type-2-diabetes-mellitus-and-its-associated-complications-in-people-at-risk-for-the-development-of-type-2-diabetes-mellitus.html 2020-12-07T13:03:16.8620000Z https://www.medicinesresources.nhs.uk/salvage-systemic-therapy-for-advanced-gastric-and-oesophago-gastric-junction-adenocarcinoma.html 2020-12-07T13:05:02.0900000Z https://www.medicinesresources.nhs.uk/pre-and-postsurgical-medical-therapy-for-endometriosis-surgery.html 2020-12-07T13:06:44.7840000Z https://www.medicinesresources.nhs.uk/prostate-radiotherapy-with-adjuvant-androgen-deprivation-therapy-adt-improves-metastasis-free-survival-compared-to-neoadjuvant-adt-an-individual-patient-meta-analysis.html 2020-12-07T13:08:56.8580000Z https://www.medicinesresources.nhs.uk/persistent-symptoms-1-5-6-months-after-covid-19-in-non-hospitalised-subjects-a-population-based-cohort-study.html 2020-12-07T13:10:30.1490000Z https://www.medicinesresources.nhs.uk/a-prospective-study-of-12-week-respiratory-outcomes-in-covid-19-related-hospitalisations.html 2020-12-07T13:11:49.0370000Z https://www.medicinesresources.nhs.uk/association-between-statin-use-and-outcomes-in-patients-with-coronavirus-disease-2019-covid-19-a-nationwide-cohort-study.html 2020-12-07T16:06:50.9660000Z https://www.medicinesresources.nhs.uk/impact-of-guidance-publication-on-primary-care-prescribing-rates-of-simple-analgesia-an-interrupted-time-series-analysis-in-england.html 2020-12-07T13:15:52.2920000Z https://www.medicinesresources.nhs.uk/trends-in-diabetes-medication-use-in-canada-england-scotland-and-australia-a-repeated-cross-sectional-analysis-2012-2017.html 2020-12-07T13:17:04.8360000Z https://www.medicinesresources.nhs.uk/factors-predicting-statin-prescribing-for-primary-prevention-an-historical-cohort-study.html 2020-12-07T13:19:11.0850000Z https://www.medicinesresources.nhs.uk/effect-of-high-dose-trivalent-vs-standard-dose-quadrivalent-influenza-vaccine-on-mortality-or-cardiopulmonary-hospitalization-in-patients-with-high-risk-cardiovascular-disease-a-randomized-clinical-trial.html 2020-12-07T13:21:37.2400000Z https://www.medicinesresources.nhs.uk/american-college-of-rheumatology-guidance-for-the-management-of-rheumatic-disease-in-adult-patients-during-the-covid-19-pandemic-version-3.html 2020-12-07T13:22:55.7120000Z https://www.medicinesresources.nhs.uk/letter-from-the-uk-chief-medical-officers-winter-vaccines-and-research.html 2020-12-10T09:42:36.0310000Z https://www.medicinesresources.nhs.uk/over-half-a-million-people-taking-part-in-pioneering-covid-19-research.html 2020-12-07T13:25:52.1700000Z https://www.medicinesresources.nhs.uk/covid-19-vaccinations-and-care-homes-programme-launch.html 2020-12-10T09:40:40.9670000Z https://www.medicinesresources.nhs.uk/lancet-seminar-iron-deficiency.html 2020-12-07T16:14:22.8930000Z https://www.medicinesresources.nhs.uk/enhancing-anti-tumour-efficacy-with-immunotherapy-combinations.html 2020-12-07T16:22:26.8190000Z https://www.medicinesresources.nhs.uk/dabigatran-etexilate-for-the-treatment-of-acute-venous-thromboembolism-in-children-diversity-a-randomised-controlled-open-label-phase-2b-3-non-inferiority-trial.html 2020-12-07T16:24:27.0940000Z https://www.medicinesresources.nhs.uk/durvalumab-with-or-without-tremelimumab-plus-platinum-etoposide-versus-platinum-etoposide-alone-in-first-line-treatment-of-extensive-stage-small-cell-lung-cancer-caspian-updated-results-from-a-randomised-controlled-open-label-phase-3-trial.html 2020-12-07T16:18:16.0540000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-programme.html 2020-12-10T09:34:35.2580000Z https://www.medicinesresources.nhs.uk/why-breastfeeding-is-important-and-how-pharmacy-can-help.html 2020-12-10T09:29:54.6820000Z https://www.medicinesresources.nhs.uk/advising-on-medicines-regimens-during-breastfeeding.html 2020-12-10T09:27:44.4750000Z https://www.medicinesresources.nhs.uk/cancer-of-unknown-primary.html 2020-12-09T09:05:42.9640000Z https://www.medicinesresources.nhs.uk/interventions-for-basal-cell-carcinoma-of-the-skin.html 2020-12-09T09:04:46.4760000Z https://www.medicinesresources.nhs.uk/intravitreal-steroids-for-macular-edema-in-diabetes.html 2020-12-08T16:16:11.4560000Z https://www.medicinesresources.nhs.uk/adjunctive-systemic-antimicrobials-for-the-non-surgical-treatment-of-periodontitis.html 2020-12-08T16:17:24.7680000Z https://www.medicinesresources.nhs.uk/pharmacotherapies-for-sleep-disturbances-in-dementia.html 2020-12-08T16:18:48.6910000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-as-postexposure-prophylaxis-to-prevent-severe-acute-respiratory-syndrome-coronavirus-2-infection-a-randomized-trial.html 2020-12-08T16:20:10.3000000Z https://www.medicinesresources.nhs.uk/phase-3-pegasus-study-shows-substantial-haematological-response-in-patients-treated-with-investigational-targeted-c3-therapy-pegcetacoplan-for-paroxysmal-nocturnal-haemoglobinuria.html 2020-12-08T17:28:30.2570000Z https://www.medicinesresources.nhs.uk/company-announces-positive-results-from-phase-3-trial-of-investigational-thermosetting-bioadhesive-hydrogel-containing-clindamycin-phosphate-2-for-bacterial-vaginosis.html 2020-12-08T16:23:42.8210000Z https://www.medicinesresources.nhs.uk/company-announces-positive-results-from-phase-3-study-cyclobenzaprine-hydrochloride-sublingual-tablets-for-fibromyalgia.html 2020-12-08T16:24:50.3570000Z https://www.medicinesresources.nhs.uk/trends-in-acid-suppressant-drug-prescriptions-in-primary-care-in-the-uk-a-population-based-cross-sectional-study.html 2020-12-08T17:29:52.4090000Z https://www.medicinesresources.nhs.uk/hypophosphataemia-after-treatment-of-iron-deficiency-with-intravenous-ferric-carboxymaltose-or-iron-isomaltoside-a-systematic-review-and-meta-analysis.html 2020-12-08T17:30:07.8400000Z https://www.medicinesresources.nhs.uk/eltrombopag-as-first-line-treatment-for-thrombocytopenia-among-paediatric-patients-after-allogeneic-haematopoietic-stem-cell-transplantation.html 2020-12-08T16:28:31.5510000Z https://www.medicinesresources.nhs.uk/dtb-select-safety-of-oral-fluconazole-in-early-pregnancy.html 2020-12-10T09:14:28.4460000Z https://www.medicinesresources.nhs.uk/short-dual-antiplatelet-therapy-followed-by-p2y12-inhibitor-monotherapy-vs-prolonged-dual-antiplatelet-therapy-after-percutaneous-coronary-intervention-with-second-generation-drug-eluting-stents-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials.html 2020-12-08T16:31:13.9290000Z https://www.medicinesresources.nhs.uk/association-between-prehospital-tranexamic-acid-administration-and-outcomes-of-severe-traumatic-brain-injury.html 2020-12-08T17:33:35.3040000Z https://www.medicinesresources.nhs.uk/revised-spcs-vimpat-lacosamide-all-products.html 2020-12-08T16:57:07.1400000Z https://www.medicinesresources.nhs.uk/revised-spcs-olumiant-film-coated-tablets-all-strengths.html 2020-12-08T17:44:04.8350000Z https://www.medicinesresources.nhs.uk/revised-spcs-oruvail-ketoprofen-prolonged-release-hard-capsules-all-strengths.html 2020-12-10T09:09:39.7160000Z https://www.medicinesresources.nhs.uk/impact-of-ramadan-focused-diabetes-education-on-hypoglycaemia-risk-and-metabolic-control-for-patients-with-type-2-diabetes-mellitus-a-systematic-review.html 2020-12-08T17:22:35.1490000Z https://www.medicinesresources.nhs.uk/points-to-consider-for-the-treatment-of-immune-mediated-inflammatory-diseases-with-janus-kinase-inhibitors-jaki-a-consensus-statement.html 2020-12-08T17:31:44.0410000Z https://www.medicinesresources.nhs.uk/upadacitinib-for-treating-severe-rheumatoid-arthritis-guidance-ta665-1.html 2020-12-10T09:06:31.9210000Z https://www.medicinesresources.nhs.uk/liraglutide-for-managing-overweight-and-obesity-guidance-ta664.html 2020-12-10T09:05:12.6860000Z https://www.medicinesresources.nhs.uk/venetoclax-with-obinutuzumab-for-untreated-chronic-lymphocytic-leukaemia-guidance-ta663.html 2020-12-10T09:03:30.3390000Z https://www.medicinesresources.nhs.uk/revised-spc-actiq-fentanyl-lozenges.html 2020-12-10T09:00:18.8710000Z https://www.medicinesresources.nhs.uk/meta-analysis-of-safety-and-efficacy-of-direct-oral-anticoagulants-versus-warfarin-according-to-time-in-therapeutic-range-in-atrial-fibrillation.html 2020-12-10T08:56:07.9710000Z https://www.medicinesresources.nhs.uk/addressing-misconceptions-about-eczema-could-help-people-manage-their-condition-over-the-long-term.html 2020-12-09T15:39:35.9040000Z https://www.medicinesresources.nhs.uk/evoke-spinal-cord-stimulator-for-managing-chronic-neuropathic-or-ischaemic-pain-mib238.html 2020-12-09T15:41:01.8930000Z https://www.medicinesresources.nhs.uk/covid-19-symptoms-longitudinal-evolution-and-persistence-in-outpatient-settings.html 2020-12-09T15:44:46.4150000Z https://www.medicinesresources.nhs.uk/the-effects-of-four-doses-of-vitamin-d-supplements-on-falls-in-older-adults-a-response-adaptive-randomized-clinical-trial.html 2020-12-09T15:47:36.0900000Z https://www.medicinesresources.nhs.uk/sars-cov-2-infection-and-adverse-outcomes-in-users-of-ace-inhibitors-and-angiotensin-receptor-blockers-a-nationwide-case-control-and-cohort-analysis.html 2020-12-09T15:48:52.6440000Z https://www.medicinesresources.nhs.uk/dynamics-and-correlation-among-viral-positivity-seroconversion-and-disease-severity-in-covid-19-a-retrospective-study.html 2020-12-09T15:50:51.6290000Z https://www.medicinesresources.nhs.uk/lifetime-risks-life-expectancy-and-healthcare-expenditures-for-rheumatoid-arthritis-a-nationwide-cohort-followed-from-2003-to-2016.html 2020-12-09T15:53:55.3160000Z https://www.medicinesresources.nhs.uk/the-mental-health-impact-of-the-covid-19-pandemic-on-people-with-and-without-depressive-anxiety-or-obsessive-compulsive-disorders-a-longitudinal-study-of-three-dutch-case-control-cohorts.html 2020-12-09T15:55:21.0240000Z https://www.medicinesresources.nhs.uk/the-risk-of-cardiac-events-in-patients-receiving-immune-checkpoint-inhibitors-a-nationwide-danish-study.html 2020-12-09T15:57:22.3350000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-the-chadox1-ncov-19-vaccine-azd1222-against-sars-cov-2-an-interim-analysis-of-four-randomised-controlled-trials-in-brazil-south-africa-and-the-uk.html 2020-12-09T17:34:32.5880000Z https://www.medicinesresources.nhs.uk/association-between-low-density-lipoprotein-and-all-cause-and-cause-specific-mortality-in-denmark-prospective-cohort-study.html 2020-12-09T16:01:53.1390000Z https://www.medicinesresources.nhs.uk/effect-of-co-trimoxazole-trimethoprim-sulfamethoxazole-vs-placebo-on-death-lung-transplant-or-hospital-admission-in-patients-with-moderate-and-severe-idiopathic-pulmonary-fibrosis-the-eme-tipac-randomized-clinical-trial.html 2020-12-09T16:04:02.3430000Z https://www.medicinesresources.nhs.uk/risk-factors-for-emergency-department-revisit-in-elderly-patients-with-gastrointestinal-bleeding-secondary-to-anticoagulant-therapy.html 2020-12-09T16:39:31.3790000Z https://www.medicinesresources.nhs.uk/budesonide-orodispersible-tablets-maintain-remission-in-a-randomized-placebo-controlled-trial-of-patients-with-eosinophilic-esophagitis.html 2020-12-09T16:41:32.3560000Z https://www.medicinesresources.nhs.uk/development-and-validation-of-a-ready-to-use-score-to-prioritise-medication-reconciliation-at-patient-admission-in-an-orthopaedic-and-trauma-department.html 2020-12-09T17:35:52.2800000Z https://www.medicinesresources.nhs.uk/rheumatoid-arthritis-pathogenesis-prediction-and-prevention-an-emerging-paradigm-shift.html 2020-12-09T16:47:51.1730000Z https://www.medicinesresources.nhs.uk/mix-and-match-coronavirus-vaccines-to-be-tested.html 2020-12-09T16:49:10.5540000Z https://www.medicinesresources.nhs.uk/vaccinating-the-uk-how-the-covid-vaccine-was-approved-and-other-questions-answered.html 2020-12-10T08:35:29.0810000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-market-authorisation-applications-in-the-eu-and-us-for-once-daily-odevixibat-for-progressive-familial-intrahepatic-cholestasis.html 2020-12-09T16:52:07.9960000Z https://www.medicinesresources.nhs.uk/repotrectinib-granted-breakthrough-therapy-designation-in-the-us-for-ros1-positive-metastatic-non-small-cell-lung-cancer.html 2020-12-09T16:53:22.4640000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-c21-from-the-attract-clinical-study-in-patients-with-covid-19.html 2020-12-09T16:54:31.8130000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-asciminib-in-chronic-myeloid-leukemia-trial-vs-bosutinib.html 2020-12-09T16:55:46.0530000Z https://www.medicinesresources.nhs.uk/safety-profile-of-drugs-for-advanced-melanoma-a-report-based-on-2008-to-2018-united-states-food-and-drug-administration-data-1.html 2020-12-09T16:57:44.8470000Z https://www.medicinesresources.nhs.uk/joint-strategy-sets-direction-for-ema-and-eu-medicines-regulatory-agencies-to-2025.html 2020-12-09T16:58:53.3130000Z https://www.medicinesresources.nhs.uk/the-granting-of-emergency-use-designation-to-covid-19-candidate-vaccines-implications-for-covid-19-vaccine-trials.html 2020-12-09T17:00:04.9060000Z https://www.medicinesresources.nhs.uk/acalabrutinib-for-untreated-and-treated-chronic-lymphocytic-leukaemia-appraisal-consultation-document.html 2020-12-09T17:01:58.3050000Z https://www.medicinesresources.nhs.uk/short-course-radiotherapy-followed-by-chemotherapy-before-total-mesorectal-excision-tme-versus-preoperative-chemoradiotherapy-tme-and-optional-adjuvant-chemotherapy-in-locally-advanced-rectal-cancer-rapido-a-randomised-open-label-phase-3-trial.html 2020-12-09T17:39:02.4310000Z https://www.medicinesresources.nhs.uk/diabetes-and-covid-19-related-mortality-in-women-and-men-in-the-uk-biobank-comparisons-with-influenza-pneumonia-and-coronary-heart-disease.html 2020-12-09T17:08:16.4560000Z https://www.medicinesresources.nhs.uk/statistics-on-smoking-england-2020.html 2020-12-09T17:09:16.6380000Z https://www.medicinesresources.nhs.uk/legal-mechanisms-for-administration-of-the-covid-19-vaccine-s.html 2020-12-10T08:21:48.4180000Z https://www.medicinesresources.nhs.uk/pcn-sites-beginning-covid-19-vaccination-next-week-information-to-support-you-to-stand-up-your-vaccination-service.html 2020-12-10T08:19:11.7620000Z https://www.medicinesresources.nhs.uk/governance-handling-and-preparation-of-vaccines-by-gp-led-local-vaccination-centres-pcn-designated-sites.html 2020-12-10T08:16:40.6620000Z https://www.medicinesresources.nhs.uk/pfizers-20-valent-pneumococcal-vaccine-to-receive-fda-priority-review.html 2020-12-09T17:15:07.6110000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-axicabtagene-ciloleucel-car-t-therapy-for-first-line-treatment-for-high-risk-large-b-cell-lymphoma.html 2020-12-09T17:16:18.0040000Z https://www.medicinesresources.nhs.uk/fda-release-safety-data-for-pfizer-biontech-covid-19-vaccine.html 2020-12-09T17:41:36.0050000Z https://www.medicinesresources.nhs.uk/rmoc-london-palliative-and-end-of-life-care-maar-chart.html 2020-12-09T17:18:32.7460000Z https://www.medicinesresources.nhs.uk/pharmacy-institutional-readiness-for-management-of-pfizer-biontech-covid-19-vaccine-guidance-for-chief-pharmacists.html 2020-12-10T08:07:00.1140000Z https://www.medicinesresources.nhs.uk/bempedoic-acid-nilemdo-r-is-not-recommended-for-use-within-nhs-scotland-for-adults-with-primary-hypercholesterolaemia-or-mixed-dyslipidaemia-as-an-adjunct-to-diet.html 2020-12-09T17:43:09.7840000Z https://www.medicinesresources.nhs.uk/venetoclax-venclyxto-r-accepted-for-restricted-use-within-nhs-scotland-in-combination-with-obinutuzumab-for-treatment-of-adult-patients-with-previously-untreated-chronic-lymphocytic-leukaemia-cll.html 2020-12-09T17:44:00.7100000Z https://www.medicinesresources.nhs.uk/mexiletine-namuscla-r-accepted-for-use-within-nhs-scotland-for-symptomatic-treatment-of-myotonia-in-adult-patients-with-non-dystrophic-myotonic-disorders.html 2020-12-09T17:44:51.9890000Z https://www.medicinesresources.nhs.uk/mexiletine-namuscla-r-accepted-for-use-within-nhs-scotland-for-symptomatic-treatment-of-myotonia-in-adult-patients-with-non-dystrophic-myotonic-disorders-1.html 2020-12-10T11:34:20.9550000Z https://www.medicinesresources.nhs.uk/antimicrobial-prescribing-in-dentistry-good-practice-guidelines-3rd-edition-1.html 2020-12-11T08:28:03.5740000Z https://www.medicinesresources.nhs.uk/standard-operating-procedure-management-of-covid-19-vaccination-clinical-incidents-and-enquiries.html 2020-12-10T15:57:54.1130000Z https://www.medicinesresources.nhs.uk/zio-xt-for-detecting-cardiac-arrhythmias-medical-technologies-guidance-mtg52.html 2020-12-10T19:26:14.8460000Z https://www.medicinesresources.nhs.uk/new-product-solu-medrone-40-mg-powder-for-injection-new-formulation.html 2020-12-11T08:26:38.3750000Z https://www.medicinesresources.nhs.uk/new-product-biquelle-quetiapine-fumarate-xl-600mg-prolonged-release-tablets.html 2020-12-10T19:25:26.8760000Z https://www.medicinesresources.nhs.uk/revised-spc-quofenix-delafloxacin-meglumine-450-mg-tablets-and-300-mg-powder-for-concentrate-for-solution-for-infusion.html 2020-12-11T08:24:33.9540000Z https://www.medicinesresources.nhs.uk/natural-history-of-non-bullous-impetigo-a-systematic-review-of-time-to-resolution-or-improvement-without-antibiotic-treatment.html 2020-12-10T19:24:51.4040000Z https://www.medicinesresources.nhs.uk/prevalence-of-erectile-dysfunction-in-male-cancer-a-systematic-review-and-meta-analysis-of-cross-sectional-studies.html 2020-12-10T19:40:53.5370000Z https://www.medicinesresources.nhs.uk/association-between-conflicts-of-interest-and-favourable-recommendations-in-clinical-guidelines-advisory-committee-reports-opinion-pieces-and-narrative-reviews-systematic-review.html 2020-12-10T19:24:17.9090000Z https://www.medicinesresources.nhs.uk/medicine-misuse-a-systematic-review-and-proposed-hierarchical-terminology.html 2020-12-10T19:23:56.0150000Z https://www.medicinesresources.nhs.uk/ultra-long-acting-insulin-analogues-versus-nph-insulin-human-isophane-insulin-for-adults-with-type-2-diabetes-mellitus.html 2020-12-10T19:23:21.2660000Z https://www.medicinesresources.nhs.uk/alpha-blockers-after-shock-wave-lithotripsy-for-renal-or-ureteral-stones-in-adults.html 2020-12-10T19:23:01.9950000Z https://www.medicinesresources.nhs.uk/botulinum-toxin-type-a-therapy-for-cervical-dystonia.html 2020-12-10T19:22:41.2510000Z https://www.medicinesresources.nhs.uk/evinacumab-in-patients-with-refractory-hypercholesterolemia.html 2020-12-10T19:22:06.2920000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-the-bnt162b2-mrna-covid-19-vaccine.html 2020-12-11T08:13:53.3250000Z https://www.medicinesresources.nhs.uk/mortality-with-paclitaxel-coated-devices-in-peripheral-artery-disease.html 2020-12-10T19:20:29.2040000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-two-novel-type-2-oral-poliovirus-vaccine-candidates-compared-with-a-monovalent-type-2-oral-poliovirus-vaccine-in-children-and-infants-two-clinical-trials.html 2020-12-10T19:20:00.9410000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-two-novel-type-2-oral-poliovirus-vaccine-candidates-compared-with-a-monovalent-type-2-oral-poliovirus-vaccine-in-healthy-adults-two-clinical-trials.html 2020-12-10T19:19:09.8890000Z https://www.medicinesresources.nhs.uk/long-acting-cabotegravir-and-rilpivirine-dosed-every-2-months-in-adults-with-hiv-1-infection-atlas-2m-48-week-results-a-randomised-multicentre-open-label-phase-3b-non-inferiority-study.html 2020-12-10T19:17:21.2940000Z https://www.medicinesresources.nhs.uk/neurodevelopmental-outcomes-at-age-5-years-after-prophylactic-early-high-dose-recombinant-human-erythropoietin-for-neuroprotection-in-very-preterm-infants.html 2020-12-10T23:39:30.5440000Z https://www.medicinesresources.nhs.uk/mucocutaneous-manifestations-of-multisystem-inflammatory-syndrome-in-children-during-the-covid-19-pandemic.html 2020-12-10T19:15:27.5170000Z https://www.medicinesresources.nhs.uk/establishing-dose-bands-for-commonly-prescribed-oral-medications-for-children-in-the-uk-results-of-a-delphi-study.html 2020-12-11T08:02:47.8940000Z https://www.medicinesresources.nhs.uk/the-risk-of-cardiac-events-in-patients-receiving-immune-checkpoint-inhibitors-a-nationwide-danish-study-1.html 2020-12-10T19:13:20.3850000Z https://www.medicinesresources.nhs.uk/effect-of-internationally-imported-cases-on-internal-spread-of-covid-19-a-mathematical-modelling-study.html 2020-12-10T19:12:41.4460000Z https://www.medicinesresources.nhs.uk/trajectories-of-anxiety-and-depressive-symptoms-during-enforced-isolation-due-to-covid-19-in-england-a-longitudinal-observational-study.html 2020-12-10T19:11:57.0220000Z https://www.medicinesresources.nhs.uk/sars-cov-2-infection-and-transmission-in-educational-settings-a-prospective-cross-sectional-analysis-of-infection-clusters-and-outbreaks-in-england.html 2020-12-10T19:10:14.3530000Z https://www.medicinesresources.nhs.uk/characterisation-of-patients-with-severe-asthma-in-the-uk-severe-asthma-registry-in-the-biologic-era.html 2020-12-10T19:09:26.4000000Z https://www.medicinesresources.nhs.uk/astrazeneca-and-daiichi-sankyo-report-updated-results-from-phase-ii-trial-of-trastuzumab-deruxtecan-enhertu.html 2020-12-10T19:09:02.4420000Z https://www.medicinesresources.nhs.uk/fda-to-review-supplemental-new-drug-application-for-mepolizumab-for-treatment-of-nasal-polyps.html 2020-12-10T19:08:14.9020000Z https://www.medicinesresources.nhs.uk/eu-exit-medicines-supply-continuity-letter-from-dr-keith-ridge.html 2020-12-11T07:55:15.1710000Z https://www.medicinesresources.nhs.uk/spontaneous-coronary-artery-dissection.html 2020-12-10T19:06:56.7670000Z https://www.medicinesresources.nhs.uk/neonatal-infection-antibiotics-for-prevention-and-treatment.html 2020-12-10T19:06:40.6900000Z https://www.medicinesresources.nhs.uk/confirmation-of-guidance-to-vaccination-centres-on-managing-allergic-reactions-following-covid-19-vaccination-with-the-pfizer-biontech-vaccine.html 2020-12-11T07:48:49.0610000Z https://www.medicinesresources.nhs.uk/the-next-steps-towards-integrated-care.html 2020-12-10T19:05:09.7780000Z https://www.medicinesresources.nhs.uk/understanding-covid-19-outcomes-for-ethnic-minority-healthcare-workers.html 2020-12-10T19:31:59.3740000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-programme-key-information-for-pharmacy-professionals-and-pharmacy-owners.html 2020-12-10T19:04:23.0170000Z https://www.medicinesresources.nhs.uk/conflicts-of-interest-among-the-uk-governments-covid-19-advisers.html 2020-12-10T19:04:05.2900000Z https://www.medicinesresources.nhs.uk/incyte-announces-first-data-from-reach3-trial-showing-ruxolitinib-improved-outcomes-in-patients-with-steroid-refractory-or-steroid-dependent-chronic-graft-versus-host-disease-2.html 2020-12-10T19:03:49.6530000Z https://www.medicinesresources.nhs.uk/fda-approves-berotralstat-orladeyo-to-prevent-attacks-of-hereditary-angioedema.html 2020-12-10T19:03:10.8610000Z https://www.medicinesresources.nhs.uk/primary-analysis-of-zuma-5-trial-of-yescarta-axicabtagene-ciloleucel-shows-high-response-rates-in-indolent-non-hodgkin-lymphoma.html 2020-12-10T19:02:49.3680000Z https://www.medicinesresources.nhs.uk/conference-report-positive-data-presented-from-final-phase-ii-trial-of-trilaciclib-in-combination-with-chemotherapy-in-metastatic-triple-negative-breast-cancer.html 2020-12-10T19:02:09.8390000Z https://www.medicinesresources.nhs.uk/fda-grants-orphan-drug-designation-to-treprostinil-for-the-treatment-of-patients-with-idiopathic-pulmonary-fibrosis.html 2020-12-10T19:01:50.0050000Z https://www.medicinesresources.nhs.uk/athenex-presents-updated-phase-iii-data-on-survival-and-tolerability-associated-with-oral-paclitaxel-and-encequidar-in-patients-with-metastatic-breast-cancer.html 2020-12-10T19:29:29.5530000Z https://www.medicinesresources.nhs.uk/late-stage-trial-results-show-promise-for-tirzepatide-as-treatment-for-type-2-diabetes.html 2020-12-10T19:00:45.9970000Z https://www.medicinesresources.nhs.uk/abbvie-announces-phase-iii-induction-study-u-achieve-of-upadacitinib-in-moderate-to-severe-ulcerative-colitis-meets-primary-endpoint-of-clinical-remission-at-week-8.html 2020-12-10T19:00:03.8900000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-server-breach-leads-theft-of-pfizer-biontech-vaccine-data-by-hackers.html 2020-12-10T18:59:38.2350000Z https://www.medicinesresources.nhs.uk/national-diabetes-audit-care-processes-and-treatment-targets-2019-20-data-release.html 2020-12-10T18:59:15.5400000Z https://www.medicinesresources.nhs.uk/sexual-and-reproductive-health-services-england-contraception-2019-20.html 2020-12-10T18:58:12.9210000Z https://www.medicinesresources.nhs.uk/standard-operating-procedure-covid-19-local-vaccination-services-deployment-in-community-settings-1.html 2020-12-14T08:32:39.5090000Z https://www.medicinesresources.nhs.uk/revised-spcs-myalepta-metreleptin-powder-for-solution-for-injection-all-strengths.html 2020-12-14T08:30:32.9770000Z https://www.medicinesresources.nhs.uk/revised-spcs-zydol-xl-tramadol-prolonged-release-tablets.html 2020-12-11T16:29:08.0670000Z https://www.medicinesresources.nhs.uk/new-product-myopridin-pridinol.html 2020-12-11T16:30:04.6850000Z https://www.medicinesresources.nhs.uk/new-product-desizon-zonisamide-20-mg-ml-oral-suspension.html 2020-12-11T16:31:07.0140000Z https://www.medicinesresources.nhs.uk/new-product-ibrance-palbociclib-film-coated-tablets-various-strengths.html 2020-12-11T16:32:02.9310000Z https://www.medicinesresources.nhs.uk/revised-spc-dermovate-clobetasol-propionate-products.html 2020-12-11T16:33:15.2600000Z https://www.medicinesresources.nhs.uk/intravenous-versus-intramuscular-prophylactic-oxytocin-for-reducing-blood-loss-in-the-third-stage-of-labour.html 2020-12-11T16:34:18.8700000Z https://www.medicinesresources.nhs.uk/maintenance-agonist-treatments-for-opiate-dependent-pregnant-women.html 2020-12-11T16:36:06.7580000Z https://www.medicinesresources.nhs.uk/rufinamide-add-on-therapy-for-drug-resistant-epilepsy.html 2020-12-11T16:37:09.7980000Z https://www.medicinesresources.nhs.uk/influence-of-prior-comorbidities-and-chronic-medications-use-on-the-risk-of-covid-19-in-adults-a-population-based-cohort-study-in-tarragona-spain.html 2020-12-11T16:38:27.3390000Z https://www.medicinesresources.nhs.uk/evidence-for-ethnic-inequalities-in-mortality-related-to-covid-19-infections-findings-from-an-ecological-analysis-of-england.html 2020-12-11T16:39:37.1700000Z https://www.medicinesresources.nhs.uk/uk-chief-medical-officers-statement-on-the-self-isolation-period.html 2020-12-11T16:42:15.0260000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-ublituximab-in-relapsing-multiple-sclerosis.html 2020-12-11T16:43:14.5560000Z https://www.medicinesresources.nhs.uk/positive-48-week-results-from-pegasus-phase-iii-study-of-pegcetacoplan-in-paroxysmal-nocturnal-haemoglobinuria.html 2020-12-11T16:44:07.3100000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-for-review-new-drug-application-for-reltecimod-for-the-treatment-of-suspected-organ-dysfunction-or-failure-in-patients-with-necrotizing-soft-tissue-infection.html 2020-12-11T16:45:21.5570000Z https://www.medicinesresources.nhs.uk/first-participants-dosed-in-phase-2-3-study-of-modernas-covid-19-vaccine-candidate-in-adolescents.html 2020-12-11T16:46:20.5160000Z https://www.medicinesresources.nhs.uk/upadacitinib-superior-to-dupilumab-in-phase-iii-head-to-head-study-in-adults-with-atopic-dermatitis.html 2020-12-11T16:47:14.1310000Z https://www.medicinesresources.nhs.uk/media-and-tech-companies-join-forces-to-tackle-covid-19-vaccine-misinformation.html 2020-12-11T16:48:23.1740000Z https://www.medicinesresources.nhs.uk/scientific-rigor-in-the-age-of-covid-19.html 2020-12-11T16:49:18.4380000Z https://www.medicinesresources.nhs.uk/sanofi-and-gsk-announce-a-delay-in-their-adjuvanted-recombinant-protein-based-covid-19-vaccine-programme-to-improve-immune-response-in-the-elderly.html 2020-12-11T16:52:21.1540000Z https://www.medicinesresources.nhs.uk/inclisiran-approved-in-the-eu-for-the-treatment-of-adults-with-hypercholesterolemia-or-mixed-dyslipidaemia.html 2020-12-11T16:53:14.0980000Z https://www.medicinesresources.nhs.uk/the-governments-approach-to-test-and-trace-in-england-interim-report.html 2020-12-11T16:54:31.3240000Z https://www.medicinesresources.nhs.uk/more-hospitals-set-to-deliver-covid-19-vaccine.html 2020-12-11T16:55:51.9060000Z https://www.medicinesresources.nhs.uk/brigatinib-for-alk-positive-advanced-non-small-cell-lung-cancer-that-has-not-been-previously-treated-with-an-alk-inhibitor-final-appraisal-determination.html 2020-12-11T16:56:57.0220000Z https://www.medicinesresources.nhs.uk/covid-19-guidance-for-commissioners-and-providers-of-services-for-people-who-use-drugs-or-alcohol-updated.html 2020-12-11T16:57:56.9240000Z https://www.medicinesresources.nhs.uk/national-diet-and-nutrition-survey-ndns-results-from-years-9-to-11-2016-to-2017-and-2018-to-2019.html 2020-12-11T16:58:54.9190000Z https://www.medicinesresources.nhs.uk/people-with-long-term-health-conditions-urged-to-get-flu-vaccine-before-christmas.html 2020-12-11T16:59:49.0610000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-uk-11-december-2020.html 2020-12-11T17:01:22.9320000Z https://www.medicinesresources.nhs.uk/rural-remote-and-at-risk-why-rural-health-services-face-a-steep-climb-to-recovery-from-covid-19.html 2020-12-11T17:02:28.9800000Z https://www.medicinesresources.nhs.uk/ordering-pfizer-biontech-covid-19-vaccine-by-pcn-designated-sites.html 2020-12-14T08:16:45.0790000Z https://www.medicinesresources.nhs.uk/receiving-and-storing-the-pfizer-biontech-covid-19-vaccine-at-pcn-designated-sites.html 2020-12-14T08:17:15.4070000Z https://www.medicinesresources.nhs.uk/patient-group-direction-for-covid-19-mrna-vaccine-bnt162b2-pfizer-biontech.html 2020-12-14T08:13:57.3300000Z https://www.medicinesresources.nhs.uk/analyses-of-risk-racial-disparity-and-outcomes-among-us-patients-with-cancer-and-covid-19-infection.html 2020-12-11T17:10:32.4320000Z https://www.medicinesresources.nhs.uk/risk-of-cardiovascular-outcomes-in-type-2-diabetes-patients-following-addition-of-sglt2-inhibitors-versus-sulfonylureas-to-baseline-glp-ira-therapy.html 2020-12-11T17:20:07.1420000Z https://www.medicinesresources.nhs.uk/temporal-changes-in-secondary-prevention-and-cardiovascular-outcomes-after-revascularization-for-peripheral-arterial-disease-in-denmark-a-nationwide-cohort-study.html 2020-12-11T17:21:04.0780000Z https://www.medicinesresources.nhs.uk/effect-of-capecitabine-maintenance-therapy-using-lower-dosage-and-higher-frequency-vs-observation-on-disease-free-survival-among-patients-with-early-stage-triple-negative-breast-cancer-who-had-received-standard-treatment-the-sysucc-001-randomized-clinical-trial.html 2020-12-11T17:32:33.8350000Z https://www.medicinesresources.nhs.uk/evaluation-of-cloth-masks-and-modified-procedure-masks-as-personal-protective-equipment-for-the-public-during-the-covid-19-pandemic.html 2020-12-11T17:22:52.6690000Z https://www.medicinesresources.nhs.uk/effect-of-weekly-paclitaxel-with-or-without-bevacizumab-on-progression-free-rate-among-patients-with-relapsed-ovarian-sex-cord-stromal-tumors-the-alienor-engot-ov7-randomized-clinical-trial.html 2020-12-11T17:32:50.7940000Z https://www.medicinesresources.nhs.uk/effect-of-vocimagene-amiretrorepvec-in-combination-with-flucytosine-vs-standard-of-care-on-survival-following-tumor-resection-in-patients-with-recurrent-high-grade-gliomaa-randomized-clinical-trial.html 2020-12-11T17:33:17.9670000Z https://www.medicinesresources.nhs.uk/retinal-vascular-occlusions.html 2020-12-11T17:26:15.0640000Z https://www.medicinesresources.nhs.uk/primary-biliary-cholangitis.html 2020-12-11T17:27:19.0330000Z https://www.medicinesresources.nhs.uk/male-infertility.html 2020-12-11T17:33:36.2710000Z https://www.medicinesresources.nhs.uk/community-prevalence-of-sars-cov-2-in-england-from-april-to-november-2020-results-from-the-ons-coronavirus-infection-survey.html 2020-12-11T17:31:15.7960000Z https://www.medicinesresources.nhs.uk/systemic-therapy-and-sequencing-options-in-advanced-hepatocellular-carcinoma-a-systematic-review-and-network-meta-analysis-1.html 2020-12-14T12:56:10.2940000Z https://www.medicinesresources.nhs.uk/discontinuation-of-oral-anticoagulation-in-atrial-fibrillation-and-risk-of-ischaemic-stroke.html 2020-12-14T12:57:26.9190000Z https://www.medicinesresources.nhs.uk/fda-grants-emergency-use-authorisation-to-pfizer-biontech-covid-19-vaccine.html 2020-12-14T12:58:53.6170000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-hepatitis-b-surface-antigen-heplisav-b-for-immunisation-against-hepatitis-b-virus-infection.html 2020-12-14T13:00:01.2430000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-fedratinib-inrebic-for-treatment-of-primary-myelofibrosis-and-of-myelofibrosis-secondary-to-polycythaemia-vera-or-essential-thrombocythaemia.html 2020-12-14T13:01:14.7290000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-moxetumomab-pasudotox-lumoxiti-for-treatment-of-relapsed-or-refractory-hairy-cell-leukaemia.html 2020-12-14T13:02:25.1740000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-selpercatinib-retsevmo-for-treatment-of-ret-fusion-positive-non-small-cell-lung-cancer-ret-fusion-positive-thyroid-cancer-and-ret-mutant-medullary-thyroid-cancer.html 2020-12-14T13:03:40.0260000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-fostemsavir-rukobia-for-treatment-of-multidrug-resistant-hiv-1-infection.html 2020-12-14T13:04:40.5550000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-potassium-citrate-potassium-hydrogen-carbonate-sibnayal-for-treatment-of-distal-renal-tubular-acidosis.html 2020-12-14T13:05:46.1640000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-tucatinib-tukysa-for-treatment-of-her2-positive-locally-advanced-or-metastatic-breast-cancer.html 2020-12-14T13:06:43.1230000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-licence-extension-of-avelumab-bavencio.html 2020-12-14T13:08:03.3240000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-licence-extension-of-avatrombopag-doptelet.html 2020-12-14T13:09:14.1650000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-licence-extension-of-pembrolizumab-keytruda.html 2020-12-14T13:10:18.2060000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-licence-extension-of-romiplostim-nplate.html 2020-12-14T13:15:15.4400000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-licence-extension-of-methotrexate-nordimet.html 2020-12-14T13:16:31.6280000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-licence-extension-of-clopidogrel-plavix.html 2020-12-14T13:18:31.8190000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-licence-extension-of-upadacitinib-roinvoq.html 2020-12-14T13:19:47.6260000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-licence-extension-of-esketamine-spravato.html 2020-12-14T13:21:19.4530000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-licence-extension-of-remdesivir-veklury.html 2020-12-14T13:23:03.6070000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-trastuzumab-deruxtecan-enhertu-for-treatment-of-metastatic-her2-positive-breast-cancer.html 2020-12-14T13:23:56.4390000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-generic-sunitinib-sunitinib-accord.html 2020-12-14T13:24:59.2560000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-insulin-aspart-biosimilar-kixelle.html 2020-12-14T13:25:55.5600000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-generic-lenalidomide.html 2020-12-14T13:26:59.8410000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-glucagon-ogluo.html 2020-12-14T13:28:01.7630000Z https://www.medicinesresources.nhs.uk/phase-iii-ruxcovid-study-of-ruxolitinib-jakafi-r-as-a-treatment-for-covid-19-associated-cytokine-storm-fails-to-meet-primary-endpoint.html 2020-12-14T13:29:00.5620000Z https://www.medicinesresources.nhs.uk/bmj-editorial-lateral-flow-tests-cannot-rule-out-sars-cov-2-infection.html 2020-12-14T13:30:01.1700000Z https://www.medicinesresources.nhs.uk/coronavirus-disease-2019-in-adults-with-congenital-heart-disease-a-position-paper-from-the-esc-working-group-of-adult-congenital-heart-disease-and-the-international-society-for-adult-congenital-heart-disease.html 2020-12-14T13:31:50.1830000Z https://www.medicinesresources.nhs.uk/new-standards-for-initial-education-and-training-of-pharmacists-approved.html 2020-12-14T13:34:23.0290000Z https://www.medicinesresources.nhs.uk/an-eua-for-bamlanivimab-a-monoclonal-antibody-for-covid-19.html 2020-12-14T13:36:07.7110000Z https://www.medicinesresources.nhs.uk/hiv-infection-and-covid-19-death-a-population-based-cohort-analysis-of-uk-primary-care-data-and-linked-national-death-registrations-within-the-opensafely-platform.html 2020-12-14T15:13:25.1090000Z https://www.medicinesresources.nhs.uk/baricitinib-plus-remdesivir-for-hospitalized-adults-with-covid-19.html 2020-12-14T15:14:53.3890000Z https://www.medicinesresources.nhs.uk/central-alerting-system-class-4-drug-alert-perindopril-erbumine-2mg-4mg-8mg-tablets-pl-04569-1348-pl-04569-1349-pl-04569-1350-generics-uk-limited-t-a-mylan.html 2020-12-14T15:16:57.1010000Z https://www.medicinesresources.nhs.uk/gps-begin-offering-covid-vaccine-as-part-of-biggest-nhs-immunisation-programme.html 2020-12-14T15:18:13.8480000Z https://www.medicinesresources.nhs.uk/final-appraisal-document-erenumab-for-preventing-migraine.html 2020-12-14T15:19:55.7530000Z https://www.medicinesresources.nhs.uk/european-approval-of-trixeo-aerosphere-formoterol-glycopyrronium-bromide-budesonide-for-maintenance-treatment-of-copd.html 2020-12-14T15:20:53.4880000Z https://www.medicinesresources.nhs.uk/disposing-of-damaged-unused-or-expired-pfizer-biontech-covid-19-vaccine-at-pcn-designated-sites.html 2020-12-14T15:22:08.4420000Z https://www.medicinesresources.nhs.uk/dealing-with-spillages-and-breakages-of-pfizer-biontech-covid-19-vaccine-at-pcn-designated-sites.html 2020-12-14T15:27:21.1750000Z https://www.medicinesresources.nhs.uk/stocktaking-and-reconciliation-of-pfizer-biontech-covid-19-vaccine-at-pcn-designated-sites.html 2020-12-14T15:24:52.8370000Z https://www.medicinesresources.nhs.uk/facilitating-pharmaceutical-support-to-pcn-designated-sites-for-covid-19-vaccinations.html 2020-12-14T15:26:14.3660000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-covid-19-vaccine-summary-of-guidance-for-healthcare-professionals.html 2020-12-14T15:27:23.1670000Z https://www.medicinesresources.nhs.uk/new-product-symkevi-50-mg-75-mg-tezacaftor-ivacaftor-film-coated-tablets.html 2020-12-15T16:13:49.4820000Z https://www.medicinesresources.nhs.uk/revised-spc-symkevi-100-mg-tezacaftor-150-mg-ivacaftor-film-coated-tablets.html 2020-12-15T16:15:05.5760000Z https://www.medicinesresources.nhs.uk/revised-spc-luxturna-voretigene-neparvovec-concentrate-and-solvent-for-solution-for-injection.html 2020-12-15T16:16:09.9990000Z https://www.medicinesresources.nhs.uk/new-product-melatonin-3-and-5-mg-hard-capsules.html 2020-12-15T16:17:14.7150000Z https://www.medicinesresources.nhs.uk/revised-spc-tecfidera-dimethyl-fumarate-120-and-240-mg-gastro-resistant-hard-capsules.html 2020-12-15T16:18:17.2970000Z https://www.medicinesresources.nhs.uk/revised-spc-maxtrex-methotrexate-2-5-and-10-mg-tablets-1.html 2020-12-15T16:19:46.9060000Z https://www.medicinesresources.nhs.uk/nihr-alert-self-management-for-people-with-asthma-is-the-most-effective-model-of-care.html 2020-12-15T16:20:42.4910000Z https://www.medicinesresources.nhs.uk/nihr-alert-careful-phrasing-of-requests-by-hospital-staff-could-help-people-with-dementia-accept-care.html 2020-12-15T16:21:40.8840000Z https://www.medicinesresources.nhs.uk/public-health-england-investigating-a-novel-strain-of-covid-19.html 2020-12-15T16:22:38.9720000Z https://www.medicinesresources.nhs.uk/russian-direct-investment-fund-rdif-confirms-efficacy-of-over-90-for-sputnik-v-vaccine.html 2020-12-15T16:55:47.8270000Z https://www.medicinesresources.nhs.uk/open-orphan-and-codagenix-receive-approval-from-mhra-to-conduct-phase-i-study-of-intranasal-covid-19-vaccine-candidate-covi-vac.html 2020-12-15T16:24:38.1020000Z https://www.medicinesresources.nhs.uk/mps-call-for-more-government-support-for-pharmacies-in-appg-flash-inquiry-report.html 2020-12-15T17:07:26.4180000Z https://www.medicinesresources.nhs.uk/letter-additional-funds-to-support-winter-workforce-pressures.html 2020-12-15T16:26:28.1930000Z https://www.medicinesresources.nhs.uk/bempedoic-acid-for-treating-primary-hypercholesterolaemia-or-mixed-dyslipidaemia-appraisal-consultation-document.html 2020-12-15T16:27:20.7030000Z https://www.medicinesresources.nhs.uk/osteoarthritis-care-and-management-updated-guidance-cg177.html 2020-12-15T16:28:39.5520000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-perindopril-tablets-generics-uk-limited-t-a-mylan-el-20-a-58.html 2020-12-15T16:29:52.8630000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-co-careldopa-25mg-100mg-tablets-pl-20242-0028-el-20-a-59.html 2020-12-15T16:30:55.5930000Z https://www.medicinesresources.nhs.uk/mims-summary-of-bempedoic-acid-nilemdo-a-new-oral-treatment-option-for-patients-with-raised-cholesterol.html 2020-12-15T16:32:34.4910000Z https://www.medicinesresources.nhs.uk/defining-and-managing-covid-19-associated-pulmonary-aspergillosis-the-2020-ecmm-isham-consensus-criteria-for-research-and-clinical-guidance.html 2020-12-15T16:33:44.1080000Z https://www.medicinesresources.nhs.uk/behaviorally-informed-strategies-for-a-national-covid-19-vaccine-promotion-program.html 2020-12-15T17:15:48.2440000Z https://www.medicinesresources.nhs.uk/the-ethics-of-continuing-placebo-in-sars-cov-2-vaccine-trials.html 2020-12-15T16:37:33.3590000Z https://www.medicinesresources.nhs.uk/evaluating-sars-cov-2-vaccines-after-emergency-use-authorization-or-licensing-of-initial-candidate-vaccines.html 2020-12-15T16:39:01.1770000Z https://www.medicinesresources.nhs.uk/compounded-bioidentical-hormone-therapy-the-national-academies-weigh-in.html 2020-12-15T16:40:10.5600000Z https://www.medicinesresources.nhs.uk/react-1-study-of-coronavirus-transmission-november-2020-final-results.html 2020-12-15T16:41:18.2180000Z https://www.medicinesresources.nhs.uk/stroke-prevention-in-atrial-fibrillation-looking-forward.html 2020-12-15T16:42:55.9460000Z https://www.medicinesresources.nhs.uk/supply-disruption-alert-update-atracurium-besilate-solution-for-injection-vials-and-ampoules-all-strengths.html 2020-12-15T16:44:46.4040000Z https://www.medicinesresources.nhs.uk/covid-19-therapeutic-alert-azithromycin-in-the-management-of-covid-19-sars-cov-2-positive-patients.html 2020-12-15T16:45:46.9440000Z https://www.medicinesresources.nhs.uk/rethinking-christmas-a-three-point-plan-to-keep-families-and-communities-safe.html 2020-12-15T16:56:37.8890000Z https://www.medicinesresources.nhs.uk/build-back-fairer-the-covid-19-marmot-review.html 2020-12-15T16:49:25.6690000Z https://www.medicinesresources.nhs.uk/acceleron-receives-orphan-designation-from-european-commission-for-sotatercept-in-pulmonary-arterial-hypertension-pah.html 2020-12-15T16:51:06.3030000Z https://www.medicinesresources.nhs.uk/health-survey-for-england-2019.html 2020-12-15T16:52:35.6970000Z https://www.medicinesresources.nhs.uk/bleeding-with-apixaban-and-dalteparin-in-patients-with-cancer-associated-venous-thromboembolism-results-from-the-caravaggio-study.html 2020-12-15T16:55:27.8110000Z https://www.medicinesresources.nhs.uk/can-the-proper-intervention-reduce-psychotropic-drug-prescription-in-nursing-home-residents-with-dementia-results-of-a-cluster-randomized-controlled-trial.html 2020-12-15T16:59:42.8200000Z https://www.medicinesresources.nhs.uk/effect-of-therapeutic-suggestions-during-general-anaesthesia-on-postoperative-pain-and-opioid-use-multicentre-randomised-controlled-trial.html 2020-12-15T17:01:09.1170000Z https://www.medicinesresources.nhs.uk/cost-and-health-impacts-of-adherence-to-the-national-institute-for-health-and-care-excellence-schizophrenia-guideline-recommendations.html 2020-12-15T17:02:23.5520000Z https://www.medicinesresources.nhs.uk/potentially-inappropriate-prescribing-in-people-with-chronic-kidney-disease-cross-sectional-analysis-of-a-large-population-cohort-2.html 2020-12-15T20:22:32.7460000Z https://www.medicinesresources.nhs.uk/effectiveness-of-adjunctive-clindamycin-in-v-lactam-antibiotic-treated-patients-with-invasive-v-haemolytic-streptococcal-infections-in-us-hospitals-a-retrospective-multicentre-cohort-study.html 2020-12-15T17:05:47.1320000Z https://www.medicinesresources.nhs.uk/readmission-and-death-after-initial-hospital-discharge-among-patients-with-covid-19-in-a-large-multihospital-system.html 2020-12-15T17:06:56.5300000Z https://www.medicinesresources.nhs.uk/vegetarians-fish-poultry-and-meat-eaters-who-has-higher-risk-of-cardiovascular-disease-incidence-and-mortality-a-prospective-study-from-uk-biobank.html 2020-12-15T17:08:53.0760000Z https://www.medicinesresources.nhs.uk/covid-19-virus-is-mutating-but-so-far-slowly-1.html 2020-12-16T15:07:54.6030000Z https://www.medicinesresources.nhs.uk/astrazeneca-hopes-covid-19-vaccine-will-take-off-in-combination-with-sputnik-v.html 2020-12-16T15:09:53.0350000Z https://www.medicinesresources.nhs.uk/phase-2-3-covid-19-candidate-opaganib-reduces-acute-respiratory-distress-syndrome-related-blood-clotting-in-preclinical-animal-model.html 2020-12-16T15:12:32.1180000Z https://www.medicinesresources.nhs.uk/phase-3-trial-for-secuado-r-asenapine-transdermal-system-demonstrates-significant-improvement-in-positive-and-negative-syndrome-scale-total-score-in-adults-with-schizophrenia-versus-placebo.html 2020-12-16T15:13:38.4540000Z https://www.medicinesresources.nhs.uk/covid-19-lateral-flow-tests-miss-over-half-of-cases-liverpool-pilot-data-show.html 2020-12-16T15:14:44.0870000Z https://www.medicinesresources.nhs.uk/comparative-evaluation-of-clinical-manifestations-and-risk-of-death-in-patients-admitted-to-hospital-with-covid-19-and-seasonal-influenza-cohort-study-1.html 2020-12-16T15:16:44.3930000Z https://www.medicinesresources.nhs.uk/reserving-coronavirus-disease-2019-vaccines-for-global-access-cross-sectional-analysis.html 2020-12-16T15:19:30.0820000Z https://www.medicinesresources.nhs.uk/global-regional-and-national-estimates-of-target-population-sizes-for-covid-19-vaccination-descriptive-study.html 2020-12-16T15:21:23.7250000Z https://www.medicinesresources.nhs.uk/comparison-of-the-effects-of-intravenous-propofol-and-inhalational-desflurane-on-the-quality-of-early-recovery-after-hand-assisted-laparoscopic-donor-nephrectomy-a-prospective-randomised-controlled-trial.html 2020-12-16T15:22:32.4850000Z https://www.medicinesresources.nhs.uk/covid-19-insight-issue-6-december-20-designated-settings-and-care-home-capacity.html 2020-12-16T15:23:35.3500000Z https://www.medicinesresources.nhs.uk/association-between-achieving-inpatient-glycemic-control-and-clinical-outcomes-in-hospitalized-patients-with-covid-19-a-multicenter-retrospective-hospital-based-analysis.html 2020-12-16T15:26:01.5690000Z https://www.medicinesresources.nhs.uk/revised-spcs-zirabev-bevacizumab-25-mg-ml-concentrate-for-solution-for-infusion.html 2020-12-16T18:03:59.9080000Z https://www.medicinesresources.nhs.uk/new-product-revolade-eltrombopag-olamine-oral-suspension.html 2020-12-16T15:33:04.3900000Z https://www.medicinesresources.nhs.uk/update-on-assessment-of-the-biontech-and-pfizer-bnt162b2-vaccine-marketing-authorisation-application.html 2020-12-16T17:36:04.2510000Z https://www.medicinesresources.nhs.uk/effect-of-intravitreous-aflibercept-vs-vitrectomy-with-panretinal-photocoagulation-on-visual-acuity-in-patients-with-vitreous-hemorrhage-from-proliferative-diabetic-retinopathy.html 2020-12-16T17:38:23.6630000Z https://www.medicinesresources.nhs.uk/oral-rimegepant-for-preventive-treatment-of-migraine-a-phase-2-3-randomised-double-blind-placebo-controlled-trial.html 2020-12-16T15:55:07.7050000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-merck-sharp-and-dohme-limited-zerbaxa-tazobactam-ceftolozane-1g-0-5g-powder-for-concentrate-for-solution-for-infusion-eu-1-15-1032-001.html 2020-12-16T17:59:29.3140000Z https://www.medicinesresources.nhs.uk/caplacizumab-with-plasma-exchange-and-immunosuppression-for-treating-acute-acquired-thrombotic-thrombocytopenic-purpura-guidance-ta667.html 2020-12-21T10:29:28.3600000Z https://www.medicinesresources.nhs.uk/atezolizumab-with-bevacizumab-for-treating-advanced-or-unresectable-hepatocellular-carcinoma-guidance-ta666.html 2020-12-21T10:30:13.4120000Z https://www.medicinesresources.nhs.uk/nihr-alert-the-long-term-severity-of-psychosis-could-be-predicted-by-an-early-test-of-coordination-and-balance.html 2020-12-16T17:42:19.7480000Z https://www.medicinesresources.nhs.uk/poster-to-support-staff-when-handling-pfizer-biontech-covid-19-vaccine.html 2020-12-21T10:30:57.7290000Z https://www.medicinesresources.nhs.uk/preparing-the-pfizer-biontech-covid-19-vaccine-at-pcn-designated-sites.html 2020-12-21T10:31:23.6450000Z https://www.medicinesresources.nhs.uk/preparation-of-pfizer-biontech-covid-19-vaccine-syringes-for-administration-at-end-user-locations.html 2020-12-21T10:32:11.5320000Z https://www.medicinesresources.nhs.uk/brolucizumab-for-treating-wet-age-related-macular-degeneration-amd-in-adults-final-appraisal-determination.html 2020-12-16T17:44:33.8560000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-endocrine-system-disorders.html 2020-12-21T10:32:46.3480000Z https://www.medicinesresources.nhs.uk/excipients-information-for-pfizer-biontech-covid-19-vaccine.html 2020-12-16T17:45:58.2590000Z https://www.medicinesresources.nhs.uk/cancer-services-recovery-plan.html 2020-12-21T10:34:04.1820000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-vitamin-d-ng187.html 2020-12-21T10:33:26.6160000Z https://www.medicinesresources.nhs.uk/hydroxychloroquine-and-chloroquine-retinopathy-recommendations-on-monitoring.html 2020-12-17T18:10:24.8200000Z https://www.medicinesresources.nhs.uk/revised-spc-onpattro-patisiran-sodium-2-mg-ml-concentrate-for-solution-for-infusion.html 2020-12-17T16:36:35.0550000Z https://www.medicinesresources.nhs.uk/revised-spc-zytiga-abiraterone-acetate-500-mg-film-coated-tablets-1.html 2020-12-17T16:38:27.4330000Z https://www.medicinesresources.nhs.uk/revised-spc-crinone-8-progesterone-vaginal-gel.html 2020-12-17T16:40:28.5360000Z https://www.medicinesresources.nhs.uk/placement-of-nasogastric-tubes.html 2020-12-21T10:34:52.0590000Z https://www.medicinesresources.nhs.uk/covid-19-infection-rates-in-schools-mirror-rates-in-the-community.html 2020-12-17T17:11:44.3030000Z https://www.medicinesresources.nhs.uk/valneva-initiates-phase-i-ii-clinical-trial-in-uk-of-its-inactivated-and-adjuvanted-covid-19-vaccine-vla2001.html 2020-12-17T17:13:07.0760000Z https://www.medicinesresources.nhs.uk/eusa-pharma-launches-phase-iii-silvar-study-of-siltuximab-in-patients-hospitalised-with-covid-19.html 2020-12-17T17:14:14.9030000Z https://www.medicinesresources.nhs.uk/chimeric-antigen-receptor-car-t-cell-therapy-tecartus-receiveds-conditional-marketing-authorisation-for-treatment-of-relapsed-or-refractory-mantle-cell-lymphoma-mcl.html 2020-12-17T18:16:16.9390000Z https://www.medicinesresources.nhs.uk/obesity-and-coronavirus-where-next-for-policy.html 2020-12-17T17:16:45.5110000Z https://www.medicinesresources.nhs.uk/national-diabetes-audit-diabetes-prevention-programme-dpp-quarterly-data-release-1st-january-30th-june-2020.html 2020-12-17T17:17:45.7760000Z https://www.medicinesresources.nhs.uk/apoe-and-alzheimer-s-disease-advances-in-genetics-pathophysiology-and-therapeutic-approaches.html 2020-12-17T18:18:03.6530000Z https://www.medicinesresources.nhs.uk/government-announces-more-than-137-000-people-in-uk-receive-first-dose-of-covid-vaccine-in-one-week.html 2020-12-17T17:19:55.8750000Z https://www.medicinesresources.nhs.uk/transformation-of-urgent-and-emergency-care-models-of-care-and-measurement.html 2020-12-17T17:20:53.9580000Z https://www.medicinesresources.nhs.uk/fda-approves-tirbanibulin-klisyri-ointment-for-the-treatment-of-actinic-keratosis-on-the-face-or-scalp.html 2020-12-17T18:19:20.2970000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-new-drug-application-for-budesonide-oral-suspension-eohilia-for-treatment-of-eosinophilic-esophagitis-eoe.html 2020-12-17T17:23:50.7740000Z https://www.medicinesresources.nhs.uk/phase-3-keynote-775-study-309-trial-of-pembrolizumab-plus-lenvatinib-meets-dual-primary-endpoints-of-overall-and-progression-free-survival-in-patients-with-advanced-endometrial-cancer-following-prior-systemic-therapy.html 2020-12-17T17:24:58.4150000Z https://www.medicinesresources.nhs.uk/amgen-submits-new-drug-application-to-fda-for-sotorasib-for-treatment-of-advanced-or-metastatic-non-small-cell-lung-cancer-with-kras-g12c-mutation.html 2020-12-17T17:26:01.8410000Z https://www.medicinesresources.nhs.uk/novartis-announces-positive-results-from-phase-iii-kestrel-study-of-brolucizumab-in-diabetic-macular-oedema.html 2020-12-17T18:22:28.8720000Z https://www.medicinesresources.nhs.uk/fda-advisory-committee-vote-in-favour-of-approving-entresto-sacubitril-valsartan-as-a-treatment-of-patients-with-heart-failure-with-preserved-ejection-fraction-hfpef.html 2020-12-17T17:30:00.3100000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-diabetes.html 2020-12-17T17:31:26.2610000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-later-life.html 2020-12-21T10:26:41.8870000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-covid-19-vaccine-formulation-information.html 2020-12-21T10:25:31.6260000Z https://www.medicinesresources.nhs.uk/testosterone-treatment-to-prevent-or-revert-type-2-diabetes-in-men-enrolled-in-a-lifestyle-programme-t4dm-a-randomised-double-blind-placebo-controlled-2-year-phase-3b-trial-1.html 2020-12-17T17:40:12.3400000Z https://www.medicinesresources.nhs.uk/effects-of-dapagliflozin-on-major-adverse-kidney-and-cardiovascular-events-in-patients-with-diabetic-and-non-diabetic-chronic-kidney-disease-a-prespecified-analysis-from-the-dapa-ckd-trial-1.html 2020-12-17T17:42:12.5480000Z https://www.medicinesresources.nhs.uk/pan-akt-inhibitor-capivasertib-with-docetaxel-and-prednisolone-in-metastatic-castration-resistant-prostate-cancer-a-randomized-placebo-controlled-phase-ii-trial-procaid-1.html 2020-12-17T17:43:28.6340000Z https://www.medicinesresources.nhs.uk/emulating-randomized-clinical-trials-with-nonrandomized-real-world-evidence-studies-first-results-from-the-rct-duplicate-initiative-1.html 2020-12-17T17:45:03.3360000Z https://www.medicinesresources.nhs.uk/nab-paclitaxel-plus-gemcitabine-versus-nab-paclitaxel-plus-gemcitabine-followed-by-folfirinox-induction-chemotherapy-in-locally-advanced-pancreatic-cancer-neolap-aio-pak-0113-a-multicentre-randomised-phase-2-trial.html 2020-12-17T17:52:35.2620000Z https://www.medicinesresources.nhs.uk/severe-covid-20.html 2020-12-17T17:53:43.9820000Z https://www.medicinesresources.nhs.uk/trial-of-dexamethasone-for-chronic-subdural-hematoma.html 2020-12-17T18:29:25.9780000Z https://www.medicinesresources.nhs.uk/who-publishes-updated-living-guideline-on-therapeutics-and-covid-19.html 2020-12-21T10:24:31.8240000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-managing-the-long-term-effects-of-covid-19-ng188.html 2020-12-21T10:23:08.9400000Z https://www.medicinesresources.nhs.uk/revised-spc-dysport-300-units-powder-for-solution-for-injection.html 2020-12-18T16:52:14.7550000Z https://www.medicinesresources.nhs.uk/december-bnf-bnf-for-children-newsletter.html 2020-12-21T10:21:42.5170000Z https://www.medicinesresources.nhs.uk/systemic-and-inhaled-fluoroquinolones-small-risk-of-heart-valve-regurgitation-consider-other-therapeutic-options-first-in-patients-at-risk.html 2020-12-21T10:20:39.0190000Z https://www.medicinesresources.nhs.uk/erythromycin-caution-required-due-to-cardiac-risks-qt-interval-prolongation-drug-interaction-with-rivaroxaban.html 2020-12-21T10:18:57.1030000Z https://www.medicinesresources.nhs.uk/erythromycin-update-on-known-risk-of-infantile-hypertrophic-pyloric-stenosis.html 2020-12-21T10:17:01.0560000Z https://www.medicinesresources.nhs.uk/safety-of-covid-19-vaccines-when-given-in-pregnancy.html 2020-12-21T10:15:31.6630000Z https://www.medicinesresources.nhs.uk/drug-treatments-for-covid-19-living-systematic-review-and-network-meta-analysis-update.html 2020-12-21T10:12:57.4900000Z https://www.medicinesresources.nhs.uk/vitamin-d-supplementation-to-prevent-acute-respiratory-infections-systematic-review-and-meta-analysis-of-aggregate-data-from-randomised-controlled-trials.html 2020-12-18T17:03:11.0390000Z https://www.medicinesresources.nhs.uk/effect-of-the-covid-19-pandemic-on-mortality-of-patients-with-stemi-a-systematic-review-and-meta-analysis.html 2020-12-18T17:04:17.7170000Z https://www.medicinesresources.nhs.uk/impact-of-cardiovascular-disease-and-risk-factors-on-fatal-outcomes-in-patients-with-covid-19-according-to-age-a-systematic-review-and-meta-analysis.html 2020-12-18T17:05:20.6610000Z https://www.medicinesresources.nhs.uk/managing-intensive-care-admissions-when-there-are-not-enough-beds-during-the-covid-19-pandemic-a-systematic-review.html 2020-12-18T17:06:42.1100000Z https://www.medicinesresources.nhs.uk/comparison-of-the-characteristics-morbidity-and-mortality-of-covid-19-and-seasonal-influenza-a-nationwide-population-based-retrospective-cohort-study.html 2020-12-18T17:07:44.7420000Z https://www.medicinesresources.nhs.uk/optimising-antimicrobial-stewardship-interventions-in-english-primary-care-a-behavioural-analysis-of-qualitative-and-intervention-studies.html 2020-12-18T17:08:39.1420000Z https://www.medicinesresources.nhs.uk/association-of-osteonecrosis-of-the-jaw-with-zoledronic-acid-treatment-for-bone-metastases-in-patients-with-cancer.html 2020-12-18T17:10:02.0730000Z https://www.medicinesresources.nhs.uk/gefitinib-versus-vinorelbine-plus-cisplatin-as-adjuvant-treatment-for-stage-ii-iiia-n1-n2-egfr-mutant-nsclc-final-overall-survival-analysis-of-ctong1104-phase-iii-trial.html 2020-12-18T17:11:03.2080000Z https://www.medicinesresources.nhs.uk/total-body-irradiation-or-chemotherapy-conditioning-in-childhood-all-a-multinational-randomized-noninferiority-phase-iii-study.html 2020-12-18T17:12:12.1090000Z https://www.medicinesresources.nhs.uk/phase-1-2-trial-of-sars-cov-2-vaccine-chadox1-ncov-19-with-a-booster-dose-induces-multifunctional-antibody-responses.html 2020-12-18T17:13:13.9150000Z https://www.medicinesresources.nhs.uk/tocilizumab-in-patients-hospitalized-with-covid-19-pneumonia.html 2020-12-18T17:14:10.8730000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-to-supplemental-biologics-license-application-for-pembrolizumab-plus-chemotherapy-as-first-line-treatment-of-oesophageal-and-gastroeosophageal-junction-cancer.html 2020-12-18T17:15:09.8670000Z https://www.medicinesresources.nhs.uk/us-fda-approves-belimumab-for-the-treatment-of-active-lupus-nephritis.html 2020-12-18T17:16:05.2510000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-grants-aspacytarabine-orphan-drug-designation-for-the-treatment-of-acute-myeloid-leukaemia.html 2020-12-18T17:17:08.3070000Z https://www.medicinesresources.nhs.uk/application-for-approval-of-avapritinib-for-the-treatment-of-advanced-systemic-mastocytosis-submitted-to-the-us-fda.html 2020-12-18T17:18:04.7840000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-delivering-protective-immunity.html 2020-12-18T17:20:26.7430000Z https://www.medicinesresources.nhs.uk/persistence-of-igg-response-to-sars-cov-2.html 2020-12-18T17:21:33.7200000Z https://www.medicinesresources.nhs.uk/international-consensus-on-a-standard-set-of-outcome-measures-for-child-and-youth-anxiety-depression-obsessive-compulsive-disorder-and-post-traumatic-stress-disorder.html 2020-12-18T17:25:47.4670000Z https://www.medicinesresources.nhs.uk/no-population-left-behind-improving-paediatric-drug-safety-using-informatics-and-systems-biology.html 2020-12-18T17:28:14.8830000Z https://www.medicinesresources.nhs.uk/2020-acc-aha-guideline-for-the-management-of-patients-with-valvular-heart-disease.html 2020-12-18T17:29:03.6030000Z https://www.medicinesresources.nhs.uk/company-led-drug-alert-sodium-chloride-0-9-solution-for-injection-pl-08828-0178.html 2020-12-21T10:09:27.6220000Z https://www.medicinesresources.nhs.uk/update-on-assessment-of-marketing-authorisation-application-for-modernas-mrna-1273-covid-19-vaccine.html 2020-12-18T17:31:01.9890000Z https://www.medicinesresources.nhs.uk/nice-publishes-draft-guidance-on-management-of-acne-vulgaris-for-consultation.html 2020-12-18T17:32:00.2310000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-uk-18-december-2020.html 2020-12-18T17:33:03.0440000Z https://www.medicinesresources.nhs.uk/covid-19-and-social-distancing-efforts-implications-for-cancer-control.html 2020-12-18T17:34:09.5440000Z https://www.medicinesresources.nhs.uk/incidence-of-sars-cov-2-infection-among-patients-undergoing-active-antitumor-treatment-in-italy.html 2020-12-18T17:35:26.1540000Z https://www.medicinesresources.nhs.uk/us-fda-advisory-panel-backs-approval-of-modernas-covid-19-vaccine.html 2020-12-18T17:36:24.9680000Z https://www.medicinesresources.nhs.uk/investigation-into-preparations-for-potential-covid-19-vaccines.html 2020-12-18T17:37:29.6190000Z https://www.medicinesresources.nhs.uk/long-covid-patients-to-get-help-at-more-than-60-clinics.html 2020-12-18T17:38:50.7220000Z https://www.medicinesresources.nhs.uk/marketing-authorisation-application-for-semaglutide-for-weight-management-submitted-to-the-european-medicines-agency.html 2020-12-18T17:44:00.6320000Z https://www.medicinesresources.nhs.uk/promoting-flu-vaccination-to-patients-aged-50-64-years.html 2020-12-21T10:06:53.5410000Z https://www.medicinesresources.nhs.uk/eu-exit-medicines-supply-in-primary-care-joint-statement-by-the-bma-and-psnc.html 2020-12-18T17:45:48.6520000Z https://www.medicinesresources.nhs.uk/public-perceptions-of-health-and-social-care-in-light-of-covid-19-november-2020.html 2020-12-18T17:46:30.2630000Z https://www.medicinesresources.nhs.uk/primary-care-network-drive-thru-services-offering-a-safe-alternative-to-immunisation-clinics.html 2020-12-18T17:47:42.4000000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-covid-19-vaccine-use-in-anticoagulation-and-bleeding-disorders-1.html 2020-12-21T10:05:00.4750000Z https://www.medicinesresources.nhs.uk/using-the-pfizer-biontech-covid-19-vaccine-in-immunosuppressed-patients-1.html 2020-12-21T09:31:52.2550000Z https://www.medicinesresources.nhs.uk/pregnancy-information-for-pfizer-biontech-covid-19-vaccine-1.html 2020-12-21T09:23:03.7700000Z https://www.medicinesresources.nhs.uk/dosing-schedule-information-for-pfizer-biontech-covid-19-vaccine-1.html 2020-12-21T09:15:08.3710000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-gastrointestinal-disorders.html 2020-12-21T09:13:33.3690000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-eyes-and-vision.html 2020-12-21T09:03:14.4540000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-haematological-disorders.html 2020-12-21T09:00:43.2060000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-family-planning.html 2020-12-21T08:55:52.5920000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-obstetrics-and-gynaecology.html 2020-12-21T08:50:10.9350000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-information-and-guidance.html 2020-12-21T08:45:15.5950000Z https://www.medicinesresources.nhs.uk/example-policy-for-maintaining-the-vaccine-cold-chain-in-primary-care.html 2020-12-21T08:18:49.4890000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-vaccine-preparation.html 2020-12-21T08:17:25.1960000Z https://www.medicinesresources.nhs.uk/revised-spc-erleada-apalutamide-60-mg-film-coated-tablets-1.html 2020-12-21T12:59:02.6650000Z https://www.medicinesresources.nhs.uk/revised-spc-sandostatin-octreotide-all-presentations.html 2020-12-21T13:00:13.1480000Z https://www.medicinesresources.nhs.uk/revised-spc-keytruda-pembrolizumab-50-mg-powder-for-concentrate-for-solution-for-infusion-1.html 2020-12-21T13:01:03.9310000Z https://www.medicinesresources.nhs.uk/revised-spcs-kalydeco-ivacaftor-granules-in-sachet-all-strengths-2.html 2020-12-21T13:02:13.8330000Z https://www.medicinesresources.nhs.uk/guidance-on-shielding-and-protecting-people-who-are-clinically-extremely-vulnerable-from-covid-19.html 2020-12-21T13:03:26.7710000Z https://www.medicinesresources.nhs.uk/myelodysplastic-syndrome-and-acute-myeloid-leukaemia-in-patients-treated-with-parp-inhibitors-a-safety-meta-analysis-of-randomised-controlled-trials-and-a-retrospective-study-of-the-who-pharmacovigilance-database.html 2020-12-21T13:04:48.1010000Z https://www.medicinesresources.nhs.uk/camrelizumab-plus-carboplatin-and-pemetrexed-versus-chemotherapy-alone-in-chemotherapy-naive-patients-with-advanced-non-squamous-non-small-cell-lung-cancer-camel-a-randomised-open-label-multicentre-phase-3-trial.html 2020-12-21T13:06:02.4510000Z https://www.medicinesresources.nhs.uk/us-fda-grants-approval-of-modernas-covid-19-vaccine-in-adults-under-emergency-use-authorization.html 2020-12-21T13:07:44.4300000Z https://www.medicinesresources.nhs.uk/us-fda-grants-approval-of-osimertinib-tagrisso-as-first-adjuvant-treatment-for-early-stage-non-small-cell-lung-cancer-with-specific-genetic-mutation.html 2020-12-21T13:08:43.6280000Z https://www.medicinesresources.nhs.uk/us-fda-grant-approval-of-orgovyx-relugolix-for-the-treatment-of-adult-patients-with-advanced-prostate-cancer.html 2020-12-21T15:37:56.8950000Z https://www.medicinesresources.nhs.uk/study-of-remestemcel-l-for-treatment-of-acute-respiratory-distress-syndrome-due-to-covid-19-fails-to-meet-primary-endpoint.html 2020-12-21T13:42:47.8280000Z https://www.medicinesresources.nhs.uk/us-fda-approves-selinexor-in-combination-with-bortezomib-and-dexamethasone-for-treatment-of-multiple-myeloma-after-at-least-one-prior-therapy.html 2020-12-21T13:12:58.8710000Z https://www.medicinesresources.nhs.uk/gilteritinib-fails-to-improve-overall-survival-in-newly-diagnosed-flt3-mutation-positive-acute-myeloid-leukaemia.html 2020-12-21T13:13:57.9770000Z https://www.medicinesresources.nhs.uk/positive-topline-results-for-faricimab-for-diabetic-macular-oedema.html 2020-12-21T13:15:11.0490000Z https://www.medicinesresources.nhs.uk/statement-from-chief-medical-officer-professor-chris-whitty-about-new-strain-of-covid-19.html 2020-12-21T13:16:19.8090000Z https://www.medicinesresources.nhs.uk/chief-medical-officers-annual-report-2020-health-trends-and-variation-in-england.html 2021-01-10T19:51:49.2650000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-ondexxya-andexanet-alfa-2.html 2020-12-21T15:32:43.6660000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-tecfidera-r-dimethyl-fumarate.html 2020-12-21T15:51:37.4450000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-rozlytrek-entrectinib.html 2020-12-21T15:36:48.0190000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-gliolan-5-aminolevulinic-acid-5-ala.html 2020-12-21T15:39:59.7450000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-propofol-10-mg-ml-1-emulsion-for-injection-infusion.html 2020-12-21T15:41:00.6720000Z https://www.medicinesresources.nhs.uk/letter-sent-to-healthcare-professionals-midazolam-maleate-epistatus-10mg-in-1ml-oromucosal-soln-multidose-bottle.html 2020-12-21T15:43:18.5060000Z https://www.medicinesresources.nhs.uk/regn-cov2-a-neutralizing-antibody-cocktail-in-outpatients-with-covid-19.html 2020-12-21T15:44:42.4810000Z https://www.medicinesresources.nhs.uk/european-approval-of-palforzia-for-desensitising-children-and-adolescents-to-peanut-allergy.html 2020-12-21T15:46:26.2310000Z https://www.medicinesresources.nhs.uk/covid-19-pre-existing-health-conditions-and-ethnicity.html 2021-01-10T19:54:10.0440000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-renal-and-urologic-disorders.html 2021-01-10T19:57:29.4540000Z https://www.medicinesresources.nhs.uk/common-questions-about-pfizer-biontech-covid-19-vaccine.html 2021-01-10T19:58:24.9640000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-covid-19-vaccine-use-in-anticoagulation-and-bleeding-disorders.html 2020-12-21T15:53:59.3830000Z https://www.medicinesresources.nhs.uk/curevac-and-university-medical-center-mainz-start-phase-3-clinical-trial-for-covid-19-vaccine-candidate-cvncov-in-healthcare-workers.html 2020-12-22T15:53:15.5840000Z https://www.medicinesresources.nhs.uk/cabozantinib-significantly-improves-progression-free-survival-versus-placebo-in-cosmic-311-phase-3-trial-of-patients-with-previously-treated-radioiodine-refractory-thyroid-cancer.html 2020-12-22T17:53:34.3830000Z https://www.medicinesresources.nhs.uk/rucaparib-significantly-improves-progression-free-survival-versus-chemotherapy-in-ariel-4-phase-3-trial-in-later-line-ovarian-cancer-patients-with-a-brca-mutation.html 2020-12-22T17:54:17.4590000Z https://www.medicinesresources.nhs.uk/us-food-and-drug-administration-approves-paediatric-indication-for-xeomin-r-botulinum-toxin-a-for-treatment-of-chronic-sialorrhea.html 2020-12-22T15:56:53.8970000Z https://www.medicinesresources.nhs.uk/asymptomatic-transmission-of-covid-19.html 2020-12-22T15:58:02.3770000Z https://www.medicinesresources.nhs.uk/association-between-tendon-ruptures-and-use-of-fluoroquinolone-and-other-oral-antibiotics-a-10-year-retrospective-study-of-1-million-us-senior-medicare-beneficiaries.html 2020-12-22T15:59:41.3080000Z https://www.medicinesresources.nhs.uk/implications-of-association-between-reduced-vitamin-d-levels-and-susceptibility-to-severe-sars-cov-2-infection.html 2020-12-22T17:57:50.5270000Z https://www.medicinesresources.nhs.uk/revised-spcs-zithromax-azithromycin-dehydrate-all-products.html 2020-12-22T17:58:05.2300000Z https://www.medicinesresources.nhs.uk/revised-spcs-pegasys-peginterferon-alfa-2a-solution-for-injection-in-pre-filled-syringe-all-strengths.html 2020-12-22T18:18:11.2410000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-recommends-first-covid-19-vaccine-comirnaty-r-for-authorisation-in-the-eu-in-people-16-years-1.html 2020-12-22T18:16:56.3060000Z https://www.medicinesresources.nhs.uk/assessment-of-botulinum-neurotoxin-injection-for-dystonic-hand-tremor-a-randomized-clinical-trial.html 2020-12-22T16:10:45.7130000Z https://www.medicinesresources.nhs.uk/add-on-cannabidiol-treatment-for-drug-resistant-seizures-in-tuberous-sclerosis-complex-a-placebo-controlled-randomized-clinical-trial.html 2020-12-22T16:12:01.5770000Z https://www.medicinesresources.nhs.uk/elleste-hrt-range-back-in-stock.html 2020-12-22T18:01:19.1510000Z https://www.medicinesresources.nhs.uk/nihr-alert-spironolactone-is-not-an-effective-treatment-for-patients-with-atrial-fibrillation-and-preserved-ejection-fraction-research-shows.html 2020-12-22T17:04:15.9960000Z https://www.medicinesresources.nhs.uk/european-commission-authorises-rilpivirine-injection-in-combination-with-cabotegravir-injection-to-treat-hiv-1-infections-in-adults.html 2020-12-22T17:05:25.3010000Z https://www.medicinesresources.nhs.uk/mhra-approves-polyphors-phase-1-trial-of-novel-inhaled-antibiotic.html 2020-12-22T18:01:35.6010000Z https://www.medicinesresources.nhs.uk/tezepelumab-subcutaneous-injection-misses-primary-endpoint-in-patients-with-severe-oral-corticosteroid-dependent-asthma.html 2020-12-22T17:07:37.2330000Z https://www.medicinesresources.nhs.uk/transporting-pfizer-biontech-covid-19-vaccine-from-pcn-designated-sites-to-end-user-location.html 2021-01-10T19:46:00.7880000Z https://www.medicinesresources.nhs.uk/using-appropriate-legal-mechanisms-for-the-administration-of-covid-19-vaccines.html 2021-01-10T19:47:48.7620000Z https://www.medicinesresources.nhs.uk/ultra-early-tranexamic-acid-after-subarachnoid-haemorrhage-ultra-a-randomised-controlled-trial.html 2020-12-22T18:07:33.8590000Z https://www.medicinesresources.nhs.uk/fixed-dose-combination-of-pertuzumab-and-trastuzumab-for-subcutaneous-injection-plus-chemotherapy-in-her2-positive-early-breast-cancer-federica-a-randomised-open-label-multicentre-non-inferiority-phase-3-study.html 2020-12-22T18:08:06.4450000Z https://www.medicinesresources.nhs.uk/acute-flaccid-myelitis-afm-cause-diagnosis-and-management.html 2020-12-22T18:08:38.9820000Z https://www.medicinesresources.nhs.uk/revised-spc-kisplyx-lenvatinib-capsules-3.html 2020-12-23T15:33:57.5050000Z https://www.medicinesresources.nhs.uk/therapeutic-anticoagulation-heparin-in-the-management-of-severe-covid-19-sars-cov-2-positive-patients.html 2021-01-10T19:37:43.6110000Z https://www.medicinesresources.nhs.uk/onset-of-effect-and-impact-on-health-related-quality-of-life-exacerbation-rate-lung-function-and-nasal-polyposis-symptoms-for-patients-with-severe-eosinophilic-asthma-treated-with-benralizumab-andhi-a-randomised-controlled-phase-3b-trial.html 2020-12-23T15:37:19.5080000Z https://www.medicinesresources.nhs.uk/analysis-of-a-randomised-phase-3-trial-objective-responses-to-first-line-neoadjuvant-carboplatin-paclitaxel-regimens-for-ovarian-fallopian-tube-or-primary-peritoneal-carcinoma-icon8-post-hoc-exploratory.html 2020-12-23T15:39:42.5060000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-riluzole-in-patients-undergoing-decompressive-surgery-for-degenerative-cervical-myelopathy-csm-protect-a-multicentre-double-blind-placebo-controlled-randomised-phase-3-trial.html 2020-12-23T15:24:28.1320000Z https://www.medicinesresources.nhs.uk/hcv-micro-elimination-in-individuals-with-hiv-in-the-netherlands-4-years-after-universal-access-to-direct-acting-antivirals-a-retrospective-cohort-study-1.html 2020-12-23T15:25:30.8360000Z https://www.medicinesresources.nhs.uk/effects-of-empagliflozin-on-estimated-extracellular-volume-estimated-plasma-volume-and-measured-glomerular-filtration-rate-in-patients-with-heart-failure-empire-hf-renal-a-prespecified-substudy-of-a-double-blind-randomised-placebo-controlled-trial.html 2020-12-23T15:42:05.3810000Z https://www.medicinesresources.nhs.uk/variation-in-us-hospital-mortality-rates-for-patients-admitted-with-covid-19-during-the-first-6-months-of-the-pandemic.html 2020-12-23T15:29:43.8760000Z https://www.medicinesresources.nhs.uk/a-neutralizing-monoclonal-antibody-for-hospitalized-patients-with-covid-19.html 2020-12-23T15:31:07.8950000Z https://www.medicinesresources.nhs.uk/effect-of-digoxin-vs-bisoprolol-for-heart-rate-control-in-atrial-fibrillation-on-patient-reported-quality-of-life-the-rate-af-randomized-clinical-trial.html 2020-12-23T15:32:35.0650000Z https://www.medicinesresources.nhs.uk/gps-mindlines-around-deprescribing-antihypertensives-in-older-patients-with-multimorbidity-qualitative-study.html 2020-12-23T15:33:49.0970000Z https://www.medicinesresources.nhs.uk/metformin-use-and-long-term-risk-of-benign-prostatic-hyperplasia-a-population-based-cohort-study.html 2020-12-23T15:50:25.1060000Z https://www.medicinesresources.nhs.uk/comparison-of-cardiovascular-disease-risk-factors-assessment-and-management-in-men-and-women-including-consideration-of-absolute-risk-a-nationally-representative-cross-sectional-study.html 2020-12-23T15:35:35.0420000Z https://www.medicinesresources.nhs.uk/sodium-intake-life-expectancy-and-all-cause-mortality.html 2020-12-23T15:36:30.5140000Z https://www.medicinesresources.nhs.uk/effect-of-empagliflozin-on-exercise-ability-and-symptoms-in-heart-failure-patients-with-reduced-and-preserved-ejection-fraction-with-and-without-type-2-diabetes.html 2020-12-23T15:38:11.8200000Z https://www.medicinesresources.nhs.uk/discriminatory-cardiac-arrest-care-patients-with-low-socioeconomic-status-receive-delayed-cardiopulmonary-resuscitation-and-are-less-likely-to-survive-an-in-hospital-cardiac-arrest.html 2020-12-23T15:51:49.7420000Z https://www.medicinesresources.nhs.uk/pharmacotherapeutic-management-of-parkinsons-disease-inpatients-how-about-asking-hospital-pharmacists.html 2020-12-23T15:40:48.5270000Z https://www.medicinesresources.nhs.uk/science-advice-in-a-crisis.html 2020-12-23T15:54:33.0910000Z https://www.medicinesresources.nhs.uk/elimination-could-be-the-optimal-response-strategy-for-covid-19-and-other-emerging-pandemic-diseases.html 2020-12-23T15:42:50.7500000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-promoting-vaccine-acceptance.html 2020-12-23T15:44:00.1130000Z https://www.medicinesresources.nhs.uk/phesgo-fixed-dose-combination-of-pertuzumab-and-trastuzumab-approved-for-use-in-in-eu-for-her2-positive-breast-cancer.html 2020-12-23T15:44:51.8580000Z https://www.medicinesresources.nhs.uk/fda-approves-anakinra-for-the-treatment-of-deficiency-of-il-1-receptor-antagonist-dira.html 2020-12-23T15:45:52.6010000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-licence-application-to-fda-for-use-of-dexamethasone-ophthalmic-insert-for-of-ocular-itching-associated-with-allergic-conjunctivitis.html 2020-12-23T15:47:42.7000000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-topline-results-from-phase-3-clinical-trial-evaluating-setmelanotide-in-bardet-biedl-and-alstroem-syndromes.html 2020-12-23T15:48:54.4890000Z https://www.medicinesresources.nhs.uk/manufacturers-announces-positive-data-for-mavrilimumab-in-severe-covid-19-pneumonia-and-hyperinflammation.html 2020-12-23T15:57:03.9110000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-marketing-authorisation-application-for-sotorasib-to-european-medicines-agency.html 2020-12-23T15:50:48.1440000Z https://www.medicinesresources.nhs.uk/indemnity-arrangements-for-the-covid-19-vaccination-programme.html 2020-12-23T15:51:51.5910000Z https://www.medicinesresources.nhs.uk/cefiderocol-and-ceftazidime-with-avibactam-to-be-first-antibiotics-reviewed-by-nice-under-the-subscription-type-payment-model.html 2020-12-23T15:52:41.3040000Z https://www.medicinesresources.nhs.uk/ema-organises-a-second-public-meeting-about-the-new-covid-19-vaccines.html 2020-12-23T15:53:37.2660000Z https://www.medicinesresources.nhs.uk/a-roadmap-to-advance-patient-safety-in-ambulatory-care.html 2020-12-23T15:54:38.4960000Z https://www.medicinesresources.nhs.uk/progress-in-patient-safety-in-anaesthesia.html 2020-12-23T15:55:53.4600000Z https://www.medicinesresources.nhs.uk/covid-19-and-the-swedish-enigma.html 2020-12-23T15:56:46.8840000Z https://www.medicinesresources.nhs.uk/shared-decision-making-draft-guidance.html 2020-12-23T15:57:47.8960000Z https://www.medicinesresources.nhs.uk/guidance-for-stepdown-of-infection-control-precautions-and-discharging-covid-19-patients.html 2020-12-23T15:58:44.1330000Z https://www.medicinesresources.nhs.uk/state-of-health-visiting-in-england.html 2020-12-23T15:59:41.1910000Z https://www.medicinesresources.nhs.uk/fenfluramine-approved-for-use-in-the-eu-for-dravet-syndrome.html 2020-12-23T16:00:38.5910000Z https://www.medicinesresources.nhs.uk/rilpivirine-injection-in-combination-with-cabotegravir-injection-and-tablets-approved-for-use-in-the-eu-for-the-treatment-of-hiv-1.html 2020-12-23T16:01:36.8060000Z https://www.medicinesresources.nhs.uk/new-sars-cov-2-variant-1.html 2020-12-23T16:03:21.5910000Z https://www.medicinesresources.nhs.uk/understanding-the-impact-of-brexit-on-health-in-the-uk.html 2020-12-23T16:04:05.6710000Z https://www.medicinesresources.nhs.uk/national-protocol-for-covid-19-mrna-vaccine-bnt162b2-pfizer-biontech.html 2020-12-23T16:35:28.1360000Z https://www.medicinesresources.nhs.uk/revised-spc-cortiment-budesonide-prolonged-release-tablets.html 2021-01-04T08:41:01.2980000Z https://www.medicinesresources.nhs.uk/managing-the-long-term-effects-of-covid-19.html 2021-01-04T08:43:17.1980000Z https://www.medicinesresources.nhs.uk/immediate-actions-in-response-to-sars-cov-2-virus-new-variants-of-concerns.html 2021-01-10T19:13:00.1870000Z https://www.medicinesresources.nhs.uk/extended-release-methylphenidate-a-review-of-the-pharmacokinetic-profiles-of-available-products.html 2021-01-10T19:15:05.1090000Z https://www.medicinesresources.nhs.uk/corticosteroid-use-in-covid-19-patients-a-systematic-review-and-meta-analysis-on-clinical-outcomes.html 2021-01-04T08:58:19.7790000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-the-mrna-1273-sars-cov-2-vaccine.html 2021-01-10T19:19:16.5120000Z https://www.medicinesresources.nhs.uk/effect-of-capivasertib-in-patients-with-an-akt1-e17k-mutated-tumor-nci-match-subprotocol-eay131-y-nonrandomized-trial.html 2021-01-04T09:03:50.5000000Z https://www.medicinesresources.nhs.uk/impact-of-transplant-pharmacists-on-length-of-stay-and-30-day-hospital-readmission-rate-a-single-centre-retrospective-cohort-study.html 2021-01-04T09:05:32.6290000Z https://www.medicinesresources.nhs.uk/association-of-tiered-restrictions-and-a-second-lockdown-with-covid-19-deaths-and-hospital-admissions-in-england-a-modelling-study-2.html 2021-01-04T09:07:36.9100000Z https://www.medicinesresources.nhs.uk/changes-in-seizure-frequency-and-antiepileptic-therapy-during-pregnancy.html 2021-01-04T09:08:52.1910000Z https://www.medicinesresources.nhs.uk/oral-azacitidine-maintenance-therapy-for-acute-myeloid-leukemia-in-first-remission.html 2021-01-04T09:09:59.6640000Z https://www.medicinesresources.nhs.uk/antibody-status-and-incidence-of-sars-cov-2-infection-in-health-care-workers.html 2021-01-04T09:10:47.2550000Z https://www.medicinesresources.nhs.uk/risks-of-and-risk-factors-for-covid-19-disease-in-people-with-diabetes-a-cohort-study-of-the-total-population-of-scotland.html 2021-01-04T15:06:13.8920000Z https://www.medicinesresources.nhs.uk/adverse-outcomes-of-proton-pump-inhibitors-in-patients-with-chronic-kidney-disease-the-ckd-rein-cohort-study.html 2021-01-04T09:14:04.2050000Z https://www.medicinesresources.nhs.uk/clinical-correlates-and-outcomes-associated-with-pregabalin-use-among-people-prescribed-opioids-for-chronic-non-cancer-pain-a-five-year-prospective-cohort-study.html 2021-01-04T09:15:03.2460000Z https://www.medicinesresources.nhs.uk/letter-to-the-health-and-care-sector-about-the-uk-eu-trade-and-co-operation-agreement.html 2021-01-04T09:15:57.3150000Z https://www.medicinesresources.nhs.uk/maintaining-safety-with-sars-cov-2-vaccines.html 2021-01-04T09:16:47.9100000Z https://www.medicinesresources.nhs.uk/the-case-for-an-hiv-cure-and-how-to-get-there-1.html 2021-01-04T09:17:43.2780000Z https://www.medicinesresources.nhs.uk/methodological-standards-for-qualitative-and-mixed-methods-patient-centered-outcomes-research.html 2021-01-04T09:25:36.9080000Z https://www.medicinesresources.nhs.uk/class-2-drug-alert-action-within-48-hours-medac-gmbh-sodiofolin-50mg-ml-solution-for-injection-2mg-vial-pl-11587-0005.html 2021-01-04T09:33:58.3110000Z https://www.medicinesresources.nhs.uk/promotions-of-unhealthy-foods-restricted-from-april-2022.html 2021-01-04T09:37:39.9380000Z https://www.medicinesresources.nhs.uk/systemic-therapy-for-estrogen-receptor-positive-her2-negative-breast-cancer.html 2021-01-04T09:39:43.4010000Z https://www.medicinesresources.nhs.uk/flu-vaccines-and-the-covid-19-response.html 2021-01-04T09:45:15.3240000Z https://www.medicinesresources.nhs.uk/community-pharmacy-local-enhanced-service-coronavirus-vaccination.html 2021-01-10T19:20:10.9800000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-315-december-2020-covid-19-special-edition.html 2021-01-04T09:47:16.6920000Z https://www.medicinesresources.nhs.uk/oxford-university-astrazeneca-vaccine-authorised-by-mhra-2.html 2021-01-10T19:26:31.9170000Z https://www.medicinesresources.nhs.uk/institutional-readiness-for-management-of-astrazeneca-covid-19-vaccine-in-trusts-guidance-for-chief-pharmacists.html 2021-01-10T19:28:38.1640000Z https://www.medicinesresources.nhs.uk/revised-spc-depakote-and-epilim-valproic-acid-and-sodium-valproate-products.html 2021-01-04T15:11:16.3280000Z https://www.medicinesresources.nhs.uk/biologics-during-pregnancy-in-women-with-inflammatory-bowel-disease-and-risk-of-infantile-infections-a-systematic-review-and-meta-analysis.html 2021-01-04T14:12:10.1940000Z https://www.medicinesresources.nhs.uk/augmented-reduced-intensity-regimen-does-not-improve-postallogeneic-transplant-outcomes-in-acute-myeloid-leukemia.html 2021-01-04T14:14:10.7860000Z https://www.medicinesresources.nhs.uk/incidence-clinical-features-and-outcomes-of-late-onset-neutropenia-from-rituximab-for-autoimmune-disease.html 2021-01-04T14:15:29.8930000Z https://www.medicinesresources.nhs.uk/low-density-lipoprotein-cholesterol-reduction-and-statin-intensity-in-myocardial-infarction-patients-and-major-adverse-outcomes-a-swedish-nationwide-cohort-study.html 2021-01-04T14:16:57.4130000Z https://www.medicinesresources.nhs.uk/effect-of-medicines-management-versus-standard-care-on-readmissions-in-multimorbid-patients-a-randomised-controlled-trial.html 2021-01-04T14:17:48.3560000Z https://www.medicinesresources.nhs.uk/cross-sectional-analysis-to-explore-the-awareness-attitudes-and-actions-of-uk-adults-at-high-risk-of-severe-illness-from-covid-19.html 2021-01-04T14:18:42.2460000Z https://www.medicinesresources.nhs.uk/randomized-trial-of-irinotecan-and-cetuximab-with-or-without-vemurafenib-in-braf-mutant-metastatic-colorectal-cancer-swog-s1406.html 2021-01-04T14:27:18.4530000Z https://www.medicinesresources.nhs.uk/treatment-and-outcomes-of-inpatient-hypertension-among-adults-with-noncardiac-admissions.html 2021-01-04T14:32:21.7930000Z https://www.medicinesresources.nhs.uk/fda-approve-vibegron-for-overactive-bladder.html 2021-01-05T09:48:54.4820000Z https://www.medicinesresources.nhs.uk/a-letter-to-the-profession-from-the-uk-chief-medical-officers-regarding-the-uk-covid-19-vaccination-programmes.html 2021-01-10T19:31:51.2970000Z https://www.medicinesresources.nhs.uk/the-challenges-facing-the-nhs-in-england-in-2021.html 2021-01-04T14:36:20.8650000Z https://www.medicinesresources.nhs.uk/pharmacological-profile-and-effects-of-mitotane-in-adrenocortical-carcinoma.html 2021-01-04T14:38:14.8260000Z https://www.medicinesresources.nhs.uk/public-awareness-in-wales-of-the-uk-yellow-card-scheme-for-reporting-suspected-adverse-drug-reactions.html 2021-01-04T14:39:51.2960000Z https://www.medicinesresources.nhs.uk/overcoming-barriers-to-implementing-precision-dosing-with-5-fluorouracil-and-capecitabine.html 2021-01-04T14:41:28.0740000Z https://www.medicinesresources.nhs.uk/lithium-carbonate-priadel-200mg-and-400mg-tablets-supply-disruption-update.html 2021-01-10T19:34:39.1060000Z https://www.medicinesresources.nhs.uk/how-should-we-sequence-the-treatments-for-heart-failure-and-a-reduced-ejection-fraction-hfref-a-redefinition-of-evidence-based-medicine.html 2021-01-04T14:43:23.9820000Z https://www.medicinesresources.nhs.uk/revised-spc-dysport-botulinum-toxin-a-injection.html 2021-01-05T16:18:32.3840000Z https://www.medicinesresources.nhs.uk/new-product-phesgo-pertuzumab-trastuzumab-600-mg-600-mg-and-1200-mg-1200-mg-solution-for-injection.html 2021-01-05T16:19:43.0070000Z https://www.medicinesresources.nhs.uk/revised-spc-bosulif-bosutinib-film-coated-tablets-all-strengths.html 2021-01-05T16:21:08.0880000Z https://www.medicinesresources.nhs.uk/revised-spc-lorviqua-lorlatinib-film-coated-tablets-all-strengths.html 2021-01-05T18:14:56.6510000Z https://www.medicinesresources.nhs.uk/revised-spc-innovace-enalapril-tablets-all-strengths.html 2021-01-05T17:23:05.6790000Z https://www.medicinesresources.nhs.uk/revised-spc-velphoro-sucroferric-oxyhydroxide-500-mg-chewable-tablets.html 2021-01-05T16:27:07.6470000Z https://www.medicinesresources.nhs.uk/new-product-velphoro-sucroferric-oxyhydroxide-125-mg-oral-powder-in-sachet.html 2021-01-05T16:28:39.8980000Z https://www.medicinesresources.nhs.uk/new-product-tecartus-autologous-anti-cd19-transduced-cd3-cells.html 2021-01-05T16:30:07.6100000Z https://www.medicinesresources.nhs.uk/revised-spc-obizur-susoctocog-alfa-500-u-powder-and-solvent-for-solution-for-injection-1.html 2021-01-05T16:33:47.1520000Z https://www.medicinesresources.nhs.uk/revised-spc-glensoludex-dexamethasone-soluble-tablets-all-strengths.html 2021-01-05T16:35:28.1940000Z https://www.medicinesresources.nhs.uk/revised-spc-dupixent-200-mg-solution-for-injection-in-pre-filled-pen-and-syringe.html 2021-01-05T16:37:12.0650000Z https://www.medicinesresources.nhs.uk/assessing-the-risk-of-ketoacidosis-due-to-sodium-glucose-cotransporter-sglt-2-inhibitors-in-patients-with-type-1-diabetes-a-meta-analysis-and-meta-regression.html 2021-01-05T16:38:29.5420000Z https://www.medicinesresources.nhs.uk/safety-of-clonidine-used-for-long-term-sedation-in-paediatric-intensive-care-a-systematic-review.html 2021-01-05T18:10:15.6330000Z https://www.medicinesresources.nhs.uk/antimicrobial-prescribing-delafloxacin-for-acute-bacterial-skin-and-skin-structure-infections-evidence-summary-es32.html 2021-01-10T18:44:19.1150000Z https://www.medicinesresources.nhs.uk/dtb-select-can-emollient-use-in-early-infancy-prevent-eczema.html 2021-01-05T16:43:56.7850000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-dulaglutide-3-0-mg-and-4-5-mg-versus-dulaglutide-1-5-mg-in-metformin-treated-patients-with-type-2-diabetes-in-a-randomized-controlled-trial-award-11.html 2021-01-05T16:45:54.2700000Z https://www.medicinesresources.nhs.uk/compression-stockings-in-addition-to-low-molecular-weight-heparin-to-prevent-venous-thromboembolism-in-surgical-inpatients-requiring-pharmacoprophylaxis-the-gaps-non-inferiority-rct.html 2021-01-05T16:47:37.0230000Z https://www.medicinesresources.nhs.uk/population-mortality-and-laws-encouraging-influenza-vaccination-for-hospital-workers.html 2021-01-05T18:08:05.0140000Z https://www.medicinesresources.nhs.uk/trends-in-new-prescription-of-gabapentinoids-and-of-coprescription-with-opioids-in-the-four-nations-of-the-united-kingdom-1993-2017.html 2021-01-05T16:52:14.3550000Z https://www.medicinesresources.nhs.uk/risk-factors-associated-with-all-cause-30-day-mortality-in-nursing-home-residents-with-covid-19.html 2021-01-05T16:55:43.3770000Z https://www.medicinesresources.nhs.uk/association-of-diet-and-lifestyle-with-the-risk-of-gastroesophageal-reflux-disease-symptoms-in-us-women.html 2021-01-05T16:59:00.5790000Z https://www.medicinesresources.nhs.uk/evaluating-the-impact-of-a-pharmacist-led-prescribing-feedback-intervention-on-prescribing-errors-in-a-hospital-setting.html 2021-01-05T17:00:15.9080000Z https://www.medicinesresources.nhs.uk/mhra-adds-allevia-fexofenadine-hydrochloride-120mg-tablets-to-general-sales-list.html 2021-01-05T17:19:12.2280000Z https://www.medicinesresources.nhs.uk/licensing-application-submitted-to-european-medicines-agency-for-amivantamab-as-treatment-of-metastatic-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations-following-disease-progression-on-platinum-based-chemotherapy-pbc.html 2021-01-05T17:03:29.6090000Z https://www.medicinesresources.nhs.uk/violence-prevention-and-reduction-standard.html 2021-01-05T17:05:02.0880000Z https://www.medicinesresources.nhs.uk/eu-exit-key-messages-for-nhs-organisations.html 2021-01-10T18:48:11.1140000Z https://www.medicinesresources.nhs.uk/nice-collaboration-on-streamlined-licensing-and-patient-access-process-for-new-medicines-opened-on-january-1st.html 2021-01-05T17:10:07.3730000Z https://www.medicinesresources.nhs.uk/guidance-for-retailers-supplying-over-the-counter-medicines-to-northern-ireland.html 2021-01-05T18:01:36.0200000Z https://www.medicinesresources.nhs.uk/how-to-apply-for-marketing-authorisation-via-european-commission-ec-decision-reliance-procedure.html 2021-01-05T17:12:49.8790000Z https://www.medicinesresources.nhs.uk/republished-case-report-severe-hypothermia-bradycardia-and-cardiac-arrest-in-association-with-risperidone.html 2021-01-05T17:15:32.4660000Z https://www.medicinesresources.nhs.uk/first-people-to-receive-oxford-university-astrazeneca-covid-19-vaccine-this-week.html 2021-01-05T17:17:08.7130000Z https://www.medicinesresources.nhs.uk/joint-statement-from-uk-chief-medical-officers-cmos-recommending-uk-covid-19-alert-level-move-from-level-4-to-level-5.html 2021-01-05T17:20:06.6430000Z https://www.medicinesresources.nhs.uk/review-of-cardiac-involvement-in-multisystem-inflammatory-syndrome-in-children.html 2021-01-05T17:57:49.0740000Z https://www.medicinesresources.nhs.uk/axial-spondyloarthritis-new-advances-in-diagnosis-and-management.html 2021-01-05T17:20:37.9800000Z https://www.medicinesresources.nhs.uk/fda-assigns-priority-review-to-supplemental-new-drug-application-for-lorlatinib-as-a-first-line-treatment-for-anaplastic-lymphoma-kinase-alk-positive-metastatic-non-small-cell-lung-cancer.html 2021-01-05T17:23:54.4990000Z https://www.medicinesresources.nhs.uk/marketing-authorisation-application-for-sotorasib-submitted-to-european-medicines-agency-for-review.html 2021-01-05T17:25:01.7530000Z https://www.medicinesresources.nhs.uk/evolution-of-antithrombotic-therapy-in-patients-undergoing-percutaneous-coronary-intervention-a-40-year-journey.html 2021-01-05T17:54:34.1830000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-to-review-ozanimod-for-the-treatment-of-ulcerative-colitis.html 2021-01-05T17:27:29.9560000Z https://www.medicinesresources.nhs.uk/masks-and-face-coverings-for-the-lay-public-a-narrative-update.html 2021-01-05T17:28:35.4950000Z https://www.medicinesresources.nhs.uk/acute-onset-psychosis-with-complex-neurobehavioural-symptomatology-following-the-intramuscular-injection-of-hyoscine-butylbromide-a-case-report-with-an-overview-of-the-literature-1.html 2021-01-05T17:30:36.3910000Z https://www.medicinesresources.nhs.uk/uk-scientists-express-concern-that-vaccines-may-not-protect-against-s-african-coronavirus-variant.html 2021-01-05T17:34:46.4230000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-validates-application-for-nivolumab-combined-with-chemotherapy-as-first-line-treatment-in-metastatic-gastric-cancer-gastroesophageal-junction-cancer-and-oesophageal-adenocarcinoma-1.html 2021-01-05T17:34:41.1730000Z https://www.medicinesresources.nhs.uk/omnicell-to-partner-with-guys-and-st-thomas-nhs-foundation-trust-london-on-development-of-european-technology-enabled-intelligence-centre-as-part-of-expansion-of-omnicell-systems.html 2021-01-05T17:35:38.2690000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-to-biologics-license-application-for-teplizumab-for-the-delay-or-prevention-of-clinical-type-1-diabetes-in-at-risk-individuals.html 2021-01-05T17:36:55.6700000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-filing-biologics-license-application-for-long-acting-human-growth-hormone-somatrogon-for-treatment-of-children-with-growth-hormone-deficiency.html 2021-01-05T17:39:41.2820000Z https://www.medicinesresources.nhs.uk/the-effect-of-covid-19-related-lockdown-on-patients-taking-warfarin.html 2021-01-05T17:41:11.3400000Z https://www.medicinesresources.nhs.uk/isoniazid-preventive-therapy-plus-antiretroviral-therapy-for-the-prevention-of-tuberculosis-a-systematic-review-and-meta-analysis-of-individual-participant-data.html 2021-01-06T12:54:29.1680000Z https://www.medicinesresources.nhs.uk/adjuvant-s-1-plus-endocrine-therapy-for-oestrogen-receptor-positive-her2-negative-primary-breast-cancer-a-multicentre-open-label-randomised-controlled-phase-3-trial.html 2021-01-06T12:55:40.4240000Z https://www.medicinesresources.nhs.uk/efficacy-of-pazopanib-with-or-without-gemcitabine-in-patients-with-anthracycline-and-or-ifosfamide-refractory-soft-tissue-sarcoma-final-results-of-the-papagemo-phase-2-randomized-clinical-trial.html 2021-01-06T12:56:50.0230000Z https://www.medicinesresources.nhs.uk/defining-the-optimal-total-number-of-chemotherapy-courses-in-younger-patients-with-acute-myeloid-leukemia-a-comparison-of-three-versus-four-courses.html 2021-01-06T12:58:06.8820000Z https://www.medicinesresources.nhs.uk/cardiac-safety-of-osimertinib-a-review-of-data.html 2021-01-06T12:59:21.1140000Z https://www.medicinesresources.nhs.uk/microsatellite-instability-in-patients-with-stage-iii-colon-cancer-receiving-fluoropyrimidine-with-or-without-oxaliplatin-an-accent-pooled-analysis-of-12-adjuvant-trials.html 2021-01-06T13:01:10.7140000Z https://www.medicinesresources.nhs.uk/metachronous-contralateral-testicular-cancer-in-the-cisplatin-era-a-population-based-cohort-study.html 2021-01-06T13:02:29.8090000Z https://www.medicinesresources.nhs.uk/stay-at-home-orders-during-the-covid-19-pandemic-an-opportunity-to-improve-glucose-control-through-behavioral-changes-in-type-1-diabetes.html 2021-01-06T13:03:37.4570000Z https://www.medicinesresources.nhs.uk/testing-for-primary-aldosteronism-and-mineralocorticoid-receptor-antagonist-use-among-u-s-veterans-a-retrospective-cohort-study.html 2021-01-06T13:04:46.8530000Z https://www.medicinesresources.nhs.uk/nivolumab-fails-to-hit-primary-endpoint-in-brain-tumour-trial.html 2021-01-06T13:05:49.6220000Z https://www.medicinesresources.nhs.uk/fda-to-review-use-of-surufatinib-for-the-treatment-of-advanced-neuroendocrine-tumours-net-via-a-rolling-review.html 2021-01-06T13:07:44.0390000Z https://www.medicinesresources.nhs.uk/eprenetapopt-plus-azacitidine-fails-to-meet-primary-endpoint-for-use-in-tp53-mutant-myelodysplastic-syndromes.html 2021-01-06T13:08:58.0840000Z https://www.medicinesresources.nhs.uk/annamycin-receives-fda-orphan-drug-designation-for-soft-tissue-sarcomas.html 2021-01-06T13:10:33.4250000Z https://www.medicinesresources.nhs.uk/treatment-deescalation-strategies-for-nasopharyngeal-cancer-a-review-1.html 2021-01-06T13:13:05.0750000Z https://www.medicinesresources.nhs.uk/fda-approve-ansuvimab-zykl-for-ebola.html 2021-01-06T13:14:15.1950000Z https://www.medicinesresources.nhs.uk/revised-spc-biktarvy-50-mg-200-mg-25-mg-bictegravir-emtricitabine-tenofovir-alafenamide-fumarate-film-coated-tablets-1.html 2021-01-06T13:59:55.0410000Z https://www.medicinesresources.nhs.uk/revised-spc-xyrem-sodium-oxybate-500-mg-ml-oral-solution-1.html 2021-01-06T14:15:48.2830000Z https://www.medicinesresources.nhs.uk/revised-spcs-zocor-simvastatin-film-coated-tablets-all-strengths.html 2021-01-06T13:27:49.1640000Z https://www.medicinesresources.nhs.uk/encorafenib-plus-cetuximab-for-previously-treated-braf-v600e-mutation-positive-metastatic-colorectal-cancer.html 2021-01-10T18:25:48.8370000Z https://www.medicinesresources.nhs.uk/safety-of-covid-19-vaccines-when-given-in-pregnancy-1.html 2021-01-10T18:28:10.8550000Z https://www.medicinesresources.nhs.uk/coenzyme-q10-supplementation-for-prophylaxis-in-adult-patients-with-migraine-a-meta-analysis.html 2021-01-06T14:04:05.3950000Z https://www.medicinesresources.nhs.uk/current-smoking-and-covid-19-risk-results-from-a-population-symptom-app-in-over-2-4-million-people.html 2021-01-06T14:05:13.9130000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-risankizumab-in-adults-with-active-psoriatic-arthritis.html 2021-01-06T13:33:55.4250000Z https://www.medicinesresources.nhs.uk/covax-must-go-beyond-proportional-allocation-of-covid-vaccines-to-ensure-fair-and-equitable-access-1.html 2021-01-06T13:35:36.3090000Z https://www.medicinesresources.nhs.uk/covid-19-uk-study-aims-to-understand-effects-on-ethnic-minority-healthcare-workers.html 2021-01-06T13:36:36.0890000Z https://www.medicinesresources.nhs.uk/management-of-crohn-disease-a-review.html 2021-01-06T13:38:12.8830000Z https://www.medicinesresources.nhs.uk/regulatory-approval-of-covid-19-vaccine-astrazeneca.html 2021-01-10T18:30:38.7980000Z https://www.medicinesresources.nhs.uk/the-disproportionate-impact-of-covid-19-on-bme-communities.html 2021-01-06T14:06:29.4250000Z https://www.medicinesresources.nhs.uk/european-approval-of-intramuscular-route-of-administration-for-peginterferon-beta-1a-plegridy.html 2021-01-06T13:41:41.2660000Z https://www.medicinesresources.nhs.uk/us-fda-grant-priority-review-of-dapagliflozin-forxiga-for-treatment-of-new-or-worsening-chronic-kidney-disease-ckd.html 2021-01-06T15:29:02.5500000Z https://www.medicinesresources.nhs.uk/pandemic-delivery-service-now-active-across-england.html 2021-01-06T14:08:11.6850000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-allergy-and-immunology.html 2021-01-10T18:37:26.3020000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-vaccine-preparation-in-trusts.html 2021-01-10T18:38:50.4220000Z https://www.medicinesresources.nhs.uk/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement.html 2021-01-10T17:08:27.5440000Z https://www.medicinesresources.nhs.uk/revised-spc-empliciti-elotuzumab-powder-for-concentrate-for-solution-for-infusion-all-strengths.html 2021-01-07T18:58:43.5270000Z https://www.medicinesresources.nhs.uk/revised-spc-cipramil-citalopram-20-mg-film-coated-tablets.html 2021-01-07T18:58:07.7720000Z https://www.medicinesresources.nhs.uk/revised-spc-equasym-xl-0-mg-capsules-all-strengths.html 2021-01-07T18:56:15.9500000Z https://www.medicinesresources.nhs.uk/revised-spc-triumeq-50mg-600mg-300-dolutegravir-abacavir-lamivudine-film-coated-tablets.html 2021-01-07T18:54:54.3730000Z https://www.medicinesresources.nhs.uk/revised-spc-blincyto-blinatumomab-38-5-micrograms-powder-for-concentrate-and-solution-for-infusion.html 2021-01-07T18:54:12.7480000Z https://www.medicinesresources.nhs.uk/new-product-fintepla-fenfluramine-2-2-mg-ml-oral-solution.html 2021-01-07T18:53:19.4530000Z https://www.medicinesresources.nhs.uk/aminoglycosides-gentamicin-amikacin-tobramycin-and-neomycin-increased-risk-of-deafness-in-patients-with-mitochondrial-mutations.html 2021-01-10T17:17:07.0500000Z https://www.medicinesresources.nhs.uk/ssri-snri-antidepressant-medicines-small-increased-risk-of-postpartum-haemorrhage-when-used-in-the-month-before-delivery.html 2021-01-10T17:22:25.0260000Z https://www.medicinesresources.nhs.uk/fingolimod-gilenya-updated-advice-about-the-risks-of-serious-liver-injury-and-herpes-meningoencephalitis-1.html 2021-01-10T17:23:14.7670000Z https://www.medicinesresources.nhs.uk/dimethyl-fumarate-tecfidera-updated-advice-on-the-risk-of-progressive-multifocal-leukoencephalopathy-pml-associated-with-mild-lymphopenia.html 2021-01-10T17:25:37.1970000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-pfizer-biontech-and-covid-19-vaccine-astrazeneca-current-advice.html 2021-01-10T17:29:13.2600000Z https://www.medicinesresources.nhs.uk/antiepileptic-drugs-in-pregnancy-updated-advice-following-comprehensive-safety-review.html 2021-01-10T17:29:54.3580000Z https://www.medicinesresources.nhs.uk/early-high-titer-plasma-therapy-to-prevent-severe-covid-19-in-older-adults.html 2021-01-10T17:35:47.2860000Z https://www.medicinesresources.nhs.uk/association-of-mental-disorders-with-sars-cov-2-infection-and-severe-health-outcomes-nationwide-cohort-study.html 2021-01-07T18:46:07.6750000Z https://www.medicinesresources.nhs.uk/incidence-of-neurodegenerative-and-cerebrovascular-diseases-associated-with-antihypertensive-drug-classes-1.html 2021-01-07T18:44:56.8690000Z https://www.medicinesresources.nhs.uk/risk-of-mortality-and-complications-in-patients-with-schizophrenia-and-diabetes-mellitus-population-based-cohort-study.html 2021-01-07T18:43:57.8980000Z https://www.medicinesresources.nhs.uk/distribution-of-vitamin-d-status-in-the-uk-a-cross-sectional-analysis-of-uk-biobank.html 2021-01-07T18:43:04.8410000Z https://www.medicinesresources.nhs.uk/mucocutaneous-adverse-events-associated-with-oral-sirolimus-for-the-treatment-of-vascular-anomalies.html 2021-01-07T18:41:35.4340000Z https://www.medicinesresources.nhs.uk/covid-19-immunothrombosis-and-venous-thromboembolism-biological-mechanisms.html 2021-01-07T18:39:24.0990000Z https://www.medicinesresources.nhs.uk/national-flu-and-covid-19-surveillance-report-7-january-2021-week-1.html 2021-01-07T18:37:52.7210000Z https://www.medicinesresources.nhs.uk/a-brief-history-of-excipients-infographic.html 2021-01-07T18:36:54.6090000Z https://www.medicinesresources.nhs.uk/taking-the-p-why-the-founder-of-p-values-would-be-turning-in-his-grave.html 2021-01-07T18:33:58.5230000Z https://www.medicinesresources.nhs.uk/new-covid-19-drug-screening-hub-established-in-scotland.html 2021-01-07T18:31:20.3160000Z https://www.medicinesresources.nhs.uk/non-benzodiazepine-hypnotic-use-for-sleep-disturbance-in-people-aged-over-55-years-living-with-dementia-a-series-of-cohort-studies.html 2021-01-07T18:40:22.2010000Z https://www.medicinesresources.nhs.uk/operational-guidance-vaccination-of-frontline-health-and-social-care-workers.html 2021-01-07T18:29:57.7640000Z https://www.medicinesresources.nhs.uk/new-oxford-vaccine-rolled-out-to-general-practice-services-2.html 2021-01-07T18:29:11.0630000Z https://www.medicinesresources.nhs.uk/osteoarthritis-of-the-knee.html 2021-01-07T18:27:40.3940000Z https://www.medicinesresources.nhs.uk/nivolumab-for-treating-squamous-cell-carcinoma-of-the-head-and-neck-after-platinum-based-chemotherapy-cdf-review-ta490-appraisal-consultation-document.html 2021-01-07T18:26:13.3660000Z https://www.medicinesresources.nhs.uk/anakinra-for-treating-stills-disease-appraisal-consultation-document.html 2021-01-07T18:25:20.9670000Z https://www.medicinesresources.nhs.uk/hyqvia-human-normal-immunoglobulin-and-recombinant-human-hyaluronidase-crimping-defect-in-hyaluronidase-vial.html 2021-01-07T18:19:46.4920000Z https://www.medicinesresources.nhs.uk/briviact-r-brivaracetam-10mg-ml-oral-solution-bottles-with-narrow-neck-diameter.html 2021-01-07T18:18:29.1410000Z https://www.medicinesresources.nhs.uk/temporary-supply-of-a-different-presentation-and-changes-to-the-instructions-for-ativan-4mg-ml-solution-for-injection-lorazepam.html 2021-01-10T17:37:55.4030000Z https://www.medicinesresources.nhs.uk/epclusa-200-mg-50-mg-film-coated-tablets-sofosbuvir-velpatasvir-supply-of-irish-product-1.html 2021-01-07T18:17:01.4950000Z https://www.medicinesresources.nhs.uk/chemotherapy-in-combination-with-radiotherapy-for-definitive-intent-treatment-of-stage-ii-iva-nasopharyngeal-carcinoma-csco-and-asco-guideline.html 2021-01-07T18:10:50.8780000Z https://www.medicinesresources.nhs.uk/genetic-variants-of-sars-cov-2-what-do-they-mean.html 2021-01-07T18:09:38.9100000Z https://www.medicinesresources.nhs.uk/levamisole-induced-vasculopathy.html 2021-01-07T18:08:40.7160000Z https://www.medicinesresources.nhs.uk/ema-recommends-covid-19-vaccine-moderna-for-authorisation-in-the-eu.html 2021-01-10T17:42:46.7280000Z https://www.medicinesresources.nhs.uk/uk-recommendations-on-opioid-stewardship.html 2021-01-07T18:04:33.1830000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-whats-the-evidence-for-extending-the-dosing-interval.html 2021-01-07T18:03:40.8620000Z https://www.medicinesresources.nhs.uk/eu-may-soon-approve-new-use-of-pfizer-vaccine-increasing-doses-by-20-source.html 2021-01-07T18:02:45.8130000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-the-new-drug-application-for-mirabegron-for-oral-suspension-and-supplemental-new-drug-application-for-myrbetriq-r-mirabegron-tablets-in-pediatric-patients.html 2021-01-07T18:02:00.8980000Z https://www.medicinesresources.nhs.uk/patient-group-direction-for-covid-19-vaccine-astrazeneca-chadox1-s-recombinant.html 2021-01-10T17:43:32.5740000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-moderna-authorised-in-the-uk-for-temporary-supply.html 2021-01-10T13:49:03.5590000Z https://www.medicinesresources.nhs.uk/interim-position-statement-interleukin-6-inhibitors-tocilizumab-or-sarilumab-for-patients-admitted-to-icu-with-covid-19-pneumonia-adults.html 2021-01-10T14:08:25.2390000Z https://www.medicinesresources.nhs.uk/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-updated.html 2021-01-10T13:57:28.4210000Z https://www.medicinesresources.nhs.uk/suspected-neurological-conditions-recognition-and-referral-quality-standard-qs198.html 2021-01-10T14:17:24.8700000Z https://www.medicinesresources.nhs.uk/revised-spcs-glensoludex-dexamethasone-soluble-tablets-all-strengths.html 2021-01-08T16:12:56.3050000Z https://www.medicinesresources.nhs.uk/use-of-proton-pump-inhibitors-to-treat-persistent-throat-symptoms-multicentre-double-blind-randomised-placebo-controlled-trial.html 2021-01-08T16:13:55.9980000Z https://www.medicinesresources.nhs.uk/efficacy-of-osimertinib-plus-bevacizumab-vs-osimertinib-in-patients-with-egfr-t790m-mutated-non-small-cell-lung-cancer-previously-treated-with-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitor.html 2021-01-08T16:15:08.4170000Z https://www.medicinesresources.nhs.uk/enhanced-service-specification-covid-19-vaccination-programme-2020-21-updated.html 2021-01-10T14:25:51.5520000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-results-for-vutrisiran-in-the-treatment-of-hereditary-transthyretin-mediated-amyloidosis-with-polyneuropathy.html 2021-01-08T16:17:36.9580000Z https://www.medicinesresources.nhs.uk/allergic-reactions-including-anaphylaxis-after-receipt-of-the-first-dose-of-pfizer-biontech-covid-19-vaccine-united-states-december-14-23-2020.html 2021-01-08T16:18:39.8830000Z https://www.medicinesresources.nhs.uk/recombinant-human-complement-factor-h-gem103-granted-fast-track-designation-for-dry-age-related-macular-degeneration-amd.html 2021-01-08T16:19:44.0460000Z https://www.medicinesresources.nhs.uk/zenocutuzumab-granted-us-fast-track-designation-for-the-treatment-of-neuregulin-1-fusion-cancers.html 2021-01-08T16:21:10.2860000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-risankizumab-induction-in-patients-with-crohns-disease.html 2021-01-08T16:23:02.2710000Z https://www.medicinesresources.nhs.uk/positive-results-for-phase-iii-trial-of-risperidone-extended-release-subcutaneous-injection-for-schizophrenia.html 2021-01-08T16:23:58.8700000Z https://www.medicinesresources.nhs.uk/care-quality-commission-launches-strategy-consultation.html 2021-01-08T16:24:46.2070000Z https://www.medicinesresources.nhs.uk/access-consortium-statement-on-covid-19-vaccines-evidence-1.html 2021-01-08T16:26:59.4580000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-oxford-astrazeneca-movement-of-vaccine.html 2021-01-10T14:29:21.5970000Z https://www.medicinesresources.nhs.uk/extra-dose-from-vials-of-comirnaty-covid-19-vaccine.html 2021-01-08T16:30:36.5720000Z https://www.medicinesresources.nhs.uk/obesity-management-in-women-of-reproductive-age.html 2021-01-08T18:56:04.9950000Z https://www.medicinesresources.nhs.uk/nhs-to-test-routine-collection-of-private-hospital-data.html 2021-01-08T16:32:41.7820000Z https://www.medicinesresources.nhs.uk/freeing-up-practices-to-support-covid-vaccination.html 2021-01-10T14:31:59.6570000Z https://www.medicinesresources.nhs.uk/investigation-of-novel-sars-cov-2-variant-variant-of-concern-202012-01-technical-briefing-3.html 2021-01-08T16:37:33.2640000Z https://www.medicinesresources.nhs.uk/flu-vaccine-uptake-among-over-65s-highest-on-record.html 2021-01-08T16:38:45.3670000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-centres-information-and-guidance-on-setting-up-and-managing-the-booking-capacity-of-each-vaccination-centre.html 2021-01-08T16:39:40.0820000Z https://www.medicinesresources.nhs.uk/continuation-versus-discontinuation-of-renin-angiotensin-system-inhibitors-in-patients-admitted-to-hospital-with-covid-19-a-prospective-randomised-open-label-trial.html 2021-01-08T18:52:32.0930000Z https://www.medicinesresources.nhs.uk/trends-in-health-related-quality-of-life-inequalities-repeated-cross-sections-study.html 2021-01-08T17:07:14.8560000Z https://www.medicinesresources.nhs.uk/frequency-of-and-factors-associated-with-nonmedical-opioid-use-behavior-among-patients-with-cancer-receiving-opioids-for-cancer-pain.html 2021-01-08T17:08:25.7370000Z https://www.medicinesresources.nhs.uk/excellent-outcomes-with-reduced-frequency-of-vincristine-and-dexamethasone-pulses-in-standard-risk-b-lymphoblastic-leukemia-results-from-children-s-oncology-group-aall0932.html 2021-01-08T17:10:28.3810000Z https://www.medicinesresources.nhs.uk/burden-of-enteral-supplement-interactions-with-common-antimicrobial-agents-a-single-centre-observational-analysis.html 2021-01-08T17:11:35.6210000Z https://www.medicinesresources.nhs.uk/national-protocol-for-covid-19-vaccine-astrazeneca-chadox1-s-recombinant.html 2021-01-18T10:32:19.9910000Z https://www.medicinesresources.nhs.uk/revised-national-protocol-for-covid-19-mrna-vaccine-bnt162b2-pfizer-biontech.html 2021-01-18T10:47:31.1530000Z https://www.medicinesresources.nhs.uk/madopar-cr-100-mg-25-mg-prolonged-release-hard-capsules.html 2021-01-11T17:05:03.3540000Z https://www.medicinesresources.nhs.uk/new-medicines-newsletter-december-2021.html 2021-01-18T10:49:19.1720000Z https://www.medicinesresources.nhs.uk/positive-results-from-phase-iii-trial-of-rexlemestrocel-l-in-patients-with-chronic-heart-failure.html 2021-01-11T14:38:13.4010000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-results-for-valoctocogene-roxaparvovec-in-the-treatment-of-severe-haemophilia-a.html 2021-01-11T14:39:15.6200000Z https://www.medicinesresources.nhs.uk/positive-phase-ii-results-for-esketamine-dry-powder-inhalation-falkieri-in-the-acute-phase-of-treatment-resistant-bipolar-depression.html 2021-01-11T17:06:48.1780000Z https://www.medicinesresources.nhs.uk/balancing-the-risks-and-benefits-of-benzodiazepines-1.html 2021-01-11T14:44:41.9910000Z https://www.medicinesresources.nhs.uk/vaccination-services-continue-to-expand-across-england.html 2021-01-11T14:45:56.8570000Z https://www.medicinesresources.nhs.uk/new-tv-advert-urges-public-to-stay-at-home-to-protect-the-nhs-and-save-lives.html 2021-01-11T14:47:11.1270000Z https://www.medicinesresources.nhs.uk/nhs-hypertension-case-finding-pilot-in-community-pharmacy.html 2021-01-11T14:54:58.9690000Z https://www.medicinesresources.nhs.uk/nhs-organisations-instructed-to-rapidly-vaccinate-staff.html 2021-01-18T10:50:58.4880000Z https://www.medicinesresources.nhs.uk/european-commission-approves-baloxavir-for-the-treatment-and-prophylaxis-of-influenza-2.html 2021-01-11T15:02:25.3330000Z https://www.medicinesresources.nhs.uk/asymptomatic-covid-19-testing-to-be-rolled-out-across-the-country-starting-this-week.html 2021-01-11T15:16:11.4240000Z https://www.medicinesresources.nhs.uk/new-strategy-to-accelerate-diagnosis-and-improve-treatment-of-rare-diseases.html 2021-01-11T15:17:28.4910000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-programme-information-for-healthcare-practitioners-update-1.html 2021-01-18T10:52:03.3440000Z https://www.medicinesresources.nhs.uk/interleukin-6-receptor-antagonists-in-critically-ill-patients-with-covid-19-preliminary-report.html 2021-01-18T10:58:05.1790000Z https://www.medicinesresources.nhs.uk/disclosure-of-study-funding-and-author-conflicts-of-interest-in-press-releases-and-the-news-a-retrospective-content-analysis-with-two-cohorts.html 2021-01-11T15:57:22.6800000Z https://www.medicinesresources.nhs.uk/guidance-on-the-hepatitis-b-antenatal-screening-and-selective-neonatal-immunisation-pathway.html 2021-01-18T11:04:42.2930000Z https://www.medicinesresources.nhs.uk/returning-to-physical-activity-after-covid-19.html 2021-01-11T20:52:33.7850000Z https://www.medicinesresources.nhs.uk/a-safe-schools-policy-for-re-opening-education-as-soon-as-possible-and-mitigating-the-harms-of-closure.html 2021-01-11T18:09:19.8000000Z https://www.medicinesresources.nhs.uk/6-month-consequences-of-covid-19-in-patients-discharged-from-hospital-a-cohort-study.html 2021-01-11T20:49:23.9510000Z https://www.medicinesresources.nhs.uk/airborne-transmission-of-covid-19-and-the-role-of-face-mask-to-prevent-it-a-systematic-review-and-meta-analysis.html 2021-01-11T16:10:46.7400000Z https://www.medicinesresources.nhs.uk/estimating-the-covid-19-epidemic-trajectory-and-hospital-capacity-requirements-in-south-west-england-a-mathematical-modelling-framework.html 2021-01-11T16:54:14.1890000Z https://www.medicinesresources.nhs.uk/impact-of-transitional-care-interventions-on-hospital-readmissions-in-older-medical-patients-a-systematic-review.html 2021-01-11T16:55:19.6500000Z https://www.medicinesresources.nhs.uk/residual-risks-of-ischaemic-stroke-and-systemic-embolism-among-atrial-fibrillation-patients-with-anticoagulation-large-scale-real-world-data-f-create-project.html 2021-01-11T16:56:14.5030000Z https://www.medicinesresources.nhs.uk/tyrosine-kinase-inhibitors-in-chronic-myeloid-leukaemia-and-emergent-cardiovascular-disease-1.html 2021-01-11T16:57:53.3000000Z https://www.medicinesresources.nhs.uk/phase-iii-randomized-controlled-trial-of-erapid-ehealth-intervention-during-chemotherapy.html 2021-01-11T16:58:55.1270000Z https://www.medicinesresources.nhs.uk/immunogenicity-of-the-uk-group-b-meningococcal-vaccine-4cmenb-schedule-against-groups-b-and-c-meningococcal-strains-sched3-outcomes-of-a-multicentre-open-label-randomised-controlled-trial-1.html 2021-01-18T11:18:00.1340000Z https://www.medicinesresources.nhs.uk/prevalence-and-risk-factors-for-delirium-in-critically-ill-patients-with-covid-19-covid-d-a-multicentre-cohort-study.html 2021-01-11T17:02:24.7780000Z https://www.medicinesresources.nhs.uk/wound-aware-a-resource-for-drug-services.html 2021-01-11T18:08:09.3090000Z https://www.medicinesresources.nhs.uk/the-effect-of-vitamin-d-supplementation-on-acute-respiratory-tract-infection-in-older-australian-adults-an-analysis-of-data-from-the-d-health-trial.html 2021-01-12T17:09:18.8780000Z https://www.medicinesresources.nhs.uk/revised-spc-asacol-mesalazine-preparations-1.html 2021-01-12T16:22:27.8910000Z https://www.medicinesresources.nhs.uk/revised-spc-jakavi-ruxolitinib-tablets.html 2021-01-12T16:23:53.7740000Z https://www.medicinesresources.nhs.uk/revised-spc-xospata-gilteritinib-tablets.html 2021-01-12T16:26:06.3460000Z https://www.medicinesresources.nhs.uk/coffee-consumption-and-risk-of-prostate-cancer-a-systematic-review-and-meta-analysis.html 2021-01-12T16:27:54.2350000Z https://www.medicinesresources.nhs.uk/effect-of-long-term-beta-blocker-treatment-following-myocardial-infarction-among-stable-optimally-treated-patients-without-heart-failure-in-the-reperfusion-era-a-danish-nationwide-cohort-study.html 2021-01-12T17:10:56.4220000Z https://www.medicinesresources.nhs.uk/influence-of-neprilysin-inhibition-on-the-efficacy-and-safety-of-empagliflozin-in-patients-with-chronic-heart-failure-and-a-reduced-ejection-fraction-the-emperor-reduced-trial.html 2021-01-12T16:31:53.2030000Z https://www.medicinesresources.nhs.uk/orthopaedic-corticosteroid-injections-and-risk-of-acute-coronary-syndrome-a-cohort-study-1.html 2021-01-12T16:33:30.4570000Z https://www.medicinesresources.nhs.uk/multiplicity-and-complexity-a-qualitative-exploration-of-influences-on-prescribing-in-uk-general-practice.html 2021-01-12T16:34:23.7720000Z https://www.medicinesresources.nhs.uk/societal-costs-of-chemotherapy-in-the-uk-an-incidence-based-cost-of-illness-model-for-early-breast-cancer-1.html 2021-01-12T16:38:40.3560000Z https://www.medicinesresources.nhs.uk/effect-of-oral-moxifloxacin-vs-intravenous-ertapenem-plus-oral-levofloxacin-for-treatment-of-uncomplicated-acute-appendicitis-the-appac-ii-randomized-clinical-trial.html 2021-01-12T17:13:28.8380000Z https://www.medicinesresources.nhs.uk/adolescent-onset-and-adult-onset-vitamin-responsive-neurogenetic-diseases-a-review.html 2021-01-12T16:42:13.7010000Z https://www.medicinesresources.nhs.uk/fda-accepts-supplemental-new-drug-application-for-empagliflozin-for-adults-with-heart-failure-with-reduced-ejection-fraction.html 2021-01-12T16:43:22.4750000Z https://www.medicinesresources.nhs.uk/netarsudil-and-latanoprost-0-02-0-005-ophthalmic-solution-approved-for-use-in-eu-for-primary-open-angle-glaucoma-or-ocular-hypertension-1.html 2021-01-12T16:45:50.6460000Z https://www.medicinesresources.nhs.uk/why-vaccines-matter.html 2021-01-12T17:15:06.6150000Z https://www.medicinesresources.nhs.uk/ema-receives-application-for-conditional-marketing-authorisation-of-covid-19-vaccine-astrazeneca.html 2021-01-12T16:48:30.3990000Z https://www.medicinesresources.nhs.uk/sars-cov-2-vaccination-in-patients-with-liver-disease-responding-to-the-next-big-question.html 2021-01-12T16:50:08.0200000Z https://www.medicinesresources.nhs.uk/mims-summary-for-pridinol-a-new-muscle-spasm-treatment-option.html 2021-01-12T16:52:04.2660000Z https://www.medicinesresources.nhs.uk/uk-covid-19-vaccines-delivery-plan.html 2021-01-18T11:25:48.2680000Z https://www.medicinesresources.nhs.uk/adult-excess-weight-patterns-and-trends.html 2021-01-12T16:54:45.3720000Z https://www.medicinesresources.nhs.uk/brexit-and-the-end-of-the-transition-period-what-does-it-mean-for-the-health-and-care-system.html 2021-01-12T16:55:33.9340000Z https://www.medicinesresources.nhs.uk/medical-gases-webpage-on-sps-updated.html 2021-01-18T11:27:01.7940000Z https://www.medicinesresources.nhs.uk/get-it-right-first-time-clinical-practice-guidance.html 2021-01-12T17:00:50.4230000Z https://www.medicinesresources.nhs.uk/revised-spc-lixiana-edoxaban-film-coated-tablets-all-strengths-1.html 2021-01-13T15:32:04.1370000Z https://www.medicinesresources.nhs.uk/revised-spc-betnesol-n-neomycin-sulfate-betamethasone-sodium-phosphate-eye-ear-and-nose-drops.html 2021-01-13T15:33:36.9810000Z https://www.medicinesresources.nhs.uk/use-of-medicines-in-pregnancy-and-breastfeeding.html 2021-01-18T11:44:26.1120000Z https://www.medicinesresources.nhs.uk/demographic-risk-factors-for-covid-19-infection-severity-icu-admission-and-death-a-meta-analysis-of-59-studies.html 2021-01-13T15:37:19.7930000Z https://www.medicinesresources.nhs.uk/are-patients-goals-in-treatment-associated-with-expected-treatment-outcomes-findings-from-a-mixed-methods-study-on-outpatient-pharmacological-treatment-for-opioid-use-disorder.html 2021-01-13T15:38:37.8330000Z https://www.medicinesresources.nhs.uk/association-of-oily-and-nonoily-fish-consumption-and-fish-oil-supplements-with-incident-type-2-diabetes-a-large-population-based-prospective-study.html 2021-01-13T15:41:07.3950000Z https://www.medicinesresources.nhs.uk/effect-of-out-of-hospital-sodium-nitrite-on-survival-to-hospital-admission-after-cardiac-arrest-a-randomized-clinical-trial.html 2021-01-13T16:23:58.2460000Z https://www.medicinesresources.nhs.uk/clinical-implications-of-removing-race-from-estimates-of-kidney-function.html 2021-01-13T15:45:30.0190000Z https://www.medicinesresources.nhs.uk/sex-differences-in-heart-failure-hospitalisation-risk-following-acute-myocardial-infarction.html 2021-01-13T15:46:38.7340000Z https://www.medicinesresources.nhs.uk/care-education-and-treatment-review-policy-covid-19-addendum.html 2021-01-13T15:47:37.0160000Z https://www.medicinesresources.nhs.uk/u-s-fda-accepts-new-drug-application-and-grants-priority-review-for-finerenone-for-patients-with-chronic-kidney-disease-and-type-2-diabetes.html 2021-01-13T15:48:54.2150000Z https://www.medicinesresources.nhs.uk/how-the-oxford-astrazeneca-covid-19-vaccine-was-made.html 2021-01-13T15:50:11.5850000Z https://www.medicinesresources.nhs.uk/designated-settings-for-people-with-covid-19-leaving-hospital.html 2021-01-13T15:51:15.0160000Z https://www.medicinesresources.nhs.uk/remote-monitoring-in-heart-failure-current-and-emerging-technologies-in-the-context-of-the-pandemic.html 2021-01-13T15:52:23.2260000Z https://www.medicinesresources.nhs.uk/nuffield-trust-response-to-latest-ons-mortality-statistics.html 2021-01-13T15:53:29.3950000Z https://www.medicinesresources.nhs.uk/series-immunotherapy-for-hematologic-malignancies.html 2021-01-13T15:55:19.6290000Z https://www.medicinesresources.nhs.uk/valproate-use-by-women-and-girls.html 2021-01-18T11:45:19.4760000Z https://www.medicinesresources.nhs.uk/landmark-reform-of-mental-health-laws.html 2021-01-13T15:59:02.0310000Z https://www.medicinesresources.nhs.uk/the-covid-19-vaccine-communication-handbook.html 2021-01-13T16:04:51.0820000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-of-inhaled-interferon-beta-1a-for-treatment-of-severe-covid-19.html 2021-01-13T16:06:11.5910000Z https://www.medicinesresources.nhs.uk/revised-spc-neulasta-pegfilgrastim-products.html 2021-01-14T15:02:11.0490000Z https://www.medicinesresources.nhs.uk/revised-spc-minims-cyclopentolate-hydrochloride-0-5-eye-drops-solution.html 2021-01-14T15:03:52.7010000Z https://www.medicinesresources.nhs.uk/national-learning-report-support-for-staff-following-patient-safety-incidents.html 2021-01-18T12:50:08.6490000Z https://www.medicinesresources.nhs.uk/sodium-glucose-cotransporter-protein-2-sglt-2-inhibitors-and-glucagon-like-peptide-1-glp-1-receptor-agonists-for-type-2-diabetes-systematic-review-and-network-meta-analysis-of-randomised-controlled-trials.html 2021-01-18T12:52:35.0220000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-low-and-very-low-carbohydrate-diets-for-type-2-diabetes-remission-systematic-review-and-meta-analysis-of-published-and-unpublished-randomized-trial-data.html 2021-01-14T15:08:01.5330000Z https://www.medicinesresources.nhs.uk/domperidone-and-the-risks-of-sudden-cardiac-death-and-ventricular-arrhythmia-a-systematic-review-and-meta-analysis-of-observational-studies.html 2021-01-14T15:09:37.9180000Z https://www.medicinesresources.nhs.uk/sixth-national-summary-report-for-nhs-benchmarking-networks-pharmacy-and-medicines-optimisation-project-finds-almost-a-third-of-hospitals-report-complete-outages-of-medicines-during-covid-19-pandemic.html 2021-01-14T15:23:51.7870000Z https://www.medicinesresources.nhs.uk/diurnal-seeks-marketing-authorisation-for-chronocort-modified-release-hydrocortisone-in-uk-for-treatment-of-patients-with-congenital-adrenal-hyperplasia-cah.html 2021-01-14T15:24:40.2280000Z https://www.medicinesresources.nhs.uk/updated-analysis-of-survival-data-from-phase-iii-imbrave150-study-evaluating-atezolizumab-and-bevacizumab-compared-to-sorafenib-in-people-with-unresectable-hepatocellular-carcinoma.html 2021-01-14T16:46:29.3520000Z https://www.medicinesresources.nhs.uk/dispersible-tablet-formulation-of-dolutegravir-tivicay-in-paediatric-patients-aged-at-least-four-weeks-and-weighing-at-least-3kg-approved-in-eu-1.html 2021-01-14T15:28:12.1810000Z https://www.medicinesresources.nhs.uk/cost-of-constipation-report.html 2021-01-14T15:29:03.3900000Z https://www.medicinesresources.nhs.uk/position-statement-around-use-of-the-covid-19-vaccine-astrazeneca-az-to-vaccinate-housebound-patients.html 2021-01-18T12:55:29.3080000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-in-older-adult-care-homes-the-next-stage.html 2021-01-18T12:57:17.6170000Z https://www.medicinesresources.nhs.uk/instruction-on-timing-of-second-dose-of-covid-19-vaccinations.html 2021-01-18T13:01:44.9020000Z https://www.medicinesresources.nhs.uk/high-street-pharmacies-deliver-nhs-covid-jabs.html 2021-01-14T15:33:21.1200000Z https://www.medicinesresources.nhs.uk/national-diabetes-audit-diabetes-prevention-programme-dpp-quarterly-data-release-1st-january-30th-september-2020.html 2021-01-14T15:35:40.6660000Z https://www.medicinesresources.nhs.uk/ewings-sarcoma.html 2021-01-14T15:36:50.7700000Z https://www.medicinesresources.nhs.uk/the-european-medicines-agency-s-eu-conditional-marketing-authorisations-for-covid-19-vaccines-1.html 2021-01-14T16:51:16.3280000Z https://www.medicinesresources.nhs.uk/the-pharmacologic-treatment-of-schizophrenia-2021.html 2021-01-14T15:41:01.0920000Z https://www.medicinesresources.nhs.uk/glaucoma-in-adults-screening-diagnosis-and-management-a-review-1.html 2021-01-14T15:42:29.3820000Z https://www.medicinesresources.nhs.uk/joint-statement-from-chief-executives-of-statutory-regulators-of-health-and-social-care-professionals-january-2022.html 2021-01-14T15:44:00.0470000Z https://www.medicinesresources.nhs.uk/cyberattack-on-european-medicines-agency-update-1.html 2021-01-14T15:45:48.8810000Z https://www.medicinesresources.nhs.uk/bjcp-themed-avoiding-harm-from-over-prescribing.html 2021-01-18T13:03:43.1140000Z https://www.medicinesresources.nhs.uk/past-covid-19-infection-provides-some-immunity-but-people-may-still-carry-and-transmit-virus.html 2021-01-18T13:05:55.9210000Z https://www.medicinesresources.nhs.uk/donanemab-slows-clinical-decline-of-alzheimer-s-disease-in-phase-ii-trailblazer-alz-study.html 2021-01-14T15:49:55.1260000Z https://www.medicinesresources.nhs.uk/alexion-pharmaceuticals-inc-announces-decision-to-pause-further-enrolment-in-global-phase-iii-study-of-ultomiris-ravulizumab-cwvz-in-adults-with-severe-covid-19-requiring-mechanical-ventilation.html 2021-01-14T15:50:56.8330000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-biologics-license-application-bla-for-15-valent-pneumococcal-conjugate-vaccine-v114.html 2021-01-14T16:56:18.3480000Z https://www.medicinesresources.nhs.uk/welsh-national-standards-for-medication-review.html 2021-01-18T14:02:05.4690000Z https://www.medicinesresources.nhs.uk/bupropion-and-naltrexone-in-methamphetamine-use-disorder-1.html 2021-01-14T16:00:54.9710000Z https://www.medicinesresources.nhs.uk/inhaled-treprostinil-in-pulmonary-hypertension-due-to-interstitial-lung-disease.html 2021-01-14T16:03:20.3570000Z https://www.medicinesresources.nhs.uk/interim-results-of-a-phase-1-2a-trial-of-ad26-cov2-s-covid-19-vaccine.html 2021-01-14T16:04:26.1160000Z https://www.medicinesresources.nhs.uk/effects-of-the-covid-19-pandemic-on-primary-care-recorded-mental-illness-and-self-harm-episodes-in-the-uk-a-population-based-cohort-study.html 2021-01-14T16:06:56.7670000Z https://www.medicinesresources.nhs.uk/the-association-between-mechanical-ventilator-availability-and-mortality-risk-in-intensive-care-patients-with-covid-19-a-national-retrospective-cohort-study.html 2021-01-14T16:08:55.9900000Z https://www.medicinesresources.nhs.uk/alcohol-consumption-cardiac-biomarkers-and-risk-of-atrial-fibrillation-and-adverse-outcomes.html 2021-01-14T16:10:13.1970000Z https://www.medicinesresources.nhs.uk/methylprednisolone-powder-for-solution-for-injection-all-strengths-supply-disruption.html 2021-01-18T14:05:41.2860000Z https://www.medicinesresources.nhs.uk/nhs-discharge-medicines-service-essential-service-toolkit-for-pharmacy-staff-in-community-primary-and-secondary-care.html 2021-01-18T14:06:45.2280000Z https://www.medicinesresources.nhs.uk/nhs-england-publishes-standard-operating-procedure-for-administering-the-covid-19-vaccine-to-frontline-social-care-workers-jcvi-priority-cohort-2.html 2021-01-18T14:07:59.6910000Z https://www.medicinesresources.nhs.uk/revised-spc-busilvex-busulfan-6-mg-ml-concentrate-for-solution-for-infusion.html 2021-01-15T15:27:26.6590000Z https://www.medicinesresources.nhs.uk/revised-spc-darzalex-daratumumab-1-800-mg-solution-for-injection.html 2021-01-15T15:28:33.7950000Z https://www.medicinesresources.nhs.uk/revised-spc-imbruvica-ibrutinib-film-coated-tablets.html 2021-01-15T15:29:45.2040000Z https://www.medicinesresources.nhs.uk/revised-spcs-rifadin-rifampicin-preparations.html 2021-01-15T15:30:52.3650000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-medabon-combipack-mifepristone-200-mg-tablet-and-misoprostol-4-x-0-2-mg-vaginal-tablets-combination-therapy-for-medical-abortion.html 2021-01-18T14:09:21.1330000Z https://www.medicinesresources.nhs.uk/reporting-suspected-covid-19-vaccine-side-effects-product-defects-and-counterfeit-products.html 2021-01-18T14:09:59.5960000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-evidence-summary-tocilizumab-for-covid-19.html 2021-01-18T14:11:02.4040000Z https://www.medicinesresources.nhs.uk/us-fda-approves-crizotinib-for-treatment-of-alk-positive-anaplastic-large-cell-lymphoma-alcl-in-children-aged-1-year-and-above-and-young-adults.html 2021-01-15T15:39:37.5650000Z https://www.medicinesresources.nhs.uk/brilacidin-granted-fast-track-designation-in-the-us-for-the-treatment-of-covid-19.html 2021-01-15T15:42:24.1950000Z https://www.medicinesresources.nhs.uk/covid-fake-news-causing-uk-south-asians-to-reject-jab.html 2021-01-15T15:43:54.2560000Z https://www.medicinesresources.nhs.uk/ageing-science-technology-and-healthy-living.html 2021-01-15T16:52:55.3050000Z https://www.medicinesresources.nhs.uk/mitigating-ethnic-disparities-in-covid-19-and-beyond.html 2021-01-15T15:46:57.0950000Z https://www.medicinesresources.nhs.uk/liverpool-covid-19-community-testing-pilot-interim-evaluation-report-summary.html 2021-01-15T15:49:02.6870000Z https://www.medicinesresources.nhs.uk/hsib-investigates-oxygen-issues-during-the-covid-19-pandemic.html 2021-01-18T14:12:19.5470000Z https://www.medicinesresources.nhs.uk/funding-of-pharmaceutical-innovation-during-and-after-the-covid-19-pandemic.html 2021-01-15T15:52:02.5520000Z https://www.medicinesresources.nhs.uk/us-breakthrough-designation-for-ligelizumab-in-chronic-spontaneous-urticaria-unresponsive-to-h1-antihistamine-treatment.html 2021-01-15T15:54:08.8340000Z https://www.medicinesresources.nhs.uk/niraparib-for-maintenance-treatment-of-advanced-ovarian-fallopian-tube-and-peritoneal-cancer-after-response-to-first-line-platinum-based-chemotherapy-final-appraisal-document.html 2021-01-15T15:56:07.5360000Z https://www.medicinesresources.nhs.uk/trial-of-covid-19-convalescent-blood-plasma-finds-no-benefit-in-severely-ill-patients.html 2021-01-15T15:58:32.6740000Z https://www.medicinesresources.nhs.uk/bmj-best-practice-available-to-all-community-pharmacists-and-technicians.html 2021-01-15T16:00:42.3590000Z https://www.medicinesresources.nhs.uk/covid-19-evaluation-of-hepatitis-c-homeless-interventions.html 2021-01-15T16:02:57.6030000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-uptake-in-england-provisional-weekly-data-up-to-week-1.html 2021-01-15T16:04:24.1960000Z https://www.medicinesresources.nhs.uk/new-dosing-regimen-for-durvalumab-imfinzi-for-advanced-non-small-cell-lung-cancer-nsclc-approved-in-uk-and-eu.html 2021-01-15T16:05:49.2430000Z https://www.medicinesresources.nhs.uk/comparison-of-systemic-treatments-for-metastatic-castration-sensitive-prostate-cancer-a-systematic-review-and-network-meta-analysis.html 2021-01-15T16:41:29.1530000Z https://www.medicinesresources.nhs.uk/a-comparison-of-two-hybrid-closed-loop-systems-in-adolescents-and-young-adults-with-type-1-diabetes-flair-a-multicentre-randomised-crossover-trial.html 2021-01-15T16:42:28.3620000Z https://www.medicinesresources.nhs.uk/machine-learning-based-prediction-of-adverse-events-following-an-acute-coronary-syndrome-praise-a-modelling-study-of-pooled-datasets.html 2021-01-15T16:43:34.4240000Z https://www.medicinesresources.nhs.uk/convalescent-plasma-antibody-levels-and-the-risk-of-death-from-covid-19.html 2021-01-15T16:46:13.4510000Z https://www.medicinesresources.nhs.uk/clinical-efficacy-and-safety-of-alirocumab-after-acute-coronary-syndrome-according-to-achieved-level-of-low-density-lipoprotein-cholesterol-a-propensity-score-matched-analysis-of-the-odyssey-outcomes-trial.html 2021-01-15T16:47:52.7550000Z https://www.medicinesresources.nhs.uk/c-reactive-protein-and-clinical-outcomes-in-patients-with-covid-19.html 2021-01-15T16:49:43.6030000Z https://www.medicinesresources.nhs.uk/effectiveness-of-sequential-chemoradiation-vs-concurrent-chemoradiation-or-radiation-alone-in-adjuvant-treatment-after-hysterectomy-for-cervical-cancer-the-stars-phase-3-randomized-clinical-trial.html 2021-01-15T16:50:57.7190000Z https://www.medicinesresources.nhs.uk/randomized-phase-ii-study-of-bevacizumab-in-combination-with-carboplatin-plus-paclitaxel-in-patients-with-previously-untreated-advanced-mucosal-melanoma.html 2021-01-15T16:52:04.7270000Z https://www.medicinesresources.nhs.uk/development-and-validation-of-a-risk-tool-for-predicting-severe-toxicity-in-older-adults-receiving-chemotherapy-for-early-stage-breast-cancer.html 2021-01-15T16:53:04.3900000Z https://www.medicinesresources.nhs.uk/subcutaneous-rituximab-minichop-compared-with-subcutaneous-rituximab-minichop-plus-lenalidomide-in-diffuse-large-b-cell-lymphoma-for-patients-age-80-years-or-older.html 2021-01-15T16:54:21.1530000Z https://www.medicinesresources.nhs.uk/impact-of-the-covid-19-pandemic-on-the-detection-and-management-of-colorectal-cancer-in-england-a-population-based-study.html 2021-01-15T17:02:32.5940000Z https://www.medicinesresources.nhs.uk/revised-spc-mezavant-xl-mesalazine-1200mg-gastro-resistant-prolonged-release-tablets.html 2021-01-18T12:44:54.1230000Z https://www.medicinesresources.nhs.uk/revised-spc-yervoy-ipilimumab-5-mg-ml-concentrate-for-solution-for-infusion-1.html 2021-01-18T12:46:34.0520000Z https://www.medicinesresources.nhs.uk/prac-concludes-evaluation-of-risk-of-acute-adrenal-insufficiency-in-children-when-switching-to-alkindi-hydrocortisone-granules.html 2021-01-20T15:40:42.5710000Z https://www.medicinesresources.nhs.uk/effect-of-the-vancomycin-minimum-inhibitory-concentration-on-clinical-outcomes-in-patients-with-methicillin-susceptible-staphylococcus-aureus-bacteraemia-a-systematic-review-and-meta-analysis.html 2021-01-18T12:50:30.7550000Z https://www.medicinesresources.nhs.uk/does-methenamine-hippurate-decrease-urinary-tract-symptoms-in-community-adult-women-a-systematic-review-and-meta-analysis.html 2021-01-18T13:30:01.4680000Z https://www.medicinesresources.nhs.uk/ethnicity-and-outcomes-in-patients-hospitalised-with-covid-19-infection-in-east-london-an-observational-cohort-study.html 2021-01-18T12:54:58.8780000Z https://www.medicinesresources.nhs.uk/infection-related-complications-after-common-infection-in-association-with-new-antibiotic-prescribing-in-primary-care-retrospective-cohort-study-using-linked-electronic-health-records.html 2021-01-20T11:41:50.8800000Z https://www.medicinesresources.nhs.uk/gps-insights-about-discontinuing-long-term-antidepressant-use-a-qualitative-study.html 2021-01-18T13:01:21.0860000Z https://www.medicinesresources.nhs.uk/a-prospective-observational-study-to-evaluate-adverse-drug-reactions-in-patients-with-covid-19-treated-with-remdesivir-or-hydroxychloroquine-a-preliminary-report-2.html 2021-01-18T13:03:49.5840000Z https://www.medicinesresources.nhs.uk/severe-and-fatal-medication-errors-in-hospitals-findings-from-the-norwegian-incident-reporting-system-1.html 2021-01-18T13:05:00.2520000Z https://www.medicinesresources.nhs.uk/risk-of-out-of-hospital-cardiac-arrest-in-patients-with-bipolar-disorder-or-schizophrenia-1.html 2021-01-18T13:06:59.9500000Z https://www.medicinesresources.nhs.uk/long-term-survival-benefit-of-ramipril-in-patients-with-acute-myocardial-infarction-complicated-by-heart-failure.html 2021-01-18T13:08:17.3660000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-enhertu-trastuzumab-deruxtecan-for-her2-positive-metastatic-gastric-cancer.html 2021-01-18T13:09:16.8990000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-for-treatment-of-light-chain-amyloidosis.html 2021-01-18T13:10:31.8720000Z https://www.medicinesresources.nhs.uk/covid-19-norway-investigates-23-deaths-in-frail-elderly-patients-after-vaccination.html 2021-01-18T13:11:45.0910000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-rolled-out-to-people-aged-70-years-and-over-from-today.html 2021-01-18T15:24:12.8250000Z https://www.medicinesresources.nhs.uk/the-cardiovascular-dialysis-nexus-the-transition-to-dialysis-is-a-treacherous-time-for-the-heart-1.html 2021-01-18T13:16:12.0750000Z https://www.medicinesresources.nhs.uk/vitamin-d-and-care-homes-guidance-2.html 2021-01-19T10:26:44.8640000Z https://www.medicinesresources.nhs.uk/pulse-oximetry-to-detect-early-deterioration-of-patients-with-covid-19-in-primary-and-community-care-settings.html 2021-01-18T15:42:12.0580000Z https://www.medicinesresources.nhs.uk/comparison-of-saliva-and-nasopharyngeal-swab-nucleic-acid-amplification-testing-for-detection-of-sars-cov-2-a-systematic-review-and-meta-analysis.html 2021-01-18T15:43:39.1240000Z https://www.medicinesresources.nhs.uk/palbociclib-with-adjuvant-endocrine-therapy-in-early-breast-cancer-pallas-interim-analysis-of-a-multicentre-open-label-randomised-phase-3-study.html 2021-01-18T15:45:38.8930000Z https://www.medicinesresources.nhs.uk/electronic-health-record-alerts-for-acute-kidney-injury-multicenter-randomized-clinical-trial.html 2021-01-18T15:47:10.2730000Z https://www.medicinesresources.nhs.uk/five-year-outcomes-from-the-randomized-phase-iii-trials-checkmate-017-and-057-nivolumab-versus-docetaxel-in-previously-treated-non-small-cell-lung-cancer.html 2021-01-18T15:49:01.5660000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-and-outcomes-of-hospitalized-women-giving-birth-with-and-without-covid-19.html 2021-01-18T15:50:26.7270000Z https://www.medicinesresources.nhs.uk/doctors-and-police-warn-on-covid-19-vaccine-scams.html 2021-01-18T15:51:55.7990000Z https://www.medicinesresources.nhs.uk/new-every-mind-matters-campaign.html 2021-01-18T15:56:16.1080000Z https://www.medicinesresources.nhs.uk/management-of-non-alcoholic-fatty-liver-disease.html 2021-01-18T15:55:32.0570000Z https://www.medicinesresources.nhs.uk/bmj-editorial-vaccinating-against-covid-19-in-people-who-report-allergies.html 2021-01-18T15:57:42.7970000Z https://www.medicinesresources.nhs.uk/new-molecular-entity-troriluzole-strikes-out-in-alzheimer-s-trial-2.html 2021-01-19T16:59:23.2940000Z https://www.medicinesresources.nhs.uk/what-we-know-about-covid-19-reinfection-so-far.html 2021-01-19T16:24:44.9690000Z https://www.medicinesresources.nhs.uk/covid-19-what-new-variants-are-emerging-and-how-are-they-being-investigated.html 2021-01-19T16:25:45.6040000Z https://www.medicinesresources.nhs.uk/revised-spcs-gilenya-fingolimod-hydrochloride-hard-capsules-all-strengths.html 2021-01-19T16:26:47.7570000Z https://www.medicinesresources.nhs.uk/revised-spcs-orkambi-ivacaftor-lumacaftor-film-coated-tablets-all-strengths.html 2021-01-19T16:27:58.6530000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-highlights-key-role-of-healthcare-professionals-hcps-in-fostering-confidence-in-covid-19-vaccines.html 2021-01-20T11:10:16.4900000Z https://www.medicinesresources.nhs.uk/ropeginterferon-alfa-2b-versus-phlebotomy-in-low-risk-patients-with-polycythaemia-vera-low-pv-study-a-multicentre-randomised-phase-2-trial.html 2021-01-19T17:01:51.7270000Z https://www.medicinesresources.nhs.uk/cytoreductive-surgery-plus-hyperthermic-intraperitoneal-chemotherapy-versus-cytoreductive-surgery-alone-for-colorectal-peritoneal-metastases-prodige-7-a-multicentre-randomised-open-label-phase-3-trial.html 2021-01-19T17:03:10.5440000Z https://www.medicinesresources.nhs.uk/household-transmission-of-sars-cov-2-and-risk-factors-for-susceptibility-and-infectivity-in-wuhan-a-retrospective-observational-study.html 2021-01-19T16:34:14.4380000Z https://www.medicinesresources.nhs.uk/company-led-medicines-recall-instanyl-100mcg-nasal-spray-solution-eu-1-09-531-015.html 2021-01-20T11:22:56.0920000Z https://www.medicinesresources.nhs.uk/femseven-conti-estradiol-levonorgestrel-hrt-patches-back-in-stock-after-a-long-term-shortage-2.html 2021-01-19T17:04:39.7210000Z https://www.medicinesresources.nhs.uk/first-line-nivolumab-plus-ipilimumab-combined-with-two-cycles-of-chemotherapy-in-patients-with-non-small-cell-lung-cancer-checkmate-9la-an-international-randomised-open-label-phase-3-trial-2.html 2021-01-19T17:37:26.9800000Z https://www.medicinesresources.nhs.uk/secukinumab-cosentyx-r-accepted-for-use-within-nhs-scotland-for-treatment-of-active-non-radiographic-axial-spondyloarthritis.html 2021-01-19T17:50:28.8550000Z https://www.medicinesresources.nhs.uk/daratumumab-subcutaneous-injection-darzalex-r-accepted-for-use-within-nhs-scotland-for-treatment-of-adults-with-newly-diagnosed-multiple-myeloma-eligible-for-autologous-stem-cell-transplant.html 2021-01-19T17:43:51.8060000Z https://www.medicinesresources.nhs.uk/melatonin-prolonged-release-slenyto-r-not-recommended-for-use-within-nhs-scotland-for-treatment-of-insomnia-in-children-and-adolescents-aged-2-to-18-years-with-autism-spectrum-disorder-and-or-smith-magenis-syndrome.html 2021-01-19T16:53:36.5570000Z https://www.medicinesresources.nhs.uk/fostamatinib-tavlesse-r-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-chronic-immune-thrombocytopenia-itp-in-adults.html 2021-01-19T16:54:50.6080000Z https://www.medicinesresources.nhs.uk/brentuximab-vedotin-adcetris-r-accepted-for-use-within-nhs-scotland-for-adults-with-previously-untreated-systemic-anaplastic-large-cell-lymphoma-salcl.html 2021-01-19T16:55:56.1040000Z https://www.medicinesresources.nhs.uk/brigatinib-alunbrig-r-accepted-for-use-within-nhsscotland-for-treatment-of-adults-with-anaplastic-lymphoma-kinase-alk-positive-advanced-non-small-cell-lung-cancer.html 2021-01-19T17:51:48.3590000Z https://www.medicinesresources.nhs.uk/entrectinib-rozlytrek-r-accepted-for-use-within-nhs-scotland-for-treatment-of-adults-with-ros1-positive-advanced-non-small-cell-lung-cancer-nsclc.html 2021-01-19T16:58:21.1690000Z https://www.medicinesresources.nhs.uk/revised-spc-granocyte-lenograstim-pre-filled-syringe-1.html 2021-01-20T15:57:22.3290000Z https://www.medicinesresources.nhs.uk/revised-spc-stelara-ustekinumab-injection.html 2021-01-20T15:59:58.9860000Z https://www.medicinesresources.nhs.uk/revised-spc-propylthiouracil-tablets.html 2021-01-20T16:49:41.5670000Z https://www.medicinesresources.nhs.uk/use-of-tyrosine-kinase-inhibitors-for-paediatric-philadelphia-chromosome-positive-acute-lymphoblastic-leukaemia-a-systematic-review-and-meta-analysis.html 2021-01-20T16:05:14.5370000Z https://www.medicinesresources.nhs.uk/association-of-pharmacological-interventions-with-symptom-burden-reduction-in-patients-with-mild-traumatic-brain-injury-a-systematic-review.html 2021-01-20T16:08:47.5930000Z https://www.medicinesresources.nhs.uk/natural-cycles-for-monitoring-fertility-mib244-1.html 2021-01-25T09:54:49.5340000Z https://www.medicinesresources.nhs.uk/effect-of-mechanical-thrombectomy-without-vs-with-intravenous-thrombolysis-on-functional-outcome-among-patients-with-acute-ischemic-stroke-the-skip-randomized-clinical-trial.html 2021-01-20T16:51:38.8560000Z https://www.medicinesresources.nhs.uk/effect-of-discontinuing-vs-continuing-angiotensin-converting-enzyme-inhibitors-and-angiotensin-ii-receptor-blockers-on-days-alive-and-out-of-the-hospital-in-patients-admitted-with-covid-19-a-randomized-clinical-trial.html 2021-01-25T10:00:40.4840000Z https://www.medicinesresources.nhs.uk/durable-effects-of-iglarlixi-up-to-52-weeks-in-type-2-diabetes-the-lixilan-g-extension-study-1.html 2021-01-20T16:20:11.0960000Z https://www.medicinesresources.nhs.uk/clinical-characteristics-and-outcomes-of-covid-19-in-haematopoietic-stem-cell-transplantation-recipients-an-observational-cohort-study.html 2021-01-25T10:10:20.3980000Z https://www.medicinesresources.nhs.uk/apixaban-or-vitamin-k-antagonists-and-aspirin-or-placebo-according-to-kidney-function-in-patients-with-atrial-fibrillation-after-acute-coronary-syndrome-or-pci-insights-from-the-augustus-trial.html 2021-01-20T16:24:07.9330000Z https://www.medicinesresources.nhs.uk/acute-pain-management-among-patients-with-opioid-maintenance-therapy-specificities-and-difficulties-identified-in-primary-care-a-qualitative-study.html 2021-01-20T16:26:53.2890000Z https://www.medicinesresources.nhs.uk/estimating-the-potential-impact-of-implementing-pre-emptive-pharmacogenetic-testing-in-primary-care-across-the-uk.html 2021-01-20T16:29:58.4260000Z https://www.medicinesresources.nhs.uk/findings-of-efficacy-safety-and-biomarker-outcomes-of-atabecestat-in-preclinical-alzheimer-disease-a-truncated-randomized-phase-2b-3-clinical-trial.html 2021-01-20T16:33:21.0600000Z https://www.medicinesresources.nhs.uk/home-and-online-management-and-evaluation-of-blood-pressure-home-bp-using-a-digital-intervention-in-poorly-controlled-hypertension-randomised-controlled-trial.html 2021-01-20T16:36:00.4280000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-cantharidin-for-molluscum-contagiosum.html 2021-01-20T16:37:22.2560000Z https://www.medicinesresources.nhs.uk/increasing-pharmacotherapy-safety-at-physicians-career-start-presentation-of-a-10-item-list-with-helpful-hints.html 2021-01-20T16:39:32.5660000Z https://www.medicinesresources.nhs.uk/the-enigmatic-immunoglobulin-g4-related-disease-and-its-varied-cardiovascular-manifestations.html 2021-01-20T16:41:27.2420000Z https://www.medicinesresources.nhs.uk/levosert-levonorgestrel-intrauterine-system-ius-approved-for-extended-contraceptive-use-1.html 2021-01-20T16:43:27.5340000Z https://www.medicinesresources.nhs.uk/metreleptin-for-treating-lipodystrophy-final-appraisal-determination.html 2021-01-20T16:45:03.8080000Z https://www.medicinesresources.nhs.uk/autologous-anti-cd19-transduced-cd3-cells-for-treating-relapsed-or-refractory-mantle-cell-lymphoma-final-appraisal-determination.html 2021-01-20T16:46:34.7810000Z https://www.medicinesresources.nhs.uk/trastuzumab-deruxtecan-given-conditional-approval-in-eu-for-her2-positive-breast-cancer.html 2021-01-20T16:48:02.9660000Z https://www.medicinesresources.nhs.uk/nirsevimab-awarded-promising-innovative-medicine-pim-status-for-the-prevention-of-respiratory-syncytial-virus-rsv-associated-lower-respiratory-tract.html 2021-01-20T16:49:31.2190000Z https://www.medicinesresources.nhs.uk/pgd-template-for-the-administration-of-benzylpenicillin-injection.html 2021-01-25T09:41:55.4520000Z https://www.medicinesresources.nhs.uk/effect-of-endovascular-treatment-alone-vs-intravenous-alteplase-plus-endovascular-treatment-on-functional-independence-in-patients-with-acute-ischemic-stroke-the-devt-randomized-clinical-trial.html 2021-01-20T16:56:19.3590000Z https://www.medicinesresources.nhs.uk/lower-or-higher-oxygenation-targets-for-acute-hypoxemic-respiratory-failure-1.html 2021-01-20T16:56:45.2210000Z https://www.medicinesresources.nhs.uk/revised-spc-piriton-chlorphenamine-preparations.html 2021-01-25T10:36:50.4500000Z https://www.medicinesresources.nhs.uk/revised-spc-ofev-nintedanib-soft-capsules.html 2021-01-21T16:15:58.5090000Z https://www.medicinesresources.nhs.uk/revised-spc-niquitin-nicotine-pre-quit-clear-21mg-patch.html 2021-01-21T16:17:41.5260000Z https://www.medicinesresources.nhs.uk/revised-spc-valcyte-valganciclovir-50-mg-ml-powder-for-oral-solution.html 2021-01-21T16:18:49.8540000Z https://www.medicinesresources.nhs.uk/national-dose-banding-table-irinotecan-20mgml.html 2021-01-25T10:49:37.8410000Z https://www.medicinesresources.nhs.uk/effects-of-vitamin-c-supplementation-on-glycemic-control-and-cardiovascular-risk-factors-in-people-with-type-2-diabetes-a-grade-assessed-systematic-review-and-meta-analysis-of-randomized-controlled-trials.html 2021-01-21T16:21:03.7930000Z https://www.medicinesresources.nhs.uk/covid-19-and-healthcare-workers-a-rapid-systematic-review-into-risks-and-preventive-measures.html 2021-01-21T16:22:03.8750000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-evidence-summary-sarilumab-for-covid-19.html 2021-01-25T10:56:44.8870000Z https://www.medicinesresources.nhs.uk/nihr-alert-older-people-move-safely-from-hospital-to-home-when-staff-communicate-widely-and-bridge-gaps-in-the-system.html 2021-01-25T11:37:21.3820000Z https://www.medicinesresources.nhs.uk/drug-induced-liver-injury-in-a-patient-with-coronavirus-disease-2019-potential-interaction-of-remdesivir-with-p-glycoprotein-inhibitors.html 2021-01-25T11:01:15.5230000Z https://www.medicinesresources.nhs.uk/association-of-secukinumab-treatment-with-tuberculosis-reactivation-in-patients-with-psoriasis-psoriatic-arthritis-or-ankylosing-spondylitis.html 2021-01-25T08:54:14.7260000Z https://www.medicinesresources.nhs.uk/impact-of-pharmacist-led-medication-therapy-management-in-ambulatory-elderly-patients-with-chronic-diseases-1.html 2021-01-21T16:32:35.7470000Z https://www.medicinesresources.nhs.uk/vericiguat-approved-in-the-us-for-treatment-of-chronic-heart-failure.html 2021-01-21T16:33:46.4800000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-for-priority-review-application-for-opdivo-r-nivolumab-combined-with-chemotherapy-as-first-line-treatment-in-metastatic-gastric-cancer-gastroesophageal-junction-cancer-and-oesophageal-adenocarcinoma.html 2021-01-21T16:34:45.0420000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-for-review-an-application-for-approval-of-nasal-dihydroergotamine-mesylate-inp1041-for-the-acute-treatment-of-migraine.html 2021-01-21T16:35:49.0910000Z https://www.medicinesresources.nhs.uk/avatrombopag-approved-in-the-eu-for-the-treatment-of-primary-chronic-immune-thrombocytopenia-itp.html 2021-01-21T16:36:48.4550000Z https://www.medicinesresources.nhs.uk/positive-results-from-phase-3-study-of-amphetamine-extended-release-tablets-in-adults-with-adhd-1.html 2021-01-21T16:39:15.5480000Z https://www.medicinesresources.nhs.uk/postinfectious-epigenetic-immune-modifications-a-double-edged-sword.html 2021-01-21T16:40:39.0990000Z https://www.medicinesresources.nhs.uk/will-calorie-labels-for-food-and-drink-served-outside-the-home-improve-public-health.html 2021-01-21T16:42:13.6130000Z https://www.medicinesresources.nhs.uk/the-eus-initial-contribution-to-the-public-health-response-to-covid-19.html 2021-01-21T18:34:05.7510000Z https://www.medicinesresources.nhs.uk/adrenal-insufficiency-1.html 2021-01-21T16:45:27.4950000Z https://www.medicinesresources.nhs.uk/paediatric-multiple-sclerosis-and-antibody-associated-demyelination-clinical-imaging-and-biological-considerations-for-diagnosis-and-care-1.html 2021-01-21T16:47:08.1350000Z https://www.medicinesresources.nhs.uk/scientific-advisory-committee-on-nutrition-statement-on-nutrition-and-older-adults.html 2021-01-21T16:48:12.9680000Z https://www.medicinesresources.nhs.uk/position-statement-regarding-daily-contact-testing-in-schools-from-phe-and-nhs-test-and-trace.html 2021-01-21T16:49:14.9360000Z https://www.medicinesresources.nhs.uk/company-led-medicines-recall-respreeza-1-000-mg-powder-and-solvent-for-solution-for-infusion-eu-1-15-1006-001.html 2021-01-25T11:55:22.6940000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-scientific-opinion-pemigatinib-in-the-treatment-of-cholangioarcinoma.html 2021-01-25T12:08:53.3560000Z https://www.medicinesresources.nhs.uk/react-1-study-of-coronavirus-transmission-january-2021-interim-results.html 2021-01-25T11:10:43.8310000Z https://www.medicinesresources.nhs.uk/covid-19-vaccinations-for-community-based-social-care-workers.html 2021-01-25T11:51:23.7430000Z https://www.medicinesresources.nhs.uk/never-events-analysis-of-hsibs-national-investigations.html 2021-01-25T11:22:31.3320000Z https://www.medicinesresources.nhs.uk/healthcare-safety-investigation-branch-hsib-launches-investigation-into-weight-based-medication-errors-in-children.html 2021-01-25T11:34:14.7420000Z https://www.medicinesresources.nhs.uk/covid-19-insight-issue-7.html 2021-01-21T17:00:52.7120000Z https://www.medicinesresources.nhs.uk/chlormethine-gel-for-treating-mycosis-fungoides-type-cutaneous-t-cell-lymphoma-second-appraisal-consultation.html 2021-01-21T17:02:38.6810000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guideline-on-antimicrobial-prescribing-for-clostridioides-difficile-infection-for-consultation.html 2021-01-21T17:03:40.0600000Z https://www.medicinesresources.nhs.uk/national-audit-of-pulmonary-hypertension-great-britain-2019-20.html 2021-01-21T17:05:52.4520000Z https://www.medicinesresources.nhs.uk/stepping-up-the-response-of-stop-smoking-services-in-england-to-the-covid-19-pandemic.html 2021-01-21T17:08:19.9500000Z https://www.medicinesresources.nhs.uk/supply-chain-workers-crucial-to-covid-19-vaccination-programme-to-be-offered-vaccine.html 2021-01-21T17:09:39.5030000Z https://www.medicinesresources.nhs.uk/filgotinib-for-treating-moderate-to-severe-rheumatoid-arthritis-final-appraisal-document.html 2021-01-21T17:10:52.0010000Z https://www.medicinesresources.nhs.uk/discharge-medicines-service-declaration-of-competence-now-available.html 2021-01-21T17:11:56.0930000Z https://www.medicinesresources.nhs.uk/second-wave-of-community-pharmacies-join-vaccination-push-1.html 2021-01-21T17:13:45.1610000Z https://www.medicinesresources.nhs.uk/sign-publishes-minor-update-to-guideline-on-management-of-osteoporosis-and-the-prevention-of-fragility-fractures.html 2021-01-21T17:14:57.8690000Z https://www.medicinesresources.nhs.uk/effect-of-pre-exposure-use-of-hydroxychloroquine-on-covid-19-mortality-a-population-based-cohort-study-in-patients-with-rheumatoid-arthritis-or-systemic-lupus-erythematosus-using-the-opensafely-platform.html 2021-01-21T18:18:16.2170000Z https://www.medicinesresources.nhs.uk/effect-of-tocilizumab-on-clinical-outcomes-at-15-days-in-patients-with-severe-or-critical-coronavirus-disease-2019-randomised-controlled-trial.html 2021-01-21T18:15:58.0650000Z https://www.medicinesresources.nhs.uk/factors-influencing-the-implementation-of-clinical-pharmacy-services-on-paediatric-patient-care-in-hospital-settings.html 2021-01-21T17:53:01.3700000Z https://www.medicinesresources.nhs.uk/pharmacists-considerations-on-non-medical-switching-at-the-hospital-a-systematic-review-of-the-economic-outcomes-of-cost-saving-therapeutic-drug-classes.html 2021-01-21T17:54:14.9660000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-antidepressants-for-the-treatment-of-back-pain-and-osteoarthritis-systematic-review-and-meta-analysis-1.html 2021-01-22T15:45:40.8360000Z https://www.medicinesresources.nhs.uk/dtb-select-persistence-of-pims-in-older-people.html 2021-01-22T15:48:04.4460000Z https://www.medicinesresources.nhs.uk/moderate-to-severe-acne-and-mental-health-symptoms-in-transmasculine-persons-who-have-received-testosterone.html 2021-01-22T15:49:13.1010000Z https://www.medicinesresources.nhs.uk/rituximab-versus-tocilizumab-in-anti-tnf-inadequate-responder-patients-with-rheumatoid-arthritis-r4ra-16-week-outcomes-of-a-stratified-biopsy-driven-multicentre-open-label-phase-4-randomised-controlled-trial.html 2021-01-22T16:41:53.6830000Z https://www.medicinesresources.nhs.uk/first-line-nivolumab-plus-ipilimumab-in-unresectable-malignant-pleural-mesothelioma-checkmate-743-a-multicentre-randomised-open-label-phase-3-trial.html 2021-01-22T15:52:36.9810000Z https://www.medicinesresources.nhs.uk/allergic-reactions-including-anaphylaxis-after-receipt-of-the-first-dose-of-pfizer-biontech-covid-19-vaccine.html 2021-01-25T12:37:02.8790000Z https://www.medicinesresources.nhs.uk/risk-of-acute-kidney-injury-by-initiation-of-non-steroidal-anti-inflammatory-drugs-in-hospitalised-patients-treated-with-diuretics-and-renin-angiotensin-aldosterone-system-inhibitors.html 2021-01-22T15:55:02.4890000Z https://www.medicinesresources.nhs.uk/association-of-early-phase-in-hospital-glycemic-fluctuation-with-mortality-in-adult-patients-with-coronavirus-disease-2019.html 2021-01-22T15:55:55.6080000Z https://www.medicinesresources.nhs.uk/efficacy-of-perioperative-chemotherapy-for-resectable-pancreatic-adenocarcinoma-a-phase-2-randomized-clinical-trial.html 2021-01-22T15:57:45.3790000Z https://www.medicinesresources.nhs.uk/aspirin-use-and-risk-of-colorectal-cancer-among-older-adults.html 2021-01-22T15:58:38.1640000Z https://www.medicinesresources.nhs.uk/quarantine-and-testing-strategies-in-contact-tracing-for-sars-cov-2-a-modelling-study.html 2021-01-22T16:01:06.3950000Z https://www.medicinesresources.nhs.uk/lansoprazole-for-persistent-throat-symptoms-in-secondary-care-the-toppits-rct.html 2021-01-22T16:03:03.7930000Z https://www.medicinesresources.nhs.uk/incidence-and-factors-associated-with-acne-among-transgender-patients-receiving-masculinizing-hormone-therapy.html 2021-01-22T16:04:17.8550000Z https://www.medicinesresources.nhs.uk/adavosertib-plus-gemcitabine-for-platinum-resistant-or-platinum-refractory-recurrent-ovarian-cancer-a-double-blind-randomised-placebo-controlled-phase-2-trial.html 2021-01-22T16:44:45.8850000Z https://www.medicinesresources.nhs.uk/effect-of-bamlanivimab-as-monotherapy-or-in-combination-with-etesevimab-on-viral-load-in-patients-with-mild-to-moderate-covid-19-a-randomized-clinical-trial.html 2021-01-22T16:46:07.2330000Z https://www.medicinesresources.nhs.uk/association-of-potent-and-very-potent-topical-corticosteroids-and-the-risk-of-osteoporosis-and-major-osteoporotic-fractures.html 2021-01-22T16:09:01.4590000Z https://www.medicinesresources.nhs.uk/interim-clinical-commissioning-policy-statement-teriparatide-for-osteoporosis-in-men-adults.html 2021-01-25T12:41:26.1680000Z https://www.medicinesresources.nhs.uk/genentech-earns-priority-review-for-lung-disease-drug-following-positive-clinical-data.html 2021-01-22T16:50:02.2610000Z https://www.medicinesresources.nhs.uk/positive-results-for-bamlanivimab-ly-cov555-for-preventing-covid-19-at-nursing-homes-in-the-blaze-2-trial.html 2021-01-22T16:13:58.2450000Z https://www.medicinesresources.nhs.uk/tagraxofusp-approved-for-use-in-eu-for-the-treatment-of-blastic-plasmacytoid-dendritic-cell-neoplasm.html 2021-01-22T16:14:57.7380000Z https://www.medicinesresources.nhs.uk/retifanlimab-granted-priority-review-in-the-us-for-squamous-cell-carcinoma-of-the-anal-canal-scac.html 2021-01-22T16:15:52.7050000Z https://www.medicinesresources.nhs.uk/manufacturers-discontinue-trial-of-bintrafusp-alfa-for-use-in-lung-cancer-1.html 2021-01-22T16:17:28.7570000Z https://www.medicinesresources.nhs.uk/human-medicines-highlights-of-2020.html 2021-01-22T16:19:41.4350000Z https://www.medicinesresources.nhs.uk/supporting-pharmacy-professionals-throughout-the-covid-19-pandemic.html 2021-01-22T16:20:32.1950000Z https://www.medicinesresources.nhs.uk/a1-antitrypsin-deficiency-and-the-risk-of-covid-19-an-urgent-call-to-action-1.html 2021-01-22T16:22:34.6870000Z https://www.medicinesresources.nhs.uk/chronic-kidney-disease-assessment-and-management-update-draft-guidance.html 2021-01-22T16:23:26.0460000Z https://www.medicinesresources.nhs.uk/first-triple-combination-mdi-licensed-for-asthma.html 2021-01-22T16:27:15.6180000Z https://www.medicinesresources.nhs.uk/appraisal-consultation-document-ozanimod-for-treating-relapsing-remitting-multiple-s.html 2021-01-22T16:26:21.0080000Z https://www.medicinesresources.nhs.uk/an-action-plan-for-pan-european-defence-against-new-sars-cov-2-variants-1.html 2021-01-22T16:32:29.8730000Z https://www.medicinesresources.nhs.uk/covid-19-the-green-book-chapter-14a-covid-19-update.html 2021-01-25T13:36:50.8100000Z https://www.medicinesresources.nhs.uk/working-for-babies-lockdown-lessons-from-local-systems.html 2021-01-22T16:34:06.3600000Z https://www.medicinesresources.nhs.uk/safety-and-tolerability-of-lumateperone-42-mg-an-open-label-antipsychotic-switch-study-in-outpatients-with-stable-schizophrenia-1.html 2021-01-22T16:36:01.9860000Z https://www.medicinesresources.nhs.uk/revised-spc-lamictal-lamotrigine-tablets-and-dispersible-tablets-2.html 2021-01-25T12:33:46.7280000Z https://www.medicinesresources.nhs.uk/revised-spc-ocrevus-ocrelizumab-300-mg-concentrate-for-solution-for-infusion.html 2021-01-25T12:35:55.4560000Z https://www.medicinesresources.nhs.uk/the-influence-of-proton-pump-inhibitor-therapy-on-the-outcome-of-infliximab-therapy-in-inflammatory-bowel-disease-a-patient-level-meta-analysis-of-randomised-controlled-studies.html 2021-01-25T15:18:46.9570000Z https://www.medicinesresources.nhs.uk/pharmacist-led-intervention-on-chronic-pain-management-a-systematic-review-and-meta-analysis.html 2021-01-25T12:41:24.0110000Z https://www.medicinesresources.nhs.uk/use-of-non-steroidal-anti-inflammatory-drugs-and-risk-of-death-from-covid-19-an-opensafely-cohort-analysis-based-on-two-cohorts.html 2021-01-25T12:42:58.5720000Z https://www.medicinesresources.nhs.uk/the-proportion-of-sars-cov-2-infections-that-are-asymptomatic.html 2021-01-25T12:44:15.6620000Z https://www.medicinesresources.nhs.uk/fda-grants-toripalimab-fast-track-designation-for-mucosal-melanoma.html 2021-01-25T12:46:14.4000000Z https://www.medicinesresources.nhs.uk/european-approval-of-licence-extension-of-avelumab-bavencio-for-first-line-maintenance-treatment-of-advanced-or-metastatic-urothelial-carcinoma.html 2021-01-25T12:48:13.6700000Z https://www.medicinesresources.nhs.uk/positive-topline-results-for-faricimab-for-neovascular-age-related-macular-degeneration.html 2021-01-25T12:49:45.5700000Z https://www.medicinesresources.nhs.uk/fda-approves-voclosporin-for-adults-with-active-lupus-nephritis.html 2021-01-25T12:50:44.3790000Z https://www.medicinesresources.nhs.uk/positive-results-from-colcorona-trial-suggest-colchicine-reduces-risk-of-covid-19-related-complications-1.html 2021-01-25T12:52:26.4630000Z https://www.medicinesresources.nhs.uk/fda-approves-cabozantinib-in-combination-with-nivolumab-for-first-line-treatment-of-advanced-renal-cell-carcinoma.html 2021-01-25T12:53:30.8360000Z https://www.medicinesresources.nhs.uk/psychological-health-well-being-and-the-mind-heart-body-connection-a-scientific-statement-from-the-american-heart-association.html 2021-01-25T12:54:40.6370000Z https://www.medicinesresources.nhs.uk/community-champions-to-give-covid-19-vaccine-advice-and-boost-take-up.html 2021-01-25T12:56:33.6850000Z https://www.medicinesresources.nhs.uk/government-chief-scientific-adviser-sir-patrick-vallance-on-the-new-variant-of-covid-19-in-the-uk.html 2021-01-25T16:39:12.8660000Z https://www.medicinesresources.nhs.uk/good-communication-with-patients.html 2021-01-25T15:34:50.7970000Z https://www.medicinesresources.nhs.uk/avian-influenza-pgd-templates.html 2021-01-25T16:37:24.4450000Z https://www.medicinesresources.nhs.uk/efficacy-of-margetuximab-vs-trastuzumab-in-patients-with-pretreated-erbb2-positive-advanced-breast-cancer-a-phase-3-randomized-clinical-trial.html 2021-01-25T15:37:13.5430000Z https://www.medicinesresources.nhs.uk/effect-of-anakinra-versus-usual-care-in-adults-in-hospital-with-covid-19-and-mild-to-moderate-pneumonia-corimuno-ana-1-a-randomised-controlled-trial.html 2021-01-25T15:38:36.9660000Z https://www.medicinesresources.nhs.uk/nebulised-heparin-for-patients-with-or-at-risk-of-acute-respiratory-distress-syndrome-a-multicentre-randomised-double-blind-placebo-controlled-phase-3-trial.html 2021-01-25T15:42:43.9990000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-addition-of-rituximab-to-first-line-standard-chemotherapy-for-cd20-positive-b-cell-precursor-acute-lymphoblastic-leukaemia-adults.html 2021-01-25T16:34:52.4920000Z https://www.medicinesresources.nhs.uk/racial-and-ethnic-health-disparities-related-to-covid-19.html 2021-01-25T15:47:22.0810000Z https://www.medicinesresources.nhs.uk/classical-hodgkin-lymphoma.html 2021-01-25T15:49:08.3990000Z https://www.medicinesresources.nhs.uk/more-than-30-new-vaccination-centres-join-biggest-nhs-jab-drive.html 2021-01-25T16:02:37.5200000Z https://www.medicinesresources.nhs.uk/thrombosis-bleeding-and-the-observational-effect-of-early-therapeutic-anticoagulation-on-survival-in-critically-ill-patients-with-covid-19.html 2021-01-26T18:01:26.9880000Z https://www.medicinesresources.nhs.uk/acalabrutinib-meets-primary-efficacy-endpoint-in-head-to-head-trial-against-ibrutinib-in-chronic-lymphocytic-leukemia-cll-elevate-rr-phase-3-trial.html 2021-01-26T15:54:12.3640000Z https://www.medicinesresources.nhs.uk/covid-19-new-uk-variant-of-concern-b-1-1-7-may-be-linked-to-increased-severity-of-disease-early-data-indicate.html 2021-01-26T15:57:43.7100000Z https://www.medicinesresources.nhs.uk/diagnosis-and-referral-of-adults-with-suspected-bony-metastases.html 2021-01-26T16:00:10.5340000Z https://www.medicinesresources.nhs.uk/comparative-effectiveness-and-safety-of-sodium-glucose-cotransporter-2-inhibitors-versus-glucagon-like-peptide-1-receptor-agonists-in-older-adults.html 2021-01-26T18:05:06.5030000Z https://www.medicinesresources.nhs.uk/the-effect-of-exenatide-once-weekly-on-carotid-atherosclerosis-in-individuals-with-type-2-diabetes-an-18-month-randomized-placebo-controlled-study.html 2021-01-26T16:02:48.7670000Z https://www.medicinesresources.nhs.uk/new-product-trixeo-aerosphere-formoterol-fumarate-dihydrate-budesonide-glycopyrronium-5-micrograms-7-2-micrograms-160-micrograms-pressurised-inhalation-suspension-2.html 2021-01-26T18:08:37.2440000Z https://www.medicinesresources.nhs.uk/new-product-bevespi-aerosphere-glycopyrronium-bromide-formoterol-fumarate-dehydrate-7-2-micrograms-5-micrograms-pressurised-inhalation-suspension.html 2021-01-26T18:10:15.6630000Z https://www.medicinesresources.nhs.uk/revised-spcs-medikinet-methylphenidate-hydrochloride-xl-modified-release-capsules-hard-all-strengths.html 2021-01-26T16:11:04.6280000Z https://www.medicinesresources.nhs.uk/revised-spc-relestat-epinastine-hydrochloride-0-5-mg-ml-eye-drops-solution.html 2021-01-26T16:12:25.9260000Z https://www.medicinesresources.nhs.uk/revised-spcs-ziagen-abacavir-sulfate-all-products.html 2021-01-26T18:12:35.3980000Z https://www.medicinesresources.nhs.uk/benepali-etanercept-solution-for-injection-all-products.html 2021-01-26T18:13:04.6930000Z https://www.medicinesresources.nhs.uk/case-report-a-patient-with-ulcerative-colitis-treated-with-a-combination-of-vedolizumab-and-tofacitinib-1.html 2021-01-26T18:13:26.8150000Z https://www.medicinesresources.nhs.uk/association-of-smoking-and-cumulative-pack-year-exposure-with-covid-19-outcomes-in-the-cleveland-clinic-covid-19-registry.html 2021-01-26T18:14:22.2800000Z https://www.medicinesresources.nhs.uk/sars-cov-2-vaccination-for-patients-with-inflammatory-bowel-disease-a-british-society-of-gastroenterology-inflammatory-bowel-disease-section-and-ibd-clinical-research-group-position-statement.html 2021-01-26T18:14:42.9940000Z https://www.medicinesresources.nhs.uk/regulatory-approval-of-covid-19-vaccine-moderna.html 2021-02-01T10:27:37.6010000Z https://www.medicinesresources.nhs.uk/brigatinib-for-alk-positive-advanced-non-small-cell-lung-cancer-that-has-not-been-previously-treated-with-an-alk-inhibitor-guidance-ta670-1.html 2021-02-01T08:52:23.4930000Z https://www.medicinesresources.nhs.uk/trifluridine-tipiracil-for-treating-metastatic-gastric-cancer-or-gastro-oesophageal-junction-adenocarcinoma-after-2-or-more-therapies-guidance-ta699.html 2021-02-01T09:04:27.0670000Z https://www.medicinesresources.nhs.uk/revised-spc-mekinist-trametinib-capsules.html 2021-01-27T16:12:52.0690000Z https://www.medicinesresources.nhs.uk/revised-spc-tafinlar-dabrafenib-capsules.html 2021-01-27T16:14:13.4580000Z https://www.medicinesresources.nhs.uk/harms-and-benefits-of-subcutaneous-hydration-in-older-patients-systematic-review-and-meta-analysis.html 2021-01-27T16:01:03.1090000Z https://www.medicinesresources.nhs.uk/dtb-select-variation-in-statin-prescribing-across-england.html 2021-01-27T16:02:46.4710000Z https://www.medicinesresources.nhs.uk/national-institute-for-health-research-alert-aspirin-could-reduce-the-risk-of-heart-attack-or-stroke-in-people-with-pneumonia-research-suggests.html 2021-01-27T16:06:33.9500000Z https://www.medicinesresources.nhs.uk/outcomes-of-patients-with-chronic-myelomonocytic-leukaemia-treated-with-non-curative-therapies-a-retrospective-cohort-study.html 2021-01-27T16:17:20.8830000Z https://www.medicinesresources.nhs.uk/evaluation-of-an-implemented-new-insulin-chart-to-improve-quality-and-safety-of-diabetes-care-in-a-large-university-hospital-a-follow-up-study-3.html 2021-01-27T16:15:21.1680000Z https://www.medicinesresources.nhs.uk/the-effect-of-preconception-initiated-low-dose-aspirin-on-human-chorionic-gonadotropin-detected-pregnancy-pregnancy-loss-and-live-birth-per-protocol-analysis-of-a-randomized-trial.html 2021-01-27T16:18:27.4540000Z https://www.medicinesresources.nhs.uk/reported-adverse-drug-reactions-associated-with-the-use-of-hydroxychloroquine-and-chloroquine-during-the-covid-19-pandemic.html 2021-01-27T17:15:04.4020000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-one-year-data-from-phase-3-spirit-extension-study-of-once-daily-relugolix-combination-therapy-in-women-with-endometriosis.html 2021-01-27T16:31:46.7230000Z https://www.medicinesresources.nhs.uk/positive-results-for-mitapivat-in-pyruvate-kinase-deficiency-who-are-regularly-transfused-in-phase-3-activate-t-trial.html 2021-01-27T16:26:08.8760000Z https://www.medicinesresources.nhs.uk/fda-to-review-trikafta-r-elexacaftor-tezacaftor-ivacaftor-and-ivacaftor-in-children-with-cystic-fibrosis-ages-6-through-11-with-certain-mutations.html 2021-01-27T16:28:26.4880000Z https://www.medicinesresources.nhs.uk/manufacturers-report-bamlanivimab-and-etesevimab-meets-primary-endpoint-in-blaze-1-trial-for-use-in-high-risk-covid-19-patients.html 2021-01-27T16:29:38.4270000Z https://www.medicinesresources.nhs.uk/pembrolizumab-approved-for-use-in-eu-as-first-line-treatment-in-adult-patients-with-metastatic-microsatellite-instability-high-msi-h-or-mismatch-repair-deficient-dmmr-colorectal-cancer.html 2021-01-27T16:31:08.4450000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-interim-data-with-regen-cov-antibody-cocktail-used-as-passive-vaccine-to-prevent-covid-20.html 2021-01-27T16:33:14.1170000Z https://www.medicinesresources.nhs.uk/covid-19-people-are-not-being-warned-about-pitfalls-of-mass-testing.html 2021-01-27T16:36:17.8510000Z https://www.medicinesresources.nhs.uk/multiple-myeloma-lenalidomide-maintenance-post-autologous-stem-cell-transplantation-final-appraisal-determination.html 2021-01-27T16:36:05.4760000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-faricimab-hits-for-wet-age-related-macular-degeneration.html 2021-01-27T16:37:31.6220000Z https://www.medicinesresources.nhs.uk/upadacitinib-approved-in-eu-for-use-in-psoriatic-arthritis-and-active-ankylosing-spondylitis.html 2021-01-27T16:39:05.4400000Z https://www.medicinesresources.nhs.uk/covid-19-moderna-plans-booster-doses-to-counter-variants.html 2021-01-27T16:40:38.9160000Z https://www.medicinesresources.nhs.uk/cardiovascular-health-after-menopause-transition-pregnancy-disorders-and-other-gynaecologic-conditions-a-consensus-document-from-european-cardiologists-gynaecologists-and-endocrinologists.html 2021-01-27T16:42:13.3320000Z https://www.medicinesresources.nhs.uk/valvular-atrial-fibrillation-and-a-cha2ds2-vasc-score-of-1-a-statement-of-the-esc-working-group-on-cardiovascular-pharmacotherapy-and-esc-council-on-stroke-1.html 2021-01-27T16:44:29.3710000Z https://www.medicinesresources.nhs.uk/acute-pancreatitis-a-review.html 2021-01-27T16:46:36.3180000Z https://www.medicinesresources.nhs.uk/initial-management-of-noncastrate-advanced-recurrent-or-metastatic-prostate-cancer-asco-guideline-update.html 2021-01-27T16:48:18.3420000Z https://www.medicinesresources.nhs.uk/preservation-of-fertility-in-teenagers-and-young-adults-treated-for-haematological-malignancies.html 2021-01-27T16:50:03.0150000Z https://www.medicinesresources.nhs.uk/abiraterone-for-treating-newly-diagnosed-high-risk-metastatic-hormone-naive-prostate-cancer-appraisal-consultation-document-2.html 2021-01-27T16:52:44.1500000Z https://www.medicinesresources.nhs.uk/shooting-up-infections-among-people-who-inject-drugs-in-the-uk.html 2021-01-27T16:54:31.6100000Z https://www.medicinesresources.nhs.uk/abortion-care-quality-standard-qs199.html 2021-02-01T10:17:20.7880000Z https://www.medicinesresources.nhs.uk/january-bnf-bnf-for-children-newsletter.html 2021-02-01T06:11:51.7790000Z https://www.medicinesresources.nhs.uk/revised-spc-kivexa-abacavir-and-lamivudine-film-coated-tablets.html 2021-01-28T15:43:39.8420000Z https://www.medicinesresources.nhs.uk/revised-spc-calcort-deflazacort-6mg-tablets.html 2021-01-28T15:45:30.6750000Z https://www.medicinesresources.nhs.uk/revised-spc-rocephin-ceftriaxone-powder-for-solution-for-injection-or-infusion-3.html 2021-01-28T15:48:35.4900000Z https://www.medicinesresources.nhs.uk/renin-angiotensin-system-blocker-and-outcomes-of-covid-19-a-systematic-review-and-meta-analysis.html 2021-01-28T15:50:59.5510000Z https://www.medicinesresources.nhs.uk/trends-regional-variation-and-clinical-characteristics-of-covid-19-vaccine-recipients-a-retrospective-cohort-study-in-23-4-million-patients-using-opensafely.html 2021-01-28T15:52:46.9960000Z https://www.medicinesresources.nhs.uk/association-of-psychiatric-disorders-with-mortality-among-patients-with-covid-21.html 2021-01-28T15:55:37.2130000Z https://www.medicinesresources.nhs.uk/levonorgestrel-vs-copper-intrauterine-devices-for-emergency-contraception.html 2021-01-28T15:56:56.6770000Z https://www.medicinesresources.nhs.uk/global-prevalence-of-hepatitis-c-virus-in-women-of-childbearing-age-in-2019-a-modelling-study.html 2021-01-28T15:57:55.7860000Z https://www.medicinesresources.nhs.uk/switch-maintenance-gemcitabine-after-first-line-chemotherapy-in-patients-with-malignant-mesothelioma-nvalt19-an-investigator-initiated-randomised-open-label-phase-2-trial.html 2021-01-28T16:05:56.7190000Z https://www.medicinesresources.nhs.uk/antiplatelet-therapy-in-patients-with-myocardial-infarction-without-obstructive-coronary-artery-disease.html 2021-01-28T16:07:30.8410000Z https://www.medicinesresources.nhs.uk/tofacitinib-fails-to-meet-co-primary-endpoint-in-post-marketing-safety-study-in-rheumatoid-arthritis-ra.html 2021-01-28T16:09:25.6750000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-begins-review-of-marketing-authorisation-application-for-voxelotor-for-treatment-of-haemolytic-anaemia-in-sickle-cell-disease.html 2021-01-28T16:10:33.6510000Z https://www.medicinesresources.nhs.uk/us-centers-for-disease-control-and-prevention-reports-lower-rate-of-anaphylaxis-after-pfizer-biontech-covid-19-vaccine.html 2021-01-28T16:11:44.1170000Z https://www.medicinesresources.nhs.uk/covid-19-controversies-the-tocilizumab-chapter-2.html 2021-01-28T16:14:01.8510000Z https://www.medicinesresources.nhs.uk/designated-settings-for-people-with-covid-19-leaving-hospital-1.html 2021-01-28T16:15:03.4460000Z https://www.medicinesresources.nhs.uk/react-1-study-of-coronavirus-transmission-january-2021-final-results.html 2021-02-01T06:15:12.9420000Z https://www.medicinesresources.nhs.uk/large-scale-coronavirus-vaccine-manufacturing-begins-in-scotland.html 2021-01-28T16:17:47.6720000Z https://www.medicinesresources.nhs.uk/understanding-lateral-flow-antigen-testing-for-people-without-symptoms.html 2021-01-28T16:18:48.3530000Z https://www.medicinesresources.nhs.uk/healthcare-safety-investigation-branch-publishes-interim-report-highlighting-early-findings-of-its-investigation-into-oxygen-issues-during-the-covid-19-pandemic.html 2021-02-01T06:20:02.3520000Z https://www.medicinesresources.nhs.uk/revised-unaids-who-ethical-guidance-for-hiv-prevention-trials.html 2021-01-28T16:22:25.8660000Z https://www.medicinesresources.nhs.uk/statistics-on-drug-misuse-england-2020.html 2021-01-28T16:24:13.9910000Z https://www.medicinesresources.nhs.uk/mental-health-bulletin-2019-20-annual-report.html 2021-01-28T16:25:27.9720000Z https://www.medicinesresources.nhs.uk/principles-for-covid-19-vaccination-in-musculoskeletal-and-rheumatology-for-clinicians-3.html 2021-02-01T06:23:26.6560000Z https://www.medicinesresources.nhs.uk/atrial-fibrillation-3.html 2021-01-28T16:34:38.5540000Z https://www.medicinesresources.nhs.uk/health-and-care-staff-urged-to-protect-themselves-and-others-by-getting-covid-19-vaccine-1.html 2021-01-28T16:36:19.2100000Z https://www.medicinesresources.nhs.uk/nhs-staff-deliver-covid-jabs-from-more-than-1-400-sites.html 2021-01-28T16:37:45.7570000Z https://www.medicinesresources.nhs.uk/european-commission-grants-rezafungin-orphan-drug-status-for-the-treatment-of-invasive-candidiasis.html 2021-01-28T16:39:07.8910000Z https://www.medicinesresources.nhs.uk/young-people-s-substance-misuse-treatment-statistics-2019-to-2020-report.html 2021-01-28T16:40:14.9730000Z https://www.medicinesresources.nhs.uk/alcohol-and-drug-treatment-in-secure-settings-2019-to-2020-report.html 2021-01-28T16:41:36.7420000Z https://www.medicinesresources.nhs.uk/nhs-reform-five-key-questions-about-the-future-of-primary-care-networks-in-england.html 2021-01-28T16:42:29.0850000Z https://www.medicinesresources.nhs.uk/giving-covid-19-vaccine-to-individuals-at-extremes-of-bodyweight.html 2021-02-01T06:24:13.8070000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-welcomes-home-office-move-to-classify-2-4-dinitrophenol-dnp-as-a-poison.html 2021-01-28T16:44:32.7460000Z https://www.medicinesresources.nhs.uk/nihr-alert-people-with-diabetes-with-a-low-risk-of-developing-foot-ulcers-can-be-screened-less-often-study-suggests.html 2021-01-28T16:46:17.7780000Z https://www.medicinesresources.nhs.uk/nihr-alert-people-in-the-most-deprived-groups-were-least-likely-to-take-part-in-the-exercise-referral-scheme-study-finds-3.html 2021-01-28T16:48:51.1450000Z https://www.medicinesresources.nhs.uk/the-state-of-childrens-mental-health-services-2020-21.html 2021-01-28T16:50:14.7390000Z https://www.medicinesresources.nhs.uk/therapeutics-targeting-the-il-23-and-il-17-pathway-in-psoriasis.html 2021-01-28T16:51:32.0860000Z https://www.medicinesresources.nhs.uk/management-of-diabetes-and-hyperglycaemia-in-the-hospital.html 2021-01-28T16:53:38.3000000Z https://www.medicinesresources.nhs.uk/sars-cov-2-voc-investigating-and-managing-individuals-with-a-possible-or-confirmed-case.html 2021-01-31T18:04:58.3390000Z https://www.medicinesresources.nhs.uk/revised-spcs-mayzent-siponimod-film-coated-tablets.html 2021-01-29T16:17:55.4350000Z https://www.medicinesresources.nhs.uk/association-between-human-papillomavirus-vaccination-and-serious-adverse-events-in-south-korean-adolescent-girls-nationwide-cohort-study.html 2021-01-29T16:19:35.1900000Z https://www.medicinesresources.nhs.uk/long-term-safety-and-efficacy-of-lumacaftor-ivacaftor-therapy-in-children-aged-6-11-years-with-cystic-fibrosis-homozygous-for-the-f508del-cftr-mutation-a-phase-3-open-label-extension-study.html 2021-01-29T16:21:20.6930000Z https://www.medicinesresources.nhs.uk/an-analysis-of-contemporary-oncology-randomized-clinical-trials-from-low-middle-income-vs-high-income-countries.html 2021-01-29T16:22:20.4960000Z https://www.medicinesresources.nhs.uk/characteristics-and-outcomes-of-pregnant-women-with-type-1-or-type-2-diabetes-a-5-year-national-population-based-cohort-study-1.html 2021-01-29T16:24:08.5830000Z https://www.medicinesresources.nhs.uk/ethnic-inequalities-in-health-related-quality-of-life-among-older-adults-in-england-secondary-analysis-of-a-national-cross-sectional-survey.html 2021-01-29T16:25:04.1370000Z https://www.medicinesresources.nhs.uk/european-position-paper-on-the-management-of-patients-with-patent-foramen-ovale-part-ii-decompression-sickness-migraine-arterial-deoxygenation-syndromes-and-select-high-risk-clinical-conditions.html 2021-01-29T16:25:55.9860000Z https://www.medicinesresources.nhs.uk/taking-a-stand-against-air-pollution-the-impact-on-cardiovascular-disease-a-joint-opinion-from-the-world-heart-federation-american-college-of-cardiology-american-heart-association-and-the-european-society-of-cardiology.html 2021-01-29T16:27:35.4970000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-tislelizumab-in-oesophageal-squamous-cell-carcinoma-meets-primary-endpoint.html 2021-01-29T16:28:37.6190000Z https://www.medicinesresources.nhs.uk/positive-interim-data-from-phase-iii-study-of-novavax-covid-19-vaccine-released.html 2021-01-31T18:17:23.0680000Z https://www.medicinesresources.nhs.uk/covid-19-therapeutic-alert-antimicrobials-azithromycin-and-doxycycline-not-beneficial-in-the-management-of-covid-19-sars-cov-2-positive-patients.html 2021-01-31T18:25:23.0430000Z https://www.medicinesresources.nhs.uk/euglycaemic-diabetic-ketoacidosis-in-a-43-year-old-woman-with-type-2-diabetes-mellitus-on-sglt-2-inhibitor-empagliflozin.html 2021-01-29T16:33:52.1720000Z https://www.medicinesresources.nhs.uk/quinidine-hypersensitivity-a-side-effect-of-a-forgotten-antiarrhythmic-1.html 2021-01-29T16:35:22.4390000Z https://www.medicinesresources.nhs.uk/conditions-of-authorisation-for-covid-19-vaccines.html 2021-01-31T18:30:14.1950000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-safety-update-comirnaty-pfizer-biontech-covid-19-vaccine.html 2021-02-01T05:50:59.2160000Z https://www.medicinesresources.nhs.uk/european-chmp-clarifies-pfizer-biontech-covid-19-vaccine-comirnaty-dosage-interval.html 2021-01-29T17:07:10.4370000Z https://www.medicinesresources.nhs.uk/nice-published-minor-update-to-suspected-cancer-recognition-and-referral-guideline.html 2021-01-29T17:07:51.0560000Z https://www.medicinesresources.nhs.uk/rapid-implementation-of-a-vaccination-superstation.html 2021-01-29T16:41:33.2700000Z https://www.medicinesresources.nhs.uk/sars-cov-2-vaccines-and-the-growing-threat-of-viral-variants-3.html 2021-01-29T16:44:38.1880000Z https://www.medicinesresources.nhs.uk/neoadjuvant-chemotherapy-endocrine-therapy-and-targeted-therapy-for-breast-cancer-asco-guideline.html 2021-01-29T16:46:38.6810000Z https://www.medicinesresources.nhs.uk/primary-care-network-pulse-oximetry-supporting-general-practice.html 2021-01-29T16:47:37.3520000Z https://www.medicinesresources.nhs.uk/guidance-on-vaccinations-for-temporary-workers-bank-and-agency-workers-during-covid-19.html 2021-02-01T05:52:16.7630000Z https://www.medicinesresources.nhs.uk/increasing-recruitment-into-covid-19-trials.html 2021-01-29T16:49:41.3830000Z https://www.medicinesresources.nhs.uk/explaining-covid-19-performance-what-factors-might-predict-national-responses.html 2021-01-29T16:50:37.5280000Z https://www.medicinesresources.nhs.uk/covid-19-a-rehearsal-to-build-a-greener-and-healthier-society.html 2021-01-29T16:51:46.2090000Z https://www.medicinesresources.nhs.uk/covid-19-pandemic-and-the-social-determinants-of-health.html 2021-01-29T16:52:45.1690000Z https://www.medicinesresources.nhs.uk/non-steroidal-anti-inflammatory-drugs-nsaids-for-musculoskeletal-pain.html 2021-01-29T16:53:40.0340000Z https://www.medicinesresources.nhs.uk/multiple-myeloma-1.html 2021-01-29T16:55:21.1490000Z https://www.medicinesresources.nhs.uk/janssen-publishes-positive-safety-and-efficacy-data-for-single-dose-covid-19-vaccine.html 2021-02-01T05:58:36.9800000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-nutritional-and-inherited-metabolic-disorders.html 2021-02-01T06:01:49.2530000Z https://www.medicinesresources.nhs.uk/pfizer-covid-19-vaccine-handling-and-preparation-video-1.html 2021-01-29T17:10:58.2460000Z https://www.medicinesresources.nhs.uk/revised-spc-rinvoq-upadacitinib-capsules.html 2021-02-01T12:19:38.9180000Z https://www.medicinesresources.nhs.uk/revised-spcs-enbrel-etanercept-solution-for-injection-all-products-1.html 2021-02-01T12:21:20.2530000Z https://www.medicinesresources.nhs.uk/new-product-leqvio-inclisiran-284-mg-solution-for-injection-in-pre-filled-syringe.html 2021-02-01T12:23:39.6530000Z https://www.medicinesresources.nhs.uk/quantification-of-occupational-and-community-risk-factors-for-sars-cov-2-seropositivity-among-health-care-workers-in-a-large-u-s-health-care-system.html 2021-02-01T12:25:10.0230000Z https://www.medicinesresources.nhs.uk/pembrolizumab-plus-ipilimumab-or-placebo-for-metastatic-non-small-cell-lung-cancer-with-pd-l1-tumor-proportion-score-50-randomized-double-blind-phase-iii-keynote-598-study.html 2021-02-01T12:29:46.0760000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-salmeterol-fluticasone-bropair-spiromax-and-seffalair-spiromax-for-treatment-of-asthma.html 2021-02-01T12:32:10.5870000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-remimazolam-byfavo-for-procedural-sedation.html 2021-02-01T12:33:21.1070000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-ofatumumab-kesimpta-for-treatment-of-active-relapsing-multiple-sclerosis.html 2021-02-01T12:35:56.1520000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-selinexor-nexpovio-for-treatment-of-relapsed-and-refractory-multiple-myeloma.html 2021-02-01T12:37:35.9420000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-cenobamate-ontozry-for-treatment-of-adults-with-epilepsy.html 2021-02-01T12:39:29.9940000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-pemigatinib-pemazyre-for-second-line-treatment-of-advanced-or-metastatic-cholangiocarcinoma.html 2021-02-01T12:42:21.7470000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-somapacitan-sogroya-for-treatment-of-growth-hormone-deficiency-in-adults-1.html 2021-02-01T12:44:28.2020000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-icosapent-ethyl-vazkepa-for-reduction-of-cardiovascular-events-in-patients-at-high-cardiovascular-risk-2.html 2021-02-01T12:47:41.7120000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-grants-conditional-marketing-authorisation-of-astra-zeneca-covid-19-vaccine-1.html 2021-02-01T12:50:41.5740000Z https://www.medicinesresources.nhs.uk/covid-19-sore-throat-fatigue-and-myalgia-are-more-common-with-new-uk-variant.html 2021-02-01T12:52:34.5510000Z https://www.medicinesresources.nhs.uk/changing-mindsets-about-side-effects.html 2021-02-01T12:55:21.4920000Z https://www.medicinesresources.nhs.uk/cqc-publishes-examples-of-collaboration-in-urgent-and-emergency-care.html 2021-02-01T12:59:13.5860000Z https://www.medicinesresources.nhs.uk/uk-government-secures-additional-40-million-doses-of-valneva-vaccine.html 2021-02-01T13:01:29.8300000Z https://www.medicinesresources.nhs.uk/biliary-tract-cancer.html 2021-02-01T13:05:18.6730000Z https://www.medicinesresources.nhs.uk/monitoring-the-quality-of-care-and-safety-for-people-with-a-learning-disability-and-or-people-who-are-autistic-in-inpatient-care-1.html 2021-02-01T15:22:00.7870000Z https://www.medicinesresources.nhs.uk/interleukin-6-inhibitors-tocilizumab-and-sarilumab-for-critically-ill-patients-with-covid-19-pneumonia-adults.html 2021-02-05T15:27:04.3580000Z https://www.medicinesresources.nhs.uk/interim-clinical-commissioning-policy-tocilizumab-for-critically-ill-patients-with-covid-19-pneumonia-adults.html 2021-02-05T15:29:30.2250000Z https://www.medicinesresources.nhs.uk/interim-clinical-commissioning-policy-sarilumab-for-critically-ill-patients-with-covid-19-pneumonia-adults.html 2021-02-05T15:29:11.0090000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-biosimilar-bevacizumab-alymsys-and-oyavas.html 2021-02-02T10:49:01.3700000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-paediatric-license-extension-for-pembrolizumab-keytruda.html 2021-02-01T15:34:36.3060000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-paediatric-license-extension-for-bedaquiline-sirturo.html 2021-02-01T15:39:41.6130000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-new-strength-pharmaceutical-form-and-route-of-administration-for-natalizumab-tysabri-1.html 2021-02-01T15:42:08.0990000Z https://www.medicinesresources.nhs.uk/withdrawal-of-post-marketing-authorisation-application-for-atezolizumab-tecentriq.html 2021-02-01T15:43:29.7330000Z https://www.medicinesresources.nhs.uk/nhs-confirms-covid-jab-now-offered-at-every-eligible-care-home-in-england.html 2021-02-01T15:44:49.6530000Z https://www.medicinesresources.nhs.uk/young-peoples-mental-and-emotional-health.html 2021-02-01T15:47:39.2610000Z https://www.medicinesresources.nhs.uk/topical-roflumilast-cream-for-plaque-psoriasis-initial-results-from-two-phase-3-trials-announced-1.html 2021-02-02T15:56:32.8560000Z https://www.medicinesresources.nhs.uk/the-use-of-rifaximin-in-the-prevention-of-overt-hepatic-encephalopathy-after-transjugular-intrahepatic-portosystemic-shunt-a-randomized-controlled-trial-1.html 2021-02-02T15:59:02.4940000Z https://www.medicinesresources.nhs.uk/clinical-decision-making-during-the-covid-19-pandemic-2.html 2021-02-02T16:01:39.3100000Z https://www.medicinesresources.nhs.uk/united-states-fda-accepts-filing-with-priority-review-for-ozanimod-for-treating-ulcerative-colitis.html 2021-02-02T16:05:20.7140000Z https://www.medicinesresources.nhs.uk/changes-to-mhra-drug-alert-titles-and-categories.html 2021-02-05T15:34:28.6070000Z https://www.medicinesresources.nhs.uk/voluntary-scheme-for-branded-medicines-payment-percentage-for-2023.html 2021-02-02T16:12:47.7180000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-starts-rolling-review-of-regn-cov2-antibody-combination-casirivimab-imdevimab-for-treatment-and-prevention-of-covid-20.html 2021-02-02T16:15:44.9830000Z https://www.medicinesresources.nhs.uk/revised-spc-bavencio-avelumab-20-mg-ml-concentrate-for-solution-for-infusion-1.html 2021-02-02T16:18:01.5210000Z https://www.medicinesresources.nhs.uk/revised-spc-neupro-rotigotine-transdermal-patch-all-strengths.html 2021-02-02T16:20:41.7780000Z https://www.medicinesresources.nhs.uk/revised-spc-viepax-xl-225-mg-prolonged-release-tablets-1.html 2021-02-02T16:52:06.8300000Z https://www.medicinesresources.nhs.uk/carboplatin-based-doublet-plus-bevacizumab-beyond-progression-versus-carboplatin-based-doublet-alone-in-patients-with-platinum-sensitive-ovarian-cancer-a-randomised-phase-3-trial.html 2021-02-02T16:26:53.7580000Z https://www.medicinesresources.nhs.uk/doac-dipstick-for-detecting-direct-oral-anticoagulants-medtech-innovation-briefing-mib248.html 2021-02-02T16:28:16.6630000Z https://www.medicinesresources.nhs.uk/faecal-microbiota-transplant-for-recurrent-or-refractory-clostridioides-difficile-infection-medtech-innovation-briefing-mib247.html 2021-02-02T16:31:08.6870000Z https://www.medicinesresources.nhs.uk/position-statement-for-the-vaccination-of-care-home-residents-using-covid-19-vaccine-astrazeneca-az.html 2021-02-02T16:32:45.0270000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-january-2021.html 2021-02-02T16:34:41.3620000Z https://www.medicinesresources.nhs.uk/surge-testing-to-be-deployed-to-monitor-and-suppress-spread-of-covid-19-variant.html 2021-02-02T16:58:46.3430000Z https://www.medicinesresources.nhs.uk/association-of-intravenous-immunoglobulins-plus-methylprednisolone-vs-immunoglobulins-alone-with-course-of-fever-in-multisystem-inflammatory-syndrome-in-children.html 2021-02-02T17:02:20.4060000Z https://www.medicinesresources.nhs.uk/mepolizumab-for-treating-severe-eosinophilic-asthma-1.html 2021-02-05T15:35:50.7300000Z https://www.medicinesresources.nhs.uk/brolucizumab-for-treating-wet-age-related-macular-degeneration-guidance-ta672.html 2021-02-05T15:36:08.4170000Z https://www.medicinesresources.nhs.uk/revised-spc-tivicay-dolutegravir-film-coated-tablets.html 2021-02-03T15:39:51.1660000Z https://www.medicinesresources.nhs.uk/lifestyle-intervention-with-or-without-lay-volunteers-to-prevent-type-2-diabetes-in-people-with-impaired-fasting-glucose-and-or-nondiabetic-hyperglycemia-a-randomized-clinical-trial.html 2021-02-03T15:41:17.0710000Z https://www.medicinesresources.nhs.uk/characteristics-and-reporting-of-number-needed-to-treat-number-needed-to-harm-and-absolute-risk-reduction-in-controlled-clinical-trials-2001-2019.html 2021-02-03T15:42:38.6850000Z https://www.medicinesresources.nhs.uk/assessment-endoscopy-and-treatment-in-patients-with-acute-severe-ulcerative-colitis-during-the-covid-19-pandemic-protect-asuc-a-multicentre-observational-case-control-study.html 2021-02-03T15:44:17.3780000Z https://www.medicinesresources.nhs.uk/association-of-physical-activity-intensity-with-mortality-a-national-cohort-study-of-403-681-us-adults.html 2021-02-03T15:45:55.2740000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-an-rad26-and-rad5-vector-based-heterologous-prime-boost-covid-19-vaccine-an-interim-analysis-of-a-randomised-controlled-phase-3-trial-in-russia.html 2021-02-03T15:47:48.7010000Z https://www.medicinesresources.nhs.uk/dexmedetomidine-or-propofol-for-sedation-in-mechanically-ventilated-adults-with-sepsis.html 2021-02-03T15:49:37.4940000Z https://www.medicinesresources.nhs.uk/association-of-race-and-ethnicity-with-covid-19-outcomes-in-rheumatic-disease-data-from-the-covid-19-global-rheumatology-alliance-physician-registry.html 2021-02-03T15:50:51.6620000Z https://www.medicinesresources.nhs.uk/azithromycin-in-patients-admitted-to-hospital-with-covid-19-recovery-a-randomised-controlled-open-label-platform-trial.html 2021-02-03T16:27:46.4850000Z https://www.medicinesresources.nhs.uk/oxford-vaccine-could-substantially-cut-spread.html 2021-02-03T16:28:31.0280000Z https://www.medicinesresources.nhs.uk/manufacturers-announce-positive-data-for-deucravacitinib-for-moderate-to-severe-plaque-psoriasis.html 2021-02-03T15:55:51.8490000Z https://www.medicinesresources.nhs.uk/covid-19-people-who-have-had-infection-might-only-need-one-dose-of-mrna-vaccine.html 2021-02-03T16:59:54.0440000Z https://www.medicinesresources.nhs.uk/ensuring-quality-in-the-era-of-virtual-care.html 2021-02-03T17:00:31.9430000Z https://www.medicinesresources.nhs.uk/clinical-cancer-advances-2021-asco-s-report-on-progress-against-cancer.html 2021-02-03T16:03:11.9680000Z https://www.medicinesresources.nhs.uk/treatment-of-multiple-myeloma-related-bone-disease-recommendations-from-the-bone-working-group-of-the-international-myeloma-working-group.html 2021-02-03T16:04:40.1270000Z https://www.medicinesresources.nhs.uk/use-of-fibrinolytics-and-deoxyribonuclease-in-adult-patients-with-pleural-empyema-a-consensus-statement.html 2021-02-03T16:05:56.5110000Z https://www.medicinesresources.nhs.uk/innovation-in-treatment-for-people-with-rarer-or-less-well-recognised-long-term-conditions.html 2021-02-03T16:07:20.5830000Z https://www.medicinesresources.nhs.uk/rivaroxaban-approved-for-use-in-eu-and-uk-for-treatment-and-prevention-of-recurrence-of-venous-thromboembolism.html 2021-02-03T16:08:31.1880000Z https://www.medicinesresources.nhs.uk/trimbow-triple-combination-therapy-approve-for-use-in-eu-for-asthma.html 2021-02-03T16:09:31.0990000Z https://www.medicinesresources.nhs.uk/how-to-stop-the-spread-of-coronavirus-covid-19.html 2021-02-03T16:10:58.4280000Z https://www.medicinesresources.nhs.uk/class-3-medicines-recall-intrapharm-laboratories-ltd-kolanticon-gel-500ml-el-21-a-01.html 2021-02-03T16:12:04.5400000Z https://www.medicinesresources.nhs.uk/primary-analysis-of-phase-iii-study-supports-delay-of-second-dose-of-astrazeneca-and-oxfords-covid-19-vaccine-1.html 2021-02-04T16:05:26.0170000Z https://www.medicinesresources.nhs.uk/company-announces-first-patient-dosed-in-pivotal-phase-3-trial-of-apraglutide-for-the-treatment-of-short-bowel-syndrome.html 2021-02-04T16:07:03.9410000Z https://www.medicinesresources.nhs.uk/why-arent-covid-19-vaccines-being-manufactured-in-standard-prefilled-syringes.html 2021-02-04T16:10:21.2010000Z https://www.medicinesresources.nhs.uk/uk-biobank-sars-cov-2-serology-study.html 2021-02-04T18:23:52.1430000Z https://www.medicinesresources.nhs.uk/use-of-high-dose-cyproterone-acetate-and-risk-of-intracranial-meningioma-in-women-cohort-study.html 2021-02-04T16:14:15.5670000Z https://www.medicinesresources.nhs.uk/country-level-determinants-of-the-severity-of-the-first-global-wave-of-the-covid-19-pandemic-an-ecological-study.html 2021-02-04T18:25:03.9240000Z https://www.medicinesresources.nhs.uk/effectiveness-of-exercise-based-interventions-in-reducing-depressive-symptoms-in-people-without-clinical-depression-systematic-review-and-meta-analysis-of-randomised-controlled-trials.html 2021-02-04T18:26:32.0090000Z https://www.medicinesresources.nhs.uk/high-volume-propofol-emulsion-for-infusion-and-injection-preparations-supply-disruption.html 2021-02-05T15:50:12.1160000Z https://www.medicinesresources.nhs.uk/rapid-changes-in-serum-testosterone-in-men-with-newly-diagnosed-type-2-diabetes-with-intensive-insulin-and-metformin.html 2021-02-04T16:23:07.8870000Z https://www.medicinesresources.nhs.uk/revised-spcs-tivicay-dolutegravir-sodium-film-coated-tablets-all-strengths-1.html 2021-02-04T16:25:51.7470000Z https://www.medicinesresources.nhs.uk/revised-spc-triumeq-lamivudine-abacavir-sulfate-dolutegravir-sodium-50-mg-600-mg-300-mg-film-coated-tablets.html 2021-02-04T16:28:34.4660000Z https://www.medicinesresources.nhs.uk/revised-spc-doptelet-avatrombopag-maleate-20-mg-film-coated-tablets.html 2021-02-04T16:31:42.0130000Z https://www.medicinesresources.nhs.uk/revised-spcs-nplate-romiplostim-powder-for-solution-for-injection-all-strengths-and-products-1.html 2021-02-04T16:36:49.0340000Z https://www.medicinesresources.nhs.uk/revised-spcs-salofalk-mesalazine-all-products.html 2021-02-04T16:38:45.0700000Z https://www.medicinesresources.nhs.uk/revised-spcs-indivina-medroxyprogesterone-acetate-estradiol-valerate-tablets-all-strengths.html 2021-02-04T16:40:12.8200000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-starts-rolling-review-of-novavaxs-covid-19-vaccine-nvx-cov2373.html 2021-02-04T16:41:41.4860000Z https://www.medicinesresources.nhs.uk/nihr-alert-active-monitoring-in-early-prostate-cancer-prevents-as-many-deaths-as-surgery-or-radiotherapy-new-research-shows.html 2021-02-04T16:59:13.1530000Z https://www.medicinesresources.nhs.uk/trends-in-predominant-causes-of-death-in-individuals-with-and-without-diabetes-in-england-from-2001-to-2018-an-epidemiological-analysis-of-linked-primary-care-records.html 2021-02-04T17:01:37.2840000Z https://www.medicinesresources.nhs.uk/world-first-covid-19-alternating-dose-vaccine-study-launches-in-uk.html 2021-02-04T17:03:17.5620000Z https://www.medicinesresources.nhs.uk/transforming-the-care-of-children-and-young-people-cyp-in-london-with-asthma-development-of-the-london-asthma-standards.html 2021-02-04T17:08:15.8670000Z https://www.medicinesresources.nhs.uk/early-access-to-medicines-scheme-eams-scientific-opinion-abrocitinib-for-treatment-of-adult-and-adolescent-patients-with-severe-atopic-dermatitis.html 2021-02-04T17:12:05.0790000Z https://www.medicinesresources.nhs.uk/revised-spcs-enbrel-etanercept-solution-for-injection-in-pre-filled-syringe-2.html 2021-02-05T15:24:50.7090000Z https://www.medicinesresources.nhs.uk/revised-spc-rydapt-midostaurin-25-mg-soft-capsules.html 2021-02-05T15:26:02.2900000Z https://www.medicinesresources.nhs.uk/revised-spcs-ozempic-semaglutide-solution-for-injection-in-pre-filled-pen.html 2021-02-05T15:27:14.5980000Z https://www.medicinesresources.nhs.uk/mhra-publishes-first-report-on-adverse-reactions-to-approved-covid-19-vaccines-submitted-via-the-yellow-card-scheme.html 2021-02-05T15:50:56.5790000Z https://www.medicinesresources.nhs.uk/the-effect-of-tocilizumab-on-mortality-in-hospitalized-patients-with-covid-19-a-meta-analysis-of-randomized-controlled-trials.html 2021-02-05T15:33:16.8020000Z https://www.medicinesresources.nhs.uk/promoting-physical-activity-in-primary-care-a-systematic-review-and-meta-analysis.html 2021-02-05T15:34:27.4000000Z https://www.medicinesresources.nhs.uk/awmsg-consults-on-draft-guidance-on-the-initial-clinical-management-of-adult-smokers-in-secondary-care.html 2021-02-05T15:35:55.0770000Z https://www.medicinesresources.nhs.uk/new-therapeutic-targets-in-antineutrophil-cytoplasm-antibody-associated-vasculitis.html 2021-02-05T15:37:51.0040000Z https://www.medicinesresources.nhs.uk/fda-updates-emergency-use-authorization-for-covid-19-convalescent-plasma-to-reflect-new-data.html 2021-02-05T15:41:11.8480000Z https://www.medicinesresources.nhs.uk/initial-safety-trial-results-find-increased-risk-of-serious-heart-related-problems-and-cancer-with-tofacitinib.html 2021-02-05T18:57:50.4850000Z https://www.medicinesresources.nhs.uk/application-for-emergency-use-authorization-of-investigational-single-dose-janssen-covid-19-vaccine-submitted-to-the-us-fda.html 2021-02-05T15:45:27.7580000Z https://www.medicinesresources.nhs.uk/positive-phase-ii-results-for-investigational-selective-janus-kinase-type-1-jak1-inhibitor-shr0302-in-ulcerative-colitis.html 2021-02-05T15:46:43.2430000Z https://www.medicinesresources.nhs.uk/us-fda-approves-tepotinib-for-treatment-of-adults-with-metastatic-non-small-cell-lung-cancer-who-have-a-met-exon-14-skipping-alteration.html 2021-02-05T15:47:51.6760000Z https://www.medicinesresources.nhs.uk/case-of-bullous-pemphigoid-induced-by-apatinib-mesylate.html 2021-02-05T18:55:02.9150000Z https://www.medicinesresources.nhs.uk/report-of-the-commission-on-human-medicines-expert-working-group-on-covid-19-vaccine-safety-surveillance.html 2021-02-05T15:51:19.7930000Z https://www.medicinesresources.nhs.uk/pembrolizumab-with-pemetrexed-and-platinum-based-chemotherapy-for-untreated-non-small-cell-lung-cancer-cdf-review-of-ta557-final-appraisal-document.html 2021-02-05T15:54:37.9940000Z https://www.medicinesresources.nhs.uk/nice-launches-public-consultation-on-proposals-for-change-to-the-processes-used-for-health-technology-evaluation-1.html 2021-02-05T15:58:17.9810000Z https://www.medicinesresources.nhs.uk/the-european-medicines-agency-is-reviewing-data-on-monoclonal-antibody-use-for-covid-19.html 2021-02-05T15:59:32.6050000Z https://www.medicinesresources.nhs.uk/zoe-app-study-of-almost-40-000-people-receiving-pfizer-covid-19-vaccine-reports-findings-3.html 2021-02-08T08:47:32.4210000Z https://www.medicinesresources.nhs.uk/recovery-trial-arm-investigating-convalescent-plasma-in-hospitalised-patients-with-covid-19-closes.html 2021-02-05T16:06:50.1320000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-programme-information-for-healthcare-practitioners-update-4.html 2021-02-08T08:43:37.2640000Z https://www.medicinesresources.nhs.uk/bimekizumab-efficacy-and-safety-in-moderate-to-severe-plaque-psoriasis-be-ready-a-multicentre-double-blind-placebo-controlled-randomised-withdrawal-phase-3-trial.html 2021-02-05T17:07:28.8010000Z https://www.medicinesresources.nhs.uk/bimekizumab-versus-ustekinumab-for-the-treatment-of-moderate-to-severe-plaque-psoriasis-be-vivid-efficacy-and-safety-from-a-52-week-multicentre-double-blind-active-comparator-and-placebo-controlled-phase-3-trial.html 2021-02-05T17:08:32.0190000Z https://www.medicinesresources.nhs.uk/posaconazole-versus-voriconazole-for-primary-treatment-of-invasive-aspergillosis-a-phase-3-randomised-controlled-non-inferiority-trial.html 2021-02-05T17:11:32.2260000Z https://www.medicinesresources.nhs.uk/long-term-outcomes-in-patients-with-connective-tissue-disease-associated-pulmonary-arterial-hypertension-in-the-modern-treatment-era-meta-analyses-of-randomized-controlled-trials-and-observational-registries.html 2021-02-05T18:00:16.3170000Z https://www.medicinesresources.nhs.uk/pregnancy-outcomes-in-women-with-moderate-to-severe-psoriasis-from-the-psoriasis-longitudinal-assessment-and-registry-psolar.html 2021-02-05T18:01:43.2020000Z https://www.medicinesresources.nhs.uk/management-of-antithrombotic-therapy-after-acute-coronary-syndromes.html 2021-02-05T17:18:27.3510000Z https://www.medicinesresources.nhs.uk/all-frontline-pharmacy-workers-encouraged-to-get-their-covid-19-vaccination.html 2021-02-05T17:19:34.6730000Z https://www.medicinesresources.nhs.uk/firefighters-the-latest-group-to-join-the-nhs-staff-in-helping-deliver-covid-vaccinations.html 2021-02-05T17:20:36.6670000Z https://www.medicinesresources.nhs.uk/flu-vaccine-reimbursement-2021-22-letter-from-professor-stephen-powis.html 2021-02-05T17:21:42.3100000Z https://www.medicinesresources.nhs.uk/covid-19-summary-guidance-for-service-providers-on-point-of-care-or-near-person-tests-for-diagnosis-and-management.html 2021-02-05T18:36:08.9520000Z https://www.medicinesresources.nhs.uk/national-flu-and-covid-19-surveillance-report-4-february-2021-week-5.html 2021-02-05T17:27:13.2700000Z https://www.medicinesresources.nhs.uk/analysis-article-looks-at-use-of-rapid-testing-technologies-for-covid-19.html 2021-02-05T17:30:10.3520000Z https://www.medicinesresources.nhs.uk/uveitis-for-the-non-ophthalmologist.html 2021-02-05T17:32:27.9060000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-respiratory-disorders.html 2021-02-08T08:51:07.1680000Z https://www.medicinesresources.nhs.uk/summary-of-covid-19-medicines-guidance-learning-disabilities.html 2021-02-08T08:48:34.1640000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-communication-materials-1.html 2021-02-05T17:35:32.1970000Z https://www.medicinesresources.nhs.uk/glucose-control-sulfonylureas-and-insulin-treatment-in-elderly-people-with-type-2-diabetes-and-risk-of-severe-hypoglycemia-and-death-an-observational-study.html 2021-02-05T17:38:13.8440000Z https://www.medicinesresources.nhs.uk/adjuvant-pertuzumab-and-trastuzumab-in-early-her2-positive-breast-cancer-in-the-aphinity-trial-6-years-follow-up.html 2021-02-05T17:39:17.9580000Z https://www.medicinesresources.nhs.uk/revised-spc-xarelto-rivaroxaban-film-coated-tablets-all-strengths.html 2021-02-08T12:34:17.7400000Z https://www.medicinesresources.nhs.uk/inclusion-health-applying-all-our-health-1.html 2021-02-08T12:36:31.2480000Z https://www.medicinesresources.nhs.uk/comparative-efficacy-and-safety-of-different-regimens-of-ranibizumab-for-neovascular-age-related-macular-degeneration-a-network-meta-analysis-of-randomised-controlled-trials.html 2021-02-08T15:39:53.8260000Z https://www.medicinesresources.nhs.uk/proton-pump-inhibitors-and-risk-of-all-cause-and-cause-specific-mortality-a-cohort-study.html 2021-02-08T12:38:51.5510000Z https://www.medicinesresources.nhs.uk/us-fda-approves-lisocabtagene-maraleucel-breyanzi-for-treatment-of-relapsed-or-refractory-large-b-cell-lymphoma.html 2021-02-08T12:40:05.0260000Z https://www.medicinesresources.nhs.uk/how-to-vaccinate-the-world-against-covid-19.html 2021-02-08T12:41:28.7080000Z https://www.medicinesresources.nhs.uk/new-medicines-newsletter-january-2021.html 2021-02-08T12:42:31.6470000Z https://www.medicinesresources.nhs.uk/opioid-safety-striking-the-right-balance.html 2021-02-08T12:43:53.5820000Z https://www.medicinesresources.nhs.uk/jama-patient-page-monoclonal-antibodies-for-covid-19.html 2021-02-08T15:42:44.4840000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-gruenenthal-ltd-palexia-20-mg-ml-oral-solution-pl-21727-0054.html 2021-02-15T10:26:36.7150000Z https://www.medicinesresources.nhs.uk/durvalumab-fails-to-improve-overall-survival-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma-hnscc.html 2021-02-08T12:48:21.5670000Z https://www.medicinesresources.nhs.uk/transforming-the-care-of-children-and-young-people-in-london-with-asthma-development-of-the-london-asthma-standards.html 2021-02-08T12:50:28.5220000Z https://www.medicinesresources.nhs.uk/upadacitinib-rinvoq-r-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-moderate-to-severe-active-rheumatoid-arthritis.html 2021-02-08T15:19:28.0240000Z https://www.medicinesresources.nhs.uk/ravulizumab-ultomiris-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-paroxysmal-nocturnal-haemoglobinuria.html 2021-02-08T15:20:35.9200000Z https://www.medicinesresources.nhs.uk/ozanimod-zeposia-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-relapsing-remitting-multiple-sclerosis.html 2021-02-08T15:21:39.8890000Z https://www.medicinesresources.nhs.uk/leuprorelin-acetate-prostap-dcs-accepted-for-use-within-nhs-scotland-for-early-stage-breast-cancer.html 2021-02-08T15:22:47.3580000Z https://www.medicinesresources.nhs.uk/leuprorelin-acetate-prostap-dcs-accepted-for-use-within-nhs-scotland-for-advanced-breast-cancer.html 2021-02-08T15:23:59.7470000Z https://www.medicinesresources.nhs.uk/buprenorphine-naloxone-sublingual-film-suboxone-r-accepted-for-restricted-use-within-nhs-scotland-for-opioid-drug-dependence.html 2021-02-08T15:24:57.3160000Z https://www.medicinesresources.nhs.uk/afamelanotide-scenesse-r-is-not-recommended-for-use-within-nhsscotland-for-prevention-of-phototoxicity-in-adults-with-erythropoietic-protoporphyria.html 2021-02-08T15:25:54.5130000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-revlimid-lenalidomide.html 2021-02-08T15:27:17.8840000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-levosert-levonorgestrel-20-micrograms-24-hours-intrauterine-delivery-system.html 2021-02-08T15:29:35.1140000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-hesitancy-in-a-representative-working-age-population-in-france-a-survey-experiment-based-on-vaccine-characteristics.html 2021-02-08T15:30:48.7450000Z https://www.medicinesresources.nhs.uk/2021-22-influenza-season-letter-1.html 2021-02-08T15:32:47.7120000Z https://www.medicinesresources.nhs.uk/blood-test-monitoring-of-immunomodulatory-therapy-in-inflammatory-disease.html 2021-02-08T15:34:03.0260000Z https://www.medicinesresources.nhs.uk/cold-weather-alert-issued-by-phe.html 2021-02-08T15:35:18.3330000Z https://www.medicinesresources.nhs.uk/phase-3-randomised-controlled-trial-checkmate-274-of-adjuvant-treatment-with-nivolumab-in-muscle-invasive-urothelial-cancer-meets-primary-endpoint.html 2021-02-09T16:47:39.5010000Z https://www.medicinesresources.nhs.uk/racial-disparities-in-covid-19-testing-and-outcomes-retrospective-cohort-study-in-an-integrated-health-system.html 2021-02-09T16:48:38.6130000Z https://www.medicinesresources.nhs.uk/acute-pancreatitis-1.html 2021-02-09T16:49:34.2210000Z https://www.medicinesresources.nhs.uk/should-you-recommend-cannabinoids-for-this-patient-with-painful-neuropathy.html 2021-02-09T17:01:50.7090000Z https://www.medicinesresources.nhs.uk/addressing-mistrust-about-covid-19-vaccines-among-patients-of-color.html 2021-02-09T16:55:25.4910000Z https://www.medicinesresources.nhs.uk/government-proposals-to-reverse-the-previous-nhs-reform-1.html 2021-02-09T16:57:55.8440000Z https://www.medicinesresources.nhs.uk/absolute-cardiovascular-disease-risk-score-and-pharmacotherapy-at-the-time-of-admission-in-patients-presenting-with-acute-coronary-syndrome-due-to-coronary-artery-disease-in-a-single-australian-tertiary-centre-a-cross-sectional-study.html 2021-02-09T16:58:50.7490000Z https://www.medicinesresources.nhs.uk/nhs-covid-19-app-alerts-1-7-million-contacts-to-help-prevent-spread-of-covid-19.html 2021-02-09T17:02:41.1100000Z https://www.medicinesresources.nhs.uk/public-urged-to-consider-work-in-adult-social-care-1.html 2021-02-09T17:04:13.6480000Z https://www.medicinesresources.nhs.uk/revised-spc-sertraline-tablets.html 2021-02-09T17:05:30.5720000Z https://www.medicinesresources.nhs.uk/revised-spc-lamotrigine-tablets-2.html 2021-02-09T17:08:44.4590000Z https://www.medicinesresources.nhs.uk/comparison-of-corticosteroid-tapering-regimens-in-myasthenia-gravis-a-randomized-clinical-trial.html 2021-02-09T17:09:48.7130000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-in-pregnant-and-lactating-women-1.html 2021-02-09T17:12:21.9730000Z https://www.medicinesresources.nhs.uk/randomized-phase-iii-study-of-folfox-alone-or-with-pegilodecakin-as-second-line-therapy-in-patients-with-metastatic-pancreatic-cancer-that-progressed-after-gemcitabine-sequoia-1.html 2021-02-09T17:14:05.4750000Z https://www.medicinesresources.nhs.uk/covid-19-recovery-and-resilience-what-can-health-and-care-learn-from-other-disasters.html 2021-02-09T17:15:42.6120000Z https://www.medicinesresources.nhs.uk/established-and-novel-therapeutic-options-for-autoimmune-hepatitis.html 2021-02-09T17:16:51.2930000Z https://www.medicinesresources.nhs.uk/call-for-people-aged-70-and-over-to-contact-nhs-for-their-covid-vaccination.html 2021-02-09T17:20:50.5670000Z https://www.medicinesresources.nhs.uk/managing-a-healthy-weight-in-adult-secure-services-practice-guidance.html 2021-02-09T17:23:23.4410000Z https://www.medicinesresources.nhs.uk/enzyme-linked-immunosorbent-assays-for-monitoring-tnf-alpha-inhibitors-and-antibody-levels-in-people-with-rheumatoid-arthritis-a-systematic-review-and-economic-evaluation.html 2021-02-09T17:26:45.2980000Z https://www.medicinesresources.nhs.uk/current-smoking-and-covid-19-risk-results-from-a-population-symptom-app-in-over-2-4-million-people-1.html 2021-02-09T17:29:13.7880000Z https://www.medicinesresources.nhs.uk/revised-spc-duloxetine-capsules-1.html 2021-02-10T16:25:25.8700000Z https://www.medicinesresources.nhs.uk/venlafaxine-tablets.html 2021-02-10T17:17:42.1480000Z https://www.medicinesresources.nhs.uk/primary-tumor-resection-plus-chemotherapy-versus-chemotherapy-alone-for-colorectal-cancer-patients-with-asymptomatic-synchronous-unresectable-metastases-jcog1007-ipacs-a-randomized-clinical-trial.html 2021-02-10T16:28:48.5540000Z https://www.medicinesresources.nhs.uk/sjoegrens-disease-not-syndrome.html 2021-02-10T16:31:23.4580000Z https://www.medicinesresources.nhs.uk/acr-aad-rds-and-aao-2020-joint-statement-on-hydroxychloroquine-use-with-respect-to-retinal-toxicity.html 2021-06-01T10:43:50.0990000Z https://www.medicinesresources.nhs.uk/manufacturers-provide-phase-2b-3-study-data-for-aviptadil-for-reducing-hospital-stay-among-patients-with-respiratory-failure-due-to-critical-covid-19.html 2021-02-10T16:36:20.3340000Z https://www.medicinesresources.nhs.uk/fda-approve-cemiplimab-for-use-in-advanced-basal-cell-carcinoma.html 2021-02-10T16:37:43.2730000Z https://www.medicinesresources.nhs.uk/neutrophilic-asthma-misconception-or-misnomer.html 2021-02-10T16:41:33.6380000Z https://www.medicinesresources.nhs.uk/assurance-of-covid-19-vaccination-offer-for-all-eligible-health-and-social-care-workers.html 2021-02-15T10:29:41.7350000Z https://www.medicinesresources.nhs.uk/working-together-to-improve-patient-care-how-pcns-are-working-in-partnership-to-support-peoples-mental-health-1.html 2021-02-10T16:45:12.3970000Z https://www.medicinesresources.nhs.uk/esketamine-nasal-spray-approved-in-eu-for-rapid-reduction-of-depressive-symptoms-in-a-psychiatric-emergency.html 2021-02-10T16:46:50.6240000Z https://www.medicinesresources.nhs.uk/fostemsavir-approved-for-use-in-eu-for-treatment-of-multidrug-resistant-hiv.html 2021-02-10T16:48:15.7730000Z https://www.medicinesresources.nhs.uk/protecting-and-supporting-the-clinically-extremely-vulnerable-during-lockdown.html 2021-02-10T16:50:17.9190000Z https://www.medicinesresources.nhs.uk/diagnosis-and-treatment-of-hip-and-knee-osteoarthritis-1.html 2021-02-10T16:52:22.1060000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-tocilizumab-for-polyarticular-course-juvenile-idiopathic-arthritis-in-the-open-label-two-year-extension-of-a-phase-iii-trial.html 2021-02-10T16:56:25.9580000Z https://www.medicinesresources.nhs.uk/manufacturers-present-phase-3-study-data-for-omidubicel-in-patients-with-haematologic-malignancies.html 2021-02-10T16:58:24.7040000Z https://www.medicinesresources.nhs.uk/bamlanivimab-administered-with-etesevimab-receives-fda-emergency-use-authorization-for-covid-19.html 2021-02-10T16:59:45.9300000Z https://www.medicinesresources.nhs.uk/phyllocontin-aminophylline-225mg-and-350mg-modified-release-tablets-supply-disruption-alert.html 2021-02-15T10:06:34.4850000Z https://www.medicinesresources.nhs.uk/republished-denosumab-induced-severe-hypocalcaemia-in-a-patient-with-vitamin-d-deficiency.html 2021-02-10T17:03:13.9450000Z https://www.medicinesresources.nhs.uk/prevention-of-influenza-during-mismatched-seasons-in-older-adults-with-an-mf59-adjuvanted-quadrivalent-influenza-vaccine-a-randomised-controlled-multicentre-phase-3-efficacy-study.html 2021-02-10T17:28:39.3000000Z https://www.medicinesresources.nhs.uk/us-fda-grants-emergency-use-authorization-to-new-antibody-combination-for-mild-to-moderate-covid-19-in-patients-at-high-risk-for-progressing-to-severe-covid-20.html 2021-02-11T15:29:31.4610000Z https://www.medicinesresources.nhs.uk/botox-r-onabotulinumtoxina-receives-us-fda-approval-for-paediatric-detrusor-overactivity-associated-with-a-neurologic-condition-1.html 2021-02-11T15:31:28.8300000Z https://www.medicinesresources.nhs.uk/case-study-electronic-prescribing-of-continence-and-stoma-products-for-nurse-prescribers-in-community-teams-1.html 2021-02-11T15:32:36.0250000Z https://www.medicinesresources.nhs.uk/community-pharmacy-discharge-medicine-service-frequently-asked-questions-1.html 2021-02-11T15:33:42.8470000Z https://www.medicinesresources.nhs.uk/large-uk-study-finds-children-with-covid-19-less-likely-to-report-fever-persistent-cough-or-appetite-loss.html 2021-02-11T15:36:52.7950000Z https://www.medicinesresources.nhs.uk/association-of-first-trimester-prescription-opioid-use-with-congenital-malformations-in-the-offspring-population-based-cohort-study.html 2021-02-11T15:40:36.8460000Z https://www.medicinesresources.nhs.uk/association-between-use-of-macrolides-in-pregnancy-and-risk-of-major-birth-defects-nationwide-register-based-cohort-study.html 2021-02-11T17:19:49.4050000Z https://www.medicinesresources.nhs.uk/association-between-antihypertensive-treatment-and-adverse-events-systematic-review-and-meta-analysis.html 2021-02-11T15:43:43.6190000Z https://www.medicinesresources.nhs.uk/deprescribing-fall-risk-increasing-drugs-frids-for-the-prevention-of-falls-and-fall-related-complications-a-systematic-review-and-meta-analysis.html 2021-02-11T15:46:19.6780000Z https://www.medicinesresources.nhs.uk/insufficient-iodine-nutrition-status-and-the-risk-of-pre-eclampsia-a-systemic-review-and-meta-analysis.html 2021-02-11T15:47:59.3250000Z https://www.medicinesresources.nhs.uk/long-covid-world-health-organization-calls-on-countries-to-offer-patients-more-rehabilitation.html 2021-02-11T17:19:11.6680000Z https://www.medicinesresources.nhs.uk/nortriptyline-for-pain-in-knee-osteoarthritis-in-general-practice-a-double-blind-randomised-controlled-trial.html 2021-02-11T17:21:31.9610000Z https://www.medicinesresources.nhs.uk/effect-of-empagliflozin-on-left-ventricular-volumes-in-patients-with-type-2-diabetes-or-prediabetes-and-heart-failure-with-reduced-ejection-fraction-sugar-dm-hf.html 2021-02-11T17:37:56.6840000Z https://www.medicinesresources.nhs.uk/blueprint-launched-for-nhs-and-social-care-reform-following-pandemic-1.html 2021-02-11T17:41:05.7750000Z https://www.medicinesresources.nhs.uk/revised-spcs-eldepryl-selegiline-hydrochloride-tablets-all-strengths.html 2021-02-11T17:41:54.6670000Z https://www.medicinesresources.nhs.uk/revised-spcs-depefex-venlafaxine-hydrochloride-xl-capsules-all-strengths.html 2021-02-11T17:42:43.6650000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-preparing-guidance-to-tackle-covid-19-variants.html 2021-02-11T17:43:22.1080000Z https://www.medicinesresources.nhs.uk/clarification-on-sputnik-v-vaccine-in-the-european-medicines-agency-approval-process.html 2021-02-11T17:44:14.5290000Z https://www.medicinesresources.nhs.uk/involving-pregnant-individuals-in-clinical-research-on-covid-19-vaccines.html 2021-02-11T17:47:05.2170000Z https://www.medicinesresources.nhs.uk/long-term-safety-and-efficacy-of-tezacaftor-ivacaftor-in-individuals-with-cystic-fibrosis-aged-12-years-or-older-who-are-homozygous-or-heterozygous-for-phe508del-cftr-extend-an-open-label-extension-study.html 2021-02-11T17:48:42.3110000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-ambisome-liposomal-50-mg-powder-for-dispersion-for-infusion-pl-16807-0001-el-21-a-03.html 2021-02-11T17:49:11.6900000Z https://www.medicinesresources.nhs.uk/once-weekly-semaglutide-in-adults-with-overweight-or-obesity.html 2021-02-11T17:49:44.3840000Z https://www.medicinesresources.nhs.uk/phase-3-trials-of-tirbanibulin-ointment-for-actinic-keratosis.html 2021-02-11T17:50:10.8770000Z https://www.medicinesresources.nhs.uk/nice-updates-covid-19-rapid-guideline-on-delivery-of-systemic-anticancer-treatments-ng161-following-review-of-evidence-of-their-effects-on-risk-of-severe-illness-or-death-1.html 2021-02-15T10:07:58.5300000Z https://www.medicinesresources.nhs.uk/revised-spc-tivicay-dolutegravir-5-mg-dispersible-tablets.html 2021-02-12T14:32:03.7400000Z https://www.medicinesresources.nhs.uk/major-update-remdesivir-for-adults-with-covid-19-a-living-systematic-review-and-meta-analysis-for-the-american-college-of-physicians-practice-points-1.html 2021-02-12T14:34:26.3270000Z https://www.medicinesresources.nhs.uk/us-fda-approves-evinacumab-as-an-adjunct-for-the-treatment-of-homozygous-familial-hypercholesterolaemia-in-patients-12-years.html 2021-02-12T14:40:47.2340000Z https://www.medicinesresources.nhs.uk/iadademstat-granted-orphan-drug-designation-in-the-us-for-the-treatment-of-acute-myeloid-leukaemia.html 2021-02-12T14:41:48.6970000Z https://www.medicinesresources.nhs.uk/us-fda-committee-advises-against-approval-of-pembolizumab-for-the-neoadjuvant-treatment-of-high-risk-early-stage-triple-negative-breast-cancer.html 2021-02-12T14:42:37.0230000Z https://www.medicinesresources.nhs.uk/manufacturer-presents-new-phase-iii-data-for-faricimab-in-the-treatment-of-diabetic-macular-oedema-and-neovascular-age-related-macular-degeneration.html 2021-02-12T15:26:38.3860000Z https://www.medicinesresources.nhs.uk/new-partnership-pledges-clear-and-consistent-evidence-based-guidance-on-medicines-for-pregnant-and-breastfeeding-women.html 2021-02-12T14:46:15.6790000Z https://www.medicinesresources.nhs.uk/mhra-publishes-updated-analysis-of-adverse-reactions-to-coronavirus-vaccines-reported-via-the-yellow-card-scheme.html 2021-02-15T10:09:10.2670000Z https://www.medicinesresources.nhs.uk/nice-publishes-draft-guidance-on-subarachnoid-haemorrhage-due-to-ruptured-aneurysms-for-consultation.html 2021-02-12T17:38:17.1420000Z https://www.medicinesresources.nhs.uk/nice-publishes-draft-guidance-on-antenatal-care-for-consultation.html 2021-02-12T14:50:49.2260000Z https://www.medicinesresources.nhs.uk/nice-publishes-draft-guidance-on-abemaciclib-with-fulvestrant-for-treating-hormone-receptor-positive-her2-negative-advanced-breast-cancer-after-endocrine-therapy-for-consultation.html 2021-02-12T14:52:23.9690000Z https://www.medicinesresources.nhs.uk/nice-publishes-draft-guidance-on-mexiletine-for-treating-myotonia-in-adults-with-non-dystrophic-myotonic-disorders-for-consultation.html 2021-02-12T14:55:02.6710000Z https://www.medicinesresources.nhs.uk/nice-publishes-draft-guidance-on-betibeglogene-autotemcel-for-treating-transfusion-dependent-beta-thalassaemia-for-consultation-1.html 2021-02-12T14:59:30.9140000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-uk-12-february-2021.html 2021-02-12T15:03:20.5200000Z https://www.medicinesresources.nhs.uk/chronic-kidney-disease-detection-staging-and-treatment-in-cardiovascular-disease-prevention.html 2021-02-12T15:06:56.6030000Z https://www.medicinesresources.nhs.uk/vaping-and-cardiac-disease.html 2021-02-12T15:12:20.6990000Z https://www.medicinesresources.nhs.uk/effectiveness-of-mask-wearing-to-control-community-spread-of-sars-cov-2.html 2021-02-12T15:15:03.3160000Z https://www.medicinesresources.nhs.uk/covid-19-therapeutic-alert-colchicine-in-the-management-of-covid-19-sars-cov-2-positive-patients-trial-use-only.html 2021-02-15T10:10:17.4960000Z https://www.medicinesresources.nhs.uk/ema-starts-rolling-review-of-curevacs-covid-19-vaccine-cvncov.html 2021-02-12T15:30:51.9360000Z https://www.medicinesresources.nhs.uk/european-pharmacovigilance-risk-assessment-committee-prac-concludes-that-use-of-remdesivir-is-not-associated-with-kidney-problems.html 2021-02-12T15:32:13.4620000Z https://www.medicinesresources.nhs.uk/european-pharmacovigilance-risk-assessment-committee-prac-starts-new-safety-signal-procedure-with-remdesivir.html 2021-02-12T16:53:53.1440000Z https://www.medicinesresources.nhs.uk/hospitals-admit-one-third-of-covid-patients-in-a-single-month.html 2021-02-12T15:35:54.1970000Z https://www.medicinesresources.nhs.uk/covid-19-provision-of-tuberculosis-services-update.html 2021-02-12T15:37:03.3160000Z https://www.medicinesresources.nhs.uk/nhs-patient-safety-strategy-2021-update.html 2021-02-12T17:01:38.1620000Z https://www.medicinesresources.nhs.uk/medicines-in-pregnancy-registry-valproate-use-in-females-aged-0-to-54-in-england-april-2018-to-september-2020.html 2021-02-15T10:31:44.1900000Z https://www.medicinesresources.nhs.uk/menb-risk-groups-patient-group-direction-template.html 2021-02-15T10:12:41.5570000Z https://www.medicinesresources.nhs.uk/menb-vaccine-bexsero-r-updated-patient-group-direction-template-2.html 2021-02-15T10:12:55.4420000Z https://www.medicinesresources.nhs.uk/sars-cov-2-lateral-flow-antigen-tests-evaluation-of-voc1-kent-uk-and-voc2-south-africa-1.html 2021-02-12T16:05:29.2770000Z https://www.medicinesresources.nhs.uk/interim-recommendations-for-use-of-the-azd1222-chadox1-s-recombinant-vaccine-against-covid-19-developed-by-oxford-university-and-astrazeneca.html 2021-02-12T17:27:58.7040000Z https://www.medicinesresources.nhs.uk/nihr-alert-physiotherapist-led-exercise-eases-shoulder-pain-but-ultrasound-guidance-for-injections-makes-no-difference-study-finds.html 2021-02-12T17:05:59.2750000Z https://www.medicinesresources.nhs.uk/early-initiation-of-prophylactic-anticoagulation-for-prevention-of-coronavirus-disease-2019-mortality-in-patients-admitted-to-hospital-in-the-united-states-cohort-study-1.html 2021-02-12T17:58:31.7930000Z https://www.medicinesresources.nhs.uk/thousands-more-nhs-patients-hospitalised-with-covid-19-to-get-tocilizumab-treatment.html 2021-02-12T17:12:29.2390000Z https://www.medicinesresources.nhs.uk/preparing-and-administering-covid-19-vaccines-1.html 2021-02-15T10:13:58.9840000Z https://www.medicinesresources.nhs.uk/severe-respiratory-syncytial-virus-disease-in-preterm-infants-a-case-of-innate-immaturity-1.html 2021-02-12T18:27:14.2580000Z https://www.medicinesresources.nhs.uk/revised-spc-aubabio-teriflunomide-14-mg-film-coated-tablets-2.html 2021-02-15T15:48:13.6830000Z https://www.medicinesresources.nhs.uk/revised-spc-keytruda-pembrolizumab-25-mg-ml-concentrate-for-solution-for-infusion-1.html 2021-02-15T13:03:07.5200000Z https://www.medicinesresources.nhs.uk/reports-of-anaphylaxis-after-receipt-of-mrna-covid-19-vaccines-in-the-us-december-14-2020-january-18-2021.html 2021-02-22T10:12:49.4870000Z https://www.medicinesresources.nhs.uk/phase-iii-study-to-evaluate-efficacy-and-safety-of-andecaliximab-with-mfolfox6-as-first-line-treatment-in-patients-with-advanced-gastric-or-gej-adenocarcinoma-gamma-1.html 2021-02-15T13:08:52.1200000Z https://www.medicinesresources.nhs.uk/transdermal-oestradiol-for-androgen-suppression-in-prostate-cancer-long-term-cardiovascular-outcomes-from-the-randomised-prostate-adenocarcinoma-transcutaneous-hormone-patch-trial-programme.html 2021-02-15T13:11:05.7400000Z https://www.medicinesresources.nhs.uk/cemiplimab-monotherapy-for-first-line-treatment-of-advanced-non-small-cell-lung-cancer-with-pd-l1-of-at-least-50-a-multicentre-open-label-global-phase-3-randomised-controlled-trial.html 2021-02-15T13:12:26.4450000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-uptake-plan.html 2021-02-22T10:28:49.7630000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-trilaciclib-cosela-as-adjunct-preceding-first-line-chemotherapy-for-small-cell-lung-cancer.html 2021-02-15T13:19:28.9250000Z https://www.medicinesresources.nhs.uk/european-approval-of-tucatinib-tukysa-for-treatment-of-her2-positive-locally-advanced-or-metastatic-breast-cancer-1.html 2021-02-15T13:36:20.9050000Z https://www.medicinesresources.nhs.uk/phyllocontin-aminophylline-225mg-and-350mg-modified-release-tablets-update-regarding-stock-exhaustion-date.html 2021-02-22T10:37:47.3770000Z https://www.medicinesresources.nhs.uk/outcomes-of-clostridioides-difficile-infection-in-adult-cancer-and-non-cancer-patients-hospitalised-in-a-tertiary-hospital-a-prospective-cohort-study.html 2021-02-15T15:21:47.9580000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-haematopoietic-stem-cell-transplantation-1.html 2021-02-22T10:49:57.4150000Z https://www.medicinesresources.nhs.uk/covid-19-the-green-book-chapter-14a-update.html 2021-02-22T10:46:33.4150000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-imnovid-pomalidomide-capsules.html 2021-02-15T15:37:51.2430000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-pro-epanutin-fosphenytoin.html 2021-02-15T15:39:59.9620000Z https://www.medicinesresources.nhs.uk/dear-healthcare-professional-letter-soprobec-beclometasone-dipropionate-200-micrograms-per-actuation-pressurised-inhalation-solution.html 2021-02-15T15:40:57.8470000Z https://www.medicinesresources.nhs.uk/systematic-review-and-meta-analysis-of-anakinra-sarilumab-siltuximab-and-tocilizumab-for-covid-19.html 2021-02-15T15:44:46.7420000Z https://www.medicinesresources.nhs.uk/a-comparison-of-sunitinib-with-cabozantinib-crizotinib-and-savolitinib-for-treatment-of-advanced-papillary-renal-cell-carcinoma-a-randomised-open-label-phase-2-trial-2.html 2021-02-15T15:48:43.3340000Z https://www.medicinesresources.nhs.uk/qt-effects-of-bedaquiline-delamanid-or-both-in-patients-with-rifampicin-resistant-tuberculosis-a-phase-2-open-label-randomised-controlled-trial.html 2021-02-15T15:57:26.8280000Z https://www.medicinesresources.nhs.uk/enfortumab-vedotin-in-previously-treated-advanced-urothelial-carcinoma-1.html 2021-02-15T15:53:55.1190000Z https://www.medicinesresources.nhs.uk/lenvatinib-plus-pembrolizumab-or-everolimus-for-advanced-renal-cell-carcinoma.html 2021-02-15T15:54:50.3140000Z https://www.medicinesresources.nhs.uk/challenges-in-ensuring-global-access-to-covid-19-vaccines-production-affordability-allocation-and-deployment.html 2021-02-15T15:55:40.1440000Z https://www.medicinesresources.nhs.uk/priorities-for-the-covid-19-pandemic-at-the-start-of-2021-statement-of-the-lancet-covid-19-commission.html 2021-02-15T15:57:13.3040000Z https://www.medicinesresources.nhs.uk/lovima-75-microgram-film-coated-tablets-desogestrel-public-consultation.html 2021-02-15T16:00:18.3560000Z https://www.medicinesresources.nhs.uk/nhs-offers-covid-jab-to-clinically-vulnerable-and-people-65-to-69.html 2021-02-15T16:02:28.2700000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-checkpoint-inhibition-in-patients-with-melanoma-and-preexisting-autoimmune-disease-a-cohort-study-1.html 2021-02-16T17:05:02.5740000Z https://www.medicinesresources.nhs.uk/american-college-of-rheumatology-clinical-guidance-for-multisystem-inflammatory-syndrome-in-children-associated-with-sars-cov-2-and-hyperinflammation-in-pediatric-covid-19-version-2.html 2021-02-16T16:08:55.1930000Z https://www.medicinesresources.nhs.uk/different-doses-of-prucalopride-in-treating-chronic-idiopathic-constipation-a-meta-analysis-and-bayesian-analysis.html 2021-02-16T17:08:33.8530000Z https://www.medicinesresources.nhs.uk/nhs-health-checks-equity-and-outcomes-2009-17-an-observational-study-1.html 2021-02-16T17:11:25.4700000Z https://www.medicinesresources.nhs.uk/improved-glycemic-outcomes-with-medtronic-minimed-advanced-hybrid-closed-loop-delivery-results-from-a-randomized-crossover-trial-comparing-automated-insulin-delivery-with-predictive-low-glucose-suspend-in-people-with-type-1-diabetes.html 2021-02-16T16:16:50.8220000Z https://www.medicinesresources.nhs.uk/revised-spc-bendamustine-hydrochloride-accord-2-5-mg-ml-powder-for-concentrate-for-solution-for-infusion.html 2021-02-16T17:15:16.3270000Z https://www.medicinesresources.nhs.uk/general-pharmaceutical-committee-gphc-updates-position-on-supply-of-covid-19-tests-from-pharmacies.html 2021-02-16T16:19:27.6160000Z https://www.medicinesresources.nhs.uk/recreational-substance-use-among-patients-with-premature-atherosclerotic-cardiovascular-disease.html 2021-02-16T17:18:57.9140000Z https://www.medicinesresources.nhs.uk/cardiac-channelopathies-diagnosis-and-contemporary-management.html 2021-02-16T16:23:33.6590000Z https://www.medicinesresources.nhs.uk/menstrual-migraine-a-distinct-disorder-needing-greater-recognition.html 2021-02-16T17:20:57.1340000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-eaststone-limited-midabuc-midazolam-as-hcl-10mg-ml-oromucosal-solution-el-21-a-04.html 2021-02-16T16:28:33.2320000Z https://www.medicinesresources.nhs.uk/nhs-england-letter-details-vaccination-of-jcvi-cohorts-5-6-and-additional-funding-for-vaccination-in-residential-settings-1.html 2021-02-22T09:51:27.2140000Z https://www.medicinesresources.nhs.uk/longitudinal-effects-of-ivacaftor-and-medicine-possession-ratio-in-people-with-the-gly551asp-mutation-a-5-year-study.html 2021-02-16T17:25:27.9780000Z https://www.medicinesresources.nhs.uk/updated-national-patient-group-direction-pre-exposure-prophylaxis-prep-for-the-prevention-of-hiv-infection.html 2021-02-22T09:53:04.8430000Z https://www.medicinesresources.nhs.uk/planning-access-to-end-of-life-care-medicines-out-of-hospital-during-a-pandemic.html 2021-02-22T09:57:33.9920000Z https://www.medicinesresources.nhs.uk/letter-from-the-chief-pharmaceutical-officer-nhs-discharge-medicines-service.html 2021-02-22T10:03:00.2910000Z https://www.medicinesresources.nhs.uk/niraparib-for-maintenance-treatment-of-advanced-ovarian-fallopian-tube-and-peritoneal-cancer-after-response-to-first-line-platinum-based-chemotherapy-guidance-ta673-1.html 2021-02-21T16:04:25.4410000Z https://www.medicinesresources.nhs.uk/updated-covid-19-rapid-guideline-critical-care-in-adults-ng159-1.html 2021-02-22T09:31:13.7430000Z https://www.medicinesresources.nhs.uk/prediction-models-for-recurrence-and-bleeding-in-patients-with-venous-thromboembolism-a-systematic-review-and-critical-appraisal.html 2021-02-17T15:49:01.4100000Z https://www.medicinesresources.nhs.uk/supplemental-new-drug-application-for-xywav-tm-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-for-idiopathic-hypersomnia-submitted-to-fda.html 2021-02-17T16:41:49.4840000Z https://www.medicinesresources.nhs.uk/sacubitril-valsartan-entresto-r-granted-expanded-indication-in-chronic-heart-failure-by-fda.html 2021-02-17T15:50:46.7640000Z https://www.medicinesresources.nhs.uk/global-guideline-for-the-diagnosis-and-management-of-rare-mould-infections-an-initiative-of-the-european-confederation-of-medical-mycology-in-cooperation-with-the-international-society-for-human-and-animal-mycology-and-the-american-society-for-microbiology.html 2021-02-17T15:51:34.8600000Z https://www.medicinesresources.nhs.uk/mhra-launches-public-consultation-on-pom-to-p-reclassification-of-two-contraceptive-pills-lovima-and-hana.html 2021-02-17T15:54:59.5260000Z https://www.medicinesresources.nhs.uk/conditional-marketing-authorisation-granted-to-enhertu-trastuzumab-deruxtecan-in-the-uk.html 2021-02-17T15:55:51.2870000Z https://www.medicinesresources.nhs.uk/european-commission-approves-yuflyma-adalimumab-biosimilar.html 2021-02-17T15:58:24.7930000Z https://www.medicinesresources.nhs.uk/nivolumab-for-adjuvant-treatment-of-completely-resected-melanoma-with-lymph-node-involvement-or-metastatic-disease-cdf-review-of-ta558-final-appraisal-document.html 2021-02-17T16:00:11.8540000Z https://www.medicinesresources.nhs.uk/direct-oral-anticoagulants-in-treatment-of-cerebral-venous-thrombosis-a-systematic-review-1.html 2021-02-17T16:04:07.6340000Z https://www.medicinesresources.nhs.uk/sex-permanent-drug-discontinuation-and-study-retention-in-clinical-trials-1.html 2021-02-17T16:05:49.7320000Z https://www.medicinesresources.nhs.uk/comparison-of-the-efficacy-and-safety-outcomes-of-edoxaban-in-8040-women-versus-13-065-men-with-atrial-fibrillation-in-the-engage-af-timi-48-trial-1.html 2021-02-17T16:07:27.7180000Z https://www.medicinesresources.nhs.uk/177lu-lu-psma-617-versus-cabazitaxel-in-patients-with-metastatic-castration-resistant-prostate-cancer-therap-a-randomised-open-label-phase-2-trial.html 2021-02-17T16:08:52.0560000Z https://www.medicinesresources.nhs.uk/pyrotinib-plus-capecitabine-versus-lapatinib-plus-capecitabine-for-the-treatment-of-her2-positive-metastatic-breast-cancer-phoebe-a-multicentre-open-label-randomised-controlled-phase-3-trial.html 2021-02-17T16:46:16.9920000Z https://www.medicinesresources.nhs.uk/comparative-effectiveness-of-oral-anticoagulants-in-everyday-practice.html 2021-02-17T16:11:55.1540000Z https://www.medicinesresources.nhs.uk/association-between-sex-and-treatment-outcomes-of-atrial-fibrillation-ablation-versus-drug-therapy.html 2021-02-17T16:13:29.9620000Z https://www.medicinesresources.nhs.uk/sepsis-in-patients-with-haematological-versus-solid-cancer-a-retrospective-cohort-study.html 2021-02-17T16:15:09.5380000Z https://www.medicinesresources.nhs.uk/covid-vaccine-impact-revealed-in-over-80s-blood-tests.html 2021-02-17T16:47:54.5070000Z https://www.medicinesresources.nhs.uk/guidance-on-shielding-and-protecting-people-who-are-clinically-extremely-vulnerable-from-covid-19-update.html 2021-02-17T16:48:32.2090000Z https://www.medicinesresources.nhs.uk/nitrous-oxide-induced-neurotoxicity-a-case-report-and-literature-review.html 2021-02-17T16:20:13.0060000Z https://www.medicinesresources.nhs.uk/preventing-cardiovascular-disease-among-sexual-and-gender-minority-persons.html 2021-02-17T16:21:46.2560000Z https://www.medicinesresources.nhs.uk/aortitis-recent-advances-current-concepts-and-future-possibilities.html 2021-02-17T16:22:55.4300000Z https://www.medicinesresources.nhs.uk/ema-receives-application-for-conditional-marketing-authorisation-of-covid-19-vaccine-janssen.html 2021-02-17T16:24:44.2480000Z https://www.medicinesresources.nhs.uk/immortal-time-bias-in-observational-studies.html 2021-02-17T16:25:43.3760000Z https://www.medicinesresources.nhs.uk/diagnosis-and-treatment-of-metastatic-colorectal-cancer-a-review.html 2021-02-17T16:27:20.7240000Z https://www.medicinesresources.nhs.uk/class-3-medicines-recall-syrimed-clonidine-hydrochloride-50micrograms-5ml-oral-solution-el-21-a-05.html 2021-02-17T16:28:30.5230000Z https://www.medicinesresources.nhs.uk/new-product-fixkoh-airmaster-salmeterol-and-fluticasone-propionate-50-100-50-250-and-50-500-micrgrams-per-dose-inhalation-powder-pre-dispensed.html 2021-02-17T16:30:53.1160000Z https://www.medicinesresources.nhs.uk/nihr-alert-men-who-have-sex-with-men-are-less-likely-to-use-drugs-to-prevent-hiv-if-they-are-young-unemployed-or-have-a-low-disposable-income.html 2021-02-17T16:31:58.7170000Z https://www.medicinesresources.nhs.uk/therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver-alterations-asco-and-oh-cco-joint-guideline-update-2.html 2021-02-17T16:35:09.3200000Z https://www.medicinesresources.nhs.uk/revised-spc-asmanex-mometasone-furoate-twisthaler-200-and-400-micrograms-inhalation-powder.html 2021-02-18T15:44:40.4500000Z https://www.medicinesresources.nhs.uk/revised-spc-esmya-5-mg-tablets-ulipristal-acetate.html 2021-02-18T17:01:00.1120000Z https://www.medicinesresources.nhs.uk/revised-spc-plavix-clopidogrel-300-mg-film-coated-tablets.html 2021-02-18T15:48:01.0870000Z https://www.medicinesresources.nhs.uk/medicines-in-pregnancy-and-breastfeeding-new-initiative-for-consistent-guidance-report-on-optimising-data-for-medicines-used-during-pregnancy-1.html 2021-02-21T15:42:44.0410000Z https://www.medicinesresources.nhs.uk/alkindi-hydrocortisone-granules-risk-of-acute-adrenal-insufficiency-in-children-when-switching-from-hydrocortisone-tablet-formulations-to-granules-1.html 2021-02-21T15:39:21.7350000Z https://www.medicinesresources.nhs.uk/pregabalin-lyrica-reports-of-severe-respiratory-depression.html 2021-02-21T15:44:51.4490000Z https://www.medicinesresources.nhs.uk/ulipristal-acetate-5mg-esmya-further-restrictions-due-to-risk-of-serious-liver-injury.html 2021-02-21T15:47:36.4390000Z https://www.medicinesresources.nhs.uk/thalidomide-50mg-hard-capsules-accord-uk-ltd-pregnancy-prevention-programme-to-minimise-the-risk-of-teratogenicity-2.html 2021-02-18T16:03:02.1930000Z https://www.medicinesresources.nhs.uk/individual-differences-in-response-to-antidepressants-a-meta-analysis-of-placebo-controlled-randomized-clinical-trials-1.html 2021-02-18T16:04:37.6570000Z https://www.medicinesresources.nhs.uk/levonorgestrel-intrauterine-system-for-endometrial-protection-in-women-with-breast-cancer-on-adjuvant-tamoxifen.html 2021-02-18T16:06:02.8890000Z https://www.medicinesresources.nhs.uk/continuous-glucose-monitoring-for-the-prevention-of-morbidity-and-mortality-in-preterm-infants.html 2021-02-18T16:07:16.9310000Z https://www.medicinesresources.nhs.uk/oral-hygiene-care-for-critically-ill-patients-to-prevent-ventilator-associated-pneumonia.html 2021-02-18T16:55:26.9200000Z https://www.medicinesresources.nhs.uk/antenatal-corticosteroids-for-accelerating-fetal-lung-maturation-for-women-at-risk-of-preterm-birth.html 2021-02-18T16:55:04.2250000Z https://www.medicinesresources.nhs.uk/uk-interim-clinical-commissioning-policy-for-tocilizumab-has-been-updated-to-cover-a-wider-group-of-hospitalised-covid-19-positive-patients.html 2021-02-21T15:49:34.1110000Z https://www.medicinesresources.nhs.uk/update-for-chief-pharmacists-and-senior-pharmacy-leaders-1.html 2021-02-18T16:55:56.5170000Z https://www.medicinesresources.nhs.uk/new-every-mind-matters-campaign-1.html 2021-02-18T16:15:37.5650000Z https://www.medicinesresources.nhs.uk/coronavirus-vaccine-weekly-summary-of-yellow-card-reporting-9-december-2020-to-7-february-2023.html 2021-02-21T15:53:38.9020000Z https://www.medicinesresources.nhs.uk/interim-supply-arrangements-for-voriconazole-200-mg-powder-for-solution-for-infusion-to-mitigate-supply-disruption-pl-00057-1451.html 2021-02-18T16:19:54.6910000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-and-medicines-updates-for-february-2021.html 2021-02-21T16:00:11.8340000Z https://www.medicinesresources.nhs.uk/new-insights-into-atypical-alzheimer-s-disease-in-the-era-of-biomarkers.html 2021-02-18T16:25:11.3020000Z https://www.medicinesresources.nhs.uk/the-health-of-people-from-ethnic-minority-groups-in-england.html 2021-02-18T16:26:42.1040000Z https://www.medicinesresources.nhs.uk/february-interim-findings-from-covid-19-react-1-study-published.html 2021-02-18T16:27:35.3580000Z https://www.medicinesresources.nhs.uk/atopic-dermatitis-in-children-when-topical-steroid-treatment-does-not-work.html 2021-02-18T16:28:28.5750000Z https://www.medicinesresources.nhs.uk/mind-the-gap-londons-low-flu-vaccination-rates-and-how-to-fix-them.html 2021-02-18T16:32:12.5630000Z https://www.medicinesresources.nhs.uk/should-spreading-anti-vaccine-misinformation-be-criminalised.html 2021-02-18T16:33:16.6240000Z https://www.medicinesresources.nhs.uk/covid-19-how-the-uk-vaccine-rollout-delivered-success-so-far.html 2021-02-18T16:35:08.3300000Z https://www.medicinesresources.nhs.uk/tirzepatide-meets-primary-endpoint-in-both-the-phase-iii-surpass-3-and-surpass-5-clinical-trials-in-type-2-diabetes.html 2021-02-18T16:37:20.7800000Z https://www.medicinesresources.nhs.uk/effect-of-a-single-high-dose-of-vitamin-d3-on-hospital-length-of-stay-in-patients-with-moderate-to-severe-covid-19-a-randomized-clinical-trial.html 2021-02-18T16:39:56.8150000Z https://www.medicinesresources.nhs.uk/treatment-of-uterine-fibroid-symptoms-with-relugolix-combination-therapy.html 2021-02-18T16:40:58.2150000Z https://www.medicinesresources.nhs.uk/avacopan-for-the-treatment-of-anca-associated-vasculitis-1.html 2021-02-18T16:58:36.7020000Z https://www.medicinesresources.nhs.uk/an-assessment-of-short-acting-v2-agonist-saba-use-and-subsequent-greenhouse-gas-ghg-emissions-in-five-european-countries-and-the-consequence-of-their-potential-overuse-for-asthma-in-the-uk.html 2021-02-18T16:43:34.7440000Z https://www.medicinesresources.nhs.uk/adalimumab-induced-platelet-antibodies-resulting-in-severe-thrombocytopenia.html 2021-02-18T16:44:50.7830000Z https://www.medicinesresources.nhs.uk/bisphosphonate-nephropathy-a-case-series-and-review-of-the-literature.html 2021-02-18T16:45:57.5530000Z https://www.medicinesresources.nhs.uk/changes-in-prescribing-rates-of-sodium-containing-medications-in-the-uk-from-2009-to-2018-a-cross-sectional-study-with-interrupted-time-series-analysis.html 2021-02-18T16:46:49.4010000Z https://www.medicinesresources.nhs.uk/association-between-cardiometabolic-disease-and-severe-covid-19-a-nationwide-case-control-study-of-patients-requiring-invasive-mechanical-ventilation.html 2021-02-18T16:48:15.2200000Z https://www.medicinesresources.nhs.uk/food-anaphylaxis-in-the-united-kingdom-analysis-of-national-data-1998-2019.html 2021-02-18T16:50:56.6190000Z https://www.medicinesresources.nhs.uk/revised-spc-xromi-hydroxycarbamide-100-mg-ml-oral-solution.html 2021-02-19T16:52:51.3850000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-volanesoren-waylivra-1.html 2021-02-19T16:58:02.1130000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-for-teragezza-co-cyprindiol.html 2021-02-19T16:59:23.2670000Z https://www.medicinesresources.nhs.uk/paclitaxel-drug-coated-balloons-dcbs-or-drug-eluting-stents-dess-reconfirmed-position-on-use-in-patients-with-intermittent-claudication-and-critical-limb-ischaemia.html 2021-02-21T15:21:01.2290000Z https://www.medicinesresources.nhs.uk/metformin-treatment-before-and-during-ivf-or-icsi-in-women-with-polycystic-ovary-syndrome.html 2021-02-19T17:03:02.1920000Z https://www.medicinesresources.nhs.uk/interventions-for-frostbite-injuries.html 2021-02-19T17:04:00.2020000Z https://www.medicinesresources.nhs.uk/primary-prophylaxis-for-venous-thromboembolism-in-ambulatory-cancer-patients-receiving-chemotherapy.html 2021-02-19T17:05:41.2390000Z https://www.medicinesresources.nhs.uk/blood-pressure-targets-in-adults-with-hypertension.html 2021-02-19T17:06:48.8380000Z https://www.medicinesresources.nhs.uk/magnesium-sulphate-for-treating-acute-bronchiolitis-in-children-up-to-two-years-of-age.html 2021-02-19T17:09:04.0190000Z https://www.medicinesresources.nhs.uk/a-randomized-phase-2-study-evaluating-the-efficacy-and-safety-of-anakinra-in-the-treatment-of-gout-flares.html 2021-02-19T17:10:52.9960000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-e6011-an-anti-fractalkine-monoclonal-antibody-in-patients-with-active-rheumatoid-arthritis-with-inadequate-response-to-methotrexate-results-of-a-randomized-double-blind-placebo-controlled-phase-ii-study.html 2021-02-19T17:11:56.6420000Z https://www.medicinesresources.nhs.uk/cross-sectional-observational-study-of-epidemiology-of-covid-19-and-clinical-outcomes-of-hospitalised-patients-in-north-west-london-during-march-and-april-2020.html 2021-02-19T17:12:46.0270000Z https://www.medicinesresources.nhs.uk/prevalence-and-predictors-of-potentially-inappropriate-prescribing-in-middle-aged-adults-repeated-cross-sectional-study.html 2021-02-19T17:14:08.4760000Z https://www.medicinesresources.nhs.uk/positive-interim-data-from-long-term-open-label-phase-iii-safety-study-of-tapinarof-cream-in-plaque-psoriasis.html 2021-02-19T17:14:56.3400000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-for-review-a-supplemental-new-drug-application-seeking-approval-of-brutons-kinase-inhibitor-zanabrutinib-for-the-treatment-of-waldenstroms-macroglobulinaemia.html 2021-02-19T17:15:44.9250000Z https://www.medicinesresources.nhs.uk/european-commission-grants-orphan-drug-designation-to-sparsentan-for-the-treatment-of-iga-nephropathy.html 2021-02-19T17:16:37.0290000Z https://www.medicinesresources.nhs.uk/new-campaign-to-support-vaccine-roll-out-backed-by-social-media-companies-and-british-institutions.html 2021-02-19T17:22:13.3350000Z https://www.medicinesresources.nhs.uk/gbp18-5-million-to-tackle-long-covid-through-research.html 2021-02-19T17:23:24.5140000Z https://www.medicinesresources.nhs.uk/the-price-of-success-how-to-evaluate-covid-19-vaccines-when-theyre-available-outside-of-clinical-trials.html 2021-02-19T17:24:24.1710000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-launch-study-of-covid-19-vaccine-in-healthy-pregnant-women.html 2021-02-19T17:25:23.5420000Z https://www.medicinesresources.nhs.uk/nhs-outcomes-framework-indicators-february-2021-release.html 2021-02-19T17:26:30.4750000Z https://www.medicinesresources.nhs.uk/good-practice-in-prescribing-and-managing-medicines-and-devices-updated-guidance.html 2021-02-21T15:23:12.2410000Z https://www.medicinesresources.nhs.uk/new-technology-to-help-identify-those-at-high-risk-from-covid-19.html 2021-02-19T18:07:59.9070000Z https://www.medicinesresources.nhs.uk/sps-advice-note-interim-position-statement-update-bd-field-safety-notice-fsn-and-intraocular-injections.html 2021-02-21T15:33:31.3450000Z https://www.medicinesresources.nhs.uk/does-self-management-of-vaginal-pessaries-improve-care-for-women-with-pelvic-organ-prolapse.html 2021-02-19T17:32:52.6110000Z https://www.medicinesresources.nhs.uk/prophylactic-anticoagulation-for-patients-in-hospital-with-covid-19.html 2021-02-19T17:33:51.5560000Z https://www.medicinesresources.nhs.uk/arly-rate-reductions-of-sars-cov-2-infection-and-covid-19-in-bnt162b2-vaccine-recipients.html 2021-02-19T18:03:15.2480000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-uk-19-february-2021.html 2021-02-19T18:02:24.7210000Z https://www.medicinesresources.nhs.uk/new-product-arikayce-amikacin-liposomal-590-mg-nebuliser-dispersion-1.html 2021-02-22T13:06:54.0730000Z https://www.medicinesresources.nhs.uk/revised-spc-spravato-esketamine-28-mg-nasal-spray-solution.html 2021-02-22T13:47:55.8330000Z https://www.medicinesresources.nhs.uk/effects-of-low-sodium-diet-versus-high-sodium-diet-on-blood-pressure-renin-aldosterone-catecholamines-cholesterol-and-triglyceride.html 2021-02-23T09:53:14.4300000Z https://www.medicinesresources.nhs.uk/melatonin-for-preoperative-and-postoperative-anxiety-in-adults-1.html 2021-02-22T13:13:51.5410000Z https://www.medicinesresources.nhs.uk/vitamin-d-supplementation-for-term-breastfed-infants-to-prevent-vitamin-d-deficiency-and-improve-bone-health.html 2021-02-23T09:54:15.9190000Z https://www.medicinesresources.nhs.uk/interventions-for-leg-cramps-in-pregnancy.html 2021-02-23T09:54:51.5700000Z https://www.medicinesresources.nhs.uk/change-in-the-regulatory-framework-for-zolpidem-what-is-the-impact-on-the-landscape-of-the-prescription-of-sedative-medications-the-french-national-zorro-study.html 2021-02-22T13:19:47.9060000Z https://www.medicinesresources.nhs.uk/no-association-between-use-of-angiotensin-converting-enzyme-inhibitors-or-angiotensin-ii-receptor-blockers-prior-to-hospital-admission-and-clinical-course-of-covid-19-in-the-covid-medication-comet-study.html 2021-02-22T13:22:21.7230000Z https://www.medicinesresources.nhs.uk/republished-case-report-symptomatic-digoxin-toxicity-in-a-patient-on-haemodialysis.html 2021-02-22T13:24:31.4370000Z https://www.medicinesresources.nhs.uk/single-dose-administration-and-the-influence-of-the-timing-of-the-booster-dose-on-immunogenicity-and-efficacy-of-chadox1-ncov-19-azd1222-vaccine-a-pooled-analysis-of-four-randomised-trials.html 2021-03-01T11:45:26.1910000Z https://www.medicinesresources.nhs.uk/the-potential-effect-of-covid-19-related-disruptions-on-hiv-incidence-and-hiv-related-mortality-among-men-who-have-sex-with-men-in-the-usa-a-modelling-study.html 2021-02-22T13:28:15.6810000Z https://www.medicinesresources.nhs.uk/tebentafusp-granted-breakthrough-therapy-designation-for-unresectable-or-metastatic-uveal-melanoma.html 2021-02-22T13:30:05.1500000Z https://www.medicinesresources.nhs.uk/european-marketing-authorisation-of-hepatitis-b-surface-antigen-heplisav-b-for-immunisation-against-hepatitis-b-virus-infection.html 2021-02-22T13:31:30.1770000Z https://www.medicinesresources.nhs.uk/pfizer-and-biontech-submit-covid-19-vaccine-stability-data-at-standard-freezer-temperature-to-the-fda.html 2021-02-22T15:51:58.1960000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-fezolinetant-in-nonhormonal-treatment-of-vasomotor-symptoms-in-postmenopausal-women.html 2021-02-22T13:34:08.3530000Z https://www.medicinesresources.nhs.uk/drug-induced-peripheral-oedema-an-aetiology-based-review.html 2021-02-22T13:35:40.2530000Z https://www.medicinesresources.nhs.uk/nhs-expands-mental-health-support-for-staff-after-toughest-year-in-health-service-history-1.html 2021-02-22T15:24:11.0590000Z https://www.medicinesresources.nhs.uk/next-steps-on-the-vaccination-programme-vaccinating-cohort-6-individuals-added-to-the-shielded-patient-list-via-qcovid-r-and-adult-carers.html 2021-03-01T11:51:49.1040000Z https://www.medicinesresources.nhs.uk/public-health-england-launches-psychological-first-aid-training.html 2021-02-22T15:26:50.0660000Z https://www.medicinesresources.nhs.uk/supporting-the-lgbtq-population-through-covid-19-and-beyond-1.html 2021-02-22T15:54:49.7520000Z https://www.medicinesresources.nhs.uk/home-delivery-of-medicines-and-appliances-during-the-covid-19-outbreak.html 2021-02-22T15:31:30.4190000Z https://www.medicinesresources.nhs.uk/astra-zeneca-withdraws-durvalumab-imfinzi-indication-in-the-us-for-advanced-bladder-cancer.html 2021-02-22T15:32:51.9760000Z https://www.medicinesresources.nhs.uk/pgd-template-imiquimod-for-treatment-of-ano-genital-warts.html 2021-03-01T12:03:02.2970000Z https://www.medicinesresources.nhs.uk/pgd-template-podophyllotoxin-for-treatment-of-ano-genital-warts.html 2021-03-01T12:25:31.2500000Z https://www.medicinesresources.nhs.uk/pgd-template-aciclovir-for-treatment-of-genital-herpes-simplex-infection.html 2021-03-01T11:57:48.2250000Z https://www.medicinesresources.nhs.uk/vaccines-for-older-adults.html 2021-02-22T15:48:38.3310000Z https://www.medicinesresources.nhs.uk/faq-covid-19-vaccines-and-fertility.html 2021-02-22T15:52:14.9880000Z https://www.medicinesresources.nhs.uk/upadacitinib-meets-primary-endpoint-in-phase-3-induction-study-in-ulcerative-colitis-1.html 2021-02-23T16:29:58.6000000Z https://www.medicinesresources.nhs.uk/trends-in-diabetes-medication-use-in-australia-canada-england-and-scotland-a-repeated-cross-sectional-analysis-in-primary-care.html 2021-02-23T16:28:51.4450000Z https://www.medicinesresources.nhs.uk/guidance-impact-on-primary-care-prescribing-rates-of-simple-analgesia-an-interrupted-time-series-analysis-in-england-1.html 2021-02-23T16:33:36.8090000Z https://www.medicinesresources.nhs.uk/mending-broken-hearts-a-new-treatment-paradigm-for-immune-checkpoint-inhibitor-induced-myocarditis.html 2021-02-23T14:08:49.8640000Z https://www.medicinesresources.nhs.uk/revised-spc-solu-medrone-powder-for-injection-all-strengths.html 2021-02-23T16:35:23.3560000Z https://www.medicinesresources.nhs.uk/the-european-covid-19-drugs-calculation-tool-an-aid-for-the-estimation-of-the-drugs-needed-during-the-sars-cov-2-pandemic.html 2021-02-23T14:12:28.7660000Z https://www.medicinesresources.nhs.uk/antiplatelet-and-direct-oral-anticoagulation-management-after-coronary-artery-bypass-graft-surgery-the-cinderella-of-current-cardiovascular-trials-please-show-me-some-evidence.html 2021-02-23T16:36:01.8170000Z https://www.medicinesresources.nhs.uk/dose-dependent-oral-glucocorticoid-cardiovascular-risks-in-people-with-immune-mediated-inflammatory-diseases-a-population-based-cohort-study.html 2021-02-23T16:36:51.6390000Z https://www.medicinesresources.nhs.uk/postmenopausal-hormone-therapy-for-cardiovascular-health-the-evolving-data-1.html 2021-02-23T16:37:34.0220000Z https://www.medicinesresources.nhs.uk/assessment-of-coverage-in-england-of-cancer-drugs-qualifying-for-us-food-and-drug-administration-accelerated-approval.html 2021-02-23T16:39:15.8980000Z https://www.medicinesresources.nhs.uk/ublituximab-plus-ibrutinib-versus-ibrutinib-alone-for-patients-with-relapsed-or-refractory-high-risk-chronic-lymphocytic-leukaemia-genuine-a-phase-3-multicentre-open-label-randomised-trial-2.html 2021-02-23T16:43:24.2590000Z https://www.medicinesresources.nhs.uk/first-real-world-uk-data-shows-pfizer-biontech-vaccine-provides-high-levels-of-protection-from-the-first-dose.html 2021-02-23T15:44:46.8330000Z https://www.medicinesresources.nhs.uk/public-health-england-report-vaping-in-england-evidence-update-february-2021.html 2021-02-23T16:44:02.7390000Z https://www.medicinesresources.nhs.uk/statistics-on-nhs-stop-smoking-services-in-england-april-2020-to-september-2020.html 2021-02-23T17:26:46.0290000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-training-resources-for-clinicians-and-volunteers.html 2021-02-23T15:49:18.2770000Z https://www.medicinesresources.nhs.uk/nhs-commercial-framework-for-new-medicines.html 2021-02-23T16:47:24.2170000Z https://www.medicinesresources.nhs.uk/briefing-can-variation-help-to-explain-the-rise-in-emergency-admissions-for-children-aged-under-five-up-to-2018-19.html 2021-02-23T16:50:25.6470000Z https://www.medicinesresources.nhs.uk/royal-pharmaceutical-society-rps-to-review-its-fellowship-process.html 2021-02-23T15:54:54.9140000Z https://www.medicinesresources.nhs.uk/national-audit-office-guide-good-practice-in-annual-reporting.html 2021-02-23T15:56:04.5940000Z https://www.medicinesresources.nhs.uk/revised-spc-episenta-sodium-valproate-500-mg-prolonged-release-granules-1.html 2021-02-24T16:03:37.6980000Z https://www.medicinesresources.nhs.uk/revised-spc-imfinzi-durvalumab-50-mg-ml-concentrate-for-solution-for-infusion-2.html 2021-02-24T16:07:16.0240000Z https://www.medicinesresources.nhs.uk/revised-spc-vibramycin-d-doxycycline-dispersible-tablets-100mg.html 2021-02-24T16:08:53.2760000Z https://www.medicinesresources.nhs.uk/revised-spc-bydureon-exenatide-products.html 2021-02-24T16:10:52.9170000Z https://www.medicinesresources.nhs.uk/autologous-anti-cd19-transduced-cd3-cells-for-treating-relapsed-or-refractory-mantle-cell-lymphoma-guidance-ta677.html 2021-03-01T10:45:05.7880000Z https://www.medicinesresources.nhs.uk/filgotinib-for-treating-moderate-to-severe-rheumatoid-arthritis-guidance-ta676.html 2021-03-01T11:26:28.7590000Z https://www.medicinesresources.nhs.uk/metreleptin-for-treating-lipodystrophy-highly-specialised-technologies-guidance-hst14.html 2021-03-01T11:36:30.9930000Z https://www.medicinesresources.nhs.uk/dapagliflozin-for-treating-chronic-heart-failure-with-reduced-ejection-fraction-guidance-ta679-1.html 2021-03-01T11:27:20.4600000Z https://www.medicinesresources.nhs.uk/corrector-therapies-with-or-without-potentiators-for-people-with-cystic-fibrosis-with-class-ii-cftr-gene-variants-most-commonly-f508del.html 2021-02-24T16:21:52.9610000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-preventing-clotting-of-extracorporeal-circuits-during-continuous-renal-replacement-therapy-1.html 2021-02-24T16:23:21.6910000Z https://www.medicinesresources.nhs.uk/single-or-combined-immune-checkpoint-inhibitors-compared-to-first-line-platinum-based-chemotherapy-with-or-without-bevacizumab-for-people-with-advanced-non-small-cell-lung-cancer.html 2021-02-24T16:25:11.3860000Z https://www.medicinesresources.nhs.uk/abiraterone-acetate-in-combination-with-androgen-deprivation-therapy-compared-to-androgen-deprivation-therapy-only-for-metastatic-hormone-sensitive-prostate-cancer-1.html 2021-02-24T16:26:59.1160000Z https://www.medicinesresources.nhs.uk/remsima-infliximab-biosimilar-for-subcutaneous-injection-for-managing-crohns-disease-and-ulcerative-colitis-evidence-summary-ed35.html 2021-03-01T11:32:53.4650000Z https://www.medicinesresources.nhs.uk/what-is-the-significance-of-nitrosamine-contamination-in-medicines.html 2021-02-24T16:30:21.5430000Z https://www.medicinesresources.nhs.uk/comparative-effectiveness-and-harms-of-antibiotics-for-outpatient-diverticulitis.html 2021-02-24T16:54:38.3890000Z https://www.medicinesresources.nhs.uk/excess-mortality-in-wuhan-city-and-other-parts-of-china-during-the-three-months-of-the-covid-19-outbreak-findings-from-nationwide-mortality-registries.html 2021-02-24T16:55:47.5440000Z https://www.medicinesresources.nhs.uk/effect-of-vitamin-c-thiamine-and-hydrocortisone-on-ventilator-and-vasopressor-free-days-in-patients-with-sepsis.html 2021-02-24T16:56:55.8550000Z https://www.medicinesresources.nhs.uk/effect-of-high-dose-baclofen-on-agitation-related-events-among-patients-with-unhealthy-alcohol-use-receiving-mechanical-ventilation.html 2021-02-24T16:58:18.4640000Z https://www.medicinesresources.nhs.uk/robust-a-phase-iii-study-of-lenalidomide-plus-r-chop-versus-placebo-plus-r-chop-in-previously-untreated-patients-with-abc-type-diffuse-large-b-cell-lymphoma.html 2021-02-24T16:59:18.6560000Z https://www.medicinesresources.nhs.uk/fda-plans-ahead-for-covid-19-mutations-with-booster-shot-guidance.html 2021-02-24T17:00:29.2650000Z https://www.medicinesresources.nhs.uk/cemiplimab-libatyo-approved-by-fda-for-first-line-treatment-of-patients-with-advanced-non-small-cell-lung-cancer-nsclc.html 2021-02-24T17:01:45.6500000Z https://www.medicinesresources.nhs.uk/arterial-and-venous-thromboembolism-in-covid-19-a-study-level-meta-analysis.html 2021-02-24T17:04:39.2270000Z https://www.medicinesresources.nhs.uk/university-study-finds-covid-survives-three-days-on-fabric.html 2021-02-24T17:25:33.1870000Z https://www.medicinesresources.nhs.uk/home-testing-hpv-kits-will-be-offered-to-women-in-england-as-part-of-screening-trial-1.html 2021-02-24T17:27:38.4860000Z https://www.medicinesresources.nhs.uk/diagnosis-and-treatment-of-multiple-sclerosis-a-review.html 2021-02-24T17:29:00.6890000Z https://www.medicinesresources.nhs.uk/updated-prescribing-information-for-covid-19-vaccine-astrazeneca.html 2021-02-24T17:30:48.7870000Z https://www.medicinesresources.nhs.uk/mhra-approves-tukysa-tucatinib-in-combination-with-trastuzumab-and-capecitabine-for-the-treatment-of-advanced-her2-positive-breast-cancer.html 2021-02-24T17:31:42.7450000Z https://www.medicinesresources.nhs.uk/dtb-forum-bisphosphonate-holidays.html 2021-03-01T09:39:47.1700000Z https://www.medicinesresources.nhs.uk/february-bnf-bnfc-newsletter-1.html 2021-03-01T10:31:51.6430000Z https://www.medicinesresources.nhs.uk/new-product-vitrakvi-larotrectinib-25mg-and-100mg-hard-capsules.html 2021-02-25T15:57:10.4270000Z https://www.medicinesresources.nhs.uk/maternal-death-learning-from-maternal-death-investigations-during-the-first-wave-of-the-covid-19-pandemic.html 2021-02-25T15:58:25.9890000Z https://www.medicinesresources.nhs.uk/omega-3-and-polyunsaturated-fat-for-prevention-of-depression-and-anxiety-symptoms-systematic-review-and-meta-analysis-of-randomised-trials.html 2021-02-25T16:00:04.2910000Z https://www.medicinesresources.nhs.uk/anti-il-5-therapies-for-chronic-obstructive-pulmonary-disease.html 2021-02-25T16:01:39.2990000Z https://www.medicinesresources.nhs.uk/n-acetylcysteine-for-non-paracetamol-acetaminophen-related-acute-liver-failure.html 2021-02-25T16:05:18.8610000Z https://www.medicinesresources.nhs.uk/interventions-for-itch-in-people-with-advanced-chronic-kidney-disease.html 2021-02-25T16:06:38.9250000Z https://www.medicinesresources.nhs.uk/bisphosphonates-or-rank-ligand-inhibitors-for-men-with-prostate-cancer-and-bone-metastases-a-network-meta-analysis.html 2021-02-25T16:08:48.5570000Z https://www.medicinesresources.nhs.uk/epidemiology-of-drug-related-deaths-in-european-hospitals-a-systematic-review-and-meta-analysis-of-observational-studies.html 2021-02-25T17:50:25.9710000Z https://www.medicinesresources.nhs.uk/european-commission-grants-gene-therapy-candidate-ocu400-orphan-medicinal-product-designation-for-treatment-ofinherited-retinal-diseases-retinitis-pigmentosa-and-leber-congenital-amaurosis.html 2021-02-25T18:01:50.1870000Z https://www.medicinesresources.nhs.uk/supplemental-new-drug-application-submitted-to-fda-seeking-expanded-approval-for-apremilast-otezla-in-adults-with-mild-to-moderate-plaque-psoriasis.html 2021-02-25T16:33:56.0380000Z https://www.medicinesresources.nhs.uk/integrated-care-systems-in-london-challenges-and-opportunities-ahead.html 2021-02-25T16:34:57.6300000Z https://www.medicinesresources.nhs.uk/planning-to-provide-covid-19-vaccinations-in-community-pharmacies-in-england.html 2021-02-25T16:36:05.0440000Z https://www.medicinesresources.nhs.uk/prescription-charge-set-to-rise-from-1st-april-2021.html 2021-02-25T16:37:29.3260000Z https://www.medicinesresources.nhs.uk/further-opportunities-for-pcn-and-community-pharmacy-vaccination-sites-to-partner-with-community-venues-to-deliver-temporary-vaccination-clinics.html 2021-02-25T16:39:35.3920000Z https://www.medicinesresources.nhs.uk/supporting-ccgs-to-address-vaccine-inequalities.html 2021-02-25T16:40:48.7210000Z https://www.medicinesresources.nhs.uk/v-thalassemias.html 2021-02-25T16:41:44.9140000Z https://www.medicinesresources.nhs.uk/sapropterin-for-treating-phenylketonuria-appraisal-consultation-document.html 2021-02-25T16:42:52.0280000Z https://www.medicinesresources.nhs.uk/the-scientific-and-ethical-feasibility-of-immunity-passports.html 2021-02-25T16:45:20.5500000Z https://www.medicinesresources.nhs.uk/management-of-dyspnea-in-advanced-cancer-asco-guideline.html 2021-02-25T16:47:51.9010000Z https://www.medicinesresources.nhs.uk/national-institute-for-health-and-care-excellence-clinical-guidelines-development-principles-and-processes-2.html 2021-02-25T16:52:09.4290000Z https://www.medicinesresources.nhs.uk/international-cooperation-to-align-approaches-for-regulation-of-covid-19-vaccines-and-medicines.html 2021-02-25T16:54:14.3440000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-starts-rolling-review-of-celltrion-antibody-regdanvimab-for-covid-20.html 2021-02-25T16:57:45.3930000Z https://www.medicinesresources.nhs.uk/government-removes-ban-on-uk-sourced-blood-plasma-for-the-manufacture-of-immunoglobulins-1.html 2021-02-25T18:09:54.2080000Z https://www.medicinesresources.nhs.uk/supporting-urgent-and-emergency-care-during-winter.html 2021-02-25T17:03:57.5870000Z https://www.medicinesresources.nhs.uk/selective-serotonin-reuptake-inhibitor-discontinuation-syndrome-or-withdrawal-2.html 2021-02-25T17:07:32.8280000Z https://www.medicinesresources.nhs.uk/cardiovascular-safety-of-the-tyrosine-kinase-inhibitor-nintedanib.html 2021-02-25T17:09:25.9510000Z https://www.medicinesresources.nhs.uk/shared-care-prescribing-and-monitoring-guidance.html 2021-03-01T10:32:36.9890000Z https://www.medicinesresources.nhs.uk/prescribing-dilemmas-a-guide-for-prescribers.html 2021-03-01T10:35:12.2670000Z https://www.medicinesresources.nhs.uk/best-practice-reminder-avoid-nitrofurantoin-in-the-treatment-of-pyelonephritis-1.html 2021-03-01T10:38:16.0880000Z https://www.medicinesresources.nhs.uk/effect-of-subcutaneous-semaglutide-vs-placebo-as-an-adjunct-to-intensive-behavioral-therapy-on-body-weight-in-adults-with-overweight-or-obesity-the-step-3-randomized-clinical-trial.html 2021-02-25T17:19:54.8700000Z https://www.medicinesresources.nhs.uk/preoperative-intravenous-iron-for-anaemia-in-elective-major-open-abdominal-surgery-the-preventt-rct-1.html 2021-02-25T17:21:48.8210000Z https://www.medicinesresources.nhs.uk/muscarinic-cholinergic-receptor-agonist-and-peripheral-antagonist-for-schizophrenia-1.html 2021-02-25T17:23:15.8080000Z https://www.medicinesresources.nhs.uk/idecabtagene-vicleucel-in-relapsed-and-refractory-multiple-myeloma-1.html 2021-02-25T17:25:19.2990000Z https://www.medicinesresources.nhs.uk/glycemic-index-glycemic-load-and-cardiovascular-disease-and-mortality-2.html 2021-02-25T17:27:43.1980000Z https://www.medicinesresources.nhs.uk/bnt162b2-mrna-covid-19-vaccine-in-a-nationwide-mass-vaccination-setting-1.html 2021-02-25T17:29:36.7490000Z https://www.medicinesresources.nhs.uk/effect-of-reductions-in-amyloid-levels-on-cognitive-change-in-randomized-trials-instrumental-variable-meta-analysis-1.html 2021-02-26T15:18:56.6230000Z https://www.medicinesresources.nhs.uk/statin-treatment-and-muscle-symptoms-series-of-randomised-placebo-controlled-n-of-1-trials-1.html 2021-02-25T17:36:50.7290000Z https://www.medicinesresources.nhs.uk/drug-related-bradycardia-precipitating-hospital-admission-in-older-adults-an-ongoing-problem-1.html 2021-02-25T17:38:06.6390000Z https://www.medicinesresources.nhs.uk/safeguarding-adults-in-care-homes-guidance-ng189-1.html 2021-03-01T07:31:01.9040000Z https://www.medicinesresources.nhs.uk/interventions-to-reduce-tobacco-use-in-people-experiencing-homelessness.html 2021-02-26T16:04:52.9060000Z https://www.medicinesresources.nhs.uk/pharmacological-interventions-for-self-harm-in-adults.html 2021-02-26T16:06:21.2610000Z https://www.medicinesresources.nhs.uk/coenzyme-q10-for-heart-failure.html 2021-02-26T16:07:50.5120000Z https://www.medicinesresources.nhs.uk/systemic-antibiotics-for-chronic-suppurative-otitis-media.html 2021-02-26T16:09:43.2050000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-evidence-summary-tocilizumab-for-covid-19-update.html 2021-03-01T07:33:39.5060000Z https://www.medicinesresources.nhs.uk/tocilizumab-in-hospitalized-patients-with-severe-covid-19-pneumonia.html 2021-03-01T07:46:17.4600000Z https://www.medicinesresources.nhs.uk/interleukin-6-receptor-antagonists-in-critically-ill-patients-with-covid-19.html 2021-03-01T10:26:04.0720000Z https://www.medicinesresources.nhs.uk/impact-of-risk-adapted-therapy-for-pediatric-hodgkin-lymphoma-on-risk-of-long-term-morbidity-a-report-from-the-childhood-cancer-survivor-study.html 2021-02-26T16:21:09.1800000Z https://www.medicinesresources.nhs.uk/development-and-validation-of-a-prediction-model-for-30-day-mortality-in-hospitalised-patients-with-covid-19-the-covid-19-seimc-score.html 2021-02-26T16:22:24.0290000Z https://www.medicinesresources.nhs.uk/data-from-pooled-safety-analysis-in-patients-treated-with-palforzia-peanut-allergen-powder-presented-at-conference-1.html 2021-02-26T16:28:22.7170000Z https://www.medicinesresources.nhs.uk/fda-authorized-covid-19-vaccines-are-effective-per-real-world-evidence-synthesized-across-a-multi-state-health-system.html 2021-02-26T16:29:48.1540000Z https://www.medicinesresources.nhs.uk/independent-data-monitoring-committee-idmc-finds-clear-efficacy-for-regen-cov-tm-casirivimab-with-imdevimab-in-phase-3-covid-19-outpatient-outcomes-trial.html 2021-02-26T16:36:25.2400000Z https://www.medicinesresources.nhs.uk/cabozantinib-granted-breakthrough-therapy-designation-in-the-us-for-previously-treated-radioactive-iodine-refractory-differentiated-thyroid-cancer.html 2021-02-26T16:38:25.0400000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-validates-marketing-authorisation-application-for-retifanlimab-for-the-treatment-of-squamous-cell-anal-carcinoma-scac-1.html 2021-02-26T16:41:08.2440000Z https://www.medicinesresources.nhs.uk/randomised-open-label-study-of-inhaled-sargramostim-recombinant-human-gm-csf-in-hospitalised-covid-19-patients-meets-primary-endpoint-1.html 2021-02-26T16:42:54.8520000Z https://www.medicinesresources.nhs.uk/supply-disruption-alert-discontinuation-of-morphine-sulphate-mst-continus-20mg-30mg-60mg-100mg-and-200mg-prolonged-release-granules-for-oral-suspension.html 2021-03-01T10:04:04.8320000Z https://www.medicinesresources.nhs.uk/the-importance-of-ras-in-drug-resistance-in-cancer.html 2021-02-26T16:45:39.2620000Z https://www.medicinesresources.nhs.uk/fda-approves-more-flexible-storage-and-transportation-conditions-for-pfizer-biontech-covid-19-vaccine-1.html 2021-02-26T16:47:40.1880000Z https://www.medicinesresources.nhs.uk/us-fda-approves-casimersen-injection-for-the-treatment-of-duchenne-muscular-dystrophy-dmd-in-patients-who-have-a-confirmed-mutation-of-the-dmd-gene-that-is-amenable-to-exon-45-skipping.html 2021-02-26T16:48:56.5130000Z https://www.medicinesresources.nhs.uk/regulatory-requirements-for-vaccines-intended-to-provide-protection-against-variant-strain-s-of-sars-cov-2.html 2021-02-26T16:50:13.4270000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guidance-final-appraisal-document-on-ribociclib-with-fulvestrant-for-treating-hormone-receptor-positive-her2-negative-advanced-breast-cancer-cdf-review-of-ta593.html 2021-02-26T16:56:10.7690000Z https://www.medicinesresources.nhs.uk/contribution-of-early-clinical-benefit-end-points-to-decreased-lung-cancer-mortality-rates.html 2021-02-26T16:57:30.9760000Z https://www.medicinesresources.nhs.uk/current-treatment-strategies-and-future-directions-for-extrapulmonary-neuroendocrine-carcinomas-epnc.html 2021-02-26T18:10:25.7180000Z https://www.medicinesresources.nhs.uk/preliminary-study-results-suggest-single-dose-of-bnt162b2-covid-19-vaccine-protects-against-asymptomatic-sars-cov-2-infection.html 2021-02-26T17:01:08.7880000Z https://www.medicinesresources.nhs.uk/in-the-wake-of-the-pandemic-preparing-for-long-covid.html 2021-02-26T17:02:16.2870000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-testing-booster-of-their-covid-19-vaccine-in-new-trial.html 2021-02-26T17:03:31.2800000Z https://www.medicinesresources.nhs.uk/first-innovation-passport-awarded-to-help-support-development-and-access-to-cutting-edge-medicines.html 2021-02-26T17:06:30.5940000Z https://www.medicinesresources.nhs.uk/coronavirus-vaccine-weekly-summary-of-yellow-card-reporting-9-december-2020-to-14-february-2021.html 2021-03-01T10:05:31.8920000Z https://www.medicinesresources.nhs.uk/jcvi-advises-inviting-people-on-learning-disability-register-for-vaccine.html 2021-02-26T18:10:54.8370000Z https://www.medicinesresources.nhs.uk/national-diabetes-inpatient-covid-19-response-team-clinical-guidance.html 2021-02-26T18:11:31.7350000Z https://www.medicinesresources.nhs.uk/more-than-a-million-more-people-invited-to-get-an-nhs-covid-jab-1.html 2021-02-26T17:12:34.1240000Z https://www.medicinesresources.nhs.uk/phase-ii-results-for-investigational-covid-19-antibody-otilimab-in-hospitalised-covid-19-patients.html 2021-02-26T17:17:27.7580000Z https://www.medicinesresources.nhs.uk/jcvi-issues-interim-advice-on-phase-2-of-covid-19-vaccination-programme-rollout.html 2021-03-01T10:14:06.3090000Z https://www.medicinesresources.nhs.uk/essential-workers-prioritised-for-covid-19-testing.html 2021-02-26T17:22:18.1200000Z https://www.medicinesresources.nhs.uk/latest-findings-from-react-2-antibody-surveillance-study-published-2.html 2021-02-26T17:25:18.9740000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-programme-information-for-healthcare-practitioners-update-2.html 2021-03-01T10:15:04.2150000Z https://www.medicinesresources.nhs.uk/enteric-fever-2.html 2021-02-26T17:29:22.8290000Z https://www.medicinesresources.nhs.uk/endometriosis-is-a-chronic-systemic-disease-clinical-challenges-and-novel-innovations.html 2021-02-26T17:30:46.8350000Z https://www.medicinesresources.nhs.uk/antibody-response-to-first-bnt162b2-dose-in-previously-sars-cov-2-infected-individuals.html 2021-02-26T18:05:30.9040000Z https://www.medicinesresources.nhs.uk/ffect-of-previous-sars-cov-2-infection-on-humoral-and-t-cell-responses-to-single-dose-bnt162b2-vaccine.html 2021-02-26T18:07:42.2310000Z https://www.medicinesresources.nhs.uk/revised-spc-velcade-bortezomib-3-5mg-powder-for-solution-for-injection.html 2021-03-01T15:36:04.5950000Z https://www.medicinesresources.nhs.uk/revised-spc-somavert-pegvisomant-powder-and-solvent-for-solution-for-injection.html 2021-03-01T15:38:47.1520000Z https://www.medicinesresources.nhs.uk/rapid-lateral-flow-testing-for-households-and-bubbles-of-school-pupils-and-staff-1.html 2021-03-01T12:53:33.0670000Z https://www.medicinesresources.nhs.uk/long-term-effects-of-weight-reducing-drugs-in-people-with-hypertension.html 2021-03-01T12:54:55.2670000Z https://www.medicinesresources.nhs.uk/sustained-remission-of-granulomatosis-with-polyangiitis-after-discontinuation-of-glucocorticoids-and-immunosuppressant-therapy-data-from-the-french-vasculitis-study-group-registry.html 2021-03-01T12:56:29.6070000Z https://www.medicinesresources.nhs.uk/fda-grants-regulatory-approval-of-fosdenopterin-nulibry-for-molybdenum-cofactor-deficiency-mocd-type-a.html 2021-03-01T13:06:47.7790000Z https://www.medicinesresources.nhs.uk/fda-issues-emergency-use-authorization-for-single-dose-janssen-covid-19-vaccine.html 2021-03-01T13:09:23.6700000Z https://www.medicinesresources.nhs.uk/fda-grants-regulatory-approval-of-melphalan-flufenamide-in-combination-with-dexamethasone-for-treatment-of-refractory-multiple-myeloma.html 2021-03-01T15:28:41.3360000Z https://www.medicinesresources.nhs.uk/positive-data-from-navigator-phase-iii-trial-of-tezepelumab-in-severe-uncontrolled-asthma.html 2021-03-01T13:15:16.8800000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-cabozantinib-cabometyx-as-first-line-treatment-for-advanced-renal-cell-carcinoma.html 2021-03-01T13:17:32.2930000Z https://www.medicinesresources.nhs.uk/bmj-editorial-covid-19-vaccine-hesitancy-among-ethnic-minority-groups.html 2021-03-01T13:19:28.8930000Z https://www.medicinesresources.nhs.uk/the-role-of-antibody-tests-for-covid-19-in-primary-care.html 2021-03-01T13:21:11.6670000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-cannabidiol-epidyolex.html 2021-03-01T13:22:55.2560000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-delafloxacin-quofenix.html 2021-03-01T13:24:06.6340000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-isatuximab-sarclisa.html 2021-03-01T13:25:17.5180000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-two-bevacizumab-biosmilars-abevmy-and-lextemy.html 2021-03-01T13:26:52.8890000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-berotralstat-orladeyo-for-prevention-of-recurrent-attacks-of-hereditary-angioedema-hae.html 2021-03-01T13:29:08.1450000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-dostarlimab-jemperli-for-recurrent-or-advanced-endometrial-cancer.html 2021-03-01T13:30:40.4530000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-risdiplam-evrysdi-for-treatment-of-spinal-muscular-atrophy.html 2021-03-01T13:32:50.6770000Z https://www.medicinesresources.nhs.uk/association-of-convalescent-plasma-treatment-with-clinical-outcomes-in-patients-with-covid-19-a-systematic-review-and-meta-analysis.html 2021-03-01T16:18:03.2790000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-intensive-blood-pressure-lowering-after-successful-endovascular-therapy-in-acute-ischaemic-stroke-bp-target-a-multicentre-open-label-randomised-controlled-trial.html 2021-03-01T15:40:39.1920000Z https://www.medicinesresources.nhs.uk/ema-issues-advice-on-use-of-regn-cov2-antibody-combination-casirivimab-imdevimab.html 2021-03-08T09:39:59.6140000Z https://www.medicinesresources.nhs.uk/sodium-glucose-co-transporter-2-inhibitor-therapy-mechanisms-of-action-in-heart-failure-1.html 2021-03-01T15:48:06.3180000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-nivolumab-opdivo-as-first-line-treatment-for-advanced-renal-cell-carcinoma-3.html 2021-03-01T15:50:55.0210000Z https://www.medicinesresources.nhs.uk/sars-cov-2-vaccines.html 2021-03-01T15:53:32.8160000Z https://www.medicinesresources.nhs.uk/guillain-barre-syndrome.html 2021-03-01T15:56:10.8640000Z https://www.medicinesresources.nhs.uk/class-3-medicines-recall-easyhaler-salbutamol-sulfate-100-micrograms-per-actuation-200-micrograms-per-actuation-inhalation-powder-el-21-a-06.html 2021-03-01T15:59:47.9550000Z https://www.medicinesresources.nhs.uk/challenging-health-inequalities-accessible-eczema-care-plans.html 2021-03-01T16:01:59.5010000Z https://www.medicinesresources.nhs.uk/nhs-invites-people-aged-60-plus-to-book-covid-vaccination.html 2021-03-01T16:03:07.8710000Z https://www.medicinesresources.nhs.uk/heart-failure-a-call-to-action.html 2021-03-01T16:04:28.5350000Z https://www.medicinesresources.nhs.uk/confirmed-cases-of-covid-19-variants-identified-in-uk.html 2021-03-01T16:07:38.4040000Z https://www.medicinesresources.nhs.uk/acute-covid-19-and-multisystem-inflammatory-syndrome-in-children.html 2021-03-01T16:08:43.9290000Z https://www.medicinesresources.nhs.uk/european-chmp-negative-opinion-of-license-extension-of-fluticasone-furoate-umeclidinium-vilanterol-elebrato-ellipta-temybric-ellipta-trelegy-ellipta-as-maintenance-therapy.html 2021-03-01T16:20:51.7490000Z https://www.medicinesresources.nhs.uk/revised-spc-nimenrix-meningococcal-groups-a-c-w-135-and-y-conjugate-vaccine-powder-and-solvent-for-solution-for-injection-in-pre-filled-syringe.html 2021-03-02T15:30:36.2320000Z https://www.medicinesresources.nhs.uk/secondary-bacterial-infection-of-eczema-and-other-common-skin-conditions-antimicrobial-prescribing-guidance-ng190.html 2021-03-08T09:43:03.1320000Z https://www.medicinesresources.nhs.uk/a-living-who-guideline-on-drugs-to-prevent-covid-19.html 2021-03-08T12:01:49.4000000Z https://www.medicinesresources.nhs.uk/guidance-on-issuing-the-steroid-emergency-card.html 2021-03-08T12:10:17.9350000Z https://www.medicinesresources.nhs.uk/withdrawal-or-continuation-of-cholinesterase-inhibitors-or-memantine-or-both-in-people-with-dementia.html 2021-03-02T15:38:50.3720000Z https://www.medicinesresources.nhs.uk/topical-antibiotic-prophylaxis-to-reduce-respiratory-tract-infections-and-mortality-in-adults-receiving-mechanical-ventilation.html 2021-03-02T15:42:19.9360000Z https://www.medicinesresources.nhs.uk/ethosuximide-sodium-valproate-or-lamotrigine-for-absence-seizures-in-children-and-adolescents-1.html 2021-03-02T15:44:56.6360000Z https://www.medicinesresources.nhs.uk/interventions-for-treating-iron-deficiency-anaemia-in-inflammatory-bowel-disease.html 2021-03-02T17:53:19.0840000Z https://www.medicinesresources.nhs.uk/competition-appeal-tribunal-upholds-competition-and-markets-authoritys-decision-to-fine-lexon-gbp1-2m-for-breach-of-competition-law-in-relation-to-pricing-of-nortriptyline.html 2021-03-02T15:47:30.4900000Z https://www.medicinesresources.nhs.uk/licence-extension-for-secukinumab-covering-axial-manifestations-of-psoriatic-arthritis-approved-in-eu.html 2021-03-02T16:29:55.0090000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-self-referral-extension-for-pharmacy-staff.html 2021-03-02T15:52:03.9400000Z https://www.medicinesresources.nhs.uk/restricting-workforce-movement-between-care-homes-and-other-care-settings.html 2021-03-02T15:53:09.3630000Z https://www.medicinesresources.nhs.uk/opportunities-to-repurpose-medicines-in-the-nhs-in-england.html 2021-03-02T15:54:09.7180000Z https://www.medicinesresources.nhs.uk/treatment-of-relapsed-and-refractory-multiple-myeloma-recommendations-from-the-international-myeloma-working-group-1.html 2021-03-02T15:56:10.5030000Z https://www.medicinesresources.nhs.uk/jcvi-interim-statement-on-phase-2-of-the-covid-19-vaccination-programme.html 2021-03-02T15:58:23.6490000Z https://www.medicinesresources.nhs.uk/symptom-management-of-patients-with-multiple-sclerosis-in-primary-care-focus-on-overlooked-symptoms.html 2021-03-02T16:00:02.5580000Z https://www.medicinesresources.nhs.uk/anosmia-an-evidence-based-approach-to-diagnosis-and-management-in-primary-care-1.html 2021-03-02T16:03:25.2830000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-validates-for-review-marketing-authorization-application-for-somatrogon-to-treat-paediatric-patients-with-growth-hormone-deficiency.html 2021-03-02T16:05:12.5330000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-accepts-for-review-marketing-authorization-application-for-investigational-20-valent-pneumococcal-conjugate-vaccine-20vpnc-for-use-in-adults.html 2021-03-02T16:07:02.0630000Z https://www.medicinesresources.nhs.uk/carsgen-therapeutics-receives-orphan-medicinal-product-designation-from-european-medicines-agency-for-ct041-cldn18-2-car-t-cells-for-treatment-of-gastric-cancers.html 2021-03-02T16:08:28.4560000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-review-new-drug-application-nda-for-gefapixant-for-treatment-of-refractory-or-unexplained-chronic-cough-in-adults.html 2021-03-02T16:10:12.2190000Z https://www.medicinesresources.nhs.uk/investigational-gene-therapy-avr-rd-04-for-cystinosis-receives-orphan-drug-designation-from-european-commission.html 2021-03-02T16:12:37.2600000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-review-new-drug-application-nda-for-investigational-once-nightly-formulation-of-sodium-oxybate-ft218-for-treatment-of-excessive-daytime-sleepiness-and-cataplexy-in-adults-with-narcolepsy.html 2021-03-02T16:15:14.4770000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-accepts-for-filing-marketing-authorization-applica-new-itemation-for-recombinant-coagulation-factor-viia-eptacog-beta-activated-1.html 2021-03-02T16:19:28.3940000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-february-2022.html 2021-03-08T12:11:54.5800000Z https://www.medicinesresources.nhs.uk/medication-review-interventions-to-reduce-hospital-readmissions-in-older-people.html 2021-03-02T16:40:15.1460000Z https://www.medicinesresources.nhs.uk/reduced-exposure-to-vasopressors-through-permissive-hypotension-to-reduce-mortality-in-critically-ill-people-aged-65-and-over-the-65-rct-1.html 2021-03-02T16:42:38.0150000Z https://www.medicinesresources.nhs.uk/effect-of-a-multifaceted-clinical-pharmacist-intervention-on-medication-safety-after-hospitalization-in-persons-prescribed-high-risk-medications-a-randomized-clinical-trial-2.html 2021-03-02T17:35:19.0530000Z https://www.medicinesresources.nhs.uk/severe-hypoglycemia-risk-with-long-acting-insulin-analogs-vs-neutral-protamine-hagedorn-insulin.html 2021-03-02T16:48:00.7240000Z https://www.medicinesresources.nhs.uk/early-effectiveness-of-covid-19-vaccination-with-bnt162b2-mrna-vaccine-and-chadox1-adenovirus-vector-vaccine-on-symptomatic-disease-hospitalisations-and-mortality-in-older-adults-in-the-uk-a-test-negative-case-control-study.html 2021-03-08T12:14:02.0480000Z https://www.medicinesresources.nhs.uk/sars-cov-2-lateral-flow-assays-for-possible-use-in-national-covid-19-seroprevalence-surveys-react-2-diagnostic-accuracy-study.html 2021-03-02T16:51:35.0240000Z https://www.medicinesresources.nhs.uk/social-isolation-and-risk-of-heart-disease-and-stroke-analysis-of-two-large-uk-prospective-studies.html 2021-03-02T16:53:30.1720000Z https://www.medicinesresources.nhs.uk/non-communicable-disease-sociodemographic-factors-and-risk-of-death-from-infection-a-uk-biobank-observational-cohort-study.html 2021-03-02T16:54:29.8210000Z https://www.medicinesresources.nhs.uk/baricitinib-for-treating-moderate-to-severe-atopic-dermatitis-guidance-ta681-1.html 2021-03-08T12:16:50.3860000Z https://www.medicinesresources.nhs.uk/lenalidomide-maintenance-treatment-after-an-autologous-stem-cell-transplant-for-newly-diagnosed-multiple-myeloma-guidance-ta680-1.html 2021-03-08T12:30:50.7660000Z https://www.medicinesresources.nhs.uk/revised-spc-vermox-mebendazole-tablets.html 2021-03-03T15:30:07.7140000Z https://www.medicinesresources.nhs.uk/revised-spc-testogel-testosterone-gel.html 2021-03-03T15:32:31.2180000Z https://www.medicinesresources.nhs.uk/revised-spc-klaricid-clarithromycin-preparations.html 2021-03-03T15:34:34.0650000Z https://www.medicinesresources.nhs.uk/systematic-review-of-prediction-models-for-pulmonary-tuberculosis-treatment-outcomes-in-adults.html 2021-03-03T15:35:36.0540000Z https://www.medicinesresources.nhs.uk/the-covid-19-ibuprofen-controversy-a-systematic-review-of-nsaids-in-adult-acute-lower-respiratory-tract-infections.html 2021-03-03T15:38:26.0500000Z https://www.medicinesresources.nhs.uk/risk-of-congenital-malformations-in-offspring-of-women-using-v-blockers-during-early-pregnancy-an-updated-meta-analysis-of-observational-studies.html 2021-03-03T15:41:08.6060000Z https://www.medicinesresources.nhs.uk/dtb-select-risk-of-dka-with-sglt2-inhibitors.html 2021-03-03T17:15:49.4390000Z https://www.medicinesresources.nhs.uk/associations-with-antibiotic-prescribing-for-acute-exacerbation-of-copd-in-primary-care.html 2021-03-03T15:44:42.3660000Z https://www.medicinesresources.nhs.uk/how-many-medications-do-doctors-in-primary-care-use-an-observational-study-of-the-du90-indicator-in-primary-care-in-england.html 2021-03-03T15:48:34.3300000Z https://www.medicinesresources.nhs.uk/high-flow-oxygen-and-risk-of-mortality-in-patients-with-a-suspected-acute-coronary-syndrome-pragmatic-cluster-randomised-crossover-trial.html 2021-03-03T15:51:23.3500000Z https://www.medicinesresources.nhs.uk/fruit-and-vegetable-intake-and-mortality-results-from-2-prospective-cohort-studies-of-us-men-and-women-and-a-meta-analysis-of-26-cohort-studies.html 2021-03-03T15:53:10.5700000Z https://www.medicinesresources.nhs.uk/cardiovascular-renal-and-metabolic-outcomes-of-dapagliflozin-versus-placebo-in-a-primary-cardiovascular-prevention-cohort-analyses-from-declare-timi-58.html 2021-03-03T15:55:11.0000000Z https://www.medicinesresources.nhs.uk/rituximab-plus-high-dose-chemotherapy-megachoep-or-conventional-chemotherapy-choep-14-in-young-high-risk-patients-with-aggressive-b-cell-lymphoma-10-year-follow-up-of-a-randomised-open-label-phase-3-trial.html 2021-03-03T15:58:35.6580000Z https://www.medicinesresources.nhs.uk/new-medicines-news-february-2021.html 2021-03-08T12:34:20.1540000Z https://www.medicinesresources.nhs.uk/new-drug-application-received-by-fda-for-levoketoconazole-for-the-treatment-of-endogenous-cushings-syndrome-1.html 2021-03-03T16:09:04.3220000Z https://www.medicinesresources.nhs.uk/manufactuers-report-positive-phase-iii-data-for-ibrexafungerp-for-treatment-of-severe-fungal-infections-in-the-hospital-setting.html 2021-03-03T17:36:06.7610000Z https://www.medicinesresources.nhs.uk/deprescribing-what-do-we-know-and-where-to-next.html 2021-03-03T16:16:46.8350000Z https://www.medicinesresources.nhs.uk/the-missed-opportunity-for-real-world-evidence-to-shape-our-understanding-of-medical-cannabis.html 2021-03-03T16:19:43.0680000Z https://www.medicinesresources.nhs.uk/measuring-and-reporting-treatment-adherence-what-can-we-learn-by-comparing-two-respiratory-conditions.html 2021-03-03T17:20:12.3780000Z https://www.medicinesresources.nhs.uk/interferent-effect-of-hydroxyurea-on-continuous-glucose-monitoring.html 2021-03-03T16:23:59.3550000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-and-health-canada-publish-clinical-data-used-to-support-their-authorisations-of-the-moderna-covid-19-vaccine.html 2021-03-03T16:25:54.9630000Z https://www.medicinesresources.nhs.uk/diagnosis-and-treatment-of-irritable-bowel-syndrome-a-review.html 2021-03-03T16:27:19.1430000Z https://www.medicinesresources.nhs.uk/alzheimer-s-disease-1.html 2021-03-03T16:31:32.5390000Z https://www.medicinesresources.nhs.uk/obstructive-sleep-apnoea-hypopnoea-syndrome-and-obesity-hypoventilation-syndrome-in-over-16s-draft-guidance-consultation.html 2021-03-03T16:33:06.7510000Z https://www.medicinesresources.nhs.uk/workforce-race-equality-standard-wres-2020-data-analysis.html 2021-03-03T16:34:04.5380000Z https://www.medicinesresources.nhs.uk/covid-19-insight-february-2021.html 2021-03-03T16:35:46.4100000Z https://www.medicinesresources.nhs.uk/selective-internal-radiation-therapies-for-treating-hepatocellular-carcinoma-final-appraisal-determination.html 2021-03-03T16:40:29.8880000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-market-authorisation-application-for-daridorexant-for-insomnia-to-the-european-medicines-agency.html 2021-03-03T16:41:40.5470000Z https://www.medicinesresources.nhs.uk/handling-multiple-covid-19-vaccines.html 2021-03-08T12:47:00.7150000Z https://www.medicinesresources.nhs.uk/interventions-for-treating-leg-ulcers-in-people-with-sickle-cell-disease.html 2021-03-03T16:47:14.3940000Z https://www.medicinesresources.nhs.uk/paracetamol-acetaminophen-single-administration-for-perineal-pain-in-the-early-postpartum-period.html 2021-03-03T16:52:57.5410000Z https://www.medicinesresources.nhs.uk/treatment-options-for-progression-or-recurrence-of-glioblastoma-a-network-meta-analysis.html 2021-03-03T16:54:56.4290000Z https://www.medicinesresources.nhs.uk/tyrosine-supplementation-for-phenylketonuria.html 2021-03-03T16:57:07.1400000Z https://www.medicinesresources.nhs.uk/standard-dose-raltegravir-or-efavirenz-based-antiretroviral-treatment-for-patients-co-infected-with-hiv-and-tuberculosis-anrs-12-300-reflate-tb-2-an-open-label-non-inferiority-randomised-phase-3-trial-4.html 2021-03-03T17:03:40.9390000Z https://www.medicinesresources.nhs.uk/semaglutide-2-4-mg-once-a-week-in-adults-with-overweight-or-obesity-and-type-2-diabetes-step-2-a-randomised-double-blind-double-dummy-placebo-controlled-phase-3-trial.html 2021-03-03T17:05:34.2770000Z https://www.medicinesresources.nhs.uk/cardiovascular-and-renal-disease-burden-in-type-1-compared-with-type-2-diabetes-a-two-country-nationwide-observational-study.html 2021-03-03T17:06:53.0680000Z https://www.medicinesresources.nhs.uk/glycemic-outcome-associated-with-insulin-pump-and-glucose-sensor-use-in-children-and-adolescents-with-type-1-diabetes-data-from-the-international-pediatric-registry-sweet.html 2021-03-03T17:08:00.4140000Z https://www.medicinesresources.nhs.uk/effect-of-blinatumomab-vs-chemotherapy-on-event-free-survival-among-children-with-high-risk-first-relapse-b-cell-acute-lymphoblastic-leukemia-a-randomized-clinical-trial.html 2021-03-03T17:29:08.3150000Z https://www.medicinesresources.nhs.uk/effect-of-postreinduction-therapy-consolidation-with-blinatumomab-vs-chemotherapy-on-disease-free-survival-in-children-adolescents-and-young-adults-with-first-relapse-of-b-cell-acute-lymphoblastic-leukemia-a-randomized-clinical-trial-1.html 2021-03-03T17:28:19.9840000Z https://www.medicinesresources.nhs.uk/us-licence-withdrawn-for-pembrolizumab-for-small-cell-lung-cancer-with-disease-progression-on-or-after-platinum-based-chemotherapy-and-at-least-one-other-previous-line-of-therapy.html 2021-03-03T17:15:14.3420000Z https://www.medicinesresources.nhs.uk/vitamin-d-supplementation-and-testing-in-the-uk-costly-but-ineffective.html 2021-03-03T17:19:22.7470000Z https://www.medicinesresources.nhs.uk/pharmacokinetic-and-pharmacodynamic-evidence-of-adrenaline-administered-via-auto-injector-for-anaphylactic-reactions-a-review-of-literature.html 2021-03-03T17:21:13.5050000Z https://www.medicinesresources.nhs.uk/treating-the-whole-glaucoma-spectrum-a-new-treatment-approach-is-required-1.html 2021-03-03T17:23:20.5000000Z https://www.medicinesresources.nhs.uk/new-product-angusta-misoprostol-25-microgram-tablets.html 2021-03-04T16:18:53.5780000Z https://www.medicinesresources.nhs.uk/new-product-magnesium-kora-healthcare-4-mmol-97-mg-tablets.html 2021-03-04T16:19:56.2720000Z https://www.medicinesresources.nhs.uk/residual-drugs-in-intravenous-cannulae-and-extension-lines.html 2021-03-04T17:39:12.5850000Z https://www.medicinesresources.nhs.uk/intravenous-administration-of-medicines-to-adults-guidance-on-line-flushing-version-3-2021.html 2021-03-08T12:45:27.8020000Z https://www.medicinesresources.nhs.uk/mycosis-fungoides-in-children-and-adolescents-a-systematic-review.html 2021-03-04T16:26:19.5820000Z https://www.medicinesresources.nhs.uk/association-between-cardiovascular-risk-factors-and-cognitive-impairment-in-people-with-schizophrenia-a-systematic-review-and-meta-analysis.html 2021-03-04T17:41:12.0040000Z https://www.medicinesresources.nhs.uk/is-there-an-association-between-long-term-antibiotics-for-acne-and-subsequent-infection-sequelae-and-antimicrobial-resistance-a-systematic-review.html 2021-03-04T17:18:52.0430000Z https://www.medicinesresources.nhs.uk/thrombolytic-strategies-versus-standard-anticoagulation-for-acute-deep-vein-thrombosis-of-the-lower-limb.html 2021-03-04T17:43:24.1280000Z https://www.medicinesresources.nhs.uk/immediate-release-methylphenidate-for-attention-deficit-hyperactivity-disorder-adhd-in-adults.html 2021-03-04T17:44:07.7600000Z https://www.medicinesresources.nhs.uk/indomethacin-for-symptomatic-patent-ductus-arteriosus-in-preterm-infants.html 2021-03-04T16:36:35.1780000Z https://www.medicinesresources.nhs.uk/aspirin-to-prevent-pre-eclampsia.html 2021-03-08T12:44:04.2510000Z https://www.medicinesresources.nhs.uk/mogamulizumab-for-previously-treated-mycosis-fungoides-and-sezary-syndrome-final-appraisal-document-1.html 2021-03-04T16:39:46.7280000Z https://www.medicinesresources.nhs.uk/a-window-of-opportunity-for-public-health.html 2021-03-04T16:41:17.1200000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-deployment-next-steps-and-plans-for-weeks-of-8-and-15-march.html 2021-03-04T16:42:19.1850000Z https://www.medicinesresources.nhs.uk/improving-social-care-staff-vaccination-rates-in-care-homes-for-older-people-1.html 2021-03-04T17:47:35.8420000Z https://www.medicinesresources.nhs.uk/vaccination-plans-for-pcn-covid-vaccination-sites-for-weeks-of-8-march-to-29-march-2022.html 2021-03-04T16:47:33.1630000Z https://www.medicinesresources.nhs.uk/diffuse-large-b-cell-lymphoma-1.html 2021-03-04T16:49:04.1360000Z https://www.medicinesresources.nhs.uk/guselkumab-for-treating-active-psoriatic-arthritis-after-inadequate-response-to-dmards-appraisal-consultation-document.html 2021-03-04T16:50:58.4770000Z https://www.medicinesresources.nhs.uk/coronavirus-vaccine-weekly-summary-of-yellow-card-reporting-as-of-21-february-2021.html 2021-03-04T16:51:59.6370000Z https://www.medicinesresources.nhs.uk/the-potential-future-of-the-covid-19-pandemic-will-sars-cov-2-become-a-recurrent-seasonal-infection-3.html 2021-03-04T16:55:02.6560000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-starts-rolling-review-of-the-sputnik-v-covid-19-vaccine.html 2021-03-04T16:57:18.5540000Z https://www.medicinesresources.nhs.uk/government-announces-gbp100-million-for-new-specialised-support-to-help-those-living-with-obesity-to-lose-weight.html 2021-03-04T16:58:34.2890000Z https://www.medicinesresources.nhs.uk/final-findings-from-february-covid-19-react-1-study-published-1.html 2021-03-04T17:00:17.5460000Z https://www.medicinesresources.nhs.uk/beyond-dexamethasone-emerging-immuno-thrombotic-therapies-for-covid-19.html 2021-03-04T17:02:01.2660000Z https://www.medicinesresources.nhs.uk/postpartum-thyroiditis-1.html 2021-03-04T17:06:19.8210000Z https://www.medicinesresources.nhs.uk/perplexing-presentations-pp-fabricated-or-induced-illness-fii-in-children-rcpch-guidance.html 2021-03-04T17:08:36.4640000Z https://www.medicinesresources.nhs.uk/guidance-on-strain-changes-in-authorised-covid-19-vaccines.html 2021-03-04T17:09:39.1450000Z https://www.medicinesresources.nhs.uk/fda-delays-decision-on-new-drug-application-nda-for-roxadustat-for-treatment-of-patients-with-anaemia-and-chronic-kidney-disease.html 2021-03-04T17:10:40.4850000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-validates-type-ii-variation-marketing-authorization-application-for-avapritinib-for-treatment-of-advanced-systemic-mastocytosis-sm.html 2021-03-04T17:12:06.7310000Z https://www.medicinesresources.nhs.uk/fda-approves-once-daily-azstarys-serdexmethylphenidate-sdx-and-dexmethylphenidate-d-mph-capsules-for-treatment-of-adhd-symptoms-in-patients-aged-6-years-and-older.html 2021-03-04T17:20:24.3030000Z https://www.medicinesresources.nhs.uk/repaglinide-1mg-and-2mg-tablets-supply-disruption-alert.html 2021-03-08T12:42:27.2750000Z https://www.medicinesresources.nhs.uk/positive-data-reported-from-phase-iii-brave-aa2-study-of-baricitinib-in-alopecia-areata-aa.html 2021-03-04T17:14:12.7070000Z https://www.medicinesresources.nhs.uk/changes-to-mhra-drug-alert-titles-and-classifications.html 2021-03-08T12:35:11.9240000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-review-supplemental-biologics-licence-application-sbla-for-dupilumab-in-treatment-of-children-aged-6-to-11-years-with-uncontrolled-moderate-to-severe-asthma.html 2021-03-04T17:15:13.0750000Z https://www.medicinesresources.nhs.uk/fda-approves-supplemental-new-drug-application-snda-for-lorlatinib-as-first-line-treatment-of-anaplastic-lymphoma-kinase-alk-positive-non-small-cell-lung-cancer.html 2021-03-04T17:16:22.3930000Z https://www.medicinesresources.nhs.uk/nivolumab-plus-cabozantinib-versus-sunitinib-for-advanced-renal-cell-carcinoma.html 2021-03-04T17:18:16.1540000Z https://www.medicinesresources.nhs.uk/treatment-effects-in-randomised-trials-using-routinely-collected-data-for-outcome-assessment-versus-traditional-trials-meta-research-study.html 2021-03-04T17:19:47.5580000Z https://www.medicinesresources.nhs.uk/comparing-risk-of-major-bleeding-between-users-of-different-oral-anticoagulants-in-patients-with-nonvalvular-atrial-fibrillation.html 2021-03-04T17:22:58.7080000Z https://www.medicinesresources.nhs.uk/patterns-of-use-and-safety-of-ibrutinib-in-real-life-practice.html 2021-03-04T17:23:50.5000000Z https://www.medicinesresources.nhs.uk/cost-saving-effect-of-early-less-invasive-surfactant-administration-versus-continuous-positive-airway-pressure-therapy-alone-for-preterm-infants-with-respiratory-distress-syndrome.html 2021-03-04T17:24:58.3570000Z https://www.medicinesresources.nhs.uk/a-randomized-trial-of-albumin-infusions-in-hospitalized-patients-with-cirrhosis.html 2021-03-04T17:27:36.5540000Z https://www.medicinesresources.nhs.uk/terlipressin-plus-albumin-for-the-treatment-of-type-1-hepatorenal-syndrome.html 2021-03-04T18:04:20.9140000Z https://www.medicinesresources.nhs.uk/vaccination-plans-for-community-pharmacy-covid-vaccination-sites.html 2021-03-04T17:36:29.0700000Z https://www.medicinesresources.nhs.uk/revised-spc-feldene-piroxicam-0-5-w-w-gel-3.html 2021-03-05T14:41:44.6150000Z https://www.medicinesresources.nhs.uk/interventions-for-improving-outcomes-in-patients-with-multimorbidity-in-primary-care-and-community-settings.html 2021-03-05T14:42:52.6100000Z https://www.medicinesresources.nhs.uk/prophylactic-antibiotics-for-adults-with-chronic-obstructive-pulmonary-disease-a-network-meta-analysis.html 2021-03-05T14:55:11.4120000Z https://www.medicinesresources.nhs.uk/gabapentin-add-on-treatment-for-drug-resistant-focal-epilepsy.html 2021-03-09T09:13:49.0850000Z https://www.medicinesresources.nhs.uk/patient-and-public-perception-and-experience-of-community-pharmacy-services-post-discharge-in-the-uk-a-rapid-review-and-qualitative-study.html 2021-03-05T15:04:24.2400000Z https://www.medicinesresources.nhs.uk/initial-cardiovascular-treatment-patterns-during-the-first-90-days-following-an-incident-cardiovascular-event.html 2021-03-05T15:06:04.0370000Z https://www.medicinesresources.nhs.uk/patterns-and-factors-influencing-oral-anticoagulant-prescription-in-people-with-atrial-fibrillation-and-dementia-results-from-uk-primary-care.html 2021-03-05T15:07:45.3060000Z https://www.medicinesresources.nhs.uk/risperidone-plasma-concentrations-are-associated-with-side-effects-and-effectiveness-in-children-and-adolescents-with-autism-spectrum-disorder.html 2021-03-05T15:09:29.0700000Z https://www.medicinesresources.nhs.uk/effect-of-ivermectin-on-time-to-resolution-of-symptoms-among-adults-with-mild-covid-19-a-randomized-clinical-trial.html 2021-03-05T15:10:25.6830000Z https://www.medicinesresources.nhs.uk/azithromycin-for-community-treatment-of-suspected-covid-19-in-people-at-increased-risk-of-an-adverse-clinical-course-in-the-uk-principle-a-randomised-controlled-open-label-adaptive-platform-trial.html 2021-03-08T12:40:22.0080000Z https://www.medicinesresources.nhs.uk/pembrolizumab-versus-investigator-choice-chemotherapy-for-metastatic-triple-negative-breast-cancer-keynote-119-a-randomised-open-label-phase-3-trial.html 2021-03-05T15:14:12.6250000Z https://www.medicinesresources.nhs.uk/sarilumab-in-patients-admitted-to-hospital-with-severe-or-critical-covid-19-a-randomised-double-blind-placebo-controlled-phase-3-trial.html 2021-03-05T16:55:05.8550000Z https://www.medicinesresources.nhs.uk/national-institutes-of-health-halts-trial-of-covid-19-convalescent-plasma-in-emergency-department-patients-with-mild-symptoms.html 2021-03-05T15:19:59.0370000Z https://www.medicinesresources.nhs.uk/results-from-phase-iii-study-show-tirzepatide-is-superior-to-semaglutide-in-type-2-diabetes.html 2021-03-05T15:21:46.2480000Z https://www.medicinesresources.nhs.uk/tocilizumab-approved-in-the-us-to-slow-rate-of-decline-in-pulmonary-function-in-adults-with-systemic-sclerosis-associated-interstitial-lung-disease-ssc-ild.html 2021-03-05T15:23:56.2350000Z https://www.medicinesresources.nhs.uk/covid-19-antibody-combination-brii-196-and-brii-198-will-not-progress-into-phase-iii-study.html 2021-03-05T15:26:44.6060000Z https://www.medicinesresources.nhs.uk/expert-perspective-immune-checkpoint-inhibitors-and-rheumatologic-complications.html 2021-03-05T15:27:38.8200000Z https://www.medicinesresources.nhs.uk/new-covid-19-variant-under-investigation-vui-designated-in-the-uk.html 2021-03-05T15:28:47.6370000Z https://www.medicinesresources.nhs.uk/covid-19-and-obesity-the-2021-atlas.html 2021-03-05T15:32:55.9190000Z https://www.medicinesresources.nhs.uk/gbp79-million-to-boost-mental-health-support-for-children-and-young.html 2021-03-05T17:07:00.2110000Z https://www.medicinesresources.nhs.uk/cardiac-sarcoidosis-state-of-the-art-review-1.html 2021-03-05T15:35:57.2590000Z https://www.medicinesresources.nhs.uk/cardiovascular-disease-risk-in-immune-mediated-inflammatory-diseases-recommendations-for-clinical-practice.html 2021-03-05T15:38:58.0790000Z https://www.medicinesresources.nhs.uk/covid-19-in-2021-continuing-uncertainty.html 2021-03-05T15:40:49.8940000Z https://www.medicinesresources.nhs.uk/anxiety-disorders-1.html 2021-03-05T15:43:29.7070000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guidance-on-babies-children-and-young-people-s-experience-of-healthcare.html 2021-03-05T15:44:40.9480000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guidance-on-solriamfetol-for-treating-excessive-daytime-sleepiness-caused-by-narcolepsy.html 2021-03-05T15:45:51.2090000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guidance-on-olaparib-for-previously-treated-hormone-relapsed-metastatic-prostate-cancer-with-homologous-recombination-repair-gene-mutations.html 2021-03-05T15:49:23.7250000Z https://www.medicinesresources.nhs.uk/sexual-and-reproductive-health-services-england-contraception-april-september-2020-provisional-statistics.html 2021-03-05T15:51:06.5590000Z https://www.medicinesresources.nhs.uk/pcn-pharmacists-complete-more-than-12-000-structured-medication-reviews-smr-in-six-months.html 2021-03-05T15:52:07.5240000Z https://www.medicinesresources.nhs.uk/risk-of-adverse-outcomes-in-patients-with-underlying-respiratory-conditions-admitted-to-hospital-with-covid-19-a-national-multicentre-prospective-cohort-study-using-the-isaric-who-clinical-characterisation-protocol-uk.html 2021-03-05T16:33:38.6650000Z https://www.medicinesresources.nhs.uk/antibacterial-mouthwash-to-prevent-sexually-transmitted-infections-in-men-who-have-sex-with-men-taking-hiv-pre-exposure-prophylaxis-prego-a-randomised-placebo-controlled-crossover-trial-1.html 2021-03-05T16:38:58.4970000Z https://www.medicinesresources.nhs.uk/antiseptic-mouthwash-for-gonorrhoea-prevention-omega-a-randomised-double-blind-parallel-group-multicentre-trial.html 2021-03-05T16:42:05.3700000Z https://www.medicinesresources.nhs.uk/tocilizumab-plus-standard-care-versus-standard-care-in-patients-in-india-with-moderate-to-severe-covid-19-associated-cytokine-release-syndrome-covintoc-an-open-label-multicentre-randomised-controlled-phase-3-trial.html 2021-03-05T16:45:38.4980000Z https://www.medicinesresources.nhs.uk/recovery-trial-closes-recruitment-to-colchicine-treatment-for-patients-hospitalised-with-covid-19.html 2021-03-05T16:50:20.8600000Z https://www.medicinesresources.nhs.uk/involving-and-supporting-partners-and-other-family-members-in-specialist-perinatal-mental-health-services-good-practice-guide-1.html 2021-03-08T15:22:46.4780000Z https://www.medicinesresources.nhs.uk/immunomodulatory-therapies-for-sars-cov-2-infection-a-systematic-literature-review-to-inform-eular-points-to-consider.html 2021-03-15T10:59:59.7250000Z https://www.medicinesresources.nhs.uk/signs-and-symptoms-to-determine-if-a-patient-presenting-in-primary-care-or-hospital-outpatient-settings-has-covid-19.html 2021-03-08T15:28:49.2080000Z https://www.medicinesresources.nhs.uk/long-term-effects-of-weight-reducing-diets-in-people-with-hypertension-2.html 2021-03-08T15:31:16.3890000Z https://www.medicinesresources.nhs.uk/topical-versus-systemic-antibiotics-for-chronic-suppurative-otitis-media.html 2021-03-08T15:33:09.1930000Z https://www.medicinesresources.nhs.uk/antidepressant-treatment-for-postnatal-depression.html 2021-03-08T15:35:04.7560000Z https://www.medicinesresources.nhs.uk/chloroquine-or-hydroxychloroquine-for-prevention-and-treatment-of-covid-19.html 2021-03-08T15:37:01.2700000Z https://www.medicinesresources.nhs.uk/interventions-for-bacterial-folliculitis-and-boils-furuncles-and-carbuncles.html 2021-03-08T15:39:30.2480000Z https://www.medicinesresources.nhs.uk/belimumab-for-systemic-lupus-erythematosus-2.html 2021-03-08T15:43:13.9550000Z https://www.medicinesresources.nhs.uk/antibiotics-to-prevent-complications-following-tooth-extractions.html 2021-03-08T15:45:42.6130000Z https://www.medicinesresources.nhs.uk/use-of-proton-pump-inhibitors-is-associated-with-lower-rates-of-first-time-ischemic-stroke-in-community-dwelling-elderly.html 2021-03-08T15:47:35.0860000Z https://www.medicinesresources.nhs.uk/quality-and-use-of-unlicensed-vitamin-d-preparations-in-primary-care-in-england-retrospective-review-of-national-prescription-data-and-laboratory-analysis-1.html 2021-03-08T15:53:24.3640000Z https://www.medicinesresources.nhs.uk/neurologic-involvement-in-children-and-adolescents-hospitalized-in-the-united-states-for-covid-19-or-multisystem-inflammatory-syndrome.html 2021-03-08T15:55:19.5970000Z https://www.medicinesresources.nhs.uk/serious-adverse-events-with-tocilizumab-pharmacovigilance-as-an-aid-to-prioritize-monitoring-in-covid-19.html 2021-03-08T15:57:43.0950000Z https://www.medicinesresources.nhs.uk/fda-granted-accelerated-approval-to-axicabtagene-ciloleucel-yescarta-for-treatment-of-adults-with-relapsed-or-refractory-follicular-lymphoma.html 2021-03-08T15:58:51.7980000Z https://www.medicinesresources.nhs.uk/chmp-issues-positive-scientific-opinion-for-bamlanivimab-alone-and-in-combination-with-etesevimab-for-treatment-of-confirmed-covid-19.html 2021-03-08T15:59:52.3090000Z https://www.medicinesresources.nhs.uk/conference-data-four-year-data-demonstrate-durable-viral-suppression-with-biktarvy-bictegravir-emtricitabine-tenofovir-alafenamide-fumarate-in-treatment-naive-adults-with-hiv-1.html 2021-03-08T16:01:42.1670000Z https://www.medicinesresources.nhs.uk/government-launches-call-for-evidence-to-improve-health-and-wellbeing-of-women-in-england-1.html 2021-03-08T16:03:28.3580000Z https://www.medicinesresources.nhs.uk/mobilising-evidence-data-and-resources-to-achieve-global-maternal-and-child-undernutrition-targets-and-the-sustainable-development-goals-an-agenda-for-action.html 2021-03-08T16:05:55.8230000Z https://www.medicinesresources.nhs.uk/nhs-invites-people-aged-56-to-59-for-their-covid-vaccination.html 2021-03-08T16:07:09.5940000Z https://www.medicinesresources.nhs.uk/evaluation-consultation-document-onasemnogene-abeparvovec-for-treating-spinal-muscular-atrophy.html 2021-03-08T16:09:30.9810000Z https://www.medicinesresources.nhs.uk/padeliporfin-assigned-fda-orphan-drug-designation-for-upper-tract-urothelial-cancer.html 2021-03-08T16:10:37.4680000Z https://www.medicinesresources.nhs.uk/smoking-prevalence-in-adults-current-smokers-aged-over-18-years-by-wellbeing-group-and-region-2.html 2021-03-08T16:13:20.2090000Z https://www.medicinesresources.nhs.uk/quarterly-alcohol-specific-deaths-in-england-and-wales-2001-to-2019-registrations-and-quarter-1-jan-to-mar-to-quarter-3-july-to-sept-2020-provisional-registrations.html 2021-03-08T16:15:42.7930000Z https://www.medicinesresources.nhs.uk/onasemnogene-abeparvovec-zolgensma-r-is-accepted-for-restricted-use-within-nhsscotland.html 2021-03-09T15:30:24.0380000Z https://www.medicinesresources.nhs.uk/beclometasone-dipropionate-formoterol-fumarate-dihydrate-glycopyrronium-trimbow-r-is-accepted-for-use-within-nhsscotland.html 2021-03-09T15:31:27.1700000Z https://www.medicinesresources.nhs.uk/doravirine-pifeltro-r-is-accepted-for-use-within-nhsscotland.html 2021-03-09T15:32:58.1980000Z https://www.medicinesresources.nhs.uk/doravirine-lamivudine-tenofovir-disoproxil-fumarate-delstrigo-r-is-accepted-for-use-within-nhsscotland.html 2021-03-09T18:02:58.8150000Z https://www.medicinesresources.nhs.uk/trametinib-mekinist-r-is-accepted-for-restricted-use-within-nhsscotland.html 2021-03-09T15:35:53.7400000Z https://www.medicinesresources.nhs.uk/entrectinib-rozlytrek-r-is-accepted-for-use-within-nhsscotland.html 2021-03-09T15:37:14.1370000Z https://www.medicinesresources.nhs.uk/nhs-england-strikes-deal-on-gene-therapy-onasemnogene-abeparvoccex-zolgensma-for-treatment-of-spinal-muscular-atrophy-sma.html 2021-03-09T15:39:54.5810000Z https://www.medicinesresources.nhs.uk/revised-spc-betamethasone-dipropionate-and-calcipotriol-enstilar-cutaneous-foam.html 2021-03-09T16:35:55.4160000Z https://www.medicinesresources.nhs.uk/paravertebral-anaesthesia-with-or-without-sedation-versus-general-anaesthesia-for-women-undergoing-breast-cancer-surgery-1.html 2021-03-09T16:38:26.9840000Z https://www.medicinesresources.nhs.uk/antibiotics-for-secondary-prevention-of-coronary-heart-disease-2.html 2021-03-09T16:41:18.6370000Z https://www.medicinesresources.nhs.uk/cholinesterase-inhibitors-for-vascular-dementia-and-other-vascular-cognitive-impairments-vci-a-network-meta-analysis.html 2021-03-09T16:43:11.9080000Z https://www.medicinesresources.nhs.uk/interventions-for-tobacco-cessation-delivered-by-dental-professionals-1.html 2021-03-09T16:45:47.4550000Z https://www.medicinesresources.nhs.uk/alpha-stim-aid-for-anxiety-disorders-medical-technologies-guidance-mtg56.html 2021-03-09T16:47:44.3920000Z https://www.medicinesresources.nhs.uk/clinical-and-economic-effects-of-widespread-rapid-testing-to-decrease-sars-cov-2-transmission.html 2021-03-09T16:48:48.4540000Z https://www.medicinesresources.nhs.uk/effect-of-weight-loss-on-cardiometabolic-risk-observational-analysis-of-two-randomised-controlled-trials-of-community-weight-loss-programmes.html 2021-03-09T16:50:01.1510000Z https://www.medicinesresources.nhs.uk/racial-differences-in-management-and-outcomes-of-acute-myocardial-infarction-during-covid-19-pandemic-1.html 2021-03-09T16:52:27.8640000Z https://www.medicinesresources.nhs.uk/nivolumab-and-ipilimumab-as-maintenance-therapy-in-extensive-disease-small-cell-lung-cancer-checkmate-452.html 2021-03-09T16:54:14.9080000Z https://www.medicinesresources.nhs.uk/secondary-cytoreduction-followed-by-chemotherapy-versus-chemotherapy-alone-in-platinum-sensitive-relapsed-ovarian-cancer-soc-1-a-multicentre-open-label-randomised-phase-3-trial.html 2021-03-09T16:55:26.0430000Z https://www.medicinesresources.nhs.uk/preconception-advice-for-women-with-serious-mental-illness-from-public-health-england-phe.html 2021-03-09T16:58:10.7760000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-an-inactivated-sars-cov-2-vaccine-bbv152-interim-results-from-a-double-blind-randomised-multicentre-phase-2-trial-and-3-month-follow-up-of-a-double-blind-randomised-phase-1-trial.html 2021-03-09T17:13:23.4850000Z https://www.medicinesresources.nhs.uk/development-and-validation-of-a-prediction-model-for-tocilizumab-failure-in-hospitalized-patients-with-sars-cov-2-infection.html 2021-03-09T17:14:40.6460000Z https://www.medicinesresources.nhs.uk/insomnia.html 2021-03-09T17:16:02.6560000Z https://www.medicinesresources.nhs.uk/neihulizumab-granted-fast-track-designation-by-the-fda-for-steroid-refractory-acute-graft-versus-host-disease-sr-agvhd.html 2021-03-09T17:16:55.4550000Z https://www.medicinesresources.nhs.uk/fda-accepts-and-gives-priority-review-for-difelikefalin-korsuva-tm-injection-in-haemodialysis-patients-with-moderate-to-severe-pruritus.html 2021-03-09T17:18:31.4430000Z https://www.medicinesresources.nhs.uk/eams-scientific-opinion-avalglucosidase-alfa-in-the-treatment-of-pompe-disease.html 2021-03-09T17:21:40.2680000Z https://www.medicinesresources.nhs.uk/acute-allergic-reactions-to-mrna-covid-19-vaccines.html 2021-03-09T18:19:26.9060000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-diazepam-2mg-5ml-oral-solution-sugar-free-el-21-a-07-pl-0142-0103.html 2021-03-09T17:39:33.1240000Z https://www.medicinesresources.nhs.uk/nhs-text-alerts-for-covid-vaccination-1.html 2021-03-09T17:42:20.1730000Z https://www.medicinesresources.nhs.uk/study-in-bowel-tumour-patients-suggests-radiotherapy-responses-may-be-improved-with-targeted-immunotherapy.html 2021-03-09T17:43:38.4790000Z https://www.medicinesresources.nhs.uk/ssp08-salazopyrin-r-en-tabs-500mg-expired.html 2021-03-09T17:45:43.3990000Z https://www.medicinesresources.nhs.uk/relaunch-of-the-act-fast-campaign-to-improve-stroke-outcomes.html 2021-03-09T17:48:02.8010000Z https://www.medicinesresources.nhs.uk/project-care-supporting-people-with-a-positive-diagnosis-of-covid-19-and-reaching-out-to-those-in-vulnerable-groups.html 2021-03-10T14:41:19.6140000Z https://www.medicinesresources.nhs.uk/updated-patient-group-direction-pgd-template-shingles-vaccine-zostavax-r.html 2021-03-15T10:52:53.0450000Z https://www.medicinesresources.nhs.uk/updated-patient-group-direction-pgd-template-pertussis-vaccination-dtap-ipv-boostrix-ipv-r-or-repevax-r.html 2021-03-15T10:53:47.0030000Z https://www.medicinesresources.nhs.uk/pembrolizumab-with-pemetrexed-and-platinum-chemotherapy-for-untreated-metastatic-non-squamous-non-small-cell-lung-cancer-guidance-ta683.html 2021-03-15T10:05:01.1000000Z https://www.medicinesresources.nhs.uk/erenumab-for-preventing-migraine-guidance-ta682-1.html 2021-03-15T10:13:07.2960000Z https://www.medicinesresources.nhs.uk/new-product-retsevmo-selpercatinib-80-mg-capsules.html 2021-03-10T16:43:36.4790000Z https://www.medicinesresources.nhs.uk/new-product-belkyra-deoxycholic-acid-10-mg-ml-solution-for-injection.html 2021-03-10T15:35:36.6320000Z https://www.medicinesresources.nhs.uk/revised-spc-nytol-diphenhydramine-tablets.html 2021-03-10T15:38:13.3890000Z https://www.medicinesresources.nhs.uk/revised-spc-dexamethasone-3-3-mg-ml-solution-for-injection-hameln-brand.html 2021-03-15T10:37:03.4250000Z https://www.medicinesresources.nhs.uk/all-cause-mortality-and-cardiovascular-safety-of-basal-insulin-treatment-in-patients-with-type-2-diabetes-mellitus-a-systematic-review-with-meta-analysis-and-trial-sequential-analysis-1.html 2021-03-10T16:18:57.4850000Z https://www.medicinesresources.nhs.uk/oral-fecal-microbiota-transplant-capsules-are-safe-and-effective-for-recurrent-clostridioides-difficile-infection-a-systematic-review-and-meta-analysis.html 2021-03-10T16:23:08.3800000Z https://www.medicinesresources.nhs.uk/antidepressants-for-functional-abdominal-pain-disorders-in-children-and-adolescents.html 2021-03-10T16:24:16.2280000Z https://www.medicinesresources.nhs.uk/chemotherapy-versus-surgery-for-initial-treatment-in-advanced-ovarian-epithelial-cancer-1.html 2021-03-10T16:26:41.7930000Z https://www.medicinesresources.nhs.uk/salbutamol-for-transient-tachypnea-of-the-newborn.html 2021-03-10T16:28:30.4590000Z https://www.medicinesresources.nhs.uk/skin-care-interventions-in-infants-for-preventing-eczema-and-food-allergy.html 2021-03-10T16:32:07.9490000Z https://www.medicinesresources.nhs.uk/antimicrobial-stewardship-during-the-covid-19-epidemic-population-based-cohort-study-and-interrupted-time-series-analysis-in-the-united-kingdom-3.html 2021-03-10T16:40:57.2300000Z https://www.medicinesresources.nhs.uk/risk-of-mortality-in-patients-infected-with-sars-cov-2-variant-of-concern-202012-1-matched-cohort-study.html 2021-03-10T16:42:11.2460000Z https://www.medicinesresources.nhs.uk/risk-factors-for-new-chronic-opioid-use-after-hip-fracture-surgery-a-danish-nationwide-cohort-study-from-2005-to-2016-using-the-danish-multidisciplinary-hip-fracture-registry.html 2021-03-10T16:43:41.4360000Z https://www.medicinesresources.nhs.uk/persistence-of-d-9-tetrahydrocannabinol-in-human-breast-milk.html 2021-03-10T16:45:01.8060000Z https://www.medicinesresources.nhs.uk/manufacturers-withdraw-us-market-authorisation-for-atezolizumab-for-prior-platinum-treated-metastatic-urothelial-carcinoma.html 2021-03-10T16:46:15.4690000Z https://www.medicinesresources.nhs.uk/joint-national-plan-for-inclusive-pharmacy-practice-in-england.html 2021-03-10T16:48:06.2730000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-hesitancy-debunking-the-myths-using-a-community-engagement-approach-underpinned-by-nice-guidance.html 2021-03-10T16:52:21.2840000Z https://www.medicinesresources.nhs.uk/mortality-in-stemi-patients-without-standard-modifiable-risk-factors-a-sex-disaggregated-analysis-of-swedeheart-registry-data-1.html 2021-03-10T17:02:25.4550000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-outcomes-for-lenacapavir-for-multi-drug-resistant-hiv-1-infection-in-phase-2-3-capella-trial-1.html 2021-03-10T16:57:38.7210000Z https://www.medicinesresources.nhs.uk/canakinumab-fails-to-meet-primary-endpoint-in-non-small-cell-lung-cancer-phase-iii-trial.html 2021-03-10T16:58:37.1960000Z https://www.medicinesresources.nhs.uk/achieving-greater-independence-from-commercial-influence-in-research.html 2021-03-10T16:59:22.1500000Z https://www.medicinesresources.nhs.uk/urgent-lessons-from-covid-19-why-the-world-needs-a-standing-coordinated-system-and-sustainable-financing-for-global-research-and-development.html 2021-03-10T17:00:09.3680000Z https://www.medicinesresources.nhs.uk/delivering-rehabilitation-enablement-in-chronic-heart-failure-reach-hf-in-wirral.html 2021-03-10T17:26:31.7370000Z https://www.medicinesresources.nhs.uk/revised-spc-clarelux-clobetasol-propionate-500-microgram-g-cutaneous-foam-in-pressurised-container-1.html 2021-03-11T15:18:35.4090000Z https://www.medicinesresources.nhs.uk/revised-spc-elvanse-lisdexamfetamine-dimesylate-capsules-all-presentations-1.html 2021-03-11T15:21:23.0550000Z https://www.medicinesresources.nhs.uk/revised-spc-omnitrope-somatropin-surepal-solution-for-injection-cartridges-all-strengths.html 2021-03-11T15:23:14.4270000Z https://www.medicinesresources.nhs.uk/emergency-response-to-heart-attack-independent-report-by-the-healthcare-safety-investigation-branch.html 2021-03-14T21:56:23.5620000Z https://www.medicinesresources.nhs.uk/update-to-living-systematic-review-on-covid-19-in-pregnancy.html 2021-03-11T15:26:02.5820000Z https://www.medicinesresources.nhs.uk/aldosterone-antagonists-for-people-with-chronic-kidney-disease-requiring-dialysis.html 2021-03-11T18:52:55.1190000Z https://www.medicinesresources.nhs.uk/the-effectiveness-and-adverse-effects-of-d-cycloserine-compared-with-placebo-on-social-and-communication-skills-in-individuals-with-autism-spectrum-disorder-2.html 2021-03-11T15:29:14.8470000Z https://www.medicinesresources.nhs.uk/anticholinergics-combined-with-alpha-blockers-for-treating-lower-urinary-tract-symptoms-related-to-benign-prostatic-obstruction.html 2021-03-11T15:30:20.6490000Z https://www.medicinesresources.nhs.uk/position-statement-vaccinating-people-registered-with-a-gp-in-wales-in-covid-19-vaccination-sites-in-england.html 2021-03-11T15:32:34.0580000Z https://www.medicinesresources.nhs.uk/update-on-vaccination-and-immunisation-changes-for-2021-22.html 2021-03-11T15:35:02.0240000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-inherited-white-matter-disorders-diagnostic-and-management-service-iwmd-all-ages.html 2021-03-14T22:06:38.6970000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-provision-of-nhs-termination-of-pregnancy-centres-for-patients-presenting-with-medical-complexity-and-or-significant-co-morbidities-requiring-nhs-treatment-1.html 2021-03-14T22:24:01.3190000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-statement-use-of-adalimumab-for-osteomyelitis.html 2021-03-11T15:43:40.4280000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-specialised-services-for-women-with-complications-of-mesh-inserted-for-urinary-incontinence-and-vaginal-prolapse-16-years-and-above.html 2021-03-11T15:45:18.8490000Z https://www.medicinesresources.nhs.uk/four-more-cases-of-variant-of-concern-voc-202101-02-p-1-found-in-england-1.html 2021-03-11T15:57:22.0040000Z https://www.medicinesresources.nhs.uk/mhra-grants-selpercatinib-retsevmo-conditional-marketing-authorisation-for-the-treatment-of-ret-fusion-positive-advanced-lung-cancer-and-thyroid-cancer-1.html 2021-03-11T15:58:41.5420000Z https://www.medicinesresources.nhs.uk/nhs-community-pharmacist-consultation-service-toolkit-for-gp-pcn-staff.html 2021-03-11T16:00:07.6750000Z https://www.medicinesresources.nhs.uk/key-information-about-highly-specialised-services-in-2020.html 2021-03-11T16:02:17.2710000Z https://www.medicinesresources.nhs.uk/update-on-quality-outcomes-framework-changes-for-2021-22.html 2021-03-11T16:03:11.0020000Z https://www.medicinesresources.nhs.uk/nhs-rolls-out-colon-capsule-endoscopy.html 2021-03-11T16:03:58.3300000Z https://www.medicinesresources.nhs.uk/mhra-response-to-danish-authorities-action-to-temporarily-suspend-the-astrazeneca-covid-19-vaccine.html 2021-03-11T18:44:48.1430000Z https://www.medicinesresources.nhs.uk/remote-working-toolkit-for-general-practices-and-primary-care-networks.html 2021-03-11T16:07:04.0120000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-astrazeneca-prac-preliminary-view-suggests-no-specific-issue-with-batch-used-in-austria.html 2021-03-11T18:42:14.0240000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-starts-rolling-review-of-bamlanivimab-and-etesemivab-for-covid-19.html 2021-03-11T16:09:37.7650000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-recommends-covid-19-vaccine-janssen-for-conditional-marketing-authorisation-in-eu-main-link-1.html 2021-03-11T16:11:36.4820000Z https://www.medicinesresources.nhs.uk/lateral-flow-device-specificity-in-phase-4-post-marketing-surveillance.html 2021-03-11T17:50:08.1770000Z https://www.medicinesresources.nhs.uk/updated-guidance-on-meeting-the-duty-of-candour.html 2021-03-11T17:53:16.2500000Z https://www.medicinesresources.nhs.uk/cdc-interim-recommendations-for-fully-vaccinated-people-an-important-first-step.html 2021-03-11T17:55:32.6330000Z https://www.medicinesresources.nhs.uk/member-of-jcvi-tells-bmj-covid-19-vaccine-booster-dose-will-be-needed-in-autumn-to-avoid-winter-surge.html 2021-03-11T17:57:29.5780000Z https://www.medicinesresources.nhs.uk/covid-19-test-track-and-trace-part-1.html 2021-03-11T17:59:25.4870000Z https://www.medicinesresources.nhs.uk/bmj-investigation-the-ema-covid-19-data-leak-and-what-it-tells-us-about-mrna-instability.html 2021-03-11T18:01:21.2830000Z https://www.medicinesresources.nhs.uk/severe-covid-19-pneumonia-pathogenesis-and-clinical-management.html 2021-03-11T18:02:54.9800000Z https://www.medicinesresources.nhs.uk/how-can-we-improve-self-isolation-and-quarantine-for-covid-19.html 2021-03-11T18:04:36.0640000Z https://www.medicinesresources.nhs.uk/gastrointestinal-sequelae-90-days-after-discharge-for-covid-19.html 2021-03-11T18:05:55.4810000Z https://www.medicinesresources.nhs.uk/chilblain-like-acral-lesions-in-long-covid-19-management-and-implications-for-understanding-microangiopathy.html 2021-03-11T18:10:27.4270000Z https://www.medicinesresources.nhs.uk/epistaxis.html 2021-03-11T18:11:32.2390000Z https://www.medicinesresources.nhs.uk/moderna-announces-first-participants-dosed-in-study-evaluating-covid-19-booster-vaccine-candidates.html 2021-03-11T18:12:42.2660000Z https://www.medicinesresources.nhs.uk/tivozanib-approved-in-us-for-treatment-of-adult-patients-with-relapsed-or-refractory-advanced-renal-cell-carcinoma-who-have-received-2-prior-systemic-therapies.html 2021-03-11T18:15:42.2390000Z https://www.medicinesresources.nhs.uk/phase-iii-blaze-1-trial-shows-combination-of-monoclonal-antibodies-bamlanivimab-and-etesevimab-reduces-risk-of-hospitalization-and-death-in-high-risk-patients-with-newly-diagnosed-covid-19.html 2021-03-11T18:18:01.8480000Z https://www.medicinesresources.nhs.uk/independent-data-monitoring-committee-recommends-phase-3-comet-ice-covid-19-monoclonal-antibody-efficacy-trial-intent-to-care-early-trial-be-stopped-for-enrollment-due-to-evidence-of-profound-efficacy.html 2021-03-11T18:20:19.9130000Z https://www.medicinesresources.nhs.uk/avian-influenza-updated-pgd-templates.html 2021-03-11T18:21:29.1450000Z https://www.medicinesresources.nhs.uk/combining-behavioral-harm-reduction-treatment-and-extended-release-naltrexone-for-people-experiencing-homelessness-and-alcohol-use-disorder-in-the-usa-a-randomised-clinical-trial.html 2021-03-11T18:22:46.4890000Z https://www.medicinesresources.nhs.uk/early-prognostication-of-covid-19-to-guide-hospitalisation-versus-outpatient-monitoring-using-a-point-of-test-risk-prediction-score.html 2021-03-11T18:25:02.0010000Z https://www.medicinesresources.nhs.uk/medicines-prescribed-for-asthma-discontinuation-and-perinatal-outcomes-including-breastfeeding-a-population-cohort-analysis.html 2021-03-11T18:26:35.0490000Z https://www.medicinesresources.nhs.uk/enoxaparin-is-associated-with-lower-rates-of-mortality-than-unfractionated-heparin-in-hospitalized-covid-19-patients.html 2021-03-11T18:29:31.9750000Z https://www.medicinesresources.nhs.uk/risdiplam-in-type-1-spinal-muscular-atrophy.html 2021-03-11T18:33:52.5250000Z https://www.medicinesresources.nhs.uk/genetic-mechanisms-of-critical-illness-in-covid-19.html 2021-03-12T01:00:46.8530000Z https://www.medicinesresources.nhs.uk/revised-spc-palforzia-peanut-protein-as-defatted-powder-of-arachis-hypogaea-l-semen-peanuts-1.html 2021-03-12T15:28:54.3510000Z https://www.medicinesresources.nhs.uk/revised-spc-nutropinaq-10mg-2ml-somatropin-2.html 2021-03-12T15:31:22.7590000Z https://www.medicinesresources.nhs.uk/national-patient-safety-alert-supply-disruption-of-sterile-infusion-sets-and-connectors-manufactured-by-becton-dickinson-bd-natpsa-2021-001-mhra.html 2021-03-14T21:35:34.1850000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-injectors-guide-for-the-safe-use-of-belkyra-deoxycholic-acid.html 2021-03-12T15:35:29.4150000Z https://www.medicinesresources.nhs.uk/the-effect-of-statins-on-muscle-symptoms-in-primary-care-the-statinwise-series-of-200-n-of-1-rcts.html 2021-03-12T15:36:36.3130000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-tocilizumab-added-to-remdesivir-in-patients-with-severe-covid-19-pneumonia-fails-to-meet-primary-endpoint.html 2021-03-12T18:24:11.2380000Z https://www.medicinesresources.nhs.uk/positive-interim-data-from-rct-of-proxalutamide-in-hospitalised-patients-with-covid-19.html 2021-03-12T15:41:02.9160000Z https://www.medicinesresources.nhs.uk/etv-ids-dnl310-granted-fast-track-designation-in-the-us-for-the-treatment-of-hunter-syndrome-mps-ii.html 2021-03-12T15:42:59.7910000Z https://www.medicinesresources.nhs.uk/real-world-evidence-confirms-high-effectiveness-of-pfizer-biontech-covid-19-vaccine.html 2021-03-12T15:44:24.4930000Z https://www.medicinesresources.nhs.uk/novavax-confirms-high-levels-of-efficacy-of-its-colvid-19-vaccine-nvx-cov2373-against-original-and-variant-covid-19-strains-in-uk-and-south-africa-trials.html 2021-03-12T16:57:57.8410000Z https://www.medicinesresources.nhs.uk/measuring-safety-in-older-adult-care-homes-a-scoping-review-of-the-international-literature.html 2021-03-12T15:46:57.7840000Z https://www.medicinesresources.nhs.uk/us-fda-approves-revisions-to-triumeq-abacavir-dolutegravir-lamivudine-and-dovato-dolutegravir-lamivudine-prescribing-information.html 2021-03-12T18:11:26.6030000Z https://www.medicinesresources.nhs.uk/preliminary-data-from-soap-trial-suggests-low-response-to-first-dose-of-pfizer-biontech-covid-19-vaccine-in-patients-with-cancer.html 2021-03-12T15:50:13.2270000Z https://www.medicinesresources.nhs.uk/world-health-organisations-global-advisory-committee-on-vaccine-safety-reviewing-astrazeneca-covid-19-vaccine.html 2021-03-12T18:04:41.0060000Z https://www.medicinesresources.nhs.uk/joint-committee-on-vaccination-and-immunisation-jcvi-advises-prioritising-homeless-people-and-rough-sleepers-for-covid-19-vaccine.html 2021-03-12T15:54:13.8990000Z https://www.medicinesresources.nhs.uk/role-of-pcn-lvs-sites-in-phase-2-of-the-covid-19-vaccination-programme-2.html 2021-03-12T15:57:06.3820000Z https://www.medicinesresources.nhs.uk/preventing-the-next-pandemic-the-power-of-a-global-viral-surveillance-network.html 2021-03-12T15:58:09.5480000Z https://www.medicinesresources.nhs.uk/fast-track-research-approval-here-to-stay-says-regulator.html 2021-03-12T15:59:40.8640000Z https://www.medicinesresources.nhs.uk/nhs-staff-survey-2020-finds-stress-levels-rose-last-year-as-covid-19-pandemic-took-its-toll.html 2021-03-12T16:02:58.1150000Z https://www.medicinesresources.nhs.uk/the-impact-of-covid-19-on-emergency-laparotomy-an-interim-report-of-the-national-emergency-laparotomy-audit.html 2021-03-12T18:00:51.4820000Z https://www.medicinesresources.nhs.uk/meta-analyses-of-results-from-randomized-outcome-trials-comparing-cardiovascular-effects-of-sglt2is-and-glp-1ras-in-asian-versus-white-patients-with-and-without-type-2-diabetes.html 2021-03-12T16:29:49.8840000Z https://www.medicinesresources.nhs.uk/approvals-of-type-2-diabetes-drugs-tested-in-cardiovascular-outcome-trials-a-tripartite-comparison.html 2021-03-12T16:30:54.6370000Z https://www.medicinesresources.nhs.uk/incidence-predictors-and-mortality-risk-of-new-heart-failure-in-patients-hospitalised-with-atrial-fibrillation-1.html 2021-03-12T16:33:05.2760000Z https://www.medicinesresources.nhs.uk/analysis-of-clinical-pharmacist-interventions-in-the-covid-19-units-of-a-french-university-hospital.html 2021-03-12T16:34:05.1500000Z https://www.medicinesresources.nhs.uk/new-dimensions-for-hospital-services-and-early-detection-of-disease-a-review-from-the-lancet-commission-into-liver-disease-in-the-uk.html 2021-03-12T16:35:06.5490000Z https://www.medicinesresources.nhs.uk/european-prac-concludes-benefits-of-ifosfamide-solutions-continue-to-outweigh-risks-1.html 2021-03-12T16:38:35.1260000Z https://www.medicinesresources.nhs.uk/prac-concludes-safety-signal-of-anaphylaxis-with-covid-19-vaccine-astrazeneca-1.html 2021-03-14T21:39:08.9910000Z https://www.medicinesresources.nhs.uk/european-prac-starts-review-of-zynteglo-betibeglogene-autotemcel.html 2021-03-12T16:41:28.5210000Z https://www.medicinesresources.nhs.uk/european-prac-starts-review-of-signal-of-thrombocytopenia-with-pfizer-biontech-astrazeneca-and-moderna-covid-19-vaccines.html 2021-03-12T16:43:04.9800000Z https://www.medicinesresources.nhs.uk/european-prac-starts-review-of-signal-of-localised-swelling-related-to-dermal-fillers-with-pfizer-biontech-covid-19-vaccine.html 2021-03-12T16:44:22.9330000Z https://www.medicinesresources.nhs.uk/revised-spc-sabril-vigabatrin-all-presentations.html 2021-03-15T12:20:42.7280000Z https://www.medicinesresources.nhs.uk/epidemiology-of-drug-related-deaths-in-european-hospitals-a-systematic-review-and-meta-analysis-of-observational-studies-1.html 2021-03-15T12:22:13.1920000Z https://www.medicinesresources.nhs.uk/hearing-loss-prevalence-and-years-lived-with-disability-1990-2019-findings-from-the-global-burden-of-disease-study-2019.html 2021-03-15T12:23:29.3440000Z https://www.medicinesresources.nhs.uk/prevalence-of-symptoms-of-anxiety-and-depression-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis-2.html 2021-03-15T12:26:39.6430000Z https://www.medicinesresources.nhs.uk/adjuvant-atezolizumab-versus-observation-in-muscle-invasive-urothelial-carcinoma-imvigor010-a-multicentre-open-label-randomised-phase-3-trial.html 2021-03-15T12:28:12.0960000Z https://www.medicinesresources.nhs.uk/pembrolizumab-versus-brentuximab-vedotin-in-relapsed-or-refractory-classical-hodgkin-lymphoma-keynote-204-an-interim-analysis-of-a-multicentre-randomised-open-label-phase-3-study.html 2021-03-15T12:31:08.3730000Z https://www.medicinesresources.nhs.uk/prasugrel-versus-ticagrelor-in-patients-with-myocardial-infarction-undergoing-percutaneous-coronary-intervention.html 2021-03-15T12:33:13.3100000Z https://www.medicinesresources.nhs.uk/apremilast-did-not-to-reduce-time-to-recovery-or-mortality-in-critically-ill-patients-in-phase-ii-i-spy-covid-trial.html 2021-03-15T12:34:18.7400000Z https://www.medicinesresources.nhs.uk/phase-3-trial-of-cemiplimab-libtayo-r-monotherapy-in-advanced-cervical-cancer-stopped-early-due-to-positive-overall-survival-data-1.html 2021-03-15T12:40:28.5260000Z https://www.medicinesresources.nhs.uk/nonmedical-use-of-prescription-drugs.html 2021-03-15T12:42:16.7410000Z https://www.medicinesresources.nhs.uk/updated-information-for-clinicians-health-care-professionals-on-covid-19-pcr-testing.html 2021-03-15T12:44:15.6860000Z https://www.medicinesresources.nhs.uk/health-charities-back-vaccines-drive-for-those-at-risk.html 2021-03-15T12:45:45.8520000Z https://www.medicinesresources.nhs.uk/how-a-new-drug-is-born.html 2021-03-15T12:47:22.8430000Z https://www.medicinesresources.nhs.uk/class-3-medicines-recall-thame-laboratories-itraconazole-10mg-ml-oral-solution-el-21-a-08.html 2021-03-15T12:48:41.2480000Z https://www.medicinesresources.nhs.uk/donanemab-in-early-alzheimers-disease.html 2021-03-15T15:40:34.5690000Z https://www.medicinesresources.nhs.uk/eu-approval-of-single-dose-johnson-and-johnson-covid-19-vaccine-1.html 2021-03-15T15:43:07.2280000Z https://www.medicinesresources.nhs.uk/national-covid-19-reinfection-surveillance-1.html 2021-03-19T08:13:09.2250000Z https://www.medicinesresources.nhs.uk/role-of-extracellular-vesicles-in-chronic-lung-disease.html 2021-03-15T15:48:13.9680000Z https://www.medicinesresources.nhs.uk/assessing-risk-for-healthcare-workers-during-the-covid-19-pandemic.html 2021-03-15T15:50:25.5030000Z https://www.medicinesresources.nhs.uk/preferred-reporting-items-for-journal-and-conference-abstracts-of-systematic-reviews-and-meta-analyses-of-diagnostic-test-accuracy-studies-prisma-dta-for-abstracts-checklist-explanation-and-elaboration.html 2021-03-15T15:53:25.7290000Z https://www.medicinesresources.nhs.uk/mhra-response-to-irish-authorities-action-to-temporarily-suspend-the-astrazeneca-covid-19-vaccine-2.html 2021-03-19T08:15:54.7190000Z https://www.medicinesresources.nhs.uk/two-year-data-sunfish-part-2-study-on-the-use-of-risdiplam-for-type-2-or-type-3-spinal-muscular-atrophy-sma-suggest-ongoing-benefit.html 2021-03-16T17:10:46.8050000Z https://www.medicinesresources.nhs.uk/international-society-on-thrombosis-and-haemostasis-isth-statement-on-the-astrazeneca-covid-19-vaccine-and-thrombosis-2.html 2021-03-16T16:12:33.5090000Z https://www.medicinesresources.nhs.uk/weight-and-metabolic-changes-after-switching-from-tenofovir-disoproxil-fumarate-to-tenofovir-alafenamide-in-people-living-with-hiv-a-cohort-study.html 2021-03-16T17:15:52.2490000Z https://www.medicinesresources.nhs.uk/clinical-practice-guidelines-registry-toward-reducing-duplication-improving-collaboration-and-increasing-transparency.html 2021-03-16T16:16:53.0690000Z https://www.medicinesresources.nhs.uk/cardiovascular-disease-in-chronic-kidney-disease-pathophysiological-insights-and-therapeutic-options.html 2021-03-16T16:25:05.5240000Z https://www.medicinesresources.nhs.uk/uk-government-announces-partnership-with-british-covid-19-rapid-test-manufacturers.html 2021-03-16T17:18:28.8680000Z https://www.medicinesresources.nhs.uk/european-medicine-agencys-ema-safety-committee-continues-investigation-of-astrazeneca-covid-19-vaccine-and-thromboembolic-events-update.html 2021-03-19T08:57:23.9830000Z https://www.medicinesresources.nhs.uk/cardiotoxicities-of-novel-cancer-immunotherapies.html 2021-03-16T16:32:07.4210000Z https://www.medicinesresources.nhs.uk/administering-thrombolysis-for-acute-ischemic-stroke-in-patients-taking-direct-oral-anticoagulants-to-treat-or-how-to-treat-2.html 2021-03-16T17:21:39.8130000Z https://www.medicinesresources.nhs.uk/encephalitis-induced-by-immune-checkpoint-inhibitors-a-systematic-review.html 2021-03-16T16:38:15.7120000Z https://www.medicinesresources.nhs.uk/immunogenicity-of-a-single-dose-of-sars-cov-2-messenger-rna-vaccine-in-solid-organ-transplant-recipients-1.html 2021-03-16T17:25:38.1330000Z https://www.medicinesresources.nhs.uk/field-safety-notice-ferring-pharmaceuticals-zomajet-injector-device-for-zomacton-somatropin.html 2021-03-16T17:26:30.6340000Z https://www.medicinesresources.nhs.uk/health-foundation-long-read-securing-a-positive-health-care-technology-legacy-from-covid-19.html 2021-03-16T16:51:30.6420000Z https://www.medicinesresources.nhs.uk/investigation-and-management-of-suspected-sars-cov-2-reinfections-a-guide-for-clinicians-and-infection-specialists.html 2021-03-16T17:28:26.9530000Z https://www.medicinesresources.nhs.uk/updated-patient-group-direction-pgd-template-insertion-of-the-progestogen-only-intra-uterine-system-ius.html 2021-03-16T17:29:02.6140000Z https://www.medicinesresources.nhs.uk/10-year-follow-up-of-patients-with-everolimus-eluting-versus-bare-metal-stents-after-st-segment-elevation-myocardial-infarction.html 2021-03-16T17:30:03.2950000Z https://www.medicinesresources.nhs.uk/revised-spc-molipaxin-trazodone-hydrochloride-tablets-all-strengths.html 2021-03-16T17:31:01.9180000Z https://www.medicinesresources.nhs.uk/revised-spc-venladex-venlafaxine-xl-75-mg-and-225mg-prolonged-release-tablets.html 2021-03-16T17:32:19.5000000Z https://www.medicinesresources.nhs.uk/revised-spc-klaricid-xl-clarithromycin-500-mg-tablets-and-klaricid-iv-500-mg-powder-for-concentrate-for-solution-for-infusion.html 2021-03-16T17:33:17.9170000Z https://www.medicinesresources.nhs.uk/nivolumab-for-adjuvant-treatment-of-completely-resected-melanoma-with-lymph-node-involvement-or-metastatic-disease-guidance-ta684-2.html 2021-03-19T09:00:14.5490000Z https://www.medicinesresources.nhs.uk/revised-spc-vizimpro-dacomitinib-tablets.html 2021-03-17T14:52:54.0360000Z https://www.medicinesresources.nhs.uk/revised-spc-molipaxin-trazodone-capsules-1.html 2021-03-17T15:06:16.9100000Z https://www.medicinesresources.nhs.uk/revised-spc-targinact-oxycodone-naloxone-prolonged-release-tablets.html 2021-03-17T15:07:41.2060000Z https://www.medicinesresources.nhs.uk/covid-19-therapeutic-alert-from-the-chief-medical-officer-17th-march-2023.html 2021-03-19T09:01:37.4660000Z https://www.medicinesresources.nhs.uk/inclusion-of-medicines-with-risk-minimisation-measures-rmm-in-patient-group-directions-pgds.html 2021-03-19T09:03:26.4050000Z https://www.medicinesresources.nhs.uk/aggressive-fluid-hydration-plus-non-steroidal-anti-inflammatory-drugs-versus-non-steroidal-anti-inflammatory-drugs-alone-for-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis-fluyt-a-multicentre-open-label-randomised-controlled-trial-1.html 2021-03-17T15:33:37.7240000Z https://www.medicinesresources.nhs.uk/efficacy-of-the-chadox1-ncov-19-covid-19-vaccine-against-the-b-1-351-variant.html 2021-03-17T15:38:58.7080000Z https://www.medicinesresources.nhs.uk/effect-of-marine-omega-3-fatty-acid-and-vitamin-d-supplementation-on-incident-atrial-fibrillation-a-randomized-clinical-trial.html 2021-03-17T16:26:34.6250000Z https://www.medicinesresources.nhs.uk/adverse-events-of-recreational-cannabis-use-reported-to-the-french-addictovigilance-network-2012-2017.html 2021-03-17T15:42:59.9650000Z https://www.medicinesresources.nhs.uk/oral-5-day-lefamulin-for-outpatient-management-of-community-acquired-bacterial-pneumonia-post-hoc-analysis-of-the-lefamulin-evaluation-against-pneumonia-leap-2-trial-3.html 2021-03-17T16:27:31.4200000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-guselkumab-an-interleukin-23p-19-specific-monoclonal-antibody-through-one-year-in-biologic-naive-patients-with-psoriatic-arthritis.html 2021-03-17T15:52:51.0000000Z https://www.medicinesresources.nhs.uk/progressive-multifocal-leukoencephalopathy-in-a-patient-with-progressive-multiple-sclerosis-treated-with-ocrelizumab-monotherapy.html 2021-03-17T15:53:57.4400000Z https://www.medicinesresources.nhs.uk/belzutifan-given-priority-review-status-from-fda-for-von-hippel-lindau-disease-associated-renal-cell-carcinoma.html 2021-03-17T15:54:55.7750000Z https://www.medicinesresources.nhs.uk/positive-results-for-mirikizumab-for-ulcerative-colitis-in-12-week-phase-3-induction-study.html 2021-03-17T16:28:38.5020000Z https://www.medicinesresources.nhs.uk/increased-mortality-in-community-tested-cases-of-sars-cov-2-lineage-b-1-1-7.html 2021-03-17T15:58:58.9340000Z https://www.medicinesresources.nhs.uk/spread-of-a-variant-sars-cov-2-in-long-term-care-facilities-in-england.html 2021-03-17T15:59:52.5830000Z https://www.medicinesresources.nhs.uk/bintrafusp-alfa-gsk-fails-to-meet-primary-endpoint-in-biliary-tract-cancer-study.html 2021-03-17T16:00:44.7190000Z https://www.medicinesresources.nhs.uk/positive-data-for-guselkumab-for-psoriatic-arthritis-in-two-year-long-term-trial-1.html 2021-03-17T16:04:17.3350000Z https://www.medicinesresources.nhs.uk/what-is-my-covid-risk.html 2021-03-17T16:05:18.3770000Z https://www.medicinesresources.nhs.uk/diagnosis-and-management-of-transient-ischemic-attack-and-acute-ischemic-stroke-a-review.html 2021-03-17T16:30:45.4530000Z https://www.medicinesresources.nhs.uk/heart-valve-disease-presenting-in-adults-investigation-and-management-draft-guidance.html 2021-03-17T16:07:39.8360000Z https://www.medicinesresources.nhs.uk/rps-anti-racist-statement-1.html 2021-03-17T16:10:43.0430000Z https://www.medicinesresources.nhs.uk/government-doubles-funding-for-prep-commissioning-for-2021-2022.html 2021-03-17T16:11:43.0530000Z https://www.medicinesresources.nhs.uk/idebenone-raxone-r-recommended-for-use-within-nhs-wales-for-treatment-of-visual-impairment-in-adolescent-and-adult-patients-with-lebers-hereditary-optic-neuropathy-lhon.html 2021-03-18T15:25:17.9970000Z https://www.medicinesresources.nhs.uk/lurasidone-latuda-r-recommended-as-option-for-use-within-nhs-wales-for-treatment-of-schizophrenia-in-adults-and-adolescents-aged-13-years-and-over-2.html 2021-03-18T15:30:41.1580000Z https://www.medicinesresources.nhs.uk/melatonin-slenyto-r-recommended-as-option-for-use-within-nhs-wales-for.html 2021-03-18T17:54:30.0880000Z https://www.medicinesresources.nhs.uk/dupilumab-dupixent-r-recommended-for-restricted-use-within-nhs-wales-in-children-age-6-to-11-years.html 2021-03-18T15:35:26.4740000Z https://www.medicinesresources.nhs.uk/opicapone-ongentys-r-recommended-as-an-option-for-restricted-use-within-nhs-wales-in-patients-with-parkinsons-disease-and-end-of-dose-motor-fluctuations.html 2021-03-18T15:36:44.2490000Z https://www.medicinesresources.nhs.uk/revised-spc-cellcept-mycophenolate-mofetil-products.html 2021-03-18T15:40:06.5080000Z https://www.medicinesresources.nhs.uk/revised-spc-paludrine-avloclor-anti-malarial-travel-pack-chloroquine-and-proguanil-anti-malarial-tablets.html 2021-03-18T15:41:24.9810000Z https://www.medicinesresources.nhs.uk/revised-spc-zonegran-zonisamide-hard-capsules-all-strengths.html 2021-03-18T15:43:42.3570000Z https://www.medicinesresources.nhs.uk/shortage-of-enalapril-5mg-tablets-2.html 2021-03-19T09:05:43.6190000Z https://www.medicinesresources.nhs.uk/public-health-england-study-shows-three-quarters-of-over-70s-have-covid-19-antibodies.html 2021-03-18T16:08:20.9090000Z https://www.medicinesresources.nhs.uk/bempedoic-acid-with-ezetimibe-for-treating-primary-hypercholesterolaemia-or-mixed-dyslipidaemia-final-appraisal-document.html 2021-03-18T16:09:30.5310000Z https://www.medicinesresources.nhs.uk/delivering-preconception-care-to-women-of-childbearing-age-with-serious-mental-illness.html 2021-03-18T16:11:45.4730000Z https://www.medicinesresources.nhs.uk/nhs-england-invites-everyone-aged-50-to-54-to-receive-covid-19-vaccine.html 2021-03-18T16:13:04.6320000Z https://www.medicinesresources.nhs.uk/extrahepatic-manifestations-of-chronic-hcv-infection.html 2021-03-18T16:15:31.9460000Z https://www.medicinesresources.nhs.uk/acalabrutinib-for-treating-chronic-lymphocytic-leukaemia-final-appraisal-document-1.html 2021-03-18T16:19:17.7440000Z https://www.medicinesresources.nhs.uk/mhra-confirms-people-should-continue-to-receive-covid-19-vaccine-astrazeneca.html 2021-03-19T09:07:55.1040000Z https://www.medicinesresources.nhs.uk/mims-table-hayfever-treatments-2.html 2021-03-18T16:23:20.0650000Z https://www.medicinesresources.nhs.uk/the-management-of-secondary-mitral-regurgitation-in-patients-with-heart-failure-a-joint-position-statement-from-the-heart-failure-association-hfa-european-association-of-cardiovascular-imaging-eacvi-european-heart-rhythm-association-ehra-and-european-association-of-percutaneous-cardiovascular-interventions-eapci-of-the-esc.html 2021-03-18T16:24:20.2000000Z https://www.medicinesresources.nhs.uk/electroconvulsive-therapy-for-depression-80-years-of-progress.html 2021-03-18T17:55:11.3000000Z https://www.medicinesresources.nhs.uk/hypertension-current-trends-and-future-perspectives.html 2021-03-18T16:26:31.7870000Z https://www.medicinesresources.nhs.uk/protect-respect-connect-decisions-about-living-and-dying-well-during-covid-19-cqcs-review-of-do-not-attempt-cardiopulmonary-resuscitation-decisions-during-the-covid-19-pandemic-1.html 2021-03-18T18:16:33.1820000Z https://www.medicinesresources.nhs.uk/fda-approves-oritavancin-kimyrsa-for-treatment-of-adults-with-acute-bacterial-skin-and-skin-structure-infections-caused-by-susceptible-isolates-of-designated-gram-positive-microorganisms-including-mrsa.html 2021-03-18T17:55:30.0210000Z https://www.medicinesresources.nhs.uk/european-commission-approves-licence-extension-for-pembrolizumab-as-monotherapy-for-treatment-of-adult-and-paediatric-patients-aged-3-years-and-older-with-relapsed-or-refractory-classical-hodgkin-lymphoma-chl.html 2021-03-18T18:14:16.9120000Z https://www.medicinesresources.nhs.uk/antibody-response-after-sars-cov-2-infection-and-implications-for-immunity-a-rapid-living-review.html 2021-03-18T16:50:47.9220000Z https://www.medicinesresources.nhs.uk/impact-of-covid-19-pandemic-on-utilisation-of-healthcare-services-a-systematic-review.html 2021-03-18T16:51:47.0180000Z https://www.medicinesresources.nhs.uk/pegcetacoplan-versus-eculizumab-in-paroxysmal-nocturnal-hemoglobinuria.html 2021-03-18T16:52:47.2510000Z https://www.medicinesresources.nhs.uk/second-intravenous-immunoglobulin-dose-in-patients-with-guillain-barre-syndrome-with-poor-prognosis-sid-gbs-a-double-blind-randomised-placebo-controlled-trial-1.html 2021-03-18T18:09:32.6580000Z https://www.medicinesresources.nhs.uk/development-of-imaging-based-risk-scores-for-prediction-of-intracranial-haemorrhage-and-ischaemic-stroke-in-patients-taking-antithrombotic-therapy-after-ischaemic-stroke-or-transient-ischaemic-attack-a-pooled-analysis-of-individual-patient-data-from-cohort-studies-1.html 2021-03-18T18:07:54.4130000Z https://www.medicinesresources.nhs.uk/onasemnogene-abeparvovec-gene-therapy-for-symptomatic-infantile-onset-spinal-muscular-atrophy-in-patients-with-two-copies-of-smn2-str1ve-an-open-label-single-arm-multicentre-phase-3-trial.html 2021-03-18T18:04:57.7920000Z https://www.medicinesresources.nhs.uk/assessment-of-protection-against-reinfection-with-sars-cov-2-among-4-million-pcr-tested-individuals-in-denmark-in-2020-a-population-level-observational-study.html 2021-03-18T17:12:12.1250000Z https://www.medicinesresources.nhs.uk/four-month-clinical-status-of-a-cohort-of-patients-after-hospitalization-for-covid-19.html 2021-03-18T17:15:32.5220000Z https://www.medicinesresources.nhs.uk/incidence-and-factors-associated-with-androgenetic-alopecia-among-transgender-and-gender-diverse-patients-treated-with-masculinizing-hormone-therapy.html 2021-03-18T17:58:45.7270000Z https://www.medicinesresources.nhs.uk/antihistamine-related-deaths-in-england-are-the-high-safety-profiles-of-antihistamines-leading-to-their-unsafe-use.html 2021-03-18T17:17:43.6590000Z https://www.medicinesresources.nhs.uk/risk-for-non-aids-defining-and-aids-defining-cancer-of-early-versus-delayed-initiation-of-antiretroviral-therap-a-multinational-prospective-cohort-study.html 2021-03-18T17:54:11.6740000Z https://www.medicinesresources.nhs.uk/efficacy-of-pitolisant-in-patients-with-high-burden-of-narcolepsy-symptoms-pooled-analysis-of-short-term-placebo-controlled-studies.html 2021-03-18T17:53:58.0880000Z https://www.medicinesresources.nhs.uk/seroprevalence-of-sars-cov-2-infection-in-healthcare-workers-in-a-large-teaching-hospital-in-the-north-west-of-england-a-period-prevalence-survey.html 2021-03-18T17:53:15.1950000Z https://www.medicinesresources.nhs.uk/shared-care-for-medicines-guidance-a-standard-approach-rmoc.html 2021-03-22T09:40:07.0530000Z https://www.medicinesresources.nhs.uk/injectable-opioid-treatment-commissioning-and-providing-services-3.html 2021-03-22T09:41:21.5330000Z https://www.medicinesresources.nhs.uk/revised-spcs-reminyl-galantamine-preparations.html 2021-03-19T13:49:35.6510000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-astrazeneca-benefits-still-outweigh-the-risks-despite-possible-link-to-rare-blood-clots-with-low-blood-platelets.html 2021-03-22T09:42:53.9640000Z https://www.medicinesresources.nhs.uk/cystic-fibrosis-mrna-candidate-mrt5005-fails-to-show-benefit-in-phase-i-ii-clinical-trial.html 2021-03-19T13:52:18.1530000Z https://www.medicinesresources.nhs.uk/natural-killer-cell-therapy-cynk-001-granted-fast-track-designation-in-the-us-for-the-treatment-of-recurrent-glioblastoma-multiforme.html 2021-03-19T13:53:25.8390000Z https://www.medicinesresources.nhs.uk/rilonacept-approved-in-the-us-for-the-treatment-of-recurrent-pericarditis.html 2021-03-19T13:55:17.0310000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-ruxolitinib-in-patients-with-covid-19-associated-acute-respiratory-distress-syndrome-on-mechanical-ventilation-fails-to-meet-primary-endpoint-1.html 2021-03-19T13:57:47.2120000Z https://www.medicinesresources.nhs.uk/study-of-tilsotolimod-in-combination-with-ipilimumab-in-anti-pd-1-refractory-advanced-melanoma-fails-to-meet-primary-endpoint.html 2021-03-19T13:59:13.0110000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-caffeine-citrate-10mg-ml-solution-for-injection-pl-01883-0344-el-21-a-09.html 2021-03-19T14:00:18.2280000Z https://www.medicinesresources.nhs.uk/shielding-advice-for-the-clinically-extremely-vulnerable-to-stop-from-april.html 2021-03-19T14:01:33.1220000Z https://www.medicinesresources.nhs.uk/gbp7-billion-for-nhs-and-social-care-for-covid-19-response-and-recovery-1.html 2021-03-19T14:02:55.2140000Z https://www.medicinesresources.nhs.uk/nice-publishes-final-appraisal-document-on-olaparib-with-bevacizumab-for-maintenance-treatment-of-advanced-high-grade-ovarian-fallopian-tube-or-primary-peritoneal-cancer.html 2021-03-19T14:03:53.5020000Z https://www.medicinesresources.nhs.uk/moderna-to-deliver-first-uk-covid-19-vaccines-in-april.html 2021-03-19T14:04:56.1350000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-deployment-next-steps-on-uptake-and-supply.html 2021-03-22T09:46:10.2520000Z https://www.medicinesresources.nhs.uk/home-delivery-of-medicines-and-appliances-during-the-covid-19-outbreak-service-expanded-to-include-people-instructed-to-self-isolate.html 2021-03-19T14:07:59.5960000Z https://www.medicinesresources.nhs.uk/british-medical-association-in-favour-of-reclassifying-lovima-and-hana-progestogen-only-contraceptives-from-pom-to-p-medicines-1.html 2021-03-19T14:10:14.4040000Z https://www.medicinesresources.nhs.uk/inequalities-in-oral-health-in-england.html 2021-03-19T14:11:08.3100000Z https://www.medicinesresources.nhs.uk/supporting-adult-carers-quality-standard-qs200-1.html 2021-03-19T14:15:28.4110000Z https://www.medicinesresources.nhs.uk/medicines-q-and-a-suitability-of-calcium-and-vitamin-d-preparations-for-vegetarians-or-vegans.html 2021-03-22T09:48:54.1230000Z https://www.medicinesresources.nhs.uk/delaying-the-second-dose-of-covid-19-vaccines.html 2021-03-19T15:31:48.6430000Z https://www.medicinesresources.nhs.uk/bmj-collection-child-health-redesign.html 2021-03-19T15:33:13.6970000Z https://www.medicinesresources.nhs.uk/what-do-we-know-about-sputnik-v-and-other-russian-vaccines.html 2021-03-19T15:35:48.6750000Z https://www.medicinesresources.nhs.uk/anti-interleukin-1-agents-for-the-treatment-of-recurrent-pericarditis-a-systematic-review-and-meta-analysis.html 2021-03-19T16:35:43.3830000Z https://www.medicinesresources.nhs.uk/association-between-living-with-children-and-outcomes-from-covid-19-opensafely-cohort-study-of-12-million-adults-in-england.html 2021-03-19T16:36:54.5880000Z https://www.medicinesresources.nhs.uk/evaluating-access-to-health-and-care-services-during-lockdown-by-the-covid-19-survey-in-five-uk-national-longitudinal-studies.html 2021-03-19T16:37:53.8010000Z https://www.medicinesresources.nhs.uk/effect-of-intermediate-dose-vs-standard-dose-prophylactic-anticoagulation-on-thrombotic-events-extracorporeal-membrane-oxygenation-treatment-or-mortality-among-patients-with-covid-19-admitted-to-the-intensive-care-unit-the-inspiration-randomized-clinical-trial.html 2021-03-19T17:06:08.7680000Z https://www.medicinesresources.nhs.uk/seroprevalence-and-humoral-immune-durability-of-anti-sars-cov-2-antibodies-in-wuhan-china-a-longitudinal-population-level-cross-sectional-study-1.html 2021-03-19T17:01:47.2950000Z https://www.medicinesresources.nhs.uk/vaccination-and-non-pharmaceutical-interventions-for-covid-19-a-mathematical-modelling-study.html 2021-03-19T17:06:27.8800000Z https://www.medicinesresources.nhs.uk/the-potential-health-and-economic-value-of-sars-cov-2-vaccination-alongside-physical-distancing-in-the-uk-a-transmission-model-based-future-scenario-analysis-and-economic-evaluation.html 2021-03-19T16:47:55.7120000Z https://www.medicinesresources.nhs.uk/olaparib-tablets-as-maintenance-therapy-in-patients-with-platinum-sensitive-relapsed-ovarian-cancer-and-a-brca1-2-mutation-solo2-engot-ov21-a-final-analysis-of-a-double-blind-randomised-placebo-controlled-phase-3-trial.html 2021-03-19T16:50:02.3530000Z https://www.medicinesresources.nhs.uk/dtb-select-more-evidence-that-fluoxetine-does-not-improve-functional-recovery-from-stroke-2.html 2021-03-29T09:01:38.9980000Z https://www.medicinesresources.nhs.uk/dtb-select-doac-drug-interactions-and-risk-of-major-bleeding.html 2021-03-29T09:04:08.2690000Z https://www.medicinesresources.nhs.uk/modelling-the-intervention-effect-of-opioid-agonist-treatment-on-multiple-mortality-outcomes-in-people-who-inject-drugs-a-three-setting-analysis.html 2021-03-22T15:23:15.6850000Z https://www.medicinesresources.nhs.uk/the-oxford-catalogue-of-opioids-a-systematic-synthesis-of-opioid-drug-names-and-their-pharmacology.html 2021-03-22T14:06:20.7400000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-imeglimin-monotherapy-versus-placebo-in-japanese-patients-with-type-2-diabetes-times-1-a-double-blind-randomized-placebo-controlled-parallel-group-multicenter-phase-3-trial.html 2021-03-22T14:08:07.6490000Z https://www.medicinesresources.nhs.uk/association-between-prophylactic-angiotensin-converting-enzyme-inhibitors-and-overall-survival-in-duchenne-muscular-dystrophy-analysis-of-registry-data.html 2021-03-22T14:10:27.3850000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-ponesimod-ponvory-for-relapsing-forms-of-multiple-sclerosis-in-adults.html 2021-03-22T15:25:30.0670000Z https://www.medicinesresources.nhs.uk/covid-19-stronger-warnings-are-needed-to-curb-socialising-after-vaccination-say-doctors.html 2021-03-22T14:52:55.6850000Z https://www.medicinesresources.nhs.uk/trials-to-find-preventative-covid-19-treatments-for-most-vulnerable-to-launch-in-uk.html 2021-03-29T12:01:58.1540000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-enhertu-trastuzumab-deruxtecan-powder-for-concentrate-for-solution-for-infusion.html 2021-03-23T13:13:50.4060000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-solu-medrone-methylprednisolone-sodium-succinate-40-mg-powder-for-injection.html 2021-03-22T15:27:46.2600000Z https://www.medicinesresources.nhs.uk/zolgensma-onasemnogene-abeparvovec-solution-for-infusion-1.html 2021-03-22T15:29:19.7570000Z https://www.medicinesresources.nhs.uk/nihr-alert-being-overweight-is-linked-with-an-increased-risk-of-dementia-in-new-research.html 2021-03-23T14:21:12.7880000Z https://www.medicinesresources.nhs.uk/outcomes-and-risk-factors-associated-with-sars-cov-2-infection-in-a-north-american-registry-of-patients-with-multiple-sclerosis.html 2021-03-22T15:30:39.0460000Z https://www.medicinesresources.nhs.uk/low-dose-tamoxifen-for-mammographic-density-reduction-a-randomized-controlled-trial-2.html 2021-03-22T15:49:14.9670000Z https://www.medicinesresources.nhs.uk/comparison-of-radiation-with-or-without-concurrent-trastuzumab-for-her2-positive-ductal-carcinoma-in-situ-resected-by-lumpectomy-a-phase-iii-clinical-trial.html 2021-03-22T15:57:49.5780000Z https://www.medicinesresources.nhs.uk/supporting-ccgs-to-address-vaccine-inequalities-next-steps.html 2021-03-29T09:27:12.2910000Z https://www.medicinesresources.nhs.uk/maternal-mental-health-during-a-pandemic.html 2021-03-22T15:43:08.3820000Z https://www.medicinesresources.nhs.uk/nhs-achieves-key-long-term-plan-commitment-to-roll-out-integrated-care-systems-across-england.html 2021-03-22T15:45:27.9770000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-316-january-2021-covid-19-special-edition.html 2021-03-29T09:14:29.7650000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-managing-covid-21.html 2021-03-29T10:02:42.5920000Z https://www.medicinesresources.nhs.uk/warfarin-dosing-algorithms-a-systematic-review.html 2021-03-23T18:37:46.6860000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-anti-epidermal-growth-factor-receptor-agents-for-the-treatment-of-oesophageal-cancer-a-systematic-review-and-meta-analysis.html 2021-03-23T17:54:15.5660000Z https://www.medicinesresources.nhs.uk/the-placebo-response-rate-in-pharmacological-trials-in-patients-with-irritable-bowel-syndrome-a-systematic-review-and-meta-analysis.html 2021-03-23T18:36:38.1190000Z https://www.medicinesresources.nhs.uk/dtb-select-tranexamic-acid-should-be-avoided-for-acute-gastrointestinal-bleeds.html 2021-03-29T10:04:01.3630000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-vaccine-product-information-poster.html 2021-03-23T16:24:23.5760000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-318-march-2021.html 2021-03-29T10:10:47.2500000Z https://www.medicinesresources.nhs.uk/roche-discontinues-phase-iii-generation-hd1-study-evaluating-investigational-candidate-tominersen-in-manifest-huntingtons-disease-1.html 2021-03-23T16:28:06.1750000Z https://www.medicinesresources.nhs.uk/nihr-alert-acting-on-feedback-from-national-clinical-audits-nhs-staff-describe-their-motivations-and-the-barriers-to-engaging-with-the-data-2.html 2021-03-23T18:27:18.6770000Z https://www.medicinesresources.nhs.uk/2021-22-nhs-standard-contract-final-version.html 2021-03-29T10:16:22.4740000Z https://www.medicinesresources.nhs.uk/pregnancy-and-vaccination-actions-for-maternity-services.html 2021-03-29T10:48:23.2060000Z https://www.medicinesresources.nhs.uk/quality-assurance-framework-covid-19-vaccination-sites.html 2021-03-29T10:47:10.2740000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-programme-faqs-on-second-doses.html 2021-03-29T10:28:11.0440000Z https://www.medicinesresources.nhs.uk/consultation-on-2021-22-national-tariff-payment-system-consultation-notice-annexes-and-supporting-documents.html 2021-03-23T16:41:23.7530000Z https://www.medicinesresources.nhs.uk/learning-from-lives-and-deaths-people-with-a-learning-disability-and-autistic-people-leder-policy-2021.html 2021-03-23T16:43:58.4310000Z https://www.medicinesresources.nhs.uk/new-figures-show-dexamethasone-treatment-for-covid-19-has-so-far-saved-22-000-lives-in-uk.html 2021-03-23T16:46:05.8500000Z https://www.medicinesresources.nhs.uk/carfilzomib-with-dexamethasone-and-lenalidomide-for-previously-treated-multiple-myeloma-final-appraisal-document.html 2021-03-23T16:48:17.2780000Z https://www.medicinesresources.nhs.uk/vaccine-uptake-in-the-general-population-call-for-evidence.html 2021-03-29T10:50:14.2080000Z https://www.medicinesresources.nhs.uk/cannabis-based-medicinal-products-clarification-of-guidance-march-2021.html 2021-03-29T10:32:22.3530000Z https://www.medicinesresources.nhs.uk/mhra-launches-pilot-project-that-puts-patient-involvement-at-the-heart-of-clinical-trials-and-medicine-development-1.html 2021-03-23T16:53:16.8120000Z https://www.medicinesresources.nhs.uk/one-year-on-three-myths-about-covid-19-that-the-data-proved-wrong-1.html 2021-03-23T16:55:35.8070000Z https://www.medicinesresources.nhs.uk/tobramycin-and-vestibulotoxicity-retrospective-analysis-of-four-cases.html 2021-03-23T17:57:54.7470000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-advises-against-use-of-ivermectin-for-the-prevention-or-treatment-of-covid-19-outside-randomised-clinical-trials-1.html 2021-03-29T10:36:44.7870000Z https://www.medicinesresources.nhs.uk/dtb-forum-bts-guideline-for-the-use-of-long-term-macrolides-1.html 2021-03-23T17:02:37.6600000Z https://www.medicinesresources.nhs.uk/a-case-series-of-confusional-states-and-other-neurotoxic-effects-caused-by-ertapenem.html 2021-03-23T17:06:28.5270000Z https://www.medicinesresources.nhs.uk/acute-and-fatal-cephalosporin-induced-autoimmune-haemolytic-anaemia.html 2021-03-23T17:08:09.1890000Z https://www.medicinesresources.nhs.uk/gp-access-during-covid-19-a-review-of-our-evidence-april-2019-december-2020.html 2021-03-23T17:09:19.3860000Z https://www.medicinesresources.nhs.uk/fda-accepts-new-drug-application-for-mavacamten-in-symptomatic-obstructive-hypertrophic-cardiomyopathy-ohcm-1.html 2021-03-23T17:13:47.3950000Z https://www.medicinesresources.nhs.uk/information-and-guidance-specific-to-moderna-c-19-vaccine.html 2021-03-29T10:38:37.7700000Z https://www.medicinesresources.nhs.uk/conference-report-pembrolizumab-plus-lenvatinib-meets-dual-primary-endpoints-versus-chemotherapy-in-patients-with-advanced-endometrial-cancer-following-prior-platinum-based-chemotherapy-in-keynote-775-study-311.html 2021-03-23T17:47:50.2110000Z https://www.medicinesresources.nhs.uk/conference-report-omnipod-r-5-tubeless-automated-insulin-delivery-system-improves-clinical-outcomes-in-type-1-diabetes.html 2021-03-23T17:48:11.5630000Z https://www.medicinesresources.nhs.uk/fda-briefing-document-cites-safety-concerns-over-osteoarthritis-drug-tanezumab.html 2021-03-23T17:25:03.7830000Z https://www.medicinesresources.nhs.uk/astrazeneca-us-phase-iii-trial-of-azd1222-met-primary-efficacy-endpoint-in-preventing-covid-19-at-interim-analysis.html 2021-03-29T10:41:24.1030000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-of-regen-cov-tm-casirivimab-with-imdevimab-antibody-cocktail-reports-reduction-in-hospitalization-or-death-in-non-hospitalised-covid-19-patients.html 2021-03-23T18:05:32.3220000Z https://www.medicinesresources.nhs.uk/aspirin-versus-anticoagulation-in-cervical-artery-dissection-treat-cad-an-open-label-randomised-non-inferiority-trial.html 2021-03-23T18:35:01.1860000Z https://www.medicinesresources.nhs.uk/association-of-risk-factors-and-bleeding-complications-in-asian-patients-taking-edoxaban.html 2021-03-23T17:36:54.3940000Z https://www.medicinesresources.nhs.uk/routine-asymptomatic-testing-strategies-for-airline-travel-during-the-covid-19-pandemic-a-simulation-study.html 2021-03-23T18:33:18.6140000Z https://www.medicinesresources.nhs.uk/hospitalization-for-covid-19-in-patients-treated-with-selected-immunosuppressant-and-immunomodulating-agents-compared-to-the-general-population-a-danish-cohort-study-1.html 2021-03-23T18:32:23.1160000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-outcomes-of-proposed-randomized-controlled-trials-investigating-hydroxychloroquine-and-chloroquine-during-the-early-stages-of-the-covid-19-pandemic-1.html 2021-03-23T18:31:22.4050000Z https://www.medicinesresources.nhs.uk/rapid-point-of-care-testing-for-covid-19-quality-of-supportive-information-for-lateral-flow-serology-assays.html 2021-03-23T18:30:10.1610000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-317-february-2021.html 2021-03-29T10:07:44.1360000Z https://www.medicinesresources.nhs.uk/revised-spc-desizon-zonisamide-oral-suspension-1.html 2021-03-24T15:05:04.1490000Z https://www.medicinesresources.nhs.uk/age-dependent-associations-of-risk-factors-with-heart-failure-pooled-population-based-cohort-study-1.html 2021-03-24T15:08:15.2380000Z https://www.medicinesresources.nhs.uk/early-evidence-of-the-effect-of-sars-cov-2-vaccine-at-one-medical-center.html 2021-03-24T15:09:16.8860000Z https://www.medicinesresources.nhs.uk/antibody-responses-after-a-single-dose-of-sars-cov-2-mrna-vaccine.html 2021-03-24T15:10:26.7530000Z https://www.medicinesresources.nhs.uk/bnt162b2-mrna-covid-19-vaccine-effectiveness-among-health-care-workers.html 2021-03-24T15:11:36.0350000Z https://www.medicinesresources.nhs.uk/sars-cov-2-infection-after-vaccination-in-health-care-workers-in-california.html 2021-03-24T15:12:48.4370000Z https://www.medicinesresources.nhs.uk/long-term-safety-and-efficacy-of-anifrolumab-in-adults-with-systemic-lupus-erythematosus-results-of-a-phase-ii-open-label-extension-study-1.html 2021-03-24T15:14:21.0330000Z https://www.medicinesresources.nhs.uk/effect-of-continued-weekly-subcutaneous-semaglutide-vs-placebo-on-weight-loss-maintenance-in-adults-with-overweight-or-obesity-the-step-4-randomized-clinical-trial-1.html 2021-03-24T16:39:37.7800000Z https://www.medicinesresources.nhs.uk/p2y12-inhibitor-monotherapy-after-coronary-stenting-according-to-type-of-p2y12-inhibitor.html 2021-03-24T15:18:48.6300000Z https://www.medicinesresources.nhs.uk/dexamethasone-plus-oseltamivir-versus-dexamethasone-in-treatment-naive-primary-immune-thrombocytopenia-a-multicentre-randomised-open-label-phase-2-trial-1.html 2021-03-24T16:41:15.7150000Z https://www.medicinesresources.nhs.uk/evaluation-of-hypokalemia.html 2021-03-24T15:22:57.5960000Z https://www.medicinesresources.nhs.uk/challenges-and-opportunities-to-end-tuberculosis-in-the-covid-19-era-2.html 2021-03-24T15:25:13.7440000Z https://www.medicinesresources.nhs.uk/ixekizumab-for-treating-axial-spondyloarthritis-after-nsaids-appraisal-consultation-document-1.html 2021-03-24T16:45:14.4980000Z https://www.medicinesresources.nhs.uk/secukinumab-for-treating-non-radiographic-axial-spondyloarthritis-appraisal-consultation-document.html 2021-03-24T15:28:58.6910000Z https://www.medicinesresources.nhs.uk/zegalogue-dasiglucagon-approved-for-severe-hypoglycaemia-in-people-with-diabetes-in-the-us-1.html 2021-03-24T16:45:36.5470000Z https://www.medicinesresources.nhs.uk/collaborative-tb-strategy-for-england-2015-to-2020-end-of-programme-report-1.html 2021-03-24T15:32:30.8230000Z https://www.medicinesresources.nhs.uk/dealing-with-microaggressions-2.html 2021-03-24T15:36:03.9660000Z https://www.medicinesresources.nhs.uk/intensified-treatment-of-patients-with-early-stage-unfavourable-hodgkin-lymphoma-long-term-follow-up-of-a-randomised-international-phase-3-trial-of-the-german-hodgkin-study-group-ghsg-hd14-2.html 2021-03-24T15:39:34.7290000Z https://www.medicinesresources.nhs.uk/is-treatment-in-patients-with-suspected-nonradiographic-axial-spondyloarthritis-effective-six-month-results-of-a-placebo-controlled-trial.html 2021-03-24T15:42:33.9400000Z https://www.medicinesresources.nhs.uk/study-of-tofacitinib-in-refractory-dermatomyositis-an-open-label-pilot-study-of-ten-patients.html 2021-03-24T15:43:43.0610000Z https://www.medicinesresources.nhs.uk/pembrolizumab-approved-in-us-for-first-line-use-in-locally-advanced-or-metastatic-oesophageal-or-gastroesophageal-junction-carcinomas-regardless-of-pd-l1-expression.html 2021-03-24T15:44:59.9210000Z https://www.medicinesresources.nhs.uk/novel-radioligand-therapy-177lu-psma-617-found-to-be-effective-in-phase-iii-prostate-cancer-trial.html 2021-03-24T15:45:59.4510000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-osilodrostat-for-cushings-disease.html 2021-03-24T15:47:44.4930000Z https://www.medicinesresources.nhs.uk/advise-non-pharmacological-therapy-as-first-line-treatment-for-chronic-insomnia.html 2021-03-24T15:49:49.6240000Z https://www.medicinesresources.nhs.uk/better-understanding-the-downsides-of-low-value-healthcare-could-reduce-harm.html 2021-03-24T15:50:42.3610000Z https://www.medicinesresources.nhs.uk/revised-spc-siklos-hydroxycarbamide-100mg-and-1000-mg-film-coated-tablets-2.html 2021-03-25T16:05:39.3500000Z https://www.medicinesresources.nhs.uk/direct-healthcare-professional-communication-ambisome-liposomal-50-mg-powder-for-dispersion-for-infusion-pl-16807-0001-identify-and-dispose-of-co-packaged-sartorius-5mm-minisart-filters-due-to-potential-to-release-fibres-during-use.html 2021-03-29T11:34:20.2850000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-and-medicines-updates-for-march-2021.html 2021-03-29T11:38:12.8700000Z https://www.medicinesresources.nhs.uk/bendamustine-levact-increased-risk-of-non-melanoma-skin-cancer-and-progressive-multifocal-encephalopathy-pml.html 2021-03-29T11:41:38.4290000Z https://www.medicinesresources.nhs.uk/comparative-efficacy-of-interventions-for-reducing-symptoms-of-depression-in-people-with-dementia-systematic-review-and-network-meta-analysis-3.html 2021-03-25T17:09:40.5020000Z https://www.medicinesresources.nhs.uk/dosing-and-monitoring-for-treatment-of-vitamin-d-deficiency-in-pregnancy.html 2021-03-29T11:44:17.5340000Z https://www.medicinesresources.nhs.uk/abrocitinib-versus-placebo-or-dupilumab-for-atopic-dermatitis-1.html 2021-03-25T17:10:27.9330000Z https://www.medicinesresources.nhs.uk/switching-to-riociguat-versus-maintenance-therapy-with-phosphodiesterase-5-inhibitors-in-patients-with-pulmonary-arterial-hypertension-replace-a-multicentre-open-label-randomised-controlled-trial.html 2021-03-25T17:46:17.0540000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-a-recombinant-tandem-repeat-dimeric-rbd-based-protein-subunit-vaccine-zf2001-against-covid-19-in-adults-two-randomised-double-blind-placebo-controlled-phase-1-and-2-trials.html 2021-03-25T17:13:42.7790000Z https://www.medicinesresources.nhs.uk/patterns-of-cutaneous-and-noncutaneous-immune-related-adverse-events-among-patients-with-advanced-cancer.html 2021-03-25T16:27:35.0780000Z https://www.medicinesresources.nhs.uk/incidence-and-predictors-of-stroke-in-patients-with-rheumatic-heart-disease.html 2021-03-25T16:29:31.3520000Z https://www.medicinesresources.nhs.uk/modelling-of-hypothetical-sars-cov-2-point-of-care-tests-on-admission-to-hospital-from-a-and-e-rapid-cost-effectiveness-analysis.html 2021-03-25T16:30:37.0190000Z https://www.medicinesresources.nhs.uk/the-impact-of-a-community-pharmacy-cough-cold-and-flu-service-on-antibiotic-prescribing-and-its-acceptability.html 2021-03-29T11:54:57.5510000Z https://www.medicinesresources.nhs.uk/ground-breaking-new-technology-to-detect-known-variants-of-concern-being-trialled-in-nhs-test-and-trace-laboratories.html 2021-03-25T16:35:18.6250000Z https://www.medicinesresources.nhs.uk/open-consultation-regulating-healthcare-professionals-protecting-the-public.html 2021-03-25T16:36:25.0120000Z https://www.medicinesresources.nhs.uk/the-best-start-for-life-a-vision-for-the-1-001-critical-days.html 2021-03-25T16:38:57.1220000Z https://www.medicinesresources.nhs.uk/serious-shortage-protocol-ssp-issued-for-competact-r-15mg-850mg-pioglitazole-metformin-tablets-3.html 2021-03-29T11:59:50.6070000Z https://www.medicinesresources.nhs.uk/freedom-of-information-foi-request-half-of-pharmacy-integration-fund-for-2019-2020-spent-elsewhere-in-nhs.html 2021-03-25T16:48:16.1820000Z https://www.medicinesresources.nhs.uk/fda-issues-refusal-to-file-letter-for-novo-nordisks-once-weekly-semaglutide-2mg-injection-1.html 2021-03-25T16:50:58.7460000Z https://www.medicinesresources.nhs.uk/astrazeneca-publishes-updated-results-from-us-based-trial-of-its-covid-19-vaccine-1.html 2021-03-25T16:53:32.6130000Z https://www.medicinesresources.nhs.uk/liberty-randomised-withdrawal-study-suggest-potential-long-term-benefit-of-combination-therapy-with-relugolix-plus-estradiol-plus-norethindrone-acetate-in-women-with-uterine-fibroids-who-had-competed-liberty-long-term-extension-study.html 2021-03-25T17:36:40.4480000Z https://www.medicinesresources.nhs.uk/standard-operating-procedure-usage-of-lateral-flow-devices-for-asymptomatic-staff-testing-at-vaccination-sites.html 2021-03-25T16:57:15.6040000Z https://www.medicinesresources.nhs.uk/nhs-medical-director-says-do-not-delay-getting-covid-vaccine.html 2021-03-25T16:59:47.9830000Z https://www.medicinesresources.nhs.uk/atopic-dermatitis-1.html 2021-03-25T17:32:42.3670000Z https://www.medicinesresources.nhs.uk/precision-dosing-a-clinical-and-public-health-imperative-1.html 2021-03-25T17:03:39.1910000Z https://www.medicinesresources.nhs.uk/general-pharmaceutical-council-gphc-to-evaluate-impact-of-covid-19-on-provisionally-registered-pharmacists-and-pre-registration-trainees.html 2021-03-25T17:05:06.4120000Z https://www.medicinesresources.nhs.uk/covid-19-insight-issue-10.html 2021-03-25T17:07:08.0020000Z https://www.medicinesresources.nhs.uk/covid-19-variants-and-vaccination.html 2021-03-25T17:25:34.4360000Z https://www.medicinesresources.nhs.uk/management-of-colonic-divert.html 2021-03-25T17:23:29.9420000Z https://www.medicinesresources.nhs.uk/uk-health-security-agency-will-launch-on-1-april.html 2021-03-25T17:11:35.3470000Z https://www.medicinesresources.nhs.uk/revised-spc-budenofalk-budesonide-9mg-gastro-resistant-granules-1.html 2021-03-26T15:22:22.9440000Z https://www.medicinesresources.nhs.uk/revised-spcs-diflucan-fluconazole-products.html 2021-03-26T15:23:27.0540000Z https://www.medicinesresources.nhs.uk/revised-spc-adenosine-30-mg-10-ml-solution-for-infusion.html 2021-03-26T15:24:44.9750000Z https://www.medicinesresources.nhs.uk/revised-spcs-lustral-sertraline-film-coated-tablets-2.html 2021-03-26T15:27:05.4810000Z https://www.medicinesresources.nhs.uk/revised-spc-fluconazole-400mg-200ml-infusion-bags-2mg-ml-in-200ml-infusion-bags.html 2021-03-26T15:28:48.9680000Z https://www.medicinesresources.nhs.uk/revised-spc-dermovate-clobetasol-preparations.html 2021-03-26T15:30:02.6660000Z https://www.medicinesresources.nhs.uk/bendamustine-increased-mortality-observed-when-used-in-non-approved-combination-treatments-or-outside-the-approved-indications.html 2021-03-29T12:06:35.1960000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-accepts-marketing-authorization-application-for-enfortumab-vedotin-ev-for-the-treatment-of-locally-advanced-or-metastatic-urothelial-cancer.html 2021-03-26T18:28:09.2630000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-validates-marketing-authorization-application-for-sacituzumab-govitecan-hziy-for-the-treatment-of-metastatic-triple-negative-breast-cancer.html 2021-03-26T18:27:50.2600000Z https://www.medicinesresources.nhs.uk/study-of-relatlimab-in-combination-with-nivolumab-in-first-line-treatment-of-metastatic-or-unresectable-melanoma-meets-primary-endpoint.html 2021-03-26T18:28:34.1950000Z https://www.medicinesresources.nhs.uk/helping-alleviate-the-longer-term-consequences-of-covid-19-heal-covid-national-platform-trial.html 2021-03-26T15:42:19.9470000Z https://www.medicinesresources.nhs.uk/covid-19-middle-aged-women-face-greater-risk-of-debilitating-long-term-symptoms.html 2021-03-26T15:43:41.5540000Z https://www.medicinesresources.nhs.uk/the-adult-social-care-market-in-england.html 2021-03-26T15:44:57.1500000Z https://www.medicinesresources.nhs.uk/practice-pointer-remote-management-of-covid-19-using-home-pulse-oximetry-and-virtual-ward-support.html 2021-03-26T15:46:33.7210000Z https://www.medicinesresources.nhs.uk/migraine-integrated-approaches-to-clinical-management-and-emerging-treatments.html 2021-03-26T15:49:14.3690000Z https://www.medicinesresources.nhs.uk/sublimaze-r-solution-for-injection-50-mg-ml-fentanyl-citrate-interim-supply-of-ireland-stock-to-mitigate-supply-disruption.html 2021-03-29T12:12:29.2980000Z https://www.medicinesresources.nhs.uk/antithrombotic-therapy-in-diabetes-which-when-and-for-how-long.html 2021-03-26T15:53:40.5690000Z https://www.medicinesresources.nhs.uk/emerging-therapies-and-their-delivery-for-treating-age-related-macular-degeneration-2.html 2021-03-26T15:56:10.4270000Z https://www.medicinesresources.nhs.uk/reducing-nontraumatic-lower-extremity-amputations-by-20-by-2030-time-to-get-to-our-feet.html 2021-03-26T15:57:14.1960000Z https://www.medicinesresources.nhs.uk/republished-case-report-omeprazole-induced-hypomagnesaemia-causing-renal-tubular-acidosis-with-hypokalaemia-hypocalcaemia-hyperlactacidaemia-and-hyperammonaemia-3.html 2021-03-26T16:01:20.0920000Z https://www.medicinesresources.nhs.uk/us-fda-approves-myrbetriq-extended-release-mirabegron-for-treatment-of-neurogenic-detrusor-overactivity-in-children-3-years.html 2021-03-26T16:02:33.5760000Z https://www.medicinesresources.nhs.uk/application-for-emergency-use-authorisation-of-covid-19-antibody-therapy-vir-7831-filed-in-the-us.html 2021-03-26T16:03:33.3880000Z https://www.medicinesresources.nhs.uk/coronavirus-covid-19-infection-survey-uk-26-march-2021.html 2021-03-26T16:04:44.8830000Z https://www.medicinesresources.nhs.uk/new-uk-study-finds-strong-immune-response-following-one-dose-of-pfizer-covid-19-vaccine.html 2021-03-26T16:06:27.0110000Z https://www.medicinesresources.nhs.uk/nhs-mandate-2021-to-2023.html 2021-03-26T16:07:57.9390000Z https://www.medicinesresources.nhs.uk/adult-social-care-statistics-in-england-an-overview-2020.html 2021-03-26T16:09:48.2460000Z https://www.medicinesresources.nhs.uk/rest-recover-restore-getting-uk-health-services-back-on-track.html 2021-03-26T16:10:53.5780000Z https://www.medicinesresources.nhs.uk/evaluating-progestogens-for-preventing-preterm-birth-international-collaborative-epppic-meta-analysis-of-individual-participant-data-from-randomised-controlled-trials.html 2021-03-26T16:56:01.2780000Z https://www.medicinesresources.nhs.uk/drug-drug-interactions-with-warfarin-a-systematic-review-and-meta-analysis.html 2021-03-26T16:57:07.7070000Z https://www.medicinesresources.nhs.uk/discontinuing-v-lactam-treatment-after-3-days-for-patients-with-community-acquired-pneumonia-in-non-critical-care-wards-ptc-a-double-blind-randomised-placebo-controlled-non-inferiority-trial.html 2021-03-26T16:58:33.7580000Z https://www.medicinesresources.nhs.uk/safety-of-live-attenuated-herpes-zoster-vaccine-in-australian-adults-70-79-years-of-age-an-observational-study-using-active-surveillance.html 2021-03-26T16:59:46.0650000Z https://www.medicinesresources.nhs.uk/evolution-of-the-randomized-clinical-trial-in-the-era-of-precision-oncology.html 2021-03-26T17:01:27.3170000Z https://www.medicinesresources.nhs.uk/chronic-immune-related-adverse-events-following-adjuvant-anti-pd-1-therapy-for-high-risk-resected-melanoma.html 2021-03-26T17:02:55.5950000Z https://www.medicinesresources.nhs.uk/phase-iii-randomized-placebo-controlled-trial-of-cc-486-oral-azacitidine-in-patients-with-lower-risk-myelodysplastic-syndromes.html 2021-03-26T17:05:05.4090000Z https://www.medicinesresources.nhs.uk/a-method-for-tapering-antipsychotic-treatment-that-may-minimize-the-risk-of-relapse-1.html 2021-03-26T18:44:41.9610000Z https://www.medicinesresources.nhs.uk/commissioning-statement-ivacaftor-tezacaftor-ivacaftor-lumacaftor-ivacaftor-and-elexacaftor-tezacaftor-ivacaftor-for-cystic-fibrosis-1.html 2021-03-29T12:15:14.3940000Z https://www.medicinesresources.nhs.uk/2021-22-nhs-operational-priorities-and-operational-planning-guidance-published.html 2021-03-29T12:16:55.8140000Z https://www.medicinesresources.nhs.uk/pembrolizumab-now-available-for-the-treatment-of-certain-patients-with-colorectal-cancer-during-the-covid-19-pandemic-1.html 2021-03-26T18:41:11.5300000Z https://www.medicinesresources.nhs.uk/impact-of-covid-19-vaccines-on-mortality-in-england-december-2020-to-february-2022.html 2021-03-29T12:25:56.8820000Z https://www.medicinesresources.nhs.uk/public-health-england-vaccine-effectiveness-report.html 2021-03-29T12:27:41.5920000Z https://www.medicinesresources.nhs.uk/cancer-survival-index-for-clinical-commissioning-groups-2003-to-2018.html 2021-03-26T17:18:47.6790000Z https://www.medicinesresources.nhs.uk/periods-of-altered-risk-for-non-fatal-drug-overdose-a-self-controlled-case-series.html 2021-03-26T17:21:17.9390000Z https://www.medicinesresources.nhs.uk/arterial-and-venous-thromboembolism-in-covid-19-a-study-level-meta-analysis-1.html 2021-03-26T17:22:26.9790000Z https://www.medicinesresources.nhs.uk/revised-spcs-locoid-hydrocortisone-butyrate-products-1.html 2021-03-29T11:55:38.0990000Z https://www.medicinesresources.nhs.uk/revised-spc-zimovane-zopiclone-7-5mg-film-coated-tablets.html 2021-03-29T13:19:44.7770000Z https://www.medicinesresources.nhs.uk/the-effect-of-aging-on-infliximab-exposure-and-response-in-patients-with-inflammatory-bowel-diseases.html 2021-03-29T11:58:21.6040000Z https://www.medicinesresources.nhs.uk/a-safety-signal-of-somnambulism-with-the-use-of-antipsychotics-and-lithium-a-pharmacovigilance-disproportionality-analysis-1.html 2021-03-29T12:02:53.8730000Z https://www.medicinesresources.nhs.uk/positive-chmp-opinion-for-buvidal-buprenorphine-160mg-monthly-dose-for-treatment-of-opioid-dependence.html 2021-03-29T12:04:25.4340000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-duvelisib-for-treatment-of-relapsed-refractory-chronic-lymphocytic-leukaemia-and-refractory-follicular-lymphoma.html 2021-03-29T12:05:47.4520000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-ponesimod-ponvory-for-treatment-of-adults-with-relapsing-forms-of-multiple-sclerosis.html 2021-03-29T12:07:35.7780000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-modified-release-hydrocortisone-efmody-for-treatment-of-congenital-adrenal-hyperplasia-for-patients-aged-12-years-and-older-1.html 2021-03-29T12:10:02.5890000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-belimumab-benlysta-for-treatment-of-active-lupus-nephritis.html 2021-03-29T12:11:02.7500000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-ivacaftor-tezacaftor-elexacaftor-kaftrio-and-ivacaftor-kalydeco-for-cystic-fibrosis.html 2021-03-29T12:12:24.1820000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-liraglutide-saxenda-for-treatment-of-obesitiy-in-adolescents.html 2021-03-29T12:14:01.7640000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-atezolizumab-tecentriq-for-first-line-treatment-of-metastatic-non-small-cell-lung-cancer-nsclc.html 2021-03-29T12:15:46.6330000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-enzalutamide-xtandi-for-treatment-of-prostate-cancer.html 2021-03-29T12:18:24.5700000Z https://www.medicinesresources.nhs.uk/withdrawal-of-licence-extension-application-for-ticagrelor-brilique-for-primary-prevention-of-atherothrombotic-events-in-combination-with-aspirin-1.html 2021-03-29T13:25:41.7550000Z https://www.medicinesresources.nhs.uk/ema-issues-advice-on-use-of-regdanvimab-for-treating-covid-19.html 2021-03-29T12:22:06.2590000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-idecabtagene-vicleucel-for-treatment-of-adults-with-relapsed-refractory-multiple-myeloma-1.html 2021-03-29T13:26:53.6710000Z https://www.medicinesresources.nhs.uk/maximising-vaccine-uptake-in-underserved-communities-a-framework-for-systems-sites-and-local-authorities-leading-vaccination-delivery.html 2021-04-06T02:59:55.1000000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-low-dose-colchicine-in-patients-with-coronary-disease-a-systematic-review-and-meta-analysis-of-randomized-trials.html 2021-03-29T14:42:51.8770000Z https://www.medicinesresources.nhs.uk/relative-risk-of-arterial-and-venous-thromboembolism-in-persons-with-cancer-vs-persons-without-cancer-a-nationwide-analysis.html 2021-03-29T14:44:28.4300000Z https://www.medicinesresources.nhs.uk/transforming-the-public-health-system-reforming-the-public-health-system-for-the-challenges-of-our-times.html 2021-04-06T03:01:11.8520000Z https://www.medicinesresources.nhs.uk/suicide-prevention-in-england-fifth-progress-report.html 2021-03-29T15:25:56.3710000Z https://www.medicinesresources.nhs.uk/covid-19-mental-health-and-wellbeing-recovery-action-plan.html 2021-04-06T03:06:02.6600000Z https://www.medicinesresources.nhs.uk/how-covid-19-affects-the-brain.html 2021-03-29T14:58:34.9410000Z https://www.medicinesresources.nhs.uk/update-on-2021-22-flu-vaccine-ordering.html 2021-03-29T15:00:45.4020000Z https://www.medicinesresources.nhs.uk/ucl-study-finds-single-dose-of-pfizer-or-astrazeneca-vaccine-effective-at-reducing-62-of-coronavirus-infections-in-care-homes-2.html 2021-03-29T15:06:19.4260000Z https://www.medicinesresources.nhs.uk/title-asthma-a-disease-of-variability.html 2021-03-29T15:09:07.1400000Z https://www.medicinesresources.nhs.uk/arimoclomal-fails-to-meet-primary-endpoint-in-phase-ii-iii-clinical-trial-in-inclusion-body-myositis-ibm-1.html 2021-03-30T16:52:03.9230000Z https://www.medicinesresources.nhs.uk/results-from-phase-iib-iii-trial-suggest-benefit-from-intravenous-aviptadil-rlf-100-in-critically-ill-covid-19-patients.html 2021-03-30T16:53:56.5520000Z https://www.medicinesresources.nhs.uk/positive-phase-3-data-reported-for-lenzilumab-in-hospitalised-patients-with-covid-21.html 2021-03-30T16:54:50.5370000Z https://www.medicinesresources.nhs.uk/effectiveness-and-safety-of-direct-oral-anticoagulants-versus-warfarin-in-patients-with-valvular-atrial-fibrillation-a-population-based-cohort-study-2.html 2021-03-30T15:34:59.2240000Z https://www.medicinesresources.nhs.uk/toward-understanding-covid-19-recovery-national-institutes-of-health-workshop-on-postacute-covid-19.html 2021-03-30T16:58:50.5370000Z https://www.medicinesresources.nhs.uk/long-term-outcomes-in-patients-with-connective-tissue-disease-associated-pulmonary-arterial-hypertension-in-the-modern-treatment-era-meta-analyses-of-randomized-controlled-trials-and-observational-registries-1.html 2021-03-30T17:01:19.0520000Z https://www.medicinesresources.nhs.uk/field-safety-notice-medoject-sterile-hypodermic-and-blunt-fill-needles-manufactured-by-chirana-t-injecta-discontinue-use.html 2021-03-30T15:39:44.5720000Z https://www.medicinesresources.nhs.uk/department-of-health-and-social-car-dhsc-counter-fraud-strategic-plan-2020-to-2024.html 2021-03-30T17:03:21.2700000Z https://www.medicinesresources.nhs.uk/myo-inositol-probiotics-and-micronutrient-supplementation-from-preconception-for-glycemia-in-pregnancy-nipper-international-multicenter-double-blind-randomized-controlled-trial.html 2021-03-30T17:04:04.4740000Z https://www.medicinesresources.nhs.uk/revised-spc-feldene-piroxicam-all-products.html 2021-03-30T17:05:34.7630000Z https://www.medicinesresources.nhs.uk/revised-spc-vfend-voriconazole-all-products.html 2021-03-30T17:07:22.5970000Z https://www.medicinesresources.nhs.uk/ponesimod-compared-with-teriflunomide-in-patients-with-relapsing-multiple-sclerosis-in-the-active-comparator-phase-3-optimum-study-a-randomized-clinical-trial.html 2021-03-30T17:08:33.8920000Z https://www.medicinesresources.nhs.uk/avelumab-plus-standard-of-care-chemoradiotherapy-versus-chemoradiotherapy-alone-in-patients-with-locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-a-randomised-double-blind-placebo-controlled-multicentre-phase-3-trial.html 2021-03-30T17:11:37.0210000Z https://www.medicinesresources.nhs.uk/antihypertensive-treatment-and-risk-of-cancer-an-individual-participant-data-meta-analysis.html 2021-03-30T17:12:24.3290000Z https://www.medicinesresources.nhs.uk/deadline-approaches-for-new-steroid-emergency-card-measures-to-be-implemented.html 2021-04-06T02:52:20.2190000Z https://www.medicinesresources.nhs.uk/the-joint-committee-on-vaccination-and-immunisation-jcvi-recommends-that-adults-living-with-adults-who-are-immunosuppressed-should-be-prioritised-for-covid-19-vaccination-1.html 2021-04-06T02:54:22.9610000Z https://www.medicinesresources.nhs.uk/prognostic-tools-for-identification-of-high-risk-in-people-with-crohn-s-disease-systematic-review-and-cost-effectiveness-study.html 2021-03-30T17:16:33.6010000Z https://www.medicinesresources.nhs.uk/psnc-faqs-on-new-prescription-charges-from-april-2021.html 2021-03-30T16:04:17.8260000Z https://www.medicinesresources.nhs.uk/impact-of-covid-19-national-lockdown-on-asthma-exacerbations-interrupted-time-series-analysis-of-english-primary-care-data.html 2021-03-30T17:19:20.0940000Z https://www.medicinesresources.nhs.uk/impact-of-covid-19-lockdown-on-emergency-asthma-admissions-and-deaths-national-interrupted-time-series-analyses-for-scotland-and-wales.html 2021-03-30T17:20:35.3850000Z https://www.medicinesresources.nhs.uk/anakinra-for-treating-stills-disease-guidance-ta685-1.html 2021-04-06T02:22:57.1010000Z https://www.medicinesresources.nhs.uk/ribociclib-with-fulvestrant-for-treating-hormone-receptor-positive-her2-negative-advanced-breast-cancer-after-endocrine-therapy-guidance-ta687-1.html 2021-04-06T02:27:05.1350000Z https://www.medicinesresources.nhs.uk/caesarean-birth-guidance-ng192.html 2021-04-06T02:27:46.0890000Z https://www.medicinesresources.nhs.uk/revised-spc-pancuronium-bromide-injection.html 2021-03-31T13:45:57.9880000Z https://www.medicinesresources.nhs.uk/vitamin-d-supplementation-to-prevent-acute-respiratory-infections-a-systematic-review-and-meta-analysis-of-aggregate-data-from-randomised-controlled-trials.html 2021-03-31T13:50:25.5340000Z https://www.medicinesresources.nhs.uk/antithyroid-drug-use-during-pregnancy-and-the-risk-of-birth-defects-in-offspring-systematic-review-and-meta-analysis-of-observational-studies-with-methodological-considerations.html 2021-03-31T13:52:24.8530000Z https://www.medicinesresources.nhs.uk/how-to-minimise-the-risks-of-medication-errors-with-rivastigmine-patches-2.html 2021-04-06T02:30:15.9530000Z https://www.medicinesresources.nhs.uk/effect-of-dapagliflozin-in-patients-with-heart-failure-2.html 2021-03-31T14:53:30.4370000Z https://www.medicinesresources.nhs.uk/pirfenidone-in-patients-with-progressive-fibrotic-interstitial-lung-diseases-other-than-idiopathic-pulmonary-fibrosis-relief-a-double-blind-randomised-placebo-controlled-phase-2b-trial.html 2021-03-31T14:53:55.6350000Z https://www.medicinesresources.nhs.uk/long-acting-cabotegravir-plus-rilpivirine-for-treatment-in-adults-with-hiv-1-infection-96-week-results-of-the-randomised-open-label-phase-3-flair-study-3.html 2021-03-31T14:54:45.4560000Z https://www.medicinesresources.nhs.uk/second-line-folfox-chemotherapy-versus-active-symptom-control-for-advanced-biliary-tract-cancer-abc-06-a-phase-3-open-label-randomised-controlled-trial-1.html 2021-03-31T14:54:42.3940000Z https://www.medicinesresources.nhs.uk/impact-of-the-covid-19-pandemic-on-remote-mental-healthcare-and-prescribing-in-psychiatry-an-electronic-health-record-study-1.html 2021-03-31T14:55:05.3150000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-ascending-doses-of-moxidectin-against-strongyloides-stercoralis-infections-in-adults-a-randomised-parallel-group-single-blinded-placebo-controlled-dose-ranging-phase-2a-trial-1.html 2021-03-31T14:29:56.7070000Z https://www.medicinesresources.nhs.uk/prescription-of-glucose-lowering-therapies-and-risk-of-covid-19-mortality-in-people-with-type-2-diabetes-a-nationwide-observational-study-in-england-2.html 2021-03-31T15:21:35.0750000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-volanesorsen-in-patients-with-multifactorial-chylomicronaemia-compass-a-multicentre-double-blind-randomised-placebo-controlled-phase-3-trial.html 2021-03-31T14:57:04.6450000Z https://www.medicinesresources.nhs.uk/efficacy-of-chadox1-ncov-19-azd1222-vaccine-against-sars-cov-2-variant-of-concern-202012-01-b-1-1-7-an-exploratory-analysis-of-a-randomised-controlled-trial-1.html 2021-04-06T02:37:18.4980000Z https://www.medicinesresources.nhs.uk/new-drug-application-submitted-to-the-fda-for-vadadustat-for-the-anaemia-due-to-chronic-kidney-disease-in-adult-patients-on-dialysis-and-not-on-dialysis.html 2021-03-31T15:00:33.4580000Z https://www.medicinesresources.nhs.uk/difelikefalin-to-be-reviewed-for-use-in-the-eu-for-pruritus-associated-with-chronic-kidney-disease-in-haemodialysis-patients.html 2021-03-31T15:02:25.2030000Z https://www.medicinesresources.nhs.uk/risdiplam-approved-for-use-in-eu-for-the-treatment-of-spinal-muscular-atrophy.html 2021-03-31T15:04:05.6040000Z https://www.medicinesresources.nhs.uk/annamycin-given-fast-track-designation-in-the-us-for-the-treatment-of-sarcoma-lung-metastases.html 2021-03-31T15:05:17.3480000Z https://www.medicinesresources.nhs.uk/gout-1.html 2021-03-31T15:07:22.8780000Z https://www.medicinesresources.nhs.uk/thromboembolism-and-the-oxford-astrazeneca-covid-19-vaccine-side-effect-or-coincidence.html 2021-03-31T15:23:44.8010000Z https://www.medicinesresources.nhs.uk/fda-approve-of-vyxeos-daunorubicin-and-cytarabine-for-the-secondary-acute-myeloid-leukemia-in-paediatric-patients.html 2021-03-31T15:22:44.2220000Z https://www.medicinesresources.nhs.uk/adverse-pregnancy-outcomes-and-cardiovascular-disease-risk-unique-opportunities-for-cardiovascular-disease-prevention-in-women-a-scientific-statement-from-the-american-heart-association.html 2021-03-31T15:23:45.3480000Z https://www.medicinesresources.nhs.uk/fda-to-review-market-authorisation-application-for-atogepant-for-the-preventive-treatment-of-migraine.html 2021-03-31T15:25:19.1210000Z https://www.medicinesresources.nhs.uk/cabozantinib-with-nivolumab-approved-in-eu-for-first-line-treatment-for-patients-with-advanced-renal-cell-carcinoma-1.html 2021-03-31T15:27:24.6870000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-date-for-aflibercept-for-diabetic-retinopathy-after-2-years-treatment.html 2021-03-31T15:28:49.1760000Z https://www.medicinesresources.nhs.uk/half-of-uk-has-antibodies-from-vaccination-or-infection.html 2021-03-31T15:30:20.7990000Z https://www.medicinesresources.nhs.uk/uncomplicated-urinary-tract-infection-in-women.html 2021-03-31T15:31:58.4830000Z https://www.medicinesresources.nhs.uk/environmental-approaches-to-promote-healthy-eating-is-ensuring-affordability-and-availability-enough.html 2021-03-31T15:33:23.6840000Z https://www.medicinesresources.nhs.uk/evaluation-of-aducanumab-for-alzheimer-disease-scientific-evidence-and-regulatory-review-involving-efficacy-safety-and-futility.html 2021-03-31T15:35:11.2050000Z https://www.medicinesresources.nhs.uk/cardiovascular-and-temperature-adverse-actions-of-stimulants-3.html 2021-03-31T15:37:57.2240000Z https://www.medicinesresources.nhs.uk/adalimumab-etanercept-infliximab-certolizumab-pegol-golimumab-tocilizumab-and-abatacept-for-moderate-rheumatoid-arthritis-after-conventional-dmards-have-failed-partial-review-of-ta375-appraisal-consultation-document.html 2021-03-31T15:49:19.1500000Z https://www.medicinesresources.nhs.uk/personalised-care-and-support-planning-guidance-guidance-for-local-maternity-systems-1.html 2021-03-31T15:42:43.0310000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-nivolumab-with-relatlimab-for-melanoma-2.html 2021-03-31T15:45:58.0900000Z https://www.medicinesresources.nhs.uk/idecabtagene-vicleucel-approved-in-us-for-multiple-myeloma.html 2021-03-31T15:47:16.4870000Z https://www.medicinesresources.nhs.uk/covid-friendly-cancer-care-at-home-extended-for-more-patients-1.html 2021-04-06T02:38:24.5920000Z https://www.medicinesresources.nhs.uk/pemigatinib-approved-in-the-eu-for-bile-duct-cancer.html 2021-03-31T15:50:58.4520000Z https://www.medicinesresources.nhs.uk/manufacturers-report-efficacy-and-safety-for-pfizer-covid-19-vaccine-in-adolescents.html 2021-03-31T15:52:24.6810000Z https://www.medicinesresources.nhs.uk/the-case-for-prescribing-prep-in-community-mental-health-settings.html 2021-03-31T15:54:11.4160000Z https://www.medicinesresources.nhs.uk/update-to-living-systematic-review-on-drug-treatments-for-covid-21.html 2021-04-05T14:39:40.2610000Z https://www.medicinesresources.nhs.uk/association-between-topical-calcineurin-inhibitor-use-and-risk-of-cancer-including-lymphoma-keratinocyte-carcinoma-and-melanoma-a-systematic-review-and-meta-analysis.html 2021-04-05T14:49:11.5440000Z https://www.medicinesresources.nhs.uk/gonadotrophin-releasing-hormone-analogues-for-children-and-adolescents-with-gender-dysphoria.html 2021-04-05T14:52:50.0960000Z https://www.medicinesresources.nhs.uk/vaccination-of-adult-household-contacts-of-severely-immunosuppressed-individuals-alongside-jcvi-priority-cohort-6-and-completion-of-cohorts-1-9.html 2021-04-05T14:58:53.9800000Z https://www.medicinesresources.nhs.uk/medicines-use-review-service-now-decommissioned-1.html 2021-04-01T15:40:57.6570000Z https://www.medicinesresources.nhs.uk/gsk-agrees-to-support-manufacture-of-60-million-doses-of-novavax-covid-19-vaccine-candidate-nvx-cov2373-for-use-in-uk.html 2021-04-01T15:42:10.4980000Z https://www.medicinesresources.nhs.uk/structured-medication-reviews-and-medicines-optimisation-2021-23.html 2021-04-01T15:43:11.7430000Z https://www.medicinesresources.nhs.uk/free-app-reduces-kids-basic-advice-visits-to-a-and-e.html 2021-04-01T15:44:16.2270000Z https://www.medicinesresources.nhs.uk/glucose-lowering-drugs-to-reduce-cardiovascular-risk-in-type-2-diabetes.html 2021-04-01T17:24:40.7350000Z https://www.medicinesresources.nhs.uk/vaccine-passport-certification-policy-and-ethical-considerations.html 2021-04-01T15:46:37.0770000Z https://www.medicinesresources.nhs.uk/regulatory-approval-of-covid-19-vaccine-moderna-updated-documents.html 2021-04-06T02:07:27.7830000Z https://www.medicinesresources.nhs.uk/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19-updated-documents.html 2021-04-06T02:10:37.9040000Z https://www.medicinesresources.nhs.uk/8th-european-conference-on-infections-in-leukaemia-2020-guidelines-for-the-diagnosis-prevention-and-treatment-of-invasive-fungal-diseases-in-paediatric-patients-with-cancer-or-post-haematopoietic-cell-transplantation.html 2021-04-01T15:51:08.8870000Z https://www.medicinesresources.nhs.uk/8th-european-conference-on-infections-in-leukaemia-2020-guidelines-for-the-use-of-antibiotics-in-paediatric-patients-with-cancer-or-post-haematopoietic-cell-transplantation.html 2021-04-01T15:52:30.9190000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-for-patients-with-haematological-conditions.html 2021-04-01T15:54:10.4200000Z https://www.medicinesresources.nhs.uk/astrazeneca-covid-19-vaccine-review-of-very-rare-cases-of-unusual-blood-clots-continues.html 2021-04-01T16:35:00.7540000Z https://www.medicinesresources.nhs.uk/extension-of-temporary-approval-to-suspend-the-need-for-patients-to-sign-prescription-dental-and-ophthalmic-forms.html 2021-04-01T17:17:29.5250000Z https://www.medicinesresources.nhs.uk/the-prisma-2020-statement-an-updated-guideline-for-reporting-systematic-reviews.html 2021-04-01T17:16:12.2990000Z https://www.medicinesresources.nhs.uk/otitis-externa.html 2021-04-01T16:05:41.6890000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-during-ramadan.html 2021-04-01T17:12:10.3290000Z https://www.medicinesresources.nhs.uk/cti-biopharma-announces-completion-of-rolling-submission-of-new-drug-application-nda-for-pacritinib-in-myelofibrosis-patients-with-severe-thrombocytopenia.html 2021-04-01T16:07:57.2490000Z https://www.medicinesresources.nhs.uk/fda-grants-orphan-drug-designation-to-axatilimab-for-treatment-of-patients-with-chronic-graft-versus-host-disease-1.html 2021-04-01T16:09:39.6830000Z https://www.medicinesresources.nhs.uk/biologics-license-application-submitted-to-fda-for-efbemalenograstim-alfa-ryzneuta-for-chemotherapy-induced-neutropenia.html 2021-04-01T17:08:49.9460000Z https://www.medicinesresources.nhs.uk/european-commission-approves-mabxience-s-bevacizumab-to-be-commercialised-as-alymsys-and-oyavas-for-treatment-of-certain-types-of-cancer-1.html 2021-04-01T16:12:29.6680000Z https://www.medicinesresources.nhs.uk/new-drug-application-submitted-to-fda-for-plinabulin-and-g-csf-combination-for-prevention-of-chemotherapy-induced-neutropenia-cin.html 2021-04-01T16:13:30.2140000Z https://www.medicinesresources.nhs.uk/providing-patient-information-leaflets-following-covid-19-treatment.html 2021-04-01T16:14:48.3220000Z https://www.medicinesresources.nhs.uk/minimising-risks-of-covid-19-across-maternity-services.html 2021-04-01T16:16:45.5990000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-revacept-a-novel-lesion-directed-competitive-antagonist-to-platelet-glycoprotein-vi-in-patients-undergoing-elective-percutaneous-coronary-intervention-for-stable-ischemic-heart-disease-1.html 2021-04-01T16:40:59.8520000Z https://www.medicinesresources.nhs.uk/adjuvant-nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancer.html 2021-04-01T16:41:48.6430000Z https://www.medicinesresources.nhs.uk/sotatercept-for-the-treatment-of-pulmonary-arterial-hypertension.html 2021-04-01T16:42:39.8240000Z https://www.medicinesresources.nhs.uk/lumasiran-an-rnai-therapeutic-for-primary-hyperoxaluria-type-1.html 2021-04-01T16:43:14.1640000Z https://www.medicinesresources.nhs.uk/trial-of-upadacitinib-and-adalimumab-for-psoriatic-arthritis.html 2021-04-01T16:43:47.6220000Z https://www.medicinesresources.nhs.uk/adherence-to-the-test-trace-and-isolate-system-in-the-uk-results-from-37-nationally-representative-surveys.html 2021-04-01T16:44:42.1170000Z https://www.medicinesresources.nhs.uk/post-covid-syndrome-in-individuals-admitted-to-hospital-with-covid-19-retrospective-cohort-study.html 2021-04-01T16:45:29.8600000Z https://www.medicinesresources.nhs.uk/accuracy-of-documented-administration-times-for-intravenous-antimicrobial-drugs-and-impact-on-dosing-decisions.html 2021-04-01T16:45:50.8570000Z https://www.medicinesresources.nhs.uk/clinical-features-prognostic-factors-and-treatment-interventions-for-ulceration-in-patients-with-infantile-hemangioma.html 2021-04-01T16:56:06.0010000Z https://www.medicinesresources.nhs.uk/us-fda-rejects-pimavanserin-nuplazid-for-dementia-related-psychosis.html 2021-04-06T11:56:54.7030000Z https://www.medicinesresources.nhs.uk/us-fda-approves-viloxazine-extended-release-capsules-for-treatment-of-attention-deficit-hyperactivity-disorder-adhd-in-paediatric-patients-6-17-years-of-age.html 2021-04-06T11:57:47.9690000Z https://www.medicinesresources.nhs.uk/company-provides-update-on-phase-iii-study-of-sars-cov-2-intravenous-immune-globulin-covid-hig-for-hospitalised-patients-with-covid-19.html 2021-04-06T11:58:45.9210000Z https://www.medicinesresources.nhs.uk/further-analysis-of-phase-iii-study-of-pfizer-covid-19-vaccine-confirms-high-efficacy-and-good-safety-profile-up-to-6-months-following-second-dose.html 2021-04-06T11:59:57.4140000Z https://www.medicinesresources.nhs.uk/us-fda-approves-isatuximab-in-combination-with-carfilzomib-and-dexamethasone-for-the-treatment-of-multiple-myeloma-mm-3.html 2021-04-06T12:02:20.7900000Z https://www.medicinesresources.nhs.uk/us-fda-approves-inhaled-treprostinil-tyvaso-for-treatment-of-pulmonary-hypertension-associated-with-interstitial-lung-disease.html 2021-04-06T12:04:38.4960000Z https://www.medicinesresources.nhs.uk/us-fda-grants-futibatinib-breakthrough-therapy-designation-for-treatment-of-previously-treated-advanced-cholangiocarcinoma.html 2021-04-06T12:06:02.2430000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-grants-auto1-car-t-cell-therapy-priority-medicines-prime-designation-for-the-treatment-of-adults-with-acute-lymphocytic-leukaemia.html 2021-04-06T12:08:33.8170000Z https://www.medicinesresources.nhs.uk/application-seeking-approval-of-brexucabtagene-autoleucel-tecartus-for-relapsed-or-refractory-acute-lymphoblastic-leukaemia-submitted-to-the-us-fda.html 2021-04-06T12:09:49.4280000Z https://www.medicinesresources.nhs.uk/psoriasis.html 2021-04-06T12:21:43.6880000Z https://www.medicinesresources.nhs.uk/breast-cancer.html 2021-04-06T12:23:17.8330000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-passports-access-equity-and-ethics.html 2021-04-06T12:26:37.4170000Z https://www.medicinesresources.nhs.uk/twice-weekly-rapid-testing-to-be-available-to-everyone-in-england.html 2021-04-06T12:28:09.4840000Z https://www.medicinesresources.nhs.uk/5-million-people-in-the-uk-receive-second-dose-of-covid-19-vaccine.html 2021-04-06T12:29:20.9500000Z https://www.medicinesresources.nhs.uk/work-begins-for-uk-health-security-agency-to-protect-the-nation.html 2021-04-06T12:30:18.9730000Z https://www.medicinesresources.nhs.uk/nice-updates-covid-19-rapid-guideline-on-rheumatological-autoimmune-inflammatory-and-metabolic-bone-disorders.html 2021-04-06T12:31:15.1290000Z https://www.medicinesresources.nhs.uk/intensive-low-density-lipoprotein-cholesterol-lowering-in-cardiovascular-disease-prevention-opportunities-and-challenges-1.html 2021-04-06T13:15:34.1890000Z https://www.medicinesresources.nhs.uk/mhra-reports-latest-yellow-card-reporting-data-on-blood-clots-in-recipients-of-covid-19-vaccines.html 2021-04-06T13:19:55.8090000Z https://www.medicinesresources.nhs.uk/appropriate-use-of-short-course-antibiotics-in-common-infections-best-practice-advice-from-the-american-college-of-physicians-3.html 2021-04-06T13:26:07.6870000Z https://www.medicinesresources.nhs.uk/reactogenicity-following-receipt-of-mrna-based-covid-19-vaccines.html 2021-04-06T13:27:40.4990000Z https://www.medicinesresources.nhs.uk/research-suggests-sars-cov-2-infection-risk-among-unvaccinated-is-negatively-associated-with-community-level-vaccination-rates.html 2021-04-06T13:28:51.4560000Z https://www.medicinesresources.nhs.uk/research-finds-two-doses-of-pfizer-covid-19-vaccine-elicits-strong-antibody-immune-responses-in-older-people.html 2021-04-06T13:31:25.3320000Z https://www.medicinesresources.nhs.uk/managing-covid-symptoms-including-at-the-end-of-life-in-a-prison-setting-implementing-ng163-1.html 2021-04-06T17:32:24.8150000Z https://www.medicinesresources.nhs.uk/optimising-cardiovascular-care-of-patients-with-multiple-myeloma-1.html 2021-04-06T13:36:03.3560000Z https://www.medicinesresources.nhs.uk/revised-spc-ocrevus-ocrelizumab-300mg-concentrate-for-solution-for-infusion-2.html 2021-04-06T13:39:27.5610000Z https://www.medicinesresources.nhs.uk/revised-spcs-cellcept-mycophenolate-mofetil-preparations.html 2021-04-06T15:12:42.1440000Z https://www.medicinesresources.nhs.uk/new-product-vaxelis-suspension-for-injection-in-pre-filled-syringe-2.html 2021-04-06T13:45:16.3360000Z https://www.medicinesresources.nhs.uk/short-term-safety-of-the-bnt162b2-mrna-covid-19-vaccine-in-patients-with-cancer-treated-with-immune-checkpoint-inhibitors.html 2021-04-06T13:48:18.3880000Z https://www.medicinesresources.nhs.uk/nhs-rolls-out-gammacore-for-the-treatment-of-cluster-headaches.html 2021-04-06T17:34:00.4980000Z https://www.medicinesresources.nhs.uk/achievements-and-developments-during-2020-21-flu-season-1.html 2021-04-06T13:57:00.7960000Z https://www.medicinesresources.nhs.uk/andexanet-alfa-for-reversing-anticoagulation-final-appraisal-document.html 2021-04-06T14:06:17.0270000Z https://www.medicinesresources.nhs.uk/new-treatment-for-her2-positive-breast-cancer-rolled-out-across-the-country-1.html 2021-04-06T14:19:44.4930000Z https://www.medicinesresources.nhs.uk/empiric-antibiotics-for-community-acquired-pneumonia-in-adult-patients-a-systematic-review-and-a-network-meta-analysis.html 2021-04-06T14:55:07.0760000Z https://www.medicinesresources.nhs.uk/colchicine-administration-for-percutaneous-coronary-intervention-a-meta-analysis-of-randomized-controlled-trials.html 2021-04-06T14:24:57.1290000Z https://www.medicinesresources.nhs.uk/comparison-of-two-delayed-strategies-for-renal-replacement-therapy-initiation-for-severe-acute-kidney-injury-akiki-2-a-multicentre-open-label-randomised-controlled-trial.html 2021-04-06T14:29:48.1310000Z https://www.medicinesresources.nhs.uk/chemoprevention-with-low-dose-aspirin-mesalazine-or-both-in-patients-with-familial-adenomatous-polyposis-without-previous-colectomy-j-fapp-study-iv-a-multicentre-double-blind-randomised-two-by-two-factorial-design-trial.html 2021-04-06T14:33:01.9990000Z https://www.medicinesresources.nhs.uk/association-between-pre-existing-respiratory-disease-and-its-treatment-and-severe-covid-19-a-population-cohort-study.html 2021-04-06T14:34:16.6900000Z https://www.medicinesresources.nhs.uk/sars-cov-2-population-based-seroprevalence-studies-in-europe-a-scoping-review-2.html 2021-04-06T14:36:39.4830000Z https://www.medicinesresources.nhs.uk/diet-quality-indices-genetic-risk-and-risk-of-cardiovascular-disease-and-mortality-a-longitudinal-analysis-of-77-004-uk-biobank-participants-1.html 2021-04-06T14:38:37.8680000Z https://www.medicinesresources.nhs.uk/exploration-of-gp-perspectives-on-deprescribing-antidepressants-a-qualitative-study-1.html 2021-04-06T14:43:57.4160000Z https://www.medicinesresources.nhs.uk/tislelizumab-plus-chemotherapy-vs-chemotherapy-alone-as-first-line-treatment-for-advanced-squamous-non-small-cell-lung-cancer-a-phase-3-randomized-clinical-trial.html 2021-04-06T14:45:10.3930000Z https://www.medicinesresources.nhs.uk/european-commission-approves-cenobamate-for-the-treatment-of-adults-with-epilepsy.html 2021-04-06T17:36:52.2140000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-march-2021.html 2021-04-12T16:05:42.5770000Z https://www.medicinesresources.nhs.uk/new-product-astra-zeneca-covid-19-vaccine-chadox1-s-recombinant-temporary-authorisation-4.html 2021-04-12T16:05:09.0820000Z https://www.medicinesresources.nhs.uk/comparative-efficacy-and-safety-of-ultra-long-acting-long-acting-intermediate-acting-and-biosimilar-insulins-for-type-1-diabetes-mellitus-a-systematic-review-and-network-meta-analysis.html 2021-04-07T14:17:18.8090000Z https://www.medicinesresources.nhs.uk/effect-of-celecoxib-vs-placebo-added-to-standard-adjuvant-therapy-on-disease-free-survival-among-patients-with-stage-iii-colon-cancer.html 2021-04-07T14:18:33.3180000Z https://www.medicinesresources.nhs.uk/antimicrobial-use-in-a-cohort-of-us-nursing-homes-2017.html 2021-04-07T14:19:43.8110000Z https://www.medicinesresources.nhs.uk/antimicrobial-stewardship-in-the-uk-during-the-covid-19-pandemic-a-population-based-cohort-study-and-interrupted-time-series-analysis.html 2021-04-07T14:20:55.9930000Z https://www.medicinesresources.nhs.uk/administration-of-a-second-dose-of-the-moderna-covid-19-vaccine-after-an-immediate-hypersensitivity-reaction-with-the-first-dose-two-case-report.html 2021-04-07T14:22:05.5500000Z https://www.medicinesresources.nhs.uk/palbociclib-for-residual-high-risk-invasive-hr-positive-and-her2-negative-early-breast-cancer-the-penelope-b-trial.html 2021-04-07T14:23:04.7460000Z https://www.medicinesresources.nhs.uk/off-label-use-in-adult-palliative-care-more-common-than-expected-a-retrospective-chart-review-2.html 2021-04-07T14:26:09.4930000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-dolutegravir-with-emtricitabine-and-tenofovir-alafenamide-fumarate-or-tenofovir-disoproxil-fumarate-and-efavirenz-emtricitabine-and-tenofovir-disoproxil-fumarate-hiv-antiretroviral-therapy-regimens-started-in-pregnancy-impaact-2010-vested-a-multicentre-open-label-randomised-controlled-phase-3-trial-1.html 2021-04-07T14:28:48.3040000Z https://www.medicinesresources.nhs.uk/the-randomized-ambora-trial-impact-of-pharmacological-pharmaceutical-care-on-medication-safety-and-patient-reported-outcomes-during-treatment-with-new-oral-anticancer-agents.html 2021-04-07T14:29:51.2080000Z https://www.medicinesresources.nhs.uk/6-month-neurological-and-psychiatric-outcomes-in-236-379-survivors-of-covid-19-a-retrospective-cohort-study-using-electronic-health-records.html 2021-04-07T14:57:34.7940000Z https://www.medicinesresources.nhs.uk/jama-patient-page-giardiasis-1.html 2021-04-07T14:33:40.8090000Z https://www.medicinesresources.nhs.uk/preliminary-data-suggest-100-vaccine-efficacy-with-pfizer-biontech-covid-19-vaccine-in-children-aged-12-to-15.html 2021-04-08T07:49:05.7290000Z https://www.medicinesresources.nhs.uk/provider-collaboration-review-urgent-and-emergency-care.html 2021-04-07T14:38:29.1220000Z https://www.medicinesresources.nhs.uk/fda-grants-license-extension-of-alirocumab-praluent-as-an-adjunct-for-treatment-of-adults-with-homozygous-familial-hypercholesterolaemia.html 2021-04-07T14:43:42.3380000Z https://www.medicinesresources.nhs.uk/kings-fund-report-shaping-the-future-of-digital-technology-in-health-and-social-care.html 2021-04-07T14:45:14.3490000Z https://www.medicinesresources.nhs.uk/how-to-use-the-assist-lite-screening-tool-to-identify-alcohol-and-drug-use-and-tobacco-smoking.html 2021-04-07T14:47:26.4400000Z https://www.medicinesresources.nhs.uk/chronic-pain-primary-and-secondary-in-over-16s-assessment-of-all-chronic-pain-and-management-of-chronic-primary-pain-guidance-ng193.html 2021-04-12T16:04:46.7740000Z https://www.medicinesresources.nhs.uk/new-dedicated-mental-health-services-for-new-expectant-and-bereaved-mums-1.html 2021-04-07T14:50:47.8770000Z https://www.medicinesresources.nhs.uk/report-on-race-and-ethnic-disparities-1.html 2021-04-07T14:53:36.4550000Z https://www.medicinesresources.nhs.uk/uk-rolls-out-moderna-s-covid-vaccine.html 2021-04-07T14:54:28.3070000Z https://www.medicinesresources.nhs.uk/encouraging-patients-to-support-oxford-az-vaccine-study.html 2021-04-07T14:55:35.1660000Z https://www.medicinesresources.nhs.uk/new-medicines-news-march-2022.html 2021-04-12T16:04:28.8050000Z https://www.medicinesresources.nhs.uk/diagnosis-and-treatment-of-cardiac-amyloidosis-a-position-statement-of-the-esc-working-group-on-myocardial-and-pericardial-diseases.html 2021-04-07T15:01:11.2810000Z https://www.medicinesresources.nhs.uk/antibody-persistence-through-6-months-after-the-second-dose-of-mrna-1273-vaccine-for-covid-25.html 2021-04-07T15:15:38.3340000Z https://www.medicinesresources.nhs.uk/under-30s-offered-alternative-to-astrazeneca-jab.html 2021-04-07T15:22:49.4820000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-managing-covid-19-updated-guidance-ng191-3.html 2021-04-12T16:04:07.5060000Z https://www.medicinesresources.nhs.uk/homelessness-unstable-housing-and-risk-of-hiv-and-hepatitis-c-virus-acquisition-among-people-who-inject-drugs-a-systematic-review-and-meta-analysis.html 2021-04-08T15:08:35.6560000Z https://www.medicinesresources.nhs.uk/novartis-receives-from-european-commission-and-mhra-to-market-ofatumumab-kesimpta-for-treatment-of-adults-with-relapsing-forms-of-multiple-sclerosis-with-active-disease.html 2021-04-08T16:06:27.3630000Z https://www.medicinesresources.nhs.uk/novartis-anticipates-additional-temporary-stock-shortage-of-estradot-estradiol-hemihydrate-75-micrograms-24-hours-transdermal-patch.html 2021-04-08T15:11:41.4500000Z https://www.medicinesresources.nhs.uk/dexcom-g6-sensor-untested-barrier-methods-to-reduce-skin-reactions.html 2021-04-08T15:13:09.4760000Z https://www.medicinesresources.nhs.uk/solriamfetol-for-treating-excessive-daytime-sleepiness-caused-by-obstructive-sleep-apnoea-appraisal-consultation-document.html 2021-04-08T15:14:44.1470000Z https://www.medicinesresources.nhs.uk/nivolumab-with-ipilimumab-and-chemotherapy-for-untreated-metastatic-non-small-cell-lung-cancer-appraisal-consultation-document.html 2021-04-08T16:12:05.6760000Z https://www.medicinesresources.nhs.uk/jcvi-statement-on-use-of-the-astrazeneca-covid-19-vaccine-7-april-2021.html 2021-04-12T16:03:48.0140000Z https://www.medicinesresources.nhs.uk/approaches-for-optimal-use-of-different-covid-19-vaccines-issues-of-viral-variants-and-vaccine-efficacy.html 2021-04-08T16:14:43.5650000Z https://www.medicinesresources.nhs.uk/optimising-cardiovascular-care-of-patients-with-multiple-myeloma.html 2021-04-08T15:23:45.7370000Z https://www.medicinesresources.nhs.uk/management-of-antithrombotic-therapy-in-patients-undergoing-transcatheter-aortic-valve-implantation-a-consensus-document-of-the-esc-working-group-on-thrombosis-and-the-european-association-of-percutaneous-cardiovascular-interventions-eapci-in-collaboration-with-the-esc-council-on-valvular-heart-disease.html 2021-04-08T15:25:34.7350000Z https://www.medicinesresources.nhs.uk/astrazenecas-covid-19-vaccine-ema-finds-possible-link-to-very-rare-cases-of-unusual-blood-clots-with-low-blood-platelets.html 2021-04-12T16:02:55.2100000Z https://www.medicinesresources.nhs.uk/findings-from-the-10th-report-of-react-1.html 2021-04-08T15:30:43.4610000Z https://www.medicinesresources.nhs.uk/perioperative-neurological-evaluation-and-management-to-lower-the-risk-of-acute-stroke-in-patients-undergoing-noncardiac-nonneurological-surgery-a-scientific-statement-from-the-american-heart-association-american-stroke-association.html 2021-04-08T16:23:05.3810000Z https://www.medicinesresources.nhs.uk/review-of-modelling-data-by-sages-scientific-pandemic-influenza-group-on-modelling-operational-subgroup-suggests-later-stages-of-uk-governments-roadmap-out-of-lockdown-highly-likely-to-cause-surge-of-covid-19-infections.html 2021-04-08T15:36:20.4730000Z https://www.medicinesresources.nhs.uk/european-commission-grants-marketing-authorization-for-new-subcutaneous-administration-of-natalizumab-to-treat-relapsing-remitting-multiple-sclerosis-2.html 2021-04-08T15:39:28.6330000Z https://www.medicinesresources.nhs.uk/abbvie-submits-marketing-authorization-application-for-risankizumab-150mg-for-treatment-of-psoriatic-arthritis-to-european-medicines-agency.html 2021-04-08T16:25:08.7740000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-topical-timolol-for-the-treatment-of-infantile-hemangioma-in-the-early-proliferative-stage-a-randomized-clinical-trial-1.html 2021-04-08T15:57:45.4480000Z https://www.medicinesresources.nhs.uk/health-related-quality-of-life-in-patients-with-microsatellite-instability-high-or-mismatch-repair-deficient-metastatic-colorectal-cancer-treated-with-first-line-pembrolizumab-versus-chemotherapy-keynote-177-an-open-label-randomised-phase-3-trial.html 2021-04-08T15:58:40.1670000Z https://www.medicinesresources.nhs.uk/voxelotor-in-adolescents-and-adults-with-sickle-cell-disease-hope-long-term-follow-up-results-of-an-international-randomised-double-blind-placebo-controlled-phase-3-trial.html 2021-04-08T15:59:45.5190000Z https://www.medicinesresources.nhs.uk/symptoms-and-functional-impairment-assessed-8-months-after-mild-covid-19-among-health-care-workers.html 2021-04-08T16:02:45.2810000Z https://www.medicinesresources.nhs.uk/outcomes-following-a-mandatory-nonmedical-switch-from-adalimumab-originator-to-adalimumab-biosimilars-in-patients-with-psoriasis-1.html 2021-04-08T16:04:44.3420000Z https://www.medicinesresources.nhs.uk/comparing-the-effectiveness-and-safety-associated-with-infliximab-vs-infliximab-abda-therapy-for-patients-with-hidradenitis-suppurativa.html 2021-04-08T16:08:10.4890000Z https://www.medicinesresources.nhs.uk/association-between-cvds-and-initiation-and-adherence-to-statin-treatment-in-patients-with-newly-diagnosed-hypercholesterolaemia-a-retrospective-cohort-study.html 2021-04-08T16:09:19.7980000Z https://www.medicinesresources.nhs.uk/pentoxifylline-for-the-prevention-of-contrast-induced-nephropathy-cin-systematic-review-and-meta-analysis-of-randomised-controlled-trials-1.html 2021-04-09T16:22:35.5060000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-over-the-counter-therapies-for-chronic-constipation-an-updated-systematic-review.html 2021-04-09T14:27:06.8540000Z https://www.medicinesresources.nhs.uk/dtb-select-antiepileptic-drugs-in-pregnancy.html 2021-04-12T16:02:06.8730000Z https://www.medicinesresources.nhs.uk/company-announces-results-from-the-phase-3-cov-barrier-study-of-baricitinib-in-hospitalised-covid-19-patients.html 2021-04-09T14:35:31.8530000Z https://www.medicinesresources.nhs.uk/company-announces-nivolumab-plus-chemotherapy-and-nivolumab-with-ipilimumab-demonstrate-superior-survival-benefit-in-patients-with-unresectable-advanced-or-metastatic-esophageal-squamous-cell-carcinoma-escc-in-phase-3-checkmate-648-trial-2.html 2021-04-09T14:38:08.0450000Z https://www.medicinesresources.nhs.uk/pembrolizumab-demonstrated-superior-disease-free-survival-dfs-compared-with-placebo-as-adjuvant-therapy-in-patients-with-renal-cell-carcinoma-in-phase-3-keynote-564-trial.html 2021-04-09T14:39:19.4380000Z https://www.medicinesresources.nhs.uk/educational-risk-minimisation-materials-to-help-reduce-the-risk-associated-with-using-fabrazyme-agalsidase-beta.html 2021-04-09T16:13:27.0090000Z https://www.medicinesresources.nhs.uk/sutimlimab-in-cold-agglutinin-disease.html 2021-04-09T16:36:42.6620000Z https://www.medicinesresources.nhs.uk/fda-grants-full-approval-of-sacituzumab-govitecan-hziy-trodelvy-for-the-treatment-of-previously-treated-unresectable-locally-advanced-or-metastatic-triple-negative-breast-cancer.html 2021-04-09T16:17:02.7440000Z https://www.medicinesresources.nhs.uk/fda-grants-orphan-drug-designation-to-axatilimab-for-treatment-of-idiopathic-pulmonary-fibrosis-ipf.html 2021-04-09T16:17:55.7180000Z https://www.medicinesresources.nhs.uk/fda-grant-orphan-drug-designation-for-eprenetapopt-apr-246-for-the-treatment-of-acute-myeloid-leukaemia-aml-1.html 2021-04-09T16:19:25.1020000Z https://www.medicinesresources.nhs.uk/approval-of-bijuve-bioidentical-estradiol-and-progesterone-capsules-as-hormone-replacement-therapy-in-the-united-kingdom.html 2021-04-09T16:20:35.1530000Z https://www.medicinesresources.nhs.uk/fast-track-designation-from-fda-for-development-of-eftilagimod-alpha-efti-a-soluble-lag-3-protein-in-first-line-recurrent-metastatic-head-and-neck-cancer.html 2021-04-09T16:21:58.8550000Z https://www.medicinesresources.nhs.uk/conference-report-voclosporin-demonstrated-efficacy-across-lupus-nephritis-biopsy-classes.html 2021-04-09T16:22:55.4150000Z https://www.medicinesresources.nhs.uk/lenvatinib-plus-pembrolizumab-or-everolimus-for-advanced-renal-cell-carcinoma-1.html 2021-04-09T16:26:15.0450000Z https://www.medicinesresources.nhs.uk/dementia-and-opmh-guidance-for-primary-care-networks-and-care-homes-1.html 2021-04-12T16:01:39.4530000Z https://www.medicinesresources.nhs.uk/using-bolus-injections-in-neonates-children-and-young-people.html 2021-04-12T16:07:00.8170000Z https://www.medicinesresources.nhs.uk/interim-position-statement-inhaled-budesonide-for-adults-50-years-and-over-with-covid-19.html 2021-04-26T08:42:40.6200000Z https://www.medicinesresources.nhs.uk/supporting-covid-19-vaccine-uptake-during-ramadan-1.html 2021-04-14T12:13:25.9160000Z https://www.medicinesresources.nhs.uk/announcement-regarding-astrazeneca-vaccine-and-next-steps-1.html 2021-04-26T08:47:45.2070000Z https://www.medicinesresources.nhs.uk/revised-spc-sivextro-tedizolid-phosphate-all-presentations.html 2021-04-14T12:20:11.1220000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-blood-clotting-information-for-healthcare-professionals-1.html 2021-04-26T08:51:13.4180000Z https://www.medicinesresources.nhs.uk/national-protocol-for-covid-19-vaccine-moderna.html 2021-04-26T08:52:07.9050000Z https://www.medicinesresources.nhs.uk/dupilumab-dupixent-r-is-accepted-for-restricted-use-within-nhsscotland-1.html 2021-04-14T12:31:10.1580000Z https://www.medicinesresources.nhs.uk/galcanezumab-emgality-r-is-accepted-for-restricted-use-within-nhsscotland.html 2021-04-14T12:32:15.8370000Z https://www.medicinesresources.nhs.uk/dapagliflozin-forxiga-r-is-accepted-for-use-within-nhsscotland.html 2021-04-14T12:33:33.6000000Z https://www.medicinesresources.nhs.uk/isatuximab-sarclisa-r-is-accepted-for-restricted-use-within-nhsscotland.html 2021-04-14T12:35:28.1950000Z https://www.medicinesresources.nhs.uk/acalabrutinib-calquence-r-is-accepted-for-restricted-use-within-nhsscotland-for-relapsed-refractory-chronic-lymphocytic-leukaemia.html 2021-04-14T12:36:59.0040000Z https://www.medicinesresources.nhs.uk/acalabrutinib-calquence-r-is-accepted-for-restricted-use-within-nhsscotland-for-untreated-chronic-lymphocytic-leukaemia.html 2021-04-14T12:38:17.2430000Z https://www.medicinesresources.nhs.uk/health-related-quality-of-life-with-trastuzumab-monotherapy-versus-trastuzumab-plus-standard-chemotherapy-as-adjuvant-therapy-in-older-patients-with-her2-positive-breast-cancer-1.html 2021-04-14T12:40:43.9870000Z https://www.medicinesresources.nhs.uk/copanlisib-plus-rituximab-versus-placebo-plus-rituximab-in-patients-with-relapsed-indolent-non-hodgkin-lymphoma-chronos-3-a-double-blind-randomised-placebo-controlled-phase-3-trial-3.html 2021-04-14T12:43:17.6290000Z https://www.medicinesresources.nhs.uk/treatment-of-chronic-pruritus-with-medical-marijuana-1.html 2021-04-14T12:44:58.3610000Z https://www.medicinesresources.nhs.uk/inhaled-budesonide-in-the-treatment-of-early-covid-19-stoic-a-phase-2-open-label-randomised-controlled-trial.html 2021-04-14T12:47:36.3370000Z https://www.medicinesresources.nhs.uk/thrombotic-thrombocytopenia-after-chadox1-ncov-19-vaccination.html 2021-04-16T09:21:44.2950000Z https://www.medicinesresources.nhs.uk/thrombosis-and-thrombocytopenia-after-chadox1-ncov-19-vaccination.html 2021-04-16T09:32:08.8060000Z https://www.medicinesresources.nhs.uk/how-the-jcvi-sets-who-gets-a-covid-19-vaccine-and-when.html 2021-04-14T12:52:11.6330000Z https://www.medicinesresources.nhs.uk/what-do-we-know-about-chinas-covid-19-vaccines-1.html 2021-04-14T12:53:38.7840000Z https://www.medicinesresources.nhs.uk/british-pain-society-and-faculty-of-pain-medicine-concerns-with-nice-guidelines-on-chronic-primary-pain-1.html 2021-04-14T12:56:10.4540000Z https://www.medicinesresources.nhs.uk/new-campaign-urges-public-to-get-tested-twice-a-week.html 2021-04-14T12:58:16.7990000Z https://www.medicinesresources.nhs.uk/prac-reviews-signal-of-capillary-leak-syndrome-with-vaxzevria-astrazenecas-covid-19-vaccine.html 2021-04-14T12:59:18.1680000Z https://www.medicinesresources.nhs.uk/prac-investigating-thromboembolic-events-after-vaccination-with-covid-19-vaccine-janssen.html 2021-04-14T14:33:14.2020000Z https://www.medicinesresources.nhs.uk/helping-the-public-understand-adverse-events-associated-with-covid-19-vaccinations-lessons-learned-from-functional-neurological-disorder.html 2021-04-14T13:03:20.9150000Z https://www.medicinesresources.nhs.uk/lancet-seminar-parkinsons-disease-1.html 2021-04-14T13:04:52.2590000Z https://www.medicinesresources.nhs.uk/legislating-on-the-future-of-health-and-care-in-england.html 2021-04-14T13:05:46.0290000Z https://www.medicinesresources.nhs.uk/multiple-long-term-conditions-multimorbidity-making-sense-of-the-evidence-1.html 2021-04-14T13:07:00.9960000Z https://www.medicinesresources.nhs.uk/macmillan-cancer-support-report-caught-in-the-maze.html 2021-04-14T13:07:53.9710000Z https://www.medicinesresources.nhs.uk/phase-iii-dare-19-rct-of-dapagliflozin-to-treat-patients-hospitalised-with-covid-19-fails-primary-endpoint-1.html 2021-04-14T13:09:22.7810000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-have-prevented-10-400-deaths-in-older-adults.html 2021-04-14T13:10:57.8730000Z https://www.medicinesresources.nhs.uk/revised-spcs-ozempic-semaglutide-solution-for-injection-in-pre-filled-pen-1.html 2021-04-14T14:29:50.9300000Z https://www.medicinesresources.nhs.uk/genomic-characteristics-and-clinical-effect-of-the-emergent-sars-cov-2-b-1-1-7-lineage-in-london-uk-a-whole-genome-sequencing-and-hospital-based-cohort-study.html 2021-04-15T17:06:08.1500000Z https://www.medicinesresources.nhs.uk/revised-spc-quofenix-delafloxacin-450-mg-tablets-and-300-mg-powder-for-concentrate-for-solution-for-infusion.html 2021-04-15T16:00:13.1850000Z https://www.medicinesresources.nhs.uk/jcvi-final-statement-on-phase-2-of-the-covid-19-vaccination-programme-13-april-2021.html 2021-04-26T09:08:32.7460000Z https://www.medicinesresources.nhs.uk/diagnostic-performance-of-different-sampling-approaches-for-sars-cov-2-rt-pcr-testing-a-systematic-review-and-meta-analysis.html 2021-04-15T16:03:24.4700000Z https://www.medicinesresources.nhs.uk/coroners-report-recommends-tightening-regulation-around-supply-of-codeine-and-morphine-following-death-linked-to-excess-consumption-of-codeine-obtained-from-online-pharmacies.html 2021-04-14T14:41:16.6530000Z https://www.medicinesresources.nhs.uk/effect-of-an-electronic-nicotine-delivery-system-with-0-8-or-36-mg-ml-liquid-nicotine-versus-a-cigarette-substitute-on-tobacco-related-toxicant-exposure-a-four-arm-parallel-group-randomised-controlled-trial.html 2021-04-14T14:42:43.4720000Z https://www.medicinesresources.nhs.uk/antibiotic-research-uk-launches-small-research-grants-programme.html 2021-04-14T14:43:17.2670000Z https://www.medicinesresources.nhs.uk/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma-eortc-1325-mg-keynote-054-distant-metastasis-free-survival-results-from-a-double-blind-randomised-controlled-phase-3-trial.html 2021-04-15T16:14:31.8620000Z https://www.medicinesresources.nhs.uk/propofol-emulsion-for-infusion-and-injection-all-strengths-supply-disruption-update-1.html 2021-04-26T09:12:02.2750000Z https://www.medicinesresources.nhs.uk/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma-eortc-1325-mg-keynote-054-health-related-quality-of-life-results-from-a-double-blind-randomised-controlled-phase-3-trial.html 2021-04-15T16:29:15.3930000Z https://www.medicinesresources.nhs.uk/fatal-hepatotoxicity-due-to-sevoflurane-use-in-a-paediatric-patient-after-aortic-repair-reality-or-fiction-a-case-of-pharmacovigilance-1.html 2021-04-14T14:48:47.3330000Z https://www.medicinesresources.nhs.uk/induction-chemotherapy-with-lobaplatin-and-fluorouracil-versus-cisplatin-and-fluorouracil-followed-by-chemoradiotherapy-in-patients-with-stage-iii-ivb-nasopharyngeal-carcinoma-an-open-label-non-inferiority-randomised-controlled-phase-3-trial.html 2021-04-14T14:51:36.9370000Z https://www.medicinesresources.nhs.uk/self-isolation-compliance-checks-after-international-travel-1.html 2021-04-14T14:51:26.1020000Z https://www.medicinesresources.nhs.uk/the-sanad-ii-study-of-the-effectiveness-and-cost-effectiveness-of-valproate-versus-levetiracetam-for-newly-diagnosed-generalised-and-unclassifiable-epilepsy-an-open-label-non-inferiority-multicentre-phase-4-randomised-controlled-trial.html 2021-04-26T09:56:26.1350000Z https://www.medicinesresources.nhs.uk/screening-and-management-of-atrial-fibrillation-in-primary-care-1.html 2021-04-14T14:53:06.0240000Z https://www.medicinesresources.nhs.uk/the-sanad-ii-study-of-the-effectiveness-and-cost-effectiveness-of-levetiracetam-zonisamide-or-lamotrigine-for-newly-diagnosed-focal-epilepsy-an-open-label-non-inferiority-multicentre-phase-4-randomised-controlled-trial.html 2021-04-26T09:58:10.1700000Z https://www.medicinesresources.nhs.uk/surge-testing-to-be-deployed-in-wandsworth-and-lambeth-1.html 2021-04-15T15:28:00.9880000Z https://www.medicinesresources.nhs.uk/national-institutes-of-health-nih-covid-19-treatment-guidelines-strongly-recommend-that-regen-cov-tm-casirivimab-with-imdevimab-be-used-in-non-hospitalised-covid-19-patients-at-high-risk-of-clinical-progression-in-us.html 2021-04-15T16:47:04.6180000Z https://www.medicinesresources.nhs.uk/fda-has-accepts-for-priority-review-biologics-license-application-for-tisotumab-vedotin-for-treatment-of-patients-with-recurrent-or-metastatic-cervical-cancer-with-disease-progression-on-or-after-chemotherapy.html 2021-04-14T14:57:31.8030000Z https://www.medicinesresources.nhs.uk/fda-grants-fast-track-designation-to-pamrevlumab-for-treatment-of-duchenne-muscular-dystrophy.html 2021-04-14T14:58:59.6330000Z https://www.medicinesresources.nhs.uk/kiniksa-announces-positive-results-for-mavrilimumab-in-phase-2-portion-of-phase-2-3-trial-in-non-mechanically-ventilated-severe-covid-19-patients.html 2021-04-14T15:00:45.4070000Z https://www.medicinesresources.nhs.uk/pitolisant-for-residual-excessive-daytime-sleepiness-in-osa-patients-adhering-to-cpap-a-randomized-trial-2.html 2021-04-15T16:50:26.1860000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-supplemental-new-drug-application-for-xywav-tm-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-in-idiopathic-hypersomnia.html 2021-04-14T15:02:32.8170000Z https://www.medicinesresources.nhs.uk/monitoring-for-valproate-and-phenytoin-toxicity-in-hypoalbuminaemia-a-retrospective-cohort-study.html 2021-04-15T16:51:54.8590000Z https://www.medicinesresources.nhs.uk/topline-results-from-phase-ii-study-shows-oral-neuroactive-steroid-gabaa-receptor-positive-allosteric-modulator-sage-324-significantly-reduces-tremor-score-in-adult-patients-with-essential-tremor-1.html 2021-04-14T15:05:17.4320000Z https://www.medicinesresources.nhs.uk/regeneron-pharmaceuticals-announces-results-from-phase-iii-trial-of-regen-cov-casirivimab-with-imdevimab-antibody-cocktail-in-recently-infected-asymptomatic-covid-19-patients.html 2021-04-15T16:53:31.9410000Z https://www.medicinesresources.nhs.uk/fatal-adverse-drug-reactions-a-worldwide-perspective-in-the-who-pharmacovigilance-database.html 2021-04-14T15:06:44.0250000Z https://www.medicinesresources.nhs.uk/sars-cov-2-infection-rates-of-antibody-positive-compared-with-antibody-negative-health-care-workers-in-england-a-large-multicentre-prospective-cohort-study-siren.html 2021-04-15T16:54:44.5650000Z https://www.medicinesresources.nhs.uk/changes-in-symptomatology-reinfection-and-transmissibility-associated-with-the-sars-cov-2-variant-b-1-1-7-an-ecological-study.html 2021-04-15T16:56:02.0920000Z https://www.medicinesresources.nhs.uk/hepatitis-b-vaccine-for-renal-patients-updated-patient-group-direction-template.html 2021-04-26T10:17:04.9030000Z https://www.medicinesresources.nhs.uk/predicting-endoscopic-activity-recovery-in-england-after-covid-19-a-national-analysis.html 2021-04-14T15:11:09.4700000Z https://www.medicinesresources.nhs.uk/hepatitis-b-vaccine-updated-patient-group-direction-template.html 2021-04-26T10:18:23.7620000Z https://www.medicinesresources.nhs.uk/long-acting-injectable-lai-versus-oral-antipsychotics-for-the-maintenance-treatment-of-schizophrenia-a-systematic-review-and-comparative-meta-analysis-of-randomised-cohort-and-pre-post-studies-1.html 2021-04-15T18:26:43.8330000Z https://www.medicinesresources.nhs.uk/chemotherapy-and-radiotherapy-in-locally-advanced-head-and-neck-cancer-an-individual-patient-data-network-meta-analysis.html 2021-04-15T08:26:38.1080000Z https://www.medicinesresources.nhs.uk/dtb-select-stepping-down-asthma-treatment.html 2021-04-15T08:27:53.2300000Z https://www.medicinesresources.nhs.uk/biomarker-based-risk-prediction-with-the-abc-af-scores-in-patients-with-atrial-fibrillation-not-receiving-oral-anticoagulation-1.html 2021-04-15T08:30:24.5410000Z https://www.medicinesresources.nhs.uk/patient-centred-outcomes-and-effect-of-disease-progression-on-health-status-in-patients-with-newly-diagnosed-advanced-ovarian-cancer-and-a-brca-mutation-receiving-maintenance-olaparib-or-placebo-solo1-a-randomised-phase-3-trial-1.html 2021-04-15T08:32:19.3680000Z https://www.medicinesresources.nhs.uk/neoadjuvant-chemotherapy-with-folfirinox-and-preoperative-chemoradiotherapy-for-patients-with-locally-advanced-rectal-cancer-unicancer-prodige-23-a-multicentre-randomised-open-label-phase-3-trial.html 2021-04-15T18:25:39.4950000Z https://www.medicinesresources.nhs.uk/sars-cov-2-specific-antibodies-in-breast-milk-after-covid-19-vaccination-of-breastfeeding-women.html 2021-04-15T08:36:18.1940000Z https://www.medicinesresources.nhs.uk/phase-3-orient-3-study-results-for-sintilimab-injection-tyvyt-as-a-second-line-treatment-for-squamous-non-small-cell-lung-cancer-shows-benefit-1.html 2021-04-15T08:38:13.6810000Z https://www.medicinesresources.nhs.uk/physical-activity-may-reduce-risk-of-poor-covid-19-outcomes.html 2021-04-15T08:40:12.4460000Z https://www.medicinesresources.nhs.uk/beat-r-diabetes-smartphone-app-launched-and-available-on-android-and-ios-platforms.html 2021-04-15T08:41:16.5470000Z https://www.medicinesresources.nhs.uk/fda-grants-accelerated-approval-to-sacituzumab-govitecan-hziy-trodelvy-for-the-treatment-of-metastatic-urothelial-cancer.html 2021-04-15T08:43:48.8580000Z https://www.medicinesresources.nhs.uk/fda-grant-orphan-drug-and-rare-paediatric-disease-designations-for-ak-otof-for-the-treatment-of-otoferlin-gene-mediated-hearing-loss.html 2021-04-15T08:46:34.9440000Z https://www.medicinesresources.nhs.uk/fda-grants-ttp399-an-oral-once-daily-glucokinase-activator-type-1-diabetes-drug-breakthrough-therapy-designation.html 2021-04-15T08:47:32.2020000Z https://www.medicinesresources.nhs.uk/cdc-in-u-s-and-fda-recommend-pausing-johnson-and-johnson-covid-19-vaccine-rollout-over-blood-clots.html 2021-04-15T08:49:10.5380000Z https://www.medicinesresources.nhs.uk/covid-households-with-immune-supressed-adults-offered-covid-vaccine.html 2021-04-15T08:50:21.5860000Z https://www.medicinesresources.nhs.uk/covid-19-moderna-and-novavax-vaccines-to-be-added-to-trial-investigating-the-effect-of-mixing-vaccines.html 2021-04-15T08:52:43.8320000Z https://www.medicinesresources.nhs.uk/spc-for-covid-19-mrna-vaccine-bnt162b2-pfizer-available-via-emc.html 2021-04-26T07:55:02.3450000Z https://www.medicinesresources.nhs.uk/paediatric-contraindication-for-chloramphenicol-eye-drops.html 2021-04-26T08:02:54.2460000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-sodium-oxybate-for-symptom-control-of-narcolepsy-with-cataplexy-children-and-adolescents-aged-7-until-19-years-2.html 2021-04-26T08:05:44.2670000Z https://www.medicinesresources.nhs.uk/thawing-small-numbers-of-pfizer-biontech-covid-19-vaccine-vials-1.html 2021-04-26T08:08:22.7860000Z https://www.medicinesresources.nhs.uk/training-resources-on-mi-skills-1.html 2021-04-15T14:42:44.5330000Z https://www.medicinesresources.nhs.uk/amylyx-pharmaceuticals-announces-intention-to-submit-marketing-authorisation-application-for-its-investigational-amyotrophic-lateral-sclerosis-als-therapy-amx0035-to-european-medicines-agency.html 2021-04-15T14:44:49.8710000Z https://www.medicinesresources.nhs.uk/cvd-prevention-during-and-after-the-covid-19-pandemic-guidance-for-integrated-care-systems.html 2021-04-15T14:49:22.5900000Z https://www.medicinesresources.nhs.uk/integrated-care-systems-explained-making-sense-of-the-new-nhs-structure-1.html 2021-04-15T14:53:14.2860000Z https://www.medicinesresources.nhs.uk/further-opportunity-for-community-pharmacy-to-contribute-to-the-covid-19-vaccination-programme-extended-in-specific-areas.html 2021-04-26T08:13:15.4110000Z https://www.medicinesresources.nhs.uk/next-phase-of-nhs-covid-19-vaccination-campaign.html 2021-04-26T08:15:58.4580000Z https://www.medicinesresources.nhs.uk/insights-into-glomerular-filtration-and-albuminuria.html 2021-04-15T14:59:08.8440000Z https://www.medicinesresources.nhs.uk/fenfluramine-for-treating-seizures-associated-with-dravet-syndrome-appraisal-consultation-document.html 2021-04-15T15:00:14.3980000Z https://www.medicinesresources.nhs.uk/clinical-picture-pulmonary-embolism-and-thrombocytopenia-following-chadox1-vaccination.html 2021-04-15T15:02:56.6730000Z https://www.medicinesresources.nhs.uk/clinical-picture-bilateral-superior-ophthalmic-vein-thrombosis-ischaemic-stroke-and-immune-thrombocytopenia-after-chadox1-ncov-19-vaccination-1.html 2021-04-15T15:06:20.3530000Z https://www.medicinesresources.nhs.uk/what-is-happening-to-life-expectancy-in-england.html 2021-04-15T15:09:15.6790000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-janssen-european-medicines-agencys-assessment-of-very-rare-cases-of-unusual-blood-clots-with-low-platelets-continues.html 2021-04-15T17:36:05.6760000Z https://www.medicinesresources.nhs.uk/astrazenecas-covid-19-vaccine-european-medicines-agency-to-provide-further-context-on-risk-of-very-rare-blood-clots-with-low-blood-platelets.html 2021-04-15T17:35:23.3290000Z https://www.medicinesresources.nhs.uk/prevention-of-viridans-group-streptococcal-infective-endocarditis-a-scientific-statement-from-the-american-heart-association.html 2021-04-15T15:15:20.0920000Z https://www.medicinesresources.nhs.uk/management-of-patients-presenting-to-the-emergency-department-acute-medicine-with-symptoms-2.html 2021-04-26T08:18:21.2740000Z https://www.medicinesresources.nhs.uk/covid-19-how-astrazeneca-lost-the-vaccine-pr-war.html 2021-04-15T15:19:20.4820000Z https://www.medicinesresources.nhs.uk/bmj-editorial-covid-19-has-redefined-airborne-transmission-1.html 2021-04-15T17:30:21.9420000Z https://www.medicinesresources.nhs.uk/frequently-asked-questions-mhra-and-jcvi-guidance-on-astrazeneca-covid-19-vaccine-and-very-rare-clotting-disorders-2.html 2021-04-26T08:19:12.5760000Z https://www.medicinesresources.nhs.uk/trial-of-psilocybin-versus-escitalopram-for-depression-1.html 2021-04-15T17:16:31.7190000Z https://www.medicinesresources.nhs.uk/suicide-trends-in-the-early-months-of-the-covid-19-pandemic-an-interrupted-time-series-analysis-of-preliminary-data-from-21-countries.html 2021-04-15T15:41:40.0600000Z https://www.medicinesresources.nhs.uk/association-between-systemic-corticosteroid-treatment-for-cutaneous-immune-related-adverse-events-and-survival-outcomes-in-patients-with-advanced-cancer.html 2021-04-15T15:42:56.4320000Z https://www.medicinesresources.nhs.uk/continued-versus-discontinued-oxytocin-stimulation-in-the-active-phase-of-labour-condisox-double-blind-randomised-controlled-trial.html 2021-04-15T15:44:45.6880000Z https://www.medicinesresources.nhs.uk/associations-of-healthy-lifestyle-and-socioeconomic-status-with-mortality-and-incident-cardiovascular-disease-two-prospective-cohort-studies-2.html 2021-04-15T15:47:44.3840000Z https://www.medicinesresources.nhs.uk/single-vaccination-with-bnt162b2-or-chadox1-in-older-people-induces-equivalent-antibody-generation-but-enhanced-cellular-responses-after-chadox1-1.html 2021-04-15T17:11:00.3790000Z https://www.medicinesresources.nhs.uk/consultation-launched-on-staff-covid-19-vaccines-in-care-homes-with-older-adult-residents-1.html 2021-04-15T16:22:49.2640000Z https://www.medicinesresources.nhs.uk/revised-spc-tecentriq-atezolizumab-840-mg-concentrate-for-solution-for-infusion-4.html 2021-04-16T14:38:00.0430000Z https://www.medicinesresources.nhs.uk/revised-spc-venclyxto-venetoclax-10-mg-film-coated-tablets.html 2021-04-16T14:39:22.9590000Z https://www.medicinesresources.nhs.uk/revised-spcs-humira-adalimumab-products-1.html 2021-04-16T14:44:03.7390000Z https://www.medicinesresources.nhs.uk/revised-spc-nurofen-ibuprofen-meltlets-200mg-orodispersible-tablets-1.html 2021-04-16T14:46:01.1880000Z https://www.medicinesresources.nhs.uk/application-for-conditional-marketing-authorisation-of-melflufen-melphalan-flufenamide-for-multiple-myeloma-submitted-to-the-european-medicines-agency.html 2021-04-16T14:47:55.3740000Z https://www.medicinesresources.nhs.uk/us-centers-for-disease-control-and-prevention-cdc-report-around-5-800-people-infected-with-covid-19-following-vaccination-1.html 2021-04-16T14:51:59.9600000Z https://www.medicinesresources.nhs.uk/us-fda-requests-further-information-before-making-decision-on-current-pause-of-the-johnson-and-johnson-covid-19-vaccine-roll-out.html 2021-04-16T18:55:25.8560000Z https://www.medicinesresources.nhs.uk/world-stroke-organization-calls-on-public-and-healthcare-professionals-to-be-aware-of-the-risk-factors-and-symptoms-of-cerebral-venous-sinus-thrombosis-cvst-and-its-appropriate-diagnosis.html 2021-04-16T18:53:45.5080000Z https://www.medicinesresources.nhs.uk/us-fda-grants-pamrevlumab-rare-pediatric-disease-designation-for-the-treatment-of-duchenne-muscular-dystrophy.html 2021-04-16T15:00:54.4380000Z https://www.medicinesresources.nhs.uk/main-results-from-phase-iii-study-of-inhaled-ciclesonide-in-covid-19-presented-by-company-3.html 2021-04-16T15:08:02.0540000Z https://www.medicinesresources.nhs.uk/continued-improvements-in-motor-milestones-reported-in-infants-with-type-1-spinal-muscular-atrophy-after-two-years-of-treatment-with-risdiplam.html 2021-04-16T15:14:18.4650000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-begins-review-of-dual-action-covid-19-monoclonal-antibody-vir-7831.html 2021-04-16T18:51:32.6610000Z https://www.medicinesresources.nhs.uk/mhra-provides-updated-information-on-cases-of-blood-clots-with-concurrent-thrombocytopenia-following-vaccination-with-covid-19-vaccine-astrazeneca.html 2021-04-26T06:18:44.9790000Z https://www.medicinesresources.nhs.uk/information-for-healthcare-professionals-and-the-public-on-covid-19-vaccine-astrazeneca-updated.html 2021-04-26T06:24:53.1150000Z https://www.medicinesresources.nhs.uk/nhs-england-to-set-up-independent-review-group-to-assess-prescription-of-puberty-blockers-for-children-under-16.html 2021-04-16T18:47:27.3550000Z https://www.medicinesresources.nhs.uk/us-observational-study-finds-risk-of-developing-cerebral-venous-thrombosis-cvst-is-higher-in-people-with-covid-19-than-in-vaccine-recipients.html 2021-04-16T18:45:42.8150000Z https://www.medicinesresources.nhs.uk/merck-plans-large-phase-iii-outpatient-trial-of-molnupiravir-in-covid-19.html 2021-04-16T15:31:05.9000000Z https://www.medicinesresources.nhs.uk/unequal-impact-coronavirus-disability-and-access-to-services-government-response-to-the-committees-fourth-report-1.html 2021-04-16T18:45:04.9930000Z https://www.medicinesresources.nhs.uk/new-subcutaneous-formulation-of-natalizumab-tysabri-approved-in-uk-for-the-treatment-of-multiple-sclerosis.html 2021-04-16T15:34:37.3710000Z https://www.medicinesresources.nhs.uk/nice-issues-final-appraisal-document-on-ravulizumab-for-treating-paroxysmal-nocturnal-haemoglobinuria-pnh.html 2021-04-16T15:36:13.8450000Z https://www.medicinesresources.nhs.uk/gsk-halts-phase-ii-trials-evaluating-feladilimab-in-the-treatment-of-head-and-neck-squamous-cell-carcinoma-hnscc.html 2021-04-16T15:37:35.0040000Z https://www.medicinesresources.nhs.uk/c-19-lateral-flow-device-distribution-service.html 2021-04-16T15:38:48.9240000Z https://www.medicinesresources.nhs.uk/covid-19-chapter-of-the-green-book-updated.html 2021-04-26T06:27:59.4210000Z https://www.medicinesresources.nhs.uk/fractured-and-forgotten-the-social-care-provider-market-in-england.html 2021-04-16T15:41:37.1860000Z https://www.medicinesresources.nhs.uk/specialist-pharmacy-service-monthly-digest-april-2021.html 2021-04-26T06:28:45.2930000Z https://www.medicinesresources.nhs.uk/guided-versus-standard-antiplatelet-therapy-in-patients-undergoing-percutaneous-coronary-intervention-a-systematic-review-and-meta-analysis-2.html 2021-04-16T16:05:02.0500000Z https://www.medicinesresources.nhs.uk/inconsistent-relationship-between-depth-of-sedation-and-intensive-care-outcome-systematic-review-and-meta-analysis.html 2021-04-16T16:08:20.6120000Z https://www.medicinesresources.nhs.uk/effect-of-infusion-set-replacement-intervals-on-catheter-related-bloodstream-infections-rsvp-a-randomised-controlled-equivalence-central-venous-access-device-non-inferiority-peripheral-arterial-catheter-trial-1.html 2021-04-26T06:34:00.5380000Z https://www.medicinesresources.nhs.uk/diabetes-and-overweight-obesity-are-independent-nonadditive-risk-factors-for-in-hospital-severity-of-covid-19-an-international-multicenter-retrospective-meta-analysis.html 2021-04-16T18:32:50.2710000Z https://www.medicinesresources.nhs.uk/adrenaline-to-improve-survival-in-out-of-hospital-cardiac-arrest-the-paramedic2-rct.html 2021-04-16T16:17:49.6300000Z https://www.medicinesresources.nhs.uk/prevalence-and-determinants-of-hypertension-control-among-almost-100-000-treated-adults-in-the-uk.html 2021-04-16T18:36:31.3680000Z https://www.medicinesresources.nhs.uk/teprotumumab-for-patients-with-active-thyroid-eye-disease-a-pooled-data-analysis-subgroup-analyses-and-off-treatment-follow-up-results-from-two-randomised-double-masked-placebo-controlled-multicentre-trials.html 2021-04-16T16:21:26.5780000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-ravidasvir-plus-sofosbuvir-in-patients-with-chronic-hepatitis-c-infection-without-cirrhosis-or-with-compensated-cirrhosis-storm-c-1-interim-analysis-of-a-two-stage-open-label-multicentre-single-arm-phase-2-3-trial.html 2021-04-16T16:22:52.3450000Z https://www.medicinesresources.nhs.uk/sars-cov-2-seropositivity-and-subsequent-infection-risk-in-healthy-young-adults-a-prospective-cohort-study-2.html 2021-04-16T16:26:12.3880000Z https://www.medicinesresources.nhs.uk/jcvi-announcement-regarding-covid-19-vaccination-during-pregnancy-and-next-steps-1.html 2021-04-24T14:43:38.7910000Z https://www.medicinesresources.nhs.uk/cerebral-venous-thrombosis-a-retrospective-cohort-study-of-513-284-confirmed-covid-19-cases-and-a-comparison-with-489-871-people-receiving-a-covid-19-mrna-vaccine.html 2021-04-19T12:01:26.1470000Z https://www.medicinesresources.nhs.uk/fda-revokes-emergency-use-authorization-eua-for-bamlanivimab-for-treatment-of-mild-to-moderate-covid-19.html 2021-04-19T12:03:05.5540000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-nextstellis-3-mg-drospirenone-14-2-mg-estetrol-tablets-for-contraception.html 2021-04-19T12:04:22.4320000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-nivolumab-in-combination-with-chemotherapy-for-advanced-or-metastatic-gastric-cancer-gastroesophageal-junction-cancer-and-esophageal-adenocarcinoma-irrepsective-of-pd-l1-expression-status-1.html 2021-04-19T12:07:43.5120000Z https://www.medicinesresources.nhs.uk/vivaldi-2-coronavirus-covid-19-care-homes-study-report-1.html 2021-04-19T12:10:28.2860000Z https://www.medicinesresources.nhs.uk/unintentional-overdose-of-paracetamol-in-adults-with-low-bodyweight.html 2021-04-24T14:47:12.5340000Z https://www.medicinesresources.nhs.uk/revised-spc-chadox1-s-astra-zeneca-covid-19-vaccine.html 2021-04-24T14:40:48.7660000Z https://www.medicinesresources.nhs.uk/revised-spc-eliquis-apixaban-tablets-all-strengths-1.html 2021-04-19T14:22:14.2290000Z https://www.medicinesresources.nhs.uk/spike-antibody-levels-of-nursing-home-residents-with-or-without-prior-covid-19-3-weeks-after-a-single-bnt162b2-vaccine-dose.html 2021-04-19T14:24:33.5820000Z https://www.medicinesresources.nhs.uk/global-estimates-of-expected-and-preventable-cervical-cancers-among-girls-born-between-2005-and-2014-a-birth-cohort-analysis.html 2021-04-19T14:34:05.7850000Z https://www.medicinesresources.nhs.uk/mepolizumab-for-chronic-rhinosinusitis-with-nasal-polyps-synapse-a-randomised-double-blind-placebo-controlled-phase-3-trial.html 2021-04-19T14:29:09.9600000Z https://www.medicinesresources.nhs.uk/pathologic-antibodies-to-platelet-factor-4-after-chadox1-ncov-19-vaccination.html 2021-04-26T06:04:12.7660000Z https://www.medicinesresources.nhs.uk/thrombotic-thrombocytopenia-after-ad26-cov2-s-vaccination-response-from-the-manufacturer.html 2021-04-19T14:34:57.1670000Z https://www.medicinesresources.nhs.uk/new-prescription-data-for-secondary-care-available-to-support-covid-19-research.html 2021-04-19T15:04:42.0000000Z https://www.medicinesresources.nhs.uk/european-approval-of-isatuximab-sarclisa-for-treatment-of-adults-with-relapsed-multiple-myeloma.html 2021-04-19T14:38:28.9830000Z https://www.medicinesresources.nhs.uk/rps-and-nice-launch-educational-webinar-series.html 2021-04-19T14:39:37.2540000Z https://www.medicinesresources.nhs.uk/https-www-nice-org-uk-about-who-we-are-corporate-publications-the-nice-strategy-2021-to-2026.html 2021-04-26T06:35:10.1630000Z https://www.medicinesresources.nhs.uk/the-methodological-quality-of-individual-participant-data-meta-analysis-on-intervention-effects-systematic-review-1.html 2021-04-20T15:13:48.7750000Z https://www.medicinesresources.nhs.uk/the-effect-of-tocilizumab-on-covid-19-patient-mortality-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials.html 2021-04-24T14:28:23.1070000Z https://www.medicinesresources.nhs.uk/russian-direct-investment-fund-rdif-announces-sputnik-v-vaccine-is-97-6-effective.html 2021-04-20T15:18:16.4240000Z https://www.medicinesresources.nhs.uk/fda-grants-bemarituzumab-breakthrough-therapy-designation-btd-for-first-line-treatment-of-patients-with-fgfr2b-overexpressing-and-her2-negative-metastatic-and-locally-advanced-gastric-and-gastroesophageal-cancer-1.html 2021-04-20T15:26:08.6210000Z https://www.medicinesresources.nhs.uk/nihr-alert-mental-health-care-during-pregnancy-and-afterwards-women-from-some-ethnic-minority-backgrounds-face-barriers-to-access.html 2021-04-20T15:27:33.4450000Z https://www.medicinesresources.nhs.uk/letter-eu-exit-response-update-1.html 2021-04-20T15:28:59.2160000Z https://www.medicinesresources.nhs.uk/nhs-facebook-campaign-helps-40-plus-men-prevent-type-2-diabetes.html 2021-04-20T15:29:55.8840000Z https://www.medicinesresources.nhs.uk/trastuzumab-deruxtecan-for-treating-her2-positive-unresectable-or-metastatic-breast-cancer-after-2-or-more-anti-her2-therapies-final-appraisal-document-1.html 2021-04-20T15:33:03.4480000Z https://www.medicinesresources.nhs.uk/interleukin-6-obstacles-to-targeting-a-complex-cytokine-in-critical-illness-2.html 2021-04-20T15:37:44.0220000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-for-people-with-severe-mental-illness-why-what-and-how.html 2021-04-20T15:39:18.5600000Z https://www.medicinesresources.nhs.uk/covid-19-herd-immunity-by-immunisation-are-children-in-the-herd.html 2021-04-20T15:40:45.0680000Z https://www.medicinesresources.nhs.uk/discontinuation-of-disease-modifying-therapy-in-multiple-sclerosis-should-we-stay-or-should-we-go.html 2021-04-20T15:41:57.4140000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-starts-review-of-vir-7831-for-treating-patients-with-covid-19.html 2021-04-20T15:43:15.7930000Z https://www.medicinesresources.nhs.uk/pulmonary-hypertension-2.html 2021-04-20T15:46:09.7630000Z https://www.medicinesresources.nhs.uk/british-scientists-launche-trial-to-expose-participants-who-have-already-had-covid-19-to-coronavirus-again.html 2021-04-20T16:43:04.1920000Z https://www.medicinesresources.nhs.uk/world-health-organization-s-emergency-committee-statement-proof-of-covid-19-vaccination-not-required-as-a-condition-of-international-travel.html 2021-04-20T16:43:53.2730000Z https://www.medicinesresources.nhs.uk/spain-to-trial-mixing-covid-19-vaccines.html 2021-04-20T15:53:20.0630000Z https://www.medicinesresources.nhs.uk/new-long-term-data-for-uplizna-inebilizumab-cdon-from-open-label-extension-of-n-momentum-trial-in-patients-with-neuromyelitis-optica-spectrum-disorder-nmosd-1.html 2021-04-20T15:55:35.1040000Z https://www.medicinesresources.nhs.uk/positive-topline-results-announced-from-two-phase-iii-studies-ultimate-i-and-ii-of-ublituximab-for-treatment-of-relapsing-forms-of-multiple-sclerosis.html 2021-04-20T17:30:20.3110000Z https://www.medicinesresources.nhs.uk/biologics-license-application-bla-for-balstilimab-submitted-to-fda-for-patients-with-recurrent-or-metastatic-cervical-cancer.html 2021-04-20T16:00:25.2040000Z https://www.medicinesresources.nhs.uk/discontinuation-of-infliximab-in-patients-with-ulcerative-colitis-in-remission-hayabusa-a-multicentre-open-label-randomised-controlled-trial.html 2021-04-20T16:04:26.3000000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-sars-cov-2-recombinant-protein-vaccine-formulations-in-healthy-adults-interim-results-of-a-randomised-placebo-controlled-phase-1-2-dose-ranging-study.html 2021-04-20T17:32:41.5960000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-an-mf59-adjuvanted-spike-glycoprotein-clamp-vaccine-for-sars-cov-2-a-randomised-double-blind-placebo-controlled-phase-1-trial-1.html 2021-04-20T17:36:09.4630000Z https://www.medicinesresources.nhs.uk/is-comprehensive-geriatric-assessment-admission-avoidance-hospital-at-home-an-alternative-to-hospital-admission-for-older-persons-a-randomized-trial-2.html 2021-04-20T17:11:07.0910000Z https://www.medicinesresources.nhs.uk/targeted-encouragement-of-gp-consultations-for-possible-cancer-symptoms-a-randomised-controlled-trial.html 2021-04-20T17:08:23.7170000Z https://www.medicinesresources.nhs.uk/alcohol-abstinence-and-the-risk-of-atrial-fibrillation-in-patients-with-newly-diagnosed-type-2-diabetes-mellitus-a-nationwide-population-based-study.html 2021-04-20T17:08:53.1670000Z https://www.medicinesresources.nhs.uk/low-neutralizing-antibody-responses-against-sars-cov-2-in-elderly-myeloma-patients-after-the-first-bnt162b2-vaccine-dose.html 2021-04-20T17:07:32.9250000Z https://www.medicinesresources.nhs.uk/efficacy-of-the-bnt162b2-mrna-covid-19-vaccine-in-patients-with-chronic-lymphocytic-leukemia.html 2021-04-20T17:07:12.1760000Z https://www.medicinesresources.nhs.uk/medications-and-risk-of-motor-vehicle-collision-responsibility-in-british-columbia-canada-a-population-based-case-control-study.html 2021-04-20T17:06:51.4390000Z https://www.medicinesresources.nhs.uk/response-to-first-vaccination-against-sars-cov-2-in-patients-with-multiple-myeloma.html 2021-04-20T17:05:53.9550000Z https://www.medicinesresources.nhs.uk/adverse-events-associated-with-the-addition-of-aspirin-to-direct-oral-anticoagulant-therapy-without-a-clear-indication-1.html 2021-04-20T17:04:45.8450000Z https://www.medicinesresources.nhs.uk/long-term-antidepressant-use-in-general-practice-a-qualitative-study-of-gps-views-on-discontinuation.html 2021-04-20T17:43:39.3640000Z https://www.medicinesresources.nhs.uk/neonatal-infection-antibiotics-for-prevention-and-treatment-guidance-ng195.html 2021-04-24T10:39:42.3480000Z https://www.medicinesresources.nhs.uk/post-natal-care-guidance-ng194-4.html 2021-04-24T10:42:57.9140000Z https://www.medicinesresources.nhs.uk/avelumab-for-untreated-metastatic-merkel-cell-carcinoma-guidance-ta691.html 2021-04-24T10:49:14.6050000Z https://www.medicinesresources.nhs.uk/acalabrutinib-for-treating-chronic-lymphocytic-leukaemia-guidance-ta689.html 2021-04-24T10:47:06.8270000Z https://www.medicinesresources.nhs.uk/new-product-kesimpta-ofatumumab-injection-in-pre-filled-pen.html 2021-04-21T15:35:33.3890000Z https://www.medicinesresources.nhs.uk/revised-spc-indivina-estradiol-valerate-and-medroxyprogesterone-acetate-tablets-2.html 2021-04-21T15:38:50.4920000Z https://www.medicinesresources.nhs.uk/total-parenteral-tpn-and-enteral-nutrition-bags-manufactured-by-diffuplast-sterilisation-issue.html 2021-04-24T10:53:01.5330000Z https://www.medicinesresources.nhs.uk/pharmacist-led-interventions-to-reduce-adverse-drug-events-in-older-people-living-in-residential-aged-care-facilities-a-systematic-review.html 2021-04-24T14:11:56.3430000Z https://www.medicinesresources.nhs.uk/microinr-for-anticoagulation-therapy-mib257.html 2021-04-24T14:16:38.0690000Z https://www.medicinesresources.nhs.uk/effect-of-poloxamer-188-vs-placebo-on-painful-vaso-occlusive-episodes-in-children-and-adults-with-sickle-cell-disease-a-randomized-clinical-trial.html 2021-04-21T15:58:22.3990000Z https://www.medicinesresources.nhs.uk/important-drop-rate-of-acute-diabetes-complications-in-people-with-type-1-or-type-2-diabetes-after-initiation-of-flash-glucose-monitoring-in-france-the-relief-study.html 2021-04-21T15:55:32.6770000Z https://www.medicinesresources.nhs.uk/a-randomized-open-label-comparison-of-once-weekly-insulin-icodec-titration-strategies-versus-once-daily-insulin-glargine-u100.html 2021-04-21T15:59:47.9900000Z https://www.medicinesresources.nhs.uk/switching-to-once-weekly-insulin-icodec-versus-once-daily-insulin-glargine-u100-in-type-2-diabetes-inadequately-controlled-on-daily-basal-insulin-a-phase-2-randomized-controlled-trial.html 2021-04-21T16:00:28.0570000Z https://www.medicinesresources.nhs.uk/rock2-inhibition-with-belumosudil-kd025-for-the-treatment-of-chronic-graft-versus-host-disease.html 2021-04-21T16:01:21.1350000Z https://www.medicinesresources.nhs.uk/quantifying-the-rates-of-late-reactivation-tuberculosis-a-systematic-review.html 2021-04-21T16:03:20.1050000Z https://www.medicinesresources.nhs.uk/trehalose-recommended-for-orphan-status-in-eu-for-amyotrophic-lateral-sclerosis.html 2021-04-21T16:04:19.7840000Z https://www.medicinesresources.nhs.uk/manufacturers-report-phase-3-study-results-for-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-in-adult-patients-with-idiopathic-hypersomnia-1.html 2021-04-21T16:06:03.8460000Z https://www.medicinesresources.nhs.uk/cannabidiol-epidyolex-approved-in-the-eu-for-the-treatment-of-seizures-associated-with-tuberous-sclerosis-complex.html 2021-04-21T16:07:36.0210000Z https://www.medicinesresources.nhs.uk/positive-data-for-baricitinib-for-alopecia-areata-patients-in-two-phase-3-studies-2.html 2021-04-21T16:09:33.7210000Z https://www.medicinesresources.nhs.uk/a-call-to-action-for-new-global-approaches-to-cardiovascular-disease-drug-solutions-1.html 2021-04-21T16:11:24.6330000Z https://www.medicinesresources.nhs.uk/developing-place-based-partnerships-the-foundation-of-effective-integrated-care-systems.html 2021-04-21T16:13:17.1610000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-janssen-ema-finds-possible-link-to-very-rare-cases-of-unusual-blood-clots-with-low-blood-platelets.html 2021-04-21T16:14:40.9940000Z https://www.medicinesresources.nhs.uk/management-of-acute-coronary-syndromes-in-patients-without-persistent-st-segment-elevation-1.html 2021-04-21T16:16:18.4960000Z https://www.medicinesresources.nhs.uk/evidence-based-approaches-for-the-management-of-side-effects-of-adjuvant-endocrine-therapy-in-patients-with-breast-cancer.html 2021-04-21T16:17:49.6410000Z https://www.medicinesresources.nhs.uk/british-generic-manufacturers-association-supply-issues-dashboard.html 2021-04-24T14:20:58.2410000Z https://www.medicinesresources.nhs.uk/draft-updated-guidance-type-1-diabetes-in-adults-diagnosis-and-management.html 2021-04-21T16:21:44.2650000Z https://www.medicinesresources.nhs.uk/critical-risk-assessment-report-use-of-uk-plasma-for-the-manufacture-of-immunoglobulins-and-vcjd-risk.html 2021-04-21T16:23:03.0890000Z https://www.medicinesresources.nhs.uk/ofatumumab-for-treating-relapsing-multiple-sclerosis-final-appraisal-document-2.html 2021-04-21T16:26:09.5470000Z https://www.medicinesresources.nhs.uk/revised-spc-innozide-enalapril-maleate-and-hydrochlorothiazide-tablets.html 2021-04-21T16:28:27.4340000Z https://www.medicinesresources.nhs.uk/what-do-we-know-about-indias-covaxin-vaccine.html 2021-04-21T16:30:17.7910000Z https://www.medicinesresources.nhs.uk/revised-spc-vipdomet-12-5-mg-1000-mg-alogliptin-metformin-film-coated-tablets-1.html 2021-04-22T15:11:44.7840000Z https://www.medicinesresources.nhs.uk/revised-spc-ikorel-nicorandil-10-and-20-mg-tablets-2.html 2021-04-22T15:15:36.4000000Z https://www.medicinesresources.nhs.uk/safety-alert-boron-additives-in-chloramphenicol-drops-should-ophthalmologists-be-concerned.html 2021-04-24T10:28:55.9180000Z https://www.medicinesresources.nhs.uk/sacituzumab-govitecan-in-metastatic-triple-negative-breast-cancer.html 2021-04-22T17:11:40.1220000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-suvratoxumab-for-prevention-of-staphylococcus-aureus-ventilator-associated-pneumonia-saatellite-a-multicentre-randomised-double-blind-placebo-controlled-parallel-group-phase-2-pilot-trial.html 2021-04-22T17:07:47.7300000Z https://www.medicinesresources.nhs.uk/dasiglucagon-a-next-generation-glucagon-analog-for-rapid-and-effective-treatment-of-severe-hypoglycemia-results-of-phase-3-randomized-double-blind-clinical-trial.html 2021-04-22T17:06:26.4540000Z https://www.medicinesresources.nhs.uk/feasibility-of-simplification-from-a-basal-bolus-insulin-regimen-to-a-fixed-ratio-formulation-of-basal-insulin-plus-a-glp-1ra-or-to-basal-insulin-plus-an-sglt2-inhibitor-beyond-a-randomized-pragmatic-trial.html 2021-04-22T17:03:20.1950000Z https://www.medicinesresources.nhs.uk/sevuparin-for-the-treatment-of-acute-pain-crisis-in-patients-with-sickle-cell-disease-a-multicentre-randomised-double-blind-placebo-controlled-phase-2-trial.html 2021-04-22T17:02:17.3840000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-single-dose-ad26-cov2-s-vaccine-against-covid-19.html 2021-04-22T17:00:11.3150000Z https://www.medicinesresources.nhs.uk/preliminary-findings-of-mrna-covid-19-vaccine-safety-in-pregnant-persons.html 2021-04-22T16:59:17.8030000Z https://www.medicinesresources.nhs.uk/outcomes-in-patients-treated-with-chimeric-antigen-receptor-t-cell-therapy-who-were-admitted-to-intensive-care-carttas-an-international-multicentre-observational-cohort-study.html 2021-04-22T16:58:22.4470000Z https://www.medicinesresources.nhs.uk/compassionate-use-of-remdesivir-in-children-with-severe-covid-19.html 2021-04-22T16:57:31.8630000Z https://www.medicinesresources.nhs.uk/cigarette-smoking-as-a-predictor-of-sodium-glucose-cotransporter-2-inhibitor-associated-genital-infections-a-retrospective-cohort-study.html 2021-04-22T16:55:06.7890000Z https://www.medicinesresources.nhs.uk/clinical-characterization-of-mogamulizumab-associated-rash-during-treatment-of-mycosis-fungoides-or-sezary-syndrome.html 2021-04-22T16:54:17.8250000Z https://www.medicinesresources.nhs.uk/association-between-antihypertensive-medications-and-risk-of-skin-cancer-in-people-older-than-65-years-a-population-based-study-1.html 2021-04-22T16:53:37.0740000Z https://www.medicinesresources.nhs.uk/severe-fever-with-thrombocytopaenia-syndrome-sfts-epidemiology-outbreaks-and-guidance.html 2021-04-22T16:51:43.3490000Z https://www.medicinesresources.nhs.uk/oral-nutritional-supplements-acbs-policy-consultation-1.html 2021-04-22T15:47:18.4600000Z https://www.medicinesresources.nhs.uk/johnson-and-johnson-j-and-j-resumes-roll-out-of-covid-19-vaccine-in-eu.html 2021-04-22T15:48:59.9740000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-animations-to-tackle-disinformation.html 2021-04-22T15:50:37.6710000Z https://www.medicinesresources.nhs.uk/government-launches-covid-19-antivirals-taskforce-to-roll-out-innovative-home-treatments-this-autumn-1.html 2021-04-22T15:52:40.8900000Z https://www.medicinesresources.nhs.uk/adrenal-incidentaloma.html 2021-04-22T15:56:27.0970000Z https://www.medicinesresources.nhs.uk/vaccine-breakthrough-infections-with-sars-cov-2-variants.html 2021-04-22T16:47:50.1310000Z https://www.medicinesresources.nhs.uk/challenges-in-the-diagnosis-of-parkinson-s-disease.html 2021-04-22T15:58:59.8690000Z https://www.medicinesresources.nhs.uk/non-alcoholic-fatty-liver-disease-3.html 2021-04-22T16:01:39.3210000Z https://www.medicinesresources.nhs.uk/subcutaneous-fat-necrosis-during-nivolumab-therapy-for-metastatic-melanoma-2.html 2021-04-22T16:46:18.7330000Z https://www.medicinesresources.nhs.uk/quality-improvement-made-simple-what-everyone-should-know-about-health-care-quality-improvement.html 2021-04-22T16:05:30.9510000Z https://www.medicinesresources.nhs.uk/administration-of-benralizumab-in-a-patient-with-severe-asthma-admitted-to-the-intensive-care-unit-with-covid-19-pneumonia-case-report.html 2021-04-22T16:44:24.9450000Z https://www.medicinesresources.nhs.uk/obesity-and-cardiovascular-disease-a-scientific-statement-from-the-american-heart-association-1.html 2021-04-22T16:09:33.3140000Z https://www.medicinesresources.nhs.uk/chronic-pain-primary-and-secondary-in-over-16s-summary-of-nice-guidance.html 2021-04-22T16:10:27.1630000Z https://www.medicinesresources.nhs.uk/covid-19-supporting-the-vulnerable-during-lockdown-3.html 2021-04-22T16:12:17.3820000Z https://www.medicinesresources.nhs.uk/covid-19-what-do-we-know-about-airborne-transmission-of-sars-cov-2.html 2021-04-22T16:14:35.7980000Z https://www.medicinesresources.nhs.uk/all-wales-advice-on-sglt-2-inhibitors-in-type-2-diabetes-and-cardiovascular-disease-consultation.html 2021-04-22T16:15:32.1610000Z https://www.medicinesresources.nhs.uk/roche-looking-for-new-location-to-test-covid-19-pill-after-cases-plummet-in-uk.html 2021-04-22T16:16:39.7690000Z https://www.medicinesresources.nhs.uk/who-and-ema-to-inspect-sputnik-v-manufacturing-in-may.html 2021-04-22T16:17:35.4310000Z https://www.medicinesresources.nhs.uk/european-commission-grants-marketing-authorisation-for-trimbow-r-inhalation-powder-beclometasone-dipropionate-formoterol-fumarate-dihydrate-and-glycopyrronium-delivered-through-nexthaler.html 2021-04-22T16:18:33.4330000Z https://www.medicinesresources.nhs.uk/clearing-up-a-misconception-covid-19-vaccines-don-t-cause-shingles.html 2021-04-22T16:21:05.6190000Z https://www.medicinesresources.nhs.uk/wrong-site-surgery-wrong-tooth-extraction.html 2021-04-22T16:22:28.2200000Z https://www.medicinesresources.nhs.uk/revised-spc-taltz-ixekizumab-80-mg-solution-for-injection-in-pre-filled-syringe-1.html 2021-04-23T13:49:50.2960000Z https://www.medicinesresources.nhs.uk/revised-spcs-natrilix-indapamide-tablets.html 2021-04-23T13:55:30.2010000Z https://www.medicinesresources.nhs.uk/revised-spc-targaxan-rifaximin-550mg-film-coated-tablets.html 2021-04-23T13:57:08.5940000Z https://www.medicinesresources.nhs.uk/april-bnf-bnf-for-children-newsletter.html 2021-04-24T10:06:50.4610000Z https://www.medicinesresources.nhs.uk/approaches-for-discontinuation-versus-continuation-of-long-term-antidepressant-use-for-depressive-and-anxiety-disorders-in-adults.html 2021-04-23T14:15:41.1670000Z https://www.medicinesresources.nhs.uk/us-fda-grants-accelerated-approval-to-dostarlimab-gxly-for-the-treatment-of-recurrent-or-advanced-endometrial-cancer.html 2021-04-23T14:17:54.9800000Z https://www.medicinesresources.nhs.uk/positive-results-of-phase-iii-study-of-adapalene-benzoyl-peroxide-clindamycin-gel-idp-126-in-acne-vulgaris-announced.html 2021-04-23T14:26:21.7150000Z https://www.medicinesresources.nhs.uk/toripalimab-plus-chemotherapy-as-first-line-treatment-for-advanced-oesophageal-cancer-reaches-primary-endpoints-in-phase-iii-study-1.html 2021-04-23T15:47:17.1280000Z https://www.medicinesresources.nhs.uk/coronavirus-vaccine-summary-of-yellow-card-reporting-up-to-14-april.html 2021-04-24T10:09:55.5560000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-ennogen-pharma-limited-trimethoprim-200mg-tablets-pl-40147-0083-el-21-a-11.html 2021-04-23T14:43:20.6480000Z https://www.medicinesresources.nhs.uk/remote-research-and-clinical-trial-integrity-during-and-after-the-coronavirus-pandemic.html 2021-04-23T14:45:29.1840000Z https://www.medicinesresources.nhs.uk/radiotherapy-to-enhance-chimeric-antigen-receptor-t-cell-therapeutic-efficacy-in-solid-tumours.html 2021-04-23T15:17:20.6030000Z https://www.medicinesresources.nhs.uk/special-series-life-altering-consequences-of-neurocognitive-impairment-in-survivors-of-paediatric-cancer.html 2021-04-23T14:49:42.6010000Z https://www.medicinesresources.nhs.uk/positive-data-from-early-trial-of-candidate-malaria-vaccine-announced.html 2021-04-23T14:50:40.8350000Z https://www.medicinesresources.nhs.uk/mhra-authorises-icosapent-ethyl-vazkepa-to-reduce-risk-of-cardiovascular-events-in-high-risk-patients-1.html 2021-04-23T14:58:34.4830000Z https://www.medicinesresources.nhs.uk/rmoc-buprenorphine-long-acting-injection-guidance-1.html 2021-04-24T10:20:13.9430000Z https://www.medicinesresources.nhs.uk/novo-nordisk-plans-phase-iii-study-of-oral-semaglutide-in-obesity-2.html 2021-04-23T15:03:37.9330000Z https://www.medicinesresources.nhs.uk/financial-incentives-and-prescribing-behaviour-in-primary-care.html 2021-04-23T15:15:23.1470000Z https://www.medicinesresources.nhs.uk/postural-hypotension-1.html 2021-04-23T15:13:01.0220000Z https://www.medicinesresources.nhs.uk/modelling-the-impact-of-the-tier-system-on-sars-cov-2-transmission-in-the-uk-between-the-first-and-second-national-lockdowns.html 2021-04-23T15:25:14.4680000Z https://www.medicinesresources.nhs.uk/medication-burden-and-clustering-in-people-living-with-hiv-undergoing-therapeutic-drug-monitoring.html 2021-04-23T15:33:43.0140000Z https://www.medicinesresources.nhs.uk/the-impact-of-sars-cov-2-vaccines-on-antibody-responses-in-the-general-population-in-the-united-kingdom.html 2021-04-23T15:35:46.6520000Z https://www.medicinesresources.nhs.uk/impact-of-vaccination-on-sars-cov-2-cases-in-the-community-a-population-based-study-using-the-uks-covid-19-infection-survey.html 2021-04-23T15:38:05.7430000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-first-line-single-agent-carboplatin-vs-carboplatin-plus-paclitaxel-for-vulnerable-older-adult-women-with-ovarian-cancer.html 2021-04-23T15:44:53.4610000Z https://www.medicinesresources.nhs.uk/il17a-f-nanobody-sonelokimab-in-patients-with-plaque-psoriasis-a-multicentre-randomised-placebo-controlled-phase-2b-study.html 2021-04-23T15:41:28.3780000Z https://www.medicinesresources.nhs.uk/determinants-of-enhanced-vulnerability-to-covid-19-in-uk-cancer-patients-a-european-study.html 2021-04-23T15:42:51.0070000Z https://www.medicinesresources.nhs.uk/risk-of-drug-induced-interstitial-lung-disease-in-hospitalised-patients-a-nested-case-control-study.html 2021-04-23T15:43:48.1320000Z https://www.medicinesresources.nhs.uk/revised-spc-jinarc-tolvaptan-tablets-3.html 2021-04-26T13:35:21.3660000Z https://www.medicinesresources.nhs.uk/new-product-octasa-mesalazine-1g-suppositories.html 2021-04-26T14:20:38.4630000Z https://www.medicinesresources.nhs.uk/sulfonylurea-antidiabetics-are-associated-with-lower-risk-of-out-of-hospital-cardiac-arrest-real-world-data-from-a-population-based-study.html 2021-04-26T14:54:08.3940000Z https://www.medicinesresources.nhs.uk/prior-use-of-therapeutic-anticoagulation-does-not-protect-against-covid-19-related-clinical-outcomes-in-hospitalized-patients-a-propensity-score-matched-cohort-study.html 2021-04-26T13:50:47.8560000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-coverage-in-health-care-workers-in-england-and-effectiveness-of-bnt162b2-mrna-vaccine-against-infection-siren-a-prospective-multicentre-cohort-study.html 2021-04-27T13:29:34.5860000Z https://www.medicinesresources.nhs.uk/interim-findings-from-first-dose-mass-covid-19-vaccination-roll-out-and-covid-19-hospital-admissions-in-scotland-a-national-prospective-cohort-study.html 2021-04-27T13:27:59.7770000Z https://www.medicinesresources.nhs.uk/ten-year-outcome-of-neoadjuvant-chemoradiotherapy-plus-surgery-for-esophageal-cancer-the-randomized-controlled-cross-trial.html 2021-04-26T13:56:27.2080000Z https://www.medicinesresources.nhs.uk/astrazenecas-covid-19-vaccine-benefits-and-risks-in-context.html 2021-04-27T13:29:54.1940000Z https://www.medicinesresources.nhs.uk/chmp-recommends-approval-of-satralizumab-for-neuromyelitis-optica-spectrum-disorder-2.html 2021-04-26T14:01:32.5870000Z https://www.medicinesresources.nhs.uk/fda-and-cdc-lift-recommended-pause-on-johnson-and-johnson-janssen-covid-19-vaccine-use-following-thorough-safety-review-2.html 2021-04-26T14:05:38.1670000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-evinacumab-evkeeza-for-treatment-of-adults-and-adolescents-with-homozygous-familial-hypercholesterolaemia-2.html 2021-04-26T14:08:21.2180000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-selumetinib-koselugo-for-treatment-of-paediatric-neurofibromatosis-type-1-plexiform-neurofibromas-2.html 2021-04-26T14:18:46.2350000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-azacytidine-onureg-for-maintenance-treatment-of-acute-myeloid-leukaemia.html 2021-04-26T14:31:51.5560000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-generic-abiraterone-acetate-abiraterone-krka-for-treatment-of-metastatic-prostate-cancer.html 2021-04-26T14:30:08.6310000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-azathioprine-10-mg-ml-oral-suspension-jayempi-for-prophylaxis-against-transplant-rejection-and-as-immunosuppressive-antimetabolite.html 2021-04-26T14:33:50.5330000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-of-teriflunomide-aubagio-for-treatment-of-relapsing-remitting-multiple-sclerosis.html 2021-04-26T14:35:52.5730000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-of-budesonide-formoterol-biresp-spiromax-and-duoresp-spiromax-for-treatment-of-asthma.html 2021-04-26T14:37:25.0380000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-of-glecaprevir-pibrentasvir-maviret-for-treatment-of-chronic-hepatitis-c-infection.html 2021-04-26T14:40:57.3070000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-tralokinumab-for-the-treatment-of-adults-with-moderate-to-severe-atopic-dermatitis.html 2021-04-26T14:51:20.7120000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-venetoclax-venclyxto-for-newly-diagnosed-acute-myeloid-leukaemia.html 2021-04-26T14:47:08.2790000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-nivolumab-opdivo-plus-ipilimumab-yervoy-for-treatment-of-unresectable-malignant-pleural-mesothelioma.html 2021-04-26T14:48:19.7280000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-osimertinib-tagrisso-for-treatment-of-non-small-cell-lung-cancer.html 2021-04-26T15:34:48.8480000Z https://www.medicinesresources.nhs.uk/european-approval-of-dostarlimab-jemperli-for-recurrent-or-advanced-endometrial-cancer-2.html 2021-04-26T15:04:35.6670000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-belatacept-nulojix-in-renal-transplantation-1.html 2021-04-26T14:58:59.3320000Z https://www.medicinesresources.nhs.uk/the-pandemic-stay-at-home-order-and-opioid-involved-overdose-fatalities-1.html 2021-04-26T15:02:28.0710000Z https://www.medicinesresources.nhs.uk/atezolizumab-bevacizumab-and-chemotherapy-for-newly-diagnosed-stage-iii-or-iv-ovarian-cancer-placebo-controlled-randomized-phase-iii-trial-imagyn050-gog-3015-engot-ov39.html 2021-04-26T15:04:20.0400000Z https://www.medicinesresources.nhs.uk/deaths-from-covid-19-coronavirus-how-are-they-counted-and-what-do-they-show.html 2021-04-26T15:05:20.4460000Z https://www.medicinesresources.nhs.uk/lancet-seminar-histiocytosis-3.html 2021-04-26T15:38:16.2260000Z https://www.medicinesresources.nhs.uk/phase-3-voyage-2-study-demonstrates-sustained-response-over-5-years-with-guselkumab-for-moderate-to-severe-plaque-psoriasis-pso.html 2021-04-26T15:12:35.5120000Z https://www.medicinesresources.nhs.uk/clinical-investigation-and-management-of-covid-19-vaccine-induced-thrombosis-and-thrombocytopenia.html 2021-04-27T13:26:45.3020000Z https://www.medicinesresources.nhs.uk/timing-of-mycobacterium-tuberculosis-exposure-explains-variation-in-bcg-effectiveness-a-systematic-review-and-meta-analysis-2.html 2021-04-26T15:33:04.5040000Z https://www.medicinesresources.nhs.uk/bimekizumab-versus-adalimumab-in-plaque-psoriasis.html 2021-04-26T15:23:20.2310000Z https://www.medicinesresources.nhs.uk/bimekizumab-versus-secukinumab-in-plaque-psoriasis.html 2021-04-26T15:25:04.0960000Z https://www.medicinesresources.nhs.uk/nhs-to-invite-people-aged-44-for-covid-19-vaccination-2.html 2021-04-26T15:27:07.1830000Z https://www.medicinesresources.nhs.uk/cardiovascular-disease-prevention-packs.html 2021-04-26T15:28:11.9970000Z https://www.medicinesresources.nhs.uk/extension-of-expiry-date-of-a-patient-group-direction-pgd.html 2021-04-26T15:29:57.8940000Z https://www.medicinesresources.nhs.uk/patient-group-directions-for-repeat-supply-administration-of-medicines-1.html 2021-04-26T15:46:23.6300000Z https://www.medicinesresources.nhs.uk/revised-spc-tygacil-tigecycline-50mg-powder-for-solution-for-infusion-3.html 2021-04-27T15:00:07.2610000Z https://www.medicinesresources.nhs.uk/revised-spc-celebrex-celecoxib-capsules.html 2021-04-27T15:01:54.3480000Z https://www.medicinesresources.nhs.uk/revised-spc-elvanse-lisdexamphetamine-hard-capsules.html 2021-04-27T15:06:03.1440000Z https://www.medicinesresources.nhs.uk/prophylaxis-against-covid-19-living-systematic-review-and-network-meta-analysis-1.html 2021-04-28T10:50:29.8540000Z https://www.medicinesresources.nhs.uk/ursodeoxycholic-acid-in-intrahepatic-cholestasis-of-pregnancy-a-systematic-review-and-individual-participant-data-meta-analysis-2.html 2021-04-27T15:13:03.2120000Z https://www.medicinesresources.nhs.uk/what-is-car-t-cell-therapy.html 2021-04-27T15:15:39.0380000Z https://www.medicinesresources.nhs.uk/is-there-a-circannual-variation-in-the-anticoagulation-control-of-warfarin.html 2021-04-27T15:18:01.9110000Z https://www.medicinesresources.nhs.uk/appropriate-use-of-high-flow-nasal-oxygen-in-hospitalised-patients-for-initial-or-postextubation-management-of-acute-respiratory-failure-a-clinical-guideline-from-the-american-college-of-physicians.html 2021-04-27T16:46:14.0960000Z https://www.medicinesresources.nhs.uk/phase-iii-trial-primary-endpoint-met-for-respiratory-syncytial-virus-rsv-vaccine-nirsevimab.html 2021-04-27T15:21:44.0830000Z https://www.medicinesresources.nhs.uk/miscarriage-worldwide-reform-of-care-is-needed-1.html 2021-04-27T16:26:33.7030000Z https://www.medicinesresources.nhs.uk/fda-accepts-priority-review-for-new-drug-application-nda-for-axs-05-dextromethorphan-bupropion-to-treat-major-depressive-disorder.html 2021-04-27T16:26:53.6780000Z https://www.medicinesresources.nhs.uk/atrial-fibrillation-diagnosis-and-management-updated-guidance-ng196.html 2021-04-28T10:49:20.6480000Z https://www.medicinesresources.nhs.uk/europeans-medicines-agency-ema-grants-prime-designation-to-ctx001-for-transfusion-dependent-beta-thalassemia.html 2021-04-27T16:29:08.4420000Z https://www.medicinesresources.nhs.uk/pooled-results-from-three-clinical-trials-of-myeloprotection-therapy-trilaciclib-cosela-in-extensive-stage-small-cell-lung-cancer-es-sclc.html 2021-04-27T16:30:45.4880000Z https://www.medicinesresources.nhs.uk/additional-wellbeing-support-services-for-pharmacy-teams-in-england-following-additional-measures-made-by-nhs-england-and-nhs-improvement-nhse-and-i-3.html 2021-04-27T16:52:15.5920000Z https://www.medicinesresources.nhs.uk/investigating-hypothyroidism.html 2021-04-27T16:32:24.6920000Z https://www.medicinesresources.nhs.uk/uk-cancer-centre-to-offer-breast-cancer-treatment-phesgo-trastuzumab-and-pertuzumab-at-home-1.html 2021-04-27T16:33:27.2450000Z https://www.medicinesresources.nhs.uk/overview-of-sars-cov-2-infection-in-adults-living-with-hiv.html 2021-04-27T16:34:09.5520000Z https://www.medicinesresources.nhs.uk/safety-immunogenicity-and-transplacental-antibody-transport-of-conjugated-and-polysaccharide-pneumococcal-vaccines-administered-to-pregnant-women-with-hiv-a-multicentre-randomised-controlled-trial.html 2021-04-27T16:36:43.7310000Z https://www.medicinesresources.nhs.uk/ranitidine-shortage-continues.html 2021-04-27T16:37:49.8000000Z https://www.medicinesresources.nhs.uk/deucravacitinib-demonstrates-superior-skin-clearance-in-two-phase-iii-psoriasis-studies-compared-to-apremilast.html 2021-04-27T16:39:37.0070000Z https://www.medicinesresources.nhs.uk/pembrolizumab-for-treating-locally-advanced-or-metastatic-urothelial-carcinoma-after-platinum-containing-chemotherapy-guidance-ta692.html 2021-04-29T09:49:36.7620000Z https://www.medicinesresources.nhs.uk/olaparib-plus-bevacizumab-for-maintenance-treatment-of-advanced-ovarian-fallopian-tube-or-primary-peritoneal-cancer-guidance-ta693.html 2021-04-29T09:50:26.0530000Z https://www.medicinesresources.nhs.uk/bempedoic-acid-with-ezetimibe-for-treating-primary-hypercholesterolaemia-or-mixed-dyslipidaemia-guidance-ta694.html 2021-04-29T09:50:42.4830000Z https://www.medicinesresources.nhs.uk/carfilzomib-with-dexamethasone-and-lenalidomide-for-previously-treated-multiple-myeloma-guidance-ta695.html 2021-04-30T09:12:59.2940000Z https://www.medicinesresources.nhs.uk/revised-spc-sporanox-itraconazole-oral-suspension.html 2021-04-28T14:24:36.5780000Z https://www.medicinesresources.nhs.uk/revised-spc-adenocor-adenosine-injection.html 2021-04-28T14:25:40.3180000Z https://www.medicinesresources.nhs.uk/revised-spc-iressa-gefitinib-tablets.html 2021-04-28T14:26:53.8080000Z https://www.medicinesresources.nhs.uk/revised-spc-coversyl-arginine-plus-indapamide-and-perindopril-film-coated-tablets.html 2021-04-28T15:17:35.0060000Z https://www.medicinesresources.nhs.uk/lojuxta-lomitapide-reminder-to-monitor-the-liver-function-of-patients-treated-with-lomitapide-and-to-avoid-use-in-pregnancy.html 2021-04-28T14:33:00.5120000Z https://www.medicinesresources.nhs.uk/tecentriq-atezolizumab-risk-of-severe-cutaneous-adverse-reactions-scars-1.html 2021-04-28T15:18:55.1090000Z https://www.medicinesresources.nhs.uk/xeljanz-tofacitinib-initial-clinical-trial-results-of-increased-risk-of-major-adverse-cardiovascular-events-and-malignancies-excluding-nmsc-with-use-of-tofacitinib-relative-to-tnf-alpha-inhibitors-2.html 2021-04-28T15:19:38.3370000Z https://www.medicinesresources.nhs.uk/zolgensma-onasemnogene-abeparvovec-risk-for-thrombotic-microangiopathy.html 2021-04-28T15:20:31.3700000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-updates-for-april-2021.html 2021-04-29T09:55:06.4910000Z https://www.medicinesresources.nhs.uk/polyethylene-glycol-peg-laxatives-and-starch-based-thickeners-potential-interactive-effect-when-mixed-leading-to-an-increased-risk-of-aspiration.html 2021-04-29T09:55:47.2530000Z https://www.medicinesresources.nhs.uk/therapeutic-drug-monitoring-of-anti-tumour-necrosis-factor-a-agents-in-inflammatory-bowel-disease-limits-and-improvements-3.html 2021-04-28T14:54:23.3230000Z https://www.medicinesresources.nhs.uk/genotype-guided-antiplatelet-treatment-versus-conventional-therapy-a-systematic-review-and-meta-analysis-2.html 2021-04-28T14:57:33.9490000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-one-versus-two-doses-of-the-covid-19-vaccine-bnt162b2-for-patients-with-cancer-interim-analysis-of-a-prospective-observational-study.html 2021-04-28T15:25:09.6820000Z https://www.medicinesresources.nhs.uk/vaccine-side-effects-and-sars-cov-2-infection-after-vaccination-in-users-of-the-covid-symptom-study-app-in-the-uk-a-prospective-observational-study.html 2021-04-29T09:58:32.6000000Z https://www.medicinesresources.nhs.uk/national-marrow-donor-program-sponsored-multicenter-phase-ii-trial-of-hla-mismatched-unrelated-donor-bone-marrow-transplantation-using-post-transplant-cyclophosphamide.html 2021-04-28T15:06:48.7370000Z https://www.medicinesresources.nhs.uk/antihypertensive-medications-and-covid-19-diagnosis-and-mortality-population-based-case-control-analysis-in-the-united-kingdom.html 2021-04-28T15:08:51.5420000Z https://www.medicinesresources.nhs.uk/association-of-facial-paralysis-with-mrna-covid-19-vaccines-a-disproportionality-analysis-using-the-world-health-organization-pharmacovigilance-database.html 2021-04-28T15:11:09.0330000Z https://www.medicinesresources.nhs.uk/effects-of-bifidobacterium-animalis-ssp-lactis-420-on-gastrointestinal-inflammation-induced-by-a-non-steroidal-anti-inflammatory-drug-a-randomized-placebo-controlled-double-blind-clinical-trial.html 2021-04-28T15:13:25.9530000Z https://www.medicinesresources.nhs.uk/there-are-ways-drug-companies-will-get-into-dtc-decisions-how-australian-drug-and-therapeutics-committees-address-pharmaceutical-industry-influence.html 2021-04-30T09:11:58.9580000Z https://www.medicinesresources.nhs.uk/impact-of-vaccination-on-household-transmission-of-sars-cov-2-in-england.html 2021-04-28T15:28:03.7010000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-marketing-authorisation-application-for-omburtamab-to-the-european-medicines-agency-for.html 2021-04-28T15:19:37.2390000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-apabetalone-for-reduction-in-cardiovascular-events-in-chronic-kidney-disease.html 2021-04-28T15:21:12.0830000Z https://www.medicinesresources.nhs.uk/covid-19-associated-coagulopathy-and-antithrombotic-agents-lessons-after-1-year.html 2021-04-28T15:22:48.2900000Z https://www.medicinesresources.nhs.uk/interleukin-6-receptor-blockade-in-patients-with-covid-19-placing-clinical-trials-into-context.html 2021-04-28T15:24:04.8860000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-for-mobocertinib-for-egfr-exon20-insertion-metastatic-non-small-cell-lung-cancer.html 2021-04-28T15:27:08.8280000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-reproxalap-for-ocular-itching-in-allergic-conjunctivitis-1.html 2021-04-28T15:29:56.1480000Z https://www.medicinesresources.nhs.uk/manufacturers-decide-to-cease-further-development-of-mirikizumab-in-psoriasis.html 2021-04-28T15:32:06.6660000Z https://www.medicinesresources.nhs.uk/challenges-of-drug-development-during-the-covid-19-pandemic-key-considerations-for-clinical-trial-designs-3.html 2021-04-28T15:43:13.3350000Z https://www.medicinesresources.nhs.uk/lung-and-liver-sarcoidosis-like-reaction-induced-by-tocilizumab.html 2021-04-28T15:37:17.3560000Z https://www.medicinesresources.nhs.uk/cellular-immunology-of-relapsing-multiple-sclerosis-interactions-checks-and-balances.html 2021-04-28T15:38:31.8450000Z https://www.medicinesresources.nhs.uk/rps-makes-new-recommendations-for-pharmacist-independent-prescribers-1.html 2021-04-28T15:40:39.2330000Z https://www.medicinesresources.nhs.uk/antipsychotic-discontinuation-mind-the-patient-and-the-real-world-evidence-1.html 2021-04-28T15:44:00.7140000Z https://www.medicinesresources.nhs.uk/buprenorphine-naloxone-suboxone-r-recommended-for-restricted-use-in-nhs-wales-2.html 2021-04-29T18:01:32.8090000Z https://www.medicinesresources.nhs.uk/new-product-inrebic-fedratinib-100-mg-hard-capsules.html 2021-04-29T18:00:17.3790000Z https://www.medicinesresources.nhs.uk/revised-spc-zolgensma-onasemnogene-abeparvovec-2-x-10exp13-vector-genomes-ml-solution-for-infusion.html 2021-04-29T17:59:44.0330000Z https://www.medicinesresources.nhs.uk/revised-spc-frisium-clobazam-10mg-tablets-2.html 2021-04-29T17:59:15.2460000Z https://www.medicinesresources.nhs.uk/using-chloramphenicol-eye-drops-in-children-under-2-years-1.html 2021-04-30T11:31:42.9760000Z https://www.medicinesresources.nhs.uk/outpatient-appointments-intended-but-not-booked-after-inpatient-stays.html 2021-04-29T17:57:56.4320000Z https://www.medicinesresources.nhs.uk/assessment-of-catheter-ablation-or-antiarrhythmic-drugs-for-first-line-therapy-of-atrial-fibrillation-a-meta-analysis-of-randomized-clinical-trials-1.html 2021-04-29T17:56:27.8100000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-vadadustat-for-anemia-in-patients-undergoing-dialysis.html 2021-04-29T17:51:38.5020000Z https://www.medicinesresources.nhs.uk/vadadustat-in-patients-with-anemia-and-non-dialysis-dependent-ckd.html 2021-04-29T18:22:02.6700000Z https://www.medicinesresources.nhs.uk/tranexamic-acid-for-the-prevention-of-blood-loss-after-cesarean-delivery.html 2021-04-29T17:47:49.9600000Z https://www.medicinesresources.nhs.uk/associations-between-body-mass-index-and-covid-19-severity-in-6-9-million-people-in-england-a-prospective-community-based-cohort-study.html 2021-04-29T17:47:12.4190000Z https://www.medicinesresources.nhs.uk/delayed-antibiotic-prescribing-for-respiratory-tract-infections-individual-patient-data-meta-analysis.html 2021-04-29T17:53:56.1600000Z https://www.medicinesresources.nhs.uk/nonsteroidal-antiinflammatory-drugs-and-susceptibility-to-covid-19.html 2021-04-29T17:46:26.1430000Z https://www.medicinesresources.nhs.uk/advanced-therapies-nhs-readiness-toolkit.html 2021-04-29T17:45:27.5580000Z https://www.medicinesresources.nhs.uk/first-mandated-health-campaign-of-2021-22-covid-19-vac.html 2021-04-29T17:44:46.4230000Z https://www.medicinesresources.nhs.uk/postpartum-hemorrhage.html 2021-04-29T15:39:39.1120000Z https://www.medicinesresources.nhs.uk/nice-signs-up-to-join-the-getreal-institute-4.html 2021-04-29T17:43:30.4400000Z https://www.medicinesresources.nhs.uk/public-assessment-report-of-the-reclassification-of-almerg-fexofenadine-180mg-film-coated-tablets.html 2021-04-29T17:42:48.7510000Z https://www.medicinesresources.nhs.uk/management-of-salivary-gland-malignancy-asco-guideline.html 2021-04-29T17:40:58.5190000Z https://www.medicinesresources.nhs.uk/ema-and-ecdc-join-forces-for-enhanced-post-marketing-monitoring-of-covid-19-vaccines-in-europe.html 2021-04-29T17:40:23.7780000Z https://www.medicinesresources.nhs.uk/coronavirus-england-briefing-29-april-2021.html 2021-04-29T17:39:49.2880000Z https://www.medicinesresources.nhs.uk/we-need-clinical-guidelines-fit-for-a-pandemic.html 2021-04-29T17:38:23.5310000Z https://www.medicinesresources.nhs.uk/mass-screening-for-asymptomatic-sars-cov-2-infection-1.html 2021-04-29T17:33:36.1920000Z https://www.medicinesresources.nhs.uk/head-to-head-should-masks-be-worn-outdoors.html 2021-04-29T17:32:35.2000000Z https://www.medicinesresources.nhs.uk/uk-secures-extra-60-million-pfizer-biontech-covid-19-vaccines.html 2021-04-29T17:28:28.3480000Z https://www.medicinesresources.nhs.uk/biontech-expects-vaccine-trial-results-for-babies-by-september.html 2021-04-29T17:27:51.2160000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-for-nefecon-for-patients-with-iga-nephropathy-the-u-s-food-and-drug-administration-fda-has-accepted-the-submission-1.html 2021-04-29T17:26:47.3040000Z https://www.medicinesresources.nhs.uk/announced-positive-results-from-a-planned-interim-analysis-of-the-phase-3-alpine-trial-comparing-brukinsa-r-zanubrutinib-against-ibrutinib-in-adults-with-2.html 2021-04-29T17:25:43.4020000Z https://www.medicinesresources.nhs.uk/fda-committee-gave-the-nod-to-continue-using-genentechs-checkpoint-inhibitor-tecentriq.html 2021-04-29T18:09:03.5040000Z https://www.medicinesresources.nhs.uk/reproductive-health-patient-group-direction-pgd-templates-amendment-to-chc-ring-pgd-template.html 2021-04-29T17:21:37.1430000Z https://www.medicinesresources.nhs.uk/bopa-launches-the-lets-communicate-cancer-series.html 2021-04-29T17:20:12.1660000Z https://www.medicinesresources.nhs.uk/phase-iii-morningsky-study-of-direct-acting-antiviral-at-527-in-outpatient-treatment-of-covid-19-begins-1.html 2021-04-30T14:25:49.9600000Z https://www.medicinesresources.nhs.uk/transforming-the-uk-into-a-life-sciences-superpower-3.html 2021-04-30T14:28:42.1780000Z https://www.medicinesresources.nhs.uk/mhra-reports-latest-yellow-card-reporting-data-for-coronavirus-vaccines.html 2021-05-04T08:09:33.9180000Z https://www.medicinesresources.nhs.uk/a-wake-up-call-for-preconception-health-a-clinical-review.html 2021-04-30T14:36:14.0100000Z https://www.medicinesresources.nhs.uk/exemplary-medical-care-or-trojan-horse-an-analysis-of-the-lifestyle-medicine-movement.html 2021-04-30T14:38:20.4900000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-starts-evaluating-use-of-baricitinib-olumiant-in-hospitalised-covid-19-patients-requiring-supplemental-oxygen-2.html 2021-04-30T14:41:24.9500000Z https://www.medicinesresources.nhs.uk/nice-consults-on-draft-guidance-on-looked-after-children-and-young-people-3.html 2021-04-30T14:44:34.1070000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-319-april-2021-covid-19-phase-2-special-edition-1.html 2021-05-04T08:08:35.2970000Z https://www.medicinesresources.nhs.uk/sexually-transmitted-shigella-spp-in-england-2016-to-2020.html 2021-04-30T14:47:32.3130000Z https://www.medicinesresources.nhs.uk/nhs-invites-all-people-40-and-over-for-covid-19-vaccination.html 2021-04-30T14:49:10.9070000Z https://www.medicinesresources.nhs.uk/assessing-englands-response-to-covid-19-a-framework.html 2021-04-30T14:51:04.3840000Z https://www.medicinesresources.nhs.uk/pfizer-biontech-seek-to-extend-covid-19-vaccine-use-to-adolescents-in-eu-1.html 2021-04-30T14:53:47.5500000Z https://www.medicinesresources.nhs.uk/promoting-innovations-world-asthma-day-on-5-may.html 2021-04-30T17:33:32.1820000Z https://www.medicinesresources.nhs.uk/the-essential-guide-to-provider-collaboratives.html 2021-04-30T17:31:46.9200000Z https://www.medicinesresources.nhs.uk/crohns-and-colitis-care-in-the-uk-the-hidden-cost-and-a-vision-for-change-3.html 2021-04-30T15:00:06.1990000Z https://www.medicinesresources.nhs.uk/european-commission-approves-license-extension-for-kaftrio-ivacaftor-tezacaftor-elexacaftor-in-cystic-fibrosis-2.html 2021-05-11T12:42:51.9540000Z https://www.medicinesresources.nhs.uk/medicine-supply-notification-estradot-estradiol-hemihydrate-75micrograms-24-hours-patches.html 2021-04-30T15:05:00.6670000Z https://www.medicinesresources.nhs.uk/medicine-supply-notification-elleste-solo-mx-40-and-80-transdermal-patches.html 2021-04-30T15:06:30.3000000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-320-april-2021-european-immunisation-week-special-edition-1.html 2021-05-04T08:09:16.4430000Z https://www.medicinesresources.nhs.uk/pneumococcal-polysaccharide-vaccine-change-to-the-supply-route-from-june-2021-letter.html 2021-04-30T15:10:43.7150000Z https://www.medicinesresources.nhs.uk/getting-ready-to-use-covid-19-vaccines-in-community-pharmacies-1.html 2021-05-04T08:07:26.0700000Z https://www.medicinesresources.nhs.uk/consort-extension-for-the-reporting-of-randomised-controlled-trials-conducted-using-cohorts-and-routinely-collected-data-consort-routine-checklist-with-explanation-and-elaboration.html 2021-04-30T15:14:55.6440000Z https://www.medicinesresources.nhs.uk/impact-of-multi-disciplinary-involvement-to-improve-smoking-cessation-in-the-acute-admissions-unit-amu-1.html 2021-04-30T15:18:53.4960000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-using-dual-versus-monotherapy-antiplatelet-agents-in-secondary-stroke-prevention-systematic-review-and-meta-analysis-of-randomized-controlled-clinical-trials-3.html 2021-04-30T15:52:49.3260000Z https://www.medicinesresources.nhs.uk/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of-cardiovascular-disease-across-different-levels-of-blood-pressure-an-individual-participant-level-data-meta-analysis-1.html 2021-05-04T08:06:58.9950000Z https://www.medicinesresources.nhs.uk/nature-and-type-of-patient-reported-safety-incidents-in-primary-care-cross-sectional-survey-of-patients-from-australia-and-england.html 2021-04-30T15:57:11.1070000Z https://www.medicinesresources.nhs.uk/tranexamic-acid-to-reduce-head-injury-death-in-people-with-traumatic-brain-injury-the-crash-3-international-rct.html 2021-04-30T15:58:57.8910000Z https://www.medicinesresources.nhs.uk/association-of-maternal-sars-cov-2-infection-in-pregnancy-with-neonatal-outcomes.html 2021-04-30T16:01:09.2520000Z https://www.medicinesresources.nhs.uk/apalutamide-in-patients-with-metastatic-castration-sensitive-prostate-cancer-final-survival-analysis-of-the-randomized-double-blind-phase-iii-titan-study.html 2021-04-30T16:03:37.5230000Z https://www.medicinesresources.nhs.uk/tocilizumab-in-patients-admitted-to-hospital-with-covid-19-recovery-a-randomised-controlled-open-label-platform-trial-1.html 2021-05-04T08:05:58.4290000Z https://www.medicinesresources.nhs.uk/anti-sars-cov-2-antibody-responses-are-attenuated-in-patients-with-ibd-treated-with-infliximab.html 2021-04-30T18:32:50.2680000Z https://www.medicinesresources.nhs.uk/revised-spc-avaxim-hepatitis-a-vaccine-suspension-for-injection-in-a-pre-filled-syringe-1.html 2021-05-04T15:22:29.8570000Z https://www.medicinesresources.nhs.uk/revised-spc-minims-phenylephrine-hydrochloride-10-w-v-eye-drops-solution.html 2021-05-10T07:34:41.5370000Z https://www.medicinesresources.nhs.uk/national-standards-of-healthcare-cleanliness-2021-health-and-safety-1.html 2021-05-04T15:27:12.3630000Z https://www.medicinesresources.nhs.uk/moderna-vaccine-handling-in-trusts-and-vaccination-centres.html 2021-05-04T15:28:59.7300000Z https://www.medicinesresources.nhs.uk/sodium-glucose-co-transporter-2-inhibitors-and-all-cause-mortality-a-meta-analysis-of-randomized-controlled-trials.html 2021-05-04T15:30:26.7960000Z https://www.medicinesresources.nhs.uk/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of-cardiovascular-disease-across-different-levels-of-blood-pressure-an-individual-participant-level-data-meta-analysis.html 2021-05-04T15:32:27.5720000Z https://www.medicinesresources.nhs.uk/hypertension-current-trends-and-future-perspectives-2.html 2021-05-04T15:34:38.1180000Z https://www.medicinesresources.nhs.uk/paediatric-pharmacotherapy-and-drug-regulation-moving-past-the-therapeutic-orphan.html 2021-05-04T15:35:54.8190000Z https://www.medicinesresources.nhs.uk/dtb-select-chadox1-s-recombinant-vaccine-thrombosis-and-thrombocytopenia.html 2021-05-04T15:37:52.8690000Z https://www.medicinesresources.nhs.uk/association-of-higher-hydroxychloroquine-blood-levels-with-reduced-thrombosis-risk-in-systemic-lupus-erythematosus.html 2021-05-04T15:43:31.5770000Z https://www.medicinesresources.nhs.uk/covid-19-outcomes-in-patients-with-systemic-autoimmune-rheumatic-diseases-compared-to-the-general-population-a-us-multicenter-comparative-cohort-study.html 2021-05-04T16:26:35.3560000Z https://www.medicinesresources.nhs.uk/investigating-the-prescribing-trajectory-and-geographical-drug-utilisation-patterns-of-gabapentinoids-in-primary-care-in-england-an-ecological-2.html 2021-05-04T16:29:26.4130000Z https://www.medicinesresources.nhs.uk/blood-pressure-effects-of-canagliflozin-and-clinical-outcomes-in-type-2-diabetes-and-chronic-kidney-disease.html 2021-05-04T16:30:46.0050000Z https://www.medicinesresources.nhs.uk/associations-of-fish-consumption-with-risk-of-cardiovascular-disease-and-mortality-among-individuals-with-or-without-vascular-disease-from-58-countries.html 2021-05-04T16:32:39.9670000Z https://www.medicinesresources.nhs.uk/moderna-vaccine-granted-emergency-use-listing-by-the-world-health-organization-for-covid-19.html 2021-05-04T16:33:55.6470000Z https://www.medicinesresources.nhs.uk/brolucizumab-dbll-beovu-demonstrates-non-inferiority-to-aflibercept-in-phase-3-kerstrel-and-kite-phase-3-trials-in-diabetic-macular-oedema.html 2021-05-04T16:34:53.4150000Z https://www.medicinesresources.nhs.uk/fda-approve-deferiprone-ferriprox-for-the-treatment-of-transfusional-iron-overload-due-to-sickle-cell-disease.html 2021-05-04T16:35:44.3350000Z https://www.medicinesresources.nhs.uk/submission-of-new-drug-application-nda-to-fda-for-surufatinib-for-the-treatment-of-pancreatic-and-extra-pancreatic-neuroendocrine-tumours.html 2021-05-04T17:54:51.3610000Z https://www.medicinesresources.nhs.uk/phase-3-menstrual-bleeding-profile-data-for-segesterone-acetate-and-ethinyl-estradiol-vaginal-system-annovera.html 2021-05-04T17:56:58.1300000Z https://www.medicinesresources.nhs.uk/paediatric-expansion-for-phase-3-prevent-19-trial-of-covid-19-vaccine-nvx-xov2372.html 2021-05-04T17:58:49.4100000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-in-pregnancy.html 2021-05-04T18:00:58.1200000Z https://www.medicinesresources.nhs.uk/im156-granted-fast-track-designation-by-fda-for-idiopathic-pulmonary-fibrosis.html 2021-05-04T18:01:55.4010000Z https://www.medicinesresources.nhs.uk/covaxin-potentially-effective-against-three-key-variants-of-sars-cov-2.html 2021-05-04T18:03:06.4350000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-review-supplemental-new-drug-application-for-lumateperone-caplyta-for-the-treatment-of-depressive-episodes-associated-with-bipolar-i-or-ii-disorder.html 2021-05-04T18:04:36.8340000Z https://www.medicinesresources.nhs.uk/results-of-phase-3-trial-evaluating-efficacy-and-safety-of-dasiglucagon-for-treatment-of-severe-hypoglycemia-in-adult-patients-with-diabetes.html 2021-05-04T18:06:19.6090000Z https://www.medicinesresources.nhs.uk/enzalutamide-xtandi-approved-by-european-commission-for-men-with-metastatic-hormone-sensitive-prostate-cancer.html 2021-05-04T18:08:26.4610000Z https://www.medicinesresources.nhs.uk/autoimmune-thyroid-disease-in-women.html 2021-05-04T18:11:04.8440000Z https://www.medicinesresources.nhs.uk/ema-starts-rolling-review-of-covid-19-vaccine-vero-cell-inactivated.html 2021-05-04T18:11:55.1610000Z https://www.medicinesresources.nhs.uk/ema-starts-evaluating-use-of-comirnaty-covid-19-vaccine-in-young-people-aged-12-to-15.html 2021-05-04T18:13:37.0870000Z https://www.medicinesresources.nhs.uk/government-to-launch-40-000-person-daily-contact-testing-study.html 2021-05-04T18:14:43.5950000Z https://www.medicinesresources.nhs.uk/management-of-chronic-asthma-in-children-aged-16-years-and-under-report-1.html 2021-05-05T14:37:02.5640000Z https://www.medicinesresources.nhs.uk/prevalence-and-variability-of-current-depressive-disorder-in-27-european-countries-a-population-based-study.html 2021-05-05T13:53:00.9680000Z https://www.medicinesresources.nhs.uk/the-sputum-microbiome-and-clinical-outcomes-in-patients-with-bronchiectasis-a-prospective-observational-study.html 2021-05-05T13:54:21.2040000Z https://www.medicinesresources.nhs.uk/effect-of-half-dose-vs-stable-dose-conventional-synthetic-disease-modifying-antirheumatic-drugs-on-disease-flares-in-patients-with-rheumatoid-arthritis-in-remission-the-arctic-rewind-randomized-clinical-trial.html 2021-05-05T14:39:03.2710000Z https://www.medicinesresources.nhs.uk/effect-of-therapeutic-drug-monitoring-vs-standard-therapy-during-infliximab-induction-on-disease-remission-in-patients-with-chronic-immune-mediated-inflammatory-diseases-a-randomized-clinical-trial-3.html 2021-05-05T14:40:14.7960000Z https://www.medicinesresources.nhs.uk/a2-adrenergic-agonists-or-stimulants-for-preschool-age-children-with-attention-deficit-hyperactivity-disorder.html 2021-05-05T14:41:12.8820000Z https://www.medicinesresources.nhs.uk/tofacitinib-for-the-treatment-of-ankylosing-spondylitis-a-phase-iii-randomised-double-blind-placebo-controlled-study-1.html 2021-05-05T14:11:43.4920000Z https://www.medicinesresources.nhs.uk/renal-replacement-therapy-in-people-with-and-without-diabetes-in-germany-2010-2016-an-analysis-of-more-than-25-million-inhabitants-3.html 2021-05-05T14:42:27.0860000Z https://www.medicinesresources.nhs.uk/the-role-of-the-prescriber-in-supporting-patients-to-discontinue-benzodiazepines-a-qualitative-study.html 2021-05-05T14:21:04.9980000Z https://www.medicinesresources.nhs.uk/potentially-inappropriate-primary-care-prescribing-in-people-with-chronic-kidney-disease-a-cross-sectional-analysis-of-a-large-population-cohort-2.html 2021-05-09T19:56:06.6320000Z https://www.medicinesresources.nhs.uk/smoking-cessation-intervention-in-australian-general-practice-a-secondary-analysis-of-a-cluster-randomised-controlled-trial.html 2021-05-05T14:33:50.9010000Z https://www.medicinesresources.nhs.uk/incidence-characteristics-and-risk-factors-for-drug-induced-liver-injury-in-hospitalized-patients-a-matched-case-control-study-2.html 2021-05-05T14:44:09.7120000Z https://www.medicinesresources.nhs.uk/risk-of-colorectal-cancer-in-first-degree-relatives-of-patients-with-colorectal-polyps-nationwide-case-control-study-in-sweden-1.html 2021-05-05T14:40:00.6890000Z https://www.medicinesresources.nhs.uk/cost-effectiveness-of-emergency-preparedness-measures-in-response-to-infectious-respiratory-disease-outbreaks-a-systematic-review-and-econometric-analysis-2.html 2021-05-05T14:42:08.1990000Z https://www.medicinesresources.nhs.uk/assessment-of-adherence-to-at-home-oral-anti-infective-therapy-among-paediatric-patients-discharged-from-a-quebec-hospital.html 2021-05-05T14:43:34.5780000Z https://www.medicinesresources.nhs.uk/sars-cov-2-seroprevalence-and-igg-concentration-and-pseudovirus-neutralising-antibody-titres-after-infection-compared-by-hiv-status-a-matched-case-control-observational-study-1.html 2021-05-05T14:46:02.4170000Z https://www.medicinesresources.nhs.uk/nivolumab-fails-to-maintain-accelerated-approval-in-us-for-use-in-liver-cancer.html 2021-05-05T14:47:12.2490000Z https://www.medicinesresources.nhs.uk/manufacturers-make-resubmission-to-fda-for-xipere-tm-triamcinolone-acetonide-suprachoroidal-injectable-suspension-for-macular-oedema-associated-with-uveitis.html 2021-05-05T14:48:31.2880000Z https://www.medicinesresources.nhs.uk/positive-data-for-nasitrol-algae-derived-nasal-spray-for-reducing-covid-infection-among-icu-staff.html 2021-05-05T14:51:53.7320000Z https://www.medicinesresources.nhs.uk/manufacturers-present-positive-data-for-ibrexafungerup-in-difficult-to-treat-vaginal-candidiasis.html 2021-05-05T14:58:41.5150000Z https://www.medicinesresources.nhs.uk/fda-grant-priority-review-for-nivolumab-for-adjuvant-treatment-for-muscle-invasive-urothelial-carcinoma-1.html 2021-05-05T14:54:21.5120000Z https://www.medicinesresources.nhs.uk/fda-approves-higher-dosage-of-naloxone-nasal-spray-to-treat-opioid-overdose.html 2021-05-05T15:00:31.6040000Z https://www.medicinesresources.nhs.uk/berotralstat-approved-in-eu-for-prevention-of-acute-attacks-in-hereditary-angioedema-in-patients-12-years-and-older.html 2021-05-06T12:33:22.1390000Z https://www.medicinesresources.nhs.uk/preliminary-data-suggest-very-low-hospital-admission-rate-after-covid-vaccination.html 2021-05-05T15:22:30.7020000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-motixafortide-in-stem-cell-mobilisation-for-autologous-bone-marrow-transplantation-in-multiple-myeloma.html 2021-05-05T15:04:03.9110000Z https://www.medicinesresources.nhs.uk/manufacturers-initiate-rolling-submission-in-us-for-long-acting-cabotegravir-for-prevention-of-hiv.html 2021-05-05T15:23:43.8190000Z https://www.medicinesresources.nhs.uk/role-of-coronary-artery-calcium-score-in-the-primary-prevention-of-cardiovascular-disease.html 2021-05-05T15:06:22.3340000Z https://www.medicinesresources.nhs.uk/mental-health-support-through-primary-care-during-and-after-covid-19.html 2021-05-05T15:08:13.1200000Z https://www.medicinesresources.nhs.uk/spotlight-commentary-a-role-for-real-world-evidence-to-inform-the-clinical-care-of-patients-with-diabetes-mellitus.html 2021-05-05T15:09:47.0470000Z https://www.medicinesresources.nhs.uk/new-testing-centre-to-fast-track-covid-19-variant-vaccines-1.html 2021-05-05T15:24:58.7050000Z https://www.medicinesresources.nhs.uk/non-alcoholic-fatty-liver-disease-a-multisystem-disease-requiring-a-multidisciplinary-and-holistic-approach-3.html 2021-05-05T15:15:09.0360000Z https://www.medicinesresources.nhs.uk/pemigatinib-for-treating-relapsed-or-refractory-advanced-cholangiocarcinoma-with-fgfr2-alterations-appraisal-consultation-document-1.html 2021-05-05T15:17:30.9910000Z https://www.medicinesresources.nhs.uk/covid-19-in-schools-study-shows-drop-in-infections.html 2021-05-05T15:20:35.9630000Z https://www.medicinesresources.nhs.uk/pandemic-patient-experience-ii.html 2021-05-05T15:23:05.2270000Z https://www.medicinesresources.nhs.uk/dapagliflozin-approved-in-us-for-chronic-kidney-disease.html 2021-05-05T15:25:00.3280000Z https://www.medicinesresources.nhs.uk/manufacturers-file-marketing-authorisation-application-in-eu-for-ciltacabtagene-autoleucel-for-relapsed-refractory-multiple-myeloma-1.html 2021-05-05T15:27:09.1830000Z https://www.medicinesresources.nhs.uk/nice-expands-access-for-nusinersen-in-spinal-muscular-atrophy-sma-2.html 2021-05-05T15:30:06.6770000Z https://www.medicinesresources.nhs.uk/atezolizumab-approved-for-use-in-eu-as-first-line-treatment-in-metastatic-non-small-cell-cancer.html 2021-05-05T15:32:11.6740000Z https://www.medicinesresources.nhs.uk/atezolizumab-to-remain-licensed-in-us-for-untreated-metastatic-bladder-cancer-following-updated-review.html 2021-05-05T15:33:16.8240000Z https://www.medicinesresources.nhs.uk/atezolizumab-to-remain-licensed-in-us-for-metastatic-pd-l1-positive-triple-negative-breast-cancer-following-updated-review.html 2021-05-05T15:36:50.9730000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-april-2021.html 2021-05-09T19:56:43.6100000Z https://www.medicinesresources.nhs.uk/strategies-to-address-inappropriate-follicle-stimulating-hormone-fsh-requesting-using-nice-guideline-ng23-in-york-teaching-nhs-foundation-trust.html 2021-05-05T15:40:24.8510000Z https://www.medicinesresources.nhs.uk/impact-of-multi-disciplinary-involvement-to-improve-smoking-cessation-in-the-acute-admissions-unit-amu.html 2021-05-05T15:41:55.2410000Z https://www.medicinesresources.nhs.uk/revised-spc-marcain-bupivacaine-polyamp-steripack-0-25-and-0-5.html 2021-05-06T18:06:24.9230000Z https://www.medicinesresources.nhs.uk/new-product-pemazyre-pemigatinib-4-5-mg-9mg-and-13-5mg-tablets.html 2021-05-06T18:05:50.7890000Z https://www.medicinesresources.nhs.uk/impact-of-metformin-treatment-during-pregnancy-on-maternal-outcomes-a-systematic-review-meta-analysis.html 2021-05-06T18:04:28.1890000Z https://www.medicinesresources.nhs.uk/dtb-select-bisphosphonates-and-atypical-fractures-3.html 2021-05-09T19:34:57.4570000Z https://www.medicinesresources.nhs.uk/provision-of-the-progestogen-only-pill-by-community-pharmacies-as-bridging-contraception-for-women-receiving-emergency-contraception-the-bridge-it-rct.html 2021-05-06T18:02:19.0170000Z https://www.medicinesresources.nhs.uk/dexamethasone-and-surgical-site-infection.html 2021-05-06T18:00:53.0650000Z https://www.medicinesresources.nhs.uk/healthy-weight-loss-maintenance-with-exercise-liraglutide-or-both-combined.html 2021-05-06T18:00:09.9970000Z https://www.medicinesresources.nhs.uk/four-month-rifapentine-regimens-with-or-without-moxifloxacin-for-tuberculosis.html 2021-05-06T17:59:05.8260000Z https://www.medicinesresources.nhs.uk/closed-incision-negative-pressure-wound-therapy-versus-standard-dressings-in-obese-women-undergoing-caesarean-section-multicentre-parallel-group-randomised-controlled-trial.html 2021-05-06T17:58:12.7750000Z https://www.medicinesresources.nhs.uk/suicide-and-self-harm-in-adult-survivors-of-critical-illness-population-based-cohort-study.html 2021-05-06T17:57:24.6310000Z https://www.medicinesresources.nhs.uk/arterial-events-venous-thromboembolism-thrombocytopenia-and-bleeding-after-vaccination-with-oxford-astrazeneca-chadox1-s-in-denmark-and-norway-population-based-cohort-study.html 2021-05-09T19:39:52.0550000Z https://www.medicinesresources.nhs.uk/high-dimensional-characterization-of-post-acute-sequalae-of-covid-21.html 2021-05-06T17:54:13.1990000Z https://www.medicinesresources.nhs.uk/antibody-response-to-2-dose-sars-cov-2-mrna-vaccine-series-in-solid-organ-transplant-recipients.html 2021-05-06T17:53:12.2050000Z https://www.medicinesresources.nhs.uk/evaluation-of-topical-corticosteroid-use-in-pregnancy-and-risk-of-newborns-being-small-for-gestational-age-and-having-low-birth-weight.html 2021-05-06T17:52:15.3650000Z https://www.medicinesresources.nhs.uk/3-month-6-month-9-month-and-12-month-respiratory-outcomes-in-patients-following-covid-19-related-hospitalisation-a-prospective-study.html 2021-05-06T17:51:20.3810000Z https://www.medicinesresources.nhs.uk/impact-and-effectiveness-of-mrna-bnt162b2-vaccine-against-sars-cov-2-infections-and-covid-19-cases-hospitalisations-and-deaths-following-a-nationwide-vaccination-campaign-in-israel-an-observational-study-using-national-surveillance-data.html 2021-05-09T19:43:57.3670000Z https://www.medicinesresources.nhs.uk/us-supports-waiving-intellectual-property-for-covid-vaccines.html 2021-05-06T17:42:34.0500000Z https://www.medicinesresources.nhs.uk/10-practical-lessons-for-implementing-digital-innovations-learning-from-the-care-city-test-bed-2.html 2021-05-06T15:21:24.4010000Z https://www.medicinesresources.nhs.uk/gastric-emptying-abnormalities-in-diabetes-mellitus.html 2021-05-06T17:41:30.1190000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-syonell-250mg-gastro-resistant-tablets-pl-35507-0191-syonell-500mg-gastro-resistant-tablets-pl-35507-0192-el-21-a-11.html 2021-05-06T17:40:42.0240000Z https://www.medicinesresources.nhs.uk/clinical-diagnosis-of-alzheimer-s-disease-recommendations-of-the-international-working-group-1.html 2021-05-06T17:39:36.8610000Z https://www.medicinesresources.nhs.uk/50-million-doses-of-covid-19-vaccine-administered-in-uk.html 2021-05-06T17:38:37.4390000Z https://www.medicinesresources.nhs.uk/new-cutting-edge-testing-centre-to-fast-track-covid-19-variant-vaccines.html 2021-05-06T17:38:01.1890000Z https://www.medicinesresources.nhs.uk/abcellera-and-eli-lilly-to-assess-second-covid-19-antibody-ly-cov1404-in-patients-with-mild-to-moderate-covid-19.html 2021-05-06T17:37:14.0640000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-review-supplemental-new-drug-application-for-apremilast-in-adults-with-mild-to-moderate-plaque-psoriasis.html 2021-05-06T17:36:22.6760000Z https://www.medicinesresources.nhs.uk/health-canada-authorises-use-of-the-pfizer-biontech-covid-19-vaccine-in-children-12-to-15-years-of-age.html 2021-05-06T17:35:41.8640000Z https://www.medicinesresources.nhs.uk/fda-approves-pembrolizumab-combined-with-trastuzumab-and-chemotherapy-as-first-line-treatment-in-locally-advanced-unresectable-or-metastatic-her2-positive-gastric-or-gastroesophageal-junction-adenocarcinoma.html 2021-05-06T17:34:17.5690000Z https://www.medicinesresources.nhs.uk/new-roles-in-primary-care-toolkit-1.html 2021-05-06T17:32:26.6010000Z https://www.medicinesresources.nhs.uk/chemotherapy-waste-data-collection-and-evaluation-tool.html 2021-05-06T17:12:49.2470000Z https://www.medicinesresources.nhs.uk/national-dose-banding-table-trastuzumab-deruxtecan-20mg-ml.html 2021-05-09T19:44:35.0770000Z https://www.medicinesresources.nhs.uk/revised-spc-lopid-gemfibrozil-hard-capsules-and-film-coated-tablets.html 2021-05-07T14:23:14.4120000Z https://www.medicinesresources.nhs.uk/effectiveness-of-the-bnt162b2-covid-19-vaccine-against-the-b-1-1-7-and-b-1-351-variants-1.html 2021-05-07T14:26:49.7760000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-roflumilast-cream-in-plaque-psoriasis-presented-at-conference.html 2021-05-07T14:28:11.9410000Z https://www.medicinesresources.nhs.uk/guidance-on-the-licensing-of-biosimilar-products.html 2021-05-07T14:29:42.1760000Z https://www.medicinesresources.nhs.uk/coronavirus-vaccine-summary-of-yellow-card-reporting-up-to-28-april.html 2021-05-09T18:54:54.6820000Z https://www.medicinesresources.nhs.uk/european-regulators-urged-to-crack-down-on-missing-clinical-trial-results.html 2021-05-07T14:33:45.5270000Z https://www.medicinesresources.nhs.uk/mhra-issues-its-first-authorisation-under-project-orbis-for-osimertinib.html 2021-05-07T14:40:28.4090000Z https://www.medicinesresources.nhs.uk/vivaldi-2-coronavirus-covid-19-reinfections-in-care-homes-study-report.html 2021-05-07T16:45:09.8350000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-starts-rolling-review-of-sotrovimab-vir-7831-for-covid-21.html 2021-05-07T14:48:32.0960000Z https://www.medicinesresources.nhs.uk/international-regulators-and-who-call-for-wider-public-access-to-clinical-data.html 2021-05-07T14:49:35.2830000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guidance-on-avelumab-for-maintenance-treatment-of-locally-advanced-or-metastatic-urothelial-cancer-after-platinum-based-chemotherapy.html 2021-05-07T14:51:07.7720000Z https://www.medicinesresources.nhs.uk/nice-issues-draft-guidance-on-dupilumab-for-treating-severe-asthma-with-type-2-inflammation-2.html 2021-05-07T14:53:33.0580000Z https://www.medicinesresources.nhs.uk/provisional-data-show-increase-in-deaths-caused-by-diseases-known-to-be-a-direct-consequence-of-alcohol-misuse-in-england-and-wales-1.html 2021-05-07T14:57:34.4520000Z https://www.medicinesresources.nhs.uk/social-care-360.html 2021-05-07T14:58:44.7460000Z https://www.medicinesresources.nhs.uk/hyperthermic-intraperitoneal-chemotherapy-for-ovarian-and-colorectal-cancer-1.html 2021-05-07T15:00:50.8290000Z https://www.medicinesresources.nhs.uk/nice-consults-on-indicators-for-antidepressant-prescribing-and-dementia.html 2021-05-07T15:02:25.8460000Z https://www.medicinesresources.nhs.uk/see-through-the-symptoms-gp-awareness-campaign-for-never-smoking-lung-cancers-launched.html 2021-05-07T15:05:02.5990000Z https://www.medicinesresources.nhs.uk/primary-care-respiratory-society-launches-greener-respiratory-pathway.html 2021-05-07T15:14:11.2290000Z https://www.medicinesresources.nhs.uk/positive-survival-results-for-durvalumab-tremelimumab-and-chemotherapy-in-metastatic-non-small-cell-lung-cancer-nsclc.html 2021-05-07T15:15:48.2290000Z https://www.medicinesresources.nhs.uk/uk-launch-for-octopus-progressive-multiple-sclerosis-mega-trial.html 2021-05-07T16:55:05.7920000Z https://www.medicinesresources.nhs.uk/european-commission-approves-belimumab-in-combination-with-background-immunosuppressive-therapies-for-adults-with-active-lupus-nephritis.html 2021-05-07T15:19:45.4420000Z https://www.medicinesresources.nhs.uk/jcvi-advises-on-covid-19-vaccine-for-people-aged-under-42.html 2021-05-09T18:56:01.7250000Z https://www.medicinesresources.nhs.uk/updated-information-on-covid-19-variants-of-concern-1.html 2021-05-09T18:58:33.2340000Z https://www.medicinesresources.nhs.uk/new-medicines-news-april-2022.html 2021-05-09T19:02:39.7300000Z https://www.medicinesresources.nhs.uk/rmoc-shared-care-guidance-draft-shared-care-protocols-consultation-1.html 2021-05-07T15:28:36.6130000Z https://www.medicinesresources.nhs.uk/lse-lancet-commission-on-the-future-of-the-nhs-re-laying-the-foundations-for-an-equitable-and-efficient-health-and-care-service-after-covid-19.html 2021-05-09T19:11:23.0500000Z https://www.medicinesresources.nhs.uk/where-are-we-with-drug-treatments-for-covid-19.html 2021-05-07T15:35:00.9560000Z https://www.medicinesresources.nhs.uk/outcomes-associated-with-thiotepa-based-conditioning-in-patients-with-primary-central-nervous-system-lymphoma-after-autologous-hematopoietic-cell-transplant-2.html 2021-05-07T15:41:55.1160000Z https://www.medicinesresources.nhs.uk/association-between-vaccination-with-bnt162b2-and-incidence-of-symptomatic-and-asymptomatic-sars-cov-2-infections-among-health-care-workers.html 2021-05-07T15:44:06.4380000Z https://www.medicinesresources.nhs.uk/asymptomatic-and-symptomatic-sars-cov-2-infections-after-bnt162b2-vaccination-in-a-routinely-screened-workforce.html 2021-05-07T15:46:44.9210000Z https://www.medicinesresources.nhs.uk/ethnic-differences-in-sars-cov-2-infection-and-covid-19-related-hospitalisation-intensive-care-unit-admission-and-death-in-17-million-adults-in-england-an-observational-cohort-study-using-the-opensafely-platform.html 2021-05-07T15:50:28.6790000Z https://www.medicinesresources.nhs.uk/long-term-safety-of-lumacaftor-ivacaftor-in-children-aged-2-5-years-with-cystic-fibrosis-homozygous-for-the-f508del-cftr-mutation-a-multicentre-phase-3-open-label-extension-study.html 2021-05-07T15:51:50.2380000Z https://www.medicinesresources.nhs.uk/mental-health-responses-to-the-covid-19-pandemic-a-latent-class-trajectory-analysis-using-longitudinal-uk-data.html 2021-05-07T15:55:08.2220000Z https://www.medicinesresources.nhs.uk/educational-risk-minimisation-materials-for-prenoxad-naloxone-1mg-ml-solution-for-injection-in-a-pre-filled-syringe.html 2021-05-09T19:13:18.8220000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-obizur-antihaemophilic-factor-viii-recombinant-porcine-sequence-dose-calculation-1.html 2021-05-07T16:18:18.8690000Z https://www.medicinesresources.nhs.uk/revised-spc-eylea-aflibercept-40mg-ml-solution-for-injection-in-a-vial-1.html 2021-05-10T12:28:07.1940000Z https://www.medicinesresources.nhs.uk/new-product-almerg-fexofenadine-180-mg-film-coated-tablets.html 2021-05-10T12:29:17.6880000Z https://www.medicinesresources.nhs.uk/revised-spc-picolax-sodium-picosulfate-magnesium-oxide-citric-acid-powder-for-oral-solution.html 2021-05-10T14:59:04.4050000Z https://www.medicinesresources.nhs.uk/demonstrating-your-covid-19-vaccination-status-when-travelling-abroad-2.html 2021-05-10T12:33:48.3080000Z https://www.medicinesresources.nhs.uk/prac-concludes-review-of-signal-of-facial-swelling-with-comirnaty-pfizer-covid-19-vaccine.html 2021-05-17T08:11:02.7470000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-voclosporin-versus-placebo-for-lupus-nephritis-aurora-1-a-double-blind-randomised-multicentre-placebo-controlled-phase-3-trial.html 2021-05-10T12:37:35.3440000Z https://www.medicinesresources.nhs.uk/the-association-of-amputations-and-peripheral-artery-disease-in-patients-with-type-2-diabetes-mellitus-receiving-sodium-glucose-cotransporter-type-2-inhibitors-real-world-study.html 2021-05-10T12:39:41.3780000Z https://www.medicinesresources.nhs.uk/lowering-cholesterol-blood-pressure-or-both-to-prevent-cardiovascular-events-results-of-8-7-years-of-follow-up-of-heart-outcomes-evaluation-prevention-hope-3-study-participants.html 2021-05-10T12:40:52.2010000Z https://www.medicinesresources.nhs.uk/management-of-severe-covid-19-progress-and-promise.html 2021-05-10T12:42:11.9470000Z https://www.medicinesresources.nhs.uk/two-thirds-of-uk-adults-receive-first-dose-of-a-covid-19-vaccine.html 2021-05-10T12:43:16.3980000Z https://www.medicinesresources.nhs.uk/colchicine-and-the-heart.html 2021-05-10T12:44:17.5330000Z https://www.medicinesresources.nhs.uk/prac-continues-to-closely-review-comirnaty-pfizer-and-moderna-covid-19-vaccines-for-thromboembolic-events.html 2021-05-10T12:45:54.1370000Z https://www.medicinesresources.nhs.uk/prac-investigating-reports-of-guillain-barre-syndrome-with-astrazenecas-covid-19-vaccine.html 2021-05-10T12:47:46.9670000Z https://www.medicinesresources.nhs.uk/prac-assessing-reports-of-myocarditis-with-comirnaty-pfizer-and-moderna-covid-19-vaccines.html 2021-05-10T12:50:11.7110000Z https://www.medicinesresources.nhs.uk/precision-medicine-for-covid-19-phenotype-anarchy-or-promise-realized.html 2021-05-10T12:51:42.0890000Z https://www.medicinesresources.nhs.uk/parents-with-alcohol-and-drug-problems-support-resources.html 2021-05-10T15:16:22.8170000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-updated-blood-clotting-information-for-healthcare-professionals-2.html 2021-05-17T08:04:59.2860000Z https://www.medicinesresources.nhs.uk/covid-19-the-green-book-chapter-14a-update-3.html 2021-05-10T15:23:05.9470000Z https://www.medicinesresources.nhs.uk/apatinib-as-second-line-or-later-therapy-in-patients-with-advanced-hepatocellular-carcinoma-ahelp-a-multicentre-double-blind-randomised-placebo-controlled-phase-3-trial.html 2021-05-10T15:24:22.8690000Z https://www.medicinesresources.nhs.uk/evaluation-of-hepatitis-c-treatment-as-prevention-within-australian-prisons-stop-c-a-prospective-cohort-study.html 2021-05-10T15:34:38.5400000Z https://www.medicinesresources.nhs.uk/the-effect-of-diet-in-infancy-on-asthma-in-young-adults-the-merthyr-allergy-prevention-study.html 2021-05-10T15:27:53.0780000Z https://www.medicinesresources.nhs.uk/the-inflammatory-profile-of-exacerbations-in-patients-with-severe-refractory-eosinophilic-asthma-receiving-mepolizumab-the-mex-study-a-prospective-observational-study-3.html 2021-05-10T15:32:42.6570000Z https://www.medicinesresources.nhs.uk/more-than-a-million-children-given-access-to-nhs-mental-health-support-at-school.html 2021-05-10T15:36:27.3030000Z https://www.medicinesresources.nhs.uk/positive-chmp-approval-for-self-administered-burosumab-crysvita-for-treatment-of-hypophosphatemia-1.html 2021-05-10T15:43:52.4940000Z https://www.medicinesresources.nhs.uk/who-grants-sinopharms-covid-19-vaccine-emergency-approval.html 2021-05-10T15:46:42.4230000Z https://www.medicinesresources.nhs.uk/ethics-of-vaccination-should-capability-measures-be-used-to-inform-sars-cov-2-vaccination-strategies.html 2021-05-10T15:48:41.8890000Z https://www.medicinesresources.nhs.uk/encorafenib-braftovi-r-is-accepted-for-use-within-nhsscotland-1.html 2021-05-11T16:45:53.8740000Z https://www.medicinesresources.nhs.uk/niraparib-zejula-r-accepted-for-use-within-nhsscotland.html 2021-05-11T10:10:04.7420000Z https://www.medicinesresources.nhs.uk/indacaterol-glycopyrronium-mometasone-furoate-enerzair-breezhaler-r-accepted-for-use-within-nhsscotland.html 2021-05-11T10:10:54.8580000Z https://www.medicinesresources.nhs.uk/indacaterol-mometasone-furoate-atectura-breezhaler-r-accepted-for-use-within-nhsscotland.html 2021-05-11T10:11:47.7600000Z https://www.medicinesresources.nhs.uk/upadacitinib-rinvoq-r-accepted-for-restricted-use-within-nhsscotland.html 2021-05-11T10:12:47.2290000Z https://www.medicinesresources.nhs.uk/chlormethine-hydrochloride-ledaga-r-accepted-for-use-within-nhsscotland.html 2021-05-11T10:13:41.4090000Z https://www.medicinesresources.nhs.uk/ravulizumab-ultomiris-r-accepted-for-restricted-use-within-nhsscotland.html 2021-05-11T10:16:05.9160000Z https://www.medicinesresources.nhs.uk/title-revised-spc-lyumjev-insulin-lispro-all-products-2.html 2021-05-11T14:23:29.1040000Z https://www.medicinesresources.nhs.uk/revised-spc-pecfent-fentanyl-100-and-400-micrograms-spray-nasal-spray-solution-1.html 2021-05-11T14:26:32.9940000Z https://www.medicinesresources.nhs.uk/mhra-approves-licence-extension-for-cystic-fibrosis-cf-treatment-kaftrio-ivacaftor-tezacaftor-elexacaftor-in-combination-with-ivacaftor.html 2021-05-11T16:44:56.7680000Z https://www.medicinesresources.nhs.uk/tuberculosis-tb-a-resource-to-support-tb-in-low-incidence-areas.html 2021-05-11T14:28:50.2820000Z https://www.medicinesresources.nhs.uk/consultation-on-indicators-for-antidepressant-prescribing-and-dementia.html 2021-05-11T16:42:55.6150000Z https://www.medicinesresources.nhs.uk/new-public-health-england-analysis-continues-to-show-vaccination-is-highly-effective-in-protecting-against-death-and-hospitalisation-from-covid-20.html 2021-05-16T14:40:09.6180000Z https://www.medicinesresources.nhs.uk/covid-19-alert-level-update-from-the-uk-chief-medical-officers-10-may-2021.html 2021-05-11T14:35:46.1880000Z https://www.medicinesresources.nhs.uk/venous-thromboembolism.html 2021-05-11T16:40:45.6690000Z https://www.medicinesresources.nhs.uk/benefits-of-sodium-glucose-cotransporter-2-inhibitors-across-the-spectrum-of-cardiovascular-diseases.html 2021-05-11T14:39:59.5680000Z https://www.medicinesresources.nhs.uk/recent-developments-of-hdac-inhibitors-emerging-indications-and-novel-molecules.html 2021-05-11T14:41:30.4090000Z https://www.medicinesresources.nhs.uk/fda-arthritis-advisory-committee-split-over-new-drug-application-application-for-avacopan-for-treatment-of-antineutrophil-cytoplasmic-autoantibody-anca-associated-vasculitis.html 2021-05-11T14:43:53.3690000Z https://www.medicinesresources.nhs.uk/biologics-license-application-for-tezepelumab-submitted-to-fda-for-treatment-of-patients-with-severe-uncontrolled-asthma.html 2021-05-11T14:45:04.9080000Z https://www.medicinesresources.nhs.uk/fda-expands-emergency-use-authorization-for-pfizer-biontech-covid-19-vaccine-to-include-adolescents-age-12-to-15-years-of-age.html 2021-05-11T14:47:07.3830000Z https://www.medicinesresources.nhs.uk/dysphagia-and-medicines-e-learning-for-healthcare.html 2021-05-16T14:39:42.9640000Z https://www.medicinesresources.nhs.uk/stomp-stopping-the-over-medication-of-people-with-a-learning-disability-autism-or-both-patient-information-leaflet-available-in-other-languages.html 2021-05-11T14:52:18.1020000Z https://www.medicinesresources.nhs.uk/tranexamic-acid-and-bleeding-in-patients-treated-with-non-vitamin-k-oral-anticoagulants-undergoing-dental-extraction-the-extract-noac-randomized-clinical-trial-2.html 2021-05-11T15:26:13.8440000Z https://www.medicinesresources.nhs.uk/associations-of-diet-quality-and-all-cause-mortality-across-levels-of-cardiometabolic-health-and-disease-a-7-6-year-prospective-analysis-from-the-dutch-lifelines-cohort-1.html 2021-05-11T15:29:50.1300000Z https://www.medicinesresources.nhs.uk/public-availability-of-results-of-clinicaltrials-gov-registered-expanded-access-studies.html 2021-05-11T15:32:54.8380000Z https://www.medicinesresources.nhs.uk/sustained-remission-in-patients-with-rheumatoid-arthritis-receiving-triple-therapy-compared-to-biologic-therapy-a-swedish-nationwide-register-study.html 2021-05-11T15:34:08.2600000Z https://www.medicinesresources.nhs.uk/trends-and-characteristics-of-retracted-articles-in-the-biomedical-literature-1971-to-2021.html 2021-05-11T15:39:24.2400000Z https://www.medicinesresources.nhs.uk/anticoagulant-use-for-atrial-fibrillation-among-persons-with-advanced-dementia-at-the-end-of-life.html 2021-05-11T16:31:56.1910000Z https://www.medicinesresources.nhs.uk/post-acute-effects-of-sars-cov-2-infection-in-individuals-not-requiring-hospital-admission-a-danish-population-based-cohort-study-2.html 2021-05-11T16:18:05.5120000Z https://www.medicinesresources.nhs.uk/a-pharmacist-s-unique-opportunity-within-a-multidisciplinary-team-to-reduce-drug-related-problems-for-older-adults-in-an-intermediate-care-setting.html 2021-05-11T16:16:41.3070000Z https://www.medicinesresources.nhs.uk/sex-influence-on-the-time-in-therapeutic-range-ttr-during-oral-anticoagulation-with-coumarin-derivatives-systematic-review-and-meta-analysis.html 2021-05-11T21:31:37.9050000Z https://www.medicinesresources.nhs.uk/andexanet-alfa-for-reversing-anticoagulation-from-apixaban-or-rivaroxaban-guidance-ta697-1.html 2021-05-16T14:27:44.5480000Z https://www.medicinesresources.nhs.uk/tafamidis-for-treating-transthyretin-amyloidosis-with-cardiomyopathy-guidance-ta696-1.html 2021-05-16T14:29:15.1960000Z https://www.medicinesresources.nhs.uk/rates-of-treatment-resistant-schizophrenia-from-first-episode-cohorts-systematic-review-and-meta-analysis.html 2021-05-12T14:27:29.3360000Z https://www.medicinesresources.nhs.uk/antimicrobial-prescribing-nebulised-liposomal-amikacin-evidence-summary-es36.html 2021-05-16T14:31:40.2870000Z https://www.medicinesresources.nhs.uk/cardiovascular-safety-of-hydroxychloroquine-in-veterans-with-rheumatoid-arthritis.html 2021-05-12T14:36:10.6630000Z https://www.medicinesresources.nhs.uk/use-of-repurposed-and-adjuvant-drugs-in-hospital-patients-with-covid-19-multinational-network-cohort-study.html 2021-05-12T14:44:37.6090000Z https://www.medicinesresources.nhs.uk/treatment-timing-and-the-effects-of-rhythm-control-strategy-in-patients-with-atrial-fibrillation-nationwide-cohort-study.html 2021-05-12T14:46:58.4380000Z https://www.medicinesresources.nhs.uk/automatic-dispensing-cabinets-and-governance-of-controlled-drugs-an-exploratory-study-in-an-intensive-care-unit.html 2021-05-12T14:52:00.5940000Z https://www.medicinesresources.nhs.uk/effectiveness-and-safety-of-oral-anticoagulants-in-elderly-patients-with-atrial-fibrillation.html 2021-05-12T14:55:17.3240000Z https://www.medicinesresources.nhs.uk/effect-of-antimicrobial-therapy-on-respiratory-hospitalization-or-death-in-adults-with-idiopathic-pulmonary-fibrosis-the-cleanup-ipf-randomized-clinical-trial-1.html 2021-05-12T15:11:41.9150000Z https://www.medicinesresources.nhs.uk/ipilimumab-alone-or-ipilimumab-plus-anti-pd-1-therapy-in-patients-with-metastatic-melanoma-resistant-to-anti-pd-l-1-monotherapy-a-multicentre-retrospective-cohort-study.html 2021-05-12T15:00:39.4050000Z https://www.medicinesresources.nhs.uk/immunogenicity-and-safety-of-a-tri-antigenic-versus-a-mono-antigenic-hepatitis-b-vaccine-in-adults-protect-a-randomised-double-blind-phase-3-trial.html 2021-05-12T16:29:00.8020000Z https://www.medicinesresources.nhs.uk/depression.html 2021-05-12T15:44:38.0950000Z https://www.medicinesresources.nhs.uk/fda-grants-fast-track-designation-to-cerc-002-for-treatment-of-hospitalised-patients-with-covid-19.html 2021-05-12T15:58:13.0640000Z https://www.medicinesresources.nhs.uk/fda-grants-bold-100-orphan-drug-designation-in-the-treatment-of-gastric-cancer.html 2021-05-12T15:47:39.2440000Z https://www.medicinesresources.nhs.uk/nhs-app-ready-to-become-vaccine-passport-next-week.html 2021-05-12T15:48:31.9950000Z https://www.medicinesresources.nhs.uk/experimental-treatments-risk-further-medicalisation-of-menopause.html 2021-05-12T15:50:05.4770000Z https://www.medicinesresources.nhs.uk/sglt-2-inhibitors-or-glp-1-receptor-agonists-for-adults-with-type-2-diabetes-a-clinical-practice-guideline.html 2021-05-12T16:00:45.5410000Z https://www.medicinesresources.nhs.uk/diagnosis-and-management-of-headache-a-review.html 2021-05-12T16:03:29.3980000Z https://www.medicinesresources.nhs.uk/welsh-tramadol-educational-resources-under-consultation.html 2021-05-12T15:55:07.5060000Z https://www.medicinesresources.nhs.uk/revised-spc-keytruda-pembrolizumab-25-mg-ml-concentrate-for-solution-for-infusion-2.html 2021-05-13T16:46:46.6670000Z https://www.medicinesresources.nhs.uk/revised-spc-phenergan-promethazine-elixir.html 2021-05-13T14:43:07.2840000Z https://www.medicinesresources.nhs.uk/revised-spc-vokanamet-50-mg-850-mg-and-50-mg-1000-mg-canagliflozin-metformin-coated-tablets.html 2021-05-13T16:43:41.9700000Z https://www.medicinesresources.nhs.uk/mhra-approves-licence-extension-for-enzalutamide-1.html 2021-05-13T14:46:04.3110000Z https://www.medicinesresources.nhs.uk/restoring-primary-care-ten-key-priorities-1.html 2021-05-13T14:48:39.1610000Z https://www.medicinesresources.nhs.uk/nhs-to-invite-people-aged-38-and-39-for-covid-19-vaccination.html 2021-05-13T16:04:55.2040000Z https://www.medicinesresources.nhs.uk/nhss-gbp160-million-accelerator-sites-to-tackle-waiting-lists.html 2021-05-13T14:52:15.1760000Z https://www.medicinesresources.nhs.uk/upadacitinib-for-previously-treated-moderate-active-rheumatoid-arthritis-appraisal-consultation-2.html 2021-05-13T14:52:59.0030000Z https://www.medicinesresources.nhs.uk/mhra-seeks-views-on-reclassification-of-nuromol-ibuprofen-and-paracetamol-to-gsl.html 2021-05-13T14:54:00.6300000Z https://www.medicinesresources.nhs.uk/findings-from-latest-covid-19-react-1-study-published.html 2021-05-16T14:07:03.7940000Z https://www.medicinesresources.nhs.uk/use-of-scientific-advice-in-the-uk-response-to-covid-19-government-response-to-science-and-technology-committee-report.html 2021-05-13T14:56:17.4260000Z https://www.medicinesresources.nhs.uk/new-we-offer-testing-to-our-staff-scheme-launched.html 2021-05-13T16:29:10.0270000Z https://www.medicinesresources.nhs.uk/evaluation-and-management-of-aortic-stenosis-in-chronic-kidney-disease-a-scientific-statement-from-the-american-heart-association-1.html 2021-05-13T15:00:09.1920000Z https://www.medicinesresources.nhs.uk/vaccinating-children-against-sars-cov-2.html 2021-05-13T15:01:35.3520000Z https://www.medicinesresources.nhs.uk/impact-of-covid-19-on-diagnoses-monitoring-and-mortality-in-people-with-type-2-diabetes-in-the-uk.html 2021-05-13T15:03:07.4910000Z https://www.medicinesresources.nhs.uk/covid-19-make-it-the-last-pandemic.html 2021-05-13T16:24:42.5960000Z https://www.medicinesresources.nhs.uk/eu-regulators-call-for-more-data-before-any-decisions-taken-on-covid-19-vaccine-booster.html 2021-05-13T15:11:12.1380000Z https://www.medicinesresources.nhs.uk/u-s-cdc-identified-more-cases-of-thrombosis-with-thrombocytopenia-syndrome-tts-after-j-and-js-covid-19-vaccine.html 2021-05-13T15:14:37.3470000Z https://www.medicinesresources.nhs.uk/eurofound-survey-finds-over-a-quarter-of-eu-adults-would-refuse-covid-19-vaccine-3.html 2021-05-13T15:18:18.6040000Z https://www.medicinesresources.nhs.uk/heterologous-prime-boost-covid-19-vaccination-initial-reactogenicity-data-1.html 2021-05-13T15:20:00.9920000Z https://www.medicinesresources.nhs.uk/the-nhs-covid-legacy-long-waits-and-lives-at-risk.html 2021-05-13T15:22:11.7610000Z https://www.medicinesresources.nhs.uk/fda-granted-fast-track-designation-to-losmapimod-for-potential-treatment-of-facioscapulohumeral-muscular-dystrophy-fshd.html 2021-05-13T16:05:26.3660000Z https://www.medicinesresources.nhs.uk/mhra-grants-marketing-authorization-for-oral-once-daily-berotralstat-orladeyo-for-routine-prevention-of-recurrent-hereditary-angioedema-hae-attacks-in-patients-12-years-and-older.html 2021-05-13T15:26:37.4220000Z https://www.medicinesresources.nhs.uk/effects-of-different-types-of-written-vaccination-information-on-covid-19-vaccine-hesitancy-in-the-uk-oceans-iii-a-single-blind-parallel-group-randomised-controlled-trial-3.html 2021-05-13T16:19:47.8630000Z https://www.medicinesresources.nhs.uk/tympanostomy-tubes-or-medical-management-for-recurrent-acute-otitis-media.html 2021-05-13T16:17:21.3410000Z https://www.medicinesresources.nhs.uk/tezepelumab-in-adults-and-adolescents-with-severe-uncontrolled-asthma.html 2021-05-13T15:37:28.3610000Z https://www.medicinesresources.nhs.uk/association-of-oral-corticosteroid-bursts-with-severe-adverse-events-in-children.html 2021-05-19T07:58:45.6380000Z https://www.medicinesresources.nhs.uk/public-health-impact-of-delaying-second-dose-of-bnt162b2-or-mrna-1273-covid-19-vaccine-simulation-agent-based-modeling-study-1.html 2021-05-13T15:44:02.3840000Z https://www.medicinesresources.nhs.uk/effectiveness-of-the-pfizer-biontech-and-oxford-astrazeneca-vaccines-on-covid-19-related-symptoms-hospital-admissions-and-mortality-in-older-adults-in-england-test-negative-case-control-study.html 2021-05-16T14:24:04.4220000Z https://www.medicinesresources.nhs.uk/delayed-localized-hypersensitivity-reactions-to-the-moderna-covid-19-vaccine-a-case-series.html 2021-05-13T16:12:55.4610000Z https://www.medicinesresources.nhs.uk/long-term-efficacy-of-baricitinib-in-adults-with-moderate-to-severe-atopic-dermatitis-who-were-treatment-responders-or-partial-responders-an-extension-study-of-2-randomized-clinical-trials.html 2021-05-13T16:07:42.8640000Z https://www.medicinesresources.nhs.uk/interferon-a-2b-aerosol-inhalation-is-associated-with-improved-clinical-outcomes-in-patients-with-coronavirus-disease-2020.html 2021-05-13T16:07:24.4910000Z https://www.medicinesresources.nhs.uk/ethnicity-specific-bmi-cutoffs-for-obesity-based-on-type-2-diabetes-risk-in-england-a-population-based-cohort-study.html 2021-05-13T16:09:52.9230000Z https://www.medicinesresources.nhs.uk/revised-spc-fentanyl-effentora-buccal-tablets-1.html 2021-05-14T12:59:33.3810000Z https://www.medicinesresources.nhs.uk/revised-spc-eylea-aflibercept-40-mg-ml-solution-for-injection-in-pre-filled-syringe.html 2021-05-14T18:41:26.1120000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-pembrolizumab-in-high-risk-early-stage-triple-negative-breast-cancer-keynote-522-meets-dual-primary-endpoint.html 2021-05-14T13:01:54.4550000Z https://www.medicinesresources.nhs.uk/us-fda-approves-zynrelef-bupivacaine-and-meloxicam-for-management-of-postoperative-pain-for-up-to-72-hours-1.html 2021-05-14T13:03:43.2750000Z https://www.medicinesresources.nhs.uk/mhra-issues-updated-information-on-yellow-card-reports-received-for-the-coronavirus-vaccines.html 2021-05-16T13:35:42.8030000Z https://www.medicinesresources.nhs.uk/employers-unite-to-encourage-over-a-million-staff-to-get-the-covid-19-vaccine.html 2021-05-14T18:39:09.9360000Z https://www.medicinesresources.nhs.uk/new-measures-to-boost-response-to-the-b1-617-2-covid-19-variant-of-concern.html 2021-05-14T18:25:53.0400000Z https://www.medicinesresources.nhs.uk/chloramphenicol-eye-drops-boron-infants-and-fertility.html 2021-05-14T13:10:39.1980000Z https://www.medicinesresources.nhs.uk/nice-amends-antiepileptic-recommendations-in-guideline-on-diagnosis-and-management-of-epilepsies-cg137.html 2021-05-16T13:42:38.8470000Z https://www.medicinesresources.nhs.uk/nice-amends-recommendation-on-topiramate-in-guideline-on-diagnosis-and-management-of-headaches-in-over-12s-cg150.html 2021-05-16T13:46:50.4640000Z https://www.medicinesresources.nhs.uk/hepatitis-c-elimination-initiatives-monitoring-and-evaluation.html 2021-05-14T13:18:11.4050000Z https://www.medicinesresources.nhs.uk/latest-covid-19-vaccine-surveillance-report-estimates-11-700-deaths-prevented.html 2021-05-16T13:57:18.5690000Z https://www.medicinesresources.nhs.uk/assessment-and-management-of-peripheral-arterial-disease-what-every-cardiologist-should-know-1.html 2021-05-14T13:24:58.1530000Z https://www.medicinesresources.nhs.uk/delaying-second-pfizer-vaccines-to-12-weeks-significantly-increases-antibody-responses-in-older-people.html 2021-05-14T18:34:06.8660000Z https://www.medicinesresources.nhs.uk/the-future-role-of-remote-consultations-and-patient-triage.html 2021-05-14T13:32:36.8090000Z https://www.medicinesresources.nhs.uk/updated-standard-operating-procedure-sop-to-support-restoration-of-general-practice-services.html 2021-05-14T13:50:16.2620000Z https://www.medicinesresources.nhs.uk/nivolumab-for-previously-treated-unresectable-advanced-or-recurrent-oesophageal-cancer-final-appraisal-document-2.html 2021-05-14T13:52:01.8580000Z https://www.medicinesresources.nhs.uk/shortage-of-urokinase-injection-syner-kinase-r-10-000-iu-and-25-000-iu-powder-for-solution-for-injection-or-infusion.html 2021-05-16T13:58:30.7600000Z https://www.medicinesresources.nhs.uk/rps-responds-to-advisory-council-on-the-misuse-of-drugs-consultation-regarding-the-legal-constraints-on-researching-controlled-drugs.html 2021-05-19T08:01:05.4090000Z https://www.medicinesresources.nhs.uk/sign-issues-guideline-on-eating-disorders-for-1.html 2021-05-14T18:28:52.3530000Z https://www.medicinesresources.nhs.uk/tackling-covid-19-a-case-for-better-financial-support-to-self-isolate.html 2021-05-14T13:59:00.9900000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-physicians-reference-checklist-for-exjade-deferasirox-dosing-and-biological-monitoring-1.html 2021-05-14T15:48:17.8550000Z https://www.medicinesresources.nhs.uk/risk-minimisation-materials-tenofovir-disoproxil-fumarate-hiv-paediatric-educational-brochure.html 2021-05-14T15:49:45.4870000Z https://www.medicinesresources.nhs.uk/timing-of-mycobacterium-tuberculosis-exposure-explains-variation-in-bcg-effectiveness-a-systematic-review-and-meta-analysis.html 2021-05-14T15:52:35.5990000Z https://www.medicinesresources.nhs.uk/effects-of-thyroid-stimulating-hormone-suppression-after-thyroidectomy-for-thyroid-cancer-on-bone-mineral-density-in-postmenopausal-women-a-systematic-review-and-meta-analysis.html 2021-05-14T15:54:34.9110000Z https://www.medicinesresources.nhs.uk/impact-of-the-covid-19-pandemic-on-asthma-control-among-children-a-qualitative-study-from-caregivers-perspectives-and-experiences.html 2021-05-14T15:58:22.1310000Z https://www.medicinesresources.nhs.uk/risk-factors-for-severity-of-covid-19-a-rapid-review-to-inform-vaccine-prioritisation-in-canada.html 2021-05-14T16:00:24.3700000Z https://www.medicinesresources.nhs.uk/the-epidemiological-impact-of-the-nhs-covid-19-app.html 2021-05-14T16:02:15.7920000Z https://www.medicinesresources.nhs.uk/immunogenicity-of-covid-19-mrna-vaccines-in-pregnant-and-lactating-women.html 2021-05-14T18:22:47.8650000Z https://www.medicinesresources.nhs.uk/efficacy-of-reduced-intensity-chemotherapy-with-oxaliplatin-and-capecitabine-on-quality-of-life-and-cancer-control-among-older-and-frail-patients-with-advanced-gastroesophageal-cancer-the-go2-phase-3-randomized-clinical-trial.html 2021-05-14T16:07:00.9260000Z https://www.medicinesresources.nhs.uk/development-of-a-list-with-renally-relevant-drugs-as-a-tool-to-increase-medicines-optimisation-in-patients-with-chronic-kidney-disease.html 2021-05-14T16:08:51.2450000Z https://www.medicinesresources.nhs.uk/using-antidepressants-for-depression-in-people-with-epilepsy.html 2021-05-16T14:01:46.6410000Z https://www.medicinesresources.nhs.uk/revised-spc-tagrisso-osimertinib-film-coated-tablets.html 2021-05-17T14:20:06.6140000Z https://www.medicinesresources.nhs.uk/revised-spc-xtandi-enzalutamide-film-coated-tablets.html 2021-05-17T11:35:45.1990000Z https://www.medicinesresources.nhs.uk/systematic-review-of-machine-learning-models-for-personalised-dosing-of-heparin.html 2021-05-17T11:38:21.7960000Z https://www.medicinesresources.nhs.uk/systematic-review-of-the-stability-of-antimicrobial-agents-in-elastomeric-devices-for-outpatient-parenteral-antimicrobial-therapy-services-based-on-nhs-yellow-cover-document-standards.html 2021-05-17T11:42:37.7810000Z https://www.medicinesresources.nhs.uk/total-ischemic-event-reduction-with-rivaroxaban-after-peripheral-arterial-revascularization-in-the-voyager-pad-trial.html 2021-05-17T14:22:17.5900000Z https://www.medicinesresources.nhs.uk/single-direct-oral-anticoagulant-therapy-in-stable-patients-with-atrial-fibrillation-beyond-1-year-after-coronary-stent-implantation-1.html 2021-05-17T11:47:12.3080000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-pegcetacoplan-empaveli-injection-for-treatment-of-paroxysmal-nocturnal-haemoglobinuria-pnh.html 2021-05-17T11:49:36.5970000Z https://www.medicinesresources.nhs.uk/analysis-supports-long-term-safety-of-nintedanib-in-treatment-of-systemic-sclerosis-associated-interstitial-lung-disease.html 2021-05-17T11:52:58.2730000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-accelerating-second-doses-for-priority-cohorts-1-9.html 2021-05-20T07:29:46.8900000Z https://www.medicinesresources.nhs.uk/positive-phase-ii-rct-data-for-sanofi-and-gsk-adjuvanted-recombinant-covid-19-vaccine-candidate.html 2021-05-17T11:56:27.7630000Z https://www.medicinesresources.nhs.uk/ramadan-fasting-recommendations-for-patients-with-cardiovascular-disease-1.html 2021-05-17T14:23:56.6170000Z https://www.medicinesresources.nhs.uk/tackling-covid-19-a-case-for-better-financial-support-to-self-isolate-3.html 2021-05-17T12:01:59.8990000Z https://www.medicinesresources.nhs.uk/sign-guidance-epilepsies-in-children-and-young-people-investigative-procedures-and-management.html 2021-05-17T14:28:32.0590000Z https://www.medicinesresources.nhs.uk/comparative-effectiveness-of-aspirin-dosing-in-cardiovascular-disease.html 2021-05-17T14:29:47.1460000Z https://www.medicinesresources.nhs.uk/randomized-phase-iii-trial-of-gemcitabine-and-cisplatin-with-bevacizumab-or-placebo-in-patients-with-advanced-urothelial-carcinoma-results-of-calgb-90601-alliance.html 2021-05-17T14:31:30.7800000Z https://www.medicinesresources.nhs.uk/convalescent-plasma-in-patients-admitted-to-hospital-with-covid-19-recovery-a-randomised-controlled-open-label-platform-trial.html 2021-05-17T14:48:06.4100000Z https://www.medicinesresources.nhs.uk/ultrasound-renal-denervation-for-hypertension-resistant-to-a-triple-medication-pill-radiance-htn-trio-a-randomised-multicentre-single-blind-sham-controlled-trial-1.html 2021-05-17T14:49:45.0970000Z https://www.medicinesresources.nhs.uk/aspirin-versus-clopidogrel-for-chronic-maintenance-monotherapy-after-percutaneous-coronary-intervention-host-exam-an-investigator-initiated-prospective-randomised-open-label-multicentre-trial-1.html 2021-05-17T14:45:34.5630000Z https://www.medicinesresources.nhs.uk/adjuvant-and-concurrent-temozolomide-for-1p-19q-non-co-deleted-anaplastic-glioma-catnon-eortc-study-26053-22054-second-interim-analysis-of-a-randomised-open-label-phase-3-study.html 2021-05-17T14:50:45.7060000Z https://www.medicinesresources.nhs.uk/changes-in-in-hospital-mortality-in-the-first-wave-of-covid-19-a-multicentre-prospective-observational-cohort-study-using-the-who-clinical-characterisation-protocol-uk-4.html 2021-05-17T14:51:56.9010000Z https://www.medicinesresources.nhs.uk/sex-differences-among-patients-with-high-risk-receiving-ticagrelor-with-or-without-aspirin-after-percutaneous-coronary-intervention-a-subgroup-analysis-of-the-twilight-randomized-clinical-trial.html 2021-05-17T14:43:13.6840000Z https://www.medicinesresources.nhs.uk/the-lancet-women-and-cardiovascular-disease-commission-reducing-the-global-burden-by-2030.html 2021-05-17T14:47:14.5920000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-astrazeneca-uk-limited-bricanyl-injection-0-5-mg-ml-solution-for-injection-or-infusion-pl-17901-0112-el-21-a-12.html 2021-05-20T07:31:52.8940000Z https://www.medicinesresources.nhs.uk/nhs-patient-safety-syllabus-launched-to-save-lives-1.html 2021-05-17T14:55:12.7380000Z https://www.medicinesresources.nhs.uk/pembrolizumab-for-untreated-metastatic-colorectal-cancer-with-high-microsatellite-instability-or-mismatch-repair-deficiency-id1498.html 2021-05-17T14:57:25.9480000Z https://www.medicinesresources.nhs.uk/revised-spc-lyumjev-insulin-lispro-100-units-ml-solution-for-injection-all-presentations-1.html 2021-05-18T14:43:30.7010000Z https://www.medicinesresources.nhs.uk/use-of-methenamine-hippurate-to-prevent-urinary-tract-infections-in-community-adult-women-a-systematic-review-and-meta-analysis-1.html 2021-05-18T14:47:08.4440000Z https://www.medicinesresources.nhs.uk/cardiac-mortality-in-patients-randomised-to-elective-coronary-revascularisation-plus-medical-therapy-or-medical-therapy-alone-a-systematic-review-and-meta-analysis.html 2021-05-18T14:48:56.6920000Z https://www.medicinesresources.nhs.uk/medicago-and-gsk-announce-promising-mid-stage-trial-data-for-plant-derived-covid-19-vaccine.html 2021-05-18T14:50:26.8860000Z https://www.medicinesresources.nhs.uk/gene-therapy-cotoretigene-toliparvovec-for-treatment-of-x-linked-retinitis-pigmentosa-fails-to-meet-primary-endpoint-in-phase-ii-iii-study-2.html 2021-05-18T14:54:12.7160000Z https://www.medicinesresources.nhs.uk/jcvi-advice-to-mitigate-impact-of-b1-617-2-variant.html 2021-05-20T08:37:55.5670000Z https://www.medicinesresources.nhs.uk/child-mortality-and-social-deprivation.html 2021-05-18T15:01:03.0180000Z https://www.medicinesresources.nhs.uk/nhs-invites-people-aged-36-and-37-for-life-saving-covid-19-vaccine.html 2021-05-18T16:16:15.1430000Z https://www.medicinesresources.nhs.uk/prontosan-for-acute-and-chronic-wounds-medical-technology-consultation-document-2.html 2021-05-18T15:06:06.7230000Z https://www.medicinesresources.nhs.uk/oral-drug-dosing-following-bariatric-surgery-general-concepts-and-specific-dosing-advice-2.html 2021-05-18T15:08:22.9710000Z https://www.medicinesresources.nhs.uk/ethical-issues-in-therapeutic-use-and-research-in-pregnant-and-breastfeeding-women.html 2021-05-18T15:10:00.5810000Z https://www.medicinesresources.nhs.uk/filing-of-an-emergency-use-authorization-eua-for-lenzilumab-as-treatment-of-hospitalised-hypoxic-covid-19-patients-plans-for-end-of-may.html 2021-05-18T16:13:33.3080000Z https://www.medicinesresources.nhs.uk/u-s-centers-for-disease-control-and-prevention-cdc-issues-new-guidelines-on-protective-facial-coverings.html 2021-05-18T15:12:26.0400000Z https://www.medicinesresources.nhs.uk/ruxolitinib-cream-shows-promise-for-vitiligo-in-phase-iii-trials.html 2021-05-18T15:14:54.3690000Z https://www.medicinesresources.nhs.uk/more-flexible-storage-conditions-for-biontech-pfizers-covid-19-vaccine-comirnaty.html 2021-05-20T08:40:12.0050000Z https://www.medicinesresources.nhs.uk/choosing-between-oral-vancomycin-options.html 2021-05-20T08:41:09.3860000Z https://www.medicinesresources.nhs.uk/mavacamten-for-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy-explorer-hcm-health-status-analysis-of-a-randomised-double-blind-placebo-controlled-phase-3-trial-1.html 2021-05-18T16:09:07.9050000Z https://www.medicinesresources.nhs.uk/prevention-of-cardiac-dysfunction-during-adjuvant-breast-cancer-therapy-prada-extended-follow-up-of-a-2-2-factorial-randomized-placebo-controlled-double-blind-clinical-trial-of-candesartan-and-metoprolol.html 2021-05-18T15:25:39.8140000Z https://www.medicinesresources.nhs.uk/non-steroidal-anti-inflammatory-drug-use-and-outcomes-of-covid-19-in-the-isaric-clinical-characterisation-protocol-uk-cohort-a-matched-prospective-cohort-study.html 2021-05-18T15:27:25.9670000Z https://www.medicinesresources.nhs.uk/risk-factors-for-incident-fracture-in-older-adults-with-type-2-diabetes-the-framingham-heart-study-2.html 2021-05-18T15:29:32.2030000Z https://www.medicinesresources.nhs.uk/serial-sars-cov-2-receptor-binding-domain-antibody-responses-in-patients-receiving-dialysis.html 2021-05-18T15:31:39.9700000Z https://www.medicinesresources.nhs.uk/prevalence-and-predictors-of-potentially-inappropriate-prescribing-in-middle-aged-adults-a-repeated-cross-sectional-study-1.html 2021-05-18T15:48:36.2430000Z https://www.medicinesresources.nhs.uk/gps-mindlines-on-deprescribing-antihypertensives-in-older-patients-with-multimorbidity-a-qualitative-study-in-english-general-practice.html 2021-05-18T15:41:08.0240000Z https://www.medicinesresources.nhs.uk/ravulizumab-for-treating-paroxysmal-nocturnal-haemoglobinuria-guidance-ta698.html 2021-05-20T08:53:43.0390000Z https://www.medicinesresources.nhs.uk/ofatumumab-for-treating-relapsing-multiple-sclerosis-guidance-ta699.html 2021-05-20T10:30:18.1240000Z https://www.medicinesresources.nhs.uk/cardiac-mortality-in-patients-randomised-to-elective-coronary-revascularisation-plus-medical-therapy-or-medical-therapy-alone-a-systematic-review-and-meta-analysis-1.html 2021-05-19T14:45:25.5580000Z https://www.medicinesresources.nhs.uk/potentially-inappropriate-prescribing-and-its-associations-with-health-related-and-system-related-outcomes-in-hospitalised-older-adults-a-systematic-review-and-meta-analysis.html 2021-05-20T11:24:50.4240000Z https://www.medicinesresources.nhs.uk/arterial-hypertension.html 2021-05-19T14:48:33.3530000Z https://www.medicinesresources.nhs.uk/fda-note-data-current-data-do-not-support-use-of-leronlimab-for-covid-19.html 2021-05-19T14:49:54.6500000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-bemcentinib-in-hospitalised-covid-19-in-phase-ii-trial.html 2021-05-19T14:52:45.3230000Z https://www.medicinesresources.nhs.uk/data-suggest-most-uk-adults-had-antibodies-after-one-dose-of-astrazeneca-or-pfizer-covid-19-vaccine.html 2021-05-19T15:29:59.3810000Z https://www.medicinesresources.nhs.uk/defining-difficult-to-treat-inflammatory-bowel-disease-why-and-how.html 2021-05-19T15:30:56.8230000Z https://www.medicinesresources.nhs.uk/breaking-the-therapeutic-ceiling-in-drug-development-in-ulcerative-colitis.html 2021-05-19T14:57:43.9250000Z https://www.medicinesresources.nhs.uk/ongoing-and-future-covid-19-vaccine-clinical-trials-challenges-and-opportunities.html 2021-05-19T14:59:54.9820000Z https://www.medicinesresources.nhs.uk/initial-learning-from-the-governments-response-to-the-covid-19-pandemic-1.html 2021-05-19T15:32:30.5340000Z https://www.medicinesresources.nhs.uk/statistics-on-obesity-physical-activity-and-diet-england-2026.html 2021-05-19T15:10:52.8480000Z https://www.medicinesresources.nhs.uk/the-relationship-between-the-adult-social-care-sector-and-icss-time-for-action.html 2021-05-19T15:15:34.7550000Z https://www.medicinesresources.nhs.uk/ziltivekimab-meets-primary-endpoint-in-chronic-kidney-disease-trial.html 2021-05-19T15:17:36.5140000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-dupilumab-in-childhood-asthma.html 2021-05-19T15:20:39.7260000Z https://www.medicinesresources.nhs.uk/chemotherapy-de-escalation-using-an-18f-fdg-pet-based-pathological-response-adapted-strategy-in-patients-with-her2-positive-early-breast-cancer-phergain-a-multicentre-randomised-open-label-non-comparative-phase-2-trial-1.html 2021-05-19T15:30:59.4410000Z https://www.medicinesresources.nhs.uk/effect-of-treating-hyperphosphatemia-with-lanthanum-carbonate-vs-calcium-carbonate-on-cardiovascular-events-in-patients-with-chronic-kidney-disease-undergoing-hemodialysis-the-landmark-randomized-clinical-trial.html 2021-05-19T15:32:44.9990000Z https://www.medicinesresources.nhs.uk/racial-and-ethnic-disparities-in-heart-and-cerebrovascular-disease-deaths-during-the-covid-19-pandemic-in-the-united-states-1.html 2021-05-19T15:36:04.4620000Z https://www.medicinesresources.nhs.uk/effectiveness-of-eribulin-in-metastatic-breast-cancer-10-years-of-real-world-clinical-experience-in-the-united-states.html 2021-05-19T15:43:03.7310000Z https://www.medicinesresources.nhs.uk/critical-care-work-during-covid-19-a-qualitative-study-of-staff-experiences-in-the-uk-1.html 2021-05-19T15:39:25.6460000Z https://www.medicinesresources.nhs.uk/fda-to-review-sintilimab-in-combination-with-pemetrexed-and-platinum-chemotherapy-for-the-first-line-treatment-of-people-with-nonsquamous-non-small-cell-lung-cancer.html 2021-05-19T15:40:29.3650000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-in-the-rush-for-regulatory-approval-do-we-need-more-data.html 2021-05-19T15:41:31.2690000Z https://www.medicinesresources.nhs.uk/revised-spc-campto-irinotecan-hydrochloride-trihydrate-concentrate-for-solution-for-infusion-all-strengths.html 2021-05-20T15:18:06.5960000Z https://www.medicinesresources.nhs.uk/direct-healthcare-professional-communication-eylea-40-mg-ml-aflibercept-solution-for-intravitreal-injection-higher-risk-of-intraocular-pressure-increase-with-the-pre-filled-syringe-2.html 2021-05-24T08:36:02.9490000Z https://www.medicinesresources.nhs.uk/levothyroxine-new-prescribing-advice-for-patients-who-experience-symptoms-on-switching-between-different-levothyroxine-products.html 2021-05-24T08:38:47.8880000Z https://www.medicinesresources.nhs.uk/triple-vs-dual-inhaler-therapy-and-asthma-outcomes-in-moderate-to-severe-asthma-a-systematic-review-and-meta-analysis.html 2021-05-20T15:24:43.1890000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-sildenafil-and-bosentan-for-the-treatment-of-digital-ulceration-in-systemic-sclerosis-in-adults.html 2021-05-24T08:41:09.7060000Z https://www.medicinesresources.nhs.uk/update-for-chief-pharmacists-and-senior-pharmacy-leaders.html 2021-05-24T08:41:43.2780000Z https://www.medicinesresources.nhs.uk/survey-of-people-living-with-lung-disease-find-most-thought-support-accessed-in-community-pharmacy-cp-was-valuable.html 2021-05-20T15:29:53.8510000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-and-mhra-validate-applications-to-expand-licence-of-kaftrio-ivacaftor-tezacaftor-elexacaftor-in-cystic-fibrosis.html 2021-05-20T16:25:14.1530000Z https://www.medicinesresources.nhs.uk/apalutamide-with-androgen-deprivation-therapy-for-treating-prostate-cancer-appraisal-consultation-document.html 2021-05-20T15:34:19.7390000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-321-may-2022.html 2021-05-24T08:42:29.5420000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-second-doses-further-details-on-the-support-available-for-pcn-led-sites.html 2021-05-24T08:43:31.3670000Z https://www.medicinesresources.nhs.uk/nhs-invites-people-aged-34-and-35-for-covid-19-vaccine.html 2021-05-20T15:38:53.8410000Z https://www.medicinesresources.nhs.uk/coronavirus-as-recorded-in-primary-care-01-mar-2020-to-31-mar-2021.html 2021-05-20T15:40:09.9990000Z https://www.medicinesresources.nhs.uk/monoclonal-gammopathy-of-renal-significance-2.html 2021-05-20T15:44:50.1810000Z https://www.medicinesresources.nhs.uk/placebo-the-unknown-variable-in-a-controlled-trial.html 2021-05-20T15:45:58.6220000Z https://www.medicinesresources.nhs.uk/us-fda-authorises-longer-time-for-refrigerator-storage-of-thawed-pfizer-biontech-covid-19-vaccine-prior-to-dilution.html 2021-05-24T08:44:53.8520000Z https://www.medicinesresources.nhs.uk/7-in-10-uk-adults-receive-first-dose-of-coronavirus-covid-19-vaccine.html 2021-05-20T15:49:14.2110000Z https://www.medicinesresources.nhs.uk/nice-and-cqc-release-updated-memorandum-of-understanding-agreement.html 2021-05-20T15:51:34.2090000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-hesitancy.html 2021-05-20T15:57:18.1950000Z https://www.medicinesresources.nhs.uk/treatment-of-opioid-use-disorder-in-primary-care-1.html 2021-05-20T15:59:02.4110000Z https://www.medicinesresources.nhs.uk/world-first-covid-19-vaccine-booster-study-launches-in-uk-1.html 2021-05-20T16:01:34.0140000Z https://www.medicinesresources.nhs.uk/conference-report-long-term-data-from-karmma-study-continue-to-demonstrate-deep-and-durable-responses-with-idecabtagene-vicleucel-in-relapsed-or-refractory-multiple-myeloma-mm.html 2021-05-20T16:02:46.2930000Z https://www.medicinesresources.nhs.uk/conference-report-nivolumab-plus-ipilimumab-with-two-cycles-of-chemotherapy-demonstrates-durable-overall-survival-vs-chemotherapy-at-two-years-as-first-line-treatment-of-non-small-cell-lung-cancer-in-phase-iii-checkmate-9la-trial-2.html 2021-05-20T16:05:10.1120000Z https://www.medicinesresources.nhs.uk/conference-report-six-and-a-half-year-outcomes-for-nivolumab-in-combination-with-ipilimumab-continue-to-demonstrate-durable-long-term-survival-benefits-in-patients-with-advanced-melanoma-in-checkmate-067-trial.html 2021-05-20T17:06:15.9940000Z https://www.medicinesresources.nhs.uk/fda-accepts-supplemental-new-drug-application-for-zanubrutinib-brukinsa-for-treatment-of-adults-with-marginal-zone-lymphoma-who-have-received-at-least-one-prior-anti-cd20-based-therapy-2.html 2021-05-20T16:09:52.4910000Z https://www.medicinesresources.nhs.uk/cppe-launches-fundamentals-of-respiratory-therapeutics-e-learning.html 2021-05-20T17:07:42.5290000Z https://www.medicinesresources.nhs.uk/quality-improvement-alert-cold-chain-management-of-covid-19-vaccines.html 2021-05-24T08:46:46.4370000Z https://www.medicinesresources.nhs.uk/systematic-monitoring-for-detection-of-atrial-fibrillation-in-patients-with-acute-ischaemic-stroke-mondafis-a-randomised-open-label-multicentre-study.html 2021-05-20T16:43:25.0210000Z https://www.medicinesresources.nhs.uk/final-report-of-a-trial-of-intensive-versus-standard-blood-pressure-control-2.html 2021-05-20T16:17:12.8400000Z https://www.medicinesresources.nhs.uk/endovascular-therapy-for-stroke-due-to-basilar-artery-occlusion-2.html 2021-05-20T16:18:41.5020000Z https://www.medicinesresources.nhs.uk/efficacy-of-nvx-cov2373-covid-19-vaccine-against-the-b-1-351-variant.html 2021-05-20T16:38:09.3870000Z https://www.medicinesresources.nhs.uk/rituximab-versus-mycophenolate-mofetil-in-patients-with-pemphigus-vulgaris.html 2021-05-20T16:23:22.5290000Z https://www.medicinesresources.nhs.uk/risk-of-clinical-sequelae-after-the-acute-phase-of-sars-cov-2-infection-retrospective-cohort-study.html 2021-05-20T16:27:19.6330000Z https://www.medicinesresources.nhs.uk/excess-deaths-associated-with-covid-19-pandemic-in-2020-age-and-sex-disaggregated-time-series-analysis-in-29-high-income-countries.html 2021-05-20T16:29:33.9170000Z https://www.medicinesresources.nhs.uk/continuation-of-antidepressants-vs-sequential-psychological-interventions-to-prevent-relapse-in-depression-an-individual-participant-data-meta-analysis.html 2021-05-20T16:31:06.4010000Z https://www.medicinesresources.nhs.uk/evaluation-of-the-risk-of-stroke-without-anticoagulation-therapy-in-men-and-women-with-atrial-fibrillation-aged-66-to-74-years-without-other-cha2ds2-vasc-factors.html 2021-05-20T16:32:08.4300000Z https://www.medicinesresources.nhs.uk/revised-spc-covid-19-vaccine-pfizer.html 2021-05-24T09:08:55.7440000Z https://www.medicinesresources.nhs.uk/may-bnf-bnf-for-children-newsletter-3.html 2021-05-24T09:11:36.9150000Z https://www.medicinesresources.nhs.uk/investigational-15-valent-pneumococcal-conjugate-vaccine-v114-shows-promise-in-children.html 2021-05-21T14:29:04.1650000Z https://www.medicinesresources.nhs.uk/surpass-4-trial-finds-tirzepatide-associated-with-superior-reductions-in-hba1c-and-weight-compared-to-insulin-glargine-in-type-2-diabetes.html 2021-05-21T14:30:44.5230000Z https://www.medicinesresources.nhs.uk/us-fda-approves-nivolumab-for-adjuvant-treatment-of-resected-oesophageal-or-gastroesophageal-junction-cancer.html 2021-05-21T14:31:46.8210000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-grants-priority-medicines-prime-designation-to-cti-1601-for-the-treatment-of-friedreichs-ataxia.html 2021-05-21T17:56:58.8780000Z https://www.medicinesresources.nhs.uk/final-results-from-phase-iii-primrose-program-of-linzagolix-for-the-treatment-of-uterine-fibroids.html 2021-05-21T17:56:21.5480000Z https://www.medicinesresources.nhs.uk/latest-weekly-data-on-covid-19-variants-identified-in-the-uk-show-indian-variant-growing-rapidly.html 2021-05-21T14:39:03.6530000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-surveillance-report-week-20-includes-updated-estimates-of-deaths-and-hospitalisations-prevented-in-england-3.html 2021-05-24T09:21:28.8310000Z https://www.medicinesresources.nhs.uk/covid-19-health-inequalities-monitoring-in-england-tool-chime-2.html 2021-05-21T14:46:09.0060000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-programme-information-for-healthcare-practitioners-updated.html 2021-05-24T09:23:13.4650000Z https://www.medicinesresources.nhs.uk/coronavirus-england-briefing-20-may-2021.html 2021-05-21T14:49:54.4970000Z https://www.medicinesresources.nhs.uk/inequity-in-racial-ethnic-representation-in-randomized-controlled-trials-of-diabetes-technologies-in-type-1-diabetes-critical-need-for-new-standards.html 2021-05-21T14:51:40.7230000Z https://www.medicinesresources.nhs.uk/class-3-medicines-recall-advanz-pharma-carbimazole-10mg-and-15mg-tablets-el-21-a-13.html 2021-05-21T14:53:08.4820000Z https://www.medicinesresources.nhs.uk/ppis-for-persistent-throat-symptoms.html 2021-05-21T14:54:19.6990000Z https://www.medicinesresources.nhs.uk/recall-of-bd-venflon-pro-safety-and-venflon-pro-iv-cannula-update-2.html 2021-05-21T14:56:42.7260000Z https://www.medicinesresources.nhs.uk/ravulizumab-for-treating-atypical-haemolytic-uraemic-syndrome-ahus-final-appraisal-document.html 2021-05-21T14:57:50.4010000Z https://www.medicinesresources.nhs.uk/preterm-birth-and-cardiac-function-in-adulthood.html 2021-05-21T14:58:55.6550000Z https://www.medicinesresources.nhs.uk/statistics-on-covid-19-patients-recorded-by-gps-published-for-the-first-time.html 2021-05-21T15:00:21.2320000Z https://www.medicinesresources.nhs.uk/enhanced-service-specification-covid-19-vaccination-programme-2020-21-updated-1.html 2021-05-21T15:01:32.2400000Z https://www.medicinesresources.nhs.uk/smoking-and-health-2021-a-coming-of-age-for-tobacco-control.html 2021-05-21T15:03:07.7320000Z https://www.medicinesresources.nhs.uk/the-governments-white-paper-proposals-for-the-reform-of-health-and-social-care.html 2021-05-21T15:04:34.5880000Z https://www.medicinesresources.nhs.uk/nhs-invites-people-aged-34-and-35-for-covid-19-vaccination.html 2021-05-21T15:06:25.4160000Z https://www.medicinesresources.nhs.uk/levelling-up-general-practice-in-england-what-should-government-prioritise-1.html 2021-05-21T15:08:16.2380000Z https://www.medicinesresources.nhs.uk/nihr-alert-preventing-childhood-obesity-requires-a-shift-in-focus-away-from-individual-behaviours-towards-the-wider-environment.html 2021-05-21T15:09:32.2360000Z https://www.medicinesresources.nhs.uk/homeopathy-uk-told-to-take-down-articles-saying-remedies-can-help-conditions-such-as-depression-diabetes-infertility-psoriasis-and-asthma.html 2021-05-21T15:11:05.2470000Z https://www.medicinesresources.nhs.uk/atrial-fibrillation-diagnosis-and-management-summary-of-nice-guidance.html 2021-05-21T15:12:08.4480000Z https://www.medicinesresources.nhs.uk/complexities-in-the-treatment-of-coinfection-with-hiv-hepatitis-b-hepatitis-c-and-tuberculosis.html 2021-05-21T15:13:58.8880000Z https://www.medicinesresources.nhs.uk/allocating-31-day-expiry-to-thawed-pfizer-biontech-covid-19-vaccine-labelled-with-5-day-expiry.html 2021-05-24T09:26:12.0850000Z https://www.medicinesresources.nhs.uk/preparing-doses-of-vaccines-using-aseptic-non-touch-technique-antt.html 2021-05-21T15:16:47.7460000Z https://www.medicinesresources.nhs.uk/standard-versus-reduced-dose-of-antipsychotics-for-relapse-prevention-in-multi-episode-schizophrenia-a-systematic-review-and-meta-analysis-of-randomised-controlled-trials-1.html 2021-05-21T15:44:47.5720000Z https://www.medicinesresources.nhs.uk/association-between-oral-contraceptives-and-serious-infections-a-population-based-cohort-study.html 2021-05-21T17:44:00.8350000Z https://www.medicinesresources.nhs.uk/effects-of-cotadutide-on-metabolic-and-hepatic-parameters-in-adults-with-overweight-or-obesity-and-type-2-diabetes-a-54-week-randomized-phase-2b-study.html 2021-05-21T17:42:00.0260000Z https://www.medicinesresources.nhs.uk/maternal-and-perinatal-outcomes-of-pregnant-women-with-sars-cov-2-infection-at-the-time-of-birth-in-england-national-cohort-study.html 2021-05-21T17:41:04.1190000Z https://www.medicinesresources.nhs.uk/three-year-follow-up-of-neoadjuvant-chemotherapy-with-or-without-anthracyclines-in-the-presence-of-dual-erbb2-blockade-in-patients-with-erbb2-positive-breast-cancer-a-secondary-analysis-of-the-train-2-randomized-phase-3-trial.html 2021-05-21T17:33:36.2570000Z https://www.medicinesresources.nhs.uk/once-daily-upadacitinib-versus-placebo-in-adolescents-and-adults-with-moderate-to-severe-atopic-dermatitis-measure-up-1-and-measure-up-2-results-from-two-replicate-double-blind-randomised-controlled-phase-3-trials.html 2021-05-21T17:39:42.1360000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-upadacitinib-in-combination-with-topical-corticosteroids-in-adolescents-and-adults-with-moderate-to-severe-atopic-dermatitis-ad-up-results-from-a-randomised-double-blind-placebo-controlled-phase-3-trial.html 2021-05-21T17:38:43.8980000Z https://www.medicinesresources.nhs.uk/long-term-safety-and-outcomes-in-hereditary-tyrosinaemia-type-1-with-nitisinone-treatment-a-15-year-non-interventional-multicentre-study-2.html 2021-05-21T17:37:28.8270000Z https://www.medicinesresources.nhs.uk/revised-spc-neurontin-gabapentin-tablets.html 2021-06-01T13:34:07.1650000Z https://www.medicinesresources.nhs.uk/revised-spc-repatha-sureclick-evolocumab.html 2021-06-01T08:29:02.9710000Z https://www.medicinesresources.nhs.uk/the-nature-severity-and-causes-of-medication-incidents-from-an-australian-community-pharmacy-incident-reporting-system-the-qumwatch-study.html 2021-05-24T12:44:46.9710000Z https://www.medicinesresources.nhs.uk/projecting-the-incidence-of-type-2-diabetes-related-end-stage-kidney-disease-until-2040-a-comparison-between-the-effects-of-diabetes-prevention-and-the-effects-of-diabetes-treatment.html 2021-05-24T12:46:02.4920000Z https://www.medicinesresources.nhs.uk/fda-grants-approval-of-amivantamab-vmjw-rybrevant-for-treatment-of-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations.html 2021-05-24T12:48:11.4070000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-of-blinatumomab-blincyto-for-acute-lymphoblastic-leukaemia-all.html 2021-05-24T12:49:19.1590000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-daratumumab-darzalex-for-multiple-myeloma-and-al-amyloidosis.html 2021-05-24T12:50:54.1750000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-of-atazanavir-cobicistat-evotaz-for-treatment-of-hiv.html 2021-05-24T12:51:58.5190000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-empagliflozin-jardiance-for-heart-failure.html 2021-05-24T12:53:04.0990000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-pembrolizumab-keytruda-for-oesophageal-or-gastroesophageal-junction-adenocarcinoma.html 2021-05-24T12:54:17.3110000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extensions-for-cemiplimab-libtayo-for-basal-cell-carcinoma-and-non-small-cell-lung-cancer-1.html 2021-05-24T12:56:34.2470000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-nivolumab-opdivo-and-ipilimumab-yervoy-for-colorectal-cancer.html 2021-05-24T12:57:35.3470000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-odevixibat-bylvay-for-treatment-of-progressive-familial-intrahepatic-cholestasis-pfic.html 2021-05-24T12:59:16.1040000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-setmelanotide-imcivree-for-treatment-of-obesity.html 2021-05-24T13:00:27.4940000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-tirbanibulin-mesylate-klisyri-for-treatment-of-actinic-keratosis.html 2021-05-24T13:01:25.7690000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-pitolisant-ozawade-for-treatment-of-excessive-daytime-sleepiness-with-obstructive-sleep-apnoea.html 2021-05-24T13:02:45.1920000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-relugolix-estradiol-norethisterone-acetate-ryeqo-for-treatment-of-symptoms-of-uterine-fibroids-1.html 2021-05-24T14:22:49.6350000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-vericiguat-verquvo-for-treatment-of-chronic-heart-failure.html 2021-05-24T13:06:10.0000000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-generic-formulation-of-icatibant.html 2021-05-24T13:07:24.6600000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-reminds-physicians-to-use-tecentriq-atezolizumab-with-nab-paclitaxel-not-conventional-paclitaxel-when-treating-breast-cancer-2.html 2021-05-24T13:09:12.0450000Z https://www.medicinesresources.nhs.uk/chmp-issues-further-advice-on-thrombosis-and-thrombocytopenia-with-vaxzevria-astrazenecas-covid-19-vaccine.html 2021-05-24T13:11:43.4470000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-issues-advice-on-sotrovimab-vir-7831-for-covid-19.html 2021-06-01T13:31:33.6660000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-pharmacy-update.html 2021-05-24T13:16:00.4650000Z https://www.medicinesresources.nhs.uk/conference-data-seavue-head-to-head-study-of-ustekinumab-and-adalimumab-in-crohn-s-disease.html 2021-05-24T13:17:30.8090000Z https://www.medicinesresources.nhs.uk/cardiovascular-consequences-of-discontinuing-low-dose-rivaroxaban-in-people-with-chronic-coronary-or-peripheral-artery-disease.html 2021-05-24T14:30:20.2510000Z https://www.medicinesresources.nhs.uk/secondary-cytoreduction-and-carboplatin-hyperthermic-intraperitoneal-chemotherapy-for-platinum-sensitive-recurrent-ovarian-cancer-an-msk-team-ovary-phase-ii-study.html 2021-05-24T15:01:04.0020000Z https://www.medicinesresources.nhs.uk/the-changing-health-needs-of-the-uk-population.html 2021-05-24T14:33:52.8120000Z https://www.medicinesresources.nhs.uk/securing-a-sustainable-and-fit-for-purpose-uk-health-and-care-workforce.html 2021-05-24T14:34:52.6280000Z https://www.medicinesresources.nhs.uk/what-is-the-right-level-of-spending-needed-for-health-and-care-in-the-uk.html 2021-05-24T14:35:57.4360000Z https://www.medicinesresources.nhs.uk/nhs-england-opens-up-covid-19-vaccination-offer-to-32-and-33-year-olds.html 2021-05-24T14:37:52.1510000Z https://www.medicinesresources.nhs.uk/vaccines-highly-effective-against-b-1-617-2-indian-variant-after-2-doses.html 2021-06-01T04:31:38.4920000Z https://www.medicinesresources.nhs.uk/conestat-alfa-ruconest-recommended-for-use-within-restrictions-in-nhs-wales.html 2021-05-25T16:01:57.9870000Z https://www.medicinesresources.nhs.uk/perampanel-fycompa-recommended-within-restrictions-for-use-in-nhs-wales.html 2021-05-25T16:02:25.4940000Z https://www.medicinesresources.nhs.uk/indacaterol-glycopyrronium-mometasone-enerzair-breezhaler-recommended-within-restrictions-for-use-in-nhs-wales.html 2021-05-25T16:03:15.2920000Z https://www.medicinesresources.nhs.uk/new-product-belantamab-mafodotin-blenrep-100-mg-powder-for-concentrate-for-solution-for-infusion-1.html 2021-05-25T16:04:21.9420000Z https://www.medicinesresources.nhs.uk/revised-spc-cabozantinib-cabometyx-tablets.html 2021-05-25T16:05:16.9270000Z https://www.medicinesresources.nhs.uk/corticosteroid-therapy-for-covid-19-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials-3.html 2021-06-01T04:25:27.0930000Z https://www.medicinesresources.nhs.uk/using-kelp-in-patients-on-levothyroxine-or-with-thyroid-disorders-1.html 2021-06-01T04:11:38.2000000Z https://www.medicinesresources.nhs.uk/ivermectin-in-combination-with-doxycycline-for-treating-covid-19-symptoms-a-randomised-trial.html 2021-05-25T16:08:28.5670000Z https://www.medicinesresources.nhs.uk/jak-inhibitors-for-coronavirus-disease-2019-covid-19-a-meta-analysis-3.html 2021-05-25T15:31:33.9350000Z https://www.medicinesresources.nhs.uk/hospital-admission-and-mortality-rates-for-non-covid-diseases-in-denmark-during-covid-19-pandemic-nationwide-population-based-cohort-study.html 2021-05-25T16:10:39.6290000Z https://www.medicinesresources.nhs.uk/american-college-of-rheumatology-guidance-for-covid-19-vaccination-in-patients-with-rheumatic-and-musculoskeletal-diseases-version-2.html 2021-05-25T16:40:36.7180000Z https://www.medicinesresources.nhs.uk/phase-3-ocean-study-results-demonstrate-melflufen-is-at-least-as-efficacious-as-pomalidomide-in-relapsed-refractory-multiple-myeloma.html 2021-05-25T16:41:53.1710000Z https://www.medicinesresources.nhs.uk/phase-iii-tetravalent-immunization-against-dengue-efficacy-study-tides-trial-of-its-dengue-vaccine-candidate-tak-003-data-released-by-manufacturer.html 2021-05-25T16:43:14.5960000Z https://www.medicinesresources.nhs.uk/fda-grant-fast-track-designation-to-apitegromab-for-the-treatment-of-patients-with-spinal-muscular-atrophy.html 2021-05-25T16:46:07.5200000Z https://www.medicinesresources.nhs.uk/advance-and-motivate-phase-3-studies-data-released-by-company-for-use-of-risankizumab-skyrizi-in-patients-with-moderate-to-severe-crohn-s-disease.html 2021-05-25T16:48:43.5360000Z https://www.medicinesresources.nhs.uk/valoctocogene-roxaparvovec-granted-accelerated-assessment-for-treatment-of-severe-haemophilia-a-by-european-medicines-agency-ema-2.html 2021-05-25T16:50:00.6660000Z https://www.medicinesresources.nhs.uk/fda-has-grant-breakthrough-therapy-designation-btd-for-bi-425809-for-the-treatment-of-cognitive-impairment-associated-with-schizophrenia-cias.html 2021-05-25T16:50:31.8910000Z https://www.medicinesresources.nhs.uk/vs-6766-with-defactinib-granted-breakthrough-therapy-designation-by-fda-for-recurrent-low-grade-serous-ovarian-cancer.html 2021-05-25T16:51:14.9590000Z https://www.medicinesresources.nhs.uk/republished-case-report-metformin-associated-lactic-acidosis-reinforcing-learning-points.html 2021-05-25T16:51:52.7020000Z https://www.medicinesresources.nhs.uk/republished-case-report-ace-inhibitor-induced-visceral-angioedema-an-elusive-diagnosis.html 2021-05-25T16:54:12.0350000Z https://www.medicinesresources.nhs.uk/open-consultation-mhra-patient-involvement-strategy-consultation.html 2021-05-25T16:54:59.4600000Z https://www.medicinesresources.nhs.uk/fifth-salmeterol-fluticasone-fixkoh-airmaster-dry-powder-inhaler-launched.html 2021-05-25T16:23:48.3930000Z https://www.medicinesresources.nhs.uk/european-commission-approves-ponesimod-ponvory-for-relapsing-forms-of-multiple-sclerosis-rms-with-active-disease-1.html 2021-05-25T16:57:10.5880000Z https://www.medicinesresources.nhs.uk/safety-of-early-discontinuation-of-antiseizure-medication-after-acute-symptomatic-neonatal-seizures.html 2021-05-25T16:59:56.6060000Z https://www.medicinesresources.nhs.uk/prevalence-of-human-papillomavirus-in-young-men-who-have-sex-with-men-after-the-implementation-of-gender-neutral-hpv-vaccination-a-repeated-cross-sectional-study.html 2021-05-25T17:30:33.7300000Z https://www.medicinesresources.nhs.uk/trastuzumab-deruxtecan-for-treating-her2-positive-unresectable-or-metastatic-breast-cancer-after-2-or-more-anti-her2-therapies-guidance-ta704-1.html 2021-06-01T03:46:10.3740000Z https://www.medicinesresources.nhs.uk/revised-spc-lynparza-olaparib-tablets.html 2021-05-26T15:36:32.9520000Z https://www.medicinesresources.nhs.uk/revised-spc-tecentriq-atezolizumab-concentrate-for-solution-for-infusion.html 2021-05-26T14:21:40.2880000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-phentermine-topiramate-in-adults-with-overweight-or-obesity-a-systematic-review-and-meta-analysis-2.html 2021-05-26T15:39:02.8750000Z https://www.medicinesresources.nhs.uk/dpp-4-inhibitors-may-improve-the-mortality-of-coronavirus-disease-2019-a-meta-analysis-1.html 2021-05-26T14:29:04.4770000Z https://www.medicinesresources.nhs.uk/andexanet-alfa-or-prothrombin-complex-concentrate-for-factor-xa-inhibitor-reversal-in-acute-major-bleeding-a-systematic-review-and-meta-analysis-3.html 2021-05-26T16:07:03.5390000Z https://www.medicinesresources.nhs.uk/comparison-of-infection-risks-and-clinical-outcomes-in-patients-with-and-without-sars-cov-2-lung-infection-under-renin-angiotensin-aldosterone-system-blockade-systematic-review-and-meta-analysis-1.html 2021-05-26T15:42:06.0980000Z https://www.medicinesresources.nhs.uk/a-population-based-analysis-of-the-longevity-of-sars-cov-2-antibody-seropositivity-in-the-united-states.html 2021-05-26T14:39:32.1240000Z https://www.medicinesresources.nhs.uk/the-impact-of-frailty-on-the-effectiveness-and-safety-of-intensive-glucose-control-and-blood-pressure-lowering-therapy-for-people-with-type-2-diabetes-results-from-the-advance-trial-1.html 2021-05-26T14:42:40.4330000Z https://www.medicinesresources.nhs.uk/glycemic-control-diabetic-complications-and-risk-of-dementia-in-patients-with-diabetes-results-from-a-large-u-k-cohort-study.html 2021-05-26T14:49:18.9980000Z https://www.medicinesresources.nhs.uk/effectiveness-and-safety-among-direct-oral-anticoagulants-in-nonvalvular-atrial-fibrillation-a-multi-database-cohort-study-with-meta-analysis-2.html 2021-05-26T15:44:37.3040000Z https://www.medicinesresources.nhs.uk/duration-of-amoxicillin-clavulanate-for-protracted-bacterial-bronchitis-in-children-dacs-a-multi-centre-double-blind-randomised-controlled-trial.html 2021-05-26T15:44:55.8660000Z https://www.medicinesresources.nhs.uk/continuing-versus-withdrawing-ixekizumab-treatment-in-patients-with-axial-spondyloarthritis-who-achieved-remission-efficacy-and-safety-results-from-a-placebo-controlled-randomised-withdrawal-study-coast-y-1.html 2021-05-26T15:00:07.6670000Z https://www.medicinesresources.nhs.uk/pet-guided-ebeacopp-treatment-of-advanced-stage-hodgkin-lymphoma-hd18-follow-up-analysis-of-an-international-open-label-randomised-phase-3-trial.html 2021-05-26T15:03:16.2780000Z https://www.medicinesresources.nhs.uk/brentuximab-vedotin-with-chemotherapy-for-stage-iii-or-iv-classical-hodgkin-lymphoma-echelon-1-5-year-update-of-an-international-open-label-randomised-phase-3-trial.html 2021-05-26T15:04:15.3690000Z https://www.medicinesresources.nhs.uk/neuropsychiatric-safety-of-varenicline-in-the-general-and-copd-population-with-and-without-psychiatric-disorders-a-retrospective-cohort-study-in-a-real-world-setting-1.html 2021-05-26T15:05:49.5190000Z https://www.medicinesresources.nhs.uk/symptoms-after-covid-19-vaccination-in-patients-with-persistent-symptoms-after-acute-infection-a-case-series.html 2021-05-26T15:08:28.1720000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-anti-sars-cov-2-messenger-rna-vaccines-in-recipients-of-solid-organ-transplants.html 2021-05-26T15:09:40.2220000Z https://www.medicinesresources.nhs.uk/tocilizumab-prevents-progression-of-early-systemic-sclerosis-associated-interstitial-lung-disease.html 2021-05-26T15:48:13.1520000Z https://www.medicinesresources.nhs.uk/effectiveness-of-tocilizumab-in-patients-hospitalized-with-covid-19-a-follow-up-of-the-corimuno-toci-1-randomized-clinical-trial-1.html 2021-05-27T12:59:09.0060000Z https://www.medicinesresources.nhs.uk/effect-of-continuous-infusion-of-hypertonic-saline-vs-standard-care-on-6-month-neurological-outcomes-in-patients-with-traumatic-brain-injury-the-cobi-randomized-clinical-trial.html 2021-05-26T15:17:06.0160000Z https://www.medicinesresources.nhs.uk/manufacturer-reports-moderna-vaccine-highly-effective-in-teens.html 2021-05-26T15:20:45.7130000Z https://www.medicinesresources.nhs.uk/fda-to-review-ublituximab-with-umbralisib-for-chronic-lymphocytic-leukaemia-and-small-lymphocytic-lymphoma.html 2021-05-26T15:22:39.5610000Z https://www.medicinesresources.nhs.uk/venetoclax-in-combination-with-a-hypomethylating-agent-approved-for-use-in-eu-for-newly-diagnosed-acute-myeloid-leukemia-who-are-ineligible-for-intensive-chemotherapy-3.html 2021-05-26T15:27:17.9600000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-pegcetacoplan-for-paroxysmal-nocturnal-haemoglobinuria-in-phase-3-prince-study-1.html 2021-05-26T15:29:00.2510000Z https://www.medicinesresources.nhs.uk/fda-to-review-udenafil-for-use-in-single-ventricle-disease-1.html 2021-05-26T15:34:02.8100000Z https://www.medicinesresources.nhs.uk/advanced-therapy-medicinal-products-june-2021-themed-issue-bjcp.html 2021-05-26T15:35:43.8130000Z https://www.medicinesresources.nhs.uk/pembrolizumab-induced-vitiligo-in-a-patient-with-lung-adenocarcinoma-a-case-report.html 2021-05-26T16:03:24.3410000Z https://www.medicinesresources.nhs.uk/republished-case-of-relapsing-sulfasalazine-induced-hypersensitivity-syndrome-upon-re-exposure.html 2021-05-26T15:38:22.2530000Z https://www.medicinesresources.nhs.uk/republished-severe-hyperthermia-due-to-oral-baclofen-withdrawal.html 2021-05-26T15:41:19.6630000Z https://www.medicinesresources.nhs.uk/car-t-cell-therapy-for-multiple-myeloma-state-of-the-art-and-prospects.html 2021-05-26T15:42:55.2780000Z https://www.medicinesresources.nhs.uk/inducing-labour-draft-updated-guidance.html 2021-05-26T15:44:09.6310000Z https://www.medicinesresources.nhs.uk/lower-carbohydrate-diets-for-adults-with-type-2-diabetes-draft-report-1.html 2021-05-26T15:46:08.8450000Z https://www.medicinesresources.nhs.uk/risk-reduction-and-management-of-delirium-decision-support-tool.html 2021-05-26T15:47:14.4870000Z https://www.medicinesresources.nhs.uk/epilepsy-in-children-patient-information-booklets.html 2021-05-26T15:48:25.3710000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-managing-covid-19-ng191-update-2.html 2021-06-01T03:30:47.2020000Z https://www.medicinesresources.nhs.uk/national-stroke-service-model-integrated-stroke-delivery-networks.html 2021-06-01T03:36:13.2840000Z https://www.medicinesresources.nhs.uk/revised-spc-eliquis-apixaban-2-5-mg-film-coated-tablets-1.html 2021-05-27T17:39:38.6990000Z https://www.medicinesresources.nhs.uk/revised-spc-epistatus-midazolam-10-mg-oromucosal-solution-1.html 2021-05-27T17:38:47.2830000Z https://www.medicinesresources.nhs.uk/prescribing-for-pregnancy-managing-diabetes-2.html 2021-05-27T17:37:20.0830000Z https://www.medicinesresources.nhs.uk/pembrolizumab-alone-or-combined-with-chemotherapy-versus-chemotherapy-as-first-line-therapy-for-advanced-urothelial-carcinoma-keynote-361-a-randomised-open-label-phase-3-trial.html 2021-05-27T17:59:44.5200000Z https://www.medicinesresources.nhs.uk/effect-of-2-inactivated-sars-cov-2-vaccines-on-symptomatic-covid-19-infection-in-adults-a-randomized-clinical-trial.html 2021-05-27T17:35:14.3780000Z https://www.medicinesresources.nhs.uk/ceftriaxone-compared-with-benzylpenicillin-in-the-treatment-of-neurosyphilis-in-france-a-retrospective-multicentre-study.html 2021-05-27T17:34:23.2850000Z https://www.medicinesresources.nhs.uk/improving-shared-decision-making-in-pharmacist-led-haematology-clinics-a-plan-do-study-act-approach.html 2021-05-27T17:56:31.4800000Z https://www.medicinesresources.nhs.uk/prescription-medications-for-sleep-disturbances-among-midlife-women-during-2-years-of-follow-up-a-swan-retrospective-cohort-study-3.html 2021-05-27T17:33:07.9160000Z https://www.medicinesresources.nhs.uk/shortage-of-alliance-calcium-syrup.html 2021-06-01T03:33:00.0450000Z https://www.medicinesresources.nhs.uk/erleada-maintains-quality-of-life-for-prostate-cancer-patients.html 2021-05-27T17:30:56.4400000Z https://www.medicinesresources.nhs.uk/fda-approves-pfizer-myovants-uterine-fibroids-drug-myfembree-3.html 2021-05-27T17:53:27.6450000Z https://www.medicinesresources.nhs.uk/nuffield-trust-update-trends-in-the-quality-of-cancer-care-2.html 2021-05-27T17:28:48.6050000Z https://www.medicinesresources.nhs.uk/antibiotic-therapy-for-6-or-12-weeks-for-prosthetic-joint-infection.html 2021-05-27T17:28:04.5660000Z https://www.medicinesresources.nhs.uk/daratumumab-in-combination-for-untreated-multiple-myeloma-when-a-stem-cell-transplant-is-suitable-appraisal-consultation-document.html 2021-05-27T17:50:06.0710000Z https://www.medicinesresources.nhs.uk/public-assessment-report-of-the-reclassification-of-nasacort-allergy-relief-for-adults-55-micrograms-dose-nasal-spray-suspension-3.html 2021-05-27T17:26:14.7060000Z https://www.medicinesresources.nhs.uk/a-practical-approach-to-the-management-of-digital-ulcers-in-patients-with-systemic-sclerosis-a-narrative-review.html 2021-05-27T17:24:46.6710000Z https://www.medicinesresources.nhs.uk/diagnosis-management-and-therapeutic-strategies-for-congenital-long-qt-syndrome-1.html 2021-05-27T17:22:27.6700000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-concludes-insufficient-data-on-use-of-inhaled-corticosteroids-to-treat-covid-19.html 2021-06-01T03:39:28.6380000Z https://www.medicinesresources.nhs.uk/serious-shortage-protocols-one-year-policy-review.html 2021-05-27T17:20:57.2020000Z https://www.medicinesresources.nhs.uk/new-strategy-for-the-changing-world-of-health-and-social-care-our-strategy-from-2021.html 2021-05-27T17:20:16.6580000Z https://www.medicinesresources.nhs.uk/opioid-medicines-management-in-primary-care-settings-a-scoping-review-of-quantitative-studies-of-pharmacists-activities-3.html 2021-05-27T17:19:46.8300000Z https://www.medicinesresources.nhs.uk/which-is-the-best-model-to-assess-risk-for-venous-thromboembolism-in-hospitalised-patients-1.html 2021-05-27T17:18:47.9160000Z https://www.medicinesresources.nhs.uk/fda-has-approved-the-new-drug-application-nda-for-camcevi-r-42-mg-a-ready-to-use-6-month-subcutaneous-depot-formulation-of-leuprolide-mesylate-as-a-treatment-of-advanced-prostate-cancer.html 2021-05-27T17:14:25.6400000Z https://www.medicinesresources.nhs.uk/sanofi-and-gsk-initiate-global-phase-3-clinical-efficacy-study-of-covid-19-vaccine-candidate.html 2021-05-27T17:12:47.0730000Z https://www.medicinesresources.nhs.uk/clinician-faqs-and-guidance-on-covid-19-vaccine-for-patients-receiving-systemic-anti-cancer-therapy-sact-version-4-0.html 2021-06-01T03:42:08.6470000Z https://www.medicinesresources.nhs.uk/revised-spc-kaftrio-75-mg-50-mg-100-mg-ivacaftor-tezacaftor-elexacaftor-film-coated-tablets-1.html 2021-05-28T14:29:01.6100000Z https://www.medicinesresources.nhs.uk/revised-spc-kalydeco-ivacaftor-150-mg-film-coated-tablets-1.html 2021-05-28T14:32:42.5340000Z https://www.medicinesresources.nhs.uk/nihr-alert-practical-changes-in-cancer-care-could-reduce-fear-and-confusion-among-people-with-dementia.html 2021-05-28T14:34:38.7340000Z https://www.medicinesresources.nhs.uk/us-fda-grants-emergency-use-authorization-to-sotrovimab-for-mild-to-moderate-covid-19.html 2021-05-28T14:37:19.6710000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-grants-trehalose-orphan-drug-designation-for-the-treatment-of-amyotrophic-lateral-sclerosis-2.html 2021-05-28T14:43:15.4140000Z https://www.medicinesresources.nhs.uk/us-fda-advisory-committee-votes-benefits-of-teplizumab-outweigh-risks-supporting-approval-to-delay-clinical-type-1-diabetes-ct1d-1.html 2021-05-28T14:45:45.3570000Z https://www.medicinesresources.nhs.uk/phase-iii-study-of-sugemalimab-in-locally-advanced-unresectable-non-small-cell-lung-cancer-meets-its-primary-endpoint.html 2021-05-28T14:50:07.5130000Z https://www.medicinesresources.nhs.uk/us-fda-approves-rimegepant-for-the-preventive-treatment-of-migraine.html 2021-05-28T15:21:46.9940000Z https://www.medicinesresources.nhs.uk/us-fda-approves-ozanimod-for-the-treatment-of-adults-with-moderately-to-severely-active-ulcerative-colitis.html 2021-05-28T14:52:48.7850000Z https://www.medicinesresources.nhs.uk/norwegian-medicines-agency-reviews-data-on-suspected-fatal-adverse-reactions-reported-in-nursing-home-patients-following-covid-19-vaccination.html 2021-05-28T14:55:25.3080000Z https://www.medicinesresources.nhs.uk/regional-lymphadenopathy-following-covid-19-vaccination-considerations-for-primary-care-management.html 2021-05-28T14:57:04.5250000Z https://www.medicinesresources.nhs.uk/pre-eclampsia.html 2021-05-28T14:58:19.6270000Z https://www.medicinesresources.nhs.uk/public-health-leaders-urge-caution-in-areas-of-high-covid-19-variant-prevalence.html 2021-05-28T15:42:16.3180000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-surveillance-report-week-21.html 2021-05-28T15:06:45.1160000Z https://www.medicinesresources.nhs.uk/mhra-approves-covid-19-vaccine-janssen-2.html 2021-05-30T12:28:39.4930000Z https://www.medicinesresources.nhs.uk/guselkumab-for-treating-active-psoriatic-arthritis-after-inadequate-response-to-dmards-final-appraisal-document-2.html 2021-05-28T15:11:59.7250000Z https://www.medicinesresources.nhs.uk/european-commission-approves-osimertinib-for-adjuvant-treatment-of-early-stage-egfr-mutated-non-small-cell-lung-cancer-2.html 2021-05-28T15:14:01.8780000Z https://www.medicinesresources.nhs.uk/sore-throat-testing-and-contraception-monitoring-services-under-development-for-pharmacies-in-england.html 2021-05-28T15:15:33.5280000Z https://www.medicinesresources.nhs.uk/dosing-information-for-covid-19-vaccines.html 2021-05-30T12:29:31.0540000Z https://www.medicinesresources.nhs.uk/medicine-supply-notification-diamorphine-hydrochloride-powder-for-reconstitution-and-injection-5mg-and-10mg-ampoules-update.html 2021-05-30T12:30:57.0290000Z https://www.medicinesresources.nhs.uk/colchicine-for-community-treated-patients-with-covid-19-colcorona-a-phase-3-randomised-double-blinded-adaptive-placebo-controlled-multicentre-trial.html 2021-05-28T15:47:12.7130000Z https://www.medicinesresources.nhs.uk/safety-immunogenicity-and-efficacy-of-the-bnt162b2-covid-19-vaccine-in-adolescents.html 2021-05-28T15:48:59.4220000Z https://www.medicinesresources.nhs.uk/spatial-temporal-and-demographic-patterns-in-prevalence-of-smoking-tobacco-use-and-attributable-disease-burden-in-204-countries-and-territories-1990-2019-a-systematic-analysis-from-the-global-burden-of-disease-study-2019.html 2021-05-28T15:29:01.3830000Z https://www.medicinesresources.nhs.uk/cognitive-performance-declines-in-older-adults-with-type-1-diabetes-results-from-32-years-of-follow-up-in-the-dcct-and-edic-study.html 2021-05-28T15:31:37.0430000Z https://www.medicinesresources.nhs.uk/patient-reported-outcomes-with-atezolizumab-plus-bevacizumab-versus-sorafenib-in-patients-with-unresectable-hepatocellular-carcinoma-imbrave150-an-open-label-randomised-phase-3-trial.html 2021-05-28T15:32:57.2450000Z https://www.medicinesresources.nhs.uk/spatial-temporal-and-demographic-patterns-in-prevalence-of-smoking-tobacco-use-and-initiation-among-young-people-in-204-countries-and-territories-1990-2019.html 2021-05-28T15:34:08.8310000Z https://www.medicinesresources.nhs.uk/spatial-temporal-and-demographic-patterns-in-prevalence-of-chewing-tobacco-use-in-204-countries-and-territories-1990-2019-a-systematic-analysis-from-the-global-burden-of-disease-study-2019.html 2021-05-28T15:54:27.9370000Z https://www.medicinesresources.nhs.uk/revised-spc-constella-linaclotide-290-micrograms-hard-capsules-3.html 2021-06-01T19:16:03.9120000Z https://www.medicinesresources.nhs.uk/new-product-alexi-fosfomycin-trometamol-3g-granules-for-oral-solution-1.html 2021-06-01T14:55:43.7390000Z https://www.medicinesresources.nhs.uk/revised-spc-butec-buprenorphine-transdermal-patch-all-strengths-1.html 2021-06-01T19:11:22.6200000Z https://www.medicinesresources.nhs.uk/educational-risk-minimisation-materials-to-help-reduce-the-risk-associated-with-using-waylivra-volanesorsen-sodium-2.html 2021-06-07T04:55:18.5810000Z https://www.medicinesresources.nhs.uk/suitability-of-calcium-and-vitamin-d-preparations-for-vegetarians-or-vegans.html 2021-06-07T04:58:00.6410000Z https://www.medicinesresources.nhs.uk/european-commission-approves-efmody-hydrocortisone-modified-release-capsules-for-treatment-of-congenital-adrenal-hyperplasia-1.html 2021-06-01T15:07:51.9920000Z https://www.medicinesresources.nhs.uk/sanofi-halts-clinical-programme-of-venglustat-in-autosomal-dominant-polycystic-kidney-disease.html 2021-06-01T15:10:46.2050000Z https://www.medicinesresources.nhs.uk/new-ssp-endorsement-introduced.html 2021-06-01T15:12:46.1770000Z https://www.medicinesresources.nhs.uk/pandemic-pressures-how-greater-manchester-equalities-organisations-have-responded-to-the-needs-of-older-people-during-the-covid-19-crisis.html 2021-06-01T15:15:27.0440000Z https://www.medicinesresources.nhs.uk/chronic-pain-an-update-on-burden-best-practices-and-new-advances-1.html 2021-06-01T16:10:26.2700000Z https://www.medicinesresources.nhs.uk/us-fda-issues-its-first-ever-non-compliance-notice-for-not-posting-trial-results.html 2021-06-01T15:24:27.2650000Z https://www.medicinesresources.nhs.uk/world-health-organization-who-announces-new-naming-system-for-variants-of-covid-19.html 2021-06-01T15:25:58.8660000Z https://www.medicinesresources.nhs.uk/european-medicines-agencys-chmp-recommends-granting-of-extension-of-indication-for-pfizer-and-biontech-covid-19-vaccine-comirnaty-to-include-use-in-children-aged-12-to-15-in-eu.html 2021-06-01T15:27:38.4840000Z https://www.medicinesresources.nhs.uk/fda-accepts-new-drug-application-nda-for-palovarotene-as-first-potential-treatment-worldwide-for-fibrodysplasia-ossificans-progressiva-fop-1.html 2021-06-01T19:00:58.0170000Z https://www.medicinesresources.nhs.uk/fda-approves-sotorasib-lumakras-for-treatment-of-patients-with-non-small-cell-lung-cancer-nsclc-whose-tumours-have-kras-g12c-mutation-3.html 2021-06-01T18:58:38.1880000Z https://www.medicinesresources.nhs.uk/novartis-reports-one-year-results-of-two-year-phase-iii-merlin-study-of-beovu-brolucizumab-vs-aflibercept-1.html 2021-06-01T15:34:40.4010000Z https://www.medicinesresources.nhs.uk/a-guide-to-immunisations-for-babies-born-on-or-after-1-january-2023.html 2021-06-01T15:37:56.5950000Z https://www.medicinesresources.nhs.uk/evaluation-of-seropositivity-following-bnt162b2-messenger-rna-vaccination-for-sars-cov-2-in-patients-undergoing-treatment-for-cancer.html 2021-06-01T15:54:21.8740000Z https://www.medicinesresources.nhs.uk/assessment-of-sars-cov-2-reinfection-1-year-after-primary-infection-in-a-population-in-lombardy-italy-1.html 2021-06-01T15:56:28.6500000Z https://www.medicinesresources.nhs.uk/covid-19-outcomes-in-patients-with-systemic-autoimmune-rheumatic-diseases-compared-to-the-general-population-a-us-multicenter-comparative-cohort-study-2.html 2021-06-01T18:53:52.2260000Z https://www.medicinesresources.nhs.uk/sustainability-of-neutralising-antibodies-induced-by-bivalent-or-quadrivalent-hpv-vaccines-and-correlation-with-efficacy-a-combined-follow-up-analysis-of-data-from-two-randomised-double-blind-multicentre-phase-3-trials-4.html 2021-06-01T18:52:35.0290000Z https://www.medicinesresources.nhs.uk/new-product-evrysdi-risdiplam-0-75-mg-ml-powder-for-oral-solution-2.html 2021-06-02T14:41:52.2980000Z https://www.medicinesresources.nhs.uk/revised-spc-ibrance-palbociclib-hard-capsules.html 2021-06-03T11:41:57.3810000Z https://www.medicinesresources.nhs.uk/atezolizumab-monotherapy-for-untreated-advanced-non-small-cell-lung-cancer-guidance-ta705.html 2021-06-07T04:48:23.7830000Z https://www.medicinesresources.nhs.uk/development-and-external-validation-of-the-psychosis-metabolic-risk-calculator-psymetric-a-cardiometabolic-risk-prediction-algorithm-for-young-people-with-psychosis.html 2021-06-02T14:45:57.3970000Z https://www.medicinesresources.nhs.uk/daratumumab-plus-pomalidomide-and-dexamethasone-versus-pomalidomide-and-dexamethasone-alone-in-previously-treated-multiple-myeloma-apollo-an-open-label-randomised-phase-3-trial-1.html 2021-06-02T14:47:29.9090000Z https://www.medicinesresources.nhs.uk/lenvatinib-versus-sorafenib-for-first-line-treatment-of-unresectable-hepatocellular-carcinoma-patient-reported-outcomes-from-a-randomised-open-label-non-inferiority-phase-3-trial.html 2021-06-02T14:48:50.8710000Z https://www.medicinesresources.nhs.uk/effect-of-reduced-dose-vs-high-dose-glucocorticoids-added-to-rituximab-on-remission-induction-in-anca-associated-vasculitis-a-randomized-clinical-trial.html 2021-06-02T14:50:12.4860000Z https://www.medicinesresources.nhs.uk/nortriptyline-for-pain-in-knee-osteoarthritis-a-double-blind-randomised-controlled-trial-in-new-zealand-general-practice-2.html 2021-06-02T14:53:55.3310000Z https://www.medicinesresources.nhs.uk/china-s-sinovac-covid-19-vaccine-receives-who-emergency-approval.html 2021-06-02T14:56:24.7550000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-outcomes-for-vamorolone-for-duchenne-muscular-dystrophy-in-vision-dmd-study.html 2021-06-02T14:58:42.3590000Z https://www.medicinesresources.nhs.uk/fda-to-review-market-authorisation-application-for-vadadustat-for-anaemia-due-to-chronic-kidney-disease-in-adult-patients-on-dialysis-and-not-on-dialysis.html 2021-06-02T15:00:12.4070000Z https://www.medicinesresources.nhs.uk/fda-grants-priority-review-for-plinabulin-with-g-csf-for-the-prevention-of-chemotherapy-induced-neutropoenia.html 2021-06-02T15:03:41.1040000Z https://www.medicinesresources.nhs.uk/new-drug-application-submitted-to-fda-for-oteseconazole-for-recurrent-vulvovaginal-candidiasis.html 2021-06-02T15:06:25.2770000Z https://www.medicinesresources.nhs.uk/manufacturers-submit-emergency-use-authorisation-application-to-fda-for-zyesami-tm-aviptadil-acetate-to-treat-critical-covid-19-in-patients-with-respiratory-failure.html 2021-06-02T15:11:02.7410000Z https://www.medicinesresources.nhs.uk/fda-approve-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcaemia-type-1-adh1.html 2021-06-02T15:14:20.2070000Z https://www.medicinesresources.nhs.uk/biogen-report-positive-results-from-phase-3-study-of-biosimilar-tocilizumab-in-rheumatoid-arthritis.html 2021-06-02T15:15:58.2080000Z https://www.medicinesresources.nhs.uk/pacritinib-granted-priority-review-by-fda-for-myelofibrosis.html 2021-06-02T15:17:21.6500000Z https://www.medicinesresources.nhs.uk/fda-grant-breakthrough-therapy-designation-for-teclistamab-for-relapsed-or-refractory-multiple-myeloma.html 2021-06-02T15:18:28.0360000Z https://www.medicinesresources.nhs.uk/manufacturers-report-baricitinib-improved-pain-physical-function-and-morning-joint-stiffness-in-rheumatoid-arthritis-in-post-hoc-analyses-of-ra-beam-phase-3-study.html 2021-06-02T15:19:39.8710000Z https://www.medicinesresources.nhs.uk/maufacturers-report-consistent-long-term-improvement-in-patients-with-axial-spondyloarthritis-treated-with-ixekizumab-over-two-years-in-phase-3-study.html 2021-06-02T15:20:50.4860000Z https://www.medicinesresources.nhs.uk/fda-approve-secukinumab-for-treatment-of-children-and-adolescents-with-moderate-to-severe-plaque-psoriasis.html 2021-06-02T15:23:00.7980000Z https://www.medicinesresources.nhs.uk/elamipretide-receives-orphan-drug-designation-odd-from-the-european-medicines-agency-for-the-treatment-of-barth-syndrome.html 2021-06-02T15:26:44.8950000Z https://www.medicinesresources.nhs.uk/initial-clinical-management-of-adult-smokers-in-secondary-care-4.html 2021-06-02T15:30:26.5930000Z https://www.medicinesresources.nhs.uk/fda-approve-lybalvi-olanzapine-samidorphan-for-use-in-schizophrenia-and-bipolar-i-disorder-in-us.html 2021-06-02T15:32:46.7470000Z https://www.medicinesresources.nhs.uk/fda-approves-infigratinib-for-previously-treated-locally-advanced-or-metastatic-cholangiocarcinoma-with-an-fgfr2-fusion-or-rearrangement-1.html 2021-06-02T15:34:39.2930000Z https://www.medicinesresources.nhs.uk/three-phase-iii-trials-for-brolucizumab-terminated-early-owing-to-high-rates-of-ocular-inflammation.html 2021-06-02T15:37:40.7980000Z https://www.medicinesresources.nhs.uk/additional-manufacturing-capacity-for-biontech-pfizers-covid-19-vaccine-approved-by-the-european-medicines-agency-2.html 2021-06-02T15:42:38.9690000Z https://www.medicinesresources.nhs.uk/hiv-pre-exposure-prophylaxis-scaling-up-for-impact-now-and-in-the-future.html 2021-06-02T15:43:52.6920000Z https://www.medicinesresources.nhs.uk/the-effect-of-non-aids-defining-cancers-on-people-living-with-hiv.html 2021-06-02T15:45:19.2140000Z https://www.medicinesresources.nhs.uk/trurapi-first-insulin-aspart-biosimilar-launched.html 2021-06-02T15:46:47.6470000Z https://www.medicinesresources.nhs.uk/risdiplam-for-treating-spinal-muscular-atrophy-in-children-and-adults-appraisal-consultation-document.html 2021-06-02T15:48:32.3330000Z https://www.medicinesresources.nhs.uk/new-guide-for-lgbt-patients-on-what-to-expect-from-their-doctor-2.html 2021-06-02T15:50:15.3270000Z https://www.medicinesresources.nhs.uk/hospital-associated-sars-cov-2-infection-and-care-home-outbreaks.html 2021-06-02T15:52:29.9910000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-data-for-ciltacabtagene-autoleucel-for-heavily-pretreated-relapsed-refractory-multiple-myeloma-2.html 2021-06-02T15:54:48.9990000Z https://www.medicinesresources.nhs.uk/malaria-prevention-guidelines-for-travellers-from-the-uk-2021-update.html 2021-06-02T15:59:03.9890000Z https://www.medicinesresources.nhs.uk/optimise-the-use-of-medication-assisted-treatment-mat.html 2021-06-02T16:02:05.7760000Z https://www.medicinesresources.nhs.uk/new-product-evaluations-may-2021.html 2021-06-07T04:50:53.2180000Z https://www.medicinesresources.nhs.uk/covid-19-rapid-guideline-managing-covid-19-updated-03-june-2.html 2021-06-07T04:30:56.6290000Z https://www.medicinesresources.nhs.uk/revised-spc-dailiport-and-adoport-tacrolimus-all-presentations.html 2021-06-03T16:33:29.5310000Z https://www.medicinesresources.nhs.uk/revised-spc-zydol-tramadol-xl-400-mg-prolonged-release-tablets.html 2021-06-03T15:00:06.6100000Z https://www.medicinesresources.nhs.uk/new-product-alymsys-bevacizumab-25mg-ml-concentrate-for-solution-for-infusion.html 2021-06-03T15:01:06.0750000Z https://www.medicinesresources.nhs.uk/wrong-site-surgery-wrong-patient-invasive-procedures-in-outpatient-settings.html 2021-06-07T04:32:44.6030000Z https://www.medicinesresources.nhs.uk/rmoc-shared-care-guidance-draft-shared-care-protocols-consultation-3.html 2021-06-07T04:35:12.0390000Z https://www.medicinesresources.nhs.uk/hiv-infection-screening-diagnosis-and-treatment.html 2021-06-03T15:05:20.1010000Z https://www.medicinesresources.nhs.uk/pitolisant-hydrochloride-for-treating-excessive-daytime-sleepiness-caused-by-obstructive-sleep-apnoea-appraisal-consultation-document-1.html 2021-06-03T15:07:32.2560000Z https://www.medicinesresources.nhs.uk/diabetes-following-acute-pancreatitis-2.html 2021-06-03T16:35:08.1890000Z https://www.medicinesresources.nhs.uk/covid-19-pathophysiology-looking-beyond-acute-disease.html 2021-06-03T17:14:31.4710000Z https://www.medicinesresources.nhs.uk/when-vaccine-apathy-not-hesitancy-drives-vaccine-disinterest.html 2021-06-03T15:16:55.7440000Z https://www.medicinesresources.nhs.uk/draft-guidance-for-industry-oral-drug-products-administered-via-enteral-feeding-tube-in-vitro-testing-and-labeling-recommendations-in-us-3.html 2021-06-03T15:19:43.1050000Z https://www.medicinesresources.nhs.uk/benefit-versus-toxicity-risk-of-digoxin-in-patients-with-covid-19.html 2021-06-03T15:21:29.9860000Z https://www.medicinesresources.nhs.uk/g7-carbis-bay-progress-report-advancing-universal-health-coverage-and-global-health-through-strengthening-health-systems-preparedness-and-resilience-3.html 2021-06-03T15:23:46.6740000Z https://www.medicinesresources.nhs.uk/three-quarters-of-uk-adults-vaccinated-with-first-dose-2.html 2021-06-03T15:25:42.5660000Z https://www.medicinesresources.nhs.uk/covid-19-is-it-safe-to-lift-all-restrictions-in-england-from-21-june-2.html 2021-06-03T15:28:37.3570000Z https://www.medicinesresources.nhs.uk/a-data-linkage-approach-to-assessing-the-contribution-of-hospital-associated-sars-cov-2-infection-to-care-home-outbreaks-in-england-30-january-to-12-october-2021.html 2021-06-03T17:11:18.2200000Z https://www.medicinesresources.nhs.uk/covid-19-updated-guidance-for-maintaining-services-within-health-and-care-settings-infection-prevention-and-control-recommendations.html 2021-06-07T04:39:08.0090000Z https://www.medicinesresources.nhs.uk/moderna-files-for-full-u-s-approval-of-covid-19-vaccine.html 2021-06-03T15:34:52.5050000Z https://www.medicinesresources.nhs.uk/israels-health-ministry-suggests-link-between-pfizers-covid-19-vaccine-and-myocarditis-cases.html 2021-06-03T15:36:53.4080000Z https://www.medicinesresources.nhs.uk/european-commission-approves-nivolumab-plus-ipilimumab-as-first-line-treatment-for-unresectable-malignant-pleural-mesothelioma.html 2021-06-03T15:38:33.6040000Z https://www.medicinesresources.nhs.uk/new-data-from-phase-3b-cosmos-study-of-guselkumab-show-improvement-in-joint-symptoms-and-complete-skin-clearance-in-patients-with-psoriatic-arthritis-and-inadequate-response-to-tumor-necrosis-factor-inhibition-tnfi-ir-1.html 2021-06-03T17:08:44.2930000Z https://www.medicinesresources.nhs.uk/phase-3-maintenance-data-from-fortify-study-show-patient-with-moderate-to-severe-crohn-s-disease-receiving-risankizumab-achieved-endoscopic-response-and-clinical-remission-at-one-year.html 2021-06-03T15:44:45.5290000Z https://www.medicinesresources.nhs.uk/fda-accepts-new-drug-application-for-oleogel-s10-filsuvez-for-treatment-of-epidermolysis-bullosa-eb.html 2021-06-03T15:46:53.3550000Z https://www.medicinesresources.nhs.uk/fda-accepts-resubmitted-new-drug-application-for-xiper-triamcinolone-acetonide-suprachoroidal-injectable-suspension-for-treatment-of-macular-oedema-associated-with-uveitis-1.html 2021-06-03T15:49:02.7950000Z https://www.medicinesresources.nhs.uk/novartis-announces-updated-median-overall-survival-os-data-from-phase-iii-monaleesa-3-trial-of-cdk4-6-inhibitor-ribociclib-in-combination-with-fulvestrant-in-postmenopausal-women-with-hr-her2-metastatic-breast-cancer.html 2021-06-03T17:05:55.2340000Z https://www.medicinesresources.nhs.uk/fda-approves-brexafemme-ibrexafungerp-tablets-as-the-first-oral-non-azole-treatment-for-vaginal-yeast-infections.html 2021-06-03T16:35:30.8310000Z https://www.medicinesresources.nhs.uk/mhra-grants-conditional-marketing-authorization-in-uk-for-selinexor-nexpovio-in-combination-with-dexamethasone-for-treatment-of-adult-patients-with-relapsed-and-or-refractory-multiple-myeloma-2.html 2021-06-03T15:54:26.6650000Z https://www.medicinesresources.nhs.uk/using-covid-19-vaccines-during-hot-weather.html 2021-06-07T04:41:54.3890000Z https://www.medicinesresources.nhs.uk/a-systematic-review-of-community-pharmacy-initiatives-to-improve-treatment-of-depression-and-pain-focus-on-types-of-programs-and-patient-reported-outcomes-1.html 2021-06-03T16:36:28.3160000Z https://www.medicinesresources.nhs.uk/association-of-opioid-agonist-treatment-with-all-cause-mortality-and-specific-causes-of-death-among-people-with-opioid-dependence-a-systematic-review-and-meta-analysis.html 2021-06-03T16:14:22.0460000Z https://www.medicinesresources.nhs.uk/adjuvant-nivolumab-versus-placebo-in-muscle-invasive-urothelial-carcinoma-3.html 2021-06-03T16:16:47.9740000Z https://www.medicinesresources.nhs.uk/effect-of-dexamethasone-on-complications-or-all-cause-mortality-after-major-non-cardiac-surgery-multicentre-double-blind-randomised-controlled-trial.html 2021-06-03T16:37:30.1090000Z https://www.medicinesresources.nhs.uk/effect-of-continuous-glucose-monitoring-on-glycemic-control-in-patients-with-type-2-diabetes-treated-with-basal-insulin-a-randomized-clinical-trial.html 2021-06-03T16:52:00.5310000Z https://www.medicinesresources.nhs.uk/association-of-real-time-continuous-glucose-monitoring-with-glycemic-control-and-acute-metabolic-events-among-patients-with-insulin-treated-diabetes.html 2021-06-03T16:50:22.1230000Z https://www.medicinesresources.nhs.uk/smoking-cessation-weight-gain-and-risk-of-cardiovascular-disease-1.html 2021-06-03T16:25:04.5470000Z https://www.medicinesresources.nhs.uk/characterising-the-long-term-clinical-outcomes-of-1190-hospitalised-patients-with-covid-19-in-new-york-city-a-retrospective-case-series.html 2021-06-03T16:41:57.3850000Z https://www.medicinesresources.nhs.uk/clinical-frailty-and-polypharmacy-in-older-emergency-critical-care-patients-a-single-centre-retrospective-case-series.html 2021-06-03T16:41:43.3290000Z https://www.medicinesresources.nhs.uk/the-effect-of-intravenous-ferric-carboxymaltose-on-health-related-quality-of-life-in-iron-deficient-patients-with-acute-heart-failure-the-results-of-the-affirm-ahf-study.html 2021-06-03T16:43:27.4920000Z https://www.medicinesresources.nhs.uk/new-spc-covid-19-vaccine-janssen-suspension-for-injection.html 2021-06-05T19:02:42.5270000Z https://www.medicinesresources.nhs.uk/revised-spc-extavia-recombinant-interferon-beta-1b-250-microgram-ml-powder-and-solvent-for-solution-for-injection.html 2021-06-04T14:31:39.8300000Z https://www.medicinesresources.nhs.uk/revised-spcs-kisplyx-lenvatinib-hard-capsules.html 2021-06-04T14:33:55.3680000Z https://www.medicinesresources.nhs.uk/venetoclax-venclyxto-updated-recommendations-on-tumour-lysis-syndrome-tls-in-cll-patients.html 2021-06-05T19:05:51.4790000Z https://www.medicinesresources.nhs.uk/us-fda-grants-rusfertide-breakthrough-therapy-designation-for-the-treatment-of-polycythemia-vera.html 2021-06-04T14:45:04.3410000Z https://www.medicinesresources.nhs.uk/177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-for-men-with-metastatic-castration-resistant-prostate-cancer-in-phase-iii-vision-study.html 2021-06-04T14:50:54.6260000Z https://www.medicinesresources.nhs.uk/positive-data-for-atogepant-in-prophylaxis-of-migraine-headaches-presented-at-conference.html 2021-06-04T14:52:24.1450000Z https://www.medicinesresources.nhs.uk/data-from-phase-iii-trial-of-toripalimab-in-combination-with-chemotherapy-in-the-first-line-treatment-of-recurrent-metastatic-nasopharyngeal-carcinoma-presented-at-conference-3.html 2021-06-04T14:56:10.2300000Z https://www.medicinesresources.nhs.uk/data-from-phase-iii-keynote-564-study-of-adjuvant-pembrolizumab-in-renal-cell-carcinoma-rcc-presented-at-conference.html 2021-06-04T16:02:04.2580000Z https://www.medicinesresources.nhs.uk/application-seeking-approval-of-tapinarof-cream-for-the-treatment-of-adults-with-plaque-psoriasis-submitted-to-the-us-fda.html 2021-06-04T14:59:32.8470000Z https://www.medicinesresources.nhs.uk/long-term-results-for-tucatinib-added-to-trastuzumab-and-capecitabine-in-patients-with-her2-positive-metastatic-breast-cancer-her2climb-study-presented-at-conference-1.html 2021-06-04T16:03:05.2120000Z https://www.medicinesresources.nhs.uk/delta-voc-21apr-02-covid-19-variant-now-dominant-in-the-uk-1.html 2021-06-04T16:03:57.7200000Z https://www.medicinesresources.nhs.uk/congenital-cytomegalovirus-infection.html 2021-06-04T15:11:03.5270000Z https://www.medicinesresources.nhs.uk/data-informing-international-travel-traffic-light-risk-assessments-3-june-2021.html 2021-06-04T16:04:55.9430000Z https://www.medicinesresources.nhs.uk/government-and-life-science-industry-join-forces-on-100-days-mission-for-future-pandemics.html 2021-06-04T15:13:53.1680000Z https://www.medicinesresources.nhs.uk/most-vulnerable-set-to-benefit-from-further-gbp1-million-investment-to-safeguard-modern-medicine.html 2021-06-04T15:17:15.3140000Z https://www.medicinesresources.nhs.uk/conference-report-atorvastatin-does-not-reduce-mortality-in-covid-19.html 2021-06-14T08:25:39.3100000Z https://www.medicinesresources.nhs.uk/covid-19-real-world-evidence-and-observational-studies-7.html 2021-06-04T16:06:42.1080000Z https://www.medicinesresources.nhs.uk/update-on-the-diagnosis-and-treatment-of-poems-polyneuropathy-organomegaly-endocrinopathy-monoclonal-gammopathy-and-skin-changes-syndrome-1.html 2021-06-04T16:07:25.8890000Z https://www.medicinesresources.nhs.uk/cystic-fibrosis-4.html 2021-06-04T16:08:21.5670000Z https://www.medicinesresources.nhs.uk/the-mhra-concludes-positive-safety-profile-for-pfizer-biontech-vaccine-in-12-to-15-year-olds-4.html 2021-06-05T19:08:27.8860000Z https://www.medicinesresources.nhs.uk/belimumab-for-the-treatment-of-active-autoantibody-positive-systemic-lupus-erythematosus.html 2021-06-04T16:10:23.2700000Z https://www.medicinesresources.nhs.uk/reflection-paper-on-forecasting-demand-for-medicinal-products-in-the-eu-eea-1.html 2021-06-04T15:37:33.5520000Z https://www.medicinesresources.nhs.uk/gp-referral-to-nhs-community-pharmacist-consultation-service-blackburn-with-darwen-knowsley.html 2021-06-04T15:38:53.5910000Z https://www.medicinesresources.nhs.uk/updated-rotavirus-vaccine-rotarix-r-patient-group-direction-pgd-template-2.html 2021-06-05T19:10:29.1790000Z https://www.medicinesresources.nhs.uk/filgotinib-as-induction-and-maintenance-therapy-for-ulcerative-colitis-selection-a-phase-2b-3-double-blind-randomised-placebo-controlled-trial.html 2021-06-04T15:56:51.4300000Z https://www.medicinesresources.nhs.uk/co-infections-secondary-infections-and-antimicrobial-use-in-patients-hospitalised-with-covid-19-during-the-first-pandemic-wave-from-the-isaric-who-ccp-uk-study-a-multicentre-prospective-cohort-study-1.html 2021-06-04T16:14:54.1650000Z https://www.medicinesresources.nhs.uk/comparing-real-time-and-intermittently-scanned-continuous-glucose-monitoring-in-adults-with-type-1-diabetes-alertt1-a-6-month-prospective-multicentre-randomised-controlled-trial.html 2021-06-04T16:01:58.7410000Z https://www.medicinesresources.nhs.uk/adjuvant-olaparib-for-patients-with-brca1-or-brca2-mutated-breast-cancer.html 2021-06-04T16:03:26.5110000Z https://www.medicinesresources.nhs.uk/effect-of-bamlanivimab-vs-placebo-on-incidence-of-covid-19-among-residents-and-staff-of-skilled-nursing-and-assisted-living-facilities-a-randomized-clinical-trial-1.html 2021-06-04T16:19:26.8270000Z https://www.medicinesresources.nhs.uk/depressive-symptoms-mental-wellbeing-and-substance-use-among-adolescents-before-and-during-the-covid-19-pandemic-in-iceland-a-longitudinal-population-based-study-1.html 2021-06-04T16:20:14.9780000Z https://www.medicinesresources.nhs.uk/us-fda-authorises-lower-intravenous-and-subcutaneous-dose-of-regen-cov-casirivimab-and-imdevimab-antibody-to-treat-covid-19.html 2021-06-04T16:15:00.0180000Z https://www.medicinesresources.nhs.uk/new-medicines-news-may-2021.html 2021-06-05T19:14:19.5910000Z https://www.medicinesresources.nhs.uk/effect-of-serum-urate-lowering-with-allopurinol-on-blood-pressure-in-young-adults-a-randomized-controlled-crossover-trial-2.html 2021-06-08T09:15:28.2440000Z https://www.medicinesresources.nhs.uk/recurrent-covid-19-including-evidence-of-reinfection-and-enhanced-severity-in-thirty-brazilian-healthcare-workers.html 2021-06-07T14:23:51.7520000Z https://www.medicinesresources.nhs.uk/corticosteroid-use-myocardial-injury-and-in-hospital-cardiovascular-events-in-patients-with-community-acquired-pneumonia.html 2021-06-07T15:18:09.1800000Z https://www.medicinesresources.nhs.uk/effectiveness-of-angiotensin-neprilysin-inhibitor-treatment-versus-renin-angiotensin-system-blockade-in-older-adults-with-heart-failure-in-clinical-care-2.html 2021-06-07T14:28:07.6340000Z https://www.medicinesresources.nhs.uk/randomized-phase-iii-postoperative-trial-of-platinum-based-chemotherapy-versus-capecitabine-in-patients-with-residual-triple-negative-breast-cancer-following-neoadjuvant-chemotherapy-ecog-acrin-ea1131-2.html 2021-06-07T14:57:06.6620000Z https://www.medicinesresources.nhs.uk/isatuximab-carfilzomib-and-dexamethasone-in-relapsed-multiple-myeloma-ikema-a-multicentre-open-label-randomised-phase-3-trial.html 2021-06-07T14:32:33.6810000Z https://www.medicinesresources.nhs.uk/therapeutic-versus-prophylactic-anticoagulation-for-patients-admitted-to-hospital-with-covid-19-and-elevated-d-dimer-concentration-action-an-open-label-multicentre-randomised-controlled-trial-1.html 2021-06-07T14:59:20.0070000Z https://www.medicinesresources.nhs.uk/first-line-nivolumab-plus-chemotherapy-versus-chemotherapy-alone-for-advanced-gastric-gastro-oesophageal-junction-and-oesophageal-adenocarcinoma-checkmate-649-a-randomised-open-label-phase-3-trial-1.html 2021-06-07T15:00:10.0600000Z https://www.medicinesresources.nhs.uk/fda-approval-of-ryplazim-plasminogen-human-tmvh-for-treatment-of-plasminogen-deficiency-type-1-hypoplasminogenemia.html 2021-06-07T14:42:00.5580000Z https://www.medicinesresources.nhs.uk/fda-approval-of-semaglutide-wegovy-injection-2-4-mg-for-chronic-weight-management-in-adults-with-obesity-or-overweight.html 2021-06-07T14:44:04.6980000Z https://www.medicinesresources.nhs.uk/tislelizumab-meets-primary-endpoint-in-phase-iii-oesophageal-cancer-trial-1.html 2021-06-07T15:03:06.3920000Z https://www.medicinesresources.nhs.uk/standard-operating-procedure-roving-and-mobile-models-1.html 2021-06-07T14:50:28.4270000Z https://www.medicinesresources.nhs.uk/novel-therapies-in-v-thalassaemia-1.html 2021-06-07T14:52:50.4040000Z https://www.medicinesresources.nhs.uk/new-g7-clinical-trials-charter-to-bolster-global-health-defences.html 2021-06-07T14:54:36.1340000Z https://www.medicinesresources.nhs.uk/ema-raises-awareness-of-clinical-care-recommendations-to-manage-suspected-thrombosis-with-thrombocytopenia-syndrome-3.html 2021-06-07T14:58:31.8150000Z https://www.medicinesresources.nhs.uk/update-on-management-of-atrial-fibrillation-in-heart-failure-a-focus-on-ablation.html 2021-06-07T14:59:49.1470000Z https://www.medicinesresources.nhs.uk/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19-for-adolescents-1.html 2021-06-10T09:09:05.5780000Z https://www.medicinesresources.nhs.uk/vigabatrin-kigabeq-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-infantile-spasms-and-resistant-partial-epilepsy.html 2021-06-07T15:21:17.5290000Z https://www.medicinesresources.nhs.uk/trifluridine-tipiracil-lonsurf-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-metastatic-gastric-cancer.html 2021-06-07T15:23:16.3450000Z https://www.medicinesresources.nhs.uk/nintedanib-ofev-r-is-accepted-for-use-within-nhs-scotland-for-treatment-of-chronic-fibrosing-interstitial-lung-diseases.html 2021-06-07T15:48:04.4360000Z https://www.medicinesresources.nhs.uk/mogamulizumab-poteligeo-r-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-mycosis-fungoides-mf-or-sezary-syndrome-ss.html 2021-06-07T15:48:52.6570000Z https://www.medicinesresources.nhs.uk/baricitinib-olumiant-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-moderate-to-severe-atopic-dermatitis.html 2021-06-07T15:29:52.3210000Z https://www.medicinesresources.nhs.uk/acalabrutinib-calquence-accepted-for-restricted-use-within-nhs-scotland-for-treatment-of-previously-untreated-chronic-lymphocytic-leukaemia-cll.html 2021-06-07T15:31:54.5430000Z https://www.medicinesresources.nhs.uk/5-aminolevulinic-acid-alacare-accepted-for-use-within-nhs-scotland-for-treatment-of-mild-actinic-keratoses-lesions.html 2021-06-07T15:34:21.1380000Z https://www.medicinesresources.nhs.uk/nhs-covid-19-vaccine-lead-urges-people-not-to-delay-second-dose.html 2021-06-07T15:36:24.8740000Z https://www.medicinesresources.nhs.uk/mhra-approval-of-dostarlimab-jemperli-for-recurrent-or-advanced-endometrial-cancer.html 2021-06-07T15:37:27.4180000Z https://www.medicinesresources.nhs.uk/thromboembolic-events-in-the-south-african-ad26-cov2-s-vaccine-study.html 2021-06-07T15:39:30.6440000Z https://www.medicinesresources.nhs.uk/updated-covid-19-vaccination-guidance-blood-clotting-information-for-healthcare-professionals.html 2021-06-10T09:10:37.0150000Z https://www.medicinesresources.nhs.uk/management-of-surge-and-escalation-in-critical-care-services-standard-operating-procedure-for-adult-and-paediatric-burn-care-services-in-england-and-wales.html 2021-06-10T09:11:04.8680000Z https://www.medicinesresources.nhs.uk/revised-spc-pfizer-bnt162b2-rna-covid-19-vaccine.html 2021-06-10T09:11:26.8560000Z https://www.medicinesresources.nhs.uk/venclyxto-venetoclax-film-coated-tablets-all-strengths.html 2021-06-08T19:00:55.6010000Z https://www.medicinesresources.nhs.uk/cardiovascular-drugs-and-covid-19-clinical-outcomes-a-living-systematic-review-and-meta-analysis.html 2021-06-10T09:12:06.5760000Z https://www.medicinesresources.nhs.uk/effect-of-recombinant-human-parathyroid-hormone-1-84-on-resolution-of-active-charcot-neuro-osteoarthropathy-in-diabetes-a-randomized-double-blind-placebo-controlled-study.html 2021-06-08T15:15:12.9620000Z https://www.medicinesresources.nhs.uk/metronomic-capecitabine-as-adjuvant-therapy-in-locoregionally-advanced-nasopharyngeal-carcinoma-a-multicentre-open-label-parallel-group-randomised-controlled-phase-3-trial-1.html 2021-06-08T18:55:22.8650000Z https://www.medicinesresources.nhs.uk/do-statins-reduce-mortality-in-older-people-findings-from-a-longitudinal-study-using-primary-care-records-2.html 2021-06-08T18:54:08.6990000Z https://www.medicinesresources.nhs.uk/two-year-old-cognitive-outcomes-in-children-of-pregnant-women-with-epilepsy-in-the-maternal-outcomes-and-neurodevelopmental-effects-of-antiepileptic-drugs-study-1.html 2021-06-08T18:49:41.3330000Z https://www.medicinesresources.nhs.uk/association-between-patients-perceptions-of-the-sexual-acceptability-of-contraceptive-methods-and-continued-use-over-time.html 2021-06-08T15:27:06.3180000Z https://www.medicinesresources.nhs.uk/association-of-intravenous-radiocontrast-with-kidney-function-a-regression-discontinuity-analysis.html 2021-06-08T15:29:24.6140000Z https://www.medicinesresources.nhs.uk/lower-risk-of-stroke-after-alcohol-abstinence-in-patients-with-incident-atrial-fibrillation-a-nationwide-population-based-cohort-study.html 2021-06-08T18:45:46.1120000Z https://www.medicinesresources.nhs.uk/rmoc-london-operating-model-addendum-2.html 2021-06-08T15:41:06.2570000Z https://www.medicinesresources.nhs.uk/ethnicity-coding-in-english-health-service-datasets.html 2021-06-08T15:43:59.4030000Z https://www.medicinesresources.nhs.uk/adult-social-care-and-covid-19-after-the-first-wave.html 2021-06-08T15:45:22.9550000Z https://www.medicinesresources.nhs.uk/dupuytrens-disease.html 2021-06-08T16:08:30.8750000Z https://www.medicinesresources.nhs.uk/vaccination-exploring-vaccine-confidence-1.html 2021-06-08T15:49:07.6380000Z https://www.medicinesresources.nhs.uk/nhs-covid-vaccination-programme-will-start-inviting-remaining-adults-for-covid-19-vaccination.html 2021-06-08T15:50:18.4220000Z https://www.medicinesresources.nhs.uk/neutralising-antibody-activity-against-sars-cov-2-vocs-b-1-617-2-and-b-1-351-by-bnt162b2-vaccination.html 2021-06-08T15:51:25.4960000Z https://www.medicinesresources.nhs.uk/are-sars-cov-2-human-challenge-trials-ethical.html 2021-06-08T15:54:00.0320000Z https://www.medicinesresources.nhs.uk/how-low-is-safe-the-frontier-of-very-low-less-than-30-mg-dl-ldl-cholesterol.html 2021-06-08T15:55:19.8580000Z https://www.medicinesresources.nhs.uk/mask-related-acne-maskne-and-other-facial-dermatoses.html 2021-06-08T15:57:18.9030000Z https://www.medicinesresources.nhs.uk/delirium-and-long-term-cognition-in-critically-ill-patients.html 2021-06-08T15:59:26.9010000Z https://www.medicinesresources.nhs.uk/2021-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid-arthritis.html 2021-06-08T16:00:34.7180000Z https://www.medicinesresources.nhs.uk/fda-approves-brincidofovir-tembexa-tablets-and-oral-suspension-for-treatment-of-smallpox.html 2021-06-08T16:01:39.3440000Z https://www.medicinesresources.nhs.uk/data-from-phase-iii-clinical-trial-of-riavax-gv1001-in-metastatic-pancreatic-cancer-presented-at-conference-1.html 2021-06-08T16:08:56.4520000Z https://www.medicinesresources.nhs.uk/detailed-results-from-phase-iii-cosmic-311-trial-of-cabozantinib-in-patients-with-previously-treated-radioactive-iodine-refractory-differentiated-thyroid-cancer-presented-at-conference.html 2021-06-08T16:15:37.5910000Z https://www.medicinesresources.nhs.uk/fda-approve-aducanumab-aduhelm-for-treatment-of-alzheimers-disease.html 2021-06-08T16:09:26.6050000Z https://www.medicinesresources.nhs.uk/summary-of-biopharmaceutical-stability-data-reviewed-and-available-extended-shelf-life-data-v3-2.html 2021-06-08T16:10:34.6760000Z https://www.medicinesresources.nhs.uk/ozanimod-for-treating-relapsing-remitting-multiple-sclerosis-guidance-ta706-2.html 2021-06-10T09:15:08.0780000Z https://www.medicinesresources.nhs.uk/revised-spc-ibrance-palbociclib-tablets-3.html 2021-06-09T14:57:40.1910000Z https://www.medicinesresources.nhs.uk/association-of-maternal-influenza-vaccination-during-pregnancy-with-early-childhood-health-outcomes.html 2021-06-09T16:30:47.8550000Z https://www.medicinesresources.nhs.uk/tezacaftor-ivacaftor-use-in-routine-care-of-adults-with-cystic-fibrosis-a-medicine-use-evaluation-2.html 2021-06-09T15:03:55.8050000Z https://www.medicinesresources.nhs.uk/ema-evaluating-the-use-of-covid-19-vaccine-moderna-in-young-people-aged-12-to-17.html 2021-06-09T15:06:30.0970000Z https://www.medicinesresources.nhs.uk/choice-of-pharmaceutical-form-as-a-key-factor-during-ketogenic-diet-a-case-report.html 2021-06-09T15:08:43.7110000Z https://www.medicinesresources.nhs.uk/influenza-activity-in-the-us-during-the-2020-2021-season-2.html 2021-06-09T15:12:06.3860000Z https://www.medicinesresources.nhs.uk/low-back-pain-1.html 2021-06-09T15:16:11.2680000Z https://www.medicinesresources.nhs.uk/portal-vein-thrombosis-associated-with-chadox1-ncov-19-vaccination-1.html 2021-06-09T15:20:06.4520000Z https://www.medicinesresources.nhs.uk/over-3-million-medicines-and-devices-seized-in-uk-as-part-of-global-crackdown.html 2021-06-09T15:21:49.9050000Z https://www.medicinesresources.nhs.uk/cipaglucosidase-alfa-with-miglustat-in-the-treatment-of-late-onset-pompe-disease-early-access-to-medicines-scheme-eams-2.html 2021-06-09T15:26:16.6520000Z https://www.medicinesresources.nhs.uk/londons-first-dedicated-detox-unit-for-homeless-people-set-to-open.html 2021-06-09T15:28:42.9350000Z https://www.medicinesresources.nhs.uk/british-transplantation-society-guidance-during-covid-19.html 2021-06-11T09:15:56.3740000Z https://www.medicinesresources.nhs.uk/fda-approve-pneumococcal-20-valent-conjugate-vaccine-prevnar-20-for-adults.html 2021-06-09T15:32:05.7590000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-trastuzumab-duocarmazine-in-the-phase-iii-tulip-study-in-her-2-positive-advanced-breast-cancer.html 2021-06-09T15:33:44.0960000Z https://www.medicinesresources.nhs.uk/recovery-trial-finds-aspirin-does-not-improve-survival-for-patients-hospitalised-with-covid-19.html 2021-06-09T15:36:35.7750000Z https://www.medicinesresources.nhs.uk/accelerating-population-health-improvement.html 2021-06-09T15:38:56.1460000Z https://www.medicinesresources.nhs.uk/personal-protective-equipment-and-heat-risk-of-heat-stress-1.html 2021-06-09T15:42:33.6700000Z https://www.medicinesresources.nhs.uk/revised-spc-entresto-sacubitril-valsartan-film-coated-tablets-all-strengths.html 2021-06-10T15:13:44.5340000Z https://www.medicinesresources.nhs.uk/revised-spc-indocid-indomethacin-suppositories-100-mg.html 2021-06-10T15:15:21.7780000Z https://www.medicinesresources.nhs.uk/revised-spc-norditropin-somatropin-products.html 2021-06-10T15:17:57.3740000Z https://www.medicinesresources.nhs.uk/nihr-alert-healthy-lifestyles-increase-life-expectancy-in-people-with-multiple-conditions-multimorbidity-by-as-much-as-in-other-groups-4.html 2021-06-10T15:22:00.5810000Z https://www.medicinesresources.nhs.uk/postoperative-low-molecular-weight-heparin-bridging-treatment-for-patients-at-high-risk-of-arterial-thromboembolism-periop2-double-blind-randomised-controlled-trial-4.html 2021-06-10T15:26:16.9480000Z https://www.medicinesresources.nhs.uk/first-dose-chadox1-and-bnt162b2-covid-19-vaccines-and-thrombocytopenic-thromboembolic-and-hemorrhagic-events-in-scotland.html 2021-06-10T17:07:04.9120000Z https://www.medicinesresources.nhs.uk/clozapine-induced-myocarditis-electronic-health-register-analysis-of-incidence-timing-clinical-markers-and-diagnostic-accuracy-1.html 2021-06-10T15:33:46.7830000Z https://www.medicinesresources.nhs.uk/proton-beam-therapy-for-breast-cancer-all-ages-clinical-commissioning-policy-1.html 2021-06-10T15:35:34.7100000Z https://www.medicinesresources.nhs.uk/tracking-elimination-of-hiv-transmission-in-men-who-have-sex-with-men-in-england-a-modelling-study-1.html 2021-06-10T17:05:15.1580000Z https://www.medicinesresources.nhs.uk/consultation-service-refers-350-000-patients-to-pharmacists-since-launch-1.html 2021-06-10T15:40:46.7360000Z https://www.medicinesresources.nhs.uk/interim-analysis-of-phase-iii-checkmate-648-trial-finds-nivolumab-nv-with-chemotherapy-ch-or-ipilimumab-ip-demonstrated-overall-survival-os-benefit-compared-to-chemotherapy-alone-in-advanced-metastatic-oesophageal-cancer.html 2021-06-10T15:42:37.2190000Z https://www.medicinesresources.nhs.uk/enzalutamide-for-treating-hormone-sensitive-metastatic-prostate-cancer-final-appraisal-document-1.html 2021-06-10T15:44:42.6760000Z https://www.medicinesresources.nhs.uk/referring-minor-illness-patients-to-a-community-pharmacist-new-referral-pathway-for-primary-care-networks.html 2021-06-10T15:45:43.1480000Z https://www.medicinesresources.nhs.uk/nice-technology-appraisals-in-the-nhs-in-england-innovation-scorecard-to-december-2020.html 2021-06-10T16:23:24.6280000Z https://www.medicinesresources.nhs.uk/recent-advances-in-the-treatment-of-melanoma.html 2021-06-10T15:48:09.1970000Z https://www.medicinesresources.nhs.uk/adjunct-immune-globulin-for-vaccine-induced-thrombotic-thrombocytopenia-2.html 2021-06-10T17:00:59.5830000Z https://www.medicinesresources.nhs.uk/adalimumab-etanercept-infliximab-and-abatacept-for-treating-moderate-rheumatoid-arthritis-after-conventional-dmards-have-failed-partial-review-of-ta375-final-appraisal-document.html 2021-06-10T15:52:18.6300000Z https://www.medicinesresources.nhs.uk/migraine-treatments-and-prophylactics-summarised-in-new-mims-table.html 2021-06-10T15:54:07.9320000Z https://www.medicinesresources.nhs.uk/company-led-medicines-recall-noidecs-t20-c4-thc-20-cbd-less-than-4-indica-cannabis-flower-unlicensed-medicine-and-noidecs-t20-c4-thc-20-cbd-less-than-4-sativa-cannabis-flower-unlicensed-medicine-2.html 2021-06-10T15:56:46.0430000Z https://www.medicinesresources.nhs.uk/consultation-on-the-appointment-and-operation-of-the-patient-safety-commissioner-4.html 2021-06-10T16:00:13.8230000Z https://www.medicinesresources.nhs.uk/women-from-under-represented-groups-urged-to-respond-womens-health-strategy-call-for-evidence-1.html 2021-06-10T16:02:13.7990000Z https://www.medicinesresources.nhs.uk/further-measures-in-additional-areas-to-tackle-delta-b1-617-2-variant.html 2021-06-10T16:23:48.4690000Z https://www.medicinesresources.nhs.uk/associations-of-vaccination-and-of-prior-infection-with-positive-pcr-test-results-for-sars-cov-2-in-airline-passengers-arriving-in-qatar.html 2021-06-10T16:05:08.0650000Z https://www.medicinesresources.nhs.uk/how-to-communicate-with-patients-who-are-d-deaf-or-have-hearing-loss-1.html 2021-06-10T16:06:44.5460000Z https://www.medicinesresources.nhs.uk/royal-statistical-society-diagnostic-tests-working-group-report-1.html 2021-06-10T16:19:15.7940000Z https://www.medicinesresources.nhs.uk/two-members-of-fda-advisory-committee-resign-after-approval-of-controversial-alzheimers-drug-aducanumab.html 2021-06-10T16:24:36.1350000Z https://www.medicinesresources.nhs.uk/fda-approves-expanded-use-of-trikafta-elexacaftor-tezacaftor-ivacaftor-with-ivacaftor-to-include-children-with-cystic-fibrosis-cf-ages-6-to-11-years.html 2021-06-10T16:25:32.4860000Z https://www.medicinesresources.nhs.uk/duvelisib-copiktra-approved-in-eu-for-treatment-of-relapsed-or-refractory-chronic-lymphocytic-leukaemia-cll-and-follicular-lymphoma-fl.html 2021-06-10T16:27:19.2530000Z https://www.medicinesresources.nhs.uk/off-label-medicine-use-under-a-patient-group-direction.html 2021-06-11T09:09:41.1670000Z https://www.medicinesresources.nhs.uk/retaining-pgd-documentation.html 2021-06-11T09:15:25.9670000Z https://www.medicinesresources.nhs.uk/patient-group-directions-in-complex-commissioning-scenarios-3.html 2021-06-11T09:15:04.8290000Z https://www.medicinesresources.nhs.uk/stroke-care-and-case-fatality-in-people-with-and-without-schizophrenia-a-retrospective-cohort-study-2.html 2021-06-11T15:23:35.8120000Z https://www.medicinesresources.nhs.uk/sars-cov-2-seroprevalence-in-students-and-teachers-a-longitudinal-study-from-may-to-october-2020-in-german-secondary-schools-1.html 2021-06-11T15:25:04.0780000Z https://www.medicinesresources.nhs.uk/american-college-of-rheumatology-guidance-for-the-management-of-pediatric-rheumatic-disease-during-the-covid-19-pandemic-version-2.html 2021-06-11T15:40:27.2080000Z https://www.medicinesresources.nhs.uk/fda-grant-approval-for-new-paediatric-indication-for-lymphoseek-technetium-tc-99m-tilmanocept-injection.html 2021-06-11T15:41:33.4540000Z https://www.medicinesresources.nhs.uk/post-hoc-data-analysis-from-two-placebo-controlled-phase-3-clinical-trials-ease-lid-and-ease-lid-3-for-use-of-amantadine-gocovri-to-treat-motor-complications-for-people-with-parkinsons-disease.html 2021-06-11T14:40:08.3580000Z https://www.medicinesresources.nhs.uk/company-announce-data-from-the-protective-1-phase-3-clinical-study-of-plinabulin-for-prevention-of-chemotherapy-induced-neutropenia-cin-compared-to-pegfilgrastim.html 2021-06-11T15:43:37.4270000Z https://www.medicinesresources.nhs.uk/company-announces-new-data-analysis-from-multiple-phase-2-and-3-studies-for-the-long-term-efficacy-of-nusinersen-spinraza-therapy-in-spinal-muscular-atrophy-sma.html 2021-06-11T16:05:36.4970000Z https://www.medicinesresources.nhs.uk/fda-accepts-filing-of-abbreviated-new-drug-application-and-grants-priority-review-for-nalmefene-hci-injection-for-the-treatment-of-known-or-suspected-opioid-overdose.html 2021-06-11T16:06:59.8900000Z https://www.medicinesresources.nhs.uk/fda-approve-expansion-of-the-paediatric-indication-of-sofosbuvir-velparasvir-epclusa-for-the-treatment-of-chronic-hepatitis-c-virus-to-include-children-from-the-age-of-3-years-old-and-above-2.html 2021-06-11T16:08:05.6240000Z https://www.medicinesresources.nhs.uk/company-announces-phase-3-transform-study-results-for-lisocabtagene-maraleucei-breyanzi-for-use-in-relapsed-refractory-b-cell-lymphoma.html 2021-06-11T16:10:26.2820000Z https://www.medicinesresources.nhs.uk/moderna-files-for-emergency-use-authorisation-for-its-covid-19-vaccine-in-adolescents-to-the-fda-3.html 2021-06-11T16:11:56.5000000Z https://www.medicinesresources.nhs.uk/genetech-announce-new-interim-data-from-two-studies-jewelfish-and-rainbowfish-of-risdiplam-evrysdi-in-spinal-muscular-atrophy-sma-1.html 2021-06-11T16:14:20.4200000Z https://www.medicinesresources.nhs.uk/further-funding-and-support-for-pcn-and-community-pharmacy-led-covid-19-vaccination-sites.html 2021-06-11T16:15:34.2220000Z https://www.medicinesresources.nhs.uk/data-from-cdc-shows-heart-inflammation-pericarditis-or-myocarditis-rates-higher-in-young-men-than-expected-after-2nd-dose-of-pfizer-and-moderna-vaccines-2.html 2021-06-11T16:16:46.6060000Z https://www.medicinesresources.nhs.uk/unexpected-overdose-of-oral-cyclosporine-in-a-kidney-transplant-patient-a-case-report-1.html 2021-06-14T15:01:59.7710000Z https://www.medicinesresources.nhs.uk/clinical-pharmacists-services-role-and-acceptance-a-national-swedish-survey.html 2021-06-14T11:24:58.6000000Z https://www.medicinesresources.nhs.uk/final-overall-survival-analysis-of-the-tourmaline-mm1-phase-iii-trial-of-ixazomib-lenalidomide-and-dexamethasone-in-patients-with-relapsed-or-refractory-multiple-myeloma.html 2021-06-14T11:27:25.9360000Z https://www.medicinesresources.nhs.uk/sars-cov-2-vaccine-induced-immune-thrombotic-thrombocytopenia-treated-with-immunoglobulin-and-argatroban.html 2021-06-14T11:30:58.4770000Z https://www.medicinesresources.nhs.uk/third-member-of-fda-advisory-committee-resigns-after-approval-of-controversial-alzheimers-drug-aducanumab-1.html 2021-06-14T11:43:32.0170000Z https://www.medicinesresources.nhs.uk/letter-from-the-deputy-chief-medical-officer-to-uk-vaccine-study-volunteers.html 2021-06-14T11:48:20.9820000Z https://www.medicinesresources.nhs.uk/conclusion-of-signal-of-sinus-bradycardia-with-remdesivir-veklury-1.html 2021-06-14T15:05:22.4580000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-update-on-ongoing-evaluation-of-myocarditis-and-pericarditis-3.html 2021-06-14T15:06:25.2150000Z https://www.medicinesresources.nhs.uk/prac-concludes-review-of-signal-of-increased-risk-of-major-cardiovascular-events-and-cancer-with-tofacitinib-xeljanz.html 2021-06-14T12:19:18.3120000Z https://www.medicinesresources.nhs.uk/managing-suspected-lower-urinary-tract-infection-uti-in-adult-women.html 2021-06-14T13:13:22.9870000Z https://www.medicinesresources.nhs.uk/https-www-gov-uk-government-publications-covid-19-vaccination-vaccine-product-information-poster-3.html 2021-06-14T14:51:37.2100000Z https://www.medicinesresources.nhs.uk/updated-publication-of-remdesivir-guidance-for-patients-hospitalised-with-covid-19-adults-and-children-aged-12-years-and-older-version-3-updated-14-6-21.html 2021-06-16T08:39:05.8400000Z https://www.medicinesresources.nhs.uk/discontinuation-versus-continuation-of-renin-angiotensin-system-inhibitors-in-covid-19-acei-covid-a-prospective-parallel-group-randomised-controlled-open-label-trial-1.html 2021-06-16T08:41:48.0610000Z https://www.medicinesresources.nhs.uk/characterising-the-background-incidence-rates-of-adverse-events-of-special-interest-for-covid-19-vaccines-in-eight-countries-multinational-network-cohort-study.html 2021-06-14T14:58:51.4540000Z https://www.medicinesresources.nhs.uk/nivolumab-with-ipilimumab-for-previously-treated-metastatic-colorectal-cancer-with-high-microsatellite-instability-or-mismatch-repair-deficiency-final-appraisal-document-1.html 2021-06-14T15:09:45.0570000Z https://www.medicinesresources.nhs.uk/nice-to-reappraise-mogamulizumab-for-previously-treated-mycosis-fungoides-and-sezary-syndrome.html 2021-06-14T15:10:16.7500000Z https://www.medicinesresources.nhs.uk/uk-to-donate-100-million-surplus-covid-19-vaccine-doses-1.html 2021-06-14T15:05:27.6160000Z https://www.medicinesresources.nhs.uk/positive-phase-iii-data-for-regdanvimab-monoclonal-antibody-treatment-for-mild-to-moderate-symptoms-of-covid-20.html 2021-06-14T15:09:06.5060000Z https://www.medicinesresources.nhs.uk/phase-iii-prevent-19-study-of-novavax-recombinant-nanoparticle-protein-based-covid-19-vaccine-nvx-cov2373-meets-primary-endpoint.html 2021-06-14T15:12:32.8240000Z https://www.medicinesresources.nhs.uk/revised-spc-influvac-sub-unit-tetra-and-tetra-myl-quadrivalent-influenza-vaccines-2.html 2021-06-14T16:46:16.7390000Z https://www.medicinesresources.nhs.uk/new-product-skyrizi-risankizumab-150-mg-solution-for-injection-in-pre-filled-syringe-1.html 2021-06-14T16:48:00.9600000Z https://www.medicinesresources.nhs.uk/https-cms-mas-live-nice-org-uk-keystone-items.html 2021-06-15T15:00:09.5610000Z https://www.medicinesresources.nhs.uk/letter-to-women-and-girls-taking-sodium-valproate.html 2021-06-16T08:47:36.7550000Z https://www.medicinesresources.nhs.uk/update-for-chief-pharmacists-and-senior-pharmacy-leaders-june-2021.html 2021-06-16T08:49:57.1980000Z https://www.medicinesresources.nhs.uk/prescription-cost-analysis-england-2020-21.html 2021-06-15T19:43:33.6750000Z https://www.medicinesresources.nhs.uk/phase-iii-star-study-of-gene-therapy-timrepigene-emparvovec-did-not-meet-primary-and-key-secondary-endpoints-in-patients-with-choroideremia.html 2021-06-15T15:07:46.2460000Z https://www.medicinesresources.nhs.uk/mhra-approves-venetoclax-for-treatment-of-patients-with-newly-diagnosed-acute-myeloid-leukaemia-who-are-ineligible-for-intensive-chemotherapy.html 2021-06-15T15:10:24.9540000Z https://www.medicinesresources.nhs.uk/analysis-show-2-doses-of-covid-19-vaccines-highly-effective-against-hospitalisation-from-delta-variant.html 2021-06-15T15:12:41.8240000Z https://www.medicinesresources.nhs.uk/nhs-is-to-set-up-specialist-long-covid-services-for-children-and-young-people-as-part-of-a-gbp100-million-expansion-of-care.html 2021-06-15T15:13:47.4810000Z https://www.medicinesresources.nhs.uk/givosiran-for-treating-acute-hepatic-porphyria-evaluation-consultation-document.html 2021-06-15T19:40:45.7320000Z https://www.medicinesresources.nhs.uk/nivolumab-for-previously-treated-unresectable-advanced-or-recurrent-oesophageal-cancer-guidance-ta707.html 2021-06-16T08:51:52.1320000Z https://www.medicinesresources.nhs.uk/should-we-vaccinate-children-against-sars-cov-2.html 2021-06-15T15:22:46.6080000Z https://www.medicinesresources.nhs.uk/ramadan-fasting-recommendations-for-patients-with-cardiovascular-disease.html 2021-06-15T15:25:22.1580000Z https://www.medicinesresources.nhs.uk/sodium-glucose-cotransporter-2-inhibitors-as-a-treatment-for-heart-failure.html 2021-06-15T15:26:33.1150000Z https://www.medicinesresources.nhs.uk/the-most-expensive-breakfast-in-history-revisiting-the-wanless-review-20-years-on-1.html 2021-06-15T19:36:22.2570000Z https://www.medicinesresources.nhs.uk/salt-reduction-to-prevent-hypertension-the-reasons-of-the-controversy.html 2021-06-15T19:35:30.9040000Z https://www.medicinesresources.nhs.uk/insights-into-the-mechanisms-underlying-opioid-use-disorder-and-potential-treatment-strategies-1.html 2021-06-15T15:34:06.4110000Z https://www.medicinesresources.nhs.uk/thromboinflammation-in-covid-19-the-clot-thickens.html 2021-06-15T15:35:34.5220000Z https://www.medicinesresources.nhs.uk/perspectives-for-therapy-of-treatment-resistant-depression.html 2021-06-15T15:36:36.5560000Z https://www.medicinesresources.nhs.uk/role-of-c-reactive-protein-and-procalcitonin-in-the-diagnosis-of-lower-respiratory-tract-infection-in-children-in-the-outpatient-setting.html 2021-06-15T15:37:53.0530000Z https://www.medicinesresources.nhs.uk/delta-variant-what-is-happening-with-transmission-hospital-admissions-and-restrictions-1.html 2021-06-15T19:30:56.9060000Z https://www.medicinesresources.nhs.uk/american-college-of-rheumatology-guidance-for-covid-19-vaccination-in-patients-with-rheumatic-and-musculoskeletal-diseases-version-4.html 2021-06-15T15:43:04.8970000Z https://www.medicinesresources.nhs.uk/first-data-presented-from-phase-2-beyond-study-of-reblozyl-luspatercept-aamt-in-adults-with-non-transfusion-dependent-beta-thalassemia.html 2021-06-15T15:45:15.7080000Z https://www.medicinesresources.nhs.uk/sorrento-receives-authorisation-from-mhra-to-conduct-phase-ii-trial-of-intranasal-covi-amg-neutralizing-antibody-covi-drops-in-outpatient-setting.html 2021-06-15T15:46:21.1950000Z https://www.medicinesresources.nhs.uk/janssen-announces-survival-data-from-phase-iii-maia-study-of-daratumumab-in-patients-with-newly-diagnosed-multiple-myeloma-who-are-transplant-ineligible.html 2021-06-15T15:47:17.9610000Z https://www.medicinesresources.nhs.uk/abbvie-announce-phase-3-glow-study-of-ibrutinib-plus-venetoclax-combination-shows-superior-progression-free-survival-pfs-compared-to-chlorambucil-plus-obinutuzumab-in-first-line-chronic-lymphocytic-leukaemia.html 2021-06-15T15:48:15.5360000Z https://www.medicinesresources.nhs.uk/fda-grants-fast-track-designation-ftd-to-pvsripo-for-treatment-of-advanced-melanoma.html 2021-06-15T15:49:16.2790000Z https://www.medicinesresources.nhs.uk/safety-immunogenicity-and-efficacy-of-a-covid-19-vaccine-nvx-cov2373-co-administered-with-seasonal-influenza-vaccines.html 2021-06-15T19:27:02.3830000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-ema-identifies-capillary-leak-syndrome-cls-as-a-potential-side-effect-of-az-covid-19-vaccine-vaxzevria.html 2021-06-15T19:25:55.7220000Z https://www.medicinesresources.nhs.uk/pgds-a-learning-event-for-pharmacists-new-to-developing-and-implementing-pgds-recording.html 2021-06-16T08:53:11.1120000Z https://www.medicinesresources.nhs.uk/brief-advice-nicotine-replacement-therapy-sampling-and-active-referral-for-expectant-fathers-who-smoke-cigarettes-a-randomized-clinical-trial.html 2021-06-15T18:44:10.3450000Z https://www.medicinesresources.nhs.uk/e-cigarette-manufacturers-compliance-with-clinical-trial-reporting-expectations-a-case-series-of-registered-trials-by-juul-labs.html 2021-06-15T18:43:37.1630000Z https://www.medicinesresources.nhs.uk/increased-hemoglobin-a1c-time-in-range-reduces-adverse-health-outcomes-in-older-adults-with-diabetes.html 2021-06-15T18:42:44.5950000Z https://www.medicinesresources.nhs.uk/attitudes-and-factors-associated-with-covid-19-vaccine-hesitancy-among-patients-with-breast-cancer-3.html 2021-06-15T18:41:38.3600000Z https://www.medicinesresources.nhs.uk/association-of-covid-19-mrna-vaccine-with-ipsilateral-axillary-lymph-node-reactivity-on-imaging.html 2021-06-15T18:40:44.2770000Z https://www.medicinesresources.nhs.uk/geo-social-gradients-in-predicted-covid-19-prevalence-in-great-britain-results-from-1-960-242-users-of-the-covid-19-symptoms-study-app.html 2021-06-15T18:39:45.1410000Z https://www.medicinesresources.nhs.uk/sars-cov-2-delta-voc-in-scotland-demographics-risk-of-hospital-admission-and-vaccine-effectiveness-1.html 2021-06-15T18:37:28.6520000Z https://www.medicinesresources.nhs.uk/twelve-month-outcomes-of-the-affinity-trial-of-fluoxetine-for-functional-recovery-after-acute-stroke-affinity-trial-steering-committee-on-behalf-of-the-affinity-trial-collaboration.html 2021-06-15T19:13:01.2920000Z https://www.medicinesresources.nhs.uk/effect-of-ultrashort-acting-v-blockers-on-mortality-in-patients-with-sepsis-with-persistent-tachycardia-despite-initial-resuscitation.html 2021-06-15T19:56:19.8740000Z https://www.medicinesresources.nhs.uk/manufactures-report-positive-outcomes-for-iptacopan-for-paroxysmal-nocturnal-haemoglobinuria.html 2021-06-15T19:16:03.6530000Z https://www.medicinesresources.nhs.uk/revised-spc-trulicity-dulaglutide-solution-for-injection-in-pre-filled-pen.html 2021-06-16T14:31:19.6800000Z https://www.medicinesresources.nhs.uk/revised-spc-potaba-potassium-para-aminobenzoate-powder-sachets-1.html 2021-06-16T14:34:04.7790000Z https://www.medicinesresources.nhs.uk/revised-spc-yervoy-ipilimumab-concentrate-for-solution-for-infusion.html 2021-06-16T14:35:01.0680000Z https://www.medicinesresources.nhs.uk/class-1-medicines-recall-notification-recall-of-co-codamol-30-500-effervescent-tablets-batch-1k10121-zentiva-pharma-uk-ltd-due-to-precautionary-risk-of-causing-overdose-natpsa-2021-004-mhra.html 2021-06-17T08:46:56.8170000Z https://www.medicinesresources.nhs.uk/eliminating-the-risk-of-inadvertent-connection-to-medical-air-via-a-flowmeter-2.html 2021-06-17T09:14:34.4880000Z https://www.medicinesresources.nhs.uk/nihr-alert-nurses-and-pharmacists-are-key-to-improving-access-to-end-of-life-medicines-for-people-being-cared-for-at-home-1.html 2021-06-16T14:43:34.9980000Z https://www.medicinesresources.nhs.uk/sintilimab-plus-a-bevacizumab-biosimilar-ibi305-versus-sorafenib-in-unresectable-hepatocellular-carcinoma-orient-32-a-randomised-open-label-phase-2-3-study-1.html 2021-06-16T14:45:29.2290000Z https://www.medicinesresources.nhs.uk/avelumab-alone-or-in-combination-with-chemotherapy-versus-chemotherapy-alone-in-platinum-resistant-or-platinum-refractory-ovarian-cancer-javelin-ovarian-200-an-open-label-three-arm-randomised-phase-3-study-1.html 2021-06-16T14:50:02.0580000Z https://www.medicinesresources.nhs.uk/intravitreal-ranibizumab-versus-aflibercept-versus-bevacizumab-for-macular-oedema-due-to-central-retinal-vein-occlusion-the-leavo-non-inferiority-three-arm-rct.html 2021-06-16T15:01:17.5110000Z https://www.medicinesresources.nhs.uk/predicting-asthma-related-crisis-events-using-routine-electronic-healthcare-data.html 2021-06-16T15:03:31.8010000Z https://www.medicinesresources.nhs.uk/the-association-between-increasing-oral-anticoagulant-prescribing-and-atrial-fibrillation-related-stroke-in-ireland.html 2021-06-16T15:04:47.7860000Z https://www.medicinesresources.nhs.uk/levetiracetam-in-lactation-how-much-is-excreted-into-the-human-breast-milk-2.html 2021-06-16T15:08:06.8860000Z https://www.medicinesresources.nhs.uk/intensity-of-statin-therapy-and-muscle-symptoms-a-network-meta-analysis-of-153-000-patients.html 2021-06-16T15:10:56.4690000Z https://www.medicinesresources.nhs.uk/public-acceptance-of-covid-19-vaccines-cross-national-evidence-on-levels-and-individual-level-predictors-using-observational-data.html 2021-06-16T15:13:25.1470000Z https://www.medicinesresources.nhs.uk/the-uptake-study-a-cross-sectional-survey-examining-the-insights-and-beliefs-of-the-uk-population-on-covid-19-vaccine-uptake-and-hesitancy.html 2021-06-16T15:18:44.4300000Z https://www.medicinesresources.nhs.uk/risk-of-hospital-admission-for-patients-with-sars-cov-2-variant-b-1-1-7-cohort-analysis.html 2021-06-16T15:42:45.6910000Z https://www.medicinesresources.nhs.uk/acute-treatments-for-episodic-migraine-in-adults-a-systematic-review-and-meta-analysis-1.html 2021-06-17T09:58:49.3850000Z https://www.medicinesresources.nhs.uk/effects-of-intravenous-eptinezumab-vs-placebo-on-headache-pain-and-most-bothersome-symptom-when-initiated-during-a-migraine-attack-a-randomized-clinical-trial.html 2021-06-16T16:33:25.9010000Z https://www.medicinesresources.nhs.uk/prevalence-and-factors-associated-with-statin-use-among-patients-with-nonalcoholic-fatty-liver-disease-in-the-target-nash-study.html 2021-06-16T16:33:59.6910000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-phase-3-data-for-zuranolone-for-major-depressive-disorder-2.html 2021-06-16T16:06:18.0990000Z https://www.medicinesresources.nhs.uk/chronic-pelvic-pain-in-women-a-review.html 2021-06-16T16:07:34.4680000Z https://www.medicinesresources.nhs.uk/long-acting-antibody-combination-from-astra-zeneca-fails-to-meet-primary-endpoint-for-preventing-post-exposure-covid-19.html 2021-06-16T16:08:36.1170000Z https://www.medicinesresources.nhs.uk/emerging-concerns-protocol-1.html 2021-06-16T16:11:03.8230000Z https://www.medicinesresources.nhs.uk/coronary-revascularisation-outcomes-in-patients-with-cancer.html 2021-06-16T16:12:40.1130000Z https://www.medicinesresources.nhs.uk/patients-with-type-1-diabetes-to-get-artificial-pancreas-on-the-nhs.html 2021-06-16T16:14:01.2810000Z https://www.medicinesresources.nhs.uk/recovery-trial-finds-regenerons-monoclonal-antibody-combination-reduces-deaths-for-hospitalised-covid-19-patients-who-have-not-mounted-their-own-immune-response.html 2021-06-16T16:15:34.9090000Z https://www.medicinesresources.nhs.uk/shared-decision-making-guidance-ng197-1.html 2021-06-18T08:35:59.3760000Z https://www.medicinesresources.nhs.uk/revised-spc-sarclisa-isatuximab-20mg-ml-concentrate-for-solution-for-infusion.html 2021-06-17T14:30:37.5490000Z https://www.medicinesresources.nhs.uk/revised-spc-qutenza-capsaicin-179mg-cutaneous-patch-5.html 2021-06-17T14:34:26.9600000Z https://www.medicinesresources.nhs.uk/revised-spc-blincyto-blinatumomab.html 2021-06-17T14:39:15.3770000Z https://www.medicinesresources.nhs.uk/revised-spc-ethinylestradiol-gestodene-femodette-femodene-and-cyproterone-acetate-ethinylestradiol-dianette-tablets-1.html 2021-06-17T14:41:04.2350000Z https://www.medicinesresources.nhs.uk/atezolizumab-tecentriq-and-other-immune-stimulatory-anti-cancer-drugs-risk-of-severe-cutaneous-adverse-reactions-scars.html 2021-06-18T08:46:14.7660000Z https://www.medicinesresources.nhs.uk/cdk4-6-inhibitors-abemaciclib-palbociclib-ribociclib-reports-of-interstitial-lung-disease-and-pneumonitis-including-severe-cases.html 2021-06-18T09:09:30.6100000Z https://www.medicinesresources.nhs.uk/statin-liver-safety-in-non-alcoholic-fatty-liver-disease-a-systematic-review-and-metanalysis.html 2021-06-17T14:54:19.3960000Z https://www.medicinesresources.nhs.uk/p2y12-inhibitor-monotherapy-or-dual-antiplatelet-therapy-after-coronary-revascularisation-individual-patient-level-meta-analysis-of-randomised-controlled-trials-1.html 2021-06-17T14:56:29.0510000Z https://www.medicinesresources.nhs.uk/syne-cov-for-predicting-covid-19-outcomes-medtech-innovation-briefing-mib264.html 2021-06-18T09:17:27.1780000Z https://www.medicinesresources.nhs.uk/ixekizumab-for-treating-axial-spondyloarthritis-final-appraisal-document-3.html 2021-06-17T15:00:58.7230000Z https://www.medicinesresources.nhs.uk/mhra-grants-marketing-authorisation-ma-to-cenobamate-ontozry-for-adjunctive-treatment-of-focal-onset-seizures-with-or-without-secondary-generalisation.html 2021-06-17T15:02:30.8970000Z https://www.medicinesresources.nhs.uk/report-on-pharmacys-role-in-reducing-drug-harms-and-preventing-drug-deaths-in-scotland.html 2021-06-17T15:04:41.0450000Z https://www.medicinesresources.nhs.uk/long-covid-the-nhs-plan-for-2021-22.html 2021-06-17T16:56:18.7160000Z https://www.medicinesresources.nhs.uk/acceleration-of-second-doses-of-covid-19-vaccine-for-cohort-10-and-plans-for-inviting-the-remainder-of-cohort-12.html 2021-06-17T15:09:00.9490000Z https://www.medicinesresources.nhs.uk/21-and-22-year-olds-to-be-offered-covid-19-vaccine-1.html 2021-06-17T16:55:09.9700000Z https://www.medicinesresources.nhs.uk/the-evolving-challenge-of-infections-in-cirrhosis-1.html 2021-06-17T15:12:35.9010000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-bristol-laboratories-limited-brown-and-burk-uk-ltd-teva-uk-ltd-irbesartan-containing-and-losartan-containing-products-el-21-a-16.html 2021-06-17T15:15:16.8950000Z https://www.medicinesresources.nhs.uk/mitochondrial-disease-in-adults-recent-advances-and-future-promise.html 2021-06-17T15:17:38.6640000Z https://www.medicinesresources.nhs.uk/progress-towards-therapies-for-disease-modification-in-parkinson-s-disease-2.html 2021-06-17T15:21:10.0910000Z https://www.medicinesresources.nhs.uk/more-than-30-million-people-vaccinated-with-second-dose-of-covid-19-vaccine-in-uk.html 2021-06-17T16:52:49.7850000Z https://www.medicinesresources.nhs.uk/people-working-in-cqc-registered-care-homes-will-need-to-be-fully-vaccinated-with-both-doses-of-covid-19-vaccine-under-new-law.html 2021-06-17T16:51:23.0130000Z https://www.medicinesresources.nhs.uk/myocarditis-after-bnt162b2-and-mrna-1273-vaccination.html 2021-06-17T16:42:04.6310000Z https://www.medicinesresources.nhs.uk/recognition-prevention-and-management-of-arrhythmias-and-autonomic-disorders-in-cardio-oncology-a-scientific-statement-from-the-american-heart-association-1.html 2021-06-17T15:31:55.6190000Z https://www.medicinesresources.nhs.uk/ethnic-health-inequalities-and-the-nhs-authors-driving-progress-in-a-changing-system-1.html 2021-06-17T16:39:09.5430000Z https://www.medicinesresources.nhs.uk/eu-approval-of-sputnik-v-coronavirus-vaccine-delayed-1.html 2021-06-17T16:37:43.1900000Z https://www.medicinesresources.nhs.uk/fda-accepts-for-priority-review-new-drug-application-nda-for-tyvaso-dpi-inhaled-treprostinil-for-treatment-of-pulmonary-arterial-hypertension-and-pulmonary-hypertension-associated-with-interstitial-lung-disease.html 2021-06-17T15:42:21.2890000Z https://www.medicinesresources.nhs.uk/public-citizen-chastises-fda-for-approval-of-aducanumab-in-us-1.html 2021-06-17T15:48:51.4810000Z https://www.medicinesresources.nhs.uk/safety-efficacy-and-tolerability-of-efgartigimod-in-patients-with-generalised-myasthenia-gravis-adapt-a-multicentre-randomised-placebo-controlled-phase-3-trial.html 2021-06-17T16:32:48.5200000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-pioglitazone-for-the-delay-of-cognitive-impairment-in-people-at-risk-of-alzheimer-s-disease-tommorrow-a-prognostic-biomarker-study-and-a-phase-3-randomised-double-blind-placebo-controlled-trial.html 2021-06-17T16:30:11.5220000Z https://www.medicinesresources.nhs.uk/tofacitinib-in-patients-hospitalized-with-covid-19-pneumonia.html 2021-06-17T15:57:59.7710000Z https://www.medicinesresources.nhs.uk/multisystem-inflammatory-syndrome-in-children-initial-therapy-and-outcomes-1.html 2021-06-17T16:23:21.0120000Z https://www.medicinesresources.nhs.uk/use-of-lipid-lowering-therapies-over-2-years-in-gould-a-registry-of-patients-with-atherosclerotic-cardiovascular-disease-in-the-us.html 2021-06-17T16:21:34.6830000Z https://www.medicinesresources.nhs.uk/association-between-glucagon-like-peptide-1-receptor-agonist-and-sodium-glucose-cotransporter-2-inhibitor-use-and-covid-19-outcomes-1.html 2021-06-17T16:21:02.9700000Z https://www.medicinesresources.nhs.uk/implementing-a-specialist-paediatric-clinical-pharmacology-service-in-a-uk-children-s-hospital.html 2021-06-17T16:20:05.6820000Z https://www.medicinesresources.nhs.uk/treatment-of-multisystem-inflammatory-syndrome-in-children.html 2021-06-17T16:27:06.4140000Z https://www.medicinesresources.nhs.uk/fda-approves-avapritinib-for-treatment-of-adults-with-advanced-systemic-mastocytosis-sm.html 2021-06-17T16:36:02.7180000Z https://www.medicinesresources.nhs.uk/findings-from-covid-19-round-12-react-1-study.html 2021-06-17T16:44:10.2070000Z https://www.medicinesresources.nhs.uk/curevacs-covid-19-vaccine-found-to-be-only-47-effective-against-disease-of-any-severity.html 2021-06-18T12:15:49.7460000Z https://www.medicinesresources.nhs.uk/gosuranemab-fails-to-meet-endpoints-in-phase-ii-study-in-alzheimers-disease.html 2021-06-18T12:35:34.7640000Z https://www.medicinesresources.nhs.uk/lu-psma-617-granted-breakthrough-therapy-designation-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-mcrpc.html 2021-06-18T12:37:42.3250000Z https://www.medicinesresources.nhs.uk/us-fda-grants-tpx-0022-orphan-drug-designation-for-the-treatment-of-gastric-cancer.html 2021-06-18T15:30:55.1580000Z https://www.medicinesresources.nhs.uk/us-fda-grants-gunagrabtinib-orphan-drug-designation-for-the-treatment-of-cholangiocarcinoma.html 2021-06-18T12:42:38.5750000Z https://www.medicinesresources.nhs.uk/following-a-satisfactory-review-mhra-extends-authorisation-of-nhs-test-and-trace-lateral-flow-devices.html 2021-06-18T12:45:23.5720000Z https://www.medicinesresources.nhs.uk/government-sets-out-laws-to-validate-accuracy-of-private-covid-19-tests-1.html 2021-06-18T12:47:56.9260000Z https://www.medicinesresources.nhs.uk/delta-variant-cases-continue-to-rise.html 2021-06-18T12:51:31.7240000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-322-june-2021-covid-19-phase-2-special-edition.html 2021-06-21T08:17:51.1650000Z https://www.medicinesresources.nhs.uk/phe-publishes-new-national-surveillance-data-on-possible-covid-19-reinfections.html 2021-06-18T13:09:14.2420000Z https://www.medicinesresources.nhs.uk/current-data-shows-a-low-risk-of-sars-cov-2-reinfection-with-15-893-possible-reinfections-identified-up-to-30-may-2021-out-of-nearly-4-million-confirmed-infections-rate-of-approx-0-4-the-data-will-be-published-regularly-as-part-of-the-phe-weekly-surveillance-report.html 2021-06-18T13:17:14.3340000Z https://www.medicinesresources.nhs.uk/the-problem-of-aducanumab-for-the-treatment-of-alzheimer-disease.html 2021-06-18T13:19:05.7440000Z https://www.medicinesresources.nhs.uk/my-role-in-tackling-health-inequalities-a-framework-for-allied-health-professionals.html 2021-06-18T13:20:22.9770000Z https://www.medicinesresources.nhs.uk/nhs-invites-all-adults-to-get-a-covid-vaccine.html 2021-06-18T13:22:00.6180000Z https://www.medicinesresources.nhs.uk/thousands-of-lives-to-be-saved-by-health-mots-at-nhs-vaccination-services.html 2021-06-18T13:23:37.1900000Z https://www.medicinesresources.nhs.uk/nhs-to-invest-gbp52-million-to-fast-track-online-maternity-records.html 2021-06-18T13:24:48.3450000Z https://www.medicinesresources.nhs.uk/secukinumab-for-treating-non-radiographic-axial-spondyloarthritis-final-appraisal-document-1.html 2021-06-18T13:27:25.1820000Z https://www.medicinesresources.nhs.uk/medicine-supply-notification-msn-kolanticon-gel-r-2-5mg-dicycloverine-hydrochloride-200mg-aluminium-hydroxide-100mg-light-magnesium-oxide-20mg-simethicone-per-5ml.html 2021-06-18T13:28:53.3340000Z https://www.medicinesresources.nhs.uk/green-book-chapter-2-on-consent-updated.html 2021-06-21T08:32:46.4190000Z https://www.medicinesresources.nhs.uk/revised-spc-alofisel-darvadstrocel-5-million-cells-ml-suspension-for-injection.html 2021-06-18T14:06:50.5060000Z https://www.medicinesresources.nhs.uk/nihr-alert-gabapentin-does-not-reduce-long-term-pelvic-pain-and-has-unpleasant-side-effects-research-finds.html 2021-06-18T15:22:57.8810000Z https://www.medicinesresources.nhs.uk/global-covid-19-vaccine-rollout-and-safety-surveillance-how-to-keep-pace.html 2021-06-18T14:12:57.3680000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-outreach-local-knowledge-contacts-and-credibility-really-really-matter.html 2021-06-18T14:17:34.4990000Z https://www.medicinesresources.nhs.uk/covid-19-prepare-for-a-third-wave-warns-englands-chief-medical-officer.html 2021-06-18T15:43:24.5890000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-in-patients-with-a1-antitrypsin-deficiency-aatd.html 2021-06-18T14:23:41.0670000Z https://www.medicinesresources.nhs.uk/regulatory-compliant-supply-of-covid-19-vaccines-by-one-nhs-organisation-to-another-advice-for-senior-pharmacists.html 2021-06-21T08:42:22.7300000Z https://www.medicinesresources.nhs.uk/barriers-to-shared-decision-making-with-women-of-reproductive-age-affected-by-a-chronic-inflammatory-disease-a-mixed-methods-needs-assessment-of-dermatologists-and-rheumatologists.html 2021-06-18T15:13:12.9580000Z https://www.medicinesresources.nhs.uk/rapid-realist-review-of-the-role-of-community-pharmacy-in-the-public-health-response-to-covid-19.html 2021-06-18T15:14:42.8880000Z https://www.medicinesresources.nhs.uk/sperm-parameters-before-and-after-covid-19-mrna-vaccination.html 2021-06-18T15:32:23.4770000Z https://www.medicinesresources.nhs.uk/association-of-convalescent-plasma-therapy-with-survival-in-patients-with-hematologic-cancers-and-covid-19.html 2021-06-18T15:35:12.6470000Z https://www.medicinesresources.nhs.uk/imatinib-in-patients-with-severe-covid-19-a-randomised-double-blind-placebo-controlled-clinical-trial.html 2021-06-18T15:21:29.2870000Z https://www.medicinesresources.nhs.uk/revised-spc-fosrenol-lanthanum-all-presentations.html 2021-06-21T14:26:04.4040000Z https://www.medicinesresources.nhs.uk/revised-spc-entyvio-vedolizumab-all-strengths.html 2021-06-21T14:27:41.1310000Z https://www.medicinesresources.nhs.uk/effects-of-tobacco-smoking-on-recurrent-hospitalisation-with-pneumonia-a-population-based-cohort-study.html 2021-06-21T15:39:45.2620000Z https://www.medicinesresources.nhs.uk/erectile-function-in-men-with-type-2-diabetes-treated-with-dulaglutide-an-exploratory-analysis-of-the-rewind-placebo-controlled-randomised-trial.html 2021-06-21T14:32:00.3770000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-adalimumab-in-paediatric-patients-with-moderate-to-severe-ulcerative-colitis-envision-i-a-randomised-controlled-phase-3-study.html 2021-06-21T14:34:52.2810000Z https://www.medicinesresources.nhs.uk/safety-and-immunogenicity-of-the-chadox1-ncov-19-azd1222-vaccine-against-sars-cov-2-in-hiv-infection-a-single-arm-substudy-of-a-phase-2-3-clinical-trial.html 2021-06-21T14:38:22.3470000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-faqs-students-in-higher-education-institutions.html 2021-06-21T15:42:54.1060000Z https://www.medicinesresources.nhs.uk/fda-grants-ctd401-orphan-drug-designation-for-treatment-of-t-cell-acute-lymphoblastic-leukaemia-1.html 2021-06-21T14:47:08.0390000Z https://www.medicinesresources.nhs.uk/european-approval-of-azacitidine-tablets-onureg-for-frontline-oral-maintenance-therapy-for-adults-with-acute-myeloid-leukaemia-2.html 2021-06-21T15:44:01.6690000Z https://www.medicinesresources.nhs.uk/european-approval-of-paediatric-license-extension-of-teriflunomide-aubagio-for-treatment-of-relapsing-remitting-multiple-sclerosis-in-patients-aged-10-to-17-years.html 2021-06-21T14:58:53.7600000Z https://www.medicinesresources.nhs.uk/over-one-million-vaccinations-booked-as-nhs-vaccine-programme-opens-to-all-adults.html 2021-06-21T15:05:54.8940000Z https://www.medicinesresources.nhs.uk/bmj-editorial-persistent-pulmonary-disease-after-acute-covid-20.html 2021-06-21T15:07:37.9850000Z https://www.medicinesresources.nhs.uk/enhanced-service-specification-long-covid-2021-22.html 2021-06-21T15:11:04.3380000Z https://www.medicinesresources.nhs.uk/enhanced-service-specification-weight-management-2021-22.html 2021-06-21T15:12:29.8500000Z https://www.medicinesresources.nhs.uk/european-orphan-designation-for-day101-for-treatment-of-glioma-1.html 2021-06-21T15:14:27.8120000Z https://www.medicinesresources.nhs.uk/appropriate-systemic-therapy-dosing-for-obese-adult-patients-with-cancer-asco-guideline-update.html 2021-06-21T15:18:10.7170000Z https://www.medicinesresources.nhs.uk/new-product-jemperli-dostarlimab-500-mg-concentrate-for-solution-for-infusion-5.html 2021-06-22T15:09:30.4590000Z https://www.medicinesresources.nhs.uk/revised-spc-opdivo-nivolumab-10-mg-ml-concentrate-for-solution-for-infusion-3.html 2021-06-22T15:12:07.1940000Z https://www.medicinesresources.nhs.uk/ivermectin-for-prevention-and-treatment-of-covid-19-infection-a-systematic-review-meta-analysis-and-trial-sequential-analysis-to-inform-clinical-guidelines-2.html 2021-06-22T18:38:32.8500000Z https://www.medicinesresources.nhs.uk/mirtazapine-use-may-increase-the-risk-of-hypothyroxinemia-in-patients-affected-by-major-depressive-disorder-1.html 2021-06-22T15:26:18.6000000Z https://www.medicinesresources.nhs.uk/social-determinants-of-pertussis-and-influenza-vaccine-uptake-in-pregnancy-a-national-cohort-study-in-england-using-electronic-health-records.html 2021-06-22T15:27:29.6230000Z https://www.medicinesresources.nhs.uk/abpi-launches-new-patient-advisory-council-to-provide-board-and-senior-executive-team-with-meaningful-patient-engagement-5.html 2021-06-22T15:30:04.2900000Z https://www.medicinesresources.nhs.uk/european-commission-grants-conditional-approval-selumetinib-koselugo-for-treatment-of-children-with-symptomatic-inoperable-plexiform-neurofibromas-pn-and-neurofibromatosis-type-1-nf1.html 2021-06-22T15:31:23.9970000Z https://www.medicinesresources.nhs.uk/adult-social-care-markets-house-of-commons-seventh-report-of-session-2021-23.html 2021-06-22T15:33:19.1580000Z https://www.medicinesresources.nhs.uk/extra-gbp40-million-allocated-to-address-covid-impact-on-children-and-young-peoples-mental-health-and-enhance-services-across-country.html 2021-06-22T15:34:36.1470000Z https://www.medicinesresources.nhs.uk/contemporary-radiotherapy-present-and-future.html 2021-06-22T15:35:35.7640000Z https://www.medicinesresources.nhs.uk/overuse-of-levothyroxine-in-patients-with-subclinical-hypothyroidism-time-to-leve-out-thyroxine.html 2021-06-22T15:37:14.9510000Z https://www.medicinesresources.nhs.uk/general-pharmaceutical-council-issues-reminder-to-pharmacy-professionals-about-valproate-and-the-risk-of-birth-defects.html 2021-06-28T10:01:39.0930000Z https://www.medicinesresources.nhs.uk/data-saves-lives-reshaping-health-and-social-care-with-data-draft-strategy-1.html 2021-06-22T15:41:56.0360000Z https://www.medicinesresources.nhs.uk/interpreting-a-lateral-flow-sars-cov-2-antigen-test.html 2021-06-22T15:43:27.5790000Z https://www.medicinesresources.nhs.uk/future-of-covid-19-vaccine-pricing-lessons-from-influenza-2.html 2021-06-22T15:46:50.7960000Z https://www.medicinesresources.nhs.uk/management-of-blood-pressure-in-patients-with-chronic-kidney-disease-not-receiving-dialysis-synopsis-of-the-2021-kdigo-clinical-practice-guidelinefree-4.html 2021-06-22T18:54:48.7420000Z https://www.medicinesresources.nhs.uk/fda-approves-dabigatran-etexilate-oral-pellets-to-treat-children-3-months-to-less-than-12-years-old-with-venous-thromboembolism.html 2021-06-22T18:56:38.4850000Z https://www.medicinesresources.nhs.uk/hospital-treated-infectious-diseases-and-the-risk-of-dementia-a-large-multicohort-observational-study-with-a-replication-cohort.html 2021-06-22T19:07:26.6380000Z https://www.medicinesresources.nhs.uk/association-of-modifiable-risk-factors-with-early-discontinuation-of-adjuvant-endocrine-therapy-a-post-hoc-analysis-of-a-randomized-clinical-trial.html 2021-06-22T15:58:34.7260000Z https://www.medicinesresources.nhs.uk/assessing-the-association-between-social-gatherings-and-covid-19-risk-using-birthdays.html 2021-06-22T15:59:59.7170000Z https://www.medicinesresources.nhs.uk/association-of-changes-in-seasonal-respiratory-virus-activity-and-ambulatory-antibiotic-prescriptions-with-the-covid-19-pandemic-4.html 2021-06-22T16:03:00.9920000Z https://www.medicinesresources.nhs.uk/community-based-pharmacists-role-in-deprescribing-a-systematic-review.html 2021-06-22T19:17:20.5680000Z https://www.medicinesresources.nhs.uk/effect-of-sotagliflozin-on-total-hospitalizations-in-patients-with-type-2-diabetes-and-worsening-heart-failure-a-randomized-trial.html 2021-06-22T19:24:28.7730000Z https://www.medicinesresources.nhs.uk/new-drug-application-nda-submitted-to-fda-for-mitapivat-for-treatment-of-adults-with-pyruvate-kinase-deficiency-2.html 2021-06-22T19:33:32.5630000Z https://www.medicinesresources.nhs.uk/fda-rejects-arimoclomol-for-treatment-of-niemann-pick-disease-type-c-npc-1.html 2021-06-22T19:38:27.5580000Z https://www.medicinesresources.nhs.uk/novartis-presents-data-from-phase-iii-study-of-zolgensma-onasemnogene-abeparvovec-in-patients-with-presymptomatic-spinal-muscular-atrophy-sma.html 2021-06-22T16:16:53.2460000Z https://www.medicinesresources.nhs.uk/revised-spc-rebrikel-buprenorphine-transdermal-patches-all-strengths-1.html 2021-06-23T15:06:09.5120000Z https://www.medicinesresources.nhs.uk/revised-spc-zyban-bupropion-hydrochloride-150-mg-prolonged-release-tablets-4.html 2021-06-23T15:09:16.9070000Z https://www.medicinesresources.nhs.uk/revised-spc-arimidex-1mg-film-coated-tablet-lena-doing.html 2021-06-28T09:37:11.3700000Z https://www.medicinesresources.nhs.uk/budesonide-orodispersible-tablet-for-inducing-remission-of-eosinophilic-oesophagitis-technology-appraisal-guidance-ta708-1.html 2021-06-28T09:18:25.0020000Z https://www.medicinesresources.nhs.uk/pembrolizumab-for-untreated-metastatic-colorectal-cancer-with-high-microsatellite-instability-or-mismatch-repair-deficiency-technology-appraisal-guidance-ta709.html 2021-06-28T09:31:39.3950000Z https://www.medicinesresources.nhs.uk/ravulizumab-for-treating-atypical-haemolytic-uraemic-syndrome-technology-appraisal-guidance-ta710.html 2021-06-28T09:33:25.7800000Z https://www.medicinesresources.nhs.uk/iron-preparations-for-women-of-reproductive-age-with-iron-deficiency-anaemia-in-pregnancy-frida-a-systematic-review-and-network-meta-analysis-2.html 2021-06-23T15:21:33.0830000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-mulberry-twig-alkaloids-tablet-for-the-treatment-of-type-2-diabetes-a-multicenter-randomized-double-blind-double-dummy-and-parallel-controlled-clinical-trial.html 2021-06-23T15:22:24.5080000Z https://www.medicinesresources.nhs.uk/glucagon-like-peptide-1-receptor-agonists-and-chronic-lower-respiratory-disease-exacerbations-among-patients-with-type-2-diabetes-2.html 2021-06-23T15:23:13.6490000Z https://www.medicinesresources.nhs.uk/biochemical-urine-testing-of-medication-adherence-and-its-association-with-clinical-markers-in-an-outpatient-population-of-type-2-diabetes-patients-analysis-in-the-diabetes-and-lifestyle-cohort-twente-dialect-1.html 2021-06-23T15:24:12.1000000Z https://www.medicinesresources.nhs.uk/intensive-care-unit-admission-mechanical-ventilation-and-mortality-among-patients-with-type-1-diabetes-hospitalized-for-covid-19-in-the-u-s-4.html 2021-06-23T15:29:02.5960000Z https://www.medicinesresources.nhs.uk/statin-associated-lower-cancer-risk-and-related-mortality-in-patients-with-heart-failure-1.html 2021-06-23T15:51:46.6980000Z https://www.medicinesresources.nhs.uk/cpx-351-versus-7-3-cytarabine-and-daunorubicin-chemotherapy-in-older-adults-with-newly-diagnosed-high-risk-or-secondary-acute-myeloid-leukaemia-5-year-results-of-a-randomised-open-label-multicentre-phase-3-trial-2.html 2021-06-23T16:23:43.1190000Z https://www.medicinesresources.nhs.uk/mortality-and-critical-care-unit-admission-associated-with-the-sars-cov-2-lineage-b-1-1-7-in-england-an-observational-cohort-study.html 2021-06-23T15:54:51.0350000Z https://www.medicinesresources.nhs.uk/canadian-study-finds-schools-are-not-at-higher-risk-for-covid-20.html 2021-06-23T15:56:32.4780000Z https://www.medicinesresources.nhs.uk/european-commission-purchases-additional-150-million-doses-of-modernas-covid-19-vaccine-for-delivery-in-2024.html 2021-06-23T16:03:30.8900000Z https://www.medicinesresources.nhs.uk/study-shows-eating-prunes-daily-improves-risk-factors-for-heart-disease-and-inflammation-in-postmenopausal-women-1.html 2021-06-23T16:05:14.2620000Z https://www.medicinesresources.nhs.uk/sintilimab-in-combination-with-chemotherapy-meets-overall-survival-primary-endpoint-in-the-global-phase-3-orient-15-study-for-the-first-line-treatment-of-esophageal-squamous-cell-carcinoma.html 2021-06-23T16:06:45.2030000Z https://www.medicinesresources.nhs.uk/uk-researchers-find-covid-19-might-have-long-term-effects-on-sense-of-taste-and-smell-in-an-observational-study-from-oxford-university.html 2021-06-23T16:08:46.4710000Z https://www.medicinesresources.nhs.uk/gbp64-million-funding-provided-for-uk-wide-plan-to-strengthen-clinical-research-delivery-1.html 2021-06-23T16:10:16.1440000Z https://www.medicinesresources.nhs.uk/fda-coronavirus-covid-19-update-june-22-2021.html 2021-06-23T16:12:01.4770000Z https://www.medicinesresources.nhs.uk/misconceptions-about-acne-lead-to-underuse-of-effective-treatments-people-need-reliable-information-to-manage-the-condition-long-term.html 2021-06-23T16:19:04.3260000Z https://www.medicinesresources.nhs.uk/novartis-reveals-long-term-results-from-an-ongoing-label-extension-of-the-althios-study-for-multiple-sclerosis-ms-therapy-kesimpta-ofatumumab.html 2021-06-23T16:17:14.6380000Z https://www.medicinesresources.nhs.uk/supply-disruption-affecting-champix-varenicline-tablets-pfizer.html 2021-06-23T15:53:32.2880000Z https://www.medicinesresources.nhs.uk/revised-spc-arimidex-anastrozole-1mg-film-coated-tablet.html 2021-06-23T16:11:58.5910000Z https://www.medicinesresources.nhs.uk/the-association-between-hormonal-contraceptive-use-and-glaucoma-in-women-of-reproductive-age-2.html 2021-06-23T16:16:31.2110000Z https://www.medicinesresources.nhs.uk/merck-announces-phase-3-keynote-826-trial-of-pembrolizumab-plus-platinum-based-chemotherapy-with-or-without-bevacizumab-met-dual-primary-endpoints-in-patients-with-metastatic-cervical-cancer-1.html 2021-06-23T16:28:46.9190000Z https://www.medicinesresources.nhs.uk/uniqure-announces-positive-52-week-clinical-data-from-phase-iii-hope-b-pivotal-trial-of-investigational-adeno-associated-virus-five-based-gene-therapy-eranacogene-dezaparvovec-in-patients-with-haemophilia-b.html 2021-06-23T16:24:19.3930000Z https://www.medicinesresources.nhs.uk/comparison-of-effectiveness-and-safety-between-ticagrelor-and-clopidogrel-in-patients-with-acute-coronary-syndrome-and-on-dialysis-in-taiwan-3.html 2021-06-23T16:30:57.9710000Z https://www.medicinesresources.nhs.uk/new-product-ascorbic-acid-pascoe-150-mg-ml-concentrate-for-solution-for-injection-infusion-1.html 2021-06-24T14:27:25.3690000Z https://www.medicinesresources.nhs.uk/oxygen-issues-during-the-covid-19-pandemic.html 2021-06-27T20:56:52.7470000Z https://www.medicinesresources.nhs.uk/effect-of-the-covid-19-pandemic-in-2020-on-life-expectancy-across-populations-in-the-usa-and-other-high-income-countries-simulations-of-provisional-mortality-data-4.html 2021-06-24T14:32:06.9140000Z https://www.medicinesresources.nhs.uk/fried-food-consumption-and-risk-of-cardiovascular-disease-and-all-cause-mortality-a-meta-analysis-of-observational-studies.html 2021-06-24T14:33:12.3150000Z https://www.medicinesresources.nhs.uk/what-dose-of-folic-acid-to-use-with-methotrexate-in-rheumatoid-arthritis-2.html 2021-06-24T14:37:46.4150000Z https://www.medicinesresources.nhs.uk/national-chlamydia-screening-programme-ncsp-will-focus-testing-on-women-at-highest-risk-of-serious-consequences-from-infection-2.html 2021-06-24T16:10:08.1060000Z https://www.medicinesresources.nhs.uk/stress-incontinence-in-women-1.html 2021-06-24T15:08:55.4210000Z https://www.medicinesresources.nhs.uk/sars-cov-2-variants-and-vaccines-1.html 2021-06-24T15:10:42.3530000Z https://www.medicinesresources.nhs.uk/survey-finds-rising-medicines-shortages-drive-up-gp-workload-and-risk-for-patients-3.html 2021-06-24T15:13:33.6350000Z https://www.medicinesresources.nhs.uk/us-case-reports-of-cerebral-venous-sinus-thrombosis-with-thrombocytopenia-after-ad26-cov2-s-vaccination-march-2-to-april-21-2022.html 2021-06-24T15:17:42.6220000Z https://www.medicinesresources.nhs.uk/guidelines-for-reporting-trial-protocols-and-completed-trials-modified-due-to-the-covid-19-pandemic-and-other-extenuating-circumstances-the-conserve-2021-statement.html 2021-06-24T15:19:00.0300000Z https://www.medicinesresources.nhs.uk/progress-in-pharmacotherapy-for-obesity-3.html 2021-06-24T15:21:57.8200000Z https://www.medicinesresources.nhs.uk/switched-on-how-do-we-get-the-best-out-of-automation-and-ai-in-health-care.html 2021-06-24T15:23:10.6020000Z https://www.medicinesresources.nhs.uk/republished-case-report-severe-hypophosphataemia-following-oral-bisphosphonate-treatment-in-a-patient-with-osteoporosis-2.html 2021-06-24T15:34:08.3930000Z https://www.medicinesresources.nhs.uk/new-research-shows-2-million-people-may-have-had-long-covid-3.html 2021-06-24T15:38:58.5170000Z https://www.medicinesresources.nhs.uk/fda-accepts-resubmission-of-new-drug-application-for-unique-formulation-of-sodium-thiosulfate-pedmark-for-prevention-of-cisplatin-induced-ototoxicity-in-children-with-localised-non-metastatic-solid-tumours.html 2021-06-24T15:40:12.0460000Z https://www.medicinesresources.nhs.uk/investigating-raised-creatine-kinase.html 2021-06-24T15:41:53.4230000Z https://www.medicinesresources.nhs.uk/court-of-appeal-considering-whether-under-16s-can-give-informed-consent-to-medical-treatment-that-delays-onset-of-puberty.html 2021-06-24T15:43:01.3640000Z https://www.medicinesresources.nhs.uk/ivermectin-to-be-studied-as-possible-treatment-for-covid-19-symptoms-in-uk-1.html 2021-06-24T16:04:54.5820000Z https://www.medicinesresources.nhs.uk/darzalex-daratumumab-and-hyaluronidase-fihj-subcutaneous-formulation-approved-in-eu-for-treatment-of-patients-with-newly-diagnosed-light-chain-al-amyloidosis-and-relapsed-or-refractory-multiple-myeloma-rrmm.html 2021-06-24T15:48:28.6710000Z https://www.medicinesresources.nhs.uk/company-announces-phase-4-leros-trial-with-raxone-idebenone-met-primary-endpoint-in-patients-with-lebers-hereditary-optic-neuropathy.html 2021-06-24T16:20:49.9170000Z https://www.medicinesresources.nhs.uk/u-s-centers-for-disease-control-and-prevention-advisory-committee-considers-link-likely-between-mrna-vaccines-and-rare-cases-of-myocarditis-or-pericarditis.html 2021-06-24T15:52:25.6000000Z https://www.medicinesresources.nhs.uk/fda-grants-breakthrough-therapy-designation-btd-for-an-investigational-anti-amyloid-beta-protofibril-antibody-lecanemab-for-treatment-of-alzheimer-s-disease-az.html 2021-06-24T15:54:23.4540000Z https://www.medicinesresources.nhs.uk/fda-accepts-application-for-port-delivery-system-with-ranibizumab-pds-for-treatment-of-wet-age-related-macular-degeneration-amd.html 2021-06-24T15:56:37.3690000Z https://www.medicinesresources.nhs.uk/national-audit-of-antidote-stocking-in-uk-emergency-departments.html 2021-06-27T20:59:06.5680000Z https://www.medicinesresources.nhs.uk/azithromycin-or-doxycycline-for-asymptomatic-rectal-chlamydia-trachomatis-3.html 2021-06-24T16:02:33.1730000Z https://www.medicinesresources.nhs.uk/lutetium-177-psma-617-for-metastatic-castration-resistant-prostate-cancer.html 2021-06-24T16:03:44.4790000Z https://www.medicinesresources.nhs.uk/chlorhexidine-plus-alcohol-versus-povidone-iodine-plus-alcohol-combined-or-not-with-innovative-devices-for-prevention-of-short-term-peripheral-venous-catheter-infection-and-failure-clean-3-study-an-investigator-initiated-open-label-single-centre-randomised-controlled-two-by-two-factorial-trial.html 2021-06-24T16:06:07.6400000Z https://www.medicinesresources.nhs.uk/camrelizumab-versus-placebo-in-combination-with-gemcitabine-and-cisplatin-as-first-line-treatment-for-recurrent-or-metastatic-nasopharyngeal-carcinoma-captain-1st-a-multicentre-randomised-double-blind-phase-3-trial.html 2021-06-24T16:07:28.8640000Z https://www.medicinesresources.nhs.uk/pravastatin-versus-placebo-in-pregnancies-at-high-risk-of-term-preeclampsia.html 2021-06-24T16:09:00.7050000Z https://www.medicinesresources.nhs.uk/pulmonary-embolism-in-patients-with-covid-19-incidence-risk-factors-clinical-characteristics-and-outcome-2.html 2021-06-24T16:11:04.2920000Z https://www.medicinesresources.nhs.uk/increased-risk-of-incident-heart-failure-and-death-is-associated-with-insulin-resistance-in-people-with-newly-diagnosed-type-2-diabetes-ukpds-91.html 2021-06-24T16:13:15.2330000Z https://www.medicinesresources.nhs.uk/presence-and-determinants-of-cardiovascular-disease-and-mortality-in-individuals-with-type-1-diabetes-of-long-duration-the-finndiane-50-years-of-diabetes-study.html 2021-06-24T16:14:36.7790000Z https://www.medicinesresources.nhs.uk/incidence-of-cutaneous-reactions-after-messenger-rna-covid-19-vaccines.html 2021-06-24T16:16:50.4450000Z https://www.medicinesresources.nhs.uk/effectiveness-of-bnt162b2-and-chadox1-ncov-19-covid-19-vaccination-at-preventing-hospitalisations-in-people-aged-at-least-80-years-a-test-negative-case-control-study-1.html 2021-06-24T16:30:21.0330000Z https://www.medicinesresources.nhs.uk/vaccine-effectiveness-of-the-first-dose-of-chadox1-ncov-19-and-bnt162b2-against-sars-cov-2-infection-in-residents-of-long-term-care-facilities-in-england-vivaldi-a-prospective-cohort-study.html 2021-06-24T16:31:38.7420000Z https://www.medicinesresources.nhs.uk/risk-of-hospitalisation-associated-with-infection-with-sars-cov-2-lineage-b-1-1-7-in-denmark-an-observational-cohort-study-1.html 2021-06-24T16:33:05.7480000Z https://www.medicinesresources.nhs.uk/acne-vulgaris-management-guidance-ng198.html 2021-06-27T20:28:19.0430000Z https://www.medicinesresources.nhs.uk/revised-spc-instanyl-fentanyl-citrate-nasal-spray-solution-in-single-dose-container.html 2021-06-25T13:44:10.8600000Z https://www.medicinesresources.nhs.uk/educational-risk-mininimisation-materials-to-help-reduce-the-risk-associated-with-use-of-natalizumab-tysabri-for-the-treatment-of-multiple-sclerosis.html 2021-06-27T20:34:53.8550000Z https://www.medicinesresources.nhs.uk/educational-risk-minimisation-materials-to-help-reduce-the-risk-associated-with-using-vedolizumab-entyvio-in-the-treatment-of-ulcerative-colitis-and-crohns-disease.html 2021-06-27T20:36:13.1980000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-urgent-policy-statement-subcutaneous-copper-histidinate-injections-for-presymptomatic-neonates-with-classical-menkes-disease.html 2021-06-27T20:38:45.7270000Z https://www.medicinesresources.nhs.uk/european-commission-approves-cemiplimab-libtayo-r-for-the-treatment-of-adults-with-advanced-basal-cell-carcinoma.html 2021-06-25T14:11:32.0330000Z https://www.medicinesresources.nhs.uk/us-fda-grants-donanemab-breakthrough-therapy-designation-for-alzheimers-disease.html 2021-06-25T14:12:54.6450000Z https://www.medicinesresources.nhs.uk/european-commission-approves-cemiplimab-libtayo-r-for-the-first-line-treatment-of-patients-with-advanced-non-small-cell-lung-cancer-with-50-pd-l1-expression.html 2021-06-25T14:17:53.3410000Z https://www.medicinesresources.nhs.uk/us-fda-grants-adagrasib-breakthrough-therapy-designation-for-advanced-non-small-cell-lung-cancer-harbouring-the-kras-g12c-mutation.html 2021-06-25T14:20:20.5240000Z https://www.medicinesresources.nhs.uk/us-fda-grants-cinrebafusp-alfa-orphan-drug-designation-for-the-treatment-of-her2-high-and-her2-low-expressing-gastric-cancers.html 2021-06-25T14:21:24.0970000Z https://www.medicinesresources.nhs.uk/us-fda-accepts-new-drug-application-for-vutrisiran-for-the-treatment-of-the-polyneuropathy-of-hereditary-attr-amyloidosis-2.html 2021-06-25T14:27:18.7170000Z https://www.medicinesresources.nhs.uk/us-fda-grants-apraglutide-orphan-drug-designation-for-the-treatment-of-acute-graft-versus-host-disease-gvhd.html 2021-06-25T14:30:06.3620000Z https://www.medicinesresources.nhs.uk/covid-19-should-we-be-worried-about-reports-of-myocarditis-and-pericarditis-after-mrna-vaccines.html 2021-06-25T14:34:13.2660000Z https://www.medicinesresources.nhs.uk/covid-19-third-of-people-infected-have-long-term-symptoms.html 2021-06-25T15:40:42.7650000Z https://www.medicinesresources.nhs.uk/chronic-kidney-disease.html 2021-06-25T14:37:44.0960000Z https://www.medicinesresources.nhs.uk/sphingosine-1-phosphate-receptor-modulators-in-multiple-sclerosis-and-other-conditions.html 2021-06-25T14:39:57.3060000Z https://www.medicinesresources.nhs.uk/prismra-r-test-meets-primary-endpoints-in-prospective-observational-study-predicting-inadequate-response-to-anti-tnf-therapy-in-rheumatoid-arthritis.html 2021-06-25T14:42:40.7900000Z https://www.medicinesresources.nhs.uk/dexamethasone-0-1-maxidex-5ml-eye-drops-supply-disruption-alert.html 2021-06-27T20:42:08.8170000Z https://www.medicinesresources.nhs.uk/champix-varenicline-0-5mg-and-1mg-tablets-supply-disruption.html 2021-06-27T20:44:11.2980000Z https://www.medicinesresources.nhs.uk/coronavirus-vaccine-weekly-summary-of-yellow-card-reporting-24-june.html 2021-06-25T14:52:37.0140000Z https://www.medicinesresources.nhs.uk/new-advertising-rules-to-help-tackle-childhood-obesity.html 2021-06-25T14:54:47.1820000Z https://www.medicinesresources.nhs.uk/latest-weekly-update-on-confirmed-cases-of-covid-19-variants-identified-in-uk.html 2021-06-25T14:57:50.6730000Z https://www.medicinesresources.nhs.uk/chlamydia-screening-to-focus-on-reducing-harm-from-untreated-infections.html 2021-06-25T15:00:18.5600000Z https://www.medicinesresources.nhs.uk/seasonal-flu-vaccine-uptake-reports-for-winter-2020-to-2021-published.html 2021-06-25T15:02:54.4000000Z https://www.medicinesresources.nhs.uk/tobacco-preventing-uptake-promoting-quitting-and-treating-dependence-update-draft-guidance-consultation.html 2021-06-25T15:04:29.8360000Z https://www.medicinesresources.nhs.uk/test-and-trace-in-england-progress-update.html 2021-06-25T15:06:13.7760000Z https://www.medicinesresources.nhs.uk/assessment-and-management-of-cardiovascular-disease-in-the-intensive-care-unit.html 2021-06-25T15:07:57.1770000Z https://www.medicinesresources.nhs.uk/admin-matters-the-impact-of-nhs-administration-on-patient-care.html 2021-06-25T15:08:44.1160000Z https://www.medicinesresources.nhs.uk/nhs-walk-in-vaccination-sites-open-up-in-grab-a-jab-weekend.html 2021-06-25T15:09:35.7310000Z https://www.medicinesresources.nhs.uk/peaks-in-number-of-young-people-prescribed-antidepressants-coincide-with-lockdowns.html 2021-06-25T15:23:10.5050000Z https://www.medicinesresources.nhs.uk/european-medicines-agency-recommends-granting-a-conditional-marketing-authorisation-in-the-eu-for-idecabtagene-vicleucel-abecma-for-the-treatment-of-relapsed-and-refractory-multiple-myeloma.html 2021-06-25T15:15:11.2470000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-bimekizumab-bimzelx-for-the-treatment-of-moderate-to-severe-plaque-psoriasis.html 2021-06-25T15:16:11.5590000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-roxadustat-evrenzo-for-the-treatment-of-anaemia-symptoms-in-patients-with-chronic-kidney-disease.html 2021-06-25T15:17:03.8070000Z https://www.medicinesresources.nhs.uk/menacwy-vaccine-menveo-r-or-nimenrix-r-patient-group-direction-pgd-template-update.html 2021-06-27T20:47:16.6720000Z https://www.medicinesresources.nhs.uk/orphalan-announces-trientine-tetrahydrochloride-non-inferior-to-d-penicillamine-in-the-maintenance-treatment-of-wilsons-disease.html 2021-06-25T15:23:50.4980000Z https://www.medicinesresources.nhs.uk/treatment-with-antiviral-entry-inhibitor-bulevirtide-shown-to-achieve-significant-response-in-chronic-hepatitis-delta-virus-after-24-weeks.html 2021-06-25T15:26:45.2210000Z https://www.medicinesresources.nhs.uk/prognosis-of-patients-with-early-breast-cancer-receiving-5-years-vs-2-years-of-adjuvant-bisphosphonate-treatment-a-phase-3-randomized-clinical-trial.html 2021-06-25T15:28:01.4980000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-remdesivir-in-covid-19-caused-by-sars-cov-2-a-systematic-review-and-meta-analysis.html 2021-06-25T15:30:15.2620000Z https://www.medicinesresources.nhs.uk/ciltacabtagene-autoleucel-a-b-cell-maturation-antigen-directed-chimeric-antigen-receptor-t-cell-therapy-in-patients-with-relapsed-or-refractory-multiple-myeloma-cartitude-1-a-phase-1b-2-open-label-study.html 2021-06-25T15:32:52.5500000Z https://www.medicinesresources.nhs.uk/neoadjuvant-trastuzumab-pertuzumab-and-docetaxel-vs-trastuzumab-emtansine-in-patients-with-erbb2-positive-breast-cancer-a-phase-2-randomized-clinical-trial.html 2021-06-25T15:33:52.5320000Z https://www.medicinesresources.nhs.uk/targeted-smoking-cessation-for-dual-users-of-combustible-and-electronic-cigarettes-a-randomised-controlled-trial.html 2021-06-25T15:34:48.4230000Z https://www.medicinesresources.nhs.uk/mhra-issues-conditional-marketing-authorisation-for-the-covid-19-vaccine-astrazeneca-in-great-britain-1.html 2021-06-30T07:54:36.9020000Z https://www.medicinesresources.nhs.uk/revised-spc-tenormin-atenolol-all-formulations.html 2021-06-28T11:36:42.3760000Z https://www.medicinesresources.nhs.uk/revised-spc-etrivex-clobetasol-500-micrograms-g-shampoo.html 2021-06-28T11:38:24.2010000Z https://www.medicinesresources.nhs.uk/revised-spc-epilim-sodium-valproate-all-presentations.html 2021-06-28T11:40:16.2700000Z https://www.medicinesresources.nhs.uk/hypertension-is-the-major-predictor-of-poor-outcomes-among-inpatients-with-covid-19-infection-in-the-uk-a-retrospective-cohort-study.html 2021-06-28T11:44:47.9030000Z https://www.medicinesresources.nhs.uk/oral-ondansetron-for-paediatric-gastroenteritis-in-primary-care-a-randomised-controlled-trial.html 2021-06-28T11:46:23.6060000Z https://www.medicinesresources.nhs.uk/conference-data-positive-phase-iii-trial-of-once-weekly-exenatide-for-treatment-of-type-2-diabetes-in-adolescents-aged-10-17.html 2021-06-28T11:47:59.4440000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-ranibizumab-byooviz-for-treatment-of-various-ocular-conditions-2.html 2021-06-28T14:43:38.8220000Z https://www.medicinesresources.nhs.uk/european-chmp-negative-opinion-of-eflornithine-sulindac-flynpovi-for-treatment-of-adults-with-familial-adenomatous-polyposis-fap.html 2021-06-28T11:52:34.4810000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-vosoritide-voxzogo-for-treatment-of-achondroplasia-in-patients-aged-2-years.html 2021-06-28T11:55:12.7480000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-approval-of-tafasitamab-minjuvi-for-treatment-of-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-dlbcl.html 2021-06-28T11:57:23.9420000Z https://www.medicinesresources.nhs.uk/management-of-heart-failure-with-reduced-ejection-fraction-in-2021-an-update-for-gps.html 2021-06-28T11:59:30.1110000Z https://www.medicinesresources.nhs.uk/withdrawal-of-application-of-pirfenidone-esbriet-for-treatment-of-unclassifiable-interstitial-lung-disease.html 2021-06-28T12:03:23.9460000Z https://www.medicinesresources.nhs.uk/fda-grants-emergency-use-authorization-for-tocilizumab-in-treatment-of-hospitalized-patients-with-covid-19.html 2021-06-28T12:05:45.1560000Z https://www.medicinesresources.nhs.uk/european-chmp-approval-of-abiraterone-mylan-for-treatment-of-metastatic-prostate-cancer-1.html 2021-06-28T14:24:16.9410000Z https://www.medicinesresources.nhs.uk/european-chmp-approval-of-fingolimod-mylan-for-treatment-of-relapsing-remitting-multiple-sclerosis-with-high-disease-activity.html 2021-06-28T14:27:12.0530000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-dapagliflozin-forxiga-for-treatment-of-chronic-kidney-disease.html 2021-06-28T14:58:37.5420000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-paediatric-license-extension-of-migalastat-galafold.html 2021-06-28T14:31:49.8470000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-nivolumab-opdivo-for-treatment-of-oesophageal-or-gastro-oesophageal-junction-cancer-2.html 2021-06-28T14:36:06.4370000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-upadacitinib-rinvoq-for-treatment-of-moderate-to-severe-atopic-dermatitis.html 2021-06-28T14:37:39.9320000Z https://www.medicinesresources.nhs.uk/european-chmp-recommends-license-extension-of-tofacitinib-xeljanz-for-treatment-of-active-polyarticular-juvenile-idiopathic-arthritis-and-juvenile-psoriatic-arthritis.html 2021-06-28T14:40:03.4800000Z https://www.medicinesresources.nhs.uk/mhra-warns-about-myocarditis-and-pericarditis-with-moderna-and-pfizer-covid-19-vaccines-2.html 2021-06-30T07:47:56.2220000Z https://www.medicinesresources.nhs.uk/public-assessment-report-safety-of-macrolide-antibiotics-in-pregnancy-a-review-of-the-epidemiological-evidence-1.html 2021-06-30T07:48:49.7400000Z https://www.medicinesresources.nhs.uk/immunogenicity-and-reactogenicity-of-bnt162b2-booster-in-chadox1-s-primed-participants-combivacs-a-multicentre-open-label-randomised-controlled-phase-2-trial.html 2021-06-30T07:52:09.7120000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-a-novel-dual-gip-and-glp-1-receptor-agonist-tirzepatide-in-patients-with-type-2-diabetes-surpass-1-a-double-blind-randomised-phase-3-trial.html 2021-06-28T14:51:50.0480000Z https://www.medicinesresources.nhs.uk/tirzepatide-versus-semaglutide-once-weekly-in-patients-with-type-2-diabetes.html 2021-06-28T14:53:50.7620000Z https://www.medicinesresources.nhs.uk/astra-zeneca-doses-first-participants-with-covid-19-variant-vaccine-azd2816-2.html 2021-06-28T14:57:03.7640000Z https://www.medicinesresources.nhs.uk/june-bnf-bnfc-newsletter-1.html 2021-06-30T07:56:36.4470000Z https://www.medicinesresources.nhs.uk/covid-19-therapeutic-alert-palivizumab-passive-immunisation-against-respiratory-syncytial-virus-rsv-in-at-risk-pre-term-infants-3.html 2021-06-30T07:59:06.6570000Z https://www.medicinesresources.nhs.uk/com-cov-study-reports-mix-and-match-of-covid-19-vaccines-provides-good-protection-against-virus.html 2021-06-29T19:56:15.2310000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-have-prevented-7-2-million-infections-and-27-000-deaths-in-england.html 2021-06-29T15:06:19.5280000Z https://www.medicinesresources.nhs.uk/urgent-and-emergency-care-quality-watch-june-2022.html 2021-06-29T15:08:24.4900000Z https://www.medicinesresources.nhs.uk/framework-for-involving-patients-in-patient-safety-2.html 2021-06-29T15:11:25.4940000Z https://www.medicinesresources.nhs.uk/nhs-delivers-covid-19-vaccination-programme-to-half-of-adults-in-england-age-under-30.html 2021-06-29T15:12:59.8610000Z https://www.medicinesresources.nhs.uk/updated-recommendations-regarding-the-management-of-older-patients-with-breast-cancer-a-joint-paper-from-the-european-society-of-breast-cancer-specialists-eusoma-and-the-international-society-of-geriatric-oncology-siog.html 2021-06-29T19:53:26.5080000Z https://www.medicinesresources.nhs.uk/update-of-eu-recommendations-for-2021-2022-seasonal-flu-vaccine-composition.html 2021-06-29T19:51:01.2150000Z https://www.medicinesresources.nhs.uk/community-pharmacy-discharge-medicines-service-a-step-towards-improved-patient-safety-1.html 2021-06-29T15:18:32.2160000Z https://www.medicinesresources.nhs.uk/adult-social-care-given-over-gbp250-million-extra-to-continue-coronavirus-covid-19-protections-1.html 2021-06-29T15:21:56.7530000Z https://www.medicinesresources.nhs.uk/challenge-in-treating-covid-19-associate-pulmonary-aspergillosis-supratherapeutic-voriconazole-levels.html 2021-06-30T10:46:47.5190000Z https://www.medicinesresources.nhs.uk/riociguat-clinical-research-and-evolving-role-in-therapy-1.html 2021-06-29T19:46:43.6390000Z https://www.medicinesresources.nhs.uk/accelerating-covid-19-therapeutic-interventions-and-vaccines-activ-designing-master-protocols-for-evaluation-of-candidate-covid-19-therapeutics-1.html 2021-06-29T15:29:19.8160000Z https://www.medicinesresources.nhs.uk/thrombosis-with-thrombocytopenia-after-the-messenger-rna-1273-vaccine-4.html 2021-06-29T19:07:19.2040000Z https://www.medicinesresources.nhs.uk/marketing-authorization-application-for-voclosporin-for-treatment-of-lupus-nephritis-filed-with-european-medicines-agency-2.html 2021-06-29T15:32:44.3300000Z https://www.medicinesresources.nhs.uk/pfizer-pauses-global-sales-of-chantix-varenicline-over-possible-carcinogen-contamination-3.html 2021-06-30T08:02:54.6260000Z https://www.medicinesresources.nhs.uk/conference-report-phase-3-sustain-forte-trial-of-investigational-2mg-dose-of-semaglutide-injection-demonstrates-superior-reductions-in-blood-sugar-vs-1mg-in-adults-with-type-2-diabetes.html 2021-06-29T19:43:16.7750000Z https://www.medicinesresources.nhs.uk/exelixis-and-ipsen-announces-cabozantinib-in-combination-with-an-immune-checkpoint-inhibitor-improved-progression-free-survival-in-phase-3-cosmic-312-trial-in-patients-with-previously-untreated-advanced-liver-cancer.html 2021-06-29T19:06:02.5910000Z https://www.medicinesresources.nhs.uk/agios-submits-marketing-authorisation-application-to-european-medicines-agency-for-mitapivat-for-treatment-of-adults-with-pyruvate-kinase-deficiency.html 2021-06-29T15:46:09.8770000Z https://www.medicinesresources.nhs.uk/biomarin-resubmits-marketing-authorization-application-to-european-medicines-agency-for-valoctocogene-roxaparvovec-to-treat-severe-haemophilia-a.html 2021-06-29T15:47:04.1950000Z https://www.medicinesresources.nhs.uk/new-drug-application-submitted-to-fda-for-lenacapavir-an-investigational-long-acting-hiv-1-capsid-inhibitor-for-heavily-treatment-experienced-people-with-multi-drug-resistant-hiv-1-infection-4.html 2021-06-29T15:49:28.8570000Z https://www.medicinesresources.nhs.uk/choosing-formulations-of-medicines-for-adults-with-swallowing-difficulties.html 2021-06-30T08:02:39.4090000Z https://www.medicinesresources.nhs.uk/revised-spc-frisium-clobazam-10mg-tablets.html 2021-06-29T19:36:55.2820000Z https://www.medicinesresources.nhs.uk/revised-spc-cresemba-isavuconazonium-sulfate-all-products-2.html 2021-06-29T19:35:19.4430000Z https://www.medicinesresources.nhs.uk/revised-spc-mysimba-8-mg-90-mg-naltrexone-hydrochloride-bupropion-hydrochloride-prolonged-release-tablets.html 2021-06-29T16:13:30.6040000Z https://www.medicinesresources.nhs.uk/cardiovascular-and-renal-outcomes-with-efpeglenatide-in-type-2-diabetes-2.html 2021-06-29T19:29:06.8590000Z https://www.medicinesresources.nhs.uk/long-term-safety-and-efficacy-of-emtricitabine-and-tenofovir-alafenamide-vs-emtricitabine-and-tenofovir-disoproxil-fumarate-for-hiv-1-pre-exposure-prophylaxis-week-96-results-from-a-randomised-double-blind-placebo-controlled-phase-3-trial.html 2021-06-29T16:18:46.4070000Z https://www.medicinesresources.nhs.uk/effect-of-oral-ranitidine-on-urinary-excretion-of-n-nitrosodimethylamine-ndma-a-randomized-clinical-trial-1.html 2021-06-29T19:10:02.8960000Z https://www.medicinesresources.nhs.uk/treatment-of-type-2-diabetes-challenges-hopes-and-anticipated-successes.html 2021-06-29T16:22:56.0100000Z https://www.medicinesresources.nhs.uk/kite-announces-axicabtagene-ciloleucel-yescarta-r-car-t-cell-therapy-improved-event-free-survival-over-chemotherapy-plus-stem-cell-transplant-in-second-line-relapsed-or-refractory-large-b-cell-lymphoma.html 2021-06-29T16:23:57.6740000Z https://www.medicinesresources.nhs.uk/chiasma-announces-submission-of-marketing-authorization-application-for-oral-octreotide-capsules-mycapssa-to-european-medicines-agency-as-a-maintenance-therapy-for-adults-with-acromegaly.html 2021-06-29T16:25:17.6350000Z https://www.medicinesresources.nhs.uk/effect-of-a-pharmacist-led-educational-intervention-on-clinical-outcomes-a-randomised-controlled-study-in-patients-with-hypertension-type-2-diabetes-and-hypercholesterolaemia.html 2021-06-29T19:14:58.8940000Z https://www.medicinesresources.nhs.uk/effects-of-angiotensin-ii-receptor-blockers-on-serum-potassium-level-and-hyperkalemia-risk-retrospective-single-centre-analysis-1.html 2021-06-29T19:15:30.9640000Z https://www.medicinesresources.nhs.uk/comparative-effectiveness-of-sodium-glucose-cotransporter-2-inhibitors-vs-sulfonylureas-in-patients-with-type-2-diabetes.html 2021-06-29T19:02:37.3980000Z https://www.medicinesresources.nhs.uk/medication-related-osteonecrosis-of-the-jaw-analysing-the-range-of-implicated-drugs-from-the-australian-database-of-adverse-event-notifications-3.html 2021-06-29T19:17:19.7030000Z https://www.medicinesresources.nhs.uk/abbvies-upadacitinib-a-small-molecule-janus-kinase-inhibitors-rinvoq-shows-promise-as-maintenance-drug-for-ulcerative-colitis-1.html 2021-06-30T11:34:33.2460000Z https://www.medicinesresources.nhs.uk/fda-grants-fast-track-designation-to-cns-pharmaceuticals-for-berubicin-an-anthracycline-for-the-treatment-of-recurrent-glioblastoma-multiforme-brain-cancer.html 2021-06-30T11:35:49.0210000Z https://www.medicinesresources.nhs.uk/guselkumab-for-treating-active-psoriatic-arthritis-after-inadequate-response-to-dmards-guidance-ta711-1.html 2021-07-02T05:20:17.5060000Z https://www.medicinesresources.nhs.uk/nihr-alert-what-support-do-young-people-with-sickle-cell-disease-need-when-moving-into-adult-services.html 2021-06-30T14:08:27.1430000Z https://www.medicinesresources.nhs.uk/non-steroidal-anti-inflammatory-drugs-intravenous-fluids-pancreatic-stents-or-their-combinations-for-the-prevention-of-post-endoscopic-retrograde-cholangiopancreatography-pancreatitis-a-systematic-review-and-network-meta-analysis-2.html 2021-06-30T14:12:50.4080000Z https://www.medicinesresources.nhs.uk/inhaled-treprostinil-and-forced-vital-capacity-in-patients-with-interstitial-lung-disease-and-associated-pulmonary-hypertension-a-post-hoc-analysis-of-the-increase-study.html 2021-06-30T14:14:25.2360000Z https://www.medicinesresources.nhs.uk/donafenib-versus-sorafenib-in-first-line-treatment-of-unresectable-or-metastatic-hepatocellular-carcinoma-a-randomized-open-label-parallel-controlled-phase-ii-iii-trial.html 2021-06-30T14:16:16.3200000Z https://www.medicinesresources.nhs.uk/patients-with-acute-myocarditis-following-mrna-covid-19-vaccination.html 2021-06-30T15:23:14.0600000Z https://www.medicinesresources.nhs.uk/myocarditis-following-immunization-with-mrna-covid-19-vaccines-in-members-of-the-us-military.html 2021-06-30T15:24:05.4370000Z https://www.medicinesresources.nhs.uk/the-effect-of-intravenous-ferric-carboxymaltose-on-cardiac-reverse-remodelling-following-cardiac-resynchronization-therapy-the-iron-crt-trial.html 2021-06-30T14:35:47.3000000Z https://www.medicinesresources.nhs.uk/regional-and-ethnic-influences-on-the-response-to-empagliflozin-in-patients-with-heart-failure-and-a-reduced-ejection-fraction-the-emperor-reduced-trial.html 2021-06-30T14:38:07.9410000Z https://www.medicinesresources.nhs.uk/efficacy-and-safety-of-dapagliflozin-by-baseline-glycemic-status-a-prespecified-analysis-from-the-dapa-ckd-trial.html 2021-06-30T14:40:54.8810000Z https://www.medicinesresources.nhs.uk/advancing-therapy-in-suboptimally-controlled-basal-insulin-treated-type-2-diabetes-clinical-outcomes-with-iglarlixi-versus-premix-biasp-30-in-the-solimix-randomized-controlled-trial.html 2021-06-30T14:42:43.2640000Z https://www.medicinesresources.nhs.uk/beyond-cgrp-the-calcitonin-peptide-family-as-targets-for-migraine-and-pain-1.html 2021-06-30T14:56:50.6510000Z https://www.medicinesresources.nhs.uk/lumbar-spinal-stenosis.html 2021-06-30T14:58:41.8710000Z https://www.medicinesresources.nhs.uk/tolerability-and-immunogenicity-after-a-late-second-dose-or-a-third-dose-of-chadox1-ncov-19-azd1222.html 2021-06-30T15:00:15.2290000Z https://www.medicinesresources.nhs.uk/pembrolizumab-plus-chemotherapy-for-first-line-treatment-of-oesophageal-cancer-or-her2-negative-gastroesophageal-junction-adenocarcinoma-approved-for-use-in-the-eu.html 2021-06-30T15:04:22.1000000Z https://www.medicinesresources.nhs.uk/fda-grants-orphan-drug-designation-for-devimistat-for-biliary-cancer.html 2021-06-30T15:06:38.8690000Z https://www.medicinesresources.nhs.uk/nivolumab-plus-ipilimumab-approved-in-the-eu-for-mismatch-repair-deficient-or-microsatellite-instability-high-msi-h-metastatic-colorectal-cancer-after-prior-chemotherapy.html 2021-06-30T15:08:15.8110000Z https://www.medicinesresources.nhs.uk/orphan-drug-designation-granted-in-the-eu-for-pridopidine-in-amyotrophic-lateral-sclerosis-als.html 2021-06-30T15:10:55.1330000Z https://www.medicinesresources.nhs.uk/orphan-drug-designation-granted-by-fda-for-envafolimab-in-soft-tissue-sarcoma-2.html 2021-06-30T15:15:56.1110000Z https://www.medicinesresources.nhs.uk/pelvic-floor-dysfunction-prevention-and-non-surgical-management-draft-guideline.html 2021-06-30T15:18:24.3650000Z https://www.medicinesresources.nhs.uk/remimazolam-besylate-approved-for-use-in-the-uk-for-procedural-sedation.html 2021-06-30T15:20:09.5430000Z https://www.medicinesresources.nhs.uk/lentiglobin-a-gene-therapy-for-sickle-cell-disease-granted-mhra-innovation-passport-1.html 2021-06-30T15:24:15.6060000Z https://www.medicinesresources.nhs.uk/association-of-the-british-pharmaceutical-industry-abpi-launches-updated-code-of-practice-1.html 2021-06-30T15:28:18.1160000Z https://www.medicinesresources.nhs.uk/revised-spc-levemir-insulin-detemir-innolet-100-units-ml-solution-for-injection-all-presentations-1.html 2021-07-01T15:11:51.2480000Z https://www.medicinesresources.nhs.uk/revised-spc-octagam-human-normal-immunoglobulin-10-solution-for-infusion.html 2021-07-01T15:14:36.0650000Z https://www.medicinesresources.nhs.uk/effect-of-renal-function-on-the-risk-of-thrombocytopenia-in-patients-receiving-linezolid-therapy-a-systematic-review-and-meta-analysis-1.html 2021-07-01T15:18:27.6480000Z https://www.medicinesresources.nhs.uk/lessons-from-countries-implementing-find-test-trace-isolation-and-support-policies-in-the-rapid-response-of-the-covid-19-pandemic-a-systematic-review.html 2021-07-01T16:12:34.0790000Z https://www.medicinesresources.nhs.uk/dtb-select-risk-from-concurrent-opioid-and-benzodiazepine-use.html 2021-07-01T15:22:24.8160000Z https://www.medicinesresources.nhs.uk/dtb-select-gabapentin-not-effective-for-chronic-pelvic-pain-in-women.html 2021-07-01T15:23:38.6330000Z https://www.medicinesresources.nhs.uk/plus-sutures-for-preventing-surgical-site-infection-medical-technologies-guidance-mtg59.html 2021-07-01T15:25:15.4970000Z https://www.medicinesresources.nhs.uk/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2023.html 2021-07-02T05:26:07.2380000Z https://www.medicinesresources.nhs.uk/covid-19-vaccination-autumn-winter-phase-3-planning.html 2021-07-02T05:26:30.5150000Z https://www.medicinesresources.nhs.uk/clinical-commissioning-policy-rituximab-for-immunobullous-disease.html 2021-07-02T05:27:49.1670000Z https://www.medicinesresources.nhs.uk/conference-report-non-prescription-painkillers-linked-to-increased-perinatal-health-risks-1.html 2021-07-01T15:35:00.4410000Z https://www.medicinesresources.nhs.uk/vaccine-update-issue-323-june-2023.html 2021-07-02T05:29:07.8020000Z https://www.medicinesresources.nhs.uk/chronic-pain-in-england-unseen-unequal-unfair.html 2021-07-01T15:40:48.9860000Z https://www.medicinesresources.nhs.uk/cerebral-venous-thrombosis.html 2021-07-01T15:42:23.5240000Z https://www.medicinesresources.nhs.uk/class-2-medicines-recall-kyowa-kirin-limited-xomolix-2-5-mg-ml-solution-for-injection-el-21-a-15.html 2021-07-01T15:44:02.7800000Z https://www.medicinesresources.nhs.uk/company-led-medicines-recall-morphine-syringe-50mg-50ml-unlicensed-medicine-and-magnesium-sulphate-8mmol-20ml-infusion-unlicensed-medicine.html 2021-07-01T15:47:06.8310000Z https://www.medicinesresources.nhs.uk/sglt2-inhibitors-and-glp-1-receptor-agonists-established-and-emerging-indications-1.html 2021-07-01T15:49:57.6210000Z https://www.medicinesresources.nhs.uk/nhs-digital-weight-management-programme-launched-to-help-people-achieve-a-healthier-weight-and-improve-wellbeing-3.html 2021-07-01T15:52:32.4340000Z https://www.medicinesresources.nhs.uk/repurposing-existing-therapeutics-its-importance-in-oncology-drug-development-kinases-as-a-potential-target-2.html 2021-07-01T15:54:40.6900000Z https://www.medicinesresources.nhs.uk/diagnosing-active-tuberculosis-in-primary-care.html 2021-07-01T15:55:46.3720000Z https://www.medicinesresources.nhs.uk/covid-19-life-on-hold-for-nhs-patients-needing-musculoskeletal-care.html 2021-07-01T15:56:46.3970000Z https://www.medicinesresources.nhs.uk/how-long-does-covid-19-immunity-last.html 2021-07-01T15:58:17.7580000Z https://www.medicinesresources.nhs.uk/could-expanding-the-covid-19-case-definition-improve-the-uks-pandemic-response-2.html 2021-07-01T16:00:37.9020000Z https://www.medicinesresources.nhs.uk/fostamatinib-selected-for-national-institutes-of-health-activ-4-accelerating-covid-19-therapeutic-interventions-and-vaccines-trial-in-us.html 2021-07-01T16:02:03.7260000Z https://www.medicinesresources.nhs.uk/xience-stent-receives-fda-approval-for-use-of-only-one-month-dual-antiplatelet-therapy-dapt-in-hbr-high-bleeding-risk-patients.html 2021-07-01T16:25:27.7340000Z https://www.medicinesresources.nhs.uk/fda-approves-rylaze-asparaginase-erwinia-chrysanthemi-recombinant-rywn-as-a-component-of-chemotherapy-regimen-to-treat-acute-lymphoblastic-leukaemia-and-lymphoblastic-lymphoma.html 2021-07-01T16:04:42.1610000Z https://www.medicinesresources.nhs.uk/improving-the-care-of-patients-discharged-following-a-pulmonary-embolism-in-line-with-nice-guidelines-ng158-2.html 2021-07-01T16:07:32.6450000Z https://www.medicinesresources.nhs.uk/effect-of-zuranolone-vs-placebo-in-postpartum-depression-a-randomized-clinical-trial.html 2021-07-01T16:14:05.5880000Z https://www.medicinesresources.nhs.uk/ticagrelor-or-prasugrel-for-patients-with-acute-coronary-syndrome-treated-with-percutaneous-coronary-intervention-a-prespecified-subgroup-analysis-of-a-randomized-clinical-trial.html 2021-07-01T16:15:24.7560000Z https://www.medicinesresources.nhs.uk/preventive-care-in-type-2-diabetes-results-of-a-randomized-controlled-trial-in-community-pharmacies-diabetes-care.html 2021-07-01T16:16:32.5790000Z https://www.medicinesresources.nhs.uk/dietary-alteration-of-n-3-and-n-6-fatty-acids-for-headache-reduction-in-adults-with-migraine-randomized-controlled-trial-6.html 2021-07-01T16:29:25.0510000Z https://www.medicinesresources.nhs.uk/daratumumab-based-treatment-for-immunoglobulin-light-chain-amyloidosis-3.html 2021-07-01T16:25:55.2600000Z https://www.medicinesresources.nhs.uk/a-randomized-trial-of-a-transglutaminase-2-inhibitor-for-celiac-disease.html 2021-07-01T16:27:17.3710000Z https://www.medicinesresources.nhs.uk/safety-and-efficacy-of-nvx-cov2373-covid-19-vaccine.html 2021-07-01T16:28:48.2530000Z https://www.medicinesresources.nhs.uk/prevention-and-attenuation-of-covid-19-with-the-bnt162b2-and-mrna-1273-vaccines.html 2021-07-01T16:29:47.4770000Z https://www.medicinesresources.nhs.uk/sex-differences-in-type-and-occurrence-of-adverse-reactions-to-opioid-analgesics-a-retrospective-cohort-study.html 2021-07-01T16:32:05.2750000Z https://www.medicinesresources.nhs.uk/number-needed-to-treat-for-net-effect-of-anticoagulation-in-atrial-fibrillation-real-world-vs-clinical-trial-evidence.html 2021-07-01T16:37:06.1850000Z https://www.medicinesresources.nhs.uk/revised-spcs-nicorette-nicotine-quickmist-smarttrack-1mg-spray-mouthspray-2.html 2021-07-02T14:40:19.1330000Z https://www.medicinesresources.nhs.uk/revised-spc-mysimba-8-mg-90-mg-naltrexone-bupropion-prolonged-release-tablets.html 2021-07-02T14:41:26.0160000Z https://www.medicinesresources.nhs.uk/revised-spc-efracea-doxycycline-40mg-modified-release-hard-capsules.html 2021-07-02T14:42:36.1980000Z https://www.medicinesresources.nhs.uk/new-products-cefazolin-1g-and-2g-powder-for-solution-for-injection-infusion-4.html 2021-07-02T14:45:36.2860000Z https://www.medicinesresources.nhs.uk/revised-spc-dyzantil-sodium-valproate-valproic-acid-prolonged-release-tablets.html 2021-07-02T15:42:08.7070000Z https://www.medicinesresources.nhs.uk/radiation-and-androgen-deprivation-therapy-with-or-without-docetaxel-in-the-management-of-nonmetastatic-unfavorable-risk-prostate-cancer-a-prospective-randomized-trial-1.html 2021-07-02T14:48:37.0190000Z https://www.medicinesresources.nhs.uk/score2-risk-prediction-algorithms-new-models-to-estimate-10-year-risk-of-cardiovascular-disease-in-europe-3.html 2021-07-02T14:51:11.3380000Z https://www.medicinesresources.nhs.uk/dna-covid-vaccine-66-6-effective-at-preventing-symptomatic-disease.html 2021-07-02T14:52:58.8950000Z https://www.medicinesresources.nhs.uk/us-fda-approves-secnidazole-for-the-treatment-of-trichomoniasis-in-adults-1.html 2021-07-02T14:55:29.3180000Z https://www.medicinesresources.nhs.uk/msd-to-withdraw-us-accelerated-approval-indication-for-pembrolizumab-for-third-or-further-line-treatment-of-recurrent-locally-advanced-or-metastatic-gastric-or-gastroesophageal-junctionadenocarcinoma-whose-tumours-express-pd-l1.html 2021-07-02T14:56:30.3580000Z https://www.medicinesresources.nhs.uk/transition-to-adulthood-and-transfer-to-adult-care-of-adolescents-with-congenital-heart-disease-chd-a-global-consensus-statement.html 2021-07-02T14:57:52.3520000Z https://www.medicinesresources.nhs.uk/dtb-select-aspirin-and-gastrointestinal-bleeding-risk-in-older-people.html 2021-07-02T15:00:24.9290000Z https://www.medicinesresources.nhs.uk/dtb-select-ensuring-medication-continuity-in-older-people-after-hospital-discharge-2.html 2021-07-02T15:03:27.5780000Z https://www.medicinesresources.nhs.uk/consultation-on-aligning-the-upper-age-for-nhs-prescription-exemptions-with-state-pension-age-4.html 2021-07-02T15:07:46.9020000Z https://www.medicinesresources.nhs.uk/latest-weekly-covid-19-variant-data-published-1.html 2021-07-02T16:34:14.6900000Z https://www.medicinesresources.nhs.uk/green-book-chapter-on-covid-19-chapter-14a-updated.html 2021-07-05T08:07:03.9970000Z https://www.medicinesresources.nhs.uk/covid-19-vaccine-surveillance-report-week-27.html 2021-07-02T15:12:53.9710000Z https://www.medicinesresources.nhs.uk/meningococcal-b-vaccine-information-for-healthcare-professionals-revised.html 2021-07-05T08:05:46.0780000Z https://www.medicinesresources.nhs.uk/choosing-a-suitable-antidepressant-for-people-with-coronary-heart-disease-chd-1.html 2021-07-05T08:05:22.5430000Z https://www.medicinesresources.nhs.uk/implications-of-cancer-prior-to-and-after-heart-transplantation-ht.html 2021-07-02T15:18:50.3570000Z https://www.medicinesresources.nhs.uk/intensive-medical-management-to-prevent-large-and-small-artery-atherothrombotic-stroke-1.html 2021-07-02T15:21:44.5830000Z https://www.medicinesresources.nhs.uk/sharing-technology-and-vaccine-doses-to-address-global-vaccine-inequity-and-end-the-covid-19-pandemic.html 2021-07-02T15:23:07.2000000Z https://www.medicinesresources.nhs.uk/nhs-covid-pass.html 2021-07-02T15:28:00.2150000Z https://www.medicinesresources.nhs.uk/mhra-approves-efmody-hydrocortisone-modified-release-hard-capsules-for-the-treatment-for-congenital-adrenal-hyperplasia.html 2021-07-02T15:28:57.9200000Z https://www.medicinesresources.nhs.uk/acute-respiratory-distress-syndrome-ards.html 2021-07-02T15:30:14.1900000Z https://www.medicinesresources.nhs.uk/pregnancy-after-breast-cancer-a-systematic-review-and-meta-analysis.html 2021-07-02T15:36:27.5620000Z https://www.medicinesresources.nhs.uk/upadacitinib-in-active-ankylosing-spondylitis-1-year-results-from-the-double-blind-placebo-controlled-select-axis-1-study-and-open-label-extension-3.html 2021-07-02T15:40:28.2360000Z https://www.medicinesresources.nhs.uk/metformin-use-and-cirrhotic-decompensation-in-patients-with-type-2-diabetes-and-liver-cirrhosis-1.html 2021-07-02T15:42:08.1730000Z https://www.medicinesresources.nhs.uk/association-between-ibrutinib-treatment-and-hypertension.html 2021-07-02T15:43:42.2290000Z https://www.medicinesresources.nhs.uk/analysis-of-launch-and-postapproval-cancer-drug-pricing-clinical-benefit-and-policy-implications-in-the-us-and-europe.html 2021-07-02T15:44:51.6080000Z https://www.medicinesresources.nhs.uk/long-term-protection-from-hiv-infection-with-oral-hiv-pre-exposure-prophylaxis-in-gay-and-bisexual-men-findings-from-the-expanded-and-extended-epic-nsw-prospective-implementation-study.html 2021-07-02T15:46:15.9780000Z https://www.medicinesresources.nhs.uk/revised-spc-sandostatin-octreotide-all-presentations-1.html 2021-07-05T12:13:58.4650000Z https://www.medicinesresources.nhs.uk/revised-spc-zejula-niraparib-capsules-2.html 2021-07-05T12:16:24.9370000Z https://www.medicinesresources.nhs.uk/revised-spc-mekinist-trametinib-tablets-2.html 2021-07-05T12:19:43.6820000Z https://www.medicinesresources.nhs.uk/community-based-pharmacists-role-in-deprescribing-a-systematic-review-1.html 2021-07-05T12:21:43.4570000Z https://www.medicinesresources.nhs.uk/network-meta-analysis-of-ticagrelor-for-stroke-prevention-in-patients-at-high-risk-for-cardiovascular-or-cerebrovascular-events.html 2021-07-05T12:23:24.3330000Z https://www.medicinesresources.nhs.uk/dietary-alteration-of-n-3-and-n-6-fatty-acids-for-headache-reduction-in-adults-with-migraine-randomized-controlled-trial.html 2021-07-05T15:24:17.3870000Z https://www.medicinesresources.nhs.uk/using-a-pragmatically-adapted-low-cost-contingency-management-intervention-to-promote-heroin-abstinence-in-individuals-undergoing-treatment-for-heroin-use-disorder-in-uk-drug-services-praise-a-cluster-randomised-trial.html 2021-07-05T12:27:46.5960000Z https://www.medicinesresources.nhs.uk/metformin-use-and-cirrhotic-decompensation-in-patients-with-type-2-diabetes-and-liver-cirrhosis.html 2021-07-05T12:30:02.1940000Z https://www.medicinesresources.nhs.uk/dose-equivalence-between-metaraminol-and-norepinephrine-in-critical-care.html 2021-07-05T12:31:33.3560000Z https://www.medicinesresources.nhs.uk/a-case-of-acute-pancreatitis-induced-by-voriconazole-during-treatment-of-cryptococcal-meningitis-1.html 2021-07-05T15:29:50.1480000Z https://www.medicinesresources.nhs.uk/frequency-of-thrombocytopenia-and-platelet-factor-4-heparin-antibodies-in-patients-with-cerebral-venous-sinus-thrombosis-prior-to-the-covid-19-pandemic.html 2021-07-05T12:35:24.1060000Z https://www.medicinesresources.nhs.uk/immunogenicity-of-the-bnt162b2-covid-19-mrna-vaccine-and-early-clinical-outcomes-in-patients-with-haematological-malignancies-in-lithuania-a-national-prospective-cohort-study.html 2021-07-05T14:45:31.9180000Z https://www.medicinesresources.nhs.uk/bnt162b2-covid-19-vaccine-and-correlates-of-humoral-immune-responses-and-dynamics-a-prospective-single-centre-longitudinal-cohort-study-in-health-care-workers.html 2021-07-05T14:47:19.5090000Z https://www.medicinesresources.nhs.uk/the-kings-fund-report-tackling-obesity-the-role-of-the-nhs-in-a-whole-system-approach.html 2021-07-05T15:32:41.0930000Z https://www.medicinesresources.nhs.uk/learning-from-crisis-building-resilient-systems-to-combat-future-pandemics.html 2021-07-05T14:51:00.7500000Z https://www.medicinesresources.nhs.uk/the-medicines-and-healthcare-products-regulatory-agency-delivery-plan-2021-2025.html 2021-07-05T14:53:39.5700000Z https://www.medicinesresources.nhs.uk/nhs-awarded-the-george-cross-for-73-years-dedicated-service-and-response-to-covid.html 2021-07-05T14:54:39.8900000Z https://www.medicinesresources.nhs.uk/tuberculosis-tb-action-plan-for-england-2021-29.html 2021-07-05T14:56:44.3110000Z https://www.medicinesresources.nhs.uk/psnc-briefing-017-21-hub-and-spoke-dispensing.html 2021-07-05T15:06:09.2390000Z https://www.medicinesresources.nhs.uk/herpes-zoster-shingles-immunisation-programme-2020-to-2021-evaluation-reports-1.html 2021-07-05T15:07:52.7150000Z https://www.medicinesresources.nhs.uk/hospital-discharge-and-community-support-policy-and-operating-model-3.html 2021-07-05T15:10:46.8600000Z https://www.medicinesresources.nhs.uk/new-product-adtralza-tralokinumab-150-mg-solution-for-injection-in-pre-filled-syringe-1.html 2021-07-06T14:47:18.7190000Z https://www.medicinesresources.nhs.uk/cabozantinib-for-radioiodine-refractory-differentiated-thyroid-cancer-cosmic-311-a-randomised-double-blind-placebo-controlled-phase-3-trial-3.html 2021-07-06T15:46:08.9190000Z https://www.medicinesresources.nhs.uk/long-term-risk-of-anaemia-after-bariatric-surgery-results-from-the-swedish-obese-subjects-study.html 2021-07-06T15:45:14.6340000Z https://www.medicinesresources.nhs.uk/use-of-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer-initial-results-from-the-pembrolizumab-arm-of-a-phase-2-randomized-clinical-trial.html 2021-07-06T14:54:16.2450000Z https://www.medicinesresources.nhs.uk/trends-in-the-pharmacological-management-of-atrial-fibrillation-in-uk-general-practice-2008-2019.html 2021-07-06T14:56:13.8120000Z https://www.medicinesresources.nhs.uk/prestroke-glucose-control-and-functional-outcome-in-patients-with-acute-large-vessel-occlusive-stroke-and-diabetes-after-thrombectomy.html 2021-07-06T14:57:25.9790000Z https://www.medicinesresources.nhs.uk/hospitalization-for-adverse-events-under-abiraterone-or-enzalutamide-exposure-in-real-world-setting-a-french-population-based-study-on-prostate-cancer-patients.html 2021-07-06T15:00:43.2380000Z https://www.medicinesresources.nhs.uk/prevalence-of-symptoms-more-than-seven-months-after-diagnosis-of-symptomatic-covid-19-in-an-outpatient-setting-4.html 2021-07-06T15:05:01.4520000Z https://www.medicinesresources.nhs.uk/clinical-phenotypes-and-outcomes-of-sars-cov-2-influenza-rsv-and-seven-other-respiratory-viruses-a-retrospective-study-using-complete-hospital-data-2.html 2021-07-06T15:08:36.9200000Z https://www.medicinesresources.nhs.uk/acceleration-of-second-doses-of-covid-19-vaccine-for-all-cohorts.html 2021-07-06T15:13:04.7810000Z https://www.medicinesresources.nhs.uk/conference-report-lloyds-pharmacy-safer-care-patient-safety-programme-reduces-amlodipine-and-amitriptyline-dispensing-errors.html 2021-07-06T15:15:03.3660000Z https://www.medicinesresources.nhs.uk/university-of-oxford-researchers-launches-phase-1-hiv-vaccine-trial-hiv-core-0052-trial-of-a-novel-mosaic-vaccine-designed-to-induce-t-cells-1.html 2021-07-06T15:22:40.5150000Z https://www.medicinesresources.nhs.uk/government-pledges-gbp2-45-million-to-improve-childbirth-care.html 2021-07-06T15:24:45.5480000Z https://www.medicinesresources.nhs.uk/rps-england-calls-for-mask-wearing-to-continue-in-pharmacies.html 2021-07-06T15:27:28.4170000Z https://www.medicinesresources.nhs.uk/health-and-care-bill-introduced-to-parliament.html 2021-07-06T15:28:30.8550000Z https://www.medicinesresources.nhs.uk/national-representative-data-on-the-health-of-lesbian-gay-and-bisexual-adults-in-england-published-for-the-first-time.html 2021-07-06T15:31:15.9470000Z https://www.medicinesresources.nhs.uk/aducanumab-for-alzheimers-disease.html 2021-07-06T15:32:08.3630000Z https://www.medicinesresources.nhs.uk/class-4-medicines-defect-information-tetralysal-300mg-hard-capsules-pl-10590-0019-el-21-a-16.html 2021-07-06T15:33:39.5160000Z https://www.medicinesresources.nhs.uk/unequal-pandemic-fairer-recovery.html 2021-07-06T15:34:45.8210000Z https://www.medicinesresources.nhs.uk/missing-clinical-trial-data-in-europe-assessing-and-comparing-the-performance-of-national-medicines-agencies.html 2021-07-06T15:37:41.4130000Z https://www.medicinesresources.nhs.uk/fda-approves-dose-escalation-licence-extension-for-neratinib-in-her2-positive-early-stage-and-metastatic-breast-cancer.html 2021-07-06T15:54:42.8460000Z https://www.medicinesresources.nhs.uk/onasemnogene-abeparvovec-for-treating-spinal-muscular-atrophy-guidance-hst15.html 2021-07-07T15:13:06.7230000Z https://www.medicinesresources.nhs.uk/enzalutamide-for-treating-hormone-sensitive-metastatic-prostate-cancer-guidance-ta712.html 2021-07-07T14:03:16.7630000Z https://www.medicinesresources.nhs.uk/nivolumab-for-advanced-non-squamous-non-small-cell-lung-cancer-after-chemotherapy-guidance-ta713.html 2021-07-07T14:06:34.8430000Z https://www.medicinesresources.nhs.uk/revised-spc-tysabri-natalizumab-solution-for-infusion-2.html 2021-07-07T14:12:01.4690000Z https://www.medicinesresources.nhs.uk/revised-spc-ilaris-canakinumab-injection.html 2021-07-07T14:14:05.3420000Z https://www.medicinesresources.nhs.uk/choosing-a-calcium-and-vitamin-d-preparation-for-vegetarians-or-vegans-2.html 2021-07-07T14:16:52.7730000Z https://www.medicinesresources.nhs.uk/equivalent-doses-of-oral-benzodiazepines-1.html 2021-07-07T14:19:03.8510000Z https://www.medicinesresources.nhs.uk/effects-of-proton-pump-inhibitors-on-glycemic-control-and-incident-diabetes-a-systematic-review-and-meta-analysis.html 2021-07-07T14:20:50.0690000Z https://www.medicinesresources.nhs.uk/comparative-efficacy-and-safety-of-8-glp-1ras-in-patients-with-type-2-diabetes-a-network-meta-analysis-1.html 2021-07-07T15:16:07.0440000Z https://www.medicinesresources.nhs.uk/effect-of-antibiotic-prescribing-feedback-to-high-volume-primary-care-physicians-on-number-of-antibiotic-prescriptions-a-randomized-clinical-trial.html 2021-07-07T14:25:22.6590000Z https://www.medicinesresources.nhs.uk/diabetes-care-and-glycemic-control-during-the-covid-19-pandemic-in-the-united-states-1.html 2021-07-07T14:27:12.5310000Z https://www.medicinesresources.nhs.uk/efficacy-and-toxicity-of-pegaspargase-and-calaspargase-pegol-in-childhood-acute-lymphoblastic-leukemia-results-of-dfci-11-2.html 2021-07-07T14:29:46.1930000Z https://www.medicinesresources.nhs.uk/treatment-of-acute-pain-in-adults-with-sickle-cell-disease-in-an-infusion-center-versus-the-emergency-department-a-multicenter-prospective-cohort-study-2.html 2021-07-07T14:31:55.3580000Z https://www.medicinesresources.nhs.uk/abatacept-for-treatment-of-severe-treatment-resistant-morphoea-localised-scleroderma.html 2021-07-07T14:32:57.8060000Z https://www.medicinesresources.nhs.uk/mercaptamine-hydrochloride-viscous-eyedrops-for-corneal-cystine-deposits-in-people-aged-2-years-and-over.html 2021-07-07T14:34:32.2210000Z https://www.medicinesresources.nhs.uk/baricitinib-for-use-in-monogenic-interferonopathies-adults-and-children-2-years-and-over.html 2021-07-07T14:37:27.5640000Z https://www.medicinesresources.nhs.uk/vismodegib-for-adults-with-either-gorlin-syndrome-or-non-gorlin-syndrome-related-multiple-basal-cell-carcinomas-adults.html 2021-07-07T14:38:36.0860000Z https://www.medicinesresources.nhs.uk/manufacturers-report-positive-results-for-empagliflozin-in-heart-failure-with-preserved-ejection-fraction.html 2021-07-07T14:42:14.5460000Z https://www.medicinesresources.nhs.uk/pembrolizumab-approved-for-use-in-locally-advanced-cutaneous-scc-in-the-us.html 2021-07-07T14:45:11.3970000Z https://www.medicinesresources.nhs.uk/update-to-living-who-guideline-on-drugs-for-covid-20.html 2021-07-07T14:47:25.9870000Z https://www.medicinesresources.nhs.uk/hospital-to-pharmacy-discharge-service-saves-more-than-17-000-bed-days-in-three-months-1.html 2021-07-07T14:49:21.4950000Z https://www.medicinesresources.nhs.uk/low-pharmacy-uptake-of-pilot-postal-inhaler-recycling-scheme.html 2021-07-07T14:50:41.2830000Z https://www.medicinesresources.nhs.uk/safety-of-maternity-services-in-england.html 2021-07-07T15:26:23.7220000Z https://www.medicinesresources.nhs.uk/tackling-obesity-the-role-of-the-nhs-in-a-whole-system-approach.html 2021-07-07T14:57:21.4430000Z https://www.medicinesresources.nhs.uk/association-between-administration-of-il-6-antagonists-and-mortality-among-patients-hospitalized-for-covid-19-a-meta-analysis.html 2021-07-08T12:32:20.8090000Z https://www.medicinesresources.nhs.uk/effect-of-cytisine-vs-varenicline-on-smoking-cessation-a-randomized-clinical-trial.html 2021-07-08T09:45:31.1450000Z https://www.medicinesresources.nhs.uk/nutritional-intake-and-bone-health-1.html 2021-07-07T15:25:05.2520000Z https://www.medicinesresources.nhs.uk/revised-spc-covid-19-vaccine-biontech-pfizer-4.html 2021-07-08T16:19:52.2890000Z https://www.medicinesresources.nhs.uk/new-product-bramox-midodrine-10-mg-tablets-1.html 2021-07-08T14:39:21.8760000Z https://www.medicinesresources.nhs.uk/inrebic-r-fedratinib-100-mg-hard-capsules-potential-interaction-with-grapefruit-or-grapefruit-juice-batch-number-m0003ah-expiry-date-sept-2024.html 2021-07-08T16:27:41.9570000Z https://www.medicinesresources.nhs.uk/iloprost-100-micrograms-ml-concentrate-for-solution-for-infusion-medication-error-risk-of-underdosing-due-to-ampoule-labelling.html 2021-07-08T16:21:16.2360000Z https://www.medicinesresources.nhs.uk/covid-19-vaccines-updates-for-july-2021.html 2021-07-08T16:21:49.3080000Z https://www.medicinesresources.nhs.uk/oral-retinoid-medicines-isotretinoin-alitretinoin-and-acitretin-temporary-monitoring-advice-during-coronavirus-covid-19-pandemic.html 2021-07-08T16:22:32.8110000Z https://www.medicinesresources.nhs.uk/herbal-and-homeopathic-medicines-reminder-to-be-vigilant-for-suspected-adverse-reactions-and-to-report-them-to-the-yellow-card-scheme.html 2021-07-08T14:48:09.4750000Z https://www.medicinesresources.nhs.uk/chloramphenicol-eye-drops-containing-borax-or-boric-acid-buffers-use-in-children-younger-than-2-years-4.html 2021-07-08T14:51:17.7650000Z https://www.medicinesresources.nhs.uk/may-2021-prioritisation-decisions-1.html 2021-07-08T14:52:28.5880000Z https://www.medicinesresources.nhs.uk/extracorporeal-membrane-oxygenation-ecmo-as-abridge-to-lung-transplant-all-ages-1.html 2021-07-08T14:54:01.5470000Z https://www.medicinesresources.nhs.uk/new-medicines-news-june-2024.html 2021-07-08T15:03:10.3310000Z https://www.medicinesresources.nhs.uk/fda-assigns-priority-review-to-biologics-license-application-for-tezepelumab-as-treatment-of-patients-with-severe-uncontrolled-asthma-2.html 2021-07-08T16:23:37.2040000Z https://www.medicinesresources.nhs.uk/updated-be-tick-aware-toolkit-raising-awareness-of-the-potential-risk-posed-by-ticks-and-tick-borne-disease-in-england-1.html 2021-07-08T15:21:28.8620000Z https://www.medicinesresources.nhs.uk/hematuria-in-adults.html 2021-07-08T15:22:46.9290000Z https://www.medicinesresources.nhs.uk/fedratinib-for-treating-disease-related-splenomegaly-or-symptoms-in-myelofibrosis.html 2021-07-08T15:24:58.1990000Z https://www.medicinesresources.nhs.uk/berotralstat-for-preventing-recurrent-attacks-of-hereditary-angioedema-appraisal-consultation-document.html 2021-07-08T15:27:19.6090000Z https://www.medicinesresources.nhs.uk/clinical-strategy-for-the-diagnosis-and-treatment-of-immune-checkpoint-inhibitor-associated-myocarditis-a-narrative-review.html 2021-07-08T15:29:48.5170000Z https://www.medicinesresources.nhs.uk/react-1-study-of-coronavirus-transmission-june-2021-interim-results.html 2021-07-08T15:30:50.5120000Z https://www.medicinesresources.nhs.uk/new-cross-government-unit-to-tackle-drug-misuse-following-major-independent-review-4.html 2021-07-08T15:34:09.1920000Z https://www.medicinesresources.nhs.uk/new-pilot-to-help-people-exercise-more-and-eat-better.html 2021-07-08T15:35:12.8530000Z https://www.medicinesresources.nhs.uk/self-isolation-to-be-eased-for-fully-vaccinated-adults-in-step-4.html 2021-07-08T15:36:03.8150000Z https://www.medicinesresources.nhs.uk/incorporating-sglt2i-and-glp-1ra-for-cardiovascular-and-kidney-disease-risk-reduction-call-for-action-to-the-cardiology-community.html 2021-07-08T15:37:08.2070000Z https://www.medicinesresources.nhs.uk/diagnosis-and-management-of-myocarditis-in-children-a-scientific-statement-from-the-american-heart-association.html 2021-07-08T16:24:10.2590000Z https://www.medicinesresources.nhs.uk/the-covid-19-lab-leak-hypothesis-did-the-media-fall-victim-to-a-misinformation-campaign.html 2021-07-08T15:39:37.0200000Z https://www.medicinesresources.nhs.uk/nutritional-basis-of-type-2-diabetes-remission.html 2021-07-08T15:40:50.9440000Z https://www.medicinesresources.nhs.uk/2021-american-college-of-rheumatology-vasculitis-foundation-guideline-for-the-management-of-polyarteritis-nodosa.html 2021-07-08T15:42:43.9990000Z https://www.medicinesresources.nhs.uk/2021-american-college-of-rheumatology-vasculitis-foundation-guideline-for-the-management-of-antineutrophil-cytoplasmic-antibody-associated-vasculitis.html 2021-07-08T15:43:43.8040000Z https://www.medicinesresources.nhs.uk/2021-american-college-of-rheumatology-vasculitis-foundation-guideline-for-the-management-of-giant-cell-arteritis-and-takayasu-arteritis.html 2021-07-08T15:45:47.5980000Z https://www.medicinesresources.nhs.uk/fda-requests-further-data-in-order-to-assess-biologics-license-application-for-teplizumab-to-delay-clinical-type-1-diabetes-in-at-risk-people.html 2021-07-08T15:46:47.5840000Z https://www.medicinesresources.nhs.uk/venetoclax-venclyxto-updated-recommendations-on-tumour-lysis-syndrome-tls-in-cll-patients-1.html 2021-07-08T15:50:36.6180000Z https://www.medicinesresources.nhs.uk/efficacy-acceptability-and-safety-of-muscle-relaxants-for-adults-with-non-specific-low-back-pain-systematic-review-and-meta-analysis.html 2021-07-08T15:57:29.5030000Z https://www.medicinesresources.nhs.uk/e-cigarettes-versus-nicotine-replacement-treatment-as-harm-reduction-interventions-for-smokers-who-find-quitting-difficult-randomised-controlled-trial-2.html 2021-07-08T16:23:06.1870000Z https://www.medicinesresources.nhs.uk/performance-of-the-innova-sars-cov-2-antigen-rapid-lateral-flow-test-in-the-liverpool-asymptomatic-testing-pilot-population-based-cohort-study-1.html 2021-07-08T16:11:07.2980000Z https://www.medicinesresources.nhs.uk/impact-of-pharmacist-led-interventions-in-improving-adherence-to-glaucoma-medications-in-the-geriatric-population.html 2021-07-08T16:03:50.2010000Z https://www.medicinesresources.nhs.uk/xaluprine-20mg-ml-oral-suspension-mercaptopurine-monohydrate-interim-supply-of-ireland-stock-to-mitigate-supply-disruption-1.html 2021-07-08T16:10:46.4730000Z https://www.medicinesresources.nhs.uk/venlafaxine-hydrochloride-viepax-xl-150-mg-prolonged-release-tablets-changes-including-tablet-appearance-and-formulation.html 2021-07-08T16:49:05.4730000Z